        <description>L-glutamine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-alanine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>asparagine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to potassium ion starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>histidine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-alanine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-histidine transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter in response to acidic pH</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="13">
      <id>BE0000236</id>
      <name>Neutral amino acid transporter B(0)</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16197915</pubmed-id>
            <citation>Bungard CI, McGivan JD: Identification of the promoter elements involved in the stimulation of ASCT2 expression by glutamine availability in HepG2 cells and the probable involvement of FXR/RXR dimers. Arch Biochem Biophys. 2005 Nov 15;443(1-2):53-9. Epub 2005 Sep 15.</citation>
          </article>
          <article>
            <pubmed-id>16516348</pubmed-id>
            <citation>Gegelashvili M, Rodriguez-Kern A, Pirozhkova I, Zhang J, Sung L, Gegelashvili G: High-affinity glutamate transporter GLAST/EAAT1 regulates cell surface expression of glutamine/neutral amino acid transporter ASCT2 in human fetal astrocytes. Neurochem Int. 2006 May-Jun;48(6-7):611-5. Epub 2006 Mar 3.</citation>
          </article>
          <article>
            <pubmed-id>17046712</pubmed-id>
            <citation>Oppedisano F, Pochini L, Galluccio M, Indiveri C: The glutamine/amino acid transporter (ASCT2) reconstituted in liposomes: transport mechanism, regulation by ATP and characterization of the glutamine/glutamate antiport. Biochim Biophys Acta. 2007 Feb;1768(2):291-8. Epub 2006 Sep 16.</citation>
          </article>
          <article>
            <pubmed-id>17094966</pubmed-id>
            <citation>Dun Y, Mysona B, Itagaki S, Martin-Studdard A, Ganapathy V, Smith SB: Functional and molecular analysis of D-serine transport in retinal Muller cells. Exp Eye Res. 2007 Jan;84(1):191-9. Epub 2006 Nov 13.</citation>
          </article>
          <article>
            <pubmed-id>17127344</pubmed-id>
            <citation>McGivan JD, Bungard CI: The transport of glutamine into mammalian cells. Front Biosci. 2007 Jan 1;12:874-82.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q15758" source="Swiss-Prot">
    <name>Neutral amino acid transporter B(0)</name>
    <general-function>Virus receptor activity</general-function>
    <specific-function>Sodium-dependent amino acids transporter that has a broad substrate specificity, with a preference for zwitterionic amino acids. It accepts as substrates all neutral amino acids, including glutamine, asparagine, and branched-chain and aromatic amino acids, and excludes methylated, anionic, and cationic amino acids. May also be activated by insulin. Through binding of the fusogenic protein syncytin-1/ERVW-1 may mediate trophoblasts syncytialization, the spontaneous fusion of their plasma membranes, an essential process in placental development (PubMed:10708449, PubMed:23492904). Acts as a cell surface receptor for feline endogenous virus RD114, baboon M7 endogenous virus and type D simian retroviruses (PubMed:10051606, PubMed:10196349).</specific-function>
    <gene-name>SLC1A5</gene-name>
    <locus>19q13.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>53-73
99-119
133-153
225-245
266-286
306-326
336-356
377-397
399-419
426-446</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.14</theoretical-pi>
    <molecular-weight>56597.64</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10943</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U53347</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1478281</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>874</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q15758</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AAAT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ASCT2</synonym>
      <synonym>ATB(0)</synonym>
      <synonym>Baboon M7 virus receptor</synonym>
      <synonym>M7V1</synonym>
      <synonym>RD114/simian type D retrovirus receptor</synonym>
      <synonym>RDR</synonym>
      <synonym>RDRC</synonym>
      <synonym>Sodium-dependent neutral amino acid transporter type 2</synonym>
      <synonym>Solute carrier family 1 member 5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000471|Neutral amino acid transporter B(0)
MVADPPRDSKGLAAAEPTANGGLALASIEDQGAAAGGYCGSRDQVRRCLRANLLVLLTVV
AVVAGVALGLGVSGAGGALALGPERLSAFVFPGELLLRLLRMIILPLVVCSLIGGAASLD
PGALGRLGAWALLFFLVTTLLASALGVGLALALQPGAASAAINASVGAAGSAENAPSKEV
LDSFLDLARNIFPSNLVSAAFRSYSTTYEERNITGTRVKVPVGQEVEGMNILGLVVFAIV
FGVALRKLGPEGELLIRFFNSFNEATMVLVSWIMWYAPVGIMFLVAGKIVEMEDVGLLFA
RLGKYILCCLLGHAIHGLLVLPLIYFLFTRKNPYRFLWGIVTPLATAFGTSSSSATLPLM
MKCVEENNGVAKHISRFILPIGATVNMDGAALFQCVAAVFIAQLSQQSLDFVKIITILVT
ATASSVGAAGIPAGGVLTLAIILEAVNLPVDHISLILAVDWLVDRSCTVLNVEGDALGAG
LLQNYVDRTESRSTEPELIQVKSELPLDPLPVPTEEGNPLLKHYRGPAGDATVASEKESV
M</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010024|Neutral amino acid transporter B(0) (SLC1A5)
ATGAACATCCTGGGCTTGGTAGTGTTTGCCATCGTCTTTGGTGTGGCGCTGCGGAAGCTG
GGGCCTGAAGGGGAGCTGCTTATCCGCTTCTTCAACTCCTTCAATGAGGCCACCATGGTT
CTGGTCTCCTGGATCATGTGGTACGCCCCTGTGGGCATCATGTTCCTGGTGGCTGGCAAG
ATCGTGGAGATGGAGGATGTGGGTTTACTCTTTGCCCGCCTTGGCAAGTACATTCTGTGC
TGCCTGCTGGGTCACGCCATCCATGGGCTCCTGGTACTGCCCCTCATCTACTTCCTCTTC
ACCCGCAAAAACCCCTACCGCTTCCTGTGGGGCATCGTGACGCCGCTGGCCACTGCCTTT
GGGACCTCTTCCAGTTCCGCCACGCTGCCGCTGATGATGAAGTGCGTGGAGGAGAATAAT
GGCGTGGCCAAGCACATCAGCCGTTTCATCCTGCCCATCGGCGCCACCGTCAACATGGAC
GGTGCCGCGCTCTTCCAGTGCGTGGCCGCAGTGTTCATTGCACAGCTCAGCCAGCAGTCC
TTGGACTTCGTAAAGATCATCACCATCCTGGTCACGGCCACAGCGTCCAGCGTGGGGGCA
GCGGGCATCCCTGCTGGAGGTGTCCTCACTCTGGCCATCATCCTCGAAGCAGTCAACCTC
CCGGTCGACCATATCTCCTTGATCCTGGCTGTGGACTGGCTAGTCGACCGGTCCTGTACC
GTCCTCAATGTAGAAGGTGACGCTCTGGGGGCAGGACTCCTCCAAAATTACGTGGACCGT
ACGGAGTCGAGAAGCACAGAGCCTGAGTTGATACAAGTGAAGAGTGAGCTGCCCCTGGAT
CCGCTGCCAGTCCCCACTGAGGAAGGAAACCCCCTCCTCAAACACTATCGGGGGCCCGCA
GGGGATGCCACGGTCGCCTCTGAGAAGGAATCAGTCATGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>melanosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neutral amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>virus receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutral amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="23">
      <id>BE0000789</id>
      <name>Large neutral amino acids transporter small subunit 2</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16249471</pubmed-id>
            <citation>Umapathy NS, Li W, Mysona BA, Smith SB, Ganapathy V: Expression and function of glutamine transporters SN1 (SNAT3) and SN2 (SNAT5) in retinal Muller cells. Invest Ophthalmol Vis Sci. 2005 Nov;46(11):3980-7.</citation>
          </article>
          <article>
            <pubmed-id>16308696</pubmed-id>
            <citation>Kirchhoff P, Dave MH, Remy C, Kosiek O, Busque SM, Dufner M, Geibel JP, Verrey F, Wagner CA: An amino acid transporter involved in gastric acid secretion. Pflugers Arch. 2006 Mar;451(6):738-48. Epub 2005 Nov 25.</citation>
          </article>
          <article>
            <pubmed-id>17273864</pubmed-id>
            <citation>Ramadan T, Camargo SM, Herzog B, Bordin M, Pos KM, Verrey F: Recycling of aromatic amino acids via TAT1 allows efflux of neutral amino acids via LAT2-4F2hc exchanger. Pflugers Arch. 2007 Jun;454(3):507-16. Epub 2007 Feb 2.</citation>
          </article>
          <article>
            <pubmed-id>17504263</pubmed-id>
            <citation>Broer S, Broer A, Hansen JT, Bubb WA, Balcar VJ, Nasrallah FA, Garner B, Rae C: Alanine metabolism, transport, and cycling in the brain. J Neurochem. 2007 Sep;102(6):1758-70. Epub 2007 May 14.</citation>
          </article>
          <article>
            <pubmed-id>16785209</pubmed-id>
            <citation>Chubb S, Kingsland AL, Broer A, Broer S: Mutation of the 4F2 heavy-chain carboxy terminus causes y+ LAT2 light-chain dysfunction. Mol Membr Biol. 2006 May-Jun;23(3):255-67.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UHI5" source="Swiss-Prot">
    <name>Large neutral amino acids transporter small subunit 2</name>
    <general-function>Toxin transporter activity</general-function>
    <specific-function>Sodium-independent, high-affinity transport of small and large neutral amino acids such as alanine, serine, threonine, cysteine, phenylalanine, tyrosine, leucine, arginine and tryptophan, when associated with SLC3A2/4F2hc. Acts as an amino acid exchanger. Has higher affinity for L-phenylalanine than LAT1 but lower affinity for glutamine and serine. L-alanine is transported at physiological concentrations. Plays a role in basolateral (re)absorption of neutral amino acids. Involved in the uptake of methylmercury (MeHg) when administered as the L-cysteine or D,L-homocysteine complexes, and hence plays a role in metal ion homeostasis and toxicity. Involved in the cellular activity of small molecular weight nitrosothiols, via the stereoselective transport of L-nitrosocysteine (L-CNSO) across the transmembrane. Plays an essential role in the reabsorption of neutral amino acids from the epithelial cells to the bloodstream in the kidney.</specific-function>
    <gene-name>SLC7A8</gene-name>
    <locus>14q11.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions>40-60
72-92
113-133
155-175
189-209
231-251
268-288
310-330
362-382
388-408
424-444
447-467</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.75</theoretical-pi>
    <molecular-weight>58381.12</molecular-weight>
    <chromosome-location>14</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11066</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC7A8</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF171669</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6642960</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UHI5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>LAT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>hLAT2</synonym>
      <synonym>L-type amino acid transporter 2</synonym>
      <synonym>LAT2</synonym>
      <synonym>Solute carrier family 7 member 8</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001574|Large neutral amino acids transporter small subunit 2
MEEGARHRNNTEKKHPGGGESDASPEAGSGGGGVALKKEIGLVSACGIIVGNIIGSGIFV
SPKGVLENAGSVGLALIVWIVTGFITVVGALCYAELGVTIPKSGGDYSYVKDIFGGLAGF
LRLWIAVLVIYPTNQAVIALTFSNYVLQPLFPTCFPPESGLRLLAAICLLLLTWVNCSSV
RWATRVQDIFTAGKLLALALIIIMGIVQICKGEYFWLEPKNAFENFQEPDIGLVALAFLQ
GSFAYGGWNFLNYVTEELVDPYKNLPRAIFISIPLVTFVYVFANVAYVTAMSPQELLASN
AVAVTFGEKLLGVMAWIMPISVALSTFGGVNGSLFTSSRLFFAGAREGHLPSVLAMIHVK
RCTPIPALLFTCISTLLMLVTSDMYTLINYVGFINYLFYGVTVAGQIVLRWKKPDIPRPI
KINLLFPIIYLLFWAFLLVFSLWSEPVVCGIGLAIMLTGVPVYFLGVYWQHKPKCFSDFI
ELLTLVSQKMCVVVYPEVERGSGTEEANEDMEEQQQPMYQPTPTKDKDVAGQPQP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016208|Large neutral amino acids transporter small subunit 2 (SLC7A8)
ATGGGGCAGTATGGGCAGGAGCTTAGCTGGAAGTGTTTGGTAAAAGCTGTGTGCCTCCAG
GAGCACTCACAGCCCTCACAGCTTCTCTGCACCCTCCTCCTCTGCTGGTGTGTCCTTGGA
AGAGAGAGGCCCTTCCGGAAGGCTCAGAGCACCTCCTCTCCTTTGGAGGGGGTTCCGAGA
TTTCTAAAACGTTTGCTCCTCACATGGGTCAACTGTTCCAGTGTGCGGTGGGCCACCCGG
GTTCAAGACATCTTCACAGCTGGGAAGCTCCTGGCCTTGGCCCTGATTATCATCATGGGG
ATTGTACAGATATGCAAAGGAGAGTACTTCTGGCTGGAGCCAAAGAATGCATTTGAGAAT
TTCCAGGAACCTGACATCGGCCTCGTCGCACTGGCTTTCCTTCAGGGCTCCTTTGCCTAT
GGAGGCTGGAACTTTCTGAATTACGTGACTGAGGAGCTTGTTGATCCCTACAAGAACCTT
CCCAGAGCCATCTTCATCTCCATCCCACTGGTCACATTTGTGTATGTCTTTGCCAATGTC
GCTTATGTCACTGCAATGTCCCCCCAGGAGCTGCTGGCATCCAACGCCGTCGCTGTGACT
TTTGGAGAGAAGCTCCTAGGAGTCATGGCCTGGATCATGCCCATTTCTGTTGCCCTGTCC
ACATTTGGAGGAGTTAATGGGTCTCTCTTCACCTCCTCTCGGCTGTTCTTCGCTGGAGCC
CGAGAGGGCCACCTTCCCAGTGTGTTGGCCATGATCCACGTGAAGCGCTGCACCCCAATC
CCAGCCCTGCTCTTCACATGCATCTCCACCCTGCTGATGCTGGTCACCAGCGACATGTAC
ACACTCATCAACTATGTGGGCTTCATCAACTACCTCTTCTATGGGGTCACGGTTGCTGGA
CAGATAGTCCTTCGCTGGAAGAAGCCTGATATCCCCCGCCCCATCAAGATCAACCTGCTG
TTCCCCATCATCTACTTGCTGTTCTGGGCCTTCCTGCTGGTCTTCAGCCTGTGGTCAGAG
CCGGTGGTGTGTGGCATTGGCCTGGCCATCATGCTGACAGGAGTGCCTGTCTATTTCCTG
GGTGTTTACTGGCAACACAAGCCCAAGTGTTTCAGTGACTTCATTGAGCTGCTAACCCTG
GTGAGCCAGAAGATGTGTGTGGTCGTGTACCCCGAGGTGGAGCGGGGCTCAGGGACAGAG
GAGGCTAATGAGGACATGGAGGAGCAGCAGCAGCCCATGTACCAACCCACTCCCACGAAG
GACAAGGACGTGGCGGGGCAGCCCCAGCCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13520</identifier>
        <name>AA_permease_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neutral amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>antiporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide antigen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>toxin transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic cation transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutral amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>metal ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organic cation transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toxin transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00131</drugbank-id>
  <drugbank-id>NUTR00011</drugbank-id>
  <drugbank-id>EXPT00512</drugbank-id>
  <name>Adenosine monophosphate</name>
  <description>Adenylic acid. Adenine nucleotide containing one phosphate group esterified to the sugar moiety in the 2&amp;#39;-, 3&amp;#39;-, or 5&amp;#39;-position.</description>
  <cas-number>61-19-8</cas-number>
  <unii>415SHH325A</unii>
  <average-mass>347.2212</average-mass>
  <monoisotopic-mass>347.063084339</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Shigehiro Kataoka, Ayako Nasu, Nobuyuki Yamaji, Motohiko Kato, "Process for preparation of N.sup.6 -substituted 3',5'-cyclic adenosine monophosphate and salt thereof." U.S. Patent US4751293, issued July, 1984.</synthesis-reference>
  <indication>For nutritional supplementation, also for treating dietary shortage or imbalance</indication>
  <pharmacodynamics>Adenosine monophosphate, also known as 5'-adenylic acid and abbreviated AMP, is a nucleotide that is found in RNA. It is an ester of phosphoric acid with the nucleoside adenosine. AMP consists of the phosphate group, the pentose sugar ribose, and the nucleobase adenine. AMP is used as a dietary supplement to boost immune activity, and is also used as a substitute sweetener to aid in the maintenance of a low-calorie diet.</pharmacodynamics>
  <mechanism-of-action>Nucleotides such as Adenosine-5'-Monophosphate affect a number of immune functions, including the reversal of malnutrition and starvation-induced immunosuppression, the enhancement of T-cell maturation and function, the enhancement of natural killer cell activity, the improvement of delayed cutaneous hypersensitivity, helping resistance to such infectious agents as Staphylococcus aureus and Candida albicans, and finally the modulation of T-cell responses toward type 1 CD4 helper lymphocytes or Th1 cells. Studies have shown that mice fed a nucleotide-free diet have both impaired humoral and cellular immune responses. The addition of dietary nucleotides normalizes both types of responses. RNA, a delivery form of nucleotides, and ribonucleotides were used in these studies. The mechanism of the immune-enhancing activity of nucleic acids/nucleotides is not clear.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as purine ribonucleoside monophosphates. These are nucleotides consisting of a purine base linked to a ribose to which one monophosphate group is attached.</description>
    <direct-parent>Purine ribonucleoside monophosphates</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Nucleosides, nucleotides, and analogues</class>
    <subclass>Purine nucleotides</subclass>
    <alternative-parent>1,2-diols</alternative-parent>
    <alternative-parent>6-aminopurines</alternative-parent>
    <alternative-parent>Aminopyrimidines and derivatives</alternative-parent>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Glycosylamines</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Imidolactams</alternative-parent>
    <alternative-parent>Monoalkyl phosphates</alternative-parent>
    <alternative-parent>Monosaccharide phosphates</alternative-parent>
    <alternative-parent>N-substituted imidazoles</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Oxacyclic compounds</alternative-parent>
    <alternative-parent>Oxolanes</alternative-parent>
    <alternative-parent>Pentose phosphates</alternative-parent>
    <alternative-parent>Primary aromatic amines</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <substituent>1,2-diol</substituent>
    <substituent>6-aminopurine</substituent>
    <substituent>Alcohol</substituent>
    <substituent>Alkyl phosphate</substituent>
    <substituent>Amine</substituent>
    <substituent>Aminopyrimidine</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Azole</substituent>
    <substituent>Glycosyl compound</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Imidazole</substituent>
    <substituent>Imidazopyrimidine</substituent>
    <substituent>Imidolactam</substituent>
    <substituent>Monoalkyl phosphate</substituent>
    <substituent>Monosaccharide</substituent>
    <substituent>Monosaccharide phosphate</substituent>
    <substituent>N-glycosyl compound</substituent>
    <substituent>N-substituted imidazole</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organic phosphoric acid derivative</substituent>
    <substituent>Organoheterocyclic compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Oxacycle</substituent>
    <substituent>Oxolane</substituent>
    <substituent>Pentose monosaccharide</substituent>
    <substituent>Pentose phosphate</substituent>
    <substituent>Pentose-5-phosphate</substituent>
    <substituent>Phosphoric acid ester</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Primary aromatic amine</substituent>
    <substituent>Purine</substituent>
    <substituent>Purine ribonucleoside monophosphate</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Secondary alcohol</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">5'-Adenosine monophosphate</synonym>
    <synonym language="" coder="">5'-Adenylic acid</synonym>
    <synonym language="" coder="">5'-AMP</synonym>
    <synonym language="" coder="">5'-O-Phosphonoadenosine</synonym>
    <synonym language="" coder="">Adenosine 5'-(dihydrogen phosphate)</synonym>
    <synonym language="" coder="">Adenosine 5'-monophosphate</synonym>
    <synonym language="" coder="">Adenosine 5'-phosphate</synonym>
    <synonym language="" coder="">ADENOSINE monophosphate</synonym>
    <synonym language="" coder="INN">Adenosine phosphate</synonym>
    <synonym language="" coder="">Adenosine-5'-Monophosphate</synonym>
    <synonym language="" coder="">Adenosine-5'-monophosphoric acid</synonym>
    <synonym language="" coder="">Adenosine-5'p</synonym>
    <synonym language="" coder="">Adenosini phosphas</synonym>
    <synonym language="" coder="">Adenylate</synonym>
    <synonym language="" coder="">Adenylic acid</synonym>
    <synonym language="" coder="">Ado5'p</synonym>
    <synonym language="" coder="">AMP</synonym>
    <synonym language="" coder="">Fosfato de adenosina</synonym>
    <synonym language="" coder="">PAdo</synonym>
    <synonym language="" coder="">Phosaden</synonym>
    <synonym language="" coder="">Phosphaden</synonym>
    <synonym language="" coder="">Phosphate d'adenosine</synonym>
  </synonyms>
  <products/>
  <international-brands>
    <international-brand>
      <name>My-B-Den</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures/>
  <packagers>
    <packager>
      <name>Spectrum Pharmaceuticals</name>
      <url>http://www.spectrumpharm.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Adenosine-5 monophosphate</description>
      <cost currency="USD">19.74</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Adenine Nucleotides</category>
      <mesh-id>D000227</mesh-id>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Glycosides</category>
      <mesh-id>D006027</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds</category>
      <mesh-id>D006571</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, 2-Ring</category>
      <mesh-id>D006574</mesh-id>
    </category>
    <category>
      <category>Nucleic Acids, Nucleotides, and Nucleosides</category>
      <mesh-id>D009706</mesh-id>
    </category>
    <category>
      <category>Nucleotides</category>
      <mesh-id>D009711</mesh-id>
    </category>
    <category>
      <category>Purine Nucleotides</category>
      <mesh-id>D011685</mesh-id>
    </category>
    <category>
      <category>Purines</category>
      <mesh-id>D011687</mesh-id>
    </category>
    <category>
      <category>Ribonucleotides</category>
      <mesh-id>D012265</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>2NSY</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00131.pdf?1265922750</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>3.31e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-4.8</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>{[(2R,3S,4R,5R)-5-(6-amino-9H-purin-9-yl)-3,4-dihydroxyoxolan-2-yl]methoxy}phosphonic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>adenylate</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>347.2212</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>347.063084339</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>NC1=C2N=CN([C@@H]3O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]3O)C2=NC=N1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C10H14N5O7P</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C10H14N5O7P/c11-8-5-9(13-2-12-8)15(3-14-5)10-7(17)6(16)4(22-10)1-21-23(18,19)20/h2-4,6-7,10,16-17H,1H2,(H2,11,12,13)(H2,18,19,20)/t4-,6-,7-,10-/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>UDMBCSSLTHHNCD-KQYNXXCUSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>186.07</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>74.07</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>30</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>10</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.23</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>4.97</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>1E+004 mg/L (at 20 °C)</value>
      <source>BEILSTEIN</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>195 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.1</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>16027</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>6083</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507628</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00020</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D02769</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>5858</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>18137</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164744376</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>A</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP001319</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Adenosine_monophosphate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL752</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP00001</smpdb-id>
      <name>Citrullinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P43007</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>O75746</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00002</smpdb-id>
      <name>Carbamoyl Phosphate Synthetase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P43007</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>O75746</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00008</smpdb-id>
      <name>Phenylalanine and Tyrosine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00029</smpdb-id>
      <name>Selenoamino Acid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB02345</drugbank-id>
          <name>Selenocysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96I15</uniprot-id>
        <uniprot-id>Q99611</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q8TCB7</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>O43252</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00033</smpdb-id>
      <name>Methionine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00050</smpdb-id>
      <name>Purine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00055</smpdb-id>
      <name>Alanine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49588</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>Q5JTZ9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00067</smpdb-id>
      <name>Aspartate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02655</drugbank-id>
          <name>D-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04252</drugbank-id>
          <name>N-Carbamoyl-L-Aspartate</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P08243</uniprot-id>
        <uniprot-id>O43776</uniprot-id>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P14868</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>Q99489</uniprot-id>
        <uniprot-id>P45381</uniprot-id>
        <uniprot-id>Q8N142</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>Q7L266</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00072</smpdb-id>
      <name>Glutamate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00144</smpdb-id>
      <name>Adenosine Deaminase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00201</smpdb-id>
      <name>Methylmalonic Aciduria Due to Cobalamin-Related Disorders</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00220</smpdb-id>
      <name>Xanthine Dehydrogenase Deficiency (Xanthinuria)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00221</smpdb-id>
      <name>Methionine Adenosyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00313</smpdb-id>
      <name>Lactic Acidemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49588</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>Q5JTZ9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00334</smpdb-id>
      <name>Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB01839</drugbank-id>
          <name>Propylene glycol</name>
        </drug>
        <drug>
          <drugbank-id>DB02897</drugbank-id>
          <name>Acetylphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03066</drugbank-id>
          <name>D-Lactic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03776</drugbank-id>
          <name>Lactaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P30613</uniprot-id>
        <uniprot-id>P35558</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P23368</uniprot-id>
        <uniprot-id>Q86WU2</uniprot-id>
        <uniprot-id>Q16775</uniprot-id>
        <uniprot-id>Q04760</uniprot-id>
        <uniprot-id>Q9UBQ7</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q8WYK0</uniprot-id>
        <uniprot-id>P07311</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00341</smpdb-id>
      <name>Hypermethioninemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00363</smpdb-id>
      <name>Ornithine Aminotransferase Deficiency (OAT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00385</smpdb-id>
      <name>Homocarnosinosis</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00481</smpdb-id>
      <name>Mitochondrial Beta-Oxidation of Medium Chain Saturated Fatty Acids</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03017</drugbank-id>
          <name>Lauric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>O43772</uniprot-id>
        <uniprot-id>Q08AH1</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>P40939</uniprot-id>
        <uniprot-id>P55084</uniprot-id>
        <uniprot-id>Q16836</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00545</smpdb-id>
      <name>Trifunctional protein deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00583</drugbank-id>
          <name>L-Carnitine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03796</drugbank-id>
          <name>Palmitic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23786</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>P40939</uniprot-id>
        <uniprot-id>P55084</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>P50416</uniprot-id>
        <uniprot-id>P33121</uniprot-id>
        <uniprot-id>P28330</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q92947</uniprot-id>
        <uniprot-id>P49748</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00711</smpdb-id>
      <name>Tobramycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00684</drugbank-id>
          <name>Tobramycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00713</smpdb-id>
      <name>Arbekacin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB06696</drugbank-id>
          <name>Arbekacin</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00727</smpdb-id>
      <name>Methacycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00931</drugbank-id>
          <name>Methacycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00738</smpdb-id>
      <name>Delavirdine Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00705</drugbank-id>
          <name>Delavirdine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00740</smpdb-id>
      <name>Efavirenz Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00625</drugbank-id>
          <name>Efavirenz</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00742</smpdb-id>
      <name>Lamivudine  Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00709</drugbank-id>
          <name>Lamivudine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00747</smpdb-id>
      <name>Zidovudine Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00495</drugbank-id>
          <name>Zidovudine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00003</smpdb-id>
      <name>Argininosuccinic Aciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P43007</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>O75746</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00016</smpdb-id>
      <name>Propanoate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03688</drugbank-id>
          <name>3-Hydroxy-Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03766</drugbank-id>
          <name>Propanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>O95822</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
        <uniprot-id>Q9H6R3</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>Q9BYZ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00044</smpdb-id>
      <name>Histidine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01971</drugbank-id>
          <name>trans-urocanic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04151</drugbank-id>
          <name>4-Methyl-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96KN2</uniprot-id>
        <uniprot-id>A5YM72</uniprot-id>
        <uniprot-id>O60678</uniprot-id>
        <uniprot-id>P19113</uniprot-id>
        <uniprot-id>P50135</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>P42357</uniprot-id>
        <uniprot-id>Q96N76</uniprot-id>
        <uniprot-id>Q96NU7</uniprot-id>
        <uniprot-id>O95954</uniprot-id>
        <uniprot-id>P49590</uniprot-id>
        <uniprot-id>P12081</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>Q8N4J0</uniprot-id>
        <uniprot-id>Q96KP4</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000958</id>
      <name>Cyclic AMP-responsive element-binding protein 1</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16879221</pubmed-id>
            <citation>Ulfhammer E, Larsson P, Karlsson L, Hrafnkelsdottir T, Bokarewa M, Tarkowski A, Jern S: TNF-alpha mediated suppression of tissue type plasminogen activator expression in vascular endothelial cells is NF-kappaB- and p38 MAPK-dependent. J Thromb Haemost. 2006 Aug;4(8):1781-9.</citation>
          </article>
          <article>
            <pubmed-id>17083486</pubmed-id>
            <citation>Saha B, Singh SK, Sarkar C, Bera R, Ratha J, Tobin DJ, Bhadra R: Activation of the Mitf promoter by lipid-stimulated activation of p38-stress signalling to CREB. Pigment Cell Res. 2006 Dec;19(6):595-605.</citation>
          </article>
          <article>
            <pubmed-id>17122581</pubmed-id>
            <citation>Kozinn J, Mao L, Arora A, Yang L, Fibuch EE, Wang JQ: Inhibition of glutamatergic activation of extracellular signal-regulated protein kinases in hippocampal neurons by the intravenous anesthetic propofol. Anesthesiology. 2006 Dec;105(6):1182-91.</citation>
          </article>
          <article>
            <pubmed-id>17300755</pubmed-id>
            <citation>Perlis RH, Purcell S, Fagerness J, Cusin C, Yamaki L, Fava M, Smoller JW: Clinical and genetic dissection of anger expression and CREB1 polymorphisms in major depressive disorder. Biol Psychiatry. 2007 Sep 1;62(5):536-40. Epub 2007 Feb 14.</citation>
          </article>
          <article>
            <pubmed-id>17324065</pubmed-id>
            <citation>Brenhouse HC, Howe ML, Stellar JR: Differential activation of cAMP response element binding protein in discrete nucleus accumbens subregions during early and late cocaine sensitization. Behav Neurosci. 2007 Feb;121(1):212-7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P16220" source="Swiss-Prot">
    <name>Cyclic AMP-responsive element-binding protein 1</name>
    <general-function>Transcriptional activator activity, rna polymerase ii transcription factor binding</general-function>
    <specific-function>Phosphorylation-dependent transcription factor that stimulates transcription upon binding to the DNA cAMP response element (CRE), a sequence present in many viral and cellular promoters. Transcription activation is enhanced by the TORC coactivators which act independently of Ser-133 phosphorylation. Involved in different cellular processes including the synchronization of circadian rhythmicity and the differentiation of adipose cells.</specific-function>
    <gene-name>CREB1</gene-name>
    <locus>2q34</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.24</theoretical-pi>
    <molecular-weight>36687.86</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2345</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CREB1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>S72459</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>240429</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P16220</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CREB1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>CREB-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001907|Cyclic AMP-responsive element-binding protein 1
MTMESGAENQQSGDAAVTEAENQQMTVQAQPQIATLAQVSMPAAHATSSAPTVTLVQLPN
GQTVQVHGVIQAAQPSVIQSPQVQTVQSSCKDLKRLFSGTQISTIAESEDSQESVDSVTD
SQKRREILSRRPSYRKILNDLSSDAPGVPRIEEEKSEEETSAPAITTVTVPTPIYQTSSG
QYIAITQGGAIQLANNGTDGVQGLQTLTMTNAAATQPGTTILQYAQTTDGQQILVPSNQV
VVQAASGDVQTYQIRTAPTSTIAPGVVMASSPALPTQPAEEAARKREVRLMKNREAAREC
RRKKKEYVKCLENRVAVLENQNKTLIEELKALKDLYCHKSD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021836|Cyclic AMP-responsive element-binding protein 1 (CREB1)
ATGACCATGGAATCTGGAGCCGAGAACCAGCAGAGTGGAGATGCAGCTGTAACAGAAGCT
GAAAACCAACAAATGACAGTTCAAGCCCAGCCACAGATTGCCACATTAGCCCAGGTATCT
ATGCCAGCAGCTCATGCAACATCATCTGCTCCCACCGTAACTCTAGTACAGCTGCCCAAT
GGGCAGACAGTTCAAGTCCATGGAGTCATTCAGGCGGCCCAGCCATCAGTTATTCAGTCT
CCACAAGTCCAAACAGTTCAGATTTCAACTATTGCAGAAAGTGAAGATTCACAGGAGTCA
GTGGATAGTGTAACTGATTCCCAAAAGCGAAGGGAAATTCTTTCAAGGAGGCCTTCCTAC
AGGAAAATTTTGAATGACTTATCTTCTGATGCACCAGGAGTGCCAAGGATTGAAGAAGAG
AAGTCTGAAGAGGAGACTTCAGCACCTGCCATCACCACTGTAACGGTGCCAACTCCAATT
TACCAAACTAGCAGTGGACAGTATATTGCCATTACCCAGGGAGGAGCAATACAGCTGGCT
AACAATGGTACCGATGGGGTACAGGGCCTGCAAACATTAACCATGACCAATGCAGCAGCC
ACTCAGCCGGGTACTACCATTCTACAGTATGCACAGACCACTGATGGACAGCAGATCTTA
GTGCCCAGCAACCAAGTTGTTGTTCAAGCTGCCTCTGGAGACGTACAAACATACCAGATT
CGCACAGCACCCACTAGCACTATTGCCCCTGGAGTTGTTATGGCATCCTCCCCAGCACTT
CCTACACAGCCTGCTGAAGAAGCAGCACGAAAGAGAGAGGTCCGTCTAATGAAGAACAGG
GAAGCAGCTCGAGAGTGTCGTAGAAAGAAGAAAGAATATGTGAAATGTTTAGAAAACAGA
GTGGCAGTGCTTGAAAATCAAAACAAGACATTGATTGAGGAGCTAAAAGCACTTAAGGAC
CTTTACTGCCACAAATCAGATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00170</identifier>
        <name>bZIP_1</name>
      </pfam>
      <pfam>
        <identifier>PF02173</identifier>
        <name>pKID</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>ATF4-CREB1 transcription factor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear euchromatin</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II distal enhancer sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription cofactor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II activating transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cAMP response element binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 4 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of hormone secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phosphatidylinositol-mediated signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucagon</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 5 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription by competitive promoter binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 9 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lung saccule development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transforming growth factor beta receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>secretory granule organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of osteoclast differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor TLR1</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of RNA polymerase II transcriptional preinitiation complex assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Type I pneumocyte differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MyD88-dependent toll-like receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor TLR6</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Notch signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cell size</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MyD88-independent toll-like receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>TRIF-dependent toll-like receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pituitary gland development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>stress-activated MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of multicellular organism growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transforming growth factor beta3 production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 10 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>viral process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 2 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to zinc ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein stabilization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>toll-like receptor 3 signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of phospholipase C activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of lipid biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0004796</id>
      <name>DNA</name>
      <organism>Human</organism>
      <actions>
        <action>component of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>17932499</pubmed-id>
            <citation>Kostylina G, Simon D, Fey MF, Yousefi S, Simon HU: Neutrophil apoptosis mediated by nicotinic acid receptors (GPR109A). Cell Death Differ. 2008 Jan;15(1):134-42. Epub 2007 Oct 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
    </target>
    <target>
      <id>BE0001277</id>
      <name>Serine/threonine-protein kinase pim-1</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P11309" source="Swiss-Prot">
    <name>Serine/threonine-protein kinase pim-1</name>
    <general-function>Transcription factor binding</general-function>
    <specific-function>Proto-oncogene with serine/threonine kinase activity involved in cell survival and cell proliferation and thus providing a selective advantage in tumorigenesis. Exerts its oncogenic activity through: the regulation of MYC transcriptional activity, the regulation of cell cycle progression and by phosphorylation and inhibition of proapoptotic proteins (BAD, MAP3K5, FOXO3). Phosphorylation of MYC leads to an increase of MYC protein stability and thereby an increase of transcriptional activity. The stabilization of MYC exerted by PIM1 might explain partly the strong synergism between these two oncogenes in tumorigenesis. Mediates survival signaling through phosphorylation of BAD, which induces release of the anti-apoptotic protein Bcl-X(L)/BCL2L1. Phosphorylation of MAP3K5, an other proapoptotic protein, by PIM1, significantly decreases MAP3K5 kinase activity and inhibits MAP3K5-mediated phosphorylation of JNK and JNK/p38MAPK subsequently reducing caspase-3 activation and cell apoptosis. Stimulates cell cycle progression at the G1-S and G2-M transitions by phosphorylation of CDC25A and CDC25C. Phosphorylation of CDKN1A, a regulator of cell cycle progression at G1, results in the relocation of CDKN1A to the cytoplasm and enhanced CDKN1A protein stability. Promote cell cycle progression and tumorigenesis by down-regulating expression of a regulator of cell cycle progression, CDKN1B, at both transcriptional and post-translational levels. Phosphorylation of CDKN1B,induces 14-3-3-proteins binding, nuclear export and proteasome-dependent degradation. May affect the structure or silencing of chromatin by phosphorylating HP1 gamma/CBX3. Acts also as a regulator of homing and migration of bone marrow cells involving functional interaction with the CXCL12-CXCR4 signaling axis.</specific-function>
    <gene-name>PIM1</gene-name>
    <locus>6p21.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.01</theoretical-pi>
    <molecular-weight>45411.905</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8986</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PIM1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M27903</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>387022</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>2158</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P11309</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PIM1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.11.1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002541|Serine/threonine-protein kinase pim-1
MPHEPHEPLTPPFSALPDPAGAPSRRQSRQRPQLSSDSPSAFRASRSHSRNATRSHSHSH
SPRHSLRHSPGSGSCGSSSGHRPCADILEVGMLLSKINSLAHLRAAPCNDLHATKLAPGK
EKEPLESQYQVGPLLGSGGFGSVYSGIRVSDNLPVAIKHVEKDRISDWGELPNGTRVPME
VVLLKKVSSGFSGVIRLLDWFERPDSFVLILERPEPVQDLFDFITERGALQEELARSFFW
QVLEAVRHCHNCGVLHRDIKDENILIDLNRGELKLIDFGSGALLKDTVYTDFDGTRVYSP
PEWIRYHRYHGRSAAVWSLGILLYDMVCGDIPFEHDEEIIRGQVFFRQRVSSECQHLIRW
CLALRPSDRPTFEEIQNHPWMQDVLLPQETAEIHLHSLSPGPSK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010889|Serine/threonine-protein kinase pim-1 (PIM1)
CTGCCGCACGAGCCCCACGAGCCGCTCACCCCGCCGTTCTCAGCGCTGCCCGACCCCGCT
GGCGCGCCCTCCCGCCGCCAGTCCCGGCAGCGCCCTCAGTTGTCCTCCGACTCGCCCTCG
GCCTTCCGCGCCAGCCGCAGCCACAGCCGCAACGCCACCCGCAGCCACAGCCACAGCCAC
AGCCCCAGGCATAGCCTTCGGCACAGCCCCGGCTCCGGCTCCTGCGGCAGCTCCTCTGGG
CACCGTCCCTGCGCCGACATCCTGGAGGTTGGGATGCTCTTGTCCAAAATCAACTCGCTT
GCCCACCTGCGCGCCGCGCCCTGCAACGACCTGCACGCCACCAAGCTGGCGCCCGGCAAG
GAGAAGGAGCCCCTGGAGTCGCAGTACCAGGTGGGCCCGCTACTGGGCAGCGGCGGCTTC
GGCTCGGTCTACTCAGGCATCCGCGTCTCCGACAACTTGCCGGTGGCCATCAAACACGTG
GAGAAGGACCGGATTTCCGACTGGGGAGAGCTGCCTAATGGCACTCGAGTGCCCATGGAA
GTGGTCCTGCTGAAGAAGGTGAGCTCGGGTTTCTCCGGCGTCATTAGGCTCCTGGACTGG
TTCGAGAGGCCCGACAGTTTCGTCCTGATCCTGGAGAGGCCCGAGCCGGTGCAAGATCTC
TTCGACTTCATCACGGAAAGGGGAGCCCTGCAAGAGGAGCTGGCCCGCAGCTTCTTCTGG
CAGGTGCTGGAGGCCGTGCGGCACTGCCACAACTGCGGGGTGCTCCACCGCGACATCAAG
GACGAAAACATCCTTATCGACCTCAATCGCGGCGAGCTCAAGCTCATCGACTTCGGGTCG
GGGGCGCTGCTCAAGGACACCGTCTACACGGACTTCGATGGGACCCGAGTGTATAGCCCT
CCAGAGTGGATCCGCTACCATCGCTACCATGGCAGGTCGGCGGCAGTCTGGTCCCTGGGG
ATCCTGCTGTATGATATGGTGTGTGGAGATATTCCTTTCGAGCATGACGAAGAGATCATC
AGGGGCCAGGTTTTCTTCAGGCAGAGGGTCTCTTCAGAATGTCAGCATCTCATTAGATGG
TGCTTGGCCCTGAGACCATCAGATAGGCCAACCTTCGAAGAAATCCAGAACCATCCATGG
ATGCAAGATGTTCTCCTGCCCCAGGAAACTGCTGAGATCCACCTCCACAGCCTGTCGCCG
GGGCCCAGCAAATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00069</identifier>
        <name>Pkinase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein serine/threonine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>manganese ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ribosomal small subunit binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of mitotic cell cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein autophosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of sequence-specific DNA binding transcription factor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hyaluronan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition of mitotic cell cycle</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000487</id>
      <name>cAMP-specific 3',5'-cyclic phosphodiesterase 4B</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17333137</pubmed-id>
            <citation>Siuciak JA, Chapin DS, McCarthy SA, Martin AN: Antipsychotic profile of rolipram: efficacy in rats and reduced sensitivity in mice deficient in the phosphodiesterase-4B (PDE4B) enzyme. Psychopharmacology (Berl). 2007 Jun;192(3):415-24. Epub 2007 Mar 2.</citation>
          </article>
          <article>
            <pubmed-id>16843095</pubmed-id>
            <citation>Porteous DJ, Thomson P, Brandon NJ, Millar JK: The genetics and biology of DISC1--an emerging role in psychosis and cognition. Biol Psychiatry. 2006 Jul 15;60(2):123-31.</citation>
          </article>
          <article>
            <pubmed-id>17088426</pubmed-id>
            <citation>Terrin A, Di Benedetto G, Pertegato V, Cheung YF, Baillie G, Lynch MJ, Elvassore N, Prinz A, Herberg FW, Houslay MD, Zaccolo M: PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol. 2006 Nov 6;175(3):441-51.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q07343" source="Swiss-Prot">
    <name>cAMP-specific 3',5'-cyclic phosphodiesterase 4B</name>
    <general-function>Metal ion binding</general-function>
    <specific-function>Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes. May be involved in mediating central nervous system effects of therapeutic agents ranging from antidepressants to antiasthmatic and anti-inflammatory agents.</specific-function>
    <gene-name>PDE4B</gene-name>
    <locus>1p31</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>4.89</theoretical-pi>
    <molecular-weight>83342.695</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8781</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PDE4B</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L20966</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>347122</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1301</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q07343</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PDE4B_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.4.53</synonym>
      <synonym>DPDE4</synonym>
      <synonym>PDE32</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000972|cAMP-specific 3',5'-cyclic phosphodiesterase 4B
MKKSRSVMTVMADDNVKDYFECSLSKSYSSSSNTLGIDLWRGRRCCSGNLQLPPLSQRQS
ERARTPEGDGISRPTTLPLTTLPSIAITTVSQECFDVENGPSPGRSPLDPQASSSAGLVL
HATFPGHSQRRESFLYRSDSDYDLSPKAMSRNSSLPSEQHGDDLIVTPFAQVLASLRSVR
NNFTILTNLHGTSNKRSPAASQPPVSRVNPQEESYQKLAMETLEELDWCLDQLETIQTYR
SVSEMASNKFKRMLNRELTHLSEMSRSGNQVSEYISNTFLDKQNDVEIPSPTQKDREKKK
KQQLMTQISGVKKLMHSSSLNNTSISRFGVNTENEDHLAKELEDLNKWGLNIFNVAGYSH
NRPLTCIMYAIFQERDLLKTFRISSDTFITYMMTLEDHYHSDVAYHNSLHAADVAQSTHV
LLSTPALDAVFTDLEILAAIFAAAIHDVDHPGVSNQFLINTNSELALMYNDESVLENHHL
AVGFKLLQEEHCDIFMNLTKKQRQTLRKMVIDMVLATDMSKHMSLLADLKTMVETKKVTS
SGVLLLDNYTDRIQVLRNMVHCADLSNPTKSLELYRQWTDRIMEEFFQQGDKERERGMEI
SPMCDKHTASVEKSQVGFIDYIVHPLWETWADLVQPDAQDILDTLEDNRNWYQSMIPQSP
SPPLDEQNRDCQGLMEKFQFELTLDEEDSEGPEKEGEGHSYFSSTKTLCVIDPENRDSLG
ETDIDIATEDKSPVDT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016107|cAMP-specific 3',5'-cyclic phosphodiesterase 4B (PDE4B)
ATGAAGGAGCACGGGGGCACCTTCAGTAGCACCGGAATCAGCGGTGGTAGCGGTGACTCT
GCTATGGACAGCCTGCAGCCGCTCCAGCCTAACTACATGCCTGTGTGTTTGTTTGCAGAA
GAATCTTATCAAAAATTAGCAATGGAAACGCTGGAGGAATTAGACTGGTGTTTAGACCAG
CTAGAGACCATACAGACCTACCGGTCTGTCAGTGAGATGGCTTCTAACAAGTTCAAAAGA
ATGCTGAACCGGGAGCTGACACACCTCTCAGAGATGAGCCGATCAGGGAACCAGGTGTCT
GAATACATTTCAAATACTTTCTTAGACAAGCAGAATGATGTGGAGATCCCATCTCCTACC
CAGAAAGACAGGGAGAAAAAGAAAAAGCAGCAGCTCATGACCCAGATAAGTGGAGTGAAG
AAATTAATGCATAGTTCAAGCCTAAACAATACAAGCATCTCACGCTTTGGAGTCAACACT
GAAAATGAAGATCACCTGGCCAAGGAGCTGGAAGACCTGAACAAATGGGGTCTTAACATC
TTTAATGTGGCTGGATATTCTCACAATAGACCCCTAACATGCATCATGTATGCTATATTC
CAGGAAAGAGACCTCCTAAAGACATTCAGAATCTCATCTGACACATTTATAACCTACATG
ATGACTTTAGAAGACCATTACCATTCTGACGTGGCATATCACAACAGCCTGCACGCTGCT
GATGTAGCCCAGTCGACCCATGTTCTCCTTTCTACACCAGCATTAGACGCTGTCTTCACA
GATTTGGAGATCCTGGCTGCCATTTTTGCAGCTGCCATCCATGACGTTGATCATCCTGGA
GTCTCCAATCAGTTTCTCATCAACACAAATTCAGAACTTGCTTTGATGTATAATGATGAA
TCTGTGTTGGAAAATCATCACCTTGCTGTGGGTTTCAAACTGCTGCAAGAAGAACACTGT
GACATCTTCATGAATCTCACCAAGAAGCAGCGTCAGACACTCAGGAAGATGGTTATTGAC
ATGGTGTTAGCAACTGATATGTCTAAACATATGAGCCTGCTGGCAGACCTGAAGACAATG
GTAGAAACGAAGAAAGTTACAAGTTCAGGCGTTCTTCTCCTAGACAACTATACCGATCGC
ATTCAGGTCCTTCGCAACATGGTACACTGTGCAGACCTGAGCAACCCCACCAAGTCCTTG
GAATTGTATCGGCAATGGACAGACCGCATCATGGAGGAATTTTTCCAGCAGGGAGACAAA
GAGCGGGAGAGGGGAATGGAAATTAGCCCAATGTGTGATAAACACACAGCTTCTGTGGAA
AAATCCCAGGTTGGTTTCATCGACTACATTGTCCATCCATTGTGGGAGACATGGGCAGAT
TTGGTACAGCCTGATGCTCAGGACATTCTCGATACCTTAGAAGATAACAGGAACTGGTAT
CAGAGCATGATACCTCAAAGTCCCTCACCACCACTGGACGAGCAGAACAGGGACTGCCAG
GGTCTGATGGAGAAGTTTCAGTTTGAACTGACTCTCGATGAGGAAGATTCTGAAGGACCT
GAGAAGGAGGGAGAGGGACACAGCTATTTCAGCAGCACAAAGACGCTTTGTGTGATTGAT
CCAGAAAACAGAGATTCCCTGGGAGAGACTGACATAGACATTGCAACAGAAGACAAGTCC
CCCGTGGATACATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00233</identifier>
        <name>PDEase_I</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Z disc</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>centrosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>excitatory synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell periphery</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>gamma-tubulin complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3',5'-cyclic-AMP phosphodiesterase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ion channel binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cAMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cAMP catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle cell contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of interferon-gamma production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>T cell receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to epinephrine stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of relaxation of cardiac muscle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutrophil homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of high voltage-gated calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutrophil chemotaxis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of interleukin-2 production</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000007</id>
      <name>Glycogen phosphorylase, liver form</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P06737" source="Swiss-Prot">
    <name>Glycogen phosphorylase, liver form</name>
    <general-function>Vitamin binding</general-function>
    <specific-function>Phosphorylase is an important allosteric enzyme in carbohydrate metabolism. Enzymes from different sources differ in their regulatory mechanisms and in their natural substrates. However, all known phosphorylases share catalytic and structural properties.</specific-function>
    <gene-name>PYGL</gene-name>
    <locus>14q21-q22</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.17</theoretical-pi>
    <molecular-weight>97147.82</molecular-weight>
    <chromosome-location>14</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9725</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PYGL</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M14636</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183353</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P06737</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PYGL_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.1.1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037666|Glycogen phosphorylase, liver form
MAKPLTDQEKRRQISIRGIVGVENVAELKKSFNRHLHFTLVKDRNVATTRDYYFALAHTV
RDHLVGRWIRTQQHYYDKCPKRVYYLSLEFYMGRTLQNTMINLGLQNACDEAIYQLGLDI
EELEEIEEDAGLGNGGLGRLAACFLDSMATLGLAAYGYGIRYEYGIFNQKIRDGWQVEEA
DDWLRYGNPWEKSRPEFMLPVHFYGKVEHTNTGTKWIDTQVVLALPYDTPVPGYMNNTVN
TMRLWSARAPNDFNLRDFNVGDYIQAVLDRNLAENISRVLYPNDNFFEGKELRLKQEYFV
VAATLQDIIRRFKASKFGSTRGAGTVFDAFPDQVAIQLNDTHPALAIPELMRIFVDIEKL
PWSKAWELTQKTFAYTNHTVLPEALERWPVDLVEKLLPRHLEIIYEINQKHLDRIVALFP
KDVDRLRRMSLIEEEGSKRINMAHLCIVGSHAVNGVAKIHSDIVKTKVFKDFSELEPDKF
QNKTNGITPRRWLLLCNPGLAELIAEKIGEDYVKDLSQLTKLHSFLGDDVFLRELAKVKQ
ENKLKFSQFLETEYKVKINPSSMFDVQVKRIHEYKRQLLNCLHVITMYNRIKKDPKKLFV
PRTVIIGGKAAPGYHMAKMIIKLITSVADVVNNDPMVGSKLKVIFLENYRVSLAEKVIPA
TDLSEQISTAGTEASGTGNMKFMLNGALTIGTMDGANVEMAEEAGEENLFIFGMRIDDVA
ALDKKGYEAKEYYEALPELKLVIDQIDNGFFSPKQPDLFKDIINMLFYHDRFKVFADYEA
YVKCQDKVSQLYMNPKAWNTMVLKNIAASGKFSSDRTIKEYAQNIWNVEPSDLKISLSNE
SNKVNGN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0009869|Glycogen phosphorylase, liver form (PYGL)
ATGGCGAAGCCCCTGACGGACCAGGAGAAGCGGCGGCAGATCAGCATCCGCGGCATCGTG
GGCGTGGAGAACGTGGCAGAGCTGAAGAAGAGTTTCAACCGGCACCTGCACTTCACGCTG
GTCAAGGACCGCAACGTGGCCACCACCCGCGACTACTACTTCGCGCTGGCGCACACGGTG
CGCGACCACCTGGTGGGGCGCTGGATCCGCACGCAGCAGCACTACTACGACAAGTGCCCC
AAGCTTGGATTGGATATAGAAGAGTTAGAAGAAATTGAAGAAGATGCTGGACTTGGCAAT
GGTGGTCTTGGGAGACTTGCTGCCTGCTTCTTGGATTCCATGGCAACCCTGGGACTTGCA
GCCTATGGATACGGCATTCGGTATGAATATGGGATTTTCAATCAGAAGATCCGAGATGGA
TGGCAGGTAGAAGAAGCAGATGATTGGCTCAGATATGGAAACCCTTGGGAGAAGTCCCGC
CCAGAATTCATGCTGCCTGTGCACTTCTATGGAAAAGTAGAACACACCAACACCGGGACC
AAGTGGATTGACACTCAAGTGGTCCTGGCTCTGCCATATGACACCCCCGTGCCCGGCTAC
ATGAATAACACTGTCAACACCATGCGCCTCTGGTCTGCTCGGGCACCAAATGACTTTAAC
CTCAGAGACTTTAATGTTGGAGACTACATTCAGGCTGTGCTGGACCGAAACCTGGCCGAG
AACATCTCCCGGGTCCTCTATCCCAATGACAATTTTTTTGAAGGGAAGGAGCTAAGATTG
AAGCAGGAATACTTTGTGGTGGCTGCAACCTTGCAAGATATCATCCGCCGTTTCAAAGCC
TCCAAGTTTGGCTCCACCCGTGGTGCAGGAACTGTGTTTGATGCCTTCCCGGATCAGGTG
GCCATCCAGCTGAATGACACTCACCCTGCACTCGCGATCCCTGAGCTGATGAGGATTTTT
GTGGATATTGAAAAACTGCCCTGGTCCAAGGCATGGGAGCTCACCCAGAAGACCTTCGCC
TACACCAACCACACAGTGCTCCCGGAAGCCCTGGAGCGCTGGCCCGTGGACCTGGTGGAG
AAGCTGCTCCCTCGACATTTGGAAATCATTTATGAGATAAATCAGAAGCATTTAGATAGA
ATTGTGGCCTTGTTTCCTAAAGATGTGGACCGTCTGAGAAGGATGTCTCTGATAGAAGAG
GAAGGAAGCAAAAGGATCAACATGGCCCATCTCTGCATTGTCGGTTCCCATGCTGTGAAT
GGCGTGGCTAAAATCCACTCAGACATCGTGAAGACTAAAGTATTCAAGGACTTCAGTGAG
CTAGAACCTGACAAGTTTCAGAATAAAACCAATGGGATCACTCCAAGGCGCTGGCTCCTA
CTCTGCAACCCAGGACTTGCAGAGCTCATAGCAGAGAAAATTGGAGAAGACTATGTGAAA
GACCTGAGCCAGCTGACGAAGCTCCACAGCTTCCTGGGTGATGATGTCTTCCTCCGGGAA
CTCGCCAAGGTGAAGCAGGAGAATAAGCTGAAGTTTTCTCAGTTCCTGGAGACGGAGTAC
AAAGTGAAGATCAACCCATCCTCCATGTTTGATGTCCAGGTGAAGAGGATACATGAGTAC
AAGCGACAGCTCTTGAACTGTCTGCATGTGATCACGATGTACAACCGCATTAAGAAAGAC
CCTAAGAAGTTATTCGTGCCAAGGACAGTTATCATTGGTGGTAAAGCTGCCCCAGGATAT
CACATGGCCAAAATGATCATAAAGCTGATCACTTCAGTGGCAGATGTGGTGAACAATGAC
CCTATGGTTGGAAGCAAGTTGAAAGTCATCTTCTTGGAGAACTACAGAGTATCTCTTGCT
GAAAAAGTCATTCCAGCCACAGATCTGTCAGAGCAGATTTCCACTGCAGGCACCGAAGCC
TCGGGGACAGGCAATATGAAGTTCATGCTAAATGGGGCCCTAACTATCGGGACCATGGAT
GGGGCCAATGTGGAAATGGCAGAAGAAGCTGGGGAAGAGAACCTGTTCATCTTTGGCATG
AGGATAGATGATGTGGCTGCTTTGGACAAGAAAGGGTACGAGGCAAAAGAATACTATGAG
GCACTTCCAGAGCTGAAGCTGGTCATTGATCAAATTGACAATGGCTTTTTTTCTCCCAAG
CAGCCTGACCTCTTCAAAGATATCATCAACATGCTATTTTATCATGACAGGTTTAAAGTC
TTTGCAGACTACGAAGCCTATGTCAAGTGTCAAGATAAAGTGAGTCAGCTGTACATGAAT
CCAAAGGCCTGGAACACAATGGTACTCAAAAACATAGCTGCCTCGGGGAAATTCTCCAGT
GACCGAACAATTAAAGAATATGCCCAAAACATCTGGAACGTGGAACCTTCAGATCTAAAG
ATTTCTCTATCCAATGAATCTAACAAAGTCAATGGAAATTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00343</identifier>
        <name>Phosphorylase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glucose binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycogen phosphorylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>purine nucleobase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>bile acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>5-phosphoribose 1-diphosphate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycogen catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycogen metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>necroptotic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000254</id>
      <name>5'-AMP-activated protein kinase subunit beta-1</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16513051</pubmed-id>
            <citation>Richter EA, Kiens B, Wojtaszewski JF: [5'-adenosine monophosphate-activated protein kinase and lifestyle-mediated diseases]. Ugeskr Laeger. 2006 Feb 27;168(9):896-900.</citation>
          </article>
          <article>
            <pubmed-id>16518831</pubmed-id>
            <citation>Neurath KM, Keough MP, Mikkelsen T, Claffey KP: AMP-dependent protein kinase alpha 2 isoform promotes hypoxia-induced VEGF expression in human glioblastoma. Glia. 2006 May;53(7):733-43.</citation>
          </article>
          <article>
            <pubmed-id>16620308</pubmed-id>
            <citation>McGee SL, Hargreaves M: Exercise and skeletal muscle glucose transporter 4 expression: molecular mechanisms. Clin Exp Pharmacol Physiol. 2006 Apr;33(4):395-9.</citation>
          </article>
          <article>
            <pubmed-id>16634986</pubmed-id>
            <citation>Whitehead JP, Richards AA, Hickman IJ, Macdonald GA, Prins JB: Adiponectin--a key adipokine in the metabolic syndrome. Diabetes Obes Metab. 2006 May;8(3):264-80.</citation>
          </article>
          <article>
            <pubmed-id>16642960</pubmed-id>
            <citation>Ruderman NB, Saha AK: Metabolic syndrome: adenosine monophosphate-activated protein kinase and malonyl coenzyme A. Obesity (Silver Spring). 2006 Feb;14 Suppl 1:25S-33S.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y478" source="Swiss-Prot">
    <name>5'-AMP-activated protein kinase subunit beta-1</name>
    <general-function>Protein kinase activity</general-function>
    <specific-function>Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3).</specific-function>
    <gene-name>PRKAB1</gene-name>
    <locus>12q24.1</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.37</theoretical-pi>
    <molecular-weight>30382.085</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9378</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PRKAB1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ224515</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2916800</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1543</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y478</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AAKB1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPK</synonym>
      <synonym>AMPK subunit beta-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036980|5'-AMP-activated protein kinase subunit beta-1
MGNTSSERAALERHGGHKTPRRDSSGGTKDGDRPKILMDSPEDADLFHSEEIKAPEKEEF
LAWQHDLEVNDKAPAQARPTVFRWTGGGKEVYLSGSFNNWSKLPLTRSHNNFVAILDLPE
GEHQYKFFVDGQWTHDPSEPIVTSQLGTVNNIIQVKKTDFEVFDALMVDSQKCSDVSELS
SSPPGPYHQEPYVCKPEERFRAPPILPPHLLQVILNKDTGISCDPALLPEPNHVMLNHLY
ALSIKDGVMVLSATHRYKKKYVTTLLYKPI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010037|5'-AMP-activated protein kinase subunit beta-1 (PRKAB1)
ATGGGCAATACCAGCAGTGAGCGCGCCGCGCTGGAGCGGCATGGTGGCCATAAGACGCCC
CGGAGGGACAGCTCGGGGGGCACCAAGGACGGGGACAGGCCCAAGATCCTGATGGACAGC
CCCGAAGACGCCGACCTCTTCCACTCCGAGGAAATCAAGGCACCAGAGAAGGAGGAATTC
CTGGCCTGGCAGCATGATCTGGAAGTGAATGATAAAGCTCCCGCCCAGGCTCGGCCAACG
GTGTTTCGATGGACGGGGGGCGGAAAGGAAGTTTACTTATCTGGGTCCTTCAACAACTGG
AGTAAACTTCCCCTCACCAGAAGCCACAATAACTTTGTAGCCATCCTGGATCTGCCGGAA
GGAGAGCATCAGTACAAGTTCTTTGTGGATGGTCAGTGGACGCACGACCCTTCCGAGCCC
ATAGTAACCAGCCAGCTTGGCACAGTTAACAACATCATTCAAGTGAAGAAAACTGACTTT
GAAGTATTTGATGCTTTAATGGTGGATTCCCAAAAGTGCTCCGATGTGTCTGAGCTGTCC
AGTTCTCCCCCAGGACCCTACCATCAGGAGCCCTACGTCTGCAAACCCGAAGAGCGCTTT
CGGGCACCCCCTATTCTCCCCCCACATCTCCTCCAGGTCATCCTGAACAAGGACACGGGG
ATTTCCTGTGATCCAGCTTTGCTTCCTGAGCCCAATCACGTCATGCTGAACCACCTATAC
GCGCTGTCTATCAAGGATGGAGTGATGGTGCTCAGCGCAACCCACCGGTACAAGAAGAAG
TACGTCACCACCTTGTTATACAAGCCCATATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04739</identifier>
        <name>AMPKBI</name>
      </pfam>
      <pfam>
        <identifier>PF16561</identifier>
        <name>AMPK1_CBM</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleotide-activated protein kinase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP-activated protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organelle organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrion organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell cycle arrest</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>macroautophagy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein heterooligomerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane organization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001473</id>
      <name>Histidine triad nucleotide-binding protein 1</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17337452</pubmed-id>
            <citation>Chou TF, Tikh IB, Horta BA, Ghosh B, De Alencastro RB, Wagner CR: Engineered monomeric human histidine triad nucleotide-binding protein 1 hydrolyzes fluorogenic acyl-adenylate and lysyl-tRNA synthetase-generated lysyl-adenylate. J Biol Chem. 2007 May 18;282(20):15137-47. Epub 2007 Mar 2.</citation>
          </article>
          <article>
            <pubmed-id>17158446</pubmed-id>
            <citation>Chou TF, Wagner CR: Lysyl-tRNA synthetase-generated lysyl-adenylate is a substrate for histidine triad nucleotide binding proteins. J Biol Chem. 2007 Feb 16;282(7):4719-27. Epub 2006 Dec 8.</citation>
          </article>
          <article>
            <pubmed-id>17217311</pubmed-id>
            <citation>Chou TF, Baraniak J, Kaczmarek R, Zhou X, Cheng J, Ghosh B, Wagner CR: Phosphoramidate pronucleotides: a comparison of the phosphoramidase substrate specificity of human and Escherichia coli histidine triad nucleotide binding proteins. Mol Pharm. 2007 Mar-Apr;4(2):208-17. Epub 2007 Jan 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P49773" source="Swiss-Prot">
    <name>Histidine triad nucleotide-binding protein 1</name>
    <general-function>Protein kinase c binding</general-function>
    <specific-function>Hydrolyzes purine nucleotide phosphoramidates with a single phosphate group, including adenosine 5'monophosphoramidate (AMP-NH2), adenosine 5'monophosphomorpholidate (AMP-morpholidate) and guanosine 5'monophosphomorpholidate (GMP-morpholidate). Hydrolyzes lysyl-AMP (AMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) generated by lysine tRNA ligase, as well as Met-AMP, His-AMP and Asp-AMP, lysyl-GMP (GMP-N-epsilon-(N-alpha-acetyl lysine methyl ester)) and AMP-N-alanine methyl ester. Can also convert adenosine 5'-O-phosphorothioate and guanosine 5'-O-phosphorothioate to the corresponding nucleoside 5'-O-phosphates with concomitant release of hydrogen sulfide. In addition, functions as scaffolding protein that modulates transcriptional activation by the LEF1/TCF1-CTNNB1 complex and by the complex formed with MITF and CTNNB1. Modulates p53/TP53 levels and p53/TP53-mediated apoptosis. Modulates proteasomal degradation of target proteins by the SCF (SKP2-CUL1-F-box protein) E3 ubiquitin-protein ligase complex.</specific-function>
    <gene-name>HINT1</gene-name>
    <locus>5q31.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.96</theoretical-pi>
    <molecular-weight>13801.815</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4912</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>HINT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U27143</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>862933</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P49773</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>HINT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.-.-.-</synonym>
      <synonym>Adenosine 5'-monophosphoramidase</synonym>
      <synonym>HINT</synonym>
      <synonym>PKCI-1</synonym>
      <synonym>PKCI1</synonym>
      <synonym>PRKCNH1</synonym>
      <synonym>Protein kinase C inhibitor 1</synonym>
      <synonym>Protein kinase C-interacting protein 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016443|Histidine triad nucleotide-binding protein 1
MADEIAKAQVARPGGDTIFGKIIRKEIPAKIIFEDDRCLAFHDISPQAPTHFLVIPKKHI
SQISVAEDDDESLLGHLMIVGKKCAADLGLNKGYRMVVNEGSDGGQSVYHVHLHVLGGRQ
MHWPPG</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016444|Histidine triad nucleotide-binding protein 1 (HINT1)
ATGGCAGATGAGATTGCCAAGGCTCAGGTCGCTCGGCCTGGTGGCGACACGATCTTTGGG
AAGATCATCCGCAAGGAAATACCAGCCAAAATCATTTTTGAGGATGACCGGTGCCTTGCT
TTCCATGACATTTCCCCTCAAGCACCAACACATTTTCTGGTGATACCCAAGAAACATATA
TCCCAGATTTCTGTGGCAGAAGATGATGATGAAAGTCTTCTTGGACACTTAATGATTGTT
GGCAAGAAATGTGCTGCTGATCTGGGCCTGAATAAGGGTTATCGAATGGTGGTGAATGAA
GGTTCAGATGGTGGACAGTCTGTCTATCACGTTCATCTCCATGTTCTTGGAGGTCGGCAA
ATGCATTGGCCTCCTGGTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01230</identifier>
        <name>HIT</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>histone deacetylase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>hydrolase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>nucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein kinase C binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intrinsic apoptotic signaling pathway by p53 class mediator</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine ribonucleotide catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of calcium-mediated signaling</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001287</id>
      <name>cAMP-specific 3',5'-cyclic phosphodiesterase 4D</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17088426</pubmed-id>
            <citation>Terrin A, Di Benedetto G, Pertegato V, Cheung YF, Baillie G, Lynch MJ, Elvassore N, Prinz A, Herberg FW, Houslay MD, Zaccolo M: PGE(1) stimulation of HEK293 cells generates multiple contiguous domains with different [cAMP]: role of compartmentalized phosphodiesterases. J Cell Biol. 2006 Nov 6;175(3):441-51.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q08499" source="Swiss-Prot">
    <name>cAMP-specific 3',5'-cyclic phosphodiesterase 4D</name>
    <general-function>Ubiquitin protein ligase binding</general-function>
    <specific-function>Hydrolyzes the second messenger cAMP, which is a key regulator of many important physiological processes.</specific-function>
    <gene-name>PDE4D</gene-name>
    <locus>5q12</locus>
    <cellular-location>Apical cell membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.25</theoretical-pi>
    <molecular-weight>91114.1</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8783</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PDE4D</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L20970</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>347130</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1303</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q08499</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PDE4D_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.4.53</synonym>
      <synonym>DPDE3</synonym>
      <synonym>PDE43</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002560|cAMP-specific 3',5'-cyclic phosphodiesterase 4D
MEAEGSSAPARAGSGEGSDSAGGATLKAPKHLWRHEQHHQYPLRQPQFRLLHPHHHLPPP
PPPSPQPQPQCPLQPPPPPPLPPPPPPPGAARGRYASSGATGRVRHRGYSDTERYLYCRA
MDRTSYAVETGHRPGLKKSRMSWPSSFQGLRRFDVDNGTSAGRSPLDPMTSPGSGLILQA
NFVHSQRRESFLYRSDSDYDLSPKSMSRNSSIASDIHGDDLIVTPFAQVLASLRTVRNNF
AALTNLQDRAPSKRSPMCNQPSINKATITEEAYQKLASETLEELDWCLDQLETLQTRHSV
SEMASNKFKRMLNRELTHLSEMSRSGNQVSEFISNTFLDKQHEVEIPSPTQKEKEKKKRP
MSQISGVKKLMHSSSLTNSSIPRFGVKTEQEDVLAKELEDVNKWGLHVFRIAELSGNRPL
TVIMHTIFQERDLLKTFKIPVDTLITYLMTLEDHYHADVAYHNNIHAADVVQSTHVLLST
PALEAVFTDLEILAAIFASAIHDVDHPGVSNQFLINTNSELALMYNDSSVLENHHLAVGF
KLLQEENCDIFQNLTKKQRQSLRKMVIDIVLATDMSKHMNLLADLKTMVETKKVTSSGVL
LLDNYSDRIQVLQNMVHCADLSNPTKPLQLYRQWTDRIMEEFFRQGDRERERGMEISPMC
DKHNASVEKSQVGFIDYIVHPLWETWADLVHPDAQDILDTLEDNREWYQSTIPQSPSPAP
DDPEEGRQGQTEKFQFELTLEEDGESDTEKDSGSQVEEDTSCSDSKTLCTQDSESTEIPL
DEQVEEEAVGEEEESQPEACVIDDRSPDT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020514|cAMP-specific 3',5'-cyclic phosphodiesterase 4D (PDE4D)
ATGGAGGCAGAGGGCAGCAGCGCGCCGGCCCGGGCGGGCAGCGGAGAGGGCAGCGACAGC
GCCGGCGGGGCCACGCTCAAAGCCCCCAAGCATCTCTGGAGGCACGAGCAGCACCACCAG
TACCCGCTCCGGCAGCCCCAGTTCCGCCTCCTGCATCCCCATCACCACCTGCCCCCGCCG
CCGCCACCCTCGCCCCAGCCCCAGCCCCAGTGTCCGCTACAGCCGCCGCCGCCGCCCCCC
CTGCCGCCGCCCCCGCCGCCGCCCGGGGCTGCCCGCGGCCGCTACGCCTCGAGCGGGGCC
ACCGGCCGCGTCCGGCATCGCGGCTACTCGGACACCGAGCGCTACCTGTACTGTCGCGCC
ATGGACCGCACCTCCTACGCGGTGGAGACCGGCCACCGGCCCGGCCTGAAGAAATCCAGG
ATGTCCTGGCCCTCCTCGTTCCAGGGACTCAGGCGTTTTGATGTGGACAATGGCACATCT
GCGGGACGGAGTCCCTTGGATCCCATGACCAGCCCAGGATCCGGGCTAATTCTCCAAGCA
AATTTTGTCCACAGTCAACGACGGGAGTCCTTCCTGTATCGATCCGACAGCGATTATGAC
CTCTCTCCAAAGTCTATGTCCCGGAACTCCTCCATTGCCAGTGATATACACGGAGATGAC
TTGATTGTGACTCCATTTGCTCAGGTCTTGGCCAGTCTGCGAACTGTACGAAACAACTTT
GCTGCATTAACTAATTTGCAAGATCGAGCACCTAGCAAAAGATCACCCATGTGCAACCAA
CCATCCATCAACAAAGCCACCATAACAGAGGAGGCCTACCAGAAACTGGCCAGCGAGACC
CTGGAGGAGCTGGACTGGTGTCTGGACCAGCTAGAGACCCTACAGACCAGGCACTCCGTC
AGTGAGATGGCCTCCAACAAGTTTAAAAGGATGCTTAATCGGGAGCTCACCCATCTCTCT
GAAATGAGTCGGTCTGGAAATCAAGTGTCAGAGTTTATATCAAACACATTCTTAGATAAG
CAACATGAAGTGGAAATTCCTTCTCCAACTCAGAAGGAAAAGGAGAAAAAGAAAAGACCA
ATGTCTCAGATCAGTGGAGTCAAGAAATTGATGCACAGCTCTAGTCTGACTAATTCAAGT
ATCCCAAGGTTTGGAGTTAAAACTGAACAAGAAGATGTCCTTGCCAAGGAACTAGAAGAT
GTGAACAAATGGGGTCTTCATGTTTTCAGAATAGCAGAGTTGTCTGGTAACCGGCCCTTG
ACTGTTATCATGCACACCATTTTTCAGGAACGGGATTTATTAAAAACATTTAAAATTCCA
GTAGATACTTTAATTACATATCTTATGACTCTCGAAGACCATTACCATGCTGATGTGGCC
TATCACAACAATATCCATGCTGCAGATGTTGTCCAGTCTACTCATGTGCTATTATCTACA
CCTGCTTTGGAGGCTGTGTTTACAGATTTGGAGATTCTTGCAGCAATTTTTGCCAGTGCA
ATACATGATGTAGATCATCCTGGTGTGTCCAATCAATTTCTGATCAATACAAACTCTGAA
CTTGCCTTGATGTACAATGATTCCTCAGTCTTAGAGAACCATCATTTGGCTGTGGGCTTT
AAATTGCTTCAGGAAGAAAACTGTGACATTTTCCAGAATTTGACCAAAAAACAAAGACAA
TCTTTAAGGAAAATGGTCATTGACATCGTACTTGCAACAGATATGTCAAAACACATGAAT
CTACTGGCTGATTTGAAGACTATGGTTGAAACTAAGAAAGTGACAAGCTCTGGAGTTCTT
CTTCTTGATAATTATTCCGATAGGATTCAGGTTCTTCAGAATATGGTGCACTGTGCAGAT
CTGAGCAACCCAACAAAGCCTCTCCAGCTGTACCGCCAGTGGACGGACCGGATAATGGAG
GAGTTCTTCCGCCAAGGAGACCGAGAGAGGGAACGTGGCATGGAGATAAGCCCCATGTGT
GACAAGCACAATGCTTCCGTGGAAAAATCACAGGTGGGCTTCATAGACTATATTGTTCAT
CCCCTCTGGGAGACATGGGCAGACCTCGTCCACCCTGACGCCCAGGATATTTTGGACACT
TTGGAGGACAATCGTGAATGGTACCAGAGCACAATCCCTCAGAGCCCCTCTCCTGCACCT
GATGACCCAGAGGAGGGCCGGCAGGGTCAAACTGAGAAATTCCAGTTTGAACTAACTTTA
GAGGAAGATGGTGAGTCAGACACGGAAAAGGACAGTGGCAGTCAAGTGGAAGAAGACACT
AGCTGCAGTGACTCCAAGACTCTTTGTACTCAAGACTCAGAGTCTACTGAAATTCCCCTT
GATGAACAGGTTGAAGAGGAGGCAGTAGGGGAAGAAGAGGAAAGCCAGCCTGAAGCCTGT
GTCATAGATGATCGTTCTCCTGACACGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00233</identifier>
        <name>PDEase_I</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>myofibril</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>calcium channel complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>voltage-gated calcium channel complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>centrosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ion channel binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>scaffold protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3',5'-cyclic-AMP phosphodiesterase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>beta-2 adrenergic receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3',5'-cyclic-nucleotide phosphodiesterase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cAMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ubiquitin protein ligase binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adrenergic receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to cAMP</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adrenergic receptor signaling pathway involved in positive regulation of heart rate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cAMP-mediated signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of heart contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle cell contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cell communication by electrical coupling involved in cardiac conduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein kinase A signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lung development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of heart rate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of interleukin-2 production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organism growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to epinephrine stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of smooth muscle cell migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>smooth muscle contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of smooth muscle cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cAMP catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutrophil chemotaxis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>establishment of endothelial barrier</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cAMP metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of relaxation of cardiac muscle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of interferon-gamma production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of G-protein coupled receptor protein signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of interleukin-5 production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>T cell receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein complex assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of peptidyl-serine phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000746</id>
      <name>Acetyl-coenzyme A synthetase 2-like, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NUB1" source="Swiss-Prot">
    <name>Acetyl-coenzyme A synthetase 2-like, mitochondrial</name>
    <general-function>Atp binding</general-function>
    <specific-function>Important for maintaining normal body temperature during fasting and for energy homeostasis. Essential for energy expenditure under ketogenic conditions (By similarity). Converts acetate to acetyl-CoA so that it can be used for oxidation through the tricarboxylic cycle to produce ATP and CO(2).</specific-function>
    <gene-name>ACSS1</gene-name>
    <locus>20p11.23-p11.21</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.11</theoretical-pi>
    <molecular-weight>74856.1</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16091</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ACSS1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AL035661</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>56203090</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NUB1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ACS2L_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.1</synonym>
      <synonym>ACAS2L</synonym>
      <synonym>AceCS2</synonym>
      <synonym>Acetate--CoA ligase 2</synonym>
      <synonym>Acetyl-CoA synthetase 2</synonym>
      <synonym>Acyl-CoA synthetase short-chain family member 1</synonym>
      <synonym>KIAA1846</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001488|Acetyl-coenzyme A synthetase 2-like, mitochondrial
MAARTLGRGVGRLLGSLRGLSGQPARPPCGVSAPRRAASGPSGSAPAVAAAAAQPGSYPA
LSAQAAREPAAFWGPLARDTLVWDTPYHTVWDCDFSTGKIGWFLGGQLNVSVNCLDQHVR
KSPESVALIWERDEPGTEVRITYRELLETTCRLANTLKRHGVHRGDRVAIYMPVSPLAVA
AMLACARIGAVHTVIFAGFSAESLAGRINDAKCKVVITFNQGLRGGRVVELKKIVDEAVK
HCPTVQHVLVAHRTDNKVHMGDLDVPLEQEMAKEDPVCAPESMGSEDMLFMLYTSGSTGM
PKGIVHTQAGYLLYAALTHKLVFDHQPGDIFGCVADIGWITGHSYVVYGPLCNGATSVLF
ESTPVYPNAGRYWETVERLKINQFYGAPTAVRLLLKYGDAWVKKYDRSSLRTLGSVGEPI
NCEAWEWLHRVVGDSRCTLVDTWWQTETGGICIAPRPSEEGAEILPAMAMRPFFGIVPVL
MDEKGSVVEGSNVSGALCISQAWPGMARTIYGDHQRFVDAYFKAYPGYYFTGDGAYRTEG
GYYQITGRMDDVINISGHRLGTAEIEDAIADHPAVPESAVIGYPHDIKGEAAFAFIVVKD
SAGDSDVVVQELKSMVATKIAKYAVPDEILVVKRLPKTRSGKVMRRLLRKIITSEAQELG
DTTTLEDPSIIAEILSVYQKCKDKQAAAK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010526|Acetyl-coenzyme A synthetase 2-like, mitochondrial (ACSS1)
ATGGCGGCGCGCACCCTGGGCCGCGGCGTCGGGAGGCTGCTGGGCAGCCTGCGAGGGCTC
TCGGGGCAGCCCGCGCGGCCGCCGTGCGGGGTGAGCGCGCCGCGCAGGGCGGCCTCGGGA
CCCTCGGGCAGCGCTCCCGCAGTTGCAGCAGCAGCAGCACAGCCAGGCTCGTATCCCGCG
CTGAGTGCACAGGCAGCCCGGGAGCCGGCCGCCTTCTGGGGGCCTCTGGCGCGGGACACT
CTCGTGTGGGACACCCCCTACCACACCGTCTGGGACTGCGACTTCAGCACTGGCAAGATC
GGCTGGTTCCTGGGAGGCCAGTTAAATGTCTCTGTCAACTGCTTGGACCAGCATGTTCGG
AAGTCCCCCGAGAGCGTTGCTTTGATCTGGGAGCGCGATGAGCCTGGAACGGAAGTGAGG
ATCACCTACAGGGAACTACTGGAGACCACGTGCCGCCTGGCCAACACGCTGAAGAGGCAT
GGAGTCCACCGTGGGGACCGTGTTGCCATCTACATGCCCGTGTCCCCATTGGCTGTGGCA
GCAATGCTGGCCTGTGCCAGGATCGGAGCTGTCCACACAGTCATCTTTGCTGGCTTCAGT
GCAGAGTCCTTGGCTGGGAGGATCAATGATGCCAAGTGCAAGGTGGTTATCACCTTCAAC
CAAGGACTCCGGGGTGGGCGCGTGGTGGAGCTGAAGAAAATAGTGGATGAGGCTGTGAAG
CACTGCCCCACCGTGCAGCATGTCCTGGTGGCTCACAGGACAGACAACAAGGTCCACATG
GGGGATCTGGACGTCCCGCTGGAGCAGGAAATGGCCAAGGAGGACCCTGTTTGCGCCCCA
GAGAGCATGGGCAGTGAGGACATGCTCTTCATGCTGTACACCTCAGGGAGCACCGGAATG
CCCAAGGGCATCGTCCATACCCAGGCAGGCTACCTGCTCTATGCCGCCCTGACTCACAAG
CTTGTGTTTGACCACCAGCCAGGTGACATCTTTGGCTGTGTGGCCGACATCGGTTGGATT
ACAGGACACAGCTACGTGGTGTATGGGCCTCTCTGCAATGGTGCCACCAGCGTCCTTTTT
GAGAGCACCCCAGTTTATCCCAATGCTGGTCGGTACTGGGAGACAGTAGAGAGGTTGAAG
ATCAATCAGTTCTATGGCGCCCCAACGGCTGTCCGGCTGTTGCTGAAATACGGTGATGCC
TGGGTGAAGAAGTATGATCGCTCCTCCCTGCGGACCCTGGGGTCAGTGGGAGAGCCCATC
AACTGTGAGGCCTGGGAGTGGCTTCACAGGGTGGTGGGGGACAGCAGGTGCACGCTGGTG
GACACCTGGTGGCAGACAGGTGGCATCTGCATCGCACCACGGCCCTCGGAAGAAGGGGCG
GAAATCCTCCCTGCCATGGCGATGAGGCCCTTCTTTGGCATCGTCCCCGTCCTCATGGAT
GAGAAGGGCAGCGTCGTGGAGGGCAGCAACGTCTCCGGGGCCCTGTGCATCTCCCAGGCC
TGGCCGGGCATGGCCAGGACCATCTATGGCGACCACCAGCGATTTGTGGACGCCTACTTC
AAGGCCTACCCAGGCTATTACTTCACTGGAGACGGGGCTTACCGAACTGAGGGCGGCTAT
TACCAGATCACAGGGCGGATGGATGATGTCATCAACATCAGTGGCCACCGGCTGGGGACC
GCAGAGATTGAGGACGCCATCGCCGACCACCCTGCAGTACCAGAAAGTGCTGTCATTGGC
TACCCCCACGACATCAAAGGAGAAGCTGCCTTTGCCTTCATTGTGGTGAAAGATAGTGCG
GGTGACTCAGATGTGGTGGTGCAGGAGCTCAAGTCCATGGTGGCCACCAAGATCGCCAAA
TATGCTGTGCCTGATGAGATCCTGGTGGTGAAACGTCTTCCAAAAACCAGGTCTGGGAAG
GTCATGCGGCGGCTCCTGAGGAAGATCATCACTAGTGAGGCCCAGGAGCTGGGAGACACT
ACCACCTTGGAGGACCCCAGCATCATCGCAGAGATCCTGAGTGTCTACCAGAAGTGCAAG
GACAAGCAGGCTGCTGCTAAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00501</identifier>
        <name>AMP-binding</name>
      </pfam>
      <pfam>
        <identifier>PF16177</identifier>
        <name>ACAS_N</name>
      </pfam>
      <pfam>
        <identifier>PF13193</identifier>
        <name>AMP-binding_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>acetate-CoA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ethanol oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetyl-CoA biosynthetic process from acetate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>propionate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetyl-CoA biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000350</id>
      <name>Acetyl-coenzyme A synthetase, cytoplasmic</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17350930</pubmed-id>
            <citation>Ingram-Smith C, Smith KS: AMP-forming acetyl-CoA synthetases in Archaea show unexpected diversity in substrate utilization. Archaea. 2007 May;2(2):95-107.</citation>
          </article>
          <article>
            <pubmed-id>17303131</pubmed-id>
            <citation>Linne U, Schafer A, Stubbs MT, Marahiel MA: Aminoacyl-coenzyme A synthesis catalyzed by adenylation domains. FEBS Lett. 2007 Mar 6;581(5):905-10. Epub 2007 Feb 7.</citation>
          </article>
          <article>
            <pubmed-id>16981708</pubmed-id>
            <citation>Ingram-Smith C, Woods BI, Smith KS: Characterization of the acyl substrate binding pocket of acetyl-CoA synthetase. Biochemistry. 2006 Sep 26;45(38):11482-90.</citation>
          </article>
          <article>
            <pubmed-id>17497934</pubmed-id>
            <citation>Reger AS, Carney JM, Gulick AM: Biochemical and crystallographic analysis of substrate binding and conformational changes in acetyl-CoA synthetase. Biochemistry. 2007 Jun 5;46(22):6536-46. Epub 2007 May 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NR19" source="Swiss-Prot">
    <name>Acetyl-coenzyme A synthetase, cytoplasmic</name>
    <general-function>Atp binding</general-function>
    <specific-function>Activates acetate so that it can be used for lipid synthesis or for energy generation.</specific-function>
    <gene-name>ACSS2</gene-name>
    <locus>20q11.22</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.43</theoretical-pi>
    <molecular-weight>78579.11</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:15814</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ACSS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF263614</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>8439651</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NR19</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ACSA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.1</synonym>
      <synonym>ACAS2</synonym>
      <synonym>AceCS</synonym>
      <synonym>Acetate--CoA ligase</synonym>
      <synonym>Acetyl-CoA synthetase</synonym>
      <synonym>ACS</synonym>
      <synonym>Acyl-activating enzyme</synonym>
      <synonym>Acyl-CoA synthetase short-chain family member 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000697|Acetyl-coenzyme A synthetase, cytoplasmic
MGLPEERVRSGSGSRGQEEAGAGGRARSWSPPPEVSRSAHVPSLQRYRELHRRSVEEPRE
FWGDIAKEFYWKTPCPGPFLRYNFDVTKGKIFIEWMKGATTNICYNVLDRNVHEKKLGDK
VAFYWEGNEPGETTQITYHQLLVQVCQFSNVLRKQGIQKGDRVAIYMPMIPELVVAMLAC
ARIGALHSIVFAGFSSESLCERILDSSCSLLITTDAFYRGEKLVNLKELADEALQKCQEK
GFPVRCCIVVKHLGRAELGMGDSTSQSPPIKRSCPDVQISWNQGIDLWWHELMQEAGDEC
EPEWCDAEDPLFILYTSGSTGKPKGVVHTVGGYMLYVATTFKYVFDFHAEDVFWCTADIG
WITGHSYVTYGPLANGATSVLFEGIPTYPDVNRLWSIVDKYKVTKFYTAPTAIRLLMKFG
DEPVTKHSRASLQVLGTVGEPINPEAWLWYHRVVGAQRCPIVDTFWQTETGGHMLTPLPG
ATPMKPGSATFPFFGVAPAILNESGEELEGEAEGYLVFKQPWPGIMRTVYGNHERFETTY
FKKFPGYYVTGDGCQRDQDGYYWITGRIDDMLNVSGHLLSTAEVESALVEHEAVAEAAVV
GHPHPVKGECLYCFVTLCDGHTFSPKLTEELKKQIREKIGPIATPDYIQNAPGLPKTRSG
KIMRRVLRKIAQNDHDLGDMSTVADPSVISHLFSHRCLTIQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010104|Acetyl-coenzyme A synthetase, cytoplasmic (ACSS2)
ATGGGGCTTCCTGAGGAGCGGGTCCGGAGCGGCAGCGGGAGCCGGGGCCAGGAGGAAGCT
GGAGCCGGAGGCCGGGCGCGGAGTTGGTCTCCGCCGCCCGAGGTCAGCCGCTCCGCGCAC
GTCCCCTCGCTGCAGCGCTACCGCGAGCTGCACCGGCGCTCCGTGGAGGAGCCGCGGGAA
TTCTGGGGAGACATTGCCAAGGAATTTTACTGGAAGACTCCATGCCCTGGCCCATTCCTT
CGGTACAACTTTGATGTGACTAAAGGGAAAATCTTCATTGAGTGGATGAAAGGAGCAACT
ACCAACATCTGCTACAATGTACTGGATCGAAATGTCCATGAGAAAAAGCTTGGAGATAAA
GTTGCTTTTTACTGGGAGGGCAATGAGCCAGGGGAGACCACTCAGATCACATACCATCAG
CTTCTGGTCCAAGTGTGTCAGTTCAGCAATGTTCTCCGAAAACAGGGCATTCAGAAGGGG
GACCGAGTGGCCATCTACATGCCTATGATCCCAGAGCTTGTGGTGGCCATGCTGGCATGT
GCCCGCATTGGGGCTTTGCACTCCATTGTGTTTGCAGGCTTCTCTTCAGAGTCTCTATGT
GAACGGATCTTGGATTCCAGCTGCAGTCTTCTCATCACTACAGATGCCTTCTACAGGGGG
GAAAAGCTTGTGAACCTGAAGGAGCTGGCTGACGAGGCCCTGCAGAAGTGTCAGGAGAAG
GGTTTCCCAGTAAGATGCTGCATTGTGGTCAAGCACCTGGGGCGGGCAGAGCTCGGCATG
GGTGACTCCACCAGCCAGTCCCCCCCAATTAAGAGGTCATGCCCAGATGTGCAGGGTAAA
CTGAAAGAGAAATCCAAGCGTGTTCAGCCCCAGATCTCATGGAACCAAGGGATTGACTTG
TGGTGGCATGAGCTCATGCAAGAGGCAGGGGATGAGTGTGAGCCCGAGTGGTGTGATGCC
GAGGACCCACTCTTCATCCTGTACACCAGTGGCTCCACAGGCAAACCCAAGGGTGTGGTT
CACACAGTTGGGGGCTACATGCTCTATGTAGCCACAACCTTCAAGTATGTGTTTGACTTC
CATGCAGAGGATGTGTTCTGGTGCACGGCAGACATTGGTTGGATCACTGGTCATTCCTAC
GTCACCTATGGGCCACTGGCCAATGGTGCCACCAGTGTTTTGTTTGAGGGGATTCCCACA
TATCCGGACGTGAACCGCCTGTGGAGCATTGTGGACAAATACAAGGTGACCAAGTTCTAC
ACAGCACCCACAGCCATCCGTCTGCTCATGAAGTTTGGAGATGAGCCTGTCACCAAGCAT
AGCCGGGCATCCTTGCAGGTGTTAGGCACAGTGGGTGAACCCATCAACCCTGAGGCCTGG
CTATGGTACCACCGGGTGGTAGGTGCCCAGCGCTGCCCCATCGTGGACACCTTCTGGCAA
ACAGAGACAGGTGGCCACATGTTGACTCCCCTTCCTGGTGCCACACCCATGAAACCCGGT
TCTGCTACTTTCCCATTCTTTGGTGTAGCTCCTGCAATCCTGAATGAGTCCGGGGAAGAG
TTGGAAGGTGAAGCTGAAGGTTATCTGGTGTTCAAGCAGCCCTGGCCAGGGATCATGCGC
ACAGTCTATGGGAACCACGAACGCTTTGAGACAACCTACTTTAAGAAGTTTCCTGGATAC
TATGTTACAGGAGATGGCTGCCAGCGGGACCAGGATGGCTATTACTGGATCACTGGCAGG
ATTGATGACATGCTCAATGTATCTGGACACCTGCTGAGTACAGCAGAGGTGGAGTCAGCA
CTTGTGGAACATGAGGCTGTTGCAGAGGCAGCTGTGGTGGGCCACCCTCATCCTGTGAAG
GGTGAATGCCTCTACTGCTTTGTCACCTTGTGTGATGGCCACACCTTCAGCCCCAAGCTC
ACCGAGGAGCTCAAGAAGCAGATTAGAGAAAAGATTGGCCCCATTGCCACACCAGACTAC
ATCCAGAATGCACCTGGCTTGCCTAAAACCCGCTCAGGGAAAATCATGAGGCGAGTGCTT
CGGAAGATTGCTCAGAATGACCATGACCTCGGGGACATGTCTACTGTGGCTGACCCATCT
GTCATCAGTCACCTCTTCAGCCACCGCTGCCTGACCATCCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00501</identifier>
        <name>AMP-binding</name>
      </pfam>
      <pfam>
        <identifier>PF16177</identifier>
        <name>ACAS_N</name>
      </pfam>
      <pfam>
        <identifier>PF13193</identifier>
        <name>AMP-binding_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>acetate-CoA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ethanol oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetyl-CoA biosynthetic process from acetate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>propionate biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000677</id>
      <name>5'-AMP-activated protein kinase catalytic subunit alpha-1</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17167165</pubmed-id>
            <citation>Mayes MA, Laforest MF, Guillemette C, Gilchrist RB, Richard FJ: Adenosine 5'-monophosphate kinase-activated protein kinase (PRKA) activators delay meiotic resumption in porcine oocytes. Biol Reprod. 2007 Apr;76(4):589-97. Epub 2006 Dec 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13131" source="Swiss-Prot">
    <name>5'-AMP-activated protein kinase catalytic subunit alpha-1</name>
    <general-function>Tau-protein kinase activity</general-function>
    <specific-function>Catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Regulates lipid synthesis by phosphorylating and inactivating lipid metabolic enzymes such as ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and cholesterol synthesis by phosphorylating acetyl-CoA carboxylase (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes, respectively. Regulates insulin-signaling and glycolysis by phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose uptake in muscle by increasing the translocation of the glucose transporter SLC2A4/GLUT4 to the plasma membrane, possibly by mediating phosphorylation of TBC1D4/AS160. Regulates transcription and chromatin structure by phosphorylating transcription regulators involved in energy metabolism such as CRTC2/TORC2, FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A, p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of glucose homeostasis in liver by phosphorylating CRTC2/TORC2, leading to CRTC2/TORC2 sequestration in the cytoplasm. In response to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph), leading to promote transcription. Acts as a key regulator of cell growth and proliferation by phosphorylating TSC2, RPTOR and ATG1/ULK1: in response to nutrient limitation, negatively regulates the mTORC1 complex by phosphorylating RPTOR component of the mTORC1 complex and by phosphorylating and activating TSC2. In response to nutrient limitation, promotes autophagy by phosphorylating and activating ATG1/ULK1. AMPK also acts as a regulator of circadian rhythm by mediating phosphorylation of CRY1, leading to destabilize it. May regulate the Wnt signaling pathway by phosphorylating CTNNB1, leading to stabilize it. Also has tau-protein kinase activity: in response to amyloid beta A4 protein (APP) exposure, activated by CAMKK2, leading to phosphorylation of MAPT/TAU; however the relevance of such data remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1, NOS3 and SLC12A1.</specific-function>
    <gene-name>PRKAA1</gene-name>
    <locus>5p12</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.64</theoretical-pi>
    <molecular-weight>64008.64</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9376</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PRKAA1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB022017</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4115829</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1541</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13131</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AAPK1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.11.1</synonym>
      <synonym>ACACA kinase</synonym>
      <synonym>Acetyl-CoA carboxylase kinase</synonym>
      <synonym>AMPK subunit alpha-1</synonym>
      <synonym>AMPK1</synonym>
      <synonym>HMGCR kinase</synonym>
      <synonym>Hydroxymethylglutaryl-CoA reductase kinase</synonym>
      <synonym>Tau-protein kinase PRKAA1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037059|5'-AMP-activated protein kinase catalytic subunit alpha-1
MRRLSSWRKMATAEKQKHDGRVKIGHYILGDTLGVGTFGKVKVGKHELTGHKVAVKILNR
QKIRSLDVVGKIRREIQNLKLFRHPHIIKLYQVISTPSDIFMVMEYVSGGELFDYICKNG
RLDEKESRRLFQQILSGVDYCHRHMVVHRDLKPENVLLDAHMNAKIADFGLSNMMSDGEF
LRTSCGSPNYAAPEVISGRLYAGPEVDIWSSGVILYALLCGTLPFDDDHVPTLFKKICDG
IFYTPQYLNPSVISLLKHMLQVDPMKRATIKDIREHEWFKQDLPKYLFPEDPSYSSTMID
DEALKEVCEKFECSEEEVLSCLYNRNHQDPLAVAYHLIIDNRRIMNEAKDFYLATSPPDS
FLDDHHLTRPHPERVPFLVAETPRARHTLDELNPQKSKHQGVRKAKWHLGIRSQSRPNDI
MAEVCRAIKQLDYEWKVVNPYYLRVRRKNPVTSTYSKMSLQLYQVDSRTYLLDFRSIDDE
ITEAKSGTATPQRSGSVSNYRSCQRSDSDAEAQGKSSEVSLTSSVTSLDSSPVDLTPRPG
SHTIEFFEMCANLIKILAQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010471|5'-AMP-activated protein kinase catalytic subunit alpha-1 (PRKAA1)
ATGCGCAGACTCAGTTCCTGGAGAAAGATGGCGACAGCCGAGAAGCAGAAACACGACGGG
CGGGTGAAGATCGGCCACTACATTCTGGGTGACACGCTGGGGGTCGGCACCTTCGGCAAA
GTGAAGGTTGGCAAACATGAATTGACTGGGCATAAAGTAGCTGTGAAGATACTCAATCGA
CAGAAGATTCGGAGCCTTGATGTGGTAGGAAAAATCCGCAGAGAAATTCAGAACCTCAAG
CTTTTCAGGCATCCTCATATAATTAAACTGTACCAGGTCATCAGTACACCATCTGATATT
TTCATGGTGATGGAATATGTCTCAGGAGGAGAGCTATTTGATTATATCTGTAAGAATGGA
AGGCTGGATGAAAAAGAAAGTCGGCGTCTGTTCCAACAGATCCTTTCTGGTGTGGATTAT
TGTCACAGGCATATGGTGGTCCATAGAGATTTGAAACCTGAAAATGTCCTGCTTGATGCA
CACATGAATGCAAAGATAGCTGATTTTGGTCTTTCAAACATGATGTCAGATGGTGAATTT
TTAAGAACAAGTTGTGGCTCACCCAACTATGCTGCACCAGAAGTAATTTCAGGAAGATTG
TATGCAGGCCCAGAGGTAGATATATGGAGCAGTGGGGTTATTCTCTATGCTTTATTATGT
GGAACCCTTCCATTTGATGATGACCATGTGCCAACTCTTTTTAAGAAGATATGTGATGGG
ATCTTCTATACCCCTCAATATTTAAATCCTTCTGTGATTAGCCTTTTGAAACATATGCTG
CAGGTGGATCCCATGAAGAGGGCCACAATCAAAGATATCAGGGAACATGAATGGTTTAAA
CAGGACCTTCCAAAATATCTCTTTCCTGAGGATCCATCATATAGTTCAACCATGATTGAT
GATGAAGCCTTAAAAGAAGTATGTGAAAAGTTTGAGTGCTCAGAAGAGGAAGTTCTCAGC
TGTCTTTACAACAGAAATCACCAGGATCCTTTGGCAGTTGCCTACCATCTCATAATAGAT
AACAGGAGAATAATGAATGAAGCCAAAGATTTCTATTTGGCGACAAGCCCACCTGATTCT
TTTCTTGATGATCATCACCTGACTCGGCCCCATCCTGAAAGAGTACCATTCTTGGTTGCT
GAAACACCAAGGGCACGCCATACCCTTGATGAATTAAATCCACAGAAATCCAAACACCAA
GGTGTAAGGAAAGCAAAATGGCATTTAGGAATTAGAAGTCAAAGTCGACCAAATGATATT
ATGGCAGAAGTATGTAGAGCAATCAAACAATTGGATTATGAATGGAAGGTTGTAAACCCA
TATTATTTGCGTGTACGAAGGAAGAATCCTGTGACAAGCACTTACTCCAAAATGAGTCTA
CAGTTATACCAAGTGGATAGTAGAACTTATCTACTGGATTTCCGTAGTATTGATGATGAA
ATTACAGAAGCCAAATCAGGGACTGCTACTCCACAGAGATCGGGATCAGTTAGCAACTAT
CGATCTTGCCAAAGGAGTGATTCAGATGCTGAGGCTCAAGGAAAATCCTCAGAAGTTTCT
CTTACCTCATCTGTGACCTCACTTGACTCTTCTCCTGTTGACCTAACTCCAAGACCTGGA
AGTCACACAATAGAATTTTTTGAGATGTGTGCAAATCTAATTAAAATTCTTGCACAATAA
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00069</identifier>
        <name>Pkinase</name>
      </pfam>
      <pfam>
        <identifier>PF16579</identifier>
        <name>AdenylateSensor</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleotide-activated protein kinase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>[acetyl-CoA carboxylase] kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cAMP-dependent protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>histone serine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chromatin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tau-protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP-activated protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>macroautophagy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of energy homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of glucose import in response to insulin stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of skeletal muscle tissue development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of peptidyl-serine phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein heterooligomerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of vesicle-mediated transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hydrogen peroxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to camptothecin</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to gamma radiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to caffeine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucose starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Wnt signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of lipid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cholesterol biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell cycle arrest</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of glycolytic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of glucosylceramide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of TOR signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to nutrient levels</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rhythmic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to prostaglandin E stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of autophagy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cold acclimation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to UV</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of cholesterol biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>histone-serine phosphorylation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000774</id>
      <name>5'-AMP-activated protein kinase subunit beta-2</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O43741" source="Swiss-Prot">
    <name>5'-AMP-activated protein kinase subunit beta-2</name>
    <general-function>Identical protein binding</general-function>
    <specific-function>Non-catalytic subunit of AMP-activated protein kinase (AMPK), an energy sensor protein kinase that plays a key role in regulating cellular energy metabolism. In response to reduction of intracellular ATP levels, AMPK activates energy-producing pathways and inhibits energy-consuming processes: inhibits protein, carbohydrate and lipid biosynthesis, as well as cell growth and proliferation. AMPK acts via direct phosphorylation of metabolic enzymes, and by longer-term effects via phosphorylation of transcription regulators. Also acts as a regulator of cellular polarity by remodeling the actin cytoskeleton; probably by indirectly activating myosin. Beta non-catalytic subunit acts as a scaffold on which the AMPK complex assembles, via its C-terminus that bridges alpha (PRKAA1 or PRKAA2) and gamma subunits (PRKAG1, PRKAG2 or PRKAG3).</specific-function>
    <gene-name>PRKAB2</gene-name>
    <locus>1q21.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.44</theoretical-pi>
    <molecular-weight>30301.985</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9379</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PRKAB2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ224538</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2916802</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1544</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O43741</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AAKB2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPK subunit beta-2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001544|5'-AMP-activated protein kinase subunit beta-2
MGNTTSDRVSGERHGAKAARSEGAGGHAPGKEHKIMVGSTDDPSVFSLPDSKLPGDKEFV
SWQQDLEDSVKPTQQARPTVIRWSEGGKEVFISGSFNNWSTKIPLIKSHNDFVAILDLPE
GEHQYKFFVDGQWVHDPSEPVVTSQLGTINNLIHVKKSDFEVFDALKLDSMESSETSCRD
LSSSPPGPYGQEMYAFRSEERFKSPPILPPHLLQVILNKDTNISCDPALLPEPNHVMLNH
LYALSIKDSVMVLSATHRYKKKYVTTLLYKPI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016202|5'-AMP-activated protein kinase subunit beta-2 (PRKAB2)
ATGGGAAACACCACCAGCGACCGGGTGTCCGGGGAGCGCCACGGCGCCAAGGCTGCACGC
TCCGAGGGCGCAGGCGGCCATGCCCCGGGGAAGGAGCACAAGATCATGGTGGGGAGTACG
GACGACCCCAGCGTGTTCAGCCTCCCTGACTCCAAGCTCCCTGGGGACAAAGAGTTTGTA
TCATGGCAGCAGGATTTGGAGGACTCCGTAAAGCCCACACAGCAGGCCCGGCCCACTGTT
ATCCGCTGGTCTGAAGGAGGCAAGGAGGTCTTCATCTCTGGGTCCTTCAACAATTGGAGC
ACCAAGATTCCACTGATTAAGAGCCATAATGACTTTGTTGCCATCCTGGACCTCCCTGAG
GGAGAGCACCAATACAAGTTCTTTGTGGATGGACAGTGGGTTCATGATCCATCAGAGCCT
GTGGTTACCAGTCAGCTTGGCACAATTAACAATTTGATCCATGTCAAGAAATCTGATTTT
GAGGTGTTCGATGCTTTAAAGTTAGATTCTATGGAAAGTTCTGAGACATCTTGTAGAGAC
CTTTCCAGCTCACCCCCAGGGCCTTATGGTCAAGAAATGTATGCGTTTCGATCTGAGGAA
AGATTCAAATCCCCACCCATCCTTCCTCCTCATCTACTTCAAGTTATTCTTAACAAAGAC
ACTAATATTTCTTGTGACCCAGCCTTACTCCCTGAGCCCAACCATGTTATGCTGAACCAT
CTCTATGCATTGTCCATTAAGGACAGTGTGATGGTCCTTAGCGCAACCCATCGCTACAAG
AAGAAGTATGTTACTACTCTGCTATACAAGCCCATTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04739</identifier>
        <name>AMPKBI</name>
      </pfam>
      <pfam>
        <identifier>PF16561</identifier>
        <name>AMPK1_CBM</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleotide-activated protein kinase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell cycle arrest</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>energy reserve metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organelle organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrion organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carnitine shuttle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>macroautophagy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein phosphorylation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000269</id>
      <name>Adenylate cyclase type 1</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16895552</pubmed-id>
            <citation>Yang ZF, Sun Y, Li CZ, Wang HW, Wang XJ, Zheng YQ, Liu K, Liu YM: Reduced sinoatrial cAMP content plays a role in postnatal heart rate slowing in the rabbit. Clin Exp Pharmacol Physiol. 2006 Aug;33(8):757-62.</citation>
          </article>
          <article>
            <pubmed-id>17229090</pubmed-id>
            <citation>Nicol X, Bennis M, Ishikawa Y, Chan GC, Reperant J, Storm DR, Gaspar P: Role of the calcium modulated cyclases in the development of the retinal projections. Eur J Neurosci. 2006 Dec;24(12):3401-14.</citation>
          </article>
          <article>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q08828" source="Swiss-Prot">
    <name>Adenylate cyclase type 1</name>
    <general-function>Metal ion binding</general-function>
    <specific-function>Catalyzes the formation of the signaling molecule cAMP in response to G-protein signaling. Mediates responses to increased cellular Ca(2+)/calmodulin levels (By similarity). May be involved in regulatory processes in the central nervous system. May play a role in memory and learning. Plays a role in the regulation of the circadian rhythm of daytime contrast sensitivity probably by modulating the rhythmic synthesis of cyclic AMP in the retina (By similarity).</specific-function>
    <gene-name>ADCY1</gene-name>
    <locus>7p13-p12</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>64-84
88-108
125-145
158-178
183-203
214-234
611-631
635-655
674-694
725-745
753-773
775-794</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.49</theoretical-pi>
    <molecular-weight>123438.85</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:232</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ADCY1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AC069008</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>41472630</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q08828</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ADCY1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.6.1.1</synonym>
      <synonym>Adenylate cyclase type I</synonym>
      <synonym>Adenylyl cyclase 1</synonym>
      <synonym>ATP pyrophosphate-lyase 1</synonym>
      <synonym>Ca(2+)/calmodulin-activated adenylyl cyclase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010229|Adenylate cyclase type 1
MAGAPRGGGGGGGGAGEPGGAERAAGTSRRRGLRACDEEFACPELEALFRGYTLRLEQAA
TLKALAVLSLLAGALALAELLGAPGPAPGLAKGSHPVHCVLFLALLVVTNVRSLQVPQLQ
QVGQLALLFSLTFALLCCPFALGGPARGSAGAAGGPATAEQGVWQLLLVTFVSYALLPVR
SLLAIGFGLVVAASHLLVTATLVPAKRPRLWRTLGANALLFVGVNMYGVFVRILTERSQR
KAFLQARSCIEDRLRLEDENEKQERLLMSLLPRNVAMEMKEDFLKPPERIFHKIYIQRHD
NVSILFADIVGFTGLASQCTAQELVKLLNELFGKFDELATENHCRRIKILGDCYYCVSGL
TQPKTDHAHCCVEMGLDMIDTITSVAEATEVDLNMRVGLHTGRVLCGVLGLRKWQYDVWS
NDVTLANVMEAAGLPGKVHITKTTLACLNGDYEVEPGYGHERNSFLKTHNIETFFIVPSH
RRKIFPGLILSDIKPAKRMKFKTVCYLLVQLMHCRKMFKAEIPFSNVMTCEDDDKRRALR
TASEKLRNRSSFSTNVVYTTPGTRVNRYISRLLEARQTELEMADLNFFTLKYKHVEREQK
YHQLQDEYFTSAVVLTLILAALFGLVYLLIFPQSVVVLLLLVFCICFLVACVLYLHITRV
QCFPGCLTIQIRTVLCIFIVVLIYSVAQGCVVGCLPWAWSSKPNSSLVVLSSGGQRTALP
TLPCESTHHALLCCLVGTLPLAIFFRVSSLPKMILLSGLTTSYILVLELSGYTRTGGGAV
SGRSYEPIVAILLFSCALALHARQVDIRLRLDYLWAAQAEEEREDMEKVKLDNRRILFNL
LPAHVAQHFLMSNPRNMDLYYQSYSQVGVMFASIPNFNDFYIELDGNNMGVECLRLLNEI
IADFDELMEKDFYKDIEKIKTIGSTYMAAVGLAPTSGTKAKKSISSHLSTLADFAIEMFD
VLDEINYQSYNDFVLRVGINVGPVVAGVIGARRPQYDIWGNTVNVASRMDSTGVQGRIQV
TEEVHRLLRRCPYHFVCRGKVSVKGKGEMLTYFLEGRTDGNGSQIRSLGLDRKMCPFGRA
GLQGRRPPVCPMPGVSVRAGLPPHSPGQYLPSAAAGKEA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0000536|314 bp
ATGAAGGAGGACTTCCTGAAGCCCCCTGAGAGGATTTTCCACAAGATTTACATCCAGAGG
CACGACAATGTGAGCATCCTGTTTGCTGACATCGTGGGTTTCACGGGCTTGGCATCCCAG
TGCACAGCCCAGGAGCTGGTGAAACTCCTCAATGAGCTCTTCGGCAAGTTCGATGAATTA
GCCACGGAGAACCACTGTCGCCGCATCAAGATTCTCGGGGACTGCTACTACTGCGTGTCG
GGCCTCACCCAGCCCAAGACTGACCATGCCCACTGCTGTGTGGAGATGGGACTCGACATG
ATTGATACCATCAC</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00211</identifier>
        <name>Guanylate_cyc</name>
      </pfam>
      <pfam>
        <identifier>PF16214</identifier>
        <name>AC_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane raft</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenylate cyclase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium- and calmodulin-responsive adenylate cyclase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cAMP biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-activating G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cAMP-mediated signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of phospholipase C activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to forskolin</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucagon stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>renal water homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>energy reserve metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lithium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-inhibiting G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of protein kinase A activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axonogenesis</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000639</id>
      <name>Long-chain-fatty-acid--CoA ligase 1</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16981708</pubmed-id>
            <citation>Ingram-Smith C, Woods BI, Smith KS: Characterization of the acyl substrate binding pocket of acetyl-CoA synthetase. Biochemistry. 2006 Sep 26;45(38):11482-90.</citation>
          </article>
          <article>
            <pubmed-id>17350930</pubmed-id>
            <citation>Ingram-Smith C, Smith KS: AMP-forming acetyl-CoA synthetases in Archaea show unexpected diversity in substrate utilization. Archaea. 2007 May;2(2):95-107.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P33121" source="Swiss-Prot">
    <name>Long-chain-fatty-acid--CoA ligase 1</name>
    <general-function>Long-chain fatty acid-coa ligase activity</general-function>
    <specific-function>Activation of long-chain fatty acids for both synthesis of cellular lipids, and degradation via beta-oxidation. Preferentially uses palmitoleate, oleate and linoleate.</specific-function>
    <gene-name>ACSL1</gene-name>
    <locus>4q34-q35</locus>
    <cellular-location>Mitochondrion outer membrane</cellular-location>
    <transmembrane-regions>25-45</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.16</theoretical-pi>
    <molecular-weight>77942.685</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3569</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ACSL1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D10040</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>219900</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P33121</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ACSL1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.3</synonym>
      <synonym>ACS1</synonym>
      <synonym>Acyl-CoA synthetase 1</synonym>
      <synonym>FACL1</synonym>
      <synonym>FACL2</synonym>
      <synonym>LACS</synonym>
      <synonym>LACS 1</synonym>
      <synonym>LACS 2</synonym>
      <synonym>LACS1</synonym>
      <synonym>LACS2</synonym>
      <synonym>Long-chain acyl-CoA synthetase 1</synonym>
      <synonym>Long-chain acyl-CoA synthetase 2</synonym>
      <synonym>Long-chain fatty acid-CoA ligase 2</synonym>
      <synonym>Palmitoyl-CoA ligase 1</synonym>
      <synonym>Palmitoyl-CoA ligase 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001274|Long-chain-fatty-acid--CoA ligase 1
MQAHELFRYFRMPELVDFRQYVRTLPTNTLMGFGAFAALTTFWYATRPKPLKPPCDLSMQ
SVEVAGSGGARRSALLDSDEPLVYFYDDVTTLYEGFQRGIQVSNNGPCLGSRKPDQPYEW
LSYKQVAELSECIGSALIQKGFKTAPDQFIGIFAQNRPEWVIIEQGCFAYSMVIVPLYDT
LGNEAITYIVNKAELSLVFVDKPEKAKLLLEGVENKLIPGLKIIVVMDAYGSELVERGQR
CGVEVTSMKAMEDLGRANRRKPKPPAPEDLAVICFTSGTTGNPKGAMVTHRNIVSDCSAF
VKATENTVNPCPDDTLISFLPLAHMFERVVECVMLCHGAKIGFFQGDIRLLMDDLKVLQP
TVFPVVPRLLNRMFDRIFGQANTTLKRWLLDFASKRKEAELRSGIIRNNSLWDRLIFHKV
QSSLGGRVRLMVTGAAPVSATVLTFLRAALGCQFYEGYGQTECTAGCCLTMPGDWTAGHV
GAPMPCNLIKLVDVEEMNYMAAEGEGEVCVKGPNVFQGYLKDPAKTAEALDKDGWLHTGD
IGKWLPNGTLKIIDRKKHIFKLAQGEYIAPEKIENIYMRSEPVAQVFVHGESLQAFLIAI
VVPDVETLCSWAQKRGFEGSFEELCRNKDVKKAILEDMVRLGKDSGLKPFEQVKGITLHP
ELFSIDNGLLTPTMKAKRPELRNYFRSQIDDLYSTIKV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021652|Long-chain-fatty-acid--CoA ligase 1 (ACSL1)
ATGCAAGCCCATGAGCTGTTCCGGTATTTTCGAATGCCAGAGCTGGTTGACTTCCGACAG
TACGTGCGTACTCTTCCGACCAACACGCTTATGGGCTTCGGAGCTTTTGCAGCACTCACC
ACCTTCTGGTACGCCACGAGACCCAAACCCCTGAAGCCGCCATGCGACCTCTCCATGCAG
TCAGTGGAAGTGGCGGGTAGTGGTGGTGCACGAAGATCCGCACTACTTGACAGCGACGAG
CCCTTGGTGTATTTCTATGATGATGTCACAACATTATACGAAGGTTTCCAGAGGGGAATA
CAGGTGTCAAATAATGGCCCTTGTTTAGGCTCTCGGAAACCAGACCAACCCTATGAATGG
CTTTCATATAAACAGGTTGCAGAATTGTCGGAGTGCATAGGCTCAGCACTGATCCAGAAG
GGCTTCAAGACTGCCCCAGATCAGTTCATTGGCATCTTTGCTCAAAATAGACCTGAGTGG
GTGATTATTGAACAAGGATGCTTTGCTTATTCGATGGTGATCGTTCCACTTTATGATACC
CTTGGAAATGAAGCCATCACGTACATAGTCAACAAAGCTGAACTCTCTCTGGTTTTTGTT
GACAAGCCAGAGAAGGCCAAACTCTTATTAGAGGGTGTAGAAAATAAGTTAATACCAGGC
CTTAAAATCATAGTTGTCATGGATGCCTACGGCAGTGAACTGGTGGAACGAGGCCAGAGG
TGTGGGGTGGAAGTCACCAGCATGAAGGCGATGGAGGACCTGGGAAGAGCCAACAGACGG
AAGCCCAAGCCTCCAGCACCTGAAGATCTTGCAGTAATTTGTTTCACAAGTGGAACTACA
GGCAACCCCAAAGGAGCAATGGTCACTCACCGAAACATAGTGAGCGATTGTTCAGCTTTT
GTGAAAGCAACAGAGAATACAGTCAATCCTTGCCCAGATGATACTTTGATATCTTTCTTG
CCTCTCGCCCATATGTTTGAGAGAGTTGTAGAGTGTGTAATGCTGTGTCATGGAGCTAAA
ATCGGATTTTTCCAAGGAGATATCAGGCTGCTCATGGATGACCTCAAGGTGCTTCAACCC
ACTGTCTTCCCCGTGGTTCCAAGACTGCTGAACCGGATGTTTGACCGAATTTTCGGACAA
GCAAACACCACGCTGAAGCGATGGCTCTTGGACTTTGCCTCCAAGAGGAAAGAAGCAGAG
CTTCGCAGCGGCATCATCAGAAACAACAGCCTGTGGGACCGGCTGATCTTCCACAAAGTA
CAGTCGAGCCTGGGCGGAAGAGTCCGGCTGATGGTGACAGGAGCCGCCCCGGTGTCTGCC
ACTGTGCTGACGTTCCTCAGAGCAGCCCTGGGCTGTCAGTTTTATGAAGGATACGGACAG
ACAGAGTGCACTGCCGGGTGCTGCCTGACCATGCCTGGAGACTGGACCGCAGGCCATGTT
GGGGCCCCGATGCCGTGCAATTTGATAAAACTTGTTGATGTGGAAGAAATGAATTACATG
GCTGCCGAGGGCGAGGGCGAGGTGTGTGTGAAAGGGCCAAATGTATTTCAGGGCTACTTG
AAGGACCCAGCGAAAACAGCAGAAGCTTTGGACAAAGACGGCTGGTTACACACAGGGGAC
ATTGGAAAATGGTTACCAAATGGCACCTTGAAAATTATCGACCGGAAAAAGCACATATTT
AAGCTGGCACAAGGAGAATACATAGCCCCTGAAAAGATTGAAAATATCTACATGCGAAGT
GAGCCTGTTGCTCAGGTGTTTGTCCACGGAGAAAGCCTGCAGGCATTTCTCATTGCAATT
GTGGTACCAGATGTTGAGACATTATGTTCCTGGGCCCAAAAGAGAGGATTTGAAGGGTCG
TTTGAGGAACTGTGCAGAAATAAGGATGTCAAAAAAGCTATCCTCGAAGATATGGTGAGA
CTTGGGAAGGATTCTGGTCTGAAACCATTTGAACAGGTCAAAGGCATCACATTGCACCCT
GAATTATTTTCTATCGACAATGGCCTTCTGACTCCAACAATGAAGGCGAAAAGGCCAGAG
CTGCGGAACTATTTCAGGTCGCAGATAGATGACCTCTATTCCACTATCAAGGTTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00501</identifier>
        <name>AMP-binding</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial outer membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>peroxisomal membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>long-chain fatty acid-CoA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-chain fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-chain fatty acid import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>triglyceride biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adiponectin-activated signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alpha-linolenic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oleic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>unsaturated fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organic cyclic compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-chain fatty-acyl-CoA biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of protein serine/threonine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>linoleic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002431</id>
      <name>Fructose-1,6-bisphosphatase 1</name>
      <organism>Human</organism>
      <actions>
        <action>antagonist</action>
        <action>inhibitory allosteric modulator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>7809062</pubmed-id>
            <citation>Xue Y, Huang S, Liang JY, Zhang Y, Lipscomb WN: Crystal structure of fructose-1,6-bisphosphatase complexed with fructose 2,6-bisphosphate, AMP, and Zn2+ at 2.0-A resolution: aspects of synergism between inhibitors. Proc Natl Acad Sci U S A. 1994 Dec 20;91(26):12482-6.</citation>
          </article>
          <article>
            <pubmed-id>18650089</pubmed-id>
            <citation>Hebeisen P, Kuhn B, Kohler P, Gubler M, Huber W, Kitas E, Schott B, Benz J, Joseph C, Ruf A: Allosteric FBPase inhibitors gain 10(5) times in potency when simultaneously binding two neighboring AMP sites. Bioorg Med Chem Lett. 2008 Aug 15;18(16):4708-12. doi: 10.1016/j.bmcl.2008.06.103. Epub 2008 Jul 5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09467" source="Swiss-Prot">
    <name>Fructose-1,6-bisphosphatase 1</name>
    <general-function>Monosaccharide binding</general-function>
    <specific-function>Catalyzes the hydrolysis of fructose 1,6-bisphosphate to fructose 6-phosphate in the presence of divalent cations, acting as a rate-limiting enzyme in gluconeogenesis. Plays a role in regulating glucose sensing and insulin secretion of pancreatic beta-cells. Appears to modulate glycerol gluconeogenesis in liver. Important regulator of appetite and adiposity; increased expression of the protein in liver after nutrient excess increases circulating satiety hormones and reduces appetite-stimulating neuropeptides and thus seems to provide a feedback mechanism to limit weight gain.</specific-function>
    <gene-name>FBP1</gene-name>
    <locus>9q22.3</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.99</theoretical-pi>
    <molecular-weight>36842.145</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3606</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FBP1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L10320</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P09467</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>F16P1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.3.11</synonym>
      <synonym>D-fructose-1,6-bisphosphate 1-phosphohydrolase 1</synonym>
      <synonym>FBP</synonym>
      <synonym>FBPase 1</synonym>
      <synonym>Liver FBPase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037205|Fructose-1,6-bisphosphatase 1
MADQAPFDTDVNTLTRFVMEEGRKARGTGELTQLLNSLCTAVKAISSAVRKAGIAHLYGI
AGSTNVTGDQVKKLDVLSNDLVMNMLKSSFATCVLVSEEDKHAIIVEPEKRGKYVVCFDP
LDGSSNIDCLVSVGTIFGIYRKKSTDEPSEKDALQPGRNLVAAGYALYGSATMLVLAMDC
GVNCFMLDPAIGEFILVDKDVKIKKKGKIYSLNEGYARDFDPAVTEYIQRKKFPPDNSAP
YGARYVGSMVADVHRTLVYGGIFLYPANKKSPNGKLRLLYECNPMAYVMEKAGGMATTGK
EAVLDVIPTDIHQRAPVILGSPDDVLEFLKVYEKHSAQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016789|Fructose-1,6-bisphosphatase 1 (FBP1)
ATGGCTGACCAGGCGCCCTTCGACACGGACGTCAACACCCTGACCCGCTTCGTCATGGAG
GAGGGCAGGAAGGCCCGCGGCACGGGCGAGTTGACCCAGCTGCTCAACTCGCTCTGCACA
GCAGTCAAAGCCATCTCTTCGGCGGTGCGCAAGGCGGGCATCGCGCACCTCTATGGCATT
GCTGGTTCTACCAACGTGACAGGTGATCAAGTTAAGAAGCTGGACGTCCTCTCCAACGAC
CTGGTTATGAACATGTTAAAGTCATCCTTTGCCACGTGTGTTCTCGTGTCAGAAGAAGAT
AAACACGCCATCATAGTGGAACCGGAGAAAAGGGGTAAATATGTGGTCTGTTTTGATCCC
CTTGATGGATCTTCCAACATCGATTGCCTTGTGTCCGTTGGAACCATTTTTGGCATCTAT
AGAAAGAAATCAACTGATGAGCCTTCTGAGAAGGATGCTCTGCAACCAGGCCGGAACCTG
GTGGCAGCCGGCTACGCACTGTATGGCAGTGCCACCATGCTGGTCCTTGCCATGGACTGT
GGGGTCAACTGCTTCATGCTGGACCCGGCCATCGGGGAGTTCATTTTGGTGGACAAGGAT
GTGAAGATAAAAAAGAAAGGTAAAATCTACAGCCTTAACGAGGGCTACGCCAGGGACTTT
GACCCTGCCGTCACTGAGTACATCCAGAGGAAGAAGTTCCCCCCAGATAATTCAGCTCCT
TATGGGGCCCGGTATGTGGGCTCCATGGTGGCTGATGTTCATCGCACTCTGGTCTACGGA
GGGATATTTCTGTACCCCGCTAACAAGAAGAGCCCCAATGGAAAGCTGAGACTGCTGTAC
GAATGCAACCCCATGGCCTACGTCATGGAGAAGGCTGGGGGAATGGCCACCACTGGGAAG
GAGGCCGTGTTAGACGTCATTCCCACAGACATTCACCAGAGGGCGCCGGTGATCTTGGGA
TCCCCCGACGACGTGCTCGAGTTCCTGAAGGTGTATGAGAAGCACTCTGCCCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00316</identifier>
        <name>FBPase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>monosaccharide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>fructose 1,6-bisphosphate 1-phosphatase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dephosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose 6-phosphate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of Ras protein signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to magnesium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of glycolytic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="3">
      <id>BE0003540</id>
      <name>Adenosine kinase</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>18560757</pubmed-id>
            <citation>Park J, Gupta RS: Adenosine kinase and ribokinase--the RK family of proteins. Cell Mol Life Sci. 2008 Sep;65(18):2875-96. doi: 10.1007/s00018-008-8123-1.</citation>
          </article>
          <article>
            <pubmed-id>17065073</pubmed-id>
            <citation>Leoncini R, Vannoni D, Santoro A, Giglioni S, Carli R, Marinello E: Adenosine kinase from rat liver: new biochemical properties. Nucleosides Nucleotides Nucleic Acids. 2006;25(9-11):1107-12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P55263" source="Swiss-Prot">
    <name>Adenosine kinase</name>
    <general-function>Poly(a) rna binding</general-function>
    <specific-function>ATP dependent phosphorylation of adenosine and other related nucleoside analogs to monophosphate derivatives. Serves as a potential regulator of concentrations of extracellular adenosine and intracellular adenine nucleotides.</specific-function>
    <gene-name>ADK</gene-name>
    <locus>10q22|10q11-q24</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.67</theoretical-pi>
    <molecular-weight>40545.075</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:257</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U50196</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1224125</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1231</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P55263</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ADK_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.1.20</synonym>
      <synonym>Adenosine 5'-phosphotransferase</synonym>
      <synonym>AK</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006821|Adenosine kinase
MAAAEEEPKPKKLKVEAPQALRENILFGMGNPLLDISAVVDKDFLDKYSLKPNDQILAED
KHKELFDELVKKFKVEYHAGGSTQNSIKVAQWMIQQPHKAATFFGCIGIDKFGEILKRKA
AEAHVDAHYYEQNEQPTGTCAACITGDNRSLIANLAAANCYKKEKHLDLEKNWMLVEKAR
VCYIAGFFLTVSPESVLKVAHHASENNRIFTLNLSAPFISQFYKESLMKVMPYVDILFGN
ETEAATFAREQGFETKDIKEIAKKTQALPKMNSKRQRIVIFTQGRDDTIMATESEVTAFA
VLDQDQKEIIDTNGAGDAFVGGFLSQLVSDKPLTECIRAGHYAASIIIRRTGCTFPEKPD
FH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0012465|Adenosine kinase (ADK)
ATGACGTCAGTCAGAGAAAATATTCTCTTTGGAATGGGAAATCCTCTGCTTGACATCTCT
GCTGTAGTGGACAAAGATTTCCTTGATAAGTATTCTCTGAAACCAAATGACCAAATCTTG
GCTGAAGACAAACACAAGGAACTGTTTGATGAACTTGTGAAAAAATTCAAAGTCGAATAT
CATGCTGGTGGCTCTACCCAGAATTCAATTAAAGTGGCTCAGTGGATGATTCAACAGCCA
CACAAAGCAGCAACATTTTTTGGATGCATTGGGATAGATAAATTTGGGGAGATCCTGAAG
AGAAAAGCTGCTGAAGCCCATGTGGATGCTCATTACTACGAGCAGAATGAGCAGCCAACA
GGAACTTGTGCTGCATGCATCACTGGTGACAACAGGTCCCTCATAGCTAATCTTGCTGCT
GCCAATTGTTATAAAAAGGAAAAACATCTTGATCTGGAGAAAAACTGGATGTTGGTAGAA
AAAGCAAGAGTTTGTTATATAGCAGGCTTTTTTCTTACAGTTTCCCCAGAGTCAGTATTA
AAGGTGGCTCACCATGCTTCTGAAAACAACAGGATTTTCACTTTGAATCTATCTGCACCG
TTTATTAGCCAGTTCTACAAGGAATCATTGATGAAAGTTATGCCTTATGTTGATATACTT
TTTGGAAATGAGACAGAAGCTGCCACTTTTGCTAGAGAGCAAGGCTTTGAGACTAAAGAC
ATTAAAGAGATAGCCAAAAAGACACAAGCCCTGCCAAAGATGAACTCAAAGAGGCAGCGA
ATCGTGATCTTCACCCAAGGGAGAGATGACACTATAATGGCTACAGAAAGTGAAGTCACT
GCTTTTGCTGTCTTGGATCAAGACCAGAAAGAAATTATTGATACCAATGGAGCTGGAGAT
GCATTTGTTGGAGGTTTTCTGTCTCAACTGGTCTCTGACAAGCCTCTGACTGAATGTATC
CGTGCTGGCCACTATGCAGCAAGCATCATAATTAGACGGACTGGCTGCACCTTTCCTGAG
AAGCCAGACTTCCACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00294</identifier>
        <name>PfkB</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenosine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine-containing compound salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>AMP salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ribonucleoside monophosphate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dATP biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme position="1">
      <id>BE0000352</id>
      <name>AMP deaminase 1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16497164</pubmed-id>
            <citation>Hanisch F, Hellsten Y, Zierz S: Ecto- and cytosolic 5'-nucleotidases in normal and AMP deaminase-deficient human skeletal muscle. Biol Chem. 2006 Jan;387(1):53-8.</citation>
          </article>
          <article>
            <pubmed-id>16646524</pubmed-id>
            <citation>Palecz D, Jaszczuk E, Gabryelak T: In vitro study of AMP-deaminase from fish (Cyprinus carpio) treated with hydrolyzable tannins. Acta Biol Hung. 2006 Mar;57(1):49-56.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P23109" source="Swiss-Prot">
    <name>AMP deaminase 1</name>
    <general-function>Metal ion binding</general-function>
    <specific-function>AMP deaminase plays a critical role in energy metabolism.</specific-function>
    <gene-name>AMPD1</gene-name>
    <locus>1p13</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.89</theoretical-pi>
    <molecular-weight>90218.455</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:468</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>AMPD1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M37931</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>10864686</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P23109</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AMPD1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.5.4.6</synonym>
      <synonym>AMP deaminase isoform M</synonym>
      <synonym>Myoadenylate deaminase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036996|AMP deaminase 1
MNVRIFYSVSQSPHSLLSLLFYCAILESRISATMPLFKLPAEEKQIDDAMRNFAEKVFAS
EVKDEGGRQEISPFDVDEICPISHHEMQAHIFHLETLSTSTEARRKKRFQGRKTVNLSIP
LSETSSTKLSHIDEYISSSPTYQTVPDFQRVQITGDYASGVTVEDFEIVCKGLYRALCIR
EKYMQKSFQRFPKTPSKYLRNIDGEAWVANESFYPVFTPPVKKGEDPFRTDNLPENLGYH
LKMKDGVVYVYPNEAAVSKDEPKPLPYPNLDTFLDDMNFLLALIAQGPVKTYTHRRLKFL
SSKFQVHQMLNEMDELKELKNNPHRDFYNCRKVDTHIHAAACMNQKHLLRFIKKSYQIDA
DRVVYSTKEKNLTLKELFAKLKMHPYDLTVDSLDVHAGRQTFQRFDKFNDKYNPVGASEL
RDLYLKTDNYINGEYFATIIKEVGADLVEAKYQHAEPRLSIYGRSPDEWSKLSSWFVCNR
IHCPNMTWMIQVPRIYDVFRSKNFLPHFGKMLENIFMPVFEATINPQADPELSVFLKHIT
GFDSVDDESKHSGHMFSSKSPKPQEWTLEKNPSYTYYAYYMYANIMVLNSLRKERGMNTF
LFRPHCGEAGALTHLMTAFMIADDISHGLNLKKSPVLQYLFFLAQIPIAMSPLSNNSLFL
EYAKNPFLDFLQKGLMISLSTDDPMQFHFTKEPLMEEYAIAAQVFKLSTCDMCEVARNSV
LQCGISHEEKVKFLGDNYLEEGPAGNDIRRTNVAQIRMAYRYETWCYELNLIAEGLKSTE
</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016069|AMP deaminase 1 (AMPD1)
ATGAATGTCAGGATATTTTATAGTGTCAGTCAGTCACCCCACAGTCTCCTCTCTCTTCTT
TTCTACTGTGCTATCCTAGAATCAAGGATTTCAGCAACAATGCCTCTGTTCAAACTCCCA
GCTGAAGAGAAACAAATTGATGATGCAATGCGCAACTTTGCTGAAAAAGTGTTTGCCTCT
GAAGTCAAAGATGAAGGAGGTCGTCAGGAGATTTCCCCCTTTGATGTGGATGAGATCTGT
CCGATTTCTCATCATGAGATGCAAGCACACATATTCCATCTGGAGACTCTGTCCACCTCC
ACAGAAGCCAGGAGAAAAAAGCGTTTCCAAGGACGGAAGACTGTTAATTTGTCCATTCCA
CTAAGTGAAACATCTTCCACCAAACTGTCCCACATTGATGAATACATTTCCTCATCTCCA
ACCTACCAGACCGTGCCTGATTTTCAGAGAGTGCAGATTACTGGTGACTATGCCTCTGGG
GTTACAGTTGAAGATTTTGAAATTGTTTGCAAAGGTCTGTATCGGGCACTATGCATACGT
GAGAAATACATGCAGAAGTCGTTTCAGAGGTTCCCTAAAACCCCTTCCAAATACTTGCGG
AACATTGATGGTGAGGCTTGGGTAGCAAATGAGAGCTTCTATCCAGTCTTTACTCCTCCT
GTGAAGAAGGGAGAGGACCCCTTCCGAACAGACAACCTTCCTGAAAACCTGGGCTATCAC
CTCAAAATGAAGGACGGTGTAGTTTACGTCTATCCTAATGAAGCAGCAGTCAGCAAAGAT
GAGCCTAAGCCACTTCCTTACCCAAATCTGGACACCTTCTTAGACGATATGAATTTTTTA
CTTGCTTTAATTGCTCAAGGACCTGTTAAGACCTATACCCACCGGCGCCTGAAGTTCCTC
TCCTCCAAGTTCCAGGTCCATCAGATGCTTAACGAGATGGACGAGTTAAAGGAGCTGAAA
AACAACCCCCACCGAGATTTTTATAACTGCAGGAAGGTGGACACCCATATCCATGCAGCC
GCTTGCATGAACCAGAAACATCTGCTGCGTTTTATTAAGAAATCTTACCAAATTGATGCT
GACAGAGTGGTCTATAGCACCAAAGAGAAGAATCTGACCCTAAAGGAACTTTTTGCTAAA
TTAAAAATGCATCCTTATGACCTGACTGTTGATTCTCTGGATGTTCATGCTGGACGCCAG
ACCTTCCAGCGTTTTGATAAGTTCAATGACAAATATAATCCTGTAGGAGCAAGTGAGCTA
CGGGACCTCTACTTGAAGACAGACAATTACATTAATGGGGAATATTTTGCCACTATCATC
AAGGAGGTAGGTGCGGACCTGGTGGAGGCCAAGTACCAGCATGCTGAGCCCCGCCTGTCC
ATCTATGGCCGCAGTCCTGATGAGTGGAGCAAACTCTCCTCCTGGTTCGTCTGCAATCGC
ATCCACTGCCCCAACATGACATGGATGATCCAGGTTCCCAGGATCTATGATGTGTTCCGT
TCCAAGAATTTCCTTCCACATTTTGGAAAAATGCTGGAGAATATTTTCATGCCAGTGTTT
GAGGCCACCATCAACCCCCAGGCTGACCCAGAACTCAGTGTCTTCCTCAAGCATATCACT
GGCTTTGACAGTGTGGATGATGAGTCCAAACACAGTGGCCACATGTTCTCCTCCAAGAGT
CCCAAGCCCCAGGAGTGGACATTGGAAAAGAATCCATCTTACACTTACTATGCCTACTAC
ATGTATGCAAACATCATGGTGCTCAACAGCCTGAGAAAGGAACGAGGCATGAATACGTTT
CTGTTCCGACCTCACTGTGGAGAAGCTGGAGCCCTCACCCATCTCATGACAGCATTCATG
ATAGCAGATGATATCTCTCATGGCCTAAATTTAAAAAAGAGTCCCGTGCTACAGTACTTG
TTTTTCTTAGCCCAAATTCCCATCGCCATGTCACCACTAAGTAACAATAGCCTATTTCTA
GAGTATGCCAAAAATCCTTTTTTGGATTTCCTTCAGAAAGGGCTAATGATCTCACTGTCT
ACAGATGACCCAATGCAATTCCACTTTACCAAGGAGCCCCTAATGGAAGAATATGCTATT
GCTGCACAAGTCTTCAAGCTGAGCACCTGTGATATGTGCGAAGTGGCAAGGAACAGTGTC
TTGCAGTGTGGAATTTCTCATGAGGAGAAAGTAAAGTTTCTGGGCGACAATTACCTTGAG
GAAGGCCCTGCTGGAAATGATATCCGGAGGACAAATGTAGCCCAAATCCGCATGGCCTAT
CGCTATGAAACCTGGTGTTATGAACTCAATTTAATTGCTGAGGGTCTTAAATCAACAGAA
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00962</identifier>
        <name>A_deaminase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP deaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine-containing compound salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>IMP salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="2">
      <id>BE0000115</id>
      <name>Adenine phosphoribosyltransferase</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17199504</pubmed-id>
            <citation>Barrett C, Alley J, Pulido JC, Spurling H, Li P, Parsons T, Mallender WD, Bembenek ME: Configuration of a scintillation proximity assay for the activity assessment of recombinant human adenine phosphoribosyltransferase. Assay Drug Dev Technol. 2006 Dec;4(6):661-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07741" source="Swiss-Prot">
    <name>Adenine phosphoribosyltransferase</name>
    <general-function>Amp binding</general-function>
    <specific-function>Catalyzes a salvage reaction resulting in the formation of AMP, that is energically less costly than de novo synthesis.</specific-function>
    <gene-name>APRT</gene-name>
    <locus>16q24</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.82</theoretical-pi>
    <molecular-weight>19607.535</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:626</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>APRT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y00486</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>28819</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P07741</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>APT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.2.7</synonym>
      <synonym>APRT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036953|Adenine phosphoribosyltransferase
MADSELQLVEQRIRSFPDFPTPGVVFRDISPVLKDPASFRAAIGLLARHLKATHGGRIDY
IAGLDSRGFLFGPSLAQELGLGCVLIRKRGKLPGPTLWASYSLEYGKAELEIQKDALEPG
QRVVVVDDLLATGGTMNAACELLGRLQAEVLECVSLVELTSLKGREKLAPVPFFSLLQYE
</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0009945|Adenine phosphoribosyltransferase (APRT)
ATGGCCGACTCCGAGCTGCAGCTGGTTGAGCAGCGGATCCGCAGCTTCCCCGACTTCCCC
ACCCCAGGCGTGGTATTCAGGGACATCTCGCCCGTCCTGAAGGACCCCGCCTCCTTCCGC
GCCGCCATCGGCCTCCTGGCGCGACACCTGAAGGCGACCCACGGGGGCCGCATCGACTAC
ATCGCAGGCCTAGACTCCCGAGGCTTCCTCTTTGGCCCCTCCCTGGCCCAGGAGCTTGGA
CTGGGCTGCGTGCTCATCCGAAAGCGGGGGAAGCTGCCAGGCCCCACTCTGTGGGCCTCC
TATTCCCTGGAGTACGGGAAGGCTGAGCTGGAGATTCAGAAAGACGCCCTGGAGCCAGGA
CAGAGGGTGGTCGTCGTGGATGATCTGCTGGCCACTGGTGGAACCATGAACGCTGCCTGT
GAGCTGCTGGGCCGCCTGCAGGCTGAGGTCCTGGAGTGCGTGAGCCTGGTGGAGCTGACC
TCGCTTAAGGGCAGGGAGAAGCTGGCACCTGTACCCTTCTTCTCTCTCCTGCAGTATGAG
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00156</identifier>
        <name>Pribosyltran</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenine phosphoribosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine-containing compound salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenine salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>AMP salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to insulin stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>grooming behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters/>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00132</drugbank-id>
  <drugbank-id>NUTR00034</drugbank-id>
  <name>Alpha-Linolenic Acid</name>
  <description>Alpha-linolenic acid (ALA) is a polyunsaturated omega-3 fatty acid. It is a component of many common vegetable oils and is important to human nutrition.</description>
  <cas-number>463-40-1</cas-number>
  <unii>0RBV727H71</unii>
  <average-mass>278.4296</average-mass>
  <monoisotopic-mass>278.224580204</monoisotopic-mass>
  <state>liquid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>12438303</pubmed-id>
        <citation>Kris-Etherton PM, Harris WS, Appel LJ: Fish consumption, fish oil, omega-3 fatty acids, and cardiovascular disease. Circulation. 2002 Nov 19;106(21):2747-57.</citation>
      </article>
      <article>
        <pubmed-id>10617967</pubmed-id>
        <citation>Connor WE: Importance of n-3 fatty acids in health and disease. Am J Clin Nutr. 2000 Jan;71(1 Suppl):171S-5S.</citation>
      </article>
      <article>
        <pubmed-id>15051847</pubmed-id>
        <citation>Brouwer IA, Katan MB, Zock PL: Dietary alpha-linolenic acid is associated with reduced risk of fatal coronary heart disease, but increased prostate cancer risk: a meta-analysis. J Nutr. 2004 Apr;134(4):919-22.</citation>
      </article>
      <article>
        <pubmed-id>11157315</pubmed-id>
        <citation>Cho E, Hung S, Willett WC, Spiegelman D, Rimm EB, Seddon JM, Colditz GA, Hankinson SE: Prospective study of dietary fat and the risk of age-related macular degeneration. Am J Clin Nutr. 2001 Feb;73(2):209-18.</citation>
      </article>
      <article>
        <pubmed-id>10775263</pubmed-id>
        <citation>Lauritzen I, Blondeau N, Heurteaux C, Widmann C, Romey G, Lazdunski M: Polyunsaturated fatty acids are potent neuroprotectors. EMBO J. 2000 Apr 17;19(8):1784-93.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Jean-Pierre Masse, "Therapeutic composition containing alpha-linolenic acid and a compound capable of promoting the passage of the acid through the cell membrane, plant extract comprising the acid and the compound, and process for the preparation of the extract." U.S. Patent US5002767, issued February, 1986.</synthesis-reference>
  <indication>For nutritional supplementation and for treating dietary shortage or imbalance.</indication>
  <pharmacodynamics>Alpha Linolenic Acid (ALA) is an 18-carbon polyunsaturated fatty acid with three double bonds. It is also called an omega-3 fatty acid, and is essential for all mammals. Alpha-linolenic acid (or omega 3 fatty acid) intake can decrease the risk of cardiovascular diseases by 1) preventing arrhythmias that can lead to sudden cardiac death, 2) decreasing the risk of thrombosis (blood clot formation) that can lead to heart attack or stroke, 3) decreasing serum triglyceride levels, 4) slowing the growth of atherosclerotic plaque, 5) improving vascular endothelial function, 6) lowering blood pressure slightly, and 7) decreasing inflammation. ALA deficiencies can lead to visual problems and sensory neuropathy. Scaly and hemorrhagic skin or scalp inflammations may also develop.</pharmacodynamics>
  <mechanism-of-action>Alpha Linolenic Acid or ALA is considered an essential fatty acid because it is required for human health, but cannot be synthesized by humans. It is in fact  a plant-derived fatty acid. Humans can synthesize other omega-3 fatty acids from ALA, including eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA). EPA is a precursor of the series-3 prostaglandins, the series-5 leukotrienes and the series-3 thromboxanes. These eicosanoids have anti-inflammatory and anti-atherogenic properties. ALA metabolites may also inhibit the production of the pro-inflammatory eicosanoids, prostaglandin E2 (PGE2) and leukotriene B4 (LTB4), as well as the pro-inflammatory cytokines, tumor necrosis factor-alpha (TNF-alpha) and interleukin-1 beta (IL-1 beta). Omega-3 fatty acids like ALA and its byproducts can modulate the expression of a number of genes, including those involved with fatty acid metabolism and inflammation. They regulate gene expression through their effects on the activity of transcription factors including NF-kappa B and members of the peroxisome proliferator-activated receptor (PPAR) family. Incorporation of ALA and its metabolites in cell membranes can affect membrane fluidity and may play a role in anti-inflammatory activity, inhibition of platelet aggregation and possibly in anti-proliferative actions of ALA. ALA is first metabolized by delta6 desaturease into steridonic acid.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as lineolic acids and derivatives. These are derivatives of lineolic acid. Lineolic acid is a polyunsaturated omega-6 18 carbon long fatty acid, with two CC double bonds at the 9- and 12-positions.</description>
    <direct-parent>Lineolic acids and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Lipids and lipid-like molecules</superclass>
    <class>Fatty Acyls</class>
    <subclass>Lineolic acids and derivatives</subclass>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Long-chain fatty acids</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Straight chain fatty acids</alternative-parent>
    <alternative-parent>Unsaturated fatty acids</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Fatty acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Long-chain fatty acid</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Octadecanoid</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Straight chain fatty acid</substituent>
    <substituent>Unsaturated fatty acid</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">(9,12,15)-linolenic acid</synonym>
    <synonym language="" coder="">(9Z,12Z,15Z)-Octadecatrienoic acid</synonym>
    <synonym language="" coder="">(Z,Z,Z)-9,12,15-octadecatrienoic acid</synonym>
    <synonym language="" coder="">9-cis,12-cis,15-cis-octadecatrienoic acid</synonym>
    <synonym language="" coder="">9,12,15-Octadecatrienoic acid</synonym>
    <synonym language="" coder="">ALA</synonym>
    <synonym language="" coder="">all-cis-9,12,15-Octadecatrienoic acid</synonym>
    <synonym language="" coder="">alpha-Linolenic acid</synonym>
    <synonym language="" coder="">cis-delta(9,12,15)-Octadecatrienoic acid</synonym>
    <synonym language="" coder="">cis,cis,cis-9,12,15-Octadecatrienoic acid</synonym>
    <synonym language="" coder="">Linolenic acid</synonym>
    <synonym language="" coder="">α-linolenic acid</synonym>
  </synonyms>
  <products>
    <product>
      <name>Folcaps Care One</name>
      <labeller>Midlothian Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>68308-167</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Folcaps Omega-3</name>
      <labeller>Midlothian Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>68308-269</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-01-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>UltimateCare ONE NF</name>
      <labeller>Trigen Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>13811-050</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-04</started-marketing-on>
      <ended-marketing-on>2017-09-16</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Folcaps Care One</name>
      <ingredients>Alpha-Linolenic Acid + Biotin + Calcium Carbonate + Calcium threonate + Cholecalciferol + Doconexent + Docusate + Folic Acid + Icosapent + Iodine + Iron + Magnesium + Nicotinamide + Pyridoxine + Riboflavin + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Folcaps Omega-3</name>
      <ingredients>Alpha-Linolenic Acid + Calcium + Calcium threonate + Cholecalciferol + Doconexent + Ferrous asparto glycinate + Folic Acid + Icosapent + Iron + Pyridoxine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>UltimateCare ONE NF</name>
      <ingredients>Alpha-Linolenic Acid + Biotin + Calcium + Calcium threonate + Cholecalciferol + Doconexent + Docusate + Ferrous asparto glycinate + Folic Acid + Icosapent + Iodine + Iron + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Freeda Vitamins</name>
      <url>http://www.freedavitamins.com</url>
    </packager>
    <packager>
      <name>Sundown Inc.</name>
      <url>http://www.sundownnaturals.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Alpha-lipoic acid 50 mg caplet</description>
      <cost currency="USD">0.12</cost>
      <unit>caplet</unit>
    </price>
    <price>
      <description>Alpha lipoic acid 200 mg tablet</description>
      <cost currency="USD">0.22</cost>
      <unit>tablet</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Diet, Food, and Nutrition</category>
      <mesh-id>D000066888</mesh-id>
    </category>
    <category>
      <category>Dietary Fats</category>
      <mesh-id>D004041</mesh-id>
    </category>
    <category>
      <category>Dietary Fats, Unsaturated</category>
      <mesh-id>D004042</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Fats</category>
      <mesh-id>D005223</mesh-id>
    </category>
    <category>
      <category>Fatty Acids</category>
      <mesh-id>D005227</mesh-id>
    </category>
    <category>
      <category>Fatty Acids, Essential</category>
      <mesh-id>D005228</mesh-id>
    </category>
    <category>
      <category>Fatty Acids, Omega-3</category>
      <mesh-id>D015525</mesh-id>
    </category>
    <category>
      <category>Fatty Acids, Unsaturated</category>
      <mesh-id>D005231</mesh-id>
    </category>
    <category>
      <category>Fish Oils</category>
      <mesh-id>D005395</mesh-id>
    </category>
    <category>
      <category>Food</category>
      <mesh-id>D005502</mesh-id>
    </category>
    <category>
      <category>Food and Beverages</category>
      <mesh-id>D019602</mesh-id>
    </category>
    <category>
      <category>Linolenic Acids</category>
      <mesh-id>D008042</mesh-id>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Oils</category>
      <mesh-id>D009821</mesh-id>
    </category>
    <category>
      <category>Physiological Phenomena</category>
      <mesh-id>D010829</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1FK6</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00132.pdf?1265922751</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>6.62</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-6</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.66e-04 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.06</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(9Z,12Z,15Z)-octadeca-9,12,15-trienoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>α linolenic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>278.4296</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>278.224580204</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C18H30O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C18H30O2/c1-2-3-4-5-6-7-8-9-10-11-12-13-14-15-16-17-18(19)20/h3-4,6-7,9-10H,2,5,8,11-17H2,1H3,(H,19,20)/b4-3-,7-6-,10-9-</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>DTOSIQBPPRVQHS-PDBXOOCHSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>37.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>89.64</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>34.98</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>13</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>4.99</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>0.000124 mg/mL at 25 °C</value>
      <source>MEYLAN,WM et al. (1996)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>-16.5 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>231 °C at 1.70E+01 mm Hg</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>6.46</value>
      <source>SANGSTER (1993)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>27432</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>5280934</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507620</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C06427</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>4444437</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50240347</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449384</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>LNL</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>1049</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>1049</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Alpha-linolenic_acid</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL8739</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP00018</smpdb-id>
      <name>Alpha Linolenic Acid and Linoleic Acid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00132</drugbank-id>
          <name>Alpha-Linolenic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00154</drugbank-id>
          <name>Dihomo-gamma-linolenic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00159</drugbank-id>
          <name>Icosapent</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>O95864</uniprot-id>
        <uniprot-id>Q9NYP7</uniprot-id>
        <uniprot-id>O60427</uniprot-id>
        <uniprot-id>Q9GZR5</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000888</id>
      <name>Fatty acid desaturase 1</name>
      <organism>Human</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16988497</pubmed-id>
            <citation>Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19.</citation>
          </article>
          <article>
            <pubmed-id>8673626</pubmed-id>
            <citation>Descomps B, Rodriguez A: [Essential fatty acids and prematurity: a triple experimental approach]. C R Seances Soc Biol Fil. 1995;189(5):781-96.</citation>
          </article>
          <article>
            <pubmed-id>11518758</pubmed-id>
            <citation>Hoffman DR, DeMar JC, Heird WC, Birch DG, Anderson RE: Impaired synthesis of DHA in patients with X-linked retinitis pigmentosa. J Lipid Res. 2001 Sep;42(9):1395-401.</citation>
          </article>
          <article>
            <pubmed-id>8487621</pubmed-id>
            <citation>Maniongui C, Blond JP, Ulmann L, Durand G, Poisson JP, Bezard J: Age-related changes in delta 6 and delta 5 desaturase activities in rat liver microsomes. Lipids. 1993 Apr;28(4):291-7.</citation>
          </article>
          <article>
            <pubmed-id>10765977</pubmed-id>
            <citation>Mohan IK, Das UN: Effect of L-arginine-nitric oxide system on the metabolism of essential fatty acids in chemical-induced diabetes mellitus. Prostaglandins Leukot Essent Fatty Acids. 2000 Jan;62(1):35-46.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="O60427" source="Swiss-Prot">
    <name>Fatty acid desaturase 1</name>
    <general-function>Oxidoreductase activity</general-function>
    <specific-function>Isoform 2 does not exhibit any catalytic activity toward 20:3n-6, but it may enhance FADS2 activity (By similarity). Isoform 1 is a component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the desaturation of dihomo-gamma-linoleic acid (DHGLA) (20:3n-6) and eicosatetraenoic acid (20:4n-3) to generate arachidonic acid (AA) (20:4n-6) and eicosapentaenoic acid (EPA)(20:5n-3), respectively.</specific-function>
    <gene-name>FADS1</gene-name>
    <locus/>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>122-142
146-170
268-288
306-326</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.15</theoretical-pi>
    <molecular-weight>51963.945</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3574</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>DKFZp762M2311</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AC004770</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3169158</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60427</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FADS1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.19.-</synonym>
      <synonym>D5D</synonym>
      <synonym>Delta-5 desaturase</synonym>
      <synonym>Delta(5) desaturase</synonym>
      <synonym>Delta(5) fatty acid desaturase</synonym>
      <synonym>FADSD5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001770|Fatty acid desaturase 1
MAPDPVAAETAAQGPTPRYFTWDEVAQRSGCEERWLVIDRKVYNISEFTRRHPGGSRVIS
HYAGQDATDPFVAFHINKGLVKKYMNSLLIGELSPEQPSFEPTKNKELTDEFRELRATVE
RMGLMKANHVFFLLYLLHILLLDGAAWLTLWVFGTSFLPFLLCAVLLSAVQAQAGWLQHD
FGHLSVFSTSKWNHLLHHFVIGHLKGAPASWWNHMHFQHHAKPNCFRKDPDINMHPFFFA
LGKILSVELGKQKKKYMPYNHQHKYFFLIGPPALLPLYFQWYIFYFVIQRKKWVDLAWMI
TFYVRFFLTYVPLLGLKAFLGLFFIVRFLESNWFVWVTQMNHIPMHIDHDRNMDWVSTQL
QATCNVHKSAFNDWFSGHLNFQIEHHLFPTMPRHNYHKVAPLVQSLCAKHGIEYQSKPLL
SAFADIIHSLKESGQLWLDAYLHQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010626|Fatty acid desaturase 1 (FADS1)
ATGGGAACGCGCGCTGCGAGGCCCGCCGGTCTGCCCTGCGGTGCTGAAAACCCGGCGCGC
AGGCGGCTGGCTCTGGGCGCGCGCCAGCAAATCCACTCCTGGAGCCCGCGGACCCCGAGC
ACGCGCCTGACAGCCCCTGCTGGCCCGGCGCGCGGCGTCGCCAGGCCAGCTATGGCCCCC
GACCCGGTGGCCGCCGAGACCGCGGCTCAGGGACCTACCCCGCGCTACTTCACCTGGGAC
GAGGTGGCCCAGCGCTCAGGGTGCGAGGAGCGGTGGCTAGTGATCGACCGTAAGGTGTAC
AACATCAGCGAGTTCACCCGCCGGCATCCAGGGGGCTCCCGGGTCATCAGCCACTACGCC
GGGCAGGATGCCACGGATCCCTTTGTGGCCTTCCACATCAACAAGGGCCTTGTGAAGAAG
TATATGAACTCTCTCCTGATTGGAGAACTGTCTCCAGAGCAGCCCAGCTTTGAGCCCACC
AAGAATAAAGAGCTGACAGATGAGTTCCGGGAGCTGCGGGCCACAGTGGAGCGGATGGGG
CTCATGAAGGCCAACCATGTCTTCTTCCTGCTGTACCTGCTGCACATCTTGCTGCTGGAT
GGTGCAGCCTGGCTCACCCTTTGGGTCTTTGGGACGTCCTTTTTGCCCTTCCTCCTCTGT
GCGGTGCTGCTCAGTGCAGTTCAGGCCCAGGCTGGCTGGCTGCAGCATGACTTTGGGCAC
CTGTCGGTCTTCAGCACCTCAAAGTGGAACCATCTGCTACATCATTTTGTGATTGGCCAC
CTGAAGGGGGCCCCCGCCAGTTGGTGGAACCACATGCACTTCCAGCACCATGCCAAGCCC
AACTGCTTCCGCAAAGACCCAGACATCAACATGCATCCCTTCTTCTTTGCCTTGGGGAAG
ATCCTCTCTGTGGAGCTTGGGAAACAGAAGAAAAAATATATGCCGTACAACCACCAGCAC
AAATACTTCTTCCTAATTGGGCCCCCAGCCTTGCTGCCTCTCTACTTCCAGTGGTATATT
TTCTATTTTGTTATCCAGCGAAAGAAGTGGGTGGACTTGGCCTGGATGATTACCTTCTAC
GTCCGCTTCTTCCTCACTTATGTGCCACTATTGGGGCTGAAAGCCTTCCTGGGCCTTTTC
TTCATAGTCAGGTTCCTGGAAAGCAACTGGTTTGTGTGGGTGACACAGATGAACCATATT
CCCATGCACATTGATCATGACCGGAACATGGACTGGGTTTCCACCCAGCTCCAGGCCACA
TGCAATGTCCACAAGTCTGCCTTCAATGACTGGTTCAGTGGACACCTCAACTTCCAGATT
GAGCACCATCTTTTTCCCACGATGCCTCGACACAATTACCACAAAGTGGCTCCCCTGGTG
CAGTCCTTGTGTGCCAAGCATGGCATAGAGTACCAGTCCAAGCCCCTGCTGTCAGCCTTC
GCCGACATCATCCACTCACTAAAGGAGTCAGGGCAGCTCTGGCTAGATGCCTATCTTCAC
CAATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00173</identifier>
        <name>Cyt-b5</name>
      </pfam>
      <pfam>
        <identifier>PF00487</identifier>
        <name>FA_desaturase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>C-5 sterol desaturase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alpha-linolenic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>unsaturated fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>icosanoid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell-cell signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>linoleic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phospholipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>unsaturated fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002246</id>
      <name>Fatty acid desaturase 2</name>
      <organism>Human</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17409318</pubmed-id>
            <citation>Portolesi R, Powell BC, Gibson RA: Competition between 24:5n-3 and ALA for Delta 6 desaturase may limit the accumulation of DHA in HepG2 cell membranes. J Lipid Res. 2007 Jul;48(7):1592-8. Epub 2007 Apr 4.</citation>
          </article>
          <article>
            <pubmed-id>16988497</pubmed-id>
            <citation>Xiang M, Rahman MA, Ai H, Li X, Harbige LS: Diet and gene expression: delta-5 and delta-6 desaturases in healthy Chinese and European subjects. Ann Nutr Metab. 2006;50(6):492-8. Epub 2006 Sep 19.</citation>
          </article>
          <article>
            <pubmed-id>17284757</pubmed-id>
            <citation>Baylin A, Ruiz-Narvaez E, Kraft P, Campos H: alpha-Linolenic acid, Delta6-desaturase gene polymorphism, and the risk of nonfatal myocardial infarction. Am J Clin Nutr. 2007 Feb;85(2):554-60.</citation>
          </article>
          <article>
            <pubmed-id>15481543</pubmed-id>
            <citation>Li MC, Bu YP, Wang GK, Hu GW, Xing LJ: [Heteologous expression of Mortierella isabellina delta6 -fatty acid desaturase gene in soybean]. Yi Chuan Xue Bao. 2004 Aug;31(8):858-63.</citation>
          </article>
          <article>
            <pubmed-id>12713571</pubmed-id>
            <citation>Ge L, Gordon JS, Hsuan C, Stenn K, Prouty SM: Identification of the delta-6 desaturase of human sebaceous glands: expression and enzyme activity. J Invest Dermatol. 2003 May;120(5):707-14.</citation>
          </article>
          <article>
            <pubmed-id>21210105</pubmed-id>
            <citation>Tan L, Meesapyodsuk D, Qiu X: Molecular analysis of 6 desaturase and 6 elongase from Conidiobolus obscurus in the biosynthesis of eicosatetraenoic acid, a omega3 fatty acid with nutraceutical potentials. Appl Microbiol Biotechnol. 2011 Apr;90(2):591-601. doi: 10.1007/s00253-010-3060-y. Epub 2011 Jan 6.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="O95864" source="Swiss-Prot">
    <name>Fatty acid desaturase 2</name>
    <general-function>Stearoyl-coa 9-desaturase activity</general-function>
    <specific-function>Component of a lipid metabolic pathway that catalyzes biosynthesis of highly unsaturated fatty acids (HUFA) from precursor essential polyunsaturated fatty acids (PUFA) linoleic acid (LA) (18:2n-6) and alpha-linolenic acid (ALA) (18:3n-3). Catalyzes the first and rate limiting step in this pathway which is the desaturation of LA (18:2n-6) and ALA (18:3n-3) into gamma-linoleic acid (GLA) (18:3n-6) and stearidonic acid (18:4n-3) respectively and other desaturation steps. Highly unsaturated fatty acids (HUFA) play pivotal roles in many biological functions. It catalizes as well the introduction of a cis double bond in palmitate to produce the mono-unsaturated fatty acid sapienate, the most abundant fatty acid in sebum.</specific-function>
    <gene-name>FADS2</gene-name>
    <locus>11q12-q13.1</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>132-152
158-178
265-285
306-326</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.18</theoretical-pi>
    <molecular-weight>52259.075</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3575</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FADS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF126799</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4406528</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O95864</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FADS2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.19.3</synonym>
      <synonym>Acyl-CoA 6-desaturase</synonym>
      <synonym>D6D</synonym>
      <synonym>Delta-6 desaturase</synonym>
      <synonym>Delta(6) desaturase</synonym>
      <synonym>Delta(6) fatty acid desaturase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004408|Fatty acid desaturase 2
MGKGGNQGEGAAEREVSVPTFSWEEIQKHNLRTDRWLVIDRKVYNITKWSIQHPGGQRVI
GHYAGEDATDAFRAFHPDLEFVGKFLKPLLIGELAPEEPSQDHGKNSKITEDFRALRKTA
EDMNLFKTNHVFFLLLLAHIIALESIAWFTVFYFGNGWIPTLITAFVLATSQAQAGWLQH
DYGHLSVYRKPKWNHLVHKFVIGHLKGASANWWNHRHFQHHAKPNIFHKDPDVNMLHVFV
LGEWQPIEYGKKKLKYLPYNHQHEYFFLIGPPLLIPMYFQYQIIMTMIVHKNWVDLAWAV
SYYIRFFITYIPFYGILGALLFLNFIRFLESHWFVWVTQMNHIVMEIDQEAYRDWFSSQL
TATCNVEQSFFNDWFSGHLNFQIEHHLFPTMPRHNLHKIAPLVKSLCAKHGIEYQEKPLL
RALLDIIRSLKKSGKLWLDAYLHK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011620|Fatty acid desaturase 2 (FADS2)
ATGCACGGCAGGGAGGCGGGACCCTTTGTTTGTGTGTGCGTGTTGTTGGCCTCCATCCCC
ACTCCCCAGACTCCACTTCTCCAGGCCTCTCTCCCGCCTTTTCATCCCGCATCCGCAGGA
CACCCAATCACCGGGCAACAGGATGCCTTCCGCGCCTTCCACCCTGACCTGGAATTCGTG
GGCAAGTTCTTGAAACCCCTGCTGATTGGTGAACTGGCCCCGGAGGAGCCCAGCCAGGAC
CACGGCAAGAACTCAAAGATCACTGAGGACTTCCGGGCCCTGAGGAAGACGGCTGAGGAC
ATGAACCTGTTCAAGACCAACCACGTGTTCTTCCTCCTCCTCCTGGCCCACATCATCGCC
CTGGAGAGCATTGCATGGTTCACTGTCTTTTACTTTGGCAATGGCTGGATTCCTACCCTC
ATCACGGCCTTTGTCCTTGCTACCTCTCAGGCCCAAGCTGGATGGCTGCAACATGATTAT
GGCCACCTGTCTGTCTACAGAAAACCCAAGTGGAACCACCTTGTCCACAAATTCGTCATT
GGCCACTTAAAGGGTGCCTCTGCCAACTGGTGGAATCATCGCCACTTCCAGCACCACGCC
AAGCCTAACATCTTCCACAAGGATCCCGATGTGAACATGCTGCACGTGTTTGTTCTGGGC
GAATGGCAGCCCATCGAGTACGGCAAGAAGAAGCTGAAATACCTGCCCTACAATCACCAG
CACGAATACTTCTTCCTGATTGGGCCGCCGCTGCTCATCCCCATGTATTTCCAGTACCAG
ATCATCATGACCATGATCGTCCATAAGAACTGGGTGGACCTGGCCTGGGCCGTCAGCTAC
TACATCCGGTTCTTCATCACCTACATCCCTTTCTACGGCATCCTGGGAGCCCTCCTTTTC
CTCAACTTCATCAGGTTCCTGGAGAGCCACTGGTTTGTGTGGGTCACACAGATGAATCAC
ATCGTCATGGAGATTGACCAGGAGGCCTACCGTGACTGGTTCAGTAGCCAGCTGACAGCC
ACCTGCAACGTGGAGCAGTCCTTCTTCAACGACTGGTTCAGTGGACACCTTAACTTCCAG
ATTGAGCACCACCTCTTCCCCACCATGCCCCGGCACAACTTACACAAGATCGCCCCGCTG
GTGAAGTCTCTATGTGCCAAGCATGGCATTGAATACCAGGAGAAGCCGCTACTGAGGGCC
CTGCTGGACATCATCAGGTCCCTGAAGAAGTCTGGGAAGCTGTGGCTGGACGCCTACCTT
CACAAATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00173</identifier>
        <name>Cyt-b5</name>
      </pfam>
      <pfam>
        <identifier>PF00487</identifier>
        <name>FA_desaturase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>linoleoyl-CoA desaturase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>stearoyl-CoA 9-desaturase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>unsaturated fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alpha-linolenic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>unsaturated fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>linoleic acid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000986</id>
      <name>Sodium/calcium exchanger 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>17059813</pubmed-id>
            <citation>Ander BP, Hurtado C, Raposo CS, Maddaford TG, Deniset JF, Hryshko LV, Pierce GN, Lukas A: Differential sensitivities of the NCX1.1 and NCX1.3 isoforms of the Na+-Ca2+ exchanger to alpha-linolenic acid. Cardiovasc Res. 2007 Jan 15;73(2):395-403. Epub 2006 Sep 23.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P32418" source="Swiss-Prot">
    <name>Sodium/calcium exchanger 1</name>
    <general-function>Ion channel binding</general-function>
    <specific-function>Mediates the exchange of one Ca(2+) ion against three to four Na(+) ions across the cell membrane, and thereby contributes to the regulation of cytoplasmic Ca(2+) levels and Ca(2+)-dependent cellular processes (PubMed:1374913, PubMed:11241183, PubMed:1476165). Contributes to Ca(2+) transport during excitation-contraction coupling in muscle. In a first phase, voltage-gated channels mediate the rapid increase of cytoplasmic Ca(2+) levels due to release of Ca(2+) stores from the endoplasmic reticulum. SLC8A1 mediates the export of Ca(2+) from the cell during the next phase, so that cytoplasmic Ca(2+) levels rapidly return to baseline. Required for normal embryonic heart development and the onset of heart contractions.</specific-function>
    <gene-name>SLC8A1</gene-name>
    <locus>2p23-p22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>75-95
137-157
171-191
205-225
232-252
801-821
825-845
875-895
907-927
945-965</transmembrane-regions>
    <signal-regions>1-35</signal-regions>
    <theoretical-pi>4.64</theoretical-pi>
    <molecular-weight>108546.06</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11068</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC8A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M91368</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>180673</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P32418</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NAC1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>CNC</synonym>
      <synonym>Na(+)/Ca(2+)-exchange protein 1</synonym>
      <synonym>NCX1</synonym>
      <synonym>Solute carrier family 8 member 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001963|Sodium/calcium exchanger 1
MYNMRRLSLSPTFSMGFHLLVTVSLLFSHVDHVIAETEMEGEGNETGECTGSYYCKKGVI
LPIWEPQDPSFGDKIARATVYFVAMVYMFLGVSIIADRFMSSIEVITSQEKEITIKKPNG
ETTKTTVRIWNETVSNLTLMALGSSAPEILLSVIEVCGHNFTAGDLGPSTIVGSAAFNMF
IIIALCVYVVPDGETRKIKHLRVFFVTAAWSIFAYTWLYIILSVISPGVVEVWEGLLTFF
FFPICVVFAWVADRRLLFYKYVYKRYRAGKQRGMIIEHEGDRPSSKTEIEMDGKVVNSHV
ENFLDGALVLEVDERDQDDEEARREMARILKELKQKHPDKEIEQLIELANYQVLSQQQKS
RAFYRIQATRLMTGAGNILKRHAADQARKAVSMHEVNTEVTENDPVSKIFFEQGTYQCLE
NCGTVALTIIRRGGDLTNTVFVDFRTEDGTANAGSDYEFTEGTVVFKPGDTQKEIRVGII
DDDIFEEDENFLVHLSNVKVSSEASEDGILEANHVSTLACLGSPSTATVTIFDDDHAGIF
TFEEPVTHVSESIGIMEVKVLRTSGARGNVIVPYKTIEGTARGGGEDFEDTCGELEFQND
EIVKTISVKVIDDEEYEKNKTFFLEIGEPRLVEMSEKKALLLNELGGFTITGKYLFGQPV
FRKVHAREHPILSTVITIADEYDDKQPLTSKEEEERRIAEMGRPILGEHTKLEVIIEESY
EFKSTVDKLIKKTNLALVVGTNSWREQFIEAITVSAGEDDDDDECGEEKLPSCFDYVMHF
LTVFWKVLFAFVPPTEYWNGWACFIVSILMIGLLTAFIGDLASHFGCTIGLKDSVTAVVF
VALGTSVPDTFASKVAATQDQYADASIGNVTGSNAVNVFLGIGVAWSIAAIYHAANGEQF
KVSPGTLAFSVTLFTIFAFINVGVLLYRRRPEIGGELGGPRTAKLLTSCLFVLLWLLYIF
FSSLEAYCHIKGF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016275|Sodium/calcium exchanger 1 (SLC8A1)
ATGTACAACATGCGGCGATTAAGTCTTTCACCCACCTTTTCAATGGGATTTCATCTGTTA
GTTACTGTGAGTCTCTTATTTTCCCATGTGGACCATGTAATTGCTGAGACAGAAATGGAA
GGAGAAGGAAATGAAACTGGTGAATGTACTGGATCATATTACTGTAAGAAAGGGGTGATT
TTGCCCATTTGGGAACCCCAAGACCCTTCTTTTGGGGACAAAATTGCTAGAGCTACTGTG
TATTTTGTGGCCATGGTCTACATGTTTCTTGGAGTCTCTATCATAGCTGATCGGTTCATG
TCCTCTATAGAAGTCATCACATCTCAAGAAAAAGAAATAACCATAAAGAAACCCAATGGA
GAGACCACCAAGACAACTGTGAGGATCTGGAATGAAACAGTTTCTAACCTGACCTTGATG
GCCCTGGGATCTTCTGCTCCTGAGATTCTCCTTTCAGTAATTGAAGTGTGTGGCCATAAC
TTCACTGCAGGAGACCTCGGTCCTAGCACCATCGTGGGAAGTGCTGCATTCAATATGTTC
ATCATTATTGCACTCTGTGTTTATGTGGTGCCTGACGGAGAGACAAGGAAGATTAAGCAT
TTGCGTGTCTTCTTTGTGACAGCAGCCTGGAGCATCTTTGCCTACACCTGGCTTTACATT
ATTTTGTCTGTCATATCTCCTGGTGTTGTGGAGGTCTGGGAAGGTTTGCTTACTTTCTTC
TTCTTTCCCATCTGTGTTGTGTTCGCTTGGGTAGCGGATAGGAGACTTCTGTTTTACAAG
TATGTCTACAAGAGGTATCGAGCTGGCAAGCAGAGGGGGATGATTATTGAACATGAAGGA
GACAGGCCATCTTCTAAGACTGAAATTGAAATGGACGGGAAAGTGGTCAATTCTCATGTT
GAAAATTTCTTAGATGGTGCTCTGGTTCTGGAGGTGGATGAGAGGGACCAAGATGATGAA
GAAGCTAGGCGAGAAATGGCTAGGATTCTGAAGGAACTTAAGCAGAAGCATCCAGATAAA
GAAATAGAGCAATTAATAGAATTAGCTAACTACCAAGTCCTAAGTCAGCAGCAAAAAAGT
AGAGCATTTTATCGCATTCAAGCTACTCGCCTCATGACTGGAGCTGGCAACATTTTAAAG
AGGCATGCAGCTGACCAAGCAAGGAAGGCTGTCAGCATGCACGAGGTCAACACTGAAGTG
ACTGAAAATGACCCTGTTAGTAAGATCTTCTTTGAACAAGGGACATATCAGTGTCTGGAG
AACTGTGGTACTGTGGCCCTTACCATTATCCGCAGAGGTGGTGATTTGACTAACACTGTG
TTTGTTGACTTCAGAACAGAGGATGGCACAGCAAATGCTGGGTCTGATTATGAATTTACT
GAAGGAACTGTGGTGTTTAAGCCTGGTGATACCCAGAAGGAAATCAGAGTGGGTATCATA
GATGATGATATCTTTGAGGAGGATGAAAATTTCCTTGTGCATCTCAGCAATGTCAAAGTA
TCTTCTGAAGCTTCAGAAGATGGCATACTGGAAGCCAATCATGTTTCTACACTTGCTTGC
CTCGGATCTCCCTCCACTGCCACTGTAACTATTTTTGATGATGACCACGCAGGCATTTTT
ACTTTTGAGGAACCTGTGACTCATGTGAGTGAGAGCATTGGCATCATGGAGGTGAAAGTA
TTGAGAACATCTGGAGCTCGAGGAAATGTTATCGTTCCATATAAAACCATCGAAGGGACT
GCCAGAGGTGGAGGGGAGGATTTTGAGGACACTTGTGGAGAGCTCGAATTCCAGAATGAT
GAAATTGTCAAAACAATATCAGTCAAGGTAATTGATGATGAGGAGTATGAGAAAAACAAG
ACCTTCTTCCTTGAGATTGGAGAGCCCCGCCTGGTGGAGATGAGTGAGAAGAAAGCCCTG
TTATTGAATGAGCTTGGTGGCTTCACAATAACAGGCCAACCTGTCTTCAGGAAGGTTCAT
GCTAGAGAACATCCGATTCTCTCTACTGTAATCACCATTGCAGACGAATATGATGACAAG
CAGCCACTGACCAGCAAAGAGGAAGAGGAGAGGCGCATTGCAGAAATGGGGCGCCCCATC
CTGGGAGAGCACACCAAGTTGGAAGTGATCATTGAAGAATCCTATGAATTCAAGAGTACT
GTGGACAAACTCATTAAGAAGACAAACCTGGCCCTTGTGGTTGGGACTAACAGCTGGAGA
GAACAGTTCATTGAAGCTATCACTGTCAGTGCTGGGGAAGATGATGACGACGATGAATGT
GGGGAAGAGAAGCTGCCCTCCTGTTTCGATTACGTGATGCACTTTCTGACTGTGTTCTGG
AAGGTCCTGTTTGCCTTCGTCCCCCCTACTGAATACTGGAATGGCTGGGCGTGTTTCATT
GTCTCCATCCTCATGATTGGCCTACTGACAGCTTTCATTGGAGACCTGGCTTCCCACTTT
GGCTGCACCATTGGCCTGAAAGATTCTGTGACTGCAGTCGTGTTCGTCGCACTTGGAACA
TCAGTGCCAGACACATTTGCCAGCAAAGTGGCAGCCACCCAGGACCAGTATGCAGACGCC
TCCATAGGTAACGTCACGGGCAGCAACGCGGTGAATGTCTTCCTGGGAATCGGTGTGGCC
TGGTCCATCGCTGCCATCTACCACGCAGCCAATGGGGAACAGTTCAAAGTGTCCCCTGGC
ACACTAGCTTTCTCTGTCACTCTCTTCACCATTTTTGCTTTCATCAATGTGGGGGTGCTG
CTGTATCGGCGGAGGCCAGAAATCGGAGGTGAGCTGGGTGGGCCCCGGACTGCCAAGCTC
CTCACATCCTGCCTCTTTGTGCTCCTATGGCTCTTGTACATTTTCTTCTCCTCCCTGGAG
GCCTACTGCCACATAAAAGGCTTCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03160</identifier>
        <name>Calx-beta</name>
      </pfam>
      <pfam>
        <identifier>PF01699</identifier>
        <name>Na_Ca_ex</name>
      </pfam>
      <pfam>
        <identifier>PF16494</identifier>
        <name>Na_Ca_ex_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intercalated disc</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sarcolemma</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>microtubule</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>T-tubule</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Z disc</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic shaft</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ankyrin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ion channel binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cytoskeletal protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transport into cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion export</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of the force of heart contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of bone mineralization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryonic placenta development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cytosolic calcium ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>muscle contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hydrogen peroxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cell communication by electrical coupling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-embryonic development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of the force of heart contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>relaxation of smooth muscle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of sodium ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to muscle stretch</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryonic heart tube development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium ion import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ATP</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell communication by electrical coupling involved in cardiac conduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular smooth muscle contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucose</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cardiac muscle contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to cAMP</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to immobilization stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cardiac muscle cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle contraction by calcium ion signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane depolarization during cardiac muscle cell action potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cytosolic calcium ion concentration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>muscle fiber development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fibroblast migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of heart rate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular sodium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium ion export</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>telencephalon development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to reactive oxygen species</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>relaxation of cardiac muscle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to caffeine</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001023</id>
      <name>Transient receptor potential cation channel subfamily V member 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8NER1" source="Swiss-Prot">
    <name>Transient receptor potential cation channel subfamily V member 1</name>
    <general-function>Transmembrane signaling receptor activity</general-function>
    <specific-function>Ligand-activated non-selective calcium permeant cation channel involved in detection of noxious chemical and thermal stimuli. Seems to mediate proton influx and may be involved in intracellular acidosis in nociceptive neurons. Involved in mediation of inflammatory pain and hyperalgesia. Sensitized by a phosphatidylinositol second messenger system activated by receptor tyrosine kinases, which involves PKC isozymes and PCL. Can be activated by endogenous compounds, including 12-hydroperoxytetraenoic acid and bradykinin. Acts as ionotropic endocannabinoid receptor with central neuromodulatory effects. Triggers a form of long-term depression (TRPV1-LTD) mediated by the endocannabinoid anandamine in the hippocampus and nucleus accumbens by affecting AMPA receptors endocytosis (By similarity). Activation by vanilloids, like capsaicin, and temperatures higher than 42 degrees Celsius, exhibits a time- and Ca(2+)-dependent outward rectification, followed by a long-lasting refractory state. Mild extracellular acidic pH (6.5) potentiates channel activation by noxious heat and vanilloids, whereas acidic conditions (pH &lt;6) directly activate the channel.</specific-function>
    <gene-name>TRPV1</gene-name>
    <locus>17p13.3</locus>
    <cellular-location>Cell junction</cellular-location>
    <transmembrane-regions>434-454
472-497
511-531
536-556
572-599
659-687</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.26</theoretical-pi>
    <molecular-weight>94955.33</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:12716</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TRPV1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ277028</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>8977866</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>507</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>507</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8NER1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>TRPV1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Capsaicin receptor</synonym>
      <synonym>Osm-9-like TRP channel 1</synonym>
      <synonym>OTRPC1</synonym>
      <synonym>TrpV1</synonym>
      <synonym>Vanilloid receptor 1</synonym>
      <synonym>VR1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037113|Transient receptor potential cation channel subfamily V member 1
MKKWSSTDLGAAADPLQKDTCPDPLDGDPNSRPPPAKPQLSTAKSRTRLFGKGDSEEAFP
VDCPHEEGELDSCPTITVSPVITIQRPGDGPTGARLLSQDSVAASTEKTLRLYDRRSIFE
AVAQNNCQDLESLLLFLQKSKKHLTDNEFKDPETGKTCLLKAMLNLHDGQNTTIPLLLEI
ARQTDSLKELVNASYTDSYYKGQTALHIAIERRNMALVTLLVENGADVQAAAHGDFFKKT
KGRPGFYFGELPLSLAACTNQLGIVKFLLQNSWQTADISARDSVGNTVLHALVEVADNTA
DNTKFVTSMYNEILMLGAKLHPTLKLEELTNKKGMTPLALAAGTGKIGVLAYILQREIQE
PECRHLSRKFTEWAYGPVHSSLYDLSCIDTCEKNSVLEVIAYSSSETPNRHDMLLVEPLN
RLLQDKWDRFVKRIFYFNFLVYCLYMIIFTMAAYYRPVDGLPPFKMEKTGDYFRVTGEIL
SVLGGVYFFFRGIQYFLQRRPSMKTLFVDSYSEMLFFLQSLFMLATVVLYFSHLKEYVAS
MVFSLALGWTNMLYYTRGFQQMGIYAVMIEKMILRDLCRFMFVYIVFLFGFSTAVVTLIE
DGKNDSLPSESTSHRWRGPACRPPDSSYNSLYSTCLELFKFTIGMGDLEFTENYDFKAVF
IILLLAYVILTYILLLNMLIALMGETVNKIAQESKNIWKLQRAITILDTEKSFLKCMRKA
FRSGKLLQVGYTPDGKDDYRWCFRVDEVNWTTWNTNVGIINEDPGNCEGVKRTLSFSLRS
SRVSGRHWKNFALVPLLREASARDRQSAQPEEVYLRQFSGSLKPEDAEVFKSPAASGEK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020500|Transient receptor potential cation channel subfamily V member 1 (TRPV1)
ATGAAGAAATGGAGCAGCACAGACTTGGGGGCAGCTGCGGACCCACTCCAAAAGGACACC
TGCCCAGACCCCCTGGATGGAGACCCTAACTCCAGGCCACCTCCAGCCAAGCCCCAGCTC
TCCACGGCCAAGAGCCGCACCCGGCTCTTTGGGAAGGGTGACTCGGAGGAGGCTTTCCCG
GTGGATTGCCCTCACGAGGAAGGTGAGCTGGACTCCTGCCCGACCATCACAGTCAGCCCT
GTTATCACCATCCAGAGGCCAGGAGACGGCCCCACCGGTGCCAGGCTGCTGTCCCAGGAC
TCTGTCGCCGCCAGCACCGAGAAGACCCTCAGGCTCTATGATCGCAGGAGTATCTTTGAA
GCCGTTGCTCAGAATAACTGCCAGGATCTGGAGAGCCTGCTGCTCTTCCTGCAGAAGAGC
AAGAAGCACCTCACAGACAACGAGTTCAAAGACCCTGAGACAGGGAAGACCTGTCTGCTG
AAAGCCATGCTCAACCTGCACGACGGACAGAACACCACCATCCCCCTGCTCCTGGAGATC
GCGCGGCAAACGGACAGCCTGAAGGAGCTTGTCAACGCCAGCTACACGGACAGCTACTAC
AAGGGCCAGACAGCACTGCACATCGCCATCGAGAGACGCAACATGGCCCTGGTGACCCTC
CTGGTGGAGAACGGAGCAGACGTCCAGGCTGCGGCCCATGGGGACTTCTTTAAGAAAACC
AAAGGGCGGCCTGGATTCTACTTCGGTGAACTGCCCCTGTCCCTGGCCGCGTGCACCAAC
CAGCTGGGCATCGTGAAGTTCCTGCTGCAGAACTCCTGGCAGACGGCCGACATCAGCGCC
AGGGACTCGGTGGGCAACACGGTGCTGCACGCCCTGGTGGAGGTGGCCGACAACACGGCC
GACAACACGAAGTTTGTGACGAGCATGTACAATGAGATTCTGATGCTGGGGGCCAAACTG
CACCCGACGCTGAAGCTGGAGGAGCTCACCAACAAGAAGGGAATGACGCCGCTGGCTCTG
GCAGCTGGGACCGGGAAGATCGGGGTCTTGGCCTATATTCTCCAGCGGGAGATCCAGGAG
CCCGAGTGCAGGCACCTGTCCAGGAAGTTCACCGAGTGGGCCTACGGGCCCGTGCACTCC
TCGCTGTACGACCTGTCCTGCATCGACACCTGCGAGAAGAACTCGGTGCTGGAGGTGATC
GCCTACAGCAGCAGCGAGACCCCTAATCGCCACGACATGCTCTTGGTGGAGCCGCTGAAC
CGACTCCTGCAGGACAAGTGGGACAGATTCGTCAAGCGCATCTTCTACTTCAACTTCCTG
GTCTACTGCCTGTACATGATCATCTTCACCATGGCTGCCTACTACAGGCCCGTGGATGGC
TTGCCTCCCTTTAAGATGGAAAAAACTGGAGACTATTTCCGAGTTACTGGAGAGATCCTG
TCTGTGTTAGGAGGAGTCTACTTCTTTTTCCGAGGGATTCAGTATTTCCTGCAGAGGCGG
CCGTCGATGAAGACCCTGTTTGTGGACAGCTACAGTGAGATGCTTTTCTTTCTGCAGTCA
CTGTTCATGCTGGCCACCGTGGTGCTGTACTTCAGCCACCTCAAGGAGTATGTGGCTTCC
ATGGTATTCTCCCTGGCCTTGGGCTGGACCAACATGCTCTACTACACCCGCGGTTTCCAG
CAGATGGGCATCTATGCCGTCATGATAGAGAAGATGATCCTGAGAGACCTGTGCCGTTTC
ATGTTTGTCTACATCGTCTTCTTGTTCGGGTTTTCCACAGCGGTGGTGACGCTGATTGAA
GACGGGAAGAATGACTCCCTGCCGTCTGAGTCCACGTCGCACAGGTGGCGGGGGCCTGCC
TGCAGGCCCCCCGATAGCTCCTACAACAGCCTGTACTCCACCTGCCTGGAGCTGTTCAAG
TTCACCATCGGCATGGGCGACCTGGAGTTCACTGAGAACTATGACTTCAAGGCTGTCTTC
ATCATCCTGCTGCTGGCCTATGTAATTCTCACCTACATCCTCCTGCTCAACATGCTCATC
GCCCTCATGGGTGAGACTGTCAACAAGATCGCACAGGAGAGCAAGAACATCTGGAAGCTG
CAGAGAGCCATCACCATCCTGGACACGGAGAAGAGCTTCCTTAAGTGCATGAGGAAGGCC
TTCCGCTCAGGCAAGCTGCTGCAGGTGGGGTACACACCTGATGGCAAGGACGACTACCGG
TGGTGCTTCAGGGTGGACGAGGTGAACTGGACCACCTGGAACACCAACGTGGGCATCATC
AACGAAGACCCGGGCAACTGTGAGGGCGTCAAGCGCACCCTGAGCTTCTCCCTGCGGTCA
AGCAGAGTTTCAGGCAGACACTGGAAGAACTTTGCCCTGGTCCCCCTTTTAAGAGAGGCA
AGTGCTCGAGATAGGCAGTCTGCTCAGCCCGAGGAAGTTTATCTGCGACAGTTTTCAGGG
TCTCTGAAGCCAGAGGACGCTGAGGTCTTCAAGAGTCCTGCCGCTTCCGGGGAGAAGTGA
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00520</identifier>
        <name>Ion_trans</name>
      </pfam>
      <pfam>
        <identifier>PF12796</identifier>
        <name>Ank_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intrinsic component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>excitatory extracellular ligand-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transmembrane signaling receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phosphoprotein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to alkaloid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>chemosensory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>thermoception</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell surface receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to ATP</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002247</id>
      <name>Elongation of very long chain fatty acids protein 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9GZR5" source="Swiss-Prot">
    <name>Elongation of very long chain fatty acids protein 4</name>
    <general-function>Transferase activity</general-function>
    <specific-function>Catalyzes the first and rate-limiting reaction of the four that constitute the long-chain fatty acids elongation cycle. This endoplasmic reticulum-bound enzymatic process, allows the addition of 2 carbons to the chain of long- and very long-chain fatty acids/VLCFAs per cycle. Condensing enzyme that specifically elongates C24:0 and C26:0 acyl-CoAs. May participate to the production of saturated and monounsaturated VLCFAs of different chain lengths that are involved in multiple biological processes as precursors of membrane lipids and lipid mediators. May play a critical role in early brain and skin development.</specific-function>
    <gene-name>ELOVL4</gene-name>
    <locus>6q14</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>42-62
78-98
127-147
165-185
188-208
217-237
247-267</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.86</theoretical-pi>
    <molecular-weight>36828.905</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:14415</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ELOVL4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF279654</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>12044051</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9GZR5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ELOV4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.3.1.199</synonym>
      <synonym>3-keto acyl-CoA synthase ELOVL4</synonym>
      <synonym>ELOVL FA elongase 4</synonym>
      <synonym>ELOVL fatty acid elongase 4</synonym>
      <synonym>Very long chain 3-ketoacyl-CoA synthase 4</synonym>
      <synonym>Very long chain 3-oxoacyl-CoA synthase 4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019253|Elongation of very long chain fatty acids protein 4
MGLLDSEPGSVLNVVSTALNDTVEFYRWTWSIADKRVENWPLMQSPWPTLSISTLYLLFV
WLGPKWMKDREPFQMRLVLIIYNFGMVLLNLFIFRELFMGSYNAGYSYICQSVDYSNNVH
EVRIAAALWWYFVSKGVEYLDTVFFILRKKNNQVSFLHVYHHCTMFTLWWIGIKWVAGGQ
AFFGAQLNSFIHVIMYSYYGLTAFGPWIQKYLWWKRYLTMLQLIQFHVTIGHTALSLYTD
CPFPKWMHWALIAYAISFIFLFLNFYIRTYKEPKKPKAGKTAMNGISANGVSKSEKQLMI
ENGKKQKNGKAKGD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019254|Elongation of very long chain fatty acids protein 4 (ELOVL4)
ATGGGGCTCCTGGACTCGGAGCCGGGTAGTGTCCTAAACGTAGTGTCCACGGCACTCAAC
GACACGGTAGAGTTCTACCGCTGGACCTGGTCCATCGCAGATAAGCGTGTGGAAAATTGG
CCTCTGATGCAGTCTCCTTGGCCTACACTAAGTATAAGCACTCTTTATCTCCTGTTTGTG
TGGCTGGGTCCAAAATGGATGAAGGACCGAGAACCTTTTCAGATGCGTCTAGTGCTCATT
ATCTATAATTTTGGGATGGTTTTGCTTAACCTCTTTATCTTCAGAGAGTTATTCATGGGA
TCATATAATGCGGGATATAGCTATATTTGCCAGAGTGTGGATTATTCTAATAATGTTCAT
GAAGTCAGGATAGCTGCTGCTCTGTGGTGGTACTTTGTATCTAAAGGAGTTGAGTATTTG
GACACAGTGTTTTTTATTCTGAGAAAGAAAAACAACCAAGTTTCTTTCCTTCATGTGTAT
CATCACTGTACGATGTTTACCTTGTGGTGGATTGGAATTAAGTGGGTTGCAGGAGGACAA
GCATTTTTTGGAGCCCAGTTGAATTCCTTTATCCATGTGATTATGTACTCATACTATGGG
TTAACTGCATTTGGCCCATGGATTCAGAAATATCTTTGGTGGAAACGATACCTGACTATG
TTGCAACTGATTCAATTCCATGTGACCATTGGGCACACGGCACTGTCTCTTTACACTGAC
TGCCCCTTCCCCAAATGGATGCACTGGGCTCTAATTGCCTATGCAATCAGCTTCATATTT
CTCTTTCTTAACTTCTACATTCGGACATACAAAGAGCCTAAGAAACCAAAAGCTGGAAAA
ACAGCCATGAATGGTATTTCAGCAAATGGTGTGAGCAAATCAGAAAAACAACTCATGATA
GAAAATGGAAAAAAGCAGAAAAATGGAAAAGCAAAAGGAGATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01151</identifier>
        <name>ELO</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>G-protein coupled photoreceptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>very long-chain fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>triglyceride biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-chain fatty-acyl-CoA biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>detection of visible light</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid elongation, saturated fatty acid</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="1">
      <id>BE0000071</id>
      <name>Peroxisome proliferator-activated receptor alpha</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>10403814</pubmed-id>
            <citation>Murakami K, Ide T, Suzuki M, Mochizuki T, Kadowaki T: Evidence for direct binding of fatty acids and eicosanoids to human peroxisome proliferators-activated receptor alpha. Biochem Biophys Res Commun. 1999 Jul 14;260(3):609-13.</citation>
          </article>
          <article>
            <pubmed-id>16731579</pubmed-id>
            <citation>Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q07869" source="Swiss-Prot">
    <name>Peroxisome proliferator-activated receptor alpha</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Ligand-activated transcription factor. Key regulator of lipid metabolism. Activated by the endogenous ligand 1-palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine (16:0/18:1-GPC). Activated by oleylethanolamide, a naturally occurring lipid that regulates satiety. Receptor for peroxisome proliferators such as hypolipidemic drugs and fatty acids. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the ACOX1 and P450 genes. Transactivation activity requires heterodimerization with RXRA and is antagonized by NR2C2. May be required for the propagation of clock information to metabolic pathways regulated by PER2.</specific-function>
    <gene-name>PPARA</gene-name>
    <locus>22q12-q13.1|22q13.31</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.2</theoretical-pi>
    <molecular-weight>52224.595</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9232</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PPARA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L02932</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>307341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>593</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>593</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q07869</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PPARA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>NR1C1</synonym>
      <synonym>Nuclear receptor subfamily 1 group C member 1</synonym>
      <synonym>PPAR</synonym>
      <synonym>PPAR-alpha</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000142|Peroxisome proliferator-activated receptor alpha
MVDTESPLCPLSPLEAGDLESPLSEEFLQEMGNIQEISQSIGEDSSGSFGFTEYQYLGSC
PGSDGSVITDTLSPASSPSSVTYPVVPGSVDESPSGALNIECRICGDKASGYHYGVHACE
GCKGFFRRTIRLKLVYDKCDRSCKIQKKNRNKCQYCRFHKCLSVGMSHNAIRFGRMPRSE
KAKLKAEILTCEHDIEDSETADLKSLAKRIYEAYLKNFNMNKVKARVILSGKASNNPPFV
IHDMETLCMAEKTLVAKLVANGIQNKEAEVRIFHCCQCTSVETVTELTEFAKAIPGFANL
DLNDQVTLLKYGVYEAIFAMLSSVMNKDGMLVAYGNGFITREFLKSLRKPFCDIMEPKFD
FAMKFNALELDDSDISLFVAAIICCGDRPGLLNVGHIEKMQEGIVHVLRLHLQSNHPDDI
FLFPKLLQKMADLRQLVTEHAQLVQIIKKTESDAALHPLLQEIYRDMY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021925|Peroxisome proliferator-activated receptor alpha (PPARA)
ATGGTGGACACGGAAAGCCCACTCTGCCCCCTCTCCCCACTCGAGGCCGGCGATCTAGAG
AGCCCGTTATCTGAAGAGTTCCTGCAAGAAATGGGAAACATCCAAGAGATTTCGCAATCC
ATCGGCGAGGATAGTTCTGGAAGCTTTGGCTTTACGGAATACCAGTATTTAGGAAGCTGT
CCTGGCTCAGATGGCTCGGTCATCACGGACACGCTTTCACCAGCTTCGAGCCCCTCCTCG
GTGACTTATCCTGTGGTCCCCGGCAGCGTGGACGAGTCTCCCAGTGGAGCATTGAACATC
GAATGTAGAATCTGCGGGGACAAGGCCTCAGGCTATCATTACGGAGTCCACGCGTGTGAA
GGCTGCAAGGGCTTCTTTCGGCGAACGATTCGACTCAAGCTGGTGTATGACAAGTGCGAC
CGCAGCTGCAAGATCCAGAAAAAGAACAGAAACAAATGCCAGTATTGTCGATTTCACAAG
TGCCTTTCTGTCGGGATGTCACACAACGCGATTCGTTTTGGACGAATGCCAAGATCTGAG
AAAGCAAAACTGAAAGCAGAAATTCTTACCTGTGAACATGACATAGAAGATTCTGAAACT
GCAGATCTCAAATCTCTGGCCAAGAGAATCTACGAGGCCTACTTGAAGAACTTCAACATG
AACAAGGTCAAAGCCCGGGTCATCCTCTCAGGAAAGGCCAGTAACAATCCACCTTTTGTC
ATACATGATATGGAGACACTGTGTATGGCTGAGAAGACGCTGGTGGCCAAGCTGGTGGCC
AATGGCATCCAGAACAAGGAGGCGGAGGTCCGCATCTTTCACTGCTGCCAGTGCACGTCA
GTGGAGACCGTCACGGAGCTCACGGAATTCGCCAAGGCCATCCCAGGCTTCGCAAACTTG
GACCTGAACGATCAAGTGACATTGCTAAAATACGGAGTTTATGAGGCCATATTCGCCATG
CTGTCTTCTGTGATGAACAAAGACGGGATGCTGGTAGCGTATGGAAATGGGTTTATAACT
CGTGAATTCCTAAAAAGCCTAAGGAAACCGTTCTGTGATATCATGGAACCCAAGTTTGAT
TTTGCCATGAAGTTCAATGCACTGGAACTGGATGACAGTGATATCTCCCTTTTTGTGGCT
GCTATCATTTGCTGTGGAGATCGTCCTGGCCTTCTAAACGTAGGACACATTGAAAAAATG
CAGGAGGGTATTGTACATGTGCTCAGACTCCACCTGCAGAGCAACCACCCGGACGATATC
TTTCTCTTCCCAAAACTTCTTCAAAAAATGGCAGACCTCCGGCAGCTGGTGACGGAGCAT
GCGCAGCTGGTGCAGATCATCAAGAAGACGGAGTCGGATGCTGCGCTGCACCCGCTACTG
CAGGAGATCTACAGGGACATGTACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional repressor activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lipid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ubiquitin conjugating enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II repressing transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoprotein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of pri-miRNA transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cholesterol storage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription regulatory region DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of macrophage derived foam cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of glycolytic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to insulin</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>circadian regulation of gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>wound healing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of leukocyte cell-cell adhesion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of blood pressure</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of appetite</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of receptor biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fatty acid beta-oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of sequestering of triglyceride</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of neuron death</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermis development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cellular ketone metabolic process by positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of lipid transport by positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fatty acid oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of glycolytic process by positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>enamel mineralization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="2">
      <id>BE0001777</id>
      <name>Bile acid receptor</name>
      <organism>Human</organism>
      <actions>
        <action>agonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>21658928</pubmed-id>
            <citation>Zhang J, Kris-Etherton PM, Thompson JT, Hannon DB, Gillies PJ, Heuvel JP: Alpha-linolenic acid increases cholesterol efflux in macrophage-derived foam cells by decreasing stearoyl CoA desaturase 1 expression: evidence for a farnesoid-X-receptor mechanism of action. J Nutr Biochem. 2012 Apr;23(4):400-9. doi: 10.1016/j.jnutbio.2011.01.004. Epub 2011 Jun 11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q96RI1" source="Swiss-Prot">
    <name>Bile acid receptor</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Ligand-activated transcription factor. Receptor for bile acids such as chenodeoxycholic acid, lithocholic acid and deoxycholic acid. Represses the transcription of the cholesterol 7-alpha-hydroxylase gene (CYP7A1) through the induction of NR0B2 or FGF19 expression, via two distinct mechanisms. Activates the intestinal bile acid-binding protein (IBABP). Activates the transcription of bile salt export pump ABCB11 by directly recruiting histone methyltransferase CARM1 to this locus.</specific-function>
    <gene-name>NR1H4</gene-name>
    <locus>12q23.1</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.81</theoretical-pi>
    <molecular-weight>55913.915</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7967</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NR1H4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U68233</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1546084</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>603</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>603</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q96RI1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NR1H4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>BAR</synonym>
      <synonym>Farnesoid X-activated receptor</synonym>
      <synonym>Farnesol receptor HRR-1</synonym>
      <synonym>FXR</synonym>
      <synonym>HRR1</synonym>
      <synonym>Nuclear receptor subfamily 1 group H member 4</synonym>
      <synonym>Retinoid X receptor-interacting protein 14</synonym>
      <synonym>RIP14</synonym>
      <synonym>RXR-interacting protein 14</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0003523|Bile acid receptor
MVMQFQGLENPIQISPHCSCTPSGFFMEMMSMKPAKGVLTEQVAGPLGQNLEVEPYSQYS
NVQFPQVQPQISSSSYYSNLGFYPQQPEEWYSPGIYELRRMPAETLYQGETEVAEMPVTK
KPRMGASAGRIKGDELCVVCGDRASGYHYNALTCEGCKGFFRRSITKNAVYKCKNGGNCV
MDMYMRRKCQECRLRKCKEMGMLAECMYTGLLTEIQCKSKRLRKNVKQHADQTVNEDSEG
RDLRQVTSTTKSCREKTELTPDQQTLLHFIMDSYNKQRMPQEITNKILKEEFSAEENFLI
LTEMATNHVQVLVEFTKKLPGFQTLDHEDQIALLKGSAVEAMFLRSAEIFNKKLPSGHSD
LLEERIRNSGISDEYITPMFSFYKSIGELKMTQEEYALLTAIVILSPDRQYIKDREAVEK
LQEPLLDVLQKLCKIHQPENPQHFACLLGRLTELRTFNHHHAEMLMSWRVNDHKFTPLLC
EIWDVQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011269|Bile acid receptor (NR1H4)
ATGGGATCAAAAATGAATCTCATTGAACATTCCCATTTACCTACCACAGATGAATTTTCT
TTTTCTGAAAATTTATTTGGTGTTTTAACAGAACAAGTGGCAGGTCCTCTGGGACAGAAC
CTGGAAGTGGAACCATACTCGCAATACAGCAATGTTCAGTTTCCCCAAGTTCAACCACAG
ATTTCCTCGTCATCCTATTATTCCAACCTGGGTTTCTACCCCCAGCAGCCTGAAGAGTGG
TACTCTCCTGGAATATATGAACTCAGGCGTATGCCAGCTGAGACTCTCTACCAGGGAGAA
ACTGAGGTAGCAGAGATGCCTGTAACAAAGAAGCCCCGCATGGGCGCGTCAGCAGGGAGG
ATCAAAGGGGATGAGCTGTGTGTTGTTTGTGGAGACAGAGCCTCTGGATACCACTATAAT
GCACTGACCTGTGAGGGGTGTAAAGGTTTCTTCAGGAGAAGCATTACCAAAAACGCTGTG
TACAAGTGTAAAAACGGGGGCAACTGTGTGATGGATATGTACATGCGAAGAAAGTGTCAA
GAGTGTCGACTAAGGAAATGCAAAGAGATGGGAATGTTGGCTGAATGTATGTATACAGGC
TTGTTAACTGAAATTCAGTGTAAATCTAAGCGACTGAGAAAAAATGTGAAGCAGCATGCA
GATCAGACCGTGAATGAAGACAGTGAAGGTCGTGACTTGCGACAAGTGACCTCGACAACA
AAGTCATGCAGGGAGAAAACTGAACTCACCCCAGATCAACAGACTCTTCTACATTTTATT
ATGGATTCATATAACAAACAGAGGATGCCTCAGGAAATAACAAATAAAATTTTAAAAGAA
GAATTCAGTGCAGAAGAAAATTTTCTCATTTTGACGGAAATGGCAACCAATCATGTACAG
GTTCTTGTAGAATTCACAAAAAAGCTACCAGGATTTCAGACTTTGGACCATGAAGACCAG
ATTGCTTTGCTGAAAGGGTCTGCGGTTGAAGCTATGTTCCTTCGTTCAGCTGAGATTTTC
AATAAGAAACTTCCGTCTGGGCATTCTGACCTATTGGAAGAAAGAATTCGAAATAGTGGT
ATCTCTGATGAATATATAACACCTATGTTTAGTTTTTATAAAAGTATTGGGGAACTGAAA
ATGACTCAAGAGGAGTATGCTCTGCTTACAGCAATTGTTATCCTGTCTCCAGATAGACAA
TACATAAAGGATAGAGAGGCAGTAGAGAAGCTTCAGGAGCCACTTCTTGATGTGCTACAA
AAGTTGTGTAAGATTCACCAGCCTGAAAATCCTCAACACTTTGCCTGTCTCCTGGGTCGC
CTGACTGAATTACGGACATTCAATCATCACCACGCTGAGATGCTGATGTCATGGAGAGTA
AACGACCACAAGTTTACCCCACTTCTCTGTGAAATCTGGGACGTGCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nuclear euchromatin</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription corepressor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>bile acid receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chenodeoxycholic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ligand-dependent nuclear receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription coactivator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II distal enhancer sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, RNA polymerase II distal enhancer sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>bile acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular bile acid receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cholesterol metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of bile acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitrogen catabolite activation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of ammonia assimilation cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of bile acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Notch signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of urea metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid and bile salt transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to bile acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to organonitrogen compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="3">
      <id>BE0001007</id>
      <name>Peroxisome proliferator-activated receptor delta</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16731579</pubmed-id>
            <citation>Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q03181" source="Swiss-Prot">
    <name>Peroxisome proliferator-activated receptor delta</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Ligand-activated transcription factor. Receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Has a preference for poly-unsaturated fatty acids, such as gamma-linoleic acid and eicosapentanoic acid. Once activated by a ligand, the receptor binds to promoter elements of target genes. Regulates the peroxisomal beta-oxidation pathway of fatty acids. Functions as transcription activator for the acyl-CoA oxidase gene. Decreases expression of NPC1L1 once activated by a ligand.</specific-function>
    <gene-name>PPARD</gene-name>
    <locus>6p21.2-p21.1</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.65</theoretical-pi>
    <molecular-weight>49902.99</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9235</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PPARD</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L07592</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>190230</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>594</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>594</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q03181</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PPARD_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>NR1C2</synonym>
      <synonym>NUC1</synonym>
      <synonym>NUCI</synonym>
      <synonym>Nuclear hormone receptor 1</synonym>
      <synonym>Nuclear receptor subfamily 1 group C member 2</synonym>
      <synonym>Peroxisome proliferator-activated receptor beta</synonym>
      <synonym>PPAR-beta</synonym>
      <synonym>PPAR-delta</synonym>
      <synonym>PPARB</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002005|Peroxisome proliferator-activated receptor delta
MEQPQEEAPEVREEEEKEEVAEAEGAPELNGGPQHALPSSSYTDLSRSSSPPSLLDQLQM
GCDGASCGSLNMECRVCGDKASGFHYGVHACEGCKGFFRRTIRMKLEYEKCERSCKIQKK
NRNKCQYCRFQKCLALGMSHNAIRFGRMPEAEKRKLVAGLTANEGSQYNPQVADLKAFSK
HIYNAYLKNFNMTKKKARSILTGKASHTAPFVIHDIETLWQAEKGLVWKQLVNGLPPYKE
ISVHVFYRCQCTTVETVRELTEFAKSIPSFSSLFLNDQVTLLKYGVHEAIFAMLASIVNK
DGLLVANGSGFVTREFLRSLRKPFSDIIEPKFEFAVKFNALELDDSDLALFIAAIILCGD
RPGLMNVPRVEAIQDTILRALEFHLQANHPDAQYLFPKLLQKMADLRQLVTEHAQMMQRI
KKTETETSLHPLLQEIYKDMY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019047|Peroxisome proliferator-activated receptor delta (PPARD)
ATGGAGCAGCCACAGGAGGAAGCCCCTGAGGTCCGGGAAGAGGAGGAGAAAGAGGAAGTG
GCAGAGGCAGAAGGAGCCCCAGAGCTCAATGGGGGACCACAGCATGCACTTCCTTCCAGC
AGCTACACAGACCTCTCCCGGAGCTCCTCGCCACCCTCACTGCTGGACCAACTGCAGATG
GGCTGTGACGGGGCCTCATGCGGCAGCCTCAACATGGAGTGCCGGGTGTGCGGGGACAAG
GCATCGGGCTTCCACTACGGTGTTCATGCATGTGAGGGGTGCAAGGGCTTCTTCCGTCGT
ACGATCCGCATGAAGCTGGAGTACGAGAAGTGTGAGCGCAGCTGCAAGATTCAGAAGAAG
AACCGCAACAAGTGCCAGTACTGCCGCTTCCAGAAGTGCCTGGCACTGGGCATGTCACAC
AACGCTATCCGTTTTGGTCGGATGCCGGAGGCTGAGAAGAGGAAGCTGGTGGCAGGGCTG
ACTGCAAACGAGGGGAGCCAGTACAACCCACAGGTGGCCGACCTGAAGGCCTTCTCCAAG
CACATCTACAATGCCTACCTGAAAAACTTCAACATGACCAAAAAGAAGGCCCGCAGCATC
CTCACCGGCAAAGCCAGCCACACGGCGCCCTTTGTGATCCACGACATCGAGACATTGTGG
CAGGCAGAGAAGGGGCTGGTGTGGAAGCAGTTGGTGAATGGCCTGCCTCCCTACAAGGAG
ATCAGCGTGCACGTCTTCTACCGCTGCCAGTGCACCACAGTGGAGACCGTGCGGGAGCTC
ACTGAGTTCGCCAAGAGCATCCCCAGCTTCAGCAGCCTCTTCCTCAACGACCAGGTTACC
CTTCTCAAGTATGGCGTGCACGAGGCCATCTTCGCCATGCTGGCCTCTATCGTCAACAAG
GACGGGCTGCTGGTAGCCAACGGCAGTGGCTTTGTCACCCGTGAGTTCCTGCGCAGCCTC
CGCAAACCCTTCAGTGATATCATTGAGCCTAAGTTTGAATTTGCTGTCAAGTTCAACGCC
CTGGAACTTGATGACAGTGACCTGGCCCTATTCATTGCGGCCATCATTCTGTGTGGAGAC
CGGCCAGGCCTCATGAACGTTCCACGGGTGGAGGCTATCCAGGACACCATCCTGCGTGCC
CTCGAATTCCACCTGCAGGCCAACCACCCTGATGCCCAGTACCTCTTCCCCAAGCTGCTG
CAGAAGATGGCTGACCTGCGGCAACTGGTCACCGAGCACGCCCAGATGATGCAGCGGATC
AAGAAGACCGAAACCGAGACCTCGCTGCACCCTCTGCTCCAGGAGATCTACAAGGACATG
TACTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lipid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>linoleic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of myoblast proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cholesterol metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>generation of precursor metabolites and energy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>decidualization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of skeletal muscle tissue regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of satellite cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of epithelial cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adipose tissue development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratinocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryo implantation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell-substrate adhesion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon ensheathment</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>wound healing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratinocyte proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of phosphatidylinositol 3-kinase signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid beta-oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of myoblast differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="4">
      <id>BE0000215</id>
      <name>Peroxisome proliferator-activated receptor gamma</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16731579</pubmed-id>
            <citation>Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P37231" source="Swiss-Prot">
    <name>Peroxisome proliferator-activated receptor gamma</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Nuclear receptor that binds peroxisome proliferators such as hypolipidemic drugs and fatty acids. Once activated by a ligand, the nuclear receptor binds to DNA specific PPAR response elements (PPRE) and modulates the transcription of its target genes, such as acyl-CoA oxidase. It therefore controls the peroxisomal beta-oxidation pathway of fatty acids. Key regulator of adipocyte differentiation and glucose homeostasis. ARF6 acts as a key regulator of the tissue-specific adipocyte P2 (aP2) enhancer. Acts as a critical regulator of gut homeostasis by suppressing NF-kappa-B-mediated proinflammatory responses. Plays a role in the regulation of cardiovascular circadian rhythms by regulating the transcription of ARNTL/BMAL1 in the blood vessels (By similarity).</specific-function>
    <gene-name>PPARG</gene-name>
    <locus>3p25</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.77</theoretical-pi>
    <molecular-weight>57619.58</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9236</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PPARG</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U79012</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1711117</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>595</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>595</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P37231</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PPARG_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>NR1C3</synonym>
      <synonym>Nuclear receptor subfamily 1 group C member 3</synonym>
      <synonym>PPAR-gamma</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000429|Peroxisome proliferator-activated receptor gamma
MGETLGDSPIDPESDSFTDTLSANISQEMTMVDTEMPFWPTNFGISSVDLSVMEDHSHSF
DIKPFTTVDFSSISTPHYEDIPFTRTDPVVADYKYDLKLQEYQSAIKVEPASPPYYSEKT
QLYNKPHEEPSNSLMAIECRVCGDKASGFHYGVHACEGCKGFFRRTIRLKLIYDRCDLNC
RIHKKSRNKCQYCRFQKCLAVGMSHNAIRFGRMPQAEKEKLLAEISSDIDQLNPESADLR
ALAKHLYDSYIKSFPLTKAKARAILTGKTTDKSPFVIYDMNSLMMGEDKIKFKHITPLQE
QSKEVAIRIFQGCQFRSVEAVQEITEYAKSIPGFVNLDLNDQVTLLKYGVHEIIYTMLAS
LMNKDGVLISEGQGFMTREFLKSLRKPFGDFMEPKFEFAVKFNALELDDSDLAIFIAVII
LSGDRPGLLNVKPIEDIQDNLLQALELQLKLNHPESSQLFAKLLQKMTDLRQIVTEHVQL
LQVIKKTETDMSLHPLLQEIYKDLY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021642|Peroxisome proliferator-activated receptor gamma (PPARG)
ATGACCATGGTTGACACAGAGATGCCATTCTGGCCCACCAACTTTGGGATCAGCTCCGTG
GATCTCTCCGTAATGGAAGACCACTCCCACTCCTTTGATATCAAGCCCTTCACTACTGTT
GACTTCTCCAGCATTTCTACTCCACATTACGAAGACATTCCATTCACAAGAACAGATCCA
GTGGTTGCAGATTACAAGTATGACCTGAAACTTCAAGAGTACCAAAGTGCAATCAAAGTG
GAGCCTGCATCTCCACCTTATTATTCTGAGAAGACTCAGCTCTACAATAAGCCTCATGAA
GAGCCTTCCAACTCCCTCATGGCAATTGAATGTCGTGTCTGTGGAGATAAAGCTTCTGGA
TTTCACTATGGAGTTCATGCTTGTGAAGGATGCAAGGGTTTCTTCCGGAGAACAATCAGA
TTGAAGCTTATCTATGACAGATGTGATCTTAACTGTCGGATCCACAAAAAAAGTAGAAAT
AAATGTCAGTACTGTCGGTTTCAGAAATGCCTTGCAGTGGGGATGTCTCATAATGCCATC
AGGTTTGGGCGGATGCCACAGGCCGAGAAGGAGAAGCTGTTGGCGGAGATCTCCAGTGAT
ATCGACCAGCTGAATCCAGAGTCCGCTGACCTCCGGGCCCTGGCAAAACATTTGTATGAC
TCATACATAAAGTCCTTCCCGCTGACCAAAGCAAAGGCGAGGGCGATCTTGACAGGAAAG
ACAACAGACAAATCACCATTCGTTATCTATGACATGAATTCCTTAATGATGGGAGAAGAT
AAAATCAAGTTCAAACACATCACCCCCCTGCAGGAGCAGAGCAAAGAGGTGGCCATCCGC
ATCTTTCAGGGCTGCCAGTTTCGCTCCGTGGAGGCTGTGCAGGAGATCACAGAGTATGCC
AAAAGCATTCCTGGTTTTGTAAATCTTGACTTGAACGACCAAGTAACTCTCCTCAAATAT
GGAGTCCACGAGATCATTTACACAATGCTGGCCTCCTTGATGAATAAAGATGGGGTTCTC
ATATCCGAGGGCCAAGGCTTCATGACAAGGGAGTTTCTAAAGAGCCTGCGAAAGCCTTTT
GGTGACTTTATGGAGCCCAAGTTTGAGTTTGCTGTGAAGTTCAATGCACTGGAATTAGAT
GACAGCGACTTGGCAATATTTATTGCTGTCATTATTCTCAGTGGAGACCGCCCAGGTTTG
CTGAATGTGAAGCCCATTGAAGACATTCAAGACAACCTGCTACAAGCCCTGGAGCTCCAG
CTGAAGCTGAACCACCCTGAGTCCTCACAGCTGTTTGCCAAGCTGCTCCAGAAAATGACA
GACCTCAGACAGATTGTCACGGAACACGTGCAGCTACTGCAGGTGATCAAGAAGACGGAG
ACAGACATGAGTCTTCACCCGCTCCTGCAGGAGATCTACAAGGACTTGTACTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
      <pfam>
        <identifier>PF12577</identifier>
        <name>PPARgamma_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>RNA polymerase II transcription factor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II transcription regulatory region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription regulatory region DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>prostaglandin receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>activating transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>alpha-actinin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>arachidonic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>retinoid X receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chromatin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ligand-dependent nuclear receptor transcription coactivator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>core promoter sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II regulatory region DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to insulin stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin A</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>low-density lipoprotein particle receptor biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cholesterol transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to vitamin E</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cholesterol storage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of cysteine-type endopeptidase activity involved in apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of interferon-gamma-mediated signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peroxisome proliferator activated receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to metformin</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of macrophage derived foam cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of sequence-specific DNA binding transcription factor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of receptor biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of smooth muscle cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to low-density lipoprotein particle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to diuretic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>placenta development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to caffeine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of sequestering of triglyceride</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-chain fatty acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>white fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to retinoic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to immobilization stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of acute inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell fate commitment</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of oligodendrocyte differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of phagocytosis, engulfment</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to mechanical stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription involved in cell fate commitment</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of collagen biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of circadian rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lithium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>monocyte differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rhythmic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hyperoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organ regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of pancreatic stellate cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brown fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estrogen</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell maturation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to prostaglandin E stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of telomerase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>diet induced thermogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoprotein transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of blood pressure</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fatty acid oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to retinoic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to cold</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="5">
      <id>BE0000412</id>
      <name>Retinoic acid receptor RXR-alpha</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16731579</pubmed-id>
            <citation>Vanden Heuvel JP, Thompson JT, Frame SR, Gillies PJ: Differential activation of nuclear receptors by perfluorinated fatty acid analogs and natural fatty acids: a comparison of human, mouse, and rat peroxisome proliferator-activated receptor-alpha, -beta, and -gamma, liver X receptor-beta, and retinoid X receptor-alpha. Toxicol Sci. 2006 Aug;92(2):476-89. Epub 2006 May 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P19793" source="Swiss-Prot">
    <name>Retinoic acid receptor RXR-alpha</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Receptor for retinoic acid. Retinoic acid receptors bind as heterodimers to their target response elements in response to their ligands, all-trans or 9-cis retinoic acid, and regulate gene expression in various biological processes. The RAR/RXR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. The high affinity ligand for RXRs is 9-cis retinoic acid. RXRA serves as a common heterodimeric partner for a number of nuclear receptors. The RXR/RAR heterodimers bind to the retinoic acid response elements (RARE) composed of tandem 5'-AGGTCA-3' sites known as DR1-DR5. In the absence of ligand, the RXR-RAR heterodimers associate with a multiprotein complex containing transcription corepressors that induce histone acetylation, chromatin condensation and transcriptional suppression. On ligand binding, the corepressors dissociate from the receptors and associate with the coactivators leading to transcriptional activation. The RXRA/PPARA heterodimer is required for PPARA transcriptional activity on fatty acid oxidation genes such as ACOX1 and the P450 system genes.</specific-function>
    <gene-name>RXRA</gene-name>
    <locus>9q34.3</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.86</theoretical-pi>
    <molecular-weight>50810.835</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10477</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>RXRA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X52773</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>35885</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>610</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>610</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P19793</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>RXRA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>NR2B1</synonym>
      <synonym>Nuclear receptor subfamily 2 group B member 1</synonym>
      <synonym>Retinoid X receptor alpha</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000821|Retinoic acid receptor RXR-alpha
MDTKHFLPLDFSTQVNSSLTSPTGRGSMAAPSLHPSLGPGIGSPGQLHSPISTLSSPING
MGPPFSVISSPMGPHSMSVPTTPTLGFSTGSPQLSSPMNPVSSSEDIKPPLGLNGVLKVP
AHPSGNMASFTKHICAICGDRSSGKHYGVYSCEGCKGFFKRTVRKDLTYTCRDNKDCLID
KRQRNRCQYCRYQKCLAMGMKREAVQEERQRGKDRNENEVESTSSANEDMPVERILEAEL
AVEPKTETYVEANMGLNPSSPNDPVTNICQAADKQLFTLVEWAKRIPHFSELPLDDQVIL
LRAGWNELLIASFSHRSIAVKDGILLATGLHVHRNSAHSAGVGAIFDRVLTELVSKMRDM
QMDKTELGCLRAIVLFNPDSKGLSNPAEVEALREKVYASLEAYCKHKYPEQPGRFAKLLL
RLPALRSIGLKCLEHLFFFKLIGDTPIDTFLMEMLEAPHQMT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0000820|1389 bp
ATGGACACCAAACATTTCCTGCCGCTCGATTTCTCCACCCAGGTGAACTCCTCCCTCACC
TCCCCGACGGGGCGAGGCTCCATGGCTGCCCCCTCGCTGCACCCGTCCCTGGGGCCTGGC
ATCGGCTCCCCGGGACAGCTGCATTCTCCCATCAGCACCCTGAGCTCCCCCATCAACGGC
ATGGGCCCGCCTTTCTCGGTCATCAGCTCCCCCATGGGCCCCCACTCCATGTCGGTGCCC
ACCACACCCACCCTGGGCTTCAGCACTGGCAGCCCCCAGCTCAGCTCACCTATGAACCCC
GTCAGCAGCAGCGAGGACATCAAGCCCCCCCTGGGCCTCAATGGCGTCCTCAAGGTCCCC
GCCCACCCCTCAGGAAACATGGCTTCCTTCACCAAGCACATCTGCGCCATCTGCGGGGAC
CGCTCCTCAGGCAAGCACTATGGAGTGTACAGCTGCGAGGGGTGCAAGGGCTTCTTCAAG
CGGACGGTGCGCAAGGACCTGACCTACACCTGCCGCGACAACAAGGACTGCCTGATTGAC
AAGCGGCAGCGGAACCGGTGCCAGTACTGCCGCTACCAGAAGTGCCTGGCCATGGGCATG
AAGCGGGAAGCCGTGCAGGAGGAGCGGCAGCGTGGCAAGGACCGGAACGAGAATGAGGTG
GAGTCGACCAGCAGCGCCAACGAGGACATGCCGGTGGAGAGGATCCTGGAGGCTGAGCTG
GCCGTGGAGCCCAAGACCGAGACCTACGTGGAGGCAAACATGGGGCTGAACCCCAGCTCG
CCGAACGACCCTGTCACCAACATTTGCCAAGCAGCCGACAAACAGCTTTTCACCCTGGTG
GAGTGGGCCAAGCGGATCCCACACTTCTCAGAGCTGCCCCTGGACGACCAGGTCATCCTG
CTGCGGGCAGGCTGGAATGAGCTGCTCATCGCCTCCTTCTCCCACCGCTCCATCGCCGTG
AAGGACGGGATCCTCCTGGCCACCGGGCTGCACGTCCACCGGAACAGCGCCCACAGCGCA
GGGGTGGGCGCCATCTTTGACAGGGTGCTGACGGAGCTTGTGTCCAAGATGCGGGACATG
CAGATGGACAAGACGGAGCTGGGCTGCCTGCGCGCCATCGTCCTCTTTAACCCTGACTCC
AAGGGGCTCTCGAACCCGGCCGAGGTGGAGGCGCTGAGGGAGAAGGTCTATGCGTCCTTG
GAGGCCTACTGCAAGCACAAGTACCCAGAGCAGCCGGGAAGGTTCGCTAAGCTCTTGCTC
CGCCTGCCGGCTCTGCGCTCCATCGGGCTCAAATGCCTGGAACATCTCTTCTTCTTCAAG
CTCATCGGGGACACACCCATTGACACCTTCCTTATGGAGATGCTGGAGGCGCCGCACCAA
ATGACTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
      <pfam>
        <identifier>PF11825</identifier>
        <name>Nuc_recep-AF1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>RNA polymerase II transcription factor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear chromatin</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein heterodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription coactivator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>9-cis retinoic acid receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>retinoic acid-responsive element binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II regulatory region sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chromatin DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>retinoic acid receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>modulation by virus of host morphology or physiology</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>camera-type eye development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peroxisome proliferator activated receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter involved in cellular response to chemical stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to selenium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of translational initiation by iron</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin A</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucocorticoid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of branching involved in prostate gland morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>midgut development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin D</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>in utero embryonic development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to insulin stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>retinoic acid receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to retinoic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cholesterol metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ventricular cardiac muscle cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryo implantation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid and bile salt transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of myelination</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ventricular cardiac muscle tissue morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>maternal placenta development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>liver development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers>
    <carrier>
      <id>BE0001821</id>
      <name>Fatty acid-binding protein, brain</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>10854433</pubmed-id>
            <citation>Balendiran GK, Schnutgen F, Scapin G, Borchers T, Xhong N, Lim K, Godbout R, Spener F, Sacchettini JC: Crystal structure and thermodynamic analysis of human brain fatty acid-binding protein. J Biol Chem. 2000 Sep 1;275(35):27045-54.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15540" source="Swiss-Prot">
    <name>Fatty acid-binding protein, brain</name>
    <general-function>Transporter activity</general-function>
    <specific-function>B-FABP could be involved in the transport of a so far unknown hydrophobic ligand with potential morphogenic activity during CNS development. It is required for the establishment of the radial glial fiber system in developing brain, a system that is necessary for the migration of immature neurons to establish cortical layers (By similarity).</specific-function>
    <gene-name>FABP7</gene-name>
    <locus>6q22-q23</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.25</theoretical-pi>
    <molecular-weight>14888.855</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3562</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FABP7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ002962</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2632065</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15540</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FABP7_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>B-FABP</synonym>
      <synonym>BLBP</synonym>
      <synonym>Brain lipid-binding protein</synonym>
      <synonym>Brain-type fatty acid-binding protein</synonym>
      <synonym>FABPB</synonym>
      <synonym>Fatty acid-binding protein 7</synonym>
      <synonym>Mammary-derived growth inhibitor related</synonym>
      <synonym>MRG</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0003608|Fatty acid-binding protein, brain
MVEAFCATWKLTNSQNFDEYMKALGVGFATRQVGNVTKPTVIISQEGDKVVIRTLSTFKN
TEISFQLGEEFDETTADDRNCKSVVSLDGDKLVHIQKWDGKETNFVREIKDGKMVMTLTF
GDVVAVRHYEKA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021304|Fatty acid-binding protein, brain (FABP7)
ATGGTGGAGGCTTTCTGTGCTACCTGGAAGCTGACCAACAGTCAGAACTTTGATGAGTAC
ATGAAGGCTCTAGGCGTGGGCTTTGCCACTAGGCAGGTGGGAAATGTGACCAAACCAACG
GTAATTATCAGTCAAGAAGGAGACAAAGTGGTCATCAGGACTCTCAGCACATTCAAGAAC
ACGGAGATTAGTTTCCAGCTGGGAGAAGAGTTTGATGAAACCACTGCAGATGATAGAAAC
TGTAAGTCTGTTGTTAGCCTGGATGGAGACAAACTTGTTCACATACAGAAATGGGATGGC
AAAGAAACAAATTTTGTAAGAGAAATTAAGGATGGCAAAATGGTTATGACCCTTACTTTT
GGTGATGTGGTTGCTGTTCGCCACTATGAGAAGGCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00061</identifier>
        <name>Lipocalin</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell-cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell projection</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell periphery</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lipid binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation in forebrain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prepulse inhibition</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>triglyceride catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </carrier>
  </carriers>
  <transporters/>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00133</drugbank-id>
  <drugbank-id>NUTR00053</drugbank-id>
  <drugbank-id>DB03375</drugbank-id>
  <name>L-Serine</name>
  <description>A non-essential amino acid occurring in natural form as the L-isomer. It is synthesized from glycine or threonine. It is involved in the biosynthesis of purines; pyrimidines; and other amino acids. [PubChem]</description>
  <cas-number>56-45-1</cas-number>
  <unii>452VLY9402</unii>
  <average-mass>105.0926</average-mass>
  <monoisotopic-mass>105.042593095</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Kenichi Ishiwata, Nobuyoshi Makiguichi, Hideki Kawashima, Tadashi Suzuki, Masami Imadegawa, "Method of producing L-serine." U.S. Patent US4782021, issued August, 1973.</synthesis-reference>
  <indication>Used as a natural moisturizing agent in some cosmetics and skin care products.</indication>
  <pharmacodynamics>Serine is classified as a nutritionally non-essential amino acid. Serine is critical for the production of the body's proteins, enzymes and muscle tissue. Serine is needed for the proper metabolism of fats and fatty acids. It also helps in the production of antibodies. Serine is used as a natural moisturizing agent in some cosmetics and skin care products. The main source of essential amino acids is from the diet, non-essential amino acids are normally synthesize by humans and other mammals from common intermediates.</pharmacodynamics>
  <mechanism-of-action>L-Serine plays a role in cell growth and development (cellular proliferation). The conversion of L-serine to glycine by serine hydroxymethyltransferase results in the formation of the one-carbon units necessary for the synthesis of the purine bases, adenine and guanine. These bases when linked to the phosphate ester of pentose sugars are essential components of DNA and RNA and the end products of energy producing metabolic pathways, ATP and GTP. In addition, L-serine conversion to glycine via this same enzyme provides the one-carbon units necessary for production of the pyrimidine nucleotide, deoxythymidine monophosphate, also an essential component of DNA.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as serine and derivatives. These are compounds containing serine or a derivative thereof resulting from reaction of serine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct-parent>Serine and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Beta hydroxy acids and derivatives</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Primary alcohols</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Beta-hydroxy acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Hydroxy acid</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Primary alcohol</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Serine or derivatives</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">(2S)-2-amino-3-Hydroxypropanoic acid</synonym>
    <synonym language="" coder="">(S)-(-)-Serine</synonym>
    <synonym language="" coder="">(S)-(−)-serine</synonym>
    <synonym language="" coder="">(S)-2-Amino-3-hydroxypropanoic acid</synonym>
    <synonym language="" coder="">(S)-alpha-Amino-beta-hydroxypropionic acid</synonym>
    <synonym language="" coder="">(S)-Serine</synonym>
    <synonym language="" coder="">beta-Hydroxy-L-alanine</synonym>
    <synonym language="" coder="">beta-Hydroxyalanine</synonym>
    <synonym language="" coder="">L-(-)-Serine</synonym>
    <synonym language="" coder="">L-(−)-serine</synonym>
    <synonym language="" coder="">L-2-Amino-3-hydroxypropionic acid</synonym>
    <synonym language="" coder="">L-3-Hydroxy-2-aminopropionic acid</synonym>
    <synonym language="" coder="">L-3-Hydroxy-alanine</synonym>
    <synonym language="" coder="">L-Ser</synonym>
    <synonym language="" coder="">L-Serin</synonym>
    <synonym language="" coder="">L-Serine</synonym>
    <synonym language="" coder="">S</synonym>
    <synonym language="" coder="">Ser</synonym>
    <synonym language="" coder="">Serine</synonym>
  </synonyms>
  <products>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143267</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143259</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143232</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143240</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142414</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142406</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142392</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142317</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142309</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142295</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142325</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143224</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142368</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142252</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142244</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4168</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019374</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4187</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4191</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4196</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4203</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00454907</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 10% W Electrolytes</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00558966</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 3.5% M</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510629</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00404160</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00523232</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613320</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613339</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7172</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4162</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4164</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4160</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on>2017-05-18</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7121</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742619</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 10% With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742651</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 15%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126745</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 5% Inj</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742643</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742635</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742724</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742740</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742759</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742627</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742716</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742767</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742783</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839302</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839310</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019437</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn Sulfite Free</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4192</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4178</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1985-09-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019398</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4179</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731366</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn-PF 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731358</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142260</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142279</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1083</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1089</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1091</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1093</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1095</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1099</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1103</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1132</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1133</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1134</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1135</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1136</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1137</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1138</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1139</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142333</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142341</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142376</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142384</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1107</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1109</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1113</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1115</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1119</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1123</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1125</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1127</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1142</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1143</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1144</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1145</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1146</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1147</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1148</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1149</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinisol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0502</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1996-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020512</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine HBC</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9350</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9010</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepatAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9371</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1982-08-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018676</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Novamine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-0468</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution, concentrate</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017957</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Olimel 3.3% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352508</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352524</dpd-id>
      <started-marketing-on>2011-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352516</dpd-id>
      <started-marketing-on>2011-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352540</dpd-id>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352532</dpd-id>
      <started-marketing-on>2011-01-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Periolimel 2.5% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352494</dpd-id>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3205</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1130</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1131</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene 10%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236875</dpd-id>
      <started-marketing-on>1997-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Primene 10%-liq IV</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161192</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ProSol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0499</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1998-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020849</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Renamin (amino Acids) Injection</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02020564</dpd-id>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2011-05-10</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00872296</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0644</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9341</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9361</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vamin 18 Electrolyte-free</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02059711</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vamin N</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065665</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Novamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn Sulfite Free</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Phosphoric acid + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>HepatAmine</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Phosphoric acid</ingredients>
    </mixture>
    <mixture>
      <name>ProSol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Clinisol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 15%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin N</name>
      <ingredients>Calcium Chloride + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium Sulfate + Potassium Chloride + Potassium hydroxide + Sodium hydroxide</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%-liq IV</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Renamin (amino Acids) Injection</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 3.5% M</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Vamin 18 Electrolyte-free</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10% W Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 5% Inj</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10% With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 7%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 7%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Threonine + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Periolimel 2.5% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 3.3% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Phosphoric acid</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine HBC</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Spectrum Pharmaceuticals</name>
      <url>http://www.spectrumpharm.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>L-serine powder</description>
      <cost currency="USD">3.85</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Neutral</category>
      <mesh-id>D021542</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution, concentrate</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1L8O</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00133.pdf?1265922741</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>0.66</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>4.80e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-amino-3-hydroxypropanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>L-serine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>105.0926</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>105.042593095</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>N[C@@H](CO)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C3H7NO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C3H7NO3/c4-2(1-5)3(6)7/h2,5H,1,4H2,(H,6,7)/t2-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>MTCFGRXMJLQNBG-REOHCLBHSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>83.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>22.04</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>9.39</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>2.03</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>8.93</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>4.25E+005 mg/L (at 25 °C)</value>
      <source>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>228 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.07</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.21 (at 25 °C)</value>
      <source>KORTUM,G ET AL (1961)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>9927</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>33384</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>5951</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46506450</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00065</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00016</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>5736</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50357212</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA451330</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>SER</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>726</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>726</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Serine</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL11298</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP00029</smpdb-id>
      <name>Selenoamino Acid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB02345</drugbank-id>
          <name>Selenocysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96I15</uniprot-id>
        <uniprot-id>Q99611</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q8TCB7</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>O43252</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00033</smpdb-id>
      <name>Methionine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00034</smpdb-id>
      <name>Sphingolipid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01861</drugbank-id>
          <name>Uridine diphosphate glucose</name>
        </drug>
        <drug>
          <drugbank-id>DB03381</drugbank-id>
          <name>Hexadecanal</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>O15270</uniprot-id>
        <uniprot-id>O15269</uniprot-id>
        <uniprot-id>Q06136</uniprot-id>
        <uniprot-id>Q9NRA0</uniprot-id>
        <uniprot-id>Q8IWX5</uniprot-id>
        <uniprot-id>O14494</uniprot-id>
        <uniprot-id>O95470</uniprot-id>
        <uniprot-id>Q6QHC5</uniprot-id>
        <uniprot-id>Q8TDN7</uniprot-id>
        <uniprot-id>Q8TCT0</uniprot-id>
        <uniprot-id>Q86VZ5</uniprot-id>
        <uniprot-id>Q6UWV6</uniprot-id>
        <uniprot-id>Q16880</uniprot-id>
        <uniprot-id>P54803</uniprot-id>
        <uniprot-id>P04062</uniprot-id>
        <uniprot-id>Q16739</uniprot-id>
        <uniprot-id>Q53H18</uniprot-id>
        <uniprot-id>Q9UBX8</uniprot-id>
        <uniprot-id>Q99999</uniprot-id>
        <uniprot-id>P15289</uniprot-id>
        <uniprot-id>P06280</uniprot-id>
        <uniprot-id>Q9UQ49</uniprot-id>
        <uniprot-id>Q9NUN7</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00221</smpdb-id>
      <name>Methionine Adenosyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00341</smpdb-id>
      <name>Hypermethioninemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15059</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/16:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15064</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/18:2(9Z,12Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15065</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/18:3(6Z,9Z,12Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15066</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/18:3(9Z,12Z,15Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15067</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/18:4(6Z,9Z,12Z,15Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15075</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/20:5(5Z,8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15077</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:0/22:1(13Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15086</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/14:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15088</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/16:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15089</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/16:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15101</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:3(8Z,11Z,14Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15102</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:4(5Z,8Z,11Z,14Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15103</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/20:4(8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15112</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(14:1(9Z)/24:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15114</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(15:0/14:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15126</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(15:0/20:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15127</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(15:0/20:1(11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15144</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/14:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15146</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/16:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15158</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/20:3(5Z,8Z,11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15159</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/20:3(8Z,11Z,14Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15163</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/22:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15170</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:0/24:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15175</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:1(9Z)/16:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP15176</smpdb-id>
      <name>Phosphatidylethanolamine Biosynthesis PE(16:1(9Z)/16:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P48651</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000323</id>
      <name>Cystathionine beta-synthase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17352495</pubmed-id>
            <citation>Sen S, Banerjee R: A pathogenic linked mutation in the catalytic core of human cystathionine beta-synthase disrupts allosteric regulation and allows kinetic characterization of a full-length dimer. Biochemistry. 2007 Apr 3;46(13):4110-6. Epub 2007 Mar 13.</citation>
          </article>
          <article>
            <pubmed-id>17629356</pubmed-id>
            <citation>Qu K, Lee SW, Bian JS, Low CM, Wong PT: Hydrogen sulfide: neurochemistry and neurobiology. Neurochem Int. 2008 Jan;52(1-2):155-65. Epub 2007 Jun 8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P35520" source="Swiss-Prot">
    <name>Cystathionine beta-synthase</name>
    <general-function>Ubiquitin protein ligase binding</general-function>
    <specific-function>Hydro-lyase catalyzing the first step of the transsulfuration pathway, where the hydroxyl group of L-serine is displaced by L-homocysteine in a beta-replacement reaction to form L-cystathionine, the precursor of L-cysteine. This catabolic route allows the elimination of L-methionine and the toxic metabolite L-homocysteine (PubMed:23981774, PubMed:20506325, PubMed:23974653). Also involved in the production of hydrogen sulfide, a gasotransmitter with signaling and cytoprotective effects on neurons (By similarity).</specific-function>
    <gene-name>CBS</gene-name>
    <locus/>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.63</theoretical-pi>
    <molecular-weight>60586.05</molecular-weight>
    <chromosome-location>21</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:1550</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CBS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L19501</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>388716</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1443</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P35520</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CBS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.2.1.22</synonym>
      <synonym>Beta-thionase</synonym>
      <synonym>Serine sulfhydrase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036990|Cystathionine beta-synthase
MPSETPQAEVGPTGCPHRSGPHSAKGSLEKGSPEDKEAKEPLWIRPDAPSRCTWQLGRPA
SESPHHHTAPAKSPKILPDILKKIGDTPMVRINKIGKKFGLKCELLAKCEFFNAGGSVKD
RISLRMIEDAERDGTLKPGDTIIEPTSGNTGIGLALAAAVRGYRCIIVMPEKMSSEKVDV
LRALGAEIVRTPTNARFDSPESHVGVAWRLKNEIPNSHILDQYRNASNPLAHYDTTADEI
LQQCDGKLDMLVASVGTGGTITGIARKLKEKCPGCRIIGVDPEGSILAEPEELNQTEQTT
YEVEGIGYDFIPTVLDRTVVDKWFKSNDEEAFTFARMLIAQEGLLCGGSAGSTVAVAVKA
AQELQEGQRCVVILPDSVRNYMTKFLSDRWMLQKGFLKEEDLTEKKPWWWHLRVQELGLS
APLTVLPTITCGHTIEILREKGFDQAPVVDEAGVILGMVTLGNMLSSLLAGKVQPSDQVG
KVIYKQFKQIRLTDTLGRLSHILEMDHFALVVHEQIQYHSTGKSSQRQMVFGVVTAIDLL
NFVAAQERDQK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010085|Cystathionine beta-synthase (CBS)
ATGCCTTCTGAGACCCCCCAGGCAGAAGTGGGGCCCACAGGCTGCCCCCACCGCTCAGGG
CCACACTCGGCGAAGGGGAGCCTGGAGAAGGGGTCCCCAGAGGATAAGGAAGCCAAGGAG
CCCCTGTGGATCCGGCCCGATGCTCCGAGCAGGTGCACCTGGCAGCTGGGCCGGCCTGCC
TCCGAGTCCCCACATCACCACACTGCCCCGGCAAAATCTCCAAAAATCTTGCCAGATATT
CTGAAGAAAATCGGGGACACCCCTATGGTCAGAATCAACAAGATTGGGAAGAAGTTCGGC
CTGAAGTGTGAGCTCTTGGCCAAGTGTGAGTTCTTCAACGCGGGCGGGAGCGTGAAGGAC
CGCATCAGCCTGCGGATGATTGAGGATGCTGAGCGCGACGGGACGCTGAAGCCCGGGGAC
ACGATTATCGAGCCGACATCCGGGAACACCGGGATCGGGCTGGCCCTGGCTGCGGCAGTG
AGGGGCTATCGCTGCATCATCGTGATGCCAGAGAAGATGAGCTCCGAGAAGGTGGACGTG
CTGCGGGCACTGGGGGCTGAGATTGTGAGGACGCCCACCAATGCCAGGTTCGACTCCCCG
GAGTCACACGTGGGGGTGGCCTGGCGGCTGAAGAACGAAATCCCCAATTCTCACATCCTA
GACCAGTACCGCAACGCCAGCAACCCCCTGGCTCACTATGACACCACCGCTGATGAGATC
CTGCAGCAGTGTGATGGGAAGCTGGACATGCTGGTGGCTTCAGTGGGCACGGGCGGCACC
ATCACGGGCATTGCCAGGAAGCTGAAGGAGAAGTGTCCTGGATGCAGGATCATTGGGGTG
GATCCCGAAGGGTCCATCCTCGCAGAGCCGGAGGAGCTGAACCAGACGGAGCAGACAACC
TACGAGGTGGAAGGGATCGGCTACGACTTCATCCCCACGGTGCTGGACAGGACGGTGGTG
GACAAGTGGTTCAAGAGCAACGATGAGGAGGCGTTCACCTTTGCCCGCATGCTGATCGCG
CAAGAGGGGCTGCTGTGCGGTGGCAGTGCTGGCAGCACGGTGGCGGTGGCCGTGAAGGCC
GCGCAGGAGCTGCAGGAGGGCCAGCGCTGCGTGGTCATTCTGCCCGACTCAGTGCGGAAC
TACATGACCAAGTTCCTGAGCGACAGGTGGATGCTGCAGAAGGGCTTTCTGAAGGAGGAG
GACCTCACGGAGAAGAAGCCCTGGTGGTGGCACCTCCGTGTTCAGGAGCTGGGCCTGTCA
GCCCCGCTGACCGTGCTCCCGACCATCACCTGTGGGCACACCATCGAGATCCTCCGGGAG
AAGGGCTTCGACCAGGCGCCCGTGGTGGATGAGGCGGGGGTAATCCTGGGAATGGTGACG
CTTGGGAACATGCTCTCGTCCCTGCTTGCCGGGAAGGTGCAGCCGTCAGACCAAGTTGGC
AAAGTCATCTACAAGCAGTTCAAACAGATCCGCCTCACGGACACGCTGGGCAGGCTCTCG
CACATCCTGGAGATGGACCACTTCGCCCTGGTGGTGCACGAGCAGATCCAGTCGCAGGAC
CAGGCCTGGGCAGGCGTGGTGGGGGGGCCTGCAGACCACAGCACCGGGAAGTCCAGTCAG
CGGCAGATGGTGTTCGGGGTGGTCACCGCCATTGACTTGCTGAACTTCGTGGCCGCCCAG
GAGCGGGACCAGAAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00291</identifier>
        <name>PALP</name>
      </pfam>
      <pfam>
        <identifier>PF00571</identifier>
        <name>CBS</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxygen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ubiquitin protein ligase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cystathionine beta-synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>nitrite reductase (NO-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>carbon monoxide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>modified amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>nitric oxide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-adenosyl-L-methionine binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine biosynthetic process from serine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine biosynthetic process via cystathionine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>DNA protection</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>homocysteine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>homocysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-cysteine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hydrogen sulfide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-serine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-serine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transsulfuration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000164</id>
      <name>L-serine dehydratase/L-threonine deaminase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>14688104</pubmed-id>
            <citation>Velayudhan J, Jones MA, Barrow PA, Kelly DJ: L-serine catabolism via an oxygen-labile L-serine dehydratase is essential for colonization of the avian gut by Campylobacter jejuni. Infect Immun. 2004 Jan;72(1):260-8.</citation>
          </article>
          <article>
            <pubmed-id>4377655</pubmed-id>
            <citation>Snell K, Walker DG: Regulation of hepatic L-serine dehydratase and L-serine-pyruvate aminotransferase in the developing neonatal rat. Biochem J. 1974 Dec;144(3):519-31.</citation>
          </article>
          <article>
            <pubmed-id>500557</pubmed-id>
            <citation>Wong HC, Lessie TG: Hydroxy amino acid metabolism in Pseudomonas cepacia: role of L-serine deaminase in dissimilation of serine, glycine, and threonine. J Bacteriol. 1979 Oct;140(1):240-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P20132" source="Swiss-Prot">
    <name>L-serine dehydratase/L-threonine deaminase</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function/>
    <gene-name>SDS</gene-name>
    <locus>12q24.13</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.07</theoretical-pi>
    <molecular-weight>34625.105</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10691</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SDS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J05037</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>338030</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P20132</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SDHL_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.3.1.17</synonym>
      <synonym>L-serine deaminase</synonym>
      <synonym>L-threonine dehydratase</synonym>
      <synonym>SDH</synonym>
      <synonym>TDH</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010184|L-serine dehydratase/L-threonine deaminase
MMSGEPLHVKTPIRDSMALSKMAGTSVYLKMDSAQPSGSFKIRGIGHFCKRWAKQGCAHF
VCSSAGNAGMAAAYAARQLGVPATIVVPSTTPALTIERLKNEGATVKVVGELLDEAFELA
KALAKNNPGWVYIPPFDDPLIWEGHASIVKELKETLWEKPGAIALSVGGGGLLCGVVQGL
QEVGWGDVPVIAMETFGAHSFHAATTAGKLVSLPKITSVAKALGVKTVGAQALKLFQEHP
IFSEVISDQEAVAAIEKFVDDEKILVEPACGAALAAVYSHVIQKLQLEGNLRTPLPSLVV
IVCGGSNISLAQLRALKEQLGMTNRLPK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010185|L-serine dehydratase/L-threonine deaminase (SDS)
ATGATGTCTGGAGAACCCCTGCACGTGAAGACCCCCATCCGTGACAGCATGGCCCTGTCC
AAAATGGCCGGCACCAGCGTCTACCTCAAGATGGACAGTGCCCAGCCCTCCGGCTCCTTC
AAGATCCGGGGCATTGGGCACTTCTGCAAGAGGTGGGCCAAGCAAGGCTGTGCACATTTT
GTCTGCTCCTCGGCGGGCAACGCAGGCATGGCGGCTGCATATGCGGCCAGGCAACTCGGC
GTCCCCGCCACCATCGTGGTGCCCAGCACCACACCTGCTCTCACCATTGAGCGCCTCAAG
AATGAAGGTGCCACAGTCAAGGTGGTGGGTGAGTTATTGGATGAAGCCTTCGAGCTGGCC
AAGGCCCTAGCGAAGAACAACCCGGGTTGGGTCTACATTCCCCCCTTTGATGACCCCCTC
ATCTGGGAAGGCCACGCTTCCATCGTGAAAGAGCTGAAGGAGACACTGTGGGAAAAGCCG
GGGGCCATCGCGCTGTCAGTGGGCGGCGGGGGCCTGCTGTGTGGAGTGGTCCAGGGGCTG
CAGGAGGTGGGCTGGGGGGACGTGCCTGTCATCGCCATGGAGACTTTTGGTGCCCACAGC
TTCCACGCTGCCACCACCGCAGGCAAACTTGTCTCCCTGCCCAAGATCACCAGTGTTGCC
AAGGCCCTGGGCGTGAAGACTGTGGGGGCTCAGGCCCTGAAGCTGTTTCAGGAACACCCC
ATTTTCTCTGAAGTTATCTCGGACCAGGAGGCTGTGGCCGCCATTGAGAAGTTCGTGGAT
GATGAGAAGATCCTGGTGGAGCCCGCCTGCGGGGCAGCCCTGGCCGCTGTCTATAGCCAC
GTGATCCAGAAGCTCCAACTGGAGGGGAATCTCCGAACCCCGCTGCCATCCCTCGTGGTC
ATCGTCTGCGGGGGCAGCAACATCAGCCTGGCCCAGCTGCGGGCGCTCAAGGAACAGCTG
GGCATGACAAATAGGTTGCCCAAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00291</identifier>
        <name>PALP</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-serine ammonia-lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-threonine ammonia-lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-serine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>threonine catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000388</id>
      <name>Serine racemase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17499824</pubmed-id>
            <citation>Fujitani Y, Horiuchi T, Ito K, Sugimoto M: Serine racemases from barley, Hordeum vulgare L., and other plant species represent a distinct eukaryotic group: gene cloning and recombinant protein characterization. Phytochemistry. 2007 Jun;68(11):1530-6. Epub 2007 May 17.</citation>
          </article>
          <article>
            <pubmed-id>17663143</pubmed-id>
            <citation>Ying-Luan Z, Zhao YL, Mori H: [Role of D-serine in the mammalian brain]. Brain Nerve. 2007 Jul;59(7):725-30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9GZT4" source="Swiss-Prot">
    <name>Serine racemase</name>
    <general-function>Threonine racemase activity</general-function>
    <specific-function>Catalyzes the synthesis of D-serine from L-serine. D-serine is a key coagonist with glutamate at NMDA receptors. Has dehydratase activity towards both L-serine and D-serine.</specific-function>
    <gene-name>SRR</gene-name>
    <locus>17p13</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.51</theoretical-pi>
    <molecular-weight>36565.905</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:14398</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SRR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF169974</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>11034785</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9GZT4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SRR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>5.1.1.18</synonym>
      <synonym>D-serine ammonia-lyase</synonym>
      <synonym>D-serine dehydratase</synonym>
      <synonym>L-serine ammonia-lyase</synonym>
      <synonym>L-serine dehydratase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016075|Serine racemase
MCAQYCISFADVEKAHINIRDSIHLTPVLTSSILNQLTGRNLFFKCELFQKTGSFKIRGA
LNAVRSLVPDALERKPKAVVTHSSGNHGQALTYAAKLEGIPAYIVVPQTAPDCKKLAIQA
YGASIVYCEPSDESRENVAKRVTEETEGIMVHPNQEPAVIAGQGTIALEVLNQVPLVDAL
VVPVGGGGMLAGIAITVKALKPSVKVYAAEPSNADDCYQSKLKGKLMPNLYPPETIADGV
KSSIGLNTWPIIRDLVDDIFTVTEDEIKCATQLVWERMKLLIEPTAGVGVAAVLSQHFQT
VSPEVKNICIVLSGGNVDLTSSITWVKQAERPASYQSVSV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0000772|1023 bp
ATGTGTGCTCAGTATTGCATCTCCTTTGCTGATGTTGAAAAAGCTCATATCAACATTCGA
GATTCTATCCACCTCACACCAGTGCTAACAAGCTCCATTTTGAATCAACTAACAGGGCGC
AATCTTTTCTTCAAATGTGAACTCTTCCAGAAAACAGGATCTTTTAAGATTCGTGGTGCT
CTCAATGCCGTCAGAAGCTTGGTTCCTGATGCTTTAGAAAGGAAGCCGAAAGCTGTTGTT
ACTCACAGCAGTGGAAACCATGGCCAGGCTCTCACCTATGCTGCCAAATTGGAAGGAATT
CCTGCTTATATTGTGGTGCCCCAGACAGCTCCAGACTGTAAAAAACTTGCAATACAAGCC
TACGGAGCGTCAATTGTATACTGTGAACCTAGTGATGAGTCCAGAGAAAATGTTGCAAAA
AGAGTTACAGAAGAAACAGAAGGCATCATGGTACATCCCAACCAGGAGCCTGCAGTGATA
GCTGGACAAGGGACAATTGCCCTGGAAGTGCTGAACCAGGTTCCTTTGGTGGATGCACTG
GTGGTACCTGTAGGTGGAGGAGGAATGCTTGCTGGAATAGCAATTACAGTTAAGGCTCTG
AAACCTAGTGTGAAGGTATATGCTGCTGAACCCTCAAATGCAGATGACTGCTACCAGTCC
AAGCTGAAGGGGAAACTGATGCCCAATCTTTATCCTCCAGAAACCATAGCAGATGGTGTC
AAATCCAGCATTGGCTTGAACACCTGGCCTATTATCAGGGACCTTGTGGATGATATCTTC
ACTGTCACAGAGGATGAAATTAAGTGTGCAACCCAGCTGGTGTGGGAGAGGATGAAACTA
CTCATTGAACCTACAGCTGGTGTTGGAGTGGCTGCTGTGCTGTCTCAACATTTTCAAACT
GTTTCCCCAGAAGTAAAGAACATTTGTATTGTGCTCAGTGGTGGAAATGTAGACTTAACC
TCCTCCATAACTTGGGTGAAGCAGGCTGAAAGGCCAGCTTCTTATCAGTCTGTTTCTGTT
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00291</identifier>
        <name>PALP</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical part of cell</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>threonine racemase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-serine ammonia-lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>PDZ domain binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>D-serine ammonia-lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine racemase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>D-serine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>serine family amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-serine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to morphine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>D-serine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000660</id>
      <name>Serine palmitoyltransferase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17559874</pubmed-id>
            <citation>Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. Epub 2007 May 10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15270" source="Swiss-Prot">
    <name>Serine palmitoyltransferase 2</name>
    <general-function>Serine c-palmitoyltransferase activity</general-function>
    <specific-function>Serine palmitoyltransferase (SPT). The heterodimer formed with LCB1/SPTLC1 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC2-SPTSSB complex displays a preference for C18-CoA substrate.</specific-function>
    <gene-name>SPTLC2</gene-name>
    <locus>14q24.3-q31</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>67-87</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.85</theoretical-pi>
    <molecular-weight>62923.765</molecular-weight>
    <chromosome-location>14</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11278</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SPTLC2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y08686</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2564249</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15270</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SPTC2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.3.1.50</synonym>
      <synonym>KIAA0526</synonym>
      <synonym>LCB 2</synonym>
      <synonym>LCB2</synonym>
      <synonym>LCB2a</synonym>
      <synonym>Long chain base biosynthesis protein 2</synonym>
      <synonym>Long chain base biosynthesis protein 2a</synonym>
      <synonym>Serine-palmitoyl-CoA transferase 2</synonym>
      <synonym>SPT 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001316|Serine palmitoyltransferase 2
MRPEPGGCCCRRTVRANGCVANGEVRNGYVRSSAAAAAAAAAGQIHHVTQNGGLYKRPFN
EAFEETPMLVAVLTYVGYGVLTLFGYLRDFLRYWRIEKCHHATEREEQKDFVSLYQDFEN
FYTRNLYMRIRDNWNRPICSVPGARVDIMERQSHDYNWSFKYTGNIIKGVINMGSYNYLG
FARNTGSCQEAAAKVLEEYGAGVCSTRQEIGNLDKHEELEELVARFLGVEAAMAYGMGFA
TNSMNIPALVGKGCLILSDELNHASLVLGARLSGATIRIFKHNNMQSLEKLLKDAIVYGQ
PRTRRPWKKILILVEGIYSMEGSIVRLPEVIALKKKYKAYLYLDEAHSIGALGPTGRGVV
EYFGLDPEDVDVMMGTFTKSFGASGGYIGGKKELIDYLRTHSHSAVYATSLSPPVVEQII
TSMKCIMGQDGTSLGKECVQQLAENTRYFRRRLKEMGFIIYGNEDSPVVPLMLYMPAKIG
AFGREMLKRNIGVVVVGFPATPIIESRARFCLSAAHTKEILDTALKEIDEVGDLLQLKYS
RHRLVPLLDRPFDETTYEETED</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010460|Serine palmitoyltransferase 2 (SPTLC2)
ATGCGGCCGGAGCCCGGAGGCTGCTGCTGCCGCCGCACGGTGCGGGCGAATGGCTGCGTG
GCGAACGGGGAAGTACGGAACGGGTACGTGAGGAGCAGCGCTGCAGCCGCAGCCGCAGCC
GCCGCCGGCCAGATCCATCATGTTACACAAAATGGAGGACTATATAAAAGACCGTTTAAT
GAAGCTTTTGAAGAAACACCAATGCTGGTTGCTGTGCTCACGTATGTGGGGTATGGCGTA
CTCACCCTCTTTGGATATCTTCGAGATTTCTTGAGGTATTGGAGAATTGAAAAGTGTCAC
CATGCAACAGAAAGAGAAGAACAAAAGGACTTTGTGTCATTGTATCAAGATTTTGAAAAC
TTTTATACAAGGAATCTGTACATGAGGATAAGAGACAACTGGAATCGGCCAATCTGTAGT
GTGCCTGGAGCCAGGGTGGACATCATGGAGAGACAGTCTCATGATTATAACTGGTCCTTC
AAGTATACAGGGAATATAATAAAGGGTGTTATAAACATGGGTTCCTACAACTATCTTGGA
TTTGCACGGAATACTGGATCATGTCAAGAAGCAGCCGCCAAAGTCCTTGAGGAGTATGGA
GCTGGAGTGTGCAGTACTCGGCAGGAAATTGGAAACCTGGACAAGCATGAAGAACTAGAG
GAGCTTGTAGCAAGGTTCTTAGGAGTAGAAGCTGCTATGGCGTATGGCATGGGATTTGCA
ACGAATTCAATGAACATTCCTGCTCTTGTTGGCAAAGGTTGCCTGATTCTGAGTGATGAA
CTGAATCATGCATCACTGGTTCTGGGAGCCAGACTGTCAGGAGCAACCATTAGAATCTTC
AAACACAACAATATGCAAAGCCTAGAGAAGCTATTGAAAGATGCCATTGTTTATGGTCAG
CCTCGGACACGAAGGCCCTGGAAGAAAATTCTCATCCTTGTGGAAGGAATATATAGCATG
GAGGGATCTATTGTTCGTCTTCCTGAAGTGATTGCCCTCAAGAAGAAATACAAGGCATAC
TTGTATCTGGATGAGGCTCACAGCATTGGCGCCCTGGGCCCCACAGGCCGGGGTGTGGTG
GAGTACTTTGGCCTGGATCCCGAGGATGTGGATGTTATGATGGGAACGTTCACAAAGAGT
TTTGGTGCTTCTGGAGGATATATTGGAGGCAAGAAGGAGCTGATAGACTACCTGCGAACA
CATTCTCATAGTGCAGTGTATGCCACGTCATTGTCACCTCCTGTAGTGGAGCAGATCATC
ACCTCCATGAAGTGCATCATGGGGCAGGATGGCACCAGCCTTGGTAAAGAGTGTGTACAA
CAGTTAGCTGAAAACACCAGGTATTTCAGGAGACGCCTGAAAGAGATGGGCTTCATCATC
TATGGAAATGAAGACTCTCCAGTAGTGCCTTTGATGCTCTACATGCCTGCCAAAATTGGC
GCCTTTGGACGGGAGATGCTGAAGCGGAACATCGGTGTCGTTGTGGTTGGATTTCCTGCC
ACCCCAATTATTGAGTCCAGAGCCAGGTTTTGCCTGTCAGCAGCTCATACCAAAGAAATA
CTTGATACTGCTTTAAAGGAGATAGATGAAGTTGGGGACCTATTGCAGCTGAAGTATTCC
CGTCATCGGTTGGTACCTCTACTGGACAGGCCCTTTGACGAGACGACGTATGAAGAAACA
GAAGACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>serine C-palmitoyltransferase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine C-palmitoyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingomyelin biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingosine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingolipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingolipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ceramide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphinganine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000441</id>
      <name>Serine palmitoyltransferase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17559874</pubmed-id>
            <citation>Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. Epub 2007 May 10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15269" source="Swiss-Prot">
    <name>Serine palmitoyltransferase 1</name>
    <general-function>Serine c-palmitoyltransferase activity</general-function>
    <specific-function>Serine palmitoyltransferase (SPT). The heterodimer formed with SPTLC2 or SPTLC3 constitutes the catalytic core. The composition of the serine palmitoyltransferase (SPT) complex determines the substrate preference. The SPTLC1-SPTLC2-SPTSSA complex shows a strong preference for C16-CoA substrate, while the SPTLC1-SPTLC3-SPTSSA isozyme uses both C14-CoA and C16-CoA as substrates, with a slight preference for C14-CoA. The SPTLC1-SPTLC2-SPTSSB complex shows a strong preference for C18-CoA substrate, while the SPTLC1-SPTLC3-SPTSSB isozyme displays an ability to use a broader range of acyl-CoAs, without apparent preference.</specific-function>
    <gene-name>SPTLC1</gene-name>
    <locus>9q22.2</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>16-36</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.87</theoretical-pi>
    <molecular-weight>52743.41</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11277</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SPTLC1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y08685</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2564247</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15269</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SPTC1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.3.1.50</synonym>
      <synonym>LCB 1</synonym>
      <synonym>LCB1</synonym>
      <synonym>Long chain base biosynthesis protein 1</synonym>
      <synonym>Serine-palmitoyl-CoA transferase 1</synonym>
      <synonym>SPT 1</synonym>
      <synonym>SPT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000879|Serine palmitoyltransferase 1
MATATEQWVLVEMVQALYEAPAYHLILEGILILWIIRLLFSKTYKLQERSDLTVKEKEEL
IEEWQPEPLVPPVPKDHPALNYNIVSGPPSHKTVVNGKECINFASFNFLGLLDNPRVKAA
ALASLKKYGVGTCGPRGFYGTFDVHLDLEDRLAKFMKTEEAIIYSYGFATIASAIPAYSK
RGDIVFVDRAACFAIQKGLQASRSDIKLFKHNDMADLERLLKEQEIEDQKNPRKARVTRR
FIVVEGLYMNTGTICPLPELVKLKYKYKARIFLEESLSFGVLGEHGRGVTEHYGINIDDI
DLISANMENALASIGGFCCGRSFVIDHQRLSGQGYCFSASLPPLLAAAAIEALNIMEENP
GIFAVLKEKCGQIHKALQGISGLKVVGESLSPAFHLQLEESTGSREQDVRLLQEIVDQCM
NRSIALTQARYLEKEEKCLPPPSIRVVVTVEQTEEELERAASTIKEVAQAVLL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016095|Serine palmitoyltransferase 1 (SPTLC1)
ATGGCGACCGCCACGGAGCAGTGGGTTCTGGTGGAGATGGTACAGGCGCTTTACGAGGCT
CCTGCTTACCATCTTATTTTGGAAGGGATTCTGATCCTCTGGATAATCAGACTTCTTTTC
TCTAAGACTTACAAATTACAAGAACGATCTGATCTTACAGTCAAGGAAAAAGAAGAACTG
ATTGAAGAGTGGCAACCAGAACCTCTTGTTCCTCCTGTCCCAAAAGACCATCCTGCTCTC
AACTACAACATCGTTTCAGGCCCTCCAAGCCACAAAACTGTGGTGAATGGAAAAGAATGT
ATAAACTTCGCCTCATTTAATTTTCTTGGATTGTTGGATAACCCTAGGGTTAAGGCAGCA
GCTTTAGCATCTCTAAAGAAGTATGGCGTGGGGACTTGTGGACCCAGAGGATTTTATGGC
ACATTTGATGTTCATTTGGATTTGGAAGACCGCCTGGCAAAATTTATGAAGACAGAAGAA
GCCATTATATACTCATATGGATTTGCCACCATAGCCAGTGCTATTCCTGCTTACTCTAAA
AGAGGGGACATTGTTTTTGTAGATAGAGCTGCCTGCTTTGCTATTCAGAAAGGATTACAG
GCATCCCGTAGTGACATTAAGTTATTTAAGCATAATGACATGGCTGACCTCGAGCGACTA
CTAAAAGAACAAGAGATCGAAGATCAAAAGAATCCTCGCAAGGCTCGTGTAACTCGGCGT
TTCATTGTAGTAGAAGGATTGTATATGAATACTGGAACTATTTGTCCTCTTCCAGAATTG
GTTAAGTTAAAATACAAATACAAAGCAAGAATCTTCCTGGAGGAAAGCCTTTCATTTGGA
GTCCTAGGAGAGCATGGCCGAGGAGTCACTGAACACTATGGAATCAATATTGATGATATT
GATCTTATCAGTGCCAACATGGAGAATGCACTTGCTTCTATTGGAGGTTTCTGCTGTGGC
AGGTCTTTTGTAATTGACCATCAGCGACTTTCCGGCCAGGGATACTGCTTTTCAGCTTCG
TTACCTCCCCTGTTAGCTGCTGCAGCAATTGAGGCCCTCAACATCATGGAAGAGAATCCA
GGTATTTTTGCAGTGTTGAAGGAAAAGTGCGGACAAATTCATAAAGCTTTACAAGGCATT
TCTGGATTAAAAGTGGTGGGGGAGTCCCTTTCTCCAGCCTTTCACCTACAACTGGAAGAG
AGCACTGGGTCTCGCGAGCAAGATGTCAGACTGCTTCAGGAAATTGTAGATCAATGCATG
AACAGAAGTATTGCATTAACTCAGGCGCGCTACTTGGAGAAAGAAGAGAAGTGTCTCCCT
CCTCCCAGAGGAAGAACTGGAGAGAGCTGCGTCCACCATCAAGGAGGTAGCCCAGGCCGT
CCTGCTCTAGGCAGAGTCCCGGGACCATGGCCTCCTGCCACACAACACGCAGAGAGGACT
CAAGACTCCCGCTGGCCATGGAGTGGCCTGAAAGAGAGCAAGAACATGTGGATCTTTGAT
AGGATTGTTACCAAATGGTGTCAGTATGGACCAATTGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>SPOTS complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>serine C-palmitoyltransferase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine C-palmitoyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingosine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of lipophagy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingolipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingolipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ceramide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphinganine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingomyelin biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000063</id>
      <name>Serine--tRNA ligase, cytoplasmic</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>16950556</pubmed-id>
            <citation>Zhang Y, Cui J, Zhang R, Wang Y, Hong M: A novel fibrinolytic serine protease from the polychaete Nereis (Neanthes) virens (Sars): purification and characterization. Biochimie. 2007 Jan;89(1):93-103. Epub 2006 Aug 22.</citation>
          </article>
          <article>
            <pubmed-id>16081124</pubmed-id>
            <citation>Follis KE, York J, Nunberg JH: Serine-scanning mutagenesis studies of the C-terminal heptad repeats in the SARS coronavirus S glycoprotein highlight the important role of the short helical region. Virology. 2005 Oct 10;341(1):122-9.</citation>
          </article>
          <article>
            <pubmed-id>16517553</pubmed-id>
            <citation>McClendon CL, Vaidehi N, Kam VW, Zhang D, Goddard WA 3rd: Fidelity of seryl-tRNA synthetase to binding of natural amino acids from HierDock first principles computations. Protein Eng Des Sel. 2006 May;19(5):195-203. Epub 2006 Mar 3.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P49591" source="Swiss-Prot">
    <name>Serine--tRNA ligase, cytoplasmic</name>
    <general-function>Serine-trna ligase activity</general-function>
    <specific-function>Catalyzes the attachment of serine to tRNA(Ser). Is also probably able to aminoacylate tRNA(Sec) with serine, to form the misacylated tRNA L-seryl-tRNA(Sec), which will be further converted into selenocysteinyl-tRNA(Sec).</specific-function>
    <gene-name>SARS</gene-name>
    <locus>1p13.3-p13.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.38</theoretical-pi>
    <molecular-weight>58776.785</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10537</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SARS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X91257</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1050527</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P49591</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYSC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.11</synonym>
      <synonym>SerRS</synonym>
      <synonym>SERS</synonym>
      <synonym>Seryl-tRNA synthetase</synonym>
      <synonym>Seryl-tRNA(Ser/Sec) synthetase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010147|Serine--tRNA ligase, cytoplasmic
MVLDLDLFRVDKGGDPALIRETQEKRFKDPGLVDQLVKADSEWRRCRFRADNLNKLKNLC
SKTIGEKMKKKEPVGDDESVPENVLSFDDLTADALANLKVSQIKKVRLLIDEAILKCDAE
RIKLEAERFENLREIGNLLHPSVPISNDEDVDNKVERIWGDCTVRKKYSHVDLVVMVDGF
EGEKGAVVAGSRGYFLKGVLVFLEQALIQYALRTLGSRGYIPIYTPFFMRKEVMQEVAQL
SQFDEELYKVIGKGSEKSDDNSYDEKYLIATSEQPIAALHRDEWLRPEDLPIKYAGLSTC
FRQEVGSHGRDTRGIFRVHQFEKIEQFVYSSPHDNKSWEMFEEMITTAEEFYQSLGIPYH
IVNIVSGSLNHAASKKLDLEAWFPGSGAFRELVSCSNCTDYQARRLRIRYGQTKKMMDKV
EFVHMLNATMCATTRTICAILENYQTEKGITVPEKLKEFMPPGLQELIPFVKPAPIEQEP
SKKQKKQHEGSKKKAAARDVTLENRLQNMEVTDA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010148|Serine--tRNA ligase, cytoplasmic (SARS)
ATGGTGCTGGATCTGGATTTGTTTCGGGTGGATAAAGGAGGGGACCCAGCCCTCATCCGA
GAGACGCAGGAGAAGCGCTTCAAGGACCCGGGACTAGTGGACCAGCTGGTGAAGGCAGAC
AGCGAGTGGCGACGATGTAGATTTCGGGCAGACAACTTGAACAAGCTGAAGAACCTATGC
AGCAAGACAATCGGAGAGAAAATGAAGAAAAAAGAGCCAGTGGGAGATGATGAGTCTGTC
CCAGAGAATGTGCTGAGTTTCGATGACCTTACTGCAGACGCTTTAGCTAACCTGAAAGTC
TCACAAATCAAAAAAGTCCGACTCCTCATTGATGAAGCCATCCTGAAGTGTGACGCGGAG
CGGATAAAGTTGGAAGCAGAGCGGTTTGAGAACCTCCGAGAGATTGGGAACCTTCTGCAC
CCTTCTGTACCCATCAGTAACGATGAGGATGTGGACAACAAAGTAGAGAGGATTTGGGGT
GATTGTACAGTCAGGAAGAAGTACTCTCATGTGGACCTGGTGGTGATGGTAGATGGCTTT
GAAGGCGAAAAGGGGGCCGTGGTGGCTGGGAGTCGAGGGTACTTCTTGAAGGGGGTCCTG
GTGTTCCTGGAACAGGCTCTCATCCAGTATGCCCTTCGCACCTTGGGAAGTCGGGGCTAC
ATTCCCATTTATACCCCCTTTTTCATGAGGAAGGAGGTCATGCAGGAGGTGGCACAGCTC
AGCCAGTTTGATGAAGAACTTTATAAGGTGATTGGCAAAGGCAGTGAAAAGTCTGATGAC
AACTCCTATGATGAGAAGTACCTGATTGCCACCTCAGAGCAGCCCATTGCTGCCCTGCAC
CGGGATGAGTGGCTCCGGCCGGAGGACCTGCCCATCAAGTATGCTGGCCTGTCTACCTGC
TTCCGTCAGGAGGTGGGCTCCCATGGCCGTGACACCCGTGGCATCTTCCGAGTCCATCAG
TTTGAGAAGATTGAACAGTTTGTGTACTCATCACCCCATGACAACAAGTCATGGGAGATG
TTTGAAGAGATGATTACCACCGCAGAGGAGTTCTACCAGTCCCTGGGGATTCCTTACCAC
ATTGTGAATATTGTCTCAGGTTCTTTGAATCATGCTGCCAGTAAGAAGCTTGACCTGGAG
GCCTGGTTTCCGGGCTCAGGAGCCTTCCGTGAGTTGGTCTCCTGTTCTAATTGCACGGAT
TACCAGGCTCGCCGGCTTCGAATCCGATATGGGCAAACCAAGAAGATGATGGACAAGGTG
GAGTTTGTCCATATGCTCAATGCTACCATGTGCGCCACTACCCGTACCATCTGCGCCATC
CTGGAGAACTACCAGACAGAGAAGGGCATCACTGTGCCTGAGAAATTGAAGGAGTTCATG
CCGCCAGGACTGCAAGAACTGATCCCCTTTGTGAAGCCTGCGCCCATTGAGCAGGAGCCA
TCAAAGAAGCAGAAGAAGCAACATGAGGGCAGCAAAAAGAAAGCAGCAGCAAGAGACGTC
ACCCTAGAAAACAGGCTGCAGAACATGGAGGTCACCGATGCTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02403</identifier>
        <name>Seryl_tRNA_N</name>
      </pfam>
      <pfam>
        <identifier>PF00587</identifier>
        <name>tRNA-synt_2b</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>selenocysteinyl-tRNA(Sec) biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>seryl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA processing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000316</id>
      <name>Serine--pyruvate aminotransferase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17557831</pubmed-id>
            <citation>Ikushiro H, Islam MM, Tojo H, Hayashi H: Molecular characterization of membrane-associated soluble serine palmitoyltransferases from Sphingobacterium multivorum and Bdellovibrio stolpii. J Bacteriol. 2007 Aug;189(15):5749-61. Epub 2007 Jun 8.</citation>
          </article>
          <article>
            <pubmed-id>17322298</pubmed-id>
            <citation>Cowart LA, Hannun YA: Selective substrate supply in the regulation of yeast de novo sphingolipid synthesis. J Biol Chem. 2007 Apr 20;282(16):12330-40. Epub 2007 Feb 23.</citation>
          </article>
          <article>
            <pubmed-id>17654249</pubmed-id>
            <citation>Son JH, Yoo HH, Kim DH: Activation of de novo synthetic pathway of ceramides is responsible for the initiation of hydrogen peroxide-induced apoptosis in HL-60 cells. J Toxicol Environ Health A. 2007 Aug;70(15-16):1310-8.</citation>
          </article>
          <article>
            <pubmed-id>17559874</pubmed-id>
            <citation>Yard BA, Carter LG, Johnson KA, Overton IM, Dorward M, Liu H, McMahon SA, Oke M, Puech D, Barton GJ, Naismith JH, Campopiano DJ: The structure of serine palmitoyltransferase; gateway to sphingolipid biosynthesis. J Mol Biol. 2007 Jul 27;370(5):870-86. Epub 2007 May 10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21549" source="Swiss-Prot">
    <name>Serine--pyruvate aminotransferase</name>
    <general-function>Transaminase activity</general-function>
    <specific-function/>
    <gene-name>AGXT</gene-name>
    <locus>2q36-q37</locus>
    <cellular-location>Peroxisome</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.55</theoretical-pi>
    <molecular-weight>43009.535</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>AGXT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X56092</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>36582</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P21549</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SPYA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.51</synonym>
      <synonym>AGT</synonym>
      <synonym>AGT1</synonym>
      <synonym>Alanine--glyoxylate aminotransferase</synonym>
      <synonym>SPAT</synonym>
      <synonym>SPT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010080|Serine--pyruvate aminotransferase
MASHKLLVTPPKALLKPLSIPNQLLLGPGPSNLPPRIMAAGGLQMIGSMSKDMYQIMDEI
KEGIQYVFQTRNPLTLVISGSGHCALEAALVNVLEPGDSFLVGANGIWGQRAVDIGERIG
ARVHPMTKDPGGHYTLQEVEEGLAQHKPVLLFLTHGESSTGVLQPLDGFGELCHRYKCLL
LVDSVASLGGTPLYMDRQGIDILYSGSQKALNAPPGTSLISFSDKAKKKMYSRKTKPFSF
YLDIKWLANFWGCDDQPRMYHHTIPVISLYSLRESLALIAEQGLENSWRQHREAAAYLHG
RLQALGLQLFVKDPALRLPTVTTVAVPAGYDWRDIVSYVIDHFDIEIMGGLGPSTGKVLR
IGLLGCNATRENVDRVTEALRAALQHCPKKKL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010081|Serine--pyruvate aminotransferase (AGXT)
ATGGCCTCTCACAAGCTGCTGGTGACCCCCCCCAAGGCCCTGCTCAAGCCCCTCTCCATC
CCCAACCAGCTCCTGCTGGGGCCTGGTCCTTCCAACCTGCCTCCTCGCATCATGGCAGCC
GGGGGGCTGCAGATGATCGGGTCCATGAGCAAGGATATGTACCAGATCATGGACGAGATC
AAGGAAGGCATCCAGTACGTGTTCCAGACCAGGAACCCACTCACACTGGTCATCTCTGGC
TCGGGACACTGTGCCCTGGAGGCCGCCCTGGTCAATGTGCTGGAGCCTGGGGACTCCTTC
CTGGTTGGGGCCAATGGCATTTGGGGGCAGCGAGCCGTGGACATCGGGGAGCGCATAGGA
GCCCGAGTGCACCCGATGACCAAGGACCCTGGAGGCCACTACACACTGCAGGAGGTGGAG
GAGGGCCTGGCCCAGCACAAGCCAGTGCTGCTGTTCTTAACCCACGGGGAGTCGTCCACC
GGCGTGCTGCAGCCCCTTGATGGCTTCGGGGAACTCTGCCACAGGTACAAGTGCCTGCTC
CTGGTGGATTCGGTGGCATCCCTGGGCGGGACCCCCCTTTACATGGACCGGCAAGGCATC
GACATCCTGTACTCGGGCTCCCAGAAGGCCCTGAACGCCCCTCCAGGGACCTCGCTCATC
TCCTTCAGTGACAAGGCCAAAAAGAAGATGTACTCCCGCAAGACGAAGCCCTTCTCCTTC
TACCTGGACATCAAGTGGCTGGCCAACTTCTGGGGCTGTGACGACCAGCCCAGGATGTAC
CATCACACAATCCCCGTCATCAGCCTGTACAGCCTGAGAGAGAGCCTGGCCCTCATTGCG
GAACAGGGCCTGGAGAACAGCTGGCGCCAGCACCGCGAGGCCGCGGCGTATCTGCATGGG
CGCCTGCAGGCACTGGGGCTGCAGCTCTTCGTGAAGGACCCGGCGCTCCGGCTTCCCACA
GTCACCACTGTGGCTGTACCCGCTGGCTATGACTGGAGAGACATCGTCAGCTACGTCATA
GACCACTTCGACATTGAGATCATGGGTGGCCTTGGGCCCTCCACGGGGAAGGTGCTGCGG
ATCGGCCTGCTGGGCTGCAATGCCACCCGCGAGAATGTGGACCGCGTGACGGAGGCCCTG
AGGGCGGCCCTGCAGCACTGCCCCAAGAAGAAGCTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00266</identifier>
        <name>Aminotran_5</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>peroxisomal matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>peroxisome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>alanine-glyoxylate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein self-association</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine-pyruvate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucocorticoid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proteasomal protein catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycine biosynthetic process, by transamination of glyoxylate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glyoxylate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-alanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-cysteine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glyoxylate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Notch signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to cAMP</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxalic acid secretion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
    <name>Monocarboxylate transporter 10</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
    <gene-name>SLC16A10</gene-name>
    <locus>6q21-q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>55492.07</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB057445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18640047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TF71</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aromatic amino acid transporter 1</synonym>
      <synonym>MCT 10</synonym>
      <synonym>MCT10</synonym>
      <synonym>Solute carrier family 16 member 10</synonym>
      <synonym>T-type amino acid transporter 1</synonym>
      <synonym>TAT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aromatic amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00134</drugbank-id>
  <drugbank-id>NUTR00038</drugbank-id>
  <name>L-Methionine</name>
  <description>A sulfur containing essential amino acid that is important in many body functions. It is a chelating agent for heavy metals. [PubChem]</description>
  <cas-number>63-68-3</cas-number>
  <unii>AE28F7PNPL</unii>
  <average-mass>149.211</average-mass>
  <monoisotopic-mass>149.051049291</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Clyde Eugene Stauffer, "Process for producing N-acyl-L-methionine." U.S. Patent US3963573, issued June, 1950.</synthesis-reference>
  <indication>Used for protein synthesis including the formation of SAMe, L-homocysteine, L-cysteine, taurine, and sulfate.</indication>
  <pharmacodynamics>L-Methionine is a principle supplier of sulfur which prevents disorders of the hair, skin and nails; helps lower cholesterol levels by increasing the liver's production of lecithin; reduces liver fat and protects the kidneys; a natural chelating agent for heavy metals; regulates the formation of ammonia and creates ammonia-free urine which reduces bladder irritation; influences hair follicles and promotes hair growth. L-methionine may protect against the toxic effects of hepatotoxins, such as acetaminophen. Methionine may have antioxidant activity.</pharmacodynamics>
  <mechanism-of-action>The mechanism of the possible anti-hepatotoxic activity of L-methionine is not entirely clear. It is thought that metabolism of high doses of acetaminophen in the liver lead to decreased levels of hepatic glutathione and increased oxidative stress. L-methionine is a precursor to L-cysteine. L-cysteine itself may have antioxidant activity. L-cysteine is also a precursor to the antioxidant glutathione. Antioxidant activity of L-methionine and metabolites of L-methionine appear to account for its possible anti-hepatotoxic activity. Recent research suggests that methionine itself has free-radical scavenging activity by virtue of its sulfur, as well as its chelating ability.</mechanism-of-action>
  <toxicity>Doses of L-methionine of up to 250 mg daily are generally well tolerated. Higher doses may cause nausea, vomiting and headache. Healthy adults taking 8 grams of L-methionine daily for four days were found to have reduced serum folate levels and leucocytosis. Healthy adults taking 13.9 grams of L-methionine daily for five days were found to have changes in serum pH and potassium and increased urinary calcium excretion. Schizophrenic patients given 10 to 20 grams of L-methionine daily for two weeks developed functional psychoses. Single doses of 8 grams precipitated encephalopathy in patients with cirrhosis.</toxicity>
  <metabolism>Hepatic</metabolism>
  <absorption>Absorbed from the lumen of the small intestine into the enterocytes by an active transport process.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as methionine and derivatives. These are compounds containing methionine or a derivative thereof resulting from reaction of methionine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct-parent>Methionine and derivatives</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Organic acids and derivatives</class>
    <subclass>Carboxylic acids and derivatives</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dialkylthioethers</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Sulfenyl compounds</alternative-parent>
    <alternative-parent>Thia fatty acids</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dialkylthioether</substituent>
    <substituent>Fatty acid</substituent>
    <substituent>Fatty acyl</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>Methionine or derivatives</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Organosulfur compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Sulfenyl compound</substituent>
    <substituent>Thia fatty acid</substituent>
    <substituent>Thioether</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT002219</drugbank-id>
      <name>Methionine hydrochloride</name>
      <unii>99JNR46OKX</unii>
      <cas-number>6810-12-4</cas-number>
      <inchikey>OSUIUMQSEFFIKM-WCCKRBBISA-N</inchikey>
      <average-mass>185.67</average-mass>
      <monoisotopic-mass>185.0277275</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="" coder="">(2S)-2-amino-4-(Methylsulfanyl)butanoic acid</synonym>
    <synonym language="" coder="">(S)-2-amino-4-(methylthio)butanoic acid</synonym>
    <synonym language="" coder="">(S)-2-amino-4-(methylthio)butyric acid</synonym>
    <synonym language="" coder="">(S)-methionine</synonym>
    <synonym language="" coder="">L-(-)-Methionine</synonym>
    <synonym language="" coder="">L-a-Amino-g-methylthiobutyric acid</synonym>
    <synonym language="" coder="">L-alpha-amino-gamma-Methylmercaptobutyric acid</synonym>
    <synonym language="" coder="">L-Methionin</synonym>
    <synonym language="" coder="">L-Methionine</synonym>
    <synonym language="" coder="">L-α-amino-γ-methylmercaptobutyric acid</synonym>
    <synonym language="" coder="">M</synonym>
    <synonym language="" coder="">Met</synonym>
    <synonym language="" coder="">Methionine</synonym>
  </synonyms>
  <products>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143267</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013975</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014106</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143259</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143232</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014009</dpd-id>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013991</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143240</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013908</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142414</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142406</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014033</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142392</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014017</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142317</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142309</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142295</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013894</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142325</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143224</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142368</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142252</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142244</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4168</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019374</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4187</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4191</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4196</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4203</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00454907</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 10% W Electrolytes</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00558966</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 3.5% M</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510629</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00404160</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00523232</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613320</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613339</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7172</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4162</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4164</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4160</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on>2017-05-18</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7121</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742619</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 10% With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742651</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 15%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126745</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 5% Inj</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742643</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742635</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742724</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742740</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742759</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742627</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742716</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742767</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742783</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839302</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839310</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019437</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn RF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4166</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-02-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018429</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn RF Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00640131</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn Sulfite Free</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4192</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4178</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1985-09-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019398</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4179</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731366</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn-PF 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731358</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013959</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013886</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013940</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02046709</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013932</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142260</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142279</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013916</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013924</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1083</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1089</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1091</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1093</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1095</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1099</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1103</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1132</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1133</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1134</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1135</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1136</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1137</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1138</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1139</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142333</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014025</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014041</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014076</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013967</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014068</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142341</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142376</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142384</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014084</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1107</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1109</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1113</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1115</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1119</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1123</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1125</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1127</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1142</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1143</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1144</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1145</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1146</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1147</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1148</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1149</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinisol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0502</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1996-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020512</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Derma-force</name>
      <labeller>Prairie Naturals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230387</dpd-id>
      <started-marketing-on>1997-04-01</started-marketing-on>
      <ended-marketing-on>2006-09-20</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Cm</name>
      <labeller>Nutrivention Nutritional Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240384</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Cw</name>
      <labeller>Body Wise International Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229796</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Cw-caplet</name>
      <labeller>Body Wise International Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02138549</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2005-10-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>FreAmine HBC</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9350</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>FreAmine III</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9010</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1971-09-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA016822</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>HepatAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9371</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1982-08-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018676</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Inhibitol - Tab</name>
      <labeller>Pep Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02198878</dpd-id>
      <started-marketing-on>1997-06-04</started-marketing-on>
      <ended-marketing-on>1999-10-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Medi Msm (methyl Sulfonyl Methane)</name>
      <labeller>Mbg Inc (Korea Institute of Science Development)</labeller>
      <ndc-id/>
      <ndc-product-code>70694-3850</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-09-16</started-marketing-on>
      <ended-marketing-on>2017-09-16</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>NephrAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-1909</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1978-02-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017766</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Novamine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-0468</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution, concentrate</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017957</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Olimel 3.3% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352508</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352524</dpd-id>
      <started-marketing-on>2011-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352516</dpd-id>
      <started-marketing-on>2011-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352540</dpd-id>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352532</dpd-id>
      <started-marketing-on>2011-01-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Periolimel 2.5% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352494</dpd-id>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3205</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1130</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1131</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene 10%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236875</dpd-id>
      <started-marketing-on>1997-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Primene 10%-liq IV</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161192</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ProSol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0499</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1998-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020849</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013983</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Renamin (amino Acids) Injection</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02020564</dpd-id>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2011-05-10</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Selenium Plus</name>
      <labeller>Sisu Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236751</dpd-id>
      <started-marketing-on>1998-03-18</started-marketing-on>
      <ended-marketing-on>2008-07-25</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388769</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00872296</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0644</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306444</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306436</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2008-03-26</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00285528</dpd-id>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388742</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9341</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9361</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vamin 18 Electrolyte-free</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02059711</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vamin N</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065665</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Acimethin</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Novamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn Sulfite Free</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Phosphoric acid + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>NephrAmine</name>
      <ingredients>L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Threonine + L-Tryptophan + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>HepatAmine</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Phosphoric acid</ingredients>
    </mixture>
    <mixture>
      <name>ProSol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Clinisol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn RF</name>
      <ingredients>L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Threonine + L-Tryptophan + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol E</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 15%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin N</name>
      <ingredients>Calcium Chloride + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium Sulfate + Potassium Chloride + Potassium hydroxide + Sodium hydroxide</ingredients>
    </mixture>
    <mixture>
      <name>Formula Cw-caplet</name>
      <ingredients>Beta carotene + Chromic chloride + L-Methionine + Magnesium + Niacin + Nicotinamide + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%-liq IV</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Renamin (amino Acids) Injection</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Inhibitol - Tab</name>
      <ingredients>Chromium + L-Methionine + Manganese</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 3.5% M</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Vamin 18 Electrolyte-free</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10% W Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Selenium Plus</name>
      <ingredients>L-Methionine + Selenium</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 5% Inj</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Formula Cw</name>
      <ingredients>Beta carotene + Chromic chloride + L-Methionine + Magnesium + Niacin + Nicotinamide + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Formula Cm</name>
      <ingredients>Choline + Ergocalciferol + Inositol nicotinate + L-Methionine + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Derma-force</name>
      <ingredients>Beta carotene + Biotin + Calcium + Cholecalciferol + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + L-Methionine + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Sulfur + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10% With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 7%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 7%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn RF Injection</name>
      <ingredients>L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Threonine + L-Tryptophan + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Threonine + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Periolimel 2.5% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 3.3% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Medi Msm (methyl Sulfonyl Methane)</name>
      <ingredients>Biotin + Cystine + L-Cysteine + L-Methionine + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine III</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Phosphoric acid</ingredients>
    </mixture>
    <mixture>
      <name>FreAmine HBC</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amend</name>
      <url/>
    </packager>
    <packager>
      <name>Spectrum Pharmaceuticals</name>
      <url>http://www.spectrumpharm.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Methionine powder</description>
      <cost currency="USD">0.03</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Dl-methionine powder</description>
      <cost currency="USD">0.26</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Essential</category>
      <mesh-id>D000601</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Neutral</category>
      <mesh-id>D021542</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Sulfur</category>
      <mesh-id>D000603</mesh-id>
    </category>
    <category>
      <category>Antidotes</category>
      <mesh-id>D000931</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Inorganic Chemicals</category>
      <mesh-id>D007287</mesh-id>
    </category>
    <category>
      <category>Organic Chemicals</category>
      <mesh-id>D009930</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution, concentrate</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="V03AB26">
      <level code="V03AB">Antidotes</level>
      <level code="V03A">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V03">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V">VARIOUS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1WKM</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00134.pdf?1265922736</msds>
  <patents/>
  <food-interactions>
    <food-interaction>Take with food.</food-interaction>
  </food-interactions>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB01235</drugbank-id>
      <name>Levodopa</name>
      <description>The therapeutic efficacy of Levodopa can be decreased when used in combination with L-Methionine.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.39e+01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-2.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-amino-4-(methylsulfanyl)butanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>L-methionine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>149.211</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>149.051049291</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CSCC[C@H](N)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C5H11NO2S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C5H11NO2S/c1-9-3-2-4(6)5(7)8/h4H,2-3,6H2,1H3,(H,7,8)/t4-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>FFEARJCKVFRZRR-BYPYZUCNSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>63.32</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>37.59</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>15.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>2.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>5.66E+004 mg/L (at 25 °C)</value>
      <source>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>283 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.87</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.42</value>
      <source>ADME Research, USCD</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.28 (at 25 °C)</value>
      <source>ULLMANN VA2:63 (1985)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>3180</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>7217</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>57844</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>6137</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46505750</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00073</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D04983</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>5907</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50142500</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA450423</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>MET</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL42336</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lme_0173.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP00253</smpdb-id>
      <name>Amikacin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00479</drugbank-id>
          <name>Amikacin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00258</smpdb-id>
      <name>Spectinomycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00919</drugbank-id>
          <name>Spectinomycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00485</smpdb-id>
      <name>Hyperglycinemia, non-ketotic</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00570</smpdb-id>
      <name>Homocystinuria-megaloblastic anemia due to defect in cobalamin metabolism, cblG complementation type</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00033</smpdb-id>
      <name>Methionine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00221</smpdb-id>
      <name>Methionine Adenosyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00341</smpdb-id>
      <name>Hypermethioninemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00711</smpdb-id>
      <name>Tobramycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00684</drugbank-id>
          <name>Tobramycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00713</smpdb-id>
      <name>Arbekacin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB06696</drugbank-id>
          <name>Arbekacin</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00727</smpdb-id>
      <name>Methacycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00931</drugbank-id>
          <name>Methacycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00123</smpdb-id>
      <name>Betaine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04401</drugbank-id>
          <name>[Formylmethyl]Trimethyl-Ammonium, N,N,N-Trimethylammonium Acetaldehyde</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49419</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00177</smpdb-id>
      <name>Cystathionine Beta-Synthase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00249</smpdb-id>
      <name>Clindamycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01190</drugbank-id>
          <name>Clindamycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00254</smpdb-id>
      <name>Gentamicin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00798</drugbank-id>
          <name>Gentamicin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00257</smpdb-id>
      <name>Netilmicin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00955</drugbank-id>
          <name>Netilmicin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00291</smpdb-id>
      <name>Doxycycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00254</drugbank-id>
          <name>Doxycycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00292</smpdb-id>
      <name>Minocycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01017</drugbank-id>
          <name>Minocycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00295</smpdb-id>
      <name>Lymecycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00256</drugbank-id>
          <name>Lymecycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00712</smpdb-id>
      <name>Tigecycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00560</drugbank-id>
          <name>Tigecycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00721</smpdb-id>
      <name>3-Phosphoglycerate dehydrogenase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00214</smpdb-id>
      <name>S-Adenosylhomocysteine (SAH) Hydrolase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00222</smpdb-id>
      <name>Glycine N-methyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01917</drugbank-id>
          <name>Putrescine</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02238</drugbank-id>
          <name>4-(Methylsulfanyl)-2-Oxobutanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03566</drugbank-id>
          <name>Spermidine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04193</drugbank-id>
          <name>L-Homoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P42898</uniprot-id>
        <uniprot-id>Q99707</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>P26358</uniprot-id>
        <uniprot-id>P17707</uniprot-id>
        <uniprot-id>P19623</uniprot-id>
        <uniprot-id>Q13126</uniprot-id>
        <uniprot-id>P23526</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P56192</uniprot-id>
        <uniprot-id>Q96DP5</uniprot-id>
        <uniprot-id>P31153</uniprot-id>
        <uniprot-id>Q9NZL9</uniprot-id>
        <uniprot-id>Q8NE62</uniprot-id>
        <uniprot-id>Q8IXL7</uniprot-id>
        <uniprot-id>Q9Y3D2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00223</smpdb-id>
      <name>Non Ketotic Hyperglycinemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00248</smpdb-id>
      <name>Clarithromycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01211</drugbank-id>
          <name>Clarithromycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00250</smpdb-id>
      <name>Erythromycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00199</drugbank-id>
          <name>Erythromycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00251</smpdb-id>
      <name>Roxithromycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00778</drugbank-id>
          <name>Roxithromycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00255</smpdb-id>
      <name>Kanamycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB01172</drugbank-id>
          <name>Kanamycin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00256</smpdb-id>
      <name>Neomycin Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00452</drugbank-id>
          <name>Framycetin</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00262</smpdb-id>
      <name>Clomocycline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00156</drugbank-id>
          <name>L-Threonine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00174</drugbank-id>
          <name>L-Asparagine</name>
        </drug>
        <drug>
          <drugbank-id>DB00453</drugbank-id>
          <name>Clomocycline</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03685</drugbank-id>
          <name>Uridine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes/>
    </pathway>
    <pathway>
      <smpdb-id>SMP00484</smpdb-id>
      <name>Dimethylglycine Dehydrogenase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000763</id>
      <name>Methionine synthase reductase</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17079868</pubmed-id>
            <citation>Kim DJ, Park BL, Koh JM, Kim GS, Kim LH, Cheong HS, Shin HD, Hong JM, Kim TH, Shin HI, Park EK, Kim SY: Methionine synthase reductase polymorphisms are associated with serum osteocalcin levels in postmenopausal women. Exp Mol Med. 2006 Oct 31;38(5):519-24.</citation>
          </article>
          <article>
            <pubmed-id>17101561</pubmed-id>
            <citation>Tvedegaard KC, Rudiger NS, Pedersen BN, Moller J: Detection of MTRR 66A--&gt;G polymorphism using the real-time polymerase chain reaction machine LightCycler for determination of composition of allele after restriction cleavage. Scand J Clin Lab Invest. 2006;66(8):685-93.</citation>
          </article>
          <article>
            <pubmed-id>17369066</pubmed-id>
            <citation>Elmore CL, Wu X, Leclerc D, Watson ED, Bottiglieri T, Krupenko NI, Krupenko SA, Cross JC, Rozen R, Gravel RA, Matthews RG: Metabolic derangement of methionine and folate metabolism in mice deficient in methionine synthase reductase. Mol Genet Metab. 2007 May;91(1):85-97. Epub 2007 Mar 21.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UBK8" source="Swiss-Prot">
    <name>Methionine synthase reductase</name>
    <general-function>Oxidoreductase activity, oxidizing metal ions, nad or nadp as acceptor</general-function>
    <specific-function>Involved in the reductive regeneration of cob(I)alamin (vitamin B12) cofactor required for the maintenance of methionine synthase in a functional state. Necessary for utilization of methylgroups from the folate cycle, thereby affecting transgenerational epigenetic inheritance. Folate pathway donates methyl groups necessary for cellular methylation and affects different pathways such as DNA methylation, possibly explaining the transgenerational epigenetic inheritance effects.</specific-function>
    <gene-name>MTRR</gene-name>
    <locus>5p15.3-p15.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.47</theoretical-pi>
    <molecular-weight>80409.22</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7473</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MTRR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF121213</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6572540</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UBK8</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MTRR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.16.1.8</synonym>
      <synonym>MSR</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037069|Methionine synthase reductase
MGAASVRAGARLVEVALCSFTVTCLEVMRRFLLLYATQQGQAKAIAEEICEQAVVHGFSA
DLHCISESDKYDLKTETAPLVVVVSTTGTGDPPDTARKFVKEIQNQTLPVDFFAHLRYGL
LGLGDSEYTYFCNGGKIIDKRLQELGARHFYDTGHADDCVGLELVVEPWIAGLWPALRKH
FRSSRGQEEISGALPVASPASSRTDLVKSELLHIESQVELLRFDDSGRKDSEVLKQNAVN
SNQSNVVIEDFESSLTRSVPPLSQASLNIPGLPPEYLQVHLQESLGQEESQVSVTSADPV
FQVPISKAVQLTTNDAIKTTLLVELDISNTDFSYQPGDAFSVICPNSDSEVQSLLQRLQL
EDKREHCVLLKIKADTKKKGATLPQHIPAGCSLQFIFTWCLEIRAIPKKAFLRALVDYTS
DSAEKRRLQELCSKQGAADYSRFVRDACACLLDLLLAFPSCQPPLSLLLEHLPKLQPRPY
SCASSSLFHPGKLHFVFNIVEFLSTATTEVLRKGVCTGWLALLVASVLQPNIHASHEDSG
KALAPKISISPRTTNSFHLPDDPSIPIIMVGPGTGIAPFIGFLQHREKLQEQHPDGNFGA
MWLFFGCRHKDRDYLFRKELRHFLKHGILTHLKVSFSRDAPVGEEEAPAKYVQDNIQLHG
QQVARILLQENGHIYVCGDAKNMAKDVHDALVQIISKEVGVEKLEAMKTLATLKEEKRYL
QDIWS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016200|Methionine synthase reductase (MTRR)
ATGAGGAGGTTTCTGTTACTATATGCTACACAGCAGGGACAGGCAAAGGCCATCGCAGAA
GAAATATGTGAGCAAGCTGTGGTACATGGATTTTCTGCAGATCTTCACTGTATTAGTGAA
TCCGATAAGTATGACCTAAAAACCGAAACAGCTCCTCTTGTTGTTGTGGTTTCTACCACG
GGCACCGGAGACCCACCCGACACAGCCCGCAAGTTTGTTAAGGAAATACAGAACCAAACA
CTGCCGGTTGATTTCTTTGCTCACCTGCGGTATGGGTTACTGGGTCTCGGTGATTCAGAA
TACACCTACTTTTGCAATGGGGGGAAGATAATTGATAAACGACTTCAAGAGCTTGGAGCC
CGGCATTTCTATGACACTGGACATGCAGATGACTGTGTAGGTTTAGAACTTGTGGTTGAG
CCGTGGATTGCTGGACTCTGGCCAGCCCTCAGAAAGCATTTTAGGTCAAGCAGAGGACAA
GAGGAGATAAGTGGCGCACTCCCGGTGGCATCACCTGCATCCTCGAGGACAGACCTTGTG
AAGTCAGAGCTGCTACACATTGAATCTCAAGTCGAGCTTCTGAGATTCGATGATTCAGGA
AGAAAGGATTCTGAGGTTTTGAAGCAAAATGCAGTGAACAGCAACCAATCCAATGTTGTA
ATTGAAGACTTTGAGTCCTCACTTACCCGTTCGGTACCCCCACTCTCACAAGCCTCTCTG
AATATTCCTGGTTTACCCCCAGAATATTTACAGGTACATCTGCAGGAGTCTCTTGGCCAG
GAGGAAAGCCAAGTATCTGTGACTTCAGCAGATCCAGTTTTTCAAGTGCCAATTTCAAAG
GCAGTTCAACTTACTACGAATGATGCCATAAAAACCACTCTGCTGGTAGAATTGGACATT
TCAAATACAGACTTTTCCTATCAGCCTGGAGATGCCTTCAGCGTGATCTGCCCTAACAGT
GATTCTGAGGTACAAAGCCTACTCCAAAGACTGCAGCTTGAAGATAAAAGAGAGCACTGC
GTCCTTTTGAAAATAAAGGCAGACACAAAGAAGAAAGGAGCTACCTTACCCCAGCATATA
CCTGCGGGATGTTCTCTCCAGTTCATTTTTACCTGGTGTCTTGAAATCCGAGCAATTCCT
AAAAAGGCATTTTTGCGAGCCCTTGTGGACTATACCAGTGACAGTGCTGAAAAGCGCAGG
CTACAGGAGCTGTGCAGTAAACAAGGGGCAGCCGATTATAGCCGCTTTGTACGAGATGCC
TGTGCCTGCTTGTTGGATCTCCTCCTCGCTTTCCCTTCTTGCCAGCCACCACTCAGTCTC
CTGCTCGAACATCTTCCTAAACTTCAACCCAGACCATATTCGTGTGCAAGCTCAAGTTTA
TTTCACCCAGGAAAGCTCCATTTTGTCTTCAACATTGTGGAATTTCTGTCTACTGCCACA
ACAGAGGTTCTGCGGAAGGGAGTATGTACAGGCTGGCTGGCCTTGTTGGTTGCTTCAGTT
CTTCAGCCAAACATACATGCATCCCATGAAGACAGCGGGAAAGCCCTGGCTCCTAAGATA
TCCATCTCTCCTCGAACAACAAATTCTTTCCACTTACCAGATGACCCCTCAATCCCCATC
ATAATGGTGGGTCCAGGAACCGGCATAGCCCCGTTTATTGGGTTCCTACAACATAGAGAG
AAACTCCAAGAACAACACCCAGATGGAAATTTTGGAGCAATGTGGTTGTTTTTTGGCTGC
AGGCATAAGGATAGGGATTATCTATTCAGAAAAGAGCTCAGACATTTCCTTAAGCATGGG
ATCTTAACTCATCTAAAGGTTTCCTTCTCAAGAGATGCTCCTGTTGGGGAGGAGGAAGCC
CCAGCAAAGTATGTGCAAGACAACATCCAGCTTCATGGCCAGCAGGTGGCGAGAATCCTC
CTCCAGGAGAACGGCCATATTTATGTGTGTGGAGATGCAAAGAATATGGCCAAGGATGTA
CATGATGCCCTTGTGCAAATAATAAGCAAAGAGGTTGGAGTTGAAAAACTAGAAGCAATG
AAAACCCTGGCCACTTTAAAAGAAGAAAAACGCTACCTTCAGGATATTTGGTCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00667</identifier>
        <name>FAD_binding_1</name>
      </pfam>
      <pfam>
        <identifier>PF00258</identifier>
        <name>Flavodoxin_1</name>
      </pfam>
      <pfam>
        <identifier>PF00175</identifier>
        <name>NAD_binding_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intermediate filament cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>FMN binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADPH binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>FAD binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, NAD(P)H as one donor, and incorporation of one atom of oxygen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>[methionine synthase] reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aquacobalamin reductase (NADPH) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADPH-hemoprotein reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>DNA methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cobalamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>homocysteine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cystathionine beta-synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000734</id>
      <name>Methionine synthase</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16618098</pubmed-id>
            <citation>Taurog RE, Matthews RG: Activation of methyltetrahydrofolate by cobalamin-independent methionine synthase. Biochemistry. 2006 Apr 25;45(16):5092-102.</citation>
          </article>
          <article>
            <pubmed-id>16788729</pubmed-id>
            <citation>Hughes JA: In vivo hydrolysis of S-adenosyl-L-methionine in Escherichia coli increases export of 5-methylthioribose. Can J Microbiol. 2006 Jun;52(6):599-602.</citation>
          </article>
          <article>
            <pubmed-id>17052662</pubmed-id>
            <citation>Reynolds E: Vitamin B12, folic acid, and the nervous system. Lancet Neurol. 2006 Nov;5(11):949-60.</citation>
          </article>
          <article>
            <pubmed-id>17222188</pubmed-id>
            <citation>Banks EC, Doughty SW, Toms SM, Wheelhouse RT, Nicolaou A: Inhibition of cobalamin-dependent methionine synthase by substituted benzo-fused heterocycles. FEBS J. 2007 Jan;274(1):287-99.</citation>
          </article>
          <article>
            <pubmed-id>17615995</pubmed-id>
            <citation>Yamada K, Kawata T, Wada M, Mori K, Tamai H, Tanaka N, Tadokoro T, Tobimatsu T, Toraya T, Maekawa A: Testicular injury to rats fed on soybean protein-based vitamin B12-deficient diet can be reduced by methionine supplementation. J Nutr Sci Vitaminol (Tokyo). 2007 Apr;53(2):95-101.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q99707" source="Swiss-Prot">
    <name>Methionine synthase</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Catalyzes the transfer of a methyl group from methyl-cobalamin to homocysteine, yielding enzyme-bound cob(I)alamin and methionine. Subsequently, remethylates the cofactor using methyltetrahydrofolate (By similarity).</specific-function>
    <gene-name>MTR</gene-name>
    <locus>1q43</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.27</theoretical-pi>
    <molecular-weight>140525.91</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7468</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MTR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U71285</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1923221</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q99707</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>METH_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.1.1.13</synonym>
      <synonym>5-methyltetrahydrofolate--homocysteine methyltransferase</synonym>
      <synonym>MS</synonym>
      <synonym>Vitamin-B12 dependent methionine synthase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001464|Methionine synthase
MSPALQDLSQPEGLKKTLRDEINAILQKRIMVLDGGMGTMIQREKLNEEHFRGQEFKDHA
RPLKGNNDILSITQPDVIYQIHKEYLLAGADIIETNTFSSTSIAQADYGLEHLAYRMNMC
SAGVARKAAEEVTLQTGIKRFVAGALGPTNKTLSVSPSVERPDYRNITFDELVEAYQEQA
KGLLDGGVDILLIETIFDTANAKAALFALQNLFEEKYAPRPIFISGTIVDKSGRTLSGQT
GEGFVISVSHGEPLCIGLNCALGAAEMRPFIEIIGKCTTAYVLCYPNAGLPNTFGDYDET
PSMMAKHLKDFAMDGLVNIVGGCCGSTPDHIREIAEAVKNCKPRVPPATAFEGHMLLSGL
EPFRIGPYTNFVNIGERCNVAGSRKFAKLIMAGNYEEALCVAKVQVEMGAQVLDVNMDDG
MLDGPSAMTRFCNLIASEPDIAKVPLCIDSSNFAVIEAGLKCCQGKCIVNSISLKEGEDD
FLEKARKIKKYGAAMVVMAFDEEGQATETDTKIRVCTRAYHLLVKKLGFNPNDIIFDPNI
LTIGTGMEEHNLYAINFIHATKVIKETLPGARISGGLSNLSFSFRGMEAIREAMHGVFLY
HAIKSGMDMGIVNAGNLPVYDDIHKELLQLCEDLIWNKDPEATEKLLRYAQTQGTGGKKV
IQTDEWRNGPVEERLEYALVKGIEKHIIEDTEEARLNQKKYPRPLNIIEGPLMNGMKIVG
DLFGAGKMFLPQVIKSARVMKKAVGHLIPFMEKEREETRVLNGTVEEEDPYQGTIVLATV
KGDVHDIGKNIVGVVLGCNNFRVIDLGVMTPCDKILKAALDHKADIIGLSGLITPSLDEM
IFVAKEMERLAIRIPLLIGGATTSKTHTAVKIAPRYSAPVIHVLDASKSVVVCSQLLDEN
LKDEYFEEIMEEYEDIRQDHYESLKERRYLPLSQARKSGFQMDWLSEPHPVKPTFIGTQV
FEDYDLQKLVDYIDWKPFFDVWQLRGKYPNRGFPKIFNDKTVGGEARKVYDDAHNMLNTL
ISQKKLRARGVVGFWPAQSIQDDIHLYAEAAVPQAAEPIATFYGLRQQAEKDSASTEPYY
CLSDFIAPLHSGIRDYLGLFAVACFGVEELSKAYEDDGDDYSSIMVKALGDRLAEAFAEE
LHERVRRELWAYCGSEQLDVADLRRLRYKGIRPAPGYPSQPDHTEKLTMWRLADIEQSTG
IRLTESLAMAPASAVSGLYFSNLKSKYFAVGKISKDQVEDYALRKNISVAEVEKWLGPIL
GYDTD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010518|Methionine synthase (MTR)
ATGTCACCCGCGCTCCAAGACCTGTCGCAACCCGAAGGTCTGAAGAAAACCCTGCGGGAT
GAGATCAATGCCATTCTGCAGAAGAGGATTATGGTGCTGGATGGAGGGATGGGGACCATG
ATCCAGCGGGAGAAGCTAAACGAAGAACACTTCCGAGGTCAGGAATTTAAAGATCATGCC
AGGCCGCTGAAAGGCAACAATGACATTTTAAGTATAACTCAGCCTGATGTCATTTACCAA
ATCCATAAGGAATACTTGCTGGCTGGGGCAGATATCATTGAAACAAATACTTTTAGCAGC
ACTAGTATTGCCCAAGCTGACTATGGCCTTGAACACTTGGCCTACCGGATGAACATGTGC
TCTGCAGGAGTGGCCAGAAAAGCTGCCGAGGAGGTAACTCTCCAGACAGGAATTAAGAGG
TTTGTGGCAGGGGCTCTGGGTCCGACTAATAAGACACTCTCTGTGTCCCCATCTGTGGAA
AGGCCGGATTATAGGAACATCACATTTGATGAGCTTGTTGAAGCATACCAAGAGCAGGCC
AAAGGACTTCTGGATGGCGGGGTTGATATCTTACTCATTGAAACTATTTTTGATACTGCC
AATGCCAAGGCAGCCTTGTTTGCACTCCAAAATCTTTTTGAGGAGAAATATGCTCCCCGG
CCTATCTTTATTTCAGGGACGATCGTTGATAAAAGTGGGCGGACTCTTTCCGGACAGACA
GGAGAGGGATTTGTCATCAGCGTGTCTCATGGAGAACCACTCTGCATTGGATTAAATTGT
GCTTTGGGTGCAGCTGAAATGAGACCTTTTATTGAAATAATTGGAAAATGTACAACAGCC
TATGTCCTCTGTTATCCCAATGCAGGTCTTCCCAACACCTTTGGTGACTATGATGAAACG
CCTTCTATGATGGCCAAGCACCTAAAGGATTTTGCTATGGATGGCTTGGTCAATATAGTT
GGAGGATGCTGTGGGTCAACACCAGATCATATCAGGGAAATTGCTGAAGCTGTGAAAAAT
TGTAAGCCTAGAGTTCCACCTGCCACTGCTTTTGAAGGACATATGTTACTGTCTGGTCTA
GAGCCCTTCAGGATTGGACCGTACACCAACTTTGTTAACATTGGAGAGCGCTGTAATGTT
GCAGGATCAAGGAAGTTTGCTAAACTCATCATGGCAGGAAACTATGAAGAAGCCTTGTGT
GTTGCCAAAGTGCAGGTGGAAATGGGAGCCCAGGTGTTGGATGTCAACATGGATGATGGC
ATGCTAGATGGTCCAAGTGCAATGACCAGATTTTGCAACTTAATTGCTTCCGAGCCAGAC
ATCGCAAAGGTACCTTTGTGCATCGACTCCTCCAATTTTGCTGTGATTGAAGCTGGGTTA
AAGTGCTGCCAAGGGAAGTGCATTGTCAATAGCATTAGTCTGAAGGAAGGAGAGGACGAC
TTCTTGGAGAAGGCCAGGAAGATTAAAAAGTATGGAGCTGCTATGGTGGTCATGGCTTTT
GATGAAGAAGGACAGGCAACAGAAACAGACACAAAAATCAGAGTGTGCACCCGGGCCTAC
CATCTGCTTGTGAAAAAACTGGGCTTTAATCCAAATGACATTATTTTTGACCCTAATATC
CTAACCATTGGGACTGGAATGGAGGAACACAACTTGTATGCCATTAATTTTATCCATGCA
ACAAAAGTCATTAAAGAAACATTACCTGGAGCCAGAATAAGTGGAGGTCTTTCCAACTTG
TCCTTCTCCTTCCGAGGAATGGAAGCCATTCGAGAAGCAATGCATGGGGTTTTCCTTTAC
CATGCAATCAAGTCTGGCATGGACATGGGGATAGTGAATGCTGGAAACCTCCCTGTGTAT
GATGATATCCATAAGGAACTTCTGCAGCTCTGTGAAGATCTCATCTGGAATAAAGACCCT
GAGGCCACTGAGAAGCTCTTACGTTATGCCCAGACTCAAGGCACAGGAGGGAAGAAAGTC
ATTCAGACTGATGAGTGGAGAAATGGCCCTGTCGAAGAACGCCTTGAGTATGCCCTTGTG
AAGGGCATTGAAAAACATATTATTGAGGATACTGAGGAAGCCAGGTTAAACCAAAAAAAA
TATCCCCGACCTCTCAATATAATTGAAGGACCCCTGATGAATGGAATGAAAATTGTTGGT
GATCTTTTTGGAGCTGGAAAAATGTTTCTACCTCAGGTTATAAAGTCAGCCCGGGTTATG
AAGAAGGCTGTTGGCCACCTTATCCCTTTCATGGAAAAAGAAAGAGAAGAAACCAGAGTG
CTTAACGGCACAGTAGAAGAAGAGGACCCTTACCAGGGCACCATCGTGCTGGCCACTGTT
AAAGGCGACGTGCACGACATAGGCAAGAACATAGTTGGAGTAGTCCTTGGCTGCAATAAT
TTCCGAGTTATTGATTTAGGAGTCATGACTCCATGTGATAAGATACTGAAAGCTGCTCTT
GACCACAAAGCAGATATAATTGGCCTGTCAGGACTCATCACTCCTTCCCTGGATGAAATG
ATTTTTGTTGCCAAGGAAATGGAGAGATTAGCTATAAGGATTCCATTGTTGATTGGAGGA
GCAACCACTTCAAAAACCCACACAGCAGTTAAAATAGCTCCGAGATACAGTGCACCTGTA
ATCCATGTCCTGGACGCGTCCAAGAGTGTGGTGGTGTGTTCCCAGCTGTTAGATGAAAAT
CTAAAGGATGAATACTTTGAGGAAATCATGGAAGAATATGAAGATATTAGACAGGACCAT
TATGAGTCTCTCAAGGAGAGGAGATACTTACCCTTAAGTCAAGCCAGAAAAAGTGGTTTC
CAAATGGATTGGCTGTCTGAACCTCACCCAGTGAAGCCCACGTTTATTGGGACCCAGGTC
TTTGAAGACTATGACCTGCAGAAGCTGGTGGACTACATTGACTGGAAGCCTTTCTTTGAT
GTCTGGCAGCTCCGGGGCAAGTACCCGAATCGAGGCTTTCCCAAGATATTTAACGACAAA
ACAGTAGGTGGAGAGGCCAGGAAGGTCTACGATGATGCCCACAATATGCTGAACACACTG
ATTAGTCAAAAGAAACTCCGGGCCCGGGGTGTGGTTGGGTTCTGGCCAGCACAGAGTATC
CAAGACGACATTCACCTGTACGCAGAGGCTGCTGTGCCCCAGGCTGCAGAGCCCATAGCC
ACCTTCTATGGGTTAAGGCAACAGGCTGAGAAGGACTCTGCCAGCACGGAGCCATACTAC
TGCCTCTCAGACTTCATCGCTCCCTTGCATTCTGGCATCCGTGACTACCTGGGCCTGTTT
GCCGTTGCCTGCTTTGGGGTAGAAGAGCTGAGCAAGGCCTATGAGGATGATGGTGACGAC
TACAGCAGCATCATGGTCAAGGCGCTGGGGGACCGGCTGGCAGAGGCCTTTGCAGAAGAG
CTCCATGAAAGAGTTCGCCGAGAACTGTGGGCCTACTGTGGCAGTGAGCAGCTGGACGTC
GCAGACCTGCGCAGGCTGCGGTACAAGGGCATCCGCCCGGCTCCTGGCTACCCCAGCCAG
CCCGACCACACCGAGAAGCTCACCATGTGGAGACTCGCAGACATCGAGCAGTCTACAGGC
ATTAGGTTAACAGAATCATTAGCAATGGCACCTGCTTCAGCAGTCTCAGGCCTCTACTTC
TCCAATTTGAAGTCCAAATATTTTGCTGTGGGGAAGATTTCCAAGGATCAGGTTGAGGAT
TATGCATTGAGGAAGAACATATCTGTGGCTGAGGTTGAGAAATGGCTTGGACCCATTTTG
GGATATGATACAGACTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00809</identifier>
        <name>Pterin_bind</name>
      </pfam>
      <pfam>
        <identifier>PF02310</identifier>
        <name>B12-binding</name>
      </pfam>
      <pfam>
        <identifier>PF02607</identifier>
        <name>B12-binding_2</name>
      </pfam>
      <pfam>
        <identifier>PF02965</identifier>
        <name>Met_synt_B12</name>
      </pfam>
      <pfam>
        <identifier>PF02574</identifier>
        <name>S-methyl_trans</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cobalamin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-adenosylmethionine-homocysteine S-methyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to axon injury</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cobalamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to nitric oxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pteridine-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001534</id>
      <name>Methionine aminopeptidase 2</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16917013</pubmed-id>
            <citation>Upadhya R, Zhang HS, Weiss LM: System for expression of microsporidian methionine amino peptidase type 2 (MetAP2) in the yeast Saccharomyces cerevisiae. Antimicrob Agents Chemother. 2006 Oct;50(10):3389-95. Epub 2006 Aug 17.</citation>
          </article>
          <article>
            <pubmed-id>16789740</pubmed-id>
            <citation>Sheppard GS, Wang J, Kawai M, Fidanze SD, BaMaung NY, Erickson SA, Barnes DM, Tedrow JS, Kolaczkowski L, Vasudevan A, Park DC, Wang GT, Sanders WJ, Mantei RA, Palazzo F, Tucker-Garcia L, Lou P, Zhang Q, Park CH, Kim KH, Petros A, Olejniczak E, Nettesheim D, Hajduk P, Henkin J, Lesniewski R, Davidsen SK, Bell RL: Discovery and optimization of anthranilic acid sulfonamides as inhibitors of methionine aminopeptidase-2: a structural basis for the reduction of albumin binding. J Med Chem. 2006 Jun 29;49(13):3832-49.</citation>
          </article>
          <article>
            <pubmed-id>16823043</pubmed-id>
            <citation>Addlagatta A, Matthews BW: Structure of the angiogenesis inhibitor ovalicin bound to its noncognate target, human Type 1 methionine aminopeptidase. Protein Sci. 2006 Aug;15(8):1842-8. Epub 2006 Jul 5.</citation>
          </article>
          <article>
            <pubmed-id>17114291</pubmed-id>
            <citation>Hu X, Addlagatta A, Lu J, Matthews BW, Liu JO: Elucidation of the function of type 1 human methionine aminopeptidase during cell cycle progression. Proc Natl Acad Sci U S A. 2006 Nov 28;103(48):18148-53. Epub 2006 Nov 17.</citation>
          </article>
          <article>
            <pubmed-id>16540317</pubmed-id>
            <citation>Nonato MC, Widom J, Clardy J: Human methionine aminopeptidase type 2 in complex with L- and D-methionine. Bioorg Med Chem Lett. 2006 May 15;16(10):2580-3. Epub 2006 Mar 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P50579" source="Swiss-Prot">
    <name>Methionine aminopeptidase 2</name>
    <general-function>Poly(a) rna binding</general-function>
    <specific-function>Cotranslationally removes the N-terminal methionine from nascent proteins. The N-terminal methionine is often cleaved when the second residue in the primary sequence is small and uncharged (Met-Ala-, Cys, Gly, Pro, Ser, Thr, or Val). The catalytic activity of human METAP2 toward Met-Val peptides is consistently two orders of magnitude higher than that of METAP1, suggesting that it is responsible for processing proteins containing N-terminal Met-Val and Met-Thr sequences in vivo.Protects eukaryotic initiation factor EIF2S1 from translation-inhibiting phosphorylation by inhibitory kinases such as EIF2AK2/PKR and EIF2AK1/HCR. Plays a critical role in the regulation of protein synthesis.</specific-function>
    <gene-name>METAP2</gene-name>
    <locus>12q22</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.57</theoretical-pi>
    <molecular-weight>52891.145</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16672</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>METAP2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U29607</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>903982</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1573</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P50579</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MAP2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.11.18</synonym>
      <synonym>Initiation factor 2-associated 67 kDa glycoprotein</synonym>
      <synonym>MAP 2</synonym>
      <synonym>MNPEP</synonym>
      <synonym>p67</synonym>
      <synonym>P67EIF2</synonym>
      <synonym>Peptidase M</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0003046|Methionine aminopeptidase 2
MAGVEEVAASGSHLNGDLDPDDREEGAASTAEEAAKKKRRKKKKSKGPSAAGEQEPDKES
GASVDEVARQLERSALEDKERDEDDEDGDGDGDGATGKKKKKKKKKRGPKVQTDPPSVPI
CDLYPNGVFPKGQECEYPPTQDGRTAAWRTTSEEKKALDQASEEIWNDFREAAEAHRQVR
KYVMSWIKPGMTMIEICEKLEDCSRKLIKENGLNAGLAFPTGCSLNNCAAHYTPNAGDTT
VLQYDDICKIDFGTHISGRIIDCAFTVTFNPKYDTLLKAVKDATNTGIKCAGIDVRLCDV
GEAIQEVMESYEVEIDGKTYQVKPIRNLNGHSIGQYRIHAGKTVPIVKGGEATRMEEGEV
YAIETFGSTGKGVVHDDMECSHYMKNFDVGHVPIRLPRTKHLLNVINENFGTLAFCRRWL
DRLGESKYLMALKNLCDLGIVDPYPPLCDIKGSYTAQFEHTILLRPTCKEVVSRGDDY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020537|Methionine aminopeptidase 2 (METAP2)
ATGGCGGGTGTGGAGGAGGTAGCGGCCTCCGGGAGCCACCTGAATGGCGACCTGGATCCA
GACGACAGGGAAGAAGGAGCTGCCTCTACGGCTGAGGAAGCAGCCAAGAAAAAAAGACGA
AAGAAGAAGAAGAGCAAAGGGCCTTCTGCAGCAGGGGAACAGGAACCTGATAAAGAATCA
GGAGCCTCAGTGGATGAAGTAGCAAGACAGTTGGAAAGATCAGCATTGGAAGATAAAGAA
AGAGATGAAGATGATGAAGATGGAGATGGCGATGGAGATGGAGCAACTGGAAAGAAGAAG
AAAAAGAAGAAGAAGAAGAGAGGACCAAAAGTTCAAACAGACCCTCCCTCAGTTCCAATA
TGTGACCTGTATCCTAATGGTGTATTTCCCAAAGGACAAGAATGCGAATACCCACCCACA
CAAGATGGGCGAACAGCTGCTTGGAGAACTACAAGTGAAGAAAAGAAAGCATTAGATCAG
GCAAGTGAAGAGATTTGGAATGATTTTCGAGAAGCTGCAGAAGCACATCGACAAGTTAGA
AAATACGTAATGAGCTGGATCAAGCCTGGGATGACAATGATAGAAATCTGTGAAAAGTTG
GAAGACTGTTCACGCAAGTTAATAAAAGAGAATGGATTAAATGCAGGCCTGGCATTTCCT
ACTGGATGTTCTCTCAATAATTGTGCTGCCCATTATACTCCCAATGCCGGTGACACAACA
GTATTACAGTATGATGACATCTGTAAAATAGACTTTGGAACACATATAAGTGGTAGGATT
ATTGACTGTGCTTTTACTGTCACTTTTAATCCCAAATATGATACGTTATTAAAAGCTGTA
AAAGATGCTACTAACACTGGAATAAAGTGTGCTGGAATTGATGTTCGTCTGTGTGATGTT
GGTGAGGCCATCCAAGAAGTTATGGAGTCCTATGAAGTTGAAATAGATGGGAAGACATAT
CAAGTGAAACCAATCCGTAATCTAAATGGACATTCAATTGGGCAATATAGAATACATGCT
GGAAAAACAGTGCCGATTGTGAAAGGAGGGGAGGCAACAAGAATGGAGGAAGGAGAAGTA
TATGCAATTGAAACCTTTGGTAGTACAGGAAAAGGTGTTGTTCATGATGATATGGAATGT
TCACATTACATGAAAAATTTTGATGTTGGACATGTGCCAATAAGGCTTCCAAGAACAAAA
CACTTGTTAAATGTCATCAATGAAAACTTTGGAACCCTTGCCTTCTGCCGCAGATGGCTG
GATCGCTTGGGAGAAAGTAAATACTTGATGGCTCTGAAGAATCTGTGTGACTTGGGCATT
GTAGATCCATATCCACCATTATGTGACATTAAAGGATCATATACAGCGCAATTTGAACAT
ACCATCCTGTTGCGTCCAACATGTAAAGAAGTTGTCAGCAGAGGAGATGACTATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00557</identifier>
        <name>Peptidase_M24</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metalloexopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aminopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metalloaminopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-terminal protein amino acid modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-methionine modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of rhodopsin mediated signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rhodopsin mediated signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein processing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phototransduction, visible light</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein initiator methionine removal</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000845</id>
      <name>Betaine--homocysteine S-methyltransferase 1</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16920841</pubmed-id>
            <citation>Slow S, Garrow TA: Liver choline dehydrogenase and kidney betaine-homocysteine methyltransferase expression are not affected by methionine or choline intake in growing rats. J Nutr. 2006 Sep;136(9):2279-83.</citation>
          </article>
          <article>
            <pubmed-id>16396637</pubmed-id>
            <citation>Sparks JD, Collins HL, Chirieac DV, Cianci J, Jokinen J, Sowden MP, Galloway CA, Sparks CE: Hepatic very-low-density lipoprotein and apolipoprotein B production are increased following in vivo induction of betaine-homocysteine S-methyltransferase. Biochem J. 2006 Apr 15;395(2):363-71.</citation>
          </article>
          <article>
            <pubmed-id>17513393</pubmed-id>
            <citation>Uthus EO, Reeves PG, Saari JT: Copper deficiency decreases plasma homocysteine in rats. J Nutr. 2007 Jun;137(6):1370-4.</citation>
          </article>
          <article>
            <pubmed-id>17350061</pubmed-id>
            <citation>Liu J, Xie Y, Cooper R, Ducharme DM, Tennant R, Diwan BA, Waalkes MP: Transplacental exposure to inorganic arsenic at a hepatocarcinogenic dose induces fetal gene expression changes in mice indicative of aberrant estrogen signaling and disrupted steroid metabolism. Toxicol Appl Pharmacol. 2007 May 1;220(3):284-91. Epub 2007 Feb 6.</citation>
          </article>
          <article>
            <pubmed-id>17389618</pubmed-id>
            <citation>Hazra A, Wu K, Kraft P, Fuchs CS, Giovannucci EL, Hunter DJ: Twenty-four non-synonymous polymorphisms in the one-carbon metabolic pathway and risk of colorectal adenoma in the Nurses' Health Study. Carcinogenesis. 2007 Jul;28(7):1510-9. Epub 2007 Mar 26.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q93088" source="Swiss-Prot">
    <name>Betaine--homocysteine S-methyltransferase 1</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Involved in the regulation of homocysteine metabolism. Converts betaine and homocysteine to dimethylglycine and methionine, respectively. This reaction is also required for the irreversible oxidation of choline.</specific-function>
    <gene-name>BHMT</gene-name>
    <locus>5q13.1-q15</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.85</theoretical-pi>
    <molecular-weight>44998.205</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:1047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BHMT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U50929</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1522683</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q93088</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BHMT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.1.1.5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016225|Betaine--homocysteine S-methyltransferase 1
MPPVGGKKAKKGILERLNAGEIVIGDGGFVFALEKRGYVKAGPWTPEAAVEHPEAVRQLH
REFLRAGSNVMQTFTFYASEDKLENRGNYVLEKISGQEVNEAACDIARQVADEGDALVAG
GVSQTPSYLSCKSETEVKKVFLQQLEVFMKKNVDFLIAEYFEHVEEAVWAVETLIASGKP
VAATMCIGPEGDLHGVPPGECAVRLVKAGASIIGVNCHFDPTISLKTVKLMKEGLEAARL
KAHLMSQPLAYHTPDCNKQGFIDLPEFPFGLEPRVATRWDIQKYAREAYNLGVRYIGGCC
GFEPYHIRAIAEELAPERGFLPPASEKHGSWGSGLDMHTKPWVRARARKEYWENLRIASG
RPYNPSMSKPDGWGVTKGTAELMQQKEATTEQQLKELFEKQKFKSQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016226|Betaine--homocysteine S-methyltransferase 1 (BHMT)
ATGCCACCCGTTGGGGGCAAAAAGGCCAAGAAGGGCATCCTAGAACGTTTAAATGCTGGA
GAGATTGTGATTGGAGATGGAGGGTTTGTCTTTGCACTGGAGAAGAGGGGCTACGTAAAG
GCAGGACCCTGGACTCCTGAAGCTGCTGTGGAGCACCCAGAAGCAGTTCGCCAGCTTCAT
CGAGAGTTCCTCAGAGCTGGCTCAAACGTCATGCAGACCTTCACCTTCTATGCGAGTGAA
GACAAGCTGGAGAACAGGGGCAACTATGTCTTAGAGAAGATATCTGGGCAGGAAGTCAAT
GAAGCTGCTTGCGACATCGCCCGACAAGTGGCTGATGAAGGAGATGCTTTGGTAGCAGGA
GGAGTGAGTCAGACACCTTCATACCTTAGCTGCAAGAGTGAAACTGAAGTCAAAAAAGTA
TTTCTGCAACAGTTAGAGGTCTTTATGAAGAAGAACGTGGACTTCTTGATTGCAGAGTAT
TTTGAACACGTTGAAGAAGCTGTGTGGGCAGTTGAAACCTTGATAGCATCCGGTAAACCT
GTGGCAGCAACCATGTGCATTGGCCCAGAAGGAGATTTGCATGGCGTGCCCCCCGGCGAG
TGTGCAGTGCGCCTGGTGAAAGCAGGAGCATCCATCATTGGTGTGAACTGCCACTTTGAC
CCCACCATTAGTTTAAAAACAGTGAAGCTCATGAAGGAGGGCTTGGAGGCTGCCCGACTG
AAAGCTCACCTGATGAGCCAGCCCTTGGCTTACCACACTCCTGACTGCAACAAGCAGGGA
TTCATCGATCTCCCAGAATTCCCATTTGGACTGGAACCCAGAGTTGCCACCAGATGGGAT
ATTCAAAAATACGCCAGAGAGGCCTACAACCTGGGGGTCAGGTACATTGGCGGGTGCTGT
GGATTTGAGCCCTACCACATCAGGGCAATTGCAGAGGAGCTGGCCCCAGAAAGGGGCTTT
TTGCCACCAGCTTCAGAAAAACATGGCAGCTGGGGAAGTGGTTTGGACATGCACACCAAA
CCCTGGGTTAGAGCAAGGGCCAGGAAGGAATACTGGGAGAATCTTCGGATAGCCTCAGGC
CGGCCATACAACCCTTCAATGTCAAAGCCAGATGGCTGGGGAGTGACCAAAGGAACAGCC
GAGCTGATGCAGCAGAAAGAAGCCACAACTGAGCAGCAGCTGAAAGAGCTCTTTGAAAAA
CAAAAATTCAAATCACAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02574</identifier>
        <name>S-methyl_trans</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-adenosylmethionine-homocysteine S-methyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>betaine-homocysteine S-methyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino-acid betaine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino-acid betaine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of homocysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-methionine salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-methylmethionine cycle</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002249</id>
      <name>S-methylmethionine--homocysteine S-methyltransferase BHMT2</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9H2M3" source="Swiss-Prot">
    <name>S-methylmethionine--homocysteine S-methyltransferase BHMT2</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Involved in the regulation of homocysteine metabolism. Converts homocysteine to methionine using S-methylmethionine (SMM) as a methyl donor.</specific-function>
    <gene-name>BHMT2</gene-name>
    <locus>5q13</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.68</theoretical-pi>
    <molecular-weight>40353.84</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:1048</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BHMT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF257473</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>11907831</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9H2M3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BHMT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.1.1.10</synonym>
      <synonym>Betaine--homocysteine S-methyltransferase 2</synonym>
      <synonym>SMM-hcy methyltransferase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004414|S-methylmethionine--homocysteine S-methyltransferase BHMT2
MAPAGRPGAKKGILERLESGEVVIGDGSFLITLEKRGYVKAGLWTPEAVIEHPDAVRQLH
MEFLRAGSNVMQTFTFSASEDNMESKWEDVNAAACDLAREVAGKGDALVAGGICQTSIYK
YQKDEARIKKLFRQQLEVFAWKNVDFLIAEYFEHVEEAVWAVEVLKESDRPVAVTMCIGP
EGDMHDITPGECAVRLVKAGASIVGVNCRFGPDTSLKTMELMKEGLEWAGLKAHLMVQPL
GFHAPDCGKEGFVDLPEYPFGLESRVATRWDIQKYAREAYNLGVRYIGGCCGFEPYHIRA
IAEELAPERGFLPPASEKHGSWGSGLDMHTKPWIRARARREYWENLLPASGRPFCPSLSK
PDF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011622|S-methylmethionine--homocysteine S-methyltransferase BHMT2 (BHMT2)
ATGGCACCTGCTGGACGCCCGGGGGCCAAGAAGGGGATTTTGGAGCGCCTGGAGAGTGGG
GAGGTTGTGATTGGAGATGGCAGCTTTCTCATTACTCTGGAGAAGAGAGGCTATGTGAAG
GCTGGGCTCTGGACTCCAGAGGCAGTGATAGAACACCCAGACGCAGTTCGTCAACTTCAC
ATGGAATTCTTGAGAGCAGGATCAAATGTCATGCAGACTTTTACCTTTTCTGCCAGTGAG
GACAATATGGAAAGCAAGTATTTTGAGCACGTTGAAGAAGCTGTGTGGGCTGTGGAAGTC
TTAAAAGAATCAGATAGACCCGTGGCAGTTACCATGTGCATAGGCCCAGAGGGAGACATG
CATGATATAACCCCCGGAGAATGTGCTGTGAGGCTGGTGAAGGCAGGGGCTTCCATCGTT
GGCGTGAACTGCCGCTTTGGGCCCGACACCAGCTTGAAGACGATGGAGCTCATGAAGGAG
GGTCTTGAGTGGGCAGGGCTGAAAGCGCACCTCATGGTGCAGCCTCTGGGGTTCCACGCG
CCTGACTGTGGCAAAGAGGGGTTTGTGGATCTCCCAGAATATCCCTTTGGACTGGAGTCC
AGAGTTGCCACCAGATGGGATATTCAAAAATACGCCAGAGAGGCCTACAACCTGGGGGTC
AGGTACATTGGCGGGTGCTGTGGATTTGAGCCCTACCACATCAGGGCAATTGCAGAGGAG
CTGGCCCCAGAAAGGGGCTTTTTGCCACCAGCTTCAGAAAAACACGGCAGCTGGGGAAGT
GGTTTGGACATGCACACCAAACCCTGGATTAGAGCAAGGGCTCGAAGGGAGTATTGGGAG
AATCTGCTGCCAGCTTCAGGCAGACCTTTCTGTCCTTCGCTGTCAAAGCCAGACTTCTAA
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02574</identifier>
        <name>S-methyl_trans</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-adenosylmethionine-homocysteine S-methyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-methylmethionine-homocysteine S-methyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-methylmethionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-methionine salvage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-methylmethionine cycle</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme>
      <id>BE0002240</id>
      <name>Glutamine synthetase</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>4144717</pubmed-id>
            <citation>Rowe WB, Meister A: Studies on the inhibition of glutamine synthetase by methionine sulfone. Biochemistry. 1973 Apr 10;12(8):1578-82.</citation>
          </article>
          <article>
            <pubmed-id>4308004</pubmed-id>
            <citation>Rowe WB, Ronzio RA, Meister A: Inhibition of glutamine synthetase by methionine sulfoximine. Studies on methionine sulfoximine phosphate. Biochemistry. 1969 Jun;8(6):2674-80.</citation>
          </article>
          <article>
            <pubmed-id>6127334</pubmed-id>
            <citation>Orr J, Haselkorn R: Regulation of glutamine synthetase activity and synthesis in free-living and symbiotic Anabaena spp. J Bacteriol. 1982 Nov;152(2):626-35.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15104" source="Swiss-Prot">
    <name>Glutamine synthetase</name>
    <general-function>Manganese ion binding</general-function>
    <specific-function>This enzyme has 2 functions: it catalyzes the production of glutamine and 4-aminobutanoate (gamma-aminobutyric acid, GABA), the latter in a pyridoxal phosphate-independent manner (By similarity). Essential for proliferation of fetal skin fibroblasts.</specific-function>
    <gene-name>GLUL</gene-name>
    <locus>1q31</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.88</theoretical-pi>
    <molecular-weight>42064.15</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLUL</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y00387</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31833</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P15104</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLNA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.1.2</synonym>
      <synonym>GLNS</synonym>
      <synonym>Glutamate decarboxylase</synonym>
      <synonym>Glutamate--ammonia ligase</synonym>
      <synonym>GS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019251|Glutamine synthetase
MTTSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEW
NFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRI
MDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHY
RACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDP
KPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRL
TGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCL
LNETGDEPFQYKN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019252|Glutamine synthetase (GLUL)
ATGACCACCTCAGCAAGTTCCCACTTAAATAAAGGCATCAAGCAGGTGTACATGTCCCTG
CCTCAGGGTGAGAAAGTCCAGGCCATGTATATCTGGATCGATGGTACTGGAGAAGGACTG
CGCTGCAAGACCCGGACCCTGGACAGTGAGCCCAAGTGTGTGGAAGAGTTGCCTGAGTGG
AATTTCGATGGCTCTAGTACTTTACAGTCTGAGGGTTCCAACAGTGACATGTATCTCGTG
CCTGCTGCCATGTTTCGGGACCCCTTCCGTAAGGACCCTAACAAGCTGGTGTTATGTGAA
GTTTTCAAGTACAATCGAAGGCCTGCAGAGACCAATTTGAGGCACACCTGTAAACGGATA
ATGGACATGGTGAGCAACCAGCACCCCTGGTTTGGCATGGAGCAGGAGTATACCCTCATG
GGGACAGATGGGCACCCCTTTGGTTGGCCTTCCAACGGCTTCCCAGGGCCCCAGGGTCCA
TATTACTGTGGTGTGGGAGCAGACAGAGCCTATGGCAGGGACATCGTGGAGGCCCATTAC
CGGGCCTGCTTGTATGCTGGAGTCAAGATTGCGGGGACTAATGCCGAGGTCATGCCTGCC
CAGTGGGAATTTCAGATTGGACCTTGTGAAGGAATCAGCATGGGAGATCATCTCTGGGTG
GCCCGTTTCATCTTGCATCGTGTGTGTGAAGACTTTGGAGTGATAGCAACCTTTGATCCT
AAGCCCATTCCTGGGAACTGGAATGGTGCAGGCTGCCATACCAACTTCAGCACCAAGGCC
ATGCGGGAGGAGAATGGTCTGAAGTACATCGAGGAGGCCATTGAGAAACTAAGCAAGCGG
CACCAGTACCACATCCGTGCCTATGATCCCAAGGGAGGCCTGGACAATGCCCGACGTCTA
ACTGGATTCCATGAAACCTCCAACATCAACGACTTTTCTGCTGGTGTAGCCAATCGTAGC
GCCAGCATACGCATTCCCCGGACTGTTGGCCAGGAGAAGAAGGGTTACTTTGAAGATCGT
CGCCCCTCTGCCAACTGCGACCCCTTTTCGGTGACAGAAGCCCTCATCCGCACGTGTCTT
CTCAATGAAACCGGCGATGAGCCCTTCCAGTACAAAAATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00120</identifier>
        <name>Gln-synt_C</name>
      </pfam>
      <pfam>
        <identifier>PF03951</identifier>
        <name>Gln-synt_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>protein complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon terminus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>glial cell projection</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>manganese ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-ammonia ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate decarboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucose</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter uptake</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of epithelial cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homooligomerization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme>
      <id>BE0002176</id>
      <name>Methylenetetrahydrofolate reductase</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>4198357</pubmed-id>
            <citation>Lor KL, Cossins EA: Regulation of C metabolism by L-methionine in Saccharomyces cerevisiae. Biochem J. 1972 Dec;130(3):773-83.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P42898" source="Swiss-Prot">
    <name>Methylenetetrahydrofolate reductase</name>
    <general-function>Protein complex binding</general-function>
    <specific-function>Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine.</specific-function>
    <gene-name>MTHFR</gene-name>
    <locus>1p36.3</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.0</theoretical-pi>
    <molecular-weight>74595.895</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7436</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MTHFR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U09806</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6139053</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P42898</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MTHR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.5.1.20</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004270|Methylenetetrahydrofolate reductase
MVNEARGNSSLNPCLEGSASSGSESSKDSSRCSTPGLDPERHERLREKMRRRLESGDKWF
SLEFFPPRTAEGAVNLISRFDRMAAGGPLYIDVTWHPAGDPGSDKETSSMMIASTAVNYC
GLETILHMTCCRQRLEEITGHLHKAKQLGLKNIMALRGDPIGDQWEEEEGGFNYAVDLVK
HIRSEFGDYFDICVAGYPKGHPEAGSFEADLKHLKEKVSAGADFIITQLFFEADTFFRFV
KACTDMGITCPIVPGIFPIQGYHSLRQLVKLSKLEVPQEIKDVIEPIKDNDAAIRNYGIE
LAVSLCQELLASGLVPGLHFYTLNREMATTEVLKRLGMWTEDPRRPLPWALSAHPKRREE
DVRPIFWASRPKSYIYRTQEWDEFPNGRWGNSSSPAFGELKDYYLFYLKSKSPKEELLKM
WGEELTSEESVFEVFVLYLSGEPNRNGHKVTCLPWNDEPLAAETSLLKEELLRVNRQGIL
TINSQPNINGKPSSDPIVGWGPSGGYVFQKAYLEFFTSRETAEALLQVLKKYELRVNYHL
VNVKGENITNAPELQPNAVTWGIFPGREIIQPTVVDPVSFMFWKDEAFALWIERWGKLYE
EESPSRTIIQYIHDNYFLVNLVDNDFPLDNCLWQVVEDTLELLNRPTQNARETEAP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020597|Methylenetetrahydrofolate reductase (MTHFR)
ATGGTGAACGAAGCCAGAGGAAACAGCAGCCTCAACCCCTGCTTGGAGGGCAGTGCCAGC
AGTGGCAGTGAGAGCTCCAAAGATAGTTCGAGATGTTCCACCCCGGGCCTGGACCCCGAG
CGGCATGAGAGACTCCGGGAGAAGATGAGGCGGCGATTGGAATCTGGTGACAAGTGGTTC
TCCCTGGAATTCTTCCCTCCTCGAACTGCTGAGGGAGCTGTCAATCTCATCTCAAGGTTT
GACCGGATGGCAGCAGGTGGCCCCCTCTACATAGACGTGACCTGGCACCCAGCAGGTGAC
CCTGGCTCAGACAAGGAGACCTCCTCCATGATGATCGCCAGCACCGCCGTGAACTACTGT
GGCCTGGAGACCATCCTGCACATGACCTGCTGCCGTCAGCGCCTGGAGGAGATCACGGGC
CATCTGCACAAAGCTAAGCAGCTGGGCCTGAAGAACATCATGGCGCTGCGGGGAGACCCA
ATAGGTGACCAGTGGGAAGAGGAGGAGGGAGGCTTCAACTACGCAGTGGACCTGGTGAAG
CACATCCGAAGTGAGTTTGGTGACTACTTTGACATCTGTGTGGCAGGTTACCCCAAAGGC
CACCCCGAAGCAGGGAGCTTTGAGGCTGACCTGAAGCACTTGAAGGAGAAGGTGTCTGCG
GGAGCCGATTTCATCATCACGCAGCTTTTCTTTGAGGCTGACACATTCTTCCGCTTTGTG
AAGGCATGCACCGACATGGGCATCACTTGCCCCATCGTCCCCGGGATCTTTCCCATCCAG
GGCTACCACTCCCTTCGGCAGCTTGTGAAGCTGTCCAAGCTGGAGGTGCCACAGGAGATC
AAGGACGTGATTGAGCCAATCAAAGACAACGATGCTGCCATCCGCAACTATGGCATCGAG
CTGGCCGTGAGCCTGTGCCAGGAGCTTCTGGCCAGTGGCTTGGTGCCAGGCCTCCACTTC
TACACCCTCAACCGCGAGATGGCTACCACAGAGGTGCTGAAGCGCCTGGGGATGTGGACT
GAGGACCCCAGGCGTCCCCTACCCTGGGCTCTCAGCGCCCACCCCAAGCGCCGAGAGGAA
GATGTACGTCCCATCTTCTGGGCCTCCAGACCAAAGAGTTACATCTACCGTACCCAGGAG
TGGGACGAGTTCCCTAACGGCCGCTGGGGCAATTCCTCTTCCCCTGCCTTTGGGGAGCTG
AAGGACTACTACCTCTTCTACCTGAAGAGCAAGTCCCCCAAGGAGGAGCTGCTGAAGATG
TGGGGGGAGGAGCTGACCAGTGAAGAAAGTGTCTTTGAAGTCTTCGTTCTTTACCTCTCG
GGAGAACCAAACCGGAATGGTCACAAAGTGACTTGCCTGCCCTGGAACGATGAGCCCCTG
GCGGCTGAGACCAGCCTGCTGAAGGAGGAGCTGCTGCGGGTGAACCGCCAGGGCATCCTC
ACCATCAACTCACAGCCCAACATCAACGGGAAGCCGTCCTCCGACCCCATCGTGGGCTGG
GGCCCCAGCGGGGGCTATGTCTTCCAGAAGGCCTACTTAGAGTTTTTCACTTCCCGCGAG
ACAGCGGAAGCACTTCTGCAAGTGCTGAAGAAGTACGAGCTCCGGGTTAATTACCACCTT
GTCAATGTGAAGGGTGAAAACATCACCAATGCCCCTGAACTGCAGCCGAATGCTGTCACT
TGGGGCATCTTCCCTGGGCGAGAGATCATCCAGCCCACCGTAGTGGATCCCGTCAGCTTC
ATGTTCTGGAAGGACGAGGCCTTTGCCCTGTGGATTGAGCGGTGGGGAAAGCTGTATGAG
GAGGAGTCCCCGTCCCGCACCATCATCCAGTACATCCACGACAACTACTTCCTGGTCAAC
CTGGTGGACAATGACTTCCCACTGGACAACTGCCTCTGGCAGGTGGTGGAAGACACATTG
GAGCTTCTCAACAGGCCCACCCAGAATGCGAGAGAAACGGAGGCTCCATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02219</identifier>
        <name>MTHFR</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein complex binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>modified amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methylenetetrahydrofolate reductase (NAD(P)H) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of histone methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heterochromatin maintenance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin B2</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>homocysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tetrahydrofolate interconversion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood circulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to folic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to interleukin-1</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="2">
      <id>BE0000304</id>
      <name>S-adenosylmethionine synthase isoform type-2</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17317269</pubmed-id>
            <citation>Rodriguez JL, Boukaba A, Sandoval J, Georgieva EI, Latasa MU, Garcia-Trevijano ER, Serviddio G, Nakamura T, Avila MA, Sastre J, Torres L, Mato JM, Lopez-Rodas G: Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells. Int J Biochem Cell Biol. 2007;39(4):842-50. Epub 2007 Jan 20.</citation>
          </article>
          <article>
            <pubmed-id>17154373</pubmed-id>
            <citation>Yang H, Magilnick N, Noureddin M, Mato JM, Lu SC: Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J Cell Physiol. 2007 Mar;210(3):766-73.</citation>
          </article>
          <article>
            <pubmed-id>16482628</pubmed-id>
            <citation>Lin WC, Lin WL: Ameliorative effect of Ganoderma lucidum on carbon tetrachloride-induced liver fibrosis in rats. World J Gastroenterol. 2006 Jan 14;12(2):265-70.</citation>
          </article>
          <article>
            <pubmed-id>17631143</pubmed-id>
            <citation>Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC: Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology. 2007 Jul;133(1):207-18. Epub 2007 Apr 11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P31153" source="Swiss-Prot">
    <name>S-adenosylmethionine synthase isoform type-2</name>
    <general-function>Methionine adenosyltransferase activity</general-function>
    <specific-function>Catalyzes the formation of S-adenosylmethionine from methionine and ATP.</specific-function>
    <gene-name>MAT2A</gene-name>
    <locus>2p11.2</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.45</theoretical-pi>
    <molecular-weight>43660.37</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6904</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MAT2A</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X68836</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>36327</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P31153</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>METK2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.6</synonym>
      <synonym>AdoMet synthase 2</synonym>
      <synonym>AMS2</synonym>
      <synonym>MAT 2</synonym>
      <synonym>MAT-II</synonym>
      <synonym>MATA2</synonym>
      <synonym>Methionine adenosyltransferase 2</synonym>
      <synonym>Methionine adenosyltransferase II</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000605|S-adenosylmethionine synthase isoform type-2
MNGQLNGFHEAFIEEGTFLFTSESVGEGHPDKICDQISDAVLDAHLQQDPDAKVACETVA
KTGMILLAGEITSRAAVDYQKVVREAVKHIGYDDSSKGFDYKTCNVLVALEQQSPDIAQG
VHLDRNEEDIGAGDQGLMFGYATDETEECMPLTIVLAHKLNAKLAELRRNGTLPWLRPDS
KTQVTVQYMQDRGAVLPIRVHTIVISVQHDEEVCLDEMRDALKEKVIKAVVPAKYLDEDT
IYHLQPSGRFVIGGPQGDAGLTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARW
VAKSLVKGGLCRRVLVQVSYAIGVSHPLSISIFHYGTSQKSERELLEIVKKNFDLRPGVI
VRDLDLKKPIYQRTAAYGHFGRDSFPWEVPKKLKY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010241|S-adenosylmethionine synthase isoform type-2 (MAT2A)
ATGAACGGACAGCTCAACGGCTTCCACGAGGCGTTCATCGAGGAGGGCACATTCCTTTTC
ACCTCAGAGTCGGTCGGGGAAGGCCACCCAGATAAGATTTGTGACCAAATCAGTGATGCT
GTCCTTGATGCCCACCTTCAGCAGGATCCTGATGCCAAAGTAGCTTGTGAAACTGTTGCT
AAAACTGGAATGATCCTTCTTGCTGGGGAAATTACATCCAGAGCTGCTGTTGACTACCAG
AAAGTGGTTCGTGAAGCTGTTAAACACATTGGATATGATGATTCTTCCAAAGGTTTTGAC
TACAAGACTTGTAACGTGCTGGTAGCCTTGGAGCAACAGTCACCAGATATTGCTCAAGGT
GTTCATCTTGACAGAAATGAAGAAGACATTGGTGCTGGAGACCAGGGCTTAATGTTTGGC
TATGCCACTGATGAAACTGAGGAGTGTATGCCTTTAACCATTGTCTTGGCACACAAGCTA
AATGCCAAACTGGCAGAACTACGCCGTAATGGCACTTTGCCTTGGTTACGCCCTGATTCT
AAAACTCAAGTTACTGTGCAGTATATGCAGGATCGAGGTGCTGTGCTTCCCATCAGAGTC
CACACAATTGTTATATCTGTTCAGCATGATGAAGAGGTTTGTCTTGATGAAATGAGGGAT
GCCCTAAAGGAGAAAGTCATCAAAGCAGTTGTGCCTGCGAAATACCTTGATGAGGATACA
ATCTACCACCTACAGCCAAGTGGCAGATTTGTTATTGGTGGGCCTCAGGGTGATGCTGGT
TTGACTGGACGCAAAATCATTGTGGACACTTATGGCGGTTGGGGTGCTCATGGAGGAGGT
GCCTTTTCAGGAAAGGATTATACCAAGGTCGACCGTTCAGCTGCTTATGCTGCTCGTTGG
GTGGCAAAATCCCTTGTTAAAGGAGGTCTGTGCCGGAGGGTTCTTGTTCAGGTCTCTTAT
GCTATTGGAGTTTCTCATCCATTATCTATCTCCATTTTCCATTATGGTACCTCTCAGAAG
AGTGAGAGAGAGCTATTAGAGATTGTGAAGAAGAATTTCGATCTCCGCCCTGGGGTCATT
GTCAGGGATCTGGATCTGAAGAAGCCAATTTATCAGAGGACTGCAGCCTATGGCCACTTT
GGTAGGGACAGCTTCCCATGGGAAGTGCCCAAAAAGCTTAAATATTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02773</identifier>
        <name>S-AdoMet_synt_C</name>
      </pfam>
      <pfam>
        <identifier>PF02772</identifier>
        <name>S-AdoMet_synt_M</name>
      </pfam>
      <pfam>
        <identifier>PF00438</identifier>
        <name>S-AdoMet_synt_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>methionine adenosyltransferase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine adenosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>one-carbon metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="3">
      <id>BE0000432</id>
      <name>Methionine-R-sulfoxide reductase B2, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16480945</pubmed-id>
            <citation>Schallreuter KU, Rubsam K, Chavan B, Zothner C, Gillbro JM, Spencer JD, Wood JM: Functioning methionine sulfoxide reductases A and B are present in human epidermal melanocytes in the cytosol and in the nucleus. Biochem Biophys Res Commun. 2006 Mar 31;342(1):145-52. Epub 2006 Feb 3.</citation>
          </article>
          <article>
            <pubmed-id>16530221</pubmed-id>
            <citation>Ranaivoson FM, Kauffmann B, Neiers F, Wu J, Boschi-Muller S, Panjikar S, Aubry A, Branlant G, Favier F: The X-ray structure of the N-terminal domain of PILB from Neisseria meningitidis reveals a thioredoxin-fold. J Mol Biol. 2006 Apr 28;358(2):443-54. Epub 2006 Feb 28.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y3D2" source="Swiss-Prot">
    <name>Methionine-R-sulfoxide reductase B2, mitochondrial</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Methionine-sulfoxide reductase that specifically reduces methionine (R)-sulfoxide back to methionine. While in many cases, methionine oxidation is the result of random oxidation following oxidative stress, methionine oxidation is also a post-translational modification that takes place on specific residue. Upon oxidative stress, may play a role in the preservation of mitochondrial integrity by decreasing the intracellular reactive oxygen species build-up through its scavenging role, hence contributing to cell survival and protein maintenance.</specific-function>
    <gene-name>MSRB2</gene-name>
    <locus>10p12</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.16</theoretical-pi>
    <molecular-weight>19536.055</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17061</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MSRB2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF151889</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4929731</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y3D2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MSRB2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.8.4.-</synonym>
      <synonym>CBS-1</synonym>
      <synonym>MSRB</synonym>
      <synonym>MsrB2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037017|Methionine-R-sulfoxide reductase B2, mitochondrial
MARLLWLLRGLTLGTAPRRAVRGQAGGGGPGTGPGLGEAGSLATCELPLAKSEWQKKLTP
EQFYVTREKGTEPPFSGIYLNNKEAGMYHCVCCDSPLFSSEKKYCSGTGWPSFSEAHGTS
GSDESHTGILRRLDTSLGSARTEVVCKQCEAHLGHVFPDGPGPNGQRFCINSVALKFKPR
KH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010302|Methionine-R-sulfoxide reductase B2, mitochondrial (MSRB2)
ATGGCGCGGCTCCTCTGGTTGCTCCGGGGCCTGACCCTCGGAACTGCGCCTCGGCGGGCG
GTGCGGGGCCAAGCGGGCGGCGGCGGGCCCGGCACCGGGCCGGGACTGGGGGAGGCAGGG
TCTCTTGCAACGTGTGAGCTGCCTCTTGCCAAGAGTGAGTGGCAAAAGAAACTAACCCCG
GAGCAGTTCTACGTCACAAGAGAAAAGGGAACGGAACCGCCTTTCAGTGGGATCTACCTG
AATAACAAGGAAGCAGGAATGTATCATTGCGTGTGCTGCGACAGTCCACTCTTCAGTTCT
GAGAAAAAGTACTGCTCTGGCACTGGGTGGCCTTCGTTTTCCGAGGCTCATGGTACGTCT
GGCTCTGATGAAAGCCACACAGGGATCCTGAGACGTCTGGATACCTCGTTAGGATCAGCT
CGCACAGAGGTTGTCTGCAAGCAGTGTGAAGCTCATCTAGGTCACGTGTTTCCTGATGGA
CCTGGGCCCAATGGTCAGAGGTTTTGCATCAACAGTGTGGCTTTGAAGTTCAAACCAAGG
AAACACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01641</identifier>
        <name>SelR</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>actin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor activity, sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide-methionine (R)-S-oxide reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>actin filament polymerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein repair</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="4">
      <id>BE0000407</id>
      <name>S-adenosylmethionine synthase isoform type-1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16435220</pubmed-id>
            <citation>Linnebank M, Lagler F, Muntau AC, Roschinger W, Olgemoller B, Fowler B, Koch HG: Methionine adenosyltransferase (MAT) I/III deficiency with concurrent hyperhomocysteinaemia: two novel cases. J Inherit Metab Dis. 2005;28(6):1167-8.</citation>
          </article>
          <article>
            <pubmed-id>17154373</pubmed-id>
            <citation>Yang H, Magilnick N, Noureddin M, Mato JM, Lu SC: Effect of hepatocyte growth factor on methionine adenosyltransferase genes and growth is cell density-dependent in HepG2 cells. J Cell Physiol. 2007 Mar;210(3):766-73.</citation>
          </article>
          <article>
            <pubmed-id>17631143</pubmed-id>
            <citation>Chen H, Xia M, Lin M, Yang H, Kuhlenkamp J, Li T, Sodir NM, Chen YH, Josef-Lenz H, Laird PW, Clarke S, Mato JM, Lu SC: Role of methionine adenosyltransferase 2A and S-adenosylmethionine in mitogen-induced growth of human colon cancer cells. Gastroenterology. 2007 Jul;133(1):207-18. Epub 2007 Apr 11.</citation>
          </article>
          <article>
            <pubmed-id>17317269</pubmed-id>
            <citation>Rodriguez JL, Boukaba A, Sandoval J, Georgieva EI, Latasa MU, Garcia-Trevijano ER, Serviddio G, Nakamura T, Avila MA, Sastre J, Torres L, Mato JM, Lopez-Rodas G: Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells. Int J Biochem Cell Biol. 2007;39(4):842-50. Epub 2007 Jan 20.</citation>
          </article>
          <article>
            <pubmed-id>16614071</pubmed-id>
            <citation>Prudova A, Bauman Z, Braun A, Vitvitsky V, Lu SC, Banerjee R: S-adenosylmethionine stabilizes cystathionine beta-synthase and modulates redox capacity. Proc Natl Acad Sci U S A. 2006 Apr 25;103(17):6489-94. Epub 2006 Apr 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q00266" source="Swiss-Prot">
    <name>S-adenosylmethionine synthase isoform type-1</name>
    <general-function>Methionine adenosyltransferase activity</general-function>
    <specific-function>Catalyzes the formation of S-adenosylmethionine from methionine and ATP.</specific-function>
    <gene-name>MAT1A</gene-name>
    <locus>10q22</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.24</theoretical-pi>
    <molecular-weight>43647.6</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6903</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MAT1A</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D49357</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>220066</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q00266</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>METK1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.6</synonym>
      <synonym>AdoMet synthase 1</synonym>
      <synonym>AMS1</synonym>
      <synonym>MAT 1</synonym>
      <synonym>MAT-I/III</synonym>
      <synonym>MATA1</synonym>
      <synonym>Methionine adenosyltransferase 1</synonym>
      <synonym>Methionine adenosyltransferase I/III</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010282|S-adenosylmethionine synthase isoform type-1
MNGPVDGLCDHSLSEGVFMFTSESVGEGHPDKICDQISDAVLDAHLKQDPNAKVACETVC
KTGMVLLCGEITSMAMVDYQRVVRDTIKHIGYDDSAKGFDFKTCNVLVALEQQSPDIAQC
VHLDRNEEDVGAGDQGLMFGYATDETEECMPLTIILAHKLNARMADLRRSGLLPWLRPDS
KTQVTVQYMQDNGAVIPVRIHTIVISVQHNEDITLEEMRRALKEQVIRAVVPAKYLDEDT
VYHLQPSGRFVIGGPQGDAGVTGRKIIVDTYGGWGAHGGGAFSGKDYTKVDRSAAYAARW
VAKSLVKAGLCRRVLVQVSYAIGVAEPLSISIFTYGTSQKTERELLDVVHKNFDLRPGVI
VRDLDLKKPIYQKTACYGHFGRSEFPWEVPRKLVF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010283|S-adenosylmethionine synthase isoform type-1 (MAT1A)
ATGAATGGACCGGTGGATGGCTTGTGTGACCACTCTCTAAGTGAAGGAGTCTTCATGTTC
ACATCGGAGTCTGTGGGAGAGGGACACCCGGATAAGATCTGTGACCAGATCAGTGATGCA
GTGCTGGATGCCCATCTCAAGCAAGACCCCAATGCCAAGGTGGCCTGTGAGACAGTGTGC
AAGACCGGCATGGTGCTGCTGTGTGGTGAGATCACCTCAATGGCCATGGTGGACTACCAG
CGGGTGGTGAGGGACACCATCAAGCACATCGGCTACGATGACTCAGCCAAGGGCTTTGAC
TTCAAGACTTGCAACGTGCTGGTGGCTTTGGAGCAGCAATCCCCAGATATTGCCCAGTGC
GTCCATCTGGACAGAAATGAGGAGGATGTGGGGGCAGGAGATCAGGGTTTGATGTTCGGC
TATGCTACCGACGAGACAGAGGAGTGCATGCCCCTCACCATCATCCTTGCTCACAAGCTC
AACGCCCGGATGGCAGACCTCAGGCGCTCCGGCCTCCTCCCCTGGCTGCGGCCTGACTCT
AAGACTCAGGTGACAGTTCAGTACATGCAGGACAATGGCGCAGTCATCCCTGTGCGCATC
CACACCATCGTCATCTCTGTGCAGCACAACGAAGACATCACGCTGGAGGAGATGCGCAGG
GCCCTGAAGGAGCAAGTCATCAGGGCCGTGGTGCCGGCCAAGTACCTGGACGAAGACACC
GTCTACCACCTGCAGCCCAGTGGGCGGTTTGTCATCGGAGGTCCCCAGGGGGATGCGGGT
GTCACTGGCCGTAAGATTATTGTGGACACCTATGGCGGCTGGGGGGCTCATGGTGGTGGG
GCCTTCTCTGGGAAGGACTACACCAAGGTAGACCGCTCAGCTGCATATGCTGCCCGCTGG
GTGGCCAAGTCTCTGGTGAAAGCAGGGCTCTGCCGGAGAGTGCTTGTCCAGGTTTCCTAT
GCCATTGGTGTGGCCGAGCCGCTGTCCATTTCCATCTTCACCTACGGAACCTCTCAGAAG
ACAGAGCGAGAGCTGCTGGATGTGGTGCATAAGAACTTCGACCTCCGGCCGGGCGTCATT
GTCAGGGATTTGGACTTGAAGAAGCCCATCTACCAGAAGACAGCATGCTACGGCCATTTC
GGAAGAAGCGAGTTCCCATGGGAGGTTCCCAGGAAGCTTGTATTTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02773</identifier>
        <name>S-AdoMet_synt_C</name>
      </pfam>
      <pfam>
        <identifier>PF02772</identifier>
        <name>S-AdoMet_synt_M</name>
      </pfam>
      <pfam>
        <identifier>PF00438</identifier>
        <name>S-AdoMet_synt_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine adenosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>one-carbon metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="5">
      <id>BE0000288</id>
      <name>Methionine-R-sulfoxide reductase B1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16542431</pubmed-id>
            <citation>Kim HY, Gladyshev VN: Alternative first exon splicing regulates subcellular distribution of methionine sulfoxide reductases. BMC Mol Biol. 2006 Mar 16;7:11.</citation>
          </article>
          <article>
            <pubmed-id>17105189</pubmed-id>
            <citation>Kim HY, Fomenko DE, Yoon YE, Gladyshev VN: Catalytic advantages provided by selenocysteine in methionine-S-sulfoxide reductases. Biochemistry. 2006 Nov 21;45(46):13697-704.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NZV6" source="Swiss-Prot">
    <name>Methionine-R-sulfoxide reductase B1</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Methionine-sulfoxide reductase that specifically reduces methionine (R)-sulfoxide back to methionine. While in many cases, methionine oxidation is the result of random oxidation following oxidative stress, methionine oxidation is also a post-translational modification that takes place on specific residue. Acts as a regulator of actin assembly by reducing methionine (R)-sulfoxide mediated by MICALs (MICAL1, MICAL2 or MICAL3) on actin, thereby promoting filament repolymerization. Plays a role in innate immunity by reducing oxidized actin, leading to actin repolymerization in macrophages (By similarity).</specific-function>
    <gene-name>MSRB1</gene-name>
    <locus>16p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.39</theoretical-pi>
    <molecular-weight>12760.095</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:14133</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SEPX1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF166124</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6649219</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NZV6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MSRB1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.8.4.-</synonym>
      <synonym>MsrB1</synonym>
      <synonym>Selenoprotein X</synonym>
      <synonym>SelX</synonym>
      <synonym>SEPX1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036984|Methionine-R-sulfoxide reductase B1
MSFCSFFGGEVFQNHFEPGVYVCAKCGYELFSSRSKYAHSSPWPAFTETIHADSVAKRPE
HNRSEALKVSCGKCGNGLGHEFLNDGPKPGQSRFUIFSSSLKFVPKGKETSASQGH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016056|Methionine-R-sulfoxide reductase B1 (MSRB1)
ATGTCGTTCTGCAGCTTCTTCGGGGGCGAGGTTTTCCAGAATCACTTTGAACCTGGCGTT
TACGTGTGTGCCAAGTGTGGCTATGAGCTGTTCTCCAGCCGCTCGAAGTATGCACACTCG
TCTCCATGGCCGGCGTTCACCGAGACCATTCACGCCGACAGCGTGGCCAAGCGTCCGGAG
CACAATAGATCTGAAGCCTTGAAGGTGTCCTGTGGCAAGTGTGGCAATGGGTTGGGCCAC
GAGTTCCTGAACGACGGCCCCAAGCCGGGGCAGTCCCGATTCTGAATATTCAGCAGCTCG
CTGAAGTTTGTCCCTAAAGGCAAAGAAACTTCTGCCTCCCAGGGTCACTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01641</identifier>
        <name>SelR</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>actin cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>actin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide-methionine (R)-S-oxide reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine-R-sulfoxide reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>actin filament polymerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein repair</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="6">
      <id>BE0000170</id>
      <name>Mitochondrial peptide methionine sulfoxide reductase</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16480945</pubmed-id>
            <citation>Schallreuter KU, Rubsam K, Chavan B, Zothner C, Gillbro JM, Spencer JD, Wood JM: Functioning methionine sulfoxide reductases A and B are present in human epidermal melanocytes in the cytosol and in the nucleus. Biochem Biophys Res Commun. 2006 Mar 31;342(1):145-52. Epub 2006 Feb 3.</citation>
          </article>
          <article>
            <pubmed-id>17624316</pubmed-id>
            <citation>Su Z, Limberis J, Martin RL, Xu R, Kolbe K, Heinemann SH, Hoshi T, Cox BF, Gintant GA: Functional consequences of methionine oxidation of hERG potassium channels. Biochem Pharmacol. 2007 Sep 1;74(5):702-11. Epub 2007 Jun 7.</citation>
          </article>
          <article>
            <pubmed-id>17126812</pubmed-id>
            <citation>Oien DB, Moskovitz J: Ablation of the mammalian methionine sulfoxide reductase A affects the expression level of cysteine deoxygenase. Biochem Biophys Res Commun. 2007 Jan 12;352(2):556-9. Epub 2006 Nov 20.</citation>
          </article>
          <article>
            <pubmed-id>17031545</pubmed-id>
            <citation>Rouhier N, Vieira Dos Santos C, Tarrago L, Rey P: Plant methionine sulfoxide reductase A and B multigenic families. Photosynth Res. 2006 Sep;89(2-3):247-62. Epub 2006 Sep 22.</citation>
          </article>
          <article>
            <pubmed-id>17500063</pubmed-id>
            <citation>Gand A, Antoine M, Boschi-Muller S, Branlant G: Characterization of the amino acids involved in substrate specificity of methionine sulfoxide reductase A. J Biol Chem. 2007 Jul 13;282(28):20484-91. Epub 2007 May 11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UJ68" source="Swiss-Prot">
    <name>Mitochondrial peptide methionine sulfoxide reductase</name>
    <general-function>Peptide-methionine (s)-s-oxide reductase activity</general-function>
    <specific-function>Has an important function as a repair enzyme for proteins that have been inactivated by oxidation. Catalyzes the reversible oxidation-reduction of methionine sulfoxide in proteins to methionine.</specific-function>
    <gene-name>MSRA</gene-name>
    <locus>8p23.1</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.21</theoretical-pi>
    <molecular-weight>26132.42</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7377</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MSRA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ242973</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6136945</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UJ68</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MSRA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.8.4.11</synonym>
      <synonym>Peptide Met(O) reductase</synonym>
      <synonym>Peptide-methionine (S)-S-oxide reductase</synonym>
      <synonym>PMSR</synonym>
      <synonym>Protein-methionine-S-oxide reductase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000339|Mitochondrial peptide methionine sulfoxide reductase
MLSATRRACQLLLLHSLFPVPRMGNSASNIVSPQEALPGRKEQTPVAAKHHVNGNRTVEP
FPEGTQMAVFGMGCFWGAERKFWVLKGVYSTQVGFAGGYTSNPTYKEVCSEKTGHAEVVR
VVYQPEHMSFEELLKVFWENHDPTQGMRQGNDHGTQYRSAIYPTSAKQMEAALSSKENYQ
KVLSEHGFGPITTDIREGQTFYYAEDYHQQYLSKNPNGYCGLGGTGVSCPVGIKK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0018928|Mitochondrial peptide methionine sulfoxide reductase (MSRA)
ATGCTCTCGGCCACCCGGAGGGCTTGCCAGCTCCTCCTCCTCCACAGCCTCTTTCCCGTC
CCGAGGATGGGCAACTCGGCCTCGAACATCGTCAGCCCCCAGGAGGCCTTGCCGGGCCGG
AAGGAACAGACCCCTGTAGCGGCCAAACATCATGTCAATGGCAACAGAACAGTCGAACCT
TTCCCAGAGGGAACACAGATGGCTGTATTTGAAAAAACTGGCCATGCAGAAGTCGTCCGA
GTGGTGTACCAGCCAGAACACATGAGTTTTGAGGAACTGCTCAAGGTCTTCTGGGAGAAT
CACGACCCGACCCAAGGTATGCGCCAGGGGAACGACCATGGCACTCAGTACCGCTCGGCC
ATCTACCCGACCTCTGCCAAGCAAATGGAGGCAGCCCTGAGCTCCAAAGAGAACTACCAA
AAGGTTCTTTCAGAGCACGGCTTCGGCCCCATCACTACCGACATCCGGGAGGGACAGACT
TTCTACTATGCGGAAGACTACCACCAGCAGTACCTGAGCAAGAACCCCAATGGCTACTGC
GGCCTTGGGGGCACCGGCGTGTCCTGCCCAGTGGGTATTAAAAAATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01625</identifier>
        <name>PMSR</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>actin cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide-methionine (S)-S-oxide reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein modification process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein repair</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="7">
      <id>BE0000543</id>
      <name>Methionine--tRNA ligase, cytoplasmic</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17327360</pubmed-id>
            <citation>Chwatko G, Boers GH, Strauss KA, Shih DM, Jakubowski H: Mutations in methylenetetrahydrofolate reductase or cystathionine beta-synthase gene, or a high-methionine diet, increase homocysteine thiolactone levels in humans and mice. FASEB J. 2007 Jun;21(8):1707-13. Epub 2007 Feb 27.</citation>
          </article>
          <article>
            <pubmed-id>16702349</pubmed-id>
            <citation>Jakubowski H: Pathophysiological consequences of homocysteine excess. J Nutr. 2006 Jun;136(6 Suppl):1741S-1749S.</citation>
          </article>
          <article>
            <pubmed-id>16787318</pubmed-id>
            <citation>Vaughan MD, Sampson PB, Daub E, Honek JF: Investigation of bioisosteric effects on the interaction of substrates/ inhibitors with the methionyl-tRNA synthetase from Escherichia coli. Med Chem. 2005 May;1(3):227-37.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P56192" source="Swiss-Prot">
    <name>Methionine--tRNA ligase, cytoplasmic</name>
    <general-function>Trna binding</general-function>
    <specific-function/>
    <gene-name>MARS</gene-name>
    <locus>12q13.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.05</theoretical-pi>
    <molecular-weight>101114.925</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6898</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MARS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X94754</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1702932</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P56192</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYMC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.10</synonym>
      <synonym>Methionyl-tRNA synthetase</synonym>
      <synonym>MetRS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001084|Methionine--tRNA ligase, cytoplasmic
MRLFVSDGVPGCLPVLAAAGRARGRAEVLISTVGPEDCVVPFLTRPKVPVLQLDSGNYLF
STSAICRYFFLLSGWEQDDLTNQWLEWEATELQPALSAALYYLVVQGKKGEDVLGSVRRA
LTHIDHSLSRQNCPFLAGETESLADIVLWGALYPLLQDPAYLPEELSALHSWFQTLSTQE
PCQRAAETVLKQQGVLALRPYLQKQPQPSPAEGRAVTNEPEEEELATLSEEEIAMAVTAW
EKGLESLPPLRPQQNPVLPVAGERNVLITSALPYVNNVPHLGNIIGCVLSADVFARYSRL
RQWNTLYLCGTDEYGTATETKALEEGLTPQEICDKYHIIHADIYRWFNISFDIFGRTTTP
QQTKITQDIFQQLLKRGFVLQDTVEQLRCEHCARFLADRFVEGVCPFCGYEEARGDQCDK
CGKLINAVELKKPQCKVCRSCPVVQSSQHLFLDLPKLEKRLEEWLGRTLPGSDWTPNAQF
ITRSWLRDGLKPRCITRDLKWGTPVPLEGFEDKVFYVWFDATIGYLSITANYTDQWERWW
KNPEQVDLYQFMAKDNVPFHSLVFPCSALGAEDNYTLVSHLIATEYLNYEDGKFSKSRGV
GVFGDMAQDTGIPADIWRFYLLYIRPEGQDSAFSWTDLLLKNNSELLNNLGNFINRAGMF
VSKFFGGYVPEMVLTPDDQRLLAHVTLELQHYHQLLEKVRIRDALRSILTISRHGNQYIQ
VNEPWKRIKGSEADRQRAGTVTGLAVNIAALLSVMLQPYMPTVSATIQAQLQLPPPACSI
LLTNFLCTLPAGHQIGTVSPLFQKLENDQIESLRQRFGGGQAKTSPKPAVVETVTTAKPQ
QIQALMDEVTKQGNIVRELKAQKADKNEVAAEVAKLLDLKKQLAVAEGKPPEAPKGKKKK
</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010378|Methionine--tRNA ligase, cytoplasmic (MARS)
ATGAGACTGTTCGTGAGTGATGGCGTCCCGGGTTGCTTGCCGGTGCTGGCCGCCGCCGGG
AGAGCCCGGGGCAGAGCAGAGGTGCTCATCAGCACTGTAGGCCCGGAAGATTGTGTGGTC
CCGTTCCTGACCCGGCCTAAGGTCCCTGTCTTGCAGCTGGATAGCGGCAACTACCTCTTC
TCCACTAGTGCAATCTGCCGATATTTTTTTTTGTTATCTGGCTGGGAGCAAGATGACCTC
ACTAACCAGTGGCTGGAATGGGAAGCGACAGAGCTGCAGCCAGCTTTGTCTGCTGCCCTG
TACTATTTAGTGGTCCAAGGCAAGAAGGGGGAAGATGTTCTTGGTTCAGTGCGGAGAGCC
CTGACTCACATTGACCACAGCTTGAGTCGTCAGAACTGTCCTTTCCTGGCTGGGGAGACA
GAATCTCTAGCCGACATTGTTTTGTGGGGAGCCCTATACCCATTACTGCAAGATCCCGCC
TACCTCCCTGAGGAGCTGAGTGCCCTGCACAGCTGGTTCCAGACACTGAGTACCCAGGAA
CCATGTCAGCGAGCTGCAGAGACTGTACTGAAACAGCAAGGTGTCCTGGCTCTCCGGCCT
TACCTCCAAAAGCAGCCCCAGCCCAGCCCCGCTGAGGGAAGGGCTGTCACCAATGAGCCT
GAGGAGGAGGAGCTGGCTACCCTATCTGAGGAGGAGATTGCTATGGCTGTTACTGCTTGG
GAGAAGGGCCTAGAAAGTTTGCCCCCGCTGCGGCCCCAGCAGAATCCAGTGTTGCCTGTG
GCTGGAGAAAGGAATGTGCTCATCACCAGTGCCCTCCCTTACGTCAACAATGTCCCCCAC
CTTGGGAACATCATTGGTTGTGTGCTCAGTGCCGATGTCTTTGCCAGGTACTCTCGCCTC
CGCCAGTGGAACACCCTCTATCTGTGTGGGACAGATGAGTATGGTACAGCAACAGAGACC
AAGGCTCTGGAGGAGGGACTAACCCCCCAGGAGATCTGCGACAAGTACCACATCATCCAT
GCTGACATCTACCGCTGGTTTAACATTTCGTTTGATATTTTTGGTCGCACCACCACTCCA
CAGCAGACCAAAATCACCCAGGACATTTTCCAGCAGTTGCTGAAACGAGGTTTTGTGCTG
CAAGATACTGTGGAGCAACTGCGATGTGAGCACTGTGCTCGCTTCCTGGCTGACCGCTTC
GTGGAGGGCGTGTGTCCCTTCTGTGGCTATGAGGAGGCTCGGGGTGACCAGTGTGACAAG
TGTGGCAAGCTCATCAATGCTGTCGAGCTTAAGAAGCCTCAGTGTAAAGTCTGCCGATCA
TGCCCTGTGGTGCAGTCGAGCCAGCACCTGTTTCTGGACCTGCCTAAGCTGGAGAAGCGA
CTGGAGGAGTGGTTGGGGAGGACATTGCCTGGCAGTGACTGGACACCCAATGCCCAGTTT
ATCACCCGTTCTTGGCTTCGGGATGGCCTCAAGCCACGCTGCATAACCCGAGACCTCAAA
TGGGGAACCCCTGTACCCTTAGAAGGTTTTGAAGACAAGGTATTCTATGTCTGGTTTGAT
GCCACTATTGGCTATCTGTCCATCACAGCCAACTACACAGACCAGTGGGAGAGATGGTGG
AAGAACCCAGAGCAAGTGGACCTGTATCAGTTCATGGCCAAAGACAATGTTCCTTTCCAT
AGCTTAGTCTTTCCTTGCTCAGCCCTAGGAGCTGAGGATAACTATACCTTGGTCAGCCAC
CTCATTGCTACAGAGTACCTGAACTATGAGGATGGGAAATTCTCTAAGAGCCGCGGTGTG
GGAGTGTTTGGGGACATGGCCCAGGACACGGGGATCCCTGCTGACATCTGGCGCTTCTAT
CTGCTGTACATTCGGCCTGAGGGCCAGGACAGTGCTTTCTCCTGGACGGACCTGCTGCTG
AAGAATAATTCTGAGCTGCTTAACAACCTGGGCAACTTCATCAACAGAGCTGGGATGTTT
GTGTCTAAGTTCTTTGGGGGCTATGTGCCTGAGATGGTGCTCACCCCTGATGATCAGCGC
CTGCTGGCCCATGTCACCCTGGAGCTCCAGCACTATCACCAGCTACTTGAGAAGGTTCGG
ATCCGGGATGCCTTGCGCAGTATCCTCACCATATCTCGACATGGCAACCAATATATTCAG
GTGAATGAGCCCTGGAAGCGGATTAAAGGCAGTGAGGCTGACAGGCAACGGGCAGGAACA
GTGACTGGCTTGGCAGTGAATATAGCTGCCTTGCTCTCTGTCATGCTTCAGCCTTACATG
CCCACGGTTAGTGCCACAATCCAGGCCCAGCTGCAGCTCCCACCTCCAGCCTGCAGTATC
CTGCTGACAAACTTCCTGTGTACCTTACCAGCAGGACACCAGATTGGCACAGTCAGTCCC
TTGTTCCAAAAATTGGAAAATGACCAGATTGAAAGTTTAAGGCAGCGCTTTGGAGGGGGC
CAGGCAAAAACGTCCCCGAAGCCAGCAGTTGTAGAGACTGTTACAACAGCCAAGCCACAG
CAGATACAAGCGCTGATGGATGAAGTGACAAAACAAGGAAACATTGTCCGAGAACTGAAA
GCACAAAAGGCAGACAAGAACGAGGTTGCTGCGGAGGTGGCGAAACTCTTGGATCTAAAG
AAACAGTTGGCTGTAGCTGAGGGGAAACCCCCTGAAGCCCCTAAAGGCAAGAAGAAAAAG
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00458</identifier>
        <name>WHEP-TRS</name>
      </pfam>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF09334</identifier>
        <name>tRNA-synt_1g</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tRNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="8">
      <id>BE0002248</id>
      <name>Methionine--tRNA ligase, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>15274629</pubmed-id>
            <citation>Spencer AC, Heck A, Takeuchi N, Watanabe K, Spremulli LL: Characterization of the human mitochondrial methionyl-tRNA synthetase. Biochemistry. 2004 Aug 3;43(30):9743-54.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q96GW9" source="Swiss-Prot">
    <name>Methionine--tRNA ligase, mitochondrial</name>
    <general-function>Methionine-trna ligase activity</general-function>
    <specific-function/>
    <gene-name>MARS2</gene-name>
    <locus>2q33.1</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.14</theoretical-pi>
    <molecular-weight>66590.29</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:25133</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MARS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB107013</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>37196758</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q96GW9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYMM_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.10</synonym>
      <synonym>Methionyl-tRNA synthetase 2</synonym>
      <synonym>Mitochondrial methionyl-tRNA synthetase</synonym>
      <synonym>MtMetRS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004412|Methionine--tRNA ligase, mitochondrial
MLRTSVLRLLGRTGASRLSLLEDFGPRYYSSGSLSAGDDACDVRAYFTTPIFYVNAAPHI
GHLYSALLADALCRHRRLRGPSTAATRFSTGTDEHGLKIQQAAATAGLAPTELCDRVSEQ
FQQLFQEAGISCTDFIRTTEARHRVAVQHFWGVLKSRGLLYKGVYEGWYCASDECFLPEA
KVTQQPGPSGDSFPVSLESGHPVSWTKEENYIFRLSQFRKPLQRWLRGNPQAITPEPFHH
VVLQWLDEELPDLSVSRRSSHLHWGIPVPGDDSQTIYVWLDALVNYLTVIGYPNAEFKSW
WPATSHIIGKDILKFHAIYWPAFLLGAGMSPPQRICVHSHWTVCGQKMSKSLGNVVDPRT
CLNRYTVDGFRYFLLRQGVPNWDCDYYDEKVVKLLNSELADALGGLLNRCTAKRINPSET
YPAFCTTCFPSEPGLVGPSVRAQAEDYALVSAVATLPKQVADHYDNFRIYKALEAVSSCV
RQTNGFVQRHAPWKLNWESPVDAPWLGTVLHVALECLRVFGTLLQPVTPSLADKLLSRLG
VSASERSLGELYFLPRFYGHPCPFEGRRLGPETGLLFPRLDQSRTWLVKAHRT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011621|Methionine--tRNA ligase, mitochondrial (MARS2)
ATGCTGCGAACGTCCGTCCTCCGCCTGCTAGGACGCACGGGGGCTAGTAGGCTGTCTCTC
CTGGAGGACTTCGGCCCACGCTACTACAGTTCGGGCTCCCTCAGTGCCGGCGATGATGCT
TGTGATGTGCGCGCCTACTTCACTACACCCATTTTCTACGTGAACGCGGCGCCGCACATC
GGGCACCTGTACTCGGCACTACTGGCGGACGCCCTATGCCGCCACCGTCGCCTCCGAGGT
CCCAGCACGGCCGCCACGCGATTCTCCACTGGTACCGACGAGCACGGGCTGAAGATTCAG
CAGGCAGCAGCTACCGCGGGCCTGGCCCCGACCGAGCTGTGCGACCGAGTCTCTGAGCAG
TTCCAGCAGCTTTTCCAGGAGGCCGGTATCTCCTGCACAGATTTCATCCGCACCACGGAG
GCCCGGCACCGGGTGGCTGTGCAGCACTTCTGGGGGGTGCTTAAGTCCCGCGGTCTGCTC
TACAAGGGCGTCTATGAAGGTTGGTATTGCGCTTCCGACGAGTGCTTCCTGCCTGAGGCC
AAGGTCACCCAGCAGCCGGGCCCATCGGGGGATTCGTTTCCTGTATCTCTCGAGAGCGGG
CATCCAGTCTCCTGGACCAAGGAAGAAAACTACATTTTCAGGCTTTCCCAGTTCCGGAAG
CCACTCCAGCGGTGGCTGCGGGGCAACCCTCAGGCGATCACCCCCGAACCATTTCATCAC
GTAGTTCTTCAGTGGCTGGACGAGGAGCTGCCCGACCTGTCCGTGTCTCGCAGAAGTAGC
CACTTGCACTGGGGCATTCCGGTGCCCGGGGATGATTCGCAGACCATCTATGTATGGCTG
GATGCCCTGGTCAACTACCTCACTGTAATTGGCTACCCAAATGCTGAGTTCAAATCTTGG
TGGCCGGCCACCTCTCATATCATAGGTAAGGACATTCTCAAATTCCATGCCATCTATTGG
CCTGCCTTCCTGTTAGGGGCCGGCATGAGCCCGCCACAGCGCATCTGTGTCCATTCCCAC
TGGACAGTCTGTGGCCAAAAGATGTCCAAGAGCTTGGGCAACGTGGTGGATCCTAGGACT
TGCCTTAACCGCTATACCGTGGATGGCTTCCGCTACTTTCTCCTTCGGCAGGGCGTCCCC
AACTGGGACTGTGACTACTATGATGAAAAGGTGGTTAAGTTGCTGAACTCCGAGCTGGCA
GATGCCTTGGGAGGTCTCTTGAACCGATGCACTGCCAAAAGAATAAATCCTTCTGAGACC
TACCCAGCCTTCTGCACTACCTGCTTCCCTAGTGAGCCAGGGTTGGTGGGGCCGTCAGTT
CGTGCTCAGGCAGAGGATTATGCTCTGGTGAGCGCAGTGGCCACTTTGCCAAAGCAGGTA
GCAGACCACTATGATAACTTTCGGATATATAAGGCTCTGGAGGCCGTGTCCAGCTGTGTC
CGGCAAACTAATGGTTTTGTCCAAAGGCATGCACCATGGAAGCTGAACTGGGAGAGCCCA
GTGGATGCTCCCTGGCTGGGTACTGTGCTTCATGTGGCCTTGGAATGTTTGCGAGTCTTT
GGGACTTTGCTGCAGCCTGTCACCCCAAGCCTAGCTGACAAGCTGCTGTCTAGGCTGGGG
GTCTCTGCCTCAGAGAGGAGTCTTGGAGAGCTCTATTTCTTGCCTCGATTCTATGGACAT
CCATGCCCTTTTGAAGGGAGGAGGCTGGGACCTGAAACTGGGCTTTTGTTTCCAAGACTA
GACCAGTCCAGGACTTGGCTGGTGAAAGCCCACCGGACCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF09334</identifier>
        <name>tRNA-synt_1g</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme position="9">
      <id>BE0002178</id>
      <name>Methionine adenosyltransferase 2 subunit beta</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11337507</pubmed-id>
            <citation>LeGros L, Halim AB, Chamberlin ME, Geller A, Kotb M: Regulation of the human MAT2B gene encoding the regulatory beta subunit of methionine adenosyltransferase, MAT II. J Biol Chem. 2001 Jul 6;276(27):24918-24. Epub 2001 May 3.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NZL9" source="Swiss-Prot">
    <name>Methionine adenosyltransferase 2 subunit beta</name>
    <general-function>Methionine adenosyltransferase regulator activity</general-function>
    <specific-function>Non-catalytic regulatory subunit of S-adenosylmethionine synthetase 2 (MAT2A), an enzyme that catalyzes the formation of S-adenosylmethionine from methionine and ATP. Regulates the activity of S-adenosylmethionine synthetase 2 by changing its kinetic properties, rendering the enzyme more susceptible to S-adenosylmethionine inhibition.</specific-function>
    <gene-name>MAT2B</gene-name>
    <locus>5q34-q35.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.39</theoretical-pi>
    <molecular-weight>37551.535</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6905</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MAT2B</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF182814</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6815285</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NZL9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MAT2B_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>MAT II beta</synonym>
      <synonym>Methionine adenosyltransferase II beta</synonym>
      <synonym>Putative dTDP-4-keto-6-deoxy-D-glucose 4-reductase</synonym>
      <synonym>TGR</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004274|Methionine adenosyltransferase 2 subunit beta
MVGREKELSIHFVPGSCRLVEEEVNIPNRRVLVTGATGLLGRAVHKEFQQNNWHAVGCGF
RRARPKFEQVNLLDSNAVHHIIHDFQPHVIVHCAAERRPDVVENQPDAASQLNVDASGNL
AKEAAAVGAFLIYISSDYVFDGTNPPYREEDIPAPLNLYGKTKLDGEKAVLENNLGAAVL
RIPILYGEVEKLEESAVTVMFDKVQFSNKSANMDHWQQRFPTHVKDVATVCRQLAEKRML
DPSIKGTFHWSGNEQMTKYEMACAIADAFNLPSSHLRPITDSPVLGAQRPRNAQLDCSKL
ETLGIGQRTPFRIGIKESLWPFLIDKRWRQTVFH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011574|Methionine adenosyltransferase 2 subunit beta (MAT2B)
ATGGTGGGGCGGGAGAAAGAGCTCTCTATACACTTTGTTCCCGGGAGCTGTCGGCTGGTG
GAGGAGGAAGTTAACATCCCTAATAGGAGGGTTCTGGTTACTGGTGCCACTGGGCTTCTT
GGCAGAGCTGTACACAAAGAATTTCAGCAGAATAATTGGCATGCAGTTGGCTGTGGTTTC
AGAAGAGCAAGACCAAAATTTGAACAGGTTAATCTGTTGGATTCTAATGCAGTTCATCAC
ATCATTCATGATTTTCAGCCCCATGTTATAGTACATTGTGCAGCAGAGAGAAGACCAGAT
GTTGTAGAAAATCAGCCAGATGCTGCCTCTCAACTTAATGTGGATGCTTCTGGGAATTTA
GCAAAGGAAGCAGCTGCTGTTGGAGCATTTCTCATCTACATTAGCTCAGATTATGTATTT
GATGGAACAAATCCACCTTACAGAGAGGAAGACATACCAGCTCCCCTAAATTTGTATGGC
AAAACAAAATTAGATGGAGAAAAGGCTGTCCTGGAGAACAATCTAGGAGCTGCTGTTTTG
AGGATTCCTATTCTGTATGGGGAAGTTGAAAAGCTCGAAGAAAGTGCTGTGACTGTTATG
TTTGATAAAGTGCAGTTCAGCAACAAGTCAGCAAACATGGATCACTGGCAGCAGAGGTTC
CCCACACATGTCAAAGATGTGGCCACTGTGTGCCGGCAGCTAGCAGAGAAGAGAATGCTG
GATCCATCAATTAAGGGAACCTTTCACTGGTCTGGCAATGAACAGATGACTAAGTATGAA
ATGGCATGTGCAATTGCAGATGCCTTCAACCTCCCCAGCAGTCACTTAAGACCTATTACT
GACAGCCCTGTCCTAGGAGCACAACGTCCGAGAAATGCTCAGCTTGACTGCTCCAAATTG
GAGACCTTGGGCATTGGCCAACGAACACCATTTCGAATTGGAATCAAAGAATCACTTTGG
CCTTTCCTCATTGACAAGAGATGGAGACAAACGGTCTTTCATTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04321</identifier>
        <name>RmlD_sub_bind</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>methionine adenosyltransferase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methionine adenosyltransferase regulator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of catalytic activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>one-carbon metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
    <name>Monocarboxylate transporter 10</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
    <gene-name>SLC16A10</gene-name>
    <locus>6q21-q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>55492.07</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB057445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18640047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TF71</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aromatic amino acid transporter 1</synonym>
      <synonym>MCT 10</synonym>
      <synonym>MCT10</synonym>
      <synonym>Solute carrier family 16 member 10</synonym>
      <synonym>T-type amino acid transporter 1</synonym>
      <synonym>TAT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aromatic amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00135</drugbank-id>
  <drugbank-id>NUTR00059</drugbank-id>
  <name>L-Tyrosine</name>
  <description>A non-essential amino acid. In animals it is synthesized from phenylalanine. It is also the precursor of epinephrine; thyroid hormones; and melanin.</description>
  <cas-number>60-18-4</cas-number>
  <unii>42HK56048U</unii>
  <average-mass>181.1885</average-mass>
  <monoisotopic-mass>181.073893223</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>17046811</pubmed-id>
        <citation>Hoffhines AJ, Damoc E, Bridges KG, Leary JA, Moore KL: Detection and purification of tyrosine-sulfated proteins using a novel anti-sulfotyrosine monoclonal antibody. J Biol Chem. 2006 Dec 8;281(49):37877-87. Epub 2006 Oct 17.</citation>
      </article>
      <article>
        <pubmed-id>16221230</pubmed-id>
        <citation>Molnar GA, Wagner Z, Marko L, Ko Szegi T, Mohas M, Kocsis B, Matus Z, Wagner L, Tamasko M, Mazak I, Laczy B, Nagy J, Wittmann I: Urinary ortho-tyrosine excretion in diabetes mellitus and renal failure: evidence for hydroxyl radical production. Kidney Int. 2005 Nov;68(5):2281-7.</citation>
      </article>
      <article>
        <pubmed-id>16298866</pubmed-id>
        <citation>Molnar GA, Nemes V, Biro Z, Ludany A, Wagner Z, Wittmann I: Accumulation of the hydroxyl free radical markers meta-, ortho-tyrosine and DOPA in cataractous lenses is accompanied by a lower protein and phenylalanine content of the water-soluble phase. Free Radic Res. 2005 Dec;39(12):1359-66.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Hai-quan Mao, Kam W. Leong, "Biodegradable poly (phosphoester-co-desaminotyrosyl L-tyrosine ester) compounds, compositions, articles and methods for making and using the same." U.S. Patent US5912225, issued May, 1960.</synthesis-reference>
  <indication>Tyrosine is claimed to act as an effective antidepressant, however results are mixed. Tyrosine has also been claimed to reduce stress and combat narcolepsy and chronic fatigue, however these claims have been refuted by some studies.</indication>
  <pharmacodynamics>Tyrosine is a nonessential amino acid synthesized in the body from phenylalanine. Tyrosine is critical for the production of the body's proteins, enzymes and muscle tissue. Tyrosine is a precursor to the neurotransmitters norepinephrine and dopamine. It can act as a mood elevator and an anti-depressant. It may improve memory and increase mental alertness. Tyrosine aids in the production of melanin and plays a critical role in the production of thyroxin (thyroid hormones). Tyrosine deficiencies are manifested by hypothyroidism, low blood pressure and low body temperature. Supplemental tyrosine has been used to reduce stress and combat narcolepsy and chronic fatigue.</pharmacodynamics>
  <mechanism-of-action>Tyrosine is produced in cells by hydroxylating the essential amino acid phenylalanine. This relationship is much like that between cysteine and methionine. Half of the phenylalanine required goes into the production of tyrosine; if the diet is rich in tyrosine itself, the requirements for phenylalanine are reduced by about 50%. The mechanism of L-tyrosine's antidepressant activity can be accounted for by the precursor role of L-tyrosine in the synthesis of the neurotransmitters norepinephrine and dopamine. Elevated brain norepinephrine and dopamine levels are thought to be associated with antidepressant effects.</mechanism-of-action>
  <toxicity>L-Tyrosine has very low toxicity. There have been very few reports of toxicity. LD&lt;sub&gt;50&lt;/sub&gt; (oral, rat) &gt; 5110 mg/kg.</toxicity>
  <metabolism>In the liver, L-tyrosine is involved in a number of biochemical reactions, including protein synthesis and oxidative catabolic reactions. L-tyrosine that is not metabolized in the liver is distributed via the systemic circulation to the various tissues of the body.</metabolism>
  <absorption>L-tyrosine is absorbed from the small intestine by a sodium-dependent active transport process.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as tyrosine and derivatives. These are compounds containing tyrosine or a derivative thereof resulting from reaction of tyrosine at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct-parent>Tyrosine and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>1-hydroxy-2-unsubstituted benzenoids</alternative-parent>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Amphetamines and derivatives</alternative-parent>
    <alternative-parent>Aralkylamines</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Monocarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Phenylalanine and derivatives</alternative-parent>
    <alternative-parent>Phenylpropanoic acids</alternative-parent>
    <substituent>1-hydroxy-2-unsubstituted benzenoid</substituent>
    <substituent>3-phenylpropanoic-acid</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Amphetamine or derivatives</substituent>
    <substituent>Aralkylamine</substituent>
    <substituent>Aromatic homomonocyclic compound</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>Monocarboxylic acid or derivatives</substituent>
    <substituent>Monocyclic benzene moiety</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Phenol</substituent>
    <substituent>Phenylalanine or derivatives</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Tyrosine or derivatives</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">(−)-α-amino-p-hydroxyhydrocinnamic acid</synonym>
    <synonym language="" coder="">(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid</synonym>
    <synonym language="" coder="">(S)-(-)-Tyrosine</synonym>
    <synonym language="" coder="">(S)-2-Amino-3-(p-hydroxyphenyl)propionic acid</synonym>
    <synonym language="" coder="">(S)-3-(p-Hydroxyphenyl)alanine</synonym>
    <synonym language="" coder="">(S)-alpha-amino-4-Hydroxybenzenepropanoic acid</synonym>
    <synonym language="" coder="">(S)-Tyrosine</synonym>
    <synonym language="" coder="">(S)-α-amino-4-hydroxybenzenepropanoic acid</synonym>
    <synonym language="" coder="">4-hydroxy-L-phenylalanine</synonym>
    <synonym language="German" coder="">L-Tyrosin</synonym>
    <synonym language="" coder="">Tyr</synonym>
    <synonym language="" coder="">Tyrosine</synonym>
    <synonym language="" coder="">Y</synonym>
  </synonyms>
  <products>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143267</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013975</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014106</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143259</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143232</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014009</dpd-id>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013991</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143240</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013908</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142414</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142406</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014033</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142392</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014017</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142317</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142309</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142295</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013894</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142325</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143224</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142368</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142252</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2015-08-05</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142244</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4168</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-08-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019374</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4187</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4191</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4196</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017789</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4203</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-03-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00454907</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 10% W Electrolytes</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00558966</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 3.5% M</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510629</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00404160</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00523232</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613320</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00613339</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn Sulfite Free</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4192</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017673</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4178</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1985-09-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019398</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4179</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731366</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn-PF 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731358</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Appbutamone</name>
      <labeller>Physician Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>68405-021</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-07-07</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Appbutamone-D</name>
      <labeller>Physician Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>68405-009</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-07-07</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Appformin</name>
      <labeller>Physician Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>68405-011</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-02-07</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Appformin-D</name>
      <labeller>Physician Therapeutics Llc</labeller>
      <ndc-id/>
      <ndc-product-code>68405-019</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-07-07</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013959</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013886</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013940</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02046709</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013932</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142260</dpd-id>
      <started-marketing-on>1996-07-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142279</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013916</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013924</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1083</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1089</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1091</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1093</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1095</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1099</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1103</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1132</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1133</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1134</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1135</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1136</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1137</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1138</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1139</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020734</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142333</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014025</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014041</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014076</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013967</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014068</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142341</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142376</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02142384</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02014084</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-15</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1107</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1109</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1113</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1115</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1119</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1123</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1125</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1127</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1142</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1143</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1144</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1145</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1146</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1147</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1148</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinimix E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1149</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020678</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Clinisol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0502</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1996-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020512</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Novamine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-0468</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution, concentrate</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017957</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Olimel 3.3% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352508</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352524</dpd-id>
      <started-marketing-on>2011-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352516</dpd-id>
      <started-marketing-on>2011-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352540</dpd-id>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352532</dpd-id>
      <started-marketing-on>2011-01-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Periolimel 2.5% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352494</dpd-id>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3205</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1130</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1131</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene 10%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236875</dpd-id>
      <started-marketing-on>1997-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Primene 10%-liq IV</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161192</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ProSol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0499</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1998-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020849</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <labeller>Baxter Corporation Clintec Nutrition Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02013983</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Renamin (amino Acids) Injection</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02020564</dpd-id>
      <started-marketing-on>1996-02-02</started-marketing-on>
      <ended-marketing-on>2011-05-10</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388769</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00872296</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0644</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-08-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018931</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306444</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00306436</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2008-03-26</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00285528</dpd-id>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00388742</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9341</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9361</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vamin 18 Electrolyte-free</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02059711</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vamin N</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065665</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Rxosine</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Appbutamone-D</name>
      <ingredients>Bupropion + L-Tyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Appformin</name>
      <ingredients>L-Tyrosine + Metformin</ingredients>
    </mixture>
    <mixture>
      <name>Appformin-D</name>
      <ingredients>L-Tyrosine + Metformin</ingredients>
    </mixture>
    <mixture>
      <name>Appbutamone</name>
      <ingredients>Bupropion + L-Tyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Novamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn Sulfite Free</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Phosphoric acid + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>ProSol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinisol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol E</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin N</name>
      <ingredients>Calcium Chloride + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium Sulfate + Potassium Chloride + Potassium hydroxide + Sodium hydroxide</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%-liq IV</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Renamin (amino Acids) Injection</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Inj Without Electrolytes 5.5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 3.5% M</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium + Potassium + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Vamin 18 Electrolyte-free</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 8.5%</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Travasol Amino Acid Inj 5.5%</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 10% W Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5% Injection With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 7%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 7%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn 8.5%</name>
      <ingredients>Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Threonine + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Calcium Chloride + Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Periolimel 2.5% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose Clinimix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Quick Mix 2.5% Travasol Aa With Electrolytes With 25% Dextrose Injec</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Without Electrolytes In 5% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Amino Acid Injection Without Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection Without Electrolytes In 10% Dextrose Quickmix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose Quickmix</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.5%travasol Amino Acid InJ.W.eleC.W.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75%travasol Amino Acid InJ.W.eleC.W.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>2.75% Travas. Amino Acid InJ.W.elecw.25%dex</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25%travasol Amino Acid InJ.W.elecw.5%dex.</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>5% Travasol Amino Acid Injection With Electrolytes In 20% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix 2.5% Travasol Aa Without Electrolytes In 10% Dextrose Injec</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25%trav. Amino Acid InJ.W.O.elect.5%dext.</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>2.5% Travasol Amino Acid Injection With Electrolytes In 10% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrlytes In 10% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection With Electrolytes In 25% Dextrose</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 25% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>4.25% Travasol Amino Acid Injection Without Electrolytes In 20% Dextrose</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 3.3% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix E</name>
      <ingredients>Dipotassium phosphate + Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Sodium acetate + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Clinimix</name>
      <ingredients>Glucose + Glycine + L-Alanine + L-Arginine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Baxter International Inc.</name>
      <url>http://www.baxter.com</url>
    </packager>
    <packager>
      <name>Medisca Inc.</name>
      <url>http://www.medisca.com</url>
    </packager>
    <packager>
      <name>Spectrum Pharmaceuticals</name>
      <url>http://www.spectrumpharm.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Tyrosine powder</description>
      <cost currency="USD">1.16</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>L-tyrosine powder</description>
      <cost currency="USD">0.94</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Aromatic</category>
      <mesh-id>D024322</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Cyclic</category>
      <mesh-id>D000598</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution, concentrate</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1WQ4</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00135.pdf?1265922749</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-2.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-1.4</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>7.67e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-amino-3-(4-hydroxyphenyl)propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>L-tyrosine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>181.1885</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>181.073893223</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>N[C@@H](CC1=CC=C(O)C=C1)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C9H11NO3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C9H11NO3/c10-8(9(12)13)5-6-1-3-7(11)4-2-6/h1-4,8,11H,5,10H2,(H,12,13)/t8-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>OUYCCCASQSFEME-QMMMGPOBSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>83.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>47.1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>18.01</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.19</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>479 mg/L (at 25 °C)</value>
      <source>SEIDELL,A (1941)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>343 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-2.26</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2.57</value>
      <source>ADME Research, USCD</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.2 (at 25 °C)</value>
      <source>LEHNINGER,A (1975)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>897</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>9750</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>58315</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>6057</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507885</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00082</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00022</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>5833</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>18129</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA451822</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>TYR</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000808</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Tyrosine</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL925</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lty_0256.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP00170</smpdb-id>
      <name>Aromatic L-Aminoacid Decarboxylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P07101</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00206</smpdb-id>
      <name>Phenylketonuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00006</smpdb-id>
      <name>Tyrosine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00494</smpdb-id>
      <name>Tyrosinemia, transient, of the newborn</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00012</smpdb-id>
      <name>Catecholamine Biosynthesis</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P07101</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00369</smpdb-id>
      <name>Tyrosinemia Type 2 (or Richner-Hanhart syndrome)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00370</smpdb-id>
      <name>Tyrosinemia Type 3 (TYRO3)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00218</smpdb-id>
      <name>Tyrosinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00429</smpdb-id>
      <name>Disulfiram Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00822</drugbank-id>
          <name>Disulfiram</name>
        </drug>
        <drug>
          <drugbank-id>DB00898</drugbank-id>
          <name>Ethanol</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P30837</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
        <uniprot-id>P00325</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>P04040</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>Q9NUB1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00497</smpdb-id>
      <name>Tyrosine hydroxylase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P07101</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00716</smpdb-id>
      <name>Thyroid hormone synthesis</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00279</drugbank-id>
          <name>Liothyronine</name>
        </drug>
        <drug>
          <drugbank-id>DB00451</drugbank-id>
          <name>Levothyroxine</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01758</drugbank-id>
          <name>3-Iodo-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02688</drugbank-id>
          <name>2,3-Didehydroalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03374</drugbank-id>
          <name>3,5-Diiodotyrosine</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q92911</uniprot-id>
        <uniprot-id>F5H104</uniprot-id>
        <uniprot-id>P01266</uniprot-id>
        <uniprot-id>P07202</uniprot-id>
        <uniprot-id>P04839</uniprot-id>
        <uniprot-id>Q9HBY0</uniprot-id>
        <uniprot-id>P13498</uniprot-id>
        <uniprot-id>Q9NRD9</uniprot-id>
        <uniprot-id>Q9NRD8</uniprot-id>
        <uniprot-id>Q9NPH5</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00008</smpdb-id>
      <name>Phenylalanine and Tyrosine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00169</smpdb-id>
      <name>Alkaptonuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00190</smpdb-id>
      <name>Hawkinsinuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00498</smpdb-id>
      <name>Dopamine beta-hydroxylase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00533</smpdb-id>
      <name>Monoamine oxidase-a deficiency (MAO-A)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00368</drugbank-id>
          <name>Norepinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00668</drugbank-id>
          <name>Epinephrine</name>
        </drug>
        <drug>
          <drugbank-id>DB00988</drugbank-id>
          <name>Dopamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01235</drugbank-id>
          <name>Levodopa</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01702</drugbank-id>
          <name>2-(3,4-Dihydroxyphenyl)Acetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01828</drugbank-id>
          <name>Methylamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02232</drugbank-id>
          <name>1,2-Dihydroxybenzene</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03205</drugbank-id>
          <name>Pyrroloquinoline Quinone</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
        <uniprot-id>P20711</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P09172</uniprot-id>
        <uniprot-id>P40126</uniprot-id>
        <uniprot-id>P11086</uniprot-id>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P07327</uniprot-id>
        <uniprot-id>P46952</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>P14174</uniprot-id>
        <uniprot-id>P19801</uniprot-id>
        <uniprot-id>P21964</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000614</id>
      <name>Tyrosine 3-monooxygenase</name>
      <organism>Human</organism>
      <actions>
        <action>binder</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17604359</pubmed-id>
            <citation>Olsovska J, Novotna J, Flieger M, Spizek J: Assay of tyrosine hydroxylase based on high-performance liquid chromatography separation and quantification of L-dopa and L-tyrosine. Biomed Chromatogr. 2007 Dec;21(12):1252-8.</citation>
          </article>
          <article>
            <pubmed-id>17451064</pubmed-id>
            <citation>Bodnar I, Hechtl D, Szekacs D, Olah M, Nagy GM: Effect of local (intracerebral and intracerebroventricular) administration of tyrosine hydroxylase inhibitor on the neuroendocrine dopaminergic neurons and prolactin release. Ideggyogy Sz. 2007 Mar 30;60(3-4):177-81.</citation>
          </article>
          <article>
            <pubmed-id>17520326</pubmed-id>
            <citation>Rostrup M, Fossbakk A, Hauge A, Kleppe R, Gnaiger E, Haavik J: Oxygen dependence of tyrosine hydroxylase. Amino Acids. 2008 Apr;34(3):455-64. Epub 2007 May 23.</citation>
          </article>
          <article>
            <pubmed-id>17561836</pubmed-id>
            <citation>Richards AB, Scheel TA, Wang K, Henkemeyer M, Kromer LF: EphB1 null mice exhibit neuronal loss in substantia nigra pars reticulata and spontaneous locomotor hyperactivity. Eur J Neurosci. 2007 May;25(9):2619-28.</citation>
          </article>
          <article>
            <pubmed-id>17578016</pubmed-id>
            <citation>Ugriumov MV: [Brain neurons partly expressing monoaminergic phenotype: distribution, development, and functional significance]. Usp Fiziol Nauk. 2007 Apr-Jun;38(2):3-25.</citation>
          </article>
          <article>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07101" source="Swiss-Prot">
    <name>Tyrosine 3-monooxygenase</name>
    <general-function>Tyrosine 3-monooxygenase activity</general-function>
    <specific-function>Plays an important role in the physiology of adrenergic neurons.</specific-function>
    <gene-name>TH</gene-name>
    <locus>11p15.5</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.25</theoretical-pi>
    <molecular-weight>58599.545</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11782</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TH</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y00414</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>37127</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P07101</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>TY3H_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.16.2</synonym>
      <synonym>TH</synonym>
      <synonym>TYH</synonym>
      <synonym>Tyrosine 3-hydroxylase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037053|Tyrosine 3-monooxygenase
MPTPDATTPQAKGFRRAVSELDAKQAEAIMVRGQGAPGPSLTGSPWPGTAAPAASYTPTP
RSPRFIGRRQSLIEDARKEREAAVAAAAAAVPSEPGDPLEAVAFEEKEGKAVLNLLFSPR
ATKPSALSRAVKVFETFEAKIHHLETRPAQRPRAGGPHLEYFVRLEVRRGDLAALLSGVR
QVSEDVRSPAGPKVPWFPRKVSELDKCHHLVTKFDPDLDLDHPGFSDQVYRQRRKLIAEI
AFQYRHGDPIPRVEYTAEEIATWKEVYTTLKGLYATHACGEHLEAFALLERFSGYREDNI
PQLEDVSRFLKERTGFQLRPVAGLLSARDFLASLAFRVFQCTQYIRHASSPMHSPEPDCC
HELLGHVPMLADRTFAQFSQDIGLASLGASDEEIEKLSTLYWFTVEFGLCKQNGEVKAYG
AGLLSSYGELLHCLSEEPEIRAFDPEAAAVQPYQDQTYQSVYFVSESFSDAKDKLRSYAS
RIQRPFSVKFDPYTLAIDVLDSPQAVRRSLEGVQDELDTLAHALSAIG</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016153|Tyrosine 3-monooxygenase (TH)
ATGCCCACCCCCGACGCCACCACGCCACAGGCCAAGGGCTTCCGCAGGGCCGTGTCTGAG
CTGGACGCCAAGCAGGCAGAGGCCATCATGTCCCCGCGGTTCATTGGGCGCAGGCAGAGC
CTCATCGAGGACGCCCGCAAGGAGCGGGAGGCGGCGGTGGCAGCAGCGGCCGCTGCAGTC
CCCTCGGAGCCCGGGGACCCCCTGGAGGCTGTGGCCTTTGAGGAGAAGGAGGGGAAGGCC
GTGCTAAACCTGCTCTTCTCCCCGAGGGCCACCAAGCCCTCGGCGCTGTCCCGAGCTGTG
AAGGTGTTTGAGACGTTTGAAGCCAAAATCCACCATCTAGAGACCCGGCCCGCCCAGAGG
CCGCGAGCTGGGGGCCCCCACCTGGAGTACTTCGTGCGCCTCGAGGTGCGCCGAGGGGAC
CTGGCCGCCCTGCTCAGTGGTGTGCGCCAGGTGTCAGAGGACGTGCGCAGCCCCGCGGGG
CCCAAGGTCCCCTGGTTCCCAAGAAAAGTGTCAGAGCTGGACAAGTGTCATCACCTGGTC
ACCAAGTTCGACCCTGACCTGGACTTGGACCACCCGGGCTTCTCGGACCAGGTGTACCGC
CAGCGCAGGAAGCTGATTGCTGAGATCGCCTTCCAGTACAGGCACGGCGACCCGATTCCC
CGTGTGGAGTACACCGCCGAGGAGATTGCCACCTGGAAGGAGGTCTACACCACGCTGAAG
GGCCTCTACGCCACGCACGCCTGCGGGGAGCACCTGGAGGCCTTTGCTTTGCTGGAGCGC
TTCAGCGGCTACCGGGAAGACAATATCCCCCAGCTGGAGGACGTCTCCCGCTTCCTGAAG
GAGCGCACGGGCTTCCAGCTGCGGCCTGTGGCCGGCCTGCTGTCCGCCCGGGACTTCCTG
GCCAGCCTGGCCTTCCGCGTGTTCCAGTGCACCCAGTATATCCGCCACGCGTCCTCGCCC
ATGCACTCCCCTGAGCCGGACTGCTGCCACGAGCTGCTGGGGCACGTGCCCATGCTGGCC
GACCGCACCTTCGCGCAGTTCTCGCAGGACATTGGCCTGGCGTCCCTGGGGGCCTCGGAT
GAGGAAATTGAGAAGCTGTCCACGCTGTACTGGTTCACGGTGGAGTTCGGGCTGTGTAAG
CAGAACGGGGAGGTGAAGGCCTATGGTGCCGGGCTGCTGTCCTCCTACGGGGAGCTCCTG
CACTGCCTGTCTGAGGAGCCTGAGATTCGGGCCTTCGACCCTGAGGCTGCGGCCGTGCAG
CCCTACCAAGACCAGACGTACCAGTCAGTCTACTTCGTGTCTGAGAGCTTCAGTGACGCC
AAGGACAAGCTCAGGAGCTATGCCTCACGCATCCAGCGCCCCTTCTCCGTGAAGTTCGAC
CCGTACACGCTGGCCATCGACGTGCTGGACAGCCCCCAGGCCGTGCGGCGCTCCCTGGAG
GGTGTCCAGGATGAGCTGGACACCCTTGCCCATGCGCTGAGTGCCATTGGCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00351</identifier>
        <name>Biopterin_H</name>
      </pfam>
      <pfam>
        <identifier>PF12549</identifier>
        <name>TOH_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>melanosome membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>smooth endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dopamine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ferric iron binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxygen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tetrahydrobiopterin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tyrosine 3-monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ferrous iron binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mating behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epinephrine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organ morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dopamine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phytoalexin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of heart contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>norepinephrine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, dopaminergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to pyrethroid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to electrical stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to manganese ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amphetamine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucose stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to corticosterone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic vesicle amine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dopamine biosynthetic process from tyrosine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>social behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pigmentation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycoside metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anatomical structure morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to water deprivation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to isolation stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient levels</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ether</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phthalate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estradiol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>terpene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cerebral cortex development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to growth factor stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to salt stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to peptide hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>circadian sleep/wake cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to light stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>eating behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>eye photoreceptor cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of sound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to immobilization stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>catecholamine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual perception</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to zinc ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sphingolipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryonic camera-type eye morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>isoquinoline alkaloid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to herbicide</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000363</id>
      <name>Tyrosine--tRNA ligase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>15840835</pubmed-id>
            <citation>Zhang Y, Wang L, Schultz PG, Wilson IA: Crystal structures of apo wild-type M. jannaschii tyrosyl-tRNA synthetase (TyrRS) and an engineered TyrRS specific for O-methyl-L-tyrosine. Protein Sci. 2005 May;14(5):1340-9.</citation>
          </article>
          <article>
            <pubmed-id>12097643</pubmed-id>
            <citation>Kiga D, Sakamoto K, Kodama K, Kigawa T, Matsuda T, Yabuki T, Shirouzu M, Harada Y, Nakayama H, Takio K, Hasegawa Y, Endo Y, Hirao I, Yokoyama S: An engineered Escherichia coli tyrosyl-tRNA synthetase for site-specific incorporation of an unnatural amino acid into proteins in eukaryotic translation and its application in a wheat germ cell-free system. Proc Natl Acad Sci U S A. 2002 Jul 23;99(15):9715-20. Epub 2002 Jul 3.</citation>
          </article>
          <article>
            <pubmed-id>12754495</pubmed-id>
            <citation>Kobayashi T, Nureki O, Ishitani R, Yaremchuk A, Tukalo M, Cusack S, Sakamoto K, Yokoyama S: Structural basis for orthogonal tRNA specificities of tyrosyl-tRNA synthetases for genetic code expansion. Nat Struct Biol. 2003 Jun;10(6):425-32.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y2Z4" source="Swiss-Prot">
    <name>Tyrosine--tRNA ligase, mitochondrial</name>
    <general-function>Tyrosine-trna ligase activity</general-function>
    <specific-function>Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).</specific-function>
    <gene-name>YARS2</gene-name>
    <locus>12p11.21</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.34</theoretical-pi>
    <molecular-weight>53198.56</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:24249</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>YARS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF132939</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4680649</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y2Z4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYYM_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.1</synonym>
      <synonym>Tyrosyl-tRNA synthetase</synonym>
      <synonym>TyrRS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010112|Tyrosine--tRNA ligase, mitochondrial
MAAPILRSFSWGRWSGTLNLSVLLPLGLRKAHSGAQGLLAAQKARGLFKDFFPETGTKIE
LPELFDRGTASFPQTIYCGFDPTADSLHVGHLLALLGLFHLQRAGHNVIALVGGATARLG
DPSGRTKEREALETERVRANARALRLGLEALAANHQQLFTDGRSWGSFTVLDNSAWYQKQ
HLVDFLAAVGGHFRMGTLLSRQSVQLRLKSPEGMSLAEFFYQVLQAYDFYYLFQRYGCRV
QLGGSDQLGNIMSGYEFINKLTGEDVFGITVPLITSTTGAKLGKSAGNAVWLNRDKTSPF
ELYQFFVRQPDDSVERYLKLFTFLPLPEIDHIMQLHVKEPERRGPQKRLAAEVTKLVHGR
EGLDSAKRCTQALYHSSIDALEVMSDQELKELFKEAPFSEFFLDPGTSVLDTCRKANAIP
DGPRGYRMITEGGVSINHQQVTNPESVLIVGQHILKNGLSLLKIGKRNFYIIKWLQL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010113|Tyrosine--tRNA ligase, mitochondrial (YARS2)
ATGGCGGCGCCCATCTTGCGGTCCTTTTCCTGGGGCCGGTGGTCTGGTACCCTAAATCTC
TCAGTATTGTTGCCCTTGGGGCTGCGTAAGGCCCACTCGGGCGCTCAGGGGTTACTGGCA
GCGCAGAAGGCTCGAGGTCTGTTCAAGGACTTCTTCCCGGAGACGGGGACGAAAATAGAG
CTCCCAGAGCTCTTCGACCGTGGCACGGCGAGTTTTCCCCAAACCATTTACTGTGGCTTC
GACCCCACGGCAGACTCGCTTCATGTGGGTCATCTACTTGCGCTGCTGGGCCTGTTTCAT
TTGCAGCGAGCGGGCCACAACGTGATCGCGCTGGTGGGAGGCGCCACGGCGCGCCTGGGA
GACCCGAGCGGCCGTACCAAGGAACGCGAGGCGCTGGAGACAGAGCGCGTGCGAGCCAAC
GCGCGAGCTCTGCGCCTAGGGCTTGAGGCCCTGGCGGCTAATCACCAGCAGCTTTTCACT
GATGGGCGCTCCTGGGGCAGCTTCACTGTGCTGGACAACTCGGCCTGGTACCAGAAGCAG
CACCTGGTGGACTTCCTGGCGGCAGTGGGGGGTCACTTCCGCATGGGGACGCTGCTGAGC
CGGCAGAGCGTGCAGCTGCGGCTCAAGAGCCCCGAGGGCATGAGCTTGGCCGAGTTCTTT
TACCAGGTGCTCCAGGCCTATGACTTCTATTACCTCTTCCAGCGTTATGGATGCAGGGTC
CAGCTGGGCGGATCTGATCAACTAGGCAACATCATGTCCGGATATGAGTTCATCAACAAG
TTGACTGGAGAAGATGTATTTGGAATCACCGTTCCTCTAATTACAAGTACAACTGGAGCA
AAGCTGGGAAAGTCTGCTGGCAACGCTGTTTGGCTAAACAGAGATAAGACATCTCCATTT
GAATTGTATCAATTCTTTGTCAGGCAACCGGACGATTCAGTGGAAAGGTACCTGAAGCTG
TTCACTTTCCTGCCCCTTCCAGAGATTGATCATATCATGCAGCTGCATGTCAAAGAGCCA
GAAAGGCGGGGTCCTCAGAAACGACTGGCAGCAGAAGTAACAAAGCTTGTTCATGGACGA
GAAGGATTGGATTCTGCTAAAAGGTGTACACAAGCCCTTTATCACAGTAGCATAGATGCA
CTGGAGGTCATGTCTGATCAGGAGTTAAAAGAGTTGTTTAAAGAAGCTCCATTTTCTGAA
TTTTTTCTCGATCCTGGAACAAGTGTCCTAGATACTTGCCGCAAAGCAAATGCCATTCCA
GATGGTCCCCGAGGGTATCGAATGATAACAGAAGGCGGAGTCAGCATAAATCACCAACAA
GTAACAAATCCTGAGAGTGTTTTAATTGTTGGACAACATATTCTCAAGAATGGACTTTCC
TTACTTAAAATAGGAAAAAGAAATTTCTACATTATAAAATGGCTTCAGTTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00579</identifier>
        <name>tRNA-synt_1b</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tyrosine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tyrosine-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tRNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrial tyrosyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000230</id>
      <name>Tyrosine--tRNA ligase, cytoplasmic</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17401211</pubmed-id>
            <citation>Bonnefond L, Frugier M, Touze E, Lorber B, Florentz C, Giege R, Rudinger-Thirion J, Sauter C: Tyrosyl-tRNA synthetase: the first crystallization of a human mitochondrial aminoacyl-tRNA synthetase. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Apr 1;63(Pt 4):338-41. Epub 2007 Mar 30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P54577" source="Swiss-Prot">
    <name>Tyrosine--tRNA ligase, cytoplasmic</name>
    <general-function>Tyrosine-trna ligase activity</general-function>
    <specific-function>Catalyzes the attachment of tyrosine to tRNA(Tyr) in a two-step reaction: tyrosine is first activated by ATP to form Tyr-AMP and then transferred to the acceptor end of tRNA(Tyr).</specific-function>
    <gene-name>YARS</gene-name>
    <locus>1p35.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.05</theoretical-pi>
    <molecular-weight>59143.025</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:12840</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>YARS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U40714</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1184699</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P54577</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYYC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.1</synonym>
      <synonym>Tyrosyl-tRNA synthetase</synonym>
      <synonym>TyrRS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036975|Tyrosine--tRNA ligase, cytoplasmic
MGDAPSPEEKLHLITRNLQEVLGEEKLKEILKERELKIYWGTATTGKPHVAYFVPMSKIA
DFLKAGCEVTILFADLHAYLDNMKAPWELLELRVSYYENVIKAMLESIGVPLEKLKFIKG
TDYQLSKEYTLDVYRLSSVVTQHDSKKAGAEVVKQVEHPLLSGLLYPGLQALDEEYLKVD
AQFGGIDQRKIFTFAEKYLPALGYSKRVHLMNPMVPGLTGSKMSSSEEESKIDLLDRKED
VKKKLKKAFCEPGNVENNGVLSFIKHVLFPLKSEFVILRDEKWGGNKTYTAYVDLEKDFA
AEVVHPGDLKNSVEVALNKLLDPIREKFNTPALKKLASAAYPDPSKQKPMAKGPAKNSEP
EEVIPSRLDIRVGKIITVEKHPDADSLYVEKIDVGEAEPRTVVSGLVQFVPKEELQDRLV
VVLCNLKPQKMRGVESQGMLLCASIEGINRQVEPLDPPAGSAPGEHVFVKGYEKGQPDEE
LKPKKKVFEKLQADFKISEECIAQWKQTNFMTKLGSISCKSLKGGNIS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010211|Tyrosine--tRNA ligase, cytoplasmic (YARS)
ATGGGGGACGCTCCCAGCCCTGAAGAGAAACTGCACCTTATCACCCGGAACCTGCAGGAG
GTTCTGGGGGAAGAGAAGCTGAAGGAGATACTGAAGGAGCGGGAACTTAAAATTTACTGG
GGAACGGCAACCACGGGCAAACCACATGTGGCTTACTTTGTGCCCATGTCAAAGATTGCA
GACTTCTTAAAGGCAGGGTGTGAGGTAACAATTCTGTTTGCGGACCTCCACGCATACCTG
GATAACATGAAAGCCCCATGGGAACTTCTAGAACTCCGAGTCAGTTACTATGAGAATGTG
ATCAAAGCAATGCTGGAGAGCATTGGTGTGCCCTTGGAGAAGCTCAAGTTCATCAAAGGC
ACTGATTACCAGCTCAGCAAAGAGTACACACTAGATGTGTACAGACTCTCCTCCGTGGTC
ACACAGCACGATTCCAAGAAGGCTGGAGCTGAGGTGGTAAAGCAGGTGGAGCACCCTTTG
CTGAGTGGCCTCTTATACCCCGGACTGCAGGCTTTGGATGAAGAGTATTTAAAAGTAGAT
GCCCAATTTGGAGGCATTGATCAGAGAAAGATTTTCACCTTTGCAGAGAAGTACCTCCCT
GCACTTGGCTATTCAAAACGGGTCCATCTGATGAATCCTATGGTTCCAGGATTAACAGGC
AGCAAAATGAGCTCTTCAGAAGAGGAGTCCAAGATTGATCTCCTTGATCGGAAGGAGGAT
GTGAAGAAAAAACTGAAGAAGGCCTTCTGTGAGCCAGGAAATGTGGAGAACAATGGGGTT
CTGTCCTTCATCAAGCATGTCCTTTTTCCCCTTAAGTCCGAGTTTGTGATCCTACGAGAT
GAGAAATGGGGTGGAAACAAAACCTACACAGCTTACGTGGACCTGGAAAAGGACTTTGCT
GCTGAGGTTGTACATCCTGGAGACCTGAAGAATTCTGTTGAAGTCGCACTGAACAAGTTG
CTGGATCCAATCCGGGAAAAGTTTAATACCCCTGCCCTGAAAAAACTGGCCAGCGCTGCC
TACCCAGATCCCTCAAAGCAGAAGCCAATGGCCAAAGGCCCTGCCAAGAATTCAGAACCA
GAGGAGGTCATCCCATCCCGGCTGGATATCCGTGTGGGGAAAATCATCACTGTGGAGAAG
CACCCAGATGCAGACAGCCTGTATGTAGAGAAGATTGACGTGGGGGAAGCTGAACCACGG
ACTGTGGTGAGCGGCCTGGTACAGTTCGTGCCCAAGGAGGAACTGCAGGACAGGCTGGTA
GTGGTGCTGTGCAACCTGAAACCCCAGAAGATGAGAGGAGTCGAGTCCCAAGGCATGCTT
CTGTGTGCTTCTATAGAAGGGATAAACCGCCAGGTTGAACCTCTGGACCCTCCGGCAGGC
TCTGCTCCTGGTGAGCACGTGTTTGTGAAGGGCTATGAAAAGGGCCAACCAGATGAGGAG
CTCAAGCCCAAGAAGAAAGTCTTCGAGAAGTTGCAGGCTGACTTCAAAATTTCTGAGGAG
TGCATCGCACAGTGGAAGCAAACCAACTTCATGACCAAGCTGGGCTCCATTTCCTGTAAA
TCGCTGAAAGGGGGGAACATTAGCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00579</identifier>
        <name>tRNA-synt_1b</name>
      </pfam>
      <pfam>
        <identifier>PF01588</identifier>
        <name>tRNA_bind</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>interleukin-8 receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tyrosine-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tRNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>signal transducer activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tyrosyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000692</id>
      <name>Tyrosine aminotransferase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17389761</pubmed-id>
            <citation>Dong S, Kang S, Gu TL, Kardar S, Fu H, Lonial S, Khoury HJ, Khuri F, Chen J: 14-3-3 Integrates prosurvival signals mediated by the AKT and MAPK pathways in ZNF198-FGFR1-transformed hematopoietic cells. Blood. 2007 Jul 1;110(1):360-9. Epub 2007 Mar 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P17735" source="Swiss-Prot">
    <name>Tyrosine aminotransferase</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine.</specific-function>
    <gene-name>TAT</gene-name>
    <locus>16q22.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.24</theoretical-pi>
    <molecular-weight>50398.895</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11573</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TAT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X52520</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>36713</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P17735</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ATTY_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.5</synonym>
      <synonym>L-tyrosine:2-oxoglutarate aminotransferase</synonym>
      <synonym>TAT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010483|Tyrosine aminotransferase
MDPYMIQMSSKGNLPSILDVHVNVGGRSSVPGKMKGRKARWSVRPSDMAKKTFNPIRAIV
DNMKVKPNPNKTMISLSIGDPTVFGNLPTDPEVTQAMKDALDSGKYNGYAPSIGFLSSRE
EIASYYHCPEAPLEAKDVILTSGCSQAIDLCLAVLANPGQNILVPRPGFSLYKTLAESMG
IEVKLYNLLPEKSWEIDLKQLEYLIDEKTACLIVNNPSNPCGSVFSKRHLQKILAVAARQ
CVPILADEIYGDMVFSDCKYEPLATLSTDVPILSCGGLAKRWLVPGWRLGWILIHDRRDI
FGNEIRDGLVKLSQRILGPCTIVQGALKSILCRTPGEFYHNTLSFLKSNADLCYGALAAI
PGLRPVRPSGAMYLMVGIEMEHFPEFENDVEFTERLVAEQSVHCLPATCFEYPNFIRVVI
TVPEVMMLEACSRIQEFCEQHYHCAEGSQEECDK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010484|Tyrosine aminotransferase (TAT)
ATGGACCCATACATGATTCAGATGAGCAGCAAAGGCAACCTCCCCTCAATTCTGGACGTG
CATGTCAACGTTGGTGGGAGAAGCTCTGTGCCGGGAAAAATGAAAGGCAGAAAGGCCAGG
TGGTCTGTGAGGCCCTCAGACATGGCCAAGAAAACTTTCAACCCCATCCGAGCCATTGTG
GACAACATGAAGGTGAAACCAAATCCAAACAAAACCATGATTTCCCTGTCCATTGGGGAC
CCTACTGTGTTTGGAAACCTGCCTACAGACCCTGAAGTTACCCAGGCAATGAAAGATGCC
CTGGACTCGGGCAAATATAATGGCTATGCCCCATCCATCGGCTTCCTATCCAGTCGGGAG
GAGATTGCTTCTTATTACCACTGTCCTGAGGCACCCCTAGAAGCTAAGGACGTCATTCTG
ACAAGTGGCTGCAGCCAAGCTATTGACCTTTGTTTAGCTGTGTTGGCCAACCCAGGGCAA
AACATCCTGGTTCCAAGACCTGGTTTCTCTCTCTACAAGACTCTGGCTGAGTCTATGGGA
ATTGAGGTCAAACTCTACAATTTGTTGCCAGAGAAATCTTGGGAAATTGACCTGAAACAA
CTGGAATATCTAATTGATGAAAAGACAGCTTGTCTCATTGTCAATAATCCATCAAACCCC
TGTGGGTCAGTGTTCAGCAAACGTCATCTTCAGAAGATTCTGGCAGTGGCTGCACGGCAG
TGTGTCCCCATCTTAGCTGATGAGATCTATGGAGACATGGTGTTTTCGGATTGCAAATAT
GAACCACTGGCCACCCTCAGCACCGATGTCCCCATCCTGTCCTGTGGAGGGCTGGCCAAG
CGCTGGCTGGTTCCTGGCTGGAGGTTGGGCTGGATCCTCATTCATGACCGAAGAGACATT
TTTGGCAATGAGATCCGAGATGGGCTGGTGAAGCTGAGTCAGCGCATTTTGGGACCCTGT
ACCATTGTCCAGGGAGCTCTGAAAAGCATCCTATGTCGCACCCCGGGAGAGTTTTACCAC
AACACTCTGAGCTTCCTCAAGTCCAATGCTGATCTCTGTTATGGGGCGTTGGCTGCCATC
CCTGGACTCCGGCCAGTCCGCCCTTCTGGGGCTATGTACCTCATGGTTGGAATTGAGATG
GAACATTTCCCAGAATTTGAGAACGATGTGGAGTTCACGGAGCGGTTAGTTGCTGAGCAG
TCTGTCCACTGCCTCCCAGCAACGTGCTTTGAGTACCCGAATTTCATCCGAGTGGTCATC
ACAGTCCCCGAGGTGATGATGCTGGAGGCGTGCAGCCGGATCCAGGAGTTCTGTGAGCAG
CACTACCATTGTGCTGAAGGCAGCCAGGAGGAGTGTGATAAATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
      <pfam>
        <identifier>PF07706</identifier>
        <name>TAT_ubiq</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-phenylalanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-tyrosine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-phenylalanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tyrosine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucocorticoid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to mercury ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0000178</id>
      <name>Monocarboxylate transporter 8</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>12871948</pubmed-id>
            <citation>Friesema EC, Ganguly S, Abdalla A, Manning Fox JE, Halestrap AP, Visser TJ: Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter. J Biol Chem. 2003 Oct 10;278(41):40128-35. Epub 2003 Jul 18.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P36021" source="Swiss-Prot">
    <name>Monocarboxylate transporter 8</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Very active and specific thyroid hormone transporter. Stimulates cellular uptake of thyroxine (T4), triiodothyronine (T3), reverse triiodothyronine (rT3) and diidothyronine. Does not transport Leu, Phe, Trp or Tyr.</specific-function>
    <gene-name>SLC16A2</gene-name>
    <locus>Xq13.2</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>97-117
144-164
172-192
201-221
230-250
259-279
323-343
357-377
387-407
410-430
448-468
478-498</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.32</theoretical-pi>
    <molecular-weight>59510.86</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10923</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC16A2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U05321</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>458255</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P36021</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT8_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>MCT 7</synonym>
      <synonym>MCT 8</synonym>
      <synonym>MCT8</synonym>
      <synonym>Monocarboxylate transporter 7</synonym>
      <synonym>Solute carrier family 16 member 2</synonym>
      <synonym>X-linked PEST-containing transporter</synonym>
      <synonym>XPCT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000355|Monocarboxylate transporter 8
MALQSQASEEAKGPWQEADQEQQEPVGSPEPESEPEPEPEPEPVPVPPPEPQPEPQPLPD
PAPLPELEFESERVHEPEPTPTVETRGTARGFQPPEGGFGWVVVFAATWCNGSIFGIHNS
VGILYSMLLEEEKEKNRQVEFQAAWVGALAMGMIFFCSPIVSIFTDRLGCRITATAGAAV
AFIGLHTSSFTSSLSLRYFTYGILFGCGCSFAFQPSLVILGHYFQRRLGLANGVVSAGSS
IFSMSFPFLIRMLGDKIKLAQTFQVLSTFMFVLMLLSLTYRPLLPSSQDTPSKRGVRTLH
QRFLAQLRKYFNMRVFRQRTYRIWAFGIAAAALGYFVPYVHLMKYVEEEFSEIKETWVLL
VCIGATSGLGRLVSGHISDSIPGLKKIYLQVLSFLLLGLMSMMIPLCRDFGGLIVVCLFL
GLCDGFFITIMAPIAFELVGPMQASQAIGYLLGMMALPMIAGPPIAGLLRNCFGDYHVAF
YFAGVPPIIGAVILFFVPLMHQRMFKKEQRDSSKDKMLAPDPDPNGELLPGSPNPEEPI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0009986|Monocarboxylate transporter 8 (SLC16A2)
ATGGCGCTGCAAAGCCAGGCGAGCGAGGAAGCAAAGGGGCCCTGGCAGGAGGCAGACCAG
GAACAGCAGGAGCCGGTGGGTAGCCCAGAGCCGGAGTCTGAGCCGGAGCCTGAGCCCGAG
CCCGAGCCCGTGCCAGTGCCCCCGCCCGAGCCCCAGCCGGAGCCCCAGCCCCTACCGGAC
CCCGCACCCCTGCCGGAGCTGGAGTTCGAGTCCGAGCGGGTGCACGAACCCGAGCCCACG
CCTACGGTAGAGACCCGCGGCACCGCGCGCGGCTTCCAGCCTCCCGAAGGTGGCTTCGGC
TGGGTGGTGGTGTTCGCTGCCACCTGGTGCAACGGCTCCATCTTCGGCATCCATAACTCT
GTCGGGATCCTCTACTCCATGCTGCTAGAGGAGGAAAAGGAAAAAAATCGCCAAGTGGAG
TTCCAAGCAGCATGGGTCGGAGCCCTCGCGATGGGTATGATCTTCTTCTGTTCTCCCATT
GTGAGTATATTCACTGACCGTTTGGGCTGCCGAATCACAGCAACCGCGGGGGCTGCCGTT
GCTTTCATTGGCCTCCATACCAGCTCCTTCACCAGCTCCCTAAGCCTGCGCTACTTCACC
TACGGGATTCTCTTTGGTTGTGGCTGTTCCTTCGCCTTTCAGCCATCCCTCGTCATCCTG
GGCCACTACTTTCAACGCCGCCTGGGTCTGGCCAATGGTGTGGTGTCTGCTGGGAGTAGC
ATTTTCTCCATGTCCTTCCCCTTCCTCATCAGAATGCTGGGGGATAAGATCAAGCTGGCC
CAAACCTTCCAGGTGCTGAGTACCTTCATGTTTGTTCTTATGCTGCTTTCACTCACCTAC
CGGCCCCTCCTGCCCAGCTCCCAGGACACCCCAAGCAAGAGAGGTGTCCGCACCCTGCAC
CAGCGCTTTCTGGCTCAGCTCAGGAAGTACTTCAACATGCGAGTGTTCCGCCAACGCACT
TACCGCATCTGGGCCTTCGGAATTGCTGCTGCTGCCCTTGGCTACTTTGTTCCCTATGTA
CACCTGATGAAGTATGTGGAGGAGGAGTTCTCAGAAATCAAGGAGACCTGGGTGCTCTTG
GTGTGTATTGGGGCTACCTCAGGCCTTGGGCGTCTTGTGTCAGGCCACATCAGTGACTCC
ATCCCTGGACTTAAGAAGATCTACTTGCAGGTCCTTTCCTTCCTGCTCCTGGGCCTGATG
TCCATGATGATTCCCCTGTGCCGGGACTTCGGGGGCCTTATCGTCGTCTGTCTTTTCCTG
GGCCTTTGCGATGGCTTCTTCATCACCATCATGGCCCCCATTGCATTTGAGCTGGTGGGC
CCAATGCAGGCCTCACAGGCCATTGGCTACCTCCTGGGCATGATGGCCCTGCCAATGATT
GCTGGGCCCCCCATTGCAGGCCTACTCCGCAACTGTTTTGGGGACTACCATGTGGCCTTC
TACTTTGCCGGTGTGCCCCCCATCATCGGGGCTGTAATCCTCTTCTTCGTCCCTCTGATG
CATCAAAGGATGTTCAAGAAAGAGCAGAGAGATTCCAGCAAGGATAAGATGTTGGCCCCT
GACCCAGACCCCAATGGGGAGCTACTGCCGGGCTCCCCCAACCCTGAGGAACCAATCTAA
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>symporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>monocarboxylic acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>thyroid hormone transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>monocarboxylic acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="2">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11827462</pubmed-id>
            <citation>Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H: The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics. 2002 Jan;79(1):95-103.</citation>
          </article>
          <article>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
    <name>Monocarboxylate transporter 10</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
    <gene-name>SLC16A10</gene-name>
    <locus>6q21-q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>55492.07</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB057445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18640047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TF71</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aromatic amino acid transporter 1</synonym>
      <synonym>MCT 10</synonym>
      <synonym>MCT10</synonym>
      <synonym>Solute carrier family 16 member 10</synonym>
      <synonym>T-type amino acid transporter 1</synonym>
      <synonym>TAT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aromatic amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00136</drugbank-id>
  <drugbank-id>NUTR00003</drugbank-id>
  <drugbank-id>APRD00246</drugbank-id>
  <drugbank-id>DB05314</drugbank-id>
  <name>Calcitriol</name>
  <description>Calcitriol or 1,25-dihydroxycholecalciferol (abbreviated 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3) is the active form of vitamin D found in the body (vitamin D3). Calcitriol is marketed under various trade names including Rocaltrol (Roche), Calcijex (Abbott) and Decostriol (Mibe, Jesalis). It is produced in the kidneys via 25-hydroxyvitamin D-1 &amp;alpha;-hydroxylase by conversion from 25-hydroxycholecalciferol (calcidiol). This is stimulated by a decrease in serum calcium, phosphate (PO&lt;sub&gt;4&lt;/sub&gt;&lt;sup&gt;3−&lt;/sup&gt;) and parathyroid hormone (PTH) levels. It regulates calcium levels by increasing the absorption of calcium and phosphate from the gastrointestinal tract, increasing calcium and phosphate reabsorption in the kidneys and inhibiting the release of PTH. Calcitriol is also commonly used as a medication in the treatment of hypocalcemia and osteoporosis.</description>
  <cas-number>32222-06-3</cas-number>
  <unii>FXC9231JVH</unii>
  <average-mass>416.6365</average-mass>
  <monoisotopic-mass>416.329045274</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>17396166</pubmed-id>
        <citation>Brawer MK: Recent Progress in the Treatment of Advanced Prostate Cancer With Intermittent Dose-Intense Calcitriol (DN-101). Rev Urol. 2007 Winter;9(1):1-8.</citation>
      </article>
      <article>
        <pubmed-id>16278401</pubmed-id>
        <citation>Beer TM, Javle M, Lam GN, Henner WD, Wong A, Trump DL: Pharmacokinetics and tolerability of a single dose of DN-101, a new formulation of calcitriol, in patients with cancer. Clin Cancer Res. 2005 Nov 1;11(21):7794-9.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Raymond E. Conrow, "Process for preparation of calcitriol lactone and related intermediates." U.S. Patent US5457245, issued April, 1994.</synthesis-reference>
  <indication>Used to treat vitamin D deficiency or insufficiency, refractory rickets (vitamin D resistant rickets), familial hypophosphatemia and hypoparathyroidism, and in the management of hypocalcemia and renal osteodystrophy in patients with chronic renal failure undergoing dialysis. Also used in conjunction with calcium in the management and prevention of primary or corticosteroid-induced osteoporosis.</indication>
  <pharmacodynamics>Calcitriol, a pharmaceutical form of vitamin D, has anti-osteoporotic, immunomodulatory, anticarcinogenic, antipsoriatic, antioxidant, and mood-modulatory activities. Calcitriol has been found to be effective in the treatment of psoriasis when applied topically. Calcitriol has been found to induce differentiation and/or inhibit cell proliferation in a number of malignant cell lines including human prostate cancer cells. Vitamin D deficiency has long been suspected to increase the susceptibility to tuberculosis. The active form of calcitriol, 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3, has been found to enhance the ability of mononuclear phagocytes to suppress the intracellular growth of &lt;i&gt;Mycobacterium tuberculosis&lt;/i&gt;. 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3 has demonstrated beneficial effects in animal models of such autoimmune diseases as rheumatoid arthritis. It has also been found to induce monocyte differentiation and to inhibit lymphocyte proliferation and production of cytokines, including interleukin IL-1 and IL-2, as well as to suppress immunoglobulin secretion by B lymphocytes. Vitamin D appears to demonstrate both immune-enhancing and immunosuppressive effects.</pharmacodynamics>
  <mechanism-of-action>The mechanism of action of calcitriol in the treatment of psoriasis is accounted for by their antiproliferative activity for keratinocytes and their stimulation of epidermal cell differentiation. The anticarcinogenic activity of the active form of Calcitriol appears to be correlated with cellular vitamin D receptor (VDR) levels. Vitamin D receptors belong to the superfamily of steroid-hormone zinc-finger receptors. VDRs selectively bind 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3 and retinoic acid X receptor (RXR) to form a heterodimeric complex that interacts with specific DNA sequences known as vitamin D-responsive elements. VDRs are ligand-activated transcription factors. The receptors activate or repress the transcription of target genes upon binding their respective ligands. It is thought that the anticarcinogenic effect of Calcitriol is mediated via VDRs in cancer cells. The immunomodulatory activity of calcitriol is thought to be mediated by vitamin D receptors (VDRs) which are expressed constitutively in monocytes but induced upon activation of T and B lymphocytes. 1,25-(OH)&lt;sub&gt;2&lt;/sub&gt;-D3 has also been found to enhance the activity of some vitamin D-receptor positive immune cells and to enhance the sensitivity of certain target cells to various cytokines secreted by immune cells.</mechanism-of-action>
  <toxicity>LD&lt;sub&gt;50&lt;/sub&gt; (oral, rat) = 620 &amp;mu;g/kg; LD&lt;sub&gt;50&lt;/sub&gt; (intraperitoneal, rat) &gt; 5 mg/kg; Overdose evident in elevated blood calcium levels causing symptoms of anorexia, nausea and vomiting, polyuria, polydipsia, weakness, pruritus, and nervousness, potentially with irreversible calcification of soft tissue in the kidney and liver.</toxicity>
  <metabolism>The first pathway involves 24-hydroxylase activity in the kidney; this enzyme is also present in many target tissues which possess the vitamin D receptor such as the intestine. The end product of this pathway is a side chain shortened metabolite, calcitroic acid. The second pathway involves the conversion of calcitriol via the stepwise hydroxylation of carbon-26 and carbon-23, and cyclization to yield ultimately 1a,25R(OH)&lt;sub&gt;2&lt;/sub&gt;-26,23S-lactone D3. The lactone appears to be the major metabolite circulating in humans.</metabolism>
  <absorption>Rapidly absorbed from the intestine.</absorption>
  <half-life>5-8 hours</half-life>
  <protein-binding>99.9%</protein-binding>
  <route-of-elimination>Enterohepatic recycling and biliary excretion of calcitriol occur. The metabolites of calcitriol are excreted primarily in feces. Cumulative excretion of radioactivity on the sixth day following intravenous administration of radiolabeled calcitriol averaged 16% in urine and 49% in feces.</route-of-elimination>
  <volume-of-distribution/>
  <clearance>* 15.3 mL/hr/kg [pediatric patients (age range: 1.8 to 16 years) undergoing peritoneal dialysis receiving dose of 10.2 ng/kg (SD 5.5 ng/kg) for 2 months]</clearance>
  <classification>
    <description>This compound belongs to the class of organic compounds known as vitamin d and derivatives. These are compounds containing a secosteroid backbone, usually secoergostane or secocholestane.</description>
    <direct-parent>Vitamin D and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Lipids and lipid-like molecules</superclass>
    <class>Steroids and steroid derivatives</class>
    <subclass>Vitamin D and derivatives</subclass>
    <alternative-parent>Cyclic alcohols and derivatives</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Tertiary alcohols</alternative-parent>
    <alternative-parent>Triterpenoids</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic homopolycyclic compound</substituent>
    <substituent>Cyclic alcohol</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Tertiary alcohol</substituent>
    <substituent>Triterpenoid</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">(1S,3R,5Z,7E)-9,10-secocholesta-5,7,10-triene-1,3,25-triol</synonym>
    <synonym language="" coder="">(1α,3β,5Z,7E)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol</synonym>
    <synonym language="" coder="">(5Z,7E)-(1S,3R)-9,10-secocholesta-5,7,10(19)-triene-1,3,25-triol</synonym>
    <synonym language="" coder="">1-alpha-25-Dihydroxyvitamin D3</synonym>
    <synonym language="" coder="">1,25-DHCC</synonym>
    <synonym language="" coder="">1,25-dihydroxycholecalciferol</synonym>
    <synonym language="" coder="">1α,25-dihydroxycholecalciferol</synonym>
    <synonym language="" coder="">1α,25-dihydroxyvitamin D3</synonym>
    <synonym language="" coder="">1α,25(OH)2D3</synonym>
    <synonym language="English/Spanish/French" coder="">Calcitriol</synonym>
    <synonym language="Latin" coder="">Calcitriolum</synonym>
  </synonyms>
  <products>
    <product>
      <name>Calcijex</name>
      <labeller>Abbvie</labeller>
      <ndc-id/>
      <ndc-product-code>0074-8110</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-06-01</started-marketing-on>
      <ended-marketing-on>2017-05-20</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>NDA018874</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcijex</name>
      <labeller>Abbvie</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00891738</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2017-01-13</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>1 mcg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcijex</name>
      <labeller>Abbvie</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00891746</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2017-01-13</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>2 mcg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code>63323-731</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-05-29</started-marketing-on>
      <ended-marketing-on>2017-09-26</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA075836</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>West Ward Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>0054-0007</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA076917</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>bryant ranch prepack</labeller>
      <ndc-id/>
      <ndc-product-code>63629-7311</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091356</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>American Regent</labeller>
      <ndc-id/>
      <ndc-product-code>0517-0132</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-03-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA075746</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code>0093-0657</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-10-15</started-marketing-on>
      <ended-marketing-on>2017-07-31</ended-marketing-on>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code>0093-0658</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-10-15</started-marketing-on>
      <ended-marketing-on>2017-10-31</ended-marketing-on>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-6265</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength>1 mg/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA075746</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>West Ward Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>0143-9728</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-02-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA077102</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-4847</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-08-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Aphena Pharma Solutions Tennessee, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>43353-034</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA076917</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Ranbaxy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63304-239</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Ranbaxy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63304-240</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Ranbaxy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>63304-241</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA021068</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-8251</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Amneal Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>65162-519</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA203289</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Amneal Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>65162-576</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-06-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA203289</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Carilion Materials Management</labeller>
      <ndc-id/>
      <ndc-product-code>68151-0088</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-8281</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Atlantic Biologicals Corps.</labeller>
      <ndc-id/>
      <ndc-product-code>17856-0723</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091356</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Strides Shasun Limited</labeller>
      <ndc-id/>
      <ndc-product-code>64380-723</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091356</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Strides Shasun Limited</labeller>
      <ndc-id/>
      <ndc-product-code>64380-724</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091356</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Aphena Pharma Solutions Tennessee, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>43353-138</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>West Ward Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>0054-3120</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-07-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Oral</route>
      <fda-application-number>ANDA076242</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-4582</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Physicians Total Care, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>54868-4584</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-12-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Heritage</labeller>
      <ndc-id/>
      <ndc-product-code>23155-118</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Heritage</labeller>
      <ndc-id/>
      <ndc-product-code>23155-119</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Dispensing Solutions, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>66336-851</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Kaiser Foundations Hospitals</labeller>
      <ndc-id/>
      <ndc-product-code>0179-0196</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-12-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Kaiser Foundations Hospitals</labeller>
      <ndc-id/>
      <ndc-product-code>0179-0197</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-12-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code>0093-7352</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-08-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Teva</labeller>
      <ndc-id/>
      <ndc-product-code>0093-7353</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Avera Mc Kennan Hospital</labeller>
      <ndc-id/>
      <ndc-product-code>69189-7354</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-10-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA075765</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Perrigo New York Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>45802-608</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Ointment</dosage-form>
      <strength>3 ug/g</strength>
      <route>Topical</route>
      <fda-application-number>NDA022087</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Golden State Medical Supply</labeller>
      <ndc-id/>
      <ndc-product-code>60429-133</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Golden State Medical Supply</labeller>
      <ndc-id/>
      <ndc-product-code>60429-134</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Amerincan Health Packaging</labeller>
      <ndc-id/>
      <ndc-product-code>68084-475</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-01</started-marketing-on>
      <ended-marketing-on>2016-11-30</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA076917</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Akorn</labeller>
      <ndc-id/>
      <ndc-product-code>17478-831</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-03-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA078066</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Aphena Pharma Solutions Tennessee, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>43353-998</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-05-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>ANDA091174</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Akorn</labeller>
      <ndc-id/>
      <ndc-product-code>17478-931</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA078066</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol</name>
      <labeller>Akorn</labeller>
      <ndc-id/>
      <ndc-product-code>17478-932</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength>2 ug/mL</strength>
      <route>Intravenous</route>
      <fda-application-number>ANDA078066</fda-application-number>
      <generic>true</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Calcitriol Injection</name>
      <labeller>Fresenius Kabi</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245686</dpd-id>
      <started-marketing-on>2003-07-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1 mcg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcitriol Injection USP</name>
      <labeller>Sterimax Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02399334</dpd-id>
      <started-marketing-on>2015-03-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1 mcg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcitriol Injection USP</name>
      <labeller>Sterimax Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02399342</dpd-id>
      <started-marketing-on>2015-04-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>2 mcg</strength>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcitriol-odan</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02431645</dpd-id>
      <started-marketing-on>2014-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>0.5 mcg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Calcitriol-odan</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02431637</dpd-id>
      <started-marketing-on>2014-10-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>0.25 mcg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Validus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>30698-143</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Validus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>30698-144</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Validus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>30698-911</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-07-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>1 ug/mL</strength>
      <route>Oral</route>
      <fda-application-number>NDA021068</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Kaiser Foundations Hospitals</labeller>
      <ndc-id/>
      <ndc-product-code>0179-0063</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-06-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>.5 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Kaiser Foundations Hospitals</labeller>
      <ndc-id/>
      <ndc-product-code>0179-0069</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-08-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol</name>
      <labeller>Aphena Pharma Solutions Tennessee, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>43353-633</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-08-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength>.25 ug/1</strength>
      <route>Oral</route>
      <fda-application-number>NDA018044</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Rocaltrol Cap 0.25mcg</name>
      <labeller>Hoffmann La Roche</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00481823</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>0.25 mcg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rocaltrol Cap 0.5mcg</name>
      <labeller>Hoffmann La Roche</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00481815</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>0.5 mcg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rocaltrol Oral Solution 1mcg/ml</name>
      <labeller>Hoffmann La Roche</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00824291</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2013-06-24</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength>1 mcg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Silkis</name>
      <labeller>Galderma</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02338572</dpd-id>
      <started-marketing-on>2010-04-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Ointment</dosage-form>
      <strength>3 mcg</strength>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vectical</name>
      <labeller>Galderma</labeller>
      <ndc-id/>
      <ndc-product-code>0299-2012</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Ointment</dosage-form>
      <strength>3 ug/g</strength>
      <route>Topical</route>
      <fda-application-number>NDA022087</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Asentar</name>
      <company/>
    </international-brand>
    <international-brand>
      <name>Calcitriol Oral Solution</name>
      <company>Roxane</company>
    </international-brand>
    <international-brand>
      <name>Decostriol</name>
      <company>Mibe Jena (Germany), Jesalis (Hong Kong, Thailand)</company>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Calcijex</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Vectical</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol Cap 0.5mcg</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol Cap 0.25mcg</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Silkis</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol Injection USP</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol-odan</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Rocaltrol Oral Solution 1mcg/ml</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol-odan</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol Injection</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol Injection USP</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcijex</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcijex</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
    <mixture>
      <name>Calcitriol</name>
      <ingredients>Calcitriol</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Abbott Laboratories Ltd.</name>
      <url>http://www.abbott.com</url>
    </packager>
    <packager>
      <name>Akorn Inc.</name>
      <url>http://www.akorn.com</url>
    </packager>
    <packager>
      <name>American Regent</name>
      <url>http://www.americanregent.com</url>
    </packager>
    <packager>
      <name>APP Pharmaceuticals</name>
      <url>http://www.apppharma.com</url>
    </packager>
    <packager>
      <name>Atlantic Biologicals Corporation</name>
      <url>http://www.atlanticbiologicals.com</url>
    </packager>
    <packager>
      <name>Cardinal Health</name>
      <url>http://www.cardinal.com</url>
    </packager>
    <packager>
      <name>Catalent Pharma Solutions</name>
      <url>http://www.catalent.com</url>
    </packager>
    <packager>
      <name>DSM Corp.</name>
      <url>http://www.dsm.com</url>
    </packager>
    <packager>
      <name>F Hoffmann-La Roche Ltd.</name>
      <url>http://www.roche.com</url>
    </packager>
    <packager>
      <name>Galderma Laboratories</name>
      <url>http://www.galderma.com</url>
    </packager>
    <packager>
      <name>Gulf Pharmaceutical Industries</name>
      <url>http://www.julphar.com</url>
    </packager>
    <packager>
      <name>Hospira Inc.</name>
      <url>http://www.hospira.com</url>
    </packager>
    <packager>
      <name>Kaiser Foundation Hospital</name>
      <url/>
    </packager>
    <packager>
      <name>Luitpold Pharmaceuticals Inc.</name>
      <url>http://www.luitpold.com</url>
    </packager>
    <packager>
      <name>Nephrx LLC</name>
      <url/>
    </packager>
    <packager>
      <name>Pharmaceutical Utilization Management Program VA Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>Physicians Total Care Inc.</name>
      <url>http://www.physicianstotalcare.com</url>
    </packager>
    <packager>
      <name>Pierre Fabre</name>
      <url>http://www.pierre-fabre.com</url>
    </packager>
    <packager>
      <name>Ranbaxy Laboratories</name>
      <url>http://www.ranbaxy.com</url>
    </packager>
    <packager>
      <name>Resource Optimization and Innovation LLC</name>
      <url/>
    </packager>
    <packager>
      <name>Roxane Labs</name>
      <url>http://www.roxane.com</url>
    </packager>
    <packager>
      <name>Teva Pharmaceutical Industries Ltd.</name>
      <url>http://www.tevapharm.com</url>
    </packager>
    <packager>
      <name>Tya Pharmaceuticals</name>
      <url/>
    </packager>
    <packager>
      <name>Validus Pharmaceuticals</name>
      <url>http://www.validuspharma.com</url>
    </packager>
  </packagers>
  <manufacturers>
    <manufacturer generic="true" url="">Roxane laboratories inc</manufacturer>
    <manufacturer generic="true" url="">Teva pharmaceuticals usa inc</manufacturer>
    <manufacturer generic="false" url="">Validus pharmaceuticals llc</manufacturer>
    <manufacturer generic="false" url="">Abbott laboratories hosp products div</manufacturer>
    <manufacturer generic="true" url="">Akorn inc</manufacturer>
    <manufacturer generic="true" url="">App pharmaceuticals llc</manufacturer>
    <manufacturer generic="true" url="">Fresenius medical care north america</manufacturer>
    <manufacturer generic="true" url="">Genix therapeutics inc</manufacturer>
    <manufacturer generic="true" url="">Hospira inc</manufacturer>
    <manufacturer generic="true" url="">Luitpold pharmaceuticals inc</manufacturer>
    <manufacturer generic="true" url="">Lyne laboratories inc</manufacturer>
    <manufacturer generic="true" url="">Teva parenteral medicines inc</manufacturer>
    <manufacturer generic="false" url="">Galderma laboratories lp</manufacturer>
  </manufacturers>
  <prices>
    <price>
      <description>Calcitriol 0.25 mcg capsule</description>
      <cost currency="USD">1.45</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Rocaltrol 0.25 mcg capsule</description>
      <cost currency="USD">1.46</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Calcitriol 0.5 mcg capsule</description>
      <cost currency="USD">1.97</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Rocaltrol 0.5 mcg capsule</description>
      <cost currency="USD">2.02</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>Vectical 3 mcg/g ointment</description>
      <cost currency="USD">4.68</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Calcitriol 1 mcg/ml ampul</description>
      <cost currency="USD">6.0</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Calcijex 1 mcg/ml</description>
      <cost currency="USD">10.68</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Calcijex 1 mcg/ml ampul</description>
      <cost currency="USD">14.7</cost>
      <unit>ml</unit>
    </price>
    <price>
      <description>Calcijex 2 mcg/ml</description>
      <cost currency="USD">19.38</cost>
      <unit>ml</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Antipsoriatics</category>
      <mesh-id/>
    </category>
    <category>
      <category>Antipsoriatics for Topical Use</category>
      <mesh-id/>
    </category>
    <category>
      <category>Bone Density Conservation Agents</category>
      <mesh-id>D050071</mesh-id>
    </category>
    <category>
      <category>Calcium Channel Agonists</category>
      <mesh-id>D002120</mesh-id>
    </category>
    <category>
      <category>Cardiovascular Agents</category>
      <mesh-id>D002317</mesh-id>
    </category>
    <category>
      <category>Chemical Actions and Uses</category>
      <mesh-id>D020164</mesh-id>
    </category>
    <category>
      <category>Cholecalciferol</category>
      <mesh-id>D002762</mesh-id>
    </category>
    <category>
      <category>Cholestanes</category>
      <mesh-id>D002776</mesh-id>
    </category>
    <category>
      <category>Cholestenes</category>
      <mesh-id>D002782</mesh-id>
    </category>
    <category>
      <category>Cytochrome P-450 CYP3A Inducers</category>
      <mesh-id>D065701</mesh-id>
    </category>
    <category>
      <category>Cytochrome P-450 CYP3A4 Inducers (weak)</category>
      <mesh-id/>
    </category>
    <category>
      <category>Cytochrome P-450 CYP3A4 Substrates</category>
      <mesh-id/>
    </category>
    <category>
      <category>Dermatologicals</category>
      <mesh-id/>
    </category>
    <category>
      <category>Diet, Food, and Nutrition</category>
      <mesh-id>D000066888</mesh-id>
    </category>
    <category>
      <category>Dihydroxycholecalciferols</category>
      <mesh-id>D004100</mesh-id>
    </category>
    <category>
      <category>Food</category>
      <mesh-id>D005502</mesh-id>
    </category>
    <category>
      <category>Food and Beverages</category>
      <mesh-id>D019602</mesh-id>
    </category>
    <category>
      <category>Growth Substances</category>
      <mesh-id>D006133</mesh-id>
    </category>
    <category>
      <category>Hydroxycholecalciferols</category>
      <mesh-id>D006887</mesh-id>
    </category>
    <category>
      <category>Lipids</category>
      <mesh-id>D008055</mesh-id>
    </category>
    <category>
      <category>Membrane Lipids</category>
      <mesh-id>D008563</mesh-id>
    </category>
    <category>
      <category>Membrane Transport Modulators</category>
      <mesh-id>D049990</mesh-id>
    </category>
    <category>
      <category>Micronutrients</category>
      <mesh-id>D018977</mesh-id>
    </category>
    <category>
      <category>Molecular Mechanisms of Pharmacological Action</category>
      <mesh-id>D045504</mesh-id>
    </category>
    <category>
      <category>Pharmacologic Actions</category>
      <mesh-id>D020228</mesh-id>
    </category>
    <category>
      <category>Physiological Effects of Drugs</category>
      <mesh-id>D045505</mesh-id>
    </category>
    <category>
      <category>Physiological Phenomena</category>
      <mesh-id>D010829</mesh-id>
    </category>
    <category>
      <category>Polycyclic Compounds</category>
      <mesh-id>D011083</mesh-id>
    </category>
    <category>
      <category>Secosteroids</category>
      <mesh-id>D012632</mesh-id>
    </category>
    <category>
      <category>Steroids</category>
      <mesh-id>D013256</mesh-id>
    </category>
    <category>
      <category>Sterols</category>
      <mesh-id>D013261</mesh-id>
    </category>
    <category>
      <category>Therapeutic Uses</category>
      <mesh-id>D045506</mesh-id>
    </category>
    <category>
      <category>Vasoconstrictor Agents</category>
      <mesh-id>D014662</mesh-id>
    </category>
    <category>
      <category>Vitamin D</category>
      <mesh-id>D014807</mesh-id>
    </category>
    <category>
      <category>Vitamins</category>
      <mesh-id>D014815</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1 ug/mL</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>.25 ug/1</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>.5 ug/1</strength>
    </dosage>
    <dosage>
      <form>Capsule, liquid filled</form>
      <route>Oral</route>
      <strength>.25 ug/1</strength>
    </dosage>
    <dosage>
      <form>Capsule, liquid filled</form>
      <route>Oral</route>
      <strength>.5 ug/1</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>1 ug/mL</strength>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength>2 ug/mL</strength>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength>1 mg/mL</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>1 mcg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength>2 mcg</strength>
    </dosage>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength>.25 ug/1</strength>
    </dosage>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength>.5 ug/1</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>1 ug/mL</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>0.25 mcg</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>0.5 mcg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength>1 mcg</strength>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Topical</route>
      <strength>3 mcg</strength>
    </dosage>
    <dosage>
      <form>Ointment</form>
      <route>Topical</route>
      <strength>3 ug/g</strength>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A11CC04">
      <level code="A11CC">Vitamin D and analogues</level>
      <level code="A11C">VITAMIN A AND D, INCL. COMBINATIONS OF THE TWO</level>
      <level code="A11">VITAMINS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
    <atc-code code="D05AX03">
      <level code="D05AX">Other antipsoriatics for topical use</level>
      <level code="D05A">ANTIPSORIATICS FOR TOPICAL USE</level>
      <level code="D05">ANTIPSORIATICS</level>
      <level code="D">DERMATOLOGICALS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>88:16.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <fda-label>//s3-us-west-2.amazonaws.com/drugbank/fda_labels/DB00136.pdf?1265922794</fda-label>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00136.pdf?1265922735</msds>
  <patents>
    <patent>
      <number>6265392</number>
      <country>United States</country>
      <approved>2000-02-02</approved>
      <expires>2020-02-02</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>6051567</number>
      <country>United States</country>
      <approved>2000-02-02</approved>
      <expires>2020-02-02</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
    <patent>
      <number>6274169</number>
      <country>United States</country>
      <approved>2000-02-02</approved>
      <expires>2020-02-02</expires>
      <pediatric-extension>true</pediatric-extension>
    </patent>
  </patents>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB09054</drugbank-id>
      <name>Idelalisib</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Idelalisib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06723</drugbank-id>
      <name>Aluminum hydroxide</name>
      <description>The serum concentration of Aluminum hydroxide can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00364</drugbank-id>
      <name>Sucralfate</name>
      <description>The serum concentration of Sucralfate can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02703</drugbank-id>
      <name>Fusidic Acid</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Fusidic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00146</drugbank-id>
      <name>Calcidiol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcidiol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00153</drugbank-id>
      <name>Ergocalciferol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Ergocalciferol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00169</drugbank-id>
      <name>Cholecalciferol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Cholecalciferol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01070</drugbank-id>
      <name>Dihydrotachysterol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Dihydrotachysterol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01436</drugbank-id>
      <name>Alfacalcidol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Alfacalcidol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02300</drugbank-id>
      <name>Calcipotriol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Calcipotriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06410</drugbank-id>
      <name>Doxercalciferol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Doxercalciferol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00910</drugbank-id>
      <name>Paricalcitol</name>
      <description>The risk or severity of adverse effects can be increased when Calcitriol is combined with Paricalcitol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00872</drugbank-id>
      <name>Conivaptan</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Conivaptan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00648</drugbank-id>
      <name>Mitotane</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Mitotane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09118</drugbank-id>
      <name>Stiripentol</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Stiripentol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01238</drugbank-id>
      <name>Aripiprazole</name>
      <description>The serum concentration of Aripiprazole can be decreased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00238</drugbank-id>
      <name>Nevirapine</name>
      <description>The metabolism of Calcitriol can be increased when combined with Nevirapine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00312</drugbank-id>
      <name>Pentobarbital</name>
      <description>The metabolism of Calcitriol can be increased when combined with Pentobarbital.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00252</drugbank-id>
      <name>Phenytoin</name>
      <description>The metabolism of Calcitriol can be increased when combined with Phenytoin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00564</drugbank-id>
      <name>Carbamazepine</name>
      <description>The metabolism of Calcitriol can be increased when combined with Carbamazepine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00615</drugbank-id>
      <name>Rifabutin</name>
      <description>The metabolism of Calcitriol can be increased when combined with Rifabutin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00794</drugbank-id>
      <name>Primidone</name>
      <description>The metabolism of Calcitriol can be increased when combined with Primidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01045</drugbank-id>
      <name>Rifampicin</name>
      <description>The metabolism of Calcitriol can be increased when combined with Rifampicin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01174</drugbank-id>
      <name>Phenobarbital</name>
      <description>The metabolism of Calcitriol can be increased when combined with Phenobarbital.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01201</drugbank-id>
      <name>Rifapentine</name>
      <description>The metabolism of Calcitriol can be increased when combined with Rifapentine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01320</drugbank-id>
      <name>Fosphenytoin</name>
      <description>The metabolism of Calcitriol can be increased when combined with Fosphenytoin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09280</drugbank-id>
      <name>Lumacaftor</name>
      <description>The metabolism of Calcitriol can be increased when combined with Lumacaftor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00220</drugbank-id>
      <name>Nelfinavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Nelfinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00224</drugbank-id>
      <name>Indinavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Indinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01118</drugbank-id>
      <name>Amiodarone</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Amiodarone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00503</drugbank-id>
      <name>Ritonavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Ritonavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00582</drugbank-id>
      <name>Voriconazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Voriconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00976</drugbank-id>
      <name>Telithromycin</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Telithromycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01026</drugbank-id>
      <name>Ketoconazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Ketoconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01072</drugbank-id>
      <name>Atazanavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Atazanavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01149</drugbank-id>
      <name>Nefazodone</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Nefazodone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01167</drugbank-id>
      <name>Itraconazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Itraconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01211</drugbank-id>
      <name>Clarithromycin</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Clarithromycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01232</drugbank-id>
      <name>Saquinavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Saquinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01263</drugbank-id>
      <name>Posaconazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Posaconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01264</drugbank-id>
      <name>Darunavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Darunavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01601</drugbank-id>
      <name>Lopinavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Lopinavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05521</drugbank-id>
      <name>Telaprevir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Telaprevir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08873</drugbank-id>
      <name>Boceprevir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Boceprevir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09065</drugbank-id>
      <name>Cobicistat</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Cobicistat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00834</drugbank-id>
      <name>Mifepristone</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Mifepristone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01083</drugbank-id>
      <name>Orlistat</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Orlistat.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00653</drugbank-id>
      <name>Magnesium Sulfate</name>
      <description>The serum concentration of Magnesium Sulfate can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01377</drugbank-id>
      <name>Magnesium oxide</name>
      <description>The serum concentration of Magnesium oxide can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01397</drugbank-id>
      <name>Magnesium salicylate</name>
      <description>The serum concentration of Magnesium salicylate can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09104</drugbank-id>
      <name>Magnesium Hydroxide</name>
      <description>The serum concentration of Magnesium hydroxide can be increased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08899</drugbank-id>
      <name>Enzalutamide</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Enzalutamide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01323</drugbank-id>
      <name>St. John's Wort</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with St. John&amp;#39;s Wort.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11057</drugbank-id>
      <name>Mineral oil</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Mineral oil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00375</drugbank-id>
      <name>Colestipol</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Colestipol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00930</drugbank-id>
      <name>Colesevelam</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Colesevelam.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01432</drugbank-id>
      <name>Cholestyramine</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Cholestyramine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08912</drugbank-id>
      <name>Dabrafenib</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Dabrafenib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01609</drugbank-id>
      <name>Deferasirox</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Deferasirox.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06717</drugbank-id>
      <name>Fosaprepitant</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Fosaprepitant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00223</drugbank-id>
      <name>Diflorasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Diflorasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00240</drugbank-id>
      <name>Alclometasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Alclometasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00253</drugbank-id>
      <name>Medrysone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Medrysone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00288</drugbank-id>
      <name>Amcinonide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Amcinonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00324</drugbank-id>
      <name>Fluorometholone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluorometholone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00394</drugbank-id>
      <name>Beclomethasone dipropionate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Beclomethasone dipropionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00443</drugbank-id>
      <name>Betamethasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Betamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00547</drugbank-id>
      <name>Desoximetasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Desoximetasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00620</drugbank-id>
      <name>Triamcinolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Triamcinolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00635</drugbank-id>
      <name>Prednisone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prednisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00655</drugbank-id>
      <name>Estrone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Estrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00663</drugbank-id>
      <name>Flumethasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Flumethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00687</drugbank-id>
      <name>Fludrocortisone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fludrocortisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00741</drugbank-id>
      <name>Hydrocortisone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Hydrocortisone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00838</drugbank-id>
      <name>Clocortolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Clocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00846</drugbank-id>
      <name>Flurandrenolide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Flurandrenolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00860</drugbank-id>
      <name>Prednisolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00896</drugbank-id>
      <name>Rimexolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Rimexolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00959</drugbank-id>
      <name>Methylprednisolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Methylprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01013</drugbank-id>
      <name>Clobetasol propionate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Clobetasol propionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01047</drugbank-id>
      <name>Fluocinonide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocinonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01130</drugbank-id>
      <name>Prednicarbate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prednicarbate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01222</drugbank-id>
      <name>Budesonide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Budesonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01234</drugbank-id>
      <name>Dexamethasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01380</drugbank-id>
      <name>Cortisone acetate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Cortisone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01384</drugbank-id>
      <name>Paramethasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Paramethasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01410</drugbank-id>
      <name>Ciclesonide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Ciclesonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01536</drugbank-id>
      <name>Androstenedione</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with 4-Androstenedione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01708</drugbank-id>
      <name>Prasterone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Prasterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02187</drugbank-id>
      <name>Equilin</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Equilin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB02789</drugbank-id>
      <name>Pregnenolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Pregnenolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB03515</drugbank-id>
      <name>Equilenin</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Equilenin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04630</drugbank-id>
      <name>Aldosterone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Aldosterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05804</drugbank-id>
      <name>Prasterone sulfate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with dehydroepiandrosterone sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06780</drugbank-id>
      <name>Desoxycorticosterone acetate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Desoxycorticosterone acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06781</drugbank-id>
      <name>Difluprednate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Difluprednate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08970</drugbank-id>
      <name>Fluprednidene</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluprednidene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08971</drugbank-id>
      <name>Fluocortolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09095</drugbank-id>
      <name>Difluocortolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Difluocortolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09378</drugbank-id>
      <name>Fluprednisolone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluprednisolone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11487</drugbank-id>
      <name>Dexamethasone isonicotinate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Dexamethasone isonicotinate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11529</drugbank-id>
      <name>Melengestrol</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Melengestrol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00180</drugbank-id>
      <name>Flunisolide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Flunisolide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00588</drugbank-id>
      <name>Fluticasone propionate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluticasone Propionate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00764</drugbank-id>
      <name>Mometasone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Mometasone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08906</drugbank-id>
      <name>Fluticasone furoate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluticasone furoate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09091</drugbank-id>
      <name>Tixocortol</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Tixocortol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11750</drugbank-id>
      <name>Clobetasol</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Clobetasol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00591</drugbank-id>
      <name>Fluocinolone Acetonide</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Fluocinolone Acetonide.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01134</drugbank-id>
      <name>Desoxycorticosterone Pivalate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Desoxycorticosterone Pivalate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01434</drugbank-id>
      <name>19-norandrostenedione</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with 19-norandrostenedione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01456</drugbank-id>
      <name>5-androstenedione</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with 5-androstenedione.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04574</drugbank-id>
      <name>Estrone sulfate</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Estrone sulfate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04870</drugbank-id>
      <name>Oleoyl-estrone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Oleoyl estrone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05107</drugbank-id>
      <name>16-Bromoepiandrosterone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with 16-Bromoepiandrosterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05212</drugbank-id>
      <name>HE3286</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with HE3286.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05402</drugbank-id>
      <name>ME-609</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with ME-609.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB05410</drugbank-id>
      <name>NCX 1022</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with NCX 1022.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06157</drugbank-id>
      <name>Istaroxime</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Istaroxime.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06250</drugbank-id>
      <name>fluasterone</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with fluasterone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08905</drugbank-id>
      <name>Formestane</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Formestane.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12081</drugbank-id>
      <name>Anecortave</name>
      <description>The therapeutic efficacy of Calcitriol can be decreased when used in combination with Anecortave.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08820</drugbank-id>
      <name>Ivacaftor</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Ivacaftor.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08933</drugbank-id>
      <name>Luliconazole</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Luliconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09048</drugbank-id>
      <name>Netupitant</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Netupitant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09073</drugbank-id>
      <name>Palbociclib</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Palbociclib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09036</drugbank-id>
      <name>Siltuximab</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Siltuximab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06273</drugbank-id>
      <name>Tocilizumab</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Tocilizumab.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00393</drugbank-id>
      <name>Nimodipine</name>
      <description>The serum concentration of Nimodipine can be decreased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09330</drugbank-id>
      <name>Osimertinib</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Osimertinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00307</drugbank-id>
      <name>Bexarotene</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Bexarotene.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00607</drugbank-id>
      <name>Nafcillin</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Nafcillin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00625</drugbank-id>
      <name>Efavirenz</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Efavirenz.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00745</drugbank-id>
      <name>Modafinil</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Modafinil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06414</drugbank-id>
      <name>Etravirine</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Etravirine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09119</drugbank-id>
      <name>Eslicarbazepine acetate</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Eslicarbazepine acetate.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00559</drugbank-id>
      <name>Bosentan</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Bosentan.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09063</drugbank-id>
      <name>Ceritinib</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Ceritinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00188</drugbank-id>
      <name>Bortezomib</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Bortezomib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00196</drugbank-id>
      <name>Fluconazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Fluconazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00208</drugbank-id>
      <name>Ticlopidine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Ticlopidine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00227</drugbank-id>
      <name>Lovastatin</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Lovastatin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00243</drugbank-id>
      <name>Ranolazine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Ranolazine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00246</drugbank-id>
      <name>Ziprasidone</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Ziprasidone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00270</drugbank-id>
      <name>Isradipine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Isradipine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00320</drugbank-id>
      <name>Dihydroergotamine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Dihydroergotamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00343</drugbank-id>
      <name>Diltiazem</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Diltiazem.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00199</drugbank-id>
      <name>Erythromycin</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Erythromycin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00203</drugbank-id>
      <name>Sildenafil</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Sildenafil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00257</drugbank-id>
      <name>Clotrimazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Clotrimazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00176</drugbank-id>
      <name>Fluvoxamine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Fluvoxamine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00285</drugbank-id>
      <name>Venlafaxine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Venlafaxine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00091</drugbank-id>
      <name>Cyclosporine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Cyclosporine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00289</drugbank-id>
      <name>Atomoxetine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Atomoxetine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00283</drugbank-id>
      <name>Clemastine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Clemastine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00254</drugbank-id>
      <name>Doxycycline</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Doxycycline.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09074</drugbank-id>
      <name>Olaparib</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Olaparib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06636</drugbank-id>
      <name>Isavuconazonium</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Isavuconazonium.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00263</drugbank-id>
      <name>Sulfisoxazole</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Sulfisoxazole.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00619</drugbank-id>
      <name>Imatinib</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Imatinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00661</drugbank-id>
      <name>Verapamil</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Verapamil.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00705</drugbank-id>
      <name>Delavirdine</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Delavirdine.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01319</drugbank-id>
      <name>Fosamprenavir</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Fosamprenavir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04855</drugbank-id>
      <name>Dronedarone</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Dronedarone.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB04868</drugbank-id>
      <name>Nilotinib</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Nilotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB08865</drugbank-id>
      <name>Crizotinib</name>
      <description>The metabolism of Calcitriol can be decreased when combined with Crizotinib.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01406</drugbank-id>
      <name>Danazol</name>
      <description>Danazol may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00956</drugbank-id>
      <name>Hydrocodone</name>
      <description>The serum concentration of Hydrocodone can be decreased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06335</drugbank-id>
      <name>Saxagliptin</name>
      <description>The serum concentration of Saxagliptin can be decreased when it is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00658</drugbank-id>
      <name>Sevelamer</name>
      <description>The serum concentration of Calcitriol can be decreased when it is combined with Sevelamer.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06290</drugbank-id>
      <name>Simeprevir</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Simeprevir.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00326</drugbank-id>
      <name>Calcium Gluceptate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium Gluceptate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01164</drugbank-id>
      <name>Calcium Chloride</name>
      <description>The risk or severity of adverse effects can be increased when Calcium Chloride is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB06724</drugbank-id>
      <name>Calcium Carbonate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium carbonate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11093</drugbank-id>
      <name>Calcium Citrate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium citrate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB11126</drugbank-id>
      <name>Calcium gluconate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium gluconate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00258</drugbank-id>
      <name>Calcium Acetate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium Acetate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13142</drugbank-id>
      <name>Calcium glubionate</name>
      <description>The risk or severity of adverse effects can be increased when Calcium glubionate is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01373</drugbank-id>
      <name>Calcium</name>
      <description>The risk or severity of adverse effects can be increased when Calcium is combined with Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00390</drugbank-id>
      <name>Digoxin</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Digoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00511</drugbank-id>
      <name>Acetyldigitoxin</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Acetyldigitoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01078</drugbank-id>
      <name>Deslanoside</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Deslanoside.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01092</drugbank-id>
      <name>Ouabain</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Ouabain.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01396</drugbank-id>
      <name>Digitoxin</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Digitoxin.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12843</drugbank-id>
      <name>Oleandrin</name>
      <description>Calcitriol may increase the arrhythmogenic activities of Anvirzel.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00232</drugbank-id>
      <name>Methyclothiazide</name>
      <description>Methyclothiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00310</drugbank-id>
      <name>Chlorthalidone</name>
      <description>Chlorthalidone may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00436</drugbank-id>
      <name>Bendroflumethiazide</name>
      <description>Bendroflumethiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00524</drugbank-id>
      <name>Metolazone</name>
      <description>Metolazone may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00774</drugbank-id>
      <name>Hydroflumethiazide</name>
      <description>Hydroflumethiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00808</drugbank-id>
      <name>Indapamide</name>
      <description>Indapamide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00880</drugbank-id>
      <name>Chlorothiazide</name>
      <description>Chlorothiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00999</drugbank-id>
      <name>Hydrochlorothiazide</name>
      <description>Hydrochlorothiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01021</drugbank-id>
      <name>Trichlormethiazide</name>
      <description>Trichlormethiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01324</drugbank-id>
      <name>Polythiazide</name>
      <description>Polythiazide may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01325</drugbank-id>
      <name>Quinethazone</name>
      <description>Quinethazone may increase the hypercalcemic activities of Calcitriol.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00673</drugbank-id>
      <name>Aprepitant</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Aprepitant.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01254</drugbank-id>
      <name>Dasatinib</name>
      <description>The serum concentration of Calcitriol can be increased when it is combined with Dasatinib.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>5.51</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-4.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>6.67e-03 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>4.35</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(1R,3S,5Z)-5-{2-[(1R,3aS,4E,7aR)-1-[(2R)-6-hydroxy-6-methylheptan-2-yl]-7a-methyl-octahydro-1H-inden-4-ylidene]ethylidene}-4-methylidenecyclohexane-1,3-diol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>calcitriol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>416.6365</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>416.329045274</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>C[C@H](CCCC(C)(C)O)[C@@]1([H])CC[C@@]2([H])\C(CCC[C@]12C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C27H44O3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C27H44O3/c1-18(8-6-14-26(3,4)30)23-12-13-24-20(9-7-15-27(23,24)5)10-11-21-16-22(28)17-25(29)19(21)2/h10-11,18,22-25,28-30H,2,6-9,12-17H2,1,3-5H3/b20-10+,21-11-/t18-,22-,23-,24+,25+,27-/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>GMRQFYUYWCNGIN-NKMMMXOESA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>60.69</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>126.53</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>51.02</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>14.39</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-1.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Insoluble</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>113-114</value>
      <source>Uskokovic, M.R., Narwid, T.A., lacobelli, J.A. and Baggiolini, E.; U.S. Patent 3,993,675;&#13;
November 23, 1976; assigned to Hoffmann-La Roche, Inc.</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>5</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>4893</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>17823</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>5280453</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46508162</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C01673</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00129</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>4444108</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50200182</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA448717</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>VDX</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000289</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>2779</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>2779</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Calcitriol</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL846</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>RxList</resource>
      <url>http://www.rxlist.com/cgi/generic2/calcitri.htm</url>
    </external-link>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/vit_0265.shtml</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/cdi/calcitriol.html</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB00136</drugbank-id>
        <name>Calcitriol</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET00575</drugbank-id>
        <name>Calcitroic acid</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000779</id>
      <name>Vitamin D3 receptor</name>
      <organism>Human</organism>
      <actions>
        <action>antagonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>15503649</pubmed-id>
            <citation>Reinhart GA: Vitamin D analogs: novel therapeutic agents for cardiovascular disease? Curr Opin Investig Drugs. 2004 Sep;5(9):947-51.</citation>
          </article>
          <article>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P11473" source="Swiss-Prot">
    <name>Vitamin D3 receptor</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Nuclear hormone receptor. Transcription factor that mediates the action of vitamin D3 by controlling the expression of hormone sensitive genes. Recruited to promoters via its interaction with BAZ1B/WSTF which mediates the interaction with acetylated histones, an essential step for VDR-promoter association. Plays a central role in calcium homeostasis.</specific-function>
    <gene-name>VDR</gene-name>
    <locus>12q13.11</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.5</theoretical-pi>
    <molecular-weight>48288.64</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:12679</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>VDR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J03258</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>340203</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>605</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>605</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P11473</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>VDR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1,25-dihydroxyvitamin D3 receptor</synonym>
      <synonym>NR1I1</synonym>
      <synonym>Nuclear receptor subfamily 1 group I member 1</synonym>
      <synonym>VDR</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001554|Vitamin D3 receptor
MEAMAASTSLPDPGDFDRNVPRICGVCGDRATGFHFNAMTCEGCKGFFRRSMKRKALFTC
PFNGDCRITKDNRRHCQACRLKRCVDIGMMKEFILTDEEVQRKREMILKRKEEEALKDSL
RPKLSEEQQRIIAILLDAHHKTYDPTYSDFCQFRPPVRVNDGGGSHPSRPNSRHTPSFSG
DSSSSCSDHCITSSDMMDSSSFSNLDLSEEDSDDPSVTLELSQLSMLPHLADLVSYSIQK
VIGFAKMIPGFRDLTSEDQIVLLKSSAIEVIMLRSNESFTMDDMSWTCGNQDYKYRVSDV
TKAGHSLELIEPLIKFQVGLKKLNLHEEEHVLLMAICIVSPDRPGVQDAALIEAIQDRLS
NTLQTYIRCRHPPPGSHLLYAKMIQKLADLRSLNEEHSKQYRCLSFQPECSMKLTPLVLE
VFGNEIS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010550|Vitamin D3 receptor (VDR)
ATGGAGGCAATGGCGGCCAGCACTTCCCTGCCTGACCCTGGAGACTTTGACCGGAACGTG
CCCCGGATCTGTGGGGTGTGTGGAGACCGAGCCACTGGCTTTCACTTCAATGCTATGACC
TGTGAAGGCTGCAAAGGCTTCTTCAGGCGAAGCATGAAGCGGAAGGCACTATTCACCTGC
CCCTTCAACGGGGACTGCCGCATCACCAAGGACAACCGACGCCACTGCCAGGCCTGCCGG
CTCAAACGCTGTGTGGACATCGGCATGATGAAGGAGTTCATTCTGACAGATGAGGAAGTG
CAGAGGAAGCGGGAGATGATCCTGAAGCGGAAGGAGGAGGAGGCCTTGAAGGACAGTCTG
CGGCCCAAGCTGTCTGAGGAGCAGCAGCGCATCATTGCCATACTGCTGGACGCCCACCAT
AAGACCTACGACCCCACCTACTCCGACTTCTGCCAGTTCCGGCCTCCAGTTCGTGTGAAT
GATGGTGGAGGGAGCCATCCTTCCAGGCCCAACTCCAGACACACTCCCAGCTTCTCTGGG
GACTCCTCCTCCTCCTGCTCAGATCACTGTATCACCTCTTCAGACATGATGGACTCGTCC
AGCTTCTCCAATCTGGATCTGAGTGAAGAAGATTCAGATGACCCTTCTGTGACCCTAGAG
CTGTCCCAGCTCTCCATGCTGCCCCACCTGGCTGACCTGGTCAGTTACAGCATCCAAAAG
GTCATTGGCTTTGCTAAGATGATACCAGGATTCAGAGACCTCACCTCTGAGGACCAGATC
GTACTGCTGAAGTCAAGTGCCATTGAGGTCATCATGTTGCGCTCCAATGAGTCCTTCACC
ATGGACGACATGTCCTGGACCTGTGGCAACCAAGACTACAAGTACCGCGTCAGTGACGTG
ACCAAAGCCGGACACAGCCTGGAGCTGATTGAGCCCCTCATCAAGTTCCAGGTGGGACTG
AAGAAGCTGAACTTGCATGAGGAGGAGCATGTCCTGCTCATGGCCATCTGCATCGTCTCC
CCAGATCGTCCTGGGGTGCAGGACGCCGCGCTGATTGAGGCCATCCAGGACCGCCTGTCC
AACACACTGCAGACGTACATCCGCTGCCGCCACCCGCCCCCGGGCAGCCACCTGCTCTAT
GCCAAGATGATCCAGAAGCTAGCCGACCTGCGCAGCCTCAATGAGGAGCACTCCAAGCAG
TACCGCTGCCTCTCCTTCCAGCCTGAGTGCAGCATGAAGCTAACGCCCCTTGTGCTCGAA
GTGTTTGGCAATGAGATCTCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00104</identifier>
        <name>Hormone_recep</name>
      </pfam>
      <pfam>
        <identifier>PF00105</identifier>
        <name>zf-C4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>RNA polymerase II transcription factor complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcitriol binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hormone receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcitriol receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lithocholic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lithocholic acid receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>retinoid X receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mammary gland branching involved in pregnancy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of keratinocyte differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of keratinocyte proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>skeletal system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of vitamin D 24-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of calcidiol 1-monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular calcium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of apoptotic process involved in mammary gland involution</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intestinal absorption</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>decidualization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="1">
      <id>BE0008987</id>
      <name>Homeobox protein Hox-A10</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>15905361</pubmed-id>
            <citation>Du H, Daftary GS, Lalwani SI, Taylor HS: Direct regulation of HOXA10 by 1,25-(OH)2D3 in human myelomonocytic cells and human endometrial stromal cells. Mol Endocrinol. 2005 Sep;19(9):2222-33. Epub 2005 May 19.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P31260" source="Swiss-Prot">
    <name>Homeobox protein Hox-A10</name>
    <general-function>Sequence-specific transcription factor which is part of a developmental regulatory system that provides cells with specific positional identities on the anterior-posterior axis. Binds to the DNA sequence 5'-AA[AT]TTTTATTAC-3'.</general-function>
    <specific-function>Histone deacetylase binding</specific-function>
    <gene-name>HOXA10</gene-name>
    <locus>7p15.2</locus>
    <cellular-location>Nucleus</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi/>
    <molecular-weight>42413.825</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:5100</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P31260</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>HXA10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Homeobox protein Hox-1.8</synonym>
      <synonym>Homeobox protein Hox-1H</synonym>
      <synonym>HOX1H</synonym>
      <synonym>PL</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0049689|Homeobox protein Hox-A10
MSARKGYLLPSPNYPTTMSCSESPAANSFLVDSLISSGRGEAGGGGGGAGGGGGGGYYAH
GGVYLPPAADLPYGLQSCGLFPTLGGKRNEAASPGSGGGGGGLGPGAHGYGPSPIDLWLD
APRSCRMEPPDGPPPPPQQQPPPPPQPPQPAPQATSCSFAQNIKEESSYCLYDSADKCPK
VSATAAELAPFPRGPPPDGCALGTSSGVPVPGYFRLSQAYGTAKGYGSGGGGAQQLGAGP
FPAQPPGRGFDLPPALASGSADAARKERALDSPPPPTLACGSGGGSQGDEEAHASSSAAE
ELSPAPSESSKASPEKDSLGNSKGENAANWLTAKSGRKKRCPYTKHQTLELEKEFLFNMY
LTRERRLEISRSVHLTDRQVKIWFQNRRMKLKKMNRENRIRELTANFNFS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0049690|Homeobox protein Hox-A10 (HOXA10)
ATGTCAGCCAGAAAGGGCTATCTGCTCCCTTCGCCAAATTATCCCACAACAATGTCATGC
TCGGAGAGCCCCGCCGCGAACTCTTTTTTGGTCGACTCGCTCATCAGCTCGGGCAGAGGC
GAGGCAGGCGGCGGTGGTGGTGGCGCGGGGGGCGGCGGCGGTGGCGGTTACTACGCCCAC
GGCGGGGTCTACCTGCCGCCCGCCGCCGACCTGCCCTACGGGCTGCAGAGCTGCGGGCTC
TTCCCCACGCTGGGCGGCAAGCGCAATGAGGCAGCGTCGCCGGGCAGCGGTGGCGGTGGC
GGGGGTCTAGGTCCCGGGGCGCACGGCTACGGGCCCTCGCCCATAGACCTGTGGCTAGAC
GCGCCCCGGTCTTGCCGGATGGAGCCGCCTGACGGGCCGCCGCCGCCGCCCCAGCAGCAG
CCGCCGCCCCCGCCGCAACCACCCCAGCCAGCGCCGCAGGCCACCTCGTGCTCTTTCGCG
CAGAACATCAAAGAAGAGAGCTCCTACTGCCTCTACGACTCGGCGGACAAATGCCCCAAA
GTCTCGGCCACCGCCGCCGAACTGGCTCCCTTCCCGCGGGGCCCGCCGCCCGACGGCTGC
GCCCTGGGCACCTCCAGCGGGGTGCCAGTGCCTGGCTACTTCCGCCTTTCTCAGGCCTAC
GGCACCGCCAAGGGCTATGGCAGCGGCGGCGGCGGCGCGCAGCAACTCGGGGCTGGCCCG
TTCCCCGCGCAGCCCCCGGGGCGCGGTTTCGATCTCCCGCCCGCGCTAGCCTCCGGCTCG
GCCGATGCGGCCCGGAAGGAGCGAGCCCTCGATTCGCCGCCGCCCCCCACGCTGGCTTGC
GGCAGCGGCGGGGGCTCGCAGGGCGACGAGGAGGCGCACGCGTCGTCCTCGGCCGCGGAG
GAGCTCTCCCCGGCCCCTTCCGAGAGCAGCAAAGCCTCGCCGGAGAAGGATTCCCTGGGC
AATTCCAAAGGTGAAAACGCAGCCAACTGGCTCACGGCAAAGAGTGGTCGGAAGAAGCGC
TGCCCCTACACGAAGCACCAGACACTGGAGCTGGAGAAGGAGTTTCTGTTCAATATGTAC
CTTACTCGAGAGCGGCGCCTAGAGATTAGCCGCAGCGTCCACCTCACGGACAGACAAGTG
AAAATCTGGTTTCAGAACCGCAGGATGAAACTGAAGAAAATGAATCGAGAAAACCGGATC
CGGGAGCTCACAGCCAACTTTAATTTTTCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00046</identifier>
        <name>Homeobox</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>transcription factor complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>histone deacetylase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proximal/distal pattern formation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>skeletal system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anterior/posterior pattern specification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryonic limb morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>male gonad development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organism development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>spermatogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>uterus development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>single fertilization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="2">
      <id>BE0001141</id>
      <name>Vitamin D-binding protein</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>8370586</pubmed-id>
            <citation>Arnaud J, Constans J: Affinity differences for vitamin D metabolites associated with the genetic isoforms of the human serum carrier protein (DBP). Hum Genet. 1993 Sep;92(2):183-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P02774" source="Swiss-Prot">
    <name>Vitamin D-binding protein</name>
    <general-function>Vitamin transporter activity</general-function>
    <specific-function>Involved in vitamin D transport and storage, scavenging of extracellular G-actin, enhancement of the chemotactic activity of C5 alpha for neutrophils in inflammation and macrophage activation.</specific-function>
    <gene-name>GC</gene-name>
    <locus>4q12-q13</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-16</signal-regions>
    <theoretical-pi>5.21</theoretical-pi>
    <molecular-weight>52963.025</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4187</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GC</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L10641</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>639896</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P02774</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>VTDB_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>DBP</synonym>
      <synonym>DBP-maf</synonym>
      <synonym>Gc</synonym>
      <synonym>Gc protein-derived macrophage activating factor</synonym>
      <synonym>Gc-globulin</synonym>
      <synonym>Gc-MAF</synonym>
      <synonym>GcMAF</synonym>
      <synonym>Group-specific component</synonym>
      <synonym>Vitamin D-binding protein-macrophage activating factor</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002269|Vitamin D-binding protein
MKRVLVLLLAVAFGHALERGRDYEKNKVCKEFSHLGKEDFTSLSLVLYSRKFPSGTFEQV
SQLVKEVVSLTEACCAEGADPDCYDTRTSALSAKSCESNSPFPVHPGTAECCTKEGLERK
LCMAALKHQPQEFPTYVEPTNDEICEAFRKDPKEYANQFMWEYSTNYGQAPLSLLVSYTK
SYLSMVGSCCTSASPTVCFLKERLQLKHLSLLTTLSNRVCSQYAAYGEKKSRLSNLIKLA
QKVPTADLEDVLPLAEDITNILSKCCESASEDCMAKELPEHTVKLCDNLSTKNSKFEDCC
QEKTAMDVFVCTYFMPAAQLPELPDVELPTNKDVCDPGNTKVMDKYTFELSRRTHLPEVF
LSKVLEPTLKSLGECCDVEDSTTCFNAKGPLLKKELSSFIDKGQELCADYSENTFTEYKK
KLAERLKAKLPDATPKELAKLVNKRSDFASNCCSINSPPLYCDSEIDAELKNIL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010798|Vitamin D-binding protein (GC)
ATGAAGAGGGTCCTGGTACTACTGCTTGCTGTGGCATTTGGACATGCTTTAGAGAGAGGC
CGGGATTATGAAAAGAATAAAGTCTGCAAGGAATTCTCCCATCTGGGAAAGGAGGACTTC
ACATCTCTGTCACTAGTCCTGTACAGTAGAAAATTTCCCAGTGGCACGTTTGAACAGGTC
AGCCAACTTGTGAAGGAAGTTGTCTCCTTGACCGAAGCCTGCTGTGCGGAAGGGGCTGAC
CCTGACTGCTATGACACCAGGACCTCAGCACTGTCTGCCAAGTCCTGTGAAAGTAATTCT
CCATTCCCCGTTCACCCAGGCACTGCTGAGTGCTGCACCAAAGAGGGCCTGGAACGAAAG
CTCTGCATGGCTGCTCTGAAACACCAGCCACAGGAATTCCCTACCTACGTGGAACCCACA
AATGATGAAATCTGTGAGGCGTTCAGGAAAGATCCAAAGGAATATGCTAATCAATTTATG
TGGGAATATTCCACTAATTACGGACAAGCTCCTCTGTCACTTTTAGTCAGTTACACCAAG
AGTTATCTTTCTATGGTAGGGTCCTGCTGTACCTCTGCAAGCCCAACTGTATGCTTTTTG
AAAGAGAGACTCCAGCTTAAACATTTATCACTTCTCACCACTCTGTCAAATAGAGTCTGC
TCACAATATGCTGCTTATGGGGAGAAGAAATCAAGGCTCAGCAATCTCATAAAGTTAGCC
CAAAAAGTGCCTACTGCTGATCTGGAGGATGTTTTGCCACTAGCTGAAGATATTACTAAC
ATCCTCTCCAAATGCTGTGAGTCTGCCTCTGAAGATTGCATGGCCAAAGAGCTGCCTGAA
CACACAGTAAAACTCTGTGACAATTTATCCACAAAGAATTCTAAGTTTGAAGACTGTTGT
CAAGAAAAAACAGCCATGGACGTTTTTGTGTGCACTTACTTCATGCCAGCTGCCCAACTC
CCCGAGCTTCCAGATGTAGAGTTGCCCACAAACAAAGATGTGTGTGATCCAGGAAACACC
AAAGTCATGGATAAGTATACATTTGAACTAAGCAGAAGGACTCATCTTCCGGAAGTATTC
CTCAGTAAGGTACTTGAGCCAACCCTAAAAAGCCTTGGTGAATGCTGTGATGTTGAAGAC
TCAACTACCTGTTTTAATGCTAAGGGCCCTCTACTAAAGAAGGAACTATCTTCTTTCATT
GACAAGGGACAAGAACTATGTGCAGATTATTCAGAAAATACATTTACTGAGTACAAGAAA
AAACTGGCAGAGCGACTAAAAGCAAAATTGCCTGATGCCACACCCACGGAACTGGCAAAG
CTGGTTAACAAGCACTCAGACTTTGCCTCCAACTGCTGTTCCATAAACTCACCTCCTCTT
TACTGTGATTCAGAGATTGATGCTGAATTGAAGAATATCCTGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00273</identifier>
        <name>Serum_albumin</name>
      </pfam>
      <pfam>
        <identifier>PF09164</identifier>
        <name>VitD-bind_III</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>lysosomal lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>blood microparticle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>actin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcidiol binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient levels</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>female pregnancy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estradiol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme>
      <id>BE0002250</id>
      <name>1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
        <action>inducer</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>20619365</pubmed-id>
            <citation>Schuster I: Cytochromes P450 are essential players in the vitamin D signaling system. Biochim Biophys Acta. 2011 Jan;1814(1):186-99. doi: 10.1016/j.bbapap.2010.06.022. Epub 2010 Jul 7.</citation>
          </article>
          <article>
            <pubmed-id>19934256</pubmed-id>
            <citation>Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970.  Epub 2009 Nov 24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q07973" source="Swiss-Prot">
    <name>1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial</name>
    <general-function>Oxidoreductase activity</general-function>
    <specific-function>Has a role in maintaining calcium homeostasis. Catalyzes the NADPH-dependent 24-hydroxylation of calcidiol (25-hydroxyvitamin D(3)) and calcitriol (1-alpha,25-dihydroxyvitamin D(3)). The enzyme can perform up to 6 rounds of hydroxylation of calcitriol leading to calcitroic acid. It also shows 23-hydroxylating activity leading to 1-alpha,25-dihydroxyvitamin D(3)-26,23-lactone as end product.</specific-function>
    <gene-name>CYP24A1</gene-name>
    <locus>20q13</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.99</theoretical-pi>
    <molecular-weight>58874.695</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2602</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CYP24A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L13286</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306704</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1365</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q07973</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CP24A_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.13.126</synonym>
      <synonym>24-OHase</synonym>
      <synonym>CYP24</synonym>
      <synonym>Cytochrome P450 24A1</synonym>
      <synonym>Cytochrome P450-CC24</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004416|1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial
MSSPISKSRSLAAFLQQLRSPRQPPRLVTSTAYTSPQPREVPVCPLTAGGETQNAAALPG
PTSWPLLGSLLQILWKGGLKKQHDTLVEYHKKYGKIFRMKLGSFESVHLGSPCLLEALYR
TESAYPQRLEIKPWKAYRDYRKEGYGLLILEGEDWQRVRSAFQKKLMKPGEVMKLDNKIN
EVLADFMGRIDELCDERGHVEDLYSELNKWSFESICLVLYEKRFGLLQKNAGDEAVNFIM
AIKTMMSTFGRMMVTPVELHKSLNTKVWQDHTLAWDTIFKSVKACIDNRLEKYSQQPSAD
FLCDIYHQNRLSKKELYAAVTELQLAAVETTANSLMWILYNLSRNPQVQQKLLKEIQSVL
PENQVPRAEDLRNMPYLKACLKESMRLTPSVPFTTRTLDKATVLGEYALPKGTVLMLNTQ
VLGSSEDNFEDSSQFRPERWLQEKEKINPFAHLPFGVGKRMCIGRRLAELQLHLALCWIV
RKYDIQATDNEPVEMLHSGTLVPSRELPIAFCQR</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016728|1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial (CYP24A1)
ATGAGCTCCCCCATCAGCAAGAGCCGCTCGCTTGCCGCCTTCCTGCAGCAGCTGCGCAGT
CCGAGGCAGCCCCCGAGACTGGTGACATCTACGGCGTACACGTCCCCTCAGCCGCGAGAG
GTGCCAGTCTGCCCGCTGACAGCTGGTGGCGAGACTCAGAACGCGGCCGCCCTGCCGGGC
CCCACCAGCTGGCCACTGCTGGGCAGCCTGCTGCAGATTCTCTGGAAAGGGGGTCTCAAG
AAACAGCACGACACCCTGGTGGAGTACCACAAGAAGTATGGCAAGATTTTCCGCATGAAG
TTGGGTTCCTTTGAGTCGGTGCACCTGGGCTCGCCATGCCTGCTGGAAGCGCTGTACCGC
ACCGAGAGCGCGTACCCGCAGCGGCTGGAGATCAAACCGTGGAAGGCCTATCGCGACTAC
CGCAAAGAAGGCTACGGGCTGCTGATCCTGGAAGGGGAAGACTGGCAGCGGGTCCGGAGT
GCCTTTCAAAAGAAACTAATGAAACCAGGGGAAGTGATGAAGCTGGACAACAAAATCAAT
GAGGTCTTGGCCGATTTTATGGGCAGAATAGATGAGCTCTGTGATGAAAGAGGCCACGTT
GAAGACTTGTACAGCGAACTGAACAAATGGTCGTTTGAAAGTATCTGCCTCGTGTTGTAT
GAGAAGAGATTTGGGCTTCTCCAGAAGAATGCAGGGGATGAAGCTGTGAACTTCATCATG
GCCATCAAAACAATGATGAGCACGTTTGGGAGGATGATGGTCACTCCAGTCGAGCTGCAC
AAGAGCCTCAACACCAAGGTCTGGCAGGACCACACTCTGGCCTGGGACACCATTTTCAAA
TCAGTCAAAGCTTGTATCGACAACCGGTTAGAGAAGTATTCTCAGCAGCCTAGTGCAGAT
TTCCTTTGTGACATTTATCACCAGAATCGGCTTTCAAAGAAAGAATTGTATGCTGCTGTC
ACAGAGCTCCAGCTGGCTGCGGTGGAAACGACAGCAAACAGTCTAATGTGGATTCTCTAC
AATTTATCCCGTAATCCCCAAGTGCAACAAAAGCTTCTTAAGGAAATTCAAAGTGTATTA
CCTGAGAATCAGGTGCCACGGGCAGAAGATTTGAGGAATATGCCGTATTTAAAAGCCTGT
CTGAAAGAATCTATGAGGCTTACGCCGAGTGTACCATTTACAACTCGGACTCTTGACAAG
GCAACAGTTCTGGGTGAATATGCTTTACCCAAAGGAACAGTGCTCATGCTAAATACCCAG
GTGTTGGGATCCAGTGAAGACAATTTTGAAGATTCAAGTCAGTTTAGACCTGAACGTTGG
CTTCAGGAGAAGGAAAAAATTAATCCTTTTGCGCATCTTCCATTTGGCGTTGGAAAAAGA
ATGTGCATTGGTCGCCGATTAGCAGAGCTTCAACTGCATTTGGCTCTTTGTTGGATTGTC
CGCAAATACGACATCCAGGCCACAGACAATGAGCCTGTTGAGATGCTACACTCAGGCACC
CTGGTGCCCAGCCGGGAACTCCCCATCGCGTTTTGCCAGCGATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00067</identifier>
        <name>p450</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>1-alpha,25-dihydroxyvitamin D3 24-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>25-hydroxycholecalciferol-24-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin D</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>osteoblast differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme>
      <id>BE0002638</id>
      <name>Cytochrome P450 3A4</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
        <action>inducer</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16207822</pubmed-id>
            <citation>Xu Y, Hashizume T, Shuhart MC, Davis CL, Nelson WL, Sakaki T, Kalhorn TF, Watkins PB, Schuetz EG, Thummel KE: Intestinal and hepatic CYP3A4 catalyze hydroxylation of 1alpha,25-dihydroxyvitamin D(3): implications for drug-induced osteomalacia. Mol Pharmacol. 2006 Jan;69(1):56-65. Epub 2005 Oct 5.</citation>
          </article>
          <article>
            <pubmed-id>19934256</pubmed-id>
            <citation>Preissner S, Kroll K, Dunkel M, Senger C, Goldsobel G, Kuzman D, Guenther S, Winnenburg R, Schroeder M, Preissner R: SuperCYP: a comprehensive database on Cytochrome P450 enzymes including a tool for analysis of CYP-drug interactions. Nucleic Acids Res. 2010 Jan;38(Database issue):D237-43. doi: 10.1093/nar/gkp970.  Epub 2009 Nov 24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08684" source="Swiss-Prot">
    <name>Cytochrome P450 3A4</name>
    <general-function>Vitamin d3 25-hydroxylase activity</general-function>
    <specific-function>Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).</specific-function>
    <gene-name>CYP3A4</gene-name>
    <locus>7q21.1</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>2-22</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.25</theoretical-pi>
    <molecular-weight>57342.67</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2637</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CYP3A4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M18907</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1337</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P08684</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CP3A4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1,8-cineole 2-exo-monooxygenase</synonym>
      <synonym>1.14.13.-</synonym>
      <synonym>Albendazole monooxygenase</synonym>
      <synonym>Albendazole sulfoxidase</synonym>
      <synonym>Cholesterol 25-hydroxylase</synonym>
      <synonym>CYP3A3</synonym>
      <synonym>CYPIIIA3</synonym>
      <synonym>CYPIIIA4</synonym>
      <synonym>Cytochrome P450 3A3</synonym>
      <synonym>Cytochrome P450 HLp</synonym>
      <synonym>Cytochrome P450 NF-25</synonym>
      <synonym>Cytochrome P450-PCN1</synonym>
      <synonym>Nifedipine oxidase</synonym>
      <synonym>Quinine 3-monooxygenase</synonym>
      <synonym>Taurochenodeoxycholate 6-alpha-hydroxylase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0021936|Cytochrome P450 3A4
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)
ATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG
CTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG
CCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT
GACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT
GTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT
GTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA
GCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA
AAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG
AGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC
ATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA
GACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT
CTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT
CCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC
GAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA
AAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC
TTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG
GCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT
AAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT
GAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT
GAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT
CACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG
AAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC
TGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG
AACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA
CTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT
GGAGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00067</identifier>
        <name>p450</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>taurochenodeoxycholate 6alpha-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxygen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D 24-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>testosterone 6-beta-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D3 25-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>albendazole monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>caffeine oxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>quinine 3-monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>drug catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heterocycle metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>monoterpenoid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>drug metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidative demethylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>androgen metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcitriol biosynthetic process from calciol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>exogenous drug catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alkaloid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>weak</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters/>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00137</drugbank-id>
  <drugbank-id>NUTR00036</drugbank-id>
  <drugbank-id>DB11138</drugbank-id>
  <name>Lutein</name>
  <description>Lutein is an xanthophyll and one of 600 known naturally occurring carotenoids. Lutein is synthesized only by plants and like other xanthophylls is found in high quantities in green leafy vegetables such as spinach, kale and yellow carrots. In green plants, xanthophylls act to modulate light energy and serve as non-photochemical quenching agents to deal with triplet chlorophyll (an excited form of chlorophyll), which is overproduced at very high light levels, during photosynthesis.</description>
  <cas-number>127-40-2</cas-number>
  <unii>X72A60C9MT</unii>
  <average-mass>568.886</average-mass>
  <monoisotopic-mass>568.428031043</monoisotopic-mass>
  <state>liquid</state>
  <groups>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>20830634</pubmed-id>
        <citation>Namitha KK, Negi PS: Chemistry and biotechnology of carotenoids. Crit Rev Food Sci Nutr. 2010 Sep;50(8):728-60. doi: 10.1080/10408398.2010.499811.</citation>
      </article>
      <article>
        <pubmed-id>20355006</pubmed-id>
        <citation>Ma L, Lin XM: Effects of lutein and zeaxanthin on aspects of eye health. J Sci Food Agric. 2010 Jan 15;90(1):2-12. doi: 10.1002/jsfa.3785.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Helmut Auweter, Heribert Bohn, Erik Luddecke, "Stable, aqueous dispersions and stable, water-dispersible dry xanthophyll powder, their production and use." U.S. Patent US6296877, issued September, 1994.</synthesis-reference>
  <indication>Xanthophylls are taken for nutritional supplementation, and also for treating dietary shortage or imbalance.</indication>
  <pharmacodynamics>Lutein was found to be present in a concentrated area of the macula, a small area of the retina responsible for central vision. The hypothesis for the natural concentration is that lutein helps protect from oxidative stress and high-energy light. Several studies show that an increase in macula pigmentation decreases the risk for eye diseases such as Age-related Macular Degeneration (AMD).</pharmacodynamics>
  <mechanism-of-action>Xanthophylls have antioxidant activity and react with active oxygen species, producing biologically active degradation products. They also can inhibit peroxidation of membrane phospholipids and reduce lipofuscin formation, both of which contribute to their antioxidant properties. Lutein is naturally present in the macula of the human retina. It filters out potentially phototoxic blue light and near-ultraviolet radiation from the macula. The protective effect is due in part, to the reactive oxygen species quenching ability of these carotenoids. Lutein is more stable to decomposition by pro-oxidants than are other carotenoids such as beta-carotene and lycopene. Lutein is abundant in the region surrounding the fovea, and lutein is the predominant pigment at the outermost periphery of the macula. Zeaxanthin, which is fully conjugated (lutein is not), may offer somewhat better protection than lutein against phototoxic damage caused by blue and near-ultraviolet light radiation. Lutein is one of only two carotenoids that have been identified in the human lens, may be protective against age-related increases in lens density and cataract formation. Again, the possible protection afforded by lutein may be accounted for, in part, by its reactive oxygen species scavenging abilities. Carotenoids also provide protection from cancer. One of the mechanisms of this is by increasing the expression of the protein connexin-43, thereby stimulating gap junctional communication and preventing unrestrained cell proliferation.</mechanism-of-action>
  <toxicity/>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as xanthophylls. These are carotenoids containing an oxygenated carotene backbone. Carotenes are characterized by the presence of two end-groups (mostly cyclohexene rings, but also cyclopentene rings or acyclic groups) linked by a long branched alkyl chain. Carotenes belonging form a subgroup of the carotenoids family. Xanthophylls arise by oxygenation of the carotene backbone.</description>
    <direct-parent>Xanthophylls</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Lipids and lipid-like molecules</class>
    <subclass>Prenol lipids</subclass>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aliphatic homomonocyclic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Xanthophyll</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">Xanthophyll</synonym>
    <synonym language="" coder="WHO-DD">Xantofyl</synonym>
  </synonyms>
  <products>
    <product>
      <name>Doctor Super Lutein</name>
      <labeller>H Lscience Co Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>59091-5001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength>20 g/100g</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Macuzin</name>
      <labeller>Sterling Knight Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69336-800</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-04-30</started-marketing-on>
      <ended-marketing-on>2017-09-13</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ocuvel</name>
      <labeller>Adler Stern Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69054-210</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-11-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ocuvel</name>
      <labeller>Adler Stern Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69054-211</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-12-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Strovite One Caplets</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0207</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-05-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tozal</name>
      <labeller>Focus Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>15821-501</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-06-01</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Strovite One Caplets</name>
      <ingredients>Biotin + Cholecalciferol + Chromium + Cupric sulfate + Cyanocobalamin + Folic Acid + Lipoic Acid + Lutein + Magnesium oxide + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Tozal</name>
      <ingredients>Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Lutein + Omega-3 fatty acids + Pyridoxine + Taurine + Vitamin A + Vitamin C + Vitamin E + Zeaxanthin + Zinc picolinate</ingredients>
    </mixture>
    <mixture>
      <name>Ocuvel</name>
      <ingredients>Copper + Folic Acid + Lutein + Vitamin C + Vitamin E + Zeaxanthin + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Ocuvel</name>
      <ingredients>Copper + Folic Acid + Lutein + Vitamin C + Vitamin E + Zeaxanthin + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Macuzin</name>
      <ingredients>Copper + Folic Acid + Lutein + Vitamin C + Vitamin E + Zeaxanthin + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Doctor Super Lutein</name>
      <ingredients>Lutein</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>20 g/100g</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1RWT</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00137.pdf?1265922740</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>8.29</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-5.9</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>7.32e-04 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>8.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(1R,4R)-4-[(1E,3E,5E,7E,9E,11E,13E,15E,17E)-18-[(4R)-4-hydroxy-2,6,6-trimethylcyclohex-1-en-1-yl]-3,7,12,16-tetramethyloctadeca-1,3,5,7,9,11,13,15,17-nonaen-1-yl]-3,5,5-trimethylcyclohex-2-en-1-ol</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>carotenoid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>568.886</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>568.428031043</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>C\C(\C=C\C=C(/C)\C=C\[C@H]1C(C)=C[C@H](O)CC1(C)C)=C/C=C/C=C(\C)/C=C/C=C(\C)/C=C/C1=C(C)C[C@@H](O)CC1(C)C</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C40H56O2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C40H56O2/c1-29(17-13-19-31(3)21-23-37-33(5)25-35(41)27-39(37,7)8)15-11-12-16-30(2)18-14-20-32(4)22-24-38-34(6)26-36(42)28-40(38,9)10/h11-25,35-37,41-42H,26-28H2,1-10H3/b12-11+,17-13+,18-14+,23-21+,24-22+,29-15+,30-16+,31-19+,32-20+/t35-,36+,37-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KBPHJBAIARWVSC-RGZFRNHPSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>40.46</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>195.06</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>73.81</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>10</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>18.22</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-0.91</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Insoluble</value>
      <source/>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>196 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>7.9</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>28838</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C08601</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>4444655</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164748318</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>LUT</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Xanthophyll</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL173929</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lut_0164.shtml</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets/>
  <enzymes/>
  <carriers>
    <carrier>
      <id>BE0000530</id>
      <name>Serum albumin</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16678417</pubmed-id>
            <citation>Zsila F, Nadolski G, Lockwood SF: Association studies of aggregated aqueous lutein diphosphate with human serum albumin and alpha1-acid glycoprotein in vitro: evidence from circular dichroism and electronic absorption spectroscopy. Bioorg Med Chem Lett. 2006 Jul 15;16(14):3797-801. Epub 2006 May 5.</citation>
          </article>
          <article>
            <pubmed-id>11273666</pubmed-id>
            <citation>Yemelyanov AY, Katz NB, Bernstein PS: Ligand-binding characterization of xanthophyll carotenoids to solubilized membrane proteins derived from human retina. Exp Eye Res. 2001 Apr;72(4):381-92.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P02768" source="Swiss-Prot">
    <name>Serum albumin</name>
    <general-function>Toxic substance binding</general-function>
    <specific-function>Serum albumin, the main protein of plasma, has a good binding capacity for water, Ca(2+), Na(+), K(+), fatty acids, hormones, bilirubin and drugs. Its main function is the regulation of the colloidal osmotic pressure of blood. Major zinc transporter in plasma, typically binds about 80% of all plasma zinc.</specific-function>
    <gene-name>ALB</gene-name>
    <locus>4q11-q13</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-18</signal-regions>
    <theoretical-pi>6.21</theoretical-pi>
    <molecular-weight>69365.94</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:399</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ALB</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>V00494</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>28590</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P02768</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ALBU_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Serum albumin precursor</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001058|Serum albumin
MKWVTFISLLFLFSSAYSRGVFRRDAHKSEVAHRFKDLGEENFKALVLIAFAQYLQQCPF
EDHVKLVNEVTEFAKTCVADESAENCDKSLHTLFGDKLCTVATLRETYGEMADCCAKQEP
ERNECFLQHKDDNPNLPRLVRPEVDVMCTAFHDNEETFLKKYLYEIARRHPYFYAPELLF
FAKRYKAAFTECCQAADKAACLLPKLDELRDEGKASSAKQRLKCASLQKFGERAFKAWAV
ARLSQRFPKAEFAEVSKLVTDLTKVHTECCHGDLLECADDRADLAKYICENQDSISSKLK
ECCEKPLLEKSHCIAEVENDEMPADLPSLAADFVESKDVCKNYAEAKDVFLGMFLYEYAR
RHPDYSVVLLLRLAKTYETTLEKCCAAADPHECYAKVFDEFKPLVEEPQNLIKQNCELFE
QLGEYKFQNALLVRYTKKVPQVSTPTLVEVSRNLGKVGSKCCKHPEAKRMPCAEDYLSVV
LNQLCVLHEKTPVSDRVTKCCTESLVNRRPCFSALEVDETYVPKEFNAETFTFHADICTL
SEKERQIKKQTALVELVKHKPKATKEQLKAVMDDFAAFVEKCCKADDKETCFAEEGKKLV
AASQAALGL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010372|Serum albumin (ALB)
ATGAAGTGGGTAACCTTTATTTCCCTTCTTTTTCTCTTTAGCTCGGCTTATTCCAGGGGT
GTGTTTCGTCGAGATGCACACAAGAGTGAGGTTGCTCATCGGTTTAAAGATTTGGGAGAA
GAAAATTTCAAAGCCTTGGTGTTGATTGCCTTTGCTCAGTATCTTCAGCAGTGTCCATTT
GAAGATCATGTAAAATTAGTGAATGAAGTAACTGAATTTGCAAAAACATGTGTTGCTGAT
GAGTCAGCTGAAAATTGTGACAAATCACTTCATACCCTTTTTGGAGACAAATTATGCACA
GTTGCAACTCTTCGTGAAACCTATGGTGAAATGGCTGACTGCTGTGCAAAACAAGAACCT
GAGAGAAATGAATGCTTCTTGCAACACAAAGATGACAACCCAAACCTCCCCCGATTGGTG
AGACCAGAGGTTGATGTGATGTGCACTGCTTTTCATGACAATGAAGAGACATTTTTGAAA
AAATACTTATATGAAATTGCCAGAAGACATCCTTACTTTTATGCCCCGGAACTCCTTTTC
TTTGCTAAAAGGTATAAAGCTGCTTTTACAGAATGTTGCCAAGCTGCTGATAAAGCTGCC
TGCCTGTTGCCAAAGCTCGATGAACTTCGGGATGAAGGGAAGGCTTCGTCTGCCAAACAG
AGACTCAAGTGTGCCAGTCTCCAAAAATTTGGAGAAAGAGCTTTCAAAGCATGGGCAGTA
GCTCGCCTGAGCCAGAGATTTCCCAAAGCTGAGTTTGCAGAAGTTTCCAAGTTAGTGACA
GATCTTACCAAAGTCCACACGGAATGCTGCCATGGAGATCTGCTTGAATGTGCTGATGAC
AGGGCGGACCTTGCCAAGTATATCTGTGAAAATCAAGATTCGATCTCCAGTAAACTGAAG
GAATGCTGTGAAAAACCTCTGTTGGAAAAATCCCACTGCATTGCCGAAGTGGAAAATGAT
GAGATGCCTGCTGACTTGCCTTCATTAGCTGCTGATTTTGTTGAAAGTAAGGATGTTTGC
AAAAACTATGCTGAGGCAAAGGATGTCTTCCTGGGCATGTTTTTGTATGAATATGCAAGA
AGGCATCCTGATTACTCTGTCGTGCTGCTGCTGAGACTTGCCAAGACATATGAAACCACT
CTAGAGAAGTGCTGTGCCGCTGCAGATCCTCATGAATGCTATGCCAAAGTGTTCGATGAA
TTTAAACCTCTTGTGGAAGAGCCTCAGAATTTAATCAAACAAAATTGTGAGCTTTTTGAG
CAGCTTGGAGAGTACAAATTCCAGAATGCGCTATTAGTTCGTTACACCAAGAAAGTACCC
CAAGTGTCAACTCCAACTCTTGTAGAGGTCTCAAGAAACCTAGGAAAAGTGGGCAGCAAA
TGTTGTAAACATCCTGAAGCAAAAAGAATGCCCTGTGCAGAAGACTATCTATCCGTGGTC
CTGAACCAGTTATGTGTGTTGCATGAGAAAACGCCAGTAAGTGACAGAGTCACCAAATGC
TGCACAGAATCCTTGGTGAACAGGCGACCATGCTTTTCAGCTCTGGAAGTCGATGAAACA
TACGTTCCCAAAGAGTTTAATGCTGAAACATTCACCTTCCATGCAGATATATGCACACTT
TCTGAGAAGGAGAGACAAATCAAGAAACAAACTGCACTTGTTGAGCTCGTGAAACACAAG
CCCAAGGCAACAAAAGAGCAACTGAAAGCTGTTATGGATGATTTCGCAGCTTTTGTAGAG
AAGTGCTGCAAGGCTGACGATAAGGAGACCTGCTTTGCCGAGGAGGGTAAAAAACTTGTT
GCTGCAAGTCAAGCTGCCTTAGGCTTATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00273</identifier>
        <name>Serum_albumin</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>blood microparticle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>protein complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>platelet alpha granule lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>fatty acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>copper ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>antioxidant activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chaperone binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>toxic substance binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet activation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium-independent organic anion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoprotein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid and bile salt transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>receptor-mediated endocytosis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hemolysis by symbiont of host erythrocytes</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>maintenance of mitochondrion location</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of programmed cell death</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet degranulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>retina homeostasis</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </carrier>
  </carriers>
  <transporters/>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00138</drugbank-id>
  <drugbank-id>NUTR00023</drugbank-id>
  <name>Cystine</name>
  <description>A covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine.</description>
  <cas-number>56-89-3</cas-number>
  <unii>48TCX9A1VT</unii>
  <average-mass>240.3</average-mass>
  <monoisotopic-mass>240.023848262</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Peter Stehle, Peter Furst, Werner Fekl, "N,N'-bis-L-amino acid-L-cystine-peptide containing amino acid preparations for oral parenteral nutrition." U.S. Patent US4968696, issued February, 1964.</synthesis-reference>
  <indication>It has been claimed that L-cysteine has anti-inflammatory properties, that it can protect against various toxins, and that it might be helpful in osteoarthritis and rheumatoid arthritis. More research will have to be done before L-cysteine can be indicated for any of these conditions. Research to date has mostly been in animal models.</indication>
  <pharmacodynamics>L-Cystine is a covalently linked dimeric nonessential amino acid formed by the oxidation of cysteine. Two molecules of cysteine are joined together by a disulfide bridge to form cystine. Cystine is a chemical substance which naturally occurs as a deposit in the urine, and can form a calculus (hard mineral formation) when deposited in the kidney. The compound produced when two cysteine molecules linked by a disulfide (S-S) bond. Cystine is required for proper vitamin B6 utilization and is also helpful in the healing of burns and wounds, breaking down mucus deposits in illnesses such as bronchitis as well as cystic fibrosis. Cysteine also assists in the supply of insulin to the pancreas, which is needed for the assimilation of sugars and starches. It increases the level of glutathione in the lungs, liver, kidneys and bone marrow, and this may have an anti-aging effect on the body by reducing age-spots etc.</pharmacodynamics>
  <mechanism-of-action>Certain conditions, e.g. an acetaminophen overdose, deplete hepatic glutathione and subject the tissues to oxidative stress resulting in loss of cellular integrity. L-Cystine serves as a major precursor for synthesis of glutathione.</mechanism-of-action>
  <toxicity>With typical doses of 1 to 1.5 grams daily, the most commonly reported side effects have been gastrointestinal, such as nausea. There are rare reports of cystine renal stone formation, Single injections of L-cysteine (0.6-1.5 g/kg) into 4-day-old pups resulted in massive damage to cortical neurons, permanent retinal dystrophy, atrophy of the brain and hyperactivity.</toxicity>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as l-cysteine-s-conjugates. These are compounds containing L-cysteine where the thio-group is conjugated.</description>
    <direct-parent>L-cysteine-S-conjugates</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Organic acids and derivatives</class>
    <subclass>Carboxylic acids and derivatives</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dialkyldisulfides</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Sulfenyl compounds</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dialkyldisulfide</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>L-cysteine-s-conjugate</substituent>
    <substituent>Organic disulfide</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Organosulfur compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Sulfenyl compound</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">(R,R)-3,3'-dithiobis(2-aminopropanoic acid)</synonym>
    <synonym language="" coder="">L-alpha-Diamino-beta-dithiolactic acid</synonym>
    <synonym language="" coder="">L-Cystine</synonym>
    <synonym language="" coder="">L-Dicysteine</synonym>
    <synonym language="" coder="">β,β'-dithiodialanine</synonym>
  </synonyms>
  <products>
    <product>
      <name>Medi Msm (methyl Sulfonyl Methane)</name>
      <labeller>Mbg Inc (Korea Institute of Science Development)</labeller>
      <ndc-id/>
      <ndc-product-code>70694-3850</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-09-16</started-marketing-on>
      <ended-marketing-on>2017-09-16</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Medi Msm (methyl Sulfonyl Methane)</name>
      <ingredients>Biotin + Cystine + L-Cysteine + L-Methionine + Thiamine</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Mason Distributors</name>
      <url/>
    </packager>
    <packager>
      <name>Tyson &amp; Associates Inc.</name>
      <url/>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Amino acid capsule</description>
      <cost currency="USD">0.08</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>A-ketoglut acid 500 mg capsule</description>
      <cost currency="USD">0.31</cost>
      <unit>capsule</unit>
    </price>
    <price>
      <description>L-alanine 600 mg capsule</description>
      <cost currency="USD">0.35</cost>
      <unit>capsule</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Acids</category>
      <mesh-id>D000143</mesh-id>
    </category>
    <category>
      <category>Acids, Noncarboxylic</category>
      <mesh-id>D000148</mesh-id>
    </category>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Diamino</category>
      <mesh-id>D000599</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Dicarboxylic</category>
      <mesh-id>D000600</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Neutral</category>
      <mesh-id>D021542</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Sulfur</category>
      <mesh-id>D000603</mesh-id>
    </category>
    <category>
      <category>Anions</category>
      <mesh-id>D000838</mesh-id>
    </category>
    <category>
      <category>Cysteine</category>
      <mesh-id>D003545</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Disulfides</category>
      <mesh-id>D004220</mesh-id>
    </category>
    <category>
      <category>Electrolytes</category>
      <mesh-id>D004573</mesh-id>
    </category>
    <category>
      <category>Gases</category>
      <mesh-id>D005740</mesh-id>
    </category>
    <category>
      <category>Hydrogen Sulfide</category>
      <mesh-id>D006862</mesh-id>
    </category>
    <category>
      <category>Inorganic Chemicals</category>
      <mesh-id>D007287</mesh-id>
    </category>
    <category>
      <category>Ions</category>
      <mesh-id>D007477</mesh-id>
    </category>
    <category>
      <category>Organic Chemicals</category>
      <mesh-id>D009930</mesh-id>
    </category>
    <category>
      <category>Sulfhydryl Compounds</category>
      <mesh-id>D013438</mesh-id>
    </category>
    <category>
      <category>Sulfides</category>
      <mesh-id>D013440</mesh-id>
    </category>
    <category>
      <category>Sulfur Compounds</category>
      <mesh-id>D013457</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Powder</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1SSQ</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00138.pdf?1265922735</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-1.2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.68e+01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-5.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2R)-2-amino-3-{[(2R)-2-amino-2-carboxyethyl]disulfanyl}propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>L-cystine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>240.3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>240.023848262</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>N[C@@H](CSSC[C@H](N)C(O)=O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C6H12N2O4S2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C6H12N2O4S2/c7-3(5(9)10)1-13-14-2-4(8)6(11)12/h3-4H,1-2,7-8H2,(H,9,10)(H,11,12)/t3-,4-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>LEVWYRKDKASIDU-IMJSIDKUSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>126.64</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>54.87</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>22.77</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.56</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.34</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>190 mg/L (at 20 °C)</value>
      <source>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>260.5 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-5.08</value>
      <source>CHMELIK,J ET AL. (1991)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>1</value>
      <source>MERCK INDEX (1996)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>16283</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00491</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D03636</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>60997</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449176</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL590540</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/lcy_0088.shtml</url>
    </external-link>
  </external-links>
  <pathways/>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000030</id>
      <name>Cystine/glutamate transporter</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>11867597</pubmed-id>
            <citation>Tomi M, Hosoya K, Takanaga H, Ohtsuki S, Terasaki T: Induction of xCT gene expression and L-cystine transport activity by diethyl maleate at the inner blood-retinal barrier. Invest Ophthalmol Vis Sci. 2002 Mar;43(3):774-9.</citation>
          </article>
          <article>
            <pubmed-id>12065721</pubmed-id>
            <citation>Hosoya K, Tomi M, Ohtsuki S, Takanaga H, Saeki S, Kanai Y, Endou H, Naito M, Tsuruo T, Terasaki T: Enhancement of L-cystine transport activity and its relation to xCT gene induction at the blood-brain barrier by diethyl maleate treatment. J Pharmacol Exp Ther. 2002 Jul;302(1):225-31.</citation>
          </article>
          <article>
            <pubmed-id>12498985</pubmed-id>
            <citation>Ruiz E, Siow RC, Bartlett SR, Jenner AM, Sato H, Bannai S, Mann GE: Vitamin C inhibits diethylmaleate-induced L-cystine transport in human vascular smooth muscle cells. Free Radic Biol Med. 2003 Jan 1;34(1):103-10.</citation>
          </article>
          <article>
            <pubmed-id>16014042</pubmed-id>
            <citation>Bridges CC, Zalups RK: Cystine and glutamate transport in renal epithelial cells transfected with human system x(-) (c). Kidney Int. 2005 Aug;68(2):653-64.</citation>
          </article>
          <article>
            <pubmed-id>12898700</pubmed-id>
            <citation>Tomi M, Funaki T, Abukawa H, Katayama K, Kondo T, Ohtsuki S, Ueda M, Obinata M, Terasaki T, Hosoya K: Expression and regulation of L-cystine transporter, system xc-, in the newly developed rat retinal Muller cell line (TR-MUL). Glia. 2003 Sep;43(3):208-17.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UPY5" source="Swiss-Prot">
    <name>Cystine/glutamate transporter</name>
    <general-function>Cystine:glutamate antiporter activity</general-function>
    <specific-function>Sodium-independent, high-affinity exchange of anionic amino acids with high specificity for anionic form of cystine and glutamate.</specific-function>
    <gene-name>SLC7A11</gene-name>
    <locus>4q28-q32</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>44-64
75-95
114-134
159-179
190-210
235-255
266-286
318-338
365-385
388-408
423-443
450-470</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.51</theoretical-pi>
    <molecular-weight>55422.44</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11059</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC7A11</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB026891</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5668545</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>902</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UPY5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>XCT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Amino acid transport system xc-</synonym>
      <synonym>Calcium channel blocker resistance protein CCBR1</synonym>
      <synonym>Solute carrier family 7 member 11</synonym>
      <synonym>xCT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0015999|Cystine/glutamate transporter
MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGVSIIIGTIIGA
GIFISPKGVLQNTGSVGMSLTIWTVCGVLSLFGALSYAELGTTIKKSGGHYTYILEVFGP
LPAFVRVWVELLIIRPAATAVISLAFGRYILEPFFIQCEIPELAIKLITAVGITVVMVLN
SMSVSWSARIQIFLTFCKLTAILIIIVPGVMQLIKGQTQNFKDAFSGRDSSITRLPLAFY
YGMYAYAGWFYLNFVTEEVENPEKTIPLAICISMAIVTIGYVLTNVAYFTTINAEELLLS
NAVAVTFSERLLGNFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSMIHV
RKHTPLPAVIVLHPLTMIMLFSGDLDSLLNFLSFARWLFIGLAVAGLIYLRYKCPDMHRP
FKVPLFIPALFSFTCLFMVALSLYSDPFSTGIGFVITLTGVPAYYLFIIWDKKPRWFRIM
SEKITRTLQIILEVVPEEDKL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016000|Cystine/glutamate transporter (SLC7A11)
ATGGTCAGAAAGCCTGTTGTGTCCACCATCTCCAAAGGAGGTTACCTGCAGGGAAATGTT
AACGGGAGGCTGCCTTCCCTGGGCAACAAGGAGCCACCTGGGCAGGAGAAAGTGCAGCTG
AAGAGGAAAGTCACTTTACTGAGGGGAGTCTCCATTATCATTGGCACCATCATTGGAGCA
GGAATCTTCATCTCTCCTAAGGGCGTGCTCCAGAACACGGGCAGCGTGGGCATGTCTCTG
ACCATCTGGACGGTGTGTGGGGTCCTGTCACTATTTGGAGCTTTGTCTTATGCTGAATTG
GGAACAACTATAAAGAAATCTGGAGGTCATTACACATATATTTTGGAAGTCTTTGGTCCA
TTACCAGCTTTTGTACGAGTCTGGGTGGAACTCCTCATAATACGCCCTGCAGCTACTGCT
GTGATATCCCTGGCATTTGGACGCTACATTCTGGAACCATTTTTTATTCAATGTGAAATC
CCTGAACTTGCGATCAAGCTCATTACAGCTGTGGGCATAACTGTAGTGATGGTCCTAAAT
AGCATGAGTGTCAGCTGGAGCGCCCGGATCCAGATTTTCTTAACCTTTTGCAAGCTCACA
GCAATTCTGATAATTATAGTCCCTGGAGTTATGCAGCTAATTAAAGGTCAAACGCAGAAC
TTTAAAGACGCCTTTTCAGGAAGAGATTCAAGTATTACGCGGTTGCCACTGGCTTTTTAT
TATGGAATGTATGCATATGCTGGCTGGTTTTACCTCAACTTTGTTACTGAAGAAGTAGAA
AACCCTGAAAAAACCATTCCCCTTGCAATATGTATATCCATGGCCATTGTCACCATTGGC
TATGTGCTGACAAATGTGGCCTACTTTACGACCATTAATGCTGAGGAGCTGCTGCTTTCA
AATGCAGTGGCAGTGACCTTTTCTGAGCGGCTACTGGGAAATTTCTCATTAGCAGTTCCG
ATCTTTGTTGCCCTCTCCTGCTTTGGCTCCATGAACGGTGGTGTGTTTGCTGTCTCCAGG
TTATTCTATGTTGCGTCTCGAGAGGGTCACCTTCCAGAAATCCTCTCCATGATTCATGTC
CGCAAGCACACTCCTCTACCAGCTGTTATTGTTTTGCACCCTTTGACAATGATAATGCTC
TTCTCTGGAGACCTCGACAGTCTTTTGAATTTCCTCAGTTTTGCCAGGTGGCTTTTTATT
GGGCTGGCAGTTGCTGGGCTGATTTATCTTCGATACAAATGCCCAGATATGCATCGTCCT
TTCAAGGTGCCACTGTTCATCCCAGCTTTGTTTTCCTTCACATGCCTCTTCATGGTTGCC
CTTTCCCTCTATTCGGACCCATTTAGTACAGGGATTGGCTTCGTCATCACTCTGACTGGA
GTCCCTGCGTATTATCTCTTTATTATATGGGACAAGAAACCCAGGTGGTTTAGAATAATG
TCAGAGAAAATAACCAGAACATTACAAATAATACTGGAAGTTGTACCAGAAGAAGATAAG
TTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13520</identifier>
        <name>AA_permease_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cystine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lens fiber cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet aggregation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000035</id>
      <name>Cystinosin</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>11689434</pubmed-id>
            <citation>Kalatzis V, Cherqui S, Antignac C, Gasnier B: Cystinosin, the protein defective in cystinosis, is a H(+)-driven lysosomal cystine transporter. EMBO J. 2001 Nov 1;20(21):5940-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60931" source="Swiss-Prot">
    <name>Cystinosin</name>
    <general-function>L-cystine transmembrane transporter activity</general-function>
    <specific-function>Cystine/H(+) symporter thought to transport cystine out of lysosomes. Plays an important role in melanin synthesis, possibly by preventing melanosome acidification and subsequent degradation of tyrosinase TYR.</specific-function>
    <gene-name>CTNS</gene-name>
    <locus>17p13</locus>
    <cellular-location>Lysosome membrane</cellular-location>
    <transmembrane-regions>122-142
162-182
206-226
238-258
262-282
298-318
336-356</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.21</theoretical-pi>
    <molecular-weight>41737.6</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2518</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CTNS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y15924</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3036851</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60931</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CTNS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037667|Cystinosin
MIRNWLTIFILFPLKLVEKCESSVSLTVPPVVKLENGSSTNVSLTLRPPLNATLVITFEI
TFRSKNITILELPDEVVVPPGVTNSSFQVTSQNVGQLTVYLHGNHSNQTGPRIRFLVIRS
SAISIINQVIGWIYFVAWSISFYPQVIMNWRRKSVIGLSFDFVALNLTGFVAYSVFNIGL
LWVPYIKEQFLLKYPNGVNPVNSNDVFFSLHAVVLTLIIIVQCCLYERGGQRVSWPAIGF
LVLAWLFAFVTMIVAAVGVTTWLQFLFCFSYIKLAVTLVKYFPQAYMNFYYKSTEGWSIG
NVLLDFTGGSFSLLQMFLQSYNNDQWTLIFGDPTKFGLGVFSIVFDVVFFIQHFCLYRKR
PGYDQLN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010137|Cystinosin (CTNS)
ATGATAAGGAATTGGCTGACTATTTTTATCCTTTTTCCCCTGAAGCTCGTAGAGAAATGT
GAGTCAAGCGTCAGCCTCACTGTTCCTCCTGTCGTAAAGCTGGAGAACGGCAGCTCGACC
AACGTCAGCCTCACCCTGCGGCCACCATTAAATGCAACCCTGGTGATCACTTTTGAAATC
ACATTTCGTTCCAAAAATATTACTATCCTTGAGCTCCCCGATGAAGTTGTGGTGCCTCCT
GGAGTGACAAACTCCTCTTTTCAAGTGACATCTCAAAATGTTGGACAACTTACTGTTTAT
CTACATGGAAATCACTCCAATCAGACCGGCCCGAGGATACGCTTTCTTGTGATCCGCAGC
AGCGCCATTAGCATCATAAACCAGGTGATTGGCTGGATCTACTTTGTGGCCTGGTCCATC
TCCTTCTACCCTCAGGTGATCATGAATTGGAGGCGGAAAAGTGTCATTGGTCTGAGCTTC
GACTTCGTGGCTCTGAACCTGACGGGCTTCGTGGCCTACAGTGTATTCAACATCGGCCTC
CTCTGGGTGCCCTACATCAAGGAGCAGTTTCTCCTCAAATACCCCAACGGAGTGAACCCC
GTGAACAGCAACGACGTCTTCTTCAGCCTGCACGCGGTTGTCCTCACGCTGATCATCATC
GTGCAGTGCTGCCTGTATGAGCGCGGTGGCCAGCGCGTGTCCTGGCCTGCCATCGGCTTC
CTGGTGCTCGCGTGGCTCTTCGCATTTGTCACCATGATCGTGGCTGCAGTGGGAGTGACC
ACGTGGCTGCAGTTTCTCTTCTGCTTCTCCTACATCAAGCTCGCAGTCACGCTGGTCAAG
TATTTTCCACAGGCCTACATGAACTTTTACTACAAAAGCACTGAGGGCTGGAGCATTGGC
AACGTGCTCCTGGACTTCACCGGGGGCAGCTTCAGCCTCCTGCAGATGTTCCTCCAGTCC
TACAACAACGACCAGTGGACGCTGATCTTCGGAGACCCAACCAAGTTTGGACTCGGGGTC
TTCTCCATCGTCTTCGACGTCGTCTTCTTCATCCAGCACTTCTGTTTGTACAGAAAGAGA
CCGGGGCTTCAGGCAGCGCGCACAGGCTCTGGCAGCCGTCTCAGGCAGGACTGGGCACCA
AGCTTGCAGCCGAAGGCCTTGCCCCAAACTACCAGCGTTTCTGCAAGCAGCTTGAAGGGC
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04193</identifier>
        <name>PQ-loop</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>lysosomal membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>melanosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>lysosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intermediate filament cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>late endosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-cystine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>melanin biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult walking behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ATP metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>grooming behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-cystine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cognition</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lens development in camera-type eye</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term memory</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002251</id>
      <name>B(0,+)-type amino acid transporter 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P82251" source="Swiss-Prot">
    <name>b(0,+)-type amino acid transporter 1</name>
    <general-function>Peptide antigen binding</general-function>
    <specific-function>Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system b(0,+)-like activity). Thought to be responsible for the high-affinity reabsorption of cystine in the kidney tubule.</specific-function>
    <gene-name>SLC7A9</gene-name>
    <locus>19q13.1</locus>
    <cellular-location>Apical cell membrane</cellular-location>
    <transmembrane-regions>30-50
61-81
100-120
149-169
179-199
211-231
252-272
297-317
349-369
375-395
410-430
435-455</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.21</theoretical-pi>
    <molecular-weight>53480.81</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11067</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC7A9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF141289</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5916108</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P82251</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BAT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>b(0,+)AT1</synonym>
      <synonym>BAT1</synonym>
      <synonym>Glycoprotein-associated amino acid transporter b0,+AT1</synonym>
      <synonym>Solute carrier family 7 member 9</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016729|b(0,+)-type amino acid transporter 1
MGDTGLRKRREDEKSIQSQEPKTTSLQKELGLISGISIIVGTIIGSGIFVSPKSVLSNTE
AVGPCLIIWAACGVLATLGALCFAELGTMITKSGGEYPYLMEAYGPIPAYLFSWASLIVI
KPTSFAIICLSFSEYVCAPFYVGCKPPQIVVKCLAAAAILFISTVNSLSVRLGSYVQNIF
TAAKLVIVAIIIISGLVLLAQGNTKNFDNSFEGAQLSVGAISLAFYNGLWAYDGWNQLNY
ITEELRNPYRNLPLAIIIGIPLVTACYILMNVSYFTVMTATELLQSQAVAVTFGDRVLYP
ASWIVPLFVAFSTIGAANGTCFTAGRLIYVAGREGHMLKVLSYISVRRLTPAPAIIFYGI
IATIYIIPGDINSLVNYFSFAAWLFYGLTILGLIVMRFTRKELERPIKVPVVIPVLMTLI
SVFLVLAPIISKPTWEYLYCVLFILSGLLFYFLFVHYKFGWAQKISKPITMHLQMLMEVV
PPEEDPE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016730|b(0,+)-type amino acid transporter 1 (SLC7A9)
ATGGGGGATACTGGCCTGAGAAAGCGGAGAGAGGATGAGAAGTCGATCCAGAGCCAAGAG
CCTAAGACCACCAGTCTCCAAAAGGAGCTGGGCCTCATCAGTGGCATCTCCATCATCGTG
GGCACCATCATTGGCTCTGGGATCTTCGTTTCCCCCAAGTCTGTGCTCAGCAACACGGAA
GCTGTGGGGCCCTGCCTCATCATATGGGCGGCTTGCGGGGTCCTCGCGACGCTGGGTGCC
CTGTGCTTTGCGGAGCTTGGCACAATGATCACCAAGTCAGGGGGAGAGTATCCCTACCTG
ATGGAGGCCTACGGGCCCATCCCCGCCTACCTCTTCTCCTGGGCCAGCCTGATCGTCATT
AAGCCCACGTCCTTCGCCATCATCTGCCTCAGCTTCTCCGAGTATGTGTGTGCGCCCTTC
TATGTGGGCTGCAAGCCTCCTCAAATCGTTGTGAAATGCCTGGCCGCCGCCGCCATCTTG
TTCATCTCGACAGTGAACTCACTGAGCGTGCGGCTGGGAAGCTACGTCCAGAACATCTTC
ACCGCGGCCAAGCTGGTGATCGTGGCCATCATCATCATCAGCGGGCTGGTGCTCCTGGCC
CAAGGAAACACAAAGAATTTTGATAATTCTTTCGAGGGCGCCCAGCTGTCTGTGGGAGCC
ATCAGCCTGGCGTTTTACAATGGACTCTGGGCCTATGATGGATGGAATCAACTCAATTAC
ATCACAGAAGAACTTAGAAACCCTTACAGAAACCTGCCTTTGGCCATTATCATCGGGATC
CCCCTGGTGACGGCGTGCTACATCCTCATGAACGTGTCCTACTTCACCGTGATGACTGCC
ACCGAACTCCTGCAGTCCCAGGCGGTGGCTGTGACATTTGGTGACCGTGTTCTCTATCCT
GCTTCTTGGATCGTTCCACTTTTTGTGGCATTTTCAACCATCGGTGCTGCTAACGGGACC
TGCTTCACAGCGGGCAGACTCATTTACGTGGCGGGCCGGGAGGGTCACATGCTCAAAGTG
CTTTCTTACATCAGCGTCAGGCGCCTCACTCCAGCCCCCGCCATCATCTTTTATGGTATC
ATAGCAACGATTTATATCATCCCTGGTGACATAAACTCGTTAGTCAATTATTTCAGCTTT
GCCGCATGGCTGTTTTATGGCCTGACGATTCTAGGACTCATCGTGATGAGATTTACAAGG
AAAGAGCTGGAAAGGCCTATCAAGGTGCCCGTAGTCATTCCCGTCTTGATGACACTCATC
TCTGTGTTTTTGGTTCTGGCTCCAATCATCAGCAAGCCCACCTGGGAGTACCTCTACTGT
GTGCTGTTTATATTAAGCGGCCTTTTATTTTACTTCCTGTTTGTCCACTACAAGTTTGGA
TGGGCTCAGAAAATCTCAAAGCCGATTACCATGCACCTTCAGATGCTAATGGAAGTGGTC
CCACCGGAGGAAGACCCTGAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13520</identifier>
        <name>AA_permease_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>brush border membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neutral amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-cystine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>antiporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide antigen binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neutral amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-cystine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein complex assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001130</id>
      <name>Neutral and basic amino acid transport protein rBAT</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q07837" source="Swiss-Prot">
    <name>Neutral and basic amino acid transport protein rBAT</name>
    <general-function>L-cystine transmembrane transporter activity</general-function>
    <specific-function>Involved in the high-affinity, sodium-independent transport of cystine and neutral and dibasic amino acids (system B(0,+)-like activity). May function as an activator of SLC7A9 and be involved in the high-affinity reabsorption of cystine in the kidney tubule.</specific-function>
    <gene-name>SLC3A1</gene-name>
    <locus>2p16.3</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>88-108</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.81</theoretical-pi>
    <molecular-weight>78851.4</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11025</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC3A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M95548</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306442</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q07837</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SLC31_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>b(0,+)-type amino acid transport protein</synonym>
      <synonym>D2h</synonym>
      <synonym>NBAT</synonym>
      <synonym>RBAT</synonym>
      <synonym>Solute carrier family 3 member 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002248|Neutral and basic amino acid transport protein rBAT
MAEDKSKRDSIEMSMKGCQTNNGFVHNEDILEQTPDPGSSTDNLKHSTRGILGSQEPDFK
GVQPYAGMPKEVLFQFSGQARYRIPREILFWLTVASVLVLIAATIAIIALSPKCLDWWQE
GPMYQIYPRSFKDSNKDGNGDLKGIQDKLDYITALNIKTVWITSFYKSSLKDFRYGVEDF
REVDPIFGTMEDFENLVAAIHDKGLKLIIDFIPNHTSDKHIWFQLSRTRTGKYTDYYIWH
DCTHENGKTIPPNNWLSVYGNSSWHFDEVRNQCYFHQFMKEQPDLNFRNPDVQEEIKEIL
RFWLTKGVDGFSLDAVKFLLEAKHLRDEIQVNKTQIPDTVTQYSELYHDFTTTQVGMHDI
VRSFRQTMDQYSTEPGRYRFMGTEAYAESIDRTVMYYGLPFIQEADFPFNNYLSMLDTVS
GNSVYEVITSWMENMPEGKWPNWMIGGPDSSRLTSRLGNQYVNVMNMLLFTLPGTPITYY
GEEIGMGNIVAANLNESYDINTLRSKSPMQWDNSSNAGFSEASNTWLPTNSDYHTVNVDV
QKTQPRSALKLYQDLSLLHANELLLNRGWFCHLRNDSHYVVYTRELDGIDRIFIVVLNFG
ESTLLNLHNMISGLPAKMRIRLSTNSADKGSKVDTSGIFLDKGEGLIFEHNTKNLLHRQT
AFRDRCFVSNRACYSSVLNILYTSC</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020511|Neutral and basic amino acid transport protein rBAT (SLC3A1)
ATGGCTGAAGATAAAAGCAAGAGAGACTCCATCGAGATGAGTATGAAGGGATGCCAGACA
AACAACGGGTTTGTCCATAATGAAGACATTCTGGAGCAGACCCCGGATCCAGGAAGCTCA
ACAGACAACCTGAAGCACAGCACCAGGGGCATCCTTGGCTCCCAGGAGCCCGACTTCAAG
GGCGTCCAGCCCTATGCGGGGATGCCCAAGGAGGTGCTGTTCCAGTTCTCTGGCCAGGCC
CGCTACCGCATACCTCGGGAGATCCTCTTCTGGCTCACAGTGGCTTCTGTGCTGGTGCTC
ATCGCGGCCACCATAGCCATCATTGCCCTCTCTCCAAAGTGCCTAGACTGGTGGCAGGAG
GGGCCCATGTACCAGATCTACCCAAGGTCTTTCAAGGACAGTAACAAGGATGGGAACGGA
GATCTGAAAGGTATTCAAGATAAACTGGACTACATCACAGCTTTAAATATAAAAACTGTT
TGGATTACTTCATTTTATAAATCGTCCCTTAAAGATTTCAGATATGGTGTTGAAGATTTC
CGGGAAGTTGATCCCATTTTTGGAACGATGGAAGATTTTGAGAATCTGGTTGCAGCCATA
CATGATAAAGGTTTAAAATTAATCATCGATTTCATACCAAACCACACGAGTGATAAACAT
ATTTGGTTTCAATTGAGTCGGACACGGACAGGAAAATATACTGATTATTATATCTGGCAT
GACTGTACCCATGAAAATGGCAAAACCATTCCACCCAACAACTGGTTAAGTGTGTATGGA
AACTCCAGTTGGCACTTTGACGAAGTGCGAAACCAATGTTATTTTCATCAGTTTATGAAA
GAGCAACCTGATTTAAATTTCCGCAATCCTGATGTTCAAGAAGAAATAAAAGAAATTTTA
CGGTTCTGGCTCACAAAGGGTGTTGATGGTTTTAGTTTGGATGCTGTTAAATTCCTCCTA
GAAGCAAAGCACCTGAGAGATGAGATCCAAGTAAATAAGACCCAAATCCCGGACACGGTC
ACACAATACTCGGAGCTGTACCATGACTTCACCACCACGCAGGTGGGAATGCACGACATT
GTCCGCAGCTTCCGGCAGACCATGGACCAATACAGCACGGAGCCCGGCAGATACAGGTTC
ATGGGGACTGAAGCCTATGCAGAGAGTATTGACAGGACCGTGATGTACTATGGATTGCCA
TTTATCCAAGAAGCTGATTTTCCCTTCAACAATTACCTCAGCATGCTAGACACTGTTTCT
GGGAACAGCGTGTATGAGGTTATCACATCCTGGATGGAAAACATGCCAGAAGGAAAATGG
CCTAACTGGATGATTGGTGGACCAGACAGTTCACGGCTGACTTCGCGTTTGGGGAATCAG
TATGTCAACGTGATGAACATGCTTCTTTTCACACTCCCTGGAACTCCTATAACTTACTAT
GGAGAAGAAATTGGAATGGGAAATATTGTAGCCGCAAATCTCAATGAAAGCTATGATATT
AATACCCTTCGCTCAAAGTCACCAATGCAGTGGGACAATAGTTCAAATGCTGGTTTTTCT
GAAGCTAGTAACACCTGGTTACCTACCAATTCAGATTACCACACTGTGAATGTTGATGTC
CAAAAGACTCAGCCCAGATCGGCTTTGAAGTTATATCAAGATTTAAGTCTACTTCATGCC
AATGAGCTACTCCTCAACAGGGGCTGGTTTTGCCATTTGAGGAATGACAGCCACTATGTT
GTGTACACAAGAGAGCTGGATGGCATCGACAGAATCTTTATCGTGGTTCTGAATTTTGGA
GAATCAACACTGTTAAATCTACATAATATGATTTCGGGCCTTCCCGCTAAAATGAGAATA
AGGTTAAGTACCAATTCTGCCGACAAAGGCAGTAAAGTTGATACAAGTGGCATTTTTCTG
GACAAGGGAGAGGGACTCATCTTTGAACACAACACGAAGAATCTCCTTCATCGCCAAACA
GCTTTCAGAGATAGATGCTTTGTTTCCAATCGAGCATGCTATTCCAGTGTACTGAACATA
CTGTATACCTCGTGTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00128</identifier>
        <name>Alpha-amylase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>brush border membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>vacuolar membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>catalytic activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cation binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>basic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-cystine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>basic amino acid transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-cystine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>basic amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
    <name>Monocarboxylate transporter 10</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
    <gene-name>SLC16A10</gene-name>
    <locus>6q21-q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>55492.07</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB057445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18640047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TF71</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aromatic amino acid transporter 1</synonym>
      <synonym>MCT 10</synonym>
      <synonym>MCT10</synonym>
      <synonym>Solute carrier family 16 member 10</synonym>
      <synonym>T-type amino acid transporter 1</synonym>
      <synonym>TAT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aromatic amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00139</drugbank-id>
  <drugbank-id>NUTR00054</drugbank-id>
  <name>Succinic acid</name>
  <description>A water-soluble, colorless crystal with an acid taste that is used as a chemical intermediate, in medicine, the manufacture of lacquers, and to make perfume esters. It is also used in foods as a sequestrant, buffer, and a neutralizing agent. (Hawley&amp;#39;s Condensed Chemical Dictionary, 12th ed, p1099; McGraw-Hill Dictionary of Scientific and Technical Terms, 4th ed, p1851)</description>
  <cas-number>110-15-6</cas-number>
  <unii>AB6MNQ6J6L</unii>
  <average-mass>118.088</average-mass>
  <monoisotopic-mass>118.02660868</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Michael Diamantoglou, Gerhard Meyer, "Process for the production of water-insoluble fibers of cellulose monoesters of maleic acid, succinic acid and phthalic acid, having an extremely high absorbability for water and physiological liquids." U.S. Patent US4734239, issued April, 1941.</synthesis-reference>
  <indication>For nutritional supplementation, also for treating dietary shortage or imbalance</indication>
  <pharmacodynamics/>
  <mechanism-of-action>Succinate is an essential component of the Krebs or citric acid cycle and serves an electron donor in the production of fumaric acid and FADH2. It also has been shown to be a good "natural" antibiotic because of its relative acidic or caustic nature (high concentrations can even cause burns). Succinate supplements have been shown to help reduce the effects of hangovers by activating the degradation of acetaldehyde - a toxic byproduct of alcohol metabolism - into CO2 and H2O through aerobic metabolism. Succinic acid has been shown to stimulate neural system recovery and bolster the immune system. Claims have also been made that it boosts awareness, concentration and reflexes.</mechanism-of-action>
  <toxicity>Oral rat LD&lt;sub&gt;50&lt;/sub&gt;: 2260 mg/kg</toxicity>
  <metabolism/>
  <absorption/>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as dicarboxylic acids and derivatives. These are organic compounds containing exactly two carboxylic acid groups.</description>
    <direct-parent>Dicarboxylic acids and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Dicarboxylic acids and derivatives</subclass>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Fatty acids and conjugates</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Fatty acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organooxygen compound</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">1,2-Ethanedicarboxylic acid</synonym>
    <synonym language="" coder="">Acide butanedioique</synonym>
    <synonym language="" coder="">Acide succinique</synonym>
    <synonym language="" coder="">Acidum succinicum</synonym>
    <synonym language="" coder="">Amber acid</synonym>
    <synonym language="" coder="">Asuccin</synonym>
    <synonym language="" coder="">Bernsteinsaeure</synonym>
    <synonym language="" coder="">Bernsteinsaure</synonym>
    <synonym language="" coder="">Butandisaeure</synonym>
    <synonym language="" coder="">Butanedioic acid</synonym>
    <synonym language="" coder="">Butanedionic acid</synonym>
    <synonym language="" coder="">Dihydrofumaric acid</synonym>
    <synonym language="" coder="">e363</synonym>
    <synonym language="" coder="">Ethylenesuccinic acid</synonym>
    <synonym language="" coder="">HOOC-CH2-CH2-COOH</synonym>
    <synonym language="" coder="">Spirit of amber</synonym>
    <synonym language="" coder="">Succinate</synonym>
    <synonym language="" coder="">Succinic acid</synonym>
  </synonyms>
  <products>
    <product>
      <name>Niferex</name>
      <labeller>Avion Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>75854-321</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-01-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Niferex</name>
      <ingredients>Cyanocobalamin + Ferrous asparto glycinate + Folic Acid + Gastric intrinsic factor + Iron Dextran + Levomefolic acid + Succinic acid + Vitamin C + Zinc</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Breckenridge Pharmaceuticals</name>
      <url>http://www.bpirx.com</url>
    </packager>
    <packager>
      <name>Contract Pharm</name>
      <url>http://www.contractpharma.com</url>
    </packager>
    <packager>
      <name>J T Baker</name>
      <url>http://www.jtbaker.com</url>
    </packager>
    <packager>
      <name>KV Pharmaceutical Co.</name>
      <url>http://www.kvpharmaceutical.com</url>
    </packager>
    <packager>
      <name>Murfreesboro Pharmaceutical Nursing Supply</name>
      <url>http://www.unitdosesupply.com</url>
    </packager>
    <packager>
      <name>National Vitamin Company</name>
      <url>http://www.nationalvitamin.com</url>
    </packager>
    <packager>
      <name>Physicians Total Care Inc.</name>
      <url>http://www.physicianstotalcare.com</url>
    </packager>
    <packager>
      <name>PruGen Inc. Pharmaceuticals</name>
      <url>http://www.prugen.com</url>
    </packager>
    <packager>
      <name>Rasi Laboratories Inc.</name>
      <url>http://www.rasilaboratories.com</url>
    </packager>
    <packager>
      <name>Seton Pharmaceuticals LLC</name>
      <url>http://www.seton.net</url>
    </packager>
    <packager>
      <name>Ther-Rx Corp.</name>
      <url>http://www.ther-rx.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Succinic acid cryst reagent</description>
      <cost currency="USD">0.15</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Acids, Acyclic</category>
      <mesh-id>D000144</mesh-id>
    </category>
    <category>
      <category>Carboxylic Acids</category>
      <mesh-id>D002264</mesh-id>
    </category>
    <category>
      <category>Dicarboxylic Acids</category>
      <mesh-id>D003998</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Organic Chemicals</category>
      <mesh-id>D009930</mesh-id>
    </category>
    <category>
      <category>Succinates</category>
      <mesh-id>D013386</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>92:02.00*</ahfs-code>
  </ahfs-codes>
  <pdb-entries>
    <pdb-entry>1CZE</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00139.pdf?1265922737</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-0.53</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>0.25</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>2.11e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>butanedioic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>succinic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>118.088</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>118.02660868</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>OC(=O)CCC(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C4H6O4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C4H6O4/c5-3(6)1-2-4(7)8/h1-2H2,(H,5,6)(H,7,8)</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>KDYFGRWQOYBRFD-UHFFFAOYSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>74.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>23.54</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>10.14</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>3.55</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>8.32E+004 mg/L (at 25 °C)</value>
      <source>YALKOWSKY,SH &amp; HE,Y (2003)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>188 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>Boiling Point</kind>
      <value>235 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.59</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.2</value>
      <source>ADME Research, USCD</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>4.21 (at 25 °C)</value>
      <source>DEAN,JA (1987)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>15741</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>1110</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46505859</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00042</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>1078</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>26121</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164747739</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>SIN</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000545</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Succinate</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL576</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP00032</smpdb-id>
      <name>Valine, Leucine and Isoleucine Degradation</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00057</smpdb-id>
      <name>Citric Acid Cycle</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00136</smpdb-id>
      <name>2-Hydroxyglutric Aciduria (D And L Form)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00173</smpdb-id>
      <name>Beta-Ketothiolase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00207</smpdb-id>
      <name>Prolidase Deficiency (PD)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00243</smpdb-id>
      <name>4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00339</smpdb-id>
      <name>Hyperinsulinism-Hyperammonemia Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00451</smpdb-id>
      <name>Refsum Disease</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>O14975</uniprot-id>
        <uniprot-id>O14832</uniprot-id>
        <uniprot-id>Q9UJ83</uniprot-id>
        <uniprot-id>P51648</uniprot-id>
        <uniprot-id>P33897</uniprot-id>
        <uniprot-id>Q9UBJ2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP02298</smpdb-id>
      <name>Glutaminolysis and Cancer</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q15758</uniprot-id>
        <uniprot-id>P43007</uniprot-id>
        <uniprot-id>Q8WUX1</uniprot-id>
        <uniprot-id>Q99417</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>P77434</uniprot-id>
        <uniprot-id>P0A959</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P00338</uniprot-id>
        <uniprot-id>P53985</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>P53396</uniprot-id>
        <uniprot-id>Q9UM01</uniprot-id>
        <uniprot-id>P42345</uniprot-id>
        <uniprot-id>Q9NWT6</uniprot-id>
        <uniprot-id>P01106</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00020</smpdb-id>
      <name>Arginine and Proline Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00030</smpdb-id>
      <name>Oxidation of Branched Chain Fatty Acids</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00583</drugbank-id>
          <name>L-Carnitine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P33121</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q9UJ83</uniprot-id>
        <uniprot-id>O14832</uniprot-id>
        <uniprot-id>Q92968</uniprot-id>
        <uniprot-id>O75381</uniprot-id>
        <uniprot-id>P43155</uniprot-id>
        <uniprot-id>Q9UKG9</uniprot-id>
        <uniprot-id>P33897</uniprot-id>
        <uniprot-id>Q9UBJ2</uniprot-id>
        <uniprot-id>O43772</uniprot-id>
        <uniprot-id>P23786</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00138</smpdb-id>
      <name>3-Hydroxy-3-Methylglutaryl-CoA Lyase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00208</smpdb-id>
      <name>Prolinemia Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00361</smpdb-id>
      <name>Hyperprolinemia Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00521</smpdb-id>
      <name>3-hydroxyisobutyric acid dehydrogenase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00522</smpdb-id>
      <name>3-hydroxyisobutyric aciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00550</smpdb-id>
      <name>Pyruvate dehydrogenase deficiency (E3)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP02291</smpdb-id>
      <name>The oncogenic action of 2-hydroxyglutarate</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>P00370</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP02292</smpdb-id>
      <name>The oncogenic action of Succinate</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00126</drugbank-id>
          <name>Vitamin C</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>Q9UBX3</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>Q16665</uniprot-id>
        <uniprot-id>Q9GZT9</uniprot-id>
        <uniprot-id>Q96KS0</uniprot-id>
        <uniprot-id>Q9H6Z9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP02358</smpdb-id>
      <name>The oncogenic action of L-2-hydroxyglutarate in  Hydroxygluaricaciduria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>Q9H9P8</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP02359</smpdb-id>
      <name>The oncogenic action of D-2-hydroxyglutarate in  Hydroxygluaricaciduria </name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04272</drugbank-id>
          <name>Citric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>O75390</uniprot-id>
        <uniprot-id>P50213</uniprot-id>
        <uniprot-id>O43837</uniprot-id>
        <uniprot-id>P51553</uniprot-id>
        <uniprot-id>Q02218</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P53597</uniprot-id>
        <uniprot-id>Q96I99</uniprot-id>
        <uniprot-id>P07954</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>Q99798</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>P21399</uniprot-id>
        <uniprot-id>O75874</uniprot-id>
        <uniprot-id>P48735</uniprot-id>
        <uniprot-id>H0YLL5</uniprot-id>
        <uniprot-id>Q9H302</uniprot-id>
        <uniprot-id>Q9Y5U8</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q8NFU7</uniprot-id>
        <uniprot-id>Q9Y2K7</uniprot-id>
        <uniprot-id>Q8N465</uniprot-id>
        <uniprot-id>Q9H9P8</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00072</smpdb-id>
      <name>Glutamate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00137</smpdb-id>
      <name>2-Methyl-3-Hydroxybutryl CoA Dehydrogenase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00139</smpdb-id>
      <name>3-Methylglutaconic Aciduria Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00141</smpdb-id>
      <name>3-Methylglutaconic Aciduria Type IV</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00199</smpdb-id>
      <name>Maple Syrup Urine Disease</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00236</smpdb-id>
      <name>Propionic Acidemia</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00355</smpdb-id>
      <name>Mitochondrial Electron Transport Chain</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02263</drugbank-id>
          <name>Glyceraldehyde-3-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02515</drugbank-id>
          <name>3-Phosphoglycerol</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04326</drugbank-id>
          <name>Dihydroxyacetone phosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>O43826</uniprot-id>
        <uniprot-id>P12235</uniprot-id>
        <uniprot-id>Q06055</uniprot-id>
        <uniprot-id>P25705</uniprot-id>
        <uniprot-id>P56381</uniprot-id>
        <uniprot-id>P06576</uniprot-id>
        <uniprot-id>P24539</uniprot-id>
        <uniprot-id>P30049</uniprot-id>
        <uniprot-id>P36542</uniprot-id>
        <uniprot-id>P00846</uniprot-id>
        <uniprot-id>P43304</uniprot-id>
        <uniprot-id>O15239</uniprot-id>
        <uniprot-id>P31040</uniprot-id>
        <uniprot-id>P21912</uniprot-id>
        <uniprot-id>Q99643</uniprot-id>
        <uniprot-id>O14521</uniprot-id>
        <uniprot-id>P99999</uniprot-id>
        <uniprot-id>P31930</uniprot-id>
        <uniprot-id>A0S183</uniprot-id>
        <uniprot-id>P21695</uniprot-id>
        <uniprot-id>P04406</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00363</smpdb-id>
      <name>Ornithine Aminotransferase Deficiency (OAT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00385</smpdb-id>
      <name>Homocarnosinosis</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002257</id>
      <name>Succinate dehydrogenase cytochrome b560 subunit, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16405730</pubmed-id>
            <citation>Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE: Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet. 2006 Jan 11;7:1.</citation>
          </article>
          <article>
            <pubmed-id>15986240</pubmed-id>
            <citation>Leibowitz G, Khaldi MZ, Shauer A, Parnes M, Oprescu AI, Cerasi E, Jonas JC, Kaiser N: Mitochondrial regulation of insulin production in rat pancreatic islets. Diabetologia. 2005 Aug;48(8):1549-59. Epub 2005 Jun 29.</citation>
          </article>
          <article>
            <pubmed-id>16288654</pubmed-id>
            <citation>Bayley JP, Devilee P, Taschner PE: The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet. 2005 Nov 16;6:39.</citation>
          </article>
          <article>
            <pubmed-id>17636259</pubmed-id>
            <citation>Szeto SS, Reinke SN, Sykes BD, Lemire BD: Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate. J Biol Chem. 2007 Sep 14;282(37):27518-26. Epub 2007 Jul 18.</citation>
          </article>
          <article>
            <pubmed-id>16232921</pubmed-id>
            <citation>Kubo Y, Takagi H, Nakamori S: Effect of gene disruption of succinate dehydrogenase on succinate production in a sake yeast strain. J Biosci Bioeng. 2000;90(6):619-24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q99643" source="Swiss-Prot">
    <name>Succinate dehydrogenase cytochrome b560 subunit, mitochondrial</name>
    <general-function>Succinate dehydrogenase activity</general-function>
    <specific-function>Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).</specific-function>
    <gene-name>SDHC</gene-name>
    <locus>1q23.3</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions>63-92
113-137
145-166</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>10.12</theoretical-pi>
    <molecular-weight>18610.03</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10682</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SDHC</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U57877</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1814226</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q99643</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>C560_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>CYB560</synonym>
      <synonym>CYBL</synonym>
      <synonym>Integral membrane protein CII-3</synonym>
      <synonym>QPs-1</synonym>
      <synonym>QPs1</synonym>
      <synonym>SDH3</synonym>
      <synonym>Succinate dehydrogenase complex subunit C</synonym>
      <synonym>Succinate-ubiquinone oxidoreductase cytochrome B large subunit</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004430|Succinate dehydrogenase cytochrome b560 subunit, mitochondrial
MAALLLRHVGRHCLRAHFSPQLCIRNAVPLGTTAKEEMERFWNKNIGSNRPLSPHITIYS
WSLPMAMSICHRGTGIALSAGVSLFGMSALLLPGNFESYLELVKSLCLGPALIHTAKFAL
VFPLMYHTWNGIRHLMWDLGKGLKIPQLYQSGVVVLVLTVLSSMGLAAM</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011627|Succinate dehydrogenase cytochrome b560 subunit, mitochondrial (SDHC)
ATGGCTGCGCTGTTGCTGAGACACGTTGGTCGTCATTGCCTCCGAGCCCACTTTAGCCCT
CAGCTCTGTATCAGAAATGCTGTTCCTTTGGGAACCACGGCCAAAGAAGAGATGGAGCGG
TTCTGGAATAAGAATATAGGTTCAAACCGTCCTCTGTCTCCCCACATTACTATCTACAGT
TGGTCTCTTCCCATGGCGATGTCCATCTGCCACCGTGGCACTGGTATTGCTTTGAGTGCA
GATGTGGGACCTAGGAAAAGGCCTGAAGATTCCCCAGCTATACCAGTCTGGAGTGGTTGT
CCTGGTTCTTACTGTGTTGTCCTCTATGGGGCTGGCAGCCATGTGAAGAAAGGAGGCTCC
CAGCATCATCTTCCTACACATTATTACATTCACCCATCTTTCTGTTTGTCATTCTTATCT
CCAGCCTGGGAAAAGTTCTCCTTATTTGTTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01127</identifier>
        <name>Sdh_cyt</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>respiratory chain complex II</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory electron transport chain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrial electron transport, succinate to ubiquinone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aerobic respiration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002258</id>
      <name>Succinate receptor 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17192395</pubmed-id>
            <citation>Macaulay IC, Tijssen MR, Thijssen-Timmer DC, Gusnanto A, Steward M, Burns P, Langford CF, Ellis PD, Dudbridge F, Zwaginga JJ, Watkins NA, van der Schoot CE, Ouwehand WH: Comparative gene expression profiling of in vitro differentiated megakaryocytes and erythroblasts identifies novel activatory and inhibitory platelet membrane proteins. Blood. 2007 Apr 15;109(8):3260-9. Epub 2006 Dec 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BXA5" source="Swiss-Prot">
    <name>Succinate receptor 1</name>
    <general-function>G-protein coupled receptor activity</general-function>
    <specific-function>Receptor for succinate.</specific-function>
    <gene-name>SUCNR1</gene-name>
    <locus>3q24-q25.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>32-52
60-80
104-124
138-158
186-206
231-251
282-302</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.18</theoretical-pi>
    <molecular-weight>38697.395</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4542</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SUCNR1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF348078</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>13517983</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>166</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>166</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9BXA5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SUCR1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>G-protein coupled receptor 91</synonym>
      <synonym>GPR91</synonym>
      <synonym>P2Y purinoceptor 1-like</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037181|Succinate receptor 1
MLGIMAWNATCKNWLAAEAALEKYYLSIFYGIEFVVGVLGNTIVVYGYIFSLKNWNSSNI
YLFNLSVSDLAFLCTLPMLIRSYANGNWIYGDVLCISNRYVLHANLYTSILFLTFISIDR
YLIIKYPFREHLLQKKEFAILISLAIWVLVTLELLPILPLINPVITDNGTTCNDFASSGD
PNYNLIYSMCLTLLGFLIPLFVMCFFYYKIALFLKQRNRQVATALPLEKPLNLVIMAVVI
FSVLFTPYHVMRNVRIASRLGSWKQYQCTQVVINSFYIVTRPLAFLNSVINPVFYFLLGD
HFRDMLMNQLRHNFKSLTSFSRWAHELLLSFREK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016732|Succinate receptor 1 (SUCNR1)
ATGCTGGGGATCATGGCATGGAATGCAACTTGCAAAAACTGGCTGGCAGCAGAGGCTGCC
CTGGAAAAGTACTACCTTTCCATTTTTTATGGGATTGAGTTCGTTGTGGGAGTCCTTGGA
AATACCATTGTTGTTTACGGCTACATCTTCTCTCTGAAGAACTGGAACAGCAGTAATATT
TATCTCTTTAACCTCTCTGTCTCTGACTTAGCTTTTCTGTGCACCCTCCCCATGCTGATA
AGGAGTTATGCCAATGGAAACTGGATATATGGAGACGTGCTCTGCATAAGCAACCGATAT
GTGCTTCATGCCAACCTCTATACCAGCATTCTCTTTCTCACTTTTATCAGCATAGATCGA
TACTTGATAATTAAGTATCCTTTCCGAGAACACCTTCTGCAAAAGAAAGAGTTTGCTATT
TTAATCTCCTTGGCCATTTGGGTTTTAGTAACCTTAGAGTTACTACCCATACTTCCCCTT
ATAAATCCTGTTATAACTGACAATGGCACCACCTGTAATGATTTTGCAAGTTCTGGAGAC
CCCAACTACAACCTCATTTACAGCATGTGTCTAACACTGTTGGGGTTCCTTATTCCTCTT
TTTGTGATGTGTTTCTTTTATTACAAGATTGCTCTCTTCCTAAAGCAGAGGAATAGGCAG
GTTGCTACTGCTCTGCCCCTTGAAAAGCCTCTCAACTTGGTCATCATGGCAGTGGTAATC
TTCTCTGTGCTTTTTACACCCTATCACGTCATGCGGAATGTGAGGATCGCTTCACGCCTG
GGGAGTTGGAAGCAGTATCAGTGCACTCAGGTCGTCATCAACTCCTTTTACATTGTGACA
CGGCCTTTGGCCTTTCTGAACAGTGTCATCAACCCTGTCTTCTATTTTCTTTTGGGAGAT
CACTTCAGGGACATGCTGATGAATCAACTGAGACACAACTTCAAATCCCTTACATCCTTT
AGCAGATGGGCTCATGAACTCCTACTTTCATTCAGAGAAAAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00001</identifier>
        <name>7tm_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>G-protein coupled receptor activity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002259</id>
      <name>Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BYC2" source="Swiss-Prot">
    <name>Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial</name>
    <general-function>3-oxoacid coa-transferase activity</general-function>
    <specific-function>Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate (By similarity).</specific-function>
    <gene-name>OXCT2</gene-name>
    <locus>1p34</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.15</theoretical-pi>
    <molecular-weight>56139.41</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:18606</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>OXCT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB050193</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>13548673</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9BYC2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SCOT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.8.3.5</synonym>
      <synonym>3-oxoacid CoA-transferase 2A</synonym>
      <synonym>SCOT-t</synonym>
      <synonym>Testis-specific succinyl-CoA:3-oxoacid CoA-transferase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016733|Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial
MAALRLLASVLGRGVPAGGSGLALSQGCARCFATSPRLRAKFYADPVEMVKDISDGATVM
IGGFGLCGIPENLIAALLRTRVKDLQVVSSNVGVEDFGLGLLLAARQVRRIVCSYVGENT
LCESQYLAGELELELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGAPIRYTPDGHL
ALMSQPREVREFNGDHFLLERAIRADFALVKGWKADRAGNVVFRRSARNFNVPMCKAADV
TAVEVEEIVEVGAFPPEDIHVPNIYVDRVIKGQKYEKRIERLTILKEEDGDAGKEEDART
RIIRRAALEFEDGMYANLGIGIPLLASNFISPSMTVHLHSENGILGLGPFPTEDEVDADL
INAGKQTVTVLPGGCFFASDDSFAMIRGGHIQLTMLGAMQVSKYGDLANWMIPGKKVKGM
GGAMDLVSSQKTRVVVTMQHCTKDNTPKIMEKCTMPLTGKRCVDRIITEKAVFDVHRKKE
LTLRELWEGLTVDDIKKSTGCAFAVSPNLRPMQQVAP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016734|Succinyl-CoA:3-ketoacid coenzyme A transferase 2, mitochondrial (OXCT2)
ATGGCGGCGCTGCGGCTCCTGGCGTCAGTGCTCGGGCGCGGGGTCCCCGCCGGCGGCTCA
GGGCTCGCGCTGTCCCAGGGCTGCGCCCGCTGCTTTGCCACCAGTCCCCGGCTCCGTGCC
AAGTTCTACGCGGACCCGGTGGAGATGGTGAAGGACATCTCTGACGGGGCGACCGTCATG
ATCGGGGGCTTCGGGCTCTGCGGGATCCCCGAGAACCTGATCGCCGCGCTGCTCAGGACC
CGCGTGAAAGACCTGCAGGTGGTCAGCAGCAACGTGGGCGTGGAGGACTTCGGCCTGGGC
CTCCTGCTGGCCGCCAGGCAGGTCCGTCGCATCGTCTGTTCCTACGTGGGCGAGAACACC
CTGTGCGAGAGCCAGTACCTGGCAGGAGAGCTGGAGCTGGAGCTCACGCCCCAGGGCACC
CTGGCCGAGCGCATCCGCGCGGGGGGCGCCGGGGTGCCCGCCTTCTACACCCCCACGGGC
TACGGGACCCTGGTCCAGGAAGGGGGCGCCCCCATCCGCTACACCCCGGACGGCCACCTG
GCGCTCATGAGCCAGCCCCGAGAGGTGAGGGAGTTCAACGGCGACCACTTCCTTTTGGAG
CGCGCCATCCGGGCAGACTTCGCCCTGGTGAAAGGGTGGAAGGCCGACCGGGCAGGAAAC
GTGGTCTTCAGGAGAAGCGCCCGCAATTTCAACGTGCCCATGTGCAAAGCTGCAGACGTC
ACGGCGGTGGAGGTGGAAGAGATCGTGGAGGTGGGGGCTTTCCCCCCAGAAGACATCCAC
GTTCCTAACATTTATGTAGATCGCGTGATAAAGGGGCAGAAATACGAGAAACGAATTGAG
CGCTTAACGATCCTGAAAGAGGAAGATGGAGACGCTGGAAAGGAAGAGGACGCCAGGACG
CGCATCATCAGACGCGCAGCTCTGGAATTTGAGGACGGCATGTACGCCAATCTGGGCATA
GGCATCCCCCTGCTGGCCAGCAACTTCATCAGTCCCAGCATGACTGTCCATCTTCACAGT
GAGAACGGGATCCTGGGCCTGGGCCCGTTTCCCACGGAAGATGAGGTGGATGCCGACCTC
ATCAATGCAGGCAAGCAGACGGTCACGGTGCTTCCCGGGGGCTGCTTCTTCGCCAGCGAC
GACTCCTTCGCCATGATCCGAGGGGGACACATCCAACTAACCATGCTTGGAGCCATGCAG
GTTTCCAAATACGGCGACCTGGCGAACTGGATGATCCCTGGCAAGAAGGTGAAAGGCATG
GGCGGTGCCATGGACTTGGTGTCCAGTCAGAAGACCAGAGTGGTGGTCACCATGCAGCAC
TGCACAAAGGACAACACCCCCAAGATCATGGAGAAATGCACCATGCCGCTGACCGGGAAG
CGGTGCGTGGACCGCATCATCACCGAGAAGGCCGTGTTTGACGTGCACAGGAAGAAAGAG
CTGACGCTGAGGGAGCTCTGGGAGGGCCTGACGGTGGACGACATCAAAAAGAGCACGGGG
TGTGCCTTTGCTGTGTCCCCGAACCTCAGGCCCATGCAGCAGGTGGCACCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01144</identifier>
        <name>CoA_trans</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>motile cilium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3-oxoacid CoA-transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ketone body catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002221</id>
      <name>Trimethyllysine dioxygenase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NVH6" source="Swiss-Prot">
    <name>Trimethyllysine dioxygenase, mitochondrial</name>
    <general-function>Trimethyllysine dioxygenase activity</general-function>
    <specific-function>Converts trimethyllysine (TML) into hydroxytrimethyllysine (HTML).</specific-function>
    <gene-name>TMLHE</gene-name>
    <locus>Xq28</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.79</theoretical-pi>
    <molecular-weight>49517.2</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:18308</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TMLHE</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF373407</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>15553435</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NVH6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>TMLH_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.8</synonym>
      <synonym>Epsilon-trimethyllysine 2-oxoglutarate dioxygenase</synonym>
      <synonym>Epsilon-trimethyllysine hydroxylase</synonym>
      <synonym>TML dioxygenase</synonym>
      <synonym>TML hydroxylase</synonym>
      <synonym>TML-alpha-ketoglutarate dioxygenase</synonym>
      <synonym>TMLD</synonym>
      <synonym>TMLH</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004359|Trimethyllysine dioxygenase, mitochondrial
MWYHRLSHLHSRLQDLLKGGVIYPALPQPNFKSLLPLAVHWHHTASKSLTCAWQQHEDHF
ELKYANTVMRFDYVWLRDHCRSASCYNSKTHQRSLDTASVDLCIKPKTIRLDETTLFFTW
PDGHVTKYDLNWLVKNSYEGQKQKVIQPRILWNAEIYQQAQVPSVDCQSFLETNEGLKKF
LQNFLLYGIAFVENVPPTQEHTEKLAERISLIRETIYGRMWYFTSDFSRGDTAYTKLALD
RHTDTTYFQEPCGIQVFHCLKHEGTGGRTLLVDGFYAAEQVLQKAPEEFELLSKVPLKHE
YIEDVGECHNHMIGIGPVLNIYPWNKELYLIRYNNYDRAVINTVPYDVVHRWYTAHRTLT
IELRRPENEFWVKLKPGRVLFIDNWRVLHGRECFTGYRQLCGCYLTRDDVLNTARLLGLQ
A</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011603|Trimethyllysine dioxygenase, mitochondrial (TMLHE)
ATGTGGTACCACAGATTGTCCCACCTACACAGCAGGCTTCAGGACTTGCTGAAGGGAGGA
GTCATATATCCGGCCCTTCCACAGCCCAACTTCAAAAGCTTACTTCCTTTAGCTGTCCAT
TGGCACCATACAGCCTCCAAGTCTCTGACTTGTGCTTGGCAGCAACATGAAGATCATTTT
GAGCTGAAATATGCTAATACCGTGATGCGCTTTGATTACGTCTGGCTTCGAGACCACTGC
CGCTCAGCATCGTGCTACAACTCTAAGACTCACCAGCGCAGCCTGGATACTGCCAGTGTG
GATTTATGTATCAAGCCAAAGACCATTCGTCTGGATGAGACCACACTCTTTTTCACTTGG
CCAGATGGTCATGTGACTAAATATGATTTGAATTGGCTGGTGAAAAACAGCTATGAAGGG
CAGAAACAAAAAGTCATCCAGCCTAGAATACTATGGAATGCTGAAATCTACCAGCAAGCC
CAAGTTCCATCGGTAGATTGCCAGAGCTTCTTAGAAACCAACGAGGGACTGAAGAAGTTT
CTGCAAAACTTTCTGCTCTATGGAATTGCATTCGTAGAAAATGTCCCTCCCACTCAAGAG
CACACAGAGAAGTTGGCAGAAAGGATCAGCTTAATCAGAGAAACCATTTATGGGAGGATG
TGGTATTTCACTTCAGACTTCTCCAGAGGTGACACTGCGTACACCAAGCTAGCTCTGGAT
CGGCACACTGACACTACCTATTTTCAAGAGCCCTGTGGCATTCAAGTGTTTCATTGTCTT
AAACATGAAGGAACTGGTGGCAGGACACTGCTAGTAGATGGATTCTATGCAGCAGAACAG
GTACTTCAAAAGGCACCTGAGGAATTTGAACTCCTCAGTAAAGTGCCATTGAAGCATGAA
TATATTGAAGATGTTGGAGAATGTCACAACCACATGATTGGGATTGGGCCAGTCTTAAAT
ATCTACCCATGGAATAAAGAGCTGTATTTGATCAGATTATTCAAAGAAAAACAAAACACG
GTCAACAGGCAGTGGAACTCCTCACTCCAATGTGATATTCCTGAGAGAATATTGACTTAT
CGTCACTTCGTCTCTGGGACAAGTATTGAACATAGGGGAAGCCTTATATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02668</identifier>
        <name>TauD</name>
      </pfam>
      <pfam>
        <identifier>PF06155</identifier>
        <name>DUF971</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>trimethyllysine dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carnitine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of oxidoreductase activity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002260</id>
      <name>Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9P2R7" source="Swiss-Prot">
    <name>Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial</name>
    <general-function>Succinate-coa ligase (adp-forming) activity</general-function>
    <specific-function>Catalyzes the ATP-dependent ligation of succinate and CoA to form succinyl-CoA.</specific-function>
    <gene-name>SUCLA2</gene-name>
    <locus>13q12.2-q13.3</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.5</theoretical-pi>
    <molecular-weight>50316.88</molecular-weight>
    <chromosome-location>13</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11448</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SUCLA2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB035863</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>7328935</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9P2R7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SUCB1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.5</synonym>
      <synonym>ATP-specific succinyl-CoA synthetase subunit beta</synonym>
      <synonym>Renal carcinoma antigen NY-REN-39</synonym>
      <synonym>SCS-betaA</synonym>
      <synonym>Succinyl-CoA synthetase beta-A chain</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004436|Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial
MAASMFYGRLVAVATLRNHRPRTAQRAAAQVLGSSGLFNNHGLQVQQQQQRNLSLHEYMS
MELLQEAGVSVPKGYVAKSPDEAYAIAKKLGSKDVVIKAQVLAGGRGKGTFESGLKGGVK
IVFSPEEAKAVSSQMIGKKLFTKQTGEKGRICNQVLVCERKYPRREYYFAITMERSFQGP
VLIGSSHGGVNIEDVAAESPEAIIKEPIDIEEGIKKEQALQLAQKMGFPPNIVESAAENM
VKLYSLFLKYDATMIEINPMVEDSDGAVLCMDAKINFDSNSAYRQKKIFDLQDWTQEDER
DKDAAKANLNYIGLDGNIGCLVNGAGLAMATMDIIKLHGGTPANFLDVGGGATVHQVTEA
FKLITSDKKVLAILVNIFGGIMRCDVIAQGIVMAVKDLEIKIPVVVRLQGTRVDDAKALI
ADSGLKILACDDLDEAARMVVKLSEIVTLAKQAHVDVKFQLPI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011628|Succinyl-CoA ligase [ADP-forming] subunit beta, mitochondrial (SUCLA2)
ATGGCGGCCTCCATGTTCTACGGCAGGCTAGTGGCCGTGGCCACCCTTCGGAACCACCGG
CCTCGGACGGCCCAGCGGGCTGCTGCTCAGGTTCTGGGAAGTTCTGGATTGTTTAATAAC
CATGGACTCCAAGTACAGCAGCAACAGCAAAGGAATCTCTCACTACATGAATACATGAGT
ATGGAATTATTGCAAGAAGCTGGTGTCTCCGTTCCCAAAGGATATGTGGCAAAGTCACCA
GATGAAGCTTATGCAATTGCCAAAAAATTAGGTTCAAAAGATGTCGTGATAAAGGCACAG
GTTTTAGCTGGTGGTAGAGGAAAAGGAACATTTGAAAGTGGCCTCAAAGGAGGAGTGAAG
ATAGTTTTCTCTCCAGAAGAAGCAAAAGCTGTTTCTTCACAAATGATTGGGAAAAAATTG
TTTACCAAGCAAACGGGAGAAAAGGGCAGAATATGCAATCAAGTATTGGTCTGTGAGCGA
AAATATCCCAGGAGAGAATACTACTTTGCAATAACAATGGAAAGGTCATTTCAAGGTCCT
GTATTAATAGGAAGTTCACATGGTGGTGTCAACATTGAAGATGTTGCTGCTGAGTCTCCT
GAAGCAATAATTAAAGAACCTATTGATATTGAAGAAGGCATCAAAAAGGAACAAGCTCTC
CAGCTTGCACAGAAGATGGGATTTCCACCTAATATTGTGGAATCAGCAGCAGAAAACATG
GTCAAGCTTTACAGCCTTTTTCTGAAATACGATGCAACCATGATAGAAATAAATCCAATG
GTGGAAGATTCAGATGGAGCTGTATTGTGTATGGATGCAAAGATCAATTTTGACTCTAAT
TCAGCCTATCGCCAAAAGAAAATCTTTGATCTACAGGACTGGACCCAGGAAGATGAAAGG
GACAAAGATGCTGCTAAGGCAAATCTCAACTACATTGGCCTCGATGGAAATATAGGCTGC
CTAGTAAATGGTGCTGGTTTGGCTATGGCCACAATGGATATAATAAAACTTCATGGAGGG
ACTCCAGCCAACTTCCTTGATGTTGGTGGTGGTGCTACAGTCCATCAAGTAACAGAAGCA
TTTAAGCTTATCACTTCAGATAAAAAGGTACTGGCTATTCTGGTCAACATTTTTGGAGGA
ATCATGCGCTGTGATGTTATTGCACAGGGTATAGTCATGGCAGTAAAAGACTTGGAAATT
AAAATACCTGTTGTGGTACGGTTACAAGGTACACGAGTCGATGATGCTAAGGCACTGATA
GCGGACAGTGGACTTAAAATACTTGCTTGTGATGACTTGGATGAAGCTGCTAGAATGGTT
GTAAAGCTCTCTGAAATAGTGACCTTAGCGAAGCAAGCACATGTGGATGTGAAATTTCAG
TTGCCAATATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF08442</identifier>
        <name>ATP-grasp_2</name>
      </pfam>
      <pfam>
        <identifier>PF00549</identifier>
        <name>Ligase_CoA</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-CoA ligase (ADP-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinyl-CoA pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinyl-CoA metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002261</id>
      <name>Mitochondrial dicarboxylate carrier</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16176879</pubmed-id>
            <citation>Ventura FV, Ruiter J, Ijlst L, de Almeida IT, Wanders RJ: Differential inhibitory effect of long-chain acyl-CoA esters on succinate and glutamate transport into rat liver mitochondria and its possible implications for long-chain fatty acid oxidation defects. Mol Genet Metab. 2005 Nov;86(3):344-52. Epub 2005 Sep 19.</citation>
          </article>
          <article>
            <pubmed-id>16027120</pubmed-id>
            <citation>Mizuarai S, Miki S, Araki H, Takahashi K, Kotani H: Identification of dicarboxylate carrier Slc25a10 as malate transporter in de novo fatty acid synthesis. J Biol Chem. 2005 Sep 16;280(37):32434-41. Epub 2005 Jul 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UBX3" source="Swiss-Prot">
    <name>Mitochondrial dicarboxylate carrier</name>
    <general-function>Dicarboxylic acid transmembrane transporter activity</general-function>
    <specific-function>Involved in translocation of malonate, malate and succinate in exchange for phosphate, sulfate, sulfite or thiosulfate across mitochondrial inner membrane.</specific-function>
    <gene-name>SLC25A10</gene-name>
    <locus>17q25.3</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions>10-30
63-82
103-123
163-182
203-223
255-275</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.91</theoretical-pi>
    <molecular-weight>31282.21</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10980</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC25A10</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ131612</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6224534</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UBX3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DIC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>DIC</synonym>
      <synonym>Solute carrier family 25 member 10</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004438|Mitochondrial dicarboxylate carrier
MAAEARVSRWYFGGLASCGAACCTHPLDLLKVHLQTQQEVKLRMTGMALRVVRTDGILAL
YSGLSASLCRQMTYSLTRFAIYETVRDRVAKGSQGPLPFHEKVLLGSVSGLAGGFVGTPA
DLVNVRMQNDVKLPQGQRRNYAHALDGLYRVAREEGLRRLFSGATMASSRGALVTVGQLS
CYDQAKQLVLSTGYLSDNIFTHFVASFIAGGCATFLCQPLDVLKTRLMNSKGEYQGVFHC
AVETAKLGPLAFYKGLVPAGIRLIPHTVLTFVFLEQLRKNFGIKVPS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020601|Mitochondrial dicarboxylate carrier (SLC25A10)
ATGGCAGCCGAGGCGCGCGTGTCGCGCTGGTACTTCGGGGGGCTGGCCTCCTGCGGGGCC
GCCTGCTGCACGCACCCGCTGGACCTGCTCAAGGTGCATCTGCAGACGCAGCAGGAGGTG
AAGCTGCGCATGACGGGCATGGCGCTGCGGGTGGTGCGTACCGACGGCATCCTGGCACTC
TACAGCGGCCTGAGCGCCTCGCTGTGCAGACAGATGACCTACTCCCTGACTCGGTTCGCC
ATCTACGAGACTGTGCGGGACCGTGTGGCCAAGGGCAGCCAGGGGCCTCTCCCCTTCCAC
GAGAAGGTGTTGCTGGGCTCCGTCAGCGGTTTAGCTGGAGGCTTCGTGGGGACGCCCGCA
GACTTGGTCAACGTCAGGATGCAGAACGACGTGAAGCTGCCCCAGGGTCAGCGGCGCAAC
TACGCCCATGCGCTGGATGGCCTGTACCGCGTAGCTCGTGAAGAGGGTCTCAGGAGACTG
TTCTCGGGTGCAACCATGGCATCCAGCCGAGGGGCCTTAGTCACTGTGGGCCAGCTGTCC
TGCTACGACCAGGCCAAGCAGCTGGTCCTTAGCACCGGGTACCTCTCTGACAACATCTTC
ACTCACTTTGTCGCCAGCTTTATTGCAGCCGCTGGTGACGAGCCCCCTCCTCAGGGTGGA
TGTGCCACGTTCCTGTGCCAGCCCCTGGATGTGCTGAAGACTCGCCTGATGAACTCCAAG
GGGGAGTATCAGGGCGTTTTCCACTGCGCCGTGGAGACAGCGAAGCTCGGGCCTCTGGCC
TTTTACAAGGGCCTCGTCCCAGCTGGCATCCGCCTCATCCCCCACACCGTGCTCACTTTT
GTGTTTCTGGAACAGCTACGCAAAAACTTTGGCATCAAAGTGCCATCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00153</identifier>
        <name>Mito_carr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dicarboxylic acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dicarboxylic acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfide oxidation, using sulfide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrial transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000176</id>
      <name>Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>16484232</pubmed-id>
            <citation>Maklashina E, Iverson TM, Sher Y, Kotlyar V, Andrell J, Mirza O, Hudson JM, Armstrong FA, Rothery RA, Weiner JH, Cecchini G: Fumarate reductase and succinate oxidase activity of Escherichia coli complex II homologs are perturbed differently by mutation of the flavin binding domain. J Biol Chem. 2006 Apr 21;281(16):11357-65. Epub 2006 Feb 15.</citation>
          </article>
          <article>
            <pubmed-id>10779596</pubmed-id>
            <citation>Takeo S, Kokaze A, Ng CS, Mizuchi D, Watanabe JI, Tanabe K, Kojima S, Kita K: Succinate dehydrogenase in Plasmodium falciparum mitochondria: molecular characterization of the SDHA and SDHB genes for the catalytic subunits, the flavoprotein (Fp) and iron-sulfur (Ip) subunits. Mol Biochem Parasitol. 2000 Apr 15;107(2):191-205.</citation>
          </article>
          <article>
            <pubmed-id>12231007</pubmed-id>
            <citation>Ackrell BA: Cytopathies involving mitochondrial complex II. Mol Aspects Med. 2002 Oct;23(5):369-84.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P31040" source="Swiss-Prot">
    <name>Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial</name>
    <general-function>Succinate dehydrogenase activity</general-function>
    <specific-function>Flavoprotein (FP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q). Can act as a tumor suppressor.</specific-function>
    <gene-name>SDHA</gene-name>
    <locus>5p15</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.41</theoretical-pi>
    <molecular-weight>72690.975</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10680</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SDHA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D30648</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>506338</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P31040</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SDHA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.3.5.1</synonym>
      <synonym>Flavoprotein subunit of complex II</synonym>
      <synonym>Fp</synonym>
      <synonym>SDH2</synonym>
      <synonym>SDHF</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000351|Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial
MSGVRGLSRLLSARRLALAKAWPTVLQTGTRGFHFTVDGNKRASAKVSDSISAQYPVVDH
EFDAVVVGAGGAGLRAAFGLSEAGFNTACVTKLFPTRSHTVAAQGGINAALGNMEEDNWR
WHFYDTVKGSDWLGDQDAIHYMTEQAPAAVVELENYGMPFSRTEDGKIYQRAFGGQSLKF
GKGGQAHRCCCVADRTGHSLLHTLYGRSLRYDTSYFVEYFALDLLMENGECRGVIALCIE
DGSIHRIRAKNTVVATGGYGRTYFSCTSAHTSTGDGTAMITRAGLPCQDLEFVQFHPTGI
YGAGCLITEGCRGEGGILINSQGERFMERYAPVAKDLASRDVVSRSMTLEIREGRGCGPE
KDHVYLQLHHLPPEQLATRLPGISETAMIFAGVDVTKEPIPVLPTVHYNMGGIPTNYKGQ
VLRHVNGQDQIVPGLYACGEAACASVHGANRLGANSLLDLVVFGRACALSIEESCRPGDK
VPPIKPNAGEESVMNLDKLRFADGSIRTSELRLSMQKSMQNHAAVFRVGSVLQEGCGKIS
KLYGDLKHLKTFDRGMVWNTDLVETLELQNLMLCALQTIYGAEARKESRGAHAREDYKVR
IDEYDYSKPIQGQQKKPFEEHWRKHTLSYVDVGTGKVTLEYRPVIDKTLNEADCATVPPA
IRSY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016026|Succinate dehydrogenase [ubiquinone] flavoprotein subunit, mitochondrial (SDHA)
ATGTCGGGGGTCCGGGGCCTGTCGCGGCTGCTGAGCGCTCGGCGCCTGGCGCTGGCCAAG
GCGTGGCCAACAGTGTTGCAAACAGGAACCCGAGGTTTTCACTTCACTGTTGATGGGAAC
AAGAGGGCATCTGCTAAAGTTTCAGATTCCATTTCTGCTCAGTATCCAGTAGTGGATCAT
GAATTTGATGCAGTGGTGGTAGGCGCTGGAGGGGCAGGCTTGCGAGCTGCATTTGGCCTT
TCTGAGGCAGGGTTTAATACAGCATGTGTTACCAAGCTGTTTCCTACCAGGTCACACACT
GTTGCAGCACAGCTAGAAAATTATGGCATGCCGTTTAGCAGAACTGAAGATGGGAAGATT
TATCAGCGTGCATTTGGTGGACAGAGCCTCAAGTTTGGAAAGGGCGGGCAGGCCCATCGG
TGCTGCTGTGTGGCTGATCGGACTGGCCACTCGCTATTGCACACCTTATATGGAAGGTCT
CTGCGATATGATACCAGCTATTTTGTGGAGTATTTTGCCTTGGATCTCCTGATGGAGAAT
GGGGAGTGCCGTGGTGTCATCGCACTGTGCATAGAGGACGGGTCCATCCATCGCATAAGA
GCAAAGAACACTGTTGTTGCCACAGGAGGCTACGGGCGCACCTACTTCAGCTGCACGTCT
GCCCACACCAGCACTGGCGACGGCACGGCCATGATCACCAGGGCAGGCCTTCCTTGCCAG
GACCTAGAGTTTGTTCAGTTCCACCCTACAGGCATATATGGTGCTGGTTGTCTCATTACG
GAAGGATGTCGTGGAGAGGGAGGCATTCTCATTAACAGTCAAGGCGAAAGGTTTATGGAG
CGATACGCCCCTGTCGCGAAGGACCTGGCGTCTAGAGATGTGGTGTCTCGGTCCATGACT
CTGGAGATCCGAGAAGGAAGAGGCTGTGGCCCTGAGAAAGATCACGTCTACCTGCAGCTG
CACCACCTACCTCCAGAGCAGCTGGCCACGCGCCTGCCTGGCATTTCAGAGACAGCCATG
ATCTTCGCTGGCGTGGACGTCACGAAGGAGCCGATCCCTGTCCTCCCCACCGTGCATTAT
AACATGGGCGGCATTCCCACCAACTACAAGGGGCAGGTCCTGAGGCACGTGAATGGCCAG
GATCAGATTGTGCCCGGCCTGTACGCCTGTGGGGAGGCCGCCTGTGCCTCGGTACATGGT
GCCAACCGCCTCGGGGCAAACTCGCTCTTGGACCTGGTTGTCTTTGGTCGGGCATGTGCC
CTGAGCATCGAAGAGTCATGCAGGCCTGGAGATAAAGTCCCTCCAATTAAACCAAACGCT
GGGGAAGAATCTGTCATGAATCTTGACAAATTGAGATTTGCTGATGGAAGCATAAGAACA
TCGGAACTGCGACTCAGCATGCAGAAGTCAATGCAAAATCATGCTGCCGTGTTCCGTGTG
GGAAGCGTGTTGCAAGAAGGTTGTGGGAAAATCAGCAAGCTCTATGGAGACCTAAAGCAC
CTGAAGACGTTCGACCGGGGAATGGTCTGGAACACGGACCTGGTGGAGACCCTGGAGCTG
CAGAACCTGATGCTGTGTGCGCTGCAGACCATCTACGGAGCAGAGGCACGGAAGGAGTCA
CGGGGCGCGCATGCCAGGGAAGACTACAAGGTGCGGATTGATGAGTACGATTACTCCAAG
CCCATCCAGGGGCAACAGAAGAAGCCCTTTGAGGAGCACTGGAGGAAGCACACCCTGTCC
TATGTGGACGTTGGCACTGGGAAGGTCACTCTGGAATATAGACCCGTGATCGACAAAACT
TTGAACGAGGCTGACTGTGCCACCGTCCCGCCAGCCATTCGCTCCTACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00890</identifier>
        <name>FAD_binding_2</name>
      </pfam>
      <pfam>
        <identifier>PF02910</identifier>
        <name>Succ_DH_flav_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate dehydrogenase (ubiquinone) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory electron transport chain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000989</id>
      <name>17-beta-hydroxysteroid dehydrogenase type 6</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>15639001</pubmed-id>
            <citation>Goel HC, Gupta D, Gupta S, Garg AP, Bala M: Protection of mitochondrial system by Hippophae rhamnoides L. against radiation-induced oxidative damage in mice. J Pharm Pharmacol. 2005 Jan;57(1):135-43.</citation>
          </article>
          <article>
            <pubmed-id>15646028</pubmed-id>
            <citation>Gupta D, Arora R, Garg AP, Bala M, Goel HC: Modification of radiation damage to mitochondrial system in vivo by Podophyllum hexandrum: mechanistic aspects. Mol Cell Biochem. 2004 Nov;266(1-2):65-77.</citation>
          </article>
          <article>
            <pubmed-id>15713802</pubmed-id>
            <citation>Dudkina NV, Eubel H, Keegstra W, Boekema EJ, Braun HP: Structure of a mitochondrial supercomplex formed by respiratory-chain complexes I and III. Proc Natl Acad Sci U S A. 2005 Mar 1;102(9):3225-9. Epub 2005 Feb 15.</citation>
          </article>
          <article>
            <pubmed-id>16371358</pubmed-id>
            <citation>Huang LS, Sun G, Cobessi D, Wang AC, Shen JT, Tung EY, Anderson VE, Berry EA: 3-nitropropionic acid is a suicide inhibitor of mitochondrial respiration that, upon oxidation by complex II, forms a covalent adduct with a catalytic base arginine in the active site of the enzyme. J Biol Chem. 2006 Mar 3;281(9):5965-72. Epub 2005 Dec 21.</citation>
          </article>
          <article>
            <pubmed-id>16405730</pubmed-id>
            <citation>Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE: Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet. 2006 Jan 11;7:1.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O14756" source="Swiss-Prot">
    <name>17-beta-hydroxysteroid dehydrogenase type 6</name>
    <general-function>Testosterone dehydrogenase (nad+) activity</general-function>
    <specific-function>NAD-dependent oxidoreductase with broad substrate specificity that shows both oxidative and reductive activity (in vitro). Has 17-beta-hydroxysteroid dehydrogenase activity towards various steroids (in vitro). Converts 5-alpha-androstan-3-alpha,17-beta-diol to androsterone and estradiol to estrone (in vitro). Has 3-alpha-hydroxysteroid dehydrogenase activity towards androsterone (in vitro). Has retinol dehydrogenase activity towards all-trans-retinol (in vitro). Can convert androsterone to epi-androsterone. Androsterone is first oxidized to 5-alpha-androstane-3,17-dione and then reduced to epi-andosterone. Can act on both C-19 and C-21 3-alpha-hydroxysteroids.</specific-function>
    <gene-name>HSD17B6</gene-name>
    <locus>12q13</locus>
    <cellular-location>Microsome membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-17</signal-regions>
    <theoretical-pi>8.91</theoretical-pi>
    <molecular-weight>35965.41</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:23316</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>HSD17B6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF016509</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2338748</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O14756</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>H17B6_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.1.1.105</synonym>
      <synonym>17-beta-HSD 6</synonym>
      <synonym>3-alpha-&gt;beta-HSE</synonym>
      <synonym>3-alpha-&gt;beta-hydroxysteroid epimerase</synonym>
      <synonym>Oxidative 3-alpha hydroxysteroid dehydrogenase</synonym>
      <synonym>RODH</synonym>
      <synonym>SDR9C6</synonym>
      <synonym>Short chain dehydrogenase/reductase family 9C member 6</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001969|17-beta-hydroxysteroid dehydrogenase type 6
MWLYLAAFVGLYYLLHWYRERQVVSHLQDKYVFITGCDSGFGNLLARQLDARGLRVLAAC
LTEKGAEQLRGQTSDRLETVTLDVTKMESIAAATQWVKEHVGDRGLWGLVNNAGILTPIT
LCEWLNTEDSMNMLKVNLIGVIQVTLSMLPLVRRARGRIVNVSSILGRVAFFVGGYCVSK
YGVEAFSDILRREIQHFGVKISIVEPGYFRTGMTNMTQSLERMKQSWKEAPKHIKETYGQ
QYFDALYNIMKEGLLNCSTNLNLVTDCMEHALTSVHPRTRYSAGWDAKFFFIPLSYLPTS
LADYILTRSWPKPAQAV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010693|17-beta-hydroxysteroid dehydrogenase type 6 (HSD17B6)
ATGTGGCTCTACCTGGCGGCCTTCGTGGGCCTGTACTACCTTCTGCACTGGTACCGGGAG
AGGCAGGTGGTGAGCCACCTCCAAGACAAGTATGTCTTTATCACGGGCTGTGACTCGGGC
TTTGGGAACCTGCTGGCCAGACAGCTGGATGCACGAGGCTTGAGAGTGCTGGCTGCGTGT
CTGACGGAGAAGGGGGCCGAGCAGCTGAGGGGCCAGACGTCTGACAGGCTGGAGACGGTG
ACCCTGGATGTTACCAAGATGGAGAGCATCGCTGCAGCTACTCAGTGGGTGAAGGAGCAT
GTGGGGGACAGAGGACTCTGGGGACTGGTGAACAATGCAGGCATTCTTACACCAATTACC
TTATGTGAGTGGCTGAACACTGAGGACTCTATGAATATGCTCAAAGTGAACCTCATTGGT
GTGATCCAGGTGACCTTGAGCATGCTTCCTTTGGTGAGGAGAGCACGGGGAAGAATTGTC
AATGTCTCCAGCATTCTGGGAAGAGTTGCTTTCTTTGTAGGAGGCTACTGTGTCTCCAAG
TATGGAGTGGAAGCCTTTTCAGATATTCTGAGGCGTGAGATTCAACATTTTGGGGTGAAA
ATCAGCATAGTTGAACCTGGCTACTTCAGAACGGGAATGACAAACATGACACAGTCCTTA
GAGCGAATGAAGCAAAGTTGGAAAGAAGCCCCCAAGCATATTAAGGAGACCTATGGACAG
CAGTATTTTGATGCCCTTTACAATATCATGAAGGAAGGGCTGTTGAATTGTAGCACAAAC
CTGAACCTGGTCACTGACTGCATGGAACATGCTCTGACATCGGTGCATCCGCGAACTCGA
TATTCAGCTGGCTGGGATGCTAAATTTTTCTTCATCCCTCTATCTTATTTACCTACATCA
CTGGCAGACTACATTTTGACTAGATCTTGGCCCAAACCAGCCCAGGCAGTCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00106</identifier>
        <name>adh_short</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>early endosome membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>estradiol 17-beta-dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>testosterone dehydrogenase (NAD+) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>retinol dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>catalytic activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>androgen biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>androgen catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000611</id>
      <name>Solute carrier family 13 member 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>15944208</pubmed-id>
            <citation>Oshiro N, Pajor AM: Functional characterization of high-affinity Na(+)/dicarboxylate cotransporter found in Xenopus laevis kidney and heart. Am J Physiol Cell Physiol. 2005 Nov;289(5):C1159-68. Epub 2005 Jun 8.</citation>
          </article>
          <article>
            <pubmed-id>17526543</pubmed-id>
            <citation>Wolff NA, Burckhardt BC, Burckhardt G, Oellerich M, Armstrong VW: Mycophenolic acid (MPA) and its glucuronide metabolites interact with transport systems responsible for excretion of organic anions in the basolateral membrane of the human kidney. Nephrol Dial Transplant. 2007 Sep;22(9):2497-503. Epub 2007 May 25.</citation>
          </article>
          <article>
            <pubmed-id>16735460</pubmed-id>
            <citation>Hagos Y, Steffgen J, Rizwan AN, Langheit D, Knoll A, Burckhardt G, Burckhardt BC: Functional roles of cationic amino acid residues in the sodium-dicarboxylate cotransporter 3 (NaDC-3) from winter flounder. Am J Physiol Renal Physiol. 2006 Dec;291(6):F1224-31. Epub 2006 May 30.</citation>
          </article>
          <article>
            <pubmed-id>16524379</pubmed-id>
            <citation>Yodoya E, Wada M, Shimada A, Katsukawa H, Okada N, Yamamoto A, Ganapathy V, Fujita T: Functional and molecular identification of sodium-coupled dicarboxylate transporters in rat primary cultured cerebrocortical astrocytes and neurons. J Neurochem. 2006 Apr;97(1):162-73. Epub 2006 Mar 8.</citation>
          </article>
          <article>
            <pubmed-id>15561973</pubmed-id>
            <citation>Burckhardt BC, Lorenz J, Kobbe C, Burckhardt G: Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNaDC-3, under voltage-clamp conditions. Am J Physiol Renal Physiol. 2005 Apr;288(4):F792-9. Epub 2004 Nov 23.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8WWT9" source="Swiss-Prot">
    <name>Solute carrier family 13 member 3</name>
    <general-function>Succinate transmembrane transporter activity</general-function>
    <specific-function>High-affinity sodium-dicarboxylate cotransporter that accepts a range of substrates with 4-5 carbon atoms. The stoichiometry is probably 3 Na(+) for 1 divalent succinate.</specific-function>
    <gene-name>SLC13A3</gene-name>
    <locus>20q12-q13.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>17-37
56-76
83-103
138-158
230-250
279-299
337-357
373-393
462-482
506-526
547-567</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.47</theoretical-pi>
    <molecular-weight>66840.355</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:14430</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC13A3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF154121</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>8132324</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8WWT9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>S13A3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>hNaDC3</synonym>
      <synonym>Na(+)/dicarboxylate cotransporter 3</synonym>
      <synonym>NaDC-3</synonym>
      <synonym>NADC3</synonym>
      <synonym>SDCT2</synonym>
      <synonym>Sodium-dependent high-affinity dicarboxylate transporter 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001219|Solute carrier family 13 member 3
MAALAAAAKKVWSARRLLVLLFTPLALLPVVFALPPKEGRCLFVILLMAVYWCTEALPLS
VTALLPIVLFPFMGILPSNKVCPQYFLDTNFLFLSGLIMASAIEEWNLHRRIALKILMLV
GVQPARLILGMMVTTSFLSMWLSNTASTAMMLPIANAILKSLFGQKEVRKDPSQESEENT
AAVRRNGLHTVPTEMQFLASTEAKDHPGETEVPLDLPADSRKEDEYRRNIWKGFLISIPY
SASIGGTATLTGTAPNLILLGQLKSFFPQCDVVNFGSWFIFAFPLMLLFLLAGWLWISFL
YGGLSFRGWRKNKSEIRTNAEDRARAVIREEYQNLGPIKFAEQAVFILFCMFAILLFTRD
PKFIPGWASLFNPGFLSDAVTGVAIVTILFFFPSQRPSLKWWFDFKAPNTETEPLLTWKK
AQETVPWNIILLLGGGFAMAKGCEESGLSVWIGGQLHPLENVPPALAVLLITVVIAFFTE
FASNTATIIIFLPVLAELAIRLRVHPLYLMIPGTVGCSFAFMLPVSTPPNSIAFASGHLL
VKDMVRTGLLMNLMGVLLLSLAMNTWAQTIFQLGTFPDWADMYSVNVTALPPTLANDTFR
TL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0018981|Solute carrier family 13 member 3 (SLC13A3)
ATGGCGGTGTACTGGTGCACGGAGGCCCTGCCGCTCTCAGTGACGGCGCTGCTGCCCATC
GTCCTCTTCCCCTTCATGGGCATCTTGCCCTCCAACAAGGTCTGCCCCCAGTACTTCCTC
GACACCAACTTCCTCTTCCTCAGTGGGCTGATCATGGCCAGCGCCATTGAGGAGTGGAAC
CTGCACCGGCGAATCGCCCTCAAGATCCTGATGCTTGTTGGAGTCCAGCCGGCCAGGCTC
ATCCTGGGGATGATGGTGACCACCTCGTTCTTGTCCATGTGGCTGAGCAACACCGCCTCC
ACTGCCATGATGCTTCCCATTGCCAATGCCATCCTGAAAAGTCTCTTTGGCCAGAAGGAG
GTTCGAAAGGACCCCAGCCAGGAGAGTGAAGAGAACACAGCTGCTGTGCGGAGAAACGGC
CTACACACTGTGCCCACGGAGATGCAGTTTCTCGCCAGCACAGAAGCCAAAGACCACCCT
GGGGAGACAGAGGTTCCACTGGATCTGCCGGCTGACTCCAGGAAGGAGGATGAATATCGT
CGGAACATCTGGAAGGGCTTCCTCATCTCCATCCCCTACTCAGCCAGTATTGGGGGCACA
GCCACACTCACGGGCACAGCCCCTAACCTCATCCTGCTTGGCCAGCTCAAGAGTTTCTTT
CCGCAGTGTGACGTGGTGAATTTCGGCTCCTGGTTCATTTTCGCCTTCCCTCTTATGCTG
TTGTTCCTGTTGGCAGGCTGGCTCTGGATCTCCTTCCTGTACGGGGGACTGAGCTTCAGG
GGCTGGAGGAAGAATAAATCTGAGATAAGAACCAATGCAGAAGATAGGGCTCGAGCTGTA
ATTCGGGAAGAATACCAGAACCTGGGGCCCATCAAGTTTGCCGAACAGGCTGTTTTCATC
CTTTTCTGCATGTTTGCCATCCTCCTCTTCACCCGGGACCCGAAGTTCATCCCTGGCTGG
GCCAGCCTCTTCAATCCTGGGTTTCTTTCTGATGCTGTCACCGGCGTGGCTATTGTCACC
ATCTTGTTCTTCTTCCCGTCCCAAAGGCCCTCTCTCAAGTGGTGGTTTGACTTCAAAGCT
CCCAACACAGAGACAGAGCCCTTGCTGACCTGGAAGAAGGCCCAGGAGACAGTGCCCTGG
AACATCATCCTTCTCCTGGGAGGGGGCTTCGCCATGGCCAAAGGCTGTGAGGAATCGGGG
CTGTCTGTATGGATTGGTGGGCAGCTGCACCCCCTGGAGAATGTGCCCCCCGCCCTGGCT
GTGCTGCTCATCACTGTGGTCATCGCCTTCTTCACTGAGTTTGCCAGCAACACGGCGACC
ATCATCATCTTCCTGCCGGTCCTGGCAGAGCTGGCCATCCGCCTGAGAGTGCACCCCCTG
TATCTGATGATTCCGGGCACAGTCGGCTGCTCCTTTGCCTTCATGCTCCCGGTCTCAACG
CCCCCCAACTCCATCGCCTTCGCCTCTGGACACTTGCTGGTCAAAGACATGGTGCGGACA
GGCCTCCTGATGAACCTGATGGGTGTCCTGCTGCTCAGTTTGGCTATGAATACCTGGGCA
CAGACCATCTTCCAGCTGGGCACCTTCCCGGACTGGGCTGATATGTACTCGGTCAATGTC
ACAGCATTGCCACCCACCTTGGCCAATGACACATTTCGGACCCTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00939</identifier>
        <name>Na_sulph_symp</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-aspartate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>citrate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>high-affinity sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>citrate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000447</id>
      <name>Solute carrier family 13 member 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16188913</pubmed-id>
            <citation>Takahashi R, Ishihara H, Tamura A, Yamaguchi S, Yamada T, Takei D, Katagiri H, Endou H, Oka Y: Cell type-specific activation of metabolism reveals that beta-cell secretion suppresses glucagon release from alpha-cells in rat pancreatic islets. Am J Physiol Endocrinol Metab. 2006 Feb;290(2):E308-16. Epub 2005 Sep 27.</citation>
          </article>
          <article>
            <pubmed-id>16735460</pubmed-id>
            <citation>Hagos Y, Steffgen J, Rizwan AN, Langheit D, Knoll A, Burckhardt G, Burckhardt BC: Functional roles of cationic amino acid residues in the sodium-dicarboxylate cotransporter 3 (NaDC-3) from winter flounder. Am J Physiol Renal Physiol. 2006 Dec;291(6):F1224-31. Epub 2006 May 30.</citation>
          </article>
          <article>
            <pubmed-id>15561973</pubmed-id>
            <citation>Burckhardt BC, Lorenz J, Kobbe C, Burckhardt G: Substrate specificity of the human renal sodium dicarboxylate cotransporter, hNaDC-3, under voltage-clamp conditions. Am J Physiol Renal Physiol. 2005 Apr;288(4):F792-9. Epub 2004 Nov 23.</citation>
          </article>
          <article>
            <pubmed-id>16030212</pubmed-id>
            <citation>Hall JA, Pajor AM: Functional characterization of a Na(+)-coupled dicarboxylate carrier protein from Staphylococcus aureus. J Bacteriol. 2005 Aug;187(15):5189-94.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13183" source="Swiss-Prot">
    <name>Solute carrier family 13 member 2</name>
    <general-function>Low-affinity sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Cotransport of sodium ions and dicarboxylates such as succinate and citrate.</specific-function>
    <gene-name>SLC13A2</gene-name>
    <locus>17p13.2</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>13-33
53-73
86-106
114-134
221-241
274-294
324-344
371-391
450-470
482-502
511-531
545-565</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.01</theoretical-pi>
    <molecular-weight>64409.495</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10917</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC13A2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U26209</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1098557</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13183</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>S13A2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Na(+)/dicarboxylate cotransporter 1</synonym>
      <synonym>NaDC-1</synonym>
      <synonym>NADC1</synonym>
      <synonym>Renal sodium/dicarboxylate cotransporter</synonym>
      <synonym>SDCT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000891|Solute carrier family 13 member 2
MATCWQALWAYRSYLIVFFVPILLLPLPILVPSKEAYCAYAIILMALFWCTEALPLAVTA
LFPLILFPMMGIVDASEVAVEYLKDSNLLFFGGLLVAIAVEHWNLHKRIALRVLLIVGVR
PAPLILGFMLVTAFLSMWISNTATSAMMVPIAHAVLDQLHSSQASSNVEEGSNNPTFELQ
EPSPQKEVTKLDNGQALPVTSASSEGRAHLSQKHLHLTQCMSLCVCYSASIGGIATLTGT
APNLVLQGQINSLFPQNGNVVNFASWFSFAFPTMVILLLLAWLWLQILFLGFNFRKNFGI
GEKMQEQQQAAYCVIQTEHRLLGPMTFAEKAISILFVILVLLWFTREPGFFLGWGNLAFP
NAKGESMVSDGTVAIFIGIIMFIIPSKFPGLTQDPENPGKLKAPLGLLDWKTVNQKMPWN
IVLLLGGGYALAKGSERSGLSEWLGNKLTPLQSVPAPAIAIILSLLVATFTECTSNVATT
TIFLPILASMAQAICLHPLYVMLPCTLATSLAFMLPVATPPNAIVFSFGDLKVLDMARAG
FLLNIIGVLIIALAINSWGIPLFSLHSFPSWAQSNTTAQCLPSLANTTTPSP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016096|Solute carrier family 13 member 2 (SLC13A2)
ATGGCCACCTGCTGGCAGGCCCTGTGGGCCTATCGCTCCTACCTGATCGTGTTCTTCGTG
CCCATTCTCCTGCTGCCTCTGCCCATCCTCGTCCCCAGTAAGGAGGCCTACTGCGCGTAT
GCCATCATCCTCATGGCGCTCTTCTGGTGCACTGAGGCCCTGCCCCTGGCCGTCACTGCC
CTCTTCCCCTTAATCCTGTTCCCTATGATGGGCATCGTGGATGCCTCTGAGATCATTCAG
AGACCATTTCCATCCAGTTTCGAGAGCCCAGGGGAATGCCAGTCTGTGGGAATGTCAGTG
ACTGCATCCCATAACCTCGGGGGCACCGTGGGAGACTCCAGGGTCTTCCCGCCGCTCAGC
CATGTCTCCACCTGCCAGGTTGCCGTCGAGTATCTTAAGGACTCCAACCTCCTGTTCTTC
GGGGGGCTGCTGGTGGCCATCGCGGTGGAACACTGGAACCTGCATAAACGCATCGCCCTC
CGTGTCCTCCTCATCGTTGGGGTGCGGCCTGCCCCGCTAATCCTGGGCTTCATGCTGGTC
ACGGCCTTCCTGTCCATGTGGATCAGCAACACGGCCACCTCAGCCATGATGGTGCCCATC
GCACATGCCGTCCTGGACCAGCTGCACAGCTCGCAAGCCAGCAGCAACGTCGAGGAGGGC
AGCAACAACCCCACCTTCGAGCTCCAGGAACCAAGTCCCCAGAAGGAGGTGACCAAGCTT
GATAATGGGCAGGCCCTCCCTGTCACGTCTGCCTCTTCGGAGGGGAGGGCACATCTCAGC
CAGAAGCATCTCCACCTCACCCAGTGCATGAGCCTGTGCGTGTGCTACTCCGCCAGCATC
GGGGGCATCGCCACGCTGACTGGCACCGCACCCAACCTGGTGCTGCAAGGCCAGATCAAC
TCGCTCTTCCCCCAAAACGGCAACGTGGTGAACTTCGCCTCCTGGTTCAGCTTCGCCTTC
CCCACCATGGTCATCTTGCTGCTGCTGGCCTGGTTGTGGCTGCAGATCCTCTTCCTGGGC
TTCAACTTCCGGAAGAACTTTGGCATTGGGGAAAAGATGCAGGAGCAACAGCAGGCAGCC
TACTGCGTCATCCAGACCGAGCACAGGCTGCTGGGCCCCATGACCTTTGCAGAAAAGGCC
ATCAGCATCCTATTCGTCATCCTGGTGCTGCTCTGGTTCACCCGGGAGCCGGGCTTTTTT
CTTGGCTGGGGCAATTTGGCTTTTCCCAATGCCAAGGGGGAGAGCATGGTGTCCGATGGG
ACAGTGGCCATCTTCATCGGCATAATTATGTTCATCATACCCTCCAAGTTCCCAGGGCTG
ACCCAGGACCCAGAAAACCCAGGGAAGCTGAAGGCCCCTCTTGGCCTCCTCGACTGGAAG
ACGGTGAACCAGAAGATGCCGTGGAATATCGTGTTATTGCTGGGTGGTGGCTATGCCCTG
GCCAAGGGCAGTGAGCGATCGGGCCTGTCAGAGTGGCTGGGAAACAAGCTGACCCCACTG
CAGAGTGTGCCAGCTCCAGCCATTGCCATCATCCTCTCCCTCCTGGTGGCCACCTTCACC
GAGTGCACTAGCAACGTGGCCACCACTACGATCTTCCTGCCCATCCTAGCCTCCATGGCC
CAGGCCATCTGCCTCCACCCTCTCTACGTCATGCTCCCCTGCACTCTGGCCACCTCCCTG
GCCTTCATGTTGCCTGTGGCCACCCCGCCCAATGCCATCGTCTTCTCTTTCGGGGACCTC
AAAGTGTTGGATATGGCCCGGGCAGGATTCCTCCTCAACATCATTGGAGTCCTGATCATC
GCACTGGCCATCAACAGCTGGGGCATCCCCCTCTTCAGCCTGCACTCTTTCCCCTCCTGG
GCACAGTCCAACACCACAGCCCAGTGCCTGCCAAGCCTGGCCAACACCACCACACCAAGC
CCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00939</identifier>
        <name>Na_sulph_symp</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>low-affinity sodium</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dicarboxylic acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000022</id>
      <name>Solute carrier family 13 member 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11161786</pubmed-id>
            <citation>Lee A, Beck L, Markovich D: The human renal sodium sulfate cotransporter (SLC13A1; hNaSi-1) cDNA and gene: organization, chromosomal localization, and functional characterization. Genomics. 2000 Dec 15;70(3):354-63.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BZW2" source="Swiss-Prot">
    <name>Solute carrier family 13 member 1</name>
    <general-function>Sodium:sulfate symporter activity</general-function>
    <specific-function>Sodium/sulfate cotransporter that mediates sulfate reabsorption in the kidney.</specific-function>
    <gene-name>SLC13A1</gene-name>
    <locus>7q31-q32</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>13-33
41-61
77-97
108-128
131-151
239-259
290-310
348-368
381-401
464-484
491-511
512-532
554-574</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.19</theoretical-pi>
    <molecular-weight>66133.62</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10916</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC13A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF260824</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>12620132</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9BZW2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>S13A1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>hNaSi-1</synonym>
      <synonym>Na(+)/sulfate cotransporter</synonym>
      <synonym>NAS1</synonym>
      <synonym>NASI1</synonym>
      <synonym>Renal sodium/sulfate cotransporter</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009881|Solute carrier family 13 member 1
MKFFSYILVYRRFLFVVFTVLVLLPLPIVLHTKEAECAYTLFVVATFWLTEALPLSVTAL
LPSLMLPMFGIMPSKKVASAYFKDFHLLLIGVICLATSIEKWNLHKRIALKMVMMVGVNP
AWLTLGFMSSTAFLSMWLSNTSTAAMVMPIAEAVVQQIINAEAEVEATQMTYFNGSTNHG
LEIDESVNGHEINERKEKTKPVPGYNNDTGKISSKVELEKNSGMRTKYRTKKGHVTRKLT
CLCIAYSSTIGGLTTITGTSTNLIFAEYFNTRYPDCRCLNFGSWFTFSFPAALIILLLSW
IWLQWLFLGFNFKEMFKCGKTKTVQQKACAEVIKQEYQKLGPIRYQEIVTLVLFIIMALL
WFSRDPGFVPGWSALFSEYPGFATDSTVALLIGLLFFLIPAKTLTKTTPTGEIVAFDYSP
LITWKEFQSFMPWDIAILVGGGFALADGCEESGLSKWIGNKLSPLGSLPAWLIILISSLM
VTSLTEVASNPATITLFLPILSPLAEAIHVNPLYILIPSTLCTSFAFLLPVANPPNAIVF
SYGHLKVIDMVKAGLGVNIVGVAVVMLGICTWIVPMFDLYTYPSWAPAMSNETMP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0009882|Solute carrier family 13 member 1 (SLC13A1)
ATGAAATTCTTCAGTTACATTCTGGTTTATCGCCGATTTCTCTTCGTGGTTTTCACTGTG
TTGGTTTTACTACCTCTGCCCATCGTCCTCCACACCAAGGAAGCAGAATGTGCCTACACA
CTCTTTGTGGTCGCCACATTTTGGCTCACAGAAGCATTGCCTCTGTCGGTAACAGCTTTG
CTACCTAGTTTAATGTTACCCATGTTTGGGATCATGCCTTCTAAGAAGGTGGCATCTGCT
TATTTCAAGGATTTTCACTTACTGCTAATTGGAGTTATCTGTTTAGCAACATCCATAGAA
AAATGGAATTTGCACAAGAGAATTGCTCTGAAAATGGTGATGATGGTTGGTGTAAATCCT
GCATGGCTGACGCTGGGGTTCATGAGCAGCACTGCCTTTTTGTCTATGTGGCTCAGCAAC
ACCTCGACGGCTGCCATGGTGATGCCCATTGCGGAGGCTGTAGTGCAGCAGATCATCAAT
GCAGAAGCAGAGGTCGAGGCCACTCAGATGACTTACTTCAACGGATCAACCAACCACGGA
CTAGAAATTGATGAAAGTGTTAATGGACATGAAATAAATGAGAGGAAAGAGAAAACAAAA
CCAGTTCCAGGATACAATAATGATACAGGGAAAATTTCAAGCAAGGTGGAGTTGGAAAAG
AACTCAGGCATGAGAACCAAATATCGAACAAAGAAGGGCCACGTGACACGTAAACTTACG
TGTTTGTGCATTGCCTACTCTTCTACCATTGGTGGACTGACAACAATCACTGGTACCTCC
ACCAACTTGATCTTTGCAGAGTATTTCAATACACGCTATCCTGACTGTCGTTGCCTCAAC
TTTGGATCATGGTTTACGTTTTCCTTCCCAGCTGCCCTTATCATTCTACTCTTATCCTGG
ATCTGGCTTCAGTGGCTTTTCCTAGGATTCAATTTTAAGGAGATGTTCAAATGTGGCAAA
ACCAAAACAGTCCAACAAAAAGCTTGTGCTGAGGTGATTAAGCAAGAATACCAAAAGCTT
GGGCCAATAAGGTATCAAGAAATTGTGACCTTGGTCCTCTTCATTATAATGGCTCTGCTA
TGGTTTAGTCGAGACCCCGGATTTGTTCCTGGTTGGTCTGCACTTTTTTCAGAGTACCCT
GGTTTTGCTACAGATTCAACTGTTGCTTTACTTATAGGGCTGCTATTCTTTCTTATCCCA
GCTAAGACACTGACTAAAACTACACCTACAGGAGAAATTGTTGCTTTTGATTACTCTCCA
CTGATTACTTGGAAAGAATTCCAGTCATTCATGCCCTGGGATATAGCCATTCTTGTTGGT
GGAGGGTTTGCCCTGGCAGATGGTTGTGAGGAGTCTGGATTATCTAAGTGGATAGGAAAT
AAATTATCTCCTCTGGGTTCATTACCAGCATGGCTAATAATTCTGATATCTTCTTTGATG
GTGACATCTTTAACTGAGGTAGCCAGCAATCCAGCTACCATTACACTCTTTCTCCCAATA
TTATCTCCATTGGCCGAAGCCATTCATGTGAACCCTCTTTATATTCTGATACCTTCTACT
CTGTGTACTTCATTTGCATTCCTCCTACCAGTAGCAAATCCACCCAATGCTATTGTCTTT
TCATATGGTCATCTGAAAGTCATTGACATGGTTAAAGCTGGACTTGGTGTCAACATTGTT
GGTGTTGCTGTGGTTATGCTTGGCATATGTACTTGGATTGTACCCATGTTTGACCTCTAC
ACTTACCCTTCGTGGGCTCCTGCTATGAGTAATGAGACCATGCCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00939</identifier>
        <name>Na_sulph_symp</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000355</id>
      <name>Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q96I99" source="Swiss-Prot">
    <name>Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial</name>
    <general-function>Succinate-coa ligase (gdp-forming) activity</general-function>
    <specific-function>Catalyzes the GTP-dependent ligation of succinate and CoA to form succinyl-CoA.</specific-function>
    <gene-name>SUCLG2</gene-name>
    <locus>3p14.1</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.18</theoretical-pi>
    <molecular-weight>46510.215</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11450</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SUCLG2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>BC007716</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>133777003</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q96I99</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SUCB2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.4</synonym>
      <synonym>GTP-specific succinyl-CoA synthetase subunit beta</synonym>
      <synonym>SCS-betaG</synonym>
      <synonym>Succinyl-CoA synthetase beta-G chain</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000707|Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial
MASPVAAQAGKLLRALALRPRFLAAGSQAVQLTSRRWLNLQEYQSKKLMSDNGVRVQRFF
VADTANEALEAAKRLNAKEIVLKAQILAGGRGKGVFNSGLKGGVHLTKDPNVVGQLAKQM
IGYNLATKQTPKEGVKVNKVMVAEALDISRETYLAILMDRSCNGPVLVGSPQGGVDIEEV
AASNPELIFKEQIDIFEGIKDSQAQRMAENLGFVGPLKSQAADQITKLYNLFLKIDATQV
EVNPFGETPEGQVVCFDAKINFDDNAEFRQKDIFAMDDKSENEPIENEAAKYDLKYIGLD
GNIACFVNGAGLAMATCDIIFLNGGKPANFLDLGGGVKEAQVYQAFKLLTADPKVEAILV
NIFGGIVNCAIIANGITKACRELELKVPLVVRLEGTNVQEAQKILNNSGLPITSAIDLED
AAKKAVASVAKK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010259|Succinyl-CoA ligase [GDP-forming] subunit beta, mitochondrial (SUCLG2)
ATGGCGTCCCCCGTAGCAGCGCAGGCCGGGAAGCTTCTGCGAGCCCTAGCGCTGCGGCCC
CGCTTCCTGGCGGCCGGGTCCCAGGCAGTTCAATTAACCTCCAGAAGATGGCTGAACCTG
CAGGAATACCAGAGCAAGAAACTGATGTCTGACAACGGAGTGAGAGTTCAAAGATTCTTT
GTAGCAGACACTGCAAATGAAGCTCTCGAGGCTGCTAAGAGACTAAATGCAAAAGAAATT
GTTTTAAAAGCCCAGATCTTAGCTGGAGGAAGAGGAAAAGGTGTCTTCAATAGTGGTTTG
AAAGGAGGTGTTCATTTAACAAAAGACCCTAATGTTGTGGGACAGCTGGCTAAACAGATG
ATTGGGTACAATCTAGCGACAAAACAAACTCCAAAAGAAGGTGTGAAAGTTAACAAGGTG
ATGGTTGCTGAAGCCTTGGATATTTCCAGAGAAACCTACCTGGCAATTCTGATGGACCGG
TCCTGCAATGGCCCCGTGCTGGTGGGCAGCCCCCAGGGGGGCGTCGACATTGAAGAGGTG
GCTGCTTCAAACCCGGAGCTCATTTTTAAGGAGCAAATTGACATTTTTGAAGGAATAAAG
GACAGCCAAGCTCAGCGGATGGCCGAAAATCTAGGCTTCGTTGGGCCTTTGAAAAGCCAG
GCTGCAGATCAAATTACGAAGCTGTATAATCTCTTCCTGAAAATTGATGCTACTCAGGTG
GAAGTGAATCCCTTTGGTGAAACTCCAGAAGGACAAGTTGTCTGTTTTGATGCCAAGATA
AACTTTGATGACAACGCAGAATTCCGACAAAAAGACATATTTGCTATGGACGACAAATCA
GAGAATGAGCCCATTGAAAATGAAGCTGCCAAATATGATCTAAAATACATAGGACTAGAT
GGGAACATTGCCTGCTTTGTGAATGGTGCTGGGCTCGCCATGGCTACTTGTGATATCATT
TTCCTTAATGGTGGGAAGCCAGCCAACTTCTTGGATCTTGGAGGTGGTGTAAAGGAAGCT
CAAGTATATCAAGCATTCAAATTGCTCACAGCTGATCCTAAGGTTGAAGCCATCCTTGTC
AATATATTTGGTGGTATCGTCAACTGTGCCATCATTGCCAATGGGATCACCAAAGCCTGC
CGGGAGCTAGAACTCAAGGTGCCCCTGGTGGTCCGGCTTGAAGGTACTTTTATGGAAAAA
AAAGGAAGTTATATGCACATAAAACAAGAAACAGGAAATTCAAATGAGAATATAACTGGT
ATCCAAGAGAACGTCGCCCACCAAAATCTGAGTAAGTGTGCCATCAGCATTTTTTTATGT
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF08442</identifier>
        <name>ATP-grasp_2</name>
      </pfam>
      <pfam>
        <identifier>PF00549</identifier>
        <name>Ligase_CoA</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>microtubule organizing center</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-CoA ligase (GDP-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GTP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinyl-CoA metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002252</id>
      <name>Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16374125</pubmed-id>
            <citation>Brink I, Schaefer O, Walz M, Neumann HP: Fluorine-18 DOPA PET imaging of paraganglioma syndrome. Clin Nucl Med. 2006 Jan;31(1):39-41.</citation>
          </article>
          <article>
            <pubmed-id>15989954</pubmed-id>
            <citation>Sun F, Huo X, Zhai Y, Wang A, Xu J, Su D, Bartlam M, Rao Z: Crystal structure of mitochondrial respiratory membrane protein complex II. Cell. 2005 Jul 1;121(7):1043-57.</citation>
          </article>
          <article>
            <pubmed-id>16288654</pubmed-id>
            <citation>Bayley JP, Devilee P, Taschner PE: The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet. 2005 Nov 16;6:39.</citation>
          </article>
          <article>
            <pubmed-id>17520677</pubmed-id>
            <citation>Lehtonen HJ, Makinen MJ, Kiuru M, Laiho P, Herva R, van Minderhout I, Hogendoorn PC, Cornelisse C, Devilee P, Launonen V, Aaltonen LA: Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. Int J Cancer. 2007 Sep 15;121(6):1386-9.</citation>
          </article>
          <article>
            <pubmed-id>16405730</pubmed-id>
            <citation>Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE: Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet. 2006 Jan 11;7:1.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O14521" source="Swiss-Prot">
    <name>Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial</name>
    <general-function>Ubiquinone binding</general-function>
    <specific-function>Membrane-anchoring subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).</specific-function>
    <gene-name>SDHD</gene-name>
    <locus>11q23</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions>64-85
91-111
121-142</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.75</theoretical-pi>
    <molecular-weight>17042.82</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10683</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SDHD</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB006202</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2351037</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O14521</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DHSD_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>CII-4</synonym>
      <synonym>CybS</synonym>
      <synonym>QPs3</synonym>
      <synonym>SDH4</synonym>
      <synonym>Succinate dehydrogenase complex subunit D</synonym>
      <synonym>Succinate-ubiquinone oxidoreductase cytochrome b small subunit</synonym>
      <synonym>Succinate-ubiquinone reductase membrane anchor subunit</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004420|Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial
MAVLWRLSAVCGALGGRALLLRTPVVRPAHISAFLQDRPIPEWCGVQHIHLSPSHHSGSK
AASLHWTSERVVSVLLLGLLPAAYLNPCSAMDYSLAAALTLHGHWGLGQVVTDYVHGDAL
QKAAKAGLLALSALTFAGLCYFNYHDVGICKAVAMLWKL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011623|Succinate dehydrogenase [ubiquinone] cytochrome b small subunit, mitochondrial (SDHD)
ATGGCGGTTCTCTGGAGGCTGAGTGCCGTTTGCGGTGCCCTAGGAGGCCGAGCTCTGTTG
CTTCGAACTCCAGTGGTCAGACCTGCTCATATCTCAGCATTTCTTCAGGACCGACCTATC
CCAGAATGGTGTGGAGTGCAGCACATACACTTGTCACCGAGCCACCATTGGGCCTTGGAC
AAGTTGTTACTGACTATGTTCATGGGGATGCCTTGCAGAAAGCTGCCAAGGCAGGGCTTT
TGGCACTTTCAGCTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05328</identifier>
        <name>CybS</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial envelope</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ubiquinone binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory electron transport chain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002253</id>
      <name>Prolyl 4-hydroxylase subunit alpha-2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15460" source="Swiss-Prot">
    <name>Prolyl 4-hydroxylase subunit alpha-2</name>
    <general-function>Procollagen-proline 4-dioxygenase activity</general-function>
    <specific-function>Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins.</specific-function>
    <gene-name>P4HA2</gene-name>
    <locus>5q31</locus>
    <cellular-location>Endoplasmic reticulum lumen</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-21</signal-regions>
    <theoretical-pi>5.43</theoretical-pi>
    <molecular-weight>60901.42</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8547</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>P4HA2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U90441</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2439985</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15460</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P4HA2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.2</synonym>
      <synonym>4-PH alpha-2</synonym>
      <synonym>Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004422|Prolyl 4-hydroxylase subunit alpha-2
MKLWVSALLMAWFGVLSCVQAEFFTSIGHMTDLIYAEKELVQSLKEYILVEEAKLSKIKS
WANKMEALTSKSAADAEGYLAHPVNAYKLVKRLNTDWPALEDLVLQDSAAGFIANLSVQR
QFFPTDEDEIGAAKALMRLQDTYRLDPGTISRGELPGTKYQAMLSVDDCFGMGRSAYNEG
DYYHTVLWMEQVLKQLDAGEEATTTKSQVLDYLSYAVFQLGDLHRALELTRRLLSLDPSH
ERAGGNLRYFEQLLEEEREKTLTNQTEAELATPEGIYERPVDYLPERDVYESLCRGEGVK
LTPRRQKRLFCRYHHGNRAPQLLIAPFKEEDEWDSPHIVRYYDVMSDEEIERIKEIAKPK
LARATVRDPKTGVLTVASYRVSKSSWLEEDDDPVVARVNRRMQHITGLTVKTAELLQVAN
YGVGGQYEPHFDFSRNDERDTFKHLGTGNRVATFLNYMSDVEAGGATVFPDLGAAIWPKK
GTAVFWYNLLRSGEGDYRTRHAACPVLVGCKWVSNKWFHERGQEFLRPCGSTEVD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021321|Prolyl 4-hydroxylase subunit alpha-2 (P4HA2)
ATGAAACTCTGGGTGTCTGCATTGCTGATGGCCTGGTTTGGTGTCCTGAGCTGTGTGCAG
GCCGAATTCTTCACCTCTATTGGGCACATGACTGACCTGATTTATGCAGAGAAAGAGCTG
GTGCAGTCTCTGAAAGAGTACATCCTTGTGGAGGAAGCCAAGCTTTCCAAGATTAAGAGC
TGGGCCAACAAAATGGAAGCCTTGACTAGCAAGTCAGCTGCTGATGCTGAGGGCTACCTG
GCTCACCCTGTGAATGCCTACAAACTGGTGAAGCGGCTAAACACAGACTGGCCTGCGCTG
GAGGACCTTGTCCTGCAGGACTCAGCTGCAGGTTTTATCGCCAACCTCTCTGTGCAGCGG
CAGTTCTTCCCCACTGATGAGGACGAGATAGGAGCTGCCAAAGCCCTGATGAGACTTCAG
GACACATACAGGCTGGACCCAGGCACAATTTCCAGAGGGGAACTTCCAGGAACCAAGTAC
CAGGCAATGCTGAGTGTGGATGACTGCTTTGGGATGGGCCGCTCGGCCTACAATGAAGGG
GACTATTATCATACGGTGTTGTGGATGGAGCAGGTGCTAAAGCAGCTTGATGCCGGGGAG
GAGGCCACCACAACCAAGTCACAGGTGCTGGACTACCTCAGCTATGCTGTCTTCCAGTTG
GGTGATCTGCACCGTGCCCTGGAGCTCACCCGCCGCCTGCTCTCCCTTGACCCAAGCCAC
GAACGAGCTGGAGGGAATCTGCGGTACTTTGAGCAGTTATTGGAGGAAGAGAGAGAAAAA
ACGTTAACAAATCAGACAGAAGCTGAGCTAGCAACCCCAGAAGGCATCTATGAGAGGCCT
GTGGACTACCTGCCTGAGAGGGATGTTTACGAGAGCCTCTGTCGTGGGGAGGGTGTCAAA
CTGACACCCCGTAGACAGAAGAGGCTTTTCTGTAGGTACCACCATGGCAACAGGGCCCCA
CAGCTGCTCATTGCCCCCTTCAAAGAGGAGGACGAGTGGGACAGCCCGCACATCGTCAGG
TACTACGATGTCATGTCTGATGAGGAAATCGAGAGGATCAAGGAGATCGCAAAACCTAAA
CTTGCACGAGCCACCGTTCGTGATCCCAAGACAGGAGTCCTCACTGTCGCCAGCTACCGG
GTTTCCAAAAGCTCCTGGCTAGAGGAAGATGATGACCCTGTTGTGGCCCGAGTAAATCGT
CGGATGCAGCATATCACAGGGTTAACAGTAAAGACTGCAGAATTGTTACAGGTTGCAAAT
TATGGAGTGGGAGGACAGTATGAACCGCACTTCGACTTCTCTAGGCGACCTTTTGACAGC
GGCCTCAAAACAGAGGGGAATAGGTTAGCGACGTTTCTTAACTACATGAGTGATGTAGAA
GCTGGTGGTGCCACCGTCTTCCCTGATCTGGGGGCTGCAATTTGGCCTAAGAAGGGTACA
GCTGTGTTCTGGTACAACCTCTTGCGGAGCGGGGAAGGTGACTACCGAACAAGACATGCT
GCCTGCCCTGTGCTTGTGGGCTGCAAGTGGGTCTCCAATAAGTGGTTCCATGAACGAGGA
CAGGAGTTCTTGAGACCTTGTGGATCAACAGAAGTTGACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF08336</identifier>
        <name>P4Ha_N</name>
      </pfam>
      <pfam>
        <identifier>PF13640</identifier>
        <name>2OG-FeII_Oxy_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>procollagen-proline 4-dioxygenase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-proline 4-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-proline hydroxylation to 4-hydroxy-L-proline</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002195</id>
      <name>Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60568" source="Swiss-Prot">
    <name>Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3</name>
    <general-function>Procollagen-lysine 5-dioxygenase activity</general-function>
    <specific-function>Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links.</specific-function>
    <gene-name>PLOD3</gene-name>
    <locus>7q22</locus>
    <cellular-location>Rough endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-24</signal-regions>
    <theoretical-pi>5.95</theoretical-pi>
    <molecular-weight>84784.505</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9083</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PLOD3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF046889</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3153235</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60568</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PLOD3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.4</synonym>
      <synonym>LH3</synonym>
      <synonym>Lysyl hydroxylase 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0020594|Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3
MTSSGPGPRFLLLLPLLLPPAASASDRPRGRDPVNPEKLLVITVATAETEGYLRFLRSAE
FFNYTVRTLGLGEEWRGGDVARTVGGGQKVRWLKKEMEKYADREDMIIMFVDSYDVILAG
SPTELLKKFVQSGSRLLFSAESFCWPEWGLAEQYPEVGTGKRFLNSGGFIGFATTIHQIV
RQWKYKDDDDDQLFYTRLYLDPGLREKLSLNLDHKSRIFQNLNGALDEVVLKFDRNRVRI
RNVAYDTLPIVVHGNGPTKLQLNYLGNYVPNGWTPEGGCGFCNQDRRTLPGGQPPPRVFL
AVFVEQPTPFLPRFLQRLLLLDYPPDRVTLFLHNNEVFHEPHIADSWPQLQDHFSAVKLV
GPEEALSPGEARDMAMDLCRQDPECEFYFSLDADAVLTNLQTLRILIEENRKVIAPMLSR
HGKLWSNFWGALSPDEYYARSEDYVELVQRKRVGVWNVPYISQAYVIRGDTLRMELPQRD
VFSGSDTDPDMAFCKSFRDKGIFLHLSNQHEFGRLLATSRYDTEHLHPDLWQIFDNPVDW
KEQYIHENYSRALEGEGIVEQPCPDVYWFPLLSEQMCDELVAEMEHYGQWSGGRHEDSRL
AGGYENVPTVDIHMKQVGYEDQWLQLLRTYVGPMTESLFPGYHTKARAVMNFVVRYRPDE
QPSLRPHHDSSTFTLNVALNHKGLDYEGGGCRFLRYDCVISSPRKGWALLHPGRLTHYHE
GLPTTWGTRYIMVSFVDP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020595|Procollagen-lysine,2-oxoglutarate 5-dioxygenase 3 (PLOD3)
ATGACCTCCTCGGGGCCTGGACCCCGGTTCCTGCTGCTGCTGCCGCTGCTGCTGCCCCCT
GCGGCCTCAGCCTCCGACCGGCCCCGGGGCCGAGACCCGGTCAACCCAGAGAAGCTGCTG
GTGATCACTGTGGCCACAGCTGAAACCGAGGGGTACCTGCGTTTCCTGCGCTCTGCGGAG
TTCTTCAACTACACTGTGCGGACCCTGGGCCTGGGAGAGGAGTGGCGAGGGGGTGATGTG
GCTCGAACAGTTGGTGGAGGACAGAAGGTCCGGTGGTTAAAGAAGGAAATGGAGAAATAC
GCTGACCGGGAGGATATGATCATCATGTTTGTGGATAGCTACGACGTGATTCTGGCCGGC
AGCCCCACAGAGCTGCTGAAGAAGTTCGTCCAGAGTGGCAGCCGCCTGCTCTTCTCTGCA
GAGAGCTTCTGCTGGCCCGAGTGGGGGCTGGCGGAGCAGTACCCTGAGGTGGGCACGGGG
AAGCGCTTCCTCAATTCTGGTGGATTCATCGGTTTTGCCACCACCATCCACCAAATCGTG
CGCCAGTGGAAGTACAAGGATGATGACGACGACCAGCTGTTCTACACACGGCTCTACCTG
GACCCAGGACTGAGGGAGAAACTCAGCCTTAATCTGGATCATAAGTCTCGGATCTTTCAG
AACCTCAACGGGGCTTTAGATGAAGTGGTTTTAAAGTTTGATCGGAACCGTGTGCGTATC
CGGAACGTGGCCTACGACACGCTCCCCATTGTGGTCCATGGAAACGGTCCCACTAAGCTG
CAGCTCAACTACCTGGGAAACTACGTCCCCAATGGCTGGACTCCTGAGGGAGGCTGTGGC
TTCTGCAACCAGGACCGGAGGACACTCCCGGGGGGGCAGCCTCCCCCCCGGGTGTTTCTG
GCCGTGTTTGTGGAACAGCCTACTCCGTTTCTGCCCCGCTTCCTGCAGCGGCTGCTACTC
CTGGACTATCCCCCCGACAGGGTCACCCTTTTCCTGCACAACAACGAGGTCTTCCATGAA
CCCCACATCGCTGACTCCTGGCCGCAGCTCCAGGACCACTTCTCAGCTGTGAAGCTCGTG
GGGCCGGAGGAGGCTCTGAGCCCAGGCGAGGCCAGGGACATGGCCATGGACCTGTGTCGG
CAGGACCCCGAGTGTGAGTTCTACTTCAGCCTGGACGCCGACGCTGTCCTCACCAACCTG
CAGACCCTGCGTATCCTCATTGAGGAGAACAGGAAGGTGATCGCCCCCATGCTGTCCCGC
CACGGCAAGCTGTGGTCCAACTTCTGGGGCGCCCTGAGCCCCGATGAGTACTACGCCCGC
TCCGAGGACTACGTGGAGCTGGTGCAGCGGAAGCGAGTGGGTGTGTGGAATGTACCATAC
ATCTCCCAGGCCTATGTGATCCGGGGTGATACCCTGCGGATGGAGCTGCCCCAGAGGGAT
GTGTTCTCGGGCAGTGACACAGACCCGGACATGGCCTTCTGTAAGAGCTTTCGAGACAAG
GGCATCTTCCTCCATCTGAGCAATCAGCATGAATTTGGCCGGCTCCTGGCCACTTCCAGA
TACGACACGGAGCACCTGCACCCCGACCTCTGGCAGATCTTCGACAACCCCGTCGACTGG
AAGGAGCAGTACATCCACGAGAACTACAGCCGGGCCCTGGAAGGGGAAGGAATCGTGGAG
CAGCCATGCCCGGACGTGTACTGGTTCCCACTGCTGTCAGAACAAATGTGTGATGAGCTG
GTGGCAGAGATGGAGCACTACGGCCAGTGGTCAGGCGGCCGGCATGAGGATTCAAGGCTG
GCTGGAGGCTACGAGAATGTGCCCACCGTGGACATCCACATGAAGCAGGTGGGGTACGAG
GACCAGTGGCTGCAGCTGCTGCGGACGTATGTGGGCCCCATGACCGAGAGCCTGTTTCCC
GGTTACCACACCAAGGCGCGGGCGGTGATGAACTTTGTGGTTCGCTACCGGCCAGACGAG
CAGCCGTCTCTGCGGCCACACCACGACTCATCCACCTTCACCCTCAACGTTGCCCTCAAC
CACAAGGGCCTGGACTATGAGGGAGGTGGCTGCCGCTTCCTGCGCTACGACTGTGTGATC
TCCTCCCCGAGGAAGGGCTGGGCACTCCTGCACCCCGGCCGCCTCACCCACTACCACGAG
GGGCTGCCAACGACCTGGGGCACACGCTACATCATGGTGTCCTTTGTCGACCCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03171</identifier>
        <name>2OG-FeII_Oxy</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen glucosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-lysine 5-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neural tube development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein localization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermis morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>in utero embryonic development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>basement membrane assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endothelial cell morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein modification process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lung morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>collagen fibril organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vasodilation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hormone stimulus</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002197</id>
      <name>Gamma-butyrobetaine dioxygenase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>10820142</pubmed-id>
            <citation>Yoshisue K, Yamamoto Y, Yoshida K, Saeki M, Minami Y, Esumi Y, Kawaguchi Y: Pharmacokinetics and biological fate of 3-(2,2, 2-trimethylhydrazinium)propionate dihydrate (MET-88), a novel cardioprotective agent, in rats. Drug Metab Dispos. 2000 Jun;28(6):687-94.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75936" source="Swiss-Prot">
    <name>Gamma-butyrobetaine dioxygenase</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Catalyzes the formation of L-carnitine from gamma-butyrobetaine.</specific-function>
    <gene-name>BBOX1</gene-name>
    <locus>11p14.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.73</theoretical-pi>
    <molecular-weight>44714.6</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:964</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BBOX1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF082868</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3746805</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O75936</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BODG_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.1</synonym>
      <synonym>BBH</synonym>
      <synonym>BBOX</synonym>
      <synonym>Gamma-BBH</synonym>
      <synonym>Gamma-butyrobetaine hydroxylase</synonym>
      <synonym>Gamma-butyrobetaine,2-oxoglutarate dioxygenase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011587|Gamma-butyrobetaine dioxygenase
MACTIQKAEALDGAHLMQILWYDEEESLYPAVWLRDNCPCSDCYLDSAKARKLLVEALDV
NIGIKGLIFDRKKVYITWPDEHYSEFQADWLKKRCFSKQARAKLQRELFFPECQYWGSEL
QLPTLDFEDVLRYDEHAYKWLSTLKKVGIVRLTGASDKPGEVSKLGKRMGFLYLTFYGHT
WQVQDKIDANNVAYTTGKLSFHTDYPALHHPPGVQLLHCIKQTVTGGDSEIVDGFNVCQK
LKKNNPQAFQILSSTFVDFTDIGVDYCDFSVQSKHKIIELDDKGQVVRINFNNATRDTIF
DVPVERVQPFYAALKEFVDLMNSKESKFTFKMNPGDVITFDNWRLLHGRRSYEAGTEISR
HLEGAYADWDVVMSRLRILRQRVENGN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011588|Gamma-butyrobetaine dioxygenase (BBOX1)
ATGGCTTGTACCATCCAAAAGGCAGAAGCACTTGACGGGGCTCATTTGATGCAGATCCTC
TGGTATGATGAGGAAGAGTCTCTCTACCCAGCTGTATGGTTGAGAGACAACTGTCCGTGC
TCTGATTGCTACCTGGATTCTGCAAAAGCACGGAAACTTCTAGTGGAAGCTCTTGATGTG
AACATTGGAATTAAAGGCTTGATATTTGACAGAAAAAAGGTGTACATCACATGGCCCGAT
GAGCATTACAGTGAATTCCAGGCTGATTGGCTGAAGAAAAGATGCTTTTCCAAGCAGGCC
AGAGCAAAGCTCCAAAGAGAATTGTTTTTTCCAGAATGCCAATACTGGGGCTCAGAGCTC
CAGCTACCCACTTTGGATTTTGAAGATGTTTTAAGATATGATGAACACGCATACAAGTGG
CTCTCCACCCTCAAGAAAGTAGGCATAGTAAGACTCACCGGAGCATCTGACAAACCAGGA
GAAGTTTCAAAACTTGGGAAAAGGATGGGTTTCCTCTATCTCACATTTTATGGACATACT
TGGCAAGTGCAAGACAAAATCGATGCAAACAATGTGGCTTACACAACTGGGAAGCTAAGC
TTTCACACTGATTATCCAGCCCTCCATCATCCACCTGGGGTTCAGCTTCTTCACTGCATA
AAGCAAACAGTCACAGGGGGTGATTCAGAAATTGTAGATGGGTTTAATGTGTGCCAAAAA
CTAAAGAAAAATAATCCTCAGGCATTCCAGATTTTGTCCTCTACCTTTGTGGACTTTACA
GACATTGGAGTGGATTACTGTGATTTTTCTGTACAATCAAAACATAAAATTATAGAGTTA
GATGATAAAGGCCAAGTGGTTCGCATCAACTTCAATAACGCAACTAGGGACACAATATTT
GATGTGCCTGTTGAAAGAGTTCAGCCTTTTTATGCTGCTCTGAAGGAGTTTGTTGACCTC
ATGAACAGCAAAGAATCCAAGTTTACCTTCAAGATGAATCCAGGTGATGTGATTACTTTT
GATAACTGGCGCTTACTTCATGGCCGACGTAGCTATGAAGCAGGAACTGAGATATCCCGC
CATCTAGAAGGAGCTTATGCTGACTGGGATGTGGTCATGTCAAGGCTTCGTATCTTAAGG
CAGAGGGTGGAGAATGGAAACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02668</identifier>
        <name>TauD</name>
      </pfam>
      <pfam>
        <identifier>PF06155</identifier>
        <name>DUF971</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>gamma-butyrobetaine dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carnitine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000060</id>
      <name>Prolyl 4-hydroxylase subunit alpha-1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P13674" source="Swiss-Prot">
    <name>Prolyl 4-hydroxylase subunit alpha-1</name>
    <general-function>Procollagen-proline 4-dioxygenase activity</general-function>
    <specific-function>Catalyzes the post-translational formation of 4-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens and other proteins.</specific-function>
    <gene-name>P4HA1</gene-name>
    <locus>10q21.3-q23.1</locus>
    <cellular-location>Endoplasmic reticulum lumen</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-17</signal-regions>
    <theoretical-pi>5.84</theoretical-pi>
    <molecular-weight>61048.775</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8546</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>P4HA1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M24486</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>190786</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P13674</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P4HA1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.2</synonym>
      <synonym>4-PH alpha-1</synonym>
      <synonym>P4HA</synonym>
      <synonym>Procollagen-proline,2-oxoglutarate-4-dioxygenase subunit alpha-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000120|Prolyl 4-hydroxylase subunit alpha-1
MIWYILIIGILLPQSLAHPGFFTSIGQMTDLIHTEKDLVTSLKDYIKAEEDKLEQIKKWA
EKLDRLTSTATKDPEGFVGHPVNAFKLMKRLNTEWSELENLVLKDMSDGFISNLTIQRQY
FPNDEDQVGAAKALLRLQDTYNLDTDTISKGNLPGVKHKSFLTAEDCFELGKVAYTEADY
YHTELWMEQALRQLDEGEISTIDKVSVLDYLSYAVYQQGDLDKALLLTKKLLELDPEHQR
ANGNLKYFEYIMAKEKDVNKSASDDQSDQKTTPKKKGVAVDYLPERQKYEMLCRGEGIKM
TPRRQKKLFCRYHDGNRNPKFILAPAKQEDEWDKPRIIRFHDIISDAEIEIVKDLAKPRL
RRATISNPITGDLETVHYRISKSAWLSGYENPVVSRINMRIQDLTGLDVSTAEELQVANY
GVGGQYEPHFDFARKDEPDAFKELGTGNRIATWLFYMSDVSAGGATVFPEVGASVWPKKG
TAVFWYNLFASGEGDYSTRHAACPVLVGNKWVSNKWLHERGQEFRRPCTLSELE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016006|Prolyl 4-hydroxylase subunit alpha-1 (P4HA1)
ATGATCTGGTATATATTAATTATAGGAATTCTGCTTCCCCAGTCTTTGGCTCATCCAGGC
TTTTTTACTTCAATTGGTCAGATGACTGATTTGATCCATACTGAGAAAGATCTGGTGACT
TCTCTGAAAGATTATATTAAGGCAGAAGAGGACAAGTTAGAACAAATAAAAAAATGGGCA
GAGAAGTTAGATCGGCTAACTAGTACAGCGACAAAAGATCCAGAAGGATTTGTTGGGCAT
CCAGTAAATGCATTCAAATTAATGAAACGTCTGAATACTGAGTGGAGTGAGTTGGAGAAT
CTGGTCCTTAAGGATATGTCAGATGGCTTTATCTCTAACCTAACCATTCAGAGACAGTAC
TTTCCTAATGATGAAGATCAGGTTGGGGCAGCCAAAGCTCTGTTACGTCTCCAGGATACC
TACAATTTGGATACAGATACCATCTCAAAGGGTAATCTTCCAGGAGTGAAACACAAATCT
TTTCTAACGGCTGAGGACTGCTTTGAGTTGGGCAAAGTGGCCTATACAGAAGCAGATTAT
TACCATACGGAACTGTGGATGGAACAAGCCCTAAGGCAACTGGATGAAGGCGAGATTTCT
ACCATAGATAAAGTCTCTGTTCTAGATTATTTGAGCTATGCGGTATATCAGCAGGGAGAC
CTGGATAAGGCACTTTTGCTCACAAAGAAGCTTCTTGAACTAGATCCTGAACATCAGAGA
GCTAATGGTAACTTAAAATATTTTGAGTATATAATGGCTAAAGAAAAAGATGTCAATAAG
TCTGCTTCAGATGACCAATCTGATCAGAAAACTACACCAAAGAAAAAAGGGGTTGCTGTG
GATTACCTGCCAGAGAGACAGAAGTACGAAATGCTGTGCCGTGGGGAGGGTATCAAAATG
ACCCCTCGGAGACAGAAAAAACTCTTTTGCCGCTACCATGATGGAAACCGTAATCCTAAA
TTTATTCTGGCTCCAGCTAAACAGGAGGATGAATGGGACAAGCCTCGTATTATTCGCTTC
CATGATATTATTTCTGATGCAGAAATTGAAATCGTCAAAGACCTAGCAAAACCAAGGCTG
AGCCGAGCTACAGTACATGACCCTGAGACTGGAAAATTGACCACAGCACAGTACAGAGTA
TCTAAGAGTGCCTGGCTCTCTGGCTATGAAAATCCTGTGGTGTCTCGAATTAATATGAGA
ATACAAGATCTAACAGGACTAGATGTTTCCACAGCAGAGGAATTACAGGTAGCAAATTAT
GGAGTTGGAGGACAGTATGAACCCCATTTTGACTTTGCACGGAAAGATGAGCCAGATGCT
TTCAAAGAGCTGGGGACAGGAAATAGAATTGCTACATGGCTGTTTTATATGAGTGATGTG
TCTGCAGGAGGAGCCACTGTTTTTCCTGAAGTTGGAGCTAGTGTTTGGCCCAAAAAAGGA
ACTGCTGTTTTCTGGTATAATCTGTTTGCCAGTGGAGAAGGAGATTATAGTACACGGCAT
GCAGCCTGTCCAGTGCTAGTTGGCAACAAATGGGTATCCAATAAATGGCTCCATGAACGT
GGACAAGAATTTCGAAGACCTTGTACGTTGTCAGAATTGGAATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03171</identifier>
        <name>2OG-FeII_Oxy</name>
      </pfam>
      <pfam>
        <identifier>PF08336</identifier>
        <name>P4Ha_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity, acting on single donors with incorporation of molecular oxygen, incorporation of two atoms of oxygen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-proline 4-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-proline hydroxylation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002254</id>
      <name>Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16232421</pubmed-id>
            <citation>Arikawa Y, Kuroyanagi T, Shimosaka M, Muratsubaki H, Enomoto K, Kodaira R, Okazaki M: Effect of gene disruptions of the TCA cycle on production of succinic acid in Saccharomyces cerevisiae. J Biosci Bioeng. 1999;87(1):28-36.</citation>
          </article>
          <article>
            <pubmed-id>16288654</pubmed-id>
            <citation>Bayley JP, Devilee P, Taschner PE: The SDH mutation database: an online resource for succinate dehydrogenase sequence variants involved in pheochromocytoma, paraganglioma and mitochondrial complex II deficiency. BMC Med Genet. 2005 Nov 16;6:39.</citation>
          </article>
          <article>
            <pubmed-id>17520677</pubmed-id>
            <citation>Lehtonen HJ, Makinen MJ, Kiuru M, Laiho P, Herva R, van Minderhout I, Hogendoorn PC, Cornelisse C, Devilee P, Launonen V, Aaltonen LA: Increased HIF1 alpha in SDH and FH deficient tumors does not cause microsatellite instability. Int J Cancer. 2007 Sep 15;121(6):1386-9.</citation>
          </article>
          <article>
            <pubmed-id>16405730</pubmed-id>
            <citation>Bayley JP, van Minderhout I, Weiss MM, Jansen JC, Oomen PH, Menko FH, Pasini B, Ferrando B, Wong N, Alpert LC, Williams R, Blair E, Devilee P, Taschner PE: Mutation analysis of SDHB and SDHC: novel germline mutations in sporadic head and neck paraganglioma and familial paraganglioma and/or pheochromocytoma. BMC Med Genet. 2006 Jan 11;7:1.</citation>
          </article>
          <article>
            <pubmed-id>17636259</pubmed-id>
            <citation>Szeto SS, Reinke SN, Sykes BD, Lemire BD: Ubiquinone-binding site mutations in the Saccharomyces cerevisiae succinate dehydrogenase generate superoxide and lead to the accumulation of succinate. J Biol Chem. 2007 Sep 14;282(37):27518-26. Epub 2007 Jul 18.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21912" source="Swiss-Prot">
    <name>Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial</name>
    <general-function>Ubiquinone binding</general-function>
    <specific-function>Iron-sulfur protein (IP) subunit of succinate dehydrogenase (SDH) that is involved in complex II of the mitochondrial electron transport chain and is responsible for transferring electrons from succinate to ubiquinone (coenzyme Q).</specific-function>
    <gene-name>SDHB</gene-name>
    <locus>1p36.1-p35</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.92</theoretical-pi>
    <molecular-weight>31629.365</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10681</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SDHB</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U17248</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>665925</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P21912</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SDHB_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.3.5.1</synonym>
      <synonym>Ip</synonym>
      <synonym>Iron-sulfur subunit of complex II</synonym>
      <synonym>SDH</synonym>
      <synonym>SDH1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011624|Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial
MAAVVALSLRRRLPATTLGGACLQASRGAQTAAATAPRIKKFAIYRWDPDKAGDKPHMQT
YEVDLNKCGPMVLDALIKIKNEVDSTLTFRRSCREGICGSCAMNINGGNTLACTRRIDTN
LNKVSKIYPLPHMYVIKDLVPDLSNFYAQYKSIEPYLKKKDESQEGKQQYLQSIEEREKL
DGLYECILCACCSTSCPSYWWNGDKYLGPAVLMQAYRWMIDSRDDFTEERLAKLQDPFSL
YRCHTIMNCTRTCPKGLNPGKAIAEIKKMMATYKEKKASV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011625|Succinate dehydrogenase [ubiquinone] iron-sulfur subunit, mitochondrial (SDHB)
ATGGCGGCGGTGGTCGCCCTCTCCTTGAGGCGCCGGTTGCCGGCCACAACCCTTGGCGGA
GCCTGCCTGCAGGCCTCCCGAGGAGCCCAGACAGCTGCAGCCACAGCTCCCCGTATCAAG
AAATTTGCCATCTATCGATGGGACCCAGACAAGGCTGGAGACAAACCTCATATGCAGACT
TATGAAGTTGACCTTAATAAATGTGGCCCCATGGTATTGGATGCTTTAATCAAGATTAAG
AATGAAGTTGACTCTACTTTGACCTTCCGAAGATCATGCAGAGAAGGCATCTGTGGCTCT
TGTGCAATGAACATCAATGGAGGCAACACTCTAGCTTGCACCCGAAGGATTGACACCAAC
CTCAATAAGGTCTCAAAAATCTACCCTCTTCCACACATGTATGTGATAAAGGATCTTGTT
CCCGATTTGAGCAACTTCTATGCACAGTACAAATCCATTGAGCCTTATTTGAAGAAGAAG
GATGAATCTCAGGAAGGCAAGCAGCAGTATCTGCAGTCCATAGAAGAGCGTGAGAAACTG
GACGGGCTCTACGAGTGCATTCTCTGTGCCTGCTGTAGCACCAGCTGCCCCAGCTACTGG
TGGAACGGAGACAAATATCTGGGGCCTGCAGTTCTTATGCAGGCCTATCGCTGGATGATT
GACTCCAGAGATGACTTCACAGAGGAGCGCCTGGCCAAGCTGCAGGACCCATTCTCTCTA
TACCGCTGCCACACCATCATGAACTGCACAAGGACCTGTCCTAAGGGTCTGAATCCAGGG
AAAGCTATTGCAGAGATCAAGAAAATGATGGCAACCTATAAGGAGAAGAAAGCTTCAGTT
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13085</identifier>
        <name>Fer2_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>2 iron, 2 sulfur cluster binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3 iron, 4 sulfur cluster binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate dehydrogenase (ubiquinone) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>4 iron, 4 sulfur cluster binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ubiquinone binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aerobic respiration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory electron transport chain</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000152</id>
      <name>Succinate-semialdehyde dehydrogenase, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>15853764</pubmed-id>
            <citation>Yogeeswari P, Sriram D, Vaigundaragavendran J: The GABA shunt: an attractive and potential therapeutic target in the treatment of epileptic disorders. Curr Drug Metab. 2005 Apr;6(2):127-39.</citation>
          </article>
          <article>
            <pubmed-id>17619587</pubmed-id>
            <citation>Popov VN, Eprintsev AT, Fedorin DN, Fomenko OIu, Igamberdiev AU: [Role of transamination in the mobilization of respiratory substrates in germinating seeds of castor oil plants]. Prikl Biokhim Mikrobiol. 2007 May-Jun;43(3):376-81.</citation>
          </article>
          <article>
            <pubmed-id>16942602</pubmed-id>
            <citation>Wang C, Zhang HB, Wang LH, Zhang LH: Succinic semialdehyde couples stress response to quorum-sensing signal decay in Agrobacterium tumefaciens. Mol Microbiol. 2006 Oct;62(1):45-56. Epub 2006 Aug 30.</citation>
          </article>
          <article>
            <pubmed-id>17584458</pubmed-id>
            <citation>Ahn SJ, Yang CH, Cooksey DA: Pseudomonas putida 06909 genes expressed during colonization on mycelial surfaces and phenotypic characterization of mutants. J Appl Microbiol. 2007 Jul;103(1):120-32.</citation>
          </article>
          <article>
            <pubmed-id>16689938</pubmed-id>
            <citation>Chiribau CB, Mihasan M, Ganas P, Igloi GL, Artenie V, Brandsch R: Final steps in the catabolism of nicotine. FEBS J. 2006 Apr;273(7):1528-36.</citation>
          </article>
          <article>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P51649" source="Swiss-Prot">
    <name>Succinate-semialdehyde dehydrogenase, mitochondrial</name>
    <general-function>Succinate-semialdehyde dehydrogenase [nad(p)+] activity</general-function>
    <specific-function>Catalyzes one step in the degradation of the inhibitory neurotransmitter gamma-aminobutyric acid (GABA).</specific-function>
    <gene-name>ALDH5A1</gene-name>
    <locus>6p22.2-p22.3</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.37</theoretical-pi>
    <molecular-weight>57214.23</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:408</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ALDH5A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y11192</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3766467</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>2466</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P51649</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SSDH_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.2.1.24</synonym>
      <synonym>Aldehyde dehydrogenase family 5 member A1</synonym>
      <synonym>NAD(+)-dependent succinic semialdehyde dehydrogenase</synonym>
      <synonym>SSADH</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000303|Succinate-semialdehyde dehydrogenase, mitochondrial
MATCIWLRSCGARRLGSTFPGCRLRPRAGGLVPASGPAPGPAQLRCYAGRLAGLSAALLR
TDSFVGGRWLPAAATFPVQDPASGAALGMVADCGVREARAAVRAAYEAFCRWREVSAKER
SSLLRKWYNLMIQNKDDLARIITAESGKPLKEAHGEILYSAFFLEWFSEEARRVYGDIIH
TPAKDRRALVLKQPIGVAAVITPWNFPSAMITRKVGAALAAGCTVVVKPAEDTPFSALAL
AELASQAGIPSGVYNVIPCSRKNAKEVGEAICTDPLVSKISFTGSTTTGKILLHHAANSV
KRVSMELGGLAPFIVFDSANVDQAVAGAMASKFRNTGQTCVCSNQFLVQRGIHDAFVKAF
AEAMKKNLRVGNGFEEGTTQGPLINEKAVEKVEKQVNDAVSKGATVVTGGKRHQLGKNFF
EPTLLCNVTQDMLCTHEETFGPLAPVIKFDTEEEAIAIANAADVGLAGYFYSQDPAQIWR
VAEQLEVGMVGVNEGLISSVECPFGGVKQSGLGREGSKYGIDEYLELKYVCYGGL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021648|Succinate-semialdehyde dehydrogenase, mitochondrial (ALDH5A1)
ATGGCGACCTGCATTTGGCTGCGGAGCTGTGGGGCCCGGCGCCTCGGGTCGACGTTTCCA
GGCTGCCGCCTCCGCCCCCGCGCCGGCGGCCTGGTCCCTGCCTCCGGGCCTGCGCCCGGC
CCGGCCCAGCTCCGCTGCTACGCTGGGCGCCTGGCGGGCCTCTCTGCGGCGCTGCTGCGC
ACCGACAGCTTCGTGGGCGGCCGCTGGCTCCCGGCCGCCGCCACCTTCCCCGTGCAAGAC
CCGGCCAGCGGCGCCGCTCTGGGCATGGTAGCCGACTGCGGGGTGCGAGAGGCCCGCGCC
GCCGTGCGCGCTGCCTACGAGGCTTTCTGCCGCTGGAGGGAGGTCTCCGCCAAGGAGAGG
AGTTCATTACTTCGGAAGTGGTACAATTTAATGATACAAAATAAGGATGACCTTGCCAGA
ATAATCACAGCTGAAAGTGGAAAGCCACTGAAGGAGGCACATGGAGAAATTCTCTATTCC
GCCTTTTTCCTAGAGTGGTTCTCTGAGGAAGCCCGCCGTGTTTACGGAGACATTATCCAC
ACCCCGGCAAAGGACAGGCGGGCCCTGGTCCTCAAGCAGCCCATAGGCGTGGCTGCAGTC
ATCACCCCGTGGAATTTCCCCAGTGCCATGATCACCCGGAAGGTGGGGGCCGCCCTGGCA
GCCGGCTGTACTGTCGTGGTGAAGCCTGCCGAAGACACGCCCTTCTCCGCCCTGGCCCTG
GCTGAGCTTGCAAGCCAGGCTGGGATTCCTTCAGGTGTATACAATGTTATTCCCTGTTCT
CGAAAGAATGCCAAGGAAGTAGGGGAGGCAATTTGTACTGATCCTCTGGTGTCCAAAATT
TCCTTTACTGGTTCAACAACTACAGGAAAGATCCTGTTGCACCACGCAGCAAACTCTGTG
AAAAGGGTCTCTATGGAGCTGGGCGGCCTTGCTCCATTTATAGTATTTGACAGTGCCAAC
GTGGACCAGGCTGTAGCAGGGGCCATGGCATCTAAATTTAGGAACACTGGACAGACTTGT
GTTTGCTCAAACCAATTCTTGGTGCAAAGGGGCATCCATGATGCCTTTGTAAAAGCATTC
GCCGAGGCCATGAAGAAGAACCTGCGCGTAGGTAATGGATTTGAGGAAGGAACTACTCAG
GGCCCATTAATTAATGAAAAAGCGGTAGAAAAGGTGGAGAAACAGGTGAATGATGCCGTT
TCTAAAGGTGCCACCGTTGTGACAGGTGGAAAACGACACCAACTTGGAAAAAATTTCTTT
GAGCCTACCCTGCTGTGCAATGTCACCCAGGACATGCTGTGCACTCATGAAGAGACTTTC
GGGCCTCTGGCACCAGTTATCAAGTTCGATACAGAGGAGGAGGCTATAGCAATCGCTAAC
GCAGCTGATGTTGGGTTAGCAGGTTATTTTTACTCTCAAGACCCAGCCCAGATCTGGAGA
GTGGCAGAGCAGCTGGAAGTGGGCATGGTTGGCGTCAACGAAGGATTAATTTCCTCTGTG
GAGTGCCCTTTTGGTGGAGTGAAGCAGTCCGGCCTTGGGCGAGAGGGGTCCAAGTATGGC
ATTGATGAGTATCTGGAACTCAAGTATGTGTGTTACGGGGGCTTGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00171</identifier>
        <name>Aldedh</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-semialdehyde dehydrogenase (NAD+) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-semialdehyde dehydrogenase [NAD(P)+] activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aldehyde dehydrogenase (NAD) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gamma-aminobutyric acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>central nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycerophospholipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory electron transport chain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acetate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>galactosylceramide metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>short-chain fatty acid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002255</id>
      <name>Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17668387</pubmed-id>
            <citation>Ostergaard E, Christensen E, Kristensen E, Mogensen B, Duno M, Shoubridge EA, Wibrand F: Deficiency of the alpha subunit of succinate-coenzyme A ligase causes fatal infantile lactic acidosis with mitochondrial DNA depletion. Am J Hum Genet. 2007 Aug;81(2):383-7. Epub 2007 Jun 4.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P53597" source="Swiss-Prot">
    <name>Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial</name>
    <general-function>Succinate-coa ligase (gdp-forming) activity</general-function>
    <specific-function>Catalyzes the ATP- or GTP-dependent ligation of succinate and CoA to form succinyl-CoA. The nature of the beta subunit determines the nucleotide specificity (By similarity).</specific-function>
    <gene-name>SUCLG1</gene-name>
    <locus>2p11.2</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.24</theoretical-pi>
    <molecular-weight>36249.505</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11449</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SUCLG1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF104921</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>9409794</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P53597</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SUCA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.2.1.4</synonym>
      <synonym>SCS-alpha</synonym>
      <synonym>Succinyl-CoA synthetase subunit alpha</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037180|Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial
MTATLAAAADIATMVSGSSGLAAARLLSRSFLLPQNGIRHCSYTASRQHLYVDKNTKIIC
QGFTGKQGTFHSQQALEYGTKLVGGTTPGKGGQTHLGLPVFNTVKEAKEQTGATASVIYV
PPPFAAAAINEAIEAEIPLVVCITEGIPQQDMVRVKHKLLRQEKTRLIGPNCPGVINPGE
CKIGIMPGHIHKKGRIGIVSRSGTLTYEAVHQTTQVGLGQSLCVGIGGDPFNGTDFIDCL
EIFLNDSATEGIILIGEIGGNAEENAAEFLKQHNSGPNSKPVVSFIAGLTAPPGRRMGHA
GAIIAGGKGGAKEKISALQSAGVVVSMSPAQLGTTIYKEFEKRKML</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016731|Succinyl-CoA ligase [ADP/GDP-forming] subunit alpha, mitochondrial (SUCLG1)
ATGACCGCAACCCTTGCCGCTGCCGCTGACATCGCTACCATGGTCTCCGGCAGCAGCGGC
CTCGCCGCCGCCCGTCTCCTGTCGCGCAGCTTCCTCCTGCCGCAGAATGGAATTCGGCAT
TGTTCCTACACAGCTTCTCGGCAACATCTCTATGTTGATAAAAATACAAAGATTATTTGC
CAGGGTTTCACTGGCAAACAGGGCACCTTTCACAGCCAGCAGGCATTGGAATATGGCACC
AAACTCGTTGGAGGAACCACTCCAGGGAAAGGAGGCCAGACACATCTGGGCTTACCTGTC
TTTAATACTGTGAAGGAGGCCAAAGAACAGACAGGAGCAACGGCTTCTGTCATTTATGTT
CCTCCGCCTTTTGCTGCTGCTGCCATTAATGAAGCTATTGAGGCAGAAATTCCCTTGGTT
GTGTGTATCACTGAAGGAATTCCCCAGCAGGACATGGTACGAGTCAAGCACAAACTGCTG
CGCCAGGAAAAGACAAGGCTAATTGGGCCCAACTGCCCTGGAGTCATCAATCCTGGAGAA
TGTAAAATTGGCATCATGCCTGGCCATATTCACAAAAAAGGAAGGATTGGCATTGTGTCC
AGATCTGGCACCCTGACTTATGAAGCAGTTCACCAAACAACGCAAGTTGGATTGGGGCAG
TCTTTGTGCGTTGGCATTGGAGGTGATCCTTTTAATGGAACAGATTTTATTGACTGCCTC
GAAATCTTTTTGAACGATTCTGCCACAGAAGGCATCATATTGATTGGTGAAATTGGTGGT
AATGCAGAAGAGAATGCTGCAGAATTTTTGAAGCAACATAATTCAGGTCCAAATTCCAAG
CCTGTAGTGTCCTTCATTGCTGGTTTAACTGCTCCTCCTGGGAGAAGAATGGGTCATGCC
GGGGCAATTATTGCTGGAGGAAAAGGTGGAGCTAAAGAGAAGATCTCTGCCCTTCAGAGT
GCAGGAGTTGTGGTCAGTATGTCTCCTGCACAGCTGGGAACCACGATCTACAAGGAATTT
GAAAAGAGGAAGATGCTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00549</identifier>
        <name>Ligase_CoA</name>
      </pfam>
      <pfam>
        <identifier>PF02629</identifier>
        <name>CoA_binding</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>succinate-CoA ligase complex (GDP-forming)</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cofactor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-CoA ligase (GDP-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GTP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-CoA ligase (ADP-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GDP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>succinyl-CoA metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleoside triphosphate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002256</id>
      <name>Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>15388917</pubmed-id>
            <citation>Coros AM, Swenson L, Wolodko WT, Fraser ME: Structure of the CoA transferase from pig heart to 1.7 A resolution. Acta Crystallogr D Biol Crystallogr. 2004 Oct;60(Pt 10):1717-25. Epub 2004 Sep 23.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P55809" source="Swiss-Prot">
    <name>Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Key enzyme for ketone body catabolism. Transfers the CoA moiety from succinate to acetoacetate. Formation of the enzyme-CoA intermediate proceeds via an unstable anhydride species formed between the carboxylate groups of the enzyme and substrate.</specific-function>
    <gene-name>OXCT1</gene-name>
    <locus>5p13.1</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.52</theoretical-pi>
    <molecular-weight>56157.175</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8527</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>OXCT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U62961</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1519052</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P55809</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SCOT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.8.3.5</synonym>
      <synonym>3-oxoacid CoA-transferase 1</synonym>
      <synonym>OXCT</synonym>
      <synonym>SCOT</synonym>
      <synonym>SCOT-s</synonym>
      <synonym>Somatic-type succinyl-CoA:3-oxoacid CoA-transferase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004428|Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial
MAALKLLSSGLRLCASARGSGATWYKGCVCSFSTSAHRHTKFYTDPVEAVKDIPDGATVL
VGGFGLCGIPENLIDALLKTGVKGLTAVSNNAGVDNFGLGLLLRSKQIKRMVSSYVGENA
EFERQYLSGELEVELTPQGTLAERIRAGGAGVPAFYTPTGYGTLVQEGGSPIKYNKDGSV
AIASKPREVREFNGQHFILEEAITGDFALVKAWKADRAGNVIFRKSARNFNLPMCKAAET
TVVEVEEIVDIGAFAPEDIHIPQIYVHRLIKGEKYEKRIERLSIRKEGDGEAKSAKPGDD
VRERIIKRAALEFEDGMYANLGIGIPLLASNFISPNITVHLQSENGVLGLGPYPRQHEAD
ADLINAGKETVTILPGASFFSSDESFAMIRGGHVDLTMLGAMQVSKYGDLANWMIPGKMV
KGMGGAMDLVSSAKTKVVVTMEHSAKGNAHKIMEKCTLPLTGKQCVNRIITEKAVFDVDK
KKGLTLIELWEGLTVDDVQKSTGCDFAVSPKLMPMQQIAN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011626|Succinyl-CoA:3-ketoacid coenzyme A transferase 1, mitochondrial (OXCT1)
ATGGCGGCTCTCAAACTCCTCTCCTCCGGGCTTCGGCTCTGCGCCTCTGCCCGCGGATCT
GGGGCAACCTGGTACAAGGGATGTGTTTGTTCCTTTTCCACCAGTGCTCATCGCCATACC
AAGTTTTATACAGATCCAGTAGAAGCTGTAAAAGACATCCCTGATGGTGCCACGGTTTTG
GTTGGTGGTTTTGGGCTATGTGGAATTCCAGAGAATCTTATAGATGCTTTACTGAAAACT
GGAGTAAAAGGACTAACTGCAGTCAGCAACAATGCAGGGGTTGACAATTTTGGTTTGGGG
CTTTTGCTTCGGTCCAAGCAGATAAAACGCATGGTCTCTTCATATGTGGGAGAAAATGCA
GAATTTGAACGACAGTACTTATCTGGTGAATTAGAAGTGGAGCTGACACCACAGGGCACA
CTTGCAGAGAGGATCCGTGCAGGCGGGGCTGGAGTTCCTGCATTTTACACCCCAACAGGG
TATGGGACCCTGGTACAAGAAGGAGGATCGCCCATCAAATACAACAAAGATGGCAGTGTT
GCCATTGCCAGTAAGCCAAGAGAGGTGAGGGAGTTCAATGGTCAGCACTTTATTTTGGAG
GAAGCAATTACAGGGGATTTTGCTTTGGTGAAAGCCTGGAAGGCGGACCGAGCAGGAAAC
GTGATTTTCAGGAAAAGTGCAAGGAATTTCAACTTGCCAATGTGCAAAGCTGCAGAAACC
ACAGTGGTAGAGGTTGAAGAAATTGTGGATATTGGAGCATTTGCTCCAGAAGACATCCAT
ATTCCTCAGATTTATGTACATCGCCTTATAAAGGGAGAAAAATATGAGAAAAGAATTGAG
CGTTTATCAATCCGGAAAGAGGGAGATGGGGAAGCCAAATCTGCTAAACCTGGAGATGAC
GTAAGGGAACGAATCATCAAGAGGGCCGCTCTTGAGTTTGAGGATGGCATGTATGCTAAT
TTGGGCATAGGAATCCCTCTCCTGGCCAGCAATTTTATCAGCCCAAATATAACTGTTCAT
CTTCAAAGTGAAAATGGAGTTCTGGGTTTGGGTCCATATCCACGACAACATGAAGCTGAT
GCAGATCTCATCAATGCAGGCAAGGAAACAGTTACTATTCTTCCAGGAGCCTCTTTTTTC
TCCAGCGATGAATCATTTGCAATGATTAGAGGTGGACACGTCGATCTGACAATGCTAGGA
GCGATGCAGGTTTCCAAATATGGTGACCTGGCTAACTGGATGATACCTGGGAAGATGGTG
AAAGGAATGGGAGGTGCTATGGATTTAGTGTCCAGTGCGAAAACCAAAGTGGTGGTCACC
ATGGAGCATTCTGCAAAGGGAAATGCACATAAAATCATGGAGAAATGTACATTACCATTG
ACTGGAAAGCAATGTGTCAACCGCATTATTACTGAAAAGGCTGTGTTTGATGTGGACAAG
AAGAAAGGGTTGACTCTGATTGAGCTCTGGGAAGGCCTGACAGTGGATGACGTACAGAAG
AGTACTGGGTGTGATTTTGCAGTTTCACCAAAACTCATGCCAATGCAGCAGATCGCAAAT
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01144</identifier>
        <name>CoA_trans</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>3-oxoacid CoA-transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adipose tissue development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of insulin secretion involved in cellular response to glucose stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ketone catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular ketone body metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ketone body catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000087</id>
      <name>Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17610258</pubmed-id>
            <citation>Cudic M, Patel DA, Lauer-Fields JL, Brew K, Fields GB: Development of a convenient peptide-based assay for lysyl hydroxylase. Biopolymers. 2008;90(3):330-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q02809" source="Swiss-Prot">
    <name>Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Forms hydroxylysine residues in -Xaa-Lys-Gly- sequences in collagens. These hydroxylysines serve as sites of attachment for carbohydrate units and are essential for the stability of the intermolecular collagen cross-links.</specific-function>
    <gene-name>PLOD1</gene-name>
    <locus>1p36.3-p36.2</locus>
    <cellular-location>Rough endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-18</signal-regions>
    <theoretical-pi>6.94</theoretical-pi>
    <molecular-weight>83549.55</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9081</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PLOD1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L06419</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>190074</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q02809</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PLOD1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.4</synonym>
      <synonym>LH1</synonym>
      <synonym>LLH</synonym>
      <synonym>Lysyl hydroxylase 1</synonym>
      <synonym>PLOD</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000174|Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1
MRPLLLLALLGWLLLAEAKGDAKPEDNLLVLTVATKETEGFRRFKRSAQFFNYKIQALGL
GEDWNVEKGTSAGGGQKVRLLKKALEKHADKEDLVILFADSYDVLFASGPRELLKKFRQA
RSQVVFSAEELIYPDRRLETKYPVVSDGKRFLGSGGFIGYAPNLSKLVAEWEGQDSDSDQ
LFYTKIFLDPEKREQINITLDHRCRIFQNLDGALDEVVLKFEMGHVRARNLAYDTLPVLI
HGNGPTKLQLNYLGNYIPRFWTFETGCTVCDEGLRSLKGIGDEALPTVLVGVFIEQPTPF
VSLFFQRLLRLHYPQKHMRLFIHNHEQHHKAQVEEFLAQHGSEYQSVKLVGPEVRMANAD
ARNMGADLCRQDRSCTYYFSVDADVALTEPNSLRLLIQQNKNVIAPLMTRHGRLWSNFWG
ALSADGYYARSEDYVDIVQGRRVGVWNVPYISNIYLIKGSALRGELQSSDLFHHSKLDPD
MAFCANIRQQDVFMFLTNRHTLGHLLSLDSYRTTHLHNDLWEVFSNPEDWKEKYIHQNYT
KALAGKLVETPCPDVYWFPIFTEVACDELVEEMEHFGQWSLGNNKDNRIQGGYENVPTID
IHMNQIGFEREWHKFLLEYIAPMTEKLYPGYYTRAQFDLAFVVRYKPDEQPSLMPHHDAS
TFTINIALNRVGVDYEGGGCRFLRYNCSIRAPRKGWTLMHPGRLTHYHEGLPTTRGTRYI
AVSFVDP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010157|Procollagen-lysine,2-oxoglutarate 5-dioxygenase 1 (PLOD1)
ATGCGGCCCCTGCTGCTACTGGCCCTGCTGGGCTGGCTGCTGCTGGCCGAAGCGAAGGGC
GACGCCAAGCCGGAGGACAACCTTTTAGTCCTCACGGTGGCCACTAAGGAGACCGAGGGA
TTCCGTCGCTTCAAGCGCTCAGCTCAGTTCTTCAACTACAAGATCCAGGCGCTTGGCCTA
GGGGAGGACTGGAATGTGGAGAAGGGGACGTCGGCAGGTGGAGGGCAGAAGGTCCGGCTG
CTGAAGAAAGCTCTGGAGAAGCACGCAGACAAGGAGGATCTGGTCATTCTCTTCGCAGAC
AGCTATGACGTGCTGTTTGCATCGGGGCCCCGGGAGCTCCTGAAGAAGTTCCGGCAGGCC
AGGAGCCAGGTGGTCTTCTCTGCTGAGGAGCTCATCTACCCAGACCGCAGGCTGGAGACC
AAGTATCCGGTGGTGTCCGATGGCAAGAGGTTCCTGGGCTCTGGAGGCTTCATCGGTTAT
GCCCCCAACCTCAGCAAACTGGTGGCCGAGTGGGAGGGCCAGGACAGCGACAGCGATCAG
CTGTTTTACACCAAGATCTTCTTGGACCCGGAGAAGAGGGAGCAGATCAATATCACCCTG
GACCACCGCTGCCGTATCTTCCAGAACCTGGATGGAGCCTTGGATGAGGTCGTGCTCAAG
TTTGAAATGGGCCATGTGAGAGCGAGGAACCTGGCCTATGACACCCTCCCGGTCCTGATC
CATGGCAACGGGCCAACCAAGCTGCAGTTGAACTACCTGGGCAACTACATCCCGCGCTTC
TGGACCTTCGAAACAGGCTGCACCGTGTGTGACGAAGGCTTGCGCAGCCTCAAGGGCATT
GGGGATGAAGCTCTGCCCACGGTCCTGGTCGGCGTGTTCATCGAACAGCCCACGCCGTTT
GTGTCCCTGTTCTTCCAGCGGCTCCTGCGGCTCCACTACCCCCAGAAACACATGCGACTT
TTCATCCACAACCACGAGCAGCACCACAAGGCTCAGGTGGAAGAGTTCCTGGCACAGCAT
GGCAGCGAGTACCAGTCTGTGAAGCTGGTGGGCCCTGAGGTGCGGATGGCGAATGCAGAT
GCCAGGAACATGGGCGCAGACCTGTGCCGGCAGGACCGCAGCTGCACCTACTACTTCAGC
GTGGATGCTGACGTGGCCCTGACCGAGCCCAACAGCCTGCGGCTGCTGATCCAACAGAAC
AAGAACGTCATTGCCCCGCTGATGACCCGGCATGGGAGGCTGTGGTCGAACTTCTGGGGG
GCTCTCAGTGCAGATGGCTACTATGCCCGTTCCGAGGACTACGTGGACATTGTGCAGGGG
CGGCGTGTTGGTGTCTGGAATGTGCCCTATATTTCAAACATCTACTTGATCAAGGGCAGT
GCCCTGCGGGGTGAGCTGCAGTCCTCAGATCTCTTCCACCACAGCAAGCTGGACCCCGAC
ATGGCCTTCTGTGCCAACATCCGGCAGCAGGATGTGTTCATGTTCCTGACCAACCGGCAC
ACCCTTGGCCATCTGCTCTCCCTAGACAGCTACCGCACCACCCACCTGCACAACGACCTC
TGGGAGGTGTTCAGCAACCCCGAGGACTGGAAGGAGAAGTACATCCACCAGAACTACACC
AAAGCCCTGGCAGGGAAGCTGGTGGAGACGCCCTGCCCGGATGTCTATTGGTTCCCCATC
TTCACGGAGGTGGCCTGTGATGAGCTGGTGGAGGAGATGGAGCACTTTGGCCAGTGGTCT
CTGGGCAACAACAAGGACAACCGCATCCAGGGTGGCTACGAGAACGTGCCGACTATTGAC
ATCCACATGAACCAGATCGGCTTTGAGCGGGAGTGGCACAAATTCCTGCTGGAGTACATT
GCGCCCATGACGGAGAAGCTCTACCCCGGCTACTACACCAGGGCCCAGTTTGACCTGGCC
TTTGTCGTCCGCTACAAGCCTGATGAGCAGCCCTCACTGATGCCACACCATGATGCCTCC
ACCTTCACCATCAACATCGCCCTGAACCGAGTCGGGGTGGATTACGAGGGCGGGGGCTGT
CGGTTCCTGCGCTACAACTGTTCCATCCGAGCCCCAAGGAAGGGCTGGACCCTCATGCAC
CCTGGACGACTCACGCATTACCATGAGGGGCTCCCCACCACCAGGGGCACCCGCTACATC
GCAGTCTCCTTCGTCGATCCCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03171</identifier>
        <name>2OG-FeII_Oxy</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-lysine 5-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ferrous iron binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hormone stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermis development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hydroxylysine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-lysine hydroxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein modification process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000528</id>
      <name>Aspartyl/asparaginyl beta-hydroxylase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q12797" source="Swiss-Prot">
    <name>Aspartyl/asparaginyl beta-hydroxylase</name>
    <general-function>Structural molecule activity</general-function>
    <specific-function>Isoform 1: specifically hydroxylates an Asp or Asn residue in certain epidermal growth factor-like (EGF) domains of a number of proteins.Isoform 8: membrane-bound Ca(2+)-sensing protein, which is a structural component of the ER-plasma membrane junctions. Isoform 8 regulates the activity of Ca(+2) released-activated Ca(+2) (CRAC) channels in T-cells.</specific-function>
    <gene-name>ASPH</gene-name>
    <locus>8q12.1</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>54-74</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>4.67</theoretical-pi>
    <molecular-weight>85862.095</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:757</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ASPH</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U03109</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>458032</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q12797</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ASPH_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.16</synonym>
      <synonym>ASP beta-hydroxylase</synonym>
      <synonym>Aspartate beta-hydroxylase</synonym>
      <synonym>BAH</synonym>
      <synonym>Peptide-aspartate beta-dioxygenase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037038|Aspartyl/asparaginyl beta-hydroxylase
MAQRKNAKSSGNSSSSGSGSGSTSAGSSSPGARRETKHGGHKNGRKGGLSGTSFFTWFMV
IALLGVWTSVAVVWFDLVDYEEVLGKLGIYDADGDGDFDVDDAKVLLGLKERSTSEPAVP
PEEAEPHTEPEEQVPVEAEPQNIEDEAKEQIQSLLHEMVHAEHVEGEDLQQEDGPTGEPQ
QEDDEFLMATDVDDRFETLEPEVSHEETEHSYHVEETVSQDCNQDMEEMMSEQENPDSSE
PVVEDERLHHDTDDVTYQVYEEQAVYEPLENEGIEITEVTAPPEDNPVEDSQVIVEEVSI
FPVEEQQEVPPETNRKTDDPEQKAKVKKKKPKLLNKFDKTIKAELDAAEKLRKRGKIEEA
VNAFKELVRKYPQSPRARYGKAQCEDDLAEKRRSNEVLRGAIETYQEVASLPDVPADLLK
LSLKRRSDRQQFLGHMRGSLLTLQRLVQLFPNDTSLKNDLGVGYLLIGDNDNAKKVYEEV
LSVTPNDGFAKVHYGFILKAQNKIAESIPYLKEGIESGDPGTDDGRFYFHLGDAMQRVGN
KEAYKWYELGHKRGHFASVWQRSLYNVNGLKAQPWWTPKETGYTELVKSLERNWKLIRDE
GLAVMDKAKGLFLPEDENLREKGDWSQFTLWQQGRRNENACKGAPKTCTLLEKFPETTGC
RRGQIKYSIMHPGTHVWPHTGPTNCRLRMHLGLVIPKEGCKIRCANETKTWEEGKVLIFD
DSFEHEVWQDASSFRLIFIVDVWHPELTPQQRRSLPAI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020468|Aspartyl/asparaginyl beta-hydroxylase (ASPH)
ATGGCTGAAGATAAAGAGACAAAGCATGGAGGACACAAGAATGGGAGGAAAGGCGGACTC
TCAGGAACTTCATTCTTCACGTGGTTTATGGTGATTGCATTGCTGGGCGTCTGGACATCT
GTAGCTGTCGTTTGGTTTGATCTTGTTGACTATGAGGAAGTTCTAGGAAAACTAGGAATC
TATGATGCTGATGGTGATGGAGATTTTGATGTGGATGATGCCAAAGTTTTATTAGGACTT
AAAGAGAGATCTACTTCAGAGCCAGCAGTCCCGCCAGAAGAGGCTGAGCCACACACTGAG
CCCGAGGAGCAGGTTCCTGTGGAGGCAGAACCCCAGAATATCGAAGATGAAGCAAAAGAA
CAAATTCAGTCCCTTCTCCATGAAATGGTACACGCAGAACATGTTGAGGGAGAAGACTTG
CAACAAGAAGATGGACCCACAGGAGAACCACAACAAGAGGATGATGAGTTTCTTATGGCG
ACTGATGTAGATGATAGATTTGAGACCCTGGAACCTGAAGTATCTCATGAAGAAACCGAG
CATAGTTACCACGTGGAAGAGACAGTTTCACAAGACTGTAATCAGGATATGGAAGAGATG
ATGTCTGAGCAGGAAAATCCAGATTCCAGTGAACCAGTAGTAGAAGATGAAAGATTGCAC
CATGATACAGATGATGTAACATACCAAGTCTATGAGGAACAAGCAGTATATGAACCTCTA
GAAAATGAAGGGATAGAAATCACAGAAGTAACTGCTCCCCCTGAGGATAATCCTGTAGAA
GATTCACAGGTAATTGTAGAAGAAGTAAGCATTTTTCCTGTGGAAGAACAGCAGGAAGTA
CCACCAGAAACAAATAGAAAAACAGATGATCCAGAACAAAAAGCAAAAGTTAAGAAAAAG
AAGCCTAAACTTTTAAATAAATTTGATAAGACTATTAAAGCTGAACTTGATGCTGCAGAA
AAACTCCGTAAAAGGGGAAAAATTGAGGAAGCAGTGAATGCATTTAAAGAACTAGTACGC
AAATACCCTCAGAGTCCACGAGCAAGATATGGGAAGGCGCAGTGTGAGGATGATTTGGCT
GAGAAGAGGAGAAGTAATGAGGTGCTACGTGGAGCCATCGAGACCTACCAAGAGGTGGCC
AGCCTACCTGATGTCCCTGCAGACCTGCTGAAGCTGAGTTTGAAGCGTCGCTCAGACAGG
CAACAATTTCTAGGTCATATGAGAGGTTCCCTGCTTACCCTGCAGAGATTAGTTCAACTA
TTTCCCAATGATACTTCCTTAAAAAATGACCTTGGCGTGGGATACCTCTTGATAGGAGAT
AATGACAATGCAAAGAAAGTTTATGAAGAGGTGCTGAGTGTGACACCTAATGATGGCTTT
GCTAAAGTCCATTATGGCTTCATCCTGAAGGCACAGAACAAAATTGCTGAGAGCATCCCA
TATTTAAAGGAAGGAATAGAATCCGGAGATCCTGGCACTGATGATGGGAGATTTTATTTC
CACCTGGGGGATGCCATGCAGAGGGTTGGGAACAAAGAGGCATATAAGTGGTATGAGCTT
GGGCACAAGAGAGGACACTTTGCATCTGTCTGGCAACGCTCACTCTACAATGTGAATGGA
CTGAAAGCACAGCCTTGGTGGACCCCAAAAGAAACGGGCTACACAGAGTTAGTAAAGTCT
TTAGAAAGAAACTGGAAGTTAATCCGAGATGAAGGCCTTGCAGTGATGGATAAAGCCAAA
GGTCTCTTCCTGCCTGAGGATGAAAACCTGAGGGAAAAAGGGGACTGGAGCCAGTTCACG
CTGTGGCAGCAAGGAAGAAGAAATGAAAATGCCTGCAAAGGAGCTCCTAAAACCTGTACC
TTACTAGAAAAGTTCCCCGAGACAACAGGATGCAGAAGAGGACAGATCAAATATTCCATC
ATGCACCCCGGGACTCACGTGTGGCCGCACACAGGGCCCACAAACTGCAGGCTCCGAATG
CACCTGGGCTTGGTGATTCCCAAGGAAGGCTGCAAGATTCGATGTGCCAACGAGACCAAG
ACCTGGGAGGAAGGCAAGGTGCTCATCTTTGATGACTCCTTTGAGCACGAGGTATGGCAG
GATGCCTCATCTTTCCGGCTGATATTCATCGTGGATGTGTGGCATCCGGAACTGACACCA
CAGCAGAGACGCAGCCTTCCAGCAATTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05279</identifier>
        <name>Asp-B-Hydro_N</name>
      </pfam>
      <pfam>
        <identifier>PF05118</identifier>
        <name>Asp_Arg_Hydrox</name>
      </pfam>
      <pfam>
        <identifier>PF13174</identifier>
        <name>TPR_6</name>
      </pfam>
      <pfam>
        <identifier>PF13181</identifier>
        <name>TPR_8</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>junctional sarcoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sarcoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cortical endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sarcoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>calcium channel complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>structural molecule activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>structural constituent of muscle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide-aspartate beta-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ion channel binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>limb morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>detection of calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pattern specification process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of intracellular protein transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of proteolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of cysteine-type endopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of store-operated calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-aspartic acid hydroxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>palate development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>muscle contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein depolymerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ATP</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of calcium ion transport into cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>face morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cell communication by electrical coupling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein stability</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002202</id>
      <name>Prolyl 3-hydroxylase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q32P28" source="Swiss-Prot">
    <name>Prolyl 3-hydroxylase 1</name>
    <general-function>Protein complex binding</general-function>
    <specific-function>Basement membrane-associated chondroitin sulfate proteoglycan (CSPG). Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly- sequences in collagens, especially types IV and V. May be involved in the secretory pathway of cells. Has growth suppressive activity in fibroblasts.</specific-function>
    <gene-name>P3H1</gene-name>
    <locus>1p34.1</locus>
    <cellular-location>Endoplasmic reticulum</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-22</signal-regions>
    <theoretical-pi>4.79</theoretical-pi>
    <molecular-weight>83393.195</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19316</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>LEPRE1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF097431</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>11127636</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q32P28</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P3H1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.7</synonym>
      <synonym>GROS1</synonym>
      <synonym>Growth suppressor 1</synonym>
      <synonym>LEPRE1</synonym>
      <synonym>Leprecan-1</synonym>
      <synonym>Leucine- and proline-enriched proteoglycan 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004321|Prolyl 3-hydroxylase 1
MAVRALKLLTTLLAVVAAASQAEVESEAGWGMVTPDLLFAEGTAAYARGDWPGVVLSMER
ALRSRAALRALRLRCRTQCAADFPWELDPDWSPSPAQASGAAALRDLSFFGGLLRRAACL
RRCLGPPAAHSLSEEMELEFRKRSPYNYLQVAYFKINKLEKAVAAAHTFFVGNPEHMEMQ
QNLDYYQTMSGVKEADFKDLETQPHMQEFRLGVRLYSEEQPQEAVPHLEAALQEYFVAYE
ECRALCEGPYDYDGYNYLEYNADLFQAITDHYIQVLNCKQNCVTELASHPSREKPFEDFL
PSHYNYLQFAYYNIGNYTQAVECAKTYLLFFPNDEVMNQNLAYYAAMLGEEHTRSIGPRE
SAKEYRQRSLLEKELLFFAYDVFGIPFVDPDSWTPEEVIPKRLQEKQKSERETAVRISQE
IGNLMKEIETLVEEKTKESLDVSRLTREGGPLLYEGISLTMNSKLLNGSQRVVMDGVISD
HECQELQRLTNVAATSGDGYRGQTSPHTPNEKFYGVTVFKALKLGQEGKVPLQSAHLYYN
VTEKVRRIMESYFRLDTPLYFSYSHLVCRTAIEEVQAERKDDSHPVHVDNCILNAETLVC
VKEPPAYTFRDYSAILYLNGDFDGGNFYFTELDAKTVTAEVQPQCGRAVGFSSGTENPHG
VKAVTRGQRCAIALWFTLDPRHSERDRVQADDLVKMLFSPEEMDLSQEQPLDAQQGPPEP
AQESLSGSESKPKDEL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011592|Prolyl 3-hydroxylase 1 (P3H1)
ATGGCGGTACGCGCGTTGAAGCTGCTGACCACACTGCTGGCTGTCGTGGCCGCTGCCTCC
CAAGCCGAGGTCGAGTCCGAGGCAGGATGGGGCATGGTGACGCCTGATCTGCTCTTCGCC
GAGGGGACCGCAGCCTACGCGCGCGGGGACTGGCCCGGGGTGGTCCTGAGCATGGAACGG
GCGCTGCGCTCCCGGGCAGCCCTCCGCGCCCTTCGCCTGCGCTGCCGCACCCAGTGTGCC
GCCGACTTCCCGTGGGAGCTGGACCCCGACTGGTCCCCCAGCCCGGCCCAGGCCTCGGGC
GCCGCCGCCCTGCGCGACCTGAGCTTCTTCGGGGGCCTTCTGCGTCGCGCTGCCTGCCTG
CGCCGCTGCCTCGGGCCGCCGGCCGCCCACTCGCTCAGCGAAGAGATGGAGCTGGAGTTC
CGCAAGCGGAGCCCCTACAACTACCTGCAGGTCGCCTACTTCAAGATCAACAAGTTGGAG
AAAGCTGTTGCTGCAGCACACACCTTCTTCGTGGGCAATCCTGAGCACATGGAAATGCAG
CAGAACCTAGACTATTACCAAACCATGTCTGGAGTGAAGGAGGCCGACTTCAAGGATCTT
GAGACTCAACCCCATATGCAAGAATTTCGACTGGGAGTGCGACTCTACTCAGAGGAACAG
CCACAGGAAGCTGTGCCCCACCTAGAGGCGGCGCTGCAAGAATACTTTGTGGCCTATGAG
GAGTGCCGTGCCCTCTGCGAAGGGCCCTATGACTACGATGGCTACAACTACCTTGAGTAC
AACGCTGACCTCTTCCAGGCCATCACAGATCATTACATCCAGGTCCTCAACTGTAAGCAG
AACTGTGTCACGGAGCTTGCTTCCCACCCAAGTCGAGAGAAGCCCTTTGAAGACTTCCTC
CCATCGCATTATAATTATCTGCAGTTTGCCTACTATAACATTGGGAATTATACACAGGCT
GTTGAATGTGCCAAGACCTATCTTCTCTTCTTCCCCAATGACGAGGTGATGAACCAAAAT
TTGGCCTATTATGCAGCTATGCTTGGAGAAGAACACACCAGATCCATCGGCCCCCGTGAG
AGTGCCAAGGAGTACCGACAGCGAAGCCTACTGGAAAAAGAACTGCTTTTCTTCGCTTAT
GATGTTTTTGGAATTCCCTTTGTGGATCCGGATTCATGGACTCCAGAAGAAGTGATTCCC
AAGAGATTGCAAGAGAAACAGAAGTCAGAACGGGAAACAGCCGTACGCATCTCCCAGGAG
ATTGGGAACCTTATGAAGGAAATCGAGACCCTTGTGGAAGAGAAGACCAAGGAGTCACTG
GATGTGAGCAGACTGACCCGGGAAGGTGGCCCCCTGCTGTATGAAGGCATCAGTCTCACC
ATGAACTCCAAACTCCTGAATGGTTCCCAGCGGGTGGTGATGGACGGCGTAATCTCTGAC
CACGAGTGTCAGGAGCTGCAGAGACTGACCAATGTGGCAGCAACCTCAGGAGATGGCTAC
CGGGGTCAGACCTCCCCACATACTCCCAATGAAAAGTTCTATGGTGTCACTGTCTTCAAA
GCCCTCAAGCTGGGGCAAGAAGGCAAAGTTCCTCTGCAGAGTGCCCACCTGTACTACAAC
GTGACGGAGAAGGTGCGGCGCATCATGGAGTCCTACTTCCGCCTGGATACGCCCCTCTAC
TTTTCCTACTCTCATCTGGTGTGCCGCACTGCCATCGAAGAGGTCCAGGCAGAGAGGAAG
GATGATAGTCATCCAGTCCACGTGGACAACTGCATCCTGAATGCCGAGACCCTCGTGTGT
GTCAAAGAGCCCCCAGCCTACACCTTCCGCGACTACAGCGCCATCCTTTACCTAAATGGG
GACTTCGATGGCGGAAACTTTTATTTCACTGAACTGGATGCCAAGACCGTGACGGCAGAG
GTGCAGCCTCAGTGTGGAAGAGCCGTGGGATTCTCTTCAGGCACTGAAAACCCACATGGA
GTGAAGGCTGTCACCAGGGGGCAGCGCTGTGCCATCGCCCTGTGGTTCACCCTGGACCCT
CGACACAGCGAGCGGGTGAGAGCAGCTCGAGCGGGACAGGGTGCAGGCAGATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13640</identifier>
        <name>2OG-FeII_Oxy_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>proteinaceous extracellular matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>macromolecular complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein complex binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-proline 3-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein hydroxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-proline hydroxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein folding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bone development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of ossification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>chaperone-mediated protein folding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein stabilization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>collagen fibril organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>collagen metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002206</id>
      <name>Prolyl 3-hydroxylase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8IVL5" source="Swiss-Prot">
    <name>Prolyl 3-hydroxylase 2</name>
    <general-function>Procollagen-proline 3-dioxygenase activity</general-function>
    <specific-function>Shows prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly-sequences in collagens, especially types II, IV and V.</specific-function>
    <gene-name>P3H2</gene-name>
    <locus>3q28</locus>
    <cellular-location>Endoplasmic reticulum</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-24</signal-regions>
    <theoretical-pi>5.47</theoretical-pi>
    <molecular-weight>80983.685</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19317</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>LEPREL1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ430351</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>27526730</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8IVL5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P3H2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.7</synonym>
      <synonym>Leprecan-like protein 1</synonym>
      <synonym>LEPREL1</synonym>
      <synonym>MLAT4</synonym>
      <synonym>Myxoid liposarcoma-associated protein 4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004329|Prolyl 3-hydroxylase 2
MRERIWAPPLLLLLPLLLPPPLWGGPPDSPRRELELEPGPLQPFDLLYASGAAAYYSGDY
ERAVRDLEAALRSHRRLREIRTRCARHCAARHPLPPPPPGEGPGAELPLFRSLLGRARCY
RSCETQRLGGPASRHRVSEDVRSDFQRRVPYNYLQRAYIKLNQLEKAVEAAHTFFVANPE
HMEMQQNIENYRATAGVEALQLVDREAKPHMESYNAGVKHYEADDFEMAIRHFEQALREY
FVEDTECRTLCEGPQRFEEYEYLGYKAGLYEAIADHYMQVLVCQHECVRELATRPGRLSP
IENFLPLHYDYLQFAYYRVGEYVKALECAKAYLLCHPDDEDVLDNVDYYESLLDDSIDPA
SIEAREDLTMFVKRHKLESELIKSAAEGLGFSYTEPNYWIRYGGRQDENRVPSGVNVEGA
EVHGFSMGKKLSPKIDRDLREGGPLLYENITFVYNSEQLNGTQRVLLDNVLSEEQCRELH
SVASGIMLVGDGYRGKTSPHTPNEKFEGATVLKALKSGYEGRVPLKSARLFYDISEKARR
IVESYFMLNSTLYFSYTHMVCRTALSGQQDRRNDLSHPIHADNCLLDPEANECWKEPPAY
TFRDYSALLYMNDDFEGGEFIFTEMDAKTVTASIKPKCGRMISFSSGGENPHGVKAVTKG
KRCAVALWFTLDPLYRELERIQADEVIAILDQEQQGKHELNINPKDEL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011595|Prolyl 3-hydroxylase 2 (P3H2)
ATGGAAATGCAGCAGAACATTGAGAATTACAGGGCGACAGCTGGTGTTGAAGCATTGCAG
TTGGTAGACAGAGAAGCCAAGCCACACATGGAGAGTTACAATGCAGGAGTTAAACATTAT
GAGGCTGATGACTTTGAGATGGCTATCAGGCACTTCGAACAAGCCTTAAGAGAATATTTC
GTTGAAGATACAGAATGCCGGACCCTATGTGAGGGGCCTCAGAGATTTGAAGAATATGAG
TATTTAGGGTATAAGGCTGGTCTGTATGAAGCTATTGCAGATCACTACATGCAGGTGCTT
GTTTGTCAGCATGAATGTGTGAGGGAACTTGCCACCCGCCCTGGCCGCCTCTCTCCCATC
GAGAATTTTCTTCCTCTGCACTATGATTACCTACAGTTTGCCTACTATCGAGTTGGTGAG
TATGTGAAAGCCCTGGAGTGTGCCAAAGCCTATCTTCTATGCCATCCAGATGATGAGGAT
GTCCTAGACAATGTGGATTACTATGAGAGTCTGCTGGATGATAGCATTGACCCGGCATCC
ATTGAGGCCAGAGAGGATTTAACAATGTTTGTGAAACGTCATAAGCTGGAGTCTGAGCTG
ATAAAATCAGCTGCAGAAGGTCTGGGGTTTTCATACACTGAACCGAATTATTGGATCAGA
TATGGAGGACGACAGGATGAGAATCGGGTCCCTTCAGGAGTGAACGTAGAGGGAGCAGAA
GTTCATGGATTCTCAATGGGAAAAAAGCTATCACCCAAGATAGATCGAGACCTAAGAGAA
GGTGGTCCTCTACTCTATGAGAACATCACATTCGTCTACAACTCGGAGCAGCTGAACGGG
ACTCAGCGGGTTCTCCTGGATAACGTCCTGTCGGAAGAACAGTGCCGGGAGCTCCACAGC
GTGGCCAGTGGAATCATGCTTGTTGGTGATGGATACAGAGGAAAAACTTCACCCCATACA
CCCAATGAAAAGTTTGAAGGTGCAACTGTCCTGAAAGCACTCAAATCTGGTTATGAAGGT
CGAGTCCCACTGAAGAGCGCTCGTCTGTTTTATGACATCAGCGAAAAGGCTCGAAGGATT
GTAGAATCTTATTTTATGCTGAACTCAACTCTGTATTTTTCCTATACACACATGGTCTGC
CGAACAGCCCTGTCTGGTCAGCAGGATAGAAGAAATGACCTCAGTCATCCCATCCATGCT
GACAACTGTTTGTTGGATCCAGAGGCCAACGAATGCTGGAAGGAGCCTCCTGCTTACACA
TTTCGAGACTATAGTGCTCTCCTATATATGAATGATGACTTTGAAGGAGGAGAATTCATA
TTCACAGAGATGGATGCTAAGACTGTGACTGCCTCTATAAAACCAAAATGTGGGCGCATG
ATCAGCTTCTCATCTGGAGGAGAGAACCCTCATGGGGTGAAGGCAGTCACCAAGGGAAAG
AGGTGTGCTGTGGCTCTGTGGTTCACCTTGGACCCACTTTATAGAGAATTGGAGCGAATA
CAGGCTGATGAAGTGATTGCAATTCTGGATCAAGAACAGCAAGGGAAGCATGAACTGAAT
ATCAACCCTAAAGATGAGCTATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07719</identifier>
        <name>TPR_2</name>
      </pfam>
      <pfam>
        <identifier>PF13640</identifier>
        <name>2OG-FeII_Oxy_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basement membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-proline 3-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-proline hydroxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>collagen metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002208</id>
      <name>Prolyl 3-hydroxylase 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8IVL6" source="Swiss-Prot">
    <name>Prolyl 3-hydroxylase 3</name>
    <general-function>Procollagen-proline 3-dioxygenase activity</general-function>
    <specific-function>Has prolyl 3-hydroxylase activity catalyzing the post-translational formation of 3-hydroxyproline in -Xaa-Pro-Gly-sequences in collagens, especially types IV and V.</specific-function>
    <gene-name>P3H3</gene-name>
    <locus>12q13</locus>
    <cellular-location>Endoplasmic reticulum</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi>6.26</theoretical-pi>
    <molecular-weight>81835.705</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19318</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>LEPREL2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U47924</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1200503</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8IVL6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P3H3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.14.11.7</synonym>
      <synonym>Leprecan-like protein 2</synonym>
      <synonym>LEPREL2</synonym>
      <synonym>Protein B</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004333|Prolyl 3-hydroxylase 3
MLRLLRPLLLLLLLPPPGSPEPPGLTQLSPGAPPQAPDLLYADGLRAYAAGAWAPAVALL
REALRSQAALGRVRLDCGASCAADPGAALPAVLLGAPEPDSGPGPTQGSWERQLLRAALR
RADCLTQCAARRLGPGGAARLRVGSALRDAFRRREPYNYLQRAYYQLKKLDLAAAAAHTF
FVANPMHLQMREDMAKYRRMSGVRPQSFRDLETPPHWAAYDTGLELLGRQEAGLALPRLE
EALQGSLAQMESCRADCEGPEEQQGAEEEEDGAASQGGLYEAIAGHWIQVLQCRQRCVGE
TATRPGRSFPVPDFLPNQLRRLHEAHAQVGNLSQAIENVLSVLLFYPEDEAAKRALNQYQ
AQLGEPRPGLGPREDIQRFILRSLGEKRQLYYAMEHLGTSFKDPDPWTPAALIPEALREK
LREDQEKRPWDHEPVKPKPLTYWKDVLLLEGVTLTQDSRQLNGSERAVLDGLLTPAECGV
LLQLAKDAAGAGARSGYRGRRSPHTPHERFEGLTVLKAAQLARAGTVGSQGAKLLLEVSE
RVRTLTQAYFSPERPLHLSFTHLVCRSAIEGEQEQRMDLSHPVHADNCVLDPDTGECWRE
PPAYTYRDYSGLLYLNDDFQGGDLFFTEPNALTVTARVRPRCGRLVAFSSGVENPHGVWA
VTRGRRCALALWHTWAPEHREQEWIEAKELLQESQEEEEEEEEEMPSKDPSPEPPSRRHQ
RVQDKTGRAPRVREEL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016712|Prolyl 3-hydroxylase 3 (P3H3)
ATGCTCCGGCTCCTCCGGCCGCTGCTGCTACTGCTGCTGCTGCCTCCCCCGGGGTCCCCT
GAGCCCCCCGGCCTGACCCAGCTGTCCCCGGGGGCGCCCCCGCAGGCCCCCGACTTGCTC
TACGCTGACGGGCTGCGCGCCTACGCGGCCGGGGCTTGGGCGCCGGCCGTGGCGCTGCTG
CGGGAGGCGCTGCGGAGCCAGGCGGCGCTGGGCCGGGTGCGGCTGGATTGCGGGGCGAGC
TGCGCGGCCGATCCGGGCGCCGCGCTCCCCGCCGTGCTTCTCGGGGCCCCGGAGCCCGAC
TCCGGGCCGGGACCCACGCAGGGGTCCTGGGAGCGACAGCTTCTCCGTGCAGCGCTCCGC
CGCGCAGACTGCCTGACCCAGTGCGCAGCACGGAGGCTGGGCCCCGGGGGCGCGGCGCGG
CTTCGCGTGGGGAGCGCGCTCCGGGACGCCTTCCGCCGTCGGGAGCCCTACAACTACCTG
CAGAGGGCCTATTACCAGTTGAAGAAGCTGGATCTGGCAGCTGCGGCAGCACACACCTTC
TTTGTAGCAAACCCCATGCACCTGCAGATGCGGGAGGACATGGCTAAGTACAGACGAATG
TCGGGAGTTCGGCCCCAGAGCTTCCGGGACCTGGAGACGCCCCCACACTGGGCAGCCTAT
GACACTGGCCTGGAGCTACTGGGGCGCCAGGAGGCAGGACTGGCACTGCCCAGGCTAGAG
GAGGCTCTTCAGGGGAGCCTGGCCCAGATGGAGAGCTGCCGTGCTGACTGTGAGGGGCCT
GAGGAGCAGCAGGGGGCTGAAGAAGAGGAGGATGGGGCTGCGAGCCAGGGGGGCCTCTAT
GAGGCCATTGCAGGACACTGGATTCAGGTCCTGCAGTGCCGGCAACGCTGTGTGGGGGAA
ACAGCCACACGCCCTGGTCGCAGCTTCCCTGTCCCAGACTTCCTTCCCAACCAGCTGAGG
CGGCTACATGAGGCCCATGCTCAGGTGGGCAATCTGTCCCAGGCTATAGAAAATGTCCTG
AGTGTCCTGCTCTTCTACCCGGAGGATGAGGCTGCCAAGAGGGCTCTGAACCAGTACCAG
GCCCAGCTGGGAGAGCCGAGACCTGGCCTCGGACCCAGAGAGGACATCCAGCGCTTCATC
CTCCGATCCCTGGGGGAGAAGAGGCAGCTCTACTATGCCATGGAGCACCTGGGGACCAGC
TTCAAGGATCCTGACCCCTGGACCCCTGCAGCTCTCATCCCTGAGGCACTTAGAGAAAAG
CTCAGAGAGGATCAAGAGAAGAGGCCTTGGGACCATGAGCCCGTGAAGCCAAAGCCCTTG
ACCTACTGGAAGGATGTCCTTCTCCTGGAGGGTGTGACCTTGACCCAGGATTCCAGGCAG
CTGAATGGGTCGGAGCGGGCGGTGTTGGATGGGCTGCTCACCCCAGCCGAGTGTGGGGTG
CTGCTGCAGCTGGCTAAGGATGCAGCTGGGGCTGGAGCCAGGTCTGGCTATCGTGGTCGC
CGCTCCCCTCACACCCCCCATGAACGCTTCGAGGGGCTCACGGTGCTTAAGGCTGCGCAG
CTGGCCCGGGCTGGGACAGTGGGCAGTCAGGGTGCTAAGCTGCTTCTGGAGGTGAGCGAG
CGGGTGCGGACCTTGACCCAGGCCTACTTCTCCCCGGAACGGCCCCTGCATCTGTCCTTC
ACCCACCTGGTGTGCCGCAGCGCCATAGAAGGAGAGCAAGAGCAGCGCATGGACCTGAGT
CACCCAGTGCACGCAGACAACTGCGTCCTGGACCCTGACACGGGAGAGTGCTGGCGGGAG
CCCCCAGCCTACACCTATCGGGACTACAGCGGACTCCTCTACCTCAACGATGACTTCCAG
GGTGGGGACCTGTTCTTCACGGAGCCCAACGCCCTCACTGTCACGGCTCGGGTGCGTCCT
CGCTGTGGGCGCCTTGTGGCCTTCAGCTCCGGTGTCGAGAATCCCCATGGGGTGTGGGCC
GTGACTCGGGGACGGCGCTGTGCCCTGGCACTGTGGCACACGTGGGCACCTGAGCACAGG
GAGCAGGAGTGGATAGAAGCCAAAGAACTGCTGCAGGAGTCACAGGAGGAGGAGGAAGAG
GAAGAGGAAGAAATGCCCAGCAAAGACCCTTCCCCAGAGCCCCCTAGCCGCAGGCACCAG
AGGGTCCAAGACAAGACTGGAAGGGCACCTCGGGTTCGGGAGGAGCTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13640</identifier>
        <name>2OG-FeII_Oxy_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-ascorbic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>procollagen-proline 3-dioxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0003645</id>
      <name>Solute carrier family 22 member 8</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11306713</pubmed-id>
            <citation>Cha SH, Sekine T, Fukushima JI, Kanai Y, Kobayashi Y, Goya T, Endou H: Identification and characterization of human organic anion transporter 3 expressing predominantly in the kidney. Mol Pharmacol. 2001 May;59(5):1277-86.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TCC7" source="Swiss-Prot">
    <name>Solute carrier family 22 member 8</name>
    <general-function>Sodium-independent organic anion transmembrane transporter activity</general-function>
    <specific-function>Plays an important role in the excretion/detoxification of endogenous and exogenous organic anions, especially from the brain and kidney. Involved in the transport basolateral of steviol, fexofenadine. Transports benzylpenicillin (PCG), estrone-3-sulfate (E1S), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), p-amino-hippurate (PAH), acyclovir (ACV) and ochratoxin (OTA).</specific-function>
    <gene-name>SLC22A8</gene-name>
    <locus>11q11</locus>
    <cellular-location>Basolateral cell membrane</cellular-location>
    <transmembrane-regions>10-30
124-144
155-175
177-197
213-233
237-257
328-348
355-375
387-407
412-432
472-492</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.05</theoretical-pi>
    <molecular-weight>59855.585</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10972</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF097491</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4378059</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TCC7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>S22A8_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>hOAT3</synonym>
      <synonym>OAT3</synonym>
      <synonym>Organic anion transporter 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007005|Solute carrier family 22 member 8
MTFSEILDRVGSMGHFQFLHVAILGLPILNMANHNLLQIFTAATPVHHCRPPHNASTGPW
VLPMGPNGKPERCLRFVHPPNASLPNDTQRAMEPCLDGWVYNSTKDSIVTEWDLVCNSNK
LKEMAQSIFMAGILIGGLVLGDLSDRFGRRPILTCSYLLLAASGSGAAFSPTFPIYMVFR
FLCGFGISGITLSTVILNVEWVPTRMRAIMSTALGYCYTFGQFILPGLAYAIPQWRWLQL
TVSIPFFVFFLSSWWTPESIRWLVLSGKSSKALKILRRVAVFNGKKEEGERLSLEELKLN
LQKEISLAKAKYTASDLFRIPMLRRMTFCLSLAWFATGFAYYSLAMGVEEFGVNLYILQI
IFGGVDVPAKFITILSLSYLGRHTTQAAALLLAGGAILALTFVPLDLQTVRTVLAVFGKG
CLSSSFSCLFLYTSELYPTVIRQTGMGVSNLWTRVGSMVSPLVKITGEVQPFIPNIIYGI
TALLGGSAALFLPETLNQPLPETIEDLENWSLRAKKPKQEPEVEKASQRIPLQPHGPGLG
SS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019450|Solute carrier family 22 member 8 (SLC22A8)
ATGACCTTCTCGGAGATCCTGGACCGTGTGGGAAGCATGGGCCATTTCCAGTTCCTGCAT
GTAGCCATACTGGGCCTCCCGATCCTCAACATGGCCAACCACAACCTGCTGCAGATCTTC
ACAGCCGCCACCCCTGTCCACCACTGTCGCCCGCCCCACAATGCCTCCACAGGGCCTTGG
GTGCTCCCCATGGGCCCAAATGGGAAGCCTGAGAGGTGCCTCCGTTTTGTACATCCGCCC
AATGCCAGCCTGCCCAATGACACCCAGAGGGCCATGGAGCCATGCCTGGATGGCTGGGTC
TACAACAGCACCAAGGACTCCATTGTGACAGAGTGGGACTTGGTGTGCAACTCCAACAAA
CTGAAGGAGATGGCCCAGTCTATCTTCATGGCAGGTATACTGATTGGAGGGCTCGTGCTT
GGAGACCTGTCTGACAGGTTTGGCCGCAGGCCCATCCTGACCTGCAGCTACCTGCTGCTG
GCAGCCAGCGGCTCCGGTGCAGCCTTCAGCCCCACCTTCCCCATCTACATGGTCTTCCGC
TTCCTGTGTGGCTTTGGCATCTCAGGCATTACCCTGAGCACCGTCATCTTGAATGTGGAA
TGGGTGCCTACCCGGATGCGGGCCATCATGTCGACAGCACTCGGGTACTGCTACACCTTT
GGCCAGTTCATTCTGCCCGGCCTGGCCTACGCCATCCCCCAGTGGCGTTGGCTGCAGTTA
ACTGTGTCCATTCCCTTCTTCGTCTTCTTCCTATCATCCTGGTGGACACCAGAGTCCATA
CGCTGGTTGGTCTTGTCTGGAAAGTCCTCGAAGGCCCTGAAGATACTCCGGCGGGTGGCT
GTCTTCAATGGCAAGAAGGAAGAGGGAGAAAGGCTCAGCTTGGAGGAGCTCAAACTCAAC
CTGCAGAAGGAGATCTCCTTGGCCAAGGCCAAGTACACCGCAAGTGACCTGTTCCGGATA
CCCATGCTGCGCCGCATGACCTTCTGTCTTTCCCTGGCCTGGTTTGCTACCGGTTTTGCC
TACTATAGTTTGGCTATGGGTGTGGAAGAATTTGGAGTCAACCTCTACATCCTCCAGATC
ATCTTTGGTGGGGTCGATGTCCCAGCCAAGTTCATCACCATCCTCTCCTTAAGCTACCTG
GGCCGGCATACCACTCAGGCCGCTGCCCTGCTCCTGGCAGGAGGGGCCATCTTGGCTCTC
ACCTTTGTGCCCTTGGACTTGCAGACCGTGAGGACAGTATTGGCTGTGTTTGGGAAGGGA
TGCCTATCCAGCTCCTTCAGCTGCCTCTTCCTCTACACAAGTGAATTATACCCCACAGTC
ATCAGGCAAACAGGTATGGGCGTAAGTAACCTGTGGACCCGCGTGGGAAGCATGGTGTCC
CCGCTGGTGAAAATCACGGGTGAGGTACAGCCCTTCATCCCCAATATCATCTACGGGATC
ACCGCCCTCCTCGGGGGCAGTGCTGCCCTCTTCCTGCCTGAGACCCTGAATCAGCCCTTG
CCAGAGACTATCGAAGACCTGGAAAACTGGTCCCTGCGGGCAAAGAAGCCAAAGCAGGAG
CCAGAGGTGGAAAAGGCCTCCCAGAGGATCCCTCTACAGCCTCACGGACCAGGCCTGGGC
TCCAGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>inorganic anion exchanger activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium-independent organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium-independent organic anion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00140</drugbank-id>
  <drugbank-id>NUTR00010</drugbank-id>
  <drugbank-id>APRD00626</drugbank-id>
  <drugbank-id>EXPT02760</drugbank-id>
  <drugbank-id>DB09358</drugbank-id>
  <name>Riboflavin</name>
  <description>Nutritional factor found in milk, eggs, malted barley, liver, kidney, heart, and leafy vegetables. The richest natural source is yeast. It occurs in the free form only in the retina of the eye, in whey, and in urine; its principal forms in tissues and cells are as flavin mononucleotide and flavin-adenine dinucleotide. [PubChem]</description>
  <cas-number>83-88-5</cas-number>
  <unii>TLM2976OFR</unii>
  <average-mass>376.3639</average-mass>
  <monoisotopic-mass>376.138284392</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
    <group>vet_approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>8604671</pubmed-id>
        <citation>Zempleni J, Galloway JR, McCormick DB: Pharmacokinetics of orally and intravenously administered riboflavin in healthy humans. Am J Clin Nutr. 1996 Jan;63(1):54-66.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Hansgeorg Ernst, Wolfram Schmidt, Joachim Paust, "Preparation of riboflavin." U.S. Patent US4567261, issued August, 1958.</synthesis-reference>
  <indication>For the treatment of ariboflavinosis (vitamin B2 deficiency).</indication>
  <pharmacodynamics>Riboflavin or vitamin B2 is an easily absorbed, water-soluble micronutrient with a key role in maintaining human health. Like the other B vitamins, it supports energy production by aiding in the metabolising of fats, carbohydrates, and proteins. Vitamin B2 is also required for red blood cell formation and respiration, antibody production, and for regulating human growth and reproduction. It is essential for healthy skin, nails, hair growth and general good health, including regulating thyroid activity. Riboflavin also helps in the prevention or treatment of many types of eye disorders, including some cases of cataracts.</pharmacodynamics>
  <mechanism-of-action>Binds to riboflavin hydrogenase, riboflavin kinase, and riboflavin synthase. Riboflavin is the precursor of flavin mononucleotide (FMN, riboflavin monophosphate) and flavin adenine dinucleotide (FAD). The antioxidant activity of riboflavin is principally derived from its role as a precursor of FAD and the role of this cofactor in the production of the antioxidant reduced glutathione. Reduced glutathione is the cofactor of the selenium-containing glutathione peroxidases among other things. The glutathione peroxidases are major antioxidant enzymes. Reduced glutathione is generated by the FAD-containing enzyme glutathione reductase.</mechanism-of-action>
  <toxicity/>
  <metabolism>Hepatic.</metabolism>
  <absorption>Vitamin B2 is readily absorbed from the upper gastrointestinal tract.</absorption>
  <half-life>66-84 minutes</half-life>
  <protein-binding>60%</protein-binding>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as flavins. These are compounds containing a flavin (7,8-dimethyl-benzo[g]pteridine-2,4-dione) moiety, with a structure characterized by an isoalloaxzine tricyclic ring.</description>
    <direct-parent>Flavins</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organoheterocyclic compounds</superclass>
    <class>Pteridines and derivatives</class>
    <subclass>Alloxazines and isoalloxazines</subclass>
    <alternative-parent>Azacyclic compounds</alternative-parent>
    <alternative-parent>Benzenoids</alternative-parent>
    <alternative-parent>Heteroaromatic compounds</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Lactams</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Polyols</alternative-parent>
    <alternative-parent>Primary alcohols</alternative-parent>
    <alternative-parent>Pyrazines</alternative-parent>
    <alternative-parent>Pyrimidones</alternative-parent>
    <alternative-parent>Quinoxalines</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Vinylogous amides</alternative-parent>
    <substituent>Alcohol</substituent>
    <substituent>Aromatic heteropolycyclic compound</substituent>
    <substituent>Azacycle</substituent>
    <substituent>Benzenoid</substituent>
    <substituent>Diazanaphthalene</substituent>
    <substituent>Flavin</substituent>
    <substituent>Heteroaromatic compound</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Lactam</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Polyol</substituent>
    <substituent>Primary alcohol</substituent>
    <substituent>Pyrazine</substituent>
    <substituent>Pyrimidine</substituent>
    <substituent>Pyrimidone</substituent>
    <substituent>Quinoxaline</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Vinylogous amide</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT000877</drugbank-id>
      <name>Riboflavin 5'-phosphate sodium</name>
      <unii>20RD1DZH99</unii>
      <cas-number>6184-17-4</cas-number>
      <inchikey>LQVGUKOCMOKKJU-QPVGXXQTSA-M</inchikey>
      <average-mass>514.36</average-mass>
      <monoisotopic-mass>514.10768889</monoisotopic-mass>
    </salt>
    <salt>
      <drugbank-id primary="true">DBSALT001766</drugbank-id>
      <name>Riboflavin 5'-phosphate sodium anhydrous</name>
      <unii>957E53WV42</unii>
      <cas-number>130-40-5</cas-number>
      <inchikey>OHSHFZJLPYLRIP-BMZHGHOISA-M</inchikey>
      <average-mass>478.33</average-mass>
      <monoisotopic-mass>478.08655952</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="" coder="">1-Deoxy-1-(7,8-dimethyl-2,4-dioxo-3,4-dihydrobenzo[g]pteridin-10(2H)-yl)pentitol</synonym>
    <synonym language="" coder="">6,7-Dimethyl-9-D-ribitylisoalloxazine</synonym>
    <synonym language="" coder="">7,8-Dimethyl-10-(D-ribo-2,3,4,5-tetrahydroxypentyl)isoalloxazine</synonym>
    <synonym language="" coder="">7,8-Dimethyl-10-ribitylisoalloxazine</synonym>
    <synonym language="" coder="">E101</synonym>
    <synonym language="" coder="">Lactoflavin</synonym>
    <synonym language="" coder="">Lactoflavine</synonym>
    <synonym language="Spanish" coder="INN">Riboflavina</synonym>
    <synonym language="French" coder="INN">Riboflavine</synonym>
    <synonym language="Latin" coder="INN">Riboflavinum</synonym>
    <synonym language="" coder="">Vitamin B2</synonym>
    <synonym language="" coder="">Vitamin G</synonym>
  </synonyms>
  <products>
    <product>
      <name>Active FE</name>
      <labeller>Gm Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58809-725</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-11-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adult Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-7862</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-05-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021163</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adult Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-7874</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021559</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adult Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-9007</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-05-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021163</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Adult Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-9015</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021559</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Alertonic</name>
      <labeller>Odan Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02103052</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Elixir</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alertonic</name>
      <labeller>Merrell Pharms Inc., Division Of Merrell Dow (Can)</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00134228</dpd-id>
      <started-marketing-on>1967-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Allbee With C 550 Cap</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932470</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2003-08-01</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Allbee With Vitamin C Cap</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932489</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-26</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Alsimine W Vitamins A D</name>
      <labeller>Alsi Cie Ltee</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00419087</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2003-05-21</ended-marketing-on>
      <dosage-form>Capsule; Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Am Caps</name>
      <labeller>New Vision Nutritionals Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238140</dpd-id>
      <started-marketing-on>1998-10-01</started-marketing-on>
      <ended-marketing-on>2002-11-20</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Antlerviron</name>
      <labeller>Classical Remedia Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02232488</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Appedrine</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00328626</dpd-id>
      <started-marketing-on>1975-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B 50 Capsules</name>
      <labeller>Rheingold Food International Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00643041</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B 6 Plus</name>
      <labeller>Anabolic Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00046698</dpd-id>
      <started-marketing-on>1967-12-31</started-marketing-on>
      <ended-marketing-on>2004-03-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B C Antistress Cap</name>
      <labeller>Les Laboratoires Bio SantÉ Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479039</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-10</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex 25mg Vitamin Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238511</dpd-id>
      <started-marketing-on>1998-08-31</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex 50 Vitamin Cap</name>
      <labeller>Bioforce Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01983490</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1997-07-22</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex 50+ Caplet</name>
      <labeller>Health Wise Nutrition Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02005271</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex 500 Tab</name>
      <labeller>Nobel Pharm Enr.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510424</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex Plus C 300mg Tab</name>
      <labeller>Nutricorp International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02022311</dpd-id>
      <started-marketing-on>2000-08-01</started-marketing-on>
      <ended-marketing-on>2009-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex Tablets</name>
      <labeller>Golden Neo Life Diamite International, Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00452831</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex W C and B12 Inj</name>
      <labeller>E L Stickley And Co Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00549762</dpd-id>
      <started-marketing-on>1963-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex W C Forte Cap</name>
      <labeller>Everest Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00515965</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-14</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex W Vit C W Non-med Yeast&amp;liver Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01900544</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>1997-09-04</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex W Vitamin C Fortis Cap</name>
      <labeller>Shoppers Drug Mart Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00414832</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-14</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex With C 300mg</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00557390</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2008-08-05</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex With C 300mg Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00723045</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Complex With C 550mg</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00557404</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Compound 50mg Tab</name>
      <labeller>Gahler Enterprises Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00730491</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Plus C 300mg Timed Release</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00537462</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2008-08-05</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Stress C + Iron &amp; Vite</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00864765</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Totum 500</name>
      <labeller>Desbergers LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00086827</dpd-id>
      <started-marketing-on>1966-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Virol</name>
      <labeller>Rolmex International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00326178</dpd-id>
      <started-marketing-on>1975-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-09</ended-marketing-on>
      <dosage-form>Elixir</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B Vitamin Compound With B12 Thunas</name>
      <labeller>Thuna Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00190357</dpd-id>
      <started-marketing-on>1984-05-31</started-marketing-on>
      <ended-marketing-on>2002-10-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B With C 500 Cap</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00532045</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-100 Caps</name>
      <labeller>Now Foods</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02247036</dpd-id>
      <started-marketing-on>2005-05-19</started-marketing-on>
      <ended-marketing-on>2008-07-11</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-100 Complex Tablets</name>
      <labeller>Viva Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243923</dpd-id>
      <started-marketing-on>2001-06-05</started-marketing-on>
      <ended-marketing-on>2009-12-18</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-100 Hi Potency B Vitamins Tab</name>
      <labeller>Natrol, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02060256</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2009-05-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-100 Vitamin Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238740</dpd-id>
      <started-marketing-on>1998-09-22</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-2 100mg With C 20mg</name>
      <labeller>Gahler Enterprises Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00700576</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-2 Caps 100mg</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984101</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-50 Complex</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00398837</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-50 Complex Tab</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00782106</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-50 Hi Potency B Vitamins Tab</name>
      <labeller>Natrol, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02060264</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2006-09-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-Combo</name>
      <labeller>Perdido Key Health And Wellness Inc</labeller>
      <ndc-id/>
      <ndc-product-code>70104-110</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-11-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intramuscular</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>B-complex</name>
      <labeller>Enrich International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238709</dpd-id>
      <started-marketing-on>1999-11-11</started-marketing-on>
      <ended-marketing-on>2001-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex 100</name>
      <labeller>Great Earth Companies, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230975</dpd-id>
      <started-marketing-on>1998-08-25</started-marketing-on>
      <ended-marketing-on>2002-10-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex 50</name>
      <labeller>Great Earth Companies, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230971</dpd-id>
      <started-marketing-on>1998-08-25</started-marketing-on>
      <ended-marketing-on>2002-10-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex Tab</name>
      <labeller>Natures Sunshine Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02010410</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2009-08-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex Tab</name>
      <labeller>SantÉ Naturelle (Ag) LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00705446</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2002-06-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex Tablets</name>
      <labeller>Shaklee Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00593915</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>2000-01-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex With Vitamin C, Biotin, Folic Acid</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243653</dpd-id>
      <started-marketing-on>2001-11-23</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-complex-50 Tab</name>
      <labeller>Jr Carlson Labs Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00627364</dpd-id>
      <started-marketing-on>1998-10-25</started-marketing-on>
      <ended-marketing-on>2005-09-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-plex</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240982</dpd-id>
      <started-marketing-on>1999-10-20</started-marketing-on>
      <ended-marketing-on>2000-01-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-plex</name>
      <labeller>Land Art Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244822</dpd-id>
      <started-marketing-on>2001-11-12</started-marketing-on>
      <ended-marketing-on>2008-06-26</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B-plex 100</name>
      <labeller>Merit Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>30727-300</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>B-plus - Tab</name>
      <labeller>Champion's Choice Advanced Nutrition Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02226618</dpd-id>
      <started-marketing-on>1997-06-11</started-marketing-on>
      <ended-marketing-on>1999-08-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B2 Tab 100mg</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00450650</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B50 B Complex Tab</name>
      <labeller>Nutristar Health Products (1987) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00576425</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B50 Complex</name>
      <labeller>Preferred Nutrition Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02247911</dpd-id>
      <started-marketing-on>2003-10-29</started-marketing-on>
      <ended-marketing-on>2005-08-04</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>B6 Plus Tab</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00393347</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2002-08-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bacmin</name>
      <labeller>Marnel Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>0682-3001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2000-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Balanced B 125 Srt</name>
      <labeller>Anabolic Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00526703</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1996-10-02</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-100 B-complex Vitamins Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00890251</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-100 Timed Release</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242278</dpd-id>
      <started-marketing-on>2000-10-24</started-marketing-on>
      <ended-marketing-on>2005-07-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-50 B-complex Vitamins Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02061252</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-50 B-complex Vitamins, Timed Rele</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02163829</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-50 Complex</name>
      <labeller>Leiner Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230318</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B-complex Vit + Vit C&amp;e Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00899828</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B100</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529710</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Balanced B50 Complex</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529729</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Beminal W C Fortis Inj</name>
      <labeller>Ayerst Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00053937</dpd-id>
      <started-marketing-on>1951-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-10</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Beminal With C Fortis Cap</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02041553</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2001-08-03</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Beminal With C Fortis Cap</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01934902</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-04</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Beminal With C Fortis Pws</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02041545</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-02</ended-marketing-on>
      <dosage-form>Powder, for solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bev 29 Tab</name>
      <labeller>Beverly International Nutrition</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00703184</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bev B-150</name>
      <labeller>Beverly International Nutrition</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00640492</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bio-fen</name>
      <labeller>Lisa &amp; Gerry Freundl</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243489</dpd-id>
      <started-marketing-on>2001-10-10</started-marketing-on>
      <ended-marketing-on>2006-09-28</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Biovim Tab</name>
      <labeller>Le Naturiste J.M.B. Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00385131</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Biovita</name>
      <labeller>Ildong Pharmaceutical Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>69862-001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-06-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Granule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Bugs Bunny and Friends Multiple Vitamins</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02152894</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2004-04-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bugs Bunny Chew Multi Vit Plus Iron</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00570532</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>C-B Complex</name>
      <labeller>Avacare, Division Of Jeunique International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00624470</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>C-Nate DHA</name>
      <labeller>Centurion Labs</labeller>
      <ndc-id/>
      <ndc-product-code>23359-105</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>C.A.G. Tab</name>
      <labeller>Nutrition For Life International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02053357</dpd-id>
      <started-marketing-on>1996-11-27</started-marketing-on>
      <ended-marketing-on>2000-08-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>C.R.T. X Multivitamin &amp; Mineral Powder Mix</name>
      <labeller>Metaform Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238856</dpd-id>
      <started-marketing-on>1998-12-08</started-marketing-on>
      <ended-marketing-on>2001-07-23</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Carbassist Tablets</name>
      <labeller>Wyeth Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02166623</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cc II</name>
      <labeller>Added Dimensions</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230583</dpd-id>
      <started-marketing-on>1997-03-26</started-marketing-on>
      <ended-marketing-on>2006-09-25</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cda-21 Vitamins With Non-medicinal Probiotic Complex</name>
      <labeller>Rx Vitamins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02235563</dpd-id>
      <started-marketing-on>2006-08-01</started-marketing-on>
      <ended-marketing-on>2007-10-25</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cedevita Plus Vitamin Supplement</name>
      <labeller>Pliva, Pharmaceutical, Chemical, Food And Cosmetic Industry, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237898</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Cedevita Sugar-free Vitamin Supplement</name>
      <labeller>Pliva, Pharmaceutical, Chemical, Food And Cosmetic Industry, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237899</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Central-vite 18 Essential</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02232993</dpd-id>
      <started-marketing-on>1998-04-24</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Century Complete</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02232446</dpd-id>
      <started-marketing-on>1998-03-17</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chela Potassium Plus</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00668486</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2000-03-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chela-chromium 200</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00668427</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2000-03-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chew.multiple Vits.with Extra C for Children</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02185652</dpd-id>
      <started-marketing-on>1996-09-19</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multiple Vit Plus Iron for Children</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02168774</dpd-id>
      <started-marketing-on>1996-09-19</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multiple Vitamins for Children</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02162407</dpd-id>
      <started-marketing-on>1996-09-19</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multiple Vitamins Plus Extra C</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02047144</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multiple Vitamins Plus Iron Tab</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02047136</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multiple Vitamins Tab</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02047128</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multivitamins</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244773</dpd-id>
      <started-marketing-on>2002-05-31</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Chewable Multivitamins Plus Iron</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244800</dpd-id>
      <started-marketing-on>2002-05-31</started-marketing-on>
      <ended-marketing-on>2007-08-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children Choice Multivit Chewable Tab</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00896365</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2009-08-04</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children Choice Multivitamin W Iron Chew Tab</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01907468</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2009-08-04</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi Vit W Iron</name>
      <labeller>Shoppers Drug Mart Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00561711</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi Vitamins</name>
      <labeller>Shoppers Drug Mart Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00561703</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi Vitamins</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02234267</dpd-id>
      <started-marketing-on>1998-04-20</started-marketing-on>
      <ended-marketing-on>2008-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi Vitamins With Iron Tablets</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02234268</dpd-id>
      <started-marketing-on>1998-05-20</started-marketing-on>
      <ended-marketing-on>2008-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi-vitamin</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240988</dpd-id>
      <started-marketing-on>2000-03-01</started-marketing-on>
      <ended-marketing-on>2007-08-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multi-vitamin Complete With Minerals</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240987</dpd-id>
      <started-marketing-on>2000-03-01</started-marketing-on>
      <ended-marketing-on>2001-07-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multiple Vit.plus Iron</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02202069</dpd-id>
      <started-marketing-on>1997-10-10</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multiple Vitamins - Tab</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02190451</dpd-id>
      <started-marketing-on>1997-10-10</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multiple Vitamins (chewable Tablets)</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239681</dpd-id>
      <started-marketing-on>1999-08-16</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multiple Vitamins With Extra Vitamin C (chewable Tablets)</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239684</dpd-id>
      <started-marketing-on>1999-08-16</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Chewable Multiple Vitamins With Iron Tablets (chewable Tablets)</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239682</dpd-id>
      <started-marketing-on>1999-08-16</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Vitamins Chewable</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00787108</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Children's Vitamins W Iron Chewable</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00787116</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chew Multi Vitamin Tab</name>
      <labeller>Nutristar Health Products (1987) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00581054</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Multiple Vitamins</name>
      <labeller>Ksl Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02089483</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Multiple Vitamins Plus Fe</name>
      <labeller>Ksl Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02089475</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Multiple Vitamins Tab</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00723053</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Multivitamins</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00674877</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Multivitamins W Iron</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00661988</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Vitamin Tab</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01911244</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Vitamins</name>
      <labeller>D.C. Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00646792</dpd-id>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Chewable Vitamins</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238785</dpd-id>
      <started-marketing-on>1998-09-25</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Childrens Multiple Vit and Min Chew Tab</name>
      <labeller>Country Health Laboratories Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00532371</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>CitraNatal DHA</name>
      <labeller>Mission Pharmacal</labeller>
      <ndc-id/>
      <ndc-product-code>0178-0898</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-11-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CitraNatal Rx</name>
      <labeller>Mission Pharmacal</labeller>
      <ndc-id/>
      <ndc-product-code>0178-0858</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-08-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>CitraNatal Rx</name>
      <labeller>Mission Pharmacal</labeller>
      <ndc-id/>
      <ndc-product-code>0178-0859</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2007-11-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Coenzyme Q10 Isotonix Vitamin and Mineral Supplement</name>
      <labeller>Market America</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245390</dpd-id>
      <started-marketing-on>2002-06-04</started-marketing-on>
      <ended-marketing-on>2008-09-04</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complete Mega B</name>
      <labeller>Gahler Enterprises Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00624950</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complete Mega B</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242229</dpd-id>
      <started-marketing-on>2001-01-02</started-marketing-on>
      <ended-marketing-on>2005-08-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complete Multivitamins and Minerals for Children</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242548</dpd-id>
      <started-marketing-on>2001-01-31</started-marketing-on>
      <ended-marketing-on>2004-06-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complete Multivitamins and Minerals Tablets Timed Release</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237940</dpd-id>
      <started-marketing-on>1999-07-26</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complex 5 - Pwr</name>
      <labeller>Ast Research</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02194309</dpd-id>
      <started-marketing-on>1996-03-15</started-marketing-on>
      <ended-marketing-on>1998-08-10</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complex-75</name>
      <labeller>Frega Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00881368</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-06</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complexe B 75mg</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00757799</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1998-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complexe B 75mg</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00753947</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complexe B Compose 75</name>
      <labeller>Les Laboratoires Bio SantÉ Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00591947</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Complexe B-75</name>
      <labeller>Frega Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237176</dpd-id>
      <started-marketing-on>1998-06-29</started-marketing-on>
      <ended-marketing-on>2008-02-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Concept DHA</name>
      <labeller>Us Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>52747-621</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-06-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Concept OB</name>
      <labeller>Us Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>52747-620</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Croq-vit Pour Enfants</name>
      <labeller>Nutrivac Ltee</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00685534</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>D'pantothenic Acid-B1-B2 Tab</name>
      <labeller>Health Thru Herbs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00612685</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2001-06-21</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Daily Energy Brand B-complex</name>
      <labeller>Enzymatic Therapy, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02247363</dpd-id>
      <started-marketing-on>2004-01-01</started-marketing-on>
      <ended-marketing-on>2008-07-25</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Derma-force</name>
      <labeller>Prairie Naturals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230387</dpd-id>
      <started-marketing-on>1997-04-01</started-marketing-on>
      <ended-marketing-on>2006-09-20</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dexatrim Tablets</name>
      <labeller>Chattem, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02193981</dpd-id>
      <started-marketing-on>1996-09-09</started-marketing-on>
      <ended-marketing-on>2005-06-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dia-vite</name>
      <labeller>R &amp; D Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00686972</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dia-vite</name>
      <labeller>R &amp; D Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231086</dpd-id>
      <started-marketing-on>1997-08-13</started-marketing-on>
      <ended-marketing-on>2003-07-16</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Diaplex</name>
      <labeller>Nephro Tech, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244961</dpd-id>
      <started-marketing-on>2002-07-10</started-marketing-on>
      <ended-marketing-on>2004-07-23</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Dynam Ampoule Et Tablet</name>
      <labeller>Cardinaux Enrg Les Produits Naturels</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00724491</dpd-id>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>E &amp; I Formulae</name>
      <labeller>Enrich International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242543</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>E.S.T. Complex</name>
      <labeller>Abundance Marketing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242768</dpd-id>
      <started-marketing-on>2000-12-06</started-marketing-on>
      <ended-marketing-on>2004-06-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Efferlife Multivitamins and Minerals</name>
      <labeller>Naturale Science Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243533</dpd-id>
      <started-marketing-on>2001-10-01</started-marketing-on>
      <ended-marketing-on>2006-10-10</ended-marketing-on>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Enviroflex - Tab</name>
      <labeller>Enviro Tech International Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230247</dpd-id>
      <started-marketing-on>1997-09-15</started-marketing-on>
      <ended-marketing-on>1999-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Escavite</name>
      <labeller>Gm Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58809-888</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Essential B Tablets</name>
      <labeller>General Nutrition Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02163373</dpd-id>
      <started-marketing-on>1997-04-18</started-marketing-on>
      <ended-marketing-on>2006-08-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Everyday Multiple Vitamins</name>
      <labeller>D.C. Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00270814</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Everyday Multiple Vitamins With Iron</name>
      <labeller>D.C. Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00241474</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Extra P.N. Vitamin-mineral Drink Mix</name>
      <labeller>Changes International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241266</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ez-flex</name>
      <labeller>Metagenics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02231159</dpd-id>
      <started-marketing-on>1997-06-30</started-marketing-on>
      <ended-marketing-on>2007-09-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Feminique W Iron and Calcium Tab</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00725099</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ferra Naka Plus Vitamins</name>
      <labeller>Naka Sales Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237394</dpd-id>
      <started-marketing-on>1999-05-05</started-marketing-on>
      <ended-marketing-on>2001-07-23</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flinstones Multiple Plus Iron</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00520837</dpd-id>
      <started-marketing-on>1971-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flintstones Multiple Vitamins</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02150433</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2004-06-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flintstones Multiple Vitamins Plus Iron</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02150395</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2004-06-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flintstones Multiple Vitamins Tab</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01981676</dpd-id>
      <started-marketing-on>1970-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Flintstones W Extra C Tab</name>
      <labeller>Miles Inc.   Pharmaceutical Division</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00522120</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Floradix Formula Liq</name>
      <labeller>Flora Manufacturing And Distributing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00483389</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2002-06-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Floravit - Syr</name>
      <labeller>Flora Manufacturing And Distributing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02164590</dpd-id>
      <started-marketing-on>1995-05-28</started-marketing-on>
      <ended-marketing-on>2009-08-05</ended-marketing-on>
      <dosage-form>Syrup</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Floriva</name>
      <labeller>Bon Geo Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>52796-173</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-09-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Floriva</name>
      <labeller>Bon Geo Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>52796-174</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-10-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Floriva</name>
      <labeller>Bon Geo Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>52796-177</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-10-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Floriva Plus</name>
      <labeller>Bon Geo Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>52796-171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-12-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Folcaps Care One</name>
      <labeller>Midlothian Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>68308-167</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Foltabs Prenatal</name>
      <labeller>Midlothian Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>68308-165</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-01-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>For Kids Only Chewable Multivit. Plus Iron</name>
      <labeller>Ksl Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02205165</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>For Kids Only Chewable Multivitamins - Tab</name>
      <labeller>Ksl Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02195771</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Adr-vitamin B2,b6 W Calpan Tab</name>
      <labeller>Metagenics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00836990</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-08-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Cn</name>
      <labeller>Balance Plus, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241070</dpd-id>
      <started-marketing-on>2000-02-09</started-marketing-on>
      <ended-marketing-on>2004-08-17</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula D.S.</name>
      <labeller>Golden Pride International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240842</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Dpr</name>
      <labeller>Balance Plus, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241066</dpd-id>
      <started-marketing-on>2000-03-08</started-marketing-on>
      <ended-marketing-on>2004-08-17</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Fm Vitamins &amp; Minerals Tab</name>
      <labeller>Metagenics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00837105</dpd-id>
      <started-marketing-on>1997-01-27</started-marketing-on>
      <ended-marketing-on>2001-10-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Lf</name>
      <labeller>Numark Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241057</dpd-id>
      <started-marketing-on>2003-12-15</started-marketing-on>
      <ended-marketing-on>2009-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula O</name>
      <labeller>General Nutrition Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02208989</dpd-id>
      <started-marketing-on>1997-09-12</started-marketing-on>
      <ended-marketing-on>2005-08-05</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula O-care Vitamin and Mineral Supplement</name>
      <labeller>For Mor International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241714</dpd-id>
      <started-marketing-on>2000-03-25</started-marketing-on>
      <ended-marketing-on>2002-06-25</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Formula Pro-B</name>
      <labeller>Balance Plus, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241071</dpd-id>
      <started-marketing-on>2000-03-08</started-marketing-on>
      <ended-marketing-on>2004-08-17</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Fortamines 10 Capsules</name>
      <labeller>Rougier Pharma Division Of Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00721522</dpd-id>
      <started-marketing-on>1974-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-27</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Fortamines-10 Comprimes</name>
      <labeller>Rougier Pharma Division Of Ratiopharm Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00721530</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Fortaplex Inj</name>
      <labeller>Kripps Pharmacy Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00463434</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Fortistress Tab</name>
      <labeller>SantÉ Naturelle (Ag) LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02039923</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Forty Plus Vitamin Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238881</dpd-id>
      <started-marketing-on>1998-10-16</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Garfield Chewable Multivits Plus Iron Tab</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932594</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gemvites Jr Tab Chewable</name>
      <labeller>Pharmavite Laboratories (1987) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00315915</dpd-id>
      <started-marketing-on>1969-12-31</started-marketing-on>
      <ended-marketing-on>1999-10-19</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Geritol Liquid</name>
      <labeller>Glaxosmithkline Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01914723</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gestamine Comprimes</name>
      <labeller>Lab Nadeau LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00722227</dpd-id>
      <started-marketing-on>1957-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gesticare DHA</name>
      <labeller>Jazz Pharmaceuticals Commercial Corp.</labeller>
      <ndc-id/>
      <ndc-product-code>18860-253</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2008-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Globucel - Methode</name>
      <labeller>Les Laboratoires Swisse Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02225379</dpd-id>
      <started-marketing-on>1997-08-30</started-marketing-on>
      <ended-marketing-on>2009-08-05</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glyco-aide Tab</name>
      <labeller>Avant Garde, Les SupplÉments</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02086387</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Harvest Of Values All B Complex Tab</name>
      <labeller>Hillestad Pharmaceuticals Usa</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01938002</dpd-id>
      <started-marketing-on>1997-09-24</started-marketing-on>
      <ended-marketing-on>2009-09-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>healthy mamaBE WELL ROUNDED BE WELL ROUNDED</name>
      <labeller>MATERNAL SCIENCE, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>58154-107</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-07-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hemarexin Amp</name>
      <labeller>Lab Bio Chimique Inc.,Division Of Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00393959</dpd-id>
      <started-marketing-on>1958-12-31</started-marketing-on>
      <ended-marketing-on>1999-01-22</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemarexin Liquid and Drinkable Ampoules</name>
      <labeller>Sabex Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230018</dpd-id>
      <started-marketing-on>1997-08-19</started-marketing-on>
      <ended-marketing-on>2009-11-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hemarexin Tab</name>
      <labeller>Lab Bio Chimique Inc.,Division Of Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00514764</dpd-id>
      <started-marketing-on>1997-12-17</started-marketing-on>
      <ended-marketing-on>2004-08-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>HemeNatal OB</name>
      <labeller>Wh Nutritionals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>76331-901</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-03-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Hi Potency B Complex W Chelated Minerals</name>
      <labeller>Klaire Labs Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00618136</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2004-01-19</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hi Potency B52 B Complex Tab</name>
      <labeller>Country Health Laboratories Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00531286</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hi Potency Balanced B-100 Complex - Tab</name>
      <labeller>Leiner Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229895</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hi Potency Stress B Tension With C</name>
      <labeller>Lee Adams Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00542482</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2010-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>High Potency Vitamin B Complex + C Tab</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01938797</dpd-id>
      <started-marketing-on>1996-10-11</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hill.vite</name>
      <labeller>Hillestad Pharmaceuticals Usa</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244784</dpd-id>
      <started-marketing-on>2001-11-14</started-marketing-on>
      <ended-marketing-on>2009-09-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Homosistrol Capsules</name>
      <labeller>Macromed Pharmicia Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237725</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Hypo Vites Tab</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00419796</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Iberet 500</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00039853</dpd-id>
      <started-marketing-on>1965-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-31</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Icaps</name>
      <labeller>Alcon, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02044048</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2009-04-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Icaps Time Release</name>
      <labeller>Alcon, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02192594</dpd-id>
      <started-marketing-on>1997-06-20</started-marketing-on>
      <ended-marketing-on>2001-08-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Inatal Advance</name>
      <labeller>Nnodum Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>63044-153</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-06-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>INATAL Ultra</name>
      <labeller>Nnodum Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>63044-154</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-06-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Infa Drops Multivitamins</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236846</dpd-id>
      <started-marketing-on>1998-05-20</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Infant Multivitamin Drops</name>
      <labeller>General Nutrition Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245538</dpd-id>
      <started-marketing-on>2002-10-20</started-marketing-on>
      <ended-marketing-on>2005-08-05</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Infantol Drops</name>
      <labeller>Church &amp; Dwight Company, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00558060</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-30</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Infuvite Adult Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-5649</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2005-05-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021163</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Infuvite Adult Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-5650</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021559</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Insur-all Vitamin Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238882</dpd-id>
      <started-marketing-on>1998-10-16</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Integra Plus</name>
      <labeller>Us Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>52747-712</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-04-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Iron 25mg With Vit B-cmplx, Vit C, Cu &amp; Mo</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02154315</dpd-id>
      <started-marketing-on>1996-07-23</started-marketing-on>
      <ended-marketing-on>2002-07-29</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Iron Polysaccharides Folic Acid DHA</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-230</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-12-20</started-marketing-on>
      <ended-marketing-on>2017-08-11</ended-marketing-on>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Isotonix Advanced B-complex Vitamins With Potassium and Magnesium</name>
      <labeller>Market America</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248193</dpd-id>
      <started-marketing-on>2004-01-27</started-marketing-on>
      <ended-marketing-on>2009-07-20</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Isotonix Calcium Plus Formula</name>
      <labeller>Market America</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237089</dpd-id>
      <started-marketing-on>1998-12-17</started-marketing-on>
      <ended-marketing-on>2001-06-28</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Isotonix Vitamin B-folic Acid-mineral Supple</name>
      <labeller>Market America</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02160900</dpd-id>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2004-07-12</ended-marketing-on>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Itabs Plus</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238908</dpd-id>
      <started-marketing-on>2000-01-01</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kanga Sport Vitamins B &amp; C Plus Minerals</name>
      <labeller>Lacombe Drugs (1992) Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241449</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kanga-B Vitamin B Group + C</name>
      <labeller>Lacombe Drugs (1992) Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241467</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kanga-kid Multi-vitamin &amp; Mineral</name>
      <labeller>Lacombe Drugs (1992) Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241474</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kanga-V Multivitamins &amp; Minerals</name>
      <labeller>Lacombe Drugs (1992) Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241448</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kenwood Liquid Supplement</name>
      <labeller>Kenwood Laboratories (Division Of Bradley Pharmaceuticals)</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239304</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kid's Choice Children's Chewable Vitamins - Tab</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230120</dpd-id>
      <started-marketing-on>1998-04-16</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kids Stuff Tablets</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02227622</dpd-id>
      <started-marketing-on>1998-04-20</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kids Stuff With Iron Tablets</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02227630</dpd-id>
      <started-marketing-on>1998-04-20</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Kimchi Vitamin chewable multivitamin</name>
      <labeller>Tobico</labeller>
      <ndc-id/>
      <ndc-product-code>52102-1001</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-03-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Kindervites</name>
      <labeller>Herbalife International Of America</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00624365</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2002-09-17</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>L.G.I.T.</name>
      <labeller>Morinda Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239036</dpd-id>
      <started-marketing-on>1999-12-15</started-marketing-on>
      <ended-marketing-on>2001-07-23</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Leritone Junior</name>
      <labeller>Institut De Recherche Biologique Yves Ponroy Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237106</dpd-id>
      <started-marketing-on>1998-12-07</started-marketing-on>
      <ended-marketing-on>2004-12-23</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lipo-B-C Tab</name>
      <labeller>Metagenics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00750719</dpd-id>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>1996-10-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liqui B Complex</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984438</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liqui B Complex Plus</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984411</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liqui Infant Vitamins</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984373</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liqui Vita</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984209</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Liquid B Complex 50</name>
      <labeller>Jamieson Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00623725</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Livron Plus Ampoule</name>
      <labeller>Medic Laboratory LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00520004</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Livron Plus Tab</name>
      <labeller>Medic Laboratory LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00485152</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Low Potency B Complex Tab</name>
      <labeller>Flora Manufacturing And Distributing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00601381</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1999-10-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lysamine Diet Supp Amp-tab</name>
      <labeller>Welcker Lyster Ltd., Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00556149</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-17</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>M.V.I. 12</name>
      <labeller>Aventis Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01927841</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-29</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>M.V.I. Paediatric</name>
      <labeller>Aventis Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01927833</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-29</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>M.V.I. Pediatric</name>
      <labeller>Hospira Worldwide, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>61703-421</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1983-04-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, powder, lyophilized, for solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA018920</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Maltlevol 12 Liq</name>
      <labeller>Carter Horner Corp.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00465496</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2002-02-07</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Maltlevol Liq</name>
      <labeller>Carter Horner Corp.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00501603</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>2005-03-21</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Maxi 10 Tab</name>
      <labeller>Desbergers LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00468797</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Maxi 6 Liq</name>
      <labeller>Desbergers LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479721</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-17</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Mega 13 Multivitamin Formula</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00782173</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-22</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Megavites Tab</name>
      <labeller>Icn Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00263915</dpd-id>
      <started-marketing-on>1973-12-31</started-marketing-on>
      <ended-marketing-on>2005-04-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Meplex T 750</name>
      <labeller>Medic Laboratory LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00134813</dpd-id>
      <started-marketing-on>1966-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Methaver</name>
      <labeller>Sterling Knight Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69336-353</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-11-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mini-B Tab</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01983652</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Mor-vites Tab</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01911236</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi - N.T.O.x Formula - Tab</name>
      <labeller>Abundance Naturally Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230199</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi 12 Injection</name>
      <labeller>Sandoz Canada Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02100606</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi B</name>
      <labeller>Seroyal International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00729094</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2009-07-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Enfants Tab</name>
      <labeller>Vitalab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01961136</dpd-id>
      <started-marketing-on>1992-12-31</started-marketing-on>
      <ended-marketing-on>1997-07-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Nt-OX</name>
      <labeller>Abundance Marketing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238889</dpd-id>
      <started-marketing-on>1999-02-01</started-marketing-on>
      <ended-marketing-on>2001-07-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Rol</name>
      <labeller>Rolmex International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00509159</dpd-id>
      <started-marketing-on>1975-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamin - Mineral</name>
      <labeller>Enrich International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237762</dpd-id>
      <started-marketing-on>1999-11-11</started-marketing-on>
      <ended-marketing-on>2001-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamin &amp; Minerals</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244988</dpd-id>
      <started-marketing-on>2002-01-04</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamin and Fluoride</name>
      <labeller>Libertas Pharma, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51862-162</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin and Fluoride</name>
      <labeller>Mayne Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>51862-161</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on>2019-10-31</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Drops with Fluoride</name>
      <labeller>Stratus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58980-501</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Drops with Fluoride</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-168</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Drops with Fluoride</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-167</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-18</started-marketing-on>
      <ended-marketing-on>2017-09-30</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Drops with Fluoride and Iron</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-169</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Drops with Fluoride with Iron</name>
      <labeller>Stratus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58980-502</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin Plus Iron</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245253</dpd-id>
      <started-marketing-on>2002-03-13</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamin with Fluoride</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-4381</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-09</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin with Fluoride</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-4382</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-09</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin with Fluoride</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-4383</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-09</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin with Fluoride</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>54569-3372</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-09</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamin-mineral Formula</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00471305</dpd-id>
      <started-marketing-on>1997-04-03</started-marketing-on>
      <ended-marketing-on>1998-01-16</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamin, Iron and Fluoride</name>
      <labeller>Mayne Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>51862-163</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on>2019-10-31</ended-marketing-on>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi Vitamines - Liq</name>
      <labeller>Land Art Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02148242</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2008-06-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vitamins &amp; Minerals</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241009</dpd-id>
      <started-marketing-on>2000-01-12</started-marketing-on>
      <ended-marketing-on>2001-04-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vite Liq Adult</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479209</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi Vite Liq Junior</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479195</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-11</name>
      <labeller>Sandoz Canada Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244696</dpd-id>
      <started-marketing-on>2002-01-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-12 Pediatric</name>
      <labeller>Sabex Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236829</dpd-id>
      <started-marketing-on>1998-04-09</started-marketing-on>
      <ended-marketing-on>2009-11-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-12/k1 Pediatric</name>
      <labeller>Sandoz Canada Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242529</dpd-id>
      <started-marketing-on>2000-11-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-min Electro C Pow Plus B2</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00666505</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1998-07-15</ended-marketing-on>
      <dosage-form>Granule, effervescent</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-Vit with Fluoride</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>54569-1270</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-04-18</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vit with Fluoride</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-1450</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vit with Fluoride</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-1449</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1997-04-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vit with Fluoride and Iron</name>
      <labeller>Qualitest</labeller>
      <ndc-id/>
      <ndc-product-code>0603-1452</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1998-01-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-814</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-28</started-marketing-on>
      <ended-marketing-on>2016-10-28</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-815</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-09-06</started-marketing-on>
      <ended-marketing-on>2016-10-28</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin</name>
      <labeller>LLC Federal Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>24451-008</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-08-12</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-vitamin Dietary Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238695</dpd-id>
      <started-marketing-on>1998-09-22</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-Vitamin Drops with Fluoride and Iron</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-327</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-02-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin Fluoride</name>
      <labeller>Stratus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58980-503</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-09-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin Fluoride and Iron Drops</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-821</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-04-20</started-marketing-on>
      <ended-marketing-on>2015-12-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin Fluoride Drops</name>
      <labeller>H.J. Harkins Company</labeller>
      <ndc-id/>
      <ndc-product-code>52959-593</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin Fluoride Drops</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-822</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-06</started-marketing-on>
      <ended-marketing-on>2015-12-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin Fluoride Drops</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-820</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-04</started-marketing-on>
      <ended-marketing-on>2016-03-31</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin with Fluoride</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-325</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-02-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin with Fluoride</name>
      <labeller>Method Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>58657-326</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-02-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-813</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-28</started-marketing-on>
      <ended-marketing-on>2016-10-28</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Mayne Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>51862-152</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on>2019-06-30</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Golden State Medical Supply</labeller>
      <ndc-id/>
      <ndc-product-code>60429-616</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-12-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Libertas Pharma, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51862-151</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Golden State Medical Supply</labeller>
      <ndc-id/>
      <ndc-product-code>60429-617</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-12-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Golden State Medical Supply</labeller>
      <ndc-id/>
      <ndc-product-code>60429-618</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-12-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-Vitamin With Fluoride</name>
      <labeller>Libertas Pharma, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51862-153</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-05-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multi-vitamines Enfants Comprime</name>
      <labeller>Herbes Universelles Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230233</dpd-id>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2009-07-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-vitamins</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241008</dpd-id>
      <started-marketing-on>1999-12-22</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multi-vitamins With Minerals</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241631</dpd-id>
      <started-marketing-on>2001-04-12</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamin Plus Minerals Tab</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529753</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamin Tab</name>
      <labeller>Adams Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00461970</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>2009-12-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins</name>
      <labeller>Gfr Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246181</dpd-id>
      <started-marketing-on>2002-10-10</started-marketing-on>
      <ended-marketing-on>2007-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00650307</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins &amp; Minerals Tablets</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246304</dpd-id>
      <started-marketing-on>2002-12-18</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins and Minerals Tab</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00662003</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins Plus Iron for Women</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239678</dpd-id>
      <started-marketing-on>1999-08-16</started-marketing-on>
      <ended-marketing-on>2006-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins Plus Iron Tab</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529982</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins Tab</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529990</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins Tab</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00662038</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins W Minerals Tab</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00365939</dpd-id>
      <started-marketing-on>1976-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins With Iron</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00650315</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multiple Vitamins With Minerals Tablets</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239680</dpd-id>
      <started-marketing-on>1999-07-16</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multisol</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00766461</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1997-02-06</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivit Et Fer Ampoules Et Comprimes</name>
      <labeller>Nobel Pharm Enr.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00773530</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-14</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivit-liq</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02131145</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamin</name>
      <labeller>Laboratoires Confab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236800</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamin Drops with Fluoride</name>
      <labeller>Sancilio &amp; Company, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-2017</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin Drops with Fluoride</name>
      <labeller>Sancilio &amp; Company, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-2018</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin Drops with Fluoride</name>
      <labeller>Sancilio &amp; Company, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-2006</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-04-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MultiVitamin Drops with Fluoride and Iron</name>
      <labeller>Sancilio &amp; Company, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-2016</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-08-24</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>54569-2384</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with Fluoride</name>
      <labeller>Pure Tek Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>59088-107</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with Fluoride</name>
      <labeller>Pure Tek Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>59088-108</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with Fluoride</name>
      <labeller>Pure Tek Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>59088-109</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-0356</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-0435</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1023</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1024</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamin with fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1025</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Multivitamines</name>
      <labeller>Rolmex International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237421</dpd-id>
      <started-marketing-on>1998-05-11</started-marketing-on>
      <ended-marketing-on>2007-07-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamines Et Mineraux</name>
      <labeller>Le Groupe M. Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238301</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamines Et Mineraux Junior Regulier</name>
      <labeller>Laboratoire Riva Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02067420</dpd-id>
      <started-marketing-on>1996-10-08</started-marketing-on>
      <ended-marketing-on>2008-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamines Et Mineraux Reguliers / Regular Multivitamins and Minerals</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237086</dpd-id>
      <started-marketing-on>1998-10-06</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamines Plus Fer Pour Enfants (chewable Tablets)</name>
      <labeller>Laboratoire Lalco Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237942</dpd-id>
      <started-marketing-on>1998-07-03</started-marketing-on>
      <ended-marketing-on>2002-09-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamines Pour Enfants (chewable Tablets)</name>
      <labeller>Laboratoire Lalco Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237941</dpd-id>
      <started-marketing-on>1998-07-03</started-marketing-on>
      <ended-marketing-on>2002-09-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamins and Minerals - Complete</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240963</dpd-id>
      <started-marketing-on>2000-02-01</started-marketing-on>
      <ended-marketing-on>2006-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamins and Multiminerals Formula Regular Tablet</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244457</dpd-id>
      <started-marketing-on>2001-11-22</started-marketing-on>
      <ended-marketing-on>2009-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamins for Children</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242559</dpd-id>
      <started-marketing-on>2001-01-31</started-marketing-on>
      <ended-marketing-on>2004-06-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Multivitamins W Iron</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00662011</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Mvc</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1012</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mvc</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1013</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mvc</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1014</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MVC-Fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1020</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MVC-Fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1021</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MVC-Fluoride</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1022</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Myhephron Dialysis and Stress Supplement</name>
      <labeller>Martin Ekwealor Pharmaceu</labeller>
      <ndc-id/>
      <ndc-product-code>58607-185</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-08-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mynephrocaps Dialysis/stress Vitamin Supplement</name>
      <labeller>Martin Ekwealor Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>58607-186</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-12-16</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>N.E.U. Complex</name>
      <labeller>Abundance Marketing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242770</dpd-id>
      <started-marketing-on>2000-12-04</started-marketing-on>
      <ended-marketing-on>2004-06-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nata Komplete</name>
      <labeller>Wh Nutritionals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>76331-909</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-25</started-marketing-on>
      <ended-marketing-on>2016-12-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>NataFort</name>
      <labeller>Mission Pharmacal</labeller>
      <ndc-id/>
      <ndc-product-code>0178-0716</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-08-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Natavite</name>
      <labeller>Schein Pharmaceutical Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230557</dpd-id>
      <started-marketing-on>1997-07-29</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo Bex Elixir</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00555118</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-12</ended-marketing-on>
      <dosage-form>Elixir</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo Vites Tab</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00456926</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo-bex</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00729191</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2005-08-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo-bex Injectable</name>
      <labeller>Brostel Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00147680</dpd-id>
      <started-marketing-on>1951-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Neo-vites &amp; Minerals Tab</name>
      <labeller>Neolab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00730343</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nephrocaps</name>
      <labeller>Amerincan Health Packaging</labeller>
      <ndc-id/>
      <ndc-product-code>68084-065</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-01-14</started-marketing-on>
      <ended-marketing-on>2015-12-29</ended-marketing-on>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nephrocaps</name>
      <labeller>Amerincan Health Packaging</labeller>
      <ndc-id/>
      <ndc-product-code>68084-126</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-08-28</started-marketing-on>
      <ended-marketing-on>2016-05-31</ended-marketing-on>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nephrocaps</name>
      <labeller>Cardinal Health</labeller>
      <ndc-id/>
      <ndc-product-code>55154-4796</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-01-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nutrifer Plus Tablets</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02042371</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-23</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nutrilite Double X</name>
      <labeller>Nutrilite, A Division Of Access Business Group, Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246512</dpd-id>
      <started-marketing-on>2002-12-15</started-marketing-on>
      <ended-marketing-on>2008-06-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Nutrol-B-complex</name>
      <labeller>Rolmex International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238321</dpd-id>
      <started-marketing-on>1999-06-28</started-marketing-on>
      <ended-marketing-on>2008-07-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>O-Cal FA multivitamin</name>
      <labeller>Pharmics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0813-9616</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1970-01-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>O-Cal Prenatal Vitamin</name>
      <labeller>Pharmics, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0813-0202</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2002-01-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Onccor</name>
      <labeller>Simone Protective Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230207</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>One A Day Advance Adults</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244891</dpd-id>
      <started-marketing-on>2002-09-12</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>One A Day Advance Adults 50+</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244483</dpd-id>
      <started-marketing-on>2002-09-12</started-marketing-on>
      <ended-marketing-on>2007-08-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>One A Day Advance Fem</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239342</dpd-id>
      <started-marketing-on>1999-03-01</started-marketing-on>
      <ended-marketing-on>2001-02-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>One A Day Advance Fem</name>
      <labeller>Bayer Inc Consumer Care</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243248</dpd-id>
      <started-marketing-on>2001-02-28</started-marketing-on>
      <ended-marketing-on>2001-08-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>One A Day Tab</name>
      <labeller>Country Health Laboratories Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00553484</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Orange Flavored Crystal Chews Tab</name>
      <labeller>Jeunique International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02079739</dpd-id>
      <started-marketing-on>1998-02-17</started-marketing-on>
      <ended-marketing-on>2006-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Orifer F</name>
      <labeller>Sanofi Aventis</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02103044</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-11-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Original Bioscal Forte Multi-vitamin Supplement Capsules</name>
      <labeller>Carram Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230146</dpd-id>
      <started-marketing-on>1997-05-07</started-marketing-on>
      <ended-marketing-on>1999-07-30</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Orti B</name>
      <labeller>Seroyal International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00584401</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>2008-10-09</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>P.N.P. Vitamin Drink</name>
      <labeller>Changes International</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241264</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>P.R.O. Complex</name>
      <labeller>Abundance Marketing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242775</dpd-id>
      <started-marketing-on>2000-12-06</started-marketing-on>
      <ended-marketing-on>2004-06-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Paramettes Chewable Multivitamins Plus Iron</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02043114</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Paramettes Chewable Multivits With Iron Tab</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932500</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Paramettes Multivits Plus Iron Tab (teens)</name>
      <labeller>Whitehall Robins Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01932616</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Paramettes Syrup</name>
      <labeller>Wyeth Ayerst Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02043084</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Syrup</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pediatric Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-7886</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021265</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pediatric Infuvite Multiple Vitamins</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-9023</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-12-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021265</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pediatric Infuvite Multiple Vitamins for Infusion</name>
      <labeller>Sandoz</labeller>
      <ndc-id/>
      <ndc-product-code>54643-5646</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-02-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA021265</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Permathene-12  -  Caplet</name>
      <labeller>Cca Industries, Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161540</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2000-12-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Phosthenine Vitamines Et Fer (ampoules Buvable)</name>
      <labeller>Laboratoires Cortunon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229507</dpd-id>
      <started-marketing-on>1997-01-23</started-marketing-on>
      <ended-marketing-on>2007-07-23</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Photrexa</name>
      <labeller>Avedro, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>25357-023</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>1.46 mg/mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>NDA203324</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Photrexa Viscous</name>
      <labeller>Avedro, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>25357-022</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution / drops</dosage-form>
      <strength>1.46 mg/mL</strength>
      <route>Ophthalmic</route>
      <fda-application-number>NDA203324</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Phytofortis + Calcium A-D</name>
      <labeller>Phyto Health Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00505900</dpd-id>
      <started-marketing-on>1983-12-31</started-marketing-on>
      <ended-marketing-on>2003-11-27</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Phytoplex B Liq</name>
      <labeller>Phyto Health Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00286982</dpd-id>
      <started-marketing-on>1973-12-31</started-marketing-on>
      <ended-marketing-on>2004-08-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Phytopure</name>
      <labeller>Laboratoire Lalco Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02028271</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2001-10-15</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PM Caps</name>
      <labeller>New Vision Nutritionals Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238133</dpd-id>
      <started-marketing-on>1998-10-01</started-marketing-on>
      <ended-marketing-on>2002-11-20</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PNV Ferrous Fumarate Docusate Folic Acid</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-273</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Plus Multivitamin</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-0617</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Plus Multivitamin</name>
      <labeller>Remedy Repack</labeller>
      <ndc-id/>
      <ndc-product-code>52125-907</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Plus Multivitamin</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1045</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Plus Multivitamin</name>
      <labeller>bryant ranch prepack</labeller>
      <ndc-id/>
      <ndc-product-code>63629-6973</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Plus Multivitamin</name>
      <labeller>Clinical Solutions Wholsesale</labeller>
      <ndc-id/>
      <ndc-product-code>58118-1045</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on>2017-07-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Vitamin</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1041</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV Prenatal Vitamin Plus Vitamin A</name>
      <labeller>Sancilio &amp; Company Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>44946-1046</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-12-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV-First</name>
      <labeller>Acella Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>42192-350</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-05-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PNV-Select</name>
      <labeller>Acella Pharmaceuticals, LLC</labeller>
      <ndc-id/>
      <ndc-product-code>42192-320</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-11-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Poly-VI-sol Drops</name>
      <labeller>Mead Johnson Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00647578</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2000-09-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Polymine Avec Zinc Et Cuivre</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630888</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Potassium Plus Vit B Complex</name>
      <labeller>Anabolic Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00527440</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1996-10-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Prefera OB plus DHA</name>
      <labeller>Alaven Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>68220-089</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreferaOB</name>
      <labeller>Meda Pharmaceuticals Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>0037-0084</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-04-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreferaOB</name>
      <labeller>Alaven Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>68220-084</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-09-27</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreferaOB plus DHA</name>
      <labeller>Alaven Pharmaceutical</labeller>
      <ndc-id/>
      <ndc-product-code>68220-083</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-11-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Pregvit</name>
      <labeller>Duchesnay Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02451573</dpd-id>
      <started-marketing-on>2016-07-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pregvit</name>
      <labeller>Duchesnay Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246067</dpd-id>
      <started-marketing-on>2003-08-25</started-marketing-on>
      <ended-marketing-on>2016-07-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pregvit Folic 4</name>
      <labeller>Duchesnay Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02263947</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pregvit Folic 5</name>
      <labeller>Duchesnay Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02276194</dpd-id>
      <started-marketing-on>2006-03-17</started-marketing-on>
      <ended-marketing-on>2016-07-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Pregvit Folic 5</name>
      <labeller>Duchesnay Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02451581</dpd-id>
      <started-marketing-on>2016-08-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PreNatal 19</name>
      <labeller>Nationwide Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>42937-706</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreNatal 19</name>
      <labeller>Nationwide Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>42937-707</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Mega Antioxidant</name>
      <labeller>Usana Health Services, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>51861-103</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-04-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Nationwide Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>42937-705</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Blenheim Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>10544-549</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-12-09</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Amneal Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>65162-668</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-509</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-03-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Av Kare, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>42291-686</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-09-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Atlantic Biologicals Corps.</labeller>
      <ndc-id/>
      <ndc-product-code>17856-0668</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Carilion Materials Management</labeller>
      <ndc-id/>
      <ndc-product-code>68151-2640</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus</name>
      <labeller>Preferreed Pharmaceuticals Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>68788-6779</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-10-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus Iron</name>
      <labeller>Major</labeller>
      <ndc-id/>
      <ndc-product-code>0904-5339</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-07</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Plus Iron</name>
      <labeller>Blenheim Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>10544-609</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-05-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreNatal Vitamins Plus</name>
      <labeller>Boca Pharmacal, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>64376-816</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-04-15</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Vitamins Plus</name>
      <labeller>Nnodum Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>63044-150</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2016-02-25</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreNatal Vitamins Plus</name>
      <labeller>bryant ranch prepack</labeller>
      <ndc-id/>
      <ndc-product-code>63629-3545</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-04-15</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Vitamins Plus Low Iron</name>
      <labeller>A S Medication Solutions</labeller>
      <ndc-id/>
      <ndc-product-code>50090-0616</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on>2017-06-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal Vitamins Plus Low Iron</name>
      <labeller>Patrin Pharma</labeller>
      <ndc-id/>
      <ndc-product-code>39328-106</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenatal, DHA</name>
      <labeller>Pure Tek Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>59088-096</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-08-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenate Elite</name>
      <labeller>Avion Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>75854-301</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-08-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenate Elite</name>
      <labeller>Avion Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>75854-314</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-06-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prenate Star</name>
      <labeller>Avion Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>75854-311</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-06-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PrePLUS</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-258</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreQue 10</name>
      <labeller>Actavis Pharma Company</labeller>
      <ndc-id/>
      <ndc-product-code>52544-079</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>PreTAB</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-259</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-09</started-marketing-on>
      <ended-marketing-on>2017-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Prevital Tab</name>
      <labeller>Bio Vita</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00887471</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>PureVit DualFe Plus</name>
      <labeller>Pure Tek Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>59088-112</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Q.T. Vitamin and Mineral Drink Mix</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238945</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Reaphirm Plant Source DHA</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-3010</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-12-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Reno Caps</name>
      <labeller>Carilion Materials Management</labeller>
      <ndc-id/>
      <ndc-product-code>68151-1928</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2008-11-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Reno Caps</name>
      <labeller>Nnodum Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>63044-622</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2008-11-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Replavite</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244872</dpd-id>
      <started-marketing-on>2001-12-19</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Replavite</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240409</dpd-id>
      <started-marketing-on>1999-10-20</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Revit Plus Cap</name>
      <labeller>Icn Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00249173</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Revit Tab</name>
      <labeller>Icn Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00629022</dpd-id>
      <started-marketing-on>1980-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Revitex Ampoules Et Comprimes</name>
      <labeller>Les Produits Gerbex Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00724041</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2005-06-29</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Revival 1 Tab</name>
      <labeller>Bio Vita</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00889423</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-12</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Riboflavin 5 Phosphate Cap 50mg</name>
      <labeller>Thorne Research Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00653527</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-13</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>50 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Riboflavin Inj 50mg/ml</name>
      <labeller>Kripps Pharmacy Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00463442</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength>50 mg</strength>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Riboflavin Tab 10mg</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00189138</dpd-id>
      <started-marketing-on>1971-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>10 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Riboflavin Tab 5mg</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00179434</dpd-id>
      <started-marketing-on>1957-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>5 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Riboflavin-S Tab 25mg</name>
      <labeller>Nutri West Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01980769</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>25 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Right Choice A.M. Multi Formula - Caplet</name>
      <labeller>Body Wise International Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229687</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Se-Natal 19</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-116</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Se-Natal 19 Chewable</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-117</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, chewable</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Se-Natal One</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-103</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-04-16</started-marketing-on>
      <ended-marketing-on>2016-10-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Se-Tan PLUS</name>
      <labeller>Seton Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>13925-118</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sibergin B - Cap</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02186675</dpd-id>
      <started-marketing-on>1996-09-03</started-marketing-on>
      <ended-marketing-on>1998-09-08</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Somarexin and C 1000</name>
      <labeller>Laboratoire Lalco Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00415820</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-29</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Somavit Brand Vitamins and Minerals Complex</name>
      <labeller>Soma Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240872</dpd-id>
      <started-marketing-on>2000-01-15</started-marketing-on>
      <ended-marketing-on>2005-08-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sopalamine/3b Plus C</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00717924</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2001-09-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Spectrum 2 Cap</name>
      <labeller>Nf Formulas Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00719064</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2008-06-26</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress B &amp; C  Caplet</name>
      <labeller>Health Wise Nutrition Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02011336</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-25</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress B Capsules With Vitamin C</name>
      <labeller>Rheingold Food International Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00694509</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress B Complex With C, E &amp; Iron</name>
      <labeller>Pharmavite</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240609</dpd-id>
      <started-marketing-on>1999-10-31</started-marketing-on>
      <ended-marketing-on>2005-07-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress B With 1000 Mg Vitamin C</name>
      <labeller>Holista Health (Canada) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246252</dpd-id>
      <started-marketing-on>2002-11-13</started-marketing-on>
      <ended-marketing-on>2008-07-17</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress B&amp;c Tab</name>
      <labeller>Bioforce Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01978233</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-04-04</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Complex 600 Avec Vit E Cuivre Zinc</name>
      <labeller>Frega Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630330</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2008-02-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Ctr Srt</name>
      <labeller>Bioenergy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00539937</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-03</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236417</dpd-id>
      <started-marketing-on>1998-05-20</started-marketing-on>
      <ended-marketing-on>2005-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula + Iron</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236422</dpd-id>
      <started-marketing-on>1998-05-20</started-marketing-on>
      <ended-marketing-on>2006-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula B-comp + 500mg Vit C Tab</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00718440</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula Multi-B Comp + 500mg Vit C Cap</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00718475</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-06</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula Multivitamin Tablets USP</name>
      <labeller>Leiner Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230556</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula Tab</name>
      <labeller>Natures Sunshine Products, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00656593</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2009-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Formula Vit B With C Complex</name>
      <labeller>Watkins Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00629472</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2000-01-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Forte Plus Lipotropic Factors</name>
      <labeller>Douglas Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01990446</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2009-09-29</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Tab</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00537128</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Tablets</name>
      <labeller>D.C. Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00536903</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stress Vitamin B With C Complex Tablets</name>
      <labeller>Purity Life Health Products A Division Of Sunopta Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245110</dpd-id>
      <started-marketing-on>2002-06-01</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Stressmates</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01983687</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1999-11-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Strovite Forte Caplet</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0204</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1996-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Strovite One Caplets</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0207</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2001-05-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Sun-rype Vitaburst</name>
      <labeller>Sun Rype Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248736</dpd-id>
      <started-marketing-on>2004-08-10</started-marketing-on>
      <ended-marketing-on>2008-03-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super B Compound W 500mg Vit C</name>
      <labeller>Gahler Enterprises Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00679186</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2000-08-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Charged Energy</name>
      <labeller>Simone Protective Pharmaceuticals, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230209</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Powder</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Daily No 2</name>
      <labeller>W.R. Enterprises Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839043</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Pantoplex</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00713821</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2000-03-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Stress Capsules</name>
      <labeller>Rheingold Food International Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00644722</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-22</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Stress Mega B Plus 1000mg Vit C Tab</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00718459</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Vitalex Ampoule Buvable</name>
      <labeller>Carmaran LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00578886</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2001-08-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super Vitalex Ampoule Buvable</name>
      <labeller>Carmaran LtÉe</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00578886</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2001-08-31</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Super-pote Vitamin Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238783</dpd-id>
      <started-marketing-on>1998-09-25</started-marketing-on>
      <ended-marketing-on>2000-06-07</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supplement De Multivitamines Infusion Arome Fruits Rouges</name>
      <labeller>Yves Rocher Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241041</dpd-id>
      <started-marketing-on>1999-10-18</started-marketing-on>
      <ended-marketing-on>2000-08-08</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite 10ml Ampoule</name>
      <labeller>Nobel Pharm Enr.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00876410</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2002-09-06</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite Bouteille 250ml</name>
      <labeller>Nobel Pharm Enr.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244095</dpd-id>
      <started-marketing-on>2002-10-31</started-marketing-on>
      <ended-marketing-on>2008-07-29</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite C 1000</name>
      <labeller>Nobel Pharm Enr.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00510874</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2002-09-06</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite Pour Enfants</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00666750</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite Stress Avec Vit E</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630861</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite Stress Avec Vit E Cuivre Et Zinc</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630845</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Supravite Stress Avec Vit E Et Fer</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00630853</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Surbex 500 Filmtab</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00520209</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2008-06-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Surbex-500 With Iron</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00690120</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2008-06-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Surbex-500 With Zinc</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00685151</dpd-id>
      <started-marketing-on>1986-12-31</started-marketing-on>
      <ended-marketing-on>2008-06-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Swical-energy-2</name>
      <labeller>Les Laboratoires Swisse Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229621</dpd-id>
      <started-marketing-on>1997-06-09</started-marketing-on>
      <ended-marketing-on>2006-02-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>T.R.I. B-plex Src</name>
      <labeller>Anabolic Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00467596</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2004-03-15</ended-marketing-on>
      <dosage-form>Capsule, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Tandem OB</name>
      <labeller>Us Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>52747-903</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-06-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tandem Plus</name>
      <labeller>Us Pharmaceutical Corporation</labeller>
      <ndc-id/>
      <ndc-product-code>52747-902</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2006-06-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tender Age Multi Vitamins</name>
      <labeller>Jamieson Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00537950</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2000-09-08</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Time Release B 100 Compound  -  Tablet</name>
      <labeller>Health Wise Nutrition Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02168111</dpd-id>
      <started-marketing-on>1996-10-22</started-marketing-on>
      <ended-marketing-on>2002-07-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Timed Release B Complex 100 Srt</name>
      <labeller>Jamieson Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02021684</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-13</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Timed Release B-complex 100</name>
      <labeller>Great Earth Companies, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230974</dpd-id>
      <started-marketing-on>1998-08-25</started-marketing-on>
      <ended-marketing-on>2002-10-02</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Timed Release B-complex 50</name>
      <labeller>Great Earth Companies, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230972</dpd-id>
      <started-marketing-on>1998-08-25</started-marketing-on>
      <ended-marketing-on>2002-10-02</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Tini-cal Ampoules</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00479128</dpd-id>
      <started-marketing-on>1966-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Toni Com Liq</name>
      <labeller>Vitalab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00840858</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2009-07-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Tonicol Et A-D-C Ampoules/comprimes</name>
      <labeller>Distributions Multi Pro Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00730769</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1999-07-21</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Tonimol Cap Liq</name>
      <labeller>Herbes Universelles Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00432172</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2009-07-15</ended-marketing-on>
      <dosage-form>Capsule; Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>TriAdvance</name>
      <labeller>Trigen Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>13811-529</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2010-09-10</started-marketing-on>
      <ended-marketing-on>2017-09-16</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Tricare Prenatal</name>
      <labeller>Medecor Pharma, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>67112-101</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2002-11-11</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Trinatal GT</name>
      <labeller>Trigen Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>13811-614</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-07-05</started-marketing-on>
      <ended-marketing-on>2017-09-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Twin Ultra Liquid Fruit Punch Flavor</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984233</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2002-09-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Twin Ultra Liquid Grape Flavor</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984225</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2007-08-01</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Twin Ultra Liquid Lemon-lime Flavor</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984241</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2005-08-30</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Twin Ultra Liquid Orange Flavor</name>
      <labeller>Twin Laboratories Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01984268</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2002-09-11</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>UltimateCare ONE NF</name>
      <labeller>Trigen Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>13811-050</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2009-12-04</started-marketing-on>
      <ended-marketing-on>2017-09-16</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ultra Enerforce</name>
      <labeller>Nutribon (1986) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244200</dpd-id>
      <started-marketing-on>2002-01-29</started-marketing-on>
      <ended-marketing-on>2005-02-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ultra Hr</name>
      <labeller>Natural Organics Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238044</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Usana Megavitamin Tablets - Tab</name>
      <labeller>Usana Health Sciences, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02226316</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2000-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vasodyn Tab</name>
      <labeller>Nutri Dyn Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00420999</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Viamon Ampoules Et Comprimes</name>
      <labeller>Lab Nadeau LtÉe, Division Of Technilab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00726133</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-28</ended-marketing-on>
      <dosage-form>Liquid; Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vigo Multivitamins Drops/lozenge</name>
      <labeller>Ashbury Research Corporation</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239461</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Lozenge</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vimeral Tab</name>
      <labeller>Icn Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00486590</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2005-04-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Virt-Caps</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-260</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-04-01</started-marketing-on>
      <ended-marketing-on>2017-08-11</ended-marketing-on>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virt-Pn</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-241</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-07-12</started-marketing-on>
      <ended-marketing-on>2017-08-09</ended-marketing-on>
      <dosage-form>Tablet, coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Virt-Vite Plus</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-210</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2014-01-14</started-marketing-on>
      <ended-marketing-on>2017-08-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vit B Complex Ctr</name>
      <labeller>Bioenergy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00539929</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-03</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vit B Complex Plus Vit C 550mg</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529702</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vit B2 Ctr Srt 200mg</name>
      <labeller>Bioenergy Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00539996</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-03</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength>200 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vit-HA Multi Vitamin and Zinc Supplement</name>
      <labeller>Rheingold Food International Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>01987267</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita B + C 500 Tab</name>
      <labeller>Laboratoire Romilo</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00751901</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-18</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita B Complex Tab</name>
      <labeller>Nutrimetics International (Canada) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00634697</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2000-07-19</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita Day Tab</name>
      <labeller>Jamieson Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02006812</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita-B</name>
      <labeller>Nutri Dyn Products Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00609668</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-22</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita-B-75 Cap</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00843555</dpd-id>
      <started-marketing-on>1989-12-31</started-marketing-on>
      <ended-marketing-on>1998-09-28</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita-flavine Cap 100mg</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00757780</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2001-08-07</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vita-worth B-complex Tablets</name>
      <labeller>General Nutrition Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02163381</dpd-id>
      <started-marketing-on>1997-04-18</started-marketing-on>
      <ended-marketing-on>2005-08-05</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitabanks Vitamin Tab</name>
      <labeller>Vitabank Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00894087</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitachrom Gc</name>
      <labeller>Nikken Usa, Incorporated</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241824</dpd-id>
      <started-marketing-on>2000-08-30</started-marketing-on>
      <ended-marketing-on>2007-10-01</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitaday Tab</name>
      <labeller>Pharmetics (2011) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00400114</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-13</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitafant</name>
      <labeller>Les Laboratoires Vachon Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02060973</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitafer - Liq</name>
      <labeller>Frega Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143658</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-12-10</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitaflex Dietary Suplement</name>
      <labeller>Home Shopping Network Direct</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237896</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitafol Caplet</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0072</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1985-05-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitafol OB Caplet</name>
      <labeller>Exeltis Usa, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0079</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2002-12-02</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitafol One</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0070</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-06-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, gelatin coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitafol Plus</name>
      <labeller>Everett Laboratories, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0092</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2012-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitafol Ultra</name>
      <labeller>Exeltis Usa, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0642-0093</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-09-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, liquid filled</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitalife  -  Capsule</name>
      <labeller>Holista Health (Canada) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02157942</dpd-id>
      <started-marketing-on>1996-11-13</started-marketing-on>
      <ended-marketing-on>2002-08-06</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin and Mineral Supplement - Liq</name>
      <labeller>Technilab Pharma Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02213869</dpd-id>
      <started-marketing-on>1998-05-25</started-marketing-on>
      <ended-marketing-on>2005-08-05</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B + C Cap</name>
      <labeller>Finlandia Consultants</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00833371</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>1997-12-02</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex</name>
      <labeller>Mylan Institutional</labeller>
      <ndc-id/>
      <ndc-product-code>67457-146</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-05-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitamin B Complex</name>
      <labeller>Flon Laboratories Llc</labeller>
      <ndc-id/>
      <ndc-product-code>71414-225</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2017-04-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitamin B Complex</name>
      <labeller>Raw Materials International Overseas Llc</labeller>
      <ndc-id/>
      <ndc-product-code>69877-026</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-07-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intramuscular; Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vitamin B Complex + C 300mg Cap</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00661961</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex + C 600mg Tab</name>
      <labeller>Randle Pharmaceutical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00662119</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-30</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex 100 Tab</name>
      <labeller>Bioforce Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02075970</dpd-id>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1997-04-04</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex 50</name>
      <labeller>Gfr Pharma Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02246190</dpd-id>
      <started-marketing-on>2002-10-10</started-marketing-on>
      <ended-marketing-on>2004-06-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex Plus 300mg Vitamin C</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02215934</dpd-id>
      <started-marketing-on>1996-11-28</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex Plus C 300mg Timed Release</name>
      <labeller>Vita Health Products Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237681</dpd-id>
      <started-marketing-on>1998-10-06</started-marketing-on>
      <ended-marketing-on>2009-08-06</ended-marketing-on>
      <dosage-form>Tablet, extended release</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex Suppl</name>
      <labeller>Avacare, Division Of Jeunique International Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00624462</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-20</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex Tab</name>
      <labeller>Nutristar Health Products (1987) Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00474797</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex W C 300mg Tab</name>
      <labeller>Lee Adams Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00556467</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>2009-12-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Complex W C Tab</name>
      <labeller>Albi Imports Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00483087</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2004-09-24</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Compound Tab</name>
      <labeller>Nutrilite, A Division Of Access Business Group, Llc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00551880</dpd-id>
      <started-marketing-on>1982-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Compound W C Tab 500mg</name>
      <labeller>Adams Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00469785</dpd-id>
      <started-marketing-on>1979-12-31</started-marketing-on>
      <ended-marketing-on>2009-10-21</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Compound W Vit C 250mg Tab</name>
      <labeller>Swiss Herbal Remedies Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00520705</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Compound With Vitamin C Fortis Capsule Dtc</name>
      <labeller>D.C. Labs Limited</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00270830</dpd-id>
      <started-marketing-on>1973-12-31</started-marketing-on>
      <ended-marketing-on>2005-07-19</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Cpd W Vit C Tab</name>
      <labeller>Icn Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00295108</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2005-04-26</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B Tablets</name>
      <labeller>Weider Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00649422</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1999-09-09</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B-2</name>
      <labeller>Sisu Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243881</dpd-id>
      <started-marketing-on>2001-09-01</started-marketing-on>
      <ended-marketing-on>2006-07-31</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B-2 50 Mg Tablets</name>
      <labeller>General Nutrition Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02164116</dpd-id>
      <started-marketing-on>1997-04-18</started-marketing-on>
      <ended-marketing-on>2006-08-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>50 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B-2 Riboflavin 100mg Capsules</name>
      <labeller>Albi Naturals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239929</dpd-id>
      <started-marketing-on>1999-04-30</started-marketing-on>
      <ended-marketing-on>2009-07-15</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B2 100 mg</name>
      <labeller>Flora Manufacturing And Distributing Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02244911</dpd-id>
      <started-marketing-on>2002-03-15</started-marketing-on>
      <ended-marketing-on>2004-08-04</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B2 100mg</name>
      <labeller>Great Earth Companies, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230623</dpd-id>
      <started-marketing-on>1998-08-25</started-marketing-on>
      <ended-marketing-on>2002-10-02</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B2 Tab 100mg</name>
      <labeller>Quest Vitamins A Div Of Purity Life Health Products</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00401722</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-06</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B2 Tab 4mg USP Chewable</name>
      <labeller>Lab Gernetic Int Ltee</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00654701</dpd-id>
      <started-marketing-on>1985-12-31</started-marketing-on>
      <ended-marketing-on>1997-02-21</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>4 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamin B2 Tablets 100mg</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00663093</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2005-03-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength>100 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamine 110 Liq</name>
      <labeller>Frega Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02008068</dpd-id>
      <started-marketing-on>1993-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamine Du Groupe B Plus Fer - Liq</name>
      <labeller>Pharmalab Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02143631</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-14</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitamines Pour Bebes Et Enfants</name>
      <labeller>Herbes Universelles Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00452599</dpd-id>
      <started-marketing-on>1978-12-31</started-marketing-on>
      <ended-marketing-on>2009-07-15</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitogen B Compound W C Fortis Capsules</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00231770</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>1997-10-14</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitogen B Stress C Vit E Zinc &amp; Cop</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00620556</dpd-id>
      <started-marketing-on>1984-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitogen B Stress C600</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00537470</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitogen Multiple Vitamins Tab</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00244341</dpd-id>
      <started-marketing-on>1966-12-31</started-marketing-on>
      <ended-marketing-on>1997-10-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitogen Multiple Vitamins W Iron</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00365890</dpd-id>
      <started-marketing-on>1976-12-31</started-marketing-on>
      <ended-marketing-on>1997-10-14</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitreat Chewable Vitamin Tab</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00243108</dpd-id>
      <started-marketing-on>1972-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vitreat Chewable Vitamins Plus Iron</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00365904</dpd-id>
      <started-marketing-on>1977-12-31</started-marketing-on>
      <ended-marketing-on>1997-08-08</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>VP-heme OB</name>
      <labeller>Virtus Pharmaceuticals</labeller>
      <ndc-id/>
      <ndc-product-code>76439-237</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2013-10-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Tablet, film coated</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vtb Vitamin and Mineral Supplement</name>
      <labeller>Garden State Nutritionals</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238947</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Women's Formula</name>
      <labeller>Pro Ma Systems</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02232894</dpd-id>
      <started-marketing-on>1998-10-31</started-marketing-on>
      <ended-marketing-on>2007-09-25</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Women's Formula</name>
      <labeller>Wn Pharmaceuticals Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02245222</dpd-id>
      <started-marketing-on>2002-04-25</started-marketing-on>
      <ended-marketing-on>2009-09-28</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Zoo Chews</name>
      <labeller>Hall Laboratories, Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00529761</dpd-id>
      <started-marketing-on>1981-12-31</started-marketing-on>
      <ended-marketing-on>2003-09-11</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Bisulase</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>PreferaOB</name>
      <ingredients>Biotin + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron saccharate + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Sodium selenate + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>CitraNatal Rx</name>
      <ingredients>Calcium Citrate + Cupric oxide + Folic Acid + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin D + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>CitraNatal Rx</name>
      <ingredients>Calcium Citrate + Cupric oxide + Docusate + Folic Acid + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin D + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>CitraNatal DHA</name>
      <ingredients>Calcium Citrate + Cupric oxide + Docusate + Folic Acid + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin D + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Vitafol One</name>
      <ingredients>Copper + Cyanocobalamin + Folic Acid + Iodine + Iron + Magnesium + Niacin + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Vitafol Caplet</name>
      <ingredients>Calcium + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitafol Plus</name>
      <ingredients>Copper + Cyanocobalamin + Folic Acid + Iodine + Iron + Lauric Acid + Magnesium + Niacin + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Strovite Forte Caplet</name>
      <ingredients>Biotin + Chromium + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Molybdenum + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Strovite One Caplets</name>
      <ingredients>Biotin + Cholecalciferol + Chromium + Cupric sulfate + Cyanocobalamin + Folic Acid + Lipoic Acid + Lutein + Magnesium oxide + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Reaphirm Plant Source DHA</name>
      <ingredients>Copper + Cyanocobalamin + Folic Acid + Iodine + Iron + Magnesium + Niacin + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>O-Cal Prenatal Vitamin</name>
      <ingredients>Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iodine + Iron + Magnesium + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Se-Tan PLUS</name>
      <ingredients>Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Iron Dextran + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Drops with Fluoride and Iron</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin</name>
      <ingredients>Cyanocobalamin + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B-plex 100</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Mega Antioxidant</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin and Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Kimchi Vitamin chewable multivitamin</name>
      <ingredients>Cholecalciferol + Collagenase clostridium histolyticum + Folic Acid + Lactic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Concept OB</name>
      <ingredients>Biotin + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Iron + Magnesium Sulfate + Manganese + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Concept DHA</name>
      <ingredients>Biotin + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Iron + Magnesium Sulfate + Niacin + Omega-3-acid ethyl esters + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Integra Plus</name>
      <ingredients>Biotin + Ferrous asparto glycinate + Folic Acid + Iron + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Tandem Plus</name>
      <ingredients>Cupric sulfate + Cyanocobalamin + Ferrous asparto glycinate + Folic Acid + Iron + Magnesium Sulfate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Tandem OB</name>
      <ingredients>Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Iron + Magnesium Sulfate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Fluoride Drops</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Fluoride ion + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Nephrocaps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Mynephrocaps Dialysis/stress Vitamin Supplement</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Drops with Fluoride with Iron</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>PureVit DualFe Plus</name>
      <ingredients>Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Iron Dextran + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc sulfate</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Reno Caps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>PreNatal Vitamins Plus</name>
      <ingredients>Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Fluoride Drops</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Fluoride ion + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Nephrocaps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>PreferaOB plus DHA</name>
      <ingredients>Biotin + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron Dextran + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PreferaOB</name>
      <ingredients>Biotin + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron Dextran + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prefera OB plus DHA</name>
      <ingredients>Biotin + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron Dextran + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Folcaps Care One</name>
      <ingredients>Alpha-Linolenic Acid + Biotin + Calcium Carbonate + Calcium threonate + Cholecalciferol + Doconexent + Docusate + Folic Acid + Icosapent + Iodine + Iron + Magnesium + Nicotinamide + Pyridoxine + Riboflavin + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Biovita</name>
      <ingredients>Bacillus subtilis + Calcium Phosphate + Nicotinamide + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Prenate Star</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cupric oxide + Cyanocobalamin + Ferrous asparto glycinate + Folic Acid + Formic Acid + Magnesium oxide + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>HemeNatal OB</name>
      <ingredients>Biotin + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron saccharate + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Sodium selenate + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Nata Komplete</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Choline + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Virt-Vite Plus</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>VP-heme OB</name>
      <ingredients>Biotin + Cholecalciferol + Copper gluconate + Cyanocobalamin + Folic Acid + Heme iron polypeptide + Iron saccharate + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Sodium selenate + Thiamine + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Virt-Pn</name>
      <ingredients>Beta carotene + Biotin + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Iron + Levomefolic acid + Magnesium oxide + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Virt-Caps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Fluoride and Iron Drops</name>
      <ingredients>Cholecalciferol + Fluoride ion + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Fluoride Drops</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Fluoride ion + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Nephrocaps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Riboflavin Inj 50mg/ml</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Chela Potassium Plus</name>
      <ingredients>Folic Acid + Iodine + Nicotinamide + Potassium + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Toni Com Liq</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Prevital Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Riboflavin Tab 10mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>B 6 Plus</name>
      <ingredients>Magnesium + Niacin + Potassium + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vita-flavine Cap 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Riboflavin-S Tab 25mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>B-2 Caps 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Multivit-liq</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Isotonix Vitamin B-folic Acid-mineral Supple</name>
      <ingredients>Cyanocobalamin + Folic Acid + Magnesium + Potassium + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Megavites Tab</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B2 Tab 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Vitamines Pour Bebes Et Enfants</name>
      <ingredients>Ergocalciferol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B2 Tab 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>B Complex Tablets</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Floradix Formula Liq</name>
      <ingredients>Folic Acid + Iron + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B-2 50 Mg Tablets</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Floravit - Syr</name>
      <ingredients>Cyanocobalamin + Iron + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B6 Plus Tab</name>
      <ingredients>Magnesium oxide + Niacin + Potassium Citrate + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Riboflavin Tab 5mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Livron Plus Ampoule</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Hemarexin Amp</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Formula Fm Vitamins &amp; Minerals Tab</name>
      <ingredients>Iron + Magnesium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Phosthenine Vitamines Et Fer (ampoules Buvable)</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Swical-energy-2</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Cc II</name>
      <ingredients>Niacin + Pantothenic acid + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B2 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Compound Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Dia-vite</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Ez-flex</name>
      <ingredients>Cyanocobalamin + Folic Acid + Magnesium + Nicotinamide + Pyridoxine + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>B50 B Complex Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Cda-21 Vitamins With Non-medicinal Probiotic Complex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Isotonix Calcium Plus Formula</name>
      <ingredients>Calcium + Cholecalciferol + Magnesium + Potassium + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Ferra Naka Plus Vitamins</name>
      <ingredients>Iron + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>C-B Complex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines Pour Enfants (chewable Tablets)</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines Plus Fer Pour Enfants (chewable Tablets)</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B-2 Riboflavin 100mg Capsules</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Formula Cn</name>
      <ingredients>Cyanocobalamin + Folic Acid + Magnesium + Pyridoxine + Riboflavin + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B2 Tab 4mg USP Chewable</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Ultra Enerforce</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multivitamins</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multivitamins Plus Iron</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B2 100 mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>B-2 100mg With C 20mg</name>
      <ingredients>Riboflavin + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Isotonix Advanced B-complex Vitamins With Potassium and Magnesium</name>
      <ingredients>Cyanocobalamin + Folic Acid + Magnesium + Potassium + Pyridoxine + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Neo-bex</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B2 Tablets 100mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Super Pantoplex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-min Electro C Pow Plus B2</name>
      <ingredients>Calcium + Magnesium + Potassium + Riboflavin + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Antlerviron</name>
      <ingredients>Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Cedevita Plus Vitamin Supplement</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Cedevita Sugar-free Vitamin Supplement</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Neo-bex Injectable</name>
      <ingredients>Dexpanthenol + Lidocaine + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Fortaplex Inj</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>M.V.I. Paediatric</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Enfants Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Everyday Multiple Vitamins With Iron</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B Complex 50 Vitamin Cap</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamine 110 Liq</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitafant</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Complexe B 75mg</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Everyday Multiple Vitamins</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Complexe B 75mg</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stressmates</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Twin Ultra Liquid Orange Flavor</name>
      <ingredients>Biotin + Chromium + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Twin Ultra Liquid Lemon-lime Flavor</name>
      <ingredients>Biotin + Chromium + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Twin Ultra Liquid Grape Flavor</name>
      <ingredients>Biotin + Chromium + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Twin Ultra Liquid Fruit Punch Flavor</name>
      <ingredients>Biotin + Chromium + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Liqui B Complex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Liqui Vita</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Liqui Infant Vitamins</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Phytoplex B Liq</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Mini-B Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Liqui B Complex Plus</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Permathene-12  -  Caplet</name>
      <ingredients>Benzocaine + Iron + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Bugs Bunny and Friends Multiple Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Gemvites Jr Tab Chewable</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Harvest Of Values All B Complex Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B Virol</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Appedrine</name>
      <ingredients>Benzocaine + Iron + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Biovim Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>C.A.G. Tab</name>
      <ingredients>Copper + Inositol nicotinate + Pyridoxine + Riboflavin + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Orange Flavored Crystal Chews Tab</name>
      <ingredients>Calcium + Cyanocobalamin + Folic Acid + Iron + Niacin + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitaday Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Maltlevol 12 Liq</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Dexatrim Tablets</name>
      <ingredients>Benzocaine + Iron + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Neo Vites Tab</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Globucel - Methode</name>
      <ingredients>Folic Acid + Nicotinamide + Riboflavin + Vitamin A + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Tonimol Cap Liq</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multi Rol</name>
      <ingredients>Calcium + Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Phytofortis + Calcium A-D</name>
      <ingredients>Calcium + Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B Complex W C and B12 Inj</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Hi Potency B52 B Complex Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Maltlevol Liq</name>
      <ingredients>Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vite Liq Junior</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vite Liq Adult</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Hi Potency Stress B Tension With C</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Tini-cal Ampoules</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Orti B</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Beminal W C Fortis Inj</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Lysamine Diet Supp Amp-tab</name>
      <ingredients>Calcium + Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chew Multi Vitamin Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vita-B</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Revit Tab</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamin Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Hi Potency B Complex W Chelated Minerals</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Manganese + Niacin + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Kindervites</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Am Caps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B Complex 25mg Vitamin Supplement</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-100 Vitamin Supplement</name>
      <ingredients>Biotin + Choline + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex Suppl</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multiple Vitamins (chewable Tablets)</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multiple Vitamins With Iron Tablets (chewable Tablets)</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multiple Vitamins With Extra Vitamin C (chewable Tablets)</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B Vitamin Compound With B12 Thunas</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Nicotinamide + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Formula Pro-B</name>
      <ingredients>Biotin + Cyanocobalamin + Inositol nicotinate + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitachrom Gc</name>
      <ingredients>Chromium + Cyanocobalamin + Folic Acid + Inositol nicotinate + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Supravite Pour Enfants</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Croq-vit Pour Enfants</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Chela-chromium 200</name>
      <ingredients>Biotin + Chromium + Cyanocobalamin + Manganese + Nicotinamide + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Bev 29 Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Niacin + Pantothenic acid + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B Compound 50mg Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Infantol Drops</name>
      <ingredients>Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multisol</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multi B</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Dynam Ampoule Et Tablet</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Viamon Ampoules Et Comprimes</name>
      <ingredients>Calcium + Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitaflex Dietary Suplement</name>
      <ingredients>Biotin + Calcium + Chromium + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Ultra Hr</name>
      <ingredients>Biotin + Choline + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines Et Mineraux</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Iodine + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Reno Caps</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Bacmin</name>
      <ingredients>Biotin + Chromium Cr-51 + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium oxide + Manganese gluconate + Nicotinamide + Pantothenic acid + Pyridoxine + Radium Ra 223 Dichloride + Riboflavin + Selenomethionine + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>O-Cal FA multivitamin</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iodine + Iron + Magnesium + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Floriva</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Levomefolic acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc gluconate</ingredients>
    </mixture>
    <mixture>
      <name>Floriva</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Levomefolic acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc gluconate</ingredients>
    </mixture>
    <mixture>
      <name>Floriva</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Levomefolic acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc gluconate</ingredients>
    </mixture>
    <mixture>
      <name>Escavite</name>
      <ingredients>Biotin + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Vitamins Plus</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Flintstones Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Orifer F</name>
      <ingredients>Calcium + Cholecalciferol + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Flintstones Multiple Vitamins Plus Iron</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Flintstones Multiple Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>For Kids Only Chewable Multivitamins - Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>For Kids Only Chewable Multivit. Plus Iron</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multiple Vitamins - Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multiple Vit.plus Iron</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Flintstones W Extra C Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Flinstones Multiple Plus Iron</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Bugs Bunny Chew Multi Vit Plus Iron</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>NataFort</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>UltimateCare ONE NF</name>
      <ingredients>Alpha-Linolenic Acid + Biotin + Calcium + Calcium threonate + Cholecalciferol + Doconexent + Docusate + Ferrous asparto glycinate + Folic Acid + Icosapent + Iodine + Iron + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Pyridoxine + Riboflavin + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>TriAdvance</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Docusate + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Trinatal GT</name>
      <ingredients>Beta carotene + Biotin + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Docusate + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Se-Natal One</name>
      <ingredients>Biotin + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Se-Natal 19</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Docusate + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Se-Natal 19 Chewable</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium acetate + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Vitamins Plus Low Iron</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>PNV-Select</name>
      <ingredients>Biotin + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PNV-First</name>
      <ingredients>Beta carotene + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron saccharate + Magnesium oxide + Nicotinamide + Omega-3 fatty acids + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PreNatal 19</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Docusate + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PreNatal 19</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Vitamin Plus Vitamin A</name>
      <ingredients>Calcium Phosphate + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vit with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Plus Multivitamin</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin</name>
      <ingredients>Cyanocobalamin + Fluoride ion + Folic Acid + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>PreNatal Vitamins Plus</name>
      <ingredients>Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenate Elite</name>
      <ingredients>Beta carotene + Biotin + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenate Elite</name>
      <ingredients>5-methyltetrahydrofolic acid + Beta carotene + Biotin + Cholecalciferol + Cupric oxide + Cyanocobalamin + Ferrous asparto glycinate + Folic Acid + Formic Acid + Magnesium oxide + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Iron Polysaccharides Folic Acid DHA</name>
      <ingredients>Beta carotene + Cholecalciferol + Cupric oxide + Cyanocobalamin + Doconexent + Folic Acid + Iron Dextran + Magnesium oxide + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PrePLUS</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PreTAB</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PNV Ferrous Fumarate Docusate Folic Acid</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cyanocobalamin + Docusate + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Lipo-B-C Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Totum 500</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Complex With C 550mg</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Stress B&amp;c Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B C Antistress Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Allbee With Vitamin C Cap</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Allbee With C 550 Cap</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Compound With Vitamin C Fortis Capsule Dtc</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>High Potency Vitamin B Complex + C Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Iberet 500</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Complex Plus C 300mg Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Meplex T 750</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vasodyn Tab</name>
      <ingredients>Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Time Release B 100 Compound  -  Tablet</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Compound W C Tab 500mg</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Livron Plus Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Surbex 500 Filmtab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vit B Complex Plus Vit C 550mg</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Stress Tablets</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B 125 Srt</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Complex 500 Tab</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex W C 300mg Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Multiple Vit and Min Chew Tab</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Formula Adr-vitamin B2,b6 W Calpan Tab</name>
      <ingredients>Pantothenic acid + Pyridoxine + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Complexe B Compose 75</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Complete Mega B</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B Complex W Vitamin C Fortis Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Liquid B Complex 50</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vita B Complex Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-100 Complex Tablets</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Super B Compound W 500mg Vit C</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Surbex-500 With Iron</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Sopalamine/3b Plus C</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B Complex With C 300mg</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi 12 Injection</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Alertonic</name>
      <ingredients>Choline + Inositol nicotinate + Nicotinamide + Pipradrol + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin and Mineral Supplement - Liq</name>
      <ingredients>Nicotinamide + Riboflavin + Sodium glycerophosphate + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vimeral Tab</name>
      <ingredients>Biotin + Calcium + Calcium + Cyanocobalamin + Folic Acid + Iron + Magnesium + Magnesium + Manganese + Nicotinamide + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Hemarexin Liquid and Drinkable Ampoules</name>
      <ingredients>Nicotinamide + Riboflavin + Sodium glycerophosphate + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Formula O-care Vitamin and Mineral Supplement</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Copper + Folic Acid + Magnesium + Manganese + Monopotassium phosphate + Pyridoxine + Riboflavin + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-11</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vita-B-75 Cap</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Super Stress Capsules</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Low Potency B Complex Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Complex-75</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B Stress C + Iron &amp; Vite</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Supravite 10ml Ampoule</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Revival 1 Tab</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B + C Cap</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-100 B-complex Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B Complex W Vit C W Non-med Yeast&amp;liver Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-complex Vit + Vit C&amp;e Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Feminique W Iron and Calcium Tab</name>
      <ingredients>Calcium + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Mor-vites Tab</name>
      <ingredients>Calcium + Cholecalciferol + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>M.V.I. 12</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Alertonic</name>
      <ingredients>Choline + Inositol nicotinate + Nicotinamide + Pipradrol + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Vitamin Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Fortistress Tab</name>
      <ingredients>Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Phytopure</name>
      <ingredients>Choline + Copper + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Magnesium + Niacin + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Beminal With C Fortis Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Timed Release B Complex 100 Srt</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex 100 Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Beminal With C Fortis Pws</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Beminal With C Fortis Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Complex 50+ Caplet</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Forte Plus Lipotropic Factors</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B With C 500 Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-50 B-complex Vitamins Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitafer - Liq</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress B &amp; C  Caplet</name>
      <ingredients>Biotin + Choline + Folic Acid + Inositol nicotinate + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B-complex Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-50 Hi Potency B Vitamins Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamine Du Groupe B Plus Fer - Liq</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-50 B-complex Vitamins, Timed Rele</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Complex 600 Avec Vit E Cuivre Zinc</name>
      <ingredients>Biotin + Cupric oxide + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Complex 5 - Pwr</name>
      <ingredients>Niacin + Pantothenic acid + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-50 Complex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Hypo Vites Tab</name>
      <ingredients>Biotin + Calcium + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Somarexin and C 1000</name>
      <ingredients>Calcium + Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Alsimine W Vitamins A D</name>
      <ingredients>Calcium + Cyanocobalamin + Dexpanthenol + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Cpd W Vit C Tab</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>T.R.I. B-plex Src</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Iron 25mg With Vit B-cmplx, Vit C, Cu &amp; Mo</name>
      <ingredients>Biotin + Copper + Cyanocobalamin + Folic Acid + Iron + Molybdenum + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Essential B Tablets</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vita-worth B-complex Tablets</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Sibergin B - Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex W C Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex Plus 300mg Vitamin C</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Compound W Vit C 250mg Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Supravite C 1000</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Geritol Liquid</name>
      <ingredients>Dexpanthenol + Ferric ammonium citrate + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B100</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins Plus Iron Tab</name>
      <ingredients>Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B50 Complex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamin Plus Minerals Tab</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Ergocalciferol + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Zoo Chews</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B Plus C 300mg Timed Release</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitogen B Stress C600</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-vitamines Enfants Comprime</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Enviroflex - Tab</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Cyanocobalamin + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>One A Day Tab</name>
      <ingredients>Biotin + Calcium + Choline + Copper + Cyanocobalamin + Ergocalciferol + Folic Acid + Inositol nicotinate + Iodine + Iron + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>B-complex 50</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Timed Release B-complex 50</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Timed Release B-complex 100</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-complex 100</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin-mineral Formula</name>
      <ingredients>Calcium + Choline + Copper + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Magnesium + Manganese + Niacin + Pantothenic acid + Potassium Iodide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>B-complex Tablets</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula + Iron</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B-complex-50 Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitogen B Stress C Vit E Zinc &amp; Cop</name>
      <ingredients>Copper + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-12 Pediatric</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Hemarexin Tab</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Complexe B-75</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Supravite Stress Avec Vit E Cuivre Et Zinc</name>
      <ingredients>Biotin + Cupric oxide + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Supravite Stress Avec Vit E Et Fer</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Supravite Stress Avec Vit E</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex Plus C 300mg Timed Release</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>PM Caps</name>
      <ingredients>Beta carotene + Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Polymine Avec Zinc Et Cuivre</name>
      <ingredients>Biotin + Cupric oxide + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Nutrol-B-complex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-complex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Super-pote Vitamin Supplement</name>
      <ingredients>Biotin + Cholecalciferol + Choline + Cyanocobalamin + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Vitamins</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>C.R.T. X Multivitamin &amp; Mineral Powder Mix</name>
      <ingredients>Magnesium + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Forty Plus Vitamin Supplement</name>
      <ingredients>Biotin + Cholecalciferol + Choline + Cyanocobalamin + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Insur-all Vitamin Supplement</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Ergocalciferol + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>One A Day Advance Fem</name>
      <ingredients>Beta carotene + Calcium + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins Plus Iron for Women</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins With Minerals Tablets</name>
      <ingredients>Calcium + Cupric sulfate + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Riboflavin 5 Phosphate Cap 50mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Replavite</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Stress B Complex With C, E &amp; Iron</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B-plex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Formula Lf</name>
      <ingredients>Choline + Cyanocobalamin + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>D'pantothenic Acid-B1-B2 Tab</name>
      <ingredients>Pantothenic acid + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Tablets</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Complete Mega B</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-100 Timed Release</name>
      <ingredients>Biotin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula Vit B With C Complex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>One A Day Advance Fem</name>
      <ingredients>Beta carotene + Calcium + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Bev B-150</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Bio-fen</name>
      <ingredients>Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Efferlife Multivitamins and Minerals</name>
      <ingredients>Biotin + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>B-complex With Vitamin C, Biotin, Folic Acid</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B-2</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Supravite Bouteille 250ml</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>One A Day Advance Adults 50+</name>
      <ingredients>Beta carotene + Biotin + Calcium + Chromium + Cupric sulfate + Cyanocobalamin + Folic Acid + Magnesium + Manganese + Molybdenum + Niacin + Pantothenic acid + Potassium + Potassium Chloride + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Hill.vite</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B-plex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Replavite</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>One A Day Advance Adults</name>
      <ingredients>Beta carotene + Biotin + Calcium + Chromium + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Magnesium + Manganese + Molybdenum + Niacin + Pantothenic acid + Potassium + Potassium Chloride + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Diaplex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Stress Vitamin B With C Complex Tablets</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Coenzyme Q10 Isotonix Vitamin and Mineral Supplement</name>
      <ingredients>Potassium + Riboflavin + Ubidecarenone + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex 50</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress B With 1000 Mg Vitamin C</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B-100 Caps</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Daily Energy Brand B-complex</name>
      <ingredients>Choline + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Surbex-500 With Zinc</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B50 Complex</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Cyanocobalamin + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula B-comp + 500mg Vit C Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Super Stress Mega B Plus 1000mg Vit C Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula Multi-B Comp + 500mg Vit C Cap</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Neo Bex Elixir</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Dia-vite</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B Complex With C 300mg Tab</name>
      <ingredients>Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>B 50 Capsules</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress B Capsules With Vitamin C</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Revitex Ampoules Et Comprimes</name>
      <ingredients>Biotin + Calcium + Cyanocobalamin + Dexpanthenol + Inositol nicotinate + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B-complex Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Mega 13 Multivitamin Formula</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B-50 Complex Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Hi Potency Balanced B-100 Complex - Tab</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Balanced B-50 Complex</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Formula Multivitamin Tablets USP</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Homosistrol Capsules</name>
      <ingredients>Cyanocobalamin + Folic Acid + Pyridoxine + Riboflavin + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vigo Multivitamins Drops/lozenge</name>
      <ingredients>Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Formula D.S.</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Kanga-V Multivitamins &amp; Minerals</name>
      <ingredients>Biotin + Calcium + Chromium + Copper + Cyanocobalamin + Ergocalciferol + Folic Acid + Iron + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Kanga Sport Vitamins B &amp; C Plus Minerals</name>
      <ingredients>Biotin + Cyanocobalamin + Magnesium + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Kanga-B Vitamin B Group + C</name>
      <ingredients>Biotin + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Kanga-kid Multi-vitamin &amp; Mineral</name>
      <ingredients>Beta carotene + Biotin + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Pregvit Folic 4</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-12/k1 Pediatric</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Super Daily No 2</name>
      <ingredients>Biotin + Calcium + Choline + Copper + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Magnesium + Manganese + Niacin + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Children's Vitamins W Iron Chewable</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Children's Vitamins Chewable</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Garfield Chewable Multivits Plus Iron Tab</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Paramettes Multivits Plus Iron Tab (teens)</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Paramettes Syrup</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Paramettes Chewable Multivitamins Plus Iron</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Paramettes Chewable Multivits With Iron Tab</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vit-HA Multi Vitamin and Zinc Supplement</name>
      <ingredients>Biotin + Choline + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Multiple Vitamins Plus Fe</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Multiple Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins W Minerals Tab</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Maxi 10 Tab</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Kids Stuff Tablets</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Kids Stuff With Iron Tablets</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Maxi 6 Liq</name>
      <ingredients>Ergocalciferol + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Tender Age Multi Vitamins</name>
      <ingredients>Ergocalciferol + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Kid's Choice Children's Chewable Vitamins - Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi Vit W Iron</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Natavite</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi Vitamins</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi Vitamins With Iron Tablets</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Infa Drops Multivitamins</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi-vitamin Complete With Minerals</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Children's Chewable Multi-vitamin</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-vitamins</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamins &amp; Minerals</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Chromium + Cyanocobalamin + Folic Acid + Iron + Magnesium + Molybdenum + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-vitamins With Minerals</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Chromium + Cyanocobalamin + Folic Acid + Iron + Magnesium + Molybdenum + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamins for Children</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin &amp; Minerals</name>
      <ingredients>Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Plus Iron</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Infant Multivitamin Drops</name>
      <ingredients>Cholecalciferol + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Poly-VI-sol Drops</name>
      <ingredients>Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Sun-rype Vitaburst</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Neo-vites &amp; Minerals Tab</name>
      <ingredients>Cholecalciferol + Iron + Magnesium + Nicotinamide + Riboflavin + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins With Iron</name>
      <ingredients>Cyanocobalamin + Ergocalciferol + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Fortamines-10 Comprimes</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Gestamine Comprimes</name>
      <ingredients>Calcium + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Fortamines 10 Capsules</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Spectrum 2 Cap</name>
      <ingredients>Beta carotene + Biotin + Calcium + Choline + Chromium + Cyanocobalamin + Folic Acid + Inositol nicotinate + Iron + Magnesium + Manganese + Molybdenum + Niacin + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Tonicol Et A-D-C Ampoules/comprimes</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Q.T. Vitamin and Mineral Drink Mix</name>
      <ingredients>Biotin + Cholecalciferol + Chromium + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Kenwood Liquid Supplement</name>
      <ingredients>Ergocalciferol + Manganese + Nicotinamide + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus Iron</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Active FE</name>
      <ingredients>Beta carotene + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Inatal Advance</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Docusate + Folic Acid + Iron + Magnesium oxide + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>INATAL Ultra</name>
      <ingredients>Calcium Citrate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Docusate + Folic Acid + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus Iron</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>C-Nate DHA</name>
      <ingredients>Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Magnesium + Omega-3 fatty acids + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>healthy mamaBE WELL ROUNDED BE WELL ROUNDED</name>
      <ingredients>Beta carotene + Biotin + Calcium Carbonate + Cholecalciferol + Copper + Ferrous bisglycinate + Folic Acid + Magnesium oxide + Methylcobalamin + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Methaver</name>
      <ingredients>Folic Acid + Methylcobalamin + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>B-Combo</name>
      <ingredients>Dexpanthenol + Methylcobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Pregvit</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Gesticare DHA</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Choline + Cyanocobalamin + Doconexent + Folic Acid + Icosapent + Iron + Niacin + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Children Choice Multivit Chewable Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Children Choice Multivitamin W Iron Chew Tab</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Revit Plus Cap</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vita Day Tab</name>
      <ingredients>Beta carotene + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Carbassist Tablets</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Women's Formula</name>
      <ingredients>Biotin + Calcium + Cholecalciferol + Choline + Chromic chloride + Copper + Cyanocobalamin + Folic Acid + Inositol nicotinate + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Leritone Junior</name>
      <ingredients>Biotin + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Somavit Brand Vitamins and Minerals Complex</name>
      <ingredients>Beta carotene + Chromium + Copper + Folic Acid + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Nutrilite Double X</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium + Calcium + Cholecalciferol + Chromic chloride + Copper + Cyanocobalamin + Folic Acid + Magnesium + Magnesium + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin C + Vitamin C + Vitamin E + Vitamin E + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Right Choice A.M. Multi Formula - Caplet</name>
      <ingredients>Beta carotene + Biotin + Chromic chloride + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Derma-force</name>
      <ingredients>Beta carotene + Biotin + Calcium + Cholecalciferol + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + L-Methionine + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Sulfur + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Icaps</name>
      <ingredients>Beta carotene + Copper + Manganese + Riboflavin + Selenium + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Glyco-aide Tab</name>
      <ingredients>Chromium + Cyanocobalamin + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamines - Liq</name>
      <ingredients>Beta carotene + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitalife  -  Capsule</name>
      <ingredients>Beta carotene + Biotin + Calcium + Choline + Chromium + Cyanocobalamin + Folic Acid + Inositol nicotinate + Magnesium + Manganese + Molybdenum + Niacin + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Icaps Time Release</name>
      <ingredients>Beta carotene + Copper + Riboflavin + Selenium + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Formula O</name>
      <ingredients>Beta carotene + Riboflavin + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Usana Megavitamin Tablets - Tab</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Niacin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Original Bioscal Forte Multi-vitamin Supplement Capsules</name>
      <ingredients>Beta carotene + Biotin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin - Mineral</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Chromium + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Manganese + Molybdenum + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Complete Multivitamins and Minerals Tablets Timed Release</name>
      <ingredients>Beta carotene + Biotin + Calcium + Choline + Chromium + Copper + Folic Acid + Inositol nicotinate + Iron + Magnesium + Manganese + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-vitamin Dietary Supplement</name>
      <ingredients>Beta carotene + Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Nt-OX</name>
      <ingredients>Beta carotene + Biotin + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Itabs Plus</name>
      <ingredients>Beta carotene + Copper + Manganese + Riboflavin + Selenium + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Supplement De Multivitamines Infusion Arome Fruits Rouges</name>
      <ingredients>Beta carotene + Biotin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>E.S.T. Complex</name>
      <ingredients>Beta carotene + Cyanocobalamin + Folic Acid + Magnesium + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>P.R.O. Complex</name>
      <ingredients>Beta carotene + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Magnesium + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Women's Formula</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Onccor</name>
      <ingredients>Beta carotene + Biotin + Choline + Chromium + Cupric oxide + Cyanocobalamin + Ergocalciferol + Folic Acid + Inositol nicotinate + Manganese + Molybdenum + Nicotinamide + Pantothenic acid + Potassium + Potassium Iodide + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Vtb Vitamin and Mineral Supplement</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Chromium + Cyanocobalamin + Folic Acid + Magnesium + Manganese + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>P.N.P. Vitamin Drink</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cyanocobalamin + Folic Acid + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Extra P.N. Vitamin-mineral Drink Mix</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cyanocobalamin + Folic Acid + Pantothenic acid + Potassium + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Pregvit Folic 5</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vit with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vit with Fluoride and Iron</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Tricare Prenatal</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Floriva Plus</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Levomefolic acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Photrexa Viscous</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Photrexa</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Vitamins Plus Low Iron</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Plus Multivitamin</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Plus Multivitamin</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Myhephron Dialysis and Stress Supplement</name>
      <ingredients>Biotin + Cyanocobalamin + Folic Acid + Niacin + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vit with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Vitabanks Vitamin Tab</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vita B + C 500 Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multiple Vitamins Plus Iron Tab</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multiple Vitamins Plus Extra C</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multiple Vit Plus Iron for Children</name>
      <ingredients>Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Chew.multiple Vits.with Extra C for Children</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B-plus - Tab</name>
      <ingredients>Beta carotene + Biotin + Choline + Cyanocobalamin + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Chewable Multiple Vitamins for Children</name>
      <ingredients>Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>B Complex W C Forte Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vit B Complex Ctr</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Stress Ctr Srt</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Inositol nicotinate + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vit B2 Ctr Srt 200mg</name>
      <ingredients>Riboflavin</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex + C 300mg Cap</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Multivitamins W Iron</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins and Minerals Tab</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex + C 600mg Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Childrens Chewable Multivitamins</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamins W Iron</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Super Charged Energy</name>
      <ingredients>Beta carotene + Biotin + Calcium + Cholecalciferol + Cyanocobalamin + Folic Acid + Magnesium + Nicotinamide + Pantothenic acid + Potassium + Potassium Chloride + Pyridoxine + Riboflavin + Sodium phosphate + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Mvc</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Mvc</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Mvc</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin and Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin, Iron and Fluoride</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Vitafol OB Caplet</name>
      <ingredients>Calcium + Copper + Cyanocobalamin + Folic Acid + Iron + Magnesium + Niacin + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Pregvit</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multi - N.T.O.x Formula - Tab</name>
      <ingredients>Beta carotene + Biotin + Cholecalciferol + Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Selenium + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Tocopherol + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin Drops with Fluoride and Iron</name>
      <ingredients>Cholecalciferol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Pregvit Folic 5</name>
      <ingredients>Beta carotene + Calcium + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Plus Multivitamin</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Vitamin</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>PNV Prenatal Plus Multivitamin</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines Et Mineraux Junior Regulier</name>
      <ingredients>Calcium + Calcium Phosphate + Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Century Complete</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium Phosphate + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Central-vite 18 Essential</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium Phosphate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamines Et Mineraux Reguliers / Regular Multivitamins and Minerals</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium Phosphate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>L.G.I.T.</name>
      <ingredients>Calcium + Calcium Phosphate + Chromium + Copper + Magnesium + Manganese + Nicotinamide + Potassium + Riboflavin + Selenium + Thiamine + Vitamin C + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamins and Minerals - Complete</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium Phosphate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Complete Multivitamins and Minerals for Children</name>
      <ingredients>Biotin + Calcium + Calcium Phosphate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamins and Multiminerals Formula Regular Tablet</name>
      <ingredients>Beta carotene + Biotin + Calcium + Calcium Phosphate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multiple Vitamins &amp; Minerals Tablets</name>
      <ingredients>Calcium + Calcium Phosphate + Cholecalciferol + Cupric sulfate + Cyanocobalamin + Folic Acid + Iron + Magnesium + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>MVC-Fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>MVC-Fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>MVC-Fluoride</name>
      <ingredients>Cyanocobalamin + Folic Acid + Niacin + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin D + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>PreQue 10</name>
      <ingredients>Cholecalciferol + Cupric oxide + Cyanocobalamin + Doconexent + Docusate + Folic Acid + Iron + Lycopene + Magnesium oxide + Riboflavin + Selenium + Thiamine + Ubidecarenone + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Formula Dpr</name>
      <ingredients>Riboflavin + Ubidecarenone</ingredients>
    </mixture>
    <mixture>
      <name>N.E.U. Complex</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Ubidecarenone + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Potassium Plus Vit B Complex</name>
      <ingredients>Nicotinamide + Pantothenic acid + Potassium gluconate + Potassium Iodide + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>E &amp; I Formulae</name>
      <ingredients>Beta carotene + Riboflavin + Vitamin A + Zinc</ingredients>
    </mixture>
    <mixture>
      <name>Vitogen B Compound W C Fortis Capsules</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Vitreat Chewable Vitamin Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitogen Multiple Vitamins Tab</name>
      <ingredients>Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitogen Multiple Vitamins W Iron</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitreat Chewable Vitamins Plus Iron</name>
      <ingredients>Cyanocobalamin + Iron + Nicotinamide + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Multivit Et Fer Ampoules Et Comprimes</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin D</ingredients>
    </mixture>
    <mixture>
      <name>Vitamin B Complex</name>
      <ingredients>Dexpanthenol + Nicotinamide + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Vitafol Ultra</name>
      <ingredients>Beta carotene + Cholecalciferol + Cupric oxide + Cyanocobalamin + Doconexent + Folic Acid + Iron + Levomefolic acid + Magnesium oxide + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Multi-Vitamin With Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal, DHA</name>
      <ingredients>Calcium Carbonate + Cholecalciferol + Choline + Cyanocobalamin + Doconexent + Folic Acid + Iron + Niacin + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Super Vitalex Ampoule Buvable</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Pyridoxine + Riboflavin + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Super Vitalex Ampoule Buvable</name>
      <ingredients>Cyanocobalamin + Dexpanthenol + Iron + Pyridoxine + Riboflavin + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>Pediatric Infuvite Multiple Vitamins for Infusion</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Infuvite Adult Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Infuvite Adult Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>M.V.I. Pediatric</name>
      <ingredients>Biotin + Cyanocobalamin + Dexpanthenol + Ergocalciferol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Pediatric Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Pediatric Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Adult Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Adult Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Adult Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Adult Infuvite Multiple Vitamins</name>
      <ingredients>Biotin + Cholecalciferol + Cyanocobalamin + Dexpanthenol + Folic Acid + Nicotinamide + Phylloquinone + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multi Vitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Folic Acid + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Vitamin A + Vitamin C + Vitamin C + Vitamin E</ingredients>
    </mixture>
    <mixture>
      <name>Foltabs Prenatal</name>
      <ingredients>Calcium Citrate + Cholecalciferol + Cupric oxide + Docusate + Folic Acid + Iron + Iron + Nicotinamide + Potassium Iodide + Pyridoxine + Riboflavin + Thiamine + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Nutrifer Plus Tablets</name>
      <ingredients>Calcium + Cholecalciferol + Copper + Cyanocobalamin + Folic Acid + Iron + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>B-100 Hi Potency B Vitamins Tab</name>
      <ingredients>Biotin + Choline + Cyanocobalamin + Folic Acid + Nicotinamide + Pantothenic acid + Pantothenic acid + Pyridoxine + Riboflavin + Thiamine</ingredients>
    </mixture>
    <mixture>
      <name>MultiVitamin Drops with Fluoride and Iron</name>
      <ingredients>Cholecalciferol + Ferrous sulfate + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Tocopherol + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Tocopherol + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Multivitamin Drops with Fluoride</name>
      <ingredients>Cholecalciferol + Cyanocobalamin + Nicotinamide + Pyridoxine + Riboflavin + Sodium fluoride + Thiamine + Tocopherol + Vitamin A + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>Prenatal Plus</name>
      <ingredients>Beta carotene + Calcium Carbonate + Cholecalciferol + Cupric oxide + Cyanocobalamin + Folic Acid + Iron + Nicotinamide + Pyridoxine + Riboflavin + Thiamine + Vitamin A + Vitamin C + Vitamin E + Zinc oxide</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amend</name>
      <url/>
    </packager>
    <packager>
      <name>C.O. Truxton Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>Carlisle Laboratories Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>Freeda Vitamins</name>
      <url>http://www.freedavitamins.com</url>
    </packager>
    <packager>
      <name>Gonberetica</name>
      <url/>
    </packager>
    <packager>
      <name>Key Co.</name>
      <url/>
    </packager>
    <packager>
      <name>Magno-Humphries Laboratories</name>
      <url>http://www.magno-humphries.com</url>
    </packager>
    <packager>
      <name>Martica Enterprises Inc.</name>
      <url/>
    </packager>
    <packager>
      <name>Martin Surgical Supply</name>
      <url/>
    </packager>
    <packager>
      <name>Mason Distributors</name>
      <url/>
    </packager>
    <packager>
      <name>Merit Pharmaceuticals</name>
      <url>http://www.meritpharm.com</url>
    </packager>
    <packager>
      <name>Nexgen Pharma Inc.</name>
      <url>http://www.nexgenpharma.com</url>
    </packager>
    <packager>
      <name>Pamlab LLC</name>
      <url>http://www.pamlab.com</url>
    </packager>
    <packager>
      <name>Particle Dynamics Co.</name>
      <url>http://www.particledynamics.com</url>
    </packager>
    <packager>
      <name>Pharmetics Inc.</name>
      <url>http://www.pharmetics.com</url>
    </packager>
    <packager>
      <name>Red River Pharma Manufacturing</name>
      <url/>
    </packager>
    <packager>
      <name>Sciele Pharma Inc.</name>
      <url/>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Vitamin b-2 25 mg tablet</description>
      <cost currency="USD">0.02</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Ribo 100 mg tablet</description>
      <cost currency="USD">0.04</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Riboflavin 50 mg tablet</description>
      <cost currency="USD">0.08</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Vitamin b-2 50 mg tablet</description>
      <cost currency="USD">0.08</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Riboflavin 100 mg tablet</description>
      <cost currency="USD">0.09</cost>
      <unit>tablet</unit>
    </price>
    <price>
      <description>Riboflavin powder</description>
      <cost currency="USD">0.44</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Biological Factors</category>
      <mesh-id>D001685</mesh-id>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Chemical Actions and Uses</category>
      <mesh-id>D020164</mesh-id>
    </category>
    <category>
      <category>Coenzymes</category>
      <mesh-id>D003067</mesh-id>
    </category>
    <category>
      <category>Dermatologic Agents</category>
      <mesh-id>D003879</mesh-id>
    </category>
    <category>
      <category>Diet, Food, and Nutrition</category>
      <mesh-id>D000066888</mesh-id>
    </category>
    <category>
      <category>Enzymes and Coenzymes</category>
      <mesh-id>D045762</mesh-id>
    </category>
    <category>
      <category>Flavins</category>
      <mesh-id>D005415</mesh-id>
    </category>
    <category>
      <category>Food</category>
      <mesh-id>D005502</mesh-id>
    </category>
    <category>
      <category>Food and Beverages</category>
      <mesh-id>D019602</mesh-id>
    </category>
    <category>
      <category>Glycosides</category>
      <mesh-id>D006027</mesh-id>
    </category>
    <category>
      <category>Growth Substances</category>
      <mesh-id>D006133</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds</category>
      <mesh-id>D006571</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, 2-Ring</category>
      <mesh-id>D006574</mesh-id>
    </category>
    <category>
      <category>Heterocyclic Compounds, 3-Ring</category>
      <mesh-id>D006575</mesh-id>
    </category>
    <category>
      <category>Micronutrients</category>
      <mesh-id>D018977</mesh-id>
    </category>
    <category>
      <category>Nucleic Acids, Nucleotides, and Nucleosides</category>
      <mesh-id>D009706</mesh-id>
    </category>
    <category>
      <category>Nucleotides</category>
      <mesh-id>D009711</mesh-id>
    </category>
    <category>
      <category>Pharmacologic Actions</category>
      <mesh-id>D020228</mesh-id>
    </category>
    <category>
      <category>Photosensitizing Agents</category>
      <mesh-id>D017319</mesh-id>
    </category>
    <category>
      <category>Physiological Effects of Drugs</category>
      <mesh-id>D045505</mesh-id>
    </category>
    <category>
      <category>Physiological Phenomena</category>
      <mesh-id>D010829</mesh-id>
    </category>
    <category>
      <category>Pigments, Biological</category>
      <mesh-id>D010860</mesh-id>
    </category>
    <category>
      <category>Pteridines</category>
      <mesh-id>D011621</mesh-id>
    </category>
    <category>
      <category>Radiation-Sensitizing Agents</category>
      <mesh-id>D011838</mesh-id>
    </category>
    <category>
      <category>Riboflavin</category>
      <mesh-id>D012256</mesh-id>
    </category>
    <category>
      <category>Ribonucleotides</category>
      <mesh-id>D012265</mesh-id>
    </category>
    <category>
      <category>Therapeutic Uses</category>
      <mesh-id>D045506</mesh-id>
    </category>
    <category>
      <category>Vitamin B Complex</category>
      <mesh-id>D014803</mesh-id>
    </category>
    <category>
      <category>Vitamins</category>
      <mesh-id>D014815</mesh-id>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Elixir</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, extended release</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder, for solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Granule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, effervescent</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Syrup</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intramuscular; Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route/>
      <strength/>
    </dosage>
    <dosage>
      <form>Powder</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, chewable</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, powder, lyophilized, for solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid; tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Granule, effervescent</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution / drops</form>
      <route>Ophthalmic</route>
      <strength>1.46 mg/mL</strength>
    </dosage>
    <dosage>
      <form>Tablet, coated</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>50 mg</strength>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intramuscular; Intravenous</route>
      <strength>50 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>10 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>5 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>25 mg</strength>
    </dosage>
    <dosage>
      <form>Kit</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule, extended release</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule; liquid</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Lozenge</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet, extended release</form>
      <route>Oral</route>
      <strength>200 mg</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule, gelatin coated</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule, liquid filled</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intramuscular; Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>50 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>100 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength>4 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet, film coated</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A11HA04">
      <level code="A11HA">Other plain vitamin preparations</level>
      <level code="A11H">OTHER PLAIN VITAMIN PREPARATIONS</level>
      <level code="A11">VITAMINS</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1HE5</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00140.pdf?1265922748</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00707</drugbank-id>
      <name>Porfimer sodium</name>
      <description>Riboflavin may increase the photosensitizing activities of Porfimer.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00460</drugbank-id>
      <name>Verteporfin</name>
      <description>Riboflavin may increase the photosensitizing activities of Verteporfin.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2.8</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>6.57e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-0.92</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>7,8-dimethyl-10-[(2S,3S,4R)-2,3,4,5-tetrahydroxypentyl]-2H,3H,4H,10H-benzo[g]pteridine-2,4-dione</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>riboflavin</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>376.3639</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>376.138284392</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC1=C(C)C=C2N(C[C@H](O)[C@H](O)[C@H](O)CO)C3=NC(=O)NC(=O)C3=NC2=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C17H20N4O6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C17H20N4O6/c1-7-3-9-10(4-8(7)2)21(5-11(23)14(25)12(24)6-22)15-13(18-9)16(26)20-17(27)19-15/h3-4,11-12,14,22-25H,5-6H2,1-2H3,(H,20,26,27)/t11-,12+,14-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>AUNGANRZJHBGPY-SCRDCRAPSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>155.05</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>96.27</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>37.5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>6.97</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>0.76</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>84.7 mg/L (at 25 °C)</value>
      <source>YALKOWSKY,SH &amp; DANNENFELSER,RM (1992)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>280 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.46</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-3.68</value>
      <source>ADME Research, USCD</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>10.2</value>
      <source>BUDAVARI,S ET AL. (1996)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>11171</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>5021</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>5015</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>17015</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>493570</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46507342</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00255</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00050</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>431981</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50362895</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA451242</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>RBF</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Riboflavin</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1534</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/rib_0263.shtml</url>
    </external-link>
    <external-link>
      <resource>Drugs.com</resource>
      <url>http://www.drugs.com/mtm/riboflavin.html</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP00070</smpdb-id>
      <name>Riboflavin Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00140</drugbank-id>
          <name>Riboflavin</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P14679</uniprot-id>
        <uniprot-id>P22413</uniprot-id>
        <uniprot-id>Q8NFF5</uniprot-id>
        <uniprot-id>P24666</uniprot-id>
        <uniprot-id>Q969G6</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0000370</id>
      <name>Riboflavin kinase</name>
      <organism>Human</organism>
      <actions>
        <action>ligand</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16081269</pubmed-id>
            <citation>Werner R, Manthey KC, Griffin JB, Zempleni J: HepG2 cells develop signs of riboflavin deficiency within 4 days of culture in riboflavin-deficient medium. J Nutr Biochem. 2005 Oct;16(10):617-24.</citation>
          </article>
          <article>
            <pubmed-id>15668000</pubmed-id>
            <citation>Solovieva IM, Kreneva RA, Errais Lopes L, Perumov DA: The riboflavin kinase encoding gene ribR of Bacillus subtilis is a part of a 10 kb operon, which is negatively regulated by the yrzC gene product. FEMS Microbiol Lett. 2005 Feb 1;243(1):51-8.</citation>
          </article>
          <article>
            <pubmed-id>17290783</pubmed-id>
            <citation>Ishchuk OP, Iatsyshyn VIu, Dmytruk KV, Voronovs'kyi AIa, Fedorovych DV, Sybirnyi AA: [Construction of the flavinogenic yeast Candida famata strains with high riboflavin kinase activity using gene engineering]. Ukr Biokhim Zh (1999). 2006 Sep-Oct;78(5):63-9.</citation>
          </article>
          <article>
            <pubmed-id>16183635</pubmed-id>
            <citation>Sandoval FJ, Roje S: An FMN hydrolase is fused to a riboflavin kinase homolog in plants. J Biol Chem. 2005 Nov 18;280(46):38337-45. Epub 2005 Sep 23.</citation>
          </article>
          <article>
            <pubmed-id>16962092</pubmed-id>
            <citation>Bertollo CM, Oliveira AC, Rocha LT, Costa KA, Nascimento EB Jr, Coelho MM: Characterization of the antinociceptive and anti-inflammatory activities of riboflavin in different experimental models. Eur J Pharmacol. 2006 Oct 10;547(1-3):184-91. Epub 2006 Jul 26.</citation>
          </article>
          <article>
            <pubmed-id>21308351</pubmed-id>
            <citation>Hirano G, Izumi H, Yasuniwa Y, Shimajiri S, Ke-Yong W, Sasagiri Y, Kusaba H, Matsumoto K, Hasegawa T, Akimoto M, Akashi K, Kohno K: Involvement of riboflavin kinase expression in cellular sensitivity against cisplatin. Int J Oncol. 2011 Apr;38(4):893-902. doi: 10.3892/ijo.2011.938. Epub 2011 Feb 9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="Q969G6" source="Swiss-Prot">
    <name>Riboflavin kinase</name>
    <general-function>Riboflavin kinase activity</general-function>
    <specific-function>Catalyzes the phosphorylation of riboflavin (vitamin B2) to form flavin-mononucleotide (FMN), hence rate-limiting enzyme in the synthesis of FAD. Essential for TNF-induced reactive oxygen species (ROS) production. Through its interaction with both TNFRSF1A and CYBA, physically and functionally couples TNFRSF1A to NADPH oxidase. TNF-activation of RFK may enhance the incorporation of FAD in NADPH oxidase, a critical step for the assembly and activation of NADPH oxidase.</specific-function>
    <gene-name>RFK</gene-name>
    <locus>9q21.13</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.22</theoretical-pi>
    <molecular-weight>17623.08</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:30324</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>RFK</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AK002011</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>7023634</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q969G6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>RIFK_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.1.26</synonym>
      <synonym>ATP:riboflavin 5'-phosphotransferase</synonym>
      <synonym>Flavokinase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037001|Riboflavin kinase
MRHLPYFCRGQVVRGFGRGSKQLGIPTANFPEQVVDNLPADISTGIYYGWASVGSGDVHK
MVVSIGWNPYYKNTKKSMETHIMHTFKEDFYGEILNVAIVGYLRPEKNFDSLESLISAIQ
GDIEEAKKRLELPEHLKIKEDNFFQVSKSKIMNGH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010118|Riboflavin kinase (RFK)
ATGAGGCACCTGCCTTACTTCTGCCGGGGTCAAGTGGTGCGGGGCTTCGGCCGCGGCTCC
AAGCAGCTGGGCATCCCCACAGCTAATTTTCCTGAGCAAGTGGTAGATAATCTTCCAGCT
GATATATCCACTGGTATTTACTATGGTTGGGCCAGTGTTGGAAGTGGAGATGTCCATAAG
ATGGTGGTGAGCATAGGATGGAACCCATATTACAAGAATACGAAGAAGTCTATGGAAACA
CATATCATGCATACCTTCAAAGAGGACTTCTATGGGGAAATCCTCAATGTGGCCATTGTT
GGCTACCTGAGACCAGAAAAGAACTTTGATTCTTTAGAGTCACTTATTTCAGCAATTCAA
GGTGATATTGAAGAAGCTAAGAAACGACTAGAGTTACCAGAACATTTGAAAATCAAAGAA
GACAATTTCTTCCAGGTTTCTAAAAGCAAAATAATGAATGGCCACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01687</identifier>
        <name>Flavokinase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>riboflavin kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>riboflavin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>reactive oxygen species metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of NAD(P)H oxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>FMN biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>riboflavin biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="2">
      <id>BE0003327</id>
      <name>Riboflavin synthase</name>
      <organism>Escherichia coli (strain K12)</organism>
      <actions>
        <action>other</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>20143812</pubmed-id>
            <citation>Kim RR, Illarionov B, Joshi M, Cushman M, Lee CY, Eisenreich W, Fischer M, Bacher A: Mechanistic insights on riboflavin synthase inspired by selective binding of the 6,7-dimethyl-8-ribityllumazine exomethylene anion. J Am Chem Soc. 2010 Mar 10;132(9):2983-90. doi: 10.1021/ja908395r.</citation>
          </article>
          <article>
            <pubmed-id>20148904</pubmed-id>
            <citation>Long Q, Ji L, Wang H, Xie J: Riboflavin biosynthetic and regulatory factors as potential novel anti-infective drug targets. Chem Biol Drug Des. 2010 Apr;75(4):339-47. doi: 10.1111/j.1747-0285.2010.00946.x. Epub 2010 Feb 8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P0AFU8" source="Swiss-Prot">
    <name>Riboflavin synthase</name>
    <general-function>Riboflavin synthase activity</general-function>
    <specific-function>Catalyzes the dismutation of two molecules of 6,7-dimethyl-8-ribityllumazine, resulting in the formation of riboflavin and 5-amino-6-(D-ribitylamino)uracil.</specific-function>
    <gene-name>ribC</gene-name>
    <locus/>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.88</theoretical-pi>
    <molecular-weight>23444.77</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="83333">Escherichia coli (strain K12)</organism>
    <external-identifiers>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X69109</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P0AFU8</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>RISA_ECOLI</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.9</synonym>
      <synonym>ribE</synonym>
      <synonym>RS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0012326|Riboflavin synthase
MFTGIVQGTAKLVSIDEKPNFRTHVVELPDHMLDGLETGASVAHNGCCLTVTEINGNHVS
FDLMKETLRITNLGDLKVGDWVNVERAAKFSDEIGGHLMSGHIMTTAEVAKILTSENNRQ
IWFKVQDSQLMKYILYKGFIGIDGISLTVGEVTPTRFCVHLIPETLERTTLGKKKLGARV
NIEIDPQTQAVVDTVERVLAARENAMNQPGTEA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0012327|Riboflavin synthase (ribC)
ATGTTTACGGGGATTGTACAGGGCACCGCAAAACTGGTGTCGATTGACGAGAAACCAAAT
TTTCGTACGCATGTGGTGGAGTTACCCGACCACATGCTGGACGGCCTGGAAACCGGTGCT
TCCGTGGCGCATAACGGTTGCTGCCTGACCGTGACGGAAATTAACGGCAACCATGTCAGT
TTTGACCTGATGAAAGAAACGTTACGCATTACCAATCTTGGCGATTTAAAAGTGGGGGAT
TGGGTAAACGTTGAGCGTGCGGCGAAATTCAGTGATGAAATTGGCGGACACTTAATGTCA
GGTCATATTATGACCACTGCTGAAGTGGCGAAAATATTAACCTCAGAAAATAATCGCCAG
ATCTGGTTTAAAGTCCAGGATAGTCAGTTGATGAAATATATTCTGTACAAAGGATTTATT
GGCATCGACGGTATTAGCCTGACCGTCGGCGAAGTCACGCCAACGCGTTTTTGCGTCCAT
TTAATTCCGGAAACACTGGAACGCACGACTCTTGGGAAGAAAAAACTTGGCGCACGCGTC
AACATTGAAATCGATCCACAAACTCAGGCAGTGGTAGATACGGTAGAACGTGTGCTGGCG
GCACGAGAAAATGCCATGAATCAACCAGGCACAGAAGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00677</identifier>
        <name>Lum_binding</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>riboflavin synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>riboflavin biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="4">
      <id>BE0000595</id>
      <name>Flavin reductase (NADPH)</name>
      <organism>Human</organism>
      <actions>
        <action>product of</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>14769034</pubmed-id>
            <citation>Russell TR, Demeler B, Tu SC: Kinetic mechanism and quaternary structure of Aminobacter aminovorans NADH:flavin oxidoreductase: an unusual flavin reductase with bound flavin. Biochemistry. 2004 Feb 17;43(6):1580-90.</citation>
          </article>
          <article>
            <pubmed-id>16544142</pubmed-id>
            <citation>van Pee KH, Patallo EP: Flavin-dependent halogenases involved in secondary metabolism in bacteria. Appl Microbiol Biotechnol. 2006 May;70(6):631-41. Epub 2006 Mar 17.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>yes</known-action>
      <polypeptide id="P30043" source="Swiss-Prot">
    <name>Flavin reductase (NADPH)</name>
    <general-function>Riboflavin reductase (nadph) activity</general-function>
    <specific-function>Broad specificity oxidoreductase that catalyzes the NADPH-dependent reduction of a variety of flavins, such as riboflavin, FAD or FMN, biliverdins, methemoglobin and PQQ (pyrroloquinoline quinone). Contributes to heme catabolism and metabolizes linear tetrapyrroles. Can also reduce the complexed Fe(3+) iron to Fe(2+) in the presence of FMN and NADPH. In the liver, converts biliverdin to bilirubin.</specific-function>
    <gene-name>BLVRB</gene-name>
    <locus>19q13.1-q13.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.76</theoretical-pi>
    <molecular-weight>22119.215</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:1063</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BLVRB</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D26308</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1384068</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P30043</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BLVRB_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.5.1.30</synonym>
      <synonym>Biliverdin reductase B</synonym>
      <synonym>Biliverdin-IX beta-reductase</synonym>
      <synonym>BVR-B</synonym>
      <synonym>FLR</synonym>
      <synonym>FR</synonym>
      <synonym>GHBP</synonym>
      <synonym>Green heme-binding protein</synonym>
      <synonym>NADPH-dependent diaphorase</synonym>
      <synonym>NADPH-flavin reductase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010413|Flavin reductase (NADPH)
MAVKKIAIFGATGQTGLTTLAQAVQAGYEVTVLVRDSSRLPSEGPRPAHVVVGDVLQAAD
VDKTVAGQDAVIVLLGTRNDLSPTTVMSEGARNIVAAMKAHGVDKVVACTSAFLLWDPTK
VPPRLQAVTDDHIRMHKVLRESGLKYVAVMPPHIGDQPLTGAYTVTLDGRGPSRVISKHD
LGHFMLRCLTTDEYDGHSTYPSHQYQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010414|Flavin reductase (NADPH) (BLVRB)
ATGGCCGTCAAGAAGATCGCGATCTTCGGCGCCACTGGCCAGACCGGGCTCACCACCCTG
GCGCAGGCGGTGCAAGCAGGTTACGAAGTGACAGTGCTGGTGCGGGACTCCTCCAGGCTG
CCATCAGAGGGGCCCCGGCCGGCCCACGTGGTAGTGGGAGATGTTCTGCAGGCAGCCGAT
GTGGACAAGACCGTGGCTGGGCAGGACGCTGTCATCGTGCTGCTGGGCACCCGCAATGAC
CTCAGTCCCACGACAGTGATGTCCGAGGGCGCCCGGAACATTGTGGCAGCCATGAAGGCT
CATGGTGTGGACAAGGTCGTGGCCTGCACCTCGGCTTTCCTGCTCTGGGACCCTACCAAG
GTGCCCCCACGACTGCAGGCTGTGACTGATGACCACATCCGGATGCACAAGGTGCTGCGG
GAATCAGGCCTGAAGTACGTGGCTGTGATGCCGCCACACATAGGAGACCAGCCACTAACT
GGGGCGTACACAGTGACCCTGGATGGACGAGGGCCCTCAAGGGTCATCTCCAAACATGAC
CTGGGCCATTTCATGCTGCGCTGCCTCACCACCGATGAGTACGACGGACACAGCACCTAC
CCCTCCCACCAGTACCAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13460</identifier>
        <name>NAD_binding_10</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>biliverdin reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>riboflavin reductase (NADPH) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>porphyrin-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heme catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme>
      <id>BE0002198</id>
      <name>Amine oxidase [flavin-containing] A</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17868200</pubmed-id>
            <citation>Strolin Benedetti M, Tipton KF, Whomsley R: Amine oxidases and monooxygenases in the in vivo metabolism of xenobiotic amines in humans: has the involvement of amine oxidases been neglected? Fundam Clin Pharmacol. 2007 Oct;21(5):467-80.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21397" source="Swiss-Prot">
    <name>Amine oxidase [flavin-containing] A</name>
    <general-function>Serotonin binding</general-function>
    <specific-function>Catalyzes the oxidative deamination of biogenic and xenobiotic amines and has important functions in the metabolism of neuroactive and vasoactive amines in the central nervous system and peripheral tissues. MAOA preferentially oxidizes biogenic amines such as 5-hydroxytryptamine (5-HT), norepinephrine and epinephrine.</specific-function>
    <gene-name>MAOA</gene-name>
    <locus>Xp11.3</locus>
    <cellular-location>Mitochondrion outer membrane</cellular-location>
    <transmembrane-regions>498-518</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.96</theoretical-pi>
    <molecular-weight>59681.27</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6833</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MAOA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M68840</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>187353</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>2489</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P21397</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AOFA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.4.3.4</synonym>
      <synonym>MAO-A</synonym>
      <synonym>Monoamine oxidase type A</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004313|Amine oxidase [flavin-containing] A
MENQEKASIAGHMFDVVVIGGGISGLSAAKLLTEYGVSVLVLEARDRVGGRTYTIRNEHV
DYVDVGGAYVGPTQNRILRLSKELGIETYKVNVSERLVQYVKGKTYPFRGAFPPVWNPIA
YLDYNNLWRTIDNMGKEIPTDAPWEAQHADKWDKMTMKELIDKICWTKTARRFAYLFVNI
NVTSEPHEVSALWFLWYVKQCGGTTRIFSVTNGGQERKFVGGSGQVSERIMDLLGDQVKL
NHPVTHVDQSSDNIIIETLNHEHYECKYVINAIPPTLTAKIHFRPELPAERNQLIQRLPM
GAVIKCMMYYKEAFWKKKDYCGCMIIEDEDAPISITLDDTKPDGSLPAIMGFILARKADR
LAKLHKEIRKKKICELYAKVLGSQEALHPVHYEEKNWCEEQYSGGCYTAYFPPGIMTQYG
RVIRQPVGRIFFAGTETATKWSGYMEGAVEAGERAAREVLNGLGKVTEKDIWVQEPESKD
VPAVEITHTFWERNLPSVSGLLKIIGFSTSVTALGFVLYKYKLLPRS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011589|Amine oxidase [flavin-containing] A (MAOA)
ATGGAGAATCAAGAGAAGGCGAGTATCGCGGGCCACATGTTCGACGTAGTCGTGATCGGA
GGTGGCATTTCAGGACTATCTGCTGCCAAACTCTTGACTGAATATGGCGTTAGTGTTTTG
GTTTTAGAAGCTCGGGACAGGGTTGGAGGAAGAACATATACTATAAGGAATGAGCATGTT
GATTACGTAGATGTTGGTGGAGCTTATGTGGGACCAACCCAAAACAGAATCTTACGCTTG
TCTAAGGAGCTGGGCATAGAGACTTACAAAGTGAATGTCAGTGAGCGTCTCGTTCAATAT
GTCAAGGGGAAAACATATCCATTTCGGGGCGCCTTTCCACCAGTATGGAATCCCATTGCA
TATTTGGATTACAATAATCTGTGGAGGACAATAGATAACATGGGGAAGGAGATTCCAACT
GATGCACCCTGGGAGGCTCAACATGCTGACAAATGGGACAAAATGACCATGAAAGAGCTC
ATTGACAAAATCTGCTGGACAAAGACTGCTAGGCGGTTTGCTTATCTTTTTGTGAATATC
AATGTGACCTCTGAGCCTCACGAAGTGTCTGCCCTGTGGTTCTTGTGGTATGTGAAGCAG
TGCGGGGGCACCACTCGGATATTCTCTGTCACCAATGGTGGCCAGGAACGGAAGTTTGTA
GGTGGATCTGGTCAAGTGAGCGAACGGATAATGGACCTCCTCGGAGACCAAGTGAAGCTG
AACCATCCTGTCACTCACGTTGACCAGTCAAGTGACAACATCATCATAGAGACGCTGAAC
CATGAACATTATGAGTGCAAATACGTAATTAATGCGATCCCTCCGACCTTGACTGCCAAG
ATTCACTTCAGACCAGAGCTTCCAGCAGAGAGAAACCAGTTAATTCAGCGGCTTCCAATG
GGAGCTGTCATTAAGTGCATGATGTATTACAAGGAGGCCTTCTGGAAGAAGAAGGATTAC
TGTGGCTGCATGATCATTGAAGATGAAGATGCTCCAATTTCAATAACCTTGGATGACACC
AAGCCAGATGGGTCACTGCCTGCCATCATGGGCTTCATTCTTGCCCGGAAAGCTGATCGA
CTTGCTAAGCTACATAAGGAAATAAGGAAGAAGAAAATCTGTGAGCTCTATGCCAAAGTG
CTGGGATCCCAAGAAGCTTTACATCCAGTGCATTATGAAGAGAAGAACTGGTGTGAGGAG
CAGTACTCTGGGGGCTGCTACACGGCCTACTTCCCTCCTGGGATCATGACTCAATATGGA
AGGGTGATTCGTCAACCCGTGGGCAGGATTTTCTTTGCGGGCACAGAGACTGCCACAAAG
TGGAGCGGCTACATGGAAGGGGCAGTTGAGGCTGGAGAACGAGCAGCTAGGGAGGTCTTA
AATGGTCTCGGGAAGGTGACCGAGAAAGATATCTGGGTACAAGAACCTGAATCAAAGGAC
GTTCCAGCGGTAGAAATCACCCACACCTTCTGGGAAAGGAACCTGCCCTCTGTTTCTGGC
CTGCTGAAGATCATTGGATTTTCCACATCAGTAACTGCCCTGGGGTTTGTGCTGTACAAA
TACAAGCTCCTGCCACGGTCTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01593</identifier>
        <name>Amino_oxidase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial outer membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serotonin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>primary amine oxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular biogenic amine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phenylethylamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dopamine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>serotonin metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme>
      <id>BE0002176</id>
      <name>Methylenetetrahydrofolate reductase</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>3676170</pubmed-id>
            <citation>Bates CJ, Fuller NJ: The effect of riboflavin deficiency on methylenetetrahydrofolate reductase (NADPH) (EC 1.5.1.20) and folate metabolism in the rat. Br J Nutr. 1986 Mar;55(2):455-64.</citation>
          </article>
          <article>
            <pubmed-id>15454103</pubmed-id>
            <citation>Macdonald HM, McGuigan FE, Fraser WD, New SA, Ralston SH, Reid DM: Methylenetetrahydrofolate reductase polymorphism interacts with riboflavin intake to influence bone mineral density. Bone. 2004 Oct;35(4):957-64.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P42898" source="Swiss-Prot">
    <name>Methylenetetrahydrofolate reductase</name>
    <general-function>Protein complex binding</general-function>
    <specific-function>Catalyzes the conversion of 5,10-methylenetetrahydrofolate to 5-methyltetrahydrofolate, a co-substrate for homocysteine remethylation to methionine.</specific-function>
    <gene-name>MTHFR</gene-name>
    <locus>1p36.3</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.0</theoretical-pi>
    <molecular-weight>74595.895</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7436</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MTHFR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U09806</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6139053</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P42898</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MTHR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.5.1.20</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004270|Methylenetetrahydrofolate reductase
MVNEARGNSSLNPCLEGSASSGSESSKDSSRCSTPGLDPERHERLREKMRRRLESGDKWF
SLEFFPPRTAEGAVNLISRFDRMAAGGPLYIDVTWHPAGDPGSDKETSSMMIASTAVNYC
GLETILHMTCCRQRLEEITGHLHKAKQLGLKNIMALRGDPIGDQWEEEEGGFNYAVDLVK
HIRSEFGDYFDICVAGYPKGHPEAGSFEADLKHLKEKVSAGADFIITQLFFEADTFFRFV
KACTDMGITCPIVPGIFPIQGYHSLRQLVKLSKLEVPQEIKDVIEPIKDNDAAIRNYGIE
LAVSLCQELLASGLVPGLHFYTLNREMATTEVLKRLGMWTEDPRRPLPWALSAHPKRREE
DVRPIFWASRPKSYIYRTQEWDEFPNGRWGNSSSPAFGELKDYYLFYLKSKSPKEELLKM
WGEELTSEESVFEVFVLYLSGEPNRNGHKVTCLPWNDEPLAAETSLLKEELLRVNRQGIL
TINSQPNINGKPSSDPIVGWGPSGGYVFQKAYLEFFTSRETAEALLQVLKKYELRVNYHL
VNVKGENITNAPELQPNAVTWGIFPGREIIQPTVVDPVSFMFWKDEAFALWIERWGKLYE
EESPSRTIIQYIHDNYFLVNLVDNDFPLDNCLWQVVEDTLELLNRPTQNARETEAP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020597|Methylenetetrahydrofolate reductase (MTHFR)
ATGGTGAACGAAGCCAGAGGAAACAGCAGCCTCAACCCCTGCTTGGAGGGCAGTGCCAGC
AGTGGCAGTGAGAGCTCCAAAGATAGTTCGAGATGTTCCACCCCGGGCCTGGACCCCGAG
CGGCATGAGAGACTCCGGGAGAAGATGAGGCGGCGATTGGAATCTGGTGACAAGTGGTTC
TCCCTGGAATTCTTCCCTCCTCGAACTGCTGAGGGAGCTGTCAATCTCATCTCAAGGTTT
GACCGGATGGCAGCAGGTGGCCCCCTCTACATAGACGTGACCTGGCACCCAGCAGGTGAC
CCTGGCTCAGACAAGGAGACCTCCTCCATGATGATCGCCAGCACCGCCGTGAACTACTGT
GGCCTGGAGACCATCCTGCACATGACCTGCTGCCGTCAGCGCCTGGAGGAGATCACGGGC
CATCTGCACAAAGCTAAGCAGCTGGGCCTGAAGAACATCATGGCGCTGCGGGGAGACCCA
ATAGGTGACCAGTGGGAAGAGGAGGAGGGAGGCTTCAACTACGCAGTGGACCTGGTGAAG
CACATCCGAAGTGAGTTTGGTGACTACTTTGACATCTGTGTGGCAGGTTACCCCAAAGGC
CACCCCGAAGCAGGGAGCTTTGAGGCTGACCTGAAGCACTTGAAGGAGAAGGTGTCTGCG
GGAGCCGATTTCATCATCACGCAGCTTTTCTTTGAGGCTGACACATTCTTCCGCTTTGTG
AAGGCATGCACCGACATGGGCATCACTTGCCCCATCGTCCCCGGGATCTTTCCCATCCAG
GGCTACCACTCCCTTCGGCAGCTTGTGAAGCTGTCCAAGCTGGAGGTGCCACAGGAGATC
AAGGACGTGATTGAGCCAATCAAAGACAACGATGCTGCCATCCGCAACTATGGCATCGAG
CTGGCCGTGAGCCTGTGCCAGGAGCTTCTGGCCAGTGGCTTGGTGCCAGGCCTCCACTTC
TACACCCTCAACCGCGAGATGGCTACCACAGAGGTGCTGAAGCGCCTGGGGATGTGGACT
GAGGACCCCAGGCGTCCCCTACCCTGGGCTCTCAGCGCCCACCCCAAGCGCCGAGAGGAA
GATGTACGTCCCATCTTCTGGGCCTCCAGACCAAAGAGTTACATCTACCGTACCCAGGAG
TGGGACGAGTTCCCTAACGGCCGCTGGGGCAATTCCTCTTCCCCTGCCTTTGGGGAGCTG
AAGGACTACTACCTCTTCTACCTGAAGAGCAAGTCCCCCAAGGAGGAGCTGCTGAAGATG
TGGGGGGAGGAGCTGACCAGTGAAGAAAGTGTCTTTGAAGTCTTCGTTCTTTACCTCTCG
GGAGAACCAAACCGGAATGGTCACAAAGTGACTTGCCTGCCCTGGAACGATGAGCCCCTG
GCGGCTGAGACCAGCCTGCTGAAGGAGGAGCTGCTGCGGGTGAACCGCCAGGGCATCCTC
ACCATCAACTCACAGCCCAACATCAACGGGAAGCCGTCCTCCGACCCCATCGTGGGCTGG
GGCCCCAGCGGGGGCTATGTCTTCCAGAAGGCCTACTTAGAGTTTTTCACTTCCCGCGAG
ACAGCGGAAGCACTTCTGCAAGTGCTGAAGAAGTACGAGCTCCGGGTTAATTACCACCTT
GTCAATGTGAAGGGTGAAAACATCACCAATGCCCCTGAACTGCAGCCGAATGCTGTCACT
TGGGGCATCTTCCCTGGGCGAGAGATCATCCAGCCCACCGTAGTGGATCCCGTCAGCTTC
ATGTTCTGGAAGGACGAGGCCTTTGCCCTGTGGATTGAGCGGTGGGGAAAGCTGTATGAG
GAGGAGTCCCCGTCCCGCACCATCATCCAGTACATCCACGACAACTACTTCCTGGTCAAC
CTGGTGGACAATGACTTCCCACTGGACAACTGCCTCTGGCAGGTGGTGGAAGACACATTG
GAGCTTCTCAACAGGCCCACCCAGAATGCGAGAGAAACGGAGGCTCCATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02219</identifier>
        <name>MTHFR</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein complex binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>modified amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methylenetetrahydrofolate reductase (NAD(P)H) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of histone methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heterochromatin maintenance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to vitamin B2</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>homocysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tetrahydrofolate interconversion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood circulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to folic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to interleukin-1</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methionine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>S-adenosylmethionine metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0001066</id>
      <name>Solute carrier family 22 member 6</name>
      <organism>Human</organism>
      <actions>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>9880528</pubmed-id>
            <citation>Kuze K, Graves P, Leahy A, Wilson P, Stuhlmann H, You G: Heterologous expression and functional characterization of a mouse renal organic anion transporter in mammalian cells. J Biol Chem. 1999 Jan 15;274(3):1519-24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q4U2R8" source="Swiss-Prot">
    <name>Solute carrier family 22 member 6</name>
    <general-function>Sodium-independent organic anion transmembrane transporter activity</general-function>
    <specific-function>Involved in the renal elimination of endogenous and exogenous organic anions. Functions as organic anion exchanger when the uptake of one molecule of organic anion is coupled with an efflux of one molecule of endogenous dicarboxylic acid (glutarate, ketoglutarate, etc). Mediates the sodium-independent uptake of 2,3-dimercapto-1-propanesulfonic acid (DMPS) (By similarity). Mediates the sodium-independent uptake of p-aminohippurate (PAH), ochratoxin (OTA), acyclovir (ACV), 3'-azido-3-'deoxythymidine (AZT), cimetidine (CMD), 2,4-dichloro-phenoxyacetate (2,4-D), hippurate (HA), indoleacetate (IA), indoxyl sulfate (IS) and 3-carboxy-4-methyl-5-propyl-2-furanpropionate (CMPF), cidofovir, adefovir, 9-(2-phosphonylmethoxyethyl) guanine (PMEG), 9-(2-phosphonylmethoxyethyl) diaminopurine (PMEDAP) and edaravone sulfate. PAH uptake is inhibited by p-chloromercuribenzenesulphonate (PCMBS), diethyl pyrocarbonate (DEPC), sulindac, diclofenac, carprofen, glutarate and okadaic acid (By similarity). PAH uptake is inhibited by benzothiazolylcysteine (BTC), S-chlorotrifluoroethylcysteine (CTFC), cysteine S-conjugates S-dichlorovinylcysteine (DCVC), furosemide, steviol, phorbol 12-myristate 13-acetate (PMA), calcium ionophore A23187, benzylpenicillin, furosemide, indomethacin, bumetamide, losartan, probenecid, phenol red, urate, and alpha-ketoglutarate.</specific-function>
    <gene-name>SLC22A6</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>10-30
136-156
165-187
191-213
225-245
249-269
338-358
369-389
396-416
426-446
456-475
485-505</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.78</theoretical-pi>
    <molecular-weight>61815.78</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10970</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>hROAT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF057039</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3831566</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1025</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q4U2R8</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>S22A6_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>hOAT1</synonym>
      <synonym>hPAHT</synonym>
      <synonym>hROAT1</synonym>
      <synonym>OAT1</synonym>
      <synonym>Organic anion transporter 1</synonym>
      <synonym>PAH transporter</synonym>
      <synonym>PAHT</synonym>
      <synonym>Renal organic anion transporter 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037120|Solute carrier family 22 member 6
MAFNDLLQQVGGVGRFQQIQVTLVVLPLLLMASHNTLQNFTAAIPTHHCRPPADANLSKN
GGLEVWLPRDRQGQPESCLRFTSPQWGLPFLNGTEANGTGATEPCTDGWIYDNSTFPSTI
VTEWDLVCSHRALRQLAQSLYMVGVLLGAMVFGYLADRLGRRKVLILNYLQTAVSGTCAA
FAPNFPIYCAFRLLSGMALAGISLNCMTLNVEWMPIHTRACVGTLIGYVYSLGQFLLAGV
AYAVPHWRHLQLLVSAPFFAFFIYSWFFIESARWHSSSGRLDLTLRALQRVARINGKREE
GAKLSMEVLRASLQKELTMGKGQASAMELLRCPTLRHLFLCLSMLWFATSFAYYGLVMDL
QGFGVSIYLIQVIFGAVDLPAKLVGFLVINSLGRRPAQMAALLLAGICILLNGVIPQDQS
IVRTSLAVLGKGCLAASFNCIFLYTGELYPTMIRQTGMGMGSTMARVGSIVSPLVSMTAE
LYPSMPLFIYGAVPVAASAVTVLLPETLGQPLPDTVQDLESRWAPTQKEAGIYPRKGKQT
RQQQEHQKYMVPLQASAQEKNGL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010747|Solute carrier family 22 member 6 (SLC22A6)
ATGGCCTTTAATGACCTCCTGCAGCAGGTGGGGGGTGTCGGCCGCTTCCAGCAGATCCAG
GTCACCCTGGTGGTCCTCCCCCTGCTCCTGATGGCTTCTCACAACACCCTGCAGAACTTC
ACTGCTGCCATCCCTACCCACCACTGCCGCCCGCCTGCCGATGCCAACCTCAGCAAGAAC
GGGGGGCTGGAGGTCTGGCTGCCCCGGGACAGGCAGGGGCAGCCTGAGTCCTGCCTCCGC
TTCACCTCCCCGCAGTGGGGACTGCCCTTTCTCAATGGCACAGAAGCCAATGGCACAGGG
GCCACAGAGCCCTGCACCGATGGCTGGATCTATGACAACAGCACCTTCCCATCTACCATC
GTGACTGAGTGGGACCTTGTGTGCTCTCACAGGGCCCTACGCCAGCTGGCCCAGTCCTTG
TACATGGTGGGGGTGCTGCTCGGAGCCATGGTGTTCGGCTACCTTGCAGACAGGCTAGGC
CGCCGGAAGGTACTCATCTTGAACTACCTGCAGACAGCTGTGTCAGGGACCTGCGCAGCC
TTCGCACCCAACTTCCCCATCTACTGCGCCTTCCGGCTCCTCTCGGGCATGGCTCTGGCT
GGCATCTCCCTCAACTGCATGACACTGAATGTGGAGTGGATGCCCATTCACACACGGGCC
TGCGTGGGCACCTTGATTGGCTATGTCTACAGCCTGGGCCAGTTCCTCCTGGCTGGTGTG
GCCTACGCTGTGCCCCACTGGCGCCACCTGCAGCTACTGGTCTCTGCGCCTTTTTTTGCC
TTCTTCATCTACTCCTGGTTCTTCATTGAGTCGGCCCGCTGGCACTCCTCCTCCGGGAGG
CTGGACCTCACCCTGAGGGCCCTGCAGAGAGTCGCCCGGATCAATGGGAAGCGGGAAGAA
GGAGCCAAATTGAGTATGGAGGTACTCCGGGCCAGTCTGCAGAAGGAGCTGACCATGGGC
AAAGGCCAGGCATCGGCCATGGAGCTGCTGCGCTGCCCCACCCTCCGCCACCTCTTCCTC
TGCCTCTCCATGCTGTGGTTTGCCACTAGCTTTGCATACTATGGGCTGGTCATGGACCTG
CAGGGCTTTGGAGTCAGCATCTACCTAATCCAGGTGATCTTTGGTGCTGTGGACCTGCCT
GCCAAGCTTGTGGGCTTCCTTGTCATCAACTCCCTGGGTCGCCGGCCTGCCCAGATGGCT
GCACTGCTGCTGGCAGGCATCTGCATCCTGCTCAATGGGGTGATACCCCAGGACCAGTCC
ATTGTCCGAACCTCTCTTGCTGTGCTGGGGAAGGGTTGTCTGGCTGCCTCCTTCAACTGC
ATCTTCCTGTATACTGGGGAACTGTATCCCACAATGATCCGGCAGACAGGCATGGGAATG
GGCAGCACCATGGCCCGAGTGGGCAGCATCGTGAGCCCACTGGTGAGCATGACTGCCGAG
CTCTACCCCTCCATGCCTCTCTTCATCTACGGTGCTGTTCCTGTGGCCGCCAGCGCTGTC
ACTGTCCTCCTGCCAGAGACCCTGGGCCAGCCACTGCCAGACACGGTGCAGGACCTGGAG
AGCAGGTGGGCCCCCACTCAGAAAGAAGCAGGGATATATCCCAGGAAAGGGAAACAGACG
CGACAGCAACAAGAGCACCAGAAGTATATGGTCCCACTGCAGGCCTCAGCACAAGAGAAG
AATGGACTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00083</identifier>
        <name>Sugar_tr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>caveola</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>protein complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>inorganic anion exchanger activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium-independent organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>chloride ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>anion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alpha-ketoglutarate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>renal tubular secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to methotrexate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homooligomerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sodium-independent organic anion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organic anion transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00141</drugbank-id>
  <drugbank-id>NUTR00040</drugbank-id>
  <name>N-Acetylglucosamine</name>
  <description>The N-acetyl derivative of glucosamine.</description>
  <cas-number>7512-17-6</cas-number>
  <unii>V956696549</unii>
  <average-mass>221.2078</average-mass>
  <monoisotopic-mass>221.089937217</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Naoko Yamano, Shizu Fujishima, Ryutarou Tanaka, "N-acetyl-D-glucosamine deacetylase and a process for preparing the same." U.S. Patent USH00014532, issued October, 1993.</synthesis-reference>
  <indication>For the treatment and prevention of osteoarthritis, by itself or in combination with chondroitin sulfate.</indication>
  <pharmacodynamics/>
  <mechanism-of-action>The mechanism of action in relieving arthritic pain and in repair of cartilage is a matter of speculation. Biochemically, glucosamine is involved in glycoprotein metabolism. Glycoproteins, known as proteoglycans, form the ground substance in the extra-cellular matrix of connective tissue. Proteoglycans are polyanionic substances of high-molecular weight and contain many different types of heteropolysaccharide side-chains covalently linked to a polypeptide-chain backbone. These polysaccharides make up to 95% of the proteoglycan structure. In fact, chemically, proteoglycans resemble polysaccharides more than they do proteins. The polysaccharide groups in proteoglycans are called glycosaminoglycans (GAGs). GAGs include hyaluronic acid, chondroitin sulfate, dermatan sulfate, keratan sulfate, heparin and heparan sulfate. All of the GAGs contain derivatives of glucosamine or galactosamine. Glucosamine derivatives are found in hyaluronic acid, keratan sulfate and heparan sulfate. Chondroitin sulfate contains derivatives of galactosamine. The glucosamine-containing glycosaminoglycan hyaluronic acid is vital for the function of articular cartilage. GAG chains are fundamental components of aggrecan found in articular cartilage. Aggrecan confers upon articular cartilage shock-absorbing properties. It does this by providing cartilage with a swelling pressure that is restrained by the tensile forces of collagen fibers. This balance confers upon articular cartilage the deformable resilience vital to its function. In the early stages of degenerative joint disease, aggrecan biosynthesis is increased. However, in later stages, aggrecan synthesis is decreased, leading eventually to the loss of cartilage resiliency and to most of the symptoms that accompany osteoarthritis. During the progression of osteoarthritis, exogenous glucosamine may have a beneficial role. It is known that, in vitro, chondrocytes do synthesize more aggregan when the culture medium is supplemented with glucosamine. N-acetylglucosamine is found to be less effective in these in vitro studies. Glucosamine has also been found to have antioxidant activity and to be beneficial in animal models of experimental arthritis. The counter anion of the glucosamine salt (i.e. chloride or sulfate) is unlikely to play any role in the action or pharmacokinetics of glucosamine. Further, the sulfate in glucosamine sulfate supplements should not be confused with the glucosamine sulfate found in such GAGs as keratan sulfate and heparan sulfate. In the case of the supplement, sulfate is the anion of the salt. In the case of the above GAGs, sulfate is present as an ester. Also, there is no glucosamine sulfate in chondroitin sulfate (source: PDRhealth).</mechanism-of-action>
  <toxicity>Mouse, intravenous LD&lt;sub&gt;50&lt;/sub&gt; is 4170 mg/kg. Side effects that have been reported are mainly mild gastrointestinal complaints such as heartburn, epigastric distress and diarrhea. No allergic reactions have been reported including sulfa-allergic reactions to glucosamine sulfate.</toxicity>
  <metabolism>A significant fraction of ingested glucosamine is catabolized by first-pass metabolism in the liver.</metabolism>
  <absorption>Approximately 90% of orally administered glucosamine (salt form) gets absorbed from the small intestine.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as hexoses. These are monosaccharides in which the sugar unit is a is a six-carbon containing moeity.</description>
    <direct-parent>Hexoses</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Organic oxygen compounds</class>
    <subclass>Organooxygen compounds</subclass>
    <alternative-parent>Acetamides</alternative-parent>
    <alternative-parent>Aminosaccharides</alternative-parent>
    <alternative-parent>Beta-hydroxy aldehydes</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organonitrogen compounds</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Polyols</alternative-parent>
    <alternative-parent>Primary alcohols</alternative-parent>
    <alternative-parent>Secondary alcohols</alternative-parent>
    <alternative-parent>Secondary carboxylic acid amides</alternative-parent>
    <substituent>Acetamide</substituent>
    <substituent>Alcohol</substituent>
    <substituent>Aldehyde</substituent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Amino saccharide</substituent>
    <substituent>Beta-hydroxy aldehyde</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxamide group</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Hexose monosaccharide</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Polyol</substituent>
    <substituent>Primary alcohol</substituent>
    <substituent>Secondary alcohol</substituent>
    <substituent>Secondary carboxylic acid amide</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">2-Acetamido-2-deoxy-D-glucose</synonym>
    <synonym language="" coder="">aldehydo-N-acetyl-D-glucosamine</synonym>
    <synonym language="" coder="">D-GlcNAc</synonym>
    <synonym language="" coder="">N-Acetyl-D-glucosamine</synonym>
    <synonym language="" coder="">N-Acetylchitosamine</synonym>
  </synonyms>
  <products/>
  <international-brands>
    <international-brand>
      <name>Aflexa</name>
      <company/>
    </international-brand>
    <international-brand>
      <name>GS-500</name>
      <company/>
    </international-brand>
    <international-brand>
      <name>Maxi GS</name>
      <company/>
    </international-brand>
    <international-brand>
      <name>Natures Blend Glucosamine</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures/>
  <packagers>
    <packager>
      <name>Gallipot</name>
      <url>http://www.gallipot.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Acetyl-d-glucosamine powder</description>
      <cost currency="USD">3.75</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Sugars</category>
      <mesh-id>D000606</mesh-id>
    </category>
    <category>
      <category>Carbohydrates</category>
      <mesh-id>D002241</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Glucosamine</category>
      <mesh-id>D005944</mesh-id>
    </category>
    <category>
      <category>Hexosamines</category>
      <mesh-id>D006595</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages/>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1XHG</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00141.pdf?1265922751</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-2.1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.18</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>1.48e+02 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>N-[(2R,3R,4S,5R)-3,4,5,6-tetrahydroxy-1-oxohexan-2-yl]acetamide</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>N acetylglucosamine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>221.2078</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>221.089937217</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>[H]C(=O)[C@H](NC(C)=O)[C@@H](O)[C@H](O)[C@H](O)CO</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C8H15NO6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C8H15NO6/c1-4(12)9-5(2-10)7(14)8(15)6(13)3-11/h2,5-8,11,13-15H,3H2,1H3,(H,9,12)/t5-,6+,7+,8+/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>MBLBDJOUHNCFQT-LXGUWJNJSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>127.09</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>48.45</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>20.49</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>11.56</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-1.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>205 °C</value>
      <source/>
    </property>
    <property>
      <kind>logP</kind>
      <value>-2.1</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>17411</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>1738118</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46509139</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00140</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>1376695</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50223349</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164752287</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>NAG</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000872</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL447878</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/glu_0122.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP00240</smpdb-id>
      <name>Salla Disease/Infantile Sialic Acid Storage Disease</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00217</smpdb-id>
      <name>Sialuria or French Type Sialuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00045</smpdb-id>
      <name>Amino Sugar Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00390</smpdb-id>
      <name>Tay-Sachs Disease</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00216</smpdb-id>
      <name>Sialuria or French Type Sialuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00534</smpdb-id>
      <name>G(M2)-Gangliosidosis: Variant B, Tay-sachs disease</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002262</id>
      <name>Beta-1,4-galactosyltransferase 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60512" source="Swiss-Prot">
    <name>Beta-1,4-galactosyltransferase 3</name>
    <general-function>N-acetyllactosamine synthase activity</general-function>
    <specific-function>Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.</specific-function>
    <gene-name>B4GALT3</gene-name>
    <locus>1q21-q23</locus>
    <cellular-location>Golgi apparatus</cellular-location>
    <transmembrane-regions>11-31</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.45</theoretical-pi>
    <molecular-weight>43927.63</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:926</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>B4GALT3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y12509</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2982510</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60512</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>B4GT3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.1.-</synonym>
      <synonym>Beta-1,4-GalTase 3</synonym>
      <synonym>UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 3</synonym>
      <synonym>UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004440|Beta-1,4-galactosyltransferase 3
MLRRLLERPCTLALLVGSQLAVMMYLSLGGFRSLSALFGRDQGPTFDYSHPRDVYSNLSH
LPGAPGGPPAPQGLPYCPERSPLLVGPVSVSFSPVPSLAEIVERNPRVEPGGRYRPAGCE
PRSRTAIIVPHRAREHHLRLLLYHLHPFLQRQQLAYGIYVIHQAGNGTFNRAKLLNVGVR
EALRDEEWDCLFLHDVDLLPENDHNLYVCDPRGPRHVAVAMNKFGYSLPYPQYFGGVSAL
TPDQYLKMNGFPNEYWGWGGEDDDIATRVRLAGMKISRPPTSVGHYKMVKHRGDKGNEEN
PHRFDLLVRTQNSWTQDGMNSLTYQLLARELGPLYTNITADIGTDPRGPRAPSGPRYPPG
SSQAFRQEMLQRRPPARPGPLSTANHTALRGSH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011629|Beta-1,4-galactosyltransferase 3 (B4GALT3)
ATGTTGCGGAGGCTGCTGGAGCGGCCTTGCACGCTGGCCCTGCTTGTGGGCTCCCAGCTG
GCTGTCATGATGTACCTGTCACTGGGGGGCTTCCGAAGTCTCAGTGCCCTATTTGGCCGA
GATCAGGGACCGACATTTGACTATTCTCACCCTCGTGATGTCTACAGTAACCTCAGTCAC
CTGCCTGGGGCCCCAGGGGGTCCTCCAGCTCCTCAAGGTCTGCCCTACTGTCCAGAACGA
TCTCCTCTCTTAGTGGGTCCTGTGTCGGTGTCCTTTAGCCCAGTGCCATCACTGGCAGAG
ATTGTGGAGCGGAATCCCCGGGTAGAACCAGGGGGCCGGTACCGCCCTGCAGGTTGTGAG
CCCCGCTCCCGAACAGCCATCATTGTGCCTCATCGTGCCCGGGAGCACCACCTGCGCCTG
CTGCTCTACCACCTGCACCCCTTCTTGCAGCGCCAGCAGCTTGCTTATGGCATCTATGTC
ATCCACCAGGCTGGAAATGGAACATTTAACAGGGCAAAACTGTTGAACGTTGGGGTGCGA
GAGGCCCTGCGTGATGAAGAGTGGGACTGCCTGTTCTTGCACGATGTGGACCTCTTGCCA
GAAAATGACCACAATCTGTATGTGTGTGACCCCCGGGGACCCCGCCATGTTGCCGTTGCT
ATGAACAAGTTTGGATACAGCCTCCCGTACCCCCAGTACTTCGGAGGAGTCTCAGCACTT
ACTCCTGACCAGTACCTGAAGATGAATGGCTTCCCCAATGAATACTGGGGCTGGGGTGGT
GAGGATGACGACATTGCTACCAGGGTGCGCCTGGCTGGGATGAAGATCTCTCGGCCCCCC
ACATCTGTAGGACACTATAAGATGGTGAAGCACCGAGGAGATAAGGGCAATGAGGAAAAT
CCCCACAGATTTGACCTCCTGGTCCGTACCCAGAATTCCTGGACGCAAGATGGGATGAAC
TCACTGACATACCAGTTGCTGGCTCGAGAGCTGGGGCCTCTTTATACCAACATCACAGCA
GACATTGGGACTGACCCTCGGGGTCCTCGGGCTCCTTCTGGGCCACGTTACCCACCTGGT
TCCTCCCAAGCCTTCCGTCAAGAGATGCTGCAACGCCGGCCCCCAGCCAGGCCTGGGCCT
CTATCTACTGCCAACCACACAGCCCTCCGAGGTTCACACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02709</identifier>
        <name>Glyco_transf_7C</name>
      </pfam>
      <pfam>
        <identifier>PF13733</identifier>
        <name>Glyco_transf_7N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi cisterna membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetyllactosamine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation via asparagine</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002263</id>
      <name>Beta-1,4-galactosyltransferase 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11948877</pubmed-id>
            <citation>Bulter T, Schumacher T, Namdjou DJ, Gutierrez Gallego R, Clausen H, Elling L: Chemoenzymatic synthesis of biotinylated nucleotide sugars as substrates for glycosyltransferases. Chembiochem. 2001 Dec 3;2(12):884-94.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60513" source="Swiss-Prot">
    <name>Beta-1,4-galactosyltransferase 4</name>
    <general-function>N-acetyllactosamine synthase activity</general-function>
    <specific-function>Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.</specific-function>
    <gene-name>B4GALT4</gene-name>
    <locus>3q13.3</locus>
    <cellular-location>Golgi apparatus</cellular-location>
    <transmembrane-regions>13-38</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.42</theoretical-pi>
    <molecular-weight>40040.865</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:927</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>B4GALT4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF038662</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3132900</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60513</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>B4GT4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.1.-</synonym>
      <synonym>Beta-1,4-GalTase 4</synonym>
      <synonym>UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 4</synonym>
      <synonym>UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011630|Beta-1,4-galactosyltransferase 4
MGFNLTFHLSYKFRLLLLLTLCLTVVGWATSNYFVGAIQEIPKAKEFMANFHKTLILGKG
KTLTNEASTKKVELDNCPSVSPYLRGQSKLIFKPDLTLEEVQAENPKVSRGRYRPQECKA
LQRVAILVPHRNREKHLMYLLEHLHPFLQRQQLDYGIYVIHQAEGKKFNRAKLLNVGYLE
ALKEENWDCFIFHDVDLVPENDFNLYKCEEHPKHLVVGRNSTGYRLRYSGYFGGVTALSR
EQFFKVNGFSNNYWGWGGEDDDLRLRVELQRMKISRPLPEVGKYTMVFHTRDKGNEVNAE
RMKLLHQVSRVWRTDGLSSCSYKLVSVEHNPLYINITVDFWFGA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011631|Beta-1,4-galactosyltransferase 4 (B4GALT4)
ATGGGCTTCAACCTGACTTTCCACCTTTCCTACAAATTCCGATTACTGTTGCTGTTGACT
TTGTGCCTGACAGTGGTTGGGTGGGCCACCAGTAACTACTTCGTGGGTGCCATTCAAGAG
ATTCCTAAAGCAAAGGAGTTCATGGCTAATTTCCATAAGACCCTCATTTTGGGGAAGGGA
AAAACTCTGACTAATGAAGCATCCACGAAGAAGGTAGAACTTGACAACTGCCCTTCTGTG
TCTCCTTACCTCAGAGGCCAGAGCAAGCTCATTTTCAAACCAGATCTCACTTTGGAAGAG
GTACAGGCAGAAAATCCCAAAGTGTCCAGAGGCCGGTATCGCCCTCAGGAATGTAAAGCT
TTACAGAGGGTCGCCATCCTCGTTCCCCACCGGAACAGAGAGAAACACCTGATGTACCTG
CTGGAACATCTGCATCCCTTCCTGCAGAGGCAGCAGCTGGATTATGGCATCTACGTCATC
CACCAGGCTGAAGGTAAAAAGTTTAATCGAGCCAAACTCTTGAATGTGGGCTATCTAGAA
GCCCTCAAGGAAGAAAATTGGGACTGCTTTATATTCCACGATGTGGACCTGGTACCCGAG
AATGACTTTAACCTTTACAAGTGTGAGGAGCATCCCAAGCATCTGGTGGTTGGCAGGAAC
AGCACTGGGTACAGGTTACGTTACAGTGGATATTTTGGGGGTGTTACTGCCCTAAGCAGA
GAGCAGTTTTTCAAGGTGAATGGATTCTCTAACAACTACTGGGGATGGGGAGGCGAAGAC
GATGACCTCAGACTCAGGGTTGAGCTCCAAAGAATGAAAATTTCCCGGCCCCTGCCTGAA
GTGGGTAAATATACAATGGTCTTCCACACTAGAGACAAAGGCAATGAGGTGAACGCAGAA
CGGATGAAGCTCTTACACCAAGTGTCACGAGTCTGGAGAACAGATGGGTTGAGTAGTTGT
TCTTATAAATTAGTATCTGTGGAACACAATCCTTTATATATCAACATCACAGTGGATTTC
TGGTTTGGTGCATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02709</identifier>
        <name>Glyco_transf_7C</name>
      </pfam>
      <pfam>
        <identifier>PF13733</identifier>
        <name>Glyco_transf_7N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi cisterna membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetyllactosamine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation via asparagine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002264</id>
      <name>Beta-1,4-galactosyltransferase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60909" source="Swiss-Prot">
    <name>Beta-1,4-galactosyltransferase 2</name>
    <general-function>N-acetyllactosamine synthase activity</general-function>
    <specific-function>Responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids. Can produce lactose.</specific-function>
    <gene-name>B4GALT2</gene-name>
    <locus>1p34-p33</locus>
    <cellular-location>Golgi apparatus</cellular-location>
    <transmembrane-regions>16-36</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.66</theoretical-pi>
    <molecular-weight>41971.815</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:925</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>B4GALT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y12510</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2995442</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60909</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>B4GT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.1.-</synonym>
      <synonym>Beta-1,4-GalTase 2</synonym>
      <synonym>UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 2</synonym>
      <synonym>UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004444|Beta-1,4-galactosyltransferase 2
MSRLLGGTLERVCKAVLLLCLLHFLVAVILYFDVYAQHLAFFSRFSARGPAHALHPAASS
SSSSSNCSRPNATASSSGLPEVPSALPGPTAPTLPPCPDSPPGLVGRLLIEFTSPMPLER
VQRENPGVLMGGRYTPPDCTPAQTVAVIIPFRHREHHLRYWLHYLHPILRRQRLRYGVYV
INQHGEDTFNRAKLLNVGFLEALKEDAAYDCFIFSDVDLVPMDDRNLYRCGDQPRHFAIA
MDKFGFRLPYAGYFGGVSGLSKAQFLRINGFPNEYWGWGGEDDDIFNRISLTGMKISRPD
IRIGRYRMIKHDRDKHNEPNPQRFTKIQNTKLTMKRDGIGSVRYQVLEVSRQPLFTNITV
DIGRPPSWPPRG</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021320|Beta-1,4-galactosyltransferase 2 (B4GALT2)
ATGAGCAGACTGCTGGGGGGGACGCTGGAGCGCGTCTGCAAGGCTGTGCTCCTTCTCTGC
CTGCTGCACTTCCTCGTGGCCGTCATCCTCTACTTTGACGTCTACGCCCAGCACCTGGCC
TTCTTCAGCCGCTTCAGTGCCCGAGGCCCTGCCCATGCCCTCCACCCAGCTGCTAGCAGC
AGCAGCAGCAGCAGCAACTGCTCCCGGCCCAACGCCACCGCCTCTAGCTCCGGGCTCCCT
GAGGTCCCCAGTGCCCTGCCCGGTCCCACGGCTCCCACGCTGCCACCCTGTCCTGACTCG
CCACCTGGTCTTGTGGGCAGACTGCTGATCGAGTTCACCTCACCCATGCCCCTGGAGCGG
GTGCAGAGGGAGAACCCAGGCGTGCTCATGGGCGGCCGATACACACCGCCCGACTGCACC
CCAGCCCAGACGGTGGCGGTCATCATCCCCTTTAGACACCGGGAACACCACCTGCGCTAC
TGGCTCCACTATCTACACCCCATCTTGAGGCGGCAGCGGCTGCGCTACGGCGTCTATGTC
ATCAACCAGCATGGTGAGGACACCTTCAACCGGGCCAAGCTGCTTAACGTGGGCTTCCTA
GAGGCGCTGAAGGAGGATGCCGCCTATGACTGCTTCATCTTCAGCGATGTGGACCTGGTC
CCCATGGATGACCGCAACCTATACCGCTGCGGCGACCAACCCCGCCACTTTGCCATTGCC
ATGGACAAGTTTGGCTTCCGGCTTCCCTATGCTGGCTACTTTGGAGGTGTGTCAGGCCTG
AGTAAGGCTCAGTTTCTGAGAATCAATGGCTTCCCCAATGAGTACTGGGGCTGGGGTGGC
GAGGATGATGACATCTTCAACCGGATCTCCCTGACTGGGATGAAGATCTCACGCCCAGAC
ATCCGAATCGGCCGCTACCGCATGATCAAGCACGACCGCGACAAGCATAACGAACCTAAC
CCTCAGAGGTTTACCAAGATTCAAAACACGAAGCTGACCATGAAGCGGGACGGCATTGGG
TCAGTGCGGTACCAGGTCTTGGAGGTGTCTCGGCAACCACTCTTCACCAATATCACAGTG
GACATTGGGCGGCCTCCGTCGTGGCCCCCTCGGGGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02709</identifier>
        <name>Glyco_transf_7C</name>
      </pfam>
      <pfam>
        <identifier>PF13733</identifier>
        <name>Glyco_transf_7N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi cisterna membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lactose synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetyllactosamine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation via asparagine</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002265</id>
      <name>N-acetyl-D-glucosamine kinase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17010375</pubmed-id>
            <citation>Weihofen WA, Berger M, Chen H, Saenger W, Hinderlich S: Structures of human N-Acetylglucosamine kinase in two complexes with N-Acetylglucosamine and with ADP/glucose: insights into substrate specificity and regulation. J Mol Biol. 2006 Dec 1;364(3):388-99. Epub 2006 Sep 3.</citation>
          </article>
          <article>
            <pubmed-id>15489439</pubmed-id>
            <citation>Uehara T, Park JT: The N-acetyl-D-glucosamine kinase of Escherichia coli and its role in murein recycling. J Bacteriol. 2004 Nov;186(21):7273-9.</citation>
          </article>
          <article>
            <pubmed-id>16674097</pubmed-id>
            <citation>An HJ, Kim DS, Park YK, Kim SK, Choi YP, Kang S, Ding B, Cho NH: Comparative proteomics of ovarian epithelial tumors. J Proteome Res. 2006 May;5(5):1082-90.</citation>
          </article>
          <article>
            <pubmed-id>16857666</pubmed-id>
            <citation>Yang C, Rodionov DA, Li X, Laikova ON, Gelfand MS, Zagnitko OP, Romine MF, Obraztsova AY, Nealson KH, Osterman AL: Comparative genomics and experimental characterization of N-acetylglucosamine utilization pathway of Shewanella oneidensis. J Biol Chem. 2006 Oct 6;281(40):29872-85. Epub 2006 Jul 20.</citation>
          </article>
          <article>
            <pubmed-id>17229727</pubmed-id>
            <citation>Nishimasu H, Fushinobu S, Shoun H, Wakagi T: Crystal structures of an ATP-dependent hexokinase with broad substrate specificity from the hyperthermophilic archaeon Sulfolobus tokodaii. J Biol Chem. 2007 Mar 30;282(13):9923-31. Epub 2007 Jan 17.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UJ70" source="Swiss-Prot">
    <name>N-acetyl-D-glucosamine kinase</name>
    <general-function>N-acylmannosamine kinase activity</general-function>
    <specific-function>Converts endogenous N-acetylglucosamine (GlcNAc), a major component of complex carbohydrates, from lysosomal degradation or nutritional sources into GlcNAc 6-phosphate. Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded. Also has ManNAc kinase activity.</specific-function>
    <gene-name>NAGK</gene-name>
    <locus>2p13.3</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.18</theoretical-pi>
    <molecular-weight>37375.305</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17174</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NAGK</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ242910</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6491737</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UJ70</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NAGK_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.1.59</synonym>
      <synonym>GlcNAc kinase</synonym>
      <synonym>N-acetylglucosamine kinase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004446|N-acetyl-D-glucosamine kinase
MAAIYGGVEGGGTRSEVLLVSEDGKILAEADGLSTNHWLIGTDKCVERINEMVNRAKRKA
GVDPLVPLRSLGLSLSGGDQEDAGRILIEELRDRFPYLSESYLITTDAAGSIATATPDGG
VVLISGTGSNCRLINPDGSESGCGGWGHMMGDEGSAYWIAHQAVKIVFDSIDNLEAAPHD
IGYVKQAMFHYFQVPDRLGILTHLYRDFDKCRFAGFCRKIAEGAQQGDPLSRYIFRKAGE
MLGRHIVAVLPEIDPVLFQGKIGLPILCVGSVWKSWELLKEGFLLALTQGREIQAQNFFS
SFTLMKLRHSSALGGASLGARHIGHLLPMDYSANAIAFYSYTFS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016735|N-acetyl-D-glucosamine kinase (NAGK)
ATGCGCACGCGCACAGGGAGTCAGCTGGCTGCGCGGGAGGTCACGGGAAGTGGGGCGGTG
CCCAGACAGCTGGAGGGAAGGAGGTGTCAGGCGGGGAGAGACGCAAACGGCGGGACCAGC
AGCGACGGTAGCAGCAGCATGGCCGCGATCTATGGGGGTGTAGAGGGGGGAGGCACACGA
TCCGAGGTCCTTTTAGTCTCAGAGGATGGGAAGATCCTGGCAGAAGCAGATGGACTGAGC
ACAAACCACTGGCTGATCGGGACAGACAAGTGTGTGGAGAGGATCAATGAGATGGTGAAC
AGGGCCAAACGGAAAGCAGGGGTGGATCCTCTGGTACCGCTGCGAAGCTTGGGCCTATCT
CTGAGCGGTGGGGACCAGGAGGACGCGGGGAGGATCCTGATCGAGGAGCTGAGGGACCGA
TTTCCCTACCTGAGTGAAAGCTACTTAATCACCACCGATGCCGCCGGCTCCATCGCCACA
GCTACACCGGATGGTGGAGTTGTGCTCATATCTGGAACAGGCTCCAACTGCAGGCTCATC
AACCCTGATGGCTCCGAGAGTGGCTGCGGCGGCTGGGGCCATATGATGGGTGATGAGGGT
TCAGCCTACTGGATCGCACACCAAGCAGTGAAAATAGTGTTTGACTCCATTGACAACCTA
GAGGCGGCTCCTCATGATATCGGCTACGTCAAACAGGCCATGTTCCACTATTTCCAGGTG
CCAGATCGGCTAGGGATACTCACTCACCTGTATAGGGACTTTGATAAATGCAGGTTTGCT
GGGTTTTGCCGGAAAATTGCAGAAGGTGCTCAGCAGGGAGACCCCCTTTCCCGCTATATC
TTCAGGAAGGCTGGGGAGATGCTGGGCAGACACATCGTAGCAGTGTTGCCCGAGATTGAC
CCGGTCTTGTTCCAGGGCAAGATTGGACTCCCCATCCTGTGCGTGGGCTCTGTGTGGAAG
AGCTGGGAGCTGCTGAAGGAAGGTTTTCTTCTGGCGCTGACCCAGGGCAGAGAGATCCAG
GCTCAGAACTTCTTCTCCAGCTTCACCCTGATGAAGCTGAGGCACTCCTCCGCTCTGGGT
GGGGCCAGCCTAGGGGCCAGGCACATCGGGCACCTCCTCCCCATGGACTATAGCGCCAAT
GCCATTGCCTTCTATTCCTACACCTTTTCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01869</identifier>
        <name>BcrAD_BadFG</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetylglucosamine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acylmannosamine kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylglucosamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylmannosamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylneuraminate catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002266</id>
      <name>N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>8294420</pubmed-id>
            <citation>Mullis KG, Huynh M, Kornfeld RH: Purification and kinetic parameters of bovine liver N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase. J Biol Chem. 1994 Jan 21;269(3):1718-26.</citation>
          </article>
          <article>
            <pubmed-id>17927214</pubmed-id>
            <citation>Chavez CA, Bohnsack RN, Kudo M, Gotschall RR, Canfield WM, Dahms NM: Domain 5 of the cation-independent mannose 6-phosphate receptor preferentially binds phosphodiesters (mannose 6-phosphate N-acetylglucosamine ester). Biochemistry. 2007 Nov 6;46(44):12604-17. Epub 2007 Oct 10.</citation>
          </article>
          <article>
            <pubmed-id>9722550</pubmed-id>
            <citation>Kornfeld R, Bao M, Brewer K, Noll C, Canfield WM: Purification and multimeric structure of bovine N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase. J Biol Chem. 1998 Sep 4;273(36):23203-10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UK23" source="Swiss-Prot">
    <name>N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase</name>
    <general-function>N-acetylglucosamine-1-phosphodiester alpha-n-acetylglucosaminidase activity</general-function>
    <specific-function>Catalyzes the second step in the formation of the mannose 6-phosphate targeting signal on lysosomal enzyme oligosaccharides by removing GlcNAc residues from GlcNAc-alpha-P-mannose moieties, which are formed in the first step. Also hydrolyzes UDP-GlcNAc, a sugar donor for Golgi N-acetylglucosaminyltransferases.</specific-function>
    <gene-name>NAGPA</gene-name>
    <locus>16p13.3</locus>
    <cellular-location>Golgi apparatus</cellular-location>
    <transmembrane-regions>449-469</transmembrane-regions>
    <signal-regions>1-25</signal-regions>
    <theoretical-pi>6.7</theoretical-pi>
    <molecular-weight>56072.49</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17378</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NAGPA</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF187072</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6425040</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UK23</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NAGPA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.4.45</synonym>
      <synonym>Mannose 6-phosphate-uncovering enzyme</synonym>
      <synonym>Phosphodiester alpha-GlcNAcase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037182|N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase
MATSTGRWLLLRLALFGFLWEASGGLDSGASRDDDLLLPYPRARARLPRDCTRVRAGNRE
HESWPPPPATPGAGGLAVRTFVSHFRDRAVAGHLTRAVEPLRTFSVLEPGGPGGCAARRR
ATVEETARAADCRVAQNGGFFRMNSGECLGNVVSDERRVSSSGGLQNAQFGIRRDGTLVT
GYLSEEEVLDTENPFVQLLSGVVWLIRNGSIYINESQATECDETQETGSFSKFVNVISAR
TAIGHDRKGQLVLFHADGQTEQRGINLWEMAEFLLKQDVVNAINLDGGGSATFVLNGTLA
SYPSDHCQDNMWRCPRQVSTVVCVHEPRCQPPDCHGHGTCVDGHCQCTGHFWRGPGCDEL
DCGPSNCSQHGLCTETGCRCDAGWTGSNCSEECPLGWHGPGCQRPCKCEHHCPCDPKTGN
CSVSRVKQCLQPPEATLRAGELSFFTRTAWLALTLALAFLLLISTAANLSLLLSRAERNR
RLHGDYAYHPLQEMNGEPLAAEKEQPGGAHNPFKD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011632|N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase (NAGPA)
ATGGCGACCTCCACGGGTCGCTGGCTTCTCCTCCGGCTTGCACTATTCGGCTTCCTCTGG
GAAGCGTCCGGCGGCCTCGACTCGGGGGCCTCCCGCGACGACGACTTGCTACTGCCCTAT
CCACGCGCGCGCGCGCGCCTCCCCCGGGACTGCACACGGGTGCGCGCCGGCAACCGCGAG
CACGAGAGTTGGCCTCCGCCTCCCGCGACTCCCGGCGCCGGCGGTCTGGCCGTGCGCACC
TTCGTGTCGCACTTCAGGGACCGCGCGGTGGCCGGCCACCTGACGCGGGCCGTTGAGCCC
CTGCGCACCTTCTCGGTGCTGGAGCCCGGTGGACCCGGCGGCTGCGCGGCGAGACGACGC
GCCACCGTGGAGGAGACGGCGCGGGCGGCCGACTGCCGTGTCGCCCAGAACGGCGGCTTC
TTCCGCATGAACTCGGGCGAGTGCCTGGGGAACGTGGTGAGCGACGAGCGGCGGGTGAGC
AGCTCCGGGGGGCTGCAGAACGCGCAGTTCGGGATCCGCCGCGACGGGACCCTGGTCACC
GGGTACCTGTCTGAGGAGGAGGTGCTGGACACTGAGAACCCATTTGTGCAGCTGCTGAGT
GGGGTCGTGTGGCTGATTCGTAATGGAAGCATCTACATCAACGAGAGCCAAGCCACAGAG
TGTGACGAGACACAGGAGACAGGTTCCTTTAGCAAATTTGTGAATGTGATATCAGCCAGG
ACGGCCATTGGCCACGACCGGAAAGGGCAGCTGGTGCTCTTTCATGCAGACGGCCAAACG
GAGCAGCGTGGCATCAACCTGTGGGAAATGGCGGAGTTCCTGCTGAAACAGGACGTGGTC
AACGCCATCAACCTGGATGGGGGTGGCTCTGCCACCTTTGTGCTCAACGGGACCTTGGCC
AGTTACCCGTCAGATCACTGCCAGGACAACATGTGGCGCTGTCCCCGCCAAGTGTCCACC
GTGGTGTGTGTGCACGAACCCCGCTGCCAGCCGCCTGACTGCCACGGCCACGGGACCTGC
GTGGACGGGCACTGCCAATGCACCGGGCACTTCTGGCGGGGTCCCGGCTGTGATGAGCTG
GACTGTGGCCCCTCTAACTGCAGCCAGCACGGACTGTGCACGGAGACCGGCTGCCGCTGT
GATGCCGGATGGACCGGGTCCAACTGCAGTGAAGAGTGTCCCCTTGGCTGGCATGGGCCG
GGCTGCCAGAGGCCTTGTAAGTGTGAGCACCATTGTCCCTGTGACCCCAAGACTGGCAAC
TGCAGCGTCTCCAGAGTAAAGCAGTGTCTCCAGCCACCTGAAGCCACCCTGAGGGCGGGA
GAACTCTCCTTTTTCACCAGGACCGCCTGGCTAGCCCTCACCCTGGCGCTGGCCTTCCTC
CTGCTGATCAGCACTGCAGCAAACCTGTCCTTGCTCCTGTCCAGAGCAGAGAGGAACCGG
CGCCTGCATGGGGACTATGCATACCACCCGCTGCAGGAGATGAACGGGGAGCCTCTGGCC
GCAGAGAAGGAGCAGCCAGGGGGCGCCCACAACCCCTTCAAGGACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF09992</identifier>
        <name>DUF2233</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi cisterna membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetylglucosamine-1-phosphodiester alpha-N-acetylglucosaminidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein modification process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lysosome organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein glycosylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein targeting to lysosome</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000391</id>
      <name>Alpha-N-acetylglucosaminidase</name>
      <organism>Human</organism>
      <actions>
        <action>activator</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>15112051</pubmed-id>
            <citation>Spiro RG: Role of N-linked polymannose oligosaccharides in targeting glycoproteins for endoplasmic reticulum-associated degradation. Cell Mol Life Sci. 2004 May;61(9):1025-41.</citation>
          </article>
          <article>
            <pubmed-id>16349528</pubmed-id>
            <citation>Nogawa M, Takahashi H, Kashiwagi A, Ohshima K, Okada H, Morikawa Y: Purification and Characterization of Exo-beta-d-Glucosaminidase from a Cellulolytic Fungus, Trichoderma reesei PC-3-7. Appl Environ Microbiol. 1998 Mar;64(3):890-5.</citation>
          </article>
          <article>
            <pubmed-id>15932346</pubmed-id>
            <citation>Vishu Kumar AB, Varadaraj MC, Gowda LR, Tharanathan RN: Characterization of chito-oligosaccharides prepared by chitosanolysis with the aid of papain and Pronase, and their bactericidal action against Bacillus cereus and Escherichia coli. Biochem J. 2005 Oct 15;391(Pt 2):167-75.</citation>
          </article>
          <article>
            <pubmed-id>17414423</pubmed-id>
            <citation>Zou L, Yang S, Hu S, Chaudry IH, Marchase RB, Chatham JC: The protective effects of PUGNAc on cardiac function after trauma-hemorrhage are mediated via increased protein O-GlcNAc levels. Shock. 2007 Apr;27(4):402-8.</citation>
          </article>
          <article>
            <pubmed-id>17576230</pubmed-id>
            <citation>Shirazi F, Kulkarni M, Deshpande MV: A rapid and sensitive method for screening of chitinase inhibitors using Ostazin Brilliant Red labelled chitin as a substrate for chitinase assay. Lett Appl Microbiol. 2007 Jun;44(6):660-5.</citation>
          </article>
          <article>
            <pubmed-id>11752352</pubmed-id>
            <citation>Chen X, Ji ZL, Chen YZ: TTD: Therapeutic Target Database. Nucleic Acids Res. 2002 Jan 1;30(1):412-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P54802" source="Swiss-Prot">
    <name>Alpha-N-acetylglucosaminidase</name>
    <general-function>Alpha-n-acetylglucosaminidase activity</general-function>
    <specific-function>Involved in the degradation of heparan sulfate.</specific-function>
    <gene-name>NAGLU</gene-name>
    <locus>17q21</locus>
    <cellular-location>Lysosome</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-23</signal-regions>
    <theoretical-pi>6.52</theoretical-pi>
    <molecular-weight>82264.92</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7632</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NAGLU</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U43572</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1171229</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P54802</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ANAG_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.2.1.50</synonym>
      <synonym>N-acetyl-alpha-glucosaminidase</synonym>
      <synonym>NAG</synonym>
      <synonym>UFHSD1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016076|Alpha-N-acetylglucosaminidase
MEAVAVAAAVGVLLLAGAGGAAGDEAREAAAVRALVARLLGPGPAADFSVSVERALAAKP
GLDTYSLGGGGAARVRVRGSTGVAAAAGLHRYLRDFCGCHVAWSGSQLRLPRPLPAVPGE
LTEATPNRYRYYQNVCTQSYSFVWWDWARWEREIDWMALNGINLALAWSGQEAIWQRVYL
ALGLTQAEINEFFTGPAFLAWGRMGNLHTWDGPLPPSWHIKQLYLQHRVLDQMRSFGMTP
VLPAFAGHVPEAVTRVFPQVNVTKMGSWGHFNCSYSCSFLLAPEDPIFPIIGSLFLRELI
KEFGTDHIYGADTFNEMQPPSSEPSYLAAATTAVYEAMTAVDTEAVWLLQGWLFQHQPQF
WGPAQIRAVLGAVPRGRLLVLDLFAESQPVYTRTASFQGQPFIWCMLHNFGGNHGLFGAL
EAVNGGPEAARLFPNSTMVGTGMAPEGISQNEVVYSLMAELGWRKDPVPDLAAWVTSFAA
RRYGVSHPDAGAAWRLLLRSVYNCSGEACRGHNRSPLVRRPSLQMNTSIWYNRSDVFEAW
RLLLTSAPSLATSPAFRYDLLDLTRQAVQELVSLYYEEARSAYLSKELASLLRAGGVLAY
ELLPALDEVLASDSRFLLGSWLEQARAAAVSEAEADFYEQNSRYQLTLWGPEGNILDYAN
KQLAGLVANYYTPRWRLFLEALVDSVAQGIPFQQHQFDKNVFQLEQAFVLSKQRYPSQPR
GDTVDLAKKIFLKYYPRWVAGSW</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016077|Alpha-N-acetylglucosaminidase (NAGLU)
ATGGAGGCGGTGGCGGTGGCCGCGGCGGTGGGGGTCCTTCTCCTGGCCGGGGCCGGGGGC
GCGGCAGGCGACGAGGCCCGGGAGGCGGCGGCCGTGCGGGCGCTCGTGGCCCGGCTGCTG
GGGCCAGGCCCCGCGGCCGACTTCTCCGTGTCGGTGGAGCGCGCTCTGGCTGCCAAGCCG
GGCTTGGACACCTACAGCCTGGGCGGCGGCGGCGCGGCGCGCGTGCGGGTGCGCGGCTCC
ACGGGCGTGGCGGCCGCCGCGGGGCTGCACCGCTACCTGCGCGACTTCTGTGGCTGCCAC
GTGGCCTGGTCCGGCTCTCAGCTGCGCCTGCCGCGGCCACTGCCAGCCGTGCCGGGGGAG
CTGACCGAGGCCACGCCCAACAGGTACCGCTATTACCAGAATGTGTGCACGCAAAGCTAC
TCTTTCGTGTGGTGGGACTGGGCCCGCTGGGAGCGAGAGATAGACTGGATGGCGCTGAAT
GGCATCAACCTGGCACTGGCCTGGAGCGGCCAGGAGGCCATCTGGCAGCGGGTGTACCTG
GCCTTGGGCCTGACCCAGGCAGAGATCAATGAGTTCTTTACTGGTCCTGCCTTCCTGGCC
TGGGGGCGAATGGGCAACCTGCACACCTGGGATGGCCCCCTGCCCCCCTCCTGGCACATC
AAGCAGCTTTACCTGCAGCACCGGGTCCTGGACCAGATGCGCTCCTTCGGCATGACCCCA
GTGCTGCCTGCATTCGCGGGGCATGTTCCCGAGGCTGTCACCAGGGTGTTCCCTCAGGTC
AATGTCACGAAGATGGGCAGTTGGGGCCACTTTAACTGTTCCTACTCCTGCTCCTTCCTT
CTGGCTCCGGAAGACCCCATATTCCCCATCATCGGGAGCCTCTTCCTGCGAGAGCTGATC
AAAGAGTTTGGCACAGACCACATCTATGGGGCCGACACTTTCAATGAGATGCAGCCACCT
TCCTCAGAGCCCTCCTACCTTGCCGCAGCCACCACTGCCGTCTATGAGGCCATGACTGCA
GTGGATACTGAGGCTGTGTGGCTGCTCCAAGGCTGGCTCTTCCAGCACCAGCCGCAGTTC
TGGGGGCCCGCCCAGATCAGGGCTGTGCTGGGAGCTGTGCCCCGTGGCCGCCTCCTGGTT
CTGGACCTGTTTGCTGAGAGCCAGCCTGTGTATACCCGCACTGCCTCCTTCCAGGGCCAG
CCCTTCATCTGGTGCATGCTGCACAACTTTGGGGGAAACCATGGTCTTTTTGGAGCCCTA
GAGGCTGTGAACGGAGGCCCAGAAGCTGCCCGCCTCTTCCCCAACTCCACCATGGTAGGC
ACGGGCATGGCCCCCGAGGGCATCAGCCAGAACGAAGTGGTCTATTCCCTCATGGCTGAG
CTGGGCTGGCGAAAGGACCCAGTGCCAGATTTGGCAGCCTGGGTGACCAGCTTTGCCGCC
CGGCGGTATGGGGTCTCCCACCCGGACGCAGGGGCAGCGTGGAGGCTACTGCTCCGGAGT
GTGTACAACTGCTCCGGGGAGGCCTGCAGGGGCCACAATCGTAGCCCGCTGGTCAGGCGG
CCGTCCCTACAGATGAATACCAGCATCTGGTACAACCGATCTGATGTGTTTGAGGCCTGG
CGGCTGCTGCTCACATCTGCTCCCTCCCTGGCCACCAGCCCCGCCTTCCGCTACGACCTG
CTGGACCTCACTCGGCAGGCAGTGCAGGAGCTGGTCAGCTTGTACTATGAGGAGGCAAGA
AGCGCCTACCTGAGCAAGGAGCTGGCCTCCCTGTTGAGGGCTGGAGGCGTCCTGGCCTAT
GAGCTGCTGCCGGCACTGGACGAGGTGCTGGCTAGTGACAGCCGCTTCTTGCTGGGCAGC
TGGCTAGAGCAGGCCCGAGCAGCGGCAGTCAGTGAGGCCGAGGCCGATTTCTACGAGCAG
AACAGCCGCTACCAGCTGACCTTGTGGGGGCCAGAAGGCAACATCCTGGACTATGCCAAC
AAGCAGCTGGCGGGGTTGGTGGCCAACTACTACACCCCTCGCTGGCGGCTTTTCCTGGAG
GCGCTGGTTGACAGTGTGGCCCAGGGCATCCCTTTCCAACAGCACCAGTTTGACAAAAAT
GTCTTCCAACTGGAGCAGGCCTTCGTTCTCAGCAAGCAGAGGTACCCCAGCCAGCCGCGA
GGAGACACTGTGGACCTGGCCAAGAAGATCTTCCTCAAATATTACCCCCGCTGGGTGGCC
GGCTCTTGGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05089</identifier>
        <name>NAGLU</name>
      </pfam>
      <pfam>
        <identifier>PF12972</identifier>
        <name>NAGLU_C</name>
      </pfam>
      <pfam>
        <identifier>PF12971</identifier>
        <name>NAGLU_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>lysosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>lysosomal lumen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>alpha-N-acetylglucosaminidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>retinal rod cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>locomotor rhythm</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>middle ear morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lysosome organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cerebellar Purkinje cell layer development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>inner ear receptor cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000109</id>
      <name>N-acylglucosamine 2-epimerase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17292397</pubmed-id>
            <citation>Lee YC, Wu HM, Chang YN, Wang WC, Hsu WH: The central cavity from the (alpha/alpha)6 barrel structure of Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase contains two key histidine residues for reversible conversion. J Mol Biol. 2007 Mar 30;367(3):895-908. Epub 2006 Nov 6.</citation>
          </article>
          <article>
            <pubmed-id>17349707</pubmed-id>
            <citation>Lee YC, Chien HC, Hsu WH: Production of N-acetyl-D-neuraminic acid by recombinant whole cells expressing Anabaena sp. CH1 N-acetyl-D-glucosamine 2-epimerase and Escherichia coli N-acetyl-D-neuraminic acid lyase. J Biotechnol. 2007 May 1;129(3):453-60. Epub 2007 Feb 9.</citation>
          </article>
          <article>
            <pubmed-id>16011304</pubmed-id>
            <citation>Takahashi S, Ogasawara H, Hiwatashi K, Hata K, Hori K, Koizumi Y, Sugiyama T: Amino acid residues conferring the nucleotide binding properties of N-acetyl-D-glucosamine 2-epimerase (renin binding protein). Biomed Res. 2005 Jun;26(3):117-21.</citation>
          </article>
          <article>
            <pubmed-id>17565386</pubmed-id>
            <citation>Ferrero MA, Martinez-Blanco H, Lopez-Velasco FF, Ezquerro-Saenz C, Navasa N, Lozano S, Rodriguez-Aparicio LB: Purification and characterization of GlcNAc-6-P 2-epimerase from Escherichia coli K92. Acta Biochim Pol. 2007;54(2):387-99. Epub 2007 Jun 14.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P51606" source="Swiss-Prot">
    <name>N-acylglucosamine 2-epimerase</name>
    <general-function>N-acylglucosamine 2-epimerase activity</general-function>
    <specific-function>Catalyzes the interconversion of N-acetylglucosamine to N-acetylmannosamine. Binds to renin forming a protein complex called high molecular weight (HMW) renin and inhibits renin activity. Involved in the N-glycolylneuraminic acid (Neu5Gc) degradation pathway: although human is not able to catalyze formation of Neu5Gc due to the inactive CMAHP enzyme, Neu5Gc is present in food and must be degraded.</specific-function>
    <gene-name>RENBP</gene-name>
    <locus>Xq28</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.2</theoretical-pi>
    <molecular-weight>48830.6</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9959</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>RENBP</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D10232</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>220053</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P51606</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>RENBP_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>5.1.3.8</synonym>
      <synonym>AGE</synonym>
      <synonym>GlcNAc 2-epimerase</synonym>
      <synonym>N-acetyl-D-glucosamine 2-epimerase</synonym>
      <synonym>Renin-binding protein</synonym>
      <synonym>RnBP</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036951|N-acylglucosamine 2-epimerase
MSKGLPARQDMEKERETLQAWKERVGQELDRVVAFWMEHSHDQEHGGFFTCLGREGRVYD
DLKYVWLQGRQVWMYCRLYRTFERFRHAQLLDAAKAGGEFLLRYARVAPPGKKCAFVLTR
DGRPVKVQRTIFSECFYTMAMNELWRATGEVRYQTEAVEMMDQIVHWVQEDASGLGRPQL
QGAPAAEPMAVPMMLLNLVEQLGEADEELAGKYAELGDWCARRILQHVQRDGQAVLENVS
EGGKELPGCLGRQQNPGHTLEAGWFLLRHCIRKGDPELRAHVIDKFLLLPFHSGWDPDHG
GLFYFQDADNFCPTQLEWAMKLWWPHSEAMIAFLMGYSDSGDPVLLRLFYQVAEYTFRQF
RDPEYGEWFGYLSREGKVALSIKGGPFKGCFHVPRCLAMCEEMLGALLSRPAPAPSPAPT
PACRGAE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010166|N-acylglucosamine 2-epimerase (RENBP)
ATGAGCAAGGGTCTCCCAGCGCGACAGGACATGGAGAAAGAGCGAGAGACTCTGCAGGCC
TGGAAGGAGCGCGTGGGGCAGGAGCTGGACCGCGTGGTGGCTTTCTGGATGGAGCACTCC
CACGACCAGGAGCACGGGGGCTTCTTCACGTGCCTTGGCCGCGAGGGGCGGGTGTATGAT
GACCTCAAGTATGTGTGGCTGCAGGGGAGGCAGGTATGGATGTATTGTCGCCTGTACCGC
ACTTTCGAGCGCTTCCGCCATGCTCAGCTTCTGGACGCAGCAAAAGCAGGTGGTGAGTTC
TTGCTGCGGTATGCCCGGGTGGCACCTCCTGGCAAGAAGTGTGCCTTTGTGCTGACTCGG
GACGGCCGCCCGGTCAAGGTGCAGCGAACCATCTTCAGTGAGTGTTTCTACACCATGGCC
ATGAACGAGCTGTGGAGAGCCACAGGGGAAGTGCGGTACCAGACGGAAGCGGTGGAGATG
ATGGATCAGATCGTCCACTGGGTGCAGGAGGACGCGTCGGGACTGGGCCGGCCCCAGCTC
CAGGGGGCCCCGGCTGCGGAGCCCATGGCGGTGCCCATGATGCTACTGAACCTGGTGGAG
CAGCTCGGGGAGGCAGATGAGGAGCTGGCGGGCAAATACGCAGAGCTGGGGGACTGGTGC
GCCCGGAGGATTCTGCAGCACGTGCAGAGGGATGGACAAGCTGTGCTGGAGAATGTGTCA
GAGGGTGGCAAGGAACTTCCTGGCTGCCTGGGGAGACAGCAGAACCCAGGCCACACGCTG
GAAGCCGGCTGGTTTCTGCTCCGTCATTGCATTCGGAAAGGCGACCCCGAACTTCGAGCC
CACGTGATTGACAAGTTCCTATTGTTGCCCTTCCACTCCGGATGGGACCCTGACCACGGA
GGCCTCTTTTACTTCCAGGATGCTGATAACTTCTGCCCCACCCAGCTGGAGTGGGCCATG
AAGCTCTGGTGGCCACACAGTGAAGCCATGATTGCCTTCCTCATGGGTTACAGTGACAGT
GGGGACCCTGTGCTGCTGCGCCTCTTCTACCAAGTGGCTGAGTACACCTTCCGCCAGTTT
CGCGATCCCGAGTACGGGGAATGGTTTGGCTACCTGAGCCGAGAGGGCAAGGTGGCCCTC
TCCATCAAGGGAGGTCCTTTCAAAGGCTGCTTCCACGTGCCGCGGTGCCTAGCCATGTGC
GAGGAGATGCTGGGCGCCCTGCTGAGCCGCCCCGCCCCCGCCCCCTCCCCCGCCCCCACC
CCCGCCTGCCGAGGCGCGGAATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07221</identifier>
        <name>GlcNAc_2-epim</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>endopeptidase inhibitor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acylglucosamine 2-epimerase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of blood pressure</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylglucosamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylmannosamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>N-acetylneuraminate catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000259</id>
      <name>Beta-1,4-galactosyltransferase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>15736931</pubmed-id>
            <citation>Ramakrishnan B, Boeggeman E, Qasba PK: Mutation of arginine 228 to lysine enhances the glucosyltransferase activity of bovine beta-1,4-galactosyltransferase I. Biochemistry. 2005 Mar 8;44(9):3202-10.</citation>
          </article>
          <article>
            <pubmed-id>16157350</pubmed-id>
            <citation>Ramasamy V, Ramakrishnan B, Boeggeman E, Ratner DM, Seeberger PH, Qasba PK: Oligosaccharide preferences of beta1,4-galactosyltransferase-I: crystal structures of Met340His mutant of human beta1,4-galactosyltransferase-I with a pentasaccharide and trisaccharides of the N-glycan moiety. J Mol Biol. 2005 Oct 14;353(1):53-67.</citation>
          </article>
          <article>
            <pubmed-id>17370997</pubmed-id>
            <citation>Boeggeman E, Ramakrishnan B, Kilgore C, Khidekel N, Hsieh-Wilson LC, Simpson JT, Qasba PK: Direct identification of nonreducing GlcNAc residues on N-glycans of glycoproteins using a novel chemoenzymatic method. Bioconjug Chem. 2007 May-Jun;18(3):806-14. Epub 2007 Mar 20.</citation>
          </article>
          <article>
            <pubmed-id>17203585</pubmed-id>
            <citation>Hidalgo A, Burgos V, Viola H, Medina J, Argibay P: Differential expression of glycans in the hippocampus of rats trained on an inhibitory learning paradigm. Neuropathology. 2006 Dec;26(6):501-7.</citation>
          </article>
          <article>
            <pubmed-id>15449940</pubmed-id>
            <citation>Ramakrishnan B, Boeggeman E, Qasba PK: Effect of the Met344His mutation on the conformational dynamics of bovine beta-1,4-galactosyltransferase: crystal structure of the Met344His mutant in complex with chitobiose. Biochemistry. 2004 Oct 5;43(39):12513-22.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15291" source="Swiss-Prot">
    <name>Beta-1,4-galactosyltransferase 1</name>
    <general-function>Udp-galactosyltransferase activity</general-function>
    <specific-function>The Golgi complex form catalyzes the production of lactose in the lactating mammary gland and could also be responsible for the synthesis of complex-type N-linked oligosaccharides in many glycoproteins as well as the carbohydrate moieties of glycolipids.The cell surface form functions as a recognition molecule during a variety of cell to cell and cell to matrix interactions, as those occurring during development and egg fertilization, by binding to specific oligosaccharide ligands on opposing cells or in the extracellular matrix.</specific-function>
    <gene-name>B4GALT1</gene-name>
    <locus>9p13</locus>
    <cellular-location>Golgi apparatus</cellular-location>
    <transmembrane-regions>25-44</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.77</theoretical-pi>
    <molecular-weight>43919.895</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:924</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>B4GALT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X14085</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>29424</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P15291</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>B4GT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.4.1.-</synonym>
      <synonym>Beta-1,4-GalTase 1</synonym>
      <synonym>GGTB2</synonym>
      <synonym>UDP-Gal:beta-GlcNAc beta-1,4-galactosyltransferase 1</synonym>
      <synonym>UDP-galactose:beta-N-acetylglucosamine beta-1,4-galactosyltransferase 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000517|Beta-1,4-galactosyltransferase 1
MRLREPLLSGSAAMPGASLQRACRLLVAVCALHLGVTLVYYLAGRDLSRLPQLVGVSTPL
QGGSNSAAAIGQSSGELRTGGARPPPPLGASSQPRPGGDSSPVVDSGPGPASNLTSVPVP
HTTALSLPACPEESPLLVGPMLIEFNMPVDLELVAKQNPNVKMGGRYAPRDCVSPHKVAI
IIPFRNRQEHLKYWLYYLHPVLQRQQLDYGIYVINQAGDTIFNRAKLLNVGFQEALKDYD
YTCFVFSDVDLIPMNDHNAYRCFSQPRHISVAMDKFGFSLPYVQYFGGVSALSKQQFLTI
NGFPNNYWGWGGEDDDIFNRLVFRGMSISRPNAVVGRCRMIRHSRDKKNEPNPQRFDRIA
HTKETMLSDGLNSLTYQVLDVQRYPLYTQITVDIGTPS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010224|Beta-1,4-galactosyltransferase 1 (B4GALT1)
ATGAGGCTTCGGGAGCCGCTCCTGAGCGGCAGCGCCGCGATGCCAGGCGCGTCCCTACAG
CGGGCCTGCCGCCTGCTCGTGGCCGTCTGCGCTCTGCACCTTGGCGTCACCCTCGTTTAC
TACCTGGCTGGCCGCGACCTGAGCCGCCTGCCCCAACTGGTCGGAGTCTCCACACCGCTG
CAGGGCGGCTCGAACAGTGCCGCCGCCATCGGGCAGTCCTCCGGGGAGCTCCGGACCGGA
GGGGCCCGGCCGCCGCCTCCTCTAGGCGCCTCCTCCCAGCCGCGCCCGGGTGGCGACTCC
AGCCCAGTCGTGGATTCTGGCCCTGGCCCCGCTAGCAACTTGACCTCGGTCCCAGTGCCC
CACACCACCGCACTGTCGCTGCCCGCCTGCCCTGAGGAGTCCCCGCTGCTTGTGGGCCCC
ATGCTGATTGAGTTTAACATGCCTGTGGACCTGGAGCTCGTGGCAAAGCAGAACCCAAAT
GTGAAGATGGGCGGCCGCTATGCCCCCAGGGACTGCGTCTCTCCTCACAAGGTGGCCATC
ATCATTCCATTCCGCAACCGGCAGGAGCACCTCAAGTACTGGCTATATTATTTGCACCCA
GTCCTGCAGCGCCAGCAGCTGGACTATGGCATCTATGTTATCAACCAGGCGGGAGACACT
ATATTCAATCGTGCTAAGCTCCTCAATGTTGGCTTTCAAGAAGCCTTGAAGGACTATGAC
TACACCTGCTTTGTGTTTAGTGACGTGGACCTCATTCCAATGAATGACCATAATGCGTAC
AGGTGTTTTTCACAGCCACGGCACATTTCCGTTGCAATGGATAAGTTTGGATTCAGCCTA
CCTTATGTTCAGTATTTTGGAGGTGTCTCTGCTCTAAGTAAACAACAGTTTCTAACCATC
AATGGATTTCCTAATAATTATTGGGGCTGGGGAGGAGAAGATGATGACATTTTTAACAGA
TTAGTTTTTAGAGGCATGTCTATATCTCGCCCAAATGCTGTGGTCGGGAGGTGTCGCATG
ATCCGCCACTCAAGAGACAAGAAAAATGAACCCAATCCTCAGAGGTTTGACCGAATTGCA
CACACAAAGGAGACAATGCTCTCTGATGGTTTGAACTCACTCACCTACCAGGTGCTGGAT
GTACAGAGATACCCATTGTATACCCAAATCACAGTGGACATCGGGACACCGAGCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02709</identifier>
        <name>Glyco_transf_7C</name>
      </pfam>
      <pfam>
        <identifier>PF13733</identifier>
        <name>Glyco_transf_7N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>desmosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>filopodium</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>glycocalyx</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi trans cisterna</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>brush border membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi cisterna membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>external side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>manganese ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>alpha-tubulin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>beta-tubulin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lactose synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>N-acetyllactosamine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>UDP-galactosyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>angiogenesis involved in wound healing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organism reproduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>binding of sperm to zona pellucida</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oligosaccharide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branching morphogenesis of an epithelial tube</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>penetration of zona pellucida</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>development of secondary sexual characteristics</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of apoptotic process involved in mammary gland involution</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation via asparagine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of epithelial cell proliferation involved in wound healing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>galactose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of acrosome reaction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cellular component movement</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>keratan sulfate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>acute inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>single fertilization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell adhesion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lactose biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Notch signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mammary gland development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00142</drugbank-id>
  <drugbank-id>NUTR00027</drugbank-id>
  <name>Glutamic Acid</name>
  <description>A peptide that is a homopolymer of glutamic acid.</description>
  <cas-number>56-86-0</cas-number>
  <unii>3KX376GY7L</unii>
  <average-mass>147.1293</average-mass>
  <monoisotopic-mass>147.053157781</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>10736373</pubmed-id>
        <citation>Smith QR: Transport of glutamate and other amino acids at the blood-brain barrier. J Nutr. 2000 Apr;130(4S Suppl):1016S-22S.</citation>
      </article>
      <article>
        <pubmed-id>15939876</pubmed-id>
        <citation>Okumoto S, Looger LL, Micheva KD, Reimer RJ, Smith SJ, Frommer WB: Detection of glutamate release from neurons by genetically encoded surface-displayed FRET nanosensors. Proc Natl Acad Sci U S A. 2005 Jun 14;102(24):8740-5. Epub 2005 Jun 6.</citation>
      </article>
      <article>
        <pubmed-id>10736365</pubmed-id>
        <citation>Reeds PJ, Burrin DG, Stoll B, Jahoor F: Intestinal glutamate metabolism. J Nutr. 2000 Apr;130(4S Suppl):978S-82S.</citation>
      </article>
      <article>
        <pubmed-id>7901400</pubmed-id>
        <citation>Corrie JE, DeSantis A, Katayama Y, Khodakhah K, Messenger JB, Ogden DC, Trentham DR: Postsynaptic activation at the squid giant synapse by photolytic release of L-glutamate from a 'caged' L-glutamate. J Physiol. 1993 Jun;465:1-8.</citation>
      </article>
      <article>
        <pubmed-id>17202478</pubmed-id>
        <citation>Augustin H, Grosjean Y, Chen K, Sheng Q, Featherstone DE: Nonvesicular release of glutamate by glial xCT transporters suppresses glutamate receptor clustering in vivo. J Neurosci. 2007 Jan 3;27(1):111-23.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Nobuharu Tujimoto, Yoshimi Kikuchi, Osamu Kurahashi, Yoshiko Kawahara, "Mutant Escherichia coli capable of enhanced L-glutamic acid production." U.S. Patent US5393671, issued August, 1960.</synthesis-reference>
  <indication>Considered to be nature's "Brain food" by improving mental capacities; helps speed the healing of ulcers; gives a "lift" from fatigue; helps control alcoholism, schizophrenia and the craving for sugar.</indication>
  <pharmacodynamics>In addition to being one of the building blocks in protein synthesis, it is the most widespread neurotransmitter in brain function, as an excitatory neurotransmitter and as a precursor for the synthesis of GABA in GABAergic neurons.&#13;
</pharmacodynamics>
  <mechanism-of-action>Glutamate activates both ionotropic and metabotropic glutamate receptors. The ionotropic ones being non-NMDA (AMPA and kainate) and NMDA receptors. Free glutamic acid cannot cross the blood-brain barrier in appreciable quantities; instead it is converted into L-glutamine, which the brain uses for fuel and protein synthesis. It is conjectured that glutamate is involved in cognitive functions like learning and memory in the brain, though excessive amounts may cause neuronal damage associated in diseases like amyotrophic lateral sclerosis, lathyrism, and Alzheimer's disease. Also, the drug phencyclidine (more commonly known as PCP) antagonizes glutamate at the NMDA receptor, causing behavior reminiscent of schizophrenia. Glutamate in action is extremely difficult to study due to its transient nature.</mechanism-of-action>
  <toxicity>Glutamate causes neuronal damage and eventual cell death, particularly when NMDA receptors are activated, High dosages of glutamic acid may include symptoms such as headaches and neurological problems.</toxicity>
  <metabolism>Hepatic</metabolism>
  <absorption>Absorbed from the lumen of the small intestine into the enterocytes.Absorption is efficient and occurs by an active transport mechanism.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of organic compounds known as glutamic acid and derivatives. These are compounds containing glutamic acid or a derivative thereof resulting from reaction of glutamic acid at the amino group or the carboxy group, or from the replacement of any hydrogen of glycine by a heteroatom.</description>
    <direct-parent>Glutamic acid and derivatives</direct-parent>
    <kingdom>Organic compounds</kingdom>
    <superclass>Organic acids and derivatives</superclass>
    <class>Carboxylic acids and derivatives</class>
    <subclass>Amino acids, peptides, and analogues</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Amino fatty acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Amino fatty acid</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Fatty acid</substituent>
    <substituent>Fatty acyl</substituent>
    <substituent>Glutamic acid or derivatives</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
  </classification>
  <salts>
    <salt>
      <drugbank-id primary="true">DBSALT002484</drugbank-id>
      <name>Glutamic acid hydrochloride</name>
      <unii>M0C2SP444T</unii>
      <cas-number>138-15-8</cas-number>
      <inchikey>RPAJSBKBKSSMLJ-DFWYDOINSA-N</inchikey>
      <average-mass>183.59</average-mass>
      <monoisotopic-mass>183.0298355</monoisotopic-mass>
    </salt>
  </salts>
  <synonyms>
    <synonym language="" coder="">(2S)-2-Aminopentanedioic acid</synonym>
    <synonym language="" coder="">(S)-2-Aminopentanedioic acid</synonym>
    <synonym language="" coder="">(S)-Glutamic acid</synonym>
    <synonym language="" coder="">Glu</synonym>
    <synonym language="" coder="">L-Glutamate</synonym>
    <synonym language="" coder="">L-Glutamic acid</synonym>
    <synonym language="" coder="">L-Glutaminic acid</synonym>
  </synonyms>
  <products>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7172</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4162</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4164</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4160</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on>2017-05-18</ended-marketing-on>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019438</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7121</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020015</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-7171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1991-12-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020041</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn II 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742619</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 10% With Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742651</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 15%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02126745</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 5% Inj</name>
      <labeller>Abbott</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742643</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>1999-08-09</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742635</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742724</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742740</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742759</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742627</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742716</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742767</dpd-id>
      <started-marketing-on>1988-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00742783</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839302</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II In Dextrose Injection</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00839310</dpd-id>
      <started-marketing-on>1991-12-31</started-marketing-on>
      <ended-marketing-on>2012-08-03</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn II with Electrolytes</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4171</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-04-03</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019437</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4178</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1985-09-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019398</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-4179</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1986-10-17</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019492</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Aminosyn-PF 10%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731366</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Aminosyn-PF 7%</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00731358</dpd-id>
      <started-marketing-on>1990-12-31</started-marketing-on>
      <ended-marketing-on>2016-07-29</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Clinisol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0502</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1996-08-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA020512</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Glutamic Acid HCl Betaine HCl W Pepsin</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00348716</dpd-id>
      <started-marketing-on>1963-12-31</started-marketing-on>
      <ended-marketing-on>2000-03-03</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glutamic Acid HCl Cap 325mg</name>
      <labeller>Stanley Pharmaceuticals, A Division Of Vita Health Products Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00179205</dpd-id>
      <started-marketing-on>1957-12-31</started-marketing-on>
      <ended-marketing-on>2002-07-31</ended-marketing-on>
      <dosage-form>Capsule</dosage-form>
      <strength>325 mg</strength>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glutamic Acid Hydrochloride Nu Life</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00064173</dpd-id>
      <started-marketing-on>1963-12-31</started-marketing-on>
      <ended-marketing-on>2005-03-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glutamic Acid Pepsin and Betaine Tablets</name>
      <labeller>Jamieson Laboratories Ltd</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00123285</dpd-id>
      <started-marketing-on>1963-12-31</started-marketing-on>
      <ended-marketing-on>1996-09-10</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Novamine</name>
      <labeller>Hospira, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0409-0468</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution, concentrate</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA017957</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Olimel 3.3% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352508</dpd-id>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352524</dpd-id>
      <started-marketing-on>2011-09-29</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 4.4% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352516</dpd-id>
      <started-marketing-on>2011-02-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352540</dpd-id>
      <started-marketing-on>2011-03-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Olimel 5.7% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352532</dpd-id>
      <started-marketing-on>2011-01-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Periolimel 2.5% E</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02352494</dpd-id>
      <started-marketing-on>2011-02-28</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3200</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Plenamine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-3205</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-01-30</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA091112</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1130</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-1131</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2003-06-19</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>ANDA075880</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Primene 10%</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02236875</dpd-id>
      <started-marketing-on>1997-11-14</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Primene 10%-liq IV</name>
      <labeller>Clintec Nutrition Company</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02161192</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-13</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>ProSol</name>
      <labeller>Baxter Laboratories</labeller>
      <ndc-id/>
      <ndc-product-code>0338-0499</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1998-08-26</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Injection, solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA020849</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Stomach Aid-digestive Aid</name>
      <labeller>Nu Life Nutrition Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>00709530</dpd-id>
      <started-marketing-on>1987-12-31</started-marketing-on>
      <ended-marketing-on>2005-03-15</ended-marketing-on>
      <dosage-form>Tablet</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9341</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>TrophAmine</name>
      <labeller>B. Braun Medical Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0264-9361</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1984-07-20</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number>NDA019018</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Vamin 18 Electrolyte-free</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02059711</dpd-id>
      <started-marketing-on>1996-12-30</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vamin N</name>
      <labeller>Fresenius Kabi Ab</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02065665</dpd-id>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2006-07-17</ended-marketing-on>
      <dosage-form>Solution</dosage-form>
      <strength/>
      <route>Intravenous</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Novamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II with Electrolytes</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Plenamine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>TrophAmine</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + N-acetyltyrosine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>ProSol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Clinisol</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Premasol - sulfite-free (Amino Acid)</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 15%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin N</name>
      <ingredients>Calcium Chloride + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium Sulfate + Potassium Chloride + Potassium hydroxide + Sodium hydroxide</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%-liq IV</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Vamin 18 Electrolyte-free</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 5% Inj</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Primene 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Cysteine + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Ornithine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 10%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% Injection</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 10% With Electrolytes</name>
      <ingredients>Dipotassium phosphate + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn-PF 7%</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Taurine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II</name>
      <ingredients>Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Periolimel 2.5% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% M In 20% Dextrose (dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% M In 10% Dextrose(dual Chamber)</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + Magnesium chloride + N-acetyltyrosine + Potassium Chloride + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 7% With 10% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II 8.5% With 50% Dextrose</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Aminosyn II In Dextrose Injection</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Valine + N-acetyltyrosine</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 3.3% E</name>
      <ingredients>Calcium Chloride + Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Magnesium chloride + Olive oil + Potassium Chloride + Sodium acetate + Sodium glycerophosphate + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Glutamic Acid HCl Cap 325mg</name>
      <ingredients>Glutamic Acid</ingredients>
    </mixture>
    <mixture>
      <name>Glutamic Acid Hydrochloride Nu Life</name>
      <ingredients>Glutamic Acid + Pepsin</ingredients>
    </mixture>
    <mixture>
      <name>Glutamic Acid HCl Betaine HCl W Pepsin</name>
      <ingredients>Glutamic Acid + Glycine betaine + Pepsin</ingredients>
    </mixture>
    <mixture>
      <name>Stomach Aid-digestive Aid</name>
      <ingredients>Glutamic Acid + Glycine betaine + Pepsin</ingredients>
    </mixture>
    <mixture>
      <name>Glutamic Acid Pepsin and Betaine Tablets</name>
      <ingredients>Glutamic Acid + Glycine betaine + Pepsin</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 4.4%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
    <mixture>
      <name>Olimel 5.7%</name>
      <ingredients>Glucose + Glutamic Acid + Glycine + L-Alanine + L-Arginine + L-Aspartic Acid + L-Histidine + L-Isoleucine + L-Leucine + L-Lysine + L-Methionine + L-Phenylalanine + L-Proline + L-Serine + L-Threonine + L-Tryptophan + L-Tyrosine + L-Valine + Olive oil + Soybean oil</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Amend</name>
      <url/>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>L-glutamic acid powder</description>
      <cost currency="USD">0.03</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Acid Preparations</category>
      <mesh-id/>
    </category>
    <category>
      <category>Alimentary Tract and Metabolism</category>
      <mesh-id/>
    </category>
    <category>
      <category>Amino Acids</category>
      <mesh-id>D000596</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Acidic</category>
      <mesh-id>D024342</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Dicarboxylic</category>
      <mesh-id>D000600</mesh-id>
    </category>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Digestives, Incl. Enzymes</category>
      <mesh-id/>
    </category>
    <category>
      <category>Excitatory Amino Acids</category>
      <mesh-id>D018846</mesh-id>
    </category>
    <category>
      <category>Gastrointestinal Acidifying Agents</category>
      <mesh-id/>
    </category>
    <category>
      <category>Glutamates</category>
      <mesh-id>D005971</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Injection, solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Capsule</form>
      <route>Oral</route>
      <strength>325 mg</strength>
    </dosage>
    <dosage>
      <form>Tablet</form>
      <route>Oral</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Injection, solution, concentrate</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Solution</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Intravenous</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="A09AB01">
      <level code="A09AB">Acid preparations</level>
      <level code="A09A">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A09">DIGESTIVES, INCL. ENZYMES</level>
      <level code="A">ALIMENTARY TRACT AND METABOLISM</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes>
    <ahfs-code>40:04.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries>
    <pdb-entry>1BGV</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00142.pdf?1265922750</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions>
    <drug-interaction>
      <drugbank-id>DB00182</drugbank-id>
      <name>Amphetamine</name>
      <description>The serum concentration of Amphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00191</drugbank-id>
      <name>Phentermine</name>
      <description>The serum concentration of Phentermine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00865</drugbank-id>
      <name>Benzphetamine</name>
      <description>The serum concentration of Benzphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01255</drugbank-id>
      <name>Lisdexamfetamine</name>
      <description>The serum concentration of Lisdexamfetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01365</drugbank-id>
      <name>Mephentermine</name>
      <description>The serum concentration of Mephentermine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01454</drugbank-id>
      <name>3,4-Methylenedioxymethamphetamine</name>
      <description>The serum concentration of 3,4-Methylenedioxymethamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01509</drugbank-id>
      <name>3,4-Methylenedioxyamphetamine</name>
      <description>The serum concentration of 3,4-Methylenedioxyamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01556</drugbank-id>
      <name>Chlorphentermine</name>
      <description>The serum concentration of Chlorphentermine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01576</drugbank-id>
      <name>Dextroamphetamine</name>
      <description>The serum concentration of Dextroamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01577</drugbank-id>
      <name>Methamphetamine</name>
      <description>The serum concentration of Methamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB09352</drugbank-id>
      <name>Hydroxyamphetamine</name>
      <description>The serum concentration of Hydroxyamphetamine hydrobromide can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00852</drugbank-id>
      <name>Pseudoephedrine</name>
      <description>The serum concentration of Pseudoephedrine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB00937</drugbank-id>
      <name>Diethylpropion</name>
      <description>The serum concentration of Diethylpropion can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01442</drugbank-id>
      <name>MMDA</name>
      <description>The serum concentration of MMDA can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01467</drugbank-id>
      <name>2,5-Dimethoxy-4-ethylamphetamine</name>
      <description>The serum concentration of 2,5-Dimethoxy-4-ethylamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB01484</drugbank-id>
      <name>4-Bromo-2,5-dimethoxyamphetamine</name>
      <description>The serum concentration of 4-Bromo-2,5-dimethoxyamphetamine can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB12080</drugbank-id>
      <name>Ritobegron</name>
      <description>The serum concentration of Ritobegron can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
    <drug-interaction>
      <drugbank-id>DB13108</drugbank-id>
      <name>Mephedrone</name>
      <description>The serum concentration of Mephedrone can be decreased when it is combined with L-Glutamic Acid.</description>
    </drug-interaction>
  </drug-interactions>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-3.5</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-0.26</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>8.06e+01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-aminopentanedioic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>L-glutamic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>147.1293</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>147.053157781</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>N[C@@H](CCC(O)=O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C5H9NO4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C5H9NO4/c6-3(5(9)10)1-2-4(7)8/h3H,1-2,6H2,(H,7,8)(H,9,10)/t3-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>WHUUTDBJXJRKMK-VKHMYHEASA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>100.62</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>31.29</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>13.32</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>4</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>5</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.88</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.54</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>8570 mg/L (at 25 °C)</value>
      <source>BULL,HB ET AL. (1978)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>224 dec °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-3.69</value>
      <source>HANSCH,C ET AL. (1995)</source>
    </property>
    <property>
      <kind>pKa</kind>
      <value>2.23 (at 0 °C)</value>
      <source>KORTUM,G ET AL (1961)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>8872</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>14451</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>16015</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>33032</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46505816</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C00025</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00007</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>30572</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>17657</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449776</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>GGL</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Therapeutic Targets Database</resource>
      <identifier>DAP000015</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>1369</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>1369</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>L-Glutamic_Acid</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL575060</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways>
    <pathway>
      <smpdb-id>SMP00007</smpdb-id>
      <name>Beta-Alanine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00117</drugbank-id>
          <name>L-Histidine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01783</drugbank-id>
          <name>Pantothenic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01849</drugbank-id>
          <name>3,4-Dihydrouracil</name>
        </drug>
        <drug>
          <drugbank-id>DB03107</drugbank-id>
          <name>Beta-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03419</drugbank-id>
          <name>Uracil</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q96KN2</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>Q9UBR1</uniprot-id>
        <uniprot-id>Q14117</uniprot-id>
        <uniprot-id>Q12882</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q16853</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00013</smpdb-id>
      <name>Cysteine Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>Q16878</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
        <uniprot-id>P25325</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P49589</uniprot-id>
        <uniprot-id>O60931</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00015</smpdb-id>
      <name>Glutathione Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00075</smpdb-id>
      <name>Arachidonic Acid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00106</smpdb-id>
      <name>Meloxicam Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00814</drugbank-id>
          <name>Meloxicam</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00109</smpdb-id>
      <name>Mefenamic Acid Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00784</drugbank-id>
          <name>Mefenamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00129</smpdb-id>
      <name>Malate-Aspartate Shuttle</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>O75746</uniprot-id>
        <uniprot-id>P40926</uniprot-id>
        <uniprot-id>Q02978</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00183</smpdb-id>
      <name>Gamma-Glutamyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00188</smpdb-id>
      <name>Guanidinoacetate Methyltransferase Deficiency (GAMT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00217</smpdb-id>
      <name>Sialuria or French Type Sialuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00141</drugbank-id>
          <name>N-Acetylglucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01296</drugbank-id>
          <name>Glucosamine</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q13231</uniprot-id>
        <uniprot-id>P06865</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>Q9Y303</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>P46926</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>O95394</uniprot-id>
        <uniprot-id>Q16222</uniprot-id>
        <uniprot-id>P51606</uniprot-id>
        <uniprot-id>Q9Y223</uniprot-id>
        <uniprot-id>P19367</uniprot-id>
        <uniprot-id>Q9NR45</uniprot-id>
        <uniprot-id>Q9BXD5</uniprot-id>
        <uniprot-id>Q8TBE9</uniprot-id>
        <uniprot-id>Q8NFW8</uniprot-id>
        <uniprot-id>Q9NRA2</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00237</smpdb-id>
      <name>3-Methylcrotonyl Coa Carboxylase Deficiency Type I</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00147</drugbank-id>
          <name>Pyridoxal</name>
        </drug>
        <drug>
          <drugbank-id>DB00149</drugbank-id>
          <name>L-Leucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00161</drugbank-id>
          <name>L-Valine</name>
        </drug>
        <drug>
          <drugbank-id>DB00167</drugbank-id>
          <name>L-Isoleucine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03229</drugbank-id>
          <name>2-Oxo-4-Methylpentanoic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04074</drugbank-id>
          <name>Alpha-ketoisovalerate</name>
        </drug>
        <drug>
          <drugbank-id>DB04183</drugbank-id>
          <name>Methylmalonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21953</uniprot-id>
        <uniprot-id>P12694</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P35914</uniprot-id>
        <uniprot-id>P54687</uniprot-id>
        <uniprot-id>P11182</uniprot-id>
        <uniprot-id>P26440</uniprot-id>
        <uniprot-id>P11310</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q96RQ3</uniprot-id>
        <uniprot-id>Q9HCC0</uniprot-id>
        <uniprot-id>P16219</uniprot-id>
        <uniprot-id>P45954</uniprot-id>
        <uniprot-id>Q9UKU7</uniprot-id>
        <uniprot-id>Q6NVY1</uniprot-id>
        <uniprot-id>P31937</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>Q99714</uniprot-id>
        <uniprot-id>P42765</uniprot-id>
        <uniprot-id>Q02252</uniprot-id>
        <uniprot-id>P05165</uniprot-id>
        <uniprot-id>P05166</uniprot-id>
        <uniprot-id>Q96PE7</uniprot-id>
        <uniprot-id>P22033</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q13825</uniprot-id>
        <uniprot-id>P54868</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P55809</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00239</smpdb-id>
      <name>Saccharopinuria/Hyperlysinemia II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00123</drugbank-id>
          <name>L-Lysine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04207</drugbank-id>
          <name>N-(5-Amino-5-Carboxypentyl)Glutamic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q9UDR5</uniprot-id>
        <uniprot-id>P49419</uniprot-id>
        <uniprot-id>Q8N5Z0</uniprot-id>
        <uniprot-id>P30084</uniprot-id>
        <uniprot-id>Q16836</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>P52569</uniprot-id>
        <uniprot-id>Q9BXI2</uniprot-id>
        <uniprot-id>Q9P0Z9</uniprot-id>
        <uniprot-id>Q92947</uniprot-id>
        <uniprot-id>Q96HY7</uniprot-id>
        <uniprot-id>P36957</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00350</smpdb-id>
      <name>Pyruvate Carboxylase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49588</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>Q5JTZ9</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00360</smpdb-id>
      <name>Hyperprolinemia Type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00362</smpdb-id>
      <name>Arginine: Glycine Amidinotransferase Deficiency (AGAT Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00365</smpdb-id>
      <name>Gout or Kelley-Seegmiller Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00369</smpdb-id>
      <name>Tyrosinemia Type 2 (or Richner-Hanhart syndrome)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00370</smpdb-id>
      <name>Tyrosinemia Type 3 (TYRO3)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00120</drugbank-id>
          <name>L-Phenylalanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00135</drugbank-id>
          <name>L-Tyrosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01592</drugbank-id>
          <name>Iron</name>
        </drug>
        <drug>
          <drugbank-id>DB01762</drugbank-id>
          <name>Acetoacetic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03884</drugbank-id>
          <name>Phenylpyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB07718</drugbank-id>
          <name>3-(4-HYDROXY-PHENYL)PYRUVIC ACID</name>
        </drug>
        <drug>
          <drugbank-id>DB08327</drugbank-id>
          <name>2-(3,6-DIHYDROXYPHENYL)ACETIC ACID</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>Q96RQ9</uniprot-id>
        <uniprot-id>P17735</uniprot-id>
        <uniprot-id>P00439</uniprot-id>
        <uniprot-id>P54577</uniprot-id>
        <uniprot-id>Q9Y285</uniprot-id>
        <uniprot-id>Q9NSD9</uniprot-id>
        <uniprot-id>P32754</uniprot-id>
        <uniprot-id>Q93099</uniprot-id>
        <uniprot-id>O43708</uniprot-id>
        <uniprot-id>P16930</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00427</smpdb-id>
      <name>Azathioprine Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB00993</drugbank-id>
          <name>Azathioprine</name>
        </drug>
        <drug>
          <drugbank-id>DB01033</drugbank-id>
          <name>Mercaptopurine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P51580</uniprot-id>
        <uniprot-id>P63000</uniprot-id>
        <uniprot-id>Q06278</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>Q14542</uniprot-id>
        <uniprot-id>Q9HAS3</uniprot-id>
        <uniprot-id>Q99808</uniprot-id>
        <uniprot-id>O43868</uniprot-id>
        <uniprot-id>O15440</uniprot-id>
        <uniprot-id>O15439</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P55263</uniprot-id>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00501</smpdb-id>
      <name>Gamma-glutamyl-transpeptidase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00504</smpdb-id>
      <name>Creatine deficiency, guanidinoacetate methyltransferase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00505</smpdb-id>
      <name>Hyperornithinemia with gyrate atrophy (HOGA)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00506</smpdb-id>
      <name>Hyperornithinemia-hyperammonemia-homocitrullinuria [HHH-syndrome]</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00507</smpdb-id>
      <name>L-arginine:glycine amidinotransferase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00129</drugbank-id>
          <name>Ornithine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00155</drugbank-id>
          <name>L-Citrulline</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00172</drugbank-id>
          <name>L-Proline</name>
        </drug>
        <drug>
          <drugbank-id>DB00360</drugbank-id>
          <name>Sapropterin</name>
        </drug>
        <drug>
          <drugbank-id>DB00435</drugbank-id>
          <name>Nitric Oxide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02838</drugbank-id>
          <name>3,4-Dihydro-2h-Pyrrolium-5-Carboxylate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03247</drugbank-id>
          <name>Riboflavin Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03904</drugbank-id>
          <name>Urea</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04388</drugbank-id>
          <name>4-Carboxy-4-Aminobutanal</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P00966</uniprot-id>
        <uniprot-id>P04424</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P04181</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>O43272</uniprot-id>
        <uniprot-id>Q96C36</uniprot-id>
        <uniprot-id>P07814</uniprot-id>
        <uniprot-id>Q7Z4N8</uniprot-id>
        <uniprot-id>Q5T160</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P12277</uniprot-id>
        <uniprot-id>P05089</uniprot-id>
        <uniprot-id>P00480</uniprot-id>
        <uniprot-id>Q9Y619</uniprot-id>
        <uniprot-id>P14920</uniprot-id>
        <uniprot-id>P17174</uniprot-id>
        <uniprot-id>P29475</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00513</smpdb-id>
      <name>Xanthinuria type II</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00173</drugbank-id>
          <name>Adenine</name>
        </drug>
        <drug>
          <drugbank-id>DB00640</drugbank-id>
          <name>Adenosine</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01700</drugbank-id>
          <name>AICA ribonucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02134</drugbank-id>
          <name>Xanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB02377</drugbank-id>
          <name>Guanine</name>
        </drug>
        <drug>
          <drugbank-id>DB02527</drugbank-id>
          <name>Cyclic Adenosine Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02857</drugbank-id>
          <name>Guanosine</name>
        </drug>
        <drug>
          <drugbank-id>DB03101</drugbank-id>
          <name>Ribose-1-Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB04076</drugbank-id>
          <name>Hypoxanthine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04299</drugbank-id>
          <name>Maleic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04335</drugbank-id>
          <name>Inosine</name>
        </drug>
        <drug>
          <drugbank-id>DB04457</drugbank-id>
          <name>2'-Deoxyguanosine-5'-Monophosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P50583</uniprot-id>
        <uniprot-id>O75414</uniprot-id>
        <uniprot-id>O75356</uniprot-id>
        <uniprot-id>Q5MY95</uniprot-id>
        <uniprot-id>Q16774</uniprot-id>
        <uniprot-id>P49902</uniprot-id>
        <uniprot-id>Q16854</uniprot-id>
        <uniprot-id>P07741</uniprot-id>
        <uniprot-id>P00491</uniprot-id>
        <uniprot-id>P00492</uniprot-id>
        <uniprot-id>Q9Y2T3</uniprot-id>
        <uniprot-id>Q9UKK9</uniprot-id>
        <uniprot-id>P21108</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P22102</uniprot-id>
        <uniprot-id>O15067</uniprot-id>
        <uniprot-id>P22234</uniprot-id>
        <uniprot-id>P30566</uniprot-id>
        <uniprot-id>P31939</uniprot-id>
        <uniprot-id>Q9BY32</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>P20839</uniprot-id>
        <uniprot-id>P36959</uniprot-id>
        <uniprot-id>P47989</uniprot-id>
        <uniprot-id>P30520</uniprot-id>
        <uniprot-id>P23109</uniprot-id>
        <uniprot-id>P00813</uniprot-id>
        <uniprot-id>P00568</uniprot-id>
        <uniprot-id>Q8NBU5</uniprot-id>
        <uniprot-id>Q08499</uniprot-id>
        <uniprot-id>Q96PN6</uniprot-id>
        <uniprot-id>P33402</uniprot-id>
        <uniprot-id>Q02153</uniprot-id>
        <uniprot-id>Q9Y233</uniprot-id>
        <uniprot-id>P10599</uniprot-id>
        <uniprot-id>P23921</uniprot-id>
        <uniprot-id>P31350</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00567</smpdb-id>
      <name>Succinic semialdehyde dehydrogenase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00698</smpdb-id>
      <name>Magnesium salicylate Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01397</drugbank-id>
          <name>Magnesium salicylate</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00702</smpdb-id>
      <name>Nepafenac Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB06802</drugbank-id>
          <name>Nepafenac</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00708</smpdb-id>
      <name>Salicylate-sodium Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00721</smpdb-id>
      <name>3-Phosphoglycerate dehydrogenase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00116</drugbank-id>
          <name>Tetrahydrofolic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00125</drugbank-id>
          <name>L-Arginine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00133</drugbank-id>
          <name>L-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00134</drugbank-id>
          <name>L-Methionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00148</drugbank-id>
          <name>Creatine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00855</drugbank-id>
          <name>Aminolevulinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02083</drugbank-id>
          <name>N,N-dimethylglycine</name>
        </drug>
        <drug>
          <drugbank-id>DB02751</drugbank-id>
          <name>Glycocyamine</name>
        </drug>
        <drug>
          <drugbank-id>DB02951</drugbank-id>
          <name>3-Hydroxypyruvic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB02957</drugbank-id>
          <name>Orotidine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03843</drugbank-id>
          <name>Formaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03915</drugbank-id>
          <name>2-Amino-3-Ketobutyric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03929</drugbank-id>
          <name>D-Serine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04343</drugbank-id>
          <name>Glyoxylic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04522</drugbank-id>
          <name>Dexfosfoserine</name>
        </drug>
        <drug>
          <drugbank-id>DB04553</drugbank-id>
          <name>2-Oxobutanoic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P21397</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>O75600</uniprot-id>
        <uniprot-id>Q9UI17</uniprot-id>
        <uniprot-id>Q9UL12</uniprot-id>
        <uniprot-id>P23378</uniprot-id>
        <uniprot-id>P48728</uniprot-id>
        <uniprot-id>P34897</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P21549</uniprot-id>
        <uniprot-id>P50440</uniprot-id>
        <uniprot-id>Q14353</uniprot-id>
        <uniprot-id>P13196</uniprot-id>
        <uniprot-id>Q93088</uniprot-id>
        <uniprot-id>Q14749</uniprot-id>
        <uniprot-id>Q8IVS8</uniprot-id>
        <uniprot-id>O43175</uniprot-id>
        <uniprot-id>Q9Y617</uniprot-id>
        <uniprot-id>P78330</uniprot-id>
        <uniprot-id>P20132</uniprot-id>
        <uniprot-id>P49591</uniprot-id>
        <uniprot-id>P34896</uniprot-id>
        <uniprot-id>P41250</uniprot-id>
        <uniprot-id>Q9GZT4</uniprot-id>
        <uniprot-id>P35520</uniprot-id>
        <uniprot-id>P32929</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0000824</id>
      <name>Metabotropic glutamate receptor 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17360958</pubmed-id>
            <citation>Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14.</citation>
          </article>
          <article>
            <pubmed-id>16751798</pubmed-id>
            <citation>Chiocchetti A, Miglio G, Mesturini R, Varsaldi F, Mocellin M, Orilieri E, Dianzani C, Fantozzi R, Dianzani U, Lombardi G: Group I mGlu receptor stimulation inhibits activation-induced cell death of human T lymphocytes. Br J Pharmacol. 2006 Jul;148(6):760-8. Epub 2006 Jun 5.</citation>
          </article>
          <article>
            <pubmed-id>17331504</pubmed-id>
            <citation>San Gabriel AM, Maekawa T, Uneyama H, Yoshie S, Torii K: mGluR1 in the fundic glands of rat stomach. FEBS Lett. 2007 Mar 20;581(6):1119-23. Epub 2007 Feb 22.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13255" source="Swiss-Prot">
    <name>Metabotropic glutamate receptor 1</name>
    <general-function>Glutamate receptor activity</general-function>
    <specific-function>G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling activates a phosphatidylinositol-calcium second messenger system. May participate in the central action of glutamate in the CNS, such as long-term potentiation in the hippocampus and long-term depression in the cerebellum.</specific-function>
    <gene-name>GRM1</gene-name>
    <locus>6q24</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>593-615
630-650
659-680
704-727
751-772
786-807
816-840</transmembrane-regions>
    <signal-regions>1-18</signal-regions>
    <theoretical-pi>6.67</theoretical-pi>
    <molecular-weight>132355.855</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4593</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRM1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U31215</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>945097</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>289</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>289</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13255</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRM1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GPRC1A</synonym>
      <synonym>MGLUR1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037086|Metabotropic glutamate receptor 1
MVGLLLFFFPAIFLEVSLLPRSPGRKVLLAGASSQRSVARMDGDVIIGALFSVHHQPPAE
KVPERKCGEIREQYGIQRVEAMFHTLDKINADPVLLPNITLGSEIRDSCWHSSVALEQSI
EFIRDSLISIRDEKDGINRCLPDGQSLPPGRTKKPIAGVIGPGSSSVAIQVQNLLQLFDI
PQIAYSATSIDLSDKTLYKYFLRVVPSDTLQARAMLDIVKRYNWTYVSAVHTEGNYGESG
MDAFKELAAQEGLCIAHSDKIYSNAGEKSFDRLLRKLRERLPKARVVVCFCEGMTVRGLL
SAMRRLGVVGEFSLIGSDGWADRDEVIEGYEVEANGGITIKLQSPEVRSFDDYFLKLRLD
TNTRNPWFPEFWQHRFQCRLPGHLLENPNFKRICTGNESLEENYVQDSKMGFVINAIYAM
AHGLQNMHHALCPGHVGLCDAMKPIDGSKLLDFLIKSSFIGVSGEEVWFDEKGDAPGRYD
IMNLQYTEANRYDYVHVGTWHEGVLNIDDYKIQMNKSGVVRSVCSEPCLKGQIKVIRKGE
VSCCWICTACKENEYVQDEFTCKACDLGWWPNADLTGCEPIPVRYLEWSNIESIIAIAFS
CLGILVTLFVTLIFVLYRDTPVVKSSSRELCYIILAGIFLGYVCPFTLIAKPTTTSCYLQ
RLLVGLSSAMCYSALVTKTNRIARILAGSKKKICTRKPRFMSAWAQVIIASILISVQLTL
VVTLIIMEPPMPILSYPSIKEVYLICNTSNLGVVAPLGYNGLLIMSCTYYAFKTRNVPAN
FNEAKYIAFTMYTTCIIWLAFVPIYFGSNYKIITTCFAVSLSVTVALGCMFTPKMYIIIA
KPERNVRSAFTTSDVVRMHVGDGKLPCRSNTFLNIFRRKKAGAGNANSNGKSVSWSEPGG
GQVPKGQHMWHRLSVHVKTNETACNQTAVIKPLTKSYQGSGKSLTFSDTSTKTLYNVEEE
EDAQPIRFSPPGSPSMVVHRRVPSAATTPPLPSHLTAEETPLFLAEPALPKGLPPPLQQQ
QQPPPQQKSLMDQLQGVVSNFSTAIPDFHAVLAGPGGPGNGLRSLYPPPPPPQHLQMLPL
QLSTFGEELVSPPADDDDDSERFKLLQEYVYEHEREGNTEEDELEEEEEDLQAASKLTPD
DSPALTPPSPFRDSVASGSSVPSSPVSESVLCTPPNVSYASVILRDYKQSSSTL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010582|Metabotropic glutamate receptor 1 (GRM1)
ATGGTCGGGCTCCTTTTGTTTTTTTTCCCAGCGATCTTTTTGGAGGTGTCCCTTCTCCCC
AGAAGCCCCGGCAGGAAAGTGTTGCTGGCAGGAGCGTCGTCTCAGCGCTCGGTGGCCAGA
ATGGACGGAGATGTCATCATTGGAGCCCTCTTCTCAGTCCATCACCAGCCTCCGGCCGAG
AAAGTGCCCGAGAGGAAGTGTGGGGAGATCAGGGAGCAGTATGGCATCCAGAGGGTGGAG
GCCATGTTCCACACGTTGGATAAGATCAACGCGGACCCGGTCCTCCTGCCCAACATCACC
CTGGGCAGTGAGATCCGGGACTCCTGCTGGCACTCTTCCGTGGCTCTGGAACAGAGCATT
GAGTTCATTAGGGACTCTCTGATTTCCATTCGAGATGAGAAGGATGGGATCAACCGGTGT
CTGCCTGACGGCCAGTCCCTCCCCCCAGGCAGGACTAAGAAGCCCATTGCGGGAGTGATC
GGTCCCGGCTCCAGCTCTGTAGCCATTCAAGTGCAGAACCTGCTCCAGCTCTTCGACATC
CCCCAGATCGCTTATTCAGCCACAAGCATCGACCTGAGTGACAAAACTTTGTACAAATAC
TTCCTGAGGGTTGTCCCTTCTGACACTTTGCAGGCAAGGGCCATGCTTGACATAGTCAAA
CGTTACAATTGGACCTATGTCTCTGCAGTCCACACGGAAGGGAATTATGGGGAGAGCGGA
ATGGACGCTTTCAAAGAGCTGGCTGCCCAGGAAGGCCTCTGTATCGCCCATTCTGACAAA
ATCTACAGCAACGCTGGGGAGAAGAGCTTTGACCGACTCTTGCGCAAACTCCGAGAGAGG
CTTCCCAAGGCTAGAGTGGTGGTCTGCTTCTGTGAAGGCATGACAGTGCGAGGACTCCTG
AGCGCCATGCGGCGCCTTGGCGTCGTGGGCGAGTTCTCACTCATTGGAAGTGATGGATGG
GCAGACAGAGATGAAGTCATTGAAGGTTATGAGGTGGAAGCCAACGGGGGAATCACGATA
AAGCTGCAGTCTCCAGAGGTCAGGTCATTTGATGATTATTTCCTGAAACTGAGGCTGGAC
ACTAACACGAGGAATCCCTGGTTCCCTGAGTTCTGGCAACATCGGTTCCAGTGCCGCCTT
CCAGGACACCTTCTGGAAAATCCCAACTTTAAACGAATCTGCACAGGCAATGAAAGCTTA
GAAGAAAACTATGTCCAGGACAGTAAGATGGGGTTTGTCATCAATGCCATCTATGCCATG
GCACATGGGCTGCAGAACATGCACCATGCCCTCTGCCCTGGCCACGTGGGCCTCTGCGAT
GCCATGAAGCCCATCGACGGCAGCAAGCTGCTGGACTTCCTCATCAAGTCCTCATTCATT
GGAGTATCTGGAGAGGAGGTGTGGTTTGATGAGAAAGGAGACGCTCCTGGAAGGTATGAT
ATCATGAATCTGCAGTACACTGAAGCTAATCGCTATGACTATGTGCACGTTGGAACCTGG
CATGAAGGAGTGCTGAACATTGATGATTACAAAATCCAGATGAACAAGAGTGGAGTGGTG
CGGTCTGTGTGCAGTGAGCCTTGCTTAAAGGGCCAGATTAAGGTTATACGGAAAGGAGAA
GTGAGCTGCTGCTGGATTTGCACGGCCTGCAAAGAGAATGAATATGTGCAAGATGAGTTC
ACCTGCAAAGCTTGTGACTTGGGATGGTGGCCCAATGCAGATCTAACAGGCTGTGAGCCC
ATTCCTGTGCGCTATCTTGAGTGGAGCAACATCGAATCCATTATAGCCATCGCCTTTTCA
TGCCTGGGAATCCTTGTTACCTTGTTTGTCACCCTAATCTTTGTACTGTACCGGGACACA
CCAGTGGTCAAATCCTCCAGTCGGGAGCTCTGCTACATCATCCTAGCTGGCATCTTCCTT
GGTTATGTGTGCCCATTCACTCTCATTGCCAAACCTACTACCACCTCCTGCTACCTCCAG
CGCCTCTTGGTTGGCCTCTCCTCTGCGATGTGCTACTCTGCTTTAGTGACTAAAACCAAT
CGTATTGCACGCATCCTGGCTGGCAGCAAGAAGAAGATCTGCACCCGGAAGCCCAGGTTC
ATGAGTGCCTGGGCTCAGGTGATCATTGCCTCAATTCTGATTAGTGTGCAACTAACCCTG
GTGGTAACCCTGATCATCATGGAACCCCCTATGCCCATTCTGTCCTACCCAAGTATCAAG
GAAGTCTACCTTATCTGCAATACCAGCAACCTGGGTGTGGTGGCCCCTTTGGGCTACAAT
GGACTCCTCATCATGAGCTGTACCTACTATGCCTTCAAGACCCGCAACGTGCCCGCCAAC
TTCAACGAGGCCAAATATATCGCGTTCACCATGTACACCACCTGTATCATCTGGCTAGCT
TTTGTGCCCATTTACTTTGGGAGCAACTACAAGATCATCACAACTTGCTTTGCAGTGAGT
CTCAGTGTAACAGTGGCTCTGGGGTGCATGTTCACTCCCAAGATGTACATCATTATTGCC
AAGCCTGAGAGGAATGTCCGCAGTGCCTTCACCACCTCTGATGTTGTCCGCATGCATGTT
GGCGATGGCAAGCTGCCCTGCCGCTCCAACACTTTCCTCAACATCTTCCGAAGAAAGAAG
GCAGGGGCAGGGAATGCCAATTCTAATGGCAAGTCTGTGTCATGGTCTGAACCAGGTGGA
GGACAGGTGCCCAAGGGACAGCATATGTGGCACCGCCTCTCTGTGCACGTGAAGACCAAT
GAGACGGCCTGCAACCAAACAGCCGTCATCAAGCCCCTCACTAAAAGTTACCAAGGCTCT
GGCAAGAGCCTGACCTTTTCAGATACCAGCACCAAGACCCTTTACAACGTAGAGGAGGAG
GAGGATGCCCAGCCGATTCGCTTTAGCCCGCCTGGTAGCCCTTCCATGGTGGTGCACAGG
CGCGTGCCAAGCGCGGCGACCACTCCGCCTCTGCCGTCCCACCTGACCGCAGAGGAGACC
CCCCTCTTCCTGGCCGAACCAGCCCTCCCCAAGGGCTTGCCCCCTCCTCTCCAGCAGCAG
CAGCAACCCCCTCCACAGCAGAAATCGCTGATGGACCAGCTCCAGGGAGTGGTCAGCAAC
TTCAGTACCGCGATCCCGGATTTTCACGCGGTGCTGGCAGGCCCCGGTGGTCCCGGGAAC
GGGCTGCGGTCCCTGTACCCGCCCCCGCCACCTCCGCAGCACCTGCAGATGCTGCCGCTG
CAGCTGAGCACCTTTGGGGAGGAGCTGGTCTCCCCGCCCGCGGACGACGACGACGACAGC
GAGAGGTTTAAGCTCCTCCAGGAGTACGTGTATGAGCACGAGCGGGAAGGGAACACGGAA
GAAGACGAACTGGAAGAGGAGGAGGAGGACCTGCAGGCGGCCAGCAAACTGACCCCGGAT
GATTCGCCTGCGCTGACGCCTCCGTCGCCTTTCCGCGACTCGGTGGCCTCGGGCAGCTCG
GTGCCCAGCTCCCCCGTGTCCGAGTCGGTGCTCTGCACCCCTCCCAACGTATCCTACGCC
TCTGTCATTCTGCGGGACTACAAGCAAAGCTCTTCCACCCTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00003</identifier>
        <name>7tm_3</name>
      </pfam>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF07562</identifier>
        <name>NCD3G</name>
      </pfam>
      <pfam>
        <identifier>PF10606</identifier>
        <name>GluR_Homer-bdg</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>G-protein coupled receptor dimeric complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>G-protein coupled receptor homodimeric complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>G-protein coupled receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to electrical stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein kinase C-activating G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dimeric G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of cytosolic calcium ion concentration involved in phospholipase C-activating G-protein coupled signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000833</id>
      <name>Metabotropic glutamate receptor 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17360958</pubmed-id>
            <citation>Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14833" source="Swiss-Prot">
    <name>Metabotropic glutamate receptor 4</name>
    <general-function>Group iii metabotropic glutamate receptor activity</general-function>
    <specific-function>G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors. Signaling inhibits adenylate cyclase activity.</specific-function>
    <gene-name>GRM4</gene-name>
    <locus>6p21.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>588-610
625-645
657-675
700-720
751-772
786-808
822-847</transmembrane-regions>
    <signal-regions>1-32</signal-regions>
    <theoretical-pi>8.98</theoretical-pi>
    <molecular-weight>101866.835</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4596</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRM4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X80818</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1160183</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>292</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>292</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q14833</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRM4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GPRC1D</synonym>
      <synonym>MGLUR4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001662|Metabotropic glutamate receptor 4
MPGKRGLGWWWARLPLCLLLSLYGPWMPSSLGKPKGHPHMNSIRIDGDITLGGLFPVHGR
GSEGKPCGELKKEKGIHRLEAMLFALDRINNDPDLLPNITLGARILDTCSRDTHALEQSL
TFVQALIEKDGTEVRCGSGGPPIITKPERVVGVIGASGSSVSIMVANILRLFKIPQISYA
STAPDLSDNSRYDFFSRVVPSDTYQAQAMVDIVRALKWNYVSTVASEGSYGESGVEAFIQ
KSREDGGVCIAQSVKIPREPKAGEFDKIIRRLLETSNARAVIIFANEDDIRRVLEAARRA
NQTGHFFWMGSDSWGSKIAPVLHLEEVAEGAVTILPKRMSVRGFDRYFSSRTLDNNRRNI
WFAEFWEDNFHCKLSRHALKKGSHVKKCTNRERIGQDSAYEQEGKVQFVIDAVYAMGHAL
HAMHRDLCPGRVGLCPRMDPVDGTQLLKYIRNVNFSGIAGNPVTFNENGDAPGRYDIYQY
QLRNDSAEYKVIGSWTDHLHLRIERMHWPGSGQQLPRSICSLPCQPGERKKTVKGMPCCW
HCEPCTGYQYQVDRYTCKTCPYDMRPTENRTGCRPIPIIKLEWGSPWAVLPLFLAVVGIA
ATLFVVITFVRYNDTPIVKASGRELSYVLLAGIFLCYATTFLMIAEPDLGTCSLRRIFLG
LGMSISYAALLTKTNRIYRIFEQGKRSVSAPRFISPASQLAITFSLISLQLLGICVWFVV
DPSHSVVDFQDQRTLDPRFARGVLKCDISDLSLICLLGYSMLLMVTCTVYAIKTRGVPET
FNEAKPIGFTMYTTCIVWLAFIPIFFGTSQSADKLYIQTTTLTVSVSLSASVSLGMLYMP
KVYIILFHPEQNVPKRKRSLKAVVTAATMSNKFTQKGNFRPNGEAKSELCENLEAPALAT
KQTYVTYTNHAI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019017|Metabotropic glutamate receptor 4 (GRM4)
ATGCCTGGGAAGAGAGGCTTGGGCTGGTGGTGGGCCCGGCTGCCCCTTTGCCTGCTCCTC
AGCCTTTACGGCCCCTGGATGCCTTCCTCCCTGGGAAAGCCCAAAGGCCACCCTCACATG
AATTCCATCCGCATAGATGGGGACATCACACTGGGAGGCCTGTTCCCGGTGCATGGCCGG
GGCTCAGAGGGCAAGCCCTGTGGAGAACTTAAGAAGGAAAAGGGCATCCACCGGCTGGAG
GCCATGCTGTTCGCCCTGGATCGCATCAACAACGACCCGGACCTGCTGCCTAACATCACG
CTGGGCGCCCGCATTCTGGACACCTGCTCCAGGGACACCCATGCCCTCGAGCAGTCGCTG
ACCTTTGTGCAGGCGCTCATCGAGAAGGATGGCACAGAGGTCCGCTGTGGCAGTGGCGGC
CCACCCATCATCACCAAGCCTGAACGTGTGGTGGGTGTCATCGGTGCTTCAGGGAGCTCG
GTCTCCATCATGGTGGCCAACATCCTTCGCCTCTTCAAGATACCCCAGATCAGCTACGCC
TCCACAGCGCCAGACCTGAGTGACAACAGCCGCTACGACTTCTTCTCCCGCGTGGTGCCC
TCGGACACGTACCAGGCCCAGGCCATGGTGGACATCGTCCGTGCCCTCAAGTGGAACTAT
GTGTCCACAGTGGCCTCGGAGGGCAGCTATGGTGAGAGCGGTGTGGAGGCCTTCATCCAG
AAGTCCCGTGAGGACGGGGGCGTGTGCATCGCCCAGTCGGTGAAGATACCACGGGAGCCC
AAGGCAGGCGAGTTCGACAAGATCATCCGCCGCCTCCTGGAGACTTCGAACGCCAGGGCA
GTCATCATCTTTGCCAACGAGGATGACATCAGGCGTGTGCTGGAGGCAGCACGAAGGGCC
AACCAGACAGGCCATTTCTTCTGGATGGGCTCTGACAGCTGGGGCTCCAAGATTGCACCT
GTGCTGCACCTGGAGGAGGTGGCTGAGGGTGCTGTCACGATCCTCCCCAAGAGGATGTCC
GTACGAGGCTTCGACCGCTACTTCTCCAGCCGCACGCTGGACAACAACCGGCGCAACATC
TGGTTTGCCGAGTTCTGGGAGGACAACTTCCACTGCAAGCTGAGCCGCCACGCCCTCAAG
AAGGGCAGCCACGTCAAGAAGTGCACCAACCGTGAGCGAATTGGGCAGGATTCAGCTTAT
GAGCAGGAGGGGAAGGTGCAGTTTGTGATCGATGCCGTGTACGCCATGGGCCACGCGCTG
CACGCCATGCACCGTGACCTGTGTCCCGGCCGCGTGGGGCTCTGCCCGCGCATGGACCCT
GTAGATGGCACCCAGCTGCTTAAGTACATCCGAAACGTCAACTTCTCAGGCATCGCAGGG
AACCCTGTGACCTTCAATGAGAATGGAGATGCGCCTGGGCGCTATGACATCTACCAATAC
CAGCTGCGCAACGATTCTGCCGAGTACAAGGTCATTGGCTCCTGGACTGACCACCTGCAC
CTTAGAATAGAGCGGATGCACTGGCCGGGGAGCGGGCAGCAGCTGCCCCGCTCCATCTGC
AGCCTGCCCTGCCAACCGGGTGAGCGGAAGAAGACAGTGAAGGGCATGCCTTGCTGCTGG
CACTGCGAGCCTTGCACAGGGTACCAGTACCAGGTGGACCGCTACACCTGTAAGACGTGT
CCCTATGACATGCGGCCCACAGAGAACCGCACGGGCTGCCGGCCCATCCCCATCATCAAG
CTTGAGTGGGGCTCGCCCTGGGCCGTGCTGCCCCTCTTCCTGGCCGTGGTGGGCATCGCT
GCCACGTTGTTCGTGGTGATCACCTTTGTGCGCTACAACGACACGCCCATCGTCAAGGCC
TCGGGCCGTGAACTGAGCTACGTGCTGCTGGCAGGCATCTTCCTGTGCTATGCCACCACC
TTCCTCATGATCGCTGAGCCCGACCTTGGCACCTGCTCGCTGCGCCGAATCTTCCTGGGA
CTAGGGATGAGCATCAGCTATGCAGCCCTGCTCACCAAGACCAACCGCATCTACCGCATC
TTCGAGCAGGGCAAGCGCTCGGTCAGTGCCCCACGCTTCATCAGCCCCGCCTCACAGCTG
GCCATCACCTTCAGCCTCATCTCGCTGCAGCTGCTGGGCATCTGTGTGTGGTTTGTGGTG
GACCCCTCCCACTCGGTGGTGGACTTCCAGGACCAGCGGACACTCGACCCCCGCTTCGCC
AGGGGTGTGCTCAAGTGTGACATCTCGGACCTGTCGCTCATCTGCCTGCTGGGCTACAGC
ATGCTGCTCATGGTCACGTGCACCGTGTATGCCATCAAGACACGCGGCGTGCCCGAGACC
TTCAATGAGGCCAAGCCCATTGGCTTCACCATGTACACCACTTGCATCGTCTGGCTGGCC
TTCATCCCCATCTTCTTTGGCACCTCGCAGTCGGCCGACAAGCTGTACATCCAGACGACG
ACGCTGACGGTCTCGGTGAGTCTGAGCGCCTCGGTGTCCCTGGGAATGCTCTACATGCCC
AAAGTCTACATCATCCTCTTCCACCCGGAGCAGAACGTGCCCAAGCGCAAGCGCAGCCTC
AAAGCCGTCGTTACGGCGGCCACCATGTCCAACAAGTTCACGCAGAAGGGCAACTTCCGG
CCCAACGGAGAGGCCAAGTCTGAGCTCTGCGAGAACCTTGAGGCCCCAGCGCTGGCCACC
AAACAGACTTACGTCACTTACACCAACCATGCAATCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00003</identifier>
        <name>7tm_3</name>
      </pfam>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF07562</identifier>
        <name>NCD3G</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>G-protein coupled receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>group III metabotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of neuron apoptotic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000827</id>
      <name>Glutamate receptor ionotropic, kainate 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>8589992</pubmed-id>
            <citation>Korczak B, Nutt SL, Fletcher EJ, Hoo KH, Elliott CE, Rampersad V, McWhinnie EA, Kamboj RK: cDNA cloning and functional properties of human glutamate receptor EAA3 (GluR5) in homomeric and heteromeric configuration. Receptors Channels. 1995;3(1):41-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16099" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, kainate 4</name>
    <general-function>Kainate selective glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists.</specific-function>
    <gene-name>GRIK4</gene-name>
    <locus>11q22.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>546-566
624-644
805-825</transmembrane-regions>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi>6.71</theoretical-pi>
    <molecular-weight>107244.485</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4582</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIK4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>S67803</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>544590</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>453</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16099</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIK4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAA1</synonym>
      <synonym>Excitatory amino acid receptor 1</synonym>
      <synonym>GluK4</synonym>
      <synonym>Glutamate receptor KA-1</synonym>
      <synonym>GRIK</synonym>
      <synonym>KA1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010583|Glutamate receptor ionotropic, kainate 4
MPRVSAPLVLLPAWLVMVACSPHSLRIAAILDDPMECSRGERLSITLAKNRINRAPERLG
KAKVEVDIFELLRDSEYETAETMCQILPKGVVAVLGPSSSPASSSIISNICGEKEVPHFK
VAPEEFVKFQFQRFTTLNLHPSNTDISVAVAGILNFFNCTTACLICAKAECLLNLEKLLR
QFLISKDTLSVRMLDDTRDPTPLLKEIRDDKTATIIIHANASMSHTILLKAAELGMVSAY
YTYIFTNLEFSLQRMDSLVDDRVNILGFSIFNQSHAFFQEFAQSLNQSWQENCDHVPFTG
PALSSALLFDAVYAVVTAVQELNRSQEIGVKPLSCGSAQIWQHGTSLMNYLRMVELEGLT
GHIEFNSKGQRSNYALKILQFTRNGFRQIGQWHVAEGLSMDSHLYASNISDTLFNTTLVV
TTILENPYLMLKGNHQEMEGNDRYEGFCVDMLKELAEILRFNYKIRLVGDGVYGVPEANG
TWTGMVGELIARKADLAVAGLTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFL
DPFSPGVWLFMLLAYLAVSCVLFLVARLTPYEWYSPHPCAQGRCNLLVNQYSLGNSLWFP
VGGFMQQGSTIAPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMDVPIESVDDLA
DQTAIEYGTIHGGSSMTFFQNSRYQTYQRMWNYMYSKQPSVFVKSTEEGIARVLNSNYAF
LLESTMNEYYRQRNCNLTQIGGLLDTKGYGIGMPVGSVFRDEFDLAILQLQENNRLEILK
RKWWEGGKCPKEEDHRAKGLGMENIGGIFVVLICGLIVAIFMAMLEFLWTLRHSEATEVS
VCQEMVTELRSIILCQDSIHPRRRRAAVPPPRPPIPEERRPRGTATLSNGKLCGAGEPDQ
LAQRLAQEAALVARGCTHIRVCPECRRFQGLRARPSPARSEESLEWEKTTNSSEPE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010584|Glutamate receptor ionotropic, kainate 4 (GRIK4)
ATGCCCCGCGTCTCGGCGCCTTTGGTGCTGCTTCCTGCGTGGCTCGTGATGGTCGCCTGC
AGCCCGCACTCCTTGAGGATCGCTGCTATCTTGGACGACCCCATGGAGTGCAGCAGAGGG
GAGCGGCTCTCCATCACCCTGGCCAAGAACCGCATCAACCGCGCTCCTGAGAGGCTGGGC
AAGGCCAAGGTCGAAGTGGACATCTTTGAGCTTCTCAGAGACAGCGAGTACGAGACTGCA
GAAACCATGTGTCAGATCCTCCCCAAGGGGGTGGTCGCTGTCCTCGGACCATCGTCCAGC
CCAGCCTCCAGCTCCATCATCAGCAACATCTGTGGAGAGAAGGAGGTCCCTCACTTCAAA
GTGGCCCCAGAGGAGTTCGTCAAGTTCCAGTTCCAGAGATTCACAACCCTGAACCTCCAC
CCCAGCAACACTGACATCAGCGTGGCTGTAGCTGGGATCCTGAACTTCTTCAACTGCACC
ACCGCCTGCCTCATCTGTGCCAAAGCAGAATGCCTTTTAAACCTAGAGAAGCTGCTCCGG
CAATTCCTTATCTCCAAGGACACGCTGTCCGTCCGCATGCTGGATGACACCCGGGACCCC
ACCCCGCTCCTCAAGGAGATCCGGGACGACAAGACCGCCACCATCATCATCCACGCCAAC
GCCTCCATGTCCCACACCATCCTCCTGAAGGCAGCCGAACTTGGGATGGTGTCAGCCTAT
TACACATACATCTTCACTAATCTGGAGTTCTCACTCCAGAGAATGGACAGCCTTGTGGAT
GATCGTGTCAACATCCTGGGATTTTCCATTTTCAACCAATCCCATGCTTTCTTCCAAGAG
TTTGCCCAGAGCCTCAACCAGTCCTGGCAGGAGAACTGTGACCATGTGCCCTTCACTGGG
CCTGCGCTCTCCTCGGCCCTGCTGTTTGATGCTGTCTATGCTGTGGTGACTGCGGTGCAG
GAACTGAACCGGAGCCAAGAGATCGGCGTGAAGCCCTTGTCCTGCGGCTCGGCCCAGATC
TGGCAGCACGGCACCAGCCTCATGAACTACCTGCGCATGGTAGAATTGGAAGGTCTTACC
GGCCACATTGAATTCAACAGCAAAGGCCAGAGGTCCAACTACGCTTTGAAAATCTTACAG
TTCACAAGGAATGGTTTTCGGCAGATCGGCCAGTGGCACGTGGCAGAGGGCCTCAGCATG
GACAGCCACCTCTATGCCTCCAACATCTCGGACACTCTCTTCAACACCACCCTGGTCGTC
ACCACCATCCTGGAGAACCCATATTTAATGCTGAAGGGGAACCACCAGGAGATGGAAGGC
AATGACCGCTACGAGGGCTTCTGTGTGGACATGCTCAAGGAGCTGGCAGAGATCCTCCGA
TTCAACTACAAGATCCGCCTGGTTGGGGATGGCGTGTACGGCGTTCCCGAGGCCAACGGC
ACCTGGACGGGAATGGTCGGGGAGCTGATCGCTAGGAAAGCAGATCTGGCTGTGGCAGGC
CTCACCATTACAGCTGAACGGGAGAAGGTGATTGATTTCTCTAAGCCATTCATGACTCTG
GGAATTAGCATTCTTTACCGCGTTCATATGGGACGCAAACCCGGCTATTTCTCCTTCCTG
GACCCATTTTCTCCGGGCGTCTGGCTCTTCATGCTTCTAGCCTATCTGGCCGTCAGCTGT
GTCCTCTTCCTGGTGGCTCGGTTGACGCCCTACGAGTGGTACAGCCCACACCCATGTGCC
CAGGGCCGGTGCAACCTCCTGGTGAACCAGTACTCCCTGGGCAACAGCCTCTGGTTTCCG
GTCGGGGGGTTCATGCAGCAAGGCTCCACCATCGCCCCTCGCGCCTTATCCACCCGCTGT
GTCAGTGGCGTCTGGTGGGCATTCACGCTGATCATCATCTCATCCTACACGGCCAACCTG
GCAGCCTTCCTGACCGTGCAGCGCATGGATGTGCCCATTGAGTCAGTGGATGACCTGGCT
GACCAGACCGCCATTGAATATGGCACAATTCACGGAGGCTCCAGCATGACCTTCTTCCAA
AATTCCCGCTACCAGACCTACCAACGCATGTGGAATTACATGTATTCCAAGCAGCCCAGC
GTGTTCGTGAAGAGCACAGAGGAGGGAATCGCCAGGGTGTTGAATTCCAACTACGCCTTC
CTCCTGGAATCCACCATGAACGAGTACTATCGGCAGCGAAACTGCAACCTCACTCAGATT
GGGGGCCTGCTGGACACCAAGGGCTATGGGATTGGCATGCCAGTCGGCTCGGTTTTCCGG
GACGAGTTTGATCTGGCCATTCTCCAGCTGCAGGAGAACAACCGCCTGGAGATCCTGAAG
CGCAAATGGTGGGAAGGAGGGAAGTGCCCCAAGGAGGAAGATCACAGAGCTAAAGGCCTG
GGAATGGAGAATATTGGTGGAATCTTTGTGGTTCTTATTTGTGGCTTAATCGTGGCCATT
TTTATGGCTATGTTGGAGTTTTTATGGACTCTCAGACACTCAGAAGCAACTGAGGTGTCC
GTCTGCCAGGAGATGGTGACCGAGCTGCGCAGCATTATCCTGTGTCAGGACAGTATCCAC
CCCCGCCGGCGGCGCGCCGCAGTCCCGCCGCCCCGGCCCCCCATCCCCGAGGAGCGCCGA
CCGCGGGGCACGGCGACGCTCAGCAACGGGAAGCTGTGCGGGGCAGGGGAGCCCGACCAG
CTCGCGCAGAGACTGGCGCAGGAGGCCGCCCTGGTGGCCCGCGGCTGCACGCACATCCGC
GTCTGCCCCGAGTGCCGCCGCTTCCAGGGCCTGCGGGCACGGCCGTCGCCCGCCCGCAGC
GAGGAGAGCCTGGAGTGGGAGAAAACCACCAACAGCAGCGAGCCCGAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>kainate selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kainate selective glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000828</id>
      <name>Glutamate receptor ionotropic, kainate 5</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11058796</pubmed-id>
            <citation>Takeda M, Haga M, Yamada H, Kinoshita M, Otsuka M, Tsuboi S, Moriyama Y: Ionotropic glutamate receptors expressed in human retinoblastoma Y79 cells. Neurosci Lett. 2000 Nov 17;294(2):97-100.</citation>
          </article>
          <article>
            <pubmed-id>2850065</pubmed-id>
            <citation>Murphy DE, Hutchison AJ, Hurt SD, Williams M, Sills MA: Characterization of the binding of [3H]-CGS 19755: a novel N-methyl-D-aspartate antagonist with nanomolar affinity in rat brain. Br J Pharmacol. 1988 Nov;95(3):932-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16478" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, kainate 5</name>
    <general-function>Kainate selective glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists. This receptor binds kainate &gt; quisqualate &gt; domoate &gt; L-glutamate &gt;&gt; AMPA &gt;&gt; NMDA = 1S,3R-ACPD.</specific-function>
    <gene-name>GRIK5</gene-name>
    <locus>19q13.2</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>545-565
623-643
804-824</transmembrane-regions>
    <signal-regions>1-14</signal-regions>
    <theoretical-pi>8.03</theoretical-pi>
    <molecular-weight>109263.695</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4583</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIK5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>S40369</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>251840</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>454</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16478</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIK5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAA2</synonym>
      <synonym>Excitatory amino acid receptor 2</synonym>
      <synonym>GluK5</synonym>
      <synonym>Glutamate receptor KA-2</synonym>
      <synonym>GRIK2</synonym>
      <synonym>KA2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037087|Glutamate receptor ionotropic, kainate 5
MPAELLLLLIVAFASPSCQVLSSLRMAAILDDQTVCGRGERLALALAREQINGIIEVPAK
ARVEVDIFELQRDSQYETTDTMCQILPKGVVSVLGPSSSPASASTVSHICGEKEIPHIKV
GPEETPRLQYLRFASVSLYPSNEDVSLAVSRILKSFNYPSASLICAKAECLLRLEELVRG
FLISKETLSVRMLDDSRDPTPLLKEIRDDKVSTIIIDANASISHLILRKASELGMTSAFY
KYILTTMDFPILHLDGIVEDSSNILGFSMFNTSHPFYPEFVRSLNMSWRENCEASTYLGP
ALSAALMFDAVHVVVSAVRELNRSQEIGVKPLACTSANIWPHGTSLMNYLRMVEYDGLTG
RVEFNSKGQRTNYTLRILEKSRQGHREIGVWYSNRTLAMNATTLDINLSQTLANKTLVVT
TILENPYVMRRPNFQALSGNERFEGFCVDMLRELAELLRFRYRLRLVEDGLYGAPEPNGS
WTGMVGELINRKADLAVAAFTITAEREKVIDFSKPFMTLGISILYRVHMGRKPGYFSFLD
PFSPAVWLFMLLAYLAVSCVLFLAARLSPYEWYNPHPCLRARPHILENQYTLGNSLWFPV
GGFMQQGSEIMPRALSTRCVSGVWWAFTLIIISSYTANLAAFLTVQRMEVPVESADDLAD
QTNIEYGTIHAGSTMTFFQNSRYQTYQRMWNYMQSKQPSVFVKSTEEGIARVLNSRYAFL
LESTMNEYHRRLNCNLTQIGGLLDTKGYGIGMPLGSPFRDEITLAILQLQENNRLEILKR
KWWEGGRCPKEEDHRAKGLGMENIGGIFIVLICGLIIAVFVAVMEFIWSTRRSAESEEVS
VCQEMLQELRHAVSCRKTSRSRRRRRPGGPSRALLSLRAVREMRLSNGKLYSAGAGGDAG
SAHGGPQRLLDDPGPPSGARPAAPTPCTHVRVCQECRRIQALRASGAGAPPRGLGVPAEA
TSPPRPRPGPAGPRELAEHE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010585|Glutamate receptor ionotropic, kainate 5 (GRIK5)
ATGCCGGCTGAGCTGCTGCTGCTGCTGATTGTTGCCTTCGCCAGCCCCAGCTGCCAGGTG
CTCTCATCACTGCGCATGGCTGCAATCCTGGATGATCAGACAGTGTGTGGCCGCGGTGAG
CGTCTGGCCTTGGCCTTGGCCCGGGAGCAGATCAACGGGATCATCGAGGTCCCAGCCAAG
GCCCGAGTGGAAGTAGACATCTTTGAGCTGCAGCGGGACAGCCAGTACGAGACCACGGAC
ACCATGTGTCAGATCTTACCCAAAGGGGTTGTGTCTGTCCTTGGGCCCTCCTCTAGCCCA
GCATCTGCCTCCACCGTGAGCCATATCTGTGGAGAGAAGGAGATCCCCCACATCAAGGTG
GGTCCCGAGGAGACACCCCGCCTTCAGTACCTTCGCTTCGCGTCTGTCAGCCTGTACCCC
AGTAACGAGGACGTCAGCTTGGCGGTCTCCCGAATCCTCAAGTCCTTCAACTACCCCTCG
GCCAGCCTCATCTGCGCCAAGGCTGAGTGCCTGCTGCGATTGGAGGAACTGGTGCGTGGC
TTCCTCATCTCCAAGGAGACGCTGTCAGTGAGGATGTTGGACGACAGCCGGGACCCCACA
CCACTGCTCAAGGAGATCCGTGATGACAAGGTGTCCACCATCATCATCGACGCCAACGCC
TCCATCTCCCACCTCATCCTCCGTAAGGCCTCGGAACTGGGAATGACCTCAGCGTTTTAC
AAGTACATCCTCACCACCATGGACTTCCCCATCCTGCATCTGGACGGTATTGTGGAGGAC
TCCTCCAACATCCTGGGCTTCTCCATGTTCAACACGTCCCACCCCTTCTACCCTGAGTTT
GTCCGCAGCCTCAACATGTCCTGGAGGGAGAACTGTGAAGCCAGCACCTACCTGGGCCCT
GCGCTGTCAGCCGCCCTGATGTTTGACGCCGTGCACGTGGTGGTGAGCGCTGTCCGAGAG
CTGAACCGCAGCCAGGAGATCGGTGTGAAGCCTCTGGCCTGTACATCGGCCAACATTTGG
CCCCACGGGACCAGCCTCATGAACTACCTGCGCATGGTAGAGTATGATGGGCTGACCGGG
CGGGTCGAGTTCAACAGCAAAGGGCAGAGAACCAACTACACCCTGCGCATCCTAGAAAAG
TCCCGGCAGGGCCACCGTGAGATTGGGGTGTGGTACTCTAACCGCACCCTGGCCATGAAT
GCCACCACCCTGGACATCAACCTGTCGCAGACACTGGCCAACAAGACCCTGGTGGTCACA
ACCATCCTGGAGAACCCATACGTCATGCGCCGGCCCAACTTCCAGGCCCTGTCGGGGAAC
GAACGCTTCGAGGGCTTCTGCGTGGACATGCTGCGGGAGCTGGCCGAGCTGCTGCGCTTC
CGCTACCGCCTGCGGTTGGTGGAGGATGGGCTGTACGGGGCGCCCGAGCCCAACGGCTCC
TGGACGGGCATGGTTGGCGAGCTCATCAACCGGAAGGCAGACCTGGCTGTGGCCGCCTTC
ACCATCACAGCTGAGCGGGAGAAGGTCATCGACTTTTCCAAGCCCTTTATGACCCTGGGG
ATCAGCATCCTCTACCGAGTGCACATGGGCCGCAAGCCTGGCTACTTCTCCTTCCTGGAC
CCCTTCTCCCCTGCTGTGTGGCTCTTCATGCTTCTTGCCTACCTGGCTGTCAGCTGCGTC
CTGTTTCTGGCTGCCAGGCTGAGCCCCTATGAGTGGTATAACCCACACCCATGCCTGCGG
GCACGCCCCCACATCCTGGAGAACCAGTACACGCTGGGCAACAGCCTGTGGTTTCCCGTG
GGGGGCTTCATGCAGCAGGGCTCGGAGATCATGCCCCGGGCGCTGTCCACGCGCTGTGTC
AGCGGAGTCTGGTGGGCCTTCACCTTGATCATCATCTCCTCCTACACGGCCAACCTGGCC
GCCTTCCTCACCGTGCAGCGCATGGAGGTGCCTGTGGAGTCGGCCGATGACCTGGCAGAT
CAGACCAACATCGAGTATGGCACCATCCACGCCGGCTCCACCATGACCTTCTTCCAGAAT
TCACGGTACCAAACGTACCAGCGCATGTGGAACTACATGCAGTCGAAGCAGCCCAGCGTG
TTCGTCAAGAGCACAGAAGAGGGCATTGCCCGCGTCCTCAACTCCCGCTACGCCTTCCTG
CTCGAGTCCACCATGAACGAATACCACCGGCGCCTCAACTGCAACCTCACCCAGATCGGG
GGACTCCTCGACACCAAGGGCTACGGCATTGGCATGCCGCTGGGCTCCCCGTTCCGGGAT
GAGATCACACTGGCCATCCTGCAGCTTCAGGAGAACAACCGGCTGGAGATCCTGAAGCGC
AAGTGGTGGGAGGGGGGCCGGTGCCCCAAGGAGGAGGACCATCGAGCTAAAGGTTTGGGC
ATGGAGAACATTGGTGGCATTTTTATCGTGCTCATCTGTGGCCTCATCATTGCTGTCTTC
GTGGCGGTCATGGAATTCATATGGTCCACACGGAGGTCAGCTGAGTCCGAGGAGACCCCA
GCTCTGCATCCAGCTGCCTGCCAGTGTTCTGCACTTGGCCCAAGGACTCCTCTGAAGGAG
CCGTCCATGCTGCTAGTAAAGGTGCCCTCCACCCGTGTCCAGGTTGCCTTCTCAAGGACA
TCCCTCCGGCAAGTCTGTCCTTTCCTCCTGCAGCATCAGTTGTCCTCTCTTTATTGGATT
CAGGCCACCAACGTACAAATATGCTGTCATTTCTCCAGTCTTAAACCCTCTCCTGACCTC
ACTTTCCCTCCCAGCCACCGCCCACTTTCTTCCCTTCTCTTTACAGCCTTGGCAGCAGTG
GGGGGTCTCCCTGATGCTTCCAGTTTCTTCTTTCCTCCCATTTCCTCTTGCCCCCCACTC
CAGTCTGGCATCGGTCCCTGCCACTCCACTGAAGCCACTCTTGTCACCAGCAACTTCCAT
GTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>kainate selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kainate selective glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>receptor clustering</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucose stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>establishment of localization in cell</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein retention in ER lumen</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic vesicle fusion to presynaptic membrane</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000834</id>
      <name>Metabotropic glutamate receptor 7</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17360958</pubmed-id>
            <citation>Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14831" source="Swiss-Prot">
    <name>Metabotropic glutamate receptor 7</name>
    <general-function>Voltage-gated calcium channel activity</general-function>
    <specific-function>G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity.</specific-function>
    <gene-name>GRM7</gene-name>
    <locus>3p26.1-p25.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>591-615
628-648
655-675
703-723
754-775
789-810
826-850</transmembrane-regions>
    <signal-regions>1-34</signal-regions>
    <theoretical-pi>7.94</theoretical-pi>
    <molecular-weight>102250.06</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4599</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRM7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X94552</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1370111</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>295</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>295</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q14831</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRM7_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GPRC1G</synonym>
      <synonym>MGLUR7</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001664|Metabotropic glutamate receptor 7
MVQLRKLLRVLTLMKFPCCVLEVLLCALAAAARGQEMYAPHSIRIEGDVTLGGLFPVHAK
GPSGVPCGDIKRENGIHRLEAMLYALDQINSDPNLLPNVTLGARILDTCSRDTYALEQSL
TFVQALIQKDTSDVRCTNGEPPVFVKPEKVVGVIGASGSSVSIMVANILRLFQIPQISYA
STAPELSDDRRYDFFSRVVPPDSFQAQAMVDIVKALGWNYVSTLASEGSYGEKGVESFTQ
ISKEAGGLCIAQSVRIPQERKDRTIDFDRIIKQLLDTPNSRAVVIFANDEDIKQILAAAK
RADQVGHFLWVGSDSWGSKINPLHQHEDIAEGAITIQPKRATVEGFDAYFTSRTLENNRR
NVWFAEYWEENFNCKLTISGSKKEDTDRKCTGQERIGKDSNYEQEGKVQFVIDAVYAMAH
ALHHMNKDLCADYRGVCPEMEQAGGKKLLKYIRNVNFNGSAGTPVMFNKNGDAPGRYDIF
QYQTTNTSNPGYRLIGQWTDELQLNIEDMQWGKGVREIPASVCTLPCKPGQRKKTQKGTP
CCWTCEPCDGYQYQFDEMTCQHCPYDQRPNENRTGCQDIPIIKLEWHSPWAVIPVFLAML
GIIATIFVMATFIRYNDTPIVRASGRELSYVLLTGIFLCYIITFLMIAKPDVAVCSFRRV
FLGLGMCISYAALLTKTNRIYRIFEQGKKSVTAPRLISPTSQLAITSSLISVQLLGVFIW
FGVDPPNIIIDYDEHKTMNPEQARGVLKCDITDLQIICSLGYSILLMVTCTVYAIKTRGV
PENFNEAKPIGFTMYTTCIVWLAFIPIFFGTAQSAEKLYIQTTTLTISMNLSASVALGML
YMPKVYIIIFHPELNVQKRKRSFKAVVTAATMSSRLSHKPSDRPNGEAKTELCENVDPNS
PAAKKKYVSYNNLVI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021276|Metabotropic glutamate receptor 7 (GRM7)
ATGGTCCAGCTGAGGAAGCTGCTCCGCGTCCTGACTTTGATGAAGTTCCCCTGCTGCGTG
CTGGAGGTGCTCCTGTGCGCGCTGGCGGCGGCGGCGCGCGGCCAGGAGATGTACGCCCCG
CACTCAATCCGGATCGAGGGGGACGTCACCCTCGGGGGGCTGTTCCCCGTGCACGCCAAG
GGTCCCAGCGGAGTGCCCTGCGGCGACATCAAGAGGGAAAACGGGATCCACAGGCTGGAA
GCGATGCTCTACGCCCTGGACCAGATCAACAGTGATCCCAACCTACTGCCCAACGTGACG
CTGGGCGCGCGGATCCTGGACACTTGTTCCAGGGACACTTACGCGCTCGAACAGTCGCTT
ACTTTCGTCCAGGCGCTCATCCAGAAGGACACCTCCGACGTGCGCTGCACCAACGGCGAA
CCGCCGGTTTTCGTCAAGCCGGAGAAAGTAGTTGGAGTGATTGGGGCTTCGGGGAGTTCG
GTCTCCATCATGGTAGCCAACATCCTGAGGCTCTTCCAGATCCCCCAGATTAGTTATGCA
TCAACGGCACCCGAGCTAAGTGATGACCGGCGCTATGACTTCTTCTCTCGCGTGGTGCCA
CCCGATTCCTTCCAAGCCCAGGCCATGGTAGACATTGTAAAGGCCCTAGGCTGGAATTAT
GTGTCTACCCTCGCATCGGAAGGAAGTTATGGAGAGAAAGGTGTGGAGTCCTTCACGCAG
ATTTCCAAAGAGGCAGGTGGACTCTGCATTGCCCAGTCCGTGAGAATCCCCCAGGAACGC
AAAGACAGGACCATTGACTTTGATAGAATTATCAAACAGCTCCTGGACACCCCCAACTCC
AGGGCCGTCGTGATTTTTGCCAACGATGAGGATATAAAGCAGATCCTTGCAGCAGCCAAA
AGAGCTGACCAAGTTGGCCATTTTCTTTGGGTGGGATCAGACAGCTGGGGATCCAAAATA
AACCCACTGCACCAGCATGAAGATATCGCAGAAGGGGCCATCACCATTCAGCCCAAGCGA
GCCACGGTGGAAGGGTTTGATGCCTACTTTACGTCCCGTACACTTGAAAACAACAGAAGA
AATGTATGGTTTGCCGAATACTGGGAGGAAAACTTCAACTGCAAGTTGACGATTAGTGGG
TCAAAAAAAGAAGACACAGATCGCAAATGCACAGGACAGGAGAGAATTGGAAAAGATTCC
AACTATGAGCAGGAGGGTAAAGTCCAGTTCGTGATTGACGCAGTCTATGCTATGGCTCAC
GCCCTTCACCACATGAACAAGGATCTCTGTGCTGACTACCGGGGTGTCTGCCCAGAGATG
GAGCAAGCTGGAGGCAAGAAGTTGCTGAAGTATATACGCAATGTTAATTTCAATGGTAGT
GCTGGCACTCCAGTGATGTTTAACAAGAACGGGGATGCACCTGGGCGTTATGACATCTTT
CAGTACCAGACCACAAACACCAGCAACCCGGGTTACCGTCTGATCGGGCAGTGGACAGAC
GAACTTCAGCTCAATATAGAAGACATGCAGTGGGGTAAAGGAGTCCGAGAGATACCCGCC
TCAGTGTGCACACTACCATGTAAGCCAGGACAGAGAAAGAAGACACAGAAAGGAACTCCT
TGCTGTTGGACCTGTGAGCCTTGCGATGGTTACCAGTACCAGTTTGATGAGATGACATGC
CAGCATTGCCCCTATGACCAGAGGCCCAATGAAAATCGAACCGGATGCCAGGATATTCCC
ATCATCAAACTGGAGTGGCACTCCCCCTGGGCTGTGATTCCTGTCTTCCTGGCAATGTTG
GGGATCATTGCCACCATCTTTGTCATGGCCACTTTCATCCGCTACAATGACACGCCCATT
GTCCGGGCATCTGGGCGGGAACTCAGCTATGTTCTTTTGACGGGCATCTTTCTTTGCTAC
ATCATCACTTTCCTGATGATTGCCAAACCAGATGTGGCAGTGTGTTCTTTCCGGCGAGTT
TTCTTGGGCTTGGGTATGTGCATCAGTTATGCAGCCCTCTTGACGAAAACAAATCGGATT
TATCGCATATTTGAGCAGGGCAAGAAATCAGTAACAGCTCCCAGACTCATAAGCCCAACA
TCACAACTGGCAATCACTTCCAGTTTAATATCAGTTCAGCTTCTAGGGGTGTTCATTTGG
TTTGGTGTTGATCCACCCAACATCATCATAGACTATGATGAACACAAGACAATGAACCCT
GAGCAAGCCAGAGGGGTTCTCAAGTGTGACATTACAGATCTCCAAATCATTTGCTCCTTG
GGATATAGCATTCTTCTCATGGTCACATGTACTGTGTATGCCATCAAGACTCGGGGTGTA
CCCGAGAATTTTAACGAAGCCAAGCCCATTGGATTCACTATGTACACGACATGTATAGTA
TGGCTTGCCTTCATTCCAATTTTTTTTGGCACCGCTCAATCAGCGGAAAAGCTCTACATA
CAAACTACCACGCTTACAATCTCCATGAACCTAAGTGCATCAGTGGCGCTGGGGATGCTA
TACATGCCGAAAGTGTACATCATCATTTTCCACCCTGAACTCAATGTCCAGAAACGGAAG
CGAAGCTTCAAGGCGGTAGTCACAGCAGCCACCATGTCATCGAGGCTGTCACACAAACCC
AGTGACAGACCCAACGGTGAGGCAAAGACCGAGCTCTGTGAAAACGTAGACCCAAACAGC
CCTGCTGCAAAAAAGAAGTATGTCAGTTATAATAACCTGGTTATCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00003</identifier>
        <name>7tm_3</name>
      </pfam>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF07562</identifier>
        <name>NCD3G</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>dendritic shaft</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>asymmetric synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell cortex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic active zone</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>voltage-gated calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenylate cyclase inhibitor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>PDZ domain binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>serine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>group III metabotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel regulator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cyclase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cAMP biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of adenylate cyclase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>short-term memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of smell</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal response to stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmission of nerve impulse</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>conditioned taste aversion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of sound</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000835</id>
      <name>Metabotropic glutamate receptor 8</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17360958</pubmed-id>
            <citation>Suzuki G, Kimura T, Satow A, Kaneko N, Fukuda J, Hikichi H, Sakai N, Maehara S, Kawagoe-Takaki H, Hata M, Azuma T, Ito S, Kawamoto H, Ohta H: Pharmacological characterization of a new, orally active and potent allosteric metabotropic glutamate receptor 1 antagonist, 4-[1-(2-fluoropyridin-3-yl)-5-methyl-1H-1,2,3-triazol-4-yl]-N-isopropyl-N-methyl- 3,6-dihydropyridine-1(2H)-carboxamide (FTIDC). J Pharmacol Exp Ther. 2007 Jun;321(3):1144-53. Epub 2007 Mar 14.</citation>
          </article>
          <article>
            <pubmed-id>16957773</pubmed-id>
            <citation>Morimoto R, Uehara S, Yatsushiro S, Juge N, Hua Z, Senoh S, Echigo N, Hayashi M, Mizoguchi T, Ninomiya T, Udagawa N, Omote H, Yamamoto A, Edwards RH, Moriyama Y: Secretion of L-glutamate from osteoclasts through transcytosis. EMBO J. 2006 Sep 20;25(18):4175-86. Epub 2006 Sep 7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O00222" source="Swiss-Prot">
    <name>Metabotropic glutamate receptor 8</name>
    <general-function>Group iii metabotropic glutamate receptor activity</general-function>
    <specific-function>G-protein coupled receptor for glutamate. Ligand binding causes a conformation change that triggers signaling via guanine nucleotide-binding proteins (G proteins) and modulates the activity of down-stream effectors, such as adenylate cyclase. Signaling inhibits adenylate cyclase activity.</specific-function>
    <gene-name>GRM8</gene-name>
    <locus>7q31.3-q32.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>584-608
621-641
648-668
696-716
747-768
782-803
819-843</transmembrane-regions>
    <signal-regions>1-33</signal-regions>
    <theoretical-pi>8.21</theoretical-pi>
    <molecular-weight>101739.575</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4600</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRM8</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U92459</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1935043</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>296</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>296</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O00222</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRM8_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GPRC1H</synonym>
      <synonym>MGLUR8</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001666|Metabotropic glutamate receptor 8
MVCEGKRSASCPCFFLLTAKFYWILTMMQRTHSQEYAHSIRVDGDIILGGLFPVHAKGER
GVPCGELKKEKGIHRLEAMLYAIDQINKDPDLLSNITLGVRILDTCSRDTYALEQSLTFV
QALIEKDASDVKCANGDPPIFTKPDKISGVIGAAASSVSIMVANILRLFKIPQISYASTA
PELSDNTRYDFFSRVVPPDSYQAQAMVDIVTALGWNYVSTLASEGNYGESGVEAFTQISR
EIGGVCIAQSQKIPREPRPGEFEKIIKRLLETPNARAVIMFANEDDIRRILEAAKKLNQS
GHFLWIGSDSWGSKIAPVYQQEEIAEGAVTILPKRASIDGFDRYFRSRTLANNRRNVWFA
EFWEENFGCKLGSHGKRNSHIKKCTGLERIARDSSYEQEGKVQFVIDAVYSMAYALHNMH
KDLCPGYIGLCPRMSTIDGKELLGYIRAVNFNGSAGTPVTFNENGDAPGRYDIFQYQITN
KSTEYKVIGHWTNQLHLKVEDMQWAHREHTHPASVCSLPCKPGERKKTVKGVPCCWHCER
CEGYNYQVDELSCELCPLDQRPNMNRTGCQLIPIIKLEWHSPWAVVPVFVAILGIIATTF
VIVTFVRYNDTPIVRASGRELSYVLLTGIFLCYSITFLMIAAPDTIICSFRRVFLGLGMC
FSYAALLTKTNRIHRIFEQGKKSVTAPKFISPASQLVITFSLISVQLLGVFVWFVVDPPH
IIIDYGEQRTLDPEKARGVLKCDISDLSLICSLGYSILLMVTCTVYAIKTRGVPETFNEA
KPIGFTMYTTCIIWLAFIPIFFGTAQSAEKMYIQTTTLTVSMSLSASVSLGMLYMPKVYI
IIFHPEQNVQKRKRSFKAVVTAATMQSKLIQKGNDRPNGEVKSELCESLETNTSSTKTTY
ISYSNHSI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010588|Metabotropic glutamate receptor 8 (GRM8)
ATGGTATGCGAGGGAAAGCGATCAGCCTCTTGCCCTTGTTTCTTCCTCTTGACCGCCAAG
TTCTACTGGATCCTCACAATGATGCAAAGAACTCACAGCCAGGAGTATGCCCATTCCATA
CGGGTGGATGGGGACATTATTTTGGGGGGTCTCTTCCCTGTCCACGCAAAGGGAGAGAGA
GGGGTGCCTTGTGGGGAGCTGAAGAAGGAAAAGGGGATTCACAGACTGGAGGCCATGCTT
TATGCAATTGACCAGATTAACAAGGACCCTGATCTCCTTTCCAACATCACTCTGGGTGTC
CGCATCCTCGACACGTGCTCTAGGGACACCTATGCTTTGGAGCAGTCTCTAACATTCGTG
CAGGCATTAATAGAGAAAGATGCTTCGGATGTGAAGTGTGCTAATGGAGATCCACCCATT
TTCACCAAGCCCGACAAGATTTCTGGCGTCATAGGTGCTGCAGCAAGCTCCGTGTCCATC
ATGGTTGCTAACATTTTAAGACTTTTTAAGATACCTCAAATCAGCTATGCATCCACAGCC
CCAGAGCTAAGTGATAACACCAGGTATGACTTTTTCTCTCGAGTGGTTCCGCCTGACTCC
TACCAAGCCCAAGCCATGGTGGACATCGTGACAGCACTGGGATGGAATTATGTTTCGACA
CTGGCTTCTGAGGGGAACTATGGTGAGAGCGGTGTGGAGGCCTTCACCCAGATCTCGAGG
GAGATTGGTGGTGTTTGCATTGCTCAGTCACAGAAAATCCCACGTGAACCAAGACCTGGA
GAATTTGAAAAAATTATCAAACGCCTGCTAGAAACACCTAATGCTCGAGCAGTGATTATG
TTTGCCAATGAGGATGACATCAGGAGGATATTGGAAGCAGCAAAAAAACTAAACCAAAGT
GGGCATTTTCTCTGGATTGGCTCAGATAGTTGGGGATCCAAAATAGCACCTGTCTATCAG
CAAGAGGAGATTGCAGAAGGGGCTGTGACAATTTTGCCCAAACGAGCATCAATTGATGGA
TTTGATCGATACTTTAGAAGCCGAACTCTTGCCAATAATCGAAGAAATGTGTGGTTTGCA
GAATTCTGGGAGGAGAATTTTGGCTGCAAGTTAGGATCACATGGGAAAAGGAACAGTCAT
ATAAAGAAATGCACAGGGCTGGAGCGAATTGCTCGGGATTCATCTTATGAACAGGAAGGA
AAGGTCCAATTTGTAATTGATGCTGTATATTCCATGGCTTACGCCCTGCACAATATGCAC
AAAGATCTCTGCCCTGGATACATTGGCCTTTGTCCACGAATGAGTACCATTGATGGGAAA
GAGCTACTTGGTTATATTCGGGCTGTAAATTTTAATGGCAGTGCTGGCACTCCTGTCACT
TTTAATGAAAACGGAGATGCTCCTGGACGTTATGATATCTTCCAGTATCAAATAACCAAC
AAAAGCACAGAGTACAAAGTCATCGGCCACTGGACCAATCAGCTTCATCTAAAAGTGGAA
GACATGCAGTGGGCTCATAGAGAACATACTCACCCGGCGTCTGTCTGCAGCCTGCCGTGT
AAGCCAGGGGAGAGGAAGAAAACGGTGAAAGGGGTCCCTTGCTGCTGGCACTGTGAACGC
TGTGAAGGTTACAACTACCAGGTGGATGAGCTGTCCTGTGAACTTTGCCCTCTGGATCAG
AGACCCAACATGAACCGCACAGGCTGCCAGCTTATCCCCATCATCAAATTGGAGTGGCAT
TCTCCCTGGGCTGTGGTGCCTGTGTTTGTTGCAATATTGGGAATCATCGCCACCACCTTT
GTGATCGTGACCTTTGTCCGCTATAATGACACACCTATCGTGAGGGCTTCAGGACGCGAA
CTTAGTTACGTGCTCCTAACGGGGATTTTTCTCTGTTATTCAATCACGTTTTTAATGATT
GCAGCACCAGATACAATCATATGCTCCTTCCGACGGGTCTTCCTAGGACTTGGCATGTGT
TTCAGCTATGCAGCCCTTCTGACCAAAACAAACCGTATCCACCGAATATTTGAGCAGGGG
AAGAAATCTGTCACAGCGCCCAAGTTCATTAGTCCAGCATCTCAGCTGGTGATCACCTTC
AGCCTCATCTCCGTCCAGCTCCTTGGAGTGTTTGTCTGGTTTGTTGTGGATCCCCCCCAC
ATCATCATTGACTATGGAGAGCAGCGGACACTAGATCCAGAGAAGGCCAGGGGAGTGCTC
AAGTGTGACATTTCTGATCTCTCACTCATTTGTTCACTTGGATACAGTATCCTCTTGATG
GTCACTTGTACTGTTTATGCCATTAAAACGAGAGGTGTCCCAGAGACTTTCAATGAAGCC
AAACCTATTGGATTTACCATGTATACCACCTGCATCATTTGGTTAGCTTTCATCCCCATC
TTTTTTGGTACAGCCCAGTCAGCAGAAAAGATGTACATCCAGACAACAACACTTACTGTC
TCCATGAGTTTAAGTGCTTCAGTATCTCTGGGCATGCTCTATATGCCCAAGGTTTATATT
ATAATTTTTCATCCAGAACAGAATGTTCAAAAACGCAAGAGGAGCTTCAAGGCTGTGGTG
ACAGCTGCCACCATGCAAAGCAAACTGATCCAAAAAGGAAATGACAGACCAAATGGCGAG
GTGAAAAGTGAACTCTGTGAGAGTCTTGAAACCAACACTTCCTCTACCAAGACAACATAT
ATCAGTTACAGCAATCATTCAATCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00003</identifier>
        <name>7tm_3</name>
      </pfam>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF07562</identifier>
        <name>NCD3G</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>group III metabotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>G-protein coupled receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual perception</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cAMP biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of smell</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002267</id>
      <name>Excitatory amino acid transporter 5</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>15128272</pubmed-id>
            <citation>Takarada T, Hinoi E, Balcar VJ, Taniura H, Yoneda Y: Possible expression of functional glutamate transporters in the rat testis. J Endocrinol. 2004 May;181(2):233-44.</citation>
          </article>
          <article>
            <pubmed-id>9108121</pubmed-id>
            <citation>Arriza JL, Eliasof S, Kavanaugh MP, Amara SG: Excitatory amino acid transporter 5, a retinal glutamate transporter coupled to a chloride conductance. Proc Natl Acad Sci U S A. 1997 Apr 15;94(8):4155-60.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O00341" source="Swiss-Prot">
    <name>Excitatory amino acid transporter 5</name>
    <general-function>Sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Transports L-glutamate; the L-glutamate uptake is sodium- and voltage-dependent and chloride-independent. Its associated chloride conductance may participate in visual processing.</specific-function>
    <gene-name>SLC1A7</gene-name>
    <locus>1p32.3</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>17-37
60-80
94-114
217-237
260-280
300-320
330-350
372-392
414-434
457-477</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>6.97</theoretical-pi>
    <molecular-weight>60657.825</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10945</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U76362</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2076762</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>872</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O00341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>EAA5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAAT5</synonym>
      <synonym>Retinal glutamate transporter</synonym>
      <synonym>Solute carrier family 1 member 7</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037183|Excitatory amino acid transporter 5
MVPHAILARGRDVCRRNGLLILSVLSVIVGCLLGFFLRTRRLSPQEISYFQFPGELLMRM
LKMMILPLVVSSLMSGLASLDAKTSSRLGVLTVAYYLWTTFMAVIVGIFMVSIIHPGSAA
QKETTEQSGKPIMSSADALLDLIRNMFPANLVEATFKQYRTKTTPVVKSPKVAPEEAPPR
RILIYGVQEENGSHVQNFALDLTPPPEVVYKSEPGTSDGMNVLGIVFFSATMGIMLGRMG
DSGAPLVSFCQCLNESVMKIVAVAVWYFPFGIVFLIAGKILEMDDPRAVGKKLGFYSVTV
VCGLVLHGLFILPLLYFFITKKNPIVFIRGILQALLIALATSSSSATLPITFKCLLENNH
IDRRIARFVLPVGATINMDGTALYEAVAAIFIAQVNNYELDFGQIITISITATAASIGAA
GIPQAGLVTMVIVLTSVGLPTDDITLIIAVDWALDRFRTMINVLGDALAAGIMAHICRKD
FARDTGTEKLLPCETKPVSLQEIVAAQQNGCVKSVAEASELTLGPTCPHHVPVQVEQDEE
LPAASLNHCTIQISELETNV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0004449|1683 bp
ATGGTGCCGCATACCATCTTGGCACGGGGGAGGGACGTGTGCAGGCGGAATGGACTCCTC
ATCCTGTCTGTGCTGTCTGTCATCGTGGGCTGCCTCCTCGGCTTCTTCTTGAGGACCCGG
CGCCTCTCACCACAGGAAATTAGTTACTTCCAGTTCCCCGGAGAGCTCCTGATGAGGATG
CTGAAGATGATGATCCTGCCACTGGTGTTCTCCAGCTTGATGTCCGGACTTGCCTCCCTG
GATGCCAAGACCTCTAGCCGCCTGGGCGTCCTCACCGTGGCGTACTACCTGTGGACCACC
TTCATGGCTGTCATCGTGGGCATCTTCATGGTCTCCATCATCCACCCAGGCAGCGCGGCC
CAGAAGGAGACCACGGAGCAGAGTGGGAAGCCCATCATGAGCTCAGCCGATGCCCTGTTG
GACCTCATCCGGAACATGTTCCCAGCCAACCTAGTAGAAGCCACATTCAAACAGTACCGC
ACCAAGACCACCCCAGTTGTCAAGTCCCCCAAGGTGGCACCAGAGGAGGCCCCTCCTCGG
CGGATCCTCATCTACGGGGTCCAGGAGGAGAATGGCTCCCATGTGCAGAACTTCGCCCTG
GACCTGACCCCGCCGCCCGAGGTCGTTTACAAGTCAGAGCCGGGCACCAGCGATGGCATG
AATGTGCTGGGCATCGTCTTCTTCTCTGCCACCATGGGCATCATGCTGGGCCGCATGGGT
GACAGCGGGGGCCCCCTGGTCAGCTTCTGCCAGTGCCTCAATGAGTCGGTCATGAAGATC
GTGGCGGTGGCTGTGTGGTATTTCCCCTTCGGCATTGTGTTCCTCATTGCGGGTAAGATC
CTGGAGATGGACGACCCCAGGGCCGTCGGCAAGAAGCTGGGCTTCTACTCAGTCACCGTG
GTGTGCGGGCTGGTGCTCCACGGGCTCTTTATCCTGCCCCTGCTCTACTTCTTCATCACC
AAGAAGAATCCCATCGTCTTCATCCGCGGCATCCTGCAGGCTCTGCTCATCGCGCTGGCC
ACCTCCTCCAGCTCAGCCACACTGCCCATCACCTTCAAGTGCCTGCTGGAGAACAACCAC
ATCGACCGGCGCATCGCTCGCTTCGTGCTGCCCGTGGGTGCCACCATCAACATGGACGGC
ACTGCGCTCTACGAGGCTGTGGCCGCCATCTTCATCGCCCAGGTCAACAACTACGAGCTG
GACTTTGGCCAGATCATCACCATCAGTATCACAGGCACTGCAGCCAGCATTGGGGCAGCT
GGCATCCCCCAGGCCGGCCTCGTCACCATGGTCATCGTGCTCACCTCCGTGGGACTGCCC
ACCGATGACATCACCCTCATCATTGGCGTTGACTGGGCTCTGGACCGTTTCCGCACCATG
ATTAACGTGCTGGGTGATGCGCTGGCAGCGGGGATCATGGCCCATATATGTCGGAAGGAT
TTTGCCCGGGACACAGGCACCGAGAAACTGCTGCCCTGCGAGACCAAGCCAGTGAGCCTC
CAGGAGATCGTGGCAGCCCAGCAGAATGGCTGTGTGAAGAGTGTAGCCGAGGCCTCCGAG
CTCACCCTGGGCCCCACCTGCCCCCACCACGTCCCCGTTCAAGTGGAGCGGGATGAGGAG
CTGCCCGCTGCGAGTCTGAACCACTGCACCATCCAGATCAGCGAGCTGGAGACCAATGTC
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dicarboxylic acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002268</id>
      <name>5-oxoprolinase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11302195</pubmed-id>
            <citation>Nishimura A, Itoh H, Oyama H, Murao S, Oda K: A simultaneous assay method for L-glutamate and L-pyroglutamate contents in soy sauce using a 5-oxoprolinase (without ATP hydrolyzing activity). Biosci Biotechnol Biochem. 2001 Feb;65(2):477-9.</citation>
          </article>
          <article>
            <pubmed-id>4514988</pubmed-id>
            <citation>Van der Werf P, Stephani RA, Orlowski M, Meister A: Inhibition of 5-oxoprolinase by 2-imidazolidone-4-carboxylic acid. Proc Natl Acad Sci U S A. 1973 Mar;70(3):759-61.</citation>
          </article>
          <article>
            <pubmed-id>6145710</pubmed-id>
            <citation>Seddon AP, Li LY, Meister A: Resolution of 5-oxo-L-prolinase into a 5-oxo-L-proline-dependent ATPase and a coupling protein. J Biol Chem. 1984 Jul 10;259(13):8091-4.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O14841" source="Swiss-Prot">
    <name>5-oxoprolinase</name>
    <general-function>Atp binding</general-function>
    <specific-function>Catalyzes the cleavage of 5-oxo-L-proline to form L-glutamate coupled to the hydrolysis of ATP to ADP and inorganic phosphate.</specific-function>
    <gene-name>OPLAH</gene-name>
    <locus>8q24.3</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.56</theoretical-pi>
    <molecular-weight>137456.195</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8149</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>OPLAH</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB122018</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>46020040</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O14841</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>OPLA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.5.2.9</synonym>
      <synonym>5-OPase</synonym>
      <synonym>5-oxo-L-prolinase</synonym>
      <synonym>Pyroglutamase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004452|5-oxoprolinase
MGSPEGRFHFAIDRGGTFTDVFAQCPGGHVRVLKLLSEDPANYADAPTEGIRRILEQEAG
MLLPRDQPLDSSHIASIRMGTTVATNALLERKGERVALLVTRGFRDLLHIGTQARGDLFD
LAVPMPEVLYEEVLEVDERVVLHRGEAGTGTPVKGRTGDLLEVQQPVDLGALRGKLEGLL
SRGIRSLAVVLMHSYTWAQHEQQVGVLARELGFTHVSLSSEAMPMVRIVPRGHTACADAY
LTPAIQRYVQGFCRGFQGQLKDVQVLFMRSDGGLAPMDTFSGSSAVLSGPAGGVVGYSAT
TYQQEGGQPVIGFDMGGTSTDVSRYAGEFEHVFEASTAGVTLQAPQLDINTVAAGGGSRL
FFRSGLFVVGPESAGAHPGPACYRKGGPVTVTDANLVLGRLLPASFPCIFGPGENQPLSP
EASRKALEAVATEVNSFLTNGPCPASPLSLEEVAMGFVRVANEAMCRPIRALTQARGHDP
SAHVLACFGGAGGQHACAIARALGMDTVHIHRHSGLLSALGLALADVVHEAQEPCSLLYA
PETFVQLDQRLSRLEEQCVDALQAQGFPRSQISTESFLHLRYQGTDCALMVSAHQHPATA
RSPRAGDFGAAFVERYMREFGFVIPERPVVVDDVRVRGTGRSGLRLEDAPKAQTGPPRVD
KMTQCYFEGGYQETPVYLLAELGYGHKLHGPCLIIDSNSTILVEPGCQAEVTKTGDICIS
VGAEVPGTVGPQLDPIQLSIFSHRFMSIAEQMGRILQRTAISTNIKERLDFSCALFGPDG
GLVSNAPHIPVHLGAMQETVQFQIQHLGADLHPGDVLLSNHPSAGGSHLPDLTVITPVFW
PGQTRPVFYVASRGHHADIGGITPGSMPPHSTMLQQEGAVFLSFKLVQGGVFQEEAVTEA
LRAPGKVPNCSGTRNLHDNLSDLRAQVAANQKGIQLVGELIGQYGLDVVQAYMGHIQANA
ELAVRDMLRAFGTSRQARGLPLEVSSEDHMDDGSPIRLRVQISLSQGSAVFDFSGTGPEV
FGNLNAPRAVTLSALIYCLRCLVGRDIPLNQGCLAPVRVVIPRGSILDPSPEAAVVGGNV
LTSQRVVDVILGAFGACAASQGCMNNVTLGNAHMGYYETVAGGAGAGPSWHGRSGVHSHM
TNTRITDPEILESRYPVILRRFELRRGSGGRGRFRGGDGVTRELLFREEALLSVLTERRA
FRPYGLHGGEPGARGLNLLIRKNGRTVNLGGKTSVTVYPGDVFCLHTPGGGGYGDPEDPA
PPPGSPPQALAFPEHGSVYEYRRAQEAV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019258|5-oxoprolinase (OPLAH)
ATGGGCAGCCCCGAGGGCCGCTTCCACTTTGCCATCGACCGTGGGGGTACCTTCACAGAC
GTCTTTGCCCAGTGCCCAGGGGGGCACGTGCGGGTCTTAAAACTGCTCTCAGAGGACCCT
GCCAACTATGCGGACGCGCCAACCGAAGGCATCCGCCGCATCCTGGAGCAGGAGGCCGGC
ATGCTCCTGCCCCGGGACCAGCCGCTGGACTCCAGTCATATCGCCAGCATCCGCATGGGC
ACCACAGTGGCCACCAACGCACTGCTGGAGCGGAAGGGGGAGCGGGTGGCGCTGCTGGTG
ACACGTGGCTTCCGAGACCTGCTGCACATTGGCACCCAAGCCCGTGGGGACCTCTTTGAC
CTGGCCGTGCCCATGCCTGAGGTGCTGTATGAAGAGGTGCTGGAGGTGGACGAACGCGTG
GTGCTGCACCGTGGAGAGGCGGGCACCGGGACGCCTGTGAAAGGCCGCACGGGGGACCTG
CTGGAAGTGCAGCAGCCTGTGGACCTGGGGGCCCTGCGTGGGAAGCTGGAGGGGCTGCTA
TCTCGAGGCATCCGCAGCCTGGCTGTGGTGCTCATGCACTCGTACACGTGGGCCCAGCAT
GAGCAGCAGGTGGGTGTGCTGGCCCGGGAGCTGGGCTTCACGCACGTGTCACTGTCCTCG
GAGGCCATGCCCATGGTGCGCATCGTCCCTCGGGGGCACACGGCCTGTGCCGACGCCTAC
CTCACGCCCGCCATCCAGCGCTACGTGCAGGGCTTCTGCCGTGGCTTCCAGGGCCAACTC
AAGGATGTGCAGGTGTTGTTCATGCGCTCCGATGGCGGCCTGGCGCCCATGGACACCTTC
AGCGGCTCCAGTGCTGTGCTCTCGGGCCCGGCCGGCGGCGTGGTGGGCTACTCAGCCACC
ACCTACCAGCAGGAGGGTGGCCAGCCTGTCATCGGCTTTGACATGGGAGGCACGTCCACG
GATGTGAGCCGCTATGCTGGGGAATTCGAGCACGTCTTCGAGGCCAGCACAGCTGGCGTC
ACCCTCCAGGCCCCGCAGCTGGACATCAACACCGTGGCAGCGGGAGGGGGTTCCCGCCTC
TTCTTCAGGTCTGGCCTCTTTGTGGTTGGGCCCGAGTCAGCAGGAGCCCACCCAGGACCC
GCCTGCTACCGCAAAGGGGGCCCTGTGACAGTGACGGATGCTAATCTGGTCCTGGGTCGC
CTGCTGCCTGCCTCCTTCCCCTGCATTTTTGGGCCGGGAGAGAACCAACCACTTTCCCCT
GAGGCCTCCCGCAAAGCCCTGGAGGCTGTGGCCACTGAGGTCAACAGCTTCCTGACCAAC
GGGCCCTGCCCGGCCTCCCCGCTGAGCCTGGAGGAGGTGGCCATGGGGTTCGTGCGCGTG
GCCAACGAGGCCATGTGCCGGCCCATCCGTGCACTCACGCAGGCAAGAGGCCATGACCCC
TCAGCCCATGTGCTGGCCTGCTTTGGGGGAGCTGGTGGGCAGCATGCATGTGCCATCGCC
CGGGCCCTGGGCATGGACACGGTGCACATCCACAGGCACAGTGGGCTGCTGTCGGCCCTG
GGGCTGGCCCTGGCTGACGTGGTGCATGAGGCACAGGAACCCTGCTCCCTGCTCTACGCG
CCTGAGACCTTCGTGCAGCTGGACCAGAGGCTGAGCCGCCTGGAGGAGCAGTGTGTGGAT
GCTCTGCAGGCCCAGGGCTTCCCCAGGTCCCAGATCAGCACTGAGAGCTTCCTGCACCTG
CGCTACCAGGGCACGGACTGTGCTCTGATGGTGTCTGCCCACCAGCACCCAGCCACAGCC
CGCTCGCCCCGTGCGGGGGACTTCGGGGCAGCCTTTGTGGAGCGGTACATGAGGGAGTTT
GGCTTTGTCATACCTGAGCGGCCGGTGGTCGTGGACGATGTGCGAGTGCGGGGCACCGGC
CGCAGTGGTCTTCGCCTCGAGGATGCCCCCAAAGCCCAGACCGGGCCTCCCCGGGTGGAC
AAGATGACCCAGTGCTACTTTGAGGGGGGCTACCAGGAGACCCCTGTGTACCTGCTGGCA
GAGCTGGGCTATGGGCACAAGCTCCATGGGCCCTGCCTCATCATCGACAGTAACAGCACC
ATCCTGGTGGAGCCAGGTTGCCAGGCAGAGGTGACCAAGACAGGGGACATCTGCATCTCC
GTGGGGGCCGAAGTCCCCGGCACAGTGGGCCCCCAGCTGGACCCTATCCAGCTGTCCATC
TTCTCACACCGCTTCATGAGCATTGCTGAGCAGATGGGCCGCATCCTGCAGCGCACAGCC
ATCTCCACCAACATCAAGGAGCGTCTGGACTTCTCCTGTGCCCTCTTTGGGCCCGATGGG
GGGCTGGTGTCCAATGCCCCCCACATCCCTGTGCACCTGGGTGCCATGCAGGAGACGGTG
CAGTTCCAGATTCAGCACCTGGGGGCCGATCTCCACCCTGGCGACGTGCTACTGAGCAAC
CATCCCAGTGCCGGGGGCAGCCACCTGCCAGACCTGACTGTTATCACACCGGTGTTTTGG
CCGGGTCAGACGCGGCCTGTGTTCTATGTGGCCAGCCGAGGGCACCACGCAGACATCGGG
GGCATCACACCAGGCTCCATGCCCCCCCACTCCACCATGCTGCAACAGGAGGGTGCCGTC
TTTCTGTCCTTCAAACTTGTCCAGGGGGGCGTCTTCCAGGAGGAGGCGGTGACGGAGGCC
CTGCGGGCGCCAGGCAAGGTCCCCAACTGCAGCGGAACCAGAAACCTGCACGACAACCTG
TCGGACCTCCGTGCCCAGGTGGCAGCCAACCAGAAGGGCATCCAGCTGGTGGGGGAGCTC
ATTGGGCAGTACGGCCTGGACGTGGTGCAGGCCTACATGGGCCATATTCAGGCAAACGCT
GAGCTGGCCGTGCGAGACATGTTGCGTGCCTTTGGAACCTCCCGGCAGGCCCGGGGCCTG
CCCCTGGAGGTGTCCTCGGAAGACCACATGGACGACGGTTCCCCCATCCGCCTCCGTGTG
CAGATCAGCCTGAGTCAGGGCAGCGCCGTGTTTGACTTCAGCGGCACTGGGCCGGAGGTG
TTTGGTAATCTCAACGCACCGCGGGCCGTAACCCTGTCCGCCCTCATCTACTGCCTGCGC
TGTCTGGTGGGCCGCGACATCCCACTCAACCAGGGCTGCCTGGCGCCAGTGCGCGTGGTC
ATTCCCCGAGGCTCCATCCTGGACCCGTCGCCCGAGGCGGCGGTGGTGGGCGGCAACGTG
CTCACGTCGCAGCGCGTGGTGGATGTCATCCTGGGGGCCTTTGGGGCCTGCGCCGCCTCC
CAGGGCTGCATGAACAACGTGACCCTGGGCAACGCCCACATGGGCTACTACGAGACGGTG
GCGGGCGGCGCGGGCGCGGGTCCCAGCTGGCACGGGCGCAGCGGTGTGCACAGCCACATG
ACCAACACACGCATCACCGACCCTGAGATCCTGGAGAGCCGGTACCCGGTCATCCTGCGC
CGCTTCGAGCTGCGGCGGGGCTCGGGGGGCAGAGGCCGCTTCCGAGGCGGCGACGGCGTC
ACCCGCGAGCTGCTCTTTCGTGAGGAGGCGCTGCTGTCAGTGCTGACCGAGCGCCGCGCC
TTCCGGCCATACGGGCTCCACGGGGGCGAGCCTGGCGCCCGCGGCCTAAACCTGCTGATC
CGCAAAAACGGCCGGACGGTGAATCTGGGCGGCAAGACGTCGGTGACCGTGTACCCCGGG
GATGTGTTCTGTCTCCACACGCCCGGCGGCGGTGGCTATGGGGACCCGGAGGACCCCGCC
CCACCGCCGGGGTCGCCCCCGCAAGCACTGGCCTTTCCCGAGCACGGCAGCGTCTATGAG
TATCGCCGGGCCCAGGAGGCCGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05378</identifier>
        <name>Hydant_A_N</name>
      </pfam>
      <pfam>
        <identifier>PF01968</identifier>
        <name>Hydantoinase_A</name>
      </pfam>
      <pfam>
        <identifier>PF02538</identifier>
        <name>Hydantoinase_B</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>5-oxoprolinase (ATP-hydrolyzing) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002235</id>
      <name>Phosphoribosylformylglycinamidine synthase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>2347042</pubmed-id>
            <citation>Jayaram HN, Lui MS, Plowman J, Pillwein K, Reardon MA, Elliott WL, Weber G: Oncolytic activity and mechanism of action of a novel L-cysteine derivative, L-cysteine, ethyl ester, S-(N-methylcarbamate) monohydrochloride. Cancer Chemother Pharmacol. 1990;26(2):88-92.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15067" source="Swiss-Prot">
    <name>Phosphoribosylformylglycinamidine synthase</name>
    <general-function>Phosphoribosylformylglycinamidine synthase activity</general-function>
    <specific-function>Phosphoribosylformylglycinamidine synthase involved in the purines biosynthetic pathway. Catalyzes the ATP-dependent conversion of formylglycinamide ribonucleotide (FGAR) and glutamine to yield formylglycinamidine ribonucleotide (FGAM) and glutamate (By similarity).</specific-function>
    <gene-name>PFAS</gene-name>
    <locus>17p13.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.55</theoretical-pi>
    <molecular-weight>144733.165</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8863</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PFAS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB002359</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2224663</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15067</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PUR4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.5.3</synonym>
      <synonym>FGAM synthase</synonym>
      <synonym>FGAR amidotransferase</synonym>
      <synonym>FGAR-AT</synonym>
      <synonym>Formylglycinamide ribonucleotide amidotransferase</synonym>
      <synonym>Formylglycinamide ribotide amidotransferase</synonym>
      <synonym>KIAA0361</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037178|Phosphoribosylformylglycinamidine synthase
MSPVLHFYVRPSGHEGAAPGHTRRKLQGKLPELQGVETELCYNVNWTAEALPSAEETKKL
MWLFGCPLLLDDVARESWLLPGSNDLLLEVGPRLNFSTPTSTNIVSVCRATGLGPVDRVE
TTRRYRLSFAHPPSAEVEAIALATLHDRMTEQHFPHPIQSFSPESMPEPLNGPINILGEG
RLALEKANQELGLALDSWDLDFYTKRFQELQRNPSTVEAFDLAQSNSEHSRHWFFKGQLH
VDGQKLVHSLFESIMSTQESSNPNNVLKFCDNSSAIQGKEVRFLRPEDPTRPSRFQQQQG
LRHVVFTAETHNFPTGVCPFSGATTGTGGRIRDVQCTGRGAHVVAGTAGYCFGNLHIPGY
NLPWEDPSFQYPGNFARPLEVAIEASNGASDYGNKFGEPVLAGFARSLGLQLPDGQRREW
IKPIMFSGGIGSMEADHISKEAPEPGMEVVKVGGPVYRIGVGGGAASSVQVQGDNTSDLD
FGAVQRGDPEMEQKMNRVIRACVEAPKGNPICSLHDQGAGGNGNVLKELSDPAGAIIYTS
RFQLGDPTLNALEIWGAEYQESNALLLRSPNRDFLTHVSARERCPACFVGTITGDRRIVL
VDDRECPVRRNGQGDAPPTPLPTPVDLELEWVLGKMPRKEFFLQRKPPMLQPLALPPGLS
VHQALERVLRLPAVASKRYLTNKVDRSVGGLVAQQQCVGPLQTPLADVAVVALSHEELIG
AATALGEQPVKSLLDPKVAARLAVAEALTNLVFALVTDLRDVKCSGNWMWAAKLPGEGAA
LADACEAMVAVMAALGVAVDGGKDSLSMAARVGTETVRAPGSLVISAYAVCPDITATVTP
DLKHPEGRGHLLYVALSPGQHRLGGTALAQCFSQLGEHPPDLDLPENLVRAFSITQGLLK
DRLLCSGHDVSDGGLVTCLLEMAFAGNCGLQVDVPVPRVDVLSVLFAEEPGLVLEVQEPD
LAQVLKRYRDAGLHCLELGHTGEAGPHAMVRVSVNGAVVLEEPVGELRALWEETSFQLDR
LQAEPRCVAEEERGLRERMGPSYCLPPTFPKASVPREPGGPSPRVAILREEGSNGDREMA
DAFHLAGFEVWDVTMQDLCSGAIGLDTFRGVAFVGGFSYADVLGSAKGWAAAVTFHPRAG
AELRRFRKRPDTFSLGVCNGCQLLALLGWVGGDPNEDAAEMGPDSQPARPGLLLRHNLSG
RYESRWASVRVGPGPALMLRGMEGAVLPVWSAHGEGYVAFSSPELQAQIEARGLAPLHWA
DDDGNPTEQYPLNPNGSPGGVAGICSCDGRHLAVMPHPERAVRPWQWAWRPPPFDTLTTS
PWLQLFINARNWTLEGSC</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011613|Phosphoribosylformylglycinamidine synthase (PFAS)
ATGTCCCCAGTCCTTCACTTCTATGTTCGTCCCTCTGGCCATGAGGGGGCAGCCCCTGGA
CACACTCGGAGGAAACTGCAAGGGAAACTGCCAGAGCTGCAGGGCGTCGAGACTGAACTG
TGCTACAACGTGAACTGGACAGCTGAGGCCCTCCCCAGTGCTGAGGAGACAAAGAAGCTG
ATGTGGCTGTTTGGTTGCCCCTTACTGCTGGATGATGTTGCTCGGGAGTCCTGGCTCCTT
CCTGGCTCCAATGACCTGCTGCTGGAGGTCGGGCCCAGGCTGAACTTCTCCACCCCAACA
TCCACCAACATCGTGTCAGTGTGCCGCGCCACTGGGCTGGGGCCTGTGGATCGTGTGGAG
ACCACCCGGCGCTACCGGCTCTCGTTTGCCCACCCCCCGTCAGCTGAGGTGGAAGCCATT
GCTCTGGCTACCCTGCACGACCGGATGACAGAGCAGCACTTCCCCCATCCCATCCAGAGT
TTCTCCCCTGAGAGCATGCCGGAACCCCTCAATGGCCCTATCAATATACTGGGTGAGGGC
CGGCTTGCGCTGGAGAAGGCCAACCAGGAGCTTGGTCTGGCTTTAGACTCTTGGGACCTA
GACTTCTACACCAAGCGCTTCCAGGAGCTACAGCGGAACCCGAGCACTGTGGAGGCCTTT
GACTTGGCGCAGTCCAATAGCGAGCACAGCCGACACTGGTTCTTCAAGGGCCAGCTCCAC
GTGGATGGGCAGAAGCTGGTGCACTCACTGTTTGAGTCCATCATGAGCACCCAGGAATCC
TCGAACCCCAACAACGTCCTCAAATTCTGTGATAACAGCAGTGCAATCCAGGGAAAGGAA
GTCCGATTCCTACGGCCTGAGGACCCCACACGGCCAAGCCGCTTCCAGCAACAGCAAGGG
CTGAGACATGTTGTCTTCACAGCAGAGACTCACAACTTTCCCACAGGAGTATGCCCCTTT
AGTGGTGCAACCACTGGCACAGGGGGCCGGATTCGAGATGTCCAGTGCACAGGCCGCGGG
GCCCACGTGGTGGCTGGCACTGCCGGCTATTGCTTTGGAAATCTGCATATTCCAGGTTAC
AATCTGCCCTGGGAGGATCCAAGCTTCCAGTATCCTGGGAATTTTGCCCGGCCCCTGGAG
GTTGCCATTGAAGCCAGTAATGGAGCTTCTGACTATGGCAACAAGTTTGGGGAACCAGTG
CTGGCTGGCTTCGCCCGCTCCTTGGGCCTCCAGCTCCCAGACGGCCAGCGGCGTGAGTGG
ATCAAGCCCATCATGTTTAGTGGGGGCATTGGGTCCATGGAAGCTGACCACATAAGCAAG
GAGGCCCCAGAGCCAGGCATGGAAGTTGTAAAGGTTGGAGGTCCCGTCTACAGGATTGGA
GTTGGAGGTGGAGCTGCTTCATCTGTGCAGGTGCAGGGAGATAACACCAGTGACCTGGAC
TTTGGGGCTGTGCAGCGAGGAGACCCGGAGATGGAACAGAAGATGAACCGTGTGATCAGG
GCTTGTGTGGAGGCCCCCAAGGGAAACCCCATCTGCAGCCTTCATGATCAGGGCGCTGGT
GGCAATGGCAATGTCCTAAAAGAGCTGAGTGACCCAGCTGGAGCCATCATTTACACCAGC
CGCTTCCAGCTTGGGGACCCAACCCTGAATGCCCTGGAAATCTGGGGGGCTGAGTACCAG
GAATCAAATGCTCTTCTGCTGAGGTCCCCCAACCGGGACTTCCTGACTCATGTCAGTGCC
CGTGAACGTTGCCCGGCTTGCTTCGTGGGCACCATCACTGGAGACCGGAGAATAGTGCTG
GTGGACGATCGGGAGTGTCCTGTCAGAAGAAATGGCCAGGGGGATGCCCCCCCGACACCC
CTGCCAACCCCTGTGGACCTGGAGCTCGAATGGGTGCTGGGCAAGATGCCTCGGAAGGAG
TTCTTCCTGCAGAGGAAGCCCCCCATGCTGCAGCCTCTGGCCTTGCCCCCAGGGCTGAGC
GTGCACCAGGCTCTGGAGAGGGTTCTGAGGCTGCCCGCCGTGGCCAGCAAGCGCTACCTC
ACCAATAAGGTGGACCGCTCTGTGGGAGGCCTGGTGGCCCAGCAGCAGTGCGTGGGGCCC
CTGCAAACTCCTCTGGCAGATGTAGCGGTTGTGGCACTGAGCCATGAGGAGCTCATAGGG
GCTGCCACAGCCTTGGGAGAACAGCCAGTCAAGAGCCTGCTGGACCCAAAAGTCGCCGCC
CGGCTGGCCGTGGCCGAAGCCCTCACCAACCTGGTGTTTGCTCTGGTCACTGACCTCCGG
GATGTGAAGTGTAGCGGGAACTGGATGTGGGCAGCCAAGCTCCCAGGGGAGGGCGCAGCT
TTGGCGGATGCCTGTGAGGCTATGGTGGCAGTGATGGCAGCCCTGGGTGTGGCAGTGGAT
GGTGGCAAGGACTCCCTCAGCATGGCTGCTCGGGTTGGCACTGAGACCGTGCGGGCTCCT
GGGTCACTGGTCATCTCAGCCTATGCCGTCTGCCCAGACATCACAGCCACTGTGACCCCA
GACCTCAAGCATCCTGAAGGGAGAGGCCATCTGCTCTATGTGGCTCTGAGCCCTGGGCAG
CACCGGCTCGGGGGCACAGCTCTGGCCCAGTGCTTCTCCCAGCTTGGGGAACACCCTCCA
GACCTGGACCTTCCTGAGAACTTGGTGCGGGCCTTCAGCATCACTCAGGGGCTGCTGAAA
GACCGCCTCCTCTGCTCAGGCCACGATGTCAGTGACGGAGGCCTCGTCACATGCCTGCTG
GAGATGGCCTTTGCTGGAAATTGCGGGCTACAGGTGGATGTGCCTGTCCCCAGGGTTGAT
GTCCTGTCTGTGCTGTTCGCTGAGGAGCCAGGCCTCGTGCTGGAGGTGCAGGAGCCAGAC
CTGGCCCAGGTGCTGAAGCGTTACCGGGATGCTGGCCTCCATTGCCTGGAGCTGGGCCAC
ACAGGCGAGGCCGGGCCCCACGCCATGGTCCGGGTGTCAGTGAACGGGGCTGTGGTTCTG
GAGGAGCCTGTTGGGGAGCTGCGAGCCCTCTGGGAGGAGACGAGTTTCCAGCTGGACCGG
CTACAGGCAGAGCCTCGCTGTGTGGCAGAGGAGGAACGGGGCCTGAGGGAGCGGATGGGG
CCCAGCTATTGCCTGCCCCCCACCTTTCCCAAAGCCTCCGTGCCCCGTGAGCCTGGTGGT
CCCAGCCCCCGAGTCGCCATCTTGCGAGAGGAGGGCAGTAATGGAGACCGGGAGATGGCC
GATGCCTTCCACTTAGCTGGGTTTGAGGTATGGGACGTGACCATGCAGGACCTCTGCTCT
GGGGCAATTGGGCTGGACACTTTCCGTGGCGTGGCCTTCGTGGGCGGCTTCAGCTATGCA
GATGTCCTGGGCTCTGCCAAAGGGTGGGCAGCTGCTGTGACCTTTCATCCCAGGGCTGGG
GCTGAGCTGAGGCGCTTCCGGAAGCGGCCAGACACCTTCAGCCTGGGCGTGTGTAATGGC
TGTCAACTGCTGGCTCTGCTCGGCTGGGTGGGAGGCGACCCCAATGAGGATGCTGCAGAG
ATGGGCCCTGACTCCCAGCCAGCCCGGCCAGGCCTTCTGCTACGCCACAACCTGTCTGGG
CGCTACGAGTCTCGCTGGGCCAGCGTGCGTGTGGGGCCTGGGCCAGCCCTGATGCTGCGA
GGGATGGAGGGCGCCGTGCTGCCCGTGTGGAGTGCGCACGGGGAAGGTTACGTAGCATTT
TCTTCTCCGGAACTCCAAGCTCAGATTGAGGCCAGGGGCTTGGCTCCACTGCACTGGGCT
GATGATGACGGGAACCCCACAGAGCAGTACCCTCTGAATCCCAATGGGTCCCCAGGGGGC
GTGGCTGGCATCTGCTCCTGTGATGGCCGCCACCTGGCTGTCATGCCTCACCCTGAGCGG
GCCGTTAGGCCTTGGCAGTGGGCATGGCGACCCCCTCCATTTGATACTCTGACCACCTCC
CCCTGGCTCCAGCTCTTTATCAATGCCCGAAACTGGACCCTGGAAGGGAGCTGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02769</identifier>
        <name>AIRS_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phosphoribosylformylglycinamidine synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine ribonucleoside monophosphate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>'de novo' IMP biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ribonucleoside monophosphate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleotide biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000721</id>
      <name>Branched-chain-amino-acid aminotransferase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15382" source="Swiss-Prot">
    <name>Branched-chain-amino-acid aminotransferase, mitochondrial</name>
    <general-function>L-valine transaminase activity</general-function>
    <specific-function>Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine. May also function as a transporter of branched chain alpha-keto acids.</specific-function>
    <gene-name>BCAT2</gene-name>
    <locus>19q13</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.82</theoretical-pi>
    <molecular-weight>44287.445</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:977</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BCAT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U68418</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2342862</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15382</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BCAT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.42</synonym>
      <synonym>BCAT(m)</synonym>
      <synonym>BCATM</synonym>
      <synonym>BCT2</synonym>
      <synonym>ECA40</synonym>
      <synonym>Placental protein 18</synonym>
      <synonym>PP18</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001438|Branched-chain-amino-acid aminotransferase, mitochondrial
MAAAALGQIWARKLLSVPWLLCGPRRYASSSFKAADLQLEMTQKPHKKPGPGEPLVFGKT
FTDHMLMVEWNDKGWGQPRIQPFQNLTLHPASSSLHYSLQLFEGMKAFKGKDQQVRLFRP
WLNMDRMLRSAMRLCLPSFDKLELLECIRRLIEVDKDWVPDAAGTSLYVRPVLIGNEPSL
GVSQPTRALLFVILCPVGAYFPGGSVTPVSLLADPAFIRAWVGGVGNYKLGGNYGPTVLV
QQEALKRGCEQVLWLYGPDHQLTEVGTMNIFVYWTHEDGVLELVTPPLNGVILPGVVRQS
LLDMAQTWGEFRVVERTITMKQLLRALEEGRVREVFGSGTACQVCPVHRILYKDRNLHIP
TMENGPELILRFQKELKEIQYGIRAHEWMFPV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019000|Branched-chain-amino-acid aminotransferase, mitochondrial (BCAT2)
ATGGCCGCAGCCGCTCTGGGGCAGCTGTTTGAGGGCATGAAGGCGTTCAAAGGCAAAGAC
CAGCAGGTGCGCCTCTTCCGCCCCTGGCTCAACATGGACCGGATGCTGCGCTCAGCCATG
CGCCTGTGCCTGCCGAGTTTCGACAAGCTGGAGTTGCTGGAGTGCATCCGCCGGCTCATC
GAAGTGGACAAGGACTGGGTCCCCGATGCCGCCGGCACCAGCCTCTATGTGCGGCCTGTG
CTCATTGGGAACGAGCCCTCGCTGGGTGTCAGCCAGCCCACGCGCGCGCTCCTGTTCGTC
ATTCTCTGCCCAGTGGGTGCCTACTTCCCTGGAGGCTCCGTGACCCCGGTCTCCCTCCTG
GCCGACCCAGCCTTCATCCGGGCCTGGGTGGGCGGGGTCGGCAACTACAAGTTAGGTGGG
AATTATGGGCCCACCGTGTTAGTGCAACAGGAGGCACTCAAGCGGGGCTGTGAACAGGTC
CTCTGGCTGTATGGGCCCGACCACCAGCTCACCGAGGTGGGAACCATGAACATCTTTGTC
TACTGGACCCACGAAGATGGGGTGCTGGAGCTGGTGACGCCCCCGCTGAATGGTGTTATC
CTGCCTGGAGTGGTCAGACAGAGTCTACTGGACATGGCTCAGACCTGGGGTGAGTTCCGG
GTGGTGGAGCGCACGATCACCATGAAGCAGTTGCTGCGGGCCCTGGAGGAGGGCCGCGTG
CGGGAAGTCTTTGGCTCGGGCACCGCTTGCCAGGTCTGCCCAGTGCACCGAATCCTGTAC
AAAGACAGGAACCTCCACATTCCCACCATGGAAAATGGGCCTGAGCTGATCCTCCGCTTC
CAGAAGGAGCTGAAGGAGATCCAGTACGGAATCAGAGCCCACGAGTGGATGTTCCCGGTG
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01063</identifier>
        <name>Aminotran_4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>branched-chain-amino-acid transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-isoleucine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-leucine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-valine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>isoleucine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leucine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of hormone levels</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>valine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000396</id>
      <name>Glutamate receptor ionotropic, NMDA 2D</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11755246</pubmed-id>
            <citation>Pliss L, Jezova D, Mares V, Balcar VJ, St'astny F: N-Acetyl-L-aspartyl-L-glutamate changes functional and structural properties of rat blood-brain barrier. Neurosci Lett. 2002 Jan 11;317(2):85-8.</citation>
          </article>
          <article>
            <pubmed-id>8886398</pubmed-id>
            <citation>Bresink I, Benke TA, Collett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL: Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol. 1996 Sep;119(2):195-204.</citation>
          </article>
          <article>
            <pubmed-id>9417820</pubmed-id>
            <citation>Sundstrom E, Whittemore S, Mo LL, Seiger A: Analysis of NMDA receptors in the human spinal cord. Exp Neurol. 1997 Dec;148(2):407-13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15399" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 2D</name>
    <general-function>Nmda glutamate receptor activity</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine.</specific-function>
    <gene-name>GRIN2D</gene-name>
    <locus>19q13.1-qter</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>584-604
657-677
845-865</transmembrane-regions>
    <signal-regions>1-27</signal-regions>
    <theoretical-pi>8.27</theoretical-pi>
    <molecular-weight>143750.685</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4588</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN2D</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U77783</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2444026</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>459</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15399</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMDE4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EB11</synonym>
      <synonym>GluN2D</synonym>
      <synonym>Glutamate [NMDA] receptor subunit epsilon-4</synonym>
      <synonym>N-methyl D-aspartate receptor subtype 2D</synonym>
      <synonym>NMDAR2D</synonym>
      <synonym>NR2D</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016080|Glutamate receptor ionotropic, NMDA 2D
MRGAGGPRGPRGPAKMLLLLALACASPFPEEAPGPGGAGGPGGGLGGARPLNVALVFSGP
AYAAEAARLGPAVAAAVRSPGLDVRPVALVLNGSDPRSLVLQLCDLLSGLRVHGVVFEDD
SRAPAVAPILDFLSAQTSLPIVAVHGGAALVLTPKEKGSTFLQLGSSTEQQLQVIFEVLE
EYDWTSFVAVTTRAPGHRAFLSYIEVLTDGSLVGWEHRGALTLDPGAGEAVLSAQLRSVS
AQIRLLFCAREEAEPVFRAAEEAGLTGSGYVWFMVGPQLAGGGGSGAPGEPPLLPGGAPL
PAGLFAVRSAGWRDDLARRVAAGVAVVARGAQALLRDYGFLPELGHDCRAQNRTHRGESL
HRYFMNITWDNRDYSFNEDGFLVNPSLVVISLTRDRTWEVVGSWEQQTLRLKYPLWSRYG
RFLQPVDDTQHLTVATLEERPFVIVEPADPISGTCIRDSVPCRSQLNRTHSPPPDAPRPE
KRCCKGFCIDILKRLAHTIGFSYDLYLVTNGKHGKKIDGVWNGMIGEVFYQRADMAIGSL
TINEERSEIVDFSVPFVETGISVMVARSNGTVSPSAFLEPYSPAVWVMMFVMCLTVVAVT
VFIFEYLSPVGYNRSLATGKRPGGSTFTIGKSIWLLWALVFNNSVPVENPRGTTSKIMVL
VWAFFAVIFLASYTANLAAFMIQEEYVDTVSGLSDRKFQRPQEQYPPLKFGTVPNGSTEK
NIRSNYPDMHSYMVRYNQPRVEEALTQLKAGKLDAFIYDAAVLNYMARKDEGCKLVTIGS
GKVFATTGYGIALHKGSRWKRPIDLALLQFLGDDEIEMLERLWLSGICHNDKIEVMSSKL
DIDNMAGVFYMLLVAMGLSLLVFAWEHLVYWRLRHCLGPTHRMDFLLAFSRGMYSCCSAE
AAPPPAKPPPPPQPLPSPAYPAPRPAPGPAPFVPRERASVDRWRRTKGAGPPGGAGLADG
FHRYYGPIEPQGLGLGLGEARAAPRGAAGRPLSPPAAQPPQKPPPSYFAIVRDKEPAEPP
AGAFPGFPSPPAPPAAAATAVGPPLCRLAFEDESPPAPARWPRSDPESQPLLGPGAGGAG
GTGGAGGGAPAAPPPCRAAPPPCPYLDLEPSPSDSEDSESLGGASLGGLEPWWFADFPYP
YAERLGPPPGRYWSVDKLGGWRAGSWDYLPPRSGPAAWHCRHCASLELLPPPRHLSCSHD
GLDGGWWAPPPPPWAAGPLPRRRARCGCPRSHPHRPRASHRTPAAAAPHHHRHRRAAGGW
DLPPPAPTSRSLEDLSSCPRAAPARRLTGPSRHARRCPHAAHWGPPLPTASHRRHRGGDL
GTRRGSAHFSSLESEV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016081|Glutamate receptor ionotropic, NMDA 2D (GRIN2D)
ATGCGCGGCGCCGGTGGCCCCCGCGGCCCTCGGGGCCCCGCTAAGATGCTGCTGCTGCTG
GCGCTGGCCTGCGCCAGCCCGTTCCCGGAGGAGGCGCCGGGGCCGGGCGGGGCCGGTGGG
CCCGGCGGCGGCCTCGGCGGGGCGCGGCCGCTCAACGTGGCGCTCGTGTTCTCGGGGCCC
GCGTACGCGGCCGAGGCGGCACGCCTGGGCCCGGCCGTGGCGGCGGCGGTGCGCAGCCCG
GGCCTAGACGTGCGGCCCGTGGCGCTGGTGCTCAACGGCTCGGACCCGCGCAGCCTCGTG
CTGCAGCTCTGCGACCTGCTGTCGGGGTTGCGCGTGCACGGCGTGGTCTTCGAAGACGAC
TCGCGCGCGCCCGCCGTCGCGCCCATCCTCGACTTCCTGTCGGCGCAGACCTCGCTGCCC
ATCGTGGCCGTGCACGGCGGCGCCGCGCTCGTGCTCACGCCCAAGGAGAAGGGCTCCACC
TTCCTGCAGCTGGGCTCTTCCACCGAGCAACAGCTTCAGGTCATCTTTGAGGTGCTGGAG
GAGTATGACTGGACGTCCTTTGTAGCCGTGACCACTCGTGCCCCTGGCCACCGGGCCTTC
CTGTCCTACATTGAGGTGCTGACTGACGGTAGTCTGGTGGGCTGGGAGCACCGCGGAGCG
CTGACGCTGGACCCTGGGGCGGGCGAGGCCGTGCTCAGTGCCCAGCTCCGCAGTGTCAGC
GCGCAGATCCGCCTGCTCTTCTGCGCCCGAGAGGAGGCCGAGCCCGTGTTCCGCGCAGCT
GAGGAGGCTGGCCTCACTGGATCTGGCTACGTCTGGTTCATGGTGGGGCCCCAGCTGGCT
GGAGGCGGGGGCTCTGGGGCCCCTGGTGAGCCCCCTCTTCTGCCAGGAGGCGCCCCCCTG
CCTGCCGGGCTGTTTGCAGTGCGCTCGGCTGGCTGGCGGGATGACCTGGCTCGGCGAGTG
GCAGCTGGCGTGGCCGTAGTGGCCAGAGGTGCCCAGGCCCTGCTGCGTGATTATGGTTTC
CTTCCTGAGCTCGGCCACGACTGTCGCGCCCAGAACCGCACCCACCGCGGCGAGAGTCTG
CATAGGTACTTCATGAACATCACGTGGGATAACCGGGATTACTCCTTCAATGAGGACGGC
TTCCTAGTGAACCCCTCCCTGGTGGTCATCTCCCTCACCAGAGACAGGACGTGGGAGGTG
GTGGGCAGCTGGGAGCAGCAGACGCTCCGCCTCAAGTACCCGCTGTGGTCCCGCTATGGT
CGCTTCCTGCAGCCAGTGGACGACACGCAGCACCTCACGGTGGCCACGCTGGAGGAAAGG
CCGTTTGTCATCGTGGAGCCTGCAGACCCTATCAGCGGCACCTGCATCCGAGACTCCGTC
CCCTGCCGGAGCCAGCTCAACCGAACCCACAGCCCTCCACCGGATGCCCCCCGCCCGGAA
AAGCGCTGCTGCAAGGGTTTCTGCATCGACATTCTGAAGCGGCTGGCGCATACCATCGGC
TTCAGCTACGACCTCTACCTGGTCACCAATGGCAAGCACGGAAAGAAGATCGATGGCGTC
TGGAACGGCATGATCGGGGAGGTGTTCTACCAGCGCGCAGACATGGCCATCGGCTCCCTC
ACCATCAACGAGGAGCGCTCCGAGATCGTGGACTTCTCCGTCCCCTTCGTGGAGACCGGC
ATCAGCGTCATGGTGGCGCGCAGCAATGGCACGGTGTCCCCCTCGGCCTTCCTCGAGCCC
TACAGCCCCGCCGTGTGGGTGATGATGTTCGTCATGTGCCTCACTGTGGTCGCCGTCACT
GTTTTCATCTTCGAGTACCTCAGTCCTGTTGGTTACAACCGCAGCCTGGCCACGGGCAAG
CGCCCTGGCGGTTCAACCTTCACCATTGGGAAATCCATCTGGCTGCTCTGGGCCCTGGTG
TTCAATAATTCGGTGCCCGTGGAGAACCCCCGGGGAACCACCAGCAAAATCATGGTGCTG
GTGTGGGCCTTCTTCGCCGTCATCTTCCTCGCCAGCTACACAGCCAACCTGGCCGCCTTC
ATGATCCAGGAGGAGTACGTGGATACTGTGTCTGGGCTCAGTGACCGCAAGTTCCAGAGG
CCCCAGGAGCAGTACCCGCCCCTGAAGTTTGGGACCGTGCCCAACGGCTCCACGGAGAAG
AACATCCGCAGCAACTATCCCGACATGCACAGCTACATGGTGCGCTACAACCAGCCCCGC
GTAGAGGAAGCGCTCACTCAGCTCAAGGCAGGGAAGCTGGACGCCTTCATCTACGATGCT
GCAGTGCTCAATTACATGGCCCGCAAGGACGAGGGCTGCAAGCTTGTCACCATCGGCTCC
GGCAAGGTCTTCGCCACGACAGGCTATGGCATCGCCCTGCACAAGGGCTCCCGCTGGAAG
CGGCCCATCGACCTGGCGTTGCTGCAGTTCCTGGGGGATGATGAGATCGAGATGCTGGAG
CGGCTGTGGCTCTCTGGGATCTGCCACAATGACAAAATCGAGGTGATGAGCAGCAAGCTG
GACATCGACAACATGGCGGGCGTCTTCTACATGCTCCTGGTGGCCATGGGCCTGTCCCTG
CTGGTCTTCGCCTGGGAGCACCTGGTGTACTGGCGCCTGCGGCACTGCCTGGGGCCCACC
CACCGCATGGACTTCCTGCTGGCCTTCTCCAGGGGCATGTACAGCTGCTGCAGCGCTGAG
GCCGCCCCACCGCCCGCCAAGCCCCCGCCGCCGCCACAGCCCCTGCCCAGCCCCGCGTAC
CCCGCGCCGCGGCCGGCTCCCGGGCCCGCACCTTTCGTGCCCCGCGAGCGCGCCTCAGTG
GACCGCTGGCGCCGGACCAAGGGCGCGGGGCCGCCGGGGGGCGCGGGCCTGGCCGACGGC
TTCCACCGCTACTACGGCCCCATCGAGCCGCAGGGCCTAGGCCTCGGCCTGGGCGAAGCG
CGCGCGGCACCGCGGGGCGCAGCCGGGCGCCCGCTGTCCCCGCCGGCCGCTCAGCCCCCG
CAGAAGCCGCCGCCCTCCTATTTCGCCATCGTACGCGACAAGGAGCCAGCCGAGCCCCCC
GCCGGCGCCTTCCCCGGCTTCCCGTCGCCGCCCGCGCCCCCCGCCGCCGCGGCCACCGCC
GTCGGGCCGCCACTCTGCCGCTTGGCCTTCGAGGACGAGAGCCCGCCGGCGCCCGCGCGG
TGGCCGCGCTCGGACCCCGAGAGCCAACCCCTGCTGGGGCCAGGCGCGGGCGGCGCGGGG
GGCACGGGGGGCGCAGGCGGAGGAGCCCCGGCCGCTCCGCCCCCGTGCCGCGCCGCGCCG
CCCCCGTGCCCTTACCTCGATCTCGAGCCGTCGCCGTCGGACTCGGAGGACTCGGAGAGC
CTGGGCGGCGCGTCGCTGGGCGGCCTGGAGCCCTGGTGGTTCGCCGACTTCCCTTACCCG
TATGCCGAGCGCCTCGGGCCGCCGCCCGGCCGCTACTGGTCGGTCGACAAGCTCGGGGGC
TGGCGCGCCGGGAGCTGGGACTACCTGCCCCCGCGCAGCGGTCCGGCCGCCTGGCACTGT
CGGCACTGCGCCAGCCTGGAGCTGCTGCCGCCGCCGCGCCATCTCAGCTGCTCGCACGAT
GGCCTGGACGGCGGCTGGTGGGCGCCACCGCCTCCACCCTGGGCCGCCGGGCCCCTGCCC
CGACGCCGGGCCCGCTGCGGGTGCCCGCGGTCGCACCCGCACCGCCCGCGGGCCTCGCAC
CGCACGCCCGCCGCCGCCGCGCCCCACCACCACAGGCACCGGCGCGCCGCTGGGGGCTGG
GACCTCCCGCCGCCCGCGCCCACCTCGCGCTCGCTCGAGGACCTCAGCTCGTGCCCTCGC
GCCGCCCCTGCGCGCAGGCTTACCGGGCCCTCCCGCCACGCTCGCAGGTGTCCGCACGCC
GCGCACTGGGGGCCGCCGCTGCCCACAGCTTCCCACCGGAGACACCGGGGCGGGGACCTG
GGCACCCGCAGGGGCTCGGCGCACTTCTCTAGCCTCGAGTCCGAGGTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small GTPase mediated signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>startle response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Ras protein signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular endothelial growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002269</id>
      <name>Glutamate receptor ionotropic, delta-2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O43424" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, delta-2</name>
    <general-function>Scaffold protein binding</general-function>
    <specific-function>Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists.</specific-function>
    <gene-name>GRID2</gene-name>
    <locus>4q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>567-587
636-656
831-851</transmembrane-regions>
    <signal-regions>1-23</signal-regions>
    <theoretical-pi>5.95</theoretical-pi>
    <molecular-weight>113355.16</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4576</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRID2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF009014</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2853315</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>449</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O43424</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRID2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluD2</synonym>
      <synonym>GLURD2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037184|Glutamate receptor ionotropic, delta-2
MEVFPFLLVLSVWWSRTWDSANADSIIHIGAIFDESAKKDDEVFRTAVGDLNQNEEILQT
EKITFSVTFVDGNNPFQAVQEACELMNQGILALVSSIGCTSAGSLQSLADAMHIPHLFIQ
RSTAGTPRSGCGLTRSNRNDDYTLSVRPPVYLHDVILRVVTEYAWQKFIIFYDSEYDIRG
IQEFLDKVSQQGMDVALQKVENNINKMITTLFDTMRIEELNRYRDTLRRAILVMNPATAK
SFITEVVETNLVAFDCHWIIINEEINDVDVQELVRRSIGRLTIIRQTFPVPQNISQRCFR
GNHRISSTLCDPKDPFAQNMEISNLYIYDTVLLLANAFHKKLEDRKWHSMASLSCIRKNS
KPWQGGRSMLETIKKGGVSGLTGELEFGENGGNPNVHFEILGTNYGEELGRGVRKLGCWN
PVTGLNGSLTDKKLENNMRGVVLRVVTVLEEPFVMVSENVLGKPKKYQGFSIDVLDALSN
YLGFNYEIYVAPDHKYGSPQEDGTWNGLVGELVFKRADIGISALTITPDRENVVDFTTRY
MDYSVGVLLRRAEKTVDMFACLAPFDLSLWACIAGTVLLVGLLVYLLNWLNPPRLQMGSM
TSTTLYNSMWFVYGSFVQQGGEVPYTTLATRMMMGAWWLFALIVISSYTANLAAFLTITR
IESSIQSLQDLSKQTEIPYGTVLDSAVYEHVRMKGLNPFERDSMYSQMWRMINRSNGSEN
NVLESQAGIQKVKYGNYAFVWDAAVLEYVAINDPDCSFYTIGNTVADRGYGIALQHGSPY
RDVFSQRILELQQNGDMDILKHKWWPKNGQCDLYSSVDTKQKGGALDIKSFAGVFCILAA
GIVLSCFIAMLETWWNKRKGSRVPSKEDDKEIDLEHLHRRVNSLCTDDDSPHKQFSTSSI
DLTPLDIDTLPTRQALEQISDFRNTHITTTTFIPEQIQTLSRTLSAKAASGFTFGNVPEH
RTGPFRHRAPNGGFFRSPIKTMSSIPYQPTPTLGLNLGNDPDRGTSI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021325|Glutamate receptor ionotropic, delta-2 (GRID2)
ATGGAAGTTTTCCCCTTTCTCTTGGTTTTGTCCGTCTGGTGGTCTCGAACCTGGGACTCG
GCGAATGCGGATTCGATCATTCACATCGGAGCAATTTTTGATGAATCTGCCAAAAAGGAT
GATGAGGTATTTCGCACTGCGGTTGGTGACCTTAACCAGAATGAGGAGATCTTACAGACT
GAGAAAATCACATTTTCAGTGACGTTTGTTGATGGCAACAACCCTTTCCAAGCAGTTCAA
GAAGATATCCGTGGAATACAGGAGTTCTTGGACAAAGTCTCTCAGCAGGGAATGGATGTT
GCACTTCAGAAGGTAGAAAACAACATCAATAAAATGATTACCACTCTCTTTGACACCATG
AGAATAGAAGAACTGAATCGCTATCGAGACACTCTTAGGCGAGCGATCCTTGTTATGAAT
CCTGCTACAGCCAAATCCTTCATTACTGAGGTTGTGGAGACTAATTTGGTTGCTTTTGAC
TGTCACTGGATCATTATAAATGAGGAAATAAACGATGTGGACGTACAGGAACTTGTAAGA
AGGTCAATTGGAAGGTTAACGATTATTCGGCAGACATTTCCAGTTCCCCAGAACATAAGT
CAGCGGTGTTTCCGTGGCAACCATCGAATATCTTCAACATTGTGTGATCCAAAGGATCCA
TTTGCTCAGAATATGGAGATTTCCAACCTTTACATATATGACACGGTGCTTCTGCTTGCT
AATGCTTTTCATAAGAAGCTGGAGGACCGAAAGTGGCACAGCATGGCAAGTCTGTCATGT
ATCAGAAAGAACTCAAAGCCCTGGCAGGGTGGGCGCTCCATGTTGGAGACCATCAAGAAG
GGTGGAGTTAGTGGGTTGACTGGAGAGCTAGAATTTGGAGAAAATGGAGGCAATCCCAAT
GTCCACTTTGAAATCCTTGGAACCAACTATGGAGAAGAGCTTGGCAGAGGTGTTCGAAAA
CTTGGTTGCTGGAATCCTGTCACAGGTCTGAATGGGTCACTGACTGACAAGAAATTGGAG
AATAACATGCGTGGAGTGGTTCTACGTGTAGTAACTGTTCTGGAAGAACCTTTTGTGATG
GTCTCTGAAAATGTCTTGGGTAAGCCGAAGAAATACCAGGGCTTCTCCATTGATGTTTTG
GATGCCTTATCTAACTACCTGGGTTTTAACTACGAAATTTACGTAGCACCGGATCACAAA
TACGGAAGCCCACAAGAAGATGGGACATGGAATGGCTTGGTAGGAGAACTTGTCTTTAAG
AGAGCCGACATAGGGATTTCTGCTTTAACCATCACTCCAGATCGTGAAAATGTGGTGGAC
TTTACGACACGTTACATGGACTACTCAGTGGGGGTACTACTTCGAAGGGCTGAAAAGACA
GTGGATATGTTTGCCTGTCTTGCACCATTTGATCTCTCTCTATGGGCTTGCATTGCTGGC
ACAGTCCTTCTGGTGGGTCTACTGGTCTACCTCTTGAACTGGCTTAATCCCCCACGATTA
CAAATGGGATCAATGACGTCTACTACTCTCTACAACTCCATGTGGTTTGTGTATGGATCT
TTTGTACAACAAGGCGGGGAAGTCCCGTACACGACTCTGGCTACCCGAATGATGATGGGG
GCTTGGTGGCTATTTGCTTTGATTGTTATCTCATCTTACACGGCAAACCTCGCTGCTTTC
CTCACTATTACACGCATTGAAAGTTCCATCCAGTCTCTCCAGGACCTTTCCAAGCAAACA
GAAATCCCTTATGGCACAGTCCTAGACTCTGCGGTATATGAGCATGTCCGCATGAAAGGA
CTGAATCCTTTTGAGAGGGACAGCATGTATTCCCAAATGTGGCGGATGATCAACCGAAGC
AATGGATCGGAGAACAATGTTCTGGAGTCCCAGGCAGGCATTCAAAAGGTAAAATATGGA
AATTATGCTTTCGTATGGGATGCAGCTGTATTGGAATATGTGGCTATCAATGACCCAGAT
TGTTCCTTTTACACCATTGGAAATACTGTTGCTGATCGGGGATATGGAATTGCATTACAA
CATGGCAGTCCTTACCGAGATGTTTTTTCACAAAGGATCCTGGAGCTTCAGCAGAATGGT
GACATGGACATCCTGAAGCACAAATGGTGGCCTAAGAATGGCCAGTGTGACCTGTACTCG
TCAGTGGACACAAAGCAGAAAGGAGGCGCCCTGGACATAAAGAGCTTTGCAGGGGTCTTT
TGTATCCTGGCTGCTGGAATTGTCCTCTCCTGCTTCATAGCCATGCTGGAGACGTGGTGG
AACAAGAGGAAAGGCTCCCGGGTTCCATCAAAAGAGGATGACAAGGAAATTGACCTGGAG
CACCTCCATAGACGTGTAAATAGCTTGTGCACAGATGACGACAGCCCCCATAAACAGTTT
TCCACCTCGTCAATTGATTTGACCCCTCTGGACATTGACACTTTGCCAACACGACAAGCA
CTGGAGCAAATCAGTGATTTCAGGAACACTCATATTACCACAACAACCTTTATCCCAGAG
CAGATCCAGACTCTTAGCCGCACACTGTCAGCTAAAGCTGCTTCTGGTTTCACTTTTGGC
AACGTGCCTGAGCACCGAACTGGCCCTTTTAGGCACAGGGCACCTAATGGGGGCTTTTTC
AGGAGTCCTATAAAAACAATGTCATCTATTCCTTATCAACCAACTCCTACCCTGGGGCTC
AATCTGGGTAATGATCCAGACCGAGGCACCTCCATATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>ionotropic glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synapse</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>scaffold protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ionotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>PDZ domain binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of neuron projection development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cerebellar granule cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prepulse inhibition</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein localization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000534</id>
      <name>Glutamate receptor ionotropic, NMDA 3B</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60391" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 3B</name>
    <general-function>Nmda glutamate receptor activity</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with reduced single-channel conductance, low calcium permeability and low voltage-dependent sensitivity to magnesium. Mediated by glycine.</specific-function>
    <gene-name>GRIN3B</gene-name>
    <locus>19p13.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>565-585
649-669
831-851</transmembrane-regions>
    <signal-regions>1-22</signal-regions>
    <theoretical-pi>9.5</theoretical-pi>
    <molecular-weight>112990.98</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16768</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN3B</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AC004528</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3025446</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>461</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60391</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMD3B_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN3B</synonym>
      <synonym>N-methyl-D-aspartate receptor subtype 3B</synonym>
      <synonym>NMDAR3B</synonym>
      <synonym>NR3B</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001066|Glutamate receptor ionotropic, NMDA 3B
MEFVRALWLGLALALGPGSAGGHPQPCGVLARLGGSVRLGALLPRAPLARARARAALARA
ALAPRLPHNLSLELVVAAPPARDPASLTRGLCQALVPPGVAALLAFPEARPELLQLHFLA
AATETPVLSLLRREARAPLGAPNPFHLQLHWASPLETLLDVLVAVLQAHAWEDVGLALCR
TQDPGGLVALWTSRAGRPPQLVLDLSRRDTGDAGLRARLAPMAAPVGGEAPVPAAVLLGC
DIARARRVLEAVPPGPHWLLGTPLPPKALPTAGLPPGLLALGEVARPPLEAAIHDIVQLV
ARALGSAAQVQPKRALLPAPVNCGDLQPAGPESPGRFLARFLANTSFQGRTGPVWVTGSS
QVHMSRHFKVWSLRRDPRGAPAWATVGSWRDGQLDLEPGGASARPPPPQGAQVWPKLRVV
TLLEHPFVFARDPDEDGQCPAGQLCLDPGTNDSATLDALFAALANGSAPRALRKCCYGYC
IDLLERLAEDTPFDFELYLVGDGKYGALRDGRWTGLVGDLLAGRAHMAVTSFSINSARSQ
VVDFTSPFFSTSLGIMVRARDTASPIGAFMWPLHWSTWLGVFAALHLTALFLTVYEWRSP
YGLTPRGRNRSTVFSYSSALNLCYAILFRRTVSSKTPKCPTGRLLMNLWAIFCLLVLSSY
TANLAAVMVGDKTFEELSGIHDPKLHHPAQGFRFGTVWESSAEAYIKKSFPDMHAHMRRH
SAPTTPRGVAMLTSDPPKLNAFIMDKSLLDYEVSIDADCKLLTVGKPFAIEGYGIGLPQN
SPLTSNLSEFISRYKSSGFIDLLHDKWYKMVPCGKRVFAVTETLQMSIYHFAGLFVLLCL
GLGSALLSSLGEHAFFRLALPRIRKGSRLQYWLHTSQKIHRALNTEPPEGSKEETAEAEP
SGPEVEQQQQQQDQPTAPEGWKRARRAVDKERRVRFLLEPAVVVAPEADAEAEAAPREGP
VWLCSYGRPPAARPTGAPQPGELQELERRIEVARERLRQALVRRGQLLAQLGDSARHRPR
RLLQARAAPAEAPPHSGRPGSQE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016125|Glutamate receptor ionotropic, NMDA 3B (GRIN3B)
ATGGAGTTTGTGCGGGCGCTGTGGCTGGGCCTGGCGCTGGCGCTGGGGCCGGGGTCCGCG
GGGGGCCACCCTCAGCCGTGCGGCGTCCTGGCGCGCCTCGGGGGCTCCGTGCGCCTGGGC
GCCCTCCTGCCCCGCGCGCCTCTCGCCCGCGCCCGCGCCCGCGCCGCCCTGGCCCGGGCC
GCCCTGGCGCCGCGGCTGCCGCACAACCTGAGCTTGGAGCTGGTGGTCGCCGCGCCCCCC
GCCCGCGACCCCGCCTCGCTGACCCGCGGCCTGTGCCAGGCGCTGGTGCCTCCGGGCGTG
GCGGCCCTGCTCGCCTTTCCCGAGGCTCGGCCCGAGCTGCTGCAGCTGCACTTCCTGGCG
GCGGCCACCGAGACCCCCGTGCTCAGCCTGCTGCGGCGGGAGGCGCGCGCGCCCCTCGGA
GCCCCGAACCCATTCCACCTGCAGCTGCACTGGGCCAGCCCCCTGGAGACGCTGCTGGAT
GTGCTGGTGGCGGTGCTGCAGGCGCACGCCTGGGAAGACGTCGGCCTGGCCCTGTGCCGC
ACTCAGGACCCCGGCGGCCTGGTGGCCCTCTGGACAAGCCGGGCTGGCCGGCCCCCACAG
CTGGTCCTGGACCTAAGCCGGCGGGACACGGGAGATGCAGGACTGCGGGCACGCCTGGCC
CCGATGGCGGCGCCAGTGGGGGGTGAAGCACCGGTACCCGCGGCGGTCCTCCTCGGCTGT
GACATCGCCCGTGCCCGTCGGGTGCTGGAGGCCGTACCTCCCGGCCCCCACTGGCTGTTG
GGGACACCACTGCCGCCCAAGGCCCTGCCCACCGCGGGGCTGCCACCAGGGCTGCTGGCG
CTGGGCGAGGTGGCACGACCCCCGCTGGAGGCCGCCATCCATGACATTGTGCAACTGGTG
GCCCGGGCGCTGGGCAGTGCGGCCCAGGTGCAGCCGAAGCGAGCCCTCCTCCCCGCCCCG
GTCAACTGCGGGGACCTGCAGCCGGCCGGGCCCGAGTCCCCGGGGCGCTTCTTGGCACGG
TTCCTGGCCAACACGTCCTTCCAGGGCCGCACGGGCCCCGTGTGGGTGACAGGCAGCTCC
CAGGTACACATGTCTCGGCACTTTAAGGTGTGGAGCCTTCGCCGGGACCCACGGGGCGCC
CCGGCCTGGGCCACGGTGGGCAGCTGGCGGGACGGCCAGCTGGACTTGGAACCGGGAGGT
GCCTCTGCACGGCCCCCGCCCCCACAGGGTGCCCAGGTCTGGCCCAAGCTGCGTGTGGTA
ACGCTGTTGGAACACCCATTTGTGTTTGCCCGTGATCCAGACGAAGACGGGCAGTGCCCA
GCGGGGCAGCTGTGCCTGGACCCTGGCACCAACGACTCGGCCACCCTGGACGCACTGTTC
GCCGCGCTGGCCAACGGCTCAGCGCCCCGTGCCCTGCGCAAGTGCTGCTACGGCTACTGC
ATTGACCTGCTGGAGCGGCTGGCGGAGGACACGCCCTTCGACTTCGAGCTGTACCTCGTG
GGTGACGGCAAGTACGGCGCCCTGCGGGACGGCCGCTGGACCGGCCTGGTCGGGGACCTG
CTGGCCGGCCGGGCCCACATGGCGGTCACCAGCTTCAGTATCAACTCCGCCCGCTCACAG
GTGGTGGACTTCACCAGCCCCTTCTTCTCCACCAGCCTGGGCATCATGGTGCGGGCACGG
GACACGGCCTCACCCATCGGTGCCTTTATGTGGCCCCTGCACTGGTCCACGTGGCTGGGC
GTCTTTGCGGCCCTGCACCTCACCGCGCTCTTCCTCACCGTGTACGAGTGGCGTAGCCCC
TACGGCCTCACGCCACGTGGCCGCAACCGCAGCACCGTCTTCTCCTACTCCTCAGCCCTC
AACCTGTGCTACGCCATCCTCTTCAGACGCACCGTGTCCAGCAAGACGCCCAAGTGCCCC
ACGGGCCGCCTGCTCATGAACCTCTGGGCCATCTTCTGCCTGCTGGTGCTGTCCAGCTAC
ACGGCCAACCTGGCTGCCGTCATGGTCGGGGACAAGACCTTCGAGGAGCTGTCGGGGATC
CACGACCCCAAGCTGCACCACCCGGCGCAGGGCTTCCGCTTCGGCACCGTGTGGGAGAGC
AGCGCCGAGGCGTACATCAAGAAGAGCTTCCCCGACATGCACGCACACATGCGGCGCCAC
AGCGCGCCCACCACGCCCCGCGGCGTCGCCATGCTCACGAGCGACCCCCCCAAGCTCAAC
GCCTTCATCATGGACAAGTCGCTCCTGGACTACGAGGTCTCCATCGACGCCGACTGCAAA
CTGCTGACCGTGGGAAAGCCCTTCGCCATTGAGGGCTATGGGATCGGACTGCCCCAGAAC
TCGCCGCTCACCTCCAACCTGTCCGAGTTCATCAGCCGCTACAAGTCCTCCGGCTTCATC
GACCTGCTCCACGACAAGTGGTACAAGATGGTGCCTTGCGGCAAGCGGGTCTTTGCGGTT
ACAGAGACCCTGCAGATGAGCATCTACCACTTCGCGGGCCTCTTCGTGTTGCTGTGCCTG
GGCCTGGGCAGCGCTCTGCTCAGCTCGCTGGGCGAGCACGCCTTCTTCCGCCTGGCGCTG
CCGCGCATCCGCAAGGGGAGCAGGCTGCAGTACTGGCTGCACACCAGCCAGAAAATCCAC
CGCGCCCTCAACACGGAGCCACCAGAGGGGTCGAAGGAGGAGACGGCAGAGGCGGAGCCC
AGCGGCCCCGAGGTGGAGCAGCAGCAGCAGCAGCAGGACCAGCCAACGGCTCCGGAGGGC
TGGAAACGGGCGCGCCGGGCCGTGGACAAGGAGCGCCGCGTGCGCTTCCTGCTGGAGCCC
GCCGTGGTTGTGGCACCCGAAGCGGACGCGGAGGCGGAGGCTGCGCCGCGAGAGGGCCCC
GTCTGGCTGTGCTCCTACGGCCGCCCGCCCGCCGCAAGGCCCACGGGGGCCCCCCAGCCC
GGGGAGCTGCAGGAGCTGGAGCGCCGCATCGAAGTCGCGCGTGAGCGGCTCCGCCAGGCC
CTGGTGCGGCGCGGCCAGCTCCTGGCACAGCTCGGGGACAGCGCACGTCACCGGCCTCGG
CGCTTGCTTCAGGCCAGAGCGGCCCCCGCGGAGGCCCCACCACACTCTGGCCGACCGGGG
AGCCAGGAATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cation channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neurotransmitter receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neurotransmitter binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein insertion into membrane</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of calcium ion transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002237</id>
      <name>Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75879" source="Swiss-Prot">
    <name>Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial</name>
    <general-function>Translation factor activity, rna binding</general-function>
    <specific-function>Allows the formation of correctly charged Gln-tRNA(Gln) through the transamidation of misacylated Glu-tRNA(Gln) in the mitochondria. The reaction takes place in the presence of glutamine and ATP through an activated gamma-phospho-Glu-tRNA(Gln).</specific-function>
    <gene-name>GATB</gene-name>
    <locus>4q27-q28</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.86</theoretical-pi>
    <molecular-weight>61863.57</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:8849</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PET112L</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF026851</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3599964</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O75879</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GATB_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.5.-</synonym>
      <synonym>Cytochrome c oxidase assembly factor PET112 homolog</synonym>
      <synonym>Glu-AdT subunit B</synonym>
      <synonym>PET112</synonym>
      <synonym>PET112L</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004391|Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial
MAAPMLRWGCRGRRWAFARVDGGSCHRRGAPTGSTSNQIRGESSVAQQPLHTAQKTRKGE
HKWAAVVGLEIHAQISSNSKLFSGSQVRFSAPPNSLVSFFDASLPGTLPVLNRRCVEAAV
MTGLALNCHINKKSLFDRKHYFYADLPAGYQITQQRLPIAVNGSLIYGVCAGKKQSQVIP
KTVRIKQIQLEQDSGKSLHDNLRSQTLIDLNRAGVGLLEVVLEPDMSCGEEAATAVRELQ
LILQALGTSQANMAEGQLRVDANISVHHPGEPLGVRTEVKNLNSIRFLAKAIDYEIQRQI
NELENGGEILNETRSFHHKLGCTMSMRDKEGKQDYRFMPEPNLPPLVLYDATSLPAGADP
QQVINIDQIRETLPELPSVTREKLVQQYGMLLEHSFTLLNEVGLLEFFQNVIKETRAEPK
KVTSWVLNTFLGYLKQQNLAVSESPVTPSALAELLDLLDSRTISSSAAKQVFEELWKREG
KTPGQIVSEKQLELMQDQGALEQLCHSVMEAHPQVVMDVKNRNPRAINKLIGLVRKATQS
RADPVMIKEILEKKLSL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019257|Glutamyl-tRNA(Gln) amidotransferase subunit B, mitochondrial (GATB)
ATGGCGGCGCCCATGCTGCGCTGGGGCTGCCGTGGAAGACGTTGGGCTTTCGCCCGGGTT
GACGGTGGTTCTTGCCACCGAAGAGGGGCTCCGACTGGGTCCACATCCAACCAGATTAGG
GGAGAGAGCTCAGTGGCTCAGCAGCCCCTCCACACGGCCCAGAAGACGAGGAAAGGTGAA
CACAAATGGGCTGCTGTGGTAGGTTTGGAAATTCATGCCCAGATTTCCTCCAACTCTAAA
CTCTTCTCTGGATCTCAAGTTCGCTTTTCAGCACCTCCAAATTCTTTGGTTTCTTTTTTT
GATGCATCTCTACCTGGAACTTTGCCGGTTCTCAACAGGAGGTGTGTAGAAGCGGCGGTG
ATGACAGGCCTGGCTCTGAACTGCCACATAAACAAGAAGTCCTTGTTTGACAGGAAGCAC
TACTTCTATGCAGACCTCCCTGCAGGCTACCAAATTACCCAGCAGAGGCTCCCAATTGCT
GTGAATGGGAGCTTGATATATGGCGTCTGTGCAGGGAAGAAGCAGAGTCAGGTGATCCCC
AAGACGGTGAGGATCAAGCAGATCCAGTTGGAGCAAGACAGTGGCAAAAGCCTCCACGAC
AACCTGAGGTCTCAGACGCTCATTGATTTGAACAGGGCAGGAGTGGGCCTTCTGGAGGTG
GTCCTGGAGCCCGACATGTCCTGTGGAGAAGAGGCGGCAACAGCTGTCAGGGAGCTGCAG
CTGATCCTTCAAGCCCTGGGGACCAGCCAGGCGAACATGGCAGAGGGCCAGTTGAGAGTG
GATGCCAATATATCCGTGCATCACCCTGGGGAGCCTTTGGGCGTTCGAACGGAAGTGAAG
AATCTCAACAGCATCAGGTTCCTGGCCAAAGCCATAGACTATGAAATTCAGAGGCAAATC
AATGAACTTGAGAATGGAGGTGAAATTCTGAACGAAACACGCTCATTTCATCACAAGCTG
GGGTGCACCATGTCAATGAGAGACAAAGAAGGAAAACAGGACTACAGGTTCATGCCAGAA
CCCAACCTGCCTCCCCTGGTGCTCTACGACGCCACATCTCTGCCCGCAGGTGCAGACCCA
CAGCAAGTGATCAATATTGACCAGATTCGGGAGACACTCCCGGAGCTCCCCAGTGTGACC
CGAGAGAAGCTTGTCCAACAGTATGGGATGCTGCTGGAACACAGCTTCACTTTGCTGAAC
GAAGTCGGCCTACTGGAGTTCTTCCAAAATGTGATAAAAGAAACTAGGGCAGAGCCAAAA
AAGGTGACTAGTTGGGTCCTCAACACTTTTCTGGGCTATTTAAAGCAACAGAACCTCGCT
GTCAGTGAGAGTCCTGTCACACCCTCTGCACTCGCTGAGCTTCTTGACCTGCTGGACAGC
AGAACAATTTCTTCATCAGCAGCTAAACAGGTGTTTGAGGAACTGTGGAAGAGGGAAGGC
AAGACTCCAGGGCAGATTGTTTCAGAAAAGCAGCTTGAACTGATGCAGGACCAGGGGGCA
CTGGAGCAGCTCTGCCACTCTGTGATGGAGGCCCATCCTCAAGTGGTAATGGATGTGAAG
AACAGAAACCCCAGAGCTATAAATAAACTGATTGGGTTGGTCCGGAAAGCGACTCAAAGC
CGAGCAGATCCAGTCATGATAAAGGAGATCCTGGAGAAGAAGCTGTCATTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02934</identifier>
        <name>GatB_N</name>
      </pfam>
      <pfam>
        <identifier>PF02637</identifier>
        <name>GatB_Yqey</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>glutamyl-tRNA(Gln) amidotransferase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>translation factor activity, RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutaminyl-tRNA synthase (glutamine-hydrolyzing) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitochondrial translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutaminyl-tRNAGln biosynthesis via transamidation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000825</id>
      <name>Glutaminase kidney isoform, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16824605</pubmed-id>
            <citation>Karmaker S, Saha TK, Yoshikawa Y, Yasui H, Sakurai H: A novel drug delivery system for type 1 diabetes: insulin-mimetic vanadyl-poly(gamma-glutamic acid) complex. J Inorg Biochem. 2006 Sep;100(9):1535-46. Epub 2006 May 24.</citation>
          </article>
          <article>
            <pubmed-id>16720907</pubmed-id>
            <citation>Shi F, Xu Z, Cen P: Efficient production of poly-gamma-glutamic acid by Bacillus subtilis ZJU-7. Appl Biochem Biotechnol. 2006 Jun;133(3):271-82.</citation>
          </article>
          <article>
            <pubmed-id>16815871</pubmed-id>
            <citation>Yang XX, Hu ZP, Xu AL, Duan W, Zhu YZ, Huang M, Sheu FS, Zhang Q, Bian JS, Chan E, Li X, Wang JC, Zhou SF: A mechanistic study on reduced toxicity of irinotecan by coadministered thalidomide, a tumor necrosis factor-alpha inhibitor. J Pharmacol Exp Ther. 2006 Oct;319(1):82-104. Epub 2006 Jun 30.</citation>
          </article>
          <article>
            <pubmed-id>16861819</pubmed-id>
            <citation>Ashiuchi M, Shimanouchi K, Horiuchi T, Kamei T, Misono H: Genetically engineered poly-gamma-glutamate producer from Bacillus subtilis ISW1214. Biosci Biotechnol Biochem. 2006 Jul;70(7):1794-7.</citation>
          </article>
          <article>
            <pubmed-id>16952838</pubmed-id>
            <citation>Ashiuchi M, Nakamura H, Yamamoto M, Misono H: Novel poly-gamma-glutamate-processing enzyme catalyzing gamma-glutamyl DD-amidohydrolysis. J Biosci Bioeng. 2006 Jul;102(1):60-5.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O94925" source="Swiss-Prot">
    <name>Glutaminase kidney isoform, mitochondrial</name>
    <general-function>Glutaminase activity</general-function>
    <specific-function>Catalyzes the first reaction in the primary pathway for the renal catabolism of glutamine. Plays a role in maintaining acid-base homeostasis. Regulates the levels of the neurotransmitter glutamate in the brain. Isoform 2 lacks catalytic activity.</specific-function>
    <gene-name>GLS</gene-name>
    <locus>2q32-q34</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.82</theoretical-pi>
    <molecular-weight>73460.56</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4331</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF158555</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5690372</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O94925</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLSK_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.5.1.2</synonym>
      <synonym>GLS</synonym>
      <synonym>GLS1</synonym>
      <synonym>K-glutaminase</synonym>
      <synonym>KIAA0838</synonym>
      <synonym>L-glutamine amidohydrolase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001646|Glutaminase kidney isoform, mitochondrial
MMRLRGSGMLRDLLLRSPAGVSATLRRAQPLVTLCRRPRGGGRPAAGPAAAARLHPWWGG
GGWPAEPLARGLSSSPSEILQELGKGSTHPQPGVSPPAAPAAPGPKDGPGETDAFGNSEG
KELVASGENKIKQGLLPSLEDLLFYTIAEGQEKIPVHKFITALKSTGLRTSDPRLKECMD
MLRLTLQTTSDGVMLDKDLFKKCVQSNIVLLTQAFRRKFVIPDFMSFTSHIDELYESAKK
QSGGKVADYIPQLAKFSPDLWGVSVCTVDGQRHSTGDTKVPFCLQSCVKPLKYAIAVNDL
GTEYVHRYVGKEPSGLRFNKLFLNEDDKPHNPMVNAGAIVVTSLIKQGVNNAEKFDYVMQ
FLNKMAGNEYVGFSNATFQSERESGDRNFAIGYYLKEKKCFPEGTDMVGILDFYFQLCSI
EVTCESASVMAATLANGGFCPITGERVLSPEAVRNTLSLMHSCGMYDFSGQFAFHVGLPA
KSGVAGGILLVVPNVMGMMCWSPPLDKMGNSVKGIHFCHDLVSLCNFHNYDNLRHFAKKL
DPRREGGDQRVKSVINLLFAAYTGDVSALRRFALSAMDMEQRDYDSRTALHVAAAEGHVE
VVKFLLEACKVNPFPKDRWNNTPMDEALHFGHHDVFKILQEYQVQYTPQGDSDNGKENQT
VHKNLDGLL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019018|Glutaminase kidney isoform, mitochondrial (GLS)
ATGATGCGGCTGCGAGGCTCGGGGATGCTGCGGGACCTGCTCCTGCGGTCGCCCGCCGGC
GTGAGCGCGACTCTGCGGCGGGCACAGCCCTTGGTCACCCTGTGCCGGCGTCCCCGAGGC
GGGGGACGGCCGGCCGCGGGCCCGGCTGCCGCCGCGCGACTCCACCCGTGGTGGGGCGGG
GGCGGCTGGCCGGCGGAGCCCCTCGCGCGGGGCCTGTCCAGCTCTCCTTCGGAGATCTTG
CAGGAGCTGGGCAAGGGGAGCACGCATCCGCAGCCCGGGGTGTCGCCACCCGCTGCCCCG
GCGGCGCCCGGCCCCAAGGACGGCCCCGGGGAGACGGACGCGTTTGGCAACAGCGAGGGC
AAAGAGCTGGTGGCCTCAGGTGAAAATAAAATAAAACAGGGTCTGTTACCTAGCTTGGAA
GATTTGCTGTTCTATACAATTGCTGAAGGACAAGAGAAAATACCTGTTCATAAATTTATT
ACAGCACTCAAATCTACAGGATTGCGAACGTCTGATCCCAGGTTGAAAGAGTGTATGGAT
ATGTTAAGATTAACTCTTCAAACAACATCAGATGGTGTCATGCTAGACAAAGATCTTTTT
AAAAAATGTGTTCAGAGCAACATTGTTTTGTTGACACAAGCATTTAGAAGAAAGTTTGTG
ATTCCTGACTTTATGTCTTTTACCTCACACATTGATGAGTTATATGAAAGTGCTAAAAAG
CAGTCTGGAGGAAAGGTTGCAGATTATATTCCTCAACTGGCCAAATTCAGTCCCGATTTG
TGGGGTGTGTCTGTTTGTACAGTAGATGGACAGAGGCATTCTACTGGAGATACCAAAGTT
CCCTTCTGTCTTCAGTCCTGTGTAAAACCTTTGAAATATGCCATTGCTGTTAATGATCTT
GGAACTGAATATGTGCATCGATATGTTGGAAAAGAGCCGAGTGGACTAAGATTCAACAAA
CTATTTTTGAATGAAGATGATAAACCACATAATCCTATGGTAAATGCTGGAGCAATTGTT
GTGACTTCACTAATAAAGCAAGGAGTAAATAATGCTGAAAAATTTGACTATGTCATGCAG
TTTTTGAATAAGATGGCTGGTAATGAATATGTTGGATTCAGTAATGCAACGTTTCAGTCT
GAAAGAGAAAGTGGAGATCGAAATTTTGCAATAGGATATTACTTAAAAGAAAAGAAGTGT
TTTCCAGAAGGCACAGACATGGTTGGTATATTAGACTTCTACTTCCAGCTGTGCTCCATT
GAAGTGACTTGTGAATCAGCCAGTGTGATGGCTGCGACACTGGCTAATGGTGGTTTCTGC
CCAATTACTGGTGAAAGAGTACTGAGCCCTGAAGCAGTTCGAAATACATTGAGTTTGATG
CATTCCTGTGGCATGTATGACTTCTCAGGGCAGTTTGCTTTCCATGTTGGTCTTCCTGCA
AAATCTGGAGTTGCTGGGGGCATTCTTTTAGTTGTCCCCAATGTTATGGGTATGATGTGC
TGGTCTCCTCCTCTGGATAAGATGGGCAACAGTGTTAAGGGAATTCACTTTTGTCACGAT
CTTGTTTCTCTGTGTAATTTCCATAACTATGATAATTTGAGACACTTTGCAAAAAAACTT
GATCCTCGAAGAGAAGGTGGTGATCAAAGGCATTCCTTTGGACCATTGGACTATGAAAGT
CTCCAACAAGAACTTGCTTTAAAAGAGACAGTATGGAAAAAAGTGTCACCTGAGTCAAAT
GAGGACATCTCTACAACTGTAGTATATAGAATGGAAAGTCTGGGAGAGAAAAGCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04960</identifier>
        <name>Glutaminase</name>
      </pfam>
      <pfam>
        <identifier>PF12796</identifier>
        <name>Ank_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of respiratory gaseous exchange by neurological system process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>suckling behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000383</id>
      <name>Aspartate aminotransferase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>261660</pubmed-id>
            <citation>Recasens M, Mandel P: Similarities between cysteinesulphinate transaminase and aspartate aminotransferase. Ciba Found Symp. 1979;(72):259-70.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00505" source="Swiss-Prot">
    <name>Aspartate aminotransferase, mitochondrial</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). Plays a key role in amino acid metabolism. Important for metabolite exchange between mitochondria and cytosol. Facilitates cellular uptake of long-chain free fatty acids.</specific-function>
    <gene-name>GOT2</gene-name>
    <locus>16q21</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.38</theoretical-pi>
    <molecular-weight>47517.285</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4433</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GOT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M22632</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>179104</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P00505</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AATM_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.1</synonym>
      <synonym>FABP-1</synonym>
      <synonym>FABPpm</synonym>
      <synonym>Fatty acid-binding protein</synonym>
      <synonym>Glutamate oxaloacetate transaminase 2</synonym>
      <synonym>Kynurenine aminotransferase 4</synonym>
      <synonym>Kynurenine aminotransferase IV</synonym>
      <synonym>Kynurenine--oxoglutarate transaminase 4</synonym>
      <synonym>Kynurenine--oxoglutarate transaminase IV</synonym>
      <synonym>mAspAT</synonym>
      <synonym>Plasma membrane-associated fatty acid-binding protein</synonym>
      <synonym>Transaminase A</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037006|Aspartate aminotransferase, mitochondrial
MALLHSGRVLPGIAAAFHPGLAAAASARASSWWTHVEMGPPDPILGVTEAFKRDTNSKKM
NLGVGAYRDDNGKPYVLPSVRKAEAQIAAKNLDKEYLPIGGLAEFCKASAELALGENSEV
LKSGRFVTVQTISGTGALRIGASFLQRFFKFSRDVFLPKPTWGNHTPIFRDAGMQLQGYR
YYDPKTCGFDFTGAVEDISKIPEQSVLLLHACAHNPTGVDPRPEQWKEIATVVKKRNLFA
FFDMAYQGFASGDGDKDAWAVRHFIEQGINVCLCQSYAKNMGLYGERVGAFTMVCKDADE
AKRVESQLKILIRPMYSNPPLNGARIAAAILNTPDLRKQWLQEVKVMADRIIGMRTQLVS
NLKKEGSTHNWQHITDQIGMFCFTGLKPEQVERLIKEFSIYMTKDGRISVAGVTSSNVGY
LAHAIHQVTK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010269|Aspartate aminotransferase, mitochondrial (GOT2)
ATGGCCCTGCTGCACTCCGGCCGCGTCCTCCCCGGGATCGCCGCCGCCTTCCACCCGGGC
CTCGCCGCCGCGGCCTCTGCCAGAGCCAGCTCCTGGTGGACCCATGTGGAAATGGGACCT
CCAGATCCCATTCTGGGAGTCACTGAAGCCTTTAAGAGGGACACCAATAGCAAAAAGATG
AATCTGGGAGTTGGTGCCTACCGGGATGATAATGGAAAGCCTTACGTTCTGCCTAGCGTC
CGCAAGTTTGTCACTGTGCAGACCATTTCTGGAACTGGAGCCTTAAGGATCGGAGCCAGT
TTTCTGCAAAGATTTTTTAAGTTCAGCCGAGATGTCTTTCTGCCCAAACCAACCTGGGGA
AACCACACACCCATCTTCAGGGATGCTGGCATGCAGCTACAAGGTTATCGGTATTATGAC
CCCAAGACTTGCGGTTTTGACTTCACAGGCGCTGTGGAGGATATTTCAAAAATACCAGAG
CAGAGTGTTCTTCTTCTGCATGCCTGCGCCCACAATCCCACGGGAGTGGACCCGCGTCCG
GAACAGTGGAAGGAAATAGCAACAGTGGTGAAGAAAAGGAATCTCTTTGCGTTCTTTGAC
ATGGCCTACCAAGGCTTTGCCAGTGGTGATGGTGATAAGGATGCCTGGGCTGTGCGCCAC
TTCATCGAACAGGGCATTAATGTTTGCCTCTGCCAATCATATGCCAAGAACATGGGCTTA
TATGGTGAGCGTGTAGGAGCCTTCACTATGGTCTGCAAAGATGCGGATGAAGCCAAAAGG
GTAGAGTCACAGTTGAAGATCTTGATCCGTCCCATGTATTCCAACCCTCCCCTCAATGGG
GCCCGGATTGCTGCTGCCATTCTGAACACCCCAGATTTGCGAAAACAATGGCTGCAAGAA
GTGAAAGTCATGGCTGACCGCATCATTGGCATGCGGACTCAACTGGTCTCCAACCTCAAG
AAGGAGGGTTCCACCCACAATTGGCAACACATCACCGACCAAATTGGCATGTTCTGTTTC
ACAGGGCTAAAGCCTGAACAGGTGGAGCGGCTGATCAAGGAGTTCTCCATCTACATGACA
AAAGATGGCCGCATCTCTGTGGCAGGGGTCACCTCCAGCAACGTGGGCTACCTTGCCCAT
GCCATTCACCAGGTCACCAAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>protein complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kynurenine-oxoglutarate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-aspartate</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-phenylalanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phospholipid binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process to 2-oxoglutarate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process to aspartate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxaloacetate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>4-hydroxyproline catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000188</id>
      <name>Bifunctional glutamate/proline--tRNA ligase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9063462</pubmed-id>
            <citation>Cerini C, Semeriva M, Gratecos D: Evolution of the aminoacyl-tRNA synthetase family and the organization of the Drosophila glutamyl-prolyl-tRNA synthetase gene. Intron/exon structure of the gene, control of expression of the two mRNAs, selective advantage of the multienzyme complex. Eur J Biochem. 1997 Feb 15;244(1):176-85.</citation>
          </article>
          <article>
            <pubmed-id>8132637</pubmed-id>
            <citation>Ting SM, Dignam JD: Post-transcriptional regulation of glutamyl-prolyl-tRNA synthetase in rat salivary gland. J Biol Chem. 1994 Mar 25;269(12):8993-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07814" source="Swiss-Prot">
    <name>Bifunctional glutamate/proline--tRNA ligase</name>
    <general-function>Rna stem-loop binding</general-function>
    <specific-function>Catalyzes the attachment of the cognate amino acid to the corresponding tRNA in a two-step reaction: the amino acid is first activated by ATP to form a covalent intermediate with AMP and is then transferred to the acceptor end of the cognate tRNA. Component of the GAIT (gamma interferon-activated inhibitor of translation) complex which mediates interferon-gamma-induced transcript-selective translation inhibition in inflammation processes. Upon interferon-gamma activation and subsequent phosphorylation dissociates from the multisynthetase complex and assembles into the GAIT complex which binds to stem loop-containing GAIT elements in the 3'-UTR of diverse inflammatory mRNAs (such as ceruplasmin) and suppresses their translation.</specific-function>
    <gene-name>EPRS</gene-name>
    <locus>1q41-q42</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.75</theoretical-pi>
    <molecular-weight>170589.705</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3418</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>EPRS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X54326</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31958</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P07814</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYEP_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Bifunctional aminoacyl-tRNA synthetase</synonym>
      <synonym>Cell proliferation-inducing gene 32 protein</synonym>
      <synonym>GLNS</synonym>
      <synonym>Glutamatyl-prolyl-tRNA synthetase</synonym>
      <synonym>PARS</synonym>
      <synonym>QARS</synonym>
      <synonym>QPRS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036967|Bifunctional glutamate/proline--tRNA ligase
MATLSLTVNSGDPPLGALLAVEHVKDDVSISVEEGKENILHVSENVIFTDVNSILRYLAR
VATTAGLYGSNLMEHTEIDHWLEFSATKLSSCDSFTSTINELNHCLSLRTYLVGNSLSLA
DLCVWATLKGNAAWQEQLKQKKAPVHVKRWFGFLEAQQAFQSVGTKWDVSTTKARVAPEK
KQDVGKFVELPGAEMGKVTVRFPPEASGYLHIGHAKAALLNQHYQVNFKGKLIMRFDDTN
PEKEKEDFEKVILEDVAMLHIKPDQFTYTSDHFETIMKYAEKLIQEGKAYVDDTPAEQMK
AEREQRIDSKHRKNPIEKNLQMWEEMKKGSQFGQSCCLRAKIDMSSNNGCMRDPTLYRCK
IQPHPRTGNKYNVYPTYDFACPIVDSIEGVTHALRTTEYHDRDEQFYWIIEALGIRKPYI
WEYSRLNLNNTVLSKRKLTWFVNEGLVDGWDDPRFPTVRGVLRRGMTVEGLKQFIAAQGS
SRSVVNMEWDKIWAFNKKVIDPVAPRYVALLKKEVIPVNVPEAQEEMKEVAKHPKNPEVG
LKPVWYSPKVFIEGADAETFSEGEMVTFINWGNLNITKIHKNADGKIISLDAKLNLENKD
YKKTTKVTWLAETTHALPIPVICVTYEHLITKPVLGKDEDFKQYVNKNSKHEELMLGDPC
LKDLKKGDIIQLQRRGFFICDQPYEPVSPYSCKEAPCVLIYIPDGHTKEMPTSGSKEKTK
VEATKNETSAPFKERPTPSLNNNCTTSEDSLVLYNRVAVQGDVVRELKAKKAPKEDVDAA
VKQLLSLKAEYKEKTGQEYKPGNPPAEIGQNISSNSSASILESKSLYDEVAAQGEVVRKL
KAEKSPKAKINEAVECLLSLKAQYKEKTGKEYIPGQPPLSQSSDSSPTRNSEPAGLETPE
AKVLFDKVASQGEVVRKLKTEKAPKDQVDIAVQELLQLKAQYKSLIGVEYKPVSATGAED
KDKKKKEKENKSEKQNKPQKQNDGQRKDPSKNQGGGLSSSGAGEGQGPKKQTRLGLEAKK
EENLADWYSQVITKSEMIEYHDISGCYILRPWAYAIWEAIKDFFDAEIKKLGVENCYFPM
FVSQSALEKEKTHVADFAPEVAWVTRSGKTELAEPIAIRPTSETVMYPAYAKWVQSHRDL
PIKLNQWCNVVRWEFKHPQPFLRTREFLWQEGHSAFATMEEAAEEVLQILDLYAQVYEEL
LAIPVVKGRKTEKEKFAGGDYTTTIEAFISASGRAIQGGTSHHLGQNFSKMFEIVFEDPK
IPGEKQFAYQNSWGLTTRTIGVMTMVHGDNMGLVLPPRVACVQVVIIPCGITNALSEEDK
EALIAKCNDYRRRLLSVNIRVRADLRDNYSPGWKFNHWELKGVPIRLEVGPRDMKSCQFV
AVRRDTGEKLTVAENEAETKLQAILEDIQVTLFTRASEDLKTHMVVANTMEDFQKILDSG
KIVQIPFCGEIDCEDWIKKTTARDQDLEPGAPSMGAKSLCIPFKPLCELQPGAKCVCGKN
PAKYYTLFGRSY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020448|Bifunctional glutamate/proline--tRNA ligase (EPRS)
ATGGCGACGCTCTCTCTGACCGTGAATTCAGGAGACCCTCCGCTAGGAGCTTTGCTGGCA
GTAGAACACGTGAAAGACGATGTCAGCATTTCCGTTGAAGAAGGGAAAGAGAATATTCTT
CATGTTTCTGAAAATGTGATATTCACAGATGTGAATTCTATACTTCGCTACTTGGCTAGA
GTTGCAACTACAGCTGGGTTATATGGCTCTAATCTGATGGAACATACTGAGATTGATCAC
TGGTTGGAGTTCAGTGCTACAAAATTATCTTCATGTGATTCCTTTACTTCTACAATTAAT
GAACTCAATCATTGCCTGTCTCTGAGAACATACTTAGTTGGAAACTCCTTGAGTTTAGCA
GATTTATGTGTTTGGGCCACCCTAAAAGGAAATGCTGCCTGGCAAGAACAGTTGAAACAG
AAGAAAGCTCCAGTTCATGTAAAACGTTGGTTTGGCTTTCTTGAAGCCCAGCAGGCCTTC
CAGTCAGTAGGTACCAAGTGGGATGTTTCAACAACCAAAGCTCGAGTGGCACCTGAGAAA
AAGCAAGATGTTGGGAAATTTGTTGAGCTTCCAGGTGCGGAGATGGGAAAGGTTACCGTC
AGATTTCCTCCAGAGGCCAGTGGTTACTTACACATTGGGCATGCAAAAGCTGCTCTTCTG
AACCAGCACTACCAGGTTAACTTTAAAGGGAAACTGATCATGAGATTTGATGACACAAAT
CCTGAAAAAGAAAAGGAAGATTTTGAGAAGGTTATCTTGGAAGATGTTGCAATGTTGCAT
ATCAAACCAGATCAATTTACTTATACTTCGGATCATTTTGAAACTATAATGAAGTATGCA
GAGAAGCTAATTCAAGAAGGGAAGGCTTATGTGGATGATACTCCTGCTGAACAGATGAAA
GCAGAACGTGAGCAGAGGATAGACTCTAAACATAGAAAAAACCCTATTGAGAAGAATCTA
CAAATGTGGGAAGAAATGAAAAAAGGGAGCCAGTTTGGTCAGTCCTGTTGTTTGCGAGCA
AAAATTGACATGAGTAGTAACAATGGATGCATGAGAGATCCAACCCTTTATCGCTGCAAA
ATTCAACCACATCCAAGAACTGGAAATAAATACAATGTTTATCCAACATATGATTTTGCC
TGCCCCATAGTTGACAGCATCGAAGGTGTTACACATGCCCTGAGAACAACAGAATACCAT
GACAGAGATGAGCAGTTTTACTGGATTATTGAAGCTTTAGGCATAAGAAAACCATATATT
TGGGAATATAGTCGGCTAAATCTCAACAACACAGTGCTATCCAAAAGAAAACTCACATGG
TTTGTCAATGAAGGACTAGTAGATGGATGGGATGACCCAAGATTTCCTACGGTTCGTGGT
GTACTGAGAAGAGGGATGACAGTTGAAGGACTGAAACAGTTTATTGCTGCTCAGGGCTCC
TCACGTTCAGTCGTGAACATGGAGTGGGACAAAATCTGGGCGTTTAACAAAAAGGTTATT
GACCCAGTGGCTCCACGATATGTTGCATTACTGAAGAAAGAAGTGATCCCAGTGAATGTA
CCTGAAGCTCAGGAGGAGATGAAAGAAGTAGCCAAACACCCAAAGAATCCTGAGGTTGGC
TTGAAGCCTGTGTGGTATAGTCCCAAAGTTTTCATTGAAGGTGCTGATGCAGAGACTTTT
TCGGAGGGTGAGATGGTTACATTTATAAATTGGGGCAACCTCAACATTACAAAAATACAC
AAAAATGCAGATGGAAAAATCATATCTCTTGATGCAAAGTTGAATTTGGAAAACAAAGAC
TACAAGAAAACCACTAAGGTCACTTGGCTTGCAGAGACTACACATGCTCTTCCTATTCCA
GTAATCTGTGTCACTTATGAGCACTTGATCACAAAGCCAGTGCTAGGAAAAGACGAGGAC
TTTAAGCAGTATGTCAACAAGAACAGTAAGCATGAAGAGCTAATGCTAGGGGATCCCTGC
CTTAAGGATTTGAAAAAAGGAGATATTATACAACTCCAGAGAAGAGGATTCTTCATATGT
GATCAACCTTATGAACCTGTTAGCCCATATAGTTGCAAGGAAGCCCCGTGTGTTTTGATA
TACATTCCTGATGGGCACACAAAGGAAATGCCAACATCAGGGTCAAAGGAAAAGACCAAA
GTAGAAGCCACAAAAAATGAGACCTCTGCTCCTTTTAAGGAAAGACCAACACCTTCTCTG
AATAATAATTGTACTACATCTGAGGATTCCTTGGTCCTTTACAATAGAGTGGCTGTTCAA
GGAGATGTGGTTCGTGAATTAAAAGCCAAGAAAGCACCAAAGGAAGATGTAGATGCAGCT
GTAAAACAGCTTTTGTCTTTGAAAGCTGAATATAAGGAGAAAACTGGCCAGGAATATAAA
CCTGGAAACCCTCCTGCTGAAATAGGACAGAATATTTCTTCTAATTCCTCAGCAAGTATT
CTGGAAAGTAAATCTCTGTATGATGAAGTTGCTGCACAAGGGGAGGTGGTTCGTAAGCTA
AAAGCTGAAAAATCCCCTAAGGCTAAAATAAATGAAGCTGTAGAATGCTTACTGTCCCTG
AAGGCTCAGTATAAAGAAAAAACTGGGAAGGAGTACATACCTGGTCAGCCCCCATTATCT
CAAAGTTCGGATTCAAGCCCAACCAGAAATTCTGAACCTGCTGGTTTAGAAACACCAGAA
GCGAAAGTACTTTTTGACAAAGTAGCTTCTCAAGGGGAAGTAGTTCGGAAACTTAAAACT
GAAAAAGCCCCTAAGGATCAAGTAGATATAGCTGTTCAAGAACTCCTTCAGCTAAAGGCA
CAGTACAAGTCTTTGATAGGAGTAGAGTATAAGCCTGTGTCGGCCACTGGAGCTGAGGAC
AAAGATAAGAAGAAGAAAGAAAAAGAAAATAAATCTGAAAAGCAGAATAAGCCTCAGAAA
CAAAATGATGGCCAAAGGAAAGACCCTTCTAAAAACCAAGGAGGTGGGCTCTCATCAAGT
GGAGCAGGAGAAGGGCAGGGGCCTAAGAAACAGACCAGGTTGGGTCTTGAGGCAAAAAAA
GAAGAAAATCTTGCTGATTGGTATTCTCAGGTCATCACAAAGTCAGAAATGATTGAATAC
CATGACATAAGTGGCTGTTATATTCTTCGTCCCTGGGCCTATGCCATTTGGGAAGCCATC
AAGGACTTTTTTGATGCTGAGATCAAGAAACTTGGTGTTGAAAACTGCTACTTCCCCATG
TTTGTGTCTCAAAGTGCATTAGAGAAAGAGAAGACTCATGTTGCTGACTTTGCCCCAGAG
GTTGCTTGGGTTACAAGATCTGGCAAAACCGAGCTGGCAGAACCAATTGCCATTCGTCCT
ACTAGTGAAACAGTAATGTATCCTGCATATGCAAAATGGGTACAGTCACACAGAGACCTG
CCCATCAAGCTCAATCAGTGGTGCAATGTGGTGCGTTGGGAATTCAAGCATCCTCAGCCT
TTCCTACGTACTCGTGAATTTCTTTGGCAGGAAGGGCACAGTGCTTTTGCTACCATGGAA
GAGGCAGCGGAAGAGGTCTTGCAGATACTTGACTTATATGCTCAGGTATATGAAGAACTC
CTGGCAATTCCTGTTGTTAAAGGAAGAAAGACGGAAAAGGAAAAATTTGCAGGAGGAGAC
TATACAACTACAATAGAAGCATTTATATCTGCTAGTGGAAGAGCTATCCAGGGAGGAACA
TCACATCATTTAGGGCAGAATTTTTCCAAAATGTTTGAAATCGTTTTTGAAGATCCAAAG
ATACCAGGAGAGAAGCAATTTGCCTATCAAAACTCCTGGGGCCTGACAACTCGAACTATT
GGTGTTATGACCATGGTTCATGGGGACAACATGGGTTTAGTATTACCACCCCGTGTAGCA
TGTGTTCAGGTGGTGATTATTCCTTGTGGCATTACCAATGCACTTTCTGAAGAAGACAAA
GAAGCGCTGATTGCAAAATGCAATGATTATCGAAGGCGATTACTCAGTGTTAACATCCGC
GTTAGAGCTGATTTACGAGATAATTATTCTCCAGGTTGGAAATTCAATCACTGGGAGCTC
AAGGGAGTTCCCATTAGACTTGAAGTTGGGCCACGTGATATGAAGAGCTGTCAGTTTGTA
GCCGTCAGACGAGATACTGGAGAAAAGCTGACAGTTGCTGAAAATGAGGCAGAGACTAAA
CTTCAAGCTATTTTGGAAGACATCCAGGTCACCCTTTTCACAAGGGCTTCTGAAGACCTT
AAGACTCATATGGTTGTGGCTAATACAATGGAAGACTTTCAGAAGATACTAGATTCTGGA
AAGATTGTTCAGATTCCATTCTGTGGGGAAATTGACTGTGAGGACTGGATCAAAAAGACC
ACTGCCAGGGATCAAGATCTTGAACCTGGTGCTCCATCCATGGGAGCTAAAAGCCTTTGC
ATCCCCTTCAAACCACTCTGTGAACTGCAGCCTGGAGCCAAATGTGTCTGTGGCAAGAAC
CCTGCCAAGTACTACACCTTATTTGGTCGCAGCTACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00587</identifier>
        <name>tRNA-synt_2b</name>
      </pfam>
      <pfam>
        <identifier>PF03129</identifier>
        <name>HGTP_anticodon</name>
      </pfam>
      <pfam>
        <identifier>PF00749</identifier>
        <name>tRNA-synt_1c</name>
      </pfam>
      <pfam>
        <identifier>PF03950</identifier>
        <name>tRNA-synt_1c_C</name>
      </pfam>
      <pfam>
        <identifier>PF00458</identifier>
        <name>WHEP-TRS</name>
      </pfam>
      <pfam>
        <identifier>PF14497</identifier>
        <name>GST_C_3</name>
      </pfam>
      <pfam>
        <identifier>PF09180</identifier>
        <name>ProRS-C_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>aminoacyl-tRNA synthetase multienzyme complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>ribonucleoprotein complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>GAIT complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>proline-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>RNA stem-loop binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GTPase binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein complex assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to interferon-gamma</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prolyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA processing</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000219</id>
      <name>Asparagine synthetase [glutamine-hydrolyzing]</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08243" source="Swiss-Prot">
    <name>Asparagine synthetase [glutamine-hydrolyzing]</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function/>
    <gene-name>ASNS</gene-name>
    <locus>7q21.3</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.85</theoretical-pi>
    <molecular-weight>64369.39</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:753</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ASNS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M27396</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>179100</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P08243</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ASNS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.5.4</synonym>
      <synonym>Cell cycle control protein TS11</synonym>
      <synonym>Glutamine-dependent asparagine synthetase</synonym>
      <synonym>TS11</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036974|Asparagine synthetase [glutamine-hydrolyzing]
MCGIWALFGSDDCLSVQCLSAMKIAHRGPDAFRFENVNGYTNCCFGFHRLAVVDPLFGMQ
PIRVKKYPYLWLCYNGEIYNHKKMQQHFEFEYQTKVDGEIILHLYDKGGIEQTICMLDGV
FAFVLLDTANKKVFLGRDTYGVRPLFKAMTEDGFLAVCSEAKGLVTLKHSATPFLKVEPF
LPGHYEVLDLKPNGKVASVEMVKYHHCRDVPLHALYDNVEKLFPGFEIETVKNNLRILFN
NAVKKRLMTDRRIGCLLSGGLDSSLVAATLLKQLKEAQVQYPLQTFAIGMEDSPDLLAAR
KVADHIGSEHYEVLFNSEEGIQALDEVIFSLETYDITTVRASVGMYLISKYIRKNTDSVV
IFSGEGSDELTQGYIYFHKAPSPEKAEEESERLLRELYLFDVLRADRTTAAHGLELRVPF
LDHRFSSYYLSLPPEMRIPKNGIEKHLLRETFEDSNLIPKEILWRPKEAFSDGITSVKNS
WFKILQEYVEHQVDDAMMANAAQKFPFNTPKTKEGYYYRQVFERHYPGRADWLSHYWMPK
WINATDPSARTLTHYKSAVKA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010013|Asparagine synthetase [glutamine-hydrolyzing] (ASNS)
ATGAAGATTGCACACAGAGGTCCAGATGCATTCCGTTTTGAGAATGTCAATGGATACACC
AACTGCTGCTTTGGATTTCACCGGTTGGCGGTAGTTGACCCGCTGTTTGGAATGCAGCCA
ATTCGAGTGAAGAAATATCCGTATTTGTGGCTCTGTTACAATGGTGAAATCTACAACCAT
AAGAAGATGCAACAGCATTTTGAATTTGAATACCAGACCAAAGTGGATGGTGAGATAATC
CTTCATCTTTATGACAAAGGAGGAATTGAGCAAACAATTTGTATGTTGGATGGTGTGTTT
GCATTTGTTTTACTGGATACTGCCAATAAGAAAGTGTTCCTGGGTAGAGATACATATGGA
GTCAGACCTTTGTTTAAAGCAATGACAGAAGATGGATTTTTGGCTGTATGTTCAGAAGCT
AAAGGTCTTGTTACATTGAAGCACTCCGCGACTCCCTTTTTAAAAGTGGAGCCTTTTCTT
CCTGGACACTATGAAGTTTTGGATTTAAAGCCAAATGGCAAAGTTGCATCCGTGGAAATG
GTTAAATATCATCACTGTCGGGATGTACCCCTGCACGCCCTCTATGACAATGTGGAGAAA
CTCTTTCCAGGTTTTGAGATAGAAACTGTGAAGAACAACCTCAGGATCCTTTTTAATAAT
GCTGTAAAGAAACGTTTGATGACAGACAGAAGGATTGGCTGCCTTTTATCAGGGGGCTTG
GACTCCAGCTTGGTTGCTGCCACTCTGTTGAAGCAGCTGAAAGAAGCCCAAGTACAGTAT
CCTCTCCAGACATTTGCAATTGGCATGGAAGACAGCCCCGATTTACTGGCTGCTAGAAAG
GTGGCAGATCATATTGGAAGTGAACATTATGAAGTCCTTTTTAACTCTGAGGAAGGCATT
CAGGCTCTGGATGAAGTCATATTTTCCTTGGAAACTTATGACATTACAACAGTTCGTGCT
TCAGTAGGTATGTATTTAATTTCCAAGTATATTCGGAAGAACACAGATAGCGTGGTGATC
TTCTCTGGAGAAGGATCAGATGAACTTACGCAGGGTTACATATATTTTCACAAGGCTCCT
TCTCCTGAAAAAGCCGAGGAGGAGAGTGAGAGGCTTCTGAGGGAACTCTATTTGTTTGAT
GTTCTCCGCGCAGATCGAACTACTGCTGCCCATGGTCTTGAACTGAGAGTCCCATTTCTA
GATCATCGATTTTCTTCCTATTACTTGTCTCTGCCACCAGAAATGAGAATTCCAAAGAAT
GGGATAGAAAAACATCTCCTGAGAGAGACGTTTGAGGATTCCAATCTGATACCCAAAGAG
ATTCTCTGGCGACCAAAAGAAGCCTTCAGTGATGGAATAACTTCAGTTAAGAATTCCTGG
TTTAAGATTTTACAGGAATACGTTGAACATCAGGTTGATGATGCAATGATGGCAAATGCA
GCCCAGAAATTTCCCTTCAATACTCCTAAAACCAAAGAAGGATATTACTACCGTCAAGTC
TTTGAACGCCATTACCCAGGCCGGGCTGACTGGCTGAGCCATTACTGGATGCCCAAGTGG
ATCAATGCCACTGACCCTTCTGCCCGCACGCTGACCCACTACAAGTCAGCTGTCAAAGCT
TAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00733</identifier>
        <name>Asn_synthase</name>
      </pfam>
      <pfam>
        <identifier>PF13537</identifier>
        <name>GATase_7</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cofactor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>asparagine synthase (glutamine-hydrolyzing) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-asparagine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>liver development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>PERK-mediated unfolded protein response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of mitotic cell cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hormone stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amino acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to follicle-stimulating hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to methotrexate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to light stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to mechanical stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>asparagine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to glucose starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endoplasmic reticulum unfolded protein response</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002240</id>
      <name>Glutamine synthetase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16673373</pubmed-id>
            <citation>Re DB, Nafia I, Melon C, Shimamoto K, Kerkerian-Le Goff L, Had-Aissouni L: Glutamate leakage from a compartmentalized intracellular metabolic pool and activation of the lipoxygenase pathway mediate oxidative astrocyte death by reversed glutamate transport. Glia. 2006 Jul;54(1):47-57.</citation>
          </article>
          <article>
            <pubmed-id>16973920</pubmed-id>
            <citation>Singh U, Sarkar D: Development of a simple high-throughput screening protocol based on biosynthetic activity of Mycobacterium tuberculosis glutamine synthetase for the identification of novel Inhibitors. J Biomol Screen. 2006 Dec;11(8):1035-42. Epub 2006 Sep 14.</citation>
          </article>
          <article>
            <pubmed-id>17284842</pubmed-id>
            <citation>Yamamoto S, Wakayama M, Tachiki T: Characterization of theanine-forming enzyme from Methylovorus mays no. 9 in respect to utilization of theanine production. Biosci Biotechnol Biochem. 2007 Feb;71(2):545-52. Epub 2007 Feb 7.</citation>
          </article>
          <article>
            <pubmed-id>16876704</pubmed-id>
            <citation>Scaraffia PY, Zhang Q, Wysocki VH, Isoe J, Wells MA: Analysis of whole body ammonia metabolism in Aedes aegypti using [15N]-labeled compounds and mass spectrometry. Insect Biochem Mol Biol. 2006 Aug;36(8):614-22. Epub 2006 May 19.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15104" source="Swiss-Prot">
    <name>Glutamine synthetase</name>
    <general-function>Manganese ion binding</general-function>
    <specific-function>This enzyme has 2 functions: it catalyzes the production of glutamine and 4-aminobutanoate (gamma-aminobutyric acid, GABA), the latter in a pyridoxal phosphate-independent manner (By similarity). Essential for proliferation of fetal skin fibroblasts.</specific-function>
    <gene-name>GLUL</gene-name>
    <locus>1q31</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.88</theoretical-pi>
    <molecular-weight>42064.15</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLUL</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y00387</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31833</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P15104</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLNA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.1.2</synonym>
      <synonym>GLNS</synonym>
      <synonym>Glutamate decarboxylase</synonym>
      <synonym>Glutamate--ammonia ligase</synonym>
      <synonym>GS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019251|Glutamine synthetase
MTTSASSHLNKGIKQVYMSLPQGEKVQAMYIWIDGTGEGLRCKTRTLDSEPKCVEELPEW
NFDGSSTLQSEGSNSDMYLVPAAMFRDPFRKDPNKLVLCEVFKYNRRPAETNLRHTCKRI
MDMVSNQHPWFGMEQEYTLMGTDGHPFGWPSNGFPGPQGPYYCGVGADRAYGRDIVEAHY
RACLYAGVKIAGTNAEVMPAQWEFQIGPCEGISMGDHLWVARFILHRVCEDFGVIATFDP
KPIPGNWNGAGCHTNFSTKAMREENGLKYIEEAIEKLSKRHQYHIRAYDPKGGLDNARRL
TGFHETSNINDFSAGVANRSASIRIPRTVGQEKKGYFEDRRPSANCDPFSVTEALIRTCL
LNETGDEPFQYKN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019252|Glutamine synthetase (GLUL)
ATGACCACCTCAGCAAGTTCCCACTTAAATAAAGGCATCAAGCAGGTGTACATGTCCCTG
CCTCAGGGTGAGAAAGTCCAGGCCATGTATATCTGGATCGATGGTACTGGAGAAGGACTG
CGCTGCAAGACCCGGACCCTGGACAGTGAGCCCAAGTGTGTGGAAGAGTTGCCTGAGTGG
AATTTCGATGGCTCTAGTACTTTACAGTCTGAGGGTTCCAACAGTGACATGTATCTCGTG
CCTGCTGCCATGTTTCGGGACCCCTTCCGTAAGGACCCTAACAAGCTGGTGTTATGTGAA
GTTTTCAAGTACAATCGAAGGCCTGCAGAGACCAATTTGAGGCACACCTGTAAACGGATA
ATGGACATGGTGAGCAACCAGCACCCCTGGTTTGGCATGGAGCAGGAGTATACCCTCATG
GGGACAGATGGGCACCCCTTTGGTTGGCCTTCCAACGGCTTCCCAGGGCCCCAGGGTCCA
TATTACTGTGGTGTGGGAGCAGACAGAGCCTATGGCAGGGACATCGTGGAGGCCCATTAC
CGGGCCTGCTTGTATGCTGGAGTCAAGATTGCGGGGACTAATGCCGAGGTCATGCCTGCC
CAGTGGGAATTTCAGATTGGACCTTGTGAAGGAATCAGCATGGGAGATCATCTCTGGGTG
GCCCGTTTCATCTTGCATCGTGTGTGTGAAGACTTTGGAGTGATAGCAACCTTTGATCCT
AAGCCCATTCCTGGGAACTGGAATGGTGCAGGCTGCCATACCAACTTCAGCACCAAGGCC
ATGCGGGAGGAGAATGGTCTGAAGTACATCGAGGAGGCCATTGAGAAACTAAGCAAGCGG
CACCAGTACCACATCCGTGCCTATGATCCCAAGGGAGGCCTGGACAATGCCCGACGTCTA
ACTGGATTCCATGAAACCTCCAACATCAACGACTTTTCTGCTGGTGTAGCCAATCGTAGC
GCCAGCATACGCATTCCCCGGACTGTTGGCCAGGAGAAGAAGGGTTACTTTGAAGATCGT
CGCCCCTCTGCCAACTGCGACCCCTTTTCGGTGACAGAAGCCCTCATCCGCACGTGTCTT
CTCAATGAAACCGGCGATGAGCCCTTCCAGTACAAAAATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00120</identifier>
        <name>Gln-synt_C</name>
      </pfam>
      <pfam>
        <identifier>PF03951</identifier>
        <name>Gln-synt_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>protein complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon terminus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>glial cell projection</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>manganese ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-ammonia ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate decarboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucose</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to starvation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter uptake</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of epithelial cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homooligomerization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000529</id>
      <name>Aspartate aminotransferase, cytoplasmic</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17444813</pubmed-id>
            <citation>Yudkoff M, Daikhin Y, Melo TM, Nissim I, Sonnewald U, Nissim I: The ketogenic diet and brain metabolism of amino acids: relationship to the anticonvulsant effect. Annu Rev Nutr. 2007;27:415-30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P17174" source="Swiss-Prot">
    <name>Aspartate aminotransferase, cytoplasmic</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Biosynthesis of L-glutamate from L-aspartate or L-cysteine. Important regulator of levels of glutamate, the major excitatory neurotransmitter of the vertebrate central nervous system. Acts as a scavenger of glutamate in brain neuroprotection. The aspartate aminotransferase activity is involved in hepatic glucose synthesis during development and in adipocyte glyceroneogenesis. Using L-cysteine as substrate, regulates levels of mercaptopyruvate, an important source of hydrogen sulfide. Mercaptopyruvate is converted into H(2)S via the action of 3-mercaptopyruvate sulfurtransferase (3MST). Hydrogen sulfide is an important synaptic modulator and neuroprotectant in the brain.</specific-function>
    <gene-name>GOT1</gene-name>
    <locus>10q24.1-q25.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.01</theoretical-pi>
    <molecular-weight>46247.14</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4432</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GOT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M37400</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>179067</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P17174</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AATC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.1</synonym>
      <synonym>cAspAT</synonym>
      <synonym>cCAT</synonym>
      <synonym>Cysteine aminotransferase, cytoplasmic</synonym>
      <synonym>Cysteine transaminase, cytoplasmic</synonym>
      <synonym>Glutamate oxaloacetate transaminase 1</synonym>
      <synonym>Transaminase A</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037039|Aspartate aminotransferase, cytoplasmic
MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQK
IANDNSLNHEYLPILGLAEFRSCASRLALGDDSPALKEKRVGGVQSLGGTGALRIGADFL
ARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLEN
APEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWA
IRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPP
AQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGM
FSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010371|Aspartate aminotransferase, cytoplasmic (GOT1)
ATGGCACCTCCGTCAGTCTTTGCCGAGGTTCCGCAGGCCCAGCCTGTCCTGGTCTTCAAG
CTCACTGCCGACTTCAGGGAGGATCCGGACCCCCGCAAGGTCAACCTGGGAGTGGGAGCA
TATCGCACGGATGACTGCCATCCCTGGGTTTTGCCAGTAGTGAAGAAAGTGGAGCAGAAG
ATTGCTAATGACAATAGCCTAAATCACGAGTATCTGCCAATCCTGGGCCTGGCTGAGTTC
CGGAGCTGTGCTTCTCGTCTTGCCCTTGGGGATGACAGCCCAGCACTCAAGGAGAAGCGG
GTAGGAGGTGTGCAATCTTTGGGGGGAACAGGTGCACTTCGAATTGGAGCTGATTTCTTA
GCGCGTTGGTACAATGGAACAAACAACAAGAACACACCTGTCTATGTGTCCTCACCAACC
TGGGAGAATCACAATGCTGTGTTTTCCGCTGCTGGTTTTAAAGACATTCGGTCCTATCGC
TACTGGGATGCAGAGAAGAGAGGATTGGACCTCCAGGGCTTCCTGAATGATCTGGAGAAT
GCTCCTGAGTTCTCCATTGTTGTCCTCCACGCCTGTGCACACAACCCAACTGGGATTGAC
CCAACTCCGGAGCAGTGGAAGCAGATTGCTTCTGTCATGAAGCACCGGTTTCTGTTCCCC
TTCTTTGACTCAGCCTATCAGGGCTTCGCATCTGGAAACCTGGAGAGAGATGCCTGGGCC
ATTCGCTATTTTGTGTCTGAAGGCTTCGAGTTCTTCTGTGCCCAGTCCTTCTCCAAGAAC
TTCGGGCTCTACAATGAGAGAGTCGGGAATCTGACTGTGGTTGGAAAAGAACCTGAGAGC
ATCCTGCAAGTCCTTTCCCAGATGGAGAAGATCGTGCGGATTACTTGGTCCAATCCCCCC
GCCCAGGGAGCACGAATTGTGGCCAGCACCCTCTCTAACCCTGAGCTCTTTGAGGAATGG
ACAGGTAATGTGAAGACAATGGCTGACCGGATTCTGACCATGAGATCTGAACTCAGGGCA
CGACTAGAAGCCCTCAAAACCCCTGGGACCTGGAACCACATCACTGATCAAATTGGCATG
TTCAGCTTCACTGGGTTGAACCCCAAGCAGGTTGAGTATCTGGTCAATGAAAAGCACATC
TACCTGCTGCCAAGTGGTCGAATCAACGTGAGTGGCTTAACCACCAAAAATCTAGATTAC
GTGGCCACCTCCATCCATGAAGCAGTCACCAAAATCCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon terminus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>lysosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-aspartate</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phosphatidylserine decarboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-phenylalanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>carboxylic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-cysteine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-methionine biosynthetic process from methylthioadenosine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gluconeogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucocorticoid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>polyamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to insulin stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process to 2-oxoglutarate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process to aspartate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Notch signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fatty acid homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxaloacetate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycerol biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000692</id>
      <name>Tyrosine aminotransferase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16840830</pubmed-id>
            <citation>Ozturk M, Chiu CY, Akdeniz N, Jenq SF, Chang SC, Hsa CY, Jap TS: Two novel mutations in the MEN1 gene in subjects with multiple endocrine neoplasia-1. J Endocrinol Invest. 2006 Jun;29(6):523-7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P17735" source="Swiss-Prot">
    <name>Tyrosine aminotransferase</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Transaminase involved in tyrosine breakdown. Converts tyrosine to p-hydroxyphenylpyruvate. Can catalyze the reverse reaction, using glutamic acid, with 2-oxoglutarate as cosubstrate (in vitro). Has much lower affinity and transaminase activity towards phenylalanine.</specific-function>
    <gene-name>TAT</gene-name>
    <locus>16q22.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.24</theoretical-pi>
    <molecular-weight>50398.895</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11573</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TAT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X52520</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>36713</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P17735</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ATTY_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.5</synonym>
      <synonym>L-tyrosine:2-oxoglutarate aminotransferase</synonym>
      <synonym>TAT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010483|Tyrosine aminotransferase
MDPYMIQMSSKGNLPSILDVHVNVGGRSSVPGKMKGRKARWSVRPSDMAKKTFNPIRAIV
DNMKVKPNPNKTMISLSIGDPTVFGNLPTDPEVTQAMKDALDSGKYNGYAPSIGFLSSRE
EIASYYHCPEAPLEAKDVILTSGCSQAIDLCLAVLANPGQNILVPRPGFSLYKTLAESMG
IEVKLYNLLPEKSWEIDLKQLEYLIDEKTACLIVNNPSNPCGSVFSKRHLQKILAVAARQ
CVPILADEIYGDMVFSDCKYEPLATLSTDVPILSCGGLAKRWLVPGWRLGWILIHDRRDI
FGNEIRDGLVKLSQRILGPCTIVQGALKSILCRTPGEFYHNTLSFLKSNADLCYGALAAI
PGLRPVRPSGAMYLMVGIEMEHFPEFENDVEFTERLVAEQSVHCLPATCFEYPNFIRVVI
TVPEVMMLEACSRIQEFCEQHYHCAEGSQEECDK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010484|Tyrosine aminotransferase (TAT)
ATGGACCCATACATGATTCAGATGAGCAGCAAAGGCAACCTCCCCTCAATTCTGGACGTG
CATGTCAACGTTGGTGGGAGAAGCTCTGTGCCGGGAAAAATGAAAGGCAGAAAGGCCAGG
TGGTCTGTGAGGCCCTCAGACATGGCCAAGAAAACTTTCAACCCCATCCGAGCCATTGTG
GACAACATGAAGGTGAAACCAAATCCAAACAAAACCATGATTTCCCTGTCCATTGGGGAC
CCTACTGTGTTTGGAAACCTGCCTACAGACCCTGAAGTTACCCAGGCAATGAAAGATGCC
CTGGACTCGGGCAAATATAATGGCTATGCCCCATCCATCGGCTTCCTATCCAGTCGGGAG
GAGATTGCTTCTTATTACCACTGTCCTGAGGCACCCCTAGAAGCTAAGGACGTCATTCTG
ACAAGTGGCTGCAGCCAAGCTATTGACCTTTGTTTAGCTGTGTTGGCCAACCCAGGGCAA
AACATCCTGGTTCCAAGACCTGGTTTCTCTCTCTACAAGACTCTGGCTGAGTCTATGGGA
ATTGAGGTCAAACTCTACAATTTGTTGCCAGAGAAATCTTGGGAAATTGACCTGAAACAA
CTGGAATATCTAATTGATGAAAAGACAGCTTGTCTCATTGTCAATAATCCATCAAACCCC
TGTGGGTCAGTGTTCAGCAAACGTCATCTTCAGAAGATTCTGGCAGTGGCTGCACGGCAG
TGTGTCCCCATCTTAGCTGATGAGATCTATGGAGACATGGTGTTTTCGGATTGCAAATAT
GAACCACTGGCCACCCTCAGCACCGATGTCCCCATCCTGTCCTGTGGAGGGCTGGCCAAG
CGCTGGCTGGTTCCTGGCTGGAGGTTGGGCTGGATCCTCATTCATGACCGAAGAGACATT
TTTGGCAATGAGATCCGAGATGGGCTGGTGAAGCTGAGTCAGCGCATTTTGGGACCCTGT
ACCATTGTCCAGGGAGCTCTGAAAAGCATCCTATGTCGCACCCCGGGAGAGTTTTACCAC
AACACTCTGAGCTTCCTCAAGTCCAATGCTGATCTCTGTTATGGGGCGTTGGCTGCCATC
CCTGGACTCCGGCCAGTCCGCCCTTCTGGGGCTATGTACCTCATGGTTGGAATTGAGATG
GAACATTTCCCAGAATTTGAGAACGATGTGGAGTTCACGGAGCGGTTAGTTGCTGAGCAG
TCTGTCCACTGCCTCCCAGCAACGTGCTTTGAGTACCCGAATTTCATCCGAGTGGTCATC
ACAGTCCCCGAGGTGATGATGCTGGAGGCGTGCAGCCGGATCCAGGAGTTCTGTGAGCAG
CACTACCATTGTGCTGAAGGCAGCCAGGAGGAGTGTGATAAATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
      <pfam>
        <identifier>PF07706</identifier>
        <name>TAT_ubiq</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-phenylalanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>amino acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-tyrosine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-phenylalanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tyrosine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucocorticoid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to mercury ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000667</id>
      <name>Alanine aminotransferase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16854580</pubmed-id>
            <citation>Ohgami N, Upadhyay S, Kabata A, Morimoto K, Kusakabe H, Suzuki H: Determination of the activities of glutamic oxaloacetic transaminase and glutamic pyruvic transaminase in a microfluidic system. Biosens Bioelectron. 2007 Feb 15;22(7):1330-6. Epub 2006 Jul 18.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P24298" source="Swiss-Prot">
    <name>Alanine aminotransferase 1</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate. Participates in cellular nitrogen metabolism and also in liver gluconeogenesis starting with precursors transported from skeletal muscles (By similarity).</specific-function>
    <gene-name>GPT</gene-name>
    <locus>8q24.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.2</theoretical-pi>
    <molecular-weight>54636.415</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4552</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U70732</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1763096</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P24298</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ALAT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.2</synonym>
      <synonym>AAT1</synonym>
      <synonym>ALT1</synonym>
      <synonym>Glutamate pyruvate transaminase 1</synonym>
      <synonym>Glutamic--alanine transaminase 1</synonym>
      <synonym>Glutamic--pyruvic transaminase 1</synonym>
      <synonym>GPT 1</synonym>
      <synonym>GPT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010464|Alanine aminotransferase 1
MASSTGDRSQAVRHGLRAKVLTLDGMNPRVRRVEYAVRGPIVQRALELEQELRQGVKKPF
TEVIRANIGDAQAMGQRPITFLRQVLALCVNPDLLSSPNFPDDAKKRAERILQACGGHSL
GAYSVSSGIQLIREDVARYIERRDGGIPADPNNVFLSTGASDAIVTVLKLLVAGEGHTRT
GVLIPIPQYPLYSATLAELGAVQVDYYLDEERAWALDVAELHRALGQARDHCRPRALCVI
NPGNPTGQVQTRECIEAVIRFAFEERLFLLADEVYQDNVYAAGSQFHSFKKVLMEMGPPY
AGQQELASFHSTSKGYMGECGFRGGYVEVVNMDAAVQQQMLKLMSVRLCPPVPGQALLDL
VVSPPAPTDPSFAQFQAEKQAVLAELAAKAKLTEQVFNEAPGISCNPVQGAMYSFPRVQL
PPRAVERAQELGLAPDMFFCLRLLEETGICVVPGSGFGQREGTYHFRMTILPPLEKLRLL
LEKLSRFHAKFTLEYS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010465|Alanine aminotransferase 1 (GPT)
ATGGCCTCGAGCACAGGTGACCGGAGCCAGGCGGTGAGGCATGGACTGAGGGCGAAGGTG
CTGACGCTGGACGGCATGAACCCGCGTGTGCGGAGAGTGGAGTACGCAGTGCGTGGCCCC
ATAGTGCAGCGAGCCTTGGAGCTGGAGCAGGAGCTGCGCCAGGGTGTGAAGAAGCCTTTC
ACCGAGGTCATCCGTGCCAACATCGGGGACGCACAGGCTATGGGGCAGAGGCCCATCACC
TTCCTGCGCCAGGTCTTGGCCCTCTGTGTTAACCCTGATCTTCTGAGCAGCCCCAACTTC
CCTGACGATGCCAAGAAAAGGGCGGAGCGCATCTTGCAGGCGTGTGGGGGCCACAGTCTG
GGGGCCTACAGCGTCAGCTCCGGCATCCAGCTGATCCGGGAGGACGTGGCGCGGTACATT
GAGAGGCGTGACGGAGGCATCCCTGCGGACCCCAACAACGTCTTCCTGTCCACAGGGGCC
AGCGATGCCATCGTGACGGTGCTGAAGCTGCTGGTGGCCGGCGAGGGCCACACACGCACG
GGTGTGCTCATCCCCATCCCCCAGTACCCACTCTACTCGGCCACGCTGGCAGAGCTGGGC
GCAGTGCAGGTGGATTACTACCTGGACGAGGAGCGTGCCTGGGCGCTGGACGTGGCCGAG
CTTCACCGTGCACTGGGCCAGGCGCGTGACCACTGCCGCCCTCGTGCGCTCTGTGTCATC
AACCCTGGCAACCCCACCGGGCAGGTGCAGACCCGCGAGTGCATCGAGGCCGTGATCCGC
TTCGCCTTCGAAGAGCGGCTCTTTCTGCTGGCGGACGAGGTGTACCAGGACAACGTGTAC
GCCGCGGGTTCGCAGTTCCACTCATTCAAGAAGGTGCTCATGGAGATGGGGCCGCCCTAC
GCCGGGCAGCAGGAGCTTGCCTCCTTCCACTCCACCTCCAAGGGCTACATGGGCGAGTGC
GGGTTCCGCGGCGGCTATGTGGAGGTGGTGAACATGGACGCTGCAGTGCAGCAGCAGATG
CTGAAGCTGATGAGTGTGCGGCTGTGCCCGCCGGTGCCAGGACAGGCCCTGCTGGACCTG
GTGGTCAGCCCGCCCGCGCCCACCGACCCCTCCTTTGCGCAGTTCCAGGCTGAGAAGCAG
GCAGTGCTGGCAGAGCTGGCGGCCAAGGCCAAGCTCACCGAGCAGGTCTTCAATGAGGCT
CCTGGCATCAGCTGCAACCCAGTGCAGGGCGCCATGTACTCCTTCCCGCGCGTGCAGCTG
CCCCCGCGGGCGGTGGAGCGCGCTCAGGAGCTGGGCCTGGCCCCCGATATGTTCTTCTGC
CTGCGCCTCCTGGAGGAGACCGGCATCTGCGTGGTGCCAGGGAGCGGCTTTGGGCAGCGG
GAAGGCACCTACCACTTCCGGATGACCATTCTGCCCCCCTTGGAGAAACTGCGGCTGCTG
CTGGAGAAGCTGAGCAGGTTCCATGCCAAGTTCACCCTCGAGTACTCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-alanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-alanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000403</id>
      <name>Vitamin K-dependent gamma-carboxylase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17327402</pubmed-id>
            <citation>Zhu A, Sun H, Raymond RM Jr, Furie BC, Furie B, Bronstein M, Kaufman RJ, Westrick R, Ginsburg D: Fatal hemorrhage in mice lacking gamma-glutamyl carboxylase. Blood. 2007 Jun 15;109(12):5270-5. Epub 2007 Feb 27.</citation>
          </article>
          <article>
            <pubmed-id>17112295</pubmed-id>
            <citation>Lal S, Jada SR, Xiang X, Lim WT, Lee EJ, Chowbay B: Pharmacogenetics of target genes across the warfarin pharmacological pathway. Clin Pharmacokinet. 2006;45(12):1189-200.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P38435" source="Swiss-Prot">
    <name>Vitamin K-dependent gamma-carboxylase</name>
    <general-function>Gamma-glutamyl carboxylase activity</general-function>
    <specific-function>Mediates the vitamin K-dependent carboxylation of glutamate residues to calcium-binding gamma-carboxyglutamate (Gla) residues with the concomitant conversion of the reduced hydroquinone form of vitamin K to vitamin K epoxide.</specific-function>
    <gene-name>GGCX</gene-name>
    <locus>2p12</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>61-81
114-134
137-157
293-313
362-382</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.1</theoretical-pi>
    <molecular-weight>87560.065</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4247</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GGCX</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M81592</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>184028</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P38435</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>VKGC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.1.1.90</synonym>
      <synonym>Gamma-glutamyl carboxylase</synonym>
      <synonym>GC</synonym>
      <synonym>Peptidyl-glutamate 4-carboxylase</synonym>
      <synonym>Vitamin K gamma glutamyl carboxylase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000803|Vitamin K-dependent gamma-carboxylase
MAVSAGSARTSPSSDKVQKDKAELISGPRQDSRIGKLLGFEWTDLSSWRRLVTLLNRPTD
PASLAVFRFLFGFLMVLDIPQERGLSSLDRKYLDGLDVCRFPLLDALRPLPLDWMYLVYT
IMFLGALGMMLGLCYRISCVLFLLPYWYVFLLDKTSWNNHSYLYGLLAFQLTFMDANHYW
SVDGLLNAHRRNAHVPLWNYAVLRGQIFIVYFIAGVKKLDADWVEGYSMEYLSRHWLFSP
FKLLLSEELTSLLVVHWGGLLLDLSAGFLLFFDVSRSIGLFFVSYFHCMNSQLFSIGMFS
YVMLASSPLFCSPEWPRKLVSYCPRRLQQLLPLKAAPQPSVSCVYKRSRGKSGQKPGLRH
QLGAAFTLLYLLEQLFLPYSHFLTQGYNNWTNGLYGYSWDMMVHSRSHQHVKITYRDGRT
GELGYLNPGVFTQSRRWKDHADMLKQYATCLSRLLPKYNVTEPQIYFDIWVSINDRFQQR
IFDPRVDIVQAAWSPFQRTSWVQPLLMDLSPWRAKLQEIKSSLDNHTEVVFIADFPGLHL
ENFVSEDLGNTSIQLLQGEVTVELVAEQKNQTLREGEKMQLPAGEYHKVYTTSPSPSCYM
YVYVNTTELALEQDLAYLQELKEKVENGSETGPLPPELQPLLEGEVKGGPEPTPLVQTFL
RRQQRLQEIERRRNTPFHERFFRFLLRKLYVFRRSFLMTCISLRNLILGRPSLEQLAQEV
TYANLRPFEAVGELNPSNTDSSHSNPPESNPDPVHSEF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0018949|Vitamin K-dependent gamma-carboxylase (GGCX)
ATGGCGGTGTCTGCCGGGTCCGCGCGGACCTCGCCCAGCTCAGATAAAGTACAGAAAGAC
AAGGCTGAACTGATCTCAGGGCCCAGGCAGGACAGCCGAATAGGGAAACTCTTGGGTTTT
GAGTGGACAGATTTGTCCAGTTGGCGGAGGCTGGTGACCCTGCTGAATCGACCAACGGAC
CCTGCAAGCTTAGCTGTCTTTCGTTTTCTTTTTGGGTTCTTGATGGTGCTAGACATTCCC
CAGGAGCGGGGGCTCAGCTCTCTGGACCGGAAATACCTTGATGGGCTGGATGTGTGCCGC
TTCCCCTTGCTGGATGCCCTACGCCCACTGCCACTTGACTGGATGTATCTTGTCTACACC
ATCATGTTTCTGGGGGCACTGGGCATGATGCTGGGCCTGTGCTACCGGATAAGCTGTGTG
TTATTCCTGCTGCCATACTGGTATGTGTTTCTCCTGGACAAGACATCATGGAACAACCAC
TCCTATCTGTATGGGTTGTTGGCCTTTCAGCTAACATTCATGGATGCAAACCACTACTGG
TCTGTGGACGGTCTGCTGAATGCCCATAGGAGGAATGCCCACGTGCCCCTTTGGAACTAT
GCAGTGCTCCGTGGCCAGATCTTCATTGTGTACTTCATTGCGGGTGTGAAAAAGCTGGAT
GCAGACTGGGTTGAAGGCTATTCCATGGAATATTTGTCCCGGCACTGGCTCTTCAGTCCC
TTCAAACTGCTGTTGTCTGAGGAGCTGACTAGCCTGCTGGTCGTGCACTGGGGTGGGCTG
CTGCTTGACCTCTCAGCTGGTTTCCTGCTCTTTTTTGATGTCTCAAGATCCATTGGCCTG
TTCTTTGTGTCCTACTTCCACTGCATGAATTCCCAGCTTTTCAGCATTGGTATGTTCTCC
TACGTCATGCTGGCCAGCAGCCCTCTCTTCTGCTCCCCTGAGTGGCCTCGGAAGCTGGTG
TCCTACTGCCCCCGAAGGTTGCAACAACTGTTGCCCCTCAAGGCAGCCCCTCAGCCCAGT
GTTTCCTGTGTGTATAAGAGGAGCCGGGGCAAAAGTGGCCAGAAGCCAGGGCTGCGCCAT
CAGCTGGGAGCTGCCTTCACCCTGCTCTACCTCCTGGAGCAGCTATTCCTGCCCTATTCT
CATTTTCTCACCCAGGGCTATAACAACTGGACAAATGGGCTGTATGGCTATTCCTGGGAC
ATGATGGTGCACTCCCGCTCCCACCAGCACGTGAAGATCACCTACCGTGATGGCCGCACT
GGCGAACTGGGCTACCTTAACCCTGGGGTATTTACACAGAGTCGGCGATGGAAGGATCAT
GCAGACATGCTGAAGCAATATGCCACTTGCCTGAGCCGCCTGCTTCCCAAGTATAATGTC
ACTGAGCCCCAGATCTACTTTGATATTTGGGTCTCCATCAATGACCGCTTCCAGCAGAGG
ATTTTTGACCCTCGTGTGGACATCGTGCAGGCCGCTTGGTCACCCTTTCAGCGCACATCC
TGGGTGCAACCACTCTTGATGGACCTGTCTCCCTGGAGGGCCAAGTTACAGGAAATCAAG
AGCAGCCTAGACAACCACACTGAGGTGGTCTTCATTGCAGATTTCCCTGGACTGCACTTG
GAGAATTTTGTGAGTGAAGACCTGGGCAACACTAGCATCCAGCTGCTGCAGGGGGAAGTG
ACTGTGGAGCTTGTGGCAGAACAGAAGAACCAGACTCTTCGAGAGGGAGAAAAAATGCAG
TTGCCTGCTGGTGAGTACCATAAGGTGTATACGACATCACCTAGCCCTTCTTGCTACATG
TACGTCTATGTCAACACTACAGAGCTTGCACTGGAGCAAGACCTGGCATATCTGCAAGAA
TTAAAGGAAAAGGTGGAGAATGGAAGTGAAACAGGGCCTCTACCCCCAGAGCTGCAGCCT
CTGTTGGAAGGGGAAGTAAAAGGGGGCCCTGAGCCAACACCTCTGGTTCAGACCTTTCTT
AGACGCCAACAAAGGCTCCAGGAGATTGAACGCCGGCGAAATACTCCTTTCCATGAGCGA
TTCTTCCGCTTCTTGTTGCGAAAGCTCTATGTCTTTCGCCGCAGCTTCCTGATGACTTGT
ATCTCACTTCGAAATCTGATATTAGGCCGTCCTTCCCTGGAGCAGCTGGCCCAGGAGGTG
ACTTATGCAAACTTGAGACCCTTTGAGGCAGTTGGAGAACTGAATCCCTCAAACACGGAT
TCTTCACATTCTAATCCTCCTGAGTCAAATCCTGATCCTGTCCACTCAGAGTTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05090</identifier>
        <name>VKG_Carbox</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>gamma-glutamyl carboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptidyl-glutamic acid carboxylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein modification process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001115</id>
      <name>Excitatory amino acid transporter 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16855093</pubmed-id>
            <citation>Glowatzki E, Cheng N, Hiel H, Yi E, Tanaka K, Ellis-Davies GC, Rothstein JD, Bergles DE: The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea. J Neurosci. 2006 Jul 19;26(29):7659-64.</citation>
          </article>
          <article>
            <pubmed-id>17088867</pubmed-id>
            <citation>Beart PM, O'Shea RD: Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol. 2007 Jan;150(1):5-17. Epub 2006 Nov 6.</citation>
          </article>
          <article>
            <pubmed-id>16959378</pubmed-id>
            <citation>Nickell J, Salvatore MF, Pomerleau F, Apparsundaram S, Gerhardt GA: Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol Aging. 2007 Nov;28(11):1737-48. Epub 2006 Sep 7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P43003" source="Swiss-Prot">
    <name>Excitatory amino acid transporter 1</name>
    <general-function>Sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Transports L-glutamate and also L- and D-aspartate. Essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. Acts as a symport by cotransporting sodium.</specific-function>
    <gene-name>SLC1A3</gene-name>
    <locus>5p13</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>48-68
91-111
123-145
238-260
281-302
319-340</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.69</theoretical-pi>
    <molecular-weight>59571.855</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10941</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L19158</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>868</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P43003</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>EAA1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAAT1</synonym>
      <synonym>GLAST</synonym>
      <synonym>GLAST-1</synonym>
      <synonym>GLAST1</synonym>
      <synonym>Sodium-dependent glutamate/aspartate transporter 1</synonym>
      <synonym>Solute carrier family 1 member 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002218|Excitatory amino acid transporter 1
MTKSNGEEPKMGGRMERFQQGVRKRTLLAKKKVQNITKEDVKSYLFRNAFVLLTVTAVIV
GTILGFTLRPYRMSYREVKYFSFPGELLMRMLQMLVLPLIISSLVTGMAALDSKASGKMG
MRAVVYYMTTTIIAVVIGIIIVIIIHPGKGTKENMHREGKIVRVTAADAFLDLIRNMFPP
NLVEACFKQFKTNYEKRSFKVPIQANETLVGAVINNVSEAMETLTRITEELVPVPGSVNG
VNALGLVVFSMCFGFVIGNMKEQGQALREFFDSLNEAIMRLVAVIMWYAPVGILFLIAGK
IVEMEDMGVIGGQLAMYTVTVIVGLLIHAVIVLPLLYFLVTRKNPWVFIGGLLQALITAL
GTSSSSATLPITFKCLEENNGVDKRVTRFVLPVGATINMDGTALYEALAAIFIAQVNNFE
LNFGQIITISITATAASIGAAGIPQAGLVTMVIVLTSVGLPTDDITLIIAVDWFLDRLRT
TTNVLGDSLGAGIVEHLSRHELKNRDVEMGNSVIEENEMKKPYQLIAQDNETEKPIDSET
KM</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010780|Excitatory amino acid transporter 1 (SLC1A3)
ATGACTAAAAGCAATGGAGAAGAGCCCAAGATGGGGGGCAGGATGGAGAGATTCCAGCAG
GGAGTCCGTAAACGCACACTTTTGGCCAAGAAGAAAGTGCAGAACATTACAAAGGAGGAT
GTTAAAAGTTACCTGTTTCGGAATGCTTTTGTGCTGCTCACAGTCACCGCTGTCATTGTG
GGTACAATCCTTGGATTTACCCTCCGACCATACAGAATGAGCTACCGGGAAGTCAAGTAC
TTCTCCTTTCCTGGGGAACTTCTGATGAGGATGTTACAGATGCTGGTCTTACCACTTATC
ATCTCCAGTCTTGTCACAGGAATGGCGGCGCTAGATAGTAAGGCATCAGGGAAGATGGGA
ATGCGAGCTGTAGTCTATTATATGACTACCACCATCATTGCTGTGGTGATTGGCATAATC
ATTGTCATCATCATCCATCCTGGGAAGGGCACAAAGGAAAACATGCACAGAGAAGGCAAA
ATTGTACGAGTGACAGCTGCAGATGCCTTCCTGGACTTGATCAGGAACATGTTCCCTCCA
AATCTGGTAGAAGCCTGCTTTAAACAGTTTAAAACCAACTATGAGAAGAGAAGCTTTAAA
GTGCCCATCCAGGCCAACGAAACGCTTGTGGGTGCTGTGATAAACAATGTGTCTGAGGCC
ATGGAGACTCTTACCCGAATCACAGAGGAGCTGGTCCCAGTTCCAGGATCTGTGAATGGA
GTCAATGCCCTGGGTCTAGTTGTCTTCTCCATGTGCTTCGGTTTTGTGATTGGAAACATG
AAGGAACAGGGGCAGGCCCTGAGAGAGTTCTTTGATTCTCTTAACGAAGCCATCATGAGA
CTGGTAGCAGTAATAATGTGGTATGCCCCCGTGGGTATTCTCTTCCTGATTGCTGGGAAG
ATTGTGGAGATGGAAGACATGGGTGTGATTGGGGGGCAGCTTGCCATGTACACCGTGACT
GTCATTGTTGGCTTACTCATTCACGCAGTCATCGTCTTGCCACTCCTCTACTTCTTGGTA
ACACGGAAAAACCCTTGGGTTTTTATTGGAGGGTTGCTGCAAGCACTCATCACCGCTCTG
GGGACCTCTTCAAGTTCTGCCACCCTACCCATCACCTTCAAGTGCCTGGAAGAGAACAAT
GGCGTGGACAAGCGCGTCACCAGATTCGTGCTCCCCGTAGGAGCCACCATTAACATGGAT
GGGACTGCCCTCTATGAGGCTTTGGCTGCCATTTTCATTGCTCAAGTTAACAACTTTGAA
CTGAACTTCGGACAAATTATTACAATCAGGGATCGCCTCCGGACCACCACCAACGTACTG
GGAGACTCCCTGGGAGCTGGGATTGTGGAGCACTTGTCACGACATGAACTGAAGAACAGA
GATGTTGAAATGGGTAACTCAGTGATTGAAGAGAATGAAATGAAGAAACCATATCAACTG
ATTGCACAGGACAATGAAACTGAGAAACCCATCGACAGTGAAACCAAGATGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>fibril</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>high-affinity glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mitophagy in response to mitochondrial depolarization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>auditory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to antibiotic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cranial nerve development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of sound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter uptake</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>malate-aspartate shuttle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to wounding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gamma-aminobutyric acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to light stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neuromuscular process controlling balance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell morphogenesis involved in neuron differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>D-aspartate import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of defense response to virus by host</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenophagy</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000884</id>
      <name>Excitatory amino acid transporter 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16718509</pubmed-id>
            <citation>King N, Lin H, McGivan JD, Suleiman MS: Expression and activity of the glutamate transporter EAAT2 in cardiac hypertrophy: implications for ischaemia reperfusion injury. Pflugers Arch. 2006 Sep;452(6):674-82. Epub 2006 May 23.</citation>
          </article>
          <article>
            <pubmed-id>16959378</pubmed-id>
            <citation>Nickell J, Salvatore MF, Pomerleau F, Apparsundaram S, Gerhardt GA: Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol Aging. 2007 Nov;28(11):1737-48. Epub 2006 Sep 7.</citation>
          </article>
          <article>
            <pubmed-id>17088867</pubmed-id>
            <citation>Beart PM, O'Shea RD: Transporters for L-glutamate: an update on their molecular pharmacology and pathological involvement. Br J Pharmacol. 2007 Jan;150(1):5-17. Epub 2006 Nov 6.</citation>
          </article>
          <article>
            <pubmed-id>16855093</pubmed-id>
            <citation>Glowatzki E, Cheng N, Hiel H, Yi E, Tanaka K, Ellis-Davies GC, Rothstein JD, Bergles DE: The glutamate-aspartate transporter GLAST mediates glutamate uptake at inner hair cell afferent synapses in the mammalian cochlea. J Neurosci. 2006 Jul 19;26(29):7659-64.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P43004" source="Swiss-Prot">
    <name>Excitatory amino acid transporter 2</name>
    <general-function>Sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Transports L-glutamate and also L- and D-aspartate. Essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. Acts as a symport by cotransporting sodium.</specific-function>
    <gene-name>SLC1A2</gene-name>
    <locus>11p13-p12</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>45-64
88-108
121-142
240-259
280-301
317-339
406-430
437-459</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>6.51</theoretical-pi>
    <molecular-weight>62103.665</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10940</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U03505</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>487341</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>869</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P43004</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>EAA2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAAT2</synonym>
      <synonym>GLT1</synonym>
      <synonym>Glutamate/aspartate transporter II</synonym>
      <synonym>Sodium-dependent glutamate/aspartate transporter 2</synonym>
      <synonym>Solute carrier family 1 member 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001762|Excitatory amino acid transporter 2
MASTEGANNMPKQVEVRMHDSHLGSEEPKHRHLGLRLCDKLGKNLLLTLTVFGVILGAVC
GGLLRLASPIHPDVVMLIAFPGDILMRMLKMLILPLIISSLITGLSGLDAKASGRLGTRA
MVYYMSTTIIAAVLGVILVLAIHPGNPKLKKQLGPGKKNDEVSSLDAFLDLIRNLFPENL
VQACFQQIQTVTKKVLVAPPPDEEANATSAVVSLLNETVTEVPEETKMVIKKGLEFKDGM
NVLGLIGFFIAFGIAMGKMGDQAKLMVDFFNILNEIVMKLVIMIMWYSPLGIACLICGKI
IAIKDLEVVARQLGMYMVTVIIGLIIHGGIFLPLIYFVVTRKNPFSFFAGIFQAWITALG
TASSAGTLPVTFRCLEENLGIDKRVTRFVLPVGATINMDGTALYEAVAAIFIAQMNGVVL
DGGQIVTVSLTATLASVGAASIPSAGLVTMLLILTAVGLPTEDISLLVAVDWLLDRMRTS
VNVVGDSFGAGIVYHLSKSELDTIDSQHRVHEDIEMTKTQSIYDDMKNHRESNSNQCVYA
AHNSVIVDECKVTLAANGKSADCSVEEEPWKREK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019025|Excitatory amino acid transporter 2 (SLC1A2)
ATGCCCAAGCAGGTGGAAGTGCGAATGCACGACAGTCATCTTGGCTCAGAGGAACCCAAG
CACCGGCACCTGGGCCTGCGCCTGTGTGACAAGCTGGGGAAGAATCTGCTGCTCACCCTG
ACGGTGTTTGGTGTCATCCTGGGAGCAGTGTGTGGAGGGCTTCTTCGCTTGGCATCTCCC
ATCCACCCTGATGTGGTTATGTTAATAGCCTTCCCAGGGGATATACTCATGAGGATGCTA
AAAATGCTCATTCTCCCTCTAATCATCTCCAGCTTAATCACAGGGTTGTCAGGCCTGGAT
GCTAAGGCTAGTGGCCGCTTGGGCACGAGAGCCATGGTGTATTACATGTCCACGACCATC
ATTGCTGCAGTACTGGGGGTCATTCTGGTCTTGGCTATCCATCCAGGCAATCCCAAGCTC
AAGAAGCAGCTGGGGCCTGGGAAGAAGAATGATGAAGTGTCCAGCCTGGATGCCTTCCTG
GACCTTATTCGAAATCTCTTCCCTGAAAACCTTGTCCAAGCCTGCTTTCAACAGATTCAA
ACAGTGACGAAGAAAGTCCTGGTTGCACCACCGCCGGACGAGGAGGCCAACGCAACCAGC
GCTGTTGTCTCTCTGTTGAACGAGACTGTGACTGAGGTGCCGGAGGAGACTAAGATGGTT
ATCAAGAAGGGCCTGGAGTTCAAGGATGGGATGAACGTCTTAGGTCTGATAGGGTTTTTC
ATTGCTTTTGGCATCGCTATGGGGAAGATGGGAGATCAGGCCAAGCTGATGGTGGATTTC
TTCAACATTTTGAATGAGATTGTAATGAAGTTAGTGATCATGATCATGTGGTACTCTCCC
CTGGGTATCGCCTGCCTGATCTGTGGAAAGATCATTGCAATCAAGGACTTAGAAGTGGTT
GCTAGGCAACTGGGGATGTACATGGTAACAGTGATCATAGGCCTCATCATCCACGGGGGC
ATCTTTCTCCCCTTGATTTACTTTGTAGTGACCAGGAAAAACCCCTTCTCCTTTTTTGCT
GGCATTTTCCAAGCTTGGATCACTGCCCTGGGCACCGCTTCCAGTGCTGGAACTTTGCCT
GTCACCTTTCGTTGCCTGGAAGAAAATCTGGGGATTGATAAGCGTGTGACTAGATTCGTC
CTTCCTGTTGGAGCAACCATTAACATGGATGGTACAGCCCTTTATGAAGCGGTAGCCGCC
ATCTTTATAGCCCAAATGAATGGTGTTGTCCTGGATGGAGGACAGATTGTGACTGTAAGC
CTCACAGCCACCCTGGCAAGCGTCGGCGCGGCCAGTATCCCCAGTGCCGGGCTGGTCACC
ATGCTCCTCATTCTGACAGCCGTGGGCCTGCCAACAGAGGACATCAGCCTGCTGGTGGCT
GTGGACTGGCTGCTGGACAGGATGAGAACTTCAGTCAATGTTGTGGGTGACTCTTTTGGG
GCTGGGATAGTCTATCACCTCTCCAAGTCTGAGCTGGATACCATTGACTCCCAGCATCGA
GTGCATGAAGATATTGAAATGACCAAGACTCAATCCATTTATGATGACATGAAGAACCAC
AGGGAAAGCAACTCTAATCAATGTGTCTATGCTGCACACAACTCTGTCATAGTAGATGAA
TGCAAGGTAACTCTGGCAGCCAATGGAAAGTCAGCCGACTGCAGTGTTGAGGAAGAACCT
TGGAAACGTGAGAAATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axolemma</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organism growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>D-aspartate import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to wounding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>telencephalon development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amino acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to extracellular stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of glucose import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001054</id>
      <name>Excitatory amino acid transporter 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16831195</pubmed-id>
            <citation>Menaker D, Bendahan A, Kanner BI: The substrate specificity of a neuronal glutamate transporter is determined by the nature of the coupling ion. J Neurochem. 2006 Oct;99(1):20-8. Epub 2006 Jul 11.</citation>
          </article>
          <article>
            <pubmed-id>17382927</pubmed-id>
            <citation>Yun JY, Park KS, Kim JH, Do SH, Zuo Z: Propofol reverses oxidative stress-attenuated glutamate transporter EAAT3 activity: evidence of protein kinase C involvement. Eur J Pharmacol. 2007 Jun 22;565(1-3):83-8. Epub 2007 Mar 3.</citation>
          </article>
          <article>
            <pubmed-id>17389249</pubmed-id>
            <citation>Tao Z, Grewer C: Cooperation of the conserved aspartate 439 and bound amino acid substrate is important for high-affinity Na+ binding to the glutamate transporter EAAC1. J Gen Physiol. 2007 Apr;129(4):331-44.</citation>
          </article>
          <article>
            <pubmed-id>16959378</pubmed-id>
            <citation>Nickell J, Salvatore MF, Pomerleau F, Apparsundaram S, Gerhardt GA: Reduced plasma membrane surface expression of GLAST mediates decreased glutamate regulation in the aged striatum. Neurobiol Aging. 2007 Nov;28(11):1737-48. Epub 2006 Sep 7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P43005" source="Swiss-Prot">
    <name>Excitatory amino acid transporter 3</name>
    <general-function>Sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Transports L-glutamate, L- and D-aspartate and L-cystein (PubMed:21123949). Essential for terminating the postsynaptic action of glutamate by rapidly removing released glutamate from the synaptic cleft. Acts as a symport by cotransporting sodium. Negatively regulated by ARL6IP5 (By similarity).</specific-function>
    <gene-name>SLC1A1</gene-name>
    <locus>9p24</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>19-38
62-82
94-114
210-229
254-273
290-309
316-335
362-381
392-411
420-439</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.36</theoretical-pi>
    <molecular-weight>57099.835</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10939</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U08989</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>507898</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>870</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P43005</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>EAA3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAAC1</synonym>
      <synonym>EAAT3</synonym>
      <synonym>Excitatory amino-acid carrier 1</synonym>
      <synonym>Neuronal and epithelial glutamate transporter</synonym>
      <synonym>Sodium-dependent glutamate/aspartate transporter 3</synonym>
      <synonym>Solute carrier family 1 member 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010739|Excitatory amino acid transporter 3
MGKPARKGCEWKRFLKNNWVLLSTVAAVVLGITTGVLVREHSNLSTLEKFYFAFPGEILM
RMLKLIILPLIISSMITGVAALDSNVSGKIGLRAVVYYFCTTLIAVILGIVLVVSIKPGV
TQKVGEIARTGSTPEVSTVDAMLDLIRNMFPENLVQACFQQYKTKREEVKPPSDPEMNMT
EESFTAVMTTAISKNKTKEYKIVGMYSDGINVLGLIVFCLVFGLVIGKMGEKGQILVDFF
NALSDATMKIVQIIMCYMPLGILFLIAGKIIEVEDWEIFRKLGLYMATVLTGLAIHSIVI
LPLIYFIVVRKNPFRFAMGMAQALLTALMISSSSATLPVTFRCAEENNQVDKRITRFVLP
VGATINMDGTALYEAVAAVFIAQLNDLDLGIGQIITISITATSASIGAAGVPQAGLVTMV
IVLSAVGLPAEDVTLIIAVDWLLDRFRTMVNVLGDAFGTGIVEKLSKKELEQMDVSSEVN
IVNPFALESTILDNEDSDTKKSYVNGGFAVDKSDTISFTQTSQF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010740|Excitatory amino acid transporter 3 (SLC1A1)
ATGGGGAAACCGGCGAGGAAAGGATGCGAGTGGAAGCGCTTCCTGAAGAATAACTGGGTG
TTGCTGTCCACCGTGGCCGCGGTGGTGCTAGGCATTACCACAGGAGTCTTGGTTCGAGAA
CACAGCAACCTCTCAACTCTAGAGAAATTCTACTTTGCTTTTCCTGGAGAAATTCTAATG
CGGATGCTGAAACTCATCATTTTGCCATTAATTATATCCAGCATGATTACAGGTGTTGCT
GCACTGGATTCCAACGTATCCGGAAAAATTGGTCTGCGCGCTGTCGTGTATTATTTCTGT
ACCACTCTCATTGCTGTTATTCTAGGTATTGTGCTGGTGGTGAGCATCAAGCCTGGTGTC
ACCCAGAAAGTGGGTGAAATTGCGAGGACAGGCAGCACCCCTGAAGTCAGTACGGTGGAT
GCCATGTTAGATCTCATCAGGAATATGTTCCCTGAGAATCTTGTCCAGGCCTGTTTTCAG
CAGTACAAAACTAAGCGTGAAGAAGTGAAGCCTCCCAGCGATCCAGAGATGAACATGACA
GAAGAGTCCTTCACAGCTGTCATGACAACTGCAATTTCCAAGAACAAAACAAAGGAATAC
AAAATTGTTGGCATGTATTCAGATGGCATAAACGTCCTGGGCTTGATTGTCTTTTGCCTT
GTCTTTGGACTTGTCATTGGAAAAATGGGAGAAAAGGGACAAATTCTGGTGGATTTCTTC
AATGCTTTGAGTGATGCAACCATGAAAATCGTTCAGATCATCATGTGTTATATGCCACTA
GGTATTTTGTTCCTGATTGCTGGGAAGATCATAGAAGTTGAAGACTGGGAAATATTCCGC
AAGCTGGGCCTTTACATGGCCACAGTCCTGACTGGGCTTGCAATCCACTCCATTGTAATT
CTCCCGCTGATATATTTCATAGTCGTACGAAAGAACCCTTTCCGATTTGCCATGGGAATG
GCCCAGGCTCTCCTGACAGCTCTCATGATCTCTTCCAGTTCAGCAACACTGCCTGTCACC
TTCCGCTGTGCTGAAGAAAATAACCAGGTGGACAAGAGGATCACTCGATTCGTGTTACCC
GTTGGTGCAACAATCAACATGGATGGGACTGCGCTCTATGAAGCAGTGGCAGCGGTGTTT
ATTGCACAGTTGAATGACCTGGACTTGGGCATTGGGCAGATCATCACCATCAGTATCACG
GCCACATCTGCCAGCATCGGAGCTGCTGGCGTGCCCCAGGCTGGCCTGGTGACCATGGTG
ATTGTGCTGAGTGCCGTGGGCCTGCCCGCCGAGGATGTCACCCTGATCATTGCTGTCGAC
TGGCTCCTGGACCGGTTCAGGACCATGGTCAACGTCCTTGGTGATGCTTTTGGGACGGGC
ATTGTGGAAAAGCTCTCCAAGAAGGAGCTGGAGCAGATGGATGTTTCATCTGAAGTCAAC
ATTGTGAATCCCTTTGCCTTGGAATCCACAATCCTTGACAACGAAGACTCAGACACCAAG
AAGTCTTATGTCAATGGAGGCTTTGCAGTAGACAAGTCTGACACCATCTCATTCACCCAG
ACCTCACAGTTCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cysteine transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of heart rate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homooligomerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>D-aspartate import</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate import</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000166</id>
      <name>Glutamate--cysteine ligase catalytic subunit</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48506" source="Swiss-Prot">
    <name>Glutamate--cysteine ligase catalytic subunit</name>
    <general-function>Magnesium ion binding</general-function>
    <specific-function/>
    <gene-name>GCLC</gene-name>
    <locus>6p12</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.98</theoretical-pi>
    <molecular-weight>72765.14</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4311</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GCLC</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M90656</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183039</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P48506</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSH1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.2.2</synonym>
      <synonym>Gamma-ECS</synonym>
      <synonym>Gamma-glutamylcysteine synthetase</synonym>
      <synonym>GCS heavy chain</synonym>
      <synonym>GLCL</synonym>
      <synonym>GLCLC</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010186|Glutamate--cysteine ligase catalytic subunit
MGLLSQGSPLSWEETKRHADHVRRHGILQFLHIYHAVKDRHKDVLKWGDEVEYMLVSFDH
ENKKVRLVLSGEKVLETLQEKGERTNPNHPTLWRPEYGSYMIEGTPGQPYGGTMSEFNTV
EANMRKRRKEATSILEENQALCTITSFPRLGCPGFTLPEVKPNPVEGGASKSLFFPDEAI
NKHPRFSTLTRNIRHRRGEKVVINVPIFKDKNTPSPFIETFTEDDEASRASKPDHIYMDA
MGFGMGNCCLQVTFQACSISEARYLYDQLATICPIVMALSAASPFYRGYVSDIDCRWGVI
SASVDDRTREERGLEPLKNNNYRISKSRYDSIDSYLSKCGEKYNDIDLTIDKEIYEQLLQ
EGIDHLLAQHVAHLFIRDPLTLFEEKIHLDDANESDHFENIQSTNWQTMRFKPPPPNSDI
GWRVEFRPMEVQLTDFENSAYVVFVVLLTRVILSYKLDFLIPLSKVDENMKVAQKRDAVL
QGMFYFRKDICKGGNAVVDGCGKAQNSTELAAEEYTLMSIDTIINGKEGVFPGLIPILNS
YLENMEVDVDTRCSILNYLKLIKKRASGELMTVARWMREFIANHPDYKQDSVITDEMNYS
LILKCNQIANELCECPELLGSAFRKVKYSGSKTDSSN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010187|Glutamate--cysteine ligase catalytic subunit (GCLC)
ATGGGGCTGCTGTCCCAGGGCTCGCCGCTGAGCTGGGAGGAAACCAAGCGCCATGCCGAC
CACGTGCGGCGGCACGGGATCCTCCAGTTCCTGCACATCTACCACGCCGTCAAGGACCGG
CACAAGGACGTTCTCAAGTGGGGCGATGAGGTGGAATACATGTTGGTATCTTTTGATCAT
GAAAATAAAAAAGTCCGGTTGGTCCTGTCTGGGGAGAAAGTTCTTGAAACTCTGCAAGAG
AAGGGGGAAAGGACAAACCCAAACCATCCTACCCTTTGGAGACCAGAGTATGGGAGTTAC
ATGATTGAAGGGACACCAGGACAGCCCTACGGAGGAACAATGTCCGAGTTCAATACAGTT
GAGGCCAACATGCGAAAACGCCGGAAGGAGGCTACTTCTATATTAGAAGAAAATCAGGCT
CTTTGCACAATAACTTCATTTCCCAGTACCTTAACAAGAAATATCCGACATAGGAGAGGA
GAAAAGGTTGTCATCAATGTACCAATATTTAAGGACAAGAATACACCATCTCCATTTATA
GAAACATTTACTGAGGATGATGAAGCTTCAAGGGCTTCTAAGCCGGATCATATTTACATG
GATGCCATGGGATTTGGAATGGGCAATTGCTGTCTCCAGGTGACATTCCAAGCCTGCAGT
ATATCTGAGGCCAGATACCTTTATGATCAGTTGGCTACTATCTGTCCAATTGTTATGGCT
TTGAGTGCTGCATCTCCCTTTTACCGAGGCTATGTGTCAGACATTGATTGTCGCTGGGGA
GTGATTTCTGCATCTGTAGATGATAGAACTCGGGAGGAGCGAGGACTGGAGCCATTGAAG
AACAATAACTATAGGATCAGTAAATCCCGATATGACTCAATAGACAGCTATTTATCTAAG
TGTGGTGAGAAATATAATGACATCGACTTGACGATAGATAAAGAGATCTACGAACAGCTG
TTGCAGGAAGGCATTGATCATCTCCTGGCCCAGCATGTTGCTCATCTCTTTATTAGAGAC
CCACTGACACTGTTTGAAGAGAAAATACACCTGGATGATGCTAATGAGTCTGACCATTTT
GAGAATATTCAGTCCACAAATTGGCAGACAATGAGATTTAAGCCCCCTCCTCCAAACTCA
GACATTGGATGGAGAGTAGAATTTCGACCCATGGAGGTGCAATTAACAGACTTTGAGAAC
TCTGCCTATGTGGTGTTTGTGGTACTGCTCACCAGAGTGATCCTTTCCTACAAATTGGAT
TTTCTCATTCCACTGTCAAAGGTTGATGAGAACATGAAGGTAGCACAGAAAAGAGATGCT
GTCTTGCAGGGAATGTTTTATTTCAGGAAAGATATTTGCAAAGGTGGCAATGCAGTGGTG
GATGGTTGTGGCAAGGCCCAGAACAGCACGGAGCTCGCTGCAGAGGAGTACACCCTCATG
AGCATAGACACCATCATCAATGGGAAGGAAGGTGTGTTTCCTGGACTGATCCCAATTCTG
AACTCTTACCTTGAAAACATGGAAGTGGATGTGGACACCAGATGTAGTATTCTGAACTAC
CTAAAGCTAATTAAGAAGAGAGCATCTGGAGAACTAATGACAGTTGCCAGATGGATGAGG
GAGTTTATCGCAAACCATCCTGACTACAAGCAAGACAGTGTCATAACTGATGAAATGAAT
TATAGCCTTATTTTGAAGTGTAACCAAATTGCAAATGAATTATGTGAATGCCCAGAGTTA
CTTGGATCAGCATTTAGGAAAGTAAAATATAGTGGAAGTAAAACTGACTCATCCAACTAG
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03074</identifier>
        <name>GCS</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>glutamate-cysteine ligase complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>coenzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-cysteine ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic mitochondrial changes</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of extrinsic apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nitrosative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of protein ubiquitination</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to heat</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of proteasomal ubiquitin-dependent protein catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to arsenic-containing substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of blood vessel size</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of mitochondrial depolarization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002270</id>
      <name>Excitatory amino acid transporter 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9224806</pubmed-id>
            <citation>Gegelashvili G, Schousboe A: High affinity glutamate transporters: regulation of expression and activity. Mol Pharmacol. 1997 Jul;52(1):6-15.</citation>
          </article>
          <article>
            <pubmed-id>9838098</pubmed-id>
            <citation>Lin CL, Tzingounis AV, Jin L, Furuta A, Kavanaugh MP, Rothstein JD: Molecular cloning and expression of the rat EAAT4 glutamate transporter subtype. Brain Res Mol Brain Res. 1998 Dec 10;63(1):174-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48664" source="Swiss-Prot">
    <name>Excitatory amino acid transporter 4</name>
    <general-function>Sodium:dicarboxylate symporter activity</general-function>
    <specific-function>Transports L-glutamate and also L- and D-aspartate. Seems to act as a symport by cotransporting sodium.</specific-function>
    <gene-name>SLC1A6</gene-name>
    <locus>19p13.12</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>56-76
99-119
133-153
265-285
306-326
345-365
370-390
418-438
460-480
481-501</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.54</theoretical-pi>
    <molecular-weight>61564.875</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10944</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC1A6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U18244</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>930337</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>871</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P48664</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>EAA4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAAT4</synonym>
      <synonym>Sodium-dependent glutamate/aspartate transporter</synonym>
      <synonym>Solute carrier family 1 member 6</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004456|Excitatory amino acid transporter 4
MSSHGNSLFLRESGQRLGRVGWLQRLQESLQQRALRTRLRLQTMTLEHVLRFLRRNAFIL
LTVSAVVIGVSLAFALRPYQLTYRQIKYFSFPGELLMRMLQMLVLPLIVSSLVTGMASLD
NKATGRMGMRAAVYYMVTTIIAVFIGILMVTIIHPGKGSKEGLHREGRIETIPTADAFMD
LIRNMFPPNLVEACFKQFKTQYSTRVVTRTMVRTENGSEPGASMPPPFSVENGTSFLENV
TRALGTLQEMLSFEETVPVPGSANGINALGLVVFSVAFGLVIGGMKHKGRVLRDFFDSLN
EAIMRLVGIIIWYAPVGILFLIAGKILEMEDMAVLGGQLGMYTLTVIVGLFLHAGIVLPL
IYFLVTHRNPFPFIGGMLQALITAMGTSSSSATLPITFRCLEEGLGVDRRITRFVLPVGA
TVNMDGTALYEALAAIFIAQVNNYELNLGQITTISITATAASVGAAGIPQAGLVTMVIVL
TSVGLPTEDITLIIAVDWFLDRLRTMTNVLGDSIGAAVIEHLSQRELELQEAELTLPSLG
KPYKSLMAQEKGASRGRGGNESAM</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011633|Excitatory amino acid transporter 4 (SLC1A6)
ATGAGCAGCCATGGCAACAGCCTGTTCCTGCGGGAGAGCGGCCAGCGGCTGGGCCGGGTG
GGCTGGCTGCAGCGGCTGCAGGAAAGCCTGCAGCAGAGAGCACTGCGCACGCGCCTGCGC
CTGCAGACCATGACCCTCGAGCACGTGCTGCGCTTCCTGCGCCGAAACGCCTTCATTCTG
CTGACGGTCAGCGCCGTGGTCATTGGGGTCAGCCTGGCCTTTGCCCTGCGCCCATATCAG
CTCACCTACCGCCAGATCAAGTACTTCTCTTTTCCTGGAGAGCTTCTGATGAGGATGCTG
CAGATGCTGGTGTTACCTCTCATTGTCTCCAGCCTGGTCACAGGTATGGCATCCCTGGAC
AACAAGGCCACGGGGCGGATGGGGATGCGGGCAGCTGTGTACTACATGGTGACCACCATC
ATCGCGGTCTTCATCGGCATCCTCATGGTCACCATCATCCATCCCGGGAAGGGCTCCAAG
GAGGGGCTGCACCGGGAGGGCCGGATCGAGACCATCCCCACAGCTGATGCCTTCATGGAC
CTGATCAGAAATATGTTTCCACCAAACCTTGTGGAGGCCTGCTTCAAACAGTTCAAGACG
CAGTACAGCACGAGGGTGGTAACCAGGACCATGGTGAGGACAGAGAACGGGTCTGAGCCG
GGTGCCTCCATGCCTCCTCCATTCTCAGTGGAGAACGGAACCAGCTTCCTGGAAAATGTC
ACTCGGGCCTTGGGTACCCTGCAGGAGATGCTGAGCTTTGAGGAGACTGTACCCGTGCCT
GGCTCCGCCAATGGCATCAACGCCCTGGGCCTCGTGGTCTTCTCTGTGGCCTTTGGGCTG
GTCATTGGTGGCATGAAACACAAGGGCAGAGTCCTCAGGGACTTCTTCGACAGCCTCAAT
GAGGCTATTATGAGGCTGGTGGGCATCATTATCTGGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00375</identifier>
        <name>SDF</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>sodium</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-aspartate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aspartate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-aspartate transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of membrane potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000755</id>
      <name>Glutamate dehydrogenase 2, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P49448" source="Swiss-Prot">
    <name>Glutamate dehydrogenase 2, mitochondrial</name>
    <general-function>Leucine binding</general-function>
    <specific-function>Important for recycling the chief excitatory neurotransmitter, glutamate, during neurotransmission.</specific-function>
    <gene-name>GLUD2</gene-name>
    <locus>Xq24-q25</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.67</theoretical-pi>
    <molecular-weight>61433.465</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4336</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLUD2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X66310</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31815</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P49448</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DHE4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.4.1.3</synonym>
      <synonym>GDH 2</synonym>
      <synonym>GLUDP1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010531|Glutamate dehydrogenase 2, mitochondrial
MYRYLAKALLPSRAGPAALGSAANHSAALLGRGRGQPAAASQPGLALAARRHYSELVADR
EDDPNFFKMVEGFFDRGASIVEDKLVKDLRTQESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTENELEKITRRFTMELAKKGFIGPGVDVPAPDMNTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFR
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEVDCDILIPAATEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NILVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLLSVQESLERKFGK
HGGTIPIVPTAEFQDSISGASEKDIVHSALAYTMERSARQIMHTAMKYNLGLDLRTAAYV
NAIEKVFKVYSEAGVTFT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010532|Glutamate dehydrogenase 2, mitochondrial (GLUD2)
ATGTACCGCTACCTGGCCAAAGCGCTGCTGCCGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCCGCGGCCAACCACTCGGCCGCGTTGCTGGGCCGGGGCCGCGGACAGCCCGCCGCCGCC
TCGCAGCCGGGGCTCGCATTGGCCGCCCGGCGCCACTACAGCGAGTTGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGTTGGTGAAGGACCTGAGGACCCAGGAAAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACCGAAAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAGAAGGGCTTTATTGGTCCTGGCGTTGAT
GTGCCTGCTCCAGACATGAACACAGGTGAGCGGGAGATGTCCTGGATTGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAACTTCATCAATGAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTAGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGTCGACTGTGACATACTGATC
CCAGCTGCCACTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGATAAGATCTTCCTGGAGAGA
AACATTTTGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCCTGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGTATATCGGGTGCA
TCTGAGAAAGACATTGTGCACTCTGCCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCACACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTC
AATGCCATTGAAAAAGTCTTCAAAGTGTACAGTGAAGCTGGTGTGACCTTCACATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00208</identifier>
        <name>ELFV_dehydrog</name>
      </pfam>
      <pfam>
        <identifier>PF02812</identifier>
        <name>ELFV_dehydrog_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GTP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate dehydrogenase (NAD+) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate dehydrogenase [NAD(P)+] activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>leucine binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000321</id>
      <name>GMP synthase [glutamine-hydrolyzing]</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12069605</pubmed-id>
            <citation>Ravasio S, Dossena L, Martin-Figueroa E, Florencio FJ, Mattevi A, Morandi P, Curti B, Vanoni MA: Properties of the recombinant ferredoxin-dependent glutamate synthase of Synechocystis PCC6803. Comparison with the Azospirillum brasilense NADPH-dependent enzyme and its isolated alpha subunit. Biochemistry. 2002 Jun 25;41(25):8120-33.</citation>
          </article>
          <article>
            <pubmed-id>16142895</pubmed-id>
            <citation>Myers RS, Amaro RE, Luthey-Schulten ZA, Davisson VJ: Reaction coupling through interdomain contacts in imidazole glycerol phosphate synthase. Biochemistry. 2005 Sep 13;44(36):11974-85.</citation>
          </article>
          <article>
            <pubmed-id>7907328</pubmed-id>
            <citation>Boehlein SK, Richards NG, Schuster SM: Glutamine-dependent nitrogen transfer in Escherichia coli asparagine synthetase B. Searching for the catalytic triad. J Biol Chem. 1994 Mar 11;269(10):7450-7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P49915" source="Swiss-Prot">
    <name>GMP synthase [glutamine-hydrolyzing]</name>
    <general-function>Pyrophosphatase activity</general-function>
    <specific-function>Involved in the de novo synthesis of guanine nucleotides which are not only essential for DNA and RNA synthesis, but also provide GTP, which is involved in a number of cellular processes important for cell division.</specific-function>
    <gene-name>GMPS</gene-name>
    <locus>3q24</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.86</theoretical-pi>
    <molecular-weight>76714.79</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4378</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GMPS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U10860</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>595410</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P49915</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GUAA_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.5.2</synonym>
      <synonym>Glutamine amidotransferase</synonym>
      <synonym>GMP synthetase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000639|GMP synthase [glutamine-hydrolyzing]
MALCNGDSKLENAGGDLKDGHHHYEGAVVILDAGAQYGKVIDRRVRELFVQSEIFPLETP
AFAIKEQGFRAIIISGGPNSVYAEDAPWFDPAIFTIGKPVLGICYGMQMMNKVFGGTVHK
KSVREDGVFNISVDNTCSLFRGLQKEEVVLLTHGDSVDKVADGFKVVARSGNIVAGIANE
SKKLYGAQFHPEVGLTENGKVILKNFLYDIAGCSGTFTVQNRELECIREIKERVGTSKVL
VLLSGGVDSTVCTALLNRALNQEQVIAVHIDNGFMRKRESQSVEEALKKLGIQVKVINAA
HSFYNGTTTLPISDEDRTPRKRISKTLNMTTSPEEKRKIIGDTFVKIANEVIGEMNLKPE
EVFLAQGTLRPDLIESASLVASGKAELIKTHHNDTELIRKLREEGKVIEPLKDFHKDEVR
ILGRELGLPEELVSRHPFPGPGLAIRVICAEEPYICKDFPETNNILKIVADFSASVKKPH
TLLQRVKACTTEEDQEKLMQITSLHSLNAFLLPIKTVGVQGDCRSYSYVCGISSKDEPDW
ESLIFLARLIPRMCHNVNRVVYIFGPPVKEPPTDVTPTFLTTGVLSTLRQADFEAHNILR
ESGYAGKISQMPVILTPLHFDRDPLQKQPSCQRSVVIRTFITSDFMTGIPATPGNEIPVE
VVLKMVTEIKKIPGISRIMYDLTSKPPGTTEWE</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010084|GMP synthase [glutamine-hydrolyzing] (GMPS)
ATGGCTCTGTGCAACGGAGACTCCAAGCTGGAGAATGCTGGAGGAGACCTTAAGGATGGC
CACCACCACTATGAAGGAGCTGTTGTCATTCTGGATGCTGGTGCTCAGTACGGGAAAGTC
ATAGACCGAAGAGTGAGGGAACTGTTCGTGCAGTCTGAAATTTTCCCCTTGGAAACACCA
GCATTTGCTATAAAGGAACAAGGATTCCGTGCTATTATCATCTCTGGAGGACCTAATTCT
GTGTATGCTGAAGATGCTCCCTGGTTTGATCCAGCAATATTCACTATTGGCAAGCCTGTT
CTTGGAATTTGCTATGGTATGCAGATGATGAATAAGGTATTTGGAGGTACTGTGCACAAA
AAAAGTGTCAGAGAAGATGGAGTTTTCAACATTAGTGTGGATAATACATGTTCATTATTC
AGGGGCCTTCAGAAGGAAGAAGTTGTTTTGCTTACACATGGAGATAGTGTAGACAAAGTA
GCTGATGGATTCAAGGTTGTGGCACGTTCTGGAAACATAGTAGCAGGCATAGCAAATGAA
TCTAAAAAGTTATATGGAGCACAGTTCCACCCTGAAGTTGGCCTTACAGAAAATGGAAAA
GTAATACTGAAGAATTTCCTTTATGATATAGCTGGATGCAGTGGAACCTTCACCGTGCAG
AACAGAGAACTTGAGTGTATTCGAGAGATCAAAGAGAGAGTAGGCACGTCAAAAGTTTTG
GTTTTACTCAGTGGTGGAGTAGACTCAACAGTTTGTACAGCTTTGCTAAATCGTGCTTTG
AACCAAGAACAAGTCATTGCTGTGCACATTGATAATGGCTTTATGAGAAAACGAGAAAGC
CAGTCTGTTGAAGAGGCCCTCAAAAAGCTTGGAATTCAGGTCAAAGTGATAAATGCTGCT
CATTCTTTCTACAATGGAACAACAACCCTACCAATATCAGATGAAGATAGAACCCCACGG
AAAAGAATTAGCAAAACGTTAAATATGACCACAAGTCCTGAAGAGAAAAGAAAAATCATT
GGGGATACTTTTGTTAAGATTGCCAATGAAGTAATTGGAGAAATGAACTTGAAACCAGAG
GAGGTTTTCCTTGCCCAAGGTACTTTACGGCCTGATCTAATTGAAAGTGCATCCCTTGTT
GCAAGTGGCAAAGCTGAACTCATCAAAACCCATCACAATGACACAGAGCTCATCAGAAAG
TTGAGAGAGGAGGGAAAAGTAATAGAACCTCTGAAAGATTTTCATAAAGATGAAGTGAGA
ATTTTGGGCAGAGAACTTGGACTTCCAGAAGAGTTAGTTTCCAGGCATCCATTTCCAGGT
CCTGGCCTGGCAATCAGAGTAATATGTGCTGAAGAACCTTATATTTGTAAGGACTTTCCT
GAAACCAACAATATTTTGAAAATAGTAGCTGATTTTTCTGCAAGTGTTAAAAAGCCACAT
ACCCTATTACAGAGAGTCAAAGCCTGCACAACAGAAGAGGATCAGGAGAAGCTGATGCAA
ATTACCAGTCTGCATTCACTGAATGCCTTCTTGCTGCCAATTAAAACTGTAGGTGTGCAG
GGTGACTGTCGTTCCTACAGTTACGTGTGTGGAATCTCCAGTAAAGATGAACCTGACTGG
GAATCACTTATTTTTCTGGCTAGGCTTATACCTCGCATGTGTCACAACGTTAACAGAGTT
GTTTATATATTTGGCCCACCAGTTAAAGAACCTCCTACAGATGTTACTCCCACTTTCTTG
ACAACAGGGGTGCTCAGTACTTTACGCCAAGCTGATTTTGAGGCCCATAACATTCTCAGG
GAGTCTGGGTATGCTGGGAAAATCAGCCAGATGCCGGTGATTTTGACACCATTACATTTT
GATCGGGACCCACTTCAAAAGCAGCCTTCATGCCAGAGATCTGTGGTTATTCGAACCTTT
ATTACTAGTGACTTCATGACTGGTATACCTGCAACACCTGGCAATGAGATCCCTGTAGAG
GTGGTATTAAAGATGGTCACTGAGATTAAGAAGATTCCTGGTATTTCTCGAATTATGTAT
GACTTAACATCAAAGCCCCCAGGAACTACTGAGTGGGAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00117</identifier>
        <name>GATase</name>
      </pfam>
      <pfam>
        <identifier>PF00958</identifier>
        <name>GMP_synt_C</name>
      </pfam>
      <pfam>
        <identifier>PF02540</identifier>
        <name>NAD_synthase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyrophosphatase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GMP synthase (glutamine-hydrolyzing) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GMP synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine ribonucleoside monophosphate biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000517</id>
      <name>Branched-chain-amino-acid aminotransferase, cytosolic</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17559390</pubmed-id>
            <citation>Smirnov SV, Samsonova NN, Novikova AE, Matrosov NG, Rushkevich NY, Kodera T, Ogawa J, Yamanaka H, Shimizu S: A novel strategy for enzymatic synthesis of 4-hydroxyisoleucine: identification of an enzyme possessing HMKP (4-hydroxy-3-methyl-2-keto-pentanoate) aldolase activity. FEMS Microbiol Lett. 2007 Aug;273(1):70-7. Epub 2007 Jun 6.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P54687" source="Swiss-Prot">
    <name>Branched-chain-amino-acid aminotransferase, cytosolic</name>
    <general-function>L-valine transaminase activity</general-function>
    <specific-function>Catalyzes the first reaction in the catabolism of the essential branched chain amino acids leucine, isoleucine, and valine.</specific-function>
    <gene-name>BCAT1</gene-name>
    <locus>12pter-q12</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>4.95</theoretical-pi>
    <molecular-weight>42965.815</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:976</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>BCAT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U21551</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1036780</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P54687</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>BCAT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.42</synonym>
      <synonym>BCAT(c)</synonym>
      <synonym>BCT1</synonym>
      <synonym>ECA39</synonym>
      <synonym>Protein ECA39</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037033|Branched-chain-amino-acid aminotransferase, cytosolic
MKDCSNGCSAECTGEGGSKEVVGTFKAKDLIVTPATILKEKPDPNNLVFGTVFTDHMLTV
EWSSEFGWEKPHIKPLQNLSLHPGSSALHYAVELFEGLKAFRGVDNKIRLFQPNLNMDRM
YRSAVRATLPVFDKEELLECIQQLVKLDQEWVPYSTSASLYIRPTFIGTEPSLGVKKPTK
ALLFVLLSPVGPYFSSGTFNPVSLWANPKYVRAWKGGTGDCKMGGNYGSSLFAQCEAVDN
GCQQVLWLYGEDHQITEVGTMNLFLYWINEDGEEELATPPLDGIILPGVTRRCILDLAHQ
WGEFKVSERYLTMDDLTTALEGNRVREMFGSGTACVVCPVSDILYKGETIHIPTMENGPK
LASRILSKLTDIQYGREESDWTIVLS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010364|Branched-chain-amino-acid aminotransferase, cytosolic (BCAT1)
ATGAAGGATTGCAGTAACGGATGCTCCGCAGAGTGTACCGGAGAAGGAGGATCAAAAGAG
GTGGTGGGGACTTTTAAGGCTAAAGACCTAATAGTCACACCAGCTACCATTTTAAAGGAA
AAACCAGACCCCAATAATCTGGTTTTTGGAACTGTGTTCACGGATCATATGCTGACGGTG
GAGTGGTCCTCAGAGTTTGGATGGGAGAAACCTCATATCAAGCCTCTTCAGAACCTGTCA
TTGCACCCTGGCTCATCAGCTTTGCACTATGCAGTGGAAGTATTTGACAAAGAAGAGCTC
TTAGAGTGTATTCAACAGCTTGTGAAATTGGATCAAGAATGGGTCCCATATTCAACATCT
GCTAGTCTGTATATTCGTCCTACATTCATTGGAACTGAGCCTTCTCTTGGAGTCAAGAAG
CCTACCAAAGCCCTGCTCTTTGTACTCTTGAGCCCAGTGGGACCTTATTTTTCAAGTGGA
ACCTTTAATCCAGTGTCCCTGTGGGCCAATCCCAAGTATGTAAGAGCCTGGAAAGGTGGA
ACTGGGGACTGCAAGATGGGAGGGAATTACGGCTCATCTCTTTTTGCCCAATGTGAAGCA
GTAGATAATGGGTGTCAGCAGGTCCTGTGGCTCTATGGAGAGGACCATCAGATCACTGAA
GTGGGAACTATGAATCTTTTTCTTTACTGGATAAATGAAGATGGAGAAGAAGAACTGGCA
ACTCCTCCACTAGATGGCATCATTCTTCCAGGAGTGACAAGGCGGTGCATTCTGGACCTG
GCACATCAGTGGGGTGAATTTAAGGTGTCAGAGAGATACCTCACCATGGATGACTTGACA
ACAGCCCTGGAGGGGAACAGAGTGAGAGAGATGTTTGGCTCTGGTACAGCCTGTGTTGTT
TGCCCAGTTTCTGATATACTGTACAAAGGCGAGACAATACACATTCCAACTATGGAGAAT
GGTCCTAAGCTGGCAAGCCGCATCTTGAGCAAATTAACTGATATCCAGTATGGAAGAGAA
GAGAGCGACTGGACAATTGTGCTATCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01063</identifier>
        <name>Aminotran_4</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-isoleucine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-leucine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-valine transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>branched-chain-amino-acid transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>G1/S transition of mitotic cell cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>branched-chain amino acid biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000253</id>
      <name>4-aminobutyrate aminotransferase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>1983997</pubmed-id>
            <citation>Imai H, Okuno T, Wu JY, Lee TJ: GABAergic innervation in cerebral blood vessels: an immunohistochemical demonstration of L-glutamic acid decarboxylase and GABA transaminase. J Cereb Blood Flow Metab. 1991 Jan;11(1):129-34.</citation>
          </article>
          <article>
            <pubmed-id>3299141</pubmed-id>
            <citation>Happola O, Paivarinta H, Soinila S, Wu JY, Panula P: Localization of L-glutamate decarboxylase and GABA transaminase immunoreactivity in the sympathetic ganglia of the rat. Neuroscience. 1987 Apr;21(1):271-81.</citation>
          </article>
          <article>
            <pubmed-id>8979623</pubmed-id>
            <citation>Far SR, Millimoria FR: Levels of glutamic acid decarboxylase (GAD), gamma amino butyric acid transaminase (GABA-T), glutamic acid dehydrogenase (GLDH) and proteins in cerebrospinal fluid of certain neurological disorders. Indian J Med Sci. 1996 Apr;50(4):99-102.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P80404" source="Swiss-Prot">
    <name>4-aminobutyrate aminotransferase, mitochondrial</name>
    <general-function>Succinate-semialdehyde dehydrogenase binding</general-function>
    <specific-function>Catalyzes the conversion of gamma-aminobutyrate and L-beta-aminoisobutyrate to succinate semialdehyde and methylmalonate semialdehyde, respectively. Can also convert delta-aminovalerate and beta-alanine.</specific-function>
    <gene-name>ABAT</gene-name>
    <locus>16p13.2</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.04</theoretical-pi>
    <molecular-weight>56438.405</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:23</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ABAT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L32961</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>602705</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>2464</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P80404</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GABT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>(S)-3-amino-2-methylpropionate transaminase</synonym>
      <synonym>2.6.1.19</synonym>
      <synonym>GABA aminotransferase</synonym>
      <synonym>GABA transaminase</synonym>
      <synonym>GABA-AT</synonym>
      <synonym>GABA-T</synonym>
      <synonym>GABAT</synonym>
      <synonym>Gamma-amino-N-butyrate transaminase</synonym>
      <synonym>L-AIBAT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010221|4-aminobutyrate aminotransferase, mitochondrial
MASMLLAQRLACSFQHSYRLLVPGSRHISQAAAKVDVEFDYDGPLMKTEVPGPRSQELMK
QLNIIQNAEAVHFFCNYEESRGNYLVDVDGNRMLDLYSQISSVPIGYSHPALLKLIQQPQ
NASMFVNRPALGILPPENFVEKLRQSLLSVAPKGMSQLITMACGSCSNENALKTIFMWYR
SKERGQRGFSQEELETCMINQAPGCPDYSILSFMGAFHGRTMGCLATTHSKAIHKIDIPS
FDWPIAPFPRLKYPLEEFVKENQQEEARCLEEVEDLIVKYRKKKKTVAGIIVEPIQSEGG
DNHASDDFFRKLRDIARKHGCAFLVDEVQTGGGCTGKFWAHEHWGLDDPADVMTFSKKMM
TGGFFHKEEFRPNAPYRIFNTWLGDPSKNLLLAEVINIIKREDLLNNAAHAGKALLTGLL
DLQARYPQFISRVRGRGTFCSFDTPDDSIRNKLILIARNKGVVLGGCGDKSIRFRPTLVF
RDHHAHLFLNIFSDILADFK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010222|4-aminobutyrate aminotransferase, mitochondrial (ABAT)
ATGGCCTCCATGTTGCTCGCCCAGCGCCTGGCCTGCAGCTTCCAGCACAGCTACCGCCTG
CTGGTGCCTGGATCCAGACACATTAGTCAAGCTGCAGCCAAAGTCGACGTTGAATTTGAT
TATGATGGGCCTCTGATGAAGACGGAAGTCCCAGGGCCTAGATCTCAGGAGTTAATGAAA
CAGCTGAATATAATTCAGAATGCAGAGGCTGTGCATTTTTTCTGCAATTACGAAGAGAGC
CGAGGCAATTACCTGGTTGATGTGGACGGCAACCGAATGCTGGATCTTTATTCCCAGATC
TCCTCTGTCCCCATAGGTTACAGCCACCCCGCCCTGCTGAAACTCATCCAACAGCCTCAA
AATGCGAGCATGTTTGTCAACAGACCCGCCCTCGGAATCCTGCCTCCGGAGAACTTTGTG
GAGAAGCTCCGGCAGTCCTTGCTCTCGGTGGCTCCCAAAGGGATGTCCCAGCTCATCACC
ATGGCCTGCGGCTCCTGCTCCAATGAAAACGCCTTAAAGACCATCTTCATGTGGTACCGG
AGCAAGGAAAGAGGGCAGAGGGGCTTCTCCCAGGAGGAGCTGGAGACGTGCATGATTAAC
CAGGCCCCTGGCTGCCCCGACTACAGCATCCTCTCCTTCATGGGCGCGTTCCATGGGAGG
ACCATGGGTTGCTTAGCGACCACGCACTCTAAAGCCATTCACAAGATCGACATCCCTTCC
TTTGACTGGCCCATCGCACCGTTCCCACGGCTGAAATACCCTCTGGAAGAGTTTGTGAAA
GAGAACCAACAGGAGGAGGCCCGCTGTCTGGAAGAGGTGGAGGATCTGATTGTGAAATAT
CGGAAAAAGAAGAAGACGGTGGCCGGGATCATCGTGGAGCCCATCCAGTCCGAGGGTGGA
GACAACCACGCATCCGATGACTTCTTTCGGAAGCTGAGAGACATCGCCAGGAAGCATGGC
TGCGCCTTCTTGGTGGACGAGGTCCAGACCGGAGGAGGCTGCACGGGCAAGTTCTGGGCC
CATGAGCACTGGGGCCTGGATGACCCAGCAGACGTGATGACCTTCAGCAAGAAGATGATG
ACTGGGGGCTTCTTCCACAAGGAGGAGTTCAGGCCTAATGCTCCCTACCGGATCTTCAAC
ACCTGGCTGGGGGACCCGTCCAAGAACCTGTTGCTGGCTGAGGTCATCAACATCATCAAG
CGGGAGGACCTGCTAAATAATGCAGCCCATGCCGGGAAGGCCCTGCTCACAGGACTGCTG
GACCTCCAGGCCCGGTACCCCCAGTTCATCAGCAGGGTGAGAGGACGAGGCACCTTTTGC
TCCTTCGATACTCCCGATGATTCCATACGGAATAAGCTCATTTTAATTGCCAGAAACAAA
GGTGTGGTGTTGGGTGGCTGTGGTGACAAATCCATTCGTTTCCGTCCCACGCTGGTCTTC
AGGGATCACCACGCTCACCTGTTCCTCAATATTTTCAGTGACATCTTAGCAGACTTCAAG
TAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00202</identifier>
        <name>Aminotran_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>4-aminobutyrate transaminase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron-sulfur cluster binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>4-aminobutyrate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>(S)-3-amino-2-methylpropionate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>succinate-semialdehyde dehydrogenase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>copulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of blood pressure</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gamma-aminobutyric acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gamma-aminobutyric acid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of heat generation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to iron ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hypoxia</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral response to cocaine</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000365</id>
      <name>Glutamate receptor ionotropic, NMDA 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17662248</pubmed-id>
            <citation>Miglio G, Dianzani C, Fallarini S, Fantozzi R, Lombardi G: Stimulation of N-methyl-D-aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. Biochem Biophys Res Commun. 2007 Sep 21;361(2):404-9. Epub 2007 Jul 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q05586" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 1</name>
    <general-function>Voltage-gated cation channel activity</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. This protein plays a key role in synaptic plasticity, synaptogenesis, excitotoxicity, memory acquisition and learning. It mediates neuronal functions in glutamate neurotransmission. Is involved in the cell surface targeting of NMDA receptors (By similarity).</specific-function>
    <gene-name>GRIN1</gene-name>
    <locus>9q34.3</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>560-580
637-657
813-833</transmembrane-regions>
    <signal-regions>1-18</signal-regions>
    <theoretical-pi>9.2</theoretical-pi>
    <molecular-weight>105371.945</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4584</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D13515</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>219920</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>455</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q05586</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMDZ1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN1</synonym>
      <synonym>Glutamate [NMDA] receptor subunit zeta-1</synonym>
      <synonym>N-methyl-D-aspartate receptor subunit NR1</synonym>
      <synonym>NMD-R1</synonym>
      <synonym>NMDAR1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000727|Glutamate receptor ionotropic, NMDA 1
MSTMRLLTLALLFSCSVARAACDPKIVNIGAVLSTRKHEQMFREAVNQANKRHGSWKIQL
NATSVTHKPNAIQMALSVCEDLISSQVYAILVSHPPTPNDHFTPTPVSYTAGFYRIPVLG
LTTRMSIYSDKSIHLSFLRTVPPYSHQSSVWFEMMRVYSWNHIILLVSDDHEGRAAQKRL
ETLLEERESKAEKVLQFDPGTKNVTALLMEAKELEARVIILSASEDDAATVYRAAAMLNM
TGSGYVWLVGEREISGNALRYAPDGILGLQLINGKNESAHISDAVGVVAQAVHELLEKEN
ITDPPRGCVGNTNIWKTGPLFKRVLMSSKYADGVTGRVEFNEDGDRKFANYSIMNLQNRK
LVQVGIYNGTHVIPNDRKIIWPGGETEKPRGYQMSTRLKIVTIHQEPFVYVKPTLSDGTC
KEEFTVNGDPVKKVICTGPNDTSPGSPRHTVPQCCYGFCIDLLIKLARTMNFTYEVHLVA
DGKFGTQERVNNSNKKEWNGMMGELLSGQADMIVAPLTINNERAQYIEFSKPFKYQGLTI
LVKKEIPRSTLDSFMQPFQSTLWLLVGLSVHVVAVMLYLLDRFSPFGRFKVNSEEEEEDA
LTLSSAMWFSWGVLLNSGIGEGAPRSFSARILGMVWAGFAMIIVASYTANLAAFLVLDRP
EERITGINDPRLRNPSDKFIYATVKQSSVDIYFRRQVELSTMYRHMEKHNYESAAEAIQA
VRDNKLHAFIWDSAVLEFEASQKCDLVTTGELFFRSGFGIGMRKDSPWKQNVSLSILKSH
ENGFMEDLDKTWVRYQECDSRSNAPATLTFENMAGVFMLVAGGIVAGIFLIFIEIAYKRH
KDARRKQMQLAFAAVNVWRKNLQDRKSGRAEPDPKKKATFRAITSTLASSFKRRRSSKDT
STGGGRGALQNQKDTVLPRRAIEREEGQLQLCSRHRES</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016071|Glutamate receptor ionotropic, NMDA 1 (GRIN1)
ATGAGCACCATGCGCCTGCTGACGCTCGCCCTGCTGTTCTCCTGCTCCGTCGCCCGTGCC
GCGTGCGACCCCAAGATCGTCAACATTGGCGCGGTGCTGAGCACGCGGAAGCACGAGCAG
ATGTTCCGCGAGGCCGTGAACCAGGCCAACAAGCGGCACGGCTCCTGGAAGATTCAGCTC
AATGCCACCTCCGTCACGCACAAGCCCAACGCCATCCAGATGGCTCTGTCGGTGTGCGAG
GACCTCATCTCCAGCCAGGTCTACGCCATCCTAGTTAGCCATCCACCTACCCCCAACGAC
CACTTCACTCCCACCCCTGTCTCCTACACAGCCGGCTTCTACCGCATACCCGTGCTGGGG
CTGACCACCCGCATGTCCATCTACTCGGACAAGAGCATCCACCTGAGCTTCCTGCGCACC
GTGCCGCCCTACTCCCACCAGTCCAGCGTGTGGTTTGAGATGATGCGTGTCTACAGCTGG
AACCACATCATCCTGCTGGTCAGCGACGACCACGAGGGCCGGGCGGCTCAGAAACGCCTG
GAGACGCTGCTGGAGGAGCGTGAGTCCAAGGCAGAGAAGGTGCTGCAGTTTGACCCAGGG
ACCAAGAACGTGACGGCCCTGCTGATGGAGGCGAAAGAGCTGGAGGCCCGGGTCATCATC
CTTTCTGCCAGCGAGGACGATGCTGCCACTGTATACCGCGCAGCCGCGATGCTGAACATG
ACGGGCTCCGGGTACGTGTGGCTGGTCGGCGAGCGCGAGATCTCGGGGAACGCCCTGCGC
TACGCCCCAGACGGCATCCTCGGGCTGCAGCTCATCAACGGCAAGAACGAGTCGGCCCAC
ATCAGCGACGCCGTGGGCGTGGTGGCCCAGGCCGTGCACGAGCTCCTCGAGAAGGAGAAC
ATCACCGACCCGCCGCGGGGCTGCGTGGGCAACACCAACATCTGGAAGACCGGGCCGCTC
TTCAAGAGAGTGCTGATGTCTTCCAAGTATGCGGATGGGGTGACTGGTCGCGTGGAGTTC
AATGAGGATGGGGACCGGAAGTTCGCCAACTACAGCATCATGAACCTGCAGAACCGCAAG
CTGGTGCAAGTGGGCATCTACAATGGCACCCACGTCATCCCTAATGACAGGAAGATCATC
TGGCCAGGCGGAGAGACAGAGAAGCCTCGAGGGTACCAGATGTCCACCAGACTGAAGATT
GTGACGATCCACCAGGAGCCCTTCGTGTACGTCAAGCCCACGCTGAGTGATGGGACATGC
AAGGAGGAGTTCACAGTCAACGGCGACCCAGTCAAGAAGGTGATCTGCACCGGGCCCAAC
GACACGTCGCCGGGCAGCCCCCGCCACACGGTGCCTCAGTGTTGCTACGGCTTTTGCATC
GACCTGCTCATCAAGCTGGCACGGACCATGAACTTCACCTACGAGGTGCACCTGGTGGCA
GATGGCAAGTTCGGCACACAGGAGCGGGTGAACAACAGCAACAAGAAGGAGTGGAATGGG
ATGATGGGCGAGCTGCTCAGCGGGCAGGCAGACATGATCGTGGCGCCGCTAACCATAAAC
AACGAGCGCGCGCAGTACATCGAGTTTTCCAAGCCCTTCAAGTACCAGGGCCTGACTATT
CTGGTCAAGAAGGAGATTCCCCGGAGCACGCTGGACTCGTTCATGCAGCCGTTCCAGAGC
ACACTGTGGCTGCTGGTGGGGCTGTCGGTGCACGTGGTGGCCGTGATGCTGTACCTGCTG
GACCGCTTCAGCCCCTTCGGCCGGTTCAAGGTGAACAGCGAGGAGGAGGAGGAGGACGCA
CTGACCCTGTCCTCGGCCATGTGGTTCTCCTGGGGCGTCCTGCTCAACTCCGGCATCGGG
GAAGGCGCCCCCAGAAGCTTCTCAGCGCGCATCCTGGGCATGGTGTGGGCCGGCTTTGCC
ATGATCATCGTGGCCTCCTACACCGCCAACCTGGCGGCCTTCCTGGTGCTGGACCGGCCG
GAGGAGCGCATCACGGGCATCAACGACCCTCGGCTGAGGAACCCCTCGGACAAGTTTATC
TACGCCACGGTGAAGCAGAGCTCCGTGGATATCTACTTCCGGCGCCAGGTGGAGCTGAGC
ACCATGTACCGGCATATGGAGAAGCACAACTACGAGAGTGCGGCGGAGGCCATCCAGGCC
GTGAGAGACAACAAGCTGCATGCCTTCATCTGGGACTCGGCGGTGCTGGAGTTCGAGGCC
TCGCAGAAGTGCGACCTGGTGACGACTGGAGAGCTGTTTTTCCGCTCGGGCTTCGGCATA
GGCATGCGCAAAGACAGCCCCTGGAAGCAGAACGTCTCCCTGTCCATCCTCAAGTCCCAC
GAGAATGGCTTCATGGAAGACCTGGACAAGACGTGGGTTCGGTATCAGGAATGTGACTCG
CGCAGCAACGCCCCTGCGACCCTTACTTTTGAGAACATGGCCGGGGTCTTCATGCTGGTA
GCTGGGGGCATCGTGGCCGGGATCTTCCTGATTTTCATCGAGATTGCCTACAAGCGGCAC
AAGGATGCTCGCCGGAAGCAGATGCAGCTGGCCTTTGCCGCCGTTAACGTGTGGCGGAAG
AACCTGCAGCAGTACCATCCCACTGATATCACGGGCCCGCTCAACCTCTCAGATCCCTCG
GTCAGCACCGTGGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
      <pfam>
        <identifier>PF10562</identifier>
        <name>CaM_bdg_C0</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>dendrite membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic cleft</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic branch</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>excitatory synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>voltage-gated cation channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neurotransmitter binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calmodulin binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of membrane potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of long-term neuronal synaptic plasticity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>respiratory gaseous exchange</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of respiratory gaseous exchange</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of axonogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prepulse inhibition</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to manganese ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>olfactory learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular calcium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>male mating behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pons maturation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Ras protein signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>conditioned taste aversion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>propylene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular endothelial growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small GTPase mediated signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>social behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of dendrite morphogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ephrin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synapse assembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein tetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to morphine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cerebral cortex development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amphetamine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>suckling behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rhythmic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to fungicide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cation transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000700</id>
      <name>Folylpolyglutamate synthase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16686541</pubmed-id>
            <citation>DeMartino JK, Hwang I, Xu L, Wilson IA, Boger DL: Discovery of a potent, nonpolyglutamatable inhibitor of glycinamide ribonucleotide transformylase. J Med Chem. 2006 May 18;49(10):2998-3002.</citation>
          </article>
          <article>
            <pubmed-id>16990006</pubmed-id>
            <citation>Gangjee A, Yang J, McGuire JJ, Kisliuk RL: Synthesis and evaluation of a classical 2,4-diamino-5-substituted-furo[2,3-d]pyrimidine and a 2-amino-4-oxo-6-substituted-pyrrolo[2,3-d]pyrimidine as antifolates. Bioorg Med Chem. 2006 Dec 15;14(24):8590-8. Epub 2006 Sep 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q05932" source="Swiss-Prot">
    <name>Folylpolyglutamate synthase, mitochondrial</name>
    <general-function>Tetrahydrofolylpolyglutamate synthase activity</general-function>
    <specific-function>Catalyzes conversion of folates to polyglutamate derivatives allowing concentration of folate compounds in the cell and the intracellular retention of these cofactors, which are important substrates for most of the folate-dependent enzymes that are involved in one-carbon transfer reactions involved in purine, pyrimidine and amino acid synthesis. Unsubstituted reduced folates are the preferred substrates. Metabolizes methotrexate (MTX) to polyglutamates.</specific-function>
    <gene-name>FPGS</gene-name>
    <locus>9q34.1</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.0</theoretical-pi>
    <molecular-weight>64608.53</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3824</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FPGS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M98045</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>292029</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q05932</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FOLC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.2.17</synonym>
      <synonym>Folylpoly-gamma-glutamate synthetase</synonym>
      <synonym>FPGS</synonym>
      <synonym>Tetrahydrofolate synthase</synonym>
      <synonym>Tetrahydrofolylpolyglutamate synthase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001396|Folylpolyglutamate synthase, mitochondrial
MSRARSHLRAALFLAAASARGITTQVAARRGLSAWPVPQEPSMEYQDAVRMLNTLQTNAG
YLEQVKRQRGDPQTQLEAMELYLARSGLQVEDLDRLNIIHVTGTKGKGSTCAFTECILRS
YGLKTGFFSSPHLVQVRERIRINGQPISPELFTKYFWRLYHRLEETKDGSCVSMPPYFRF
LTLMAFHVFLQEKVDLAVVEVGIGGAYDCTNIIRKPVVCGVSSLGIDHTSLLGDTVEKIA
WQKGGIFKQGVPAFTVLQPEGPLAVLRDRAQQISCPLYLCPMLEALEEGGPPLTLGLEGE
HQRSNAALALQLAHCWLQRQDRHGAGEPKASRPGLLWQLPLAPVFQPTSHMRLGLRNTEW
PGRTQVLRRGPLTWYLDGAHTASSAQACVRWFRQALQGRERPSGGPEVRVLLFNATGDRD
PAALLKLLQPCQFDYAVFCPNLTEVSSTGNADQQNFTVTLDQVLLRCLEHQQHWNHLDEE
QASPDLWSAPSPEPGGSASLLLAPHPPHTCSASSLVFSCISHALQWISQGRDPIFQPPSP
PKGLLTHPVAHSGASILREAAAIHVLVTGSLHLVGGVLKLLEPALSQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010491|Folylpolyglutamate synthase, mitochondrial (FPGS)
ATGCTCAATACCCTGCAGACCAATGCCGGCTACCTGGAGCAGGTGAAGCGCCAGCGGGGT
GACCCTCAGACACAGTTGGAAGCCATGGAACTGTACCTGGCACGGAGTGGGCTGCAGGTG
GAGGACTTGGACCGGCTGAACATCATCCACGTCACTGGGACGAAGGGGAAGGGCTCCACC
TGTGCCTTCACGGAATGTATCCTCCGAAGCTATGGCCTGAAGACGGGATTCTTTAGCTCT
CCCCACCTGGTGCAGGTTCGGGAGCGGATCCGCATCAATGGGCAGCCCATCAGTCCTGAG
CTCTTCACCAAGTACTTCTGGCGCCTCTACCACCGGCTGGAGGAGACCAAGGATGGCAGC
TGTGTCTCCATGCCCCCCTACTTCCGCTTCCTGACACTCATGGCCTTCCACGTCTTCCTC
CAAGAGAAGGTGGACCTGGCAGTGGTGGAGGTGGGCATTGGCGGGGCTTATGACTGCACC
AACATCATCAGGAAGCCTGTGGTGTGCGGAGTCTCCTCTCTTGGCATCGACCACACCAGC
CTCCTGGGGGATACGGTGGAGAAGATCGCATGGCAGAAAGGGGGCATCTTTAAGCAAGGT
GTCCCTGCCTTCACTGTGCTCCAACCTGAAGGTCCCCTGGCAGTGCTGAGGGACCGAGCC
CAGCAGATCTCATGTCCTCTATACCTGTGTCCGATGCTGGAGGCCCTCGAGGAAGGGGGG
CCGCCGCTGACCCTGGGCCTGGAGGGGGAGCACCAGCGGTCCAACGCCGCCTTGGCCTTG
CAGCTGGCCCACTGCTGGCTGCAGCGGCAGGACCGCCATGGTGCTGGGGAGCCAAAGGCA
TCCAGGCCAGGGCTCCTGTGGCAGCTGCCCCTGGCACCTGTGTTCCAGCCCACATCCCAC
ATGCGGCTCGGGCTTCGGAACACGGAGTGGCCGGGCCGGACGCAGGTGCTGCGGCGCGGG
CCCCTCACCTGGTACCTGGACGGTGCGCACACCGCCAGCAGCGCGCAGGCCTGCGTGCGC
TGGTTCCGCCAGGCGCTGCAGGGCCGCGAGAGGCCGAGCGGTGGCCCCGAGGTTCGAGTC
TTGCTCTTCAATGCTACCGGGGACCGGGACCCGGCGGCCCTGCTGAAGCTGCTGCAGCCC
TGCCAGTTTGACTATGCCGTCTTCTGCCCTAACCTGACAGAGGTGTCATCCACAGGCAAC
GCAGACCAACAGAACTTCACAGTGACACTGGACCAGGTCCTGCTCCGCTGCCTGGAACAC
CAGCAGCACTGGAACCACCTGGACGAAGAGCAGGCCAGCCCGGACCTCTGGAGTGCCCCC
AGCCCAGAGCCCGGTGGGTCCGCATCCCTGCTTCTGGCGCCCCACCCACCCCACACCTGC
AGTGCCAGCTCCCTCGTCTTCAGCTGCATTTCACATGCCTTGCAATGGATCAGCCAAGGC
CGAGACCCCATCTTCCAGCCACCTAGTCCCCCAAAGGGCCTCCTCACCCACCCTGTGGCT
CACAGTGGGGCCAGCATACTCCGTGAGGCTGCTGCCATCCATGTGCTAGTCACTGGCAGC
CTGCACCTGGTGGGTGGTGTCCTGAAGCTGCTGGAGCCCGCACTGTCCCAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02875</identifier>
        <name>Mur_ligase_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tetrahydrofolylpolyglutamate synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>liver development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>one-carbon metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tetrahydrofolylpolyglutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>organ regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002271</id>
      <name>Glutamyl aminopeptidase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>7448199</pubmed-id>
            <citation>Tobe H, Kojima F, Aoyagi T, Umezawa H: Purification by affinity chromatography using amastatin and properties of aminopeptidase A from pig kidney. Biochim Biophys Acta. 1980 Jun 13;613(2):459-68.</citation>
          </article>
          <article>
            <pubmed-id>11732752</pubmed-id>
            <citation>Acarturk F, Parlatan ZI, Saracoglu OF: Comparison of vaginal aminopeptidase enzymatic activities in various animals and in humans. J Pharm Pharmacol. 2001 Nov;53(11):1499-504.</citation>
          </article>
          <article>
            <pubmed-id>8568030</pubmed-id>
            <citation>Sasaki M, Bosman BW, Tan PS: Comparison of proteolytic activities in various lactobacilli. J Dairy Res. 1995 Nov;62(4):601-10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q07075" source="Swiss-Prot">
    <name>Glutamyl aminopeptidase</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Appears to have a role in the catabolic pathway of the renin-angiotensin system. Probably plays a role in regulating growth and differentiation of early B-lineage cells.</specific-function>
    <gene-name>ENPEP</gene-name>
    <locus>4q25</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>19-39</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>5.18</theoretical-pi>
    <molecular-weight>109243.58</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3355</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ENPEP</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L14721</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>291854</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q07075</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AMPE_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.11.7</synonym>
      <synonym>Aminopeptidase A</synonym>
      <synonym>AP-A</synonym>
      <synonym>Differentiation antigen gp160</synonym>
      <synonym>EAP</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011634|Glutamyl aminopeptidase
MNFAEREGSKRYCIQTKHVAILCAVVVGVGLIVGLAVGLTRSCDSSGDGGPGTAPAPSHL
PSSTASPSGPPAQDQDICPASEDESGQWKNFRLPDFVNPVHYDLHVKPLLEEDTYTGTVS
ISINLSAPTRYLWLHLRETRITRLPELKRPSGDQVQVRRCFEYKKQEYVVVEAEEELTPS
SGDGLYLLTMEFAGWLNGSLVGFYRTTYTENGQVKSIVATDHEPTDARKSFPCFDEPNKK
ATYTISITHPKEYGALSNMPVAKEESVDDKWTRTTFEKSVPMSTYLVCFAVHQFDSVKRI
SNSGKPLTIYVQPEQKHTAEYAANITKSVFDYFEEYFAMNYSLPKLDKIAIPDFGTGAME
NWGLITYRETNLLYDPKESASSNQQRVATVVAHELVHQWFGNIVTMDWWEDLWLNEGFAS
FFEFLGVNHAETDWQMRDQMLLEDVLPVQEDDSLMSSHPIIVTVTTPDEITSVFDGISYS
KGSSILRMLEDWIKPENFQKGCQMYLEKYQFKNAKTSDFWAALEEASRLPVKEVMDTWTR
QMGYPVLNVNGVKNITQKRFLLDPRANPSQPPSDLGYTWNIPVKWTEDNITSSVLFNRSE
KEGITLNSSNPSGNAFLKINPDHIGFYRVNYEVATWDSIATALSLNHKTFSSADRASLID
DAFALARAQLLDYKVALNLTKYLKREENFLPWQRVISAVTYIISMFEDDKELYPMIEEYF
QGQVKPIADSLGWNDAGDHVTKLLRSSVLGFACKMGDREALNNASSLFEQWLNGTVSLPV
NLRLLVYRYGMQNSGNEISWNYTLEQYQKTSLAQEKEKLLYGLASVKNVTLLSRYLDLLK
DTNLIKTQDVFTVIRYISYNSYGKNMAWNWIQLNWDYLVNRYTLNNRNLGRIVTIAEPFN
TELQLWQMESFFAKYPQAGAGEKPREQVLETVKNNIEWLKQHRNTIREWFFNLLESG</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011635|Glutamyl aminopeptidase (ENPEP)
ATGAACTTTGCGGAGAGAGAGGGCTCTAAGAGATACTGCATTCAAACGAAACATGTGGCC
ATTCTCTGTGCGGTGGTGGTGGGTGTAGGATTAATAGTGGGACTTGCCGTGGGCTTGACC
AGATCGTGTGACTCCAGCGGGGACGGCGGGCCGGGCACTGCGCCAGCTCCTTCCCACCTG
CCTTCTTCCACGGCCAGCCCCTCAGGTCCTCCTGCCCAGGACCAGGACATCTGCCCGGCC
AGTGAGGATGAGAGCGGACAGTGGAAAAACTTTCGACTGCCGGACTTCGTCAACCCAGTC
CACTACGACCTGCACGTGAAGCCCCTGTTGGAGGAGGACACCTACACGGGCACCGTGAGC
ATCTCCATCAACCTGAGCGCTCCCACCCGGTACCTGTGGCTGCACCTCCGGGAGACCAGG
ATCACCCGGCTCCCGGAGCTGAAGAGGCCCTCTGGGGACCAGGTGCAAGTCCGGAGGTGT
TTCGAGTACAAAAAGCAGGAGTACGTGGTGGTCGAGGCGGAGGAAGAGCTTACCCCCAGC
AGTGGAGATGGCCTGTATCTCCTGACCATGGAGTTCGCCGGCTGGCTGAACGGCTCCCTC
GTGGGATTTTATAGAACCACCTACACGGAGAACGGACAAGTCAAGAGCATAGTGGCCACC
GATCATGAACCAACAGATGCCAGGAAATCTTTTCCTTGTTTTGATGAGCCCAACAAAAAG
GCAACTTATACAATATCTATCACCCATCCCAAAGAATACGGAGCACTTTCAAATATGCCA
GTGGCGAAAGAAGAGTCAGTGGATGATAAATGGACTCGAACAACTTTTGAGAAGTCTGTC
CCCATGAGCACGTACCTGGTGTGCTTTGCTGTACATCAATTTGACTCTGTAAAGAGAATA
TCAAATAGTGGAAAACCTCTTACAATTTATGTCCAGCCAGAGCAAAAGCACACAGCCGAA
TATGCTGCAAACATAACTAAAAGTGTGTTTGATTATTTTGAAGAATACTTTGCTATGAAT
TATTCTCTTCCTAAATTAGATAAAATCGCTATTCCAGATTTTGGCACTGGTGCCATGGAG
AACTGGGGACTCATCACGTACAGAGAAACGAACCTGCTTTATGACCCTAAGGAATCAGCC
TCATCAAACCAACAGAGGGTGGCCACTGTGGTTGCCCATGAACTTGTGCATCAGTGGTTT
GGAAATATTGTGACCATGGACTGGTGGGAAGACTTGTGGCTAAATGAAGGATTTGCTTCT
TTCTTTGAGTTTCTGGGAGTAAACCATGCAGAAACAGACTGGCAAATGCGTGACCAAATG
TTACTTGAAGATGTATTACCTGTTCAAGAGGATGATTCTTTGATGTCTTCGCATCCAATT
ATTGTGACTGTGACAACCCCTGATGAAATAACATCTGTTTTTGATGGAATATCCTATAGC
AAGGGATCTTCTATTTTGAGAATGCTTGAAGACTGGATAAAACCAGAGAATTTTCAAAAA
GGATGTCAGATGTACTTGGAAAAATACCAATTCAAGAATGCAAAAACTTCTGATTTTTGG
GCAGCACTGGAAGAGGCAAGTAGGCTACCAGTGAAAGAAGTAATGGACACCTGGACCAGA
CAGATGGGTTATCCTGTGCTTAACGTGAACGGTGTCAAGAACATCACACAGAAACGCTTT
TTGTTGGACCCAAGAGCTAACCCTTCTCAGCCCCCTTCAGATCTTGGTTATACATGGAAT
ATCCCAGTTAAATGGACTGAAGATAATATAACAAGCAGTGTGTTATTTAATAGGTCAGAA
AAAGAAGGAATCACTTTGAACTCCTCTAATCCTAGTGGAAATGCTTTTCTCAAAATAAAC
CCAGATCATATTGGGTTTTATCGTGTAAATTATGAAGTAGCAACTTGGGACTCGATAGCT
ACAGCGCTCTCCTTGAACCACAAGACATTTTCTTCAGCAGATCGTGCAAGTCTTATTGAT
GATGCTTTTGCCTTGGCAAGAGCTCAACTTCTAGATTATAAGGTGGCTTTGAACTTGACC
AAGTATCTCAAAAGGGAAGAGAATTTTTTACCATGGCAGAGAGTAATTTCAGCTGTAACC
TACATCATTAGCATGTTTGAAGATGATAAAGAGCTATATCCTATGATTGAGGAATACTTC
CAAGGTCAAGTGAAGCCTATTGCAGATTCTCTGGGATGGAATGATGCTGGAGACCATGTC
ACAAAGTTACTCCGTTCCTCCGTGTTAGGGTTTGCGTGCAAGATGGGAGACAGAGAAGCC
TTGAACAATGCTTCCTCGTTATTTGAGCAGTGGCTAAATGGGACTGTAAGCCTTCCCGTA
AATCTCAGGCTTCTGGTGTATCGGTATGGGATGCAGAACTCTGGCAATGAGATTTCATGG
AACTACACTCTTGAGCAATACCAGAAAACTTCATTAGCTCAAGAAAAAGAAAAACTGCTG
TATGGATTAGCATCAGTGAAGAACGTTACTCTTTTGTCAAGGTATTTGGATTTGCTCAAG
GACACGAACCTTATTAAAACTCAGGATGTGTTTACAGTCATTCGATATATCTCATATAAC
AGCTATGGGAAGAACATGGCCTGGAATTGGATACAACTCAACTGGGACTATCTAGTCAAC
AGATATACACTCAATAACAGAAACCTTGGCCGAATTGTCACAATAGCAGAGCCATTCAAC
ACTGAACTGCAACTGTGGCAGATGGAGAGCTTTTTTGCAAAATATCCACAAGCTGGAGCA
GGAGAAAAACCTAGGGAACAAGTGCTGGAAACAGTGAAAAACAATATAGAGTGGCTAAAA
CAACATAGAAACACCATCAGAGAATGGTTTTTTAATTTACTTGAGAGTGGTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01433</identifier>
        <name>Peptidase_M1</name>
      </pfam>
      <pfam>
        <identifier>PF11838</identifier>
        <name>ERAP1_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>lysosomal membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical part of cell</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>brush border</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>external side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metalloaminopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metallopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aminopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>angiotensin catabolic process in blood</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proteolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of systemic arterial blood pressure by renin-angiotensin</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glomerulus development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell-cell signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>angiogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>angiotensin maturation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptide catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000760</id>
      <name>Glutamate receptor ionotropic, NMDA 2A</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12068077</pubmed-id>
            <citation>Rutter AR, Freeman FM, Stephenson FA: Further characterization of the molecular interaction between PSD-95 and NMDA receptors: the effect of the NR1 splice variant and evidence for modulation of channel gating. J Neurochem. 2002 Jun;81(6):1298-307.</citation>
          </article>
          <article>
            <pubmed-id>11080203</pubmed-id>
            <citation>Rutter AR, Stephenson FA: Coexpression of postsynaptic density-95 protein with NMDA receptors results in enhanced receptor expression together with a decreased sensitivity to L-glutamate. J Neurochem. 2000 Dec;75(6):2501-10.</citation>
          </article>
          <article>
            <pubmed-id>8886398</pubmed-id>
            <citation>Bresink I, Benke TA, Collett VJ, Seal AJ, Parsons CG, Henley JM, Collingridge GL: Effects of memantine on recombinant rat NMDA receptors expressed in HEK 293 cells. Br J Pharmacol. 1996 Sep;119(2):195-204.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q12879" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 2A</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels possesses high calcium permeability and voltage-dependent sensitivity to magnesium. Activation requires binding of agonist to both types of subunits.</specific-function>
    <gene-name>GRIN2A</gene-name>
    <locus>16p13.2</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>556-576
634-654
817-837</transmembrane-regions>
    <signal-regions>1-22</signal-regions>
    <theoretical-pi>7.11</theoretical-pi>
    <molecular-weight>165281.215</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4585</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN2A</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U09002</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>558749</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>456</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>456</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q12879</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMDE1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN2A</synonym>
      <synonym>Glutamate [NMDA] receptor subunit epsilon-1</synonym>
      <synonym>hNR2A</synonym>
      <synonym>N-methyl D-aspartate receptor subtype 2A</synonym>
      <synonym>NMDAR2A</synonym>
      <synonym>NR2A</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001516|Glutamate receptor ionotropic, NMDA 2A
MGRVGYWTLLVLPALLVWRGPAPSAAAEKGPPALNIAVMLGHSHDVTERELRTLWGPEQA
AGLPLDVNVVALLMNRTDPKSLITHVCDLMSGARIHGLVFGDDTDQEAVAQMLDFISSHT
FVPILGIHGGASMIMADKDPTSTFFQFGASIQQQATVMLKIMQDYDWHVFSLVTTIFPGY
REFISFVKTTVDNSFVGWDMQNVITLDTSFEDAKTQVQLKKIHSSVILLYCSKDEAVLIL
SEARSLGLTGYDFFWIVPSLVSGNTELIPKEFPSGLISVSYDDWDYSLEARVRDGIGILT
TAASSMLEKFSYIPEAKASCYGQMERPEVPMHTLHPFMVNVTWDGKDLSFTEEGYQVHPR
LVVIVLNKDREWEKVGKWENHTLSLRHAVWPRYKSFSDCEPDDNHLSIVTLEEAPFVIVE
DIDPLTETCVRNTVPCRKFVKINNSTNEGMNVKKCCKGFCIDILKKLSRTVKFTYDLYLV
TNGKHGKKVNNVWNGMIGEVVYQRAVMAVGSLTINEERSEVVDFSVPFVETGISVMVSRS
NGTVSPSAFLEPFSASVWVMMFVMLLIVSAIAVFVFEYFSPVGYNRNLAKGKAPHGPSFT
IGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEFVD
QVTGLSDKKFQRPHDYSPPFRFGTVPNGSTERNIRNNYPYMHQYMTKFNQKGVEDALVSL
KTGKLDAFIYDAAVLNYKAGRDEGCKLVTIGSGYIFATTGYGIALQKGSPWKRQIDLALL
QFVGDGEMEELETLWLTGICHNEKNEVMSSQLDIDNMAGVFYMLAAAMALSLITFIWEHL
FYWKLRFCFTGVCSDRPGLLFSISRGIYSCIHGVHIEEKKKSPDFNLTGSQSNMLKLLRS
AKNISSMSNMNSSRMDSPKRAADFIQRGSLIMDMVSDKGNLMYSDNRSFQGKESIFGDNM
NELQTFVANRQKDNLNNYVFQGQHPLTLNESNPNTVEVAVSTESKANSRPRQLWKKSVDS
IRQDSLSQNPVSQRDEATAENRTHSLKSPRYLPEEMAHSDISETSNRATCHREPDNSKNH
KTKDNFKRSVASKYPKDCSEVERTYLKTKSSSPRDKIYTIDGEKEPGFHLDPPQFVENVT
LPENVDFPDPYQDPSENFRKGDSTLPMNRNPLHNEEGLSNNDQYKLYSKHFTLKDKGSPH
SETSERYRQNSTHCRSCLSNMPTYSGHFTMRSPFKCDACLRMGNLYDIDEDQMLQETGNP
ATGEQVYQQDWAQNNALQLQKNKLRISRQHSYDNIVDKPRELDLSRPSRSISLKDRERLL
EGNFYGSLFSVPSSKLSGKKSSLFPQGLEDSKRSKSLLPDHTSDNPFLHSHRDDQRLVIG
RCPSDPYKHSLPSQAVNDSYLRSSLRSTASYCSRDSRGHNDVYISEHVMPYAANKNNMYS
TPRVLNSCSNRRVYKKMPSIESDV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016199|Glutamate receptor ionotropic, NMDA 2A (GRIN2A)
ATGGGCAGAGTGGGCTATTGGACCCTGCTGGTGCTGCCGGCCCTTCTGGTCTGGCGCGGT
CCGGCGCCGAGCGCGGCGGCGGAGAAGGGTCCCCCCGCGCTAAATATTGCGGTGATGCTG
GGTCACAGCCACGACGTGACAGAGCGCGAACTTCGAACACTGTGGGGCCCCGAGCAGGCG
GCGGGGCTGCCCCTGGACGTGAACGTGGTAGCTCTGCTGATGAACCGCACCGACCCCAAG
AGCCTCATCACGCACGTGTGCGACCTCATGTCCGGGGCACGCATCCACGGCCTCGTGTTT
GGGGACGACACGGACCAGGAGGCCGTAGCCCAGATGCTGGATTTTATCTCCTCCCACACC
TTCGTCCCCATCTTGGGCATTCATGGGGGCGCATCTATGATCATGGCTGACAAGGATCCG
ACGTCTACCTTCTTCCAGTTTGGAGCGTCCATCCAGCAGCAAGCCACGGTCATGCTGAAG
ATCATGCAGGATTATGACTGGCATGTCTTCTCCCTGGTGACCACTATCTTCCCTGGCTAC
AGGGAATTCATCAGCTTCGTCAAGACCACAGTGGACAACAGCTTTGTGGGCTGGGACATG
CAGAATGTGATCACACTGGACACTTCCTTTGAGGATGCAAAGACACAAGTCCAGCTGAAG
AAGATCCACTCTTCTGTCATCTTGCTCTACTGTTCCAAAGACGAGGCTGTTCTCATTCTG
AGTGAGGCCCGCTCCCTTGGCCTCACCGGGTATGATTTCTTCTGGATTGTCCCCAGCTTG
GTCTCTGGGAACACGGAGCTCATCCCAAAAGAGTTTCCATCGGGACTCATTTCTGTCTCC
TACGATGACTGGGACTACAGCCTGGAGGCGAGAGTGAGGGACGGCATTGGCATCCTAACC
ACCGCTGCATCTTCTATGCTGGAGAAGTTCTCCTACATCCCCGAGGCCAAGGCCAGCTGC
TACGGGCAGATGGAGAGGCCAGAGGTCCCGATGCACACCTTGCACCCATTTATGGTCAAT
GTTACATGGGATGGCAAAGACTTATCCTTCACTGAGGAAGGCTACCAGGTGCACCCCAGG
CTGGTGGTGATTGTGCTGAACAAAGACCGGGAATGGGAAAAGGTGGGCAAGTGGGAGAAC
CATACGCTGAGCCTGAGGCACGCCGTGTGGCCCAGGTACAAGTCCTTCTCCGACTGTGAG
CCGGATGACAACCATCTCAGCATCGTCACCCTGGAGGAGGCCCCATTCGTCATCGTGGAA
GACATAGACCCCCTGACCGAGACGTGTGTGAGGAACACCGTGCCATGTCGGAAGTTCGTC
AAAATCAACAATTCAACCAATGAGGGGATGAATGTGAAGAAATGCTGCAAGGGGTTCTGC
ATTGATATTCTGAAGAAGCTTTCCAGAACTGTGAAGTTTACTTACGACCTCTATCTGGTG
ACCAATGGGAAGCATGGCAAGAAAGTTAACAATGTGTGGAATGGAATGATCGGTGAAGTG
GTCTATCAACGGGCAGTCATGGCAGTTGGCTCGCTCACCATCAATGAGGAACGTTCTGAA
GTGGTGGACTTCTCTGTGCCCTTTGTGGAAACGGGAATCAGTGTCATGGTTTCAAGAAGT
AATGGCACCGTCTCACCTTCTGCTTTTCTAGAACCATTCAGCGCCTCTGTCTGGGTGATG
ATGTTTGTGATGCTGCTCATTGTTTCTGCCATAGCTGTTTTTGTCTTTGAATACTTCAGC
CCTGTTGGATACAACAGAAACTTAGCCAAAGGGAAAGCACCCCATGGGCCTTCTTTTACA
ATTGGAAAAGCTATATGGCTTCTTTGGGGCCTGGTGTTCAATAACTCCGTGCCTGTCCAG
AATCCTAAAGGGACCACCAGCAAGATCATGGTATCTGTATGGGCCTTCTTCGCTGTCATA
TTCCTGGCTAGCTACACAGCCAATCTGGCTGCCTTCATGATCCAAGAGGAATTTGTGGAC
CAAGTGACCGGCCTCAGTGACAAAAAGTTTCAGAGACCTCATGACTATTCCCCACCTTTT
CGATTTGGGACAGTGCCTAATGGAAGCACGGAGAGAAACATTCGGAATAACTATCCCTAC
ATGCATCAGTACATGACCAAATTTAATCAGAAAGGAGTAGAGGACGCCTTGGTCAGCCTG
AAAACGGGGAAGCTGGACGCTTTCATCTACGATGCCGCAGTCTTGAATTACAAGGCTGGG
AGGGATGAAGGCTGCAAGCTGGTGACCATCGGGAGTGGGTACATCTTTGCCACCACCGGT
TATGGAATTGCCCTTCAGAAAGGCTCTCCTTGGAAGAGGCAGATCGACCTGGCCTTGCTT
CAGTTTGTGGGTGATGGTGAGATGGAGGAGCTGGAGACCCTGTGGCTCACTGGGATCTGC
CACAACGAGAAGAACGAGGTGATGAGCAGCCAGCTGGACATTGACAACATGGCGGGCGTA
TTCTACATGCTGGCTGCCGCCATGGCCCTTAGCCTCATCACCTTCATCTGGGAGCACCTC
TTCTACTGGAAGCTGCGCTTCTGTTTCACGGGCGTGTGCTCCGACCGGCCTGGGTTGCTC
TTCTCCATCAGCAGGGGCATCTACAGCTGCATTCATGGAGTGCACATTGAAGAAAAGAAG
AAGTCTCCAGACTTCAATCTGACGGGATCCCAGAGCAACATGTTAAAACTCCTCCGGTCA
GCCAAAAACATTTCCAGCATGTCCAACATGAACTCCTCAAGAATGGACTCACCCAAAAGA
GCTGCTGACTTCATCCAAAGAGGTTCCCTCATCATGGACATGGTTTCAGATAAGGGGAAT
TTGATGTACTCAGACAACAGGTCCTTTCAGGGGAAAGAGAGCATTTTTGGAGACAACATG
AACGAACTCCAAACATTTGTGGCCAACCGGCAGAAGGATAACCTCAATAACTATGTATTC
CAGGGACAACATCCTCTTACTCTCAATGAGTCCAACCCTAACACGGTGGAGGTGGCCGTG
AGCACAGAATCCAAAGCGAACTCTAGACCCCGGCAGCTGTGGAAGAAATCCGTGGATTCC
ATACGCCAGGATTCACTATCCCAGAATCCAGTCTCCCAGAGGGATGAGGCAACAGCAGAG
AATAGGACCCACTCCCTAAAGAGCCCTAGGTATCTTCCAGAAGAGATGGCCCACTCTGAC
ATTTCAGAAACGTCAAATCGGGCCACGTGCCACAGGGAACCTGACAACAGTAAGAACCAC
AAAACCAAGGACAACTTTAAAAGGTCAGTGGCCTCCAAATACCCCAAGGACTGTAGTGAG
GTCGAGCGCACCTACCTGAAAACCAAATCAAGCTCCCCTAGAGACAAGATCTACACTATA
GATGGTGAGAAGGAGCCTGGTTTCCACTTAGATCCACCCCAGTTTGTTGAAAATGTGACC
CTGCCCGAGAACGTGGACTTCCCGGACCCCTACCAGGATCCCAGTGAAAACTTCCGCAAG
GGGGACTCCACGCTGCCAATGAACCGGAACCCCTTGCATAATGAAGAGGGGCTTTCCAAC
AACGACCAGTATAAACTCTACTCCAAGCACTTCACCTTGAAAGACAAGGGTTCCCCGCAC
AGTGAGACCAGCGAGCGATACCGGCAGAACTCCACGCACTGCAGAAGCTGCCTTTCCAAC
ATGCCCACCTATTCAGGCCACTTCACCATGAGGTCCCCCTTCAAGTGCGATGCCTGCCTG
CGGATGGGGAACCTCTATGACATCGATGAAGACCAGATGCTTCAGGAGACAGGTAACCCA
GCCACCGGGGAGCAGGTCTACCAGCAGGACTGGGCACAGAACAATGCCCTTCAATTACAA
AAGAACAAGCTAAGGATTAGCCGTCAGCATTCCTACGATAACATTGTCGACAAACCTAGG
GAGCTAGACCTTAGCAGGCCCTCCCGGAGCATAAGCCTCAAGGACAGGGAACGGCTTCTG
GAGGGAAATTTTTACGGCAGCCTGTTTAGTGTCCCCTCAAGCAAACTCTCGGGGAAAAAA
AGCTCCCTTTTCCCCCAAGGTCTGGAGGACAGCAAGAGGAGCAAGTCTCTCTTGCCAGAC
CACACCTCCGATAACCCTTTCCTCCACTCCCACAGGGATGACCAACGCTTGGTTATTGGG
AGATGCCCCTCGGACCCTTACAAACACTCGTTGCCATCCCAGGCGGTGAATGACAGCTAT
CTTCGGTCGTCCTTGAGGTCAACGGCATCGTACTGTTCCAGGGACAGTCGGGGCCACAAT
GATGTGTATATTTCGGAGCATGTTATGCCTTATGCTGCAAATAAGAATAATATGTACTCT
ACCCCCAGGGTTTTAAATTCCTGCAGCAATAGACGCGTGTACAAGAAAATGCCTAGTATC
GAATCTGATGTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
      <pfam>
        <identifier>PF10565</identifier>
        <name>NMDAR2_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>neurotransmitter binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>voltage-gated cation channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dopamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of long-term neuronal synaptic plasticity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to methylmercury</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term synaptic potentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amphetamine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>startle response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to magnesium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>directional locomotion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to manganese ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of protein catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to cocaine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to dsRNA</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>visual learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to carbohydrate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to other organism</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Ras protein signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>action potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>spinal cord development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein localization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular endothelial growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cerebral cortex development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small GTPase mediated signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hippocampus development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>serotonin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to amino acid stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to wounding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to fungicide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein tetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sleep</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to zinc ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>rhythmic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>learning or memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000417</id>
      <name>Glutamate receptor ionotropic, NMDA 2B</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17229973</pubmed-id>
            <citation>Verkhratsky A, Kirchhoff F: NMDA Receptors in glia. Neuroscientist. 2007 Feb;13(1):28-37.</citation>
          </article>
          <article>
            <pubmed-id>17662248</pubmed-id>
            <citation>Miglio G, Dianzani C, Fallarini S, Fantozzi R, Lombardi G: Stimulation of N-methyl-D-aspartate receptors modulates Jurkat T cell growth and adhesion to fibronectin. Biochem Biophys Res Commun. 2007 Sep 21;361(2):404-9. Epub 2007 Jul 20.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13224" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 2B</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine. In concert with DAPK1 at extrasynaptic sites, acts as a central mediator for stroke damage. Its phosphorylation at Ser-1303 by DAPK1 enhances synaptic NMDA receptor channel activity inducing injurious Ca2+ influx through them, resulting in an irreversible neuronal death (By similarity).</specific-function>
    <gene-name>GRIN2B</gene-name>
    <locus>12p12</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>558-578
635-655
818-838</transmembrane-regions>
    <signal-regions>1-26</signal-regions>
    <theoretical-pi>6.92</theoretical-pi>
    <molecular-weight>166365.885</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4586</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN2B</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U90278</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1899202</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>457</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13224</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMDE2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN2B</synonym>
      <synonym>Glutamate [NMDA] receptor subunit epsilon-2</synonym>
      <synonym>hNR3</synonym>
      <synonym>N-methyl D-aspartate receptor subtype 2B</synonym>
      <synonym>N-methyl-D-aspartate receptor subunit 3</synonym>
      <synonym>NMDAR2B</synonym>
      <synonym>NR2B</synonym>
      <synonym>NR3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010288|Glutamate receptor ionotropic, NMDA 2B
MKPRAECCSPKFWLVLAVLAVSGSRARSQKSPPSIGIAVILVGTSDEVAIKDAHEKDDFH
HLSVVPRVELVAMNETDPKSIITRICDLMSDRKIQGVVFADDTDQEAIAQILDFISAQTL
TPILGIHGGSSMIMADKDESSMFFQFGPSIEQQASVMLNIMEEYDWYIFSIVTTYFPGYQ
DFVNKIRSTIENSFVGWELEEVLLLDMSLDDGDSKIQNQLKKLQSPIILLYCTKEEATYI
FEVANSVGLTGYGYTWIVPSLVAGDTDTVPAEFPTGLISVSYDEWDYGLPARVRDGIAII
TTAASDMLSEHSFIPEPKSSCYNTHEKRIYQSNMLNRYLINVTFEGRNLSFSEDGYQMHP
KLVIILLNKERKWERVGKWKDKSLQMKYYVWPRMCPETEEQEDDHLSIVTLEEAPFVIVE
SVDPLSGTCMRNTVPCQKRIVTENKTDEEPGYIKKCCKGFCIDILKKISKSVKFTYDLYL
VTNGKHGKKINGTWNGMIGEVVMKRAYMAVGSLTINEERSEVVDFSVPFIETGISVMVSR
SNGTVSPSAFLEPFSADVWVMMFVMLLIVSAVAVFVFEYFSPVGYNRCLADGREPGGPSF
TIGKAIWLLWGLVFNNSVPVQNPKGTTSKIMVSVWAFFAVIFLASYTANLAAFMIQEEYV
DQVSGLSDKKFQRPNDFSPPFRFGTVPNGSTERNIRNNYAEMHAYMGKFNQRGVDDALLS
LKTGKLDAFIYDAAVLNYMAGRDEGCKLVTIGSGKVFASTGYGIAIQKDSGWKRQVDLAI
LQLFGDGEMEELEALWLTGICHNEKNEVMSSQLDIDNMAGVFYMLGAAMALSLITFICEH
LFYWQFRHCFMGVCSGKPGMVFSISRGIYSCIHGVAIEERQSVMNSPTATMNNTHSNILR
LLRTAKNMANLSGVNGSPQSALDFIRRESSVYDISEHRRSFTHSDCKSYNNPPCEENLFS
DYISEVERTFGNLQLKDSNVYQDHYHHHHRPHSIGSASSIDGLYDCDNPPFTTQSRSISK
KPLDIGLPSSKHSQLSDLYGKFSFKSDRYSGHDDLIRSDVSDISTHTVTYGNIEGNAAKR
RKQQYKDSLKKRPASAKSRREFDEIELAYRRRPPRSPDHKRYFRDKEGLRDFYLDQFRTK
ENSPHWEHVDLTDIYKERSDDFKRDSVSGGGPCTNRSHIKHGTGDKHGVVSGVPAPWEKN
LTNVEWEDRSGGNFCRSCPSKLHNYSTTVTGQNSGRQACIRCEACKKAGNLYDISEDNSL
QELDQPAAPVAVTSNASTTKYPQSPTNSKAQKKNRNKLRRQHSYDTFVDLQKEEAALAPR
SVSLKDKGRFMDGSPYAHMFEMSAGESTFANNKSSVPTAGHHHHNNPGGGYMLSKSLYPD
RVTQNPFIPTFGDDQCLLHGSKSYFFRQPTVAGASKARPDFRALVTNKPVVSALHGAVPA
RFQKDICIGNQSNPCVPNNKNPRAFNGSSNGHVYEKLSSIESDV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010289|Glutamate receptor ionotropic, NMDA 2B (GRIN2B)
ATGAAGCCCAGAGCGGAGTGCTGTTCTCCCAAGTTCTGGTTGGTGTTGGCCGTCCTGGCC
GTGTCAGGCAGCAGAGCTCGTTCTCAGAAGAGCCCCCCCAGCATTGGCATTGCTGTCATC
CTCGTGGGCACTTCCGACGAGGTGGCCATCAAGGATGCCCACGAGAAAGATGATTTCCAC
CATCTCTCCGTGGTACCCCGGGTGGAACTGGTAGCCATGAATGAGACCGACCCAAAGAGC
ATCATCACCCGCATCTGTGATCTCATGTCTGACCGGAAGATCCAGGGGGTGGTGTTTGCT
GATGACACAGACCAGGAAGCCATCGCCCAGATCCTCGATTTCATTTCAGCACAGACTCTC
ACCCCCATCCTGGGCATCCACGGGGGCTCCTCTATGATAATGGCAGATAAGGATGAATCC
TCCATGTTCTTCCAGTTTGGCCCATCAATTGAACAGCAAGCTTCCGTAATGCTCAACATC
ATGGAAGAATATGACTGGTACATCTTTTCTATCGTCACCACCTATTTCCCTGGCTACCAG
GACTTTGTAAACAAGATCCGCAGCACCATTGAGAATAGCTTTGTGGGCTGGGAGCTAGAG
GAGGTCCTCCTACTGGACATGTCCCTGGACGATGGAGATTCTAAGATCCAGAATCAGCTC
AAGAAACTTCAAAGCCCCATCATTCTTCTTTACTGTACCAAGGAAGAAGCCACCTACATC
TTTGAAGTGGCCAACTCAGTAGGGCTGACTGGCTATGGCTACACGTGGATCGTGCCCAGT
CTGGTGGCAGGGGATACAGACACAGTGCCTGCGGAGTTCCCCACTGGGCTCATCTCTGTA
TCATATGATGAATGGGACTATGGCCTCCCCGCCAGAGTGAGAGATGGAATTGCCATAATC
ACCACTGCTGCTTCTGACATGCTGTCTGAGCACAGCTTCATCCCTGAGCCCAAAAGCAGT
TGTTACAACACCCACGAGAAGAGAATCTACCAGTCCAATATGCTAAATAGGTATCTGATC
AATGTCACTTTTGAGGGGAGGAATTTGTCCTTCAGTGAAGATGGCTACCAGATGCACCCG
AAACTGGTGATAATTCTTCTGAACAAGGAGAGGAAGTGGGAAAGGGTGGGGAAGTGGAAA
GACAAGTCCCTGCAGATGAAGTACTATGTGTGGCCCCGAATGTGTCCAGAGACTGAAGAG
CAGGAGGATGACCATCTGAGCATTGTGACCCTGGAGGAGGCACCATTTGTCATTGTGGAA
AGTGTGGACCCTCTGAGTGGAACCTGCATGAGGAACACAGTCCCCTGCCAAAAACGCATA
GTCACTGAGAATAAAACAGACGAGGAGCCGGGTTACATCAAAAAATGCTGCAAGGGGTTC
TGTATTGACATCCTTAAGAAAATTTCTAAATCTGTGAAGTTCACCTATGACCTTTACCTG
GTTACCAATGGCAAGCATGGGAAGAAAATCAATGGAACCTGGAATGGTATGATTGGAGAG
GTGGTCATGAAGAGGGCCTACATGGCAGTGGGCTCACTCACCATCAATGAGGAACGATCG
GAGGTGGTCGACTTCTCTGTGCCCTTCATAGAGACAGGCATCAGTGTCATGGTGTCACGC
AGCAATGGGACTGTCTCACCTTCTGCCTTCTTAGAGCCATTCAGCGCTGACGTATGGGTG
ATGATGTTTGTGATGCTGCTCATCGTCTCAGCCGTGGCTGTCTTTGTCTTTGAGTACTTC
AGCCCTGTGGGTTATAACAGGTGCCTCGCTGATGGCAGAGAGCCTGGTGGACCCTCTTTC
ACCATCGGCAAAGCTATTTGGTTGCTCTGGGGTCTGGTGTTTAACAACTCCGTACCTGTG
CAGAACCCAAAGGGGACCACCTCCAAGATCATGGTGTCAGTGTGGGCCTTCTTTGCTGTC
ATCTTCCTGGCCAGCTACACTGCCAACTTAGCTGCCTTCATGATCCAAGAGGAATATGTG
GACCAGGTTTCTGGCCTGAGCGACAAAAAGTTCCAGAGACCTAATGACTTCTCACCCCCT
TTCCGCTTTGGGACCGTGCCCAACGGCAGCACAGAGAGAAATATTCGCAATAACTATGCA
GAAATGCATGCCTACATGGGAAAGTTCAACCAGAGGGGTGTAGATGATGCATTGCTCTCC
CTGAAAACAGGGAAACTGGATGCCTTCATCTATGATGCAGCAGTGCTGAACTATATGGCA
GGCAGAGATGAAGGCTGCAAGCTGGTGACCATTGGCAGTGGGAAGGTCTTTGCTTCCACT
GGCTATGGCATTGCCATCCAAAAAGATTCTGGGTGGAAGCGCCAGGTGGACCTTGCTATC
CTGCAGCTCTTTGGAGATGGGGAGATGGAAGAACTGGAAGCTCTCTGGCTCACTGGCATT
TGTCACAATGAGAAGAATGAGGTCATGAGCAGCCAGCTGGACATTGACAACATGGCAGGG
GTCTTCTACATGTTGGGGGCGGCCATGGCTCTCAGCCTCATCACCTTCATCTGCGAACAC
CTTTTCTATTGGCAGTTCCGACATTGCTTTATGGGTGTCTGTTCTGGCAAGCCTGGCATG
GTCTTCTCCATCAGCAGAGGTATCTACAGCTGCATCCATGGGGTGGCGATCGAGGAGCGC
CAGTCTGTAATGAACTCCCCCACCGCAACCATGAACAACACACACTCCAACATCCTGCGC
CTGCTGCGCACGGCCAAGAACATGGCTAACCTGTCTGGTGTGAATGGCTCACCGCAGAGC
GCCCTGGACTTCATCCGACGGGAGTCATCCGTCTATGACATCTCAGAGCACCGCCGCAGC
TTCACGCATTCTGACTGCAAATCCTACAACAACCCGCCCTGTGAGGAGAACCTCTTCAGT
GACTACATCAGTGAGGTAGAGAGAACGTTCGGGAACCTGCAGCTGAAGGACAGCAACGTG
TACCAAGATCACTACCACCATCACCACCGGCCCCATAGTATTGGCAGTGCCAGCTCCATC
GATGGGCTCTACGACTGTGACAACCCACCCTTCACCACCCAGTCCAGGTCCATCAGCAAG
AAGCCCCTGGACATCGGCCTCCCCTCCTCCAAGCACAGCCAGCTCAGTGACCTGTACGGC
AAATTCTCCTTCAAGAGCGACCGCTACAGTGGCCACGACGACTTGATCCGCTCCGATGTC
TCTGACATCTCAACCCACACCGTCACCTATGGGAACATCGAGGGCAATGCCGCCAAGAGG
CGTAAGCAGCAATATAAGGACAGCCTGAAGAAGCGGCCTGCCTCGGCCAAGTCCCGCAGG
GAGTTTGACGAGATCGAGCTGGCCTACCGTCGCCGACCGCCCCGCTCCCCTGACCACAAG
CGCTACTTCAGGGACAAGGAAGGGCTACGGGACTTCTACCTGGACCAGTTCCGAACAAAG
GAGAACTCACCCCACTGGGAGCACGTAGACCTGACCGACATCTACAAGGAGCGGAGTGAT
GACTTTAAGCGCGACTCCGTCAGCGGAGGAGGGCCCTGTACCAACAGGTCTCACATCAAG
CACGGGACGGGCGACAAACACGGCGTGGTCAGCGGGGTACCTGCACCTTGGGAGAAGAAC
CTGACCAACGTGGAGTGGGAGGACCGGTCCGGGGGCAACTTCTGCCGCAGCTGTCCCTCC
AAGCTGCACAACTACTCCACGACGGTGACGGGTCAGAACTCGGGCAGGCAGGCGTGCATC
CGGTGTGAGGCTTGCAAGAAAGCAGGCAACCTGTATGACATCAGTGAGGACAACTCCCTG
CAGGAACTGGACCAGCCGGCTGCCCCAGTGGCGGTGACGTCAAACGCCTCCACCACTAAG
TACCCTCAGAGCCCGACTAATTCCAAGGCCCAGAAGAAGAACCGGAACAAACTGCGCCGG
CAGCACTCCTACGACACCTTCGTGGACCTGCAGAAGGAAGAAGCCGCCCTGGCCCCGCGC
AGCGTAAGCCTGAAAGACAAGGGCCGATTCATGGATGGGAGCCCCTACGCCCACATGTTT
GAGATGTCAGCTGGCGAGAGCACCTTTGCCAACAACAAGTCCTCAGTGCCCACTGCCGGA
CATCACCACCACAACAACCCCGGCGGCGGGTACATGCTCAGCAAGTCGCTCTACCCTGAC
CGGGTCACGCAAAACCCTTTCATCCCCACTTTTGGGGACGACCAGTGCTTGCTCCATGGC
AGCAAATCCTACTTCTTCAGGCAGCCCACGGTGGCGGGGGCGTCGAAAGCCAGGCCGGAC
TTCCGGGCCCTTGTCACCAACAAGCCGGTGGTCTCGGCCCTTCATGGGGCCGTGCCAGCC
CGTTTCCAGAAGGACATCTGTATAGGGAACCAGTCCAACCCCTGTGTGCCTAACAACAAA
AACCCCAGGGCTTTCAATGGCTCCAGCAATGGGCATGTTTATGAGAAACTTTCTAGTATT
GAGTCTGATGTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
      <pfam>
        <identifier>PF10565</identifier>
        <name>NMDAR2_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral response to pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>startle response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular endothelial growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>suckling behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral fear response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>learning</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small GTPase mediated signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>detection of mechanical stimulus involved in sensory perception of pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>learning or memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term synaptic potentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ephrin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of protein kinase A signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>in utero embryonic development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory organ development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Ras protein signal transduction</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000454</id>
      <name>Glutamate receptor ionotropic, NMDA 2C</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>7905294</pubmed-id>
            <citation>Kuner T, Schoepfer R, Korpi ER: Ethanol inhibits glutamate-induced currents in heteromeric NMDA receptor subtypes. Neuroreport. 1993 Dec 13;5(3):297-300.</citation>
          </article>
          <article>
            <pubmed-id>10455281</pubmed-id>
            <citation>Olmos G, DeGregorio-Rocasolano N, Paz Regalado M, Gasull T, Assumpcio Boronat M, Trullas R, Villarroel A, Lerma J, Garcia-Sevilla JA: Protection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor. Br J Pharmacol. 1999 Jul;127(6):1317-26.</citation>
          </article>
          <article>
            <pubmed-id>9417820</pubmed-id>
            <citation>Sundstrom E, Whittemore S, Mo LL, Seiger A: Analysis of NMDA receptors in the human spinal cord. Exp Neurol. 1997 Dec;148(2):407-13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q14957" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 2C</name>
    <general-function>Nmda glutamate receptor activity</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with high calcium permeability and voltage-dependent sensitivity to magnesium. Mediated by glycine.</specific-function>
    <gene-name>GRIN2C</gene-name>
    <locus>17q25</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>554-574
627-647
815-835</transmembrane-regions>
    <signal-regions>1-19</signal-regions>
    <theoretical-pi>8.61</theoretical-pi>
    <molecular-weight>134207.77</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4587</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN2C</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L76224</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1196449</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>458</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q14957</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMDE3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN2C</synonym>
      <synonym>Glutamate [NMDA] receptor subunit epsilon-3</synonym>
      <synonym>N-methyl D-aspartate receptor subtype 2C</synonym>
      <synonym>NMDAR2C</synonym>
      <synonym>NR2C</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010317|Glutamate receptor ionotropic, NMDA 2C
MGGALGPALLLTSLFGAWAGLGPGQGEQGMTVAVVFSSSGPPQAQFRARLTPQSFLDLPL
EIQPLTVGVNTTNPSSLLTQICGLLGAAHVHGIVFEDNVDTEAVAQILDFISSQTHVPIL
SISGGSAVVLTPKEPGSAFLQLGVSLEQQLQVLFKVLEEYDWSAFAVITSLHPGHALFLE
GVRAVADASHVSWRLLDVVTLELGPGGPRARTQRLLRQLDAPVFVAYCSREEAEVLFAEA
AQAGLVGPGHVWLVPNLALGSTDAPPATFPVGLISVVTESWRLSLRQKVRDGVAILALGA
HSYWRQHGTLPAPAGDCRVHPGPVSPAREAFYRHLLNVTWEGRDFSFSPGGYLVQPTMVV
IALNRHRLWEMVGRWEHGVLYMKYPVWPRYSASLQPVVDSRHLTVATLEERPFVIVESPD
PGTGGCVPNTVPCRRQSNHTFSSGDVAPYTKLCCKGFCIDILKKLARVVKFSYDLYLVTN
GKHGKRVRGVWNGMIGEVYYKRADMAIGSLTINEERSEIVDFSVPFVETGISVMVARSNG
TVSPSAFLEPYSPAVWVMMFVMCLTVVAITVFMFEYFSPVSYNQNLTRGKKSGGPAFTIG
KSVWLLWALVFNNSVPIENPRGTTSKIMVLVWAFFAVIFLASYTANLAAFMIQEQYIDTV
SGLSDKKFQRPQDQYPPFRFGTVPNGSTERNIRSNYRDMHTHMVKFNQRSVEDALTSLKM
GKLDAFIYDAAVLNYMAGKDEGCKLVTIGSGKVFATTGYGIAMQKDSHWKRAIDLALLQF
LGDGETQKLETVWLSGICQNEKNEVMSSKLDIDNMAGVFYMLLVAMGLALLVFAWEHLVY
WKLRHSVPNSSQLDFLLAFSRGIYSCFSGVQSLASPPRQASPDLTASSAQASVLKMLQAA
RDMVTTAGVSSSLDRATRTIENWGGGRRAPPPSPCPTPRSGPSPCLPTPDPPPEPSPTGW
GPPDGGRAALVRRAPQPPGRPPTPGPPLSDVSRVSRRPAWEARWPVRTGHCGRHLSASER
PLSPARCHYSSFPRADRSGRPFLPLFPELEDLPLLGPEQLARREALLHAAWARGSRPRHA
SLPSSVAEAFARPSSLPAGCTGPACARPDGHSACRRLAQAQSMCLPIYREACQEGEQAGA
PAWQHRQHVCLHAHAHLPFCWGAVCPHLPPCASHGSWLSGAWGPLGHRGRTLGLGTGYRD
SGGLDEISRVARGTQGFPGPCTWRRISSLESEV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010318|Glutamate receptor ionotropic, NMDA 2C (GRIN2C)
ATGGGTGGGGCCCTGGGGCCGGCCCTGTTGCTCACCTCGCTCTTCGGTGCCTGGGCAGGG
CTGGGTCCGGGGCAGGGCGAGCAGGGCATGACGGTGGCCGTGGTGTTTAGCAGCTCAGGG
CCGCCCCAGGCCCAGTTCCGTGCCCGCCTCACCCCCCAGAGCTTCCTGGACCTACCCCTG
GAGATCCAGCCGCTCACAGTTGGGGTCAACACCACCAACCCCAGCAGCCTCCTCACCCAG
ATCTGCGGCCTCCTGGGTGCTGCCCACGTCCACGGCATTGTCTTTGAGGACAACGTGGAC
ACCGAGGCGGTGGCCCAGATCCTTGACTTCATCTCCTCCCAGACCCATGTGCCCATCCTC
AGCATCAGCGGAGGCTCTGCTGTGGTCCTCACCCCCAAGGAGCCGGGCTCCGCCTTCCTG
CAGCTGGGCGTGTCCCTGGAGCAGCAGCTGCAGGTGCTGTTCAAGGTGCTGGAAGAGTAC
GACTGGAGCGCCTTCGCCGTCATCACCAGCCTGCACCCGGGCCACGCGCTCTTCCTGGAG
GGCGTGCGCGCCGTCGCCGACGCCAGCCACGTGAGTTGGCGGCTGCTGGACGTGGTCACG
CTGGAGCTGGGCCCGGGAGGGCCGCGCGCGCGCACGCAGCGCCTGCTGCGCCAGCTCGAC
GCGCCCGTGTTTGTGGCCTACTGCTCGCGCGAGGAGGCCGAGGTGCTCTTCGCCGAGGCG
GCGCAGGCCGGTCTGGTGGGGCCCGGCCACGTGTGGCTGGTGCCCAACCTGGCGCTGGGC
AGCACCGATGCGCCCCCCGCCACCTTCCCCGTGGGCCTCATCAGCGTCGTCACCGAGAGC
TGGCGCCTCAGCCTGCGCCAGAAGGTGCGCGACGGCGTGGCCATTCTGGCCCTGGGCGCC
CACAGCTACTGGCGCCAGCATGGAACCCTGCCAGCCCCGGCCGGGGACTGCCGTGTTCAC
CCTGGGCCCGTCAGCCCTGCCCGGGAGGCCTTCTACAGGCACCTACTGAATGTCACCTGG
GAGGGCCGAGACTTCTCCTTCAGCCCTGGTGGGTACCTGGTCCAGCCCACCATGGTGGTG
ATCGCCCTCAACCGGCACCGCCTCTGGGAGATGGTGGGGCGCTGGGAGCATGGCGTCCTA
TACATGAAGTACCCCGTGTGGCCTCGCTACAGTGCCTCTCTGCAGCCTGTGGTGGACAGT
CGGCACCTGACGGTGGCCACGCTGGAAGAGCGGCCCTTTGTCATCGTGGAGAGCCCTGAC
CCTGGCACAGGAGGCTGTGTCCCCAACACCGTGCCCTGCCGCAGGCAGAGCAACCACACC
TTCAGCAGCGGGGACGTGGCCCCCTACACCAAGCTCTGCTGTAAGGGATTCTGCATCGAC
ATCCTCAAGAAGCTGGCCAGAGTGGTCAAATTCTCCTACGACCTGTACCTGGTGACCAAC
GGCAAGCATGGCAAGCGGGTGCGCGGCGTATGGAACGGCATGATTGGGGAGGTGTACTAC
AAGCGGGCAGACATGGCCATCGGCTCCCTCACCATCAATGAGGAACGCTCCGAGATCGTA
GACTTCTCTGTACCCTTTGTGGAGACGGGCATCAGTGTGATGGTGGCTCGCAGCAATGGC
ACCGTCTCCCCCTCGGCCTTCTTGGAGCCATATAGCCCTGCAGTGTGGGTGATGATGTTT
GTCATGTGCCTCACTGTGGTGGCCATCACCGTCTTCATGTTCGAGTACTTCAGCCCTGTC
AGCTACAACCAGAACCTCACCAGAGGCAAGAAGTCCGGGGGCCCAGCTTTCACTATCGGC
AAGTCCGTGTGGCTGCTGTGGGCGCTGGTCTTCAACAACTCAGTGCCCATCGAGAACCCG
CGGGGCACCACCAGCAAGATCATGGTTCTGGTCTGGGCCTTCTTTGCTGTCATCTTCCTC
GCCAGCTACACGGCCAACCTGGCCGCCTTCATGATCCAAGAGCAATACATCGACACTGTG
TCGGGCCTCAGTGACAAGAAGTTTCAGCGGCCTCAAGATCAGTACCCACCTTTCCGCTTC
GGCACGGTGCCCAACGGCAGCACGGAGCGGAACATCCGCAGTAACTACCGTGACATGCAC
ACCCACATGGTCAAGTTCAACCAGCGCTCGGTGGAGGACGCGCTCACCAGCCTCAAGATG
GGGAAGCTGGATGCCTTCATCTATGATGCTGCTGTCCTCAACTACATGGCAGGCAAGGAC
GAGGGCTGCAAGCTGGTCACCATTGGGTCTGGCAAGGTCTTTGCTACCACTGGCTACGGC
ATCGCCATGCAGAAGGACTCCCACTGGAAGCGGGCCATAGACCTGGCGCTCTTGCAGTTC
CTGGGGGACGGAGAGACACAGAAACTGGAGACAGTGTGGCTCTCAGGGATCTGCCAGAAT
GAGAAGAACGAGGTGATGAGCAGCAAGCTGGACATCGACAACATGGCAGGCGTCTTCTAC
ATGCTGCTGGTGGCCATGGGGCTGGCCCTGCTGGTCTTCGCCTGGGAGCACCTGGTCTAC
TGGAAGCTGCGCCACTCGGTGCCCAACTCATCCCAGCTGGACTTCCTGCTGGCTTTCAGC
AGGGGCATCTACAGCTGCTTCAGCGGGGTGCAGAGCCTCGCCAGCCCACCGCGGCAGGCC
AGCCCGGACCTCACGGCCAGCTCGGCCCAGGCCAGCGTGCTCAAGATGCTGCAGGCAGCC
CGCGACATGGTGACCACGGCGGGCGTAAGCAGCTCCCTGGACCGCGCCACTCGCACCATC
GAGAATTGGGGTGGCGGCCGCCGTGCGCCCCCACCGTCCCCCTGCCCGACCCCGCGGTCT
GGCCCCAGCCCATGCCTGCCCACCCCCGACCCGCCCCCAGAGCCGAGCCCCACGGGCTGG
GGACCGCCAGACGGGGGTCGCGCGGCGCTTGTGCGCAGGGCTCCGCAGCCCCCGGGCCGC
CCCCCGACGCCGGGGCCGCCCCTGTCCGACGTCTCCCGAGTGTCGCGCCGCCCAGCCTGG
GAGGCGCGGTGGCCGGTGCGGACCGGGCACTGCGGGAGGCACCTCTCGGCCTCCGAGCGG
CCCCTGTCGCCCGCGCGCTGTCACTACAGCTCCTTTCCTCGAGCCGACCGATCCGGCCGC
CCCTTCCTCCCGCTCTTCCCGGAGCTGGAGGACCTGCCGCTGCTCGGTCCGGAGCAGCTG
GCCCGGCGGGAGGCCCTGCTGCACGCGGCCTGGGCCCGGGGCTCGCGCCCGCGTCACGCT
TCCCTGCCCAGCTCCGTGGCCGAGGCCTTCGCTCGGCCCAGCTCGCTGCCCGCTGGGTGC
ACCGGCCCCGCCTGCGCCCGCCCCGACGGCCACTCGGCCTGCAGGCGCTTGGCGCAGGCG
CAGTCGATGTGCTTGCCGATCTACCGGGAGGCCTGCCAGGAGGGCGAGCAGGCAGGGGCC
CCCGCCTGGCAGCACAGACAGCACGTCTGCCTGCACGCCCACGCCCACCTGCCATTTTGC
TGGGGGGCTGTCTGTCCTCACCTTCCACCCTGTGCCAGCCACGGCTCCTGGCTCTCCGGG
GCCTGGGGGCCTCTGGGGCACAGGGGCAGGACTCTGGGGCTGGGCACAGGCTACAGAGAC
AGTGGGGGACTGGACGAGATCAGCAGGGTAGCCCGTGGGACGCAAGGCTTCCCGGGACCC
TGCACCTGGAGACGGATCTCCAGTCTGGAGTCAGAAGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
      <pfam>
        <identifier>PF10565</identifier>
        <name>NMDAR2_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cation channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Fc-epsilon receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of protein catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>activation of MAPKK activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neuromuscular process controlling balance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fibroblast growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>insulin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein localization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small GTPase mediated signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotrophin TRK receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Ras protein signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vascular endothelial growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>innate immune response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to wounding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>directional locomotion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002152</id>
      <name>Aspartate aminotransferase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q2TU84" source="TrEMBL">
    <name>Aspartate aminotransferase</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function/>
    <gene-name>GIG18</gene-name>
    <locus/>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.8</theoretical-pi>
    <molecular-weight>46319.2</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GIG18</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY513279</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>46981967</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q2TU84</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>Q2TU84_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0021983|Aspartate aminotransferase
MAPPSVFAEVPQAQPVLVFKLTADFREDPDPRKVNLGVGAYRTDDCHPWVLPVVKKVEQK
IANDNSLNHEYLPILGLAEFRSCASRLALEDDSPALKEKRVGGVQSLGGTGALRIGADFL
ARWYNGTNNKNTPVYVSSPTWENHNAVFSAAGFKDIRSYRYWDAEKRGLDLQGFLNDLEN
APEFSIVVLHACAHNPTGIDPTPEQWKQIASVMKHRFLFPFFDSAYQGFASGNLERDAWA
IRYFVSEGFEFFCAQSFSKNFGLYNERVGNLTVVGKEPESILQVLSQMEKIVRITWSNPP
AQGARIVASTLSNPELFEEWTGNVKTMADRILTMRSELRARLEALKTPGTWNHITDQIGM
FSFTGLNPKQVEYLVNEKHIYLLPSGRINVSGLTTKNLDYVATSIHEAVTKIQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0004221|1242 bp
ATGGCACCTCCGTCAGTCTTTGCCGAGGTTCCGCAGGCCCAGCCTGTCCTGGTCTTCAAG
CTCACTGCCGACTTCAGGGAGGATCCGGACCCCCGCAAGGTCAACCTGGGAGTGGGAGCA
TATCGCACGGATGACTGCCATCCCTGGGTTTTGCCAGTAGTGAAGAAAGTGGAGCAGAAG
ATTGCTAATGACAATAGCCTAAATCACGAGTATCTGCCAATCCTGGGCCTGGCTGAGTTC
CGGAGCTGTGCTTCTCGTCTTGCCCTTGAGGATGACAGCCCAGCACTCAAGGAGAAGCGG
GTAGGAGGTGTGCAATCTTTGGGGGGAACAGGTGCACTTCGAATTGGAGCTGATTTCTTA
GCGCGTTGGTACAATGGAACAAACAACAAGAACACACCTGTCTATGTGTCCTCACCAACC
TGGGAGAATCACAATGCTGTGTTTTCCGCTGCTGGTTTTAAAGACATTCGGTCCTATCGC
TACTGGGATGCAGAGAAGAGAGGATTGGACCTCCAGGGCTTCCTGAATGATCTGGAGAAT
GCTCCTGAGTTCTCCATTGTTGTCCTCCACGCCTGTGCACACAACCCAACTGGGATTGAC
CCAACTCCGGAGCAGTGGAAGCAGATTGCTTCTGTCATGAAGCACCGGTTTCTGTTCCCC
TTCTTTGACTCAGCCTATCAGGGCTTCGCATCTGGAAACCTGGAGAGAGATGCCTGGGCC
ATTCGCTATTTTGTGTCTGAAGGCTTCGAGTTCTTCTGTGCCCAGTCCTTCTCCAAGAAC
TTCGGGCTCTACAATGAGAGAGTCGGGAATCTGACTGTGGTTGGAAAAGAACCTGAGAGC
ATCCTGCAAGTCCTTTCCCAGATGGAGAAGATCGTGCGGATTACTTGGTCCAATCCCCCC
GCCCAGGGAGCACGAATTGTGGCCAGCACCCTCTCTAACCCTGAGCTCTTTGAGGAATGG
ACAGGTAATGTGAAGACAATGGCTGACCGGATTCTGACCATGAGATCTGAACTCAGGGCA
CGACTAGAAGCCCTCAAAACCCCTGGGACCTGGAACCACATCACTGATCAAATTGGCATG
TTCAGCTTCACTGGGTTGAACCCCAAGCAGGTTGAGTATCTGGTCAATGAAAAGCACATC
TACCTGCTGCCAAGTGGTCGAATCAACGTGAGTGGCTTAACCACCAAAAATCTAGATTAC
GTGGCCACCTCCATCCATGAAGCAGTCACCAAAATCCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-aspartate</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-phenylalanine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002272</id>
      <name>Probable glutamate--tRNA ligase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17161369</pubmed-id>
            <citation>Sekine S, Shichiri M, Bernier S, Chenevert R, Lapointe J, Yokoyama S: Structural bases of transfer RNA-dependent amino acid recognition and activation by glutamyl-tRNA synthetase. Structure. 2006 Dec;14(12):1791-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q5JPH6" source="Swiss-Prot">
    <name>Probable glutamate--tRNA ligase, mitochondrial</name>
    <general-function>Trna binding</general-function>
    <specific-function>Catalyzes the attachment of glutamate to tRNA(Glu) in a two-step reaction: glutamate is first activated by ATP to form Glu-AMP and then transferred to the acceptor end of tRNA(Glu).</specific-function>
    <gene-name>EARS2</gene-name>
    <locus>16p12.1</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.98</theoretical-pi>
    <molecular-weight>58688.1</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:29419</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>EARS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AL832489</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>57997136</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q5JPH6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SYEM_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.1.1.17</synonym>
      <synonym>GluRS</synonym>
      <synonym>Glutamyl-tRNA synthetase</synonym>
      <synonym>KIAA1970</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004460|Probable glutamate--tRNA ligase, mitochondrial
MAALLRRLLQRERPSAASGRPVGRREANLGTDAGVAVRVRFAPSPTGFLHLGGLRTALYN
YIFAKKYQGSFILRLEDTDQTRVVPGAAENIEDMLEWAGIPPDESPRRGGPAGPYQQSQR
LELYAQATEALLKTGAAYPCFCSPQRLELLKKEALRNHQTPRYDNRCRNMSQEQVAQKLA
KDPKPAIRFRLEQVVPAFQDLVYGWNRHEVASVEGDPVIMKSDGFPTYHLACVVDDHHMG
ISHVLRGSEWLVSTAKHLLLYQALGWQPPHFAHLPLLLNRDGSKLSKRQGDVFLEHFAAD
GFLPDSLLDIITNCGSGFAENQMGRTLPELITQFNLTQVTCHSALLDLEKLPEFNRLHLQ
RLVSNESQRRQLVGKLQVLVEEAFGCQLQNRDVLNPVYVERILLLRQGHICRLQDLVSPV
YSYLWTRPAVGRAQLDAISEKVDVIAKRVLGLLERSSMSLTQDMLNGELKKLSEGLEGTK
YSNVMKLLRMALSGQQQGPPVAEMMLALGPKEVRERIQKVVSS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016736|Probable glutamate--tRNA ligase, mitochondrial (EARS2)
ATGGCGGCGCTCCTGAGGAGACTGCTGCAGCGCGAGAGGCCTTCGGCGGCCTCTGGCCGC
CCCGTAGGACGGCGCGAGGCCAACCTGGGCACTGATGCCGGGGTTGCGGTGCGAGTGCGG
TTCGCTCCCAGCCCCACAGGCTTCTTGCACCTGGGTGGCCTCCGCACTGCCTTGTACAAC
TACATCTTTGCTAAGAAGTACCAGGGGAGCTTCATCCTGAGGCTAGAGGACACAGATCAG
ACTCGCGTTGTGCCTGGGGCAGCGGAGAATATTGAGGACATGCTGGAGTGGGCAGGCATC
CCGCCTGATGAGAGCCCCCGCCGGGGCGGTCCTGCTGGGCCCTACCAGCAATCTCAGCGG
TTGGAGCTGTATGCCCAGGCCACAGAAGCGCTGCTGAAGACCGGAGCTGCTTACCCCTGT
TTCTGCTCACCCCAGCGGCTGGAGCTCCTGAAGAAGGAGGCCTTGCGGAACCACCAGACG
CCCCGGTATGACAATCGGTGCAGGAACATGAGCCAGGAGCAGGTGGCCCAGAAGCTGGCC
AAGGACCCCAAGCCTGCGATCCGCTTCCGCCTGGAGCAGGTGGTGCCAGCCTTCCAGGAC
CTGGTCTATGGCTGGAATAGGCATGAAGTGGCCAGCGTGGAGGGAGACCCAGTCATCATG
AAGAGCGACGGCTTCCCCACATACCACCTGGCCTGCGTGGTGGACGACCACCACATGGGC
ATCAGCCACGTGCTGCGAGGCTCTGAGTGGCTCGTCTCCACTGCCAAGCACCTGCTCCTC
TACCAGGCCCTGGGCTGGCAGCCACCCCACTTCGCCCACCTGCCCCTGCTCCTCAACAGG
GATGGCAGCAAGCTCTCCAAGAGGCAAGGGGACGTTTTCCTGGAGCACTTTGCTGCTGAT
GGCTTCCTGCCCGATTCCTTGTTGGACATCATCACCAACTGTGGCTCAGGTTTTGCAGAG
AACCAAATGGGCAGGACCCTGCCGGAGCTGATCACACAGTTCAACCTGACACAGGTCACC
TGTCACTCAGCCCTGCTGGACCTGGAGAAGCTCCCAGAATTCAACAGACTGCACCTCCAG
CGGCTGGTGAGCAATGAGAGCCAGAGGCGCCAGCTGGTGGGGAAGCTGCAGGTCCTTGTG
GAGGAGGCCTTTGGTTGCCAGCTGCAAAACAGGGATGTCCTCAACCCAGTCTACGTGGAG
AGGATCCTCCTGCTGAGACAGGGTCACATTTGCCGCCTGCAGGACTTGGTGTCCCCAGTA
TACTCTTACCTGTGGACTCGCCCTGCAGTAGGTCGAGCACAGCTGGACGCCATCTCGGAG
AAGGTGGATGTGATTGCCAAGCGTGTGCTGGGGCTTCTAGAAAGATCTAGTATGAGCTTA
ACTCAGGATATGCTGAATGGAGAACTGAAGAAGCTATCAGAAGGTCTGGAAGGCACCAAG
TACAGTAATGTGATGAAACTCCTTCGGATGGCCCTCAGTGGACAGCAGCAAGGACCTCCT
GTAGCTGAGATGATGTTGGCCTTGGGACCAAAGGAAGTACGGGAACGGATCCAGAAGGTG
GTTTCCAGCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00749</identifier>
        <name>tRNA-synt_1c</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-tRNA ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tRNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-tRNA(Gln) ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for protein translation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamyl-tRNA aminoacylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tRNA aminoacylation for mitochondrial protein translation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002273</id>
      <name>Lengsin</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q5TDP6" source="Swiss-Prot">
    <name>Lengsin</name>
    <general-function>Glutamate-ammonia ligase activity</general-function>
    <specific-function>May act as a component of the cytoskeleton or as a chaperone for the reorganization of intermediate filament proteins during terminal differentiation in the lens. Does not seem to have enzymatic activity (By similarity).</specific-function>
    <gene-name>LGSN</gene-name>
    <locus>6pter-q22.33</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.3</theoretical-pi>
    <molecular-weight>57277.46</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:21016</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLULD1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF242388</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>7341339</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q5TDP6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>LGSN_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GLULD1</synonym>
      <synonym>Glutamate-ammonia ligase domain-containing protein 1</synonym>
      <synonym>Lens glutamine synthase-like</synonym>
      <synonym>LGS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004462|Lengsin
MNNEEDLLQEDSTRDEGNETEANSMNTLRRTRKKVTKPYVCSTEVGETDMSNSNDCMRDS
SQILTPPQLSSRMKHIRQAMAKNRLQFVRFEATDLHGVSRSKTIPAHFFQEKVSHGVCMP
RGYLEVIPNPKDNEMNNIRATCFNSDIVLMPELSTFRVLPWADRTARVICDTFTVTGEPL
LTSPRYIAKRQLSHLQASGFSLLSAFIYDFCIFGVPEILNSKIISFPALTFLNNHDQPFM
QELVDGLYHTGANVESFSSSTRPGQMEISFLPEFGISSADNAFTLRTGVKEVARKYNYIA
SFFIETGFCDSGILSHSLWDVDRKKNMFCSTSGTEQLTITGKKWLAGLLKHSAALSCLMA
PSVSCRKRYSKDRKDLKKSVPTTWGYNDNSCIFNIKCHGEKGTRIENKLGSATANPYLVL
AATVAAGLDGLHSSNEVLAGPDESTDFYQVEPSEIPLKLEDALVALEEDQCLRQALGETF
IRYFVAMKKYELENEEIAAERNKFLEYFI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016738|Lengsin (LGSN)
ATGAATAATGAAGAGGACCTTCTGCAGGAGGACTCAACAAGAGATGAAGGCAATGAGACT
GAAGCCAACAGCATGAACACATTAAGAAGGACAAGGAAGAAAGTCACTAAACCATATGTT
TGTTCAACTGAAGTGGGAGAAACGGATATGTCCAATTCAAATGATTGCATGAGGGACAGC
AGTCAAATTTTGACCCCACCTCAACTCTCTTCTAGAATGAAACACATTAGACAAGCCATG
GCCAAAAATCGCCTCCAGTTTGTACGATTTGAAGCAACAGACCTCCACGGCGTGTCCAGG
TCTAAGACTATCCCTGCACACTTTTTTCAAGAGAAAGTGAGCCATGGTGTTTGCATGCCC
CGAGGTTATCTTGAAGTGATACCAAATCCAAAGGACAATGAAATGAATAACATAAGAGCC
ACATGTTTTAATAGCGACATAGTCCTAATGCCAGAGTTATCAACCTTTAGAGTTTTGCCA
TGGGCTGACAGAACTGCAAGAGTGATATGTGATACCTTCACTGTGACTGTCTCTGGGATG
TCGATAGGAAGAAAAACATGTTCTGCAGCACTTCTGGAACTGAGCAGCTCACGATCACTG
GGAAAAAATGGTTGGCAGGACTCTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00120</identifier>
        <name>Gln-synt_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-ammonia ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002244</id>
      <name>Glutamine-dependent NAD(+) synthetase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q6IA69" source="Swiss-Prot">
    <name>Glutamine-dependent NAD(+) synthetase</name>
    <general-function>Nad+ synthase (glutamine-hydrolyzing) activity</general-function>
    <specific-function/>
    <gene-name>NADSYN1</gene-name>
    <locus>11q13.4</locus>
    <cellular-location>Cytoplasmic</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.46</theoretical-pi>
    <molecular-weight>79283.945</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:29832</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NADSYN1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB091316</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>28849201</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q6IA69</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NADE_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.5.1</synonym>
      <synonym>NAD(+) synthase [glutamine-hydrolyzing]</synonym>
      <synonym>NAD(+) synthetase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037179|Glutamine-dependent NAD(+) synthetase
MGRKVTVATCALNQWALDFEGNLQRILKSIEIAKNRGARYRLGPELEICGYGCWDHYYES
DTLLHSFQVLAALVESPVTQDIICDVGMPVMHRNVRYNCRVIFLNRKILLIRPKMALANE
GNYRELRWFTPWSRSRHTEEYFLPRMIQDLTKQETVPFGDAVLVTWDTCIGSEICEELWT
PHSPHIDMGLDGVEIITNASGSHQVLRKANTRVDLVTMVTSKNGGIYLLANQKGCDGDRL
YYDGCAMIAMNGSVFAQGSQFSLDDVEVLTATLDLEDVRSYRAEISSRNLAASRASPYPR
VKVDFALSCHEDLLAPISEPIEWKYHSPEEEISLGPACWLWDFLRRSQQAGFLLPLSGGV
DSAATACLIYSMCCQVCEAVRSGNEEVLADVRTIVNQISYTPQDPRDLCGRILTTCYMAS
KNSSQETCTRARELAQQIGSHHISLNIDPAVKAVMGIFSLVTGKSPLFAAHGGSSRENLA
LQNVQARIRMVLAYLFAQLSLWSRGVHGGLLVLGSANVDESLLGYLTKYDCSSADINPIG
GISKTDLRAFVQFCIQRFQLPALQSILLAPATAELEPLADGQVSQTDEEDMGMTYAELSV
YGKLRKVAKMGPYSMFCKLLGMWRHICTPRQVADKVKRFFSKYSMNRHKMTTLTPAYHAE
NYSPEDNRFDLRPFLYNTSWPWQFRCIENQVLQLERAEPQSLDGVD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020599|Glutamine-dependent NAD(+) synthetase (NADSYN1)
ATGGGCCGGAAGGTGACCGTGGCCACCTGCGCACTCAACCAGTGGGCCCTGGACTTCGAG
GGCAATTTGCAAAGAATTTTAAAGAGTATTGAAATTGCCAAAAACAGAGGAGCAAGATAC
AGGCTTGGACCAGAGCTGGAAATATGCGGCTACGGATGTTGGGATCATTATTACGAGTCG
GACACCCTCTTGCACTCGTTTCAAGTCCTAGCGGCCCTTGTGGAGTCTCCCGTCACTCAG
GACATCATCTGCGACGTGGGGATGCCTGTAATGCACCGAAACGTCCGCTACAACTGCAGA
GTGATATTCCTCAACAGGAAGATCCTGCTCATCAGACCCAAGATGGCCTTGGCCAATGAA
GGCAACTACCGCGAGCTGCGCTGGTTCACCCCGTGGTCGAGGAGTCGGCACACAGAGGAG
TACTTTCTGCCTCGGATGATACAGGACCTGACAAAGCAGGAAACCGTACCCTTCGGAGAT
GCGGTGCTGGTGACATGGGACACCTGCATTGGAAGTGAGATCTGTGAGGAGCTCTGGACA
CCCCACAGCCCGCACATCGACATGGGCCTGGATGGCGTGGAGATCATCACCAACGCCTCG
GGCAGCCACCAAGTGCTGCGCAAAGCCAACACCAGGGTGGATCTCGTGACTATGGTCACC
AGCAAGAACGGTGGGATTTACTTGCTGGCCAACCAGAAGGGTTGTGACGGGGACCGCCTG
TACTACGACGGCTGTGCCATGATTGCCATGAACGGAAGCGTCTTTGCTCAAGGATCCCAG
TTTTCTCTGGATGACGTGGAAGTCCTGACGGCCACGCTGGATCTGGAGGACGTCCGGAGC
TACAGGGCGGAGATTTCATCTCGAAACCTGGCGGCCAGCAGGGCGAGCCCCTACCCCAGA
GTGAAGGTGGACTTTGCCCTCTCGTGCCACGAGGACTTGCTGGCACCCATCTCTGAGCCC
ATCGAGTGGAAATACCACAGCCCTGAGGAGGAGATAAGCCTTGGACCTGCCTGCTGGCTC
TGGGATTTTTTAAGACGAAGTCAACAGGCAGGGTTTTTGCTGCCCTTGAGTGGCGGGGTG
GACAGCGCAGCCACCGCCTGCCTCATCTACTCCATGTGCTGCCAGGTCTGCGAGGCCGTG
AGGAGTGGAAATGAGGAAGTGCTGGCTGATGTCCGCACCATCGTGAACCAGATCAGCTAC
ACCCCCCAGGATCCCCGAGACCTCTGTGGACGCATACTGACCACCTGCTACATGGCCAGC
AAGAACTCCTCCCAGGAGACGTGCACCCGGGCCAGAGAGTTGGCCCAGCAGATTGGAAGC
CACCACATCAGTCTCAACATCGATCCAGCCGTGAAGGCCGTCATGGGCATCTTCAGCCTG
GTGACGGGGAAGAGCCCTCTGTTTGCAGCTCATGGAGGAAGCAGCAGGGAAAACCTGGCG
CTGCAAAATGTGCAGGCTCGAATACGGATGGTCCTCGCCTATCTGTTTGCTCAGTTGAGC
CTCTGGTCTCGGGGTGTCCACGGTGGGCTCCTCGTGCTGGGATCCGCCAACGTGGATGAG
AGTCTCCTGGGCTACCTGACCAAGTACGACTGCTCCAGTGCGGACATCAACCCCATAGGC
GGGATCAGCAAGACGGACCTCAGGGCCTTCGTCCAGTTCTGCATCCAGCGCTTCCAGCTT
CCTGCCCTGCAGAGCATCCTGTTGGCGCCGGCCACCGCAGAGCTGGAGCCCTTGGCTGAT
GGACAGGTGTCCCAGACCGACGAGGAAGATATGGGGATGACATATGCGGAGCTCTCGGTC
TATGGGAAACTCAGGAAGGTGGCCAAGATGGGGCCCTACAGCATGTTCTGCAAACTCCTC
GGCATGTGGAGACACATCTGCACCCCGAGACAGGTCGCTGACAAAGTGAAGCGGTTTTTC
TCCAAGTACTCCATGAACAGACACAAGATGACCACGCTCACACCCGCGTACCACGCCGAG
AACTACAGCCCTGAGGACAACAGGTTTGATCTGCGACCATTTCTGTACAACACAAGCTGG
CCTTGGCAGTTTCGGTGCATAGAAAATCAGGTGCTACAGCTCGAGAGGGCAGAGCCACAG
TCCCTGGACGGCGTGGACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00795</identifier>
        <name>CN_hydrolase</name>
      </pfam>
      <pfam>
        <identifier>PF02540</identifier>
        <name>NAD_synthase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NAD+ synthase (glutamine-hydrolyzing) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>NAD metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>NAD biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002162</id>
      <name>Kynurenine--oxoglutarate transaminase 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q6YP21" source="Swiss-Prot">
    <name>Kynurenine--oxoglutarate transaminase 3</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the irreversible transamination of the L-tryptophan metabolite L-kynurenine to form kynurenic acid (KA). May catalyze the beta-elimination of S-conjugates and Se-conjugates of L-(seleno)cysteine, resulting in the cleavage of the C-S or C-Se bond (By similarity). Has transaminase activity towards L-kynurenine, tryptophan, phenylalanine, serine, cysteine, methionine, histidine, glutamine and asparagine with glyoxylate as an amino group acceptor (in vitro). Has lower activity with 2-oxoglutarate as amino group acceptor (in vitro) (By similarity).</specific-function>
    <gene-name>CCBL2</gene-name>
    <locus>1p22.2</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.34</theoretical-pi>
    <molecular-weight>51399.855</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:33238</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CCBL2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY028624</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>37542047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q6YP21</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>KAT3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.7</synonym>
      <synonym>Cysteine-S-conjugate beta-lyase 2</synonym>
      <synonym>KAT3</synonym>
      <synonym>KATIII</synonym>
      <synonym>Kynurenine aminotransferase III</synonym>
      <synonym>Kynurenine--glyoxylate transaminase</synonym>
      <synonym>Kynurenine--oxoglutarate transaminase III</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004242|Kynurenine--oxoglutarate transaminase 3
MFLAQRSLCSLSGRAKFLKTISSSKILGFSTSAKMSLKFTNAKRIEGLDSNVWIEFTKLA
ADPSVVNLGQGFPDISPPTYVKEELSKIAAIDSLNQYTRGFGHPSLVKALSYLYEKLYQK
QIDSNKEILVTVGAYGSLFNTIQALIDEGDEVILIVPFYDCYEPMVRMAGATPVFIPLRS
KPVYGKRWSSSDWTLDPQELESKFNSKTKAIILNTPHNPLGKVYNREELQVIADLCIKYD
TLCISDEVYEWLVYSGNKHLKIATFPGMWERTITIGSAGKTFSVTGWKLGWSIGPNHLIK
HLQTVQQNTIYTCATPLQEALAQAFWIDIKRMDDPECYFNSLPKELEVKRDRMVRLLESV
GLKPIVPDGGYFIIADVSLLDPDLSDMKNNEPYDYKFVKWMTKHKKLSAIPVSAFCNSET
KSQFEKFVRFCFIKKDSTLDAAEEIIKAWSVQKS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011564|Kynurenine--oxoglutarate transaminase 3 (CCBL2)
ATGTTTTTGGCCCAGAGGAGCCTCTGCTCTCTTAGCGGTAGAGCAAAATTCCTGAAGACA
ATTTCTTCTTCCAAAATCCTCGGATTCTCTACTTCTGCTAAAATGTCACTGAAATTCACA
AATGCAAAACGGATTGAAGGACTTGATAGTAATGTGTGGATTGAATTTACCAAATTGGCT
GCAGACCCTTCTGTTGTGAATCTTGGCCAAGGCTTTCCAGATATATCCCCTCCTACATAT
GTAAAAGAAGAATTATCAAAGATTGCAGCAATCGATAGCCTGAATCAGTATACACGAGGC
TTTGGCCATCCATCACTTGTGAAAGCTCTGTCCTATCTGTATGAAAAGCTTTATCAAAAG
CAAATTGATTCAAATAAAGAAATCCTTGTGACAGTAGGAGCATATGGATCTCTTTTTAAC
ACCATTCAAGCATTAATTGATGAGGGAGATGAAGTCATACTAATAGTGCCTTTCTATGAC
TGCTATGAGCCCATGGTGAGAATGGCTGGAGCAACACCTGTTTTTATTCCCCTGAGATCT
AAACCTGTTTATGGAAAAAGATGGTCTAGTTCTGACTGGACATTAGATCCTCAAGAACTG
GAAAGTAAATTTAATTCCAAAACCAAAGCTATTATACTAAATACTCCACATAACCCACTT
GGCAAGGTGTATAACAGAGAGGAACTGCAAGTAATTGCTGACCTTTGCATCAAATATGAC
ACACTCTGCATCAGCGATGAGGTTTATGAATGGCTTGTATATTCTGGAAATAAGCACTTA
AAAATAGCTACTTTTCCAGGTATGTGGGAGAGAACAATAACAATAGGAAGTGCTGGAAAG
ACTTTCAGTGTAACTGGCTGGAAGCTTGGCTGGTCCATTGGTCCAAATCATTTGATAAAA
CATTTACAGACAGTTCAACAAAACACGATTTATACTTGTGCAACTCCTTTACAGGAAGCC
TTGGCTCAAGCTTTCTGGATTGACATCAAGCGCATGGATGACCCAGAATGTTACTTTAAT
TCTTTGCCAAAAGAGTTAGAAGTAAAAAGAGATCGGATGGTACGTTTACTTGAAAGTGTT
GGCCTAAAACCCATAGTTCCTGATGGAGGATACTTCATCATCGCTGATGTGTCTTTGCTA
GATCCAGACCTCTCTGATATGAAGAATAATGAGCCTTATGACTATAAGTTTGTGAAATGG
ATGACTAAACATAAGAAACTATCAGCCATCCCCGTTTCAGCATTCTGTAACTCAGAGACT
AAATCACAGTTTGAGAAGTTTGTGCGTTTTTGCTTCATTAAAAAAGACAGCACACTGGAT
GCTGCTGAAGAAATCATCAAGGCATGGAGTGTACAGAAGTCTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kynurenine-oxoglutarate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cysteine-S-conjugate beta-lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kynurenine-glyoxylate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>kynurenine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-kynurenine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tryptophan catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002274</id>
      <name>N-acetylglutamate synthase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17347518</pubmed-id>
            <citation>Xu Y, Labedan B, Glansdorff N: Surprising arginine biosynthesis: a reappraisal of the enzymology and evolution of the pathway in microorganisms. Microbiol Mol Biol Rev. 2007 Mar;71(1):36-47.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8N159" source="Swiss-Prot">
    <name>N-acetylglutamate synthase, mitochondrial</name>
    <general-function>Arginine binding</general-function>
    <specific-function>Plays a role in the regulation of ureagenesis by producing the essential cofactor N-acetylglutamate (NAG), thus modulating carbamoylphosphate synthase I (CPSI) activity.</specific-function>
    <gene-name>NAGS</gene-name>
    <locus>17q21.31</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.12</theoretical-pi>
    <molecular-weight>58155.835</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17996</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>NAGS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY116537</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>22651769</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8N159</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NAGS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.3.1.1</synonym>
      <synonym>Amino-acid acetyltransferase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011636|N-acetylglutamate synthase, mitochondrial
MATALMAVVLRAAAVAPRLRGRGGTGGARRLSCGARRRAARGTSPGRRLSTAWSQPQPPP
EEYAGADDVSQSPVAEEPSWVPSPRPPVPHESPEPPSGRSLVQRDIQAFLNQCGASPGEA
RHWLTQFQTCHHSADKPFAVIEVDEEVLKCQQGVSSLAFALAFLQRMDMKPLVVLGLPAP
TAPSGCLSFWEAKAQLAKSCKVLVDALRHNAAAAVPFFGGGSVLRAAEPAPHASYGGIVS
VETDLLQWCLESGSIPILCPIGETAARRSVLLDSLEVTASLAKALRPTKIIFLNNTGGLR
DSSHKVLSNVNLPADLDLVCNAEWVSTKERQQMRLIVDVLSRLPHHSSAVITAASTLLTE
LFSNKGSGTLFKNAERMLRVRSLDKLDQGRLVDLVNASFGKKLRDDYLASLRPRLHSIYV
SEGYNAAAILTMEPVLGGTPYLDKFVVSSSRQGQGSGQMLWECLRRDLQTLFWRSRVTNP
INPWYFKHSDGSFSNKQWIFFWFGLADIRDSYELVNHAKGLPDSFHKPASDPGS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011637|N-acetylglutamate synthase, mitochondrial (NAGS)
ATGGCGACGGCGCTGATGGCTGTGGTTCTGCGGGCAGCTGCTGTAGCCCCGAGGCTGAGA
GGCCGGGGAGGCACTGGGGGCGCCCGAAGGCTGAGCTGTGGCGCGCGGCGGCGGGCGGCG
AGGGGCACCAGCCCGGGGCGCCGGCTCAGCACCGCCTGGTCGCAGCCCCAGCCCCCGCCC
GAGGAGTACGCGGGCGCGGACGACGTCTCCCAGTCGCCCGTCGCCGAGGAGCCGTCGTGG
GTGCCGAGTCCCAGGCCCCCGGTGCCCCACGAGTCCCCAGAGCCTCCTTCGGGCCGCTCG
CTGGTGCAGCGGGACATCCAGGCCTTCCTGAACCAGTGCGGGGCCAGCCCTGGGGAGGCG
CGCCACTGGCTCACGCAGTTCCAGACCTGCCATCACTCCGCGGACAAGCCCTTCGCCGTC
ATCGAGGTGGACGAGGAGGTGCTCAAGTGCCAGCAGGGCGTATCCAGTCTGGCCTTTGCC
CTGGCCTTCTTGCAGCGCATGGACATGAAGCCGCTGGTGGTCCTGGGGCTGCCGGCCCCT
ACGGCTCCCTCGGGCTGTCTTTCCTTCTGGGAGGCCAAGGCGCAGCTGGCCAAGAGCTGC
AAGGTGCTGGTAGACGCGCTTCGACACAACGCCGCCGCTGCTGTGCCATTTTTTGGCGGC
GGGTCTGTGCTACGCGCTGCCGAGCCGGCTCCCCATGCCAGCTACGGCGGCATCGTCTCG
GTGGAGACAGACCTGCTGCAGTGGTGCCTGGAGTCGGGCAGCATCCCCATCCTGTGCCCC
ATCGGGGAGACGGCCGCGCGCCGCTCCGTGCTTCTCGACTCCCTGGAGGTGACCGCGTCG
CTGGCCAAGGCGCTGCGGCCCACCAAAATCATCTTCCTCAATAACACAGGCGGCCTGCGC
GACAGCAGTCATAAGGTCCTGAGTAACGTGAACCTGCCCGCCGACCTGGACCTGGTGTGC
AACGCCGAGTGGGTGAGCACAAAAGAACGGCAGCAGATGCGGCTCATCGTGGACGTGCTC
AGCCGCCTGCCCCACCACTCCTCGGCCGTCATCACCGCCGCTAGCACGCTGCTCACTGAG
CTCTTTAGCAACAAGGGGTCCGGGACCCTGTTCAAGAACGCCGAGCGAATGCTACGGGTG
CGCAGCCTGGACAAGCTGGACCAGGGCCGTCTAGTGGACCTGGTCAACGCCAGCTTCGGC
AAGAAGCTCAGGGACGACTACCTGGCCTCGCTGCGCCCGCGGCTGCACTCCATCTACGTC
TCCGAGGGGTACAACGCCGCCGCCATTCTGACCATGGAGCCCGTCCTGGGGGGCACCCCG
TACCTGGACAAATTTGTGGTGAGCTCCAGCCGCCAGGGCCAAGGCTCCGGCCAGATGCTG
TGGGAGTGCCTGCGGCGGGACCTTCAGACACTTTTCTGGCGCTCCCGGGTCACCAACCCC
ATCAATCCCTGGTACTTCAAACACAGTGATGGCAGCTTCTCCAACAAGCAGTGGATCTTC
TTCTGGTTTGGCCTGGCTGATATCCGGGACTCCTATGAGTTGGTCAACCACGCCAAGGGA
CTGCCAGACTCCTTTCACAAGCCAGCTTCTGACCCAGGCAGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04768</identifier>
        <name>NAT</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>arginine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>acetyl-CoA</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>polyamine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>urea cycle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arginine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000727</id>
      <name>Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12850557</pubmed-id>
            <citation>Kocki T, Luchowski P, Luchowska E, Wielosz M, Turski WA, Urbanska EM: L-cysteine sulphinate, endogenous sulphur-containing amino acid, inhibits rat brain kynurenic acid production via selective interference with kynurenine aminotransferase II. Neurosci Lett. 2003 Jul 31;346(1-2):97-100.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8N5Z0" source="Swiss-Prot">
    <name>Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Transaminase with broad substrate specificity. Has transaminase activity towards aminoadipate, kynurenine, methionine and glutamate. Shows activity also towards tryptophan, aspartate and hydroxykynurenine. Accepts a variety of oxo-acids as amino-group acceptors, with a preference for 2-oxoglutarate, 2-oxocaproic acid, phenylpyruvate and alpha-oxo-gamma-methiol butyric acid. Can also use glyoxylate as amino-group acceptor (in vitro).</specific-function>
    <gene-name>AADAT</gene-name>
    <locus>4q33</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.96</theoretical-pi>
    <molecular-weight>47351.17</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17929</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>AADAT</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF097994</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6165634</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8N5Z0</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AADAT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2-aminoadipate aminotransferase</synonym>
      <synonym>2-aminoadipate transaminase</synonym>
      <synonym>AadAT</synonym>
      <synonym>Alpha-aminoadipate aminotransferase</synonym>
      <synonym>KAT/AadAT</synonym>
      <synonym>KAT2</synonym>
      <synonym>Kynurenine aminotransferase II</synonym>
      <synonym>Kynurenine--oxoglutarate aminotransferase II</synonym>
      <synonym>Kynurenine--oxoglutarate transaminase 2</synonym>
      <synonym>Kynurenine--oxoglutarate transaminase II</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001450|Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial
MNYARFITAASAARNPSPIRTMTDILSRGPKSMISLAGGLPNPNMFPFKTAVITVENGKT
IQFGEEMMKRALQYSPSAGIPELLSWLKQLQIKLHNPPTIHYPPSQGQMDLCVTSGSQQG
LCKVFEMIINPGDNVLLDEPAYSGTLQSLHPLGCNIINVASDESGIVPDSLRDILSRWKP
EDAKNPQKNTPKFLYTVPNGNNPTGNSLTSERKKEIYELARKYDFLIIEDDPYYFLQFNK
FRVPTFLSMDVDGRVIRADSFSKIISSGLRIGFLTGPKPLIERVILHIQVSTLHPSTFNQ
LMISQLLHEWGEEGFMAHVDRVIDFYSNQKDAILAAADKWLTGLAEWHVPAAGMFLWIKV
KGINDVKELIEEKAVKMGVLMLPGNAFYVDSSAPSPYLRASFSSASPEQMDVAFQVLAQL
IKESL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016189|Kynurenine/alpha-aminoadipate aminotransferase, mitochondrial (AADAT)
ATGAATTACGCACGGTTCATCACGGCAGCGAGCGCAGCCAGAAACCCTTCTCCCATCCGG
ACCATGAGTGAGAAACGGGCTGACATATTGAGCAGAGGACCAAAATCGATGATCTCCTTG
GCTGGTGGCTTACCAAATCCAAACATGTTTCCTTTTAAGACTGCCGTAATCACTGTAGAA
AATGGAAAGACCATCCAATTTGGAGAAGAGATGATGAAGAGAGCACTTCAGTATTCTCCG
AGTGCTGGAATTCCAGAGCTTTTGTCCTGGCTAAAACAGTTACAAATAAAATTGCATAAT
CCTCCTACCATCCATTACCCACCCAGTCAAGGACAAATGGATCTATGTGTCACATCTGGC
AGCCAACAAGGTCTTTGTAAGGTGTTTGAAATGATCATTAATCCTGGAGATAATGTCCTC
CTAGATGAACCTGCTTATTCAGGAACTCTTCAAAGTCTGCACCCACTGGGCTGCAACATT
ATTAATGTTGCCAGTGATGAAAGTGGGATTGTTCCAGATTCCCTAAGAGACATACTTTCC
AGATGGAAACCAGAAGATGCAAAGAATCCCCAGAAAAACACCCCCAAATTTCTTTATACT
GTTCCAAATGGCAACAACCCTACTGGAAACTCATTAACCAGTGAACGCAAAAAGGAAATC
TATGAGCTTGCAAGAAAATATGATTTCCTCATAATAGAAGATGATCCTTACTATTTTCTC
CAGTTTAACAAGTTCAGGGTACCAACATTTCTTTCCATGGATGTTGATGGACGTGTCATC
AGAGCTGACTCTTTTTCAAAAATCATTTCCTCTGGGTTGAGAATAGGATTTTTAACTGGT
CCAAAACCCTTAATAGAGAGAGTTATTTTACACATACAAGTTTCAACATTGCACCCCAGC
ACTTTTAACCAGCTCATGATATCACAGCTTCTACACGAATGGGGAGAAGAAGGTTTCATG
GCTCATGTAGACAGGGTTATTGATTTCTATAGTAACCAGAAGGATGCAATACTGGCAGCT
GCAGACAAGTGGTTAACTGGTTTGGCAGAATGGCATGTTCCTGCTGCTGGAATGTTTTTA
TGGATTAAAGTTAAAGGCATTAATGATGTAAAAGAACTGATTGAAGAAAAGGCCGTTAAG
ATGGGGGTATTAATGCTCCCTGGAAATGCTTTCTACGTCGATAGCTCAGCTCCTAGCCCT
TACTTGAGAGCATCCTTCTCTTCAGCTTCTCCAGAACAGATGGATGTGGCCTTCCAGGTA
TTAGCACAACTTATAAAAGAATCTTTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>2-aminoadipate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kynurenine-oxoglutarate transaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tryptophan catabolic process to kynurenine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>kynurenine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-kynurenine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-lysine catabolic process to acetyl-CoA via saccharopine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lysine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tryptophan catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000641</id>
      <name>Glutamate receptor ionotropic, NMDA 3A</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TCU5" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, NMDA 3A</name>
    <general-function>Protein phosphatase 2a binding</general-function>
    <specific-function>NMDA receptor subtype of glutamate-gated ion channels with reduced single-channel conductance, low calcium permeability and low voltage-dependent sensitivity to magnesium. Mediated by glycine. May play a role in the development of dendritic spines. May play a role in PPP2CB-NMDAR mediated signaling mechanism (By similarity).</specific-function>
    <gene-name>GRIN3A</gene-name>
    <locus>9q31.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>675-695
749-769
931-951</transmembrane-regions>
    <signal-regions>1-23</signal-regions>
    <theoretical-pi>7.81</theoretical-pi>
    <molecular-weight>125464.07</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16767</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIN3A</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ416950</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>20372905</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>460</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TCU5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>NMD3A_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluN3A</synonym>
      <synonym>KIAA1973</synonym>
      <synonym>N-methyl-D-aspartate receptor subtype 3A</synonym>
      <synonym>NMDAR-L</synonym>
      <synonym>NMDAR3A</synonym>
      <synonym>NR3A</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037055|Glutamate receptor ionotropic, NMDA 3A
MRRLSLWWLLSRVCLLLPPPCALVLAGVPSSSSHPQPCQILKRIGHAVRVGAVHLQPWTT
APRAASRAPDDSRAGAQRDEPEPGTRRSPAPSPGARWLGSTLHGRGPPGSRKPGEGARAE
ALWPRDALLFAVDNLNRVEGLLPYNLSLEVVMAIEAGLGDLPLLPFSSPSSPWSSDPFSF
LQSVCHTVVVQGVSALLAFPQSQGEMMELDLVSLVLHIPVISIVRHEFPRESQNPLHLQL
SLENSLSSDADVTVSILTMNNWYNFSLLLCQEDWNITDFLLLTQNNSKFHLGSIINITAN
LPSTQDLLSFLQIQLESIKNSTPTVVMFGCDMESIRRIFEITTQFGVMPPELRWVLGDSQ
NVEELRTEGLPLGLIAHGKTTQSVFEHYVQDAMELVARAVATATMIQPELALIPSTMNCM
EVETTNLTSGQYLSRFLANTTFRGLSGSIRVKGSTIVSSENNFFIWNLQHDPMGKPMWTR
LGSWQGGKIVMDYGIWPEQAQRHKTHFQHPSKLHLRVVTLIEHPFVFTREVDDEGLCPAG
QLCLDPMTNDSSTLDSLFSSLHSSNDTVPIKFKKCCYGYCIDLLEKIAEDMNFDFDLYIV
GDGKYGAWKNGHWTGLVGDLLRGTAHMAVTSFSINTARSQVIDFTSPFFSTSLGILVRTR
DTAAPIGAFMWPLHWTMWLGIFVALHITAVFLTLYEWKSPFGLTPKGRNRSKVFSFSSAL
NICYALLFGRTVAIKPPKCWTGRFLMNLWAIFCMFCLSTYTANLAAVMVGEKIYEELSGI
HDPKLHHPSQGFRFGTVRESSAEDYVRQSFPEMHEYMRRYNVPATPDGVEYLKNDPEKLD
AFIMDKALLDYEVSIDADCKLLTVGKPFAIEGYGIGLPPNSPLTANISELISQYKSHGFM
DMLHDKWYRVVPCGKRSFAVTETLQMGIKHFSGLFVLLCIGFGLSILTTIGEHIVYRLLL
PRIKNKSKLQYWLHTSQRLHRAINTSFIEEKQQHFKTKRVEKRSNVGPRQLTVWNTSNLS
HDNRRKYIFSDEEGQNQLGIRIHQDIPLPPRRRELPALRTTNGKADSLNVSRNSVMQELS
ELEKQIQVIRQELQLAVSRKTELEEYQRTSRTCES</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016161|Glutamate receptor ionotropic, NMDA 3A (GRIN3A)
ATGAGGAGACTGAGTTTGTGGTGGCTGCTGAGCAGGGTCTGTCTGCTGTTGCCGCCGCCC
TGCGCACTGGTGCTGGCCGGGGTGCCCAGCTCCTCCTCGCACCCGCAGCCCTGCCAGATC
CTCAAGCGCATCGGGCACGCGGTGAGGGTGGGCGCGGTGCACTTGCAGCCCTGGACCACC
GCCCCCCGCGCGGCCAGCCGCGCTCCGGACGACAGCCGAGCAGGAGCCCAGAGGGATGAG
CCGGAGCCAGGGACTAGGCGGTCCCCGGCGCCCTCGCCGGGCGCACGCTGGTTGGGGAGC
ACCCTGCATGGCCGGGGGCCGCCGGGCTCCCGTAAGCCCGGGGAGGGCGCCAGGGCGGAG
GCCCTGTGGCCACGGGACGCCCTCCTATTTGCCGTGGACAACCTGAACCGCGTGGAAGGG
CTGCTACCCTACAACCTGTCTTTGGAAGTAGTGATGGCCATCGAGGCAGGCCTGGGCGAT
CTGCCACTTTTGCCCTTCTCCTCCCCTAGTTCGCCATGGAGCAGTGACCCTTTCTCCTTC
CTGCAAAGTGTGTGCCATACCGTGGTGGTGCAAGGGGTGTCGGCGCTGCTCGCCTTCCCC
CAGAGCCAGGGCGAAATGATGGAGCTCGACTTGGTCAGCTTAGTCCTGCACATTCCAGTG
ATCAGCATCGTGCGCCACGAGTTTCCACGGGAGAGTCAGAATCCCCTTCACCTACAACTG
AGTTTAGAAAATTCATTAAGTTCTGATGCTGATGTCACTGTCTCAATCCTGACCATGAAC
AACTGGTACAATTTTAGCTTGTTGCTGTGCCAGGAAGACTGGAACATCACCGACTTCCTC
CTCCTTACCCAGAATAATTCCAAGTTCCACCTTGGTTCTATCATCAACATCACCGCTAAC
CTCCCCTCCACCCAGGACCTCTTGAGCTTCCTACAGATCCAGCTTGAGAGTATTAAGAAC
AGCACACCCACAGTGGTGATGTTTGGCTGCGACATGGAAAGTATCCGGCGGATTTTCGAA
ATTACAACCCAGTTTGGGGTCATGCCCCCTGAACTTCGTTGGGTGCTGGGAGATTCCCAG
AATGTGGAGGAACTGAGGACAGAGGGTCTGCCCTTAGGGCTCATTGCTCATGGAAAAACA
ACACAGTCTGTCTTTGAGCACTACGTACAAGATGCTATGGAGCTGGTCGCAAGAGCTGTA
GCCACAGCCACCATGATCCAACCAGAACTTGCTCTCATTCCCAGCACGATGAACTGCATG
GAGGTGGAAACTACAAATCTCACTTCAGGACAATATTTATCAAGGTTTCTAGCCAATACC
ACTTTCAGAGGCCTCAGTGGTTCCATCAGAGTAAAAGGTTCCACCATCGTCAGCTCAGAA
AACAACTTTTTCATCTGGAATCTTCAACATGACCCCATGGGAAAGCCAATGTGGACCCGC
TTGGGCAGCTGGCAGGGGGGAAAGATTGTCATGGACTATGGAATATGGCCAGAGCAGGCC
CAGAGACACAAAACCCACTTCCAACATCCAAGTAAGCTACACTTGAGAGTGGTTACCCTG
ATTGAGCATCCTTTTGTCTTCACAAGGGAGGTAGATGATGAAGGCTTGTGCCCTGCTGGC
CAACTCTGTCTAGACCCCATGACTAATGACTCTTCCACATTGGACAGCCTTTTTAGCAGC
CTCCATAGCAGTAATGATACAGTGCCCATTAAATTCAAGAAGTGCTGCTATGGATATTGC
ATTGATCTGCTGGAAAAGATAGCAGAAGACATGAACTTTGACTTCGACCTCTATATTGTA
GGGGATGGAAAGTATGGAGCATGGAAAAATGGGCACTGGACTGGGCTAGTGGGTGATCTC
CTGAGAGGGACTGCCCACATGGCAGTCACTTCCTTTAGCATCAATACTGCACGGAGCCAG
GTGATAGATTTCACCAGCCCTTTCTTCTCCACCAGCTTGGGCATCTTAGTGAGGACCCGA
GATACAGCAGCTCCCATTGGAGCCTTCATGTGGCCACTCCACTGGACAATGTGGCTGGGG
ATTTTTGTGGCTCTGCACATCACTGCCGTCTTCCTCACTCTGTATGAATGGAAGAGTCCA
TTTGGTTTGACTCCCAAGGGGCGAAATAGAAGTAAAGTCTTCTCCTTTTCTTCAGCCTTG
AACATCTGTTATGCCCTCTTGTTTGGCAGAACAGTGGCCATCAAACCTCCAAAATGTTGG
ACTGGAAGGTTTCTAATGAACCTTTGGGCCATTTTCTGTATGTTTTGCCTTTCCACATAC
ACGGCAAACTTGGCTGCTGTCATGGTAGGTGAGAAGATCTATGAAGAGCTTTCTGGAATA
CATGACCCCAAGTTACATCATCCTTCCCAAGGATTCCGCTTTGGAACTGTCCGAGAAAGC
AGTGCTGAAGATTATGTGAGACAAAGTTTCCCAGAGATGCATGAATATATGAGAAGGTAC
AATGTTCCAGCCACCCCTGATGGAGTGGAGTATCTGAAGAATGATCCAGAGAAACTAGAC
GCCTTCATCATGGACAAAGCCCTTCTGGATTATGAAGTGTCAATAGATGCTGACTGCAAA
CTTCTCACTGTGGGGAAGCCATTTGCCATAGAAGGATACGGCATTGGCCTCCCACCCAAC
TCTCCATTGACCGCCAACATATCCGAGCTAATCAGTCAATACAAGTCACATGGGTTTATG
GATATGCTCCATGACAAGTGGTACAGGGTGGTTCCCTGTGGCAAGAGAAGTTTTGCTGTC
ACGGAGACTTTGCAAATGGGCATCAAACACTTCTCTGGGCTCTTTGTGCTGCTGTGCATT
GGATTTGGTCTGTCCATTTTGACCACCATTGGTGAGCACATAGTATACAGGCTGCTGCTA
CCACGAATCAAAAACAAATCCAAGCTGCAATACTGGCTCCACACCAGCCAGAGATTACAC
AGAGCAATAAATACATCATTTATAGAGGAAAAGCAGCAGCATTTCAAGACCAAACGTGTG
GAAAAGAGGTCTAATGTGGGACCCCGTCAGCTTACCGTATGGAATACTTCCAATCTGAGT
CATGACAACCGACGGAAATACATCTTTAGTGATGAGGAAGGACAAAACCAGCTGGGCATC
CGGATCCACCAGGACATCCCCCTCCCTCCAAGGAGAAGAGAGCTCCCTGCCTTGCGGACC
ACCAATGGGAAAGCAGACTCCCTAAATGTATCTCGGAACTCAGTGATGCAGGAACTCTCA
GAGCTCGAGAAGCAGATTCAGGTGATCCGTCAGGAGCTGCAGCTGGCTGTGAGCAGGAAA
ACGGAGCTGGAGGAGTATCAAAGGACAAGTCGGACTTGTGAGTCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron projection</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>NMDA selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein phosphatase 2A binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NMDA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prepulse inhibition</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcium ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>dendrite development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to ethanol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002166</id>
      <name>Alanine aminotransferase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TD30" source="Swiss-Prot">
    <name>Alanine aminotransferase 2</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the reversible transamination between alanine and 2-oxoglutarate to form pyruvate and glutamate.</specific-function>
    <gene-name>GPT2</gene-name>
    <locus>16q12.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>57903.11</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:18062</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPT2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY029173</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>19046894</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TD30</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ALAT2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.2</synonym>
      <synonym>AAT2</synonym>
      <synonym>ALT2</synonym>
      <synonym>Glutamate pyruvate transaminase 2</synonym>
      <synonym>Glutamic--alanine transaminase 2</synonym>
      <synonym>Glutamic--pyruvic transaminase 2</synonym>
      <synonym>GPT 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004250|Alanine aminotransferase 2
MQRAAALVRRGCGPRTPSSWGRSQSSAAAEASAVLKVRPERSRRERILTLESMNPQVKAV
EYAVRGPIVLKAGEIELELQRGIKKPFTEVIRANIGDAQAMGQQPITFLRQVMALCTYPN
LLDSPSFPEDAKKRARRILQACGGNSLGSYSASQGVNCIREDVAAYITRRDGGVPADPDN
IYLTTGASDGISTILKILVSGGGKSRTGVMIPIPQYPLYSAVISELDAIQVNYYLDEENC
WALNVNELRRAVQEAKDHCDPKVLCIINPGNPTGQVQSRKCIEDVIHFAWEEKLFLLADE
VYQDNVYSPDCRFHSFKKVLYEMGPEYSSNVELASFHSTSKGYMGECGYRGGYMEVINLH
PEIKGQLVKLLSVRLCPPVSGQAAMDIVVNPPVAGEESFEQFSREKESVLGNLAKKAKLT
EDLFNQVPGIHCNPLQGAMYAFPRIFIPAKAVEAAQAHQMAPDMFYCMKLLEETGICVVP
GSGFGQREGTYHFRMTILPPVEKLKTVLQKVKDFHINFLEKYA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016703|Alanine aminotransferase 2 (GPT2)
ATGGGGCAGCAGCCAATCACCTTCCTCCGGCAGGTGATGGCACTATGCACCTACCCAAAC
CTGCTGGACAGCCCCAGCTTCCCAGAAGATGCTAAGAAACGTGCCCGGCGGATCCTGCAG
GCTTGTGGCGGGAACAGCCTGGGGTCCTACAGTGCTAGCCAGGGTGTCAACTGCATCCGT
GAAGATGTGGCTGCCTACATCACCAGGAGGGATGGCGGTGTGCCTGCGGACCCCGACAAC
ATCTACCTGACCACGGGAGCTAGTGACGGCATTTCTACGATCCTGAAGATCCTCGTCTCC
GGGGGCGGCAAGTCACGGACAGGTGTGATGATCCCCATCCCACAATATCCCCTCTATTCA
GCTGTCATCTCTGAGCTCGACGCCATCCAGGTGAATTACTACCTGGACGAGGAGAACTGC
TGGGCGCTGAATGTGAATGAGCTCCGGCGGGCGGTGCAGGAGGCCAAAGACCACTGTGAT
CCTAAGGTGCTCTGCATAATCAACCCTGGGAACCCCACAGGCCAGGTACAAAGCAGAAAG
TGCATAGAAGATGTGATCCACTTTGCCTGGGAAGAGAAGCTCTTTCTCCTGGCTGATGAG
GTGTACCAGGACAACGTGTACTCTCCAGATTGCAGATTCCACTCCTTCAAGAAGGTGCTG
TACGAGATGGGGCCCGAGTACTCCAGCAACGTGGAGCTCGCCTCCTTCCACTCCACCTCC
AAGGGCTACATGGGCGAGTGTGGTTACAGAGGAGGCTACATGGAGGTGATCAACCTGCAC
CCTGAGATCAAGGGCCAGCTGGTGAAGCTGCTGTCGGTGCGCCTGTGCCCCCCAGTGTCT
GGGCAGGCCGCCATGGACATTGTCGTGAACCCCCCGGTGGCAGGAGAGGAGTCCTTTGAG
CAATTCAGCCGAGAGAAGGAGTCGGTCCTGGGTAATCTGGCCAAAAAAGCAAAGCTGACG
GAAGACCTGTTTAACCAAGTCCCAGGAATTCACTGCAACCCCTTGCAGGGGGCCATGTAC
GCCTTCCCTCGGATCTTCATTCCTGCCAAAGCTGTGGAGGCTGCTCAGGCCCATCAAATG
GCTCCAGACATGTTCTACTGCATGAAGCTCCTGGAGGAGACTGGCATCTGTGTCGTGCCC
GGCAGTGGCTTTGGGCAGAGGGAAGGCACTTACCACTTCAGGATGACTATCCTCCCTCCA
GTGGAGAAGCTGAAAACGGTGCTGCAGAAGGTGAAAGACTTCCACATCAACTTCCTGGAG
AAGTACGCGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00155</identifier>
        <name>Aminotran_1_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-alanine</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-alanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>2-oxoglutarate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-alanine metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002275</id>
      <name>Mitochondrial glutamate carrier 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9H1K4" source="Swiss-Prot">
    <name>Mitochondrial glutamate carrier 2</name>
    <general-function>Symporter activity</general-function>
    <specific-function>Involved in the transport of glutamate across the inner mitochondrial membrane. Glutamate is cotransported with H(+).</specific-function>
    <gene-name>SLC25A18</gene-name>
    <locus>22q11.2</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions>12-32
61-81
106-126
185-205
225-245
288-308</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.62</theoretical-pi>
    <molecular-weight>33848.44</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10988</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC25A18</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ428203</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>21322707</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9H1K4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GHC2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GC-2</synonym>
      <synonym>GC2</synonym>
      <synonym>Glutamate/H(+) symporter 2</synonym>
      <synonym>Solute carrier family 25 member 18</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011638|Mitochondrial glutamate carrier 2
MTHQDLSITAKLINGGVAGLVGVTCVFPIDLAKTRLQNQHGKAMYKGMIDCLMKTARAEG
FFGMYRGAAVNLTLVTPEKAIKLAANDFFRRLLMEDGMQRNLKMEMLAGCGAGMCQVVVT
CPMEMLKIQLQDAGRLAVHHQGSASAPSTSRSYTTGSASTHRRPSATLIAWELLRTQGLA
GLYRGLGATLLRDIPFSIIYFPLFANLNNLGFNELAGKASFAHSFVSGCVAGSIAAVAVT
PLDVLKTRIQTLKKGLGEDMYSGITDCARKLWIQEGPSAFMKGAGCRALVIAPLFGIAQG
VYFIGIGERILKCFD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011639|Mitochondrial glutamate carrier 2 (SLC25A18)
ATGACCCACCAGGATCTGAGCATCACAGCCAAACTCATCAATGGAGGTGTAGCAGGGCTC
GTGGGGGTGACCTGCGTGTTCCCCATCGACTTGGCCAAGACTCGCCTGCAGAACCAGCAT
GGGAAAGCCATGTACAAAGGAATGATCGACTGCCTGATGAAGACGGCTCGGGCGGAGGGC
TTCTTCGGCATGTACCGAGGGGCTGCAGTGAACCTCACTCTGGTCACTCCAGAGAAGGCC
ATCAAGCTGGCGGCCAACGACTTTTTCCGGCGGCTGCTCATGGAAGATGGGATGCAGCGG
AACCTGAAGATGGAGATGCTTGCCGGGTGTGGGGCTGGGATGTGCCAGGTCGTGGTGACC
TGTCCCATGGAAATGCTCAAGATTCAGCTGCAGGATGCTGGACGCCTGGCCGTCCATCAT
CAGGGCTCGGCCTCAGCACCCTCCACCTCCAGGTCCTACACAACTGGTTCGGCTTCCACC
CACAGGCGCCCCTCTGCCACCCTCATTGCCTGGGAGCTGCTCCGCACTCAGGGCCTGGCT
GGGCTCTACAGGGGCCTGGGTGCCACTCTCCTCAGAGACATTCCTTTCTCCATCATCTAC
TTCCCACTGTTTGCCAACCTTAACAACCTGGGGTTCAACGAGCTCGCCGGTAAGGCGTCC
TTTGCACATTCCTTCGTGTCAGGCTGTGTGGCAGGTTCCATAGCTGCGGTCGCAGTGACG
CCTCTAGATGTTCTGAAAACTCGAATCCAAACCCTCAAGAAAGGCCTGGGCGAGGACATG
TACAGTGGGATCACCGACTGTGCCAGGAAACTCTGGATTCAGGAGGGACCATCTGCCTTC
ATGAAAGGCGCTGGCTGCCGGGCACTGGTCATAGCACCTCTCTTTGGGATTGCTCAAGGG
GTCTATTTTATTGGGATTGGAGAGCGCATCTTAAAGTGTTTTGACTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00153</identifier>
        <name>Mito_carr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>symporter activity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002276</id>
      <name>Mitochondrial glutamate carrier 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9H936" source="Swiss-Prot">
    <name>Mitochondrial glutamate carrier 1</name>
    <general-function>Symporter activity</general-function>
    <specific-function>Involved in the transport of glutamate across the inner mitochondrial membrane. Glutamate is cotransported with H(+).</specific-function>
    <gene-name>SLC25A22</gene-name>
    <locus>11p15.5</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions>12-32
62-82
107-127
189-209
223-243
292-312</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.67</theoretical-pi>
    <molecular-weight>34469.85</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19954</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC25A22</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ428202</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>21322705</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9H936</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GHC1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GC-1</synonym>
      <synonym>GC1</synonym>
      <synonym>Glutamate/H(+) symporter 1</synonym>
      <synonym>Solute carrier family 25 member 22</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004468|Mitochondrial glutamate carrier 1
MADKQISLPAKLINGGIAGLIGVTCVFPIDLAKTRLQNQQNGQRVYTSMSDCLIKTVRSE
GYFGMYRGAAVNLTLVTPEKAIKLAANDFFRHQLSKDGQKLTLLKEMLAGCGAGTCQVIV
TTPMEMLKIQLQDAGRIAAQRKILAAQGQLSAQGGAQPSVEAPAAPRPTATQLTRDLLRS
RGIAGLYKGLGATLLRDVPFSVVYFPLFANLNQLGRPASEEKSPFYVSFLAGCVAGSAAA
VAVNPCDVVKTRLQSLQRGVNEDTYSGILDCARKILRHEGPSAFLKGAYCRALVIAPLFG
IAQVVYFLGIAESLLGLLQDPQA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016737|Mitochondrial glutamate carrier 1 (SLC25A22)
ATGGCTGATAAGCAGATCAGCCTGCCAGCCAAGCTCATCAATGGCGGCATCGCCGGGCTG
ATCGGTGTCACCTGCGTGTTTCCCATCGACCTGGCCAAGACCAGGCTGCAGAACCAGCAG
AACGGCCAGCGCGTGTACACGAGCATGTCCGACTGCCTCATCAAGACCGTCCGCTCCGAG
GGCTACTTCGGCATGTACCGGGGAGCTGCTGTGAACTTGACCCTCGTCACCCCCGAGAAG
GCCATCAAGCTGGCAGCCAACGACTTCTTCCGACATCAGCTCTCTAAGGACGGGCAGAAG
CTGACCCTGCTTAAAGAGATGCTGGCGGGCTGTGGGGCTGGCACCTGCCAGGTGATCGTG
ACCACGCCCATGGAGATGCTGAAGATCCAGCTGCAGGATGCAGGGCGCATTGCCGCCCAG
AGGAAGATCCTGGCTGCCCAGGGCCAGCTCTCGGCCCAGGGGGGTGCCCAGCCCTCAGTG
GAGGCTCCAGCTGCCCCTCGGCCCACGGCCACCCAGCTGACCCGCGACCTGCTGCGGAGC
CGTGGCATTGCCGGTCTCTACAAGGGACTCGGGGCCACGCTGCTCAGGGATGTCCCCTTC
TCTGTGGTGTACTTCCCGCTCTTTGCCAACCTGAACCAGCTGGGCCGCCCGGCGTCCGAG
GAGAAGTCGCCTTTCTACGTGTCCTTCCTGGCCGGCTGTGTGGCTGGGAGTGCCGCCGCT
GTGGCCGTCAACCCCTGTGATGTGGTGAAGACGCGGCTCCAGTCACTTCAGCGAGGCGTC
AACGAGGACACCTACTCTGGGATCCTGGACTGTGCCAGGAAGATCCTGCGGCACGAGGGC
CCCTCGGCCTTCCTGAAGGGCGCCTACTGCCGCGCGCTGGTCATCGCGCCCCTTTTCGGC
ATCGCACAGGTGGTCTACTTCCTGGGCATCGCGGAGTCCCTGCTGGGGCTGCTGCAGGAC
CCCCAGGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00153</identifier>
        <name>Mito_carr</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>symporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>L-glutamate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000073</id>
      <name>Alpha-aminoadipic semialdehyde synthase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9249048</pubmed-id>
            <citation>Gaziola SA, Teixeira CM, Lugli J, Sodek L, Azevedo RA: The enzymology of lysine catabolism in rice seeds--isolation, characterization, and regulatory properties of a lysine 2-oxoglutarate reductase/saccharopine dehydrogenase bifunctional polypeptide. Eur J Biochem. 1997 Jul 1;247(1):364-71.</citation>
          </article>
          <article>
            <pubmed-id>12226216</pubmed-id>
            <citation>Goncalves-Butruille M, Szajner P, Torigoi E, Leite A, Arruda P: Purification and Characterization of the Bifunctional Enzyme Lysine-Ketoglutarate Reductase-Saccharopine Dehydrogenase from Maize. Plant Physiol. 1996 Mar;110(3):765-771.</citation>
          </article>
          <article>
            <pubmed-id>687635</pubmed-id>
            <citation>Noda C, Ichihara A: Purification and properties of L-lysine-alpha-ketoglutarate reductase from rat liver mitochondria. Biochim Biophys Acta. 1978 Aug 7;525(2):307-13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UDR5" source="Swiss-Prot">
    <name>Alpha-aminoadipic semialdehyde synthase, mitochondrial</name>
    <general-function>Saccharopine dehydrogenase (nadp+, l-lysine-forming) activity</general-function>
    <specific-function>Bifunctional enzyme that catalyzes the first two steps in lysine degradation. The N-terminal and the C-terminal contain lysine-ketoglutarate reductase and saccharopine dehydrogenase activity, respectively.</specific-function>
    <gene-name>AASS</gene-name>
    <locus>7q31.3</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.62</theoretical-pi>
    <molecular-weight>102130.895</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17366</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>AASS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF229180</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>7264724</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UDR5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>AASS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>LKR/SDH</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009917|Alpha-aminoadipic semialdehyde synthase, mitochondrial
MLQVHRTGLGRLGVSLSKGLHHKAVLAVRREDVNAWERRAPLAPKHIKGITNLGYKVLIQ
PSNRRAIHDKDYVKAGGILQEDISEACLILGVKRPPEEKLMSRKTYAFFSHTIKAQEANM
GLLDEILKQEIRLIDYEKMVDHRGVRVVAFGQWAGVAGMINILHGMGLRLLALGHHTPFM
HIGMAHNYRNSSQAVQAVRDAGYEISLGLMPKSIGPLTFVFTGTGNVSKGAQAIFNELPC
EYVEPHELKEVSQTGDLRKVYGTVLSRHHHLVRKTDAVYDPAEYDKHPERYISRFNTDIA
PYTTCLINGIYWEQNTPRLLTRQDAQSLLAPGKFSPAGVEGCPALPHKLVAICDISADTG
GSIEFMTECTTIEHPFCMYDADQHIIHDSVEGSGILMCSIDNLPAQLPIEATECFGDMLY
PYVEEMILSDATQPLESQNFSPVVRDAVITSNGTLPDKYKYIQTLRESRERAQSLSMGTR
RKVLVLGSGYISEPVLEYLSRDGNIEITVGSDMKNQIEQLGKKYNINPVSMDICKQEEKL
GFLVAKQDLVISLLPYVLHPLVAKACITNKVNMVTASYITPALKELEKSVEDAGITIIGE
LGLDPGLDHMLAMETIDKAKEVGATIESYISYCGGLPAPEHSNNPLRYKFSWSPVGVLMN
VMQSATYLLDGKVVNVAGGISFLDAVTSMDFFPGLNLEGYPNRDSTKYAEIYGISSAHTL
LRGTLRYKGYMKALNGFVKLGLINREALPAFRPEANPLTWKQLLCDLVGISPSSEHDVLK
EAVLKKLGGDNTQLEAAEWLGLLGDEQVPQAESILDALSKHLVMKLSYGPEEKDMIVMRD
SFGIRHPSGHLEHKTIDLVAYGDINGFSAMAKTVGLPTAMAAKMLLDGEIGAKGLMGPFS
KEIYGPILERIKAEGIIYTTQSTIKP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0009918|Alpha-aminoadipic semialdehyde synthase, mitochondrial (AASS)
ATGCTGCAAGTACATAGGACTGGACTGGGCAGGCTGGGGGTCAGCCTCTCCAAGGGTCTT
CACCACAAAGCTGTGTTGGCCGTCCGGAGGGAGGATGTGAACGCCTGGGAGAGAAGGGCC
CCGCTAGCTCCCAAGCACATCAAAGGCATCACCAATCTGGGATACAAGGTCTTGATACAG
CCTTCGAATCGGCGGGCCATTCATGATAAGGACTATGTCAAAGCTGGTGGCATTCTTCAG
GAGGATATTTCTGAAGCTTGTCTAATTTTAGGAGTTAAAAGACCTCCAGAGGAAAAATTA
ATGTCCAGGAAGACTTATGCATTTTTCTCCCACACAATAAAAGCTCAGGAGGCCAATATG
GGCTTGTTGGATGAGATTCTAAAACAGGAAATTCGCCTTATTGATTATGAGAAAATGGTG
GATCATAGAGGAGTACGGGTAGTGGCATTTGGACAGTGGGCTGGTGTGGCAGGAATGATC
AACATTTTACATGGAATGGGTTTAAGGCTCCTTGCTTTGGGACATCACACACCTTTTATG
CACATTGGCATGGCTCATAACTACAGGAATAGCAGTCAGGCTGTGCAAGCTGTCCGTGAT
GCTGGCTATGAAATATCTTTGGGTTTGATGCCTAAGTCAATAGGACCCTTAACATTTGTG
TTCACAGGAACTGGTAATGTTTCTAAGGGAGCCCAAGCAATCTTTAATGAGCTACCTTGT
GAATATGTGGAGCCCCATGAATTAAAAGAAGTTTCCCAAACTGGAGACCTCAGAAAAGTG
TATGGGACGGTGTTAAGTCGTCATCATCATCTTGTCAGGAAAACAGATGCTGTGTATGAT
CCTGCAGAGTATGACAAACATCCGGAGCGCTACATAAGTCGTTTTAATACTGATATTGCA
CCCTATACAACTTGCTTAATTAATGGAATCTACTGGGAACAAAACACTCCTCGCCTCCTA
ACCCGCCAAGATGCTCAGAGTCTCCTGGCTCCGGGCAAGTTCTCACCTGCTGGTGTGGAA
GGCTGCCCTGCATTACCACACAAACTCGTGGCAATATGTGACATTTCAGCTGACACAGGA
GGGTCTATAGAGTTTATGACTGAGTGTACAACAATAGAGCATCCCTTTTGCATGTATGAT
GCAGACCAGCATATTATTCATGACAGTGTTGAAGGCTCGGGGATCCTGATGTGTTCCATT
GACAATTTGCCGGCACAGCTCCCAATTGAAGCTACAGAATGCTTTGGAGACATGCTTTAC
CCTTATGTTGAAGAAATGATATTATCAGACGCGACACAGCCTCTTGAAAGTCAGAATTTT
TCTCCTGTGGTGAGAGATGCAGTGATTACATCCAACGGTACATTACCTGATAAATATAAA
TATATCCAGACACTCCGGGAGAGCAGGGAACGTGCTCAGTCACTTTCAATGGGCACCAGG
AGAAAGGTTTTGGTTCTTGGATCTGGCTACATATCTGAGCCTGTATTAGAATATTTATCA
AGAGATGGCAATATAGAAATAACAGTAGGATCTGACATGAAGAATCAAATTGAACAGTTA
GGCAAGAAATATAATATTAATCCTGTTAGCATGGACATTTGTAAACAAGAAGAGAAGCTG
GGCTTCTTGGTGGCAAAACAGGATCTTGTCATCAGCTTGTTGCCTTATGTATTGCACCCT
CTTGTGGCCAAGGCCTGCATCACAAACAAAGTTAACATGGTCACTGCAAGCTACATCACA
CCAGCACTAAAAGAATTGGAAAAGAGTGTGGAAGATGCTGGCATCACAATCATTGGTGAA
TTGGGATTGGACCCTGGTCTGGATCACATGTTAGCAATGGAAACAATAGATAAAGCCAAG
GAAGTGGGAGCCACGATTGAATCATATATTTCCTACTGTGGTGGGCTTCCAGCCCCTGAA
CATTCAAACAATCCATTGAGATATAAATTTAGCTGGAGTCCAGTGGGAGTTTTGATGAAT
GTAATGCAGTCTGCCACCTATCTGCTCGATGGAAAGGTTGTGAATGTTGCAGGAGGCATC
TCCTTTCTTGATGCCGTTACGTCCATGGATTTTTTTCCAGGATTAAATTTGGAAGGCTAT
CCTAACAGAGACAGTACGAAATATGCTGAGATTTATGGCATTTCTTCTGCTCACACTTTG
TTGCGGGGGACACTGAGATATAAGGGATATATGAAAGCTTTGAATGGATTTGTAAAATTA
GGTCTTATAAACAGAGAAGCGCTTCCTGCCTTTAGACCTGAGGCCAACCCTCTCACCTGG
AAACAACTCCTCTGTGACCTAGTTGGGATTTCACCCTCCTCTGAGCATGATGTGTTGAAG
GAAGCTGTTCTTAAGAAACTAGGAGGAGACAATACCCAGTTGGAGGCTGCTGAATGGTTG
GGCTTACTTGGGGATGAACAAGTTCCTCAGGCAGAGTCCATTCTGGATGCCCTCTCCAAG
CATTTGGTCATGAAGCTTTCCTATGGTCCTGAAGAAAAAGATATGATTGTGATGAGAGAC
AGCTTTGGAATCAGACATCCTTCTGGACATTTAGAACATAAAACGATTGATCTTGTGGCT
TATGGGGACATCAATGGCTTTTCAGCCATGGCTAAAACCGTGGGGTTACCCACCGCCATG
GCAGCCAAAATGTTGCTTGATGGTGAAATTGGAGCCAAAGGCCTAATGGGGCCCTTTTCA
AAGGAGATCTATGGACCAATATTGGAGCGAATTAAAGCAGAAGGCATTATATATACTACA
CAGAGTACAATTAAACCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF05222</identifier>
        <name>AlaDh_PNT_N</name>
      </pfam>
      <pfam>
        <identifier>PF03435</identifier>
        <name>Sacchrp_dh_NADP</name>
      </pfam>
      <pfam>
        <identifier>PF16653</identifier>
        <name>Sacchrp_dh_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>saccharopine dehydrogenase (NAD+, L-glutamate-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>saccharopine dehydrogenase (NADP+, L-lysine-forming) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein tetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-lysine catabolic process to acetyl-CoA via saccharopine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lysine catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000003</id>
      <name>Glutaminase liver isoform, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17373776</pubmed-id>
            <citation>Dossena L, Curti B, Vanoni MA: Activation and coupling of the glutaminase and synthase reaction of glutamate synthase is mediated by E1013 of the ferredoxin-dependent enzyme, belonging to loop 4 of the synthase domain. Biochemistry. 2007 Apr 17;46(15):4473-85. Epub 2007 Mar 21.</citation>
          </article>
          <article>
            <pubmed-id>17321558</pubmed-id>
            <citation>Kita K, Suzuki T, Ochi T: Down-regulation of glutaminase C in human hepatocarcinoma cell by diphenylarsinic acid, a degradation product of chemical warfare agents. Toxicol Appl Pharmacol. 2007 May 1;220(3):262-70. Epub 2007 Jan 24.</citation>
          </article>
          <article>
            <pubmed-id>16793004</pubmed-id>
            <citation>Yoshimune K, Shirakihara Y, Shiratori A, Wakayama M, Chantawannakul P, Moriguchi M: Crystal structure of a major fragment of the salt-tolerant glutaminase from Micrococcus luteus K-3. Biochem Biophys Res Commun. 2006 Aug 11;346(4):1118-24. Epub 2006 Jun 6.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UI32" source="Swiss-Prot">
    <name>Glutaminase liver isoform, mitochondrial</name>
    <general-function>Glutaminase activity</general-function>
    <specific-function>Plays an important role in the regulation of glutamine catabolism. Promotes mitochondrial respiration and increases ATP generation in cells by catalyzing the synthesis of glutamate and alpha-ketoglutarate. Increases cellular anti-oxidant function via NADH and glutathione production. May play a role in preventing tumor proliferation.</specific-function>
    <gene-name>GLS2</gene-name>
    <locus>12q13</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.03</theoretical-pi>
    <molecular-weight>66322.225</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:29570</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF110330</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6650606</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UI32</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLSL_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.5.1.2</synonym>
      <synonym>GA</synonym>
      <synonym>GLS</synonym>
      <synonym>L-glutaminase</synonym>
      <synonym>L-glutamine amidohydrolase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0036932|Glutaminase liver isoform, mitochondrial
MRSMKALQKALSRAGSHCGRGGWGHPSRSPLLGGGVRHHLSEAAAQGRETPHSHQPQHQD
HDSSESGMLSRLGDLLFYTIAEGQERIPIHKFTTALKATGLQTSDPRLRDCMSEMHRVVQ
ESSSGGLLDRDLFRKCVSSNIVLLTQAFRKKFVIPDFEEFTGHVDRIFEDVKELTGGKVA
AYIPQLAKSNPDLWGVSLCTVDGQRHSVGHTKIPFCLQSCVKPLTYAISISTLGTDYVHK
FVGKEPSGLRYNKLSLNEEGIPHNPMVNAGAIVVSSLIKMDCNKAEKFDFVLQYLNKMAG
NEYMGFSNATFQSEKETGDRNYAIGYYLKEKKCFPKGVDMMAALDLYFQLCSVEVTCESG
SVMAATLANGGICPITGESVLSAEAVRNTLSLMHSCGMYDFSGQFAFHVGLPAKSAVSGA
ILLVVPNVMGMMCLSPPLDKLGNSHRGTSFCQKLVSLFNFHNYDNLRHCARKLDPRREGA
EIRNKTVVNLLFAAYSGDVSALRRFALSAMDMEQKDYDSRTALHVAAAEGHIEVVKFLIE
ACKVNPFAKDRWGNIPLDDAVQFNHLEVVKLLQDYQDSYTLSETQAEAAAEALSKENLES
MV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0000005|1809 bp
ATGCGCTCCATGAAGGCTCTGCAGAAGGCCCTGAGCCGGGCTGGCAGTCACTGCGGGCGA
GGAGGCTGGGGTCACCCGAGCCGGAGCCCCCTCCTTGGCGGGGGCGTCCGGCACCACCTC
AGTGAGGCCGCGGCGCAGGGCAGAGAGACGCCACACAGCCACCAGCCGCAGCACCAGGAT
CATGATTCATCAGAAAGTGGCATGCTGTCCCGCCTGGGTGATTTGCTCTTTTACACTATT
GCTGAAGGACAGGAACGAACCCCTATCCACAAGTTCACCACTGCACTAAAGGCCACTGGA
CTGCAGACATCAGATCCTCGGCTCCGAGACTGCATGAGCGAGATGCACCGCGTGGTCCAA
GAGTCCAGTAGTGGTGGCCTCTTGGACCGAGATCTCTTCCGAAAGTGTGTGAGCAGCAGC
ATTGTGCTCCTGACCCAGGCATTCCGAAAGAAGTTTGTCATTCCTGATTTTGAGGAGTTC
ACGGGCCATGTGGATCGCATCTTTGAGGATGTCAAAGAGCTCACTGGAGGCAAAGTGGCA
GCCTACATCCCTCAGCTGGCCAAGTCAAACCCAGACCTGTGGGGTGTCTCCCTGTGCACT
GTGGATGGTCAACGGCACTCTGTGGGCCACACAAAGATCCCCTTCTGCCTGCAGTCCTGT
GTGAAGCCCCTCACCTATGCCATCTCCATAAGCACCCTAGGCACTGACTACGTGCACAAG
TTTGTGGGCAAAGAGCCAAGTGGCCTGCGCTACAACAAGCTCTCCCTCGATGAGGAAGGA
ATCCCCCATAACCCCATGGTCAATGCTGGTGCCATTGTTGTCAGCTCCCTGATCAAGATG
GACTGTAACAAAGCAGAGAAGTTTGATTTTGTGTTGCAGTATCTCAACAAAATGGCTGGG
AATGAATACATGGGTTTCAGCAATGCCACATTCCAGTCAGAGAAGGAAACAGGGGATCGG
AATTATGCCATCGGCTATTATCACGAGGAAAAGAAGTGCTTTCCTAAGGGGGTGGACATG
ATGGCTGCCCTTGATCTCTACTTCCAGCTGTGTTCTGTGGAGGTCACTTGTGAATCAGGC
AGTGTCATGGCAGCCACCCTCGCCAACGGTGGGATTTGCCCCATCACAGGCGAGAGTGTG
CTGAGTGCTGAAGCAGTGCGCAACACCCTCAGCCTCATGCATTCCTGCGGCATGTATGAC
TTCTCTGGCCAGTTTGCCTTCCACGTGGGCCTGCCAGCCAAGTCAGCTGTATCAGGAGCC
ATCCTCCTGGTGGTACCCAATGTCATGGGAATGATGTGCCTGTCACCCCCATTGGACAAG
CTGGGGAACAGCCATAGGGGGACCAGCTTCTGCCAGAAGTTGGTGTCTCTCTTCAATTTC
CACAACTATGACAACCTGAGGCACTGTGCTCGGAAGTTAGACCCACGGCGTGAAGGGGCA
GAAATTCGGAACAAGACTGTGGTCAACCTGTTATTTGCTGCCTATAGTGGCGATGTCTCA
GCTCTTCGAAGGTTTGCCTTGTCAGCCATGGATATGGAACAGAAAGACTATGACTCGCGC
ACAGCTCTGCATGTTGCTGCAGCTGAAGGACACATCGAAGTTGTTAAATTCCTGATCGAG
GCTTGCAAAGTGAATCCTTTTGCCAAGGACAGGTGGGGCAACATTCCCCTGGATGATGCT
GTGCAGTTCAACCATCTGGAGGTGGTCAAACTGCTTCAAGATTACCAGGACTCCTACACA
CTCTCTGAAACTCAGGCTGAGGCAGCAGCTGAGGCCCTGTCCAAAGAGAACTTAGAAAGC
ATGGTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04960</identifier>
        <name>Glutaminase</name>
      </pfam>
      <pfam>
        <identifier>PF12796</identifier>
        <name>Ank_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of protein targeting to mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>reactive oxygen species metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002277</id>
      <name>Aspartyl aminopeptidase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>17928682</pubmed-id>
            <citation>Watanabe J, Tanaka H, Akagawa T, Mogi Y, Yamazaki T: Characterization of Aspergillus oryzae aspartyl aminopeptidase expressed in Escherichia coli. Biosci Biotechnol Biochem. 2007 Oct;71(10):2557-60. Epub 2007 Oct 7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9ULA0" source="Swiss-Prot">
    <name>Aspartyl aminopeptidase</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Aminopeptidase with specificity towards an acidic amino acid at the N-terminus. Likely to play an important role in intracellular protein and peptide metabolism.</specific-function>
    <gene-name>DNPEP</gene-name>
    <locus>2q35</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.44</theoretical-pi>
    <molecular-weight>52427.87</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2981</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>DNPEP</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF005050</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5902181</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1559</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9ULA0</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DNPEP_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.11.21</synonym>
      <synonym>ASPEP</synonym>
      <synonym>DAP</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004470|Aspartyl aminopeptidase
MQVAMNGKARKEAVQTAAKELLKFVNRSPSPFHAVAECRNRLLQAGFSELKETEKWNIKP
ESKYFMTRNSSTIIAFAVGGQYVPGNGFSLIGAHTDSPCLRVKRRSRRSQVGFQQVGVET
YGGGIWSTWFDRDLTLAGRVIVKCPTSGRLEQQLVHVERPILRIPHLAIHLQRNINENFG
PNTEMHLVPILATAIQEELEKGTPEPGPLNAVDERHHSVLMSLLCAHLGLSPKDIVEMEL
CLADTQPAVLGGAYDEFIFAPRLDNLHSCFCALQALIDSCAGPGSLATEPHVRMVTLYDN
EEVGSESAQGAQSLLTELVLRRISASCQHPTAFEEAIPKSFMISADMAHAVHPNYLDKHE
ENHRPLFHKGPVIKVNSKQRYASNAVSEALIREVANKVKVPLQDLMVRNDTPCGTTIGPI
LASRLGLRVLDLGSPQLAMHSIREMACTTGVLQTLTLFKGFFELFPSLSHNLLVD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019259|Aspartyl aminopeptidase (DNPEP)
ATGAGCGGACACAGCCCCACGCGCGGGGCCATGCAGGTGGCCATGAACGGTAAGGCCCGC
AAAGAGGCGGTGCAGACTGCGGCTAAGGAACTCCTCAAGTTCGTGAACCGGAGTCCCTCT
CCTTTCCATGCTGTGGCTGAATGCCGCAACCGCCTTCTCCAGGCTGGCTTCAGTGAACTC
AAGGAGACTGAGAAATGGAATATTAAGCCCGAGAGCAAGTACTTCATGACCAGGAACTCC
TCCACCATCATAGCTTTTGCTGTAGGGGGCCAGTACGTTCCTGGCAATGGCTTCAGCCTC
ATCGGGGCCCACACGGACAGCCCCTGCCTCCGGGTGAAACGTCGGTCTCGCCGCAGCCAG
GTGGGCTTCCAGCAAGTCGGTGTGGAGACCTATGGTGGTGGGATCTGGAGCACCTGGTTT
GACCGTGACCTGACTCTGGCTGGACGCGTCATTGTCAAGTGCCCTACCTCAGGTCGGCTG
GAGCAGCAGCTGGTGCACGTGGAGCGGCCCATTCTTCGCATCCCACACCTGGCCATCCAT
CTGCAGCGAAATATCAACGAGAACTTTGGGCCCAACACAGAGATGCATCTAGTCCCCATT
CTTGCCACAGCCATCCAGGAGGAGCTGGAGAAGGGGACTCCTGAGCCAGGGCCTCTCAAT
GCTGTGGATGAGCGGCACCATTCGGTCCTCATGTCCCTGCTCTGTGCCCATCTGGGGCTG
AGCCCCAAGGACATAGTGGAGATGGAGCTCTGCCTTGCAGACACCCAGCCTGCGGTCTTG
GGTGGTGCCTATGATGAGTTCATCTTTGCTCCTCGGCTGGACAATCTGCACAGCTGCTTC
TGTGCCCTGCAGGCCTTGATAGATTCCTGTGCAGGCCCTGGCTCCCTGGCCACAGAGCCT
CACGTGCGCATGGTCACACTCTATGACAACGAAGAGGTGGGGTCTGAGAGTGCACAGGGA
GCACAGTCACTGCTGACAGAGCTGGTGCTGCGGCGGATCTCAGCCTCGTGCCAGCACCCG
ACAGCCTTCGAGGAAGCCATACCCAAGTCCTTCATGATCAGCGCAGACATGGCCCATGCT
GTGCATCCCAACTACCTGGACAAGCATGAGGAGAACCACCGGCCTTTATTCCACAAGGGC
CCCGTGATCAAGGTGAACAGCAAGCAACGCTATGCTTCAAACGCGGTGTCAGAGGCCCTG
ATCCGAGAGGTGGCCAACAAAGTCAAGGTCCCCCTGCAGGATCTCATGGTCCGGAATGAC
ACCCCCTGTGGAACCACCATTGGACCTATCTTGGCTTCTCGGCTGGGGCTGCGGGTGCTG
GATTTAGGCAGCCCCCAACTGGCCATGCACTCTATCCGGGAGATGGCCTGCACCACAGGA
GTCCTCCAGACCCTCACCCTCTTCAAGGGCTTCTTTGAGCTGTTCCCTTCTCTAAGCCAT
AATCTCTTAGTGGATTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02127</identifier>
        <name>Peptidase_M18</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>blood microparticle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metallopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aminopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptide metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002278</id>
      <name>Glutamate receptor ionotropic, delta-1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9ULK0" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, delta-1</name>
    <general-function>Ionotropic glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists.</specific-function>
    <gene-name>GRID1</gene-name>
    <locus>10q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>563-583
638-658
831-851</transmembrane-regions>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi>6.67</theoretical-pi>
    <molecular-weight>112129.96</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4575</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRID1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>BC039263</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>24657795</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>448</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9ULK0</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRID1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GluD1</synonym>
      <synonym>KIAA1220</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004472|Glutamate receptor ionotropic, delta-1
MEALTLWLLPWICQCVSVRADSIIHIGAIFEENAAKDDRVFQLAVSDLSLNDDILQSEKI
TYSIKVIEANNPFQAVQEACDLMTQGILALVTSTGCASANALQSLTDAMHIPHLFVQRNP
GGSPRTACHLNPSPDGEAYTLASRPPVRLNDVMLRLVTELRWQKFVMFYDSEYDIRGLQS
FLDQASRLGLDVSLQKVDKNISHVFTSLFTTMKTEELNRYRDTLRRAILLLSPQGAHSFI
NEAVETNLASKDSHWVFVNEEISDPEILDLVHSALGRMTVVRQIFPSAKDNQKCTRNNHR
ISSLLCDPQEGYLQMLQISNLYLYDSVLMLANAFHRKLEDRKWHSMASLNCIRKSTKPWN
GGRSMLDTIKKGHITGLTGVMEFREDSSNPYVQFEILGTTYSETFGKDMRKLATWDSEKG
LNGSLQERPMGSRLQGLTLKVVTVLEEPFVMVAENILGQPKRYKGFSIDVLDALAKALGF
KYEIYQAPDGRYGHQLHNTSWNGMIGELISKRADLAISAITITPERESVVDFSKRYMDYS
VGILIKKPEEKISIFSLFAPFDFAVWACIAAAIPVVGVLIFVLNRIQAVRAQSAAQPRPS
ASATLHSAIWIVYGAFVQQGGESSVNSMAMRIVMGSWWLFTLIVCSSYTANLAAFLTVSR
MDNPIRTFQDLSKQVEMSYGTVRDSAVYEYFRAKGTNPLEQDSTFAELWRTISKNGGADN
CVSSPSEGIRKAKKGNYAFLWDVAVVEYAALTDDDCSVTVIGNSISSKGYGIALQHGSPY
RDLFSQRILELQDTGDLDVLKQKWWPHMGRCDLTSHASAQADGKSLKLHSFAGVFCILAI
GLLLACLVAALELWWNSNRCHQETPKEDKEVNLEQVHRRMNSLMDEDIAHKQISPASIEL
SALEMGGLAPTQTLEPTREYQNTQLSVSTFLPEQSSHGTSRTLSSGPSSNLPLPLSSSAT
MPSMQCKHRSPNGGLFRQSPVKTPIPMSFQPVPGGVLPEALDTSHGTSI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011640|Glutamate receptor ionotropic, delta-1 (GRID1)
ATGGAAGCGCTGACGCTGTGGCTTCTCCCCTGGATATGCCAGTGCGTGTCGGTGCGGGCC
GACTCCATCATCCACATCGGTGCCATCTTCGAGGAGAACGCGGCCAAGGACGACAGGGTG
TTCCAGTTGGCGGTATCCGACCTGAGCCTCAACGATGACATCCTGCAGAGCGAGAAGATC
ACCTACTCCATCAAGGTCATCGAGGCCAACAACCCATTCCAGGCTGTGCAGGAAGCCTGT
GACCTCATGACCCAGGGGATTTTGGCCTTGGTCACGTCCACTGGCTGTGCATCTGCCAAT
GCCCTGCAGTCCCTCACGGATGCCATGCACATCCCACACCTCTTTGTCCAGCGCAACCCG
GGAGGGTCGCCACGCACCGCATGCCACCTGAACCCCAGCCCCGATGGTGAGGCCTACACA
CTGGCTTCGAGACCACCCGTCCGCCTCAATGATGTCATGCTCAGGCTGGTGACGGAGCTG
CGCTGGCAGAAGTTCGTCATGTTCTACGACAGCGAGTATGATATCCGTGGGCTTCAAAGC
TTTCTGGACCAGGCCTCGCGGCTGGGCCTTGACGTCTCTTTACAAAAGGTGGACAAGAAC
ATTAGCCACGTATTCACCAGCCTCTTCACCACGATGAAGACAGAGGAGCTGAATCGCTAC
CGGGACACGCTTCGCCGCGCCATCCTGCTGCTCAGCCCACAGGGAGCCCACTCCTTCATC
AACGAGGCCGTGGAGACCAACCTGGCTTCCAAGGACAGCCACTGGGTCTTTGTGAATGAG
GAAATCAGTGACCCGGAGATCCTGGATCTGGTCCATAGTGCCCTTGGAAGGATGACCGTG
GTCCGGCAAATCTTTCCGTCTGCAAAGGACAATCAGAAATGCACGAGGAACAACCACCGC
ATCTCCTCCCTGCTCTGCGACCCCCAGGAAGGCTACCTCCAGATGCTGCAGATCTCCAAC
CTCTATCTGTATGACAGTGTTCTGATGCTGGCCAACGCCTTTCACAGGAAGCTGGAGGAC
CGGAAGTGGCATAGCATGGCGAGCCTCAACTGCATACGGAAATCCACTAAGCCATGGAAT
GGTGGGAGGTCCATGCTGGATACCATCAAAAAGGGCCACATCACTGGCCTCACTGGGGTG
ATGGAGTTTCGGGAGGACAGTTCGAATCCCTATGTCCAGTTTGAAATCCTTGGCACTACC
TATAGTGAGACTTTTGGCAAAGACATGCGCAAGTTGGCGACATGGGACTCAGAGAAGGGC
TTGAATGGCAGCTTGCAAGAGAGGCCCATGGGCAGCCGCCTCCAAGGATTGACTCTTAAA
GTGGTGACTGTCTTGGAAGAGCCTTTCGTGATGGTGGCTGAGAACATCCTAGGACAGCCC
AAGCGCTACAAAGGGTTCTCCATAGATGTCCTGGATGCACTGGCCAAGGCTCTGGGCTTT
AAATATGAGATTTACCAAGCCCCTGATGGCAGGTACGGTCACCAGCTCCATAACACCTCC
TGGAACGGGATGATCGGGGAGCTCATCAGCAAGAGAGCAGACTTGGCCATCTCTGCCATC
ACCATCACCCCAGAGAGGGAGAGCGTTGTGGACTTCAGCAAGCGGTACATGGACTATTCA
GTGGGGATTCTAATTAAGAAGCCCGAGGAGAAAATCAGCATCTTCTCCCTCTTTGCTCCA
TTTGATTTCGCTGTGTGGGCCTGCATTGCAGCAGCCATCCCTGTGGTTGGTGTGCTGATA
TTTGTGTTGAACAGGATACAGGCTGTGAGGGCTCAGAGTGCTGCCCAGCCCAGGCCGTCA
GCTTCTGCCACTCTGCACAGCGCCATCTGGATTGTCTATGGAGCCTTCGTACAGCAAGGT
GGCGAATCTTCCGTGAACTCCATGGCCATGCGCATCGTGATGGGCAGCTGGTGGCTCTTC
ACGCTCATTGTGTGCTCCTCCTACACAGCCAACCTTGCTGCCTTCCTCACAGTGTCCAGG
ATGGACAACCCCATAAGGACTTTCCAGGACCTGTCCAAACAAGTGGAAATGTCTTATGGC
ACTGTCCGGGATTCTGCTGTATATGAGTACTTCCGAGCCAAGGGCACCAACCCCCTGGAG
CAGGACAGCACGTTTGCTGAACTCTGGCGGACCATCAGCAAGAACGGAGGGGCTGACAAC
TGCGTGTCCAGTCCTTCAGAAGGCATCAGGAAGGCAAAGAAGGGGAACTACGCCTTCCTG
TGGGATGTGGCCGTGGTGGAATACGCAGCCCTGACGGATGACGACTGCTCGGTGACTGTC
ATCGGCAACAGCATCAGCAGCAAGGGTTACGGGATTGCCCTGCAGCATGGCAGCCCCTAC
AGGGACCTCTTCTCCCAGAGGATCCTGGAGCTGCAGGACACAGGGGACCTGGATGTGCTG
AAGCAGAAGTGGTGGCCGCACATGGGCCGCTGTGACCTCACCAGCCATGCCAGCGCCCAG
GCCGACGGCAAATCCCTCAAGCTGCACAGCTTCGCCGGGGTCTTCTGCATCCTGGCCATT
GGCCTGCTCCTGGCCTGCCTGGTGGCTGCCCTGGAGTTGTGGTGGAACAGCAACCGGTGC
CACCAGGAGACCCCCAAGGAGGACAAAGAAGTGAACTTGGAGCAGGTCCACCGGCGCATG
AACAGCCTCATGGATGAAGACATTGCTCACAAGCAGATTTCCCCAGCGTCGATTGAGCTC
TCGGCCCTGGAGATGGGGGGCCTGGCTCCCACCCAGACCTTGGAGCCGACACGGGAGTAC
CAGAACACCCAGCTCTCGGTCAGCACCTTTCTGCCAGAGCAGAGCAGCCATGGCACCAGC
CGGACACTCTCATCAGGGCCCAGCAGCAACCTGCCGCTGCCGCTGAGCAGCTCGGCGACC
ATGCCCTCCATGCAGTGCAAACACAGGTCACCCAACGGGGGGCTGTTCCGGCAGAGCCCG
GTGAAGACCCCCATCCCCATGTCCTTCCAGCCCGTGCCTGGAGGCGTCCTTCCAGAGGCT
CTGGACACCTCCCACGGGACCTCCATCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>ionotropic glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ionotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>social behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000030</id>
      <name>Cystine/glutamate transporter</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16719820</pubmed-id>
            <citation>Natale NR, Magnusson KR, Nelson JK: Can selective ligands for glutamate binding proteins be rationally designed? Curr Top Med Chem. 2006;6(8):823-47.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9UPY5" source="Swiss-Prot">
    <name>Cystine/glutamate transporter</name>
    <general-function>Cystine:glutamate antiporter activity</general-function>
    <specific-function>Sodium-independent, high-affinity exchange of anionic amino acids with high specificity for anionic form of cystine and glutamate.</specific-function>
    <gene-name>SLC7A11</gene-name>
    <locus>4q28-q32</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>44-64
75-95
114-134
159-179
190-210
235-255
266-286
318-338
365-385
388-408
423-443
450-470</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.51</theoretical-pi>
    <molecular-weight>55422.44</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:11059</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC7A11</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB026891</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5668545</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>902</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9UPY5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>XCT_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Amino acid transport system xc-</synonym>
      <synonym>Calcium channel blocker resistance protein CCBR1</synonym>
      <synonym>Solute carrier family 7 member 11</synonym>
      <synonym>xCT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0015999|Cystine/glutamate transporter
MVRKPVVSTISKGGYLQGNVNGRLPSLGNKEPPGQEKVQLKRKVTLLRGVSIIIGTIIGA
GIFISPKGVLQNTGSVGMSLTIWTVCGVLSLFGALSYAELGTTIKKSGGHYTYILEVFGP
LPAFVRVWVELLIIRPAATAVISLAFGRYILEPFFIQCEIPELAIKLITAVGITVVMVLN
SMSVSWSARIQIFLTFCKLTAILIIIVPGVMQLIKGQTQNFKDAFSGRDSSITRLPLAFY
YGMYAYAGWFYLNFVTEEVENPEKTIPLAICISMAIVTIGYVLTNVAYFTTINAEELLLS
NAVAVTFSERLLGNFSLAVPIFVALSCFGSMNGGVFAVSRLFYVASREGHLPEILSMIHV
RKHTPLPAVIVLHPLTMIMLFSGDLDSLLNFLSFARWLFIGLAVAGLIYLRYKCPDMHRP
FKVPLFIPALFSFTCLFMVALSLYSDPFSTGIGFVITLTGVPAYYLFIIWDKKPRWFRIM
SEKITRTLQIILEVVPEEDKL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016000|Cystine/glutamate transporter (SLC7A11)
ATGGTCAGAAAGCCTGTTGTGTCCACCATCTCCAAAGGAGGTTACCTGCAGGGAAATGTT
AACGGGAGGCTGCCTTCCCTGGGCAACAAGGAGCCACCTGGGCAGGAGAAAGTGCAGCTG
AAGAGGAAAGTCACTTTACTGAGGGGAGTCTCCATTATCATTGGCACCATCATTGGAGCA
GGAATCTTCATCTCTCCTAAGGGCGTGCTCCAGAACACGGGCAGCGTGGGCATGTCTCTG
ACCATCTGGACGGTGTGTGGGGTCCTGTCACTATTTGGAGCTTTGTCTTATGCTGAATTG
GGAACAACTATAAAGAAATCTGGAGGTCATTACACATATATTTTGGAAGTCTTTGGTCCA
TTACCAGCTTTTGTACGAGTCTGGGTGGAACTCCTCATAATACGCCCTGCAGCTACTGCT
GTGATATCCCTGGCATTTGGACGCTACATTCTGGAACCATTTTTTATTCAATGTGAAATC
CCTGAACTTGCGATCAAGCTCATTACAGCTGTGGGCATAACTGTAGTGATGGTCCTAAAT
AGCATGAGTGTCAGCTGGAGCGCCCGGATCCAGATTTTCTTAACCTTTTGCAAGCTCACA
GCAATTCTGATAATTATAGTCCCTGGAGTTATGCAGCTAATTAAAGGTCAAACGCAGAAC
TTTAAAGACGCCTTTTCAGGAAGAGATTCAAGTATTACGCGGTTGCCACTGGCTTTTTAT
TATGGAATGTATGCATATGCTGGCTGGTTTTACCTCAACTTTGTTACTGAAGAAGTAGAA
AACCCTGAAAAAACCATTCCCCTTGCAATATGTATATCCATGGCCATTGTCACCATTGGC
TATGTGCTGACAAATGTGGCCTACTTTACGACCATTAATGCTGAGGAGCTGCTGCTTTCA
AATGCAGTGGCAGTGACCTTTTCTGAGCGGCTACTGGGAAATTTCTCATTAGCAGTTCCG
ATCTTTGTTGCCCTCTCCTGCTTTGGCTCCATGAACGGTGGTGTGTTTGCTGTCTCCAGG
TTATTCTATGTTGCGTCTCGAGAGGGTCACCTTCCAGAAATCCTCTCCATGATTCATGTC
CGCAAGCACACTCCTCTACCAGCTGTTATTGTTTTGCACCCTTTGACAATGATAATGCTC
TTCTCTGGAGACCTCGACAGTCTTTTGAATTTCCTCAGTTTTGCCAGGTGGCTTTTTATT
GGGCTGGCAGTTGCTGGGCTGATTTATCTTCGATACAAATGCCCAGATATGCATCGTCCT
TTCAAGGTGCCACTGTTCATCCCAGCTTTGTTTTCCTTCACATGCCTCTTCATGGTTGCC
CTTTCCCTCTATTCGGACCCATTTAGTACAGGGATTGGCTTCGTCATCACTCTGACTGGA
GTCCCTGCGTATTATCTCTTTATTATATGGGACAAGAAACCCAGGTGGTTTAGAATAATG
TCAGAGAAAATAACCAGAACATTACAAATAATACTGGAAGTTGTACCAGAAGAAGATAAG
TTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13520</identifier>
        <name>AA_permease_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoskeleton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>rough endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>cystine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lens fiber cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet aggregation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>brain development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-glutamate transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0004640</id>
      <name>Carboxypeptidase Q</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y646" source="Swiss-Prot">
    <name>Carboxypeptidase Q</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Carboxypeptidase that may play an important role in the hydrolysis of circulating peptides. Catalyzes the hydrolysis of dipeptides with unsubstituted terminals into amino acids. May play a role in the liberation of thyroxine hormone from its thyroglobulin (Tg) precursor.</specific-function>
    <gene-name>CPQ</gene-name>
    <locus/>
    <cellular-location>Endoplasmic reticulum</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi/>
    <molecular-weight>51887.185</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16910</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y646</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CBPQ_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.17.-</synonym>
      <synonym>LCH1</synonym>
      <synonym>Lysosomal dipeptidase</synonym>
      <synonym>PGCP</synonym>
      <synonym>Plasma glutamate carboxypeptidase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0009559|Carboxypeptidase Q
MKFLIFAFFGGVHLLSLCSGKAICKNGISKRTFEEIKEEIASCGDVAKAIINLAVYGKAQ
NRSYERLALLVDTVGPRLSGSKNLEKAIQIMYQNLQQDGLEKVHLEPVRIPHWERGEESA
VMLEPRIHKIAILGLGSSIGTPPEGITAEVLVVTSFDELQRRASEARGKIVVYNQPYINY
SRTVQYRTQGAVEAAKVGALASLIRSVASFSIYSPHTGIQEYQDGVPKIPTACITVEDAE
MMSRMASHGIKIVIQLKMGAKTYPDTDSFNTVAEITGSKYPEQVVLVSGHLDSWDVGQGA
MDDGGGAFISWEALSLIKDLGLRPKRTLRLVLWTAEEQGGVGAFQYYQLHKVNISNYSLV
MESDAGTFLPTGLQFTGSEKARAIMEEVMSLLQPLNITQVLSHGEGTDINFWIQAGVPGA
SLLDDLYKYFFFHHSHGDTMTVMDPKQMNVAAAVWAVVSYVVADMEEMLPRS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0013236|Carboxypeptidase Q (CPQ)
ATGAAATTCCTTATCTTCGCATTTTTCGGTGGTGTTCACCTTTTATCCCTGTGCTCTGGG
AAAGCTATATGCAAGAATGGCATCTCTAAGAGGACTTTTGAAGAAATAAAAGAAGAAATA
GCCAGCTGTGGAGATGTTGCTAAAGCAATCATCAACCTAGCTGTTTATGGTAAAGCCCAG
AACAGATCCTATGAGCGATTGGCACTTCTGGTTGATACTGTTGGACCCAGACTGAGTGGC
TCCAAGAACCTAGAAAAAGCCATCCAAATTATGTACCAAAACCTGCAGCAAGATGGGCTG
GAGAAAGTTCACCTGGAGCCAGTGAGAATACCCCACTGGGAGAGGGGAGAAGAATCAGCT
GTGATGCTGGAGCCAAGAATTCATAAGATAGCCATCCTGGGTCTTGGCAGCAGCATTGGG
ACTCCTCCAGAAGGCATTACAGCAGAAGTTCTGGTGGTGACCTCTTTCGATGAACTGCAG
AGAAGGGCCTCAGAAGCAAGAGGGAAGATTGTTGTTTATAACCAACCTTACATCAACTAC
TCAAGGACGGTGCAATACCGAACGCAGGGGGCGGTGGAAGCTGCCAAGGTGGGGGCTTTG
GCATCTCTCATTCGATCCGTGGCCTCCTTCTCCATCTACAGTCCTCACACAGGTATTCAG
GAATACCAGGATGGCGTGCCCAAGATTCCAACAGCCTGTATTACGGTGGAAGATGCAGAA
ATGATGTCAAGAATGGCTTCTCATGGGATCAAAATTGTCATTCAGCTAAAGATGGGGGCA
AAGACCTACCCAGATACTGATTCCTTCAACACTGTAGCAGAGATCACTGGGAGCAAATAT
CCAGAACAGGTTGTACTGGTCAGTGGACATCTGGACAGCTGGGATGTTGGGCAGGGTGCC
ATGGATGATGGCGGTGGAGCCTTTATATCATGGGAAGCACTCTCACTTATTAAAGATCTT
GGGCTGCGTCCAAAGAGGACTCTGCGGCTGGTGCTCTGGACTGCAGAAGAACAAGGTGGA
GTTGGTGCCTTCCAGTATTATCAGTTACACAAGGTAAATATTTCCAACTACAGTCTGGTG
ATGGAGTCTGACGCAGGAACCTTCTTACCCACTGGGCTGCAATTCACTGGCAGTGAAAAG
GCCAGGGCCATCATGGAGGAGGTTATGAGCCTGCTGCAGCCCCTCAATATCACTCAGGTC
CTGAGCCATGGAGAAGGGACAGACATCAACTTTTGGATCCAAGCTGGAGTGCCTGGAGCC
AGTCTACTTGATGACTTATACAAGTATTTCTTCTTCCATCACTCCCACGGAGACACCATG
ACTGTCATGGATCCAAAGCAGATGAATGTTGCTGCTGCTGTTTGGGCTGTTGTTTCTTAT
GTTGTTGCAGACATGGAAGAAATGCTGCCTAGGTCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04389</identifier>
        <name>Peptidase_M28</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>lysosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metallodipeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>carboxypeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>thyroid hormone generation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proteolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>peptide catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tissue regeneration</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000603</id>
      <name>Phosphoserine aminotransferase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>10024454</pubmed-id>
            <citation>Hester G, Stark W, Moser M, Kallen J, Markovic-Housley Z, Jansonius JN: Crystal structure of phosphoserine aminotransferase from Escherichia coli at 2.3 A resolution: comparison of the unligated enzyme and a complex with alpha-methyl-l-glutamate. J Mol Biol. 1999 Feb 26;286(3):829-50.</citation>
          </article>
          <article>
            <pubmed-id>15103612</pubmed-id>
            <citation>Katsura Y, Shirouzu M, Yamaguchi H, Ishitani R, Nureki O, Kuramitsu S, Hayashi H, Yokoyama S: Crystal structure of a putative aspartate aminotransferase belonging to subgroup IV. Proteins. 2004 May 15;55(3):487-92.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y617" source="Swiss-Prot">
    <name>Phosphoserine aminotransferase</name>
    <general-function>O-phospho-l-serine:2-oxoglutarate aminotransferase activity</general-function>
    <specific-function>Catalyzes the reversible conversion of 3-phosphohydroxypyruvate to phosphoserine and of 3-hydroxy-2-oxo-4-phosphonooxybutanoate to phosphohydroxythreonine.</specific-function>
    <gene-name>PSAT1</gene-name>
    <locus>9q21.2</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>40422.355</molecular-weight>
    <chromosome-location>9</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19129</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PSAT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF113132</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>5326802</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y617</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>SERC_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.6.1.52</synonym>
      <synonym>Phosphohydroxythreonine aminotransferase</synonym>
      <synonym>PSA</synonym>
      <synonym>PSAT</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001203|Phosphoserine aminotransferase
MDAPRQVVNFGPGPAKLPHSVLLEIQKELLDYKGVGISVLEMSHRSSDFAKIINNTENLV
RELLAVPDNYKVIFLQGGGCGQFSAVPLNLIGLKAGRCADYVVTGAWSAKAAEEAKKFGT
INIVHPKLGSYTKIPDPSTWNLNPDASYVYYCANETVHGVEFDFIPDVKGAVLVCDMSSN
FLSKPVDVSKFGVIFAGAQKNVGSAGVTVVIVRDDLLGFALRECPSVLEYKVQAGNSSLY
NTPPCFSIYVMGLVLEWIKNNGGAAAMEKLSSIKSQTIYEIIDNSQGFYVCPVEPQNRSK
MNIPFRIGNAKGDDALEKRFLDKALELNMLSLKGHRSVGGIRASLYNAVTIEDVQKLAAF
MKKFLEMHQL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016150|Phosphoserine aminotransferase (PSAT1)
ATGGACGCCCCCAGGCAGGTGGTCAACTTTGGGCCTGGTCCCGCCAAGCTGCCGCACTCA
GTGTTGTTAGAGATACAAAAGGAATTATTAGACTACAAAGGAGTTGGCATTAGTGTTCTT
GAAATGAGTCACAGGTCATCAGATTTTGCCAAGATTATTAACAATACAGAGAATCTTGTG
CGGGAATTGCTAGCTGTTCCAGACAACTATAAGGTGATTTTTCTGCAAGGAGGTGGGTGC
GGCCAGTTCAGTGCTGTCCCCTTAAACCTCATTGGCTTGAAAGCAGGAAGGTGTGCTGAC
TATGTGGTGACAGGAGCTTGGTCAGCTAAGGCCGCAGAAGAAGCCAAGAAGTTTGGGACT
ATAAATATCGTTCACCCTAAACTTGGGAGTTATACAAAAATTCCAGATCCAAGCACCTGG
AACCTCAACCCAGATGCCTCCTACGTGTATTATTGCGCAAATGAGACGGTGCATGGTGTG
GAGTTTGACTTTATACCCGATGTCAAGGGAGCAGTACTGGTTTGTGACATGTCCTCAAAC
TTCCTGTCCAAGCCAGTGGATGTTTCCAAGTTTGGTGTGATTTTTGCTGGTGCCCAGAAG
AATGTTGGCTCTGCTGGGGTCACCGTGGTGATTGTCCGTGATGACCTGCTGGGGTTTGCC
CTCCGAGAGTGCCCCTCGGTCCTGGAATACAAGGTGCAGGCTGGAAACAGCTCCTTGTAC
AACACGCCTCCATGTTTCAGCATCTACGTCATGGGCTTGGTTCTGGAGTGGATTAAAAAC
AATGGAGGTGCCGCGGCCATGGAGAAGCTTAGCTCCATCAAATCTCAAACAATTTATGAG
ATTATTGATAATTCTCAAGGATTCTACGTGTCTGTGGGAGGCATCCGGGCCTCTCTGTAT
AATGCTGTCACAATTGAAGACGTTCAGAAGCTGGCCGCCTTCATGAAAAAATTTTTGGAG
ATGCATCAGCTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00266</identifier>
        <name>Aminotran_5</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>O-phospho-L-serine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-serine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyridoxine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000180</id>
      <name>Glutamate dehydrogenase 1, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>8288265</pubmed-id>
            <citation>Anagnou NP, Seuanez H, Modi W, O'Brien SJ, Papamatheakis J, Moschonas NK: Chromosomal mapping of two members of the human glutamate dehydrogenase (GLUD) gene family to chromosomes 10q22.3-q23 and Xq22-q23. Hum Hered. 1993 Nov-Dec;43(6):351-6.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00367" source="Swiss-Prot">
    <name>Glutamate dehydrogenase 1, mitochondrial</name>
    <general-function>Nad+ binding</general-function>
    <specific-function>Mitochondrial glutamate dehydrogenase that converts L-glutamate into alpha-ketoglutarate. Plays a key role in glutamine anaplerosis by producing alpha-ketoglutarate, an important intermediate in the tricarboxylic acid cycle. May be involved in learning and memory reactions by increasing the turnover of the excitatory neurotransmitter glutamate (By similarity).</specific-function>
    <gene-name>GLUD1</gene-name>
    <locus>10q23.3</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.91</theoretical-pi>
    <molecular-weight>61397.315</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4335</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLUD1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X07674</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31707</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P00367</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DHE3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.4.1.3</synonym>
      <synonym>GDH 1</synonym>
      <synonym>GLUD</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000359|Glutamate dehydrogenase 1, mitochondrial
MYRYLGEALLLSRAGPAALGSASADSAALLGWARGQPAAAPQPGLALAARRHYSEAVADR
EDDPNFFKMVEGFFDRGASIVEDKLVEDLRTRESEEQKRNRVRGILRIIKPCNHVLSLSF
PIRRDDGSWEVIEGYRAQHSQHRTPCKGGIRYSTDVSVDEVKALASLMTYKCAVVDVPFG
GAKAGVKINPKNYTDNELEKITRRFTMELAKKGFIGPGIDVPAPDMSTGEREMSWIADTY
ASTIGHYDINAHACVTGKPISQGGIHGRISATGRGVFHGIENFINEASYMSILGMTPGFG
DKTFVVQGFGNVGLHSMRYLHRFGAKCIAVGESDGSIWNPDGIDPKELEDFKLQHGSILG
FPKAKPYEGSILEADCDILIPAASEKQLTKSNAPRVKAKIIAEGANGPTTPEADKIFLER
NIMVIPDLYLNAGGVTVSYFEWLKNLNHVSYGRLTFKYERDSNYHLLMSVQESLERKFGK
HGGTIPIVPTAEFQDRISGASEKDIVHSGLAYTMERSARQIMRTAMKYNLGLDLRTAAYV
NAIEKVFKVYNEAGVTFT</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010191|Glutamate dehydrogenase 1, mitochondrial (GLUD1)
ATGTACCGCTACCTGGGCGAAGCGCTGTTGCTGTCCCGGGCCGGGCCCGCTGCCCTGGGC
TCGGCGTCCGCCGACTCGGCCGCGTTGCTGGGCTGGGCCCGGGGACAGCCCGCCGCCGCC
CCGCAGCCGGGGCTGGCATTGGCCGCCCGGCGCCACTACAGCGAGGCGGTGGCCGACCGC
GAGGACGACCCCAACTTCTTCAAGATGGTGGAGGGCTTCTTCGATCGCGGCGCCAGCATC
GTGGAGGACAAGCTGGTGGAGGACCTGAGGACCCGGGAGAGCGAGGAGCAGAAGCGGAAC
CGGGTGCGCGGCATCCTGCGGATCATCAAGCCCTGCAACCATGTGCTGAGTCTCTCCTTC
CCCATCCGGCGCGACGACGGCTCCTGGGAGGTCATCGAAGGCTACCGGGCCCAGCACAGC
CAGCACCGCACGCCCTGCAAGGGAGGTATCCGTTACAGCACTGATGTGAGTGTAGATGAA
GTAAAAGCTTTGGCTTCTCTGATGACATACAAGTGTGCAGTGGTTGATGTGCCGTTTGGG
GGTGCTAAAGCTGGTGTTAAGATCAATCCCAAGAACTATACTGATAATGAATTGGAAAAG
ATCACAAGGAGGTTCACCATGGAGCTAGCAAAAAAGGGCTTTATTGGTCCTGGCATTGAT
GTGCCTGCTCCAGACATGAGCACAGGTGAGCGGGAGATGTCCTGGATCGCTGATACCTAT
GCCAGCACCATAGGGCACTATGATATTAATGCACACGCCTGTGTTACTGGTAAACCCATC
AGCCAAGGGGGAATCCATGGACGCATCTCTGCTACTGGCCGTGGTGTCTTCCATGGGATT
GAAAATTTCATCAATGAAGCTTCTTACATGAGCATTTTAGGAATGACACCAGGGTTTGGA
GATAAAACATTTGTTGTTCAGGGATTTGGTAATGTGGGCCTACACTCTATGAGATATTTA
CATCGTTTTGGTGCTAAATGTATTGCTGTTGGTGAGTCTGATGGGAGTATATGGAATCCA
GATGGTATTGACCCAAAGGAACTGGAAGACTTCAAATTGCAACATGGGTCCATTCTGGGC
TTCCCCAAGGCAAAGCCCTATGAAGGAAGCATCTTGGAGGCCGACTGTGACATACTGATC
CCAGCTGCCAGTGAGAAGCAGTTGACCAAATCCAACGCACCCAGAGTCAAAGCCAAGATC
ATTGCTGAAGGTGCCAATGGGCCAACAACTCCAGAAGCTGACAAGATCTTCCTGGAGAGA
AACATTATGGTTATTCCAGATCTCTACTTGAATGCTGGAGGAGTGACAGTATCTTACTTT
GAGTGGCTGAAGAATCTAAATCATGTCAGCTATGGCCGTTTGACCTTCAAATATGAAAGG
GATTCTAACTACCACTTGCTCATGTCTGTTCAAGAGAGTTTAGAAAGAAAATTTGGAAAG
CATGGTGGAACTATTCCCATTGTACCCACGGCAGAGTTCCAAGACAGGATATCGGGTGCA
TCTGAGAAAGACATCGTGCACTCTGGCTTGGCATACACAATGGAGCGTTCTGCCAGGCAA
ATTATGCGCACAGCCATGAAGTATAACCTGGGATTGGACCTGAGAACAGCTGCCTATGTT
AATGCCATTGAGAAAGTCTTCAAAGTGTACAATGAAGCTGGTGTGACCTTCACATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00208</identifier>
        <name>ELFV_dehydrog</name>
      </pfam>
      <pfam>
        <identifier>PF02812</identifier>
        <name>ELFV_dehydrog_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NAD+ binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>GTP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate dehydrogenase (NAD+) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate dehydrogenase [NAD(P)+] activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>leucine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>substantia nigra development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tricarboxylic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamine metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000346</id>
      <name>Glutamate receptor ionotropic, kainate 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9254673</pubmed-id>
            <citation>Sahara Y, Noro N, Iida Y, Soma K, Nakamura Y: Glutamate receptor subunits GluR5 and KA-2 are coexpressed in rat trigeminal ganglion neurons. J Neurosci. 1997 Sep 1;17(17):6611-20.</citation>
          </article>
          <article>
            <pubmed-id>13129570</pubmed-id>
            <citation>Valgeirsson J, Christensen JK, Kristensen AS, Pickering DS, Nielsen B, Fischer CH, Brauner-Osborne H, Nielsen EO, Krogsgaard-Larsen P, Madsen U: Synthesis and in vitro pharmacology at AMPA and kainate preferring glutamate receptors of 4-heteroarylmethylidene glutamate analogues. Bioorg Med Chem. 2003 Oct 1;11(20):4341-9.</citation>
          </article>
          <article>
            <pubmed-id>10513575</pubmed-id>
            <citation>Stensbol TB, Borre L, Johansen TN, Egebjerg J, Madsen U, Ebert B, Krogsgaard-Larsen P: Resolution, absolute stereochemistry and molecular pharmacology of the enantiomers of ATPA. Eur J Pharmacol. 1999 Sep 10;380(2-3):153-62.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P39086" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, kainate 1</name>
    <general-function>Voltage-gated cation channel activity</general-function>
    <specific-function>Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. May be involved in the transmission of light information from the retina to the hypothalamus.</specific-function>
    <gene-name>GRIK1</gene-name>
    <locus/>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>577-597
654-674
835-855</transmembrane-regions>
    <signal-regions>1-30</signal-regions>
    <theoretical-pi>7.09</theoretical-pi>
    <molecular-weight>103979.665</molecular-weight>
    <chromosome-location>21</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4579</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIK1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L19058</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>455448</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>450</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>450</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P39086</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIK1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAA3</synonym>
      <synonym>Excitatory amino acid receptor 3</synonym>
      <synonym>GluK1</synonym>
      <synonym>GluR-5</synonym>
      <synonym>GLUR5</synonym>
      <synonym>Glutamate receptor 5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000689|Glutamate receptor ionotropic, kainate 1
MEHGTLLAQPGLWTRDTSWALLYFLCYILPQTAPQVLRIGGIFETVENEPVNVEELAFKF
AVTSINRNRTLMPNTTLTYDIQRINLFDSFEASRRACDQLALGVAALFGPSHSSSVSAVQ
SICNALEVPHIQTRWKHPSVDNKDLFYINLYPDYAAISRAILDLVLYYNWKTVTVVYEDS
TGLIRLQELIKAPSRYNIKIKIRQLPSGNKDAKPLLKEMKKGKEFYVIFDCSHETAAEIL
KQILFMGMMTEYYHYFFTTLDLFALDLELYRYSGVNMTGFRLLNIDNPHVSSIIEKWSME
RLQAPPRPETGLLDGMMTTEAALMYDAVYMVAIASHRASQLTVSSLQCHRHKPWRLGPRF
MNLIKEARWDGLTGHITFNKTNGLRKDFDLDIISLKEEGTEKAAGEVSKHLYKVWKKIGI
WNSNSGLNMTDSNKDKSSNITDSLANRTLIVTTILEEPYVMYRKSDKPLYGNDRFEGYCL
DLLKELSNILGFIYDVKLVPDGKYGAQNDKGEWNGMVKELIDHRADLAVAPLTITYVREK
VIDFSKPFMTLGISILYRKPNGTNPGVFSFLNPLSPDIWMYVLLACLGVSCVLFVIARFT
PYEWYNPHPCNPDSDVVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTL
IIISSYTANLAAFLTVERMESPIDSADDLAKQTKIEYGAVRDGSTMTFFKKSKISTYEKM
WAFMSSRQQTALVRNSDEGIQRVLTTDYALLMESTSIEYVTQRNCNLTQIGGLIDSKGYG
VGTPIGSPYRDKITIAILQLQEEGKLHMMKEKWWRGNGCPEEDNKEASALGVENIGGIFI
VLAAGLVLSVFVAIGEFIYKSRKNNDIEQAFCFFYGLQCKQTHPTNSTSGTTLSTDLECG
KLIREERGIRKQSSVHTV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010256|Glutamate receptor ionotropic, kainate 1 (GRIK1)
ATGGAGCACGGCACACTCCTCGCCCAGCCCGGGCTCTGGACCAGGGACACCAGCTGGGCA
CTCCTCTATTTCCTCTGCTATATCCTCCCTCAGACCGCCCCGCAAGTACTCAGGATCGGA
GGGATTTTTGAAACAGTGGAAAATGAGCCTGTTAATGTTGAAGAATTAGCTTTCAAGTTT
GCAGTCACCAGCATTAACAGAAACCGAACCCTGATGCCTAACACCACATTAACCTATGAC
ATCCAGAGAATTAACCTTTTTGATAGTTTTGAAGCCTCGCGGAGAGCATGTGACCAGCTG
GCTCTTGGTGTGGCTGCTCTCTTTGGCCCTTCCCATAGCTCCTCCGTCAGTGCTGTGCAG
TCTATTTGCAATGCTCTCGAAGTTCCACACATACAGACCCGCTGGAAACACCCCTCGGTG
GACAACAAAGATTTGTTTTACATCAACCTTTACCCAGATTATGCAGCTATCAGCAGGGCG
ATCCTGGATCTGGTCCTCTATTACAACTGGAAAACAGTGACAGTGGTGTATGAAGACAGC
ACAGGTCTAATTCGTCTACAAGAGCTCATCAAAGCTCCCTCCAGATATAATATTAAAATC
AAAATCCGCCAGCTGCCCTCTGGGAATAAAGATGCCAAGCCTTTACTCAAGGAGATGAAG
AAAGGCAAGGAGTTCTATGTGATATTTGATTGTTCACATGAAACAGCCGCTGAAATCCTT
AAGCAGATTCTGTTCATGGGCATGATGACCGAGTACTATCACTACTTTTTCACAACCCTG
GACTTATTTGCTTTGGATCTGGAACTCTATAGGTACAGTGGCGTAAACATGACCGGGTTT
CGGCTGCTTAACATTGACAACCCTCACGTGTCATCCATCATTGAGAAGTGGTCCATGGAG
AGACTGCAGGCCCCACCCAGGCCCGAGACTGGCCTTTTGGATGGCATGATGACAACTGAA
GCGGCTCTGATGTACGATGCTGTGTACATGGTGGCCATTGCCTCGCACCGGGCATCCCAG
CTGACCGTCAGCTCCCTGCAGTGCCATAGACATAAGCCATGGCGCCTCGGACCCAGATTT
ATGAACCTGATCAAAGAGGCCCGGTGGGATGGCTTGACTGGGCATATCACCTTTAATAAA
ACCAATGGCTTGAGGAAGGATTTTGATCTGGACATTATTAGTCTCAAAGAGGAAGGAACT
GAAAAGGCTGCTGGCGAAGTGTCTAAACACTTGTATAAAGTGTGGAAGAAGATTGGGATT
TGGAATTCCAACAGTGGGCTTAACATGACGGACAGCAACAAAGACAAGTCCAGCAATATC
ACTGATTCATTGGCCAACAGAACACTCATTGTCACCACCATTCTGGAAGAACCCTATGTT
ATGTACAGGAAATCTGATAAGCCTCTATATGGAAATGACAGATTTGAAGGATATTGCCTA
GACCTGTTGAAAGAATTGTCAAACATCCTGGGTTTCATTTATGATGTTAAACTAGTTCCC
GATGGCAAATATGGGGCCCAGAATGACAAAGGGGAGTGGAACGGGATGGTTAAAGAACTC
ATAGATCACAGGGCTGACCTGGCAGTGGCTCCTCTTACCATCACCTACGTGCGGGAGAAA
GTCATTGACTTCTCCAAACCCTTCATGACCCTAGGCATCAGCATTCTCTACCGGAAGCCC
AATGGTACCAATCCAGGCGTTTTCTCCTTCCTCAACCCCCTGTCTCCAGATATTTGGATG
TATGTGCTCTTAGCCTGCTTGGGAGTCAGCTGTGTACTCTTTGTGATTGCAAGGTTTACA
CCCTACGAGTGGTATAACCCCCACCCATGCAACCCTGACTCAGACGTGGTGGAAAACAAT
TTTACTTTACTAAATAGTTTCTGGTTTGGAGTTGGAGCTCTCATGCAGCAAGGATCAGAG
CTGATGCCCAAAGCTCTATCGACCAGAATAGTTGGAGGGATATGGTGGTTTTTCACCCTA
ATCATCATTTCATCCTACACGGCCAATCTGGCTGCCTTCTTGACAGTAGAGAGAATGGAA
TCCCCCATAGATTCGGCAGATGATCTGGCAAAGCAAACCAAGATAGAATATGGGGCGGTT
AGAGATGGATCAACAATGACCTTCTTCAAGAAATCAAAAATCTCCACCTATGAGAAGATG
TGGGCTTTCATGAGCAGCAGGCAGCAGACCGCCCTGGTAAGAAACAGTGATGAGGGGATC
CAGAGAGTGCTCACCACAGACTACGCGCTGCTGATGGAGTCCACCAGCATTGAGTATGTG
ACGCAGAGAAACTGCAACCTCACTCAGATCGGGGGCCTCATTGACTCCAAAGGTTACGGA
GTGGGAACACCTATTGGTTCTCCTTACCGGGATAAAATTACTATTGCTATTCTTCAACTC
CAAGAAGAAGGGAAGCTGCATATGATGAAAGAGAAGTGGTGGCGTGGGAATGGCTGCCCC
GAGGAAGACAACAAAGAAGCCAGTGCCCTGGGAGTGGAAAATATTGGAGGCATCTTCATT
GTTCTGGCTGCCGGACTGGTCCTTTCTGTATTTGTAGCTATTGGAGAATTCATATACAAA
TCACGGAAGAATAATGATATTGAACAGGCTTTTTGTTTCTTTTATGGACTGCAATGTAAG
CAAACCCATCCAACCAACTCCACTTCTGGAACTACTTTATCTACGGATTTAGAATGTGGT
AAATTAATTCGAGAGGAGAGAGGGATTCGAAAACAGTCCTCAGTTCATACTGTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>kainate selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kainate selective glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>voltage-gated cation channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>drug binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane depolarization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adult behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral response to pain</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>central nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>inhibitory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of synaptic transmission, GABAergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of gamma-aminobutyric acid secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of short-term neuronal synaptic plasticity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of synaptic transmission, GABAergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000640</id>
      <name>Glutamate receptor 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>1279377</pubmed-id>
            <citation>Stein E, Cox JA, Seeburg PH, Verdoorn TA: Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Mol Pharmacol. 1992 Nov;42(5):864-71.</citation>
          </article>
          <article>
            <pubmed-id>7679210</pubmed-id>
            <citation>Henley JM, Jenkins R, Hunt SP: Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacology. 1993 Jan;32(1):37-41.</citation>
          </article>
          <article>
            <pubmed-id>7838123</pubmed-id>
            <citation>Li F, Owens N, Verdoorn TA: Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Mol Pharmacol. 1995 Jan;47(1):148-54.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P42261" source="Swiss-Prot">
    <name>Glutamate receptor 1</name>
    <general-function>Pdz domain binding</general-function>
    <specific-function>Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.</specific-function>
    <gene-name>GRIA1</gene-name>
    <locus>5q33|5q31.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>537-557
610-630
806-826</transmembrane-regions>
    <signal-regions>1-18</signal-regions>
    <theoretical-pi>7.78</theoretical-pi>
    <molecular-weight>101505.245</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4571</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIA1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M64752</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183281</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>444</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>444</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P42261</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIA1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPA-selective glutamate receptor 1</synonym>
      <synonym>GluA1</synonym>
      <synonym>GLUH1</synonym>
      <synonym>GluR-1</synonym>
      <synonym>GluR-A</synonym>
      <synonym>GluR-K1</synonym>
      <synonym>GLUR1</synonym>
      <synonym>Glutamate receptor ionotropic, AMPA 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001276|Glutamate receptor 1
MQHIFAFFCTGFLGAVVGANFPNNIQIGGLFPNQQSQEHAAFRFALSQLTEPPKLLPQID
IVNISDSFEMTYRFCSQFSKGVYAIFGFYERRTVNMLTSFCGALHVCFITPSFPVDTSNQ
FVLQLRPELQDALISIIDHYKWQKFVYIYDADRGLSVLQKVLDTAAEKNWQVTAVNILTT
TEEGYRMLFQDLEKKKERLVVVDCESERLNAILGQIIKLEKNGIGYHYILANLGFMDIDL
NKFKESGANVTGFQLVNYTDTIPAKIMQQWKNSDARDHTRVDWKRPKYTSALTYDGVKVM
AEAFQSLRRQRIDISRRGNAGDCLANPAVPWGQGIDIQRALQQVRFEGLTGNVQFNEKGR
RTNYTLHVIEMKHDGIRKIGYWNEDDKFVPAATDAQAGGDNSSVQNRTYIVTTILEDPYV
MLKKNANQFEGNDRYEGYCVELAAEIAKHVGYSYRLEIVSDGKYGARDPDTKAWNGMVGE
LVYGRADVAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLDPLAYEIW
MCIVFAYIGVSVVLFLVSRFSPYEWHSEEFEEGRDQTTSDQSNEFGIFNSLWFSLGAFMQ
QGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDLAKQTEIA
YGTLEAGSTKEFFRRSKIAVFEKMWTYMKSAEPSVFVRTTEEGMIRVRKSKGKYAYLLES
TMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSALRNPVNLAVLKLNEQGLLDKLKNKW
WYDKGECGSGGGDSKDKTSALSLSNVAGVFYILIGGLGLAMLVALIEFCYKSRSESKRMK
GFCLIPQQSINEAIRTSTLPRNSGAGASSGGSGENGRVVSHDFPKSMQSIPCMSHSSGMP
LGATGL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010446|Glutamate receptor 1 (GRIA1)
ATGCAGCACATTTTTGCCTTCTTCTGCACCGGTTTCCTAGGCGCGGTAGTAGGTGCCAAT
TTCCCCAACAATATCCAGATCGGGGGATTATTTCCAAACCAGCAGTCACAGGAACATGCT
GCTTTTAGATTTGCTTTGTCGCAACTCACAGAGCCCCCGAAGCTGCTCCCCCAGATTGAT
ATTGTGAACATCAGCGACAGCTTTGAGATGACCTATAGATTCTGTTCCCAGTTCTCCAAA
GGAGTCTATGCCATCTTTGGGTTTTATGAACGTAGGACTGTCAACATGCTGACCTCCTTT
TGTGGGGCCCTCCACGTCTGCTTCATTACGCCGAGCTTTCCCGTTGATACATCCAATCAG
TTTGTCCTTCAGCTGCGCCCTGAACTGCAGGATGCCCTCATCAGCATCATTGACCATTAC
AAGTGGCAGAAATTTGTCTACATTTATGATGCCGACCGGGGCTTATCCGTCCTGCAGAAA
GTCCTGGATACAGCTGCTGAGAAGAACTGGCAGGTGACAGCAGTCAACATTTTGACAACC
ACAGAGGAGGGATACCGGATGCTCTTTCAGGACCTGGAGAAGAAAAAGGAGCGGCTGGTG
GTGGTGGACTGTGAATCAGAACGCCTCAATGCTATCTTGGGCCAGATTATAAAGCTAGAG
AAGAATGGCATCGGCTACCACTACATTCTTGCAAATCTGGGCTTCATGGACATTGACTTA
AACAAATTCAAGGAGAGTGGCGCCAATGTGACAGGTTTCCAGCTGGTGAACTACACAGAC
ACTATTCCGGCCAAGATCATGCAGCAGTGGAAGAATAGTGATGCTCGAGACCACACACGG
GTGGACTGGAAGAGACCCAAGTACACCTCTGCGCTCACCTACGATGGGGTGAAGGTGATG
GCTGAGGCTTTCCAGAGCCTGCGGAGGCAGAGAATTGATATATCTCGCCGGGGGAATGCT
GGGGATTGTCTGGCTAACCCAGCTGTTCCCTGGGGCCAAGGGATCGACATCCAGAGAGCT
CTGCAGCAGGTGCGATTTGAAGGTTTAACAGGAAACGTGCAGTTTAATGAGAAAGGACGC
CGGACCAACTACACGCTCCACGTGATTGAAATGAAACATGACGGCATCCGAAAGATTGGT
TACTGGAATGAAGATGATAAGTTTGTCCCTGCAGCCACCGATGCCCAAGCTGGGGGCGAT
AATTCAAGTGTTCAGAACAGAACATACATCGTCACAACAATCCTAGAAGATCCTTATGTG
ATGCTCAAGAAGAACGCCAATCAGTTTGAGGGCAATGACCGTTACGAGGGCTACTGTGTA
GAGCTGGCGGCAGAGATTGCCAAGCACGTGGGCTACTCCTACCGTCTGGAGATTGTCAGT
GATGGAAAATACGGAGCCCGAGACCCTGACACGAAGGCCTGGAATGGCATGGTGGGAGAG
CTGGTCTATGGAAGAGCAGATGTGGCTGTGGCTCCCTTAACTATCACTTTGGTCCGGGAA
GAAGTTATAGATTTCTCCAAACCATTTATGAGTTTGGGGATCTCCATCATGATTAAAAAA
CCACAGAAATCCAAGCCGGGTGTCTTCTCCTTCCTTGATCCTTTGGCTTATGAGATTTGG
ATGTGCATTGTTTTTGCCTACATTGGAGTGAGTGTTGTCCTCTTCCTGGTCAGCCGCTTC
AGTCCCTATGAATGGCACAGTGAAGAGTTTGAGGAAGGACGGGACCAGACAACCAGTGAC
CAGTCCAATGAGTTTGGGATATTCAACAGTTTGTGGTTCTCCCTGGGAGCCTTCATGCAG
CAAGGATGTGACATTTCTCCCAGGTCCCTGTCTGGTCGCATCGTTGGTGGCGTCTGGTGG
TTCTTCACCTTAATCATCATCTCCTCATATACAGCCAATCTGGCCGCCTTCCTGACCGTG
GAGAGGATGGTGTCTCCCATTGAGAGTGCAGAGGACCTAGCGAAGCAGACAGAAATTGCC
TACGGGACGCTGGAAGCAGGATCTACTAAGGAGTTCTTCAGGAGGTCTAAAATTGCTGTG
TTTGAGAAGATGTGGACATACATGAAGTCAGCAGAGCCATCAGTTTTTGTGCGGACCACA
GAGGAGGGGATGATTCGAGTGAGGAAATCCAAAGGCAAATATGCCTACCTCCTGGAGTCC
ACCATGAATGAGTACATTGAGCAGCGGAAACCCTGTGACACCATGAAGGTGGGAGGTAAC
TTGGATTCCAAAGGCTATGGCATTGCAACACCCAAGGGGTCTGCCCTGAGAAATCCAGTA
AACCTGGCAGTGTTAAAACTGAACGAGCAGGGGCTTTTGGACAAATTGAAAAACAAATGG
TGGTACGACAAGGGCGAGTGCGGCAGCGGGGGAGGTGATTCCAAGGACAAGACAAGCGCT
CTGAGCCTCAGCAATGTGGCAGGCGTGTTCTACATCCTGATCGGAGGACTTGGACTAGCC
ATGCTGGTTGCCTTAATCGAGTTCTGCTACAAATCCCGTAGTGAATCCAAGCGGATGAAG
GGTTTTTGTTTGATCCCACAGCAATCCATCAACGAAGCCATACGGACATCGACCCTCCCC
CGCAACAGCGGGGCAGGAGCCAGCAGCGGCGGCAGTGGAGAGAATGGTCGGGTGGTCAGC
CATGACTTCCCCAAGTCCATGCAATCGATTCCTTGCATGAGCCACAGTTCAGGGATGCCC
TTGGGAGCCACGGGATTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>axonal spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum-Golgi intermediate compartment membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>recycling endosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>ER to Golgi transport vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endocytic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuron spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendritic spine</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>AMPA glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMPA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>PDZ domain binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long term synaptic depression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>COPII vesicle coating</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ER to Golgi vesicle-mediated transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>membrane organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>long-term memory</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>post-translational protein modification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein N-linked glycosylation via asparagine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>receptor internalization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular protein metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000606</id>
      <name>Glutamate--cysteine ligase regulatory subunit</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17000861</pubmed-id>
            <citation>Giordano G, White CC, McConnachie LA, Fernandez C, Kavanagh TJ, Costa LG: Neurotoxicity of domoic Acid in cerebellar granule neurons in a genetic model of glutathione deficiency. Mol Pharmacol. 2006 Dec;70(6):2116-26. Epub 2006 Sep 25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48507" source="Swiss-Prot">
    <name>Glutamate--cysteine ligase regulatory subunit</name>
    <general-function>Glutamate-cysteine ligase catalytic subunit binding</general-function>
    <specific-function/>
    <gene-name>GCLM</gene-name>
    <locus>1p22.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.91</theoretical-pi>
    <molecular-weight>30726.745</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4312</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GCLM</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L35546</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>530137</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P48507</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSH0_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Gamma-ECS regulatory subunit</synonym>
      <synonym>Gamma-glutamylcysteine synthetase regulatory subunit</synonym>
      <synonym>GCS light chain</synonym>
      <synonym>GLCLR</synonym>
      <synonym>Glutamate--cysteine ligase modifier subunit</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001209|Glutamate--cysteine ligase regulatory subunit
MGTDSRAAKALLARARTLHLQTGNLLNWGRLRKKCPSTHSEELHDCIQKTLNEWSSQINP
DLVREFPDVLECTVSHAVEKINPDEREEMKVSAKLFIVESNSSSSTRSAVDMACSVLGVA
QLDSVIIASPPIEDGVNLSLEHLQPYWEELENLVQSKKIVAIGTSDLDKTQLEQLYQWAQ
VKPNSNQVNLASCCVMPPDLTAFAKQFDIQLLTHNDPKELLSEASFQEALQESIPDIQAH
EWVPLWLLRYSVIVKSRGIIKSKGYILQAKRRGS</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021272|Glutamate--cysteine ligase regulatory subunit (GCLM)
ATGGGCACCGACAGCCGCGCGGCCAAGGCGCTCCTGGCGCGGGCCCGCACCCTGCACCTG
CAGACGGGGAACCTGCTGAACTGGGGCCGCCTGCGGAAGAAGTGCCCGTCCACGCACAGC
GAGGAGGAGTTTCCAGATGTCTTGGAATGCACTGTATCTCATGCAGTAGAAAAGATAAAT
CCTGATGAAAGAGAAGAAATGAAAGTTTCTGCAAAACTGTTCATTGTAGAATCAAACTCT
TCATCATCAACTAGAAGTGCAGTTGACATGGCCTGTTCAGTCCTTGGAGTTGCACAGCTG
GATTCTGTGATCATTGCTTCACCTCCTATTGAAGATGGAGTTAATCTTTCCTTGGAGCAT
TTACAGCCTTACTGGGAGGAATTAGAAAACTTAGTTCAGAGCAAAAAGATTGTTGCCATA
GGTACCTCTGATCTAGACAAAACACAGTTGGAACAGCTGTATCAGTGGGCACAGGTAAAA
CCAAATAGTAACCAAGTTAATCTTGCCTCCTGCTGTGTGATGCCACCAGATTTGACTGCA
TTTGCTAAACAATTTGACATACAGCTGTTGACTCACAATGATCCAAAAGAACTGCTTTCT
GAAGCAAGTTTCCAAGAAGCTCTTCAGGAAAGCATTCCTGACATTCAAGCGCACGAGTGG
GTGCCGCTGTGGCTACTGCGGTATTCGGTCATTGTGAAAAGTAGAGGAATTATCAAATCA
AAAGGCTACATTTTACAAGCTAAAAGAAGGGGTTCTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00248</identifier>
        <name>Aldo_ket_red</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>glutamate-cysteine ligase complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-cysteine ligase catalytic subunit binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-cysteine ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme regulator activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of glutamate-cysteine ligase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nitrosative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic mitochondrial changes</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of blood vessel size</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sulfur amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of mitochondrial depolarization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of extrinsic apoptotic signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000568</id>
      <name>Glutamate carboxypeptidase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11916141</pubmed-id>
            <citation>Rodriguez CE, Lu H, Martinez AR, Hu Y, Brunelle A, Berkman CE: Inhibition of glutamate carboxypeptidase II by phosphonamidothionate derivatives of glutamic acid. J Enzyme Inhib. 2001 Oct;16(4):359-65.</citation>
          </article>
          <article>
            <pubmed-id>15837926</pubmed-id>
            <citation>Davis MI, Bennett MJ, Thomas LM, Bjorkman PJ: Crystal structure of prostate-specific membrane antigen, a tumor marker and peptidase. Proc Natl Acad Sci U S A. 2005 Apr 26;102(17):5981-6. Epub 2005 Apr 18.</citation>
          </article>
          <article>
            <pubmed-id>15336276</pubmed-id>
            <citation>Maung J, Mallari JP, Girtsman TA, Wu LY, Rowley JA, Santiago NM, Brunelle AN, Berkman CE: Probing for a hydrophobic a binding register in prostate-specific membrane antigen with phenylalkylphosphonamidates. Bioorg Med Chem. 2004 Sep 15;12(18):4969-79.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q04609" source="Swiss-Prot">
    <name>Glutamate carboxypeptidase 2</name>
    <general-function>Tetrahydrofolyl-poly(glutamate) polymer binding</general-function>
    <specific-function>Has both folate hydrolase and N-acetylated-alpha-linked-acidic dipeptidase (NAALADase) activity. Has a preference for tri-alpha-glutamate peptides. In the intestine, required for the uptake of folate. In the brain, modulates excitatory neurotransmission through the hydrolysis of the neuropeptide, N-aceylaspartylglutamate (NAAG), thereby releasing glutamate. Isoform PSM-4 and isoform PSM-5 would appear to be physiologically irrelevant. Involved in prostate tumor progression.Also exhibits a dipeptidyl-peptidase IV type activity. In vitro, cleaves Gly-Pro-AMC.</specific-function>
    <gene-name>FOLH1</gene-name>
    <locus>11p11.2</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>20-43</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>6.97</theoretical-pi>
    <molecular-weight>84330.015</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3788</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FOLH1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M99487</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>190664</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1606</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q04609</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FOLH1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.17.21</synonym>
      <synonym>Cell growth-inhibiting gene 27 protein</synonym>
      <synonym>FGCP</synonym>
      <synonym>Folate hydrolase 1</synonym>
      <synonym>FOLH</synonym>
      <synonym>Folylpoly-gamma-glutamate carboxypeptidase</synonym>
      <synonym>GCPII</synonym>
      <synonym>Glutamate carboxypeptidase II</synonym>
      <synonym>Membrane glutamate carboxypeptidase</synonym>
      <synonym>mGCP</synonym>
      <synonym>N-acetylated-alpha-linked acidic dipeptidase I</synonym>
      <synonym>NAALAD1</synonym>
      <synonym>NAALADase I</synonym>
      <synonym>Prostate-specific membrane antigen</synonym>
      <synonym>PSM</synonym>
      <synonym>PSMA</synonym>
      <synonym>Pteroylpoly-gamma-glutamate carboxypeptidase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001134|Glutamate carboxypeptidase 2
MWNLLHETDSAVATARRPRWLCAGALVLAGGFFLLGFLFGWFIKSSNEATNITPKHNMKA
FLDELKAENIKKFLYNFTQIPHLAGTEQNFQLAKQIQSQWKEFGLDSVELAHYDVLLSYP
NKTHPNYISIINEDGNEIFNTSLFEPPPPGYENVSDIVPPFSAFSPQGMPEGDLVYVNYA
RTEDFFKLERDMKINCSGKIVIARYGKVFRGNKVKNAQLAGAKGVILYSDPADYFAPGVK
SYPDGWNLPGGGVQRGNILNLNGAGDPLTPGYPANEYAYRRGIAEAVGLPSIPVHPIGYY
DAQKLLEKMGGSAPPDSSWRGSLKVPYNVGPGFTGNFSTQKVKMHIHSTNEVTRIYNVIG
TLRGAVEPDRYVILGGHRDSWVFGGIDPQSGAAVVHEIVRSFGTLKKEGWRPRRTILFAS
WDAEEFGLLGSTEWAEENSRLLQERGVAYINADSSIEGNYTLRVDCTPLMYSLVHNLTKE
LKSPDEGFEGKSLYESWTKKSPSPEFSGMPRISKLGSGNDFEVFFQRLGIASGRARYTKN
WETNKFSGYPLYHSVYETYELVEKFYDPMFKYHLTVAQVRGGMVFELANSIVLPFDCRDY
AVVLRKYADKIYSISMKHPQEMKTYSVSFDSLFSAVKNFTEIASKFSERLQDFDKSNPIV
LRMMNDQLMFLERAFIDPLGLPDRPFYRHVIYAPSSHNKYAGESFPGIYDALFDIESKVD
PSKAWGEVKRQIYVAAFTVQAAAETLSEVA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016135|Glutamate carboxypeptidase 2 (FOLH1)
ATGTGGAATCTCCTTCACGAAACCGACTCGGCTGTGGCCACCGCGCGCCGCCCGCGCTGG
CTGTGCGCTGGGGCGCTGGTGCTGGCGGGTGGCTTCTTTCTCCTCGGCTTCCTCTTCGGG
TGGTTTATAAAATCCTCCAATGAAGCTACTAACATTACTCCAAAGCATAATATGAAAGCA
TTTTTGGATGAATTGAAAGCTGAGAACATCAAGAAGTTCTTATATAATTTTACACAGATA
CCACATTTAGCAGGAACAGAACAAAACTTTCAGCTTGCAAAGCAAATTCAATCCCAGTGG
AAAGAATTTGGCCTGGATTCTGTTGAGCTAGCACATTATGATGTCCTGTTGTCCTACCCA
AATAAGACTCATCCCAACTACATCTCAATAATTAATGAAGATGGAAATGAGATTTTCAAC
ACATCATTATTTGAACCACCTCCTCCAGGATATGAAAATGTTTCGGATATTGTACCACCT
TTCAGTGCTTTCTCTCCTCAAGGAATGCCAGAGGGCGATCTAGTGTATGTTAACTATGCA
CGAACTGAAGACTTCTTTAAATTGGAACGGGACATGAAAATCAATTGCTCTGGGAAAATT
GTAATTGCCAGATATGGGAAAGTTTTCAGAGGAAATAAGGTTAAAAATGCCCAGCTGGCA
GGGGCCAAAGGAGTCATTCTCTACTCCGACCCTGCTGACTACTTTGCTCCTGGGGTGAAG
TCCTATCCAGATGGTTGGAATCTTCCTGGAGGTGGTGTCCAGCGTGGAAATATCCTAAAT
CTGAATGGTGCAGGAGACCCTCTCACACCAGGTTACCCAGCAAATGAATATGCTTATAGG
CGTGGAATTGCAGAGGCTGTTGGTCTTCCAAGTATTCCTGTTCATCCAATTGGATACTAT
GATGCACAGAAGCTCCTAGAAAAAATGGGTGGCTCAGCACCACCAGATAGCAGCTGGAGA
GGAAGTCTCAAAGTGCCCTACAATGTTGGACCTGGCTTTACTGGAAACTTTTCTACACAA
AAAGTCAAGATGCACATCCACTCTACCAATGAAGTGACAAGAATTTACAATGTGATAGGT
ACTCTCAGAGGAGCAGTGGAACCAGACAGATATGTCATTCTGGGAGGTCACCGGGACTCA
TGGGTGTTTGGTGGTATTGACCCTCAGAGTGGAGCAGCTGTTGTTCATGAAATTGTGAGG
AGCTTTGGAACACTGAAAAAGGAAGGGTGGAGACCTAGAAGAACAATTTTGTTTGCAAGC
TGGGATGCAGAAGAATTTGGTCTTCTTGGTTCTACTGAGTGGGCAGAGGAGAATTCAAGA
CTCCTTCAAGAGCGTGGCGTGGCTTATATTAATGCTGACTCATCTATAGAAGGAAACTAC
ACTCTGAGAGTTGATTGTACACCGCTGATGTACAGCTTGGTACACAACCTAACAAAAGAG
CTGAAAAGCCCTGATGAAGGCTTTGAAGGCAAATCTCTTTATGAAAGTTGGACTAAAAAA
AGTCCTTCCCCAGAGTTCAGTGGCATGCCCAGGATAAGCAAATTGGGATCTGGAAATGAT
TTTGAGGTGTTCTTCCAACGACTTGGAATTGCTTCAGGCAGAGCACGGTATACTAAAAAT
TGGGAAACAAACAAATTCAGCGGCTATCCACTGTATCACAGTGTCTATGAAACATATGAG
TTGGTGGAAAAGTTTTATGATCCAATGTTTAAATATCACCTCACTGTGGCCCAGGTTCGA
GGAGGGATGGTGTTTGAGCTAGCCAATTCCATAGTGCTCCCTTTTGATTGTCGAGATTAT
GCTGTAGTTTTAAGAAAGTATGCTGACAAAATCTACAGTATTTCTATGAAACATCCACAG
GAAATGAAGACATACAGTGTATCATTTGATTCACTTTTTTCTGCAGTAAAGAATTTTACA
GAAATTGCTTCCAAGTTCAGTGAGAGACTCCAGGACTTTGACAAAAGCAAGCATGTCATC
TATGCTCCAAGCAGCCACAACAAGTATGCAGGGGAGTCATTCCCAGGAATTTATGATGCT
CTGTTTGATATTGAAAGCAAAGTGGACCCTTCCAAGGCCTGGGGAGAAGTGAAGAGACAG
ATTTATGTTGCAGCCTTCACAGTGCAGGCAGCTGCAGAGACTTTGAGTGAAGTAGCCTAA
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02225</identifier>
        <name>PA</name>
      </pfam>
      <pfam>
        <identifier>PF04389</identifier>
        <name>Peptidase_M28</name>
      </pfam>
      <pfam>
        <identifier>PF04253</identifier>
        <name>TFR_dimer</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dipeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>Ac-Asp-Glu binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metallocarboxypeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>tetrahydrofolyl-poly(glutamate) polymer binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proteolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>C-terminal protein deglutamylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000602</id>
      <name>Glutamate decarboxylase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16879709</pubmed-id>
            <citation>Wei J, Lin CH, Wu H, Jin Y, Lee YH, Wu JY: Activity-dependent cleavage of brain glutamic acid decarboxylase 65 by calpain. J Neurochem. 2006 Sep;98(5):1688-95. Epub 2006 Jul 31.</citation>
          </article>
          <article>
            <pubmed-id>17600364</pubmed-id>
            <citation>Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J: Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007 Jun;61(6):544-51.</citation>
          </article>
          <article>
            <pubmed-id>17317763</pubmed-id>
            <citation>Pop SM, Wong CP, He Q, Wang Y, Wallet MA, Goudy KS, Tisch R: The type and frequency of immunoregulatory CD4+ T-cells govern the efficacy of antigen-specific immunotherapy in nonobese diabetic mice. Diabetes. 2007 May;56(5):1395-402. Epub 2007 Feb 22.</citation>
          </article>
          <article>
            <pubmed-id>16643338</pubmed-id>
            <citation>Wang FY, Zhu RM, Maemura K, Hirata I, Katsu K, Watanabe M: Expression of gamma-aminobutyric acid and glutamic acid decarboxylases in rat descending colon and their relation to epithelial differentiation. Chin J Dig Dis. 2006;7(2):103-8.</citation>
          </article>
          <article>
            <pubmed-id>17507169</pubmed-id>
            <citation>Castelli MP, Piras AP, Melis T, Succu S, Sanna F, Melis MR, Collu S, Ennas MG, Diaz G, Mackie K, Argiolas A: Cannabinoid CB1 receptors in the paraventricular nucleus and central control of penile erection: immunocytochemistry, autoradiography and behavioral studies. Neuroscience. 2007 Jun 15;147(1):197-206. Epub 2007 May 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q05329" source="Swiss-Prot">
    <name>Glutamate decarboxylase 2</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the production of GABA.</specific-function>
    <gene-name>GAD2</gene-name>
    <locus>10p11.23</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.89</theoretical-pi>
    <molecular-weight>65410.77</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4093</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GAD2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M81882</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>182934</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q05329</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DCE2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.1.1.15</synonym>
      <synonym>65 kDa glutamic acid decarboxylase</synonym>
      <synonym>GAD-65</synonym>
      <synonym>GAD65</synonym>
      <synonym>Glutamate decarboxylase 65 kDa isoform</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001201|Glutamate decarboxylase 2
MASPGSGFWSFGSEDGSGDSENPGTARAWCQVAQKFTGGIGNKLCALLYGDAEKPAESGG
SQPPRAAARKAACACDQKPCSCSKVDVNYAFLHATDLLPACDGERPTLAFLQDVMNILLQ
YVVKSFDRSTKVIDFHYPNELLQEYNWELADQPQNLEEILMHCQTTLKYAIKTGHPRYFN
QLSTGLDMVGLAADWLTSTANTNMFTYEIAPVFVLLEYVTLKKMREIIGWPGGSGDGIFS
PGGAISNMYAMMIARFKMFPEVKEKGMAALPRLIAFTSEHSHFSLKKGAAALGIGTDSVI
LIKCDERGKMIPSDLERRILEAKQKGFVPFLVSATAGTTVYGAFDPLLAVADICKKYKIW
MHVDAAWGGGLLMSRKHKWKLSGVERANSVTWNPHKMMGVPLQCSALLVREEGLMQNCNQ
MHASYLFQQDKHYDLSYDTGDKALQCGRHVDVFKLWLMWRAKGTTGFEAHVDKCLELAEY
LYNIIKNREGYEMVFDGKPQHTNVCFWYIPPSLRTLEDNEERMSRLSKVAPVIKARMMEY
GTTMVSYQPLGDKVNFFRMVISNPAATHQDIDFLIEEIERLGQDL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0018979|Glutamate decarboxylase 2 (GAD2)
ATGGCATCTCCGGGCTCTGGCTTTTGGTCTTTCGGGTCGGAAGATGGCTCTGGGGATTCC
GAGAATCCCGGCACAGCGCGAGCCTGGTGCCAAGTGGCTCAGAAGTTCACGGGCGGCATC
GGAAACAAACTGTGCGCCCTGCTCTACGGAGACGCCGAGAAGCCGGCGGAGAGCGGCGGG
AGCCAACCCCCGCGGGCCGCCGCCCGGAAGGCCGCCTGCGCCTGCGACCAGAAGCCCTGC
AGCTGCTCCAAAGTGGATGTCAACTACGCGTTTCTCCATGCAACAGACCTGCTGCCGGCG
TGTGATGGAGAAAGGCCCACTTTGGCGTTTCTGCAAGATGTTATGAACATTTTACTTCAG
TATGTGGTGAAAAGTTTCGATAGATCAACCAAAGTGATTGATTTCCATTATCCTAATGAG
CTTCTCCAAGAATATAATTGGGAATTGGCAGACCAACCACAAAATTTGGAGGAAATTTTG
ATGCATTGCCAAACAACTCTAAAATATGCAATTAAAACAGGGCATCCTAGATACTTCAAT
CAACTTTCTACTGGTTTGGATATGGTTGGATTAGCAGCAGACTGGCTGACATCAACAGCA
AATACTAACATGTTCACCTATGAAATTGCTCCAGTATTTGTGCTTTTGGAATATGTCACA
CTAAAGAAAATGAGAGAAATCATTGGCTGGCCAGGGGGCTCTGGCGATGGGATATTTTCT
CCCGGTGGCGCCATATCTAACATGTATGCCATGATGATCGCACGCTTTAAGATGTTCCCA
GAAGTCAAGGAGAAAGGAATGGCTGCTCTTCCCAGGCTCATTGCCTTCACGTCTGAACAT
AGTCATTTTTCTCTCAAGAAGGGAGCTGCAGCCTTAGGGATTGGAACAGACAGCGTGATT
CTGATTAAATGTGATGAGAGAGGGAAAATGATTCCATCTGATCTTGAAAGAAGGATTCTT
GAAGCCAAACAGAAAGGGTTTGTTCCTTTCCTCGTGAGTGCCACAGCTGGAACCACCGTG
TACGGAGCATTTGACCCCCTCTTAGCTGTCGCTGACATTTGCAAAAAGTATAAGATCTGG
ATGCATGTGGATGCAGCTTGGGGTGGGGGATTACTGATGTCCCGAAAACACAAGTGGAAA
CTGAGTGGCGTGGAGAGGGCCAACTCTGTGACGTGGAATCCACACAAGATGATGGGAGTC
CCTTTGCAGTGCTCTGCTCTCCTGGTTAGAGAAGAGGGATTGATGCAGAATTGCAACCAA
ATGCATGCCTCCTACCTCTTTCAGCAAGATAAACATTATGACCTGTCCTATGACACTGGA
GACAAGGCCTTACAGTGCGGACGCCACGTTGATGTTTTTAAACTATGGCTGATGTGGAGG
GCAAAGGGGACTACCGGGTTTGAAGCGCATGTTGATAAATGTTTGGAGTTGGCAGAGTAT
TTATACAACATCATAAAAAACCGAGAAGGATATGAGATGGTGTTTGATGGGAAGCCTCAG
CACACAAATGTCTGCTTCTGGTACATTCCTCCAAGCTTGCGTACTCTGGAAGACAATGAA
GAGAGAATGAGTCGCCTCTCGAAGGTGGCTCCAGTGATTAAAGCCAGAATGATGGAGTAT
GGAACCACAATGGTCAGCTACCAACCCTTGGGAGACAAGGTCAATTTCTTCCGCATGGTC
ATCTCAAACCCAGCGGCAACTCACCAAGACATTGACTTCCTGATTGAAGAAATAGAACGC
CTTGGACAAGATTTATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00282</identifier>
        <name>Pyridoxal_deC</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>anchored component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>inhibitory synapse</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate decarboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate decarboxylation to succinate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000378</id>
      <name>Glutamate decarboxylase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17562689</pubmed-id>
            <citation>Akama K, Takaiwa F: C-terminal extension of rice glutamate decarboxylase (OsGAD2) functions as an autoinhibitory domain and overexpression of a truncated mutant results in the accumulation of extremely high levels of GABA in plant cells. J Exp Bot. 2007;58(10):2699-707. Epub 2007 Jun 11.</citation>
          </article>
          <article>
            <pubmed-id>16769115</pubmed-id>
            <citation>Tueting P, Doueiri MS, Guidotti A, Davis JM, Costa E: Reelin down-regulation in mice and psychosis endophenotypes. Neurosci Biobehav Rev. 2006;30(8):1065-77.</citation>
          </article>
          <article>
            <pubmed-id>17600364</pubmed-id>
            <citation>Manto MU, Laute MA, Aguera M, Rogemond V, Pandolfo M, Honnorat J: Effects of anti-glutamic acid decarboxylase antibodies associated with neurological diseases. Ann Neurol. 2007 Jun;61(6):544-51.</citation>
          </article>
          <article>
            <pubmed-id>16643338</pubmed-id>
            <citation>Wang FY, Zhu RM, Maemura K, Hirata I, Katsu K, Watanabe M: Expression of gamma-aminobutyric acid and glutamic acid decarboxylases in rat descending colon and their relation to epithelial differentiation. Chin J Dig Dis. 2006;7(2):103-8.</citation>
          </article>
          <article>
            <pubmed-id>17445798</pubmed-id>
            <citation>Tronci E, Simola N, Borsini F, Schintu N, Frau L, Carminati P, Morelli M: Characterization of the antiparkinsonian effects of the new adenosine A2A receptor antagonist ST1535: acute and subchronic studies in rats. Eur J Pharmacol. 2007 Jul 2;566(1-3):94-102. Epub 2007 Mar 24.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q99259" source="Swiss-Prot">
    <name>Glutamate decarboxylase 1</name>
    <general-function>Pyridoxal phosphate binding</general-function>
    <specific-function>Catalyzes the production of GABA.</specific-function>
    <gene-name>GAD1</gene-name>
    <locus>2q31</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.67</theoretical-pi>
    <molecular-weight>66896.065</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4092</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GAD1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M81883</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>182936</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q99259</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DCE1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.1.1.15</synonym>
      <synonym>67 kDa glutamic acid decarboxylase</synonym>
      <synonym>GAD</synonym>
      <synonym>GAD-67</synonym>
      <synonym>GAD67</synonym>
      <synonym>Glutamate decarboxylase 67 kDa isoform</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000753|Glutamate decarboxylase 1
MASSTPSSSATSSNAGADPNTTNLRPTTYDTWCGVAHGCTRKLGLKICGFLQRTNSLEEK
SRLVSAFKERQSSKNLLSCENSDRDARFRRTETDFSNLFARDLLPAKNGEEQTVQFLLEV
VDILLNYVRKTFDRSTKVLDFHHPHQLLEGMEGFNLELSDHPESLEQILVDCRDTLKYGV
RTGHPRFFNQLSTGLDIIGLAGEWLTSTANTNMFTYEIAPVFVLMEQITLKKMREIVGWS
SKDGDGIFSPGGAISNMYSIMAARYKYFPEVKTKGMAAVPKLVLFTSEQSHYSIKKAGAA
LGFGTDNVILIKCNERGKIIPADFEAKILEAKQKGYVPFYVNATAGTTVYGAFDPIQEIA
DICEKYNLWLHVDAAWGGGLLMSRKHRHKLNGIERANSVTWNPHKMMGVLLQCSAILVKE
KGILQGCNQMCAGYLFQPDKQYDVSYDTGDKAIQCGRHVDIFKFWLMWKAKGTVGFENQI
NKCLELAEYLYAKIKNREEFEMVFNGEPEHTNVCFWYIPQSLRGVPDSPQRREKLHKVAP
KIKALMMESGTTMVGYQPQGDKANFFRMVISNPAATQSDIDFLIEEIERLGQDL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010267|Glutamate decarboxylase 1 (GAD1)
ATGGCGTCTTCGACCCCATCTTCGTCCGCAACCTCCTCGAACGCGGGAGCGGACCCCAAT
ACCACTAACCTGCGCCCCACAACGTACGATACCTGGTGCGGCGTGGCCCATGGATGCACC
AGAAAACTGGGGCTCAAGATCTGCGGCTTCTTGCAAAGGACCAACAGCCTGGAAGAGAAG
AGTCGCCTTGTGAGTGCCTTCAAGGAGAGGCAATCCTCCAAGAACCTGCTTTCCTGTGAA
AACAGCGACCGGGATGCCCGCTTCCGGCGCACAGAGACTGACTTCTCTAATCTGTTTGCT
AGAGATCTGCTTCCGGCTAAGAACGGTGAGGAGCAAACCGTGCAATTCCTCCTGGAAGTG
GTGGACATACTCCTCAACTATGTCCGCAAGACATTTGATCGCTCCACCAAGGTGCTGGAC
TTTCATCACCCACACCAGTTGCTGGAAGGCATGGAGGGCTTCAACTTGGAGCTCTCTGAC
CACCCCGAGTCCCTGGAGCAGATCCTGGTTGACTGCAGAGACACCTTGAAGTATGGGGTT
CGCACAGGTCATCCTCGATTTTTCAACCAGCTCTCCACTGGATTGGATATTATTGGCCTA
GCTGGAGAATGGCTGACATCAACGGCCAATACCAACATGTTTACATATGAAATTGCACCA
GTGTTTGTCCTCATGGAACAAATAACACTTAAGAAGATGAGAGAGATAGTTGGATGGTCA
AGTAAAGATGGTGATGGGATATTTTCTCCTGGGGGCGCCATATCCAACATGTACAGCATC
ATGGCTGCTCGCTACAAGTACTTCCCGGAAGTTAAGACAAAGGGCATGGCGGCTGTGCCT
AAACTGGTCCTCTTCACCTCAGAACAGAGTCACTATTCCATAAAGAAAGCTGGGGCTGCA
CTTGGCTTTGGAACTGACAATGTGATTTTGATAAAGTGCAATGAAAGGGGGAAAATAATT
CCAGCTGATTTTGAGGCAAAAATTCTTGAAGCCAAACAGAAGGGATATGTTCCCTTTTAT
GTCAATGCAACTGCTGGCACGACTGTTTATGGAGCTTTTGATCCGATACAAGAGATTGCA
GATATATGTGAGAAATATAACCTTTGGTTGCATGTCGATGCTGCCTGGGGAGGTGGGCTG
CTCATGTCCAGGAAGCACCGCCATAAACTCAACGGCATAGAAAGGGCCAACTCAGTCACC
TGGAACCCTCACAAGATGATGGGCGTGCTGTTGCAGTGCTCTGCCATTCTCGTCAAGGAA
AAGGGTATACTCCAAGGATGCAACCAGATGTGTGCAGGATACCTCTTCCAGCCAGACAAG
CAGTATGATGTCTCCTACGACACCGGGGACAAGGCAATTCAGTGTGGCCGCCACGTGGAT
ATCTTCAAGTTCTGGCTGATGTGGAAAGCAAAGGGCACAGTGGGATTTGAAAACCAGATC
AACAAATGCCTGGAACTGGCTGAATACCTCTATGCCAAGATTAAAAACAGAGAAGAATTT
GAGATGGTTTTCAATGGCGAGCCTGAGCACACAAACGTCTGTTTTTGGTATATTCCACAA
AGCCTCAGGGGTGTGCCAGACAGCCCTCAACGACGGGAAAAGCTACACAAGGTGGCTCCA
AAAATCAAAGCCCTGATGATGGAGTCAGGTACGACCATGGTTGGCTACCAGCCCCAAGGG
GACAAGGCCAACTTCTTCCGGATGGTCATCTCCAACCCAGCCGCTACCCAGTCTGACATT
GACTTCCTCATTGAGGAGATAGAAAGACTGGGCCAGGATCTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00282</identifier>
        <name>Pyridoxal_deC</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>pyridoxal phosphate binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate decarboxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein-pyridoxal-5-phosphate linkage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neurotransmitter biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate decarboxylation to succinate</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000822</id>
      <name>Formimidoyltransferase-cyclodeaminase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9837973</pubmed-id>
            <citation>Gao YS, Alvarez C, Nelson DS, Sztul E: Molecular cloning, characterization, and dynamics of rat formiminotransferase cyclodeaminase, a Golgi-associated 58-kDa protein. J Biol Chem. 1998 Dec 11;273(50):33825-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O95954" source="Swiss-Prot">
    <name>Formimidoyltransferase-cyclodeaminase</name>
    <general-function>Microtubule binding</general-function>
    <specific-function>Folate-dependent enzyme, that displays both transferase and deaminase activity. Serves to channel one-carbon units from formiminoglutamate to the folate pool.Binds and promotes bundling of vimentin filaments originating from the Golgi.</specific-function>
    <gene-name>FTCD</gene-name>
    <locus/>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.45</theoretical-pi>
    <molecular-weight>58925.93</molecular-weight>
    <chromosome-location>21</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3974</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>FTCD</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF169017</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>6537208</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O95954</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>FTCD_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Formiminotransferase-cyclodeaminase</synonym>
      <synonym>FTCD</synonym>
      <synonym>LCHC1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001640|Formimidoyltransferase-cyclodeaminase
MSQLVECVPNFSEGKNQEVIDAISGAITQTPGCVLLDVDAGPSTNRTVYTFVGPPECVVE
GALNAARVASRLIDMSRHQGEHPRMGALDVCPFIPVRGVSVDECVLCAQAFGQRLAEELD
VPVYLYGEAARMDSRRTLPAIRAGEYEALPKKLQQADWAPDFGPSSFVPSWGATATGARK
FLIAFNINLLGTKEQAHRIALNLREQGRGKDQPGRLKKVQGIGWYLDEKNLAQVSTNLLD
FEVTALHTVYEETCREAQELSLPVVGSQLVGLVPLKALLDAAAFYCEKENLFILEEEQRI
RLVVSRLGLDSLCPFSPKERIIEYLVPERGPERGLGSKSLRAFVGEVGARSAAPGGGSVA
AAAAAMGAALGSMVGLMTYGRRQFQSLDTTMRRLIPPFREASAKLTTLVDADAEAFTAYL
EAMRLPKNTPEEKDRRTAALQEGLRRAVSVPLTLAETVASLWPALQELARCGNLACRSDL
QVAAKALEMGVFGAYFNVLINLRDITDEAFKDQIHHRVSSLLQEAKTQAALVLDCLETRQ
E</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019016|Formimidoyltransferase-cyclodeaminase (FTCD)
ATGTCCCAGCTGGTGGAATGCGTCCCCAACTTTTCGGAGGGGAAGAACCAGGAGGTGATC
GACGCCATCTCTGGAGCCATCACACAGACCCCGGGCTGCGTGCTGCTGGATGTGGACGCA
GGCCCTTCCACCAACCGCACCGTGTACACCTTCGTGGGGCCGCCGGAGTGCGTGGTGGAG
GGGGCCCTCAACGCTGCCCGGGTAGCTTCCCGACTTATCGACATGAGCAGGCACCAAGGA
GAGCACCCCCGCATGGGGGCCCTAGACGTCTGCCCCTTCATCCCCGTGAGGGGCGTCAGC
GTGGATGAGTGTGTGCTCTGCGCCCAGGCCTTTGGCCAGAGGCTGGCAGAGGAGCTGGAC
GTGCCAGTTTACCTGTACGGCGAGGCAGCCAGGATGGACAGTCGCCGGACCCTGCCGGCC
ATCCGGGCCGGGGAGTACGAGGCCCTCCCTAAGAAGCTCCAGCAGGCCGACTGGGCGCCC
GACTTTGGTCCCAGCTCCTTTGTCCCCAGTTGGGGGGCCACGGCCACGGGGGCGAGGAAG
TTCCTCATTGCTTTTAACATCAACCTGCTCGGCACAAAGGAGCAAGCCCACCGCATCGCG
CTCAACCTGCGGGAGCAGGGCCGCGGGAAGGACCAGCCAGGACGTCTGAAGAAAGTTCAG
GGCATTGGCTGGTACCTGGATGAGAAGAACCTGGCTCAGGTGTCCACCAATCTTCTGGAC
TTTGAGGTCACGGCACTGCACACGGTCTACGAGGAGACCTGCCGAGAAGCACAGGAGCTG
AGCCTCCCAGTGGTGGGCTCACAGCTGGTGGGCCTGGTGCCCCTGAAGGCTCTGCTGGAT
GCGGCCGCCTTCTACTGCGAGAAGGAGAACCTCTTCATCCTGGAGGAGGAGCAGCGGATC
AGGCTGGTGGTGAGCCGGCTGGGCCTGGACTCCCTGTGCCCCTTCAGCCCTAAGGAGCGG
ATCATCGAGTACCTGGTCCCTGAGCGCGGGCCTGAGCGAGGCCTGGGCAGCAAGTCCCTG
CGCGCCTTCGTGGGGGAGGTGGGTGCCCGCTCTGCGGCCCCCGGGGGCGGCTCGGTGGCG
GCGGCCGCTGCGGCCATGGGTGCGGCGCTGGGCTCCATGGTGGGCCTCATGACCTACGGG
CGGCGCCAATTCCAGTCCCTGGACACGACGATGCGGCGCCTGATCCCGCCCTTCCGCGAG
GCTTCGGCCAAGCTAACCACGCTGGTGGATGCCGACGCCGAGGCCTTCACCGCCTACCTG
GAAGCAATGAGGCTCCCCAAGAACACACCTGAGGAAAAGGACAGGCGCACGGCGGCCCTA
CAGGAGGGTCTGAGGCGGGCAGTCTCTGTGCCGCTGACGCTGGCGGAGACGGTGGCCTCG
CTGTGGCCGGCCCTGCAGGAACTGGCCCGGTGTGGGAACCTGGCCTGCCGGTCAGACCTC
CAGGTGGCGGCCAAAGCCCTGGAGATGGGCGTGTTTGGCGCATATTTCAACGTGCTCATC
AACCTGAGGGACATCACAGACGAGGCATTTAAGGACCAGATCCACCATCGTGTTTCCAGC
CTCCTGCAGGAAGCCAAGACCCAGGCTGCACTGGTGCTGGACTGCTTGGAGACCCGGCAG
GAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF04961</identifier>
        <name>FTCD_C</name>
      </pfam>
      <pfam>
        <identifier>PF07837</identifier>
        <name>FTCD_N</name>
      </pfam>
      <pfam>
        <identifier>PF02971</identifier>
        <name>FTCD</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>Golgi apparatus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum-Golgi intermediate compartment</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>centriole</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Golgi membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>smooth endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>folic acid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>microtubule binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>formimidoyltetrahydrofolate cyclodeaminase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>formimidoyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate formimidoyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>histidine catabolic process to glutamate and formate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tetrahydrofolate interconversion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>folic acid-containing compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cytoskeleton organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>histidine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>histidine catabolic process to glutamate and formamide</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000829</id>
      <name>Glutamate receptor 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>7679210</pubmed-id>
            <citation>Henley JM, Jenkins R, Hunt SP: Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacology. 1993 Jan;32(1):37-41.</citation>
          </article>
          <article>
            <pubmed-id>1279377</pubmed-id>
            <citation>Stein E, Cox JA, Seeburg PH, Verdoorn TA: Complex pharmacological properties of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor subtypes. Mol Pharmacol. 1992 Nov;42(5):864-71.</citation>
          </article>
          <article>
            <pubmed-id>7838123</pubmed-id>
            <citation>Li F, Owens N, Verdoorn TA: Functional effects of mutations in the putative agonist binding region of recombinant alpha-amino-3-hydroxy-5-methyl-4-isoxazolepropionic acid receptors. Mol Pharmacol. 1995 Jan;47(1):148-54.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P42262" source="Swiss-Prot">
    <name>Glutamate receptor 2</name>
    <general-function>Ionotropic glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.</specific-function>
    <gene-name>GRIA2</gene-name>
    <locus>4q32-q33</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>544-564
617-637
813-833</transmembrane-regions>
    <signal-regions>1-24</signal-regions>
    <theoretical-pi>7.66</theoretical-pi>
    <molecular-weight>98820.32</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4572</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIA2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L20814</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>493134</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P42262</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIA2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPA-selective glutamate receptor 2</synonym>
      <synonym>GluA2</synonym>
      <synonym>GluR-2</synonym>
      <synonym>GluR-B</synonym>
      <synonym>GluR-K2</synonym>
      <synonym>GLUR2</synonym>
      <synonym>Glutamate receptor ionotropic, AMPA 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001654|Glutamate receptor 2
MQKIMHISVLLSPVLWGLIFGVSSNSIQIGGLFPRGADQEYSAFRVGMVQFSTSEFRLTP
HIDNLEVANSFAVTNAFCSQFSRGVYAIFGFYDKKSVNTITSFCGTLHVSFITPSFPTDG
THPFVIQMRPDLKGALLSLIEYYQWDKFAYLYDSDRGLSTLQAVLDSAAEKKWQVTAINV
GNINNDKKDEMYRSLFQDLELKKERRVILDCERDKVNDIVDQVITIGKHVKGYHYIIANL
GFTDGDLLKIQFGGANVSGFQIVDYDDSLVSKFIERWSTLEEKEYPGAHTTTIKYTSALT
YDAVQVMTEAFRNLRKQRIEISRRGNAGDCLANPAVPWGQGVEIERALKQVQVEGLSGNI
KFDQNGKRINYTINIMELKTNGPRKIGYWSEVDKMVVTLTELPSGNDTSGLENKTVVVTT
ILESPYVMMKKNHEMLEGNERYEGYCVDLAAEIAKHCGFKYKLTIVGDGKYGARDADTKI
WNGMVGELVYGKADIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFLD
PLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEFEDGRETQSSESTNEFGIFNSLWF
SLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAEDL
SKQTEIAYGTLDSGSTKEFFRRSKIAVFDKMWTYMRSAEPSVFVRTTAEGVARVRKSKGK
YAYLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGIATPKGSSLRNAVNLAVLKLNEQGLL
DKLKNKWWYDKGECGSGGGDSKEKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKSR
AEAKRMKVAKNAQNINPSSSQNSQNFATYKEGYNVYGIESVKI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016219|Glutamate receptor 2 (GRIA2)
ATGCAAAAGATTATGCATATTTCTGTCCTCCTTTCTCCTGTTTTATGGGGACTGATTTTT
GGTGTCTCTTCTAACAGCATACAGATAGGGGGGCTATTTCCTAGGGGCGCCGATCAAGAA
TACAGTGCATTTCGAGTAGGGATGGTTCAGTTTTCCACTTCGGAGTTCAGACTGACACCC
CACATCGACAATTTGGAGGTGGCAAACAGCTTCGCAGTCACTAATGCTTTCTGCTCCCAG
TTTTCGAGAGGAGTCTATGCTATTTTTGGATTTTATGACAAGAAGTCTGTAAATACCATC
ACATCATTTTGCGGAACACTCCACGTCTCCTTCATCACTCCCAGCTTCCCAACAGATGGC
ACACATCCATTTGTCATTCAGATGAGACCCGACCTCAAAGGAGCTCTCCTTAGCTTGATT
GAATACTATCAATGGGACAAGTTTGCATACCTCTATGACAGTGACAGAGGCTTATCAACA
CTGCAAGCTGTGCTGGATTCTGCTGCTGAAAAGAAATGGCAAGTGACTGCTATCAATGTG
GGAAACATTAACAATGACAAGAAAGATGAGATGTACCGATCACTTTTTCAAGATCTGGAG
TTAAAAAAGGAACGGCGTGTAATTCTGGACTGTGAAAGGGATAAAGTAAACGACATTGTA
GACCAGGTTATTACCATTGGAAAACATGTTAAAGGGTACCACTACATCATTGCAAATCTG
GGATTTACTGATGGAGACCTATTAAAAATCCAGTTTGGAGGTGCAAATGTCTCTGGATTT
CAGATAGTGGACTATGATGATTCGTTGGTATCTAAATTTATAGAAAGATGGTCAACACTG
GAAGAAAAAGAATACCCTGGAGCTCACACAACAACAATTAAGTATACTTCTGCTCTGACC
TATGATGCCGTTCAAGTGATGACTGAAGCCTTCCGCAACCTAAGGAAGCAAAGAATTGAA
ATCTCCCGAAGGGGGAATGCAGGAGACTGTCTGGCAAACCCAGCAGTGCCCTGGGGACAA
GGTGTAGAAATAGAAAGGGCCCTCAAACAGGTTCAGGTTGAAGGTCTCTCAGGAAATATA
AAGTTTGACCAGAATGGAAAAAGAATAAACTATACAATTAACATCATGGAGCTCAAAACT
AATGGGCCCCGGAAGATTGGCTACTGGAGTGAAGTGGACAAAATGGTTGTTACCCTTACT
GAGCTCCCTTCTGGAAATGACACCTCTGGGCTTGAGAATAAGACTGTTGTTGTCACCACA
ATTTTGGAATCTCCGTATGTTATGATGAAGAAAAATCATGAAATGCTTGAAGGCAATGAG
CGCTATGAGGGCTACTGTGTTGACCTGGCTGCAGAAATCGCCAAACATTGTGGGTTCAAG
TACAAGTTGACAATTGTTGGTGATGGCAAGTATGGGGCCAGGGATGCAGACACGAAAATT
TGGAATGGGATGGTTGGAGAACTTGTATATGGGAAAGCTGATATTGCAATTGCTCCATTA
ACTATTACCCTTGTGAGAGAAGAGGTGATTGACTTCTCAAAGCCCTTCATGAGCCTCGGG
ATATCTATCATGATCAAGAAGCCTCAGAAGTCCAAACCAGGAGTGTTTTCCTTTCTTGAT
CCTTTAGCCTATGAGATCTGGATGTGCATTGTTTTTGCCTACATTGGGGTCAGTGTAGTT
TTATTCCTGGTCAGCAGATTTAGCCCCTACGAGTGGCACACTGAGGAGTTTGAAGATGGA
AGAGAAACACAAAGTAGTGAATCAACTAATGAATTTGGGATTTTTAATAGTCTCTGGTTT
TCCTTGGGTGCCTTTATGCGGCAAGGATGCGATATTTCGCCAAGATCCCTCTCTGGGCGC
ATTGTTGGAGGTGTGTGGTGGTTCTTTACCCTGATCATAATCTCCTCCTACACGGCTAAC
TTAGCTGCCTTCCTGACTGTAGAGAGGATGGTGTCTCCCATCGAAAGTGCTGAGGATCTT
TCTAAGCAAACAGAAATTGCTTATGGAACATTAGACTCTGGCTCCACTAAAGAGTTTTTC
AGGAGATCTAAAATTGCAGTGTTTGATAAAATGTGGACCTACATGCGGAGTGCGGAGCCC
TCTGTGTTTGTGAGGACTACGGCCGAAGGGGTGGCTAGAGTGCGGAAGTCCAAAGGGAAA
TATGCCTACTTGTTGGAGTCCACGATGAACGAGTACATTGAGCAAAGGAAGCCTTGCGAC
ACCATGAAAGTTGGTGGAAACCTGGATTCCAAAGGCTATGGCATCGCAACACCTAAAGGA
TCCTCATTAAGAACCCCAGTAAATCTTGCAGTATTGAAACTCAGTGAGCAAGGCGTCTTA
GACAAGCTGAAAAACAAATGGTGGTACGATAAAGGTGAATGTGGAGCCAAGGACTCTGGA
AGTAAGGAAAAGACCAGTGCCCTCAGTCTGAGCAACGTTGCTGGAGTATTCTACATCCTT
GTCGGGGGCCTTGGTTTGGCAATGCTGGTGGCTTTGATTGAGTTCTGTTACAAGTCAAGG
GCCGAGGCGAAACGAATGAAGGTGGCAAAGAATGCACAGAATATTAACCCATCTTCCTCG
CAGAATTCACAGAATTTTGCAACTTATAAGGAAGGTTACAACGTATATGGCATCGAAAGT
GTTAAAATTTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endocytic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>AMPA glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>synaptic vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ionotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMPA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000831</id>
      <name>Glutamate receptor 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>7679210</pubmed-id>
            <citation>Henley JM, Jenkins R, Hunt SP: Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacology. 1993 Jan;32(1):37-41.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P42263" source="Swiss-Prot">
    <name>Glutamate receptor 3</name>
    <general-function>Extracellular-glutamate-gated ion channel activity</general-function>
    <specific-function>Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.</specific-function>
    <gene-name>GRIA3</gene-name>
    <locus>Xq25-q26</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>553-573
628-648
824-844</transmembrane-regions>
    <signal-regions>1-28</signal-regions>
    <theoretical-pi>8.74</theoretical-pi>
    <molecular-weight>101155.975</molecular-weight>
    <chromosome-location>X</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4573</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIA3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U10302</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>507829</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>446</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>446</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P42263</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIA3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPA-selective glutamate receptor 3</synonym>
      <synonym>GluA3</synonym>
      <synonym>GluR-3</synonym>
      <synonym>GluR-C</synonym>
      <synonym>GluR-K3</synonym>
      <synonym>GLUR3</synonym>
      <synonym>GLURC</synonym>
      <synonym>Glutamate receptor ionotropic, AMPA 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001658|Glutamate receptor 3
MARQKKMGQSVLRAVFFLVLGLLGHSHGGFPNTISIGGLFMRNTVQEHSAFRFAVQLYNT
NQNTTEKPFHLNYHVDHLDSSNSFSVTNAFCSQFSRGVYAIFGFYDQMSMNTLTSFCGAL
HTSFVTPSFPTDADVQFVIQMRPALKGAILSLLGHYKWEKFVYLYDTERGFSILQAIMEA
AVQNNWQVTARSVGNIKDVQEFRRIIEEMDRRQEKRYLIDCEVERINTILEQVVILGKHS
RGYHYMLANLGFTDILLERVMHGGANITGFQIVNNENPMVQQFIQRWVRLDEREFPEAKN
APLKYTSALTHDAILVIAEAFRYLRRQRVDVSRRGSAGDCLANPAVPWSQGIDIERALKM
VQVQGMTGNIQFDTYGRRTNYTIDVYEMKVSGSRKAGYWNEYERFVPFSDQQISNDSASS
ENRTIVVTTILESPYVMYKKNHEQLEGNERYEGYCVDLAYEIAKHVRIKYKLSIVGDGKY
GARDPETKIWNGMVGELVYGRADIAVAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKS
KPGVFSFLDPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHLEDNNEEPRDPQSPPDPP
NEFGIFNSLWFSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVER
MVSPIESAEDLAKQTEIAYGTLDSGSTKEFFRRSKIAVYEKMWSYMKSAEPSVFTKTTAD
GVARVRKSKGKFAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGVATPKGSALRNAVNL
AVLKLNEQGLLDKLKNKWWYDKGECGSGGGDSKDKTSALSLSNVAGVFYILVGGLGLAMM
VALIEFCYKSRAESKRMKLTKNTQNFKPAPATNTQNYATYREGYNVYGTESVKI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010586|Glutamate receptor 3 (GRIA3)
ATGGCCAGGCAGAAGAAAATGGGGCAAAGCGTGCTCCGGGCGGTCTTCTTTTTAGTCCTG
GGGCTTTTGGGTCATTCTCACGGAGGATTCCCCAACACCATCAGCATAGGTGGACTTTTC
ATGAGAAACACAGTGCAGGAGCACAGCGCTTTCCGCTTTGCCGTGCAGTTATACAACACC
AACCAGAACACCACCGAGAAGCCCTTCCATTTGAATTACCACGTAGATCACTTGGATTCC
TCCAATAGTTTTTCCGTGACAAATGCTTTCTGCTCCCAGTTCTCGAGAGGGGTGTATGCC
ATCTTTGGATTCTATGACCAGATGTCAATGAACACCCTGACCTCCTTCTGTGGGGCCCTG
CACACATCCTTTGTTACGCCTAGCTTCCCCACTGACGCAGATGTGCAGTTTGTCATCCAG
ATGCGCCCAGCCTTGAAGGGCGCTATTCTGAGTCTTCTGGGTCATTACAAGTGGGAGAAG
TTTGTGTACCTCTATGACACAGAACGAGGATTTTCCATCCTCCAAGCGATTATGGAAGCA
GCAGTGCAAAACAACTGGCAAGTAACAGCAAGGTCTGTGGGAAACATAAAGGACGTCCAA
GAATTCAGGCGCATCATTGAAGAAATGGACAGGAGGCAGGAAAAGCGATACTTGATTGAC
TGCGAAGTCGAAAGGATTAACACAATTTTGGAACAGGTTGTGATCCTAGGGAAACACTCA
AGAGGTTATCACTACATGCTCGCTAACCTGGGTTTTACTGATATTTTACTGGAAAGAGTC
ATGCATGGGGGAGCCAACATTACAGGTTTCCAGATTGTCAACAATGAAAACCCTATGGTT
CAGCAGTTCATACAGCGCTGGGTGAGGCTGGATGAAAGGGAATTCCCTGAAGCCAAGAAT
GCACCACTAAAGTATACATCTGCATTGACACACGACGCAATACTGGTCATAGCAGAAGCT
TTCCGCTACCTGAGGAGGCAGCGAGTAGATGTGTCCCGGAGAGGAAGTGCTGGAGACTGC
TTAGCAAATCCTGCTGTGCCCTGGAGTCAAGGAATTGATATTGAGAGAGCTCTGAAAATG
GTGCAAGTACAAGGAATGACTGGAAATATTCAATTTGACACTTATGGACGTAGGACAAAT
TATACCATCGATGTGTATGAAATGAAAGTCAGTGGCTCTCGAAAAGCTGGCTACTGGAAT
GAGTATGAAAGGTTTGTGCCTTTCTCAGATCAGCAAATCAGCAATGACAGTGCATCCTCA
GAGAATCGGACCATAGTAGTGACTACCATTCTGGAATCACCATATGTAATGTACAAGAAG
AACCATGAGCAACTGGAAGGAAATGAACGATATGAAGGCTATTGTGTAGACCTAGCCTAT
GAAATAGCCAAACATGTAAGGATCAAATACAAATTGTCCATCGTTGGTGACGGGAAATAT
GGTGCAAGGGATCCAGAGACTAAAATATGGAACGGCATGGTTGGGGAACTTGTCTATGGG
AGAGCTGATATAGCTGTTGCTCCACTCACTATAACATTGGTCCGTGAAGAAGTCATAGAT
TTTTCAAAGCCATTCATGAGCCTGGGCATCTCCATCATGATAAAGAAGCCTCAGAAATCA
AAACCAGGCGTATTCTCATTTCTGGATCCCCTGGCTTATGAAATCTGGATGTGCATTGTC
TTTGCTTACATTGGAGTCAGCGTAGTTCTTTTCCTAGTCAGCAGGTTCAGTCCTTATGAA
TGGCACTTGGAAGACAACAATGAAGAACCTCGTGACCCACAAAGTCCTCCTGATCCTCCA
AATGAATTTGGAATATTTAACAGTCTTTGGTTTTCCTTGGGTGCCTTTATGCAGCAAGGA
TGTGATATTTCTCCAAGATCACTCTCCGGGCGCATTGTTGGAGGGGTTTGGTGGTTCTTC
ACCCTGATCATAATTTCTTCCTATACTGCCAATCTCGCTGCTTTCCTGACTGTGGAGAGG
ATGGTTTCTCCCATAGAGAGTGCTGAAGACTTAGCTAAACAGACTGAAATTGCATATGGG
ACCCTGGACTCCGGTTCAACAAAAGAATTTTTCAGAAGATCCAAAATTGCTGTGTACGAG
AAAATGTGGTCTTACATGAAATCAGCGGAGCCATCTGTGTTTACCAAAACAACAGCAGAC
GGAGTGGCCCGAGTGCGAAAGTCCAAGGGAAAGTTCGCCTTCCTGCTGGAGTCAACCATG
AATGAGTACATTGAGCAGAGAAAACCATGTGATACGATGAAAGTTGGTGGAAATCTGGAT
TCCAAAGGCTATGGTGTGGCAACCCCTAAAGGCTCAGCATTAGGAAATGCTGTTAACCTG
GCAGTATTAAAACTGAATGAGCAAGGCCTCTTGGACAAATTGAAAAACAAATGGTGGTAC
GACAAAGGAGAGTGCGGCAGCGGGGGCGGTGACTCCAAGGACAAGACCAGCGCTCTGAGC
CTGAGCAATGTGGCAGGCGTTTTCTATATACTTGTCGGAGGTCTGGGGCTGGCCATGATG
GTGGCTTTGATAGAATTCTGTTACAAATCACGGGCAGAGTCCAAACGCATGAAACTCACA
AAGAACACCCAAAACTTTAAGCCTGCTCCTGCCACCAACACTCAGAATTATGCTACATAC
AGAGAAGGCTACAACGTGTATGGAACAGAGAGTGTTAAGATCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>AMPA glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endocytic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMPA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000830</id>
      <name>Glutamate receptor 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11406192</pubmed-id>
            <citation>Linden AM, Yu H, Zarrinmayeh H, Wheeler WJ, Skolnick P: Binding of an AMPA receptor potentiator ([3H]LY395153) to native and recombinant AMPA receptors. Neuropharmacology. 2001 Jun;40(8):1010-8.</citation>
          </article>
          <article>
            <pubmed-id>7679210</pubmed-id>
            <citation>Henley JM, Jenkins R, Hunt SP: Localisation of glutamate receptor binding sites and mRNAs to the dorsal horn of the rat spinal cord. Neuropharmacology. 1993 Jan;32(1):37-41.</citation>
          </article>
          <article>
            <pubmed-id>12008069</pubmed-id>
            <citation>Cristovao AJ, Oliveira CR, Carvalho CM: Expression of AMPA/kainate receptors during development of chick embryo retina cells: in vitro versus in vivo studies. Int J Dev Neurosci. 2002 Feb;20(1):1-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48058" source="Swiss-Prot">
    <name>Glutamate receptor 4</name>
    <general-function>Ionotropic glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. In the presence of CACNG4 or CACNG7 or CACNG8, shows resensitization which is characterized by a delayed accumulation of current flux upon continued application of glutamate.</specific-function>
    <gene-name>GRIA4</gene-name>
    <locus>11q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>545-565
618-638
814-834</transmembrane-regions>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi>8.32</theoretical-pi>
    <molecular-weight>100870.085</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4574</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIA4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U16129</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>790538</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>447</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>447</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P48058</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIA4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>AMPA-selective glutamate receptor 4</synonym>
      <synonym>GluA4</synonym>
      <synonym>GluR-4</synonym>
      <synonym>GluR-D</synonym>
      <synonym>GLUR4</synonym>
      <synonym>Glutamate receptor ionotropic, AMPA 4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037088|Glutamate receptor 4
MRIISRQIVLLFSGFWGLAMGAFPSSVQIGGLFIRNTDQEYTAFRLAIFLHNTSPNASEA
PFNLVPHVDNIETANSFAVTNAFCSQYSRGVFAIFGLYDKRSVHTLTSFCSALHISLITP
SFPTEGESQFVLQLRPSLRGALLSLLDHYEWNCFVFLYDTDRGYSILQAIMEKAGQNGWH
VSAICVENFNDVSYRQLLEELDRRQEKKFVIDCEIERLQNILEQIVSVGKHVKGYHYIIA
NLGFKDISLERFIHGGANVTGFQLVDFNTPMVIKLMDRWKKLDQREYPGSETPPKYTSAL
TYDGVLVMAETFRSLRRQKIDISRRGNAGDCLANPAAPWGQGIDMERTLKQVRIQGLTGN
VQFDHYGRRVNYTMDVFELKSTGPRKVGYWNDMDKLVLIQDVPTLGNDTAAIENRTVVVT
TIMESPYVMYKKNHEMFEGNDKYEGYCVDLASEIAKHIGIKYKIAIVPDGKYGARDADTK
IWNGMVGELVYGKAEIAIAPLTITLVREEVIDFSKPFMSLGISIMIKKPQKSKPGVFSFL
DPLAYEIWMCIVFAYIGVSVVLFLVSRFSPYEWHTEEPEDGKEGPSDQPPNEFGIFNSLW
FSLGAFMQQGCDISPRSLSGRIVGGVWWFFTLIIISSYTANLAAFLTVERMVSPIESAED
LAKQTEIAYGTLDSGSTKEFFRRSKIAVYEKMWTYMRSAEPSVFTRTTAEGVARVRKSKG
KFAFLLESTMNEYIEQRKPCDTMKVGGNLDSKGYGVATPKGSSLRTPVNLAVLKLSEAGV
LDKLKNKWWYDKGECGPKDSGSKDKTSALSLSNVAGVFYILVGGLGLAMLVALIEFCYKS
RAEAKRMKLTFSEAIRNKARLSITGSVGENGRVLTPDCPKAVHTGTAIRQSSGLAVIASD
LP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016220|Glutamate receptor 4 (GRIA4)
ATGAGGATTATTTCCAGACAGATTGTCTTGTTATTTTCTGGATTTTGGGGACTCGCCATG
GGAGCCTTTCCGAGCAGCGTGCAAATAGGTGGTCTCTTCATCCGAAACACAGATCAGGAA
TACACTGCTTTTCGATTAGCAATTTTTCTTCATAACACCAGCCCCAATGCGTCGGAAGCT
CCTTTTAATTTGGTACCTCATGTGGACAACATTGAGACAGCCAACAGTTTTGCTGTAACA
AACGCCTTCTGTTCCCAGTATTCTAGAGGAGTATTTGCCATTTTTGGACTCTATGATAAG
AGGTCGGTACATACCTTGACCTCATTCTGCAGCGCCTTACATATCTCCCTCATCACACCA
AGTTTCCCTACTGAGGGGGAGAGCCAGTTTGTGCTGCAACTAAGACCTTCGTTACGAGGA
GCACTCTTGAGTTTGCTGGATCACTACGAATGGAACTGTTTTGTCTTCCTGTATGACACA
GACAGGGGATACTCGATACTCCAAGCTATTATGGAAAAAGCAGGACAAAATGGTTGGCAT
GTCAGCGCTATATGTGTGGAAAATTTTAATGATGTCAGCTATAGGCAACTTCTAGAAGAA
CTTGACAGAAGACAAGAGAAGAAGTTTGTAATAGACTGTGAGATAGAGAGACTTCAAAAC
ATATTAGAACAGATTGTAAGTGTTGGAAAGCATGTTAAAGGCTACCATTATATCATTGCA
AACTTGGGATTCAAGGATATTTCTCTTGAGAGGTTTATACATGGTGGAGCCAATGTTACT
GGATTCCAGTTGGTGGATTTTAATACACCTATGGTAATCAAACTAATGGATCGCTGGAAG
AAACTAGATCAGAGAGAGTATCCAGGATCTGAGACTCCTCCAAAGTACACCTCTGCTCTG
ACTTATGATGGAGTCCTTGTGATGGCTGAAACTTTCCGAAGTCTTAGGAGGCAGAAAATT
GATATCTCAAGGAGAGGAAATGCTGGGGATTGTCTGGCAAATCCTGCTGCTCCATGGGGC
CAGGGAATTGACATGGAGAGGACACTCAAACAGGTTCGAATTCAAGGGCTGACAGGGAAT
GTTCAGTTTGACCACTATGGACGTAGAGTCAATTACACAATGGATGTGTTTGAGCTGAAA
AGCACAGGACCTAGAAAGGTTGGTTACTGGAATGATATGGATAAGTTAGTCTTGATTCAA
GATGTACCAACTCTTGGCAATGACACAGCTGCTATTGAGAACAGAACAGTGGTTGTAACC
ACAATTATGGAATCCCCATATGTTATGTACAAGAAAAATCATGAAATGTTTGAAGGAAAT
GACAAGTATGAAGGATACTGTGTAGATTTGGCATCTGAAATTGCAAAACATATTGGTATC
AAGTATAAAATTGCCATTGTCCCTGATGGAAAATATGGAGCAAGGGATGCAGACACAAAA
ATCTGGAATGGGATGGTAGGAGAACTTGTTTATGGGAAAGCAGAGATTGCTATTGCCCCT
CTGACAATCACTTTGGTACGAGAGGAGGTCATTGACTTTTCTAAGCCCTTCATGAGTTTG
GGCATATCTATCATGATCAAAAAGCCTCAGAAATCCAAACCAGGAGTGTTTTCCTTCTTG
GATCCTCTGGCCTATGAGATTTGGATGTGCATAGTCTTTGCCTACATTGGTGTCAGCGTG
GTCTTATTCCTAGTTAGTAGATTTAGTCCATATGAGTGGCACACAGAAGAGCCAGAGGAC
GGAAAGGAAGGACCCAGCGACCAGCCTCCCAATGAGTTTGGCATCTTTAACAGCCTCTGG
TTTTCCCTGGGTGCTTTTATGCAGCAAGGATGTGACATTTCACCCAGATCCCTCTCAGGT
CGAATTGTTGGAGGTGTTTGGTGGTTCTTTACACTCATCATTATATCATCTTATACTGCT
AACCTCGCTGCTTTCCTGACGGTTGAGCGAATGGTCTCTCCCATAGAAAGTGCAGAAGAC
CTGGCCAAACAAACAGAAATTGCCTATGGAACACTGGATTCAGGATCAACAAAAGAATTC
TTCAGAAGATCAAAAATAGCAGTGTATGAAAAGATGTGGACCTACATGCGATCAGCAGAG
CCATCAGTATTCACTAGGACTACAGCTGAGGGAGTAGCTCGTGTCCGCAAATCCAAGGGC
AAATTTGCCTTTCTCCTGGAGTCCACTATGAATGAATACATTGAGCAGCGAAAGCCATGT
GACACGATGAAAGTGGGAGGAAATCTGGATTCCAAAGGCTATGGAGTAGCAACGCCCAAG
GGTTCCTCATTAGGAACTCCTGTAAACCTTGCCGTTTTGAAACTCAGTGAGGCAGGCGTC
TTAGACAAGCTGAAAAACAAATGGTGGTACGATAAAGGTGAATGTGGACCCAAGGACTCT
GGAAGCAAGGACAAGACGAGTGCCTTGAGCCTGAGCAATGTAGCAGGCGTCTTCTACATT
CTGGTTGGCGGCTTGGGCTTGGCAATGCTGGTGGCTTTGATAGAGTTCTGTTACAAGTCC
AGGGCAGAAGCGAAGAGAATGAAGCTGACCTTTTCTGAAGCCATAAGAAACAAAGCCAGA
TTATCCATCACTGGGAGTGTGGGAGAGAATGGCCGCGTCTTGACGCCTGACTGCCCAAAG
GCTGTACACACTGGAACTGCAATCAGACAAAGTTCAGGATTGGCTGTCATTGCATCGGAC
CTACCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>AMPA glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endocytic vesicle membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ionotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>AMPA glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000823</id>
      <name>Delta-1-pyrroline-5-carboxylate synthase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12513997</pubmed-id>
            <citation>Morita Y, Nakamori S, Takagi H: L-proline accumulation and freeze tolerance of Saccharomyces cerevisiae are caused by a mutation in the PRO1 gene encoding gamma-glutamyl kinase. Appl Environ Microbiol. 2003 Jan;69(1):212-9.</citation>
          </article>
          <article>
            <pubmed-id>114173</pubmed-id>
            <citation>Krishna RV, Beilstein P, Leisinger T: Biosynthesis of proline in Pseudomonas aeruginosa. Properties of gamma-glutamyl phosphate reductase and 1-pyrroline-5-carboxylate reductase. Biochem J. 1979 Jul 1;181(1):223-30.</citation>
          </article>
          <article>
            <pubmed-id>9622938</pubmed-id>
            <citation>Kamoun P, Aral B, Saudubray JM: [A new inherited metabolic disease: delta1-pyrroline 5-carboxylate synthetase deficiency]. Bull Acad Natl Med. 1998;182(1):131-7; discussion 138-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P54886" source="Swiss-Prot">
    <name>Delta-1-pyrroline-5-carboxylate synthase</name>
    <general-function>Poly(a) rna binding</general-function>
    <specific-function>Bifunctional enzyme that converts glutamate to glutamate 5-semialdehyde, an intermediate in the biosynthesis of proline, ornithine and arginine.</specific-function>
    <gene-name>ALDH18A1</gene-name>
    <locus>10q24.3</locus>
    <cellular-location>Mitochondrion inner membrane</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.13</theoretical-pi>
    <molecular-weight>87301.53</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:9722</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ALDH18A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X94453</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1304314</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P54886</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>P5CS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aldehyde dehydrogenase family 18 member A1</synonym>
      <synonym>GSAS</synonym>
      <synonym>P5CS</synonym>
      <synonym>PYCS</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001642|Delta-1-pyrroline-5-carboxylate synthase
MLSQVYRCGFQPFNQHLLPWVKCTTVFRSHCIQPSVIRHVRSWSNIPFITVPLSRTHGKS
FAHRSELKHAKRIVVKLGSAVVTRGDECGLALGRLASIVEQVSVLQNQGREMMLVTSGAV
AFGKQRLRHEILLSQSVRQALHSGQNQLKEMAIPVLEARACAAAGQSGLMALYEAMFTQY
SICAAQILVTNLDFHDEQKRRNLNGTLHELLRMNIVPIVNTNDAVVPPAEPNSDLQGVNV
ISVKDNDSLAARLAVEMKTDLLIVLSDVEGLFDSPPGSDDAKLIDIFYPGDQQSVTFGTK
SRVGMGGMEAKVKAALWALQGGTSVVIANGTHPKVSGHVITDIVEGKKVGTFFSEVKPAG
PTVEQQGEMARSGGRMLATLEPEQRAEIIHHLADLLTDQRDEILLANKKDLEEAEGRLAA
PLLKRLSLSTSKLNSLAIGLRQIAASSQDSVGRVLRRTRIAKNLELEQVTVPIGVLLVIF
ESRPDCLPQVAALAIASGNGLLLKGGKEAAHSNRILHLLTQEALSIHGVKEAVQLVNTRE
EVEDLCRLDKMIDLIIPRGSSQLVRDIQKAAKGIPVMGHSEGICHMYVDSEASVDKVTRL
VRDSKCEYPAACNALETLLIHRDLLRTPLFDQIIDMLRVEQVKIHAGPKFASYLTFSPSE
VKSLRTEYGDLELCIEVVDNVQDAIDHIHKYGSSHTDVIVTEDENTAEFFLQHVDSACVF
WNASTRFSDGYRFGLGAEVGISTSRIHARGPVGLEGLLTTKWLLRGKDHVVSDFSEHGSL
KYLHENLPIPQRNTN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010581|Delta-1-pyrroline-5-carboxylate synthase (ALDH18A1)
ATGTTGAGTCAAGTTTACCGCTGTGGGTTCCAGCCCTTCAACCAACATCTTCTGCCCTGG
GTCAAGTGTACAACCGTCTTCAGATCTCATTGTATCCAGCCTTCAGTCATCAGACATGTT
CGTTCTTGGAGCAACATCCCGTTTATCACTGTACCCCTCAGTCGTACACATGGCAAGTCC
TTCGCCCACCGCAGTGAGCTGAAGCATGCCAAGAGAATCGTGGTGAAGCTCGGCAGTGCC
GTGGTGACCCGAGGGGATGAATGTGGCCTGGCCCTGGGGCGCTTGGCATCTATTGTTGAG
CAGGTATCAGTGCTGCAGAATCAGGGCAGAGAGATGATGCTGGTGACCAGTGGAGCCGTA
GCCTTTGGCAAACAACGCTTGCGCCATGAGATCCTTCTGTCTCAGAGCGTGCGGCAGGCC
CTCCACTCGGGGCAGAACCAGCTGAAAGAAATGGCAATTCCAGTCTTAGAGGCACGAGCC
TGTGCAGCTGCCGGACAGAGTGGGCTGATGGCCTTGTATGAGGCTATGTTTACCCAGTAC
AGCATCTGTGCTGCCCAGATTTTGGTGACCAATTTGGATTTCCATGATGAGCAGAAGCGC
CGGAACCTCAATGGAACACTTCATGAACTCCTTAGAATGAACATTGTCCCCATTGTCAAC
ACAAATGATGCTGTTGTCCCCCCAGCTGAGCCCAACAGTGACCTGCAGGGGGTTATTAGT
GTTAAAGATAATGATAGCCTGGCTGCCCGACTGGCTGTGGAAATGAAAACTGATCTCTTG
ATTGTTCTTTCAGATGTAGAAGGCCTTTTTGACAGCCCCCCAGGTTCAGATGATGCAAAG
CTTATTGATATATTTTATCCCGGAGATCAGCAGTCTGTGACATTTGGAACCAAGTCTAGA
GTGGGAATGGGTGGCATGGAAGCCAAGGTGAAAGCAGCCCTCTGGGCTTTGCAAGGTGGC
ACTTCTGTTGTTATTGCCAATGGAACCCACCCAAAGGTGTCTGGGCACGTCATCACAGAC
ATTGTGGAGGGGAAGAAAGTTGGTACCTTCTTTTCAGAAGTAAAGCCTGCAGGCCCTACT
GTTGAGCAGCAGGGAGAAATGGCGCGATCTGGAGGAAGGATGTTGGCCACCTTGGAACCT
GAGCAGAGAGCAGAAATTATCCATCATCTGGCTGATCTGTTGACGGACCAGCGTGATGAG
ATCCTGTTAGCCAACAAAAAAGACTTGGAGGAGGCAGAGGGGAGACTTGCAGCTCCTCTG
CTGAAACGTTTAAGCCTCTCCACATCCAAATTGAACAGCCTGGCCATCGGTCTGCGACAG
ATCGCAGCCTCCTCCCAGGACAGCGTGGGACGTGTTTTGCGCCGCACCCGAATCGCCAAA
AACTTGGAACTGGAACAAGTGACTGTCCCAATTGGAGTTCTGCTGGTGATCTTTGAATCT
CGTCCTGACTGTCTACCCCAGGTGGCAGCTTTGGCTATCGCAAGTGGCAATGGCTTGTTA
CTCAAAGGAGGGAAGGAGGCTGCACACAGCAACCGGATTCTCCACCTCCTGACCCAGGAG
GCTCTCTCAATCCATGGAGTCAAGGAGGCCGTGCAACTGGTGAATACCAGAGAAGAAGTT
GAAGATCTTTGCCGCCTAGACAAAATGATAGATCTGATCATTCCACGTGGCTCTTCCCAG
CTGGTCAGAGACATCCAGAAAGCTGCTAAGGGGATTCCAGTGATGGGGCACAGCGAAGGG
ATCTGTCACATGTATGTGGATTCCGAGGCCAGTGTTGATAAGGTCACCAGGCTAGTCAGA
GACTCTAAATGTGAATATCCAGCTGCCTGTAATGCTTTGGAGACTTTGTTAATCCACCGG
GATCTGCTCAGGACACCATTATTTGACCAGATCATTGATATGCTGAGAGTGGAACAGGTA
AAAATTCATGCAGGCCCCAAATTTGCCTCCTATCTGACCTTCAGCCCCTCCGAAGTGAAG
TCACTCCGAACTGAGTATGGGGACCTGGAATTATGCATTGAAGTAGTGGACAACGTTCAG
GATGCCATTGACCACATCCACAAGTATGGCAGCTCCCACACGGATGTCATCGTCACAGAG
GACGAAAACACAGCGGAGTTCTTCCTGCAGCACGTAGACAGTGCCTGTGTGTTCTGGAAT
GCCAGCACTCGCTTTTCTGATGGTTACCGCTTTGGACTGGGAGCTGAAGTGGGAATCAGT
ACATCGAGAATCCACGCCCGGGGACCAGTAGGACTTGAGGGACTGCTTACTACTAAGTGG
CTGCTGCGAGGGAAGGACCACGTGGTCTCAGATTTCTCAGAGCATGGAAGTTTAAAATAT
CTTCATGAGAACCTCCCTATTCCTCAGAGAAACACCAACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00171</identifier>
        <name>Aldedh</name>
      </pfam>
      <pfam>
        <identifier>PF00696</identifier>
        <name>AA_kinase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>poly(A) RNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate 5-kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate-5-semialdehyde dehydrogenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>citrulline biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ornithine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-proline biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proline biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000826</id>
      <name>Glutamate receptor ionotropic, kainate 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17581967</pubmed-id>
            <citation>Wong AY, MacLean DM, Bowie D: Na+/Cl- dipole couples agonist binding to kainate receptor activation. J Neurosci. 2007 Jun 20;27(25):6800-9.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13002" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, kainate 2</name>
    <general-function>Kainate selective glutamate receptor activity</general-function>
    <specific-function>Ionotropic glutamate receptor. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. Binding of the excitatory neurotransmitter L-glutamate induces a conformation change, leading to the opening of the cation channel, and thereby converts the chemical signal to an electrical impulse. The receptor then desensitizes rapidly and enters a transient inactive state, characterized by the presence of bound agonist. May be involved in the transmission of light information from the retina to the hypothalamus. Modulates cell surface expression of NETO2 (By similarity).</specific-function>
    <gene-name>GRIK2</gene-name>
    <locus>6q16.3-q21</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>562-582
636-656
820-840</transmembrane-regions>
    <signal-regions>1-31</signal-regions>
    <theoretical-pi>8.01</theoretical-pi>
    <molecular-weight>102582.475</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4580</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIK2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U16126</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>790532</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>451</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13002</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIK2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAA4</synonym>
      <synonym>Excitatory amino acid receptor 4</synonym>
      <synonym>GluK2</synonym>
      <synonym>GluR-6</synonym>
      <synonym>GLUR6</synonym>
      <synonym>Glutamate receptor 6</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001648|Glutamate receptor ionotropic, kainate 2
MKIIFPILSNPVFRRTVKLLLCLLWIGYSQGTTHVLRFGGIFEYVESGPMGAEELAFRFA
VNTINRNRTLLPNTTLTYDTQKINLYDSFEASKKACDQLSLGVAAIFGPSHSSSANAVQS
ICNALGVPHIQTRWKHQVSDNKDSFYVSLYPDFSSLSRAILDLVQFFKWKTVTVVYDDST
GLIRLQELIKAPSRYNLRLKIRQLPADTKDAKPLLKEMKRGKEFHVIFDCSHEMAAGILK
QALAMGMMTEYYHYIFTTLDLFALDVEPYRYSGVNMTGFRILNTENTQVSSIIEKWSMER
LQAPPKPDSGLLDGFMTTDAALMYDAVHVVSVAVQQFPQMTVSSLQCNRHKPWRFGTRFM
SLIKEAHWEGLTGRITFNKTNGLRTDFDLDVISLKEEGLEKIGTWDPASGLNMTESQKGK
PANITDSLSNRSLIVTTILEEPYVLFKKSDKPLYGNDRFEGYCIDLLRELSTILGFTYEI
RLVEDGKYGAQDDANGQWNGMVRELIDHKADLAVAPLAITYVREKVIDFSKPFMTLGISI
LYRKPNGTNPGVFSFLNPLSPDIWMYILLAYLGVSCVLFVIARFSPYEWYNPHPCNPDSD
VVENNFTLLNSFWFGVGALMQQGSELMPKALSTRIVGGIWWFFTLIIISSYTANLAAFLT
VERMESPIDSADDLAKQTKIEYGAVEDGATMTFFKKSKISTYDKMWAFMSSRRQSVLVKS
NEEGIQRVLTSDYAFLMESTTIEFVTQRNCNLTQIGGLIDSKGYGVGTPMGSPYRDKITI
AILQLQEEGKLHMMKEKWWRGNGCPEEESKEASALGVQNIGGIFIVLAAGLVLSVFVAVG
EFLYKSKKNAQLEKRSFCSAMVEELRMSLKCQRRLKHKPQAPVIVKTEEVINMHTFNDRR
LPGKETMA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020488|Glutamate receptor ionotropic, kainate 2 (GRIK2)
ATGAAGATTATTTTCCCGATTCTAAGTAATCCAGTCTTCAGGCGCACCGTTAAACTCCTG
CTCTGTTTACTGTGGATTGGATATTCTCAAGGAACCACACATGTATTAAGATTTGGTGGT
ATTTTTGAATATGTGGAATCTGGCCCAATGGGAGCTGAGGAACTTGCATTCAGATTTGCT
GTGAACACAATTAACAGAAACAGAACATTGCTACCCAATACTACCCTTACCTATGATACC
CAGAAGATAAACCTTTATGATAGTTTTGAAGCATCCAAGAAAGCCTGTGATCAGCTGTCT
CTTGGGGTGGCTGCCATCTTCGGGCCTTCACACAGCTCATCAGCAAACGCAGTGCAGTCC
ATCTGCAATGCTCTGGGAGTTCCCCACATACAGACCCGCTGGAAGCACCAGGTGTCAGAC
AACAAAGATTCCTTCTATGTCAGTCTCTACCCAGACTTCTCTTCACTCAGCCGTGCCATT
TTAGACCTGGTGCAGTTTTTCAAGTGGAAAACCGTCACGGTTGTGTATGATGACAGCACT
GGTCTCATTCGTTTGCAAGAGCTCATCAAAGCTCCATCAAGGTATAATCTTCGACTCAAA
ATTCGTCAGTTACCTGCTGATACAAAGGATGCAAAACCCTTACTAAAAGAAATGAAAAGA
GGCAAGGAGTTTCATGTAATCTTTGATTGTAGCCATGAAATGGCAGCAGGCATTTTAAAA
CAGGCATTAGCTATGGGAATGATGACAGAATACTATCATTATATCTTTACCACTCTGGAC
CTCTTTGCTCTTGATGTTGAGCCCTACCGATACAGTGGTGTTAACATGACAGGGTTCAGA
ATATTAAATACAGAAAATACCCAAGTCTCCTCCATCATTGAAAAGTGGTCGATGGAACGA
TTGCAGGCACCTCCGAAACCCGATTCAGGTTTGCTGGATGGATTTATGACGACTGATGCT
GCTCTAATGTATGATGCTGTGCATGTGGTGTCTGTGGCCGTTCAACAGTTTCCCCAGATG
ACAGTCAGTTCCTTGCAGTGTAATCGACATAAACCCTGGCGCTTCGGGACCCGCTTTATG
AGTCTAATTAAAGAGGCACATTGGGAAGGCCTCACAGGCAGAATAACTTTCAACAAAACC
AATGGCTTGAGAACAGATTTTGATTTGGATGTGATCAGTCTGAAGGAAGAAGGTCTAGAA
AAGATTGGAACGTGGGATCCAGCCAGTGGCCTGAATATGACAGAAAGTCAAAAGGGAAAG
CCAGCGAACATCACAGATTCCTTATCCAATCGTTCTTTGATTGTTACCACCATTTTGGAA
GAGCCTTATGTCCTTTTTAAGAAGTCTGACAAACCTCTCTATGGTAATGATCGATTTGAA
GGCTATTGCATTGATCTCCTCAGAGAGTTATCTACAATCCTTGGCTTTACATATGAAATT
AGACTTGTGGAAGATGGGAAATATGGAGCCCAGGATGATGCCAATGGACAATGGAATGGA
ATGGTTCGTGAACTAATTGATCATAAAGCTGACCTTGCAGTTGCTCCACTGGCTATTACC
TATGTTCGAGAGAAGGTCATCGACTTTTCCAAGCCCTTTATGACACTTGGAATAAGTATT
TTGTACCGCAAGCCCAATGGTACAAACCCAGGCGTCTTCTCCTTCCTGAATCCTCTCTCC
CCTGATATCTGGATGTATATTCTGCTGGCTTACTTGGGTGTCAGTTGTGTGCTCTTTGTC
ATAGCCAGGTTTAGTCCTTATGAGTGGTATAATCCACACCCTTGCAACCCTGACTCAGAC
GTGGTGGAAAACAATTTTACCTTGCTAAATAGTTTCTGGTTTGGAGTTGGAGCTCTCATG
CAGCAAGGTTCTGAGCTCATGCCCAAAGCACTGTCCACCAGGATAGTGGGAGGCATTTGG
TGGTTTTTCACACTTATCATCATTTCTTCGTATACTGCTAACTTAGCCGCCTTTCTGACA
GTGGAACGCATGGAATCCCCTATTGACTCTGCTGATGATTTAGCTAAACAAACCAAGATA
GAATATGGAGCAGTAGAGGATGGTGCAACCATGACTTTTTTCAAGAAATCAAAAATCTCC
ACGTATGACAAAATGTGGGCCTTTATGAGTAGCAGAAGGCAGTCAGTGCTGGTCAAAAGT
AATGAAGAAGGAATCCAGCGAGTCCTCACCTCTGATTATGCTTTCCTAATGGAGTCAACA
ACCATCGAGTTTGTTACCCAGCGGAACTGTAACCTGACACAGATTGGCGGCCTTATAGAC
TCTAAAGGTTATGGCGTTGGCACTCCCATGGGTTCTCCATATCGAGACAAAATTACCATA
GCAATTCTTCAGCTGCAAGAGGAAGGCAAACTGCATATGATGAAGGAGAAATGGTGGAGG
GGCAATGGTTGCCCAGAAGAGGAGAGCAAAGAGGCCAGTGCCCTGGGGGTTCAGAATATT
GGTGGCATCTTCATTGTTCTGGCAGCCGGCTTGGTGCTTTCAGTTTTTGTGGCAGTGGGA
GAATTTTTATACAAATCCAAAAAAAACGCTCAATTGGAAAAGAGAGCCAAGACTAAGTTA
CCTCAAGACTATGTATTCCTCCCTATTTTGGAGTCAGTTTCCATTTCTACAGTGTTGTCA
TCATCACCATCTTCATCATCATTATCATCATGTTCTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>kainate selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic density</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kainate selective glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neuronal action potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>inhibitory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular protein transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>modulation of synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of short-term neuronal synaptic plasticity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>receptor clustering</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral fear response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>excitatory postsynaptic potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of JNK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular calcium ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of long-term neuronal synaptic plasticity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000832</id>
      <name>Glutamate receptor ionotropic, kainate 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>1371217</pubmed-id>
            <citation>Bettler B, Egebjerg J, Sharma G, Pecht G, Hermans-Borgmeyer I, Moll C, Stevens CF, Heinemann S: Cloning of a putative glutamate receptor: a low affinity kainate-binding subunit. Neuron. 1992 Feb;8(2):257-65.</citation>
          </article>
          <article>
            <pubmed-id>11058796</pubmed-id>
            <citation>Takeda M, Haga M, Yamada H, Kinoshita M, Otsuka M, Tsuboi S, Moriyama Y: Ionotropic glutamate receptors expressed in human retinoblastoma Y79 cells. Neurosci Lett. 2000 Nov 17;294(2):97-100.</citation>
          </article>
          <article>
            <pubmed-id>8622118</pubmed-id>
            <citation>Stuhmer T, Amar M, Harvey RJ, Bermudez I, van Minnen J, Darlison MG: Structure and pharmacological properties of a molluscan glutamate-gated cation channel and its likely role in feeding behavior. J Neurosci. 1996 May 1;16(9):2869-80.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q13003" source="Swiss-Prot">
    <name>Glutamate receptor ionotropic, kainate 3</name>
    <general-function>Kainate selective glutamate receptor activity</general-function>
    <specific-function>Receptor for glutamate that functions as ligand-gated ion channel in the central nervous system and plays an important role in excitatory synaptic transmission. L-glutamate acts as an excitatory neurotransmitter at many synapses in the central nervous system. The postsynaptic actions of Glu are mediated by a variety of receptors that are named according to their selective agonists. This receptor binds domoate &gt; kainate &gt;&gt; L-glutamate = quisqualate &gt;&gt; AMPA = NMDA.</specific-function>
    <gene-name>GRIK3</gene-name>
    <locus>1p34-p33</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>564-584
637-657
821-841</transmembrane-regions>
    <signal-regions>1-31</signal-regions>
    <theoretical-pi>7.69</theoretical-pi>
    <molecular-weight>104036.06</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4581</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GRIK3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U16127</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>790534</identifier>
      </external-identifier>
      <external-identifier>
        <resource>IUPHAR</resource>
        <identifier>452</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>452</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q13003</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GRIK3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>EAA5</synonym>
      <synonym>Excitatory amino acid receptor 5</synonym>
      <synonym>GluK3</synonym>
      <synonym>GluR-7</synonym>
      <synonym>GLUR7</synonym>
      <synonym>Glutamate receptor 7</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037089|Glutamate receptor ionotropic, kainate 3
MTAPWRRLRSLVWEYWAGLLVCAFWIPDSRGMPHVIRIGGIFEYADGPNAQVMNAEEHAF
RFSANIINRNRTLLPNTTLTYDIQRIHFHDSFEATKKACDQLALGVVAIFGPSQGSCTNA
VQSICNALEVPHIQLRWKHHPLDNKDTFYVNLYPDYASLSHAILDLVQYLKWRSATVVYD
DSTGLIRLQELIMAPSRYNIRLKIRQLPIDSDDSRPLLKEMKRGREFRIIFDCSHTMAAQ
ILKQAMAMGMMTEYYHFIFTTLDLYALDLEPYRYSGVNLTGFRILNVDNPHVSAIVEKWS
MERLQAAPRSESGLLDGVMMTDAALLYDAVHIVSVCYQRAPQMTVNSLQCHRHKAWRFGG
RFMNFIKEAQWEGLTGRIVFNKTSGLRTDFDLDIISLKEDGLEKVGVWSPADGLNITEVA
KGRGPNVTDSLTNRSLIVTTVLEEPFVMFRKSDRTLYGNDRFEGYCIDLLKELAHILGFS
YEIRLVEDGKYGAQDDKGQWNGMVKELIDHKADLAVAPLTITHVREKAIDFSKPFMTLGV
SILYRKPNGTNPSVFSFLNPLSPDIWMYVLLAYLGVSCVLFVIARFSPYEWYDAHPCNPG
SEVVENNFTLLNSFWFGMGSLMQQGSELMPKALSTRIIGGIWWFFTLIIISSYTANLAAF
LTVERMESPIDSADDLAKQTKIEYGAVKDGATMTFFKKSKISTFEKMWAFMSSKPSALVK
NNEEGIQRALTADYALLMESTTIEYVTQRNCNLTQIGGLIDSKGYGIGTPMGSPYRDKIT
IAILQLQEEDKLHIMKEKWWRGSGCPEEENKEASALGIQKIGGIFIVLAAGLVLSVLVAV
GEFVYKLRKTAEREQRSFCSTVADEIRFSLTCQRRVKHKPQPPMMVKTDAVINMHTFNDR
RLPGKDSMACSTSLAPVFP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010587|Glutamate receptor ionotropic, kainate 3 (GRIK3)
ATGACCGCTCCCTGGCGGCGCCTCCGGAGTCTGGTTTGGGAATACTGGGCCGGGCTCCTC
GTGTGCGCCTTCTGGATCCCGGACTCGCGCGGGATGCCCCACGTCATCCGGATCGGAGGA
ATCTTCGAGTATGCGGACGGCCCCAACGCCCAGGTCATGAATGCCGAGGAGCATGCCTTT
CGATTTTCTGCCAACATCATCAACAGGAACAGGACTCTGCTGCCCAACACAACCTTGACC
TATGACATACAGAGGATTCACTTCCATGACAGCTTCGAGGCGACCAAAAAGGCCTGTGAC
CAGCTGGCACTGGGCGTGGTGGCGATCTTCGGCCCATCACAGGGCTCCTGCACCAATGCC
GTCCAGTCCATCTGCAATGCCCTGGAGGTGCCCCACATCCAGCTGCGTTGGAAGCACCAC
CCGCTGGACAACAAGGACACCTTCTACGTGAACCTCTACCCCGACTACGCCTCGCTCAGC
CATGCCATCCTCGACCTGGTCCAGTACCTCAAGTGGCGGTCAGCCACCGTGGTCTATGAC
GACAGTACAGGGCTCATCCGACTGCAGGAGCTCATCATGGCCCCATCAAGATACAACATC
CGCCTGAAGATCCGTCAGCTCCCCATCGACTCTGACGACTCGCGCCCCTTGCTCAAGGAG
ATGAAGCGAGGCCGGGAATTCCGCATTATCTTCGACTGCAGCCACACTATGGCGGCCCAG
ATCCTCAAGCAGGCCATGGCCATGGGCATGATGACTGAGTACTACCACTTCATCTTCACC
ACTCTGGATCTCTACGCTTTAGACCTGGAGCCCTACCGCTACTCAGGCGTGAACCTGACA
GGATTCCGGATTCTCAATGTGGACAACCCACACGTCTCGGCCATTGTGGAGAAGTGGTCC
ATGGAGCGGCTGCAGGCAGCTCCCCGGTCCGAGTCTGGCCTGCTGGATGGAGTGATGATG
ACTGATGCAGCCTTACTGTACGACGCCGTCCATATCGTGTCCGTGTGCTACCAGCGGGCA
CCACAGATGACCGTGAACTCCCTGCAGTGCCATCGGCACAAGGCCTGGCGCTTTGGCGGC
CGCTTCATGAACTTCATCAAGGAGGCTCAATGGGAAGGATTAACTGGACGAATTGTTTTC
AACAAAACTAGTGGCTTGCGGACGGATTTTGATCTGGACATCATCAGCCTGAAAGAGGAT
GGCCTGGAGAAGGTTGGGGTGTGGAGTCCTGCCGACGGGCTCAACATCACTGAGGTTGCC
AAAGGCCGAGGCCCTAATGTCACCGACTCTCTGACAAACAGATCACTCATTGTCACCACA
GTGCTGGAGGAGCCCTTCGTCATGTTTCGGAAATCAGACAGGACGCTATACGGGAATGAC
CGGTTCGAGGGCTACTGCATCGACCTGCTAAAGGAGCTGGCCCACATCCTTGGTTTCTCC
TATGAGATCCGGCTGGTGGAGGACGGCAAGTACGGGGCACAGGATGACAAGGGCCAGTGG
AACGGCATGGTCAAGGAGCTCATCGACCACAAGGCAGATCTGGCCGTGGCCCCCCTGACC
ATCACCCATGTTCGAGAGAAGGCCATCGACTTCTCCAAGCCCTTCATGACACTTGGTGTG
AGCATCCTGTATCGAAAGCCCAATGGCACCAACCCCAGCGTCTTCTCCTTCCTCAATCCC
CTGTCCCCAGACATCTGGATGTATGTTCTCCTCGCCTACCTGGGGGTCAGCTGTGTCCTC
TTCGTCATCGCCAGGTTCAGCCCTTATGAGTGGTACGATGCTCACCCCTGCAACCCTGGC
TCCGAGGTGGTGGAAAATAACTTCACTCTGCTTAACAGCTTCTGGTTTGGAATGGGATCC
CTGATGCAGCAAGGGTCTGAGCTGATGCCCAAAGCCCTGTCCACACGCATCATTGGTGGC
ATCTGGTGGTTCTTCACGCTCATCATCATCTCTTCCTACACGGCCAACCTGGCTGCCTTT
CTGACCGTGGAGCGCATGGAATCACCCATTGACTCTGCTGATGACCTGGCCAAGCAAACC
AAAATCGAGTATGGGGCTGTCAAGGATGGGGCCACCATGACCTTCTTCAAGAAATCCAAG
ATCTCCACCTTCGAGAAGATGTGGGCCTTCATGAGCAGCAAGCCATCGGCGCTGGTGAAG
AACAACGAGGAGGGCATCCAGAGGGCCCTGACGGCCGACTACGCGCTGCTCATGGAGTCC
ACCACCATCGAGTACGTCACGCAGAGGAACTGCAACCTCACCCAGATCGGGGGCCTCATT
GACTCCAAGGGCTACGGCATCGGCACGCCCATGGGCTCCCCATACCGGGACAAGATCACC
ATCGCCATCCTGCAGCTTCAGGAGGAGGACAAGCTGCATATCATGAAGGAGAAGTGGTGG
CGGGGCAGCGGGTGTCCTGAGGAGGAAAACAAAGAGGCCAGTGCCCTGGGGATCCAGAAG
ATCGGGGGCATCTTCATTGTCCTGGCCGCCGGGCTGGTCCTCTCTGTGCTGGTGGCCGTG
GGCGAGTTTGTGTACAAGCTCCGCAAAACAGCAGAGAGAGAGCAGCGTTCCTTCTGCAGC
ACCGTGGCCGATGAGATCCGTTTCTCCCTTACCTGCCAGCGTCGAGTCAAGCACAAGCCT
CAGCCTCCCATGATGGTCAAGACTGACGCCGTCATCAACATGCACACATTCAATGACCGC
CGGCTTCCCGGCAAGGACAGCATGGCCTGCAGCACATCCTTAGCCCCTGTGTTCCCCTAG
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01094</identifier>
        <name>ANF_receptor</name>
      </pfam>
      <pfam>
        <identifier>PF00060</identifier>
        <name>Lig_chan</name>
      </pfam>
      <pfam>
        <identifier>PF10613</identifier>
        <name>Lig_chan-Glu_bd</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>terminal bouton</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>kainate selective glutamate receptor complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perikaryon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>presynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>postsynaptic membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>adenylate cyclase inhibiting G-protein coupled glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ionotropic glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>extracellular-glutamate-gated ion channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kainate selective glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutamate receptor activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>adenylate cyclase-inhibiting G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>synaptic transmission, glutamatergic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ionotropic glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>G-protein coupled glutamate receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of membrane potential</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0003654</id>
      <name>Monocarboxylate transporter 10</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11278508</pubmed-id>
            <citation>Kim DK, Kanai Y, Chairoungdua A, Matsuo H, Cha SH, Endou H: Expression cloning of a Na+-independent aromatic amino acid transporter with structural similarity to H+/monocarboxylate transporters. J Biol Chem. 2001 May 18;276(20):17221-8. Epub 2001 Feb 20.</citation>
          </article>
          <article>
            <pubmed-id>11827462</pubmed-id>
            <citation>Kim DK, Kanai Y, Matsuo H, Kim JY, Chairoungdua A, Kobayashi Y, Enomoto A, Cha SH, Goya T, Endou H: The human T-type amino acid transporter-1: characterization, gene organization, and chromosomal location. Genomics. 2002 Jan;79(1):95-103.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TF71" source="Swiss-Prot">
    <name>Monocarboxylate transporter 10</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Sodium-independent transporter that mediates the update of aromatic acid. Can function as a net efflux pathway for aromatic amino acids in the basosolateral epithelial cells (By similarity).</specific-function>
    <gene-name>SLC16A10</gene-name>
    <locus>6q21-q22</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>67-87
115-135
145-165
172-192
201-221
229-249
292-312
330-350
352-372
397-417
420-440
452-472</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.77</theoretical-pi>
    <molecular-weight>55492.07</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17027</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB057445</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18640047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TF71</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT10_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>Aromatic amino acid transporter 1</synonym>
      <synonym>MCT 10</synonym>
      <synonym>MCT10</synonym>
      <synonym>Solute carrier family 16 member 10</synonym>
      <synonym>T-type amino acid transporter 1</synonym>
      <synonym>TAT1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0007022|Monocarboxylate transporter 10
MVLSQEEPDSARGTSEAQPLGPAPTGAAPPPGPGPSDSPEAAVEKVEVELAGPATAEPHE
PPEPPEGGWGWLVMLAAMWCNGSVFGIQNACGVLFVSMLETFGSKDDDKMVFKTAWVGSL
SMGMIFFCCPIVSVFTDLFGCRKTAVVGAAVGFVGLMSSSFVSSIEPLYLTYGIIFACGC
SFAYQPSLVILGHYFKKRLGLVNGIVTAGSSVFTILLPLLLRVLIDSVGLFYTLRVLCIF
MFVLFLAGFTYRPLATSTKDKESGGSGSSLFSRKKFSPPKKIFNFAIFKVTAYAVWAVGI
PLALFGYFVPYVHLMKHVNERFQDEKNKEVVLMCIGVTSGVGRLLFGRIADYVPGVKKVY
LQVLSFFFIGLMSMMIPLCSIFGALIAVCLIMGLFDGCFISIMAPIAFELVGAQDVSQAI
GFLLGFMSIPMTVGPPIAGLLRDKLGSYDVAFYLAGVPPLIGGAVLCFIPWIHSKKQREI
SKTTGKEKMEKMLENQNSLLSSSSGMFKKESDSII</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020707|Monocarboxylate transporter 10 (SLC16A10)
ATGGTGCTCTCCCAGGAGGAGCCGGACTCCGCGCGGGGCACGAGCGAGGCGCAGCCGCTC
GGCCCCGCGCCCACGGGGGCCGCTCCGCCGCCCGGCCCGGGACCCTCGGACAGCCCCGAG
GCGGCTGTCGAGAAGGTGGAGGTGGAGCTGGCGGGGCCGGCGACCGCGGAGCCCCATGAG
CCCCCCGAACCCCCCGAGGGCGGCTGGGGCTGGCTGGTGATGCTGGCGGCCATGTGGTGC
AACGGGTCGGTGTTCGGCATCCAGAACGCTTGCGGGGTGCTCTTCGTGTCCATGCTGGAA
ACCTTCGGCTCCAAAGACGATGACAAGATGGTCTTTAAGACAGCATGGGTAGGTTCTCTC
TCCATGGGGATGATTTTCTTTTGCTGCCCAATAGTCAGCGTCTTCACAGACCTATTTGGT
TGTCGGAAAACAGCTGTCGTGGGTGCTGCTGTTGGATTTGTTGGGCTCATGTCCAGTTCT
TTTGTAAGTTCCATCGAGCCTCTGTACCTTACCTATGGAATCATATTTGCCTGCGGCTGC
TCCTTTGCATACCAGCCTTCATTGGTCATTTTGGGACACTATTTCAAGAAGCGCCTTGGA
CTGGTGAATGGCATTGTCACTGCTGGCAGCAGTGTCTTCACAATCCTGCTGCCTTTGCTC
TTAAGGGTTCTGATTGACAGCGTGGGCCTCTTTTACACATTGAGGGTGCTCTGCATCTTC
ATGTTTGTTCTCTTTCTGGCTGGCTTTACTTACCGACCTCTTGCTACCAGTACCAAAGAT
AAAGAGAGTGGAGGTAGCGGATCCTCCCTCTTTTCCAGGAAAAAGTTCAGTCCTCCAAAA
AAAATTTTCAATTTTGCCATCTTCAAGGTGACAGCTTATGCAGTGTGGGCAGTTGGAATA
CCACTTGCACTTTTTGGATACTTTGTGCCTTATGTTCACTTGATGAAACATGTAAATGAA
AGATTTCAAGATGAAAAAAATAAAGAGGTTGTTCTCATGTGCATTGGCGTCACTTCAGGA
GTTGGACGACTGCTCTTTGGCCGGATTGCAGATTATGTGCCTGGTGTGAAGAAGGTTTAT
CTACAGGTACTCTCCTTTTTCTTCATTGGTCTGATGTCCATGATGATTCCTCTGTGTAGC
ATCTTTGGGGCCCTCATTGCTGTGTGCCTCATCATGGGTCTCTTCGATGGATGCTTCATT
TCCATTATGGCTCCCATAGCCTTTGAGTTAGTTGGTGCCCAGGATGTCTCCCAAGCAATT
GGATTTCTGCTCGGATTCATGTCTATACCCATGACTGTTGGCCCACCCATTGCAGGGTTA
CTTCGTGACAAACTGGGCTCCTATGATGTGGCATTCTACCTCGCTGGAGTCCCTCCCCTT
ATTGGAGGTGCTGTGCTTTGTTTTATCCCGTGGATCCATAGTAAGAAGCAAAGAGAGATC
AGTAAAACCACTGGAAAAGAAAAGATGGAGAAAATGTTGGAAAACCAGAACTCTCTGCTG
TCAAGTTCATCTGGAATGTTCAAGAAAGAATCTGACTCTATTATTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>thyroid hormone transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatic amino acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aromatic amino acid transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ion transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>amino acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="2">
      <id>BE0000669</id>
      <name>Monocarboxylate transporter 1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>10579682</pubmed-id>
            <citation>Tamai I, Sai Y, Ono A, Kido Y, Yabuuchi H, Takanaga H, Satoh E, Ogihara T, Amano O, Izeki S, Tsuji A: Immunohistochemical and functional characterization of pH-dependent intestinal absorption of weak organic acids by the monocarboxylic acid transporter MCT1. J Pharm Pharmacol. 1999 Oct;51(10):1113-21.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P53985" source="Swiss-Prot">
    <name>Monocarboxylate transporter 1</name>
    <general-function>Symporter activity</general-function>
    <specific-function>Proton-coupled monocarboxylate transporter. Catalyzes the rapid transport across the plasma membrane of many monocarboxylates such as lactate, pyruvate, branched-chain oxo acids derived from leucine, valine and isoleucine, and the ketone bodies acetoacetate, beta-hydroxybutyrate and acetate. Depending on the tissue and on cicumstances, mediates the import or export of lactic acid and ketone bodies. Required for normal nutrient assimilation, increase of white adipose tissue and body weight gain when on a high-fat diet. Plays a role in cellular responses to a high-fat diet by modulating the cellular levels of lactate and pyruvate, small molecules that contribute to the regulation of central metabolic pathways and insulin secretion, with concomitant effects on plasma insulin levels and blood glucose homeostasis.</specific-function>
    <gene-name>SLC16A1</gene-name>
    <locus>1p12</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>16-36
60-80
87-107
112-132
144-164
167-187
263-283
299-319
329-349
354-374
390-410
423-443</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.82</theoretical-pi>
    <molecular-weight>53943.685</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:10922</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>SLC16A1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L31801</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>561722</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>988</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P53985</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MOT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>MCT 1</synonym>
      <synonym>MCT1</synonym>
      <synonym>Solute carrier family 16 member 1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037057|Monocarboxylate transporter 1
MPPAVGGPVGYTPPDGGWGWAVVIGAFISIGFSYAFPKSITVFFKEIEGIFHATTSEVSW
ISSIMLAVMYGGGPISSILVNKYGSRIVMIVGGCLSGCGLIAASFCNTVQQLYVCIGVIG
GLGLAFNLNPALTMIGKYFYKRRPLANGLAMAGSPVFLCTLAPLNQVFFGIFGWRGSFLI
LGGLLLNCCVAGALMRPIGPKPTKAGKDKSKASLEKAGKSGVKKDLHDANTDLIGRHPKQ
EKRSVFQTINQFLDLTLFTHRGFLLYLSGNVIMFFGLFAPLVFLSSYGKSQHYSSEKSAF
LLSILAFVDMVARPSMGLVANTKPIRPRIQYFFAASVVANGVCHMLAPLSTTYVGFCVYA
GFFGFAFGWLSSVLFETLMDLVGPQRFSSAVGLVTIVECCPVLLGPPLLGRLNDMYGDYK
YTYWACGVVLIISGIYLFIGMGINYRLLAKEQKANEQKKESKEEETSIDVAGKPNEVTKA
AESPDQKDTDGGPKEEESPV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010466|Monocarboxylate transporter 1 (SLC16A1)
ATGCCACCAGCAGTTGGAGGTCCAGTTGGATACACCCCCCCAGATGGAGGCTGGGGCTGG
GCAGTGGTAATTGGAGCTTTCATTTCCATCGGCTTCTCTTATGCATTTCCCAAATCAATT
ACTGTCTTCTTCAAAGAGATTGAAGGTATATTCCATGCCACCACCAGCGAAGTGTCATGG
ATATCCTCCATAATGTTGGCTGTCATGTATGGTGGAGGTCCTATCAGCAGTATCCTGGTG
AATAAATATGGAAGTCGTATAGTCATGATTGTTGGTGGCTGCTTGTCAGGCTGTGGCTTG
ATTGCAGCTTCTTTCTGTAACACCGTACAGCAACTATACGTCTGTATTGGAGTCATTGGA
GGTCTTGGGCTTGCCTTCAACTTGAATCCAGCTCTGACCATGATTGGCAAGTATTTCTAC
AAGAGGCGACCATTGGCCAACGGACTGGCCATGGCAGGCAGCCCTGTGTTCCTCTGTACT
CTGGCCCCCCTCAATCAGGTTTTCTTCGGTATCTTTGGATGGAGAGGAAGCTTTCTAATT
CTTGGGGGCTTGCTACTAAACTGCTGTGTTGCTGGAGCCCTCATGCGACCAATCGGGCCC
AAGCCAACCAAGGCAGGGAAAGATAAGTCTAAAGCATCCCTTGAGAAAGCTGGAAAATCT
GGTGTGAAAAAAGATCTGCATGATGCAAATACAGATCTTATTGGAAGACACCCTAAACAA
GAGAAACGATCAGTCTTCCAAACAATTAATCAGTTCCTGGACTTAACCCTATTCACCCAC
AGAGGCTTTTTGCTATACCTCTCTGGAAATGTGATCATGTTTTTTGGACTCTTTGCACCT
TTGGTGTTTCTTAGTAGTTATGGGAAGAGTCAGCATTATTCTAGTGAGAAGTCTGCCTTC
CTTCTTTCCATTCTGGCTTTTGTTGACATGGTAGCCCGACCATCTATGGGACTTGTAGCC
AACACAAAGCCAATAAGACCTCGAATTCAGTATTTCTTTGCGGCTTCCGTTGTTGCAAAT
GGAGTGTGTCATATGCTAGCACCTTTATCCACTACCTATGTTGGATTCTGTGTCTATGCG
GGATTCTTTGGATTTGCCTTCGGGTGGCTCAGCTCCGTATTGTTTGAAACATTGATGGAC
CTTGTTGGACCCCAGAGGTTCTCCAGCGCTGTGGGATTGGTGACCATTGTGGAATGCTGT
CCTGTCCTCCTGGGGCCACCACTTTTAGGTCGGCTCAATGACATGTATGGAGACTACAAA
TACACATACTGGGCATGTGGCGTCGTCCTAATTATTTCAGGTATCTATCTCTTCATTGGC
ATGGGCATCAATTATCGACTTTTGGCAAAAGAACAGAAAGCAAACGAGCAGAAAAAGGAA
AGTAAAGAGGAAGAGACCAGTATAGATGTTGCTGGGAAGCCAAATGAAGTTACCAAAGCA
GCAGAATCTCCGGACCAGAAAGACACAGATGGAGGGCCCAAGGAGGAGGAAAGTCCAGTC
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07690</identifier>
        <name>MFS_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>centrosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lactate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic cyclic compound binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>mevalonate transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>symporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>monocarboxylic acid transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>plasma membrane lactate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of insulin secretion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>behavioral response to nutrient</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to organic cyclic compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>centrosome organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to food</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>mevalonate transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glucose homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>monocarboxylic acid transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00143</drugbank-id>
  <drugbank-id>NUTR00029</drugbank-id>
  <drugbank-id>EXPT01650</drugbank-id>
  <name>Glutathione</name>
  <description>A tripeptide with many roles in cells. It conjugates to drugs to make them more soluble for excretion, is a cofactor for some enzymes, is involved in protein disulfide bond rearrangement and reduces peroxides.</description>
  <cas-number>70-18-8</cas-number>
  <unii>GAN16C9B8O</unii>
  <average-mass>307.323</average-mass>
  <monoisotopic-mass>307.083805981</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <pubmed-id>15955607</pubmed-id>
        <citation>Struzynska L, Chalimoniuk M, Sulkowski G: The role of astroglia in Pb-exposed adult rat brain with respect to glutamate toxicity. Toxicology. 2005 Sep 1;212(2-3):185-94.</citation>
      </article>
      <article>
        <pubmed-id>1362956</pubmed-id>
        <citation>Witschi A, Reddy S, Stofer B, Lauterburg BH: The systemic availability of oral glutathione. Eur J Clin Pharmacol. 1992;43(6):667-9.</citation>
      </article>
      <article>
        <pubmed-id>8207209</pubmed-id>
        <citation>Yim CY, Hibbs JB Jr, McGregor JR, Galinsky RE, Samlowski WE: Use of N-acetyl cysteine to increase intracellular glutathione during the induction of antitumor responses by IL-2. J Immunol. 1994 Jun 15;152(12):5796-805.</citation>
      </article>
      <article>
        <pubmed-id>16427183</pubmed-id>
        <citation>Drevet JR: The antioxidant glutathione peroxidase family and spermatozoa: a complex story. Mol Cell Endocrinol. 2006 May 16;250(1-2):70-9. Epub 2006 Jan 19.</citation>
      </article>
      <article>
        <pubmed-id>14988435</pubmed-id>
        <citation>Wu G, Fang YZ, Yang S, Lupton JR, Turner ND: Glutathione metabolism and its implications for health. J Nutr. 2004 Mar;134(3):489-92.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Akihiro Mizutani, "Complexes of polysaccharides or derivatives thereof with reduced glutathione and process for preparing said complexes." U.S. Patent US4009264, issued February, 1971.</synthesis-reference>
  <indication>For nutritional supplementation, also for treating dietary shortage or imbalance</indication>
  <pharmacodynamics/>
  <mechanism-of-action>Glutathione (GSH) participates in leukotriene synthesis and is a cofactor for the enzyme glutathione peroxidase. It is also important as a hydrophilic molecule that is added to lipophilic toxins and waste in the liver during biotransformation before they can become part of the bile. Glutathione is also needed for the detoxification of methylglyoxal, a toxin produced as a by-product of metabolism. This detoxification reaction is carried out by the glyoxalase system. Glyoxalase I catalyzes the conversion of methylglyoxal and reduced glutathione to S-D-Lactoyl-glutathione. Glyoxalase II catalyzes the conversion of S-D-Lactoyl Glutathione to Reduced Glutathione and D-lactate. GSH is known as a cofactor in both conjugation reactions and reduction reactions, catalyzed by glutathione S-transferase enzymes in cytosol, microsomes, and mitochondria. However, it is capable of participating in non-enzymatic conjugation with some chemicals, as it is hypothesized to do to a significant extent with n-acetyl-p-benzoquinone imine (NAPQI), the reactive cytochrome P450 reactive metabolite formed by toxic overdose of acetaminophen. Glutathione in this capacity binds to NAPQI as a suicide substrate and in the process detoxifies it, taking the place of cellular protein sulfhydryl groups which would otherwise be toxically adducted. The preferred medical treatment to an overdose of this nature, whose efficacy has been consistently supported in literature, is the administration (usually in atomized form) of N-acetylcysteine, which is used by cells to replace spent GSSG and allow a usable GSH pool.</mechanism-of-action>
  <toxicity>ORL-MUS LD&lt;sub&gt;50&lt;/sub&gt; 5000 mg/kg, IPR-MUS LD&lt;sub&gt;50&lt;/sub&gt; 4020 mg/kg, SCU-MUS LD&lt;sub&gt;50&lt;/sub&gt; 5000 mg/kg, IVN-RBT LD&lt;sub&gt;50&lt;/sub&gt; &gt; 2000 mg/kg, IMS-MUS LD&lt;sub&gt;50&lt;/sub&gt; 4000 mg/kg</toxicity>
  <metabolism/>
  <absorption>Research suggests that glutathione is not orally bioactive, and that very little of oral glutathione tablets or capsules is actually absorbed by the body.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as peptides. These are compounds containing an amide derived from two or more amino carboxylic acid molecules (the same or different) by formation of a covalent bond from the carbonyl carbon of one to the nitrogen atom of another.</description>
    <direct-parent>Peptides</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Organic acids and derivatives</class>
    <subclass>Carboxylic acids and derivatives</subclass>
    <alternative-parent>Alkylthiols</alternative-parent>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboximidic acids</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dicarboxylic acids and derivatives</alternative-parent>
    <alternative-parent>Fatty acids and conjugates</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>N-acyl-alpha amino acids</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Propargyl-type 1,3-dipolar organic compounds</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alkylthiol</substituent>
    <substituent>Alpha peptide</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Alpha-amino acid or derivatives</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Amino acid or derivatives</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboximidic acid</substituent>
    <substituent>Carboximidic acid derivative</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Dicarboxylic acid or derivatives</substituent>
    <substituent>Fatty acid</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>N-acyl-alpha amino acid or derivatives</substituent>
    <substituent>N-acyl-alpha-amino acid</substituent>
    <substituent>Organic 1,3-dipolar compound</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Organosulfur compound</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Propargyl-type 1,3-dipolar organic compound</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">5-L-Glutamyl-L-cysteinylglycine</synonym>
    <synonym language="" coder="">gamma-L-Glutamyl-L-cysteinyl-glycine</synonym>
    <synonym language="" coder="">Glutathione</synonym>
    <synonym language="" coder="">Glutathione-SH</synonym>
    <synonym language="" coder="">GSH</synonym>
    <synonym language="" coder="">N-(N-gamma-L-Glutamyl-L-cysteinyl)glycine</synonym>
    <synonym language="" coder="">Reduced glutathione</synonym>
  </synonyms>
  <products>
    <product>
      <name>Bss Plus</name>
      <labeller>Alcon, Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>0065-0800</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>1982-06-28</started-marketing-on>
      <ended-marketing-on>2017-05-31</ended-marketing-on>
      <dosage-form>Kit</dosage-form>
      <strength/>
      <route/>
      <fda-application-number>NDA018469</fda-application-number>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>true</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>Isethion</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>Bss Plus</name>
      <ingredients>Calcium Chloride + Glucose + Glutathione + Magnesium chloride + Potassium Chloride + Sodium bicarbonate + Sodium Chloride + Sodium phosphate</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Letco Medical Inc.</name>
      <url>http://www.letcomedical.com</url>
    </packager>
    <packager>
      <name>Medisca Inc.</name>
      <url>http://www.medisca.com</url>
    </packager>
    <packager>
      <name>Spectrum Pharmaceuticals</name>
      <url>http://www.spectrumpharm.com</url>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>L-glutathione powder</description>
      <cost currency="USD">3.0</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Glutathione-l reduced powder</description>
      <cost currency="USD">10.71</cost>
      <unit>g</unit>
    </price>
    <price>
      <description>Glutathione crystals</description>
      <cost currency="USD">21.32</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Amino Acids, Peptides, and Proteins</category>
      <mesh-id>D000602</mesh-id>
    </category>
    <category>
      <category>Antidotes</category>
      <mesh-id>D000931</mesh-id>
    </category>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Oligopeptides</category>
      <mesh-id>D009842</mesh-id>
    </category>
    <category>
      <category>Peptides</category>
      <mesh-id>D010455</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Kit</form>
      <route/>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes>
    <atc-code code="V03AB32">
      <level code="V03AB">Antidotes</level>
      <level code="V03A">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V03">ALL OTHER THERAPEUTIC PRODUCTS</level>
      <level code="V">VARIOUS</level>
    </atc-code>
  </atc-codes>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1M0U</pdb-entry>
  </pdb-entries>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB00143.pdf?1265922745</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-2.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2.5</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>8.79e-01 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-4.9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-amino-4-{[(1R)-1-[(carboxymethyl)carbamoyl]-2-sulfanylethyl]carbamoyl}butanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>glutathione</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>307.323</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>307.083805981</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>N[C@@H](CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C10H17N3O6S</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C10H17N3O6S/c11-5(10(18)19)1-2-7(14)13-6(4-20)9(17)12-3-8(15)16/h5-6,20H,1-4,11H2,(H,12,17)(H,13,14)(H,15,16)(H,18,19)/t5-,6-/m0/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>RWSXRVCMGQZWBV-WDSKDSINSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>158.82</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>69.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>29.11</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>9</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.94</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.22</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Melting Point</kind>
      <value>195 °C</value>
      <source>PhysProp</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-6.4</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>1951</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>16856</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>124886</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46504598</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Compound</resource>
      <identifier>C02471</identifier>
    </external-identifier>
    <external-identifier>
      <resource>KEGG Drug</resource>
      <identifier>D00014</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>111188</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50422268</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA449780</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>GSH</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Glutathione</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL1543</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/glu_0126.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP00072</smpdb-id>
      <name>Glutamate Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00098</smpdb-id>
      <name>Ketorolac Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00465</drugbank-id>
          <name>Ketorolac</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00101</smpdb-id>
      <name>Suprofen Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00870</drugbank-id>
          <name>Suprofen</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00116</smpdb-id>
      <name>Valdecoxib Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00580</drugbank-id>
          <name>Valdecoxib</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00143</smpdb-id>
      <name>5-Oxoprolinuria</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00289</smpdb-id>
      <name>Diflunisal Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00861</drugbank-id>
          <name>Diflunisal</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00334</smpdb-id>
      <name>Pyruvate Decarboxylase E1 Component Deficiency (PDHE1 Deficiency)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB01839</drugbank-id>
          <name>Propylene glycol</name>
        </drug>
        <drug>
          <drugbank-id>DB02897</drugbank-id>
          <name>Acetylphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03066</drugbank-id>
          <name>D-Lactic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03776</drugbank-id>
          <name>Lactaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P30613</uniprot-id>
        <uniprot-id>P35558</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P23368</uniprot-id>
        <uniprot-id>Q86WU2</uniprot-id>
        <uniprot-id>Q16775</uniprot-id>
        <uniprot-id>Q04760</uniprot-id>
        <uniprot-id>Q9UBQ7</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q8WYK0</uniprot-id>
        <uniprot-id>P07311</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00353</smpdb-id>
      <name>Leukotriene C4 Synthesis Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00385</smpdb-id>
      <name>Homocarnosinosis</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00604</smpdb-id>
      <name>Cyclophosphamide Metabolism Pathway</name>
      <category>drug_metabolism</category>
      <drugs>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00531</drugbank-id>
          <name>Cyclophosphamide</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB02579</drugbank-id>
          <name>Acrylic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11712</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P33261</uniprot-id>
        <uniprot-id>P08684</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P11509</uniprot-id>
        <uniprot-id>P00352</uniprot-id>
        <uniprot-id>P30838</uniprot-id>
        <uniprot-id>P09488</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00703</smpdb-id>
      <name>Trisalicylate-choline Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01401</drugbank-id>
          <name>Choline magnesium trisalicylate</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00136</smpdb-id>
      <name>2-Hydroxyglutric Aciduria (D And L Form)</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00196</smpdb-id>
      <name>Leigh Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB01839</drugbank-id>
          <name>Propylene glycol</name>
        </drug>
        <drug>
          <drugbank-id>DB02897</drugbank-id>
          <name>Acetylphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03066</drugbank-id>
          <name>D-Lactic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03776</drugbank-id>
          <name>Lactaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P30613</uniprot-id>
        <uniprot-id>P35558</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P23368</uniprot-id>
        <uniprot-id>Q86WU2</uniprot-id>
        <uniprot-id>Q16775</uniprot-id>
        <uniprot-id>Q04760</uniprot-id>
        <uniprot-id>Q9UBQ7</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q8WYK0</uniprot-id>
        <uniprot-id>P07311</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00243</smpdb-id>
      <name>4-Hydroxybutyric Aciduria/Succinic Semialdehyde Dehydrogenase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00337</smpdb-id>
      <name>Glutathione Synthetase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00339</smpdb-id>
      <name>Hyperinsulinism-Hyperammonemia Syndrome</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00114</drugbank-id>
          <name>Pyridoxal Phosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00128</drugbank-id>
          <name>L-Aspartic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00130</drugbank-id>
          <name>L-Glutamine</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00139</drugbank-id>
          <name>Succinic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01632</drugbank-id>
          <name>Alpha-Phosphoribosylpyrophosphoric Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB01972</drugbank-id>
          <name>Guanosine-5'-Monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB02530</drugbank-id>
          <name>gamma-Aminobutyric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>A8YXX4</uniprot-id>
        <uniprot-id>Q9UI32</uniprot-id>
        <uniprot-id>Q06210</uniprot-id>
        <uniprot-id>Q96EK6</uniprot-id>
        <uniprot-id>Q9UJ70</uniprot-id>
        <uniprot-id>P27708</uniprot-id>
        <uniprot-id>P31327</uniprot-id>
        <uniprot-id>Q06203</uniprot-id>
        <uniprot-id>P49915</uniprot-id>
        <uniprot-id>Q6IA69</uniprot-id>
        <uniprot-id>P30038</uniprot-id>
        <uniprot-id>P24298</uniprot-id>
        <uniprot-id>P00367</uniprot-id>
        <uniprot-id>P00505</uniprot-id>
        <uniprot-id>Q5JPH6</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q99259</uniprot-id>
        <uniprot-id>P80404</uniprot-id>
        <uniprot-id>P51649</uniprot-id>
        <uniprot-id>P47897</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00500</smpdb-id>
      <name>5-oxoprolinase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00640</smpdb-id>
      <name>Acetaminophen Metabolism Pathway</name>
      <category>drug_metabolism</category>
      <drugs>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB00316</drugbank-id>
          <name>Acetaminophen</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03435</drugbank-id>
          <name>Uridine-5'-Diphosphate</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>P05177</uniprot-id>
        <uniprot-id>P10635</uniprot-id>
        <uniprot-id>P08684</uniprot-id>
        <uniprot-id>P11509</uniprot-id>
        <uniprot-id>O60656</uniprot-id>
        <uniprot-id>P54855</uniprot-id>
        <uniprot-id>Q9UBS4</uniprot-id>
        <uniprot-id>Q96GW1</uniprot-id>
        <uniprot-id>P11021</uniprot-id>
        <uniprot-id>Q6IN67</uniprot-id>
        <uniprot-id>Q13087</uniprot-id>
        <uniprot-id>P13667</uniprot-id>
        <uniprot-id>Q15084</uniprot-id>
        <uniprot-id>P23284</uniprot-id>
        <uniprot-id>Q9HCN8</uniprot-id>
        <uniprot-id>P22309</uniprot-id>
        <uniprot-id>P30040</uniprot-id>
        <uniprot-id>P19224</uniprot-id>
        <uniprot-id>P09211</uniprot-id>
        <uniprot-id>P30711</uniprot-id>
        <uniprot-id>P50225</uniprot-id>
        <uniprot-id>P49888</uniprot-id>
        <uniprot-id>Q06520</uniprot-id>
        <uniprot-id>P50224</uniprot-id>
        <uniprot-id>P33527</uniprot-id>
        <uniprot-id>O15439</uniprot-id>
        <uniprot-id>O15440</uniprot-id>
        <uniprot-id>Q9UNQ0</uniprot-id>
        <uniprot-id>P08183</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00700</smpdb-id>
      <name>Lornoxicam Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB06725</drugbank-id>
          <name>Lornoxicam</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00701</smpdb-id>
      <name>Phenylbutazone Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00812</drugbank-id>
          <name>Phenylbutazone</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00707</smpdb-id>
      <name>Salsalate Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01399</drugbank-id>
          <name>Salsalate</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00710</smpdb-id>
      <name>Acetaminophen  Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00316</drugbank-id>
          <name>Acetaminophen</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00015</smpdb-id>
      <name>Glutathione Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00075</smpdb-id>
      <name>Arachidonic Acid Metabolism</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00106</smpdb-id>
      <name>Meloxicam Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00814</drugbank-id>
          <name>Meloxicam</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00109</smpdb-id>
      <name>Mefenamic Acid Action Pathway</name>
      <category>drug_action</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00784</drugbank-id>
          <name>Mefenamic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00917</drugbank-id>
          <name>Dinoprostone</name>
        </drug>
        <drug>
          <drugbank-id>DB01373</drugbank-id>
          <name>Calcium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB02056</drugbank-id>
          <name>Prostaglandin D2</name>
        </drug>
        <drug>
          <drugbank-id>DB02577</drugbank-id>
          <name>Mesoheme</name>
        </drug>
        <drug>
          <drugbank-id>DB03866</drugbank-id>
          <name>Prostaglandin G2</name>
        </drug>
        <drug>
          <drugbank-id>DB04557</drugbank-id>
          <name>Arachidonic Acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P23219</uniprot-id>
        <uniprot-id>P35354</uniprot-id>
        <uniprot-id>P78329</uniprot-id>
        <uniprot-id>P09960</uniprot-id>
        <uniprot-id>Q16873</uniprot-id>
        <uniprot-id>P19440</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>Q16647</uniprot-id>
        <uniprot-id>P41222</uniprot-id>
        <uniprot-id>P42330</uniprot-id>
        <uniprot-id>P24557</uniprot-id>
        <uniprot-id>O14684</uniprot-id>
        <uniprot-id>Q8TBF2</uniprot-id>
        <uniprot-id>P16152</uniprot-id>
        <uniprot-id>P16050</uniprot-id>
        <uniprot-id>P10632</uniprot-id>
        <uniprot-id>P20813</uniprot-id>
        <uniprot-id>P34913</uniprot-id>
        <uniprot-id>P09917</uniprot-id>
        <uniprot-id>O15296</uniprot-id>
        <uniprot-id>P05181</uniprot-id>
        <uniprot-id>O75342</uniprot-id>
        <uniprot-id>P51589</uniprot-id>
        <uniprot-id>Q7Z449</uniprot-id>
        <uniprot-id>Q02928</uniprot-id>
        <uniprot-id>P18054</uniprot-id>
        <uniprot-id>P0C869</uniprot-id>
        <uniprot-id>P98187</uniprot-id>
        <uniprot-id>Q08477</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00183</smpdb-id>
      <name>Gamma-Glutamyltransferase Deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00459</smpdb-id>
      <name>Pyruvaldehyde Degradation</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03066</drugbank-id>
          <name>D-Lactic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>Q04760</uniprot-id>
        <uniprot-id>Q86WU2</uniprot-id>
        <uniprot-id>Q16775</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00501</smpdb-id>
      <name>Gamma-glutamyl-transpeptidase deficiency</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00142</drugbank-id>
          <name>Glutamic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00145</drugbank-id>
          <name>Glycine</name>
        </drug>
        <drug>
          <drugbank-id>DB00151</drugbank-id>
          <name>L-Cysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB00160</drugbank-id>
          <name>L-Alanine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB03088</drugbank-id>
          <name>Pidolic Acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03408</drugbank-id>
          <name>gamma-Glutamylcysteine</name>
        </drug>
        <drug>
          <drugbank-id>DB04701</drugbank-id>
          <name>S-METHYL-GLUTATHIONE</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P48637</uniprot-id>
        <uniprot-id>P07203</uniprot-id>
        <uniprot-id>P00390</uniprot-id>
        <uniprot-id>Q9H4Y5</uniprot-id>
        <uniprot-id>Q6P531</uniprot-id>
        <uniprot-id>P15144</uniprot-id>
        <uniprot-id>P55210</uniprot-id>
        <uniprot-id>P48506</uniprot-id>
        <uniprot-id>P48507</uniprot-id>
        <uniprot-id>O14841</uniprot-id>
        <uniprot-id>O75223</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP00558</smpdb-id>
      <name>Primary hyperoxaluria II, PH2</name>
      <category>disease</category>
      <drugs>
        <drug>
          <drugbank-id>DB00119</drugbank-id>
          <name>Pyruvic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB00121</drugbank-id>
          <name>Biotin</name>
        </drug>
        <drug>
          <drugbank-id>DB00131</drugbank-id>
          <name>Adenosine monophosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB00143</drugbank-id>
          <name>Glutathione</name>
        </drug>
        <drug>
          <drugbank-id>DB00157</drugbank-id>
          <name>NADH</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB01345</drugbank-id>
          <name>Potassium</name>
        </drug>
        <drug>
          <drugbank-id>DB01378</drugbank-id>
          <name>Magnesium</name>
        </drug>
        <drug>
          <drugbank-id>DB01593</drugbank-id>
          <name>Zinc</name>
        </drug>
        <drug>
          <drugbank-id>DB01819</drugbank-id>
          <name>Phosphoenolpyruvate</name>
        </drug>
        <drug>
          <drugbank-id>DB01839</drugbank-id>
          <name>Propylene glycol</name>
        </drug>
        <drug>
          <drugbank-id>DB02897</drugbank-id>
          <name>Acetylphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03066</drugbank-id>
          <name>D-Lactic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03147</drugbank-id>
          <name>Flavin adenine dinucleotide</name>
        </drug>
        <drug>
          <drugbank-id>DB03166</drugbank-id>
          <name>Acetic acid</name>
        </drug>
        <drug>
          <drugbank-id>DB03587</drugbank-id>
          <name>Pyruvaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB03776</drugbank-id>
          <name>Lactaldehyde</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
        <drug>
          <drugbank-id>DB04524</drugbank-id>
          <name>Malonyl-CoA</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P11498</uniprot-id>
        <uniprot-id>Q6ZMR3</uniprot-id>
        <uniprot-id>P30613</uniprot-id>
        <uniprot-id>P35558</uniprot-id>
        <uniprot-id>P40925</uniprot-id>
        <uniprot-id>P23368</uniprot-id>
        <uniprot-id>Q86WU2</uniprot-id>
        <uniprot-id>Q16775</uniprot-id>
        <uniprot-id>Q04760</uniprot-id>
        <uniprot-id>Q9UBQ7</uniprot-id>
        <uniprot-id>P15121</uniprot-id>
        <uniprot-id>P48163</uniprot-id>
        <uniprot-id>P09622</uniprot-id>
        <uniprot-id>P10515</uniprot-id>
        <uniprot-id>Q13085</uniprot-id>
        <uniprot-id>P24752</uniprot-id>
        <uniprot-id>Q8WYK0</uniprot-id>
        <uniprot-id>P07311</uniprot-id>
        <uniprot-id>P05091</uniprot-id>
        <uniprot-id>Q9NR19</uniprot-id>
        <uniprot-id>P08559</uniprot-id>
        <uniprot-id>P11177</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002279</id>
      <name>Microsomal glutathione S-transferase 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17632548</pubmed-id>
            <citation>Ago H, Kanaoka Y, Irikura D, Lam BK, Shimamura T, Austen KF, Miyano M: Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis. Nature. 2007 Aug 2;448(7153):609-12. Epub 2007 Jul 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O14880" source="Swiss-Prot">
    <name>Microsomal glutathione S-transferase 3</name>
    <general-function>Peroxidase activity</general-function>
    <specific-function>Also functions as a glutathione peroxidase.</specific-function>
    <gene-name>MGST3</gene-name>
    <locus>1q23</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>9-29
71-91
120-140</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.68</theoretical-pi>
    <molecular-weight>16516.185</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7064</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MGST3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF026977</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2583081</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O14880</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MGST3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Microsomal GST-3</synonym>
      <synonym>Microsomal GST-III</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011641|Microsomal glutathione S-transferase 3
MAVLSKEYGFVLLTGAASFIMVAHLAINVSKARKKYKVEYPIMYSTDPENGHIFNCIQRA
HQNTLEVYPPFLFFLAVGGVYHPRIASGLGLAWIVGRVLYAYGYYTGEPSKRSRGALGSI
ALLGLVGTTVCSAFQHLGWVKSGLGSGPKCCH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011642|Microsomal glutathione S-transferase 3 (MGST3)
ATGGCTGTCCTCTCTAAGGAATATGGTTTTGTGCTTCTAACTGGTGCTGCCAGCTTTATA
ATGGTGGCCCACCTAGCCATCAATGTTTCCAAGGCCCGCAAGAAGTACAAAGTGGAGTAT
CCTATCATGTACAGCACGGACCCTGAAAATGGGCACATCTTCAACTGCATTCAGCGAGCC
CACCAGAACACGTTGGAAGTGTATCCTCCCTTCTTATTTTTTCTAGCTGTTGGAGGTGTT
TACCACCCGCGTATAGCTTCTGGCCTGGGCTTGGCCTGGATTGTTGGACGAGTTCTTTAT
GCTTATGGCTATTACACGGGAGAACCCAGCAAGCGTAGTCGAGGAGCCCTGGGGTCCATC
GCCCTCCTGGGCTTGGTGGGCACAACTGTGTGCTCTGCTTTCCAGCATCTTGGTTGGGTT
AAAAGTGGCTTGGGCAGTGGACCCAAATGCTGCCATTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01124</identifier>
        <name>MAPEG</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear envelope</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organonitrogen compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001167</id>
      <name>Hematopoietic prostaglandin D synthase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>16547010</pubmed-id>
            <citation>Aritake K, Kado Y, Inoue T, Miyano M, Urade Y: Structural and functional characterization of HQL-79, an orally selective inhibitor of human hematopoietic prostaglandin D synthase. J Biol Chem. 2006 Jun 2;281(22):15277-86. Epub 2006 Mar 17.</citation>
          </article>
          <article>
            <pubmed-id>15113825</pubmed-id>
            <citation>Inoue T, Okano Y, Kado Y, Aritake K, Irikura D, Uodome N, Okazaki N, Kinugasa S, Shishitani H, Matsumura H, Kai Y, Urade Y: First determination of the inhibitor complex structure of human hematopoietic prostaglandin D synthase. J Biochem. 2004 Mar;135(3):279-83.</citation>
          </article>
          <article>
            <pubmed-id>8415655</pubmed-id>
            <citation>Urade Y, Kitahama K, Ohishi H, Kaneko T, Mizuno N, Hayaishi O: Dominant expression of mRNA for prostaglandin D synthase in leptomeninges, choroid plexus, and oligodendrocytes of the adult rat brain. Proc Natl Acad Sci U S A. 1993 Oct 1;90(19):9070-4.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O60760" source="Swiss-Prot">
    <name>Hematopoietic prostaglandin D synthase</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Bifunctional enzyme which catalyzes both the conversion of PGH2 to PGD2, a prostaglandin involved in smooth muscle contraction/relaxation and a potent inhibitor of platelet aggregation, and the conjugation of glutathione with a wide range of aryl halides and organic isothiocyanates. Also exhibits low glutathione-peroxidase activity towards cumene hydroperoxide.</specific-function>
    <gene-name>HPGDS</gene-name>
    <locus/>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.64</theoretical-pi>
    <molecular-weight>23343.65</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:17890</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D82073</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3046817</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1381</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O60760</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>HPGDS_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>5.3.99.2</synonym>
      <synonym>Glutathione S-transferase</synonym>
      <synonym>Glutathione-dependent PGD synthase</synonym>
      <synonym>Glutathione-requiring prostaglandin D synthase</synonym>
      <synonym>GST class-sigma</synonym>
      <synonym>GSTS</synonym>
      <synonym>H-PGDS</synonym>
      <synonym>PGDS</synonym>
      <synonym>Prostaglandin-H2 D-isomerase</synonym>
      <synonym>PTGDS2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016335|Hematopoietic prostaglandin D synthase
MPNYKLTYFNMRGRAEIIRYIFAYLDIQYEDHRIEQADWPEIKSTLPFGKIPILEVDGLT
LHQSLAIARYLTKNTDLAGNTEMEQCHVDAIVDTLDDFMSCFPWAEKKQDVKEQMFNELL
TYNAPHLMQDLDTYLGGREWLIGNSVTWADFYWEICSTTLLVFKPDLLDNHPRLVTLRKK
VQAIPAVANWIKRRPQTKL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016336|Hematopoietic prostaglandin D synthase (HPGDS)
ATGCCAAACTACAAACTCACTTATTTTAATATGAGGGGGAGAGCAGAAATTATTCGTTAC
ATATTTGCTTATTTGGACATACAGTATGAAGACCACAGAATAGAACAAGCTGACTGGCCT
GAAATCAAATCAACTCTCCCATTTGGAAAAATCCCCATTTTGGAAGTTGATGGACTTACT
CTTCACCAGAGCCTAGCAATAGCAAGATATTTGACCAAAAACACAGATTTGGCTGGAAAC
ACAGAAATGGAACAATGTCATGTTGATGCTATTGTGGACACTCTGGATGATTTCATGTCA
TGTTTTCCTTGGGCAGAGAAAAAGCAAGATGTGAAAGAGCAGATGTTCAATGAGCTGCTC
ACGTATAATGCGCCTCATCTTATGCAAGACTTGGACACATATTTAGGGGGGAGAGAATGG
CTTATTGGTAACTCTGTAACTTGGGCAGACTTCTACTGGGAGATTTGCAGTACCACACTT
TTGGTCTTTAAGCCTGACCTGTTAGACAACCATCCAAGGCTGGTGACTTTACGGAAGAAA
GTCCAAGCCATTCCTGCCGTCGCTAACTGGATAAAACGAAGGCCCCAAACCAAACTCTAG
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>prostaglandin-D synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cyclooxygenase pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prostaglandin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of male germ cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>locomotory behavior</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002280</id>
      <name>Thioredoxin domain-containing protein 12</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O95881" source="Swiss-Prot">
    <name>Thioredoxin domain-containing protein 12</name>
    <general-function>Protein-disulfide reductase (glutathione) activity</general-function>
    <specific-function>Possesses significant protein thiol-disulfide oxidase activity.</specific-function>
    <gene-name>TXNDC12</gene-name>
    <locus>1p32.3</locus>
    <cellular-location>Endoplasmic reticulum lumen</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-26</signal-regions>
    <theoretical-pi>5.1</theoretical-pi>
    <molecular-weight>19205.615</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:24626</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>TXNDC12</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF543416</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>23477616</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O95881</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>TXD12_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.8.4.2</synonym>
      <synonym>Endoplasmic reticulum resident protein 18</synonym>
      <synonym>Endoplasmic reticulum resident protein 19</synonym>
      <synonym>ER protein 18</synonym>
      <synonym>ER protein 19</synonym>
      <synonym>ERp18</synonym>
      <synonym>ERp19</synonym>
      <synonym>hTLP19</synonym>
      <synonym>Thioredoxin-like protein p19</synonym>
      <synonym>TLP19</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019261|Thioredoxin domain-containing protein 12
METRPRLGATCLLGFSFLLLVISSDGHNGLGKGFGDHIHWRTLEDGKKEAAASGLPLMVI
IHKSWCGACKALKPKFAESTEISELSHNFVMVNLEDEEEPKDEDFSPDGGYIPRILFLDP
SGKVHPEIINENGNPSYKYFYVSAEQVVQGMKEAQERLTGDAFRKKHLEDEL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019262|Thioredoxin domain-containing protein 12 (TXNDC12)
ATGGAGACGCGGCCTCGTCTCGGGGCCACCTGTTTGCTGGGCTTCAGTTTCCTGCTCCTC
GTCATCTCTTCTGATGGACATAATGGGCTTGGAAAGGGTTTTGGAGATCATATTCATTGG
AGGACACTGGAAGATGGGAAGAAAGAAGCAGCTGCCAGTGGACTGCCCCTGATGGTGATT
ATTCATAAATCCTGGTGTGGAGCTTGCAAAGCTCTAAAGCCCAAATTTGCAGAATCTACG
GAAATTTCAGAACTCTCCCATAATTTTGTTATGGTAAATCTTGAGGATGAAGAGGAACCC
AAAGATGAAGATTTCAGCCCTGACGGGGGTTATATTCCACGAATCCTTTTTCTGGATCCC
AGTGGCAAGGTGCATCCTGAAATCATCAATGAGAATGGAAACCCCAGCTACAAGTATTTT
TATGTCAGTGCCGAGCAAGTTGTTCAGGGGATGAAGGAAGCTCAGGAAAGGCTGACGGGT
GATGCCTTCAGAAAGAAACATCTTGAAGATGAATTGTAA</gene-sequence>
    <pfams>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peptide disulfide oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein-disulfide reductase (glutathione) activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002281</id>
      <name>Glutathione S-transferase A1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17425746</pubmed-id>
            <citation>Kim I, Keam B, Lee KH, Kim JH, Oh SY, Ra EK, Yoon SS, Park SS, Kim CS, Park S, Hong YC, Kim BK: Glutathione S-transferase A1 polymorphisms and acute graft-vs.-host disease in HLA-matched sibling allogeneic hematopoietic stem cell transplantation. Clin Transplant. 2007 Mar-Apr;21(2):207-13.</citation>
          </article>
          <article>
            <pubmed-id>17346923</pubmed-id>
            <citation>Soderdahl T, Kuppers-Munther B, Heins N, Edsbagge J, Bjorquist P, Cotgreave I, Jernstrom B: Glutathione transferases in hepatocyte-like cells derived from human embryonic stem cells. Toxicol In Vitro. 2007 Aug;21(5):929-37. Epub 2007 Feb 2.</citation>
          </article>
          <article>
            <pubmed-id>17333241</pubmed-id>
            <citation>Jonsson LS, Broberg K, Bergendorf U, Axmon A, Littorin M, Jonsson BA: Levels of 2-thiothiazolidine-4-carboxylic acid (TTCA) and effect modification of polymorphisms of glutathione-related genes in vulcanization workers in the southern Sweden rubber industries. Int Arch Occup Environ Health. 2007 Jul;80(7):589-98. Epub 2007 Feb 28.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08263" source="Swiss-Prot">
    <name>Glutathione S-transferase A1</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTA1</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.34</theoretical-pi>
    <molecular-weight>25630.785</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4626</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M15872</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306809</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P08263</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-alpha member 1</synonym>
      <synonym>GST HA subunit 1</synonym>
      <synonym>GST-epsilon</synonym>
      <synonym>GSTA1-1</synonym>
      <synonym>GTH1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011643|Glutathione S-transferase A1
MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAK
LALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPL
LKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011644|Glutathione S-transferase A1 (GSTA1)
ATGGCAGAGAAGCCCAAGCTCCACTACTTCAATGCACGGGGCAGAATGGAGTCCACCCGG
TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
CTCTATGGGAAAGACATAAAGGAGAGAGCCCTGATTGATATGTATATAGAAGGTATAGCA
GATTTGGGTGAAATGATCCTCCTTCTGCCCGTATGTCCACCTGAGGAAAAAGATGCCAAG
CTTGCCTTGATCAAAGAGAAAATAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
AAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCATCTG
GTGGAACTTCTCTACTACGTCGAGGAGCTTGACTCCAGTCTTATCTCCAGCTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAAGCAAGGAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002189</id>
      <name>Glutathione S-transferase A2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17317527</pubmed-id>
            <citation>Sharma P, Ahmad Shah Z, Kumar A, Islam F, Mishra KP: Role of combined administration of Tiron and glutathione against aluminum-induced oxidative stress in rat brain. J Trace Elem Med Biol. 2007;21(1):63-70. Epub 2007 Feb 6.</citation>
          </article>
          <article>
            <pubmed-id>17321661</pubmed-id>
            <citation>Skamarauskas J, Carter W, Fowler M, Madjd A, Lister T, Mavroudis G, Ray DE: The selective neurotoxicity produced by 3-chloropropanediol in the rat is not a result of energy deprivation. Toxicology. 2007 Apr 11;232(3):268-76. Epub 2007 Jan 21.</citation>
          </article>
          <article>
            <pubmed-id>17338280</pubmed-id>
            <citation>Ozkilic AC, Cengiz M, Ozaydin A, Cobanoglu A, Kanigur G: The role of N-acetylcysteine treatment on anti-oxidative status in patients with type II diabetes mellitus. J Basic Clin Physiol Pharmacol. 2006;17(4):245-54.</citation>
          </article>
          <article>
            <pubmed-id>17338281</pubmed-id>
            <citation>Guruvayoorappan C, Afira AH, Kuttan G: Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol. 2006;17(4):255-67.</citation>
          </article>
          <article>
            <pubmed-id>17401685</pubmed-id>
            <citation>Gupta S, Sarotra P, Aggarwal R, Dutta N, Agnihotri N: Role of oxidative stress in celecoxib-induced renal damage in wistar rats. Dig Dis Sci. 2007 Nov;52(11):3092-8. Epub 2007 Mar 31.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09210" source="Swiss-Prot">
    <name>Glutathione S-transferase A2</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTA2</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.07</theoretical-pi>
    <molecular-weight>25663.675</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4627</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M16594</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306811</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P09210</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-alpha member 2</synonym>
      <synonym>GST HA subunit 2</synonym>
      <synonym>GST-gamma</synonym>
      <synonym>GST2</synonym>
      <synonym>GSTA2-2</synonym>
      <synonym>GTH2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011580|Glutathione S-transferase A2
MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMILLLPFSQPEEQDAK
LALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPL
LKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011581|Glutathione S-transferase A2 (GSTA2)
ATGGCAGAGAAGCCCAAGCTCCACTACTCCAATATACGGGGCAGAATGGAGTCCATCCGG
TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
CTCTATGGGAAAGACATAAAGGAGAAAGCCCTGATTGATATGTATATAGAAGGTATAGCA
GATTTGGGTGAAATGATCCTTCTTCTGCCCTTTAGTCAACCTGAGGAACAAGATGCCAAG
CTTGCCTTGATCCAAGAGAAAACAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
AAGAGCCACGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCACCTG
GTGGAACTTCTCTACTACGTGGAAGAGCTTGACTCTAGCCTTATTTCCAGCTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGTAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAATCAAGGAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002282</id>
      <name>Microsomal glutathione S-transferase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17306223</pubmed-id>
            <citation>Siritantikorn A, Johansson K, Ahlen K, Rinaldi R, Suthiphongchai T, Wilairat P, Morgenstern R: Protection of cells from oxidative stress by microsomal glutathione transferase 1. Biochem Biophys Res Commun. 2007 Apr 6;355(2):592-6. Epub 2007 Feb 12.</citation>
          </article>
          <article>
            <pubmed-id>17297922</pubmed-id>
            <citation>Busenlehner LS, Alander J, Jegerscohld C, Holm PJ, Bhakat P, Hebert H, Morgenstern R, Armstrong RN: Location of substrate binding sites within the integral membrane protein microsomal glutathione transferase-1. Biochemistry. 2007 Mar 13;46(10):2812-22. Epub 2007 Feb 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P10620" source="Swiss-Prot">
    <name>Microsomal glutathione S-transferase 1</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Has a wide substrate specificity.</specific-function>
    <gene-name>MGST1</gene-name>
    <locus>12p12.3-p12.1</locus>
    <cellular-location>Microsome</cellular-location>
    <transmembrane-regions>10-33
63-96
100-123
129-148</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.71</theoretical-pi>
    <molecular-weight>17598.45</molecular-weight>
    <chromosome-location>12</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7061</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MGST1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J03746</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306808</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P10620</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MGST1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST12</synonym>
      <synonym>MGST</synonym>
      <synonym>Microsomal GST-1</synonym>
      <synonym>Microsomal GST-I</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004480|Microsomal glutathione S-transferase 1
MVDLTQVMDDEVFMAFASYATIILSKMMLMSTATAFYRLTRKVFANPEDCVAFGKGENAK
KYLRTDDRVERVRRAHLNDLENIIPFLGIGLLYSLSGPDPSTAILHFRLFVGARIYHTIA
YLTPLPQPNRALSFFVGYGVTLSMAYRLLKSKLYL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021668|Microsomal glutathione S-transferase 1 (MGST1)
ATGGTTGACCTCACCCAGGTAATGGATGATGAAGTATTCATGGCTTTTGCATCCTATGCA
ACAATTATTCTTTCAAAAATGATGCTTATGAGTACTGCAACTGCATTCTATAGATTGACA
AGAAAGGTTTTTGCCAATCCAGAAGACTGTGTAGCATTTGGCAAAGGAGAAAATGCCAAG
AAGTATCTTCGAACAGATGACAGAGTAGAACGTGTACGCAGAGCCCACCTGAATGACCTT
GAAAATATTATTCCATTTCTTGGAATTGGCCTCCTGTATTCCTTGAGTGGTCCCGACCCC
TCTACAGCCATCCTGCACTTCAGACTATTTGTCGGAGCACGGATCTACCACACCATTGCA
TATTTGACACCCCTTCCCCAGCCAAATAGAGCTTTGAGTTTTTTTGTTGGATATGGAGTT
ACTCTTTCCATGGCTTACAGGTTGCTGAAAAGTAAATTGTACCTGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01124</identifier>
        <name>MAPEG</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial outer membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>peroxisomal membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical part of cell</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>Leydig cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organonitrogen compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipid hydroperoxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotrimerization</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002283</id>
      <name>S-formylglutathione hydrolase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12904537</pubmed-id>
            <citation>Yurimoto H, Lee B, Yano T, Sakai Y, Kato N: Physiological role of S-formylglutathione hydrolase in C(1) metabolism of the methylotrophic yeast Candida boidinii. Microbiology. 2003 Aug;149(Pt 8):1971-9.</citation>
          </article>
          <article>
            <pubmed-id>7397203</pubmed-id>
            <citation>Neben I, Sahm H, Kula MR: Studies on an enzyme, S-formylglutathione hydrolase, of the dissimilatory pathway of methanol in Candida boidinii. Biochim Biophys Acta. 1980 Jul 10;614(1):81-91.</citation>
          </article>
          <article>
            <pubmed-id>2554783</pubmed-id>
            <citation>Sabatier L, Hoffschir F, al Achkar WA, Turleau C, de Grouchy J, Dutrillaux B: The decrease of catalase or esterase D activity in patients with microdeletions of 11p or 13q does not increase their radiosensitivity. Ann Genet. 1989;32(3):144-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P10768" source="Swiss-Prot">
    <name>S-formylglutathione hydrolase</name>
    <general-function>S-formylglutathione hydrolase activity</general-function>
    <specific-function>Serine hydrolase involved in the detoxification of formaldehyde.</specific-function>
    <gene-name>ESD</gene-name>
    <locus>13q14.1-q14.2</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.02</theoretical-pi>
    <molecular-weight>31462.545</molecular-weight>
    <chromosome-location>13</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:3465</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ESD</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M13450</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>182265</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P10768</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ESTD_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.2.12</synonym>
      <synonym>Esterase D</synonym>
      <synonym>FGH</synonym>
      <synonym>Methylumbelliferyl-acetate deacetylase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004482|S-formylglutathione hydrolase
MALKQISSNKCFGGLQKVFEHDSVELNCKMKFAVYLPPKAETGKCPALYWLSGLTCTEQN
FISKSGYHQSASEHGLVVIAPDTSPRGCNIKGEDESWDFGTGAGFYVDATEDPWKTNYRM
YSYVTEELPQLINANFPVDPQRMSIFGHSMGGHGALICALKNPGKYKSVSAFAPICNPVL
CPWGKKAFSGYLGTDQSKWKAYDATHLVKSYPGSQLDILIDQGKDDQFLLDGQLLPDNFI
AACTEKKIPVVFRLQEGYDHSYYFIATFITDHIRHHAKYLNA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019263|S-formylglutathione hydrolase (ESD)
ATGGCATTGAAGCAGATTTCCAGCAACAAGTGCTTTGGGGGATTGCAGAAAGTTTTTGAA
CATGACAGTGTTGAACTAAACTGCAAAATGAAATTTGCTGTCTACTTACCACCAAAGGCA
GAAACAGGAAAGTGCCCTGCACTGTATTGGCTCTCAGGTTTAACTTGCACAGAGCAAAAT
TTTATATCAAAATCTGGTTATCATCAGTCTGCTTCAGAACATGGTCTTGTTGTCATTGCT
CCAGATACCAGCCCTCGTGGCTGCAATATTAAAGGTGAAGATGAGAGCTGGGACTTTGGC
ACTGGTGCTGGATTTTATGTTGATGCCACTGAAGATCCTTGGAAAACCAACTACAGAATG
TACTCTTATGTCACAGAGGAGCTTCCCCAACTCATAAATGCCAATTTTCCAGTGGATCCC
CAAAGGATGTCTATTTTTGGCCACTCCATGGGAGGTCATGGAGCTCTGATCTGTGCTTTG
AAAAATCCTGGAAAATACAAATCTGTGTCAGCATTTGCTCCAATTTGCAACCCTGTACTC
TGTCCCTGGGGCAAAAAAGCCTTTAGTGGATATTTGGGAACAGATCAAAGTAAATGGAAG
GCTTATGATGCTACCCACCTTGTGAAATCCTATCCAGGATCTCAGCTGGACATACTAATT
GATCAAGGGAAAGATGACCAGTTTCTTTTAGATGGACAGTTACTCCCTGATAACTTCATA
GCTGCCTGTACAGAAAAGAAAATCCCCGTTGTTTTTCGATTGCAAGAGGGTTATGATCAT
AGCTACTACTTCATTGCAACCTTTATTACTGACCACATCAGACATCATGCTAAATACCTG
AATGCATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00756</identifier>
        <name>Esterase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic membrane-bounded vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>hydrolase activity, acting on ester bonds</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>carboxylic ester hydrolase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methylumbelliferyl-acetate deacetylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-formylglutathione hydrolase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>formaldehyde catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000889</id>
      <name>Gamma-glutamyltranspeptidase 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17316176</pubmed-id>
            <citation>Ohkama-Ohtsu N, Zhao P, Xiang C, Oliver DJ: Glutathione conjugates in the vacuole are degraded by gamma-glutamyl transpeptidase GGT3 in Arabidopsis. Plant J. 2007 Mar;49(5):878-88.</citation>
          </article>
          <article>
            <pubmed-id>17545509</pubmed-id>
            <citation>Martin MN, Saladores PH, Lambert E, Hudson AO, Leustek T: Localization of members of the gamma-glutamyl transpeptidase family identifies sites of glutathione and glutathione S-conjugate hydrolysis. Plant Physiol. 2007 Aug;144(4):1715-32. Epub 2007 Jun 1.</citation>
          </article>
          <article>
            <pubmed-id>17569287</pubmed-id>
            <citation>Anilakumar KR, Nagaraj NS, Santhanam K: Reduction of hexachlorocyclohexane-induced oxidative stress and cytotoxicity in rat liver by Emblica officinalis gaertn. Indian J Exp Biol. 2007 May;45(5):450-4.</citation>
          </article>
          <article>
            <pubmed-id>17644279</pubmed-id>
            <citation>Adamis PD, Panek AD, Eleutherio EC: Vacuolar compartmentation of the cadmium-glutathione complex protects Saccharomyces cerevisiae from mutagenesis. Toxicol Lett. 2007 Aug 30;173(1):1-7. Epub 2007 Jun 14.</citation>
          </article>
          <article>
            <pubmed-id>17291629</pubmed-id>
            <citation>Zhu Y, Carvey PM, Ling Z: Altered glutathione homeostasis in animals prenatally exposed to lipopolysaccharide. Neurochem Int. 2007 Mar;50(4):671-80. Epub 2007 Jan 13.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P19440" source="Swiss-Prot">
    <name>Gamma-glutamyltranspeptidase 1</name>
    <general-function>Glutathione hydrolase activity</general-function>
    <specific-function>Cleaves the gamma-glutamyl bond of extracellular glutathione (gamma-Glu-Cys-Gly), glutathione conjugates, and other gamma-glutamyl compounds. The metabolism of glutathione releases free glutamate and the dipeptide, cysteinyl-glycine, which is hydrolyzed to cysteine and glycine by dipeptidases. In the presence of high concentrations of dipeptides and some amino acids, can also catalyze a transpeptidation reaction, transferring the gamma-glutamyl moiety to an acceptor amino acid to form a new gamma-glutamyl compound. Initiates extracellular glutathione (GSH) breakdown, provides cells with a local cysteine supply and contributes to maintain intracellular GSH level. It is part of the cell antioxidant defense mechanism. Isoform 3 seems to be inactive.</specific-function>
    <gene-name>GGT1</gene-name>
    <locus>22q11.23</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>5-26</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.14</theoretical-pi>
    <molecular-weight>61409.67</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4250</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GGT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J04131</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183138</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P19440</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GGT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.3.2.2</synonym>
      <synonym>Gamma-glutamyltransferase 1</synonym>
      <synonym>GGT</synonym>
      <synonym>GGT 1</synonym>
      <synonym>Glutathione hydrolase 1</synonym>
      <synonym>Leukotriene-C4 hydrolase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001772|Gamma-glutamyltranspeptidase 1
MKKKLVVLGLLAVVLVLVIVGLCLWLPSASKEPDNHVYTRAAVAADAKQCSKIGRDALRD
GGSAVDAAIAALLCVGLMNAHSMGIGGGLFLTIYNSTTRKAEVINAREVAPRLAFATMFN
SSEQSQKGGLSVAVPGEIRGYELAHQRHGRLPWARLFQPSIQLARQGFPVGKGLAAALEN
KRTVIEQQPVLCEVFCRDRKVLREGERLTLPQLADTYETLAIEGAQAFYNGSLTAQIVKD
IQAAGGIVTAEDLNNYRAELIEHPLNISLGDVVLYMPSAPLSGPVLALILNILKGYNFSR
ESVESPEQKGLTYHRIVEAFRFAYAKRTLLGDPKFVDVTEVVRNMTSEFFAAQLRAQISD
DTTHPISYYKPEFYTPDDGGTAHLSVVAEDGSAVSATSTINLYFGSKVRSPVSGILFNNE
MDDFSSPSITNEFGVPPSPANFIQPGKQPLSSMCPTIMVGQDGQVRMVVGAAGGTQITTA
TALAIIYNLWFGYDVKRAVEEPRLHNQLLPNVTTVERNIDQAVTAALETRHHHTQIASTF
IAVVQAIVRTAGGWAAASDSRKGGEPAGY</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010627|Gamma-glutamyltranspeptidase 1 (GGT1)
ATGAAGAAGAAGTTAGTGGTGCTGGGCCTGCTGGCCGTGGTCCTGGTGCTGGTCATTGTC
GGCCTCTGTCTCTGGCTGCCCTCAGCCTCCAAGGAACCTGACAACCATGTGTACACCAGG
GCTGCCGTGGCCGCGGATGCCAAGCAGTGCTCGAAGATTGGGAGGGATGCACTGCGGGAC
GGTGGCTCTGCGGTGGATGCAGCCATTGCAGCCCTGTTGTGTGTGGGGCTCATGAATGCC
CACAGCATGGGCATCGGGGGTGGCCTCTTCCTCACCATCTACAACAGCACCACACGAAAA
GCTGAGGTCATCAACGCCCGCGAGGTGGCCCCCAGGCTGGCCTTTGCCACCATGTTCAAC
AGCTCGGAGCAGTCCCAGAAGGGGGGGCTGTCGGTGGCGGTGCCTGGGGAGATCCGAGGC
TATGAGCTGGCACACCAGCGGCATGGGCGGCTGCCCTGGGCTCGCCTCTTCCAGCCCAGC
ATCCAGCTGGCCCGCCAGGGCTTCCCCGTGGGCAAGGGCTTGGCGGCAGCCCTGGAAAAC
AAGCGGACCGTCATCGAGCAGCAGCCTGTCTTGTGTGAGGTGTTCTGCCGGGATAGAAAG
GTGCTTCGGGAGGGGGAGAGACTGACCCTGCCGCAGCTGGCTGACACCTACGAGACGCTG
GCCATCGAGGGTGCCCAGGCCTTCTACAACGGCAGCCTCACGGCCCAGATTGTGAAGGAC
ATCCAGGCGGCCGGGGGCATTGTGACAGCTGAGGACCTGAACAACTACCGTGCTGAGCTG
ATCGAGCACCCGCTGAACATCAGCCTGGGAGACGTGGTGCTGTACATGCCCAGTGCGCCG
CTCAGCGGGCCCGTGCTGGCCCTCATCCTCAACATCCTCAAAGGGTACAACTTCTCCCGG
GAGAGCGTGGAGAGCCCCGAGCAGAAGGGCCTGACGTACCACCGCATCGTAGAGGCTTTC
CGGTTTGCCTACGCCAAGAGGACCCTGCTTGGGGACCCCAAGTTTGTGGATGTGACTGAG
GTGGTCCGCAACATGACCTCCGAGTTCTTCGCTGCCCAGCTCCGGGCCCAGATCTCTGAC
GACACCACTCACCCGATCTCCTACTACAAGCCCGAGTTCTACACGCCGGATGACGGGGGC
ACTGCTCACCTGTCTGTCGTCGCAGAGGACGGCAGTGCTGTGTCCGCCACCAGCACCATC
AACCTCTACTTTGGCTCCAAGGTCCGCTCCCCGGTCAGCGGGATCCTGTTCAATAATGAA
ATGGACGACTTCAGCTCTCCCAGCATCACCAACGAGTTTGGGGTACCCCCCTCACCTGCC
AATTTCATCCAGCCAGGGAAGCAGCCGCTCTCGTCCATGTGCCCGACGATCATGGTGGGC
CAGGACGGCCAGGTCCGGATGGTGGTGGGAGCTGCTGGGGGCACACAGATCACCACGGCC
ACTGCACTGGCCATCATCTACAACCTCTGGTTCGGCTATGACGTGAAGCGGGCCGTGGAG
GAGCCCCGGCTGCACAACCAGCTTCTGCCCAACGTCACGACAGTGGAGAGAAACATTGAC
CAGGCAGTGACTGCAGCCCTGGAGACCCGGCACCATCACACCCAGATCGCGTCCACCTTC
ATCGCTGTGGTGCAAGCCATCGTCCGCACGGCTGGTGGCTGGGCAGCTGCCTCGGACTCC
AGGAAAGGCGGGGAGCCTGCCGGCTACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01019</identifier>
        <name>G_glu_transpept</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>anchored component of external side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>gamma-glutamyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione hydrolase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of immune system process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cysteine biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>spermatogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutamate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>zymogen activation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione catabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001189</id>
      <name>Glutathione S-transferase Mu 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17490601</pubmed-id>
            <citation>Kurtovic S, Jansson R, Mannervik B: Colorimetric endpoint assay for enzyme-catalyzed iodide ion release for high-throughput screening in microtiter plates. Arch Biochem Biophys. 2007 Aug 15;464(2):284-7. Epub 2007 Apr 24.</citation>
          </article>
          <article>
            <pubmed-id>17523921</pubmed-id>
            <citation>Vararattanavech A, Ketterman AJ: A functionally conserved basic residue in glutathione transferases interacts with the glycine moiety of glutathione and is pivotal for enzyme catalysis. Biochem J. 2007 Sep 1;406(2):247-56.</citation>
          </article>
          <article>
            <pubmed-id>17553661</pubmed-id>
            <citation>Gallagher EP, Huisden CM, Gardner JL: Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicol In Vitro. 2007 Dec;21(8):1365-72. Epub 2007 Apr 27.</citation>
          </article>
          <article>
            <pubmed-id>17498936</pubmed-id>
            <citation>Yalcinkaya S, Unlucerci Y, Uysal M: Methionine-supplemented diet augments hepatotoxicity and prooxidant status in chronically ethanol-treated rats. Exp Toxicol Pathol. 2007 Aug;58(6):455-9. Epub 2007 May 11.</citation>
          </article>
          <article>
            <pubmed-id>17604895</pubmed-id>
            <citation>Roh JY, Jung IH, Lee JY, Choi J: Toxic effects of di(2-ethylhexyl)phthalate on mortality, growth, reproduction and stress-related gene expression in the soil nematode Caenorhabditis elegans. Toxicology. 2007 Jul 31;237(1-3):126-33. Epub 2007 May 18.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P28161" source="Swiss-Prot">
    <name>Glutathione S-transferase Mu 2</name>
    <general-function>Receptor binding</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTM2</gene-name>
    <locus>1p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.29</theoretical-pi>
    <molecular-weight>25744.395</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4634</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTM2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M63509</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>183301</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P28161</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTM2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-mu 2</synonym>
      <synonym>GST4</synonym>
      <synonym>GSTM2-2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002365|Glutathione S-transferase Mu 2
MPMTLGYWNIRGLAHSIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNL
PYLIDGTHKITQSNAILRYIARKHNLCGESEKEQIREDILENQFMDSRMQLAKLCYDPDF
EKLKPEYLQALPEMLKLYSQFLGKQPWFLGDKITFVDFIAYDVLERNQVFEPSCLDAFPN
LKDFISRFEGLEKISAYMKSSRFLPRPVFTKMAVWGNK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016345|Glutathione S-transferase Mu 2 (GSTM2)
ATGCCCATGACACTGGGGTACTGGAACATCCGCGGGCTGGCCCATTCCATCCGCCTGCTC
CTGGAATACACAGACTCAAGCTACGAGGAAAAGAAGTACACGATGGGGGACGCTCCTGAT
TATGACAGAAGCCAGTGGCTGAATGAAAAATTCAAGCTGGGCCTGGACTTTCCCAATCTG
CCCTACTTGATTGATGGGACTCACAAGATCACCCAGAGCAACGCCATCCTGCGGTACATT
GCCCGCAAGCACAACCTGTGCGGGGAATCAGAAAAGGAGCAGATTCGCGAAGACATTTTG
GAGAACCAGTTTATGGACAGCCGTATGCAGCTGGCCAAACTCTGCTATGACCCAGATTTT
GAGAAACTGAAACCAGAATACCTGCAGGCACTCCCTGAAATGCTGAAGCTCTACTCACAG
TTTCTGGGGAAGCAGCCATGGTTTCTTGGGGACAAGATCACCTTTGTGGATTTCATCGCT
TATGATGTCCTTGAGAGAAACCAAGTATTTGAGCCCAGCTGCCTGGATGCCTTCCCAAAC
CTGAAGGACTTCATCTCCCGATTTGAGGGCTTGGAGAAGATCTCTGCCTACATGAAGTCC
AGCCGCTTCCTCCCAAGACCTGTGTTCACAAAGATGGCTGTCTGGGGCAACAAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sarcoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular detoxification of nitrogen compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitrobenzene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>relaxation of cardiac muscle</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to caffeine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002284</id>
      <name>Glutaredoxin-1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17512091</pubmed-id>
            <citation>Diwakar L, Kenchappa RS, Annepu J, Ravindranath V: Downregulation of glutaredoxin but not glutathione loss leads to mitochondrial dysfunction in female mice CNS: implications in excitotoxicity. Neurochem Int. 2007 Jul;51(1):37-46. Epub 2007 Apr 5.</citation>
          </article>
          <article>
            <pubmed-id>17460036</pubmed-id>
            <citation>Rouhier N, Unno H, Bandyopadhyay S, Masip L, Kim SK, Hirasawa M, Gualberto JM, Lattard V, Kusunoki M, Knaff DB, Georgiou G, Hase T, Johnson MK, Jacquot JP: Functional, structural, and spectroscopic characterization of a glutathione-ligated [2Fe-2S] cluster in poplar glutaredoxin C1. Proc Natl Acad Sci U S A. 2007 May 1;104(18):7379-84. Epub 2007 Apr 25.</citation>
          </article>
          <article>
            <pubmed-id>17327665</pubmed-id>
            <citation>Hakansson KO, Winther JR: Structure of glutaredoxin Grx1p C30S mutant from yeast. Acta Crystallogr D Biol Crystallogr. 2007 Mar;63(Pt 3):288-94. Epub 2007 Feb 21.</citation>
          </article>
          <article>
            <pubmed-id>17640917</pubmed-id>
            <citation>Lu J, Chew EH, Holmgren A: Targeting thioredoxin reductase is a basis for cancer therapy by arsenic trioxide. Proc Natl Acad Sci U S A. 2007 Jul 24;104(30):12288-93. Epub 2007 Jul 18.</citation>
          </article>
          <article>
            <pubmed-id>17431186</pubmed-id>
            <citation>Wang J, Pan S, Berk BC: Glutaredoxin mediates Akt and eNOS activation by flow in a glutathione reductase-dependent manner. Arterioscler Thromb Vasc Biol. 2007 Jun;27(6):1283-8. Epub 2007 Apr 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P35754" source="Swiss-Prot">
    <name>Glutaredoxin-1</name>
    <general-function>Protein n-terminus binding</general-function>
    <specific-function>Has a glutathione-disulfide oxidoreductase activity in the presence of NADPH and glutathione reductase. Reduces low molecular weight disulfides and proteins.</specific-function>
    <gene-name>GLRX</gene-name>
    <locus>5q14</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.21</theoretical-pi>
    <molecular-weight>11775.665</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4330</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLRX</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D21238</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>643695</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P35754</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLRX1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GRX</synonym>
      <synonym>Thioltransferase-1</synonym>
      <synonym>TTase-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011645|Glutaredoxin-1
MAQEFVNCKIQPGKVVVFIKPTCPYCRRAQEILSQLPIKQGLLEFVDITATNHTNEIQDY
LQQLTGARTVPRVFIGKDCIGGCSDLVSLQQSGELLTRLKQIGALQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011646|Glutaredoxin-1 (GLRX)
ATGGCTCAAGAGTTTGTGAACTGCAAAATCCAGCCTGGGAAGGTGGTTGTGTTCATCAAG
CCCACCTGCCCGTACTGCAGGAGGGCCCAAGAGATCCTCAGTCAATTGCCCATCAAACAA
GGGCTTCTGGAATTTGTCGATATCACAGCCACCAACCACACTAACGAGATTCAAGATTAT
TTGCAACAGCTCACGGGAGCAAGAACGGTGCCTCGAGTCTTTATTGGTAAAGATTGTATA
GGCGGATGCAGTGATCTAGTCTCTTTGCAACAGAGTGGGGAACTGCTGACGCGGCTAAAG
CAGATTGGAGCTCTGCAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00462</identifier>
        <name>Glutaredoxin</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein N-terminus binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione disulfide oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of membrane potential</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of sodium ion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein deglutathionylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule interconversion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001135</id>
      <name>Phospholipid hydroperoxide glutathione peroxidase, mitochondrial</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12751792</pubmed-id>
            <citation>Moreno SG, Laux G, Brielmeier M, Bornkamm GW, Conrad M: Testis-specific expression of the nuclear form of phospholipid hydroperoxide glutathione peroxidase (PHGPx). Biol Chem. 2003 Apr;384(4):635-43.</citation>
          </article>
          <article>
            <pubmed-id>17503194</pubmed-id>
            <citation>Baek IJ, Seo DS, Yon JM, Lee SR, Jin Y, Nahm SS, Jeong JH, Choo YK, Kang JK, Lee BJ, Yun YW, Nam SY: Tissue expression and cellular localization of phospholipid hydroperoxide glutathione peroxidase (PHGPx) mRNA in male mice. J Mol Histol. 2007 Jun;38(3):237-44. Epub 2007 May 15.</citation>
          </article>
          <article>
            <pubmed-id>14967915</pubmed-id>
            <citation>Nam SY, Baek IJ, Lee BJ, In CH, Jung EY, Yon JM, Ahn B, Kang JK, Yu WJ, Yun YW: Effects of 17beta-estradiol and tamoxifen on the selenoprotein phospholipid hydroperoxide glutathione peroxidase (PHGPx) mRNA expression in male reproductive organs of rats. J Reprod Dev. 2003 Oct;49(5):389-96.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P36969" source="Swiss-Prot">
    <name>Phospholipid hydroperoxide glutathione peroxidase, mitochondrial</name>
    <general-function>Phospholipid-hydroperoxide glutathione peroxidase activity</general-function>
    <specific-function>Protects cells against membrane lipid peroxidation and cell death. Required for normal sperm development and male fertility. Could play a major role in protecting mammals from the toxicity of ingested lipid hydroperoxides. Essential for embryonic development. Protects from radiation and oxidative damage.</specific-function>
    <gene-name>GPX4</gene-name>
    <locus>19p13.3</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.41</theoretical-pi>
    <molecular-weight>22174.52</molecular-weight>
    <chromosome-location>19</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4556</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X71973</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>825667</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P36969</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.12</synonym>
      <synonym>Glutathione peroxidase 4</synonym>
      <synonym>GPx-4</synonym>
      <synonym>GSHPx-4</synonym>
      <synonym>PHGPx</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037127|Phospholipid hydroperoxide glutathione peroxidase, mitochondrial
MSLGRLCRLLKPALLCGALAAPGLAGTMCASRDDWRCARSMHEFSAKDIDGHMVNLDKYR
GFVCIVTNVASQUGKTEVNYTQLVDLHARYAECGLRILAFPCNQFGKQEPGSNEEIKEFA
AGYNVKFDMFSKICVNGDDAHPLWKWMKIQPKGKGILGNAIKWNFTKFLIDKNGCVVKRY
GPMEEPLVIEKDLPHYF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010793|Phospholipid hydroperoxide glutathione peroxidase, mitochondrial (GPX4)
ATGAGCCTCGGCCGCCTTTGCCGCCTACTGAAGCCGGCGCTGCTCTGTGGGGCTCTGGCC
GCGCCTGGCCTGGCCGGGACCATGTGCGCGTCCCGGGACGACTGGCGCTGTGCGCGCTCC
ATGCACGAGTTTTCCGCCAAGGACATCGACGGGCACATGGTTAACCTGGACAAGTACCGG
GGCTTCGTGTGCATCGTCACCAACGTGGCCTCCCAGTGAGGCAAGACCGAAGTAAACTAC
ACTCAGCTCGTCGACCTGCACGCCCGATACGCTGAGTGTGGTTTGCGGATCCTGGCCTTC
CCGTGTAACCAGTTCGGGAAGCAGGAGCCAGGGAGTAACGAAGAGATCAAAGAGTTCGCC
GCGGGCTACAACGTCAAATTCGATATGTTCAGCAAGATCTGCGTGAACGGGGACGACGCC
CACCCGCTGTGGAAGTGGATGAAGATCCAACCCAAGGGCAAGGGCATCCTGGGAAATGCC
ATCAAGTGGAACTTCACCAAGTTTGGACACCGTCTCTCCACAGTTCCTCATCGACAAGAA
CGGCTGCGTGGTGAAGCGCTACGGACCCATGGAGGAGCCCCTGGTGATAGAGAAGGACCT
GCCCCACTATTTCTAGCTCCACAAGTGTGTGGCCCCGCCCGAGCCCCTGCCCACGCCCTT
GGAGCCTTCCACCGGCACTCATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear envelope</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phospholipid-hydroperoxide glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoxygenase pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phospholipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>spermatogenesis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>chromatin organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002285</id>
      <name>Glutathione S-transferase Mu 5</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11173863</pubmed-id>
            <citation>Schnakenberg E, Breuer R, Werdin R, Dreikorn K, Schloot W: Susceptibility genes: GSTM1 and GSTM3 as genetic risk factors in bladder cancer. Cytogenet Cell Genet. 2000;91(1-4):234-8.</citation>
          </article>
          <article>
            <pubmed-id>11684093</pubmed-id>
            <citation>Rao AV, Shaha C: Multiple glutathione S-transferase isoforms are present on male germ cell plasma membrane. FEBS Lett. 2001 Oct 26;507(2):174-80.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P46439" source="Swiss-Prot">
    <name>Glutathione S-transferase Mu 5</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTM5</gene-name>
    <locus>1p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.49</theoretical-pi>
    <molecular-weight>25674.455</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4637</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTM5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L02321</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>468260</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P46439</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTM5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-mu 5</synonym>
      <synonym>GSTM5-5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016741|Glutathione S-transferase Mu 5
MPMTLGYWDIRGLAHAIRLLLEYTDSSYVEKKYTLGDAPDYDRSQWLNEKFKLGLDFPNL
PYLIDGAHKITQSNAILRYIARKHNLCGETEEEKIRVDILENQVMDNHMELVRLCYDPDF
EKLKPKYLEELPEKLKLYSEFLGKRPWFAGDKITFVDFLAYDVLDMKRIFEPKCLDAFLN
LKDFISRFEGLKKISAYMKSSQFLRGLLFGKSATWNSK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016742|Glutathione S-transferase Mu 5 (GSTM5)
ATGCCCATGACTCTGGGGTACTGGGACATCCGTGGGCTGGCCCACGCCATCCGCTTGCTC
CTGGAATACACAGACTCAAGCTATGTGGAAAAGAAGTACACGCTGGGGGACGCTCCTGAC
TATGACAGAAGCCAGTGGCTGAATGAAAAATTCAAGCTGGGCCTGGACTTTCCCAATCTG
CCCTACTTGATTGATGGGGCTCACAAGATCACCCAGAGCAATGCCATCCTGCGCTACATT
GCCCGCAAGCACAACCTGTGTGGGGAGACAGAAGAGGAGAAGATTCGTGTGGACATTTTG
GAGAACCAGGTTATGGATAACCACATGGAGCTGGTCAGACTGTGCTATGACCCAGATTTT
GAGAAACTGAAGCCAAAATACTTGGAGGAACTCCCTGAAAAGCTAAAGCTCTACTCAGAG
TTTCTGGGGAAGCGGCCATGGTTTGCAGGAGACAAGATCACCTTTGTGGATTTCCTTGCC
TATGATGTCCTTGACATGAAGCGTATATTTGAGCCCAAGTGCTTGGACGCCTTCCTAAAC
TTGAAGGACTTCATCTCCCGCTTTGAGGGTTTGAAGAAGATCTCTGCCTACATGAAGTCC
AGCCAATTCCTCCGAGGTCTTTTGTTTGGAAAGTCAGCTACATGGAACAGCAAATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002286</id>
      <name>Glutathione peroxidase 6</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>17081103</pubmed-id>
            <citation>Brigelius-Flohe R: Glutathione peroxidases and redox-regulated transcription factors. Biol Chem. 2006 Oct-Nov;387(10-11):1329-35.</citation>
          </article>
          <article>
            <pubmed-id>3532684</pubmed-id>
            <citation>Myllyla V, Kihlstrom M, Takala TE, Tolonen U, Salminen A, Vihko V: Activities of some antioxidative and hexose monophosphate shunt enzymes of skeletal muscle in neuromuscular diseases. Acta Neurol Scand. 1986 Jul;74(1):17-24.</citation>
          </article>
          <article>
            <pubmed-id>17588737</pubmed-id>
            <citation>Giovannini C, Scazzocchio B, Matarrese P, Vari R, D'Archivio M, Di Benedetto R, Casciani S, Dessi MR, Straface E, Malorni W, Masella R: Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protective effects of phenolic compounds. J Nutr Biochem. 2008 Feb;19(2):118-28. Epub 2007 Jun 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P59796" source="Swiss-Prot">
    <name>Glutathione peroxidase 6</name>
    <general-function>Glutathione peroxidase activity</general-function>
    <specific-function/>
    <gene-name>GPX6</gene-name>
    <locus>6p22.1</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-19</signal-regions>
    <theoretical-pi>6.66</theoretical-pi>
    <molecular-weight>24970.46</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4558</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX6</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY324826</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>32492913</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P59796</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX6_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>GPx-6</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016739|Glutathione peroxidase 6
MFQQFQASCLVLFFLVGFAQQTLKPQNRKVDCNKGVTGTIYEYGALTLNGEEYIQFKQFA
GKHVLFVNVAAYUGLAAQYPELNALQEELKNFGVIVLAFPCNQFGKQEPGTNSEILLGLK
YVCPGSGFVPSFQLFEKGDVNGEKEQKVFTFLKNSCPPTSDLLGSSSQLFWEPMKVHDIR
WNFEKFLVGPDGVPVMHWFHQAPVSTVKSDILEYLKQFNTH</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016740|Glutathione peroxidase 6 (GPX6)
ATGTTCCAGCAGTTCCAGGCCTCCTGTCTTGTCCTGTTTTTCCTGGTTGGCTTTGCTCAG
CAGACCCTAAAGCCTCAAAATAGGAAGGTGGATTGCAACAAAGGGGTAACAGGCACCATC
TATGAGTATGGAGCCCTCACCCTCAACGGCGAGGAGTACATCCAATTCAAGCAGTTTGCA
GGCAAGCACGTCCTGTTTGTCAATGTGGCCGCCTATTGAGGCTTGGCAGCTCAGTATCCT
GAACTGAATGCACTACAGGAGGAGCTGAAGAATTTTGGTGTCATTGTGTTGGCCTTTCCC
TGCAACCAGTTTGGAAAACAAGAACCAGGAACAAACTCAGAAATACTTCTTGGTCTCAAG
TATGTGTGTCCAGGTAGTGGCTTTGTCCCCAGTTTCCAGCTCTTTGAGAAAGGGGATGTG
AATGGAGAAAAAGAACAGAAGGTCTTTACTTTCCTGAAGAACTCCTGCCCTCCGACCTCT
GATCTTTTGGGCTCATCAAGCCAACTCTTCTGGGAGCCCATGAAGGTCCATGATATCCGC
TGGAACTTTGAGAAATTTCTGGTGGGGCCCGATGGAGTCCCTGTCATGCATTGGTTCCAC
CAGGCTCCAGTCAGCACAGTCAAGTCAGACATCCTGGAGTACCTAAAGCAGTTCAATACC
CACTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001825</id>
      <name>Hydroxyacylglutathione hydrolase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11018726</pubmed-id>
            <citation>Ridderstrom M, Jemth P, Cameron AD, Mannervik B: The active-site residue tyr-175 in human glyoxalase II contributes to binding of glutathione derivatives. Biochim Biophys Acta. 2000 Sep 29;1481(2):344-8.</citation>
          </article>
          <article>
            <pubmed-id>8589803</pubmed-id>
            <citation>Chyan MK, Elia AC, Principato GB, Giovannini E, Rosi G, Norton SJ: S-fluorenylmethoxycarbonyl glutathione and diesters: inhibition of mammalian glyoxalase II. Enzyme Protein. 1994-1995;48(3):164-73.</citation>
          </article>
          <article>
            <pubmed-id>3955057</pubmed-id>
            <citation>Al-Timari A, Douglas KT: Inhibition by glutathione derivatives of bovine liver glyoxalase II (hydroxyacylglutathione hydrolase) as a probe of the N- and S-sites for substrate binding. Biochim Biophys Acta. 1986 Mar 28;870(2):219-25.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16775" source="Swiss-Prot">
    <name>Hydroxyacylglutathione hydrolase, mitochondrial</name>
    <general-function>Metal ion binding</general-function>
    <specific-function>Thiolesterase that catalyzes the hydrolysis of S-D-lactoyl-glutathione to form glutathione and D-lactic acid.</specific-function>
    <gene-name>HAGH</gene-name>
    <locus>16p13.3</locus>
    <cellular-location>Mitochondrion matrix</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.36</theoretical-pi>
    <molecular-weight>33805.645</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4805</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>HAGH</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X90999</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1237213</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16775</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLO2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.1.2.6</synonym>
      <synonym>GLO2</synonym>
      <synonym>Glx II</synonym>
      <synonym>Glyoxalase II</synonym>
      <synonym>HAGH1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037149|Hydroxyacylglutathione hydrolase, mitochondrial
MVVGRGLLGRRSLAALGAACARRGLGPALLGVFCHTDLRKNLTVDEGTMKVEVLPALTDN
YMYLVIDDETKEAAIVDPVQPQKVVDAARKHGVKLTTVLTTHHHWDHAGGNEKLVKLESG
LKVYGGDDRIGALTHKITHLSTLQVGSLNVKCLATPCHTSGHICYFVSKPGGSEPPAVFT
GDTLFVAGCGKFYEGTADEMCKALLEVLGRLPPDTRVYCGHEYTINNLKFARHVEPGNAA
IREKLAWAKEKYSIGEPTVPSTLAEEFTYNPFMRVREKTVQQHAGETDPVTTMRAVRREK
DQFKMPRD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019185|Hydroxyacylglutathione hydrolase, mitochondrial (HAGH)
ATGAAGGTAGAGGTGCTGCCTGCCCTGACCGACAACTACATGTACCTGGTCATTGATGAT
GAGACCAAGGAGGCTGCCATTGTGGATCCGGTGCAGCCCCAGAAGGTCGTGGACGCGGCG
AGAAAGCACGGGGTGAAACTGACCACAGTGCTCACCACCCACCACCACTGGGACCATGCT
GGCGGGAATGAGAAACTGGTCAAGCTGGAGTCGGGACTGAAGGTGTACGGGGGTGACGAC
CGTATCGGGGCCCTGACTCACAAGATCACTCACCTGTCCACACTGCAGGTGGGGTCTCTG
AACGTCAAGTGCCTGGCGACCCCGTGCCACACTTCAGGACACATTTGTTACTTCGTGAGC
AAGCCCGGAGGCTCGGAGCCCCCTGCCGTGTTCACAGGTGACACCTTGTTTGTGGCTGGC
TGCGGGAAGTTCTATGAAGGGACTGCGGATGAGATGTGTAAAGCTCTGCTGGAGGTCTTG
GGCCGGCTCCCCCCGGACACAAGAGTCTACTGTGGCCACGAGTACACCATCAACAACCTC
AAGTTTGCACGCCACGTGGAGCCCGGCAATGCCGCCATCCGGGAGAAGCTGGCCTGGGCC
AAGGAGAAGTACAGCATCGGGGAGCCCACAGTGCCATCCACCCTGGCAGAGGAGTTTACC
TACAACCCCTTCATGAGAGTGAGGGAGAAGACGGTGCAGCAGCACGCAGGTGAGACGGAC
CCGGTGACCACCATGCGGGCCGTGCGCAGGGAGAAGGACCAGTTCAAGATGCCCCGGGAC
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00753</identifier>
        <name>Lactamase_B</name>
      </pfam>
      <pfam>
        <identifier>PF16123</identifier>
        <name>HAGH_C</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>hydroxyacylglutathione hydrolase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylglyoxal catabolic process to D-lactate via S-lactoyl-glutathione</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002287</id>
      <name>Glutathione peroxidase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17561443</pubmed-id>
            <citation>Chattopadhyay S, Sahoo DK, Subudhi U, Chainy GB: Differential expression profiles of antioxidant enzymes and glutathione redox status in hyperthyroid rats: a temporal analysis. Comp Biochem Physiol C Toxicol Pharmacol. 2007 Sep;146(3):383-91. Epub 2007 May 3.</citation>
          </article>
          <article>
            <pubmed-id>17387467</pubmed-id>
            <citation>Du X, Takagi H: N-Acetyltransferase Mpr1 confers ethanol tolerance on Saccharomyces cerevisiae by reducing reactive oxygen species. Appl Microbiol Biotechnol. 2007 Jul;75(6):1343-51. Epub 2007 Mar 27.</citation>
          </article>
          <article>
            <pubmed-id>17513408</pubmed-id>
            <citation>Sheridan PA, Zhong N, Carlson BA, Perella CM, Hatfield DL, Beck MA: Decreased selenoprotein expression alters the immune response during influenza virus infection in mice. J Nutr. 2007 Jun;137(6):1466-71.</citation>
          </article>
          <article>
            <pubmed-id>17510403</pubmed-id>
            <citation>Walshe J, Serewko-Auret MM, Teakle N, Cameron S, Minto K, Smith L, Burcham PC, Russell T, Strutton G, Griffin A, Chu FF, Esworthy S, Reeve V, Saunders NA: Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 2007 May 15;67(10):4751-8.</citation>
          </article>
          <article>
            <pubmed-id>17297093</pubmed-id>
            <citation>Sordillo LM, O'Boyle N, Gandy JC, Corl CM, Hamilton E: Shifts in thioredoxin reductase activity and oxidant status in mononuclear cells obtained from transition dairy cattle. J Dairy Sci. 2007 Mar;90(3):1186-92.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q6NSD4" source="TrEMBL">
    <name>Glutathione peroxidase</name>
    <general-function>Glutathione peroxidase activity</general-function>
    <specific-function/>
    <gene-name>GPX1</gene-name>
    <locus/>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.23</theoretical-pi>
    <molecular-weight>16179.36</molecular-weight>
    <chromosome-location/>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>BC070258</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>47124246</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q6NSD4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>Q6NSD4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011647|Glutathione peroxidase
MNELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEVS
GAGAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLRR
YSRRFQTIDIEPDIEALLSQGLSCA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0004489|438 bp
ATGAACGAGCTGCAGCGGCGCCTCGGACCCCGGGGCCTGGTGGTGCTCGGCTTCCCGTGC
AACCAGTTTGGGCATCAGGAGAACGCCAAGAACGAAGAGATTCTGAATTCCCTCAAGTAC
GTCCGGCCTGGTGGTGGGTTCGAGCCCAACTTCATGCTCTTCGAGAAGTGCGAGGTGAGC
GGTGCGGGGGCGCACCCTCTCTTCGCCTTCCTGCGGGAGGCCCTGCCAGCTCCCAGCGAC
GACGCCACCGCGCTTATGACCGACCCCAAGCTCATCACCTGGTCTCCGGTGTGTCGCAAC
GATGTTGCCTGGAACTTTGAGAAGTTCCTGGTGGGCCCTGACGGTGTGCCCCTACGCAGG
TACAGCCGCCGCTTCCAGACCATTGACATCGAGCCTGACATCGAAGCCCTGCTGTCTCAA
GGGCTCAGCTGTGCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002288</id>
      <name>Probable glutathione peroxidase 8</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q8TED1" source="Swiss-Prot">
    <name>Probable glutathione peroxidase 8</name>
    <general-function>Peroxidase activity</general-function>
    <specific-function/>
    <gene-name>GPX8</gene-name>
    <locus>5q11.2</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>18-40</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.93</theoretical-pi>
    <molecular-weight>23880.83</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:33100</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AK074216</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>18676757</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q8TED1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX8_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>GPx-8</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011648|Probable glutathione peroxidase 8
MEPLAAYPLKCSGPRAKVFAVLLSIVLCTVTLFLLQLKFLKPKINSFYAFEVKDAKGRTV
SLEKYKGKVSLVVNVASDCQLTDRNYLGLKELHKEFGPSHFSVLAFPCNQFGESEPRPSK
EVESFARKNYGVTFPIFHKIKILGSEGEPAFRFLVDSSKKEPRWNFWKYLVNPEGQVVKF
WKPEEPIEVIRPDIAALVRQVIIKKKEDL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011649|Probable glutathione peroxidase 8 (GPX8)
ATGGAGCCTCTTGCAGCTTACCCGCTAAAATGTTCCGGGCCCAGAGCAAAGGTATTTGCA
GTTTTGCTGTCTATAGTTCTATGCACAGTAACGCTATTTCTTCTACAACTAAAATTCCTC
AAACCTAAAATCAACAGCTTTTATGCCTTTGAAGTGAAGGATGCAAAAGGAAGAACTGTT
TCTCTGGAAAAGTATAAAGGCAAAGTTTCACTAGTTGTAAACGTGGCCAGTGACTGCCAA
CTCACAGACAGAAATTACTTAGGGCTGAAGGAACTGCACAAAGAGTTTGGACCATCCCAC
TTCAGCGTGTTGGCTTTTCCCTGCAATCAGTTTGGAGAATCGGAGCCCCGCCCAAGCAAG
GAAGTAGAATCTTTTGCAAGAAAAAACTACGGAGTAACTTTCCCCATCTTCCACAAGATT
AAGATTCTAGGATCTGAAGGAGAACCTGCATTTAGATTTCTTGTTGATTCTTCAAAGAAG
GAACCAAGGTGGAATTTTTGGAAGTATCTTGTCAACCCTGAGGGTCAAGTTGTGAAGTTC
TGGAAGCCAGAGGAGCCCATTGAAGTCATCAGGCCTGACATAGCAGCTCTGGTTAGACAA
GTGATCATAAAAAAGAAAGAGGATCTATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002289</id>
      <name>Glutathione peroxidase 7</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17588737</pubmed-id>
            <citation>Giovannini C, Scazzocchio B, Matarrese P, Vari R, D'Archivio M, Di Benedetto R, Casciani S, Dessi MR, Straface E, Malorni W, Masella R: Apoptosis induced by oxidized lipids is associated with up-regulation of p66Shc in intestinal Caco-2 cells: protective effects of phenolic compounds. J Nutr Biochem. 2008 Feb;19(2):118-28. Epub 2007 Jun 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q96SL4" source="Swiss-Prot">
    <name>Glutathione peroxidase 7</name>
    <general-function>Peroxidase activity</general-function>
    <specific-function>It protects esophageal epithelia from hydrogen peroxide-induced oxidative stress. It suppresses acidic bile acid-induced reactive oxigen species (ROS) and protects against oxidative DNA damage and double-strand breaks.</specific-function>
    <gene-name>GPX7</gene-name>
    <locus>1p32</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-19</signal-regions>
    <theoretical-pi>8.46</theoretical-pi>
    <molecular-weight>20995.88</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4559</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX7</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF320068</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>25990366</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q96SL4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX7_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>CL683</synonym>
      <synonym>GPx-7</synonym>
      <synonym>GPX6</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004494|Glutathione peroxidase 7
MVAATVAAAWLLLWAAACAQQEQDFYDFKAVNIRGKLVSLEKYRGSVSLVVNVASECGFT
DQHYRALQQLQRDLGPHHFNVLAFPCNQFGQQEPDSNKEIESFARRTYSVSFPMFSKIAV
TGTGAHPAFKYLAQTSGKEPTWNFWKYLVAPDGKVVGAWDPTVSVEEVRPQITALVRKLI
LLKREDL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019260|Glutathione peroxidase 7 (GPX7)
ATGGTGGCGGCGACGGTGGCAGCGGCGTGGCTGCTCCTGTGGGCTGCGGCCTGCGCGCAG
CAGGAGCAGGACTTCTACGACTTCAAGGCGGTCAACATCCGGGGCAAACTGGTGTCGCTG
GAGAAGTACCGCGGATCGGTGTCCCTGGTGGTGAATGTGGCCAGCGAGTGCGGCTTCACA
GACCAGCACTACCGAGCCCTGCAGCAGCTGCAGCGAGACCTGGGCCCCCACCACTTTAAC
GTGCTCGCCTTCCCCTGCAACCAGTTTGGCCAACAGGAGCCTGACAGCAACAAGGAGATT
GAGAGCTTTGCCCGCCGCACCTACAGTGTCTCATTCCCCATGTTTAGCAAGATTGCAGTC
ACCGGTACTGGTGCCCATCCTGCCTTCAAGTACCTGGCCCAGACTTCTGGGAAGGAGCCC
ACCTGGAACTTCTGGAAGTACCTAGTAGCCCCAGATGGAAAGGTGGTAGGGGCTTGGGAC
CCAACTGTGTCAGTGGAGGAGGTCAGACCCCAGATCACAGCGCTCGTGAGGAAGCTCATC
CTACTGAAGCGAGAAGACTTATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum lumen</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>catalase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002290</id>
      <name>Microsomal glutathione S-transferase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17632548</pubmed-id>
            <citation>Ago H, Kanaoka Y, Irikura D, Lam BK, Shimamura T, Austen KF, Miyano M: Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis. Nature. 2007 Aug 2;448(7153):609-12. Epub 2007 Jul 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q99735" source="Swiss-Prot">
    <name>Microsomal glutathione S-transferase 2</name>
    <general-function>Leukotriene-c4 synthase activity</general-function>
    <specific-function>Can catalyze the production of LTC4 from LTA4 and reduced glutathione. Can catalyze the conjugation of 1-chloro-2,4-dinitrobenzene with reduced glutathione.</specific-function>
    <gene-name>MGST2</gene-name>
    <locus>4q28.3</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>6-26
59-79
111-131</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>9.88</theoretical-pi>
    <molecular-weight>16620.4</molecular-weight>
    <chromosome-location>4</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7063</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MGST2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U77604</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1747521</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q99735</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MGST2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST2</synonym>
      <synonym>Microsomal GST-2</synonym>
      <synonym>Microsomal GST-II</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004496|Microsomal glutathione S-transferase 2
MAGNSILLAAVSILSACQQSYFALQVGKARLKYKVTPPAVTGSPEFERVFRAQQNCVEFY
PIFIITLWMAGWYFNQVFATCLGLVYIYGRHLYFWGYSEAAKKRITGFRLSLGILALLTL
LGALGIANSFLDEYLDLNIAKKLRRQF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016743|Microsomal glutathione S-transferase 2 (MGST2)
ATGGCCGGGAACTCGATCCTGCTGGCTGCTGTCTCTATTCTCTCGGCCTGTCAGCAAAGT
TATTTTGCTTTGCAAGTTGGAAAGGCAAGATTAAAATACAAAGTTACGCCCCCAGCAGTC
ACTGGGTCACCAGAGTTTGAGAGAGTATTTCGGGCACAACAAAACTGTGTGGAGTTTTAT
CCTATATTCATAATTACATTGTGGATGGCTGGGTGGTATTTCAACCAAGTTTTTGCTACT
TGTCTGGGTCTGGTGTACATATATGGCCGTCACCTATACTTCTGGGGATATTCAGAAGCT
GCTAAAAAACGGATCACCGGTTTCCGACTGAGTCTGGGGATTTTGGCCTTGTTGACCCTC
CTAGGTGCCCTGGGAATTGCAAACAGCTTTCTGGATGAATATCTGGACCTCAATATTGCC
AAGAAACTGAGGCGGCAATTCTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01124</identifier>
        <name>MAPEG</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear envelope</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>leukotriene-C4 synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme activator activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002291</id>
      <name>Glutathione S-transferase omega-2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>16399380</pubmed-id>
            <citation>Whitbread AK, Masoumi A, Tetlow N, Schmuck E, Coggan M, Board PG: Characterization of the omega class of glutathione transferases. Methods Enzymol. 2005;401:78-99.</citation>
          </article>
          <article>
            <pubmed-id>17226937</pubmed-id>
            <citation>Board PG, Anders MW: Glutathione transferase omega 1 catalyzes the reduction of S-(phenacyl)glutathiones to acetophenones. Chem Res Toxicol. 2007 Jan;20(1):149-54.</citation>
          </article>
          <article>
            <pubmed-id>12618591</pubmed-id>
            <citation>Whitbread AK, Tetlow N, Eyre HJ, Sutherland GR, Board PG: Characterization of the human Omega class glutathione transferase genes and associated polymorphisms. Pharmacogenetics. 2003 Mar;13(3):131-44.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9H4Y5" source="Swiss-Prot">
    <name>Glutathione S-transferase omega-2</name>
    <general-function>Oxidoreductase activity</general-function>
    <specific-function>Exhibits glutathione-dependent thiol transferase activity. Has high dehydroascorbate reductase activity and may contribute to the recycling of ascorbic acid. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA).</specific-function>
    <gene-name>GSTO2</gene-name>
    <locus>10q25.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.62</theoretical-pi>
    <molecular-weight>28253.52</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:23064</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTO2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY350731</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>37777744</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9H4Y5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTO2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase omega 2-2</synonym>
      <synonym>Glutathione-dependent dehydroascorbate reductase</synonym>
      <synonym>GSTO 2-2</synonym>
      <synonym>GSTO-2</synonym>
      <synonym>MMA(V) reductase</synonym>
      <synonym>Monomethylarsonic acid reductase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004498|Glutathione S-transferase omega-2
MSGDATRTLGKGSQPPGPVPEGLIRIYSMRFCPYSHRTRLVLKAKDIRHEVVNINLRNKP
EWYYTKHPFGHIPVLETSQCQLIYESVIACEYLDDAYPGRKLFPYDPYERARQKMLLELF
CKVPHLTKECLVALRCGRECTNLKAALRQEFSNLEEILEYQNTTFFGGTCISMIDYLLWP
WFERLDVYGILDCVSHTPALRLWISAMKWDPTVCALLMDKSIFQGFLNLYFQNNPNAFDF
GLC</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011650|Glutathione S-transferase omega-2 (GSTO2)
ATGTCTGGGGATGCGACCAGGACCCTGGGGAAAGGAAGCCAGCCCCCAGGGCCAGTCCCG
GAGGGGCTGATCCGCATCTACAGCATGAGGTTCTGCCCCTATTCTCACAGGACCCGCCTC
GTCCTCAAGGCCAAAGACATCAGACATGAAGTGGTCAACATTAACCTGAGAAACAAGCCT
GAATGGTACTATACAAAGCACCCTTTTGGCCACATTCCTGTCCTGGAGACCAGCCAATGT
CAACTGATCTATGAATCTGTTATTGCTTGTGAGTACCTGGATGATGCTTATCCAGGAAGG
AAGCTGTTTCCATATGACCCTTATGAACGAGCTCGCCAAAAGATGTTATTGGAGCTATTT
TGTAAGATTCTTGAGTATCAGAACACCACCTTCTTTGGTGGAACCTGTATATCCATGATT
GATTACCTCCTCTGGCCCTGGTTTGAGCGGCTGGATGTGTATGGGATACTGGACTGTGTG
AGCCACACGCCAGCCCTGCGGCTCTGGATATCAGCCATGAAGTGGGACCCCACAGTCTGT
GCTCTTCTCATGGATAAGAGCATTTTCCAGGGCTTCTTGAATCTCTATTTTCAGAACAAC
CCTAATGCCTTTGACTTTGGGCTGTGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13417</identifier>
        <name>GST_N_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione dehydrogenase (ascorbate) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methylarsonate reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to arsenic-containing substance</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002292</id>
      <name>Glutaredoxin-2, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17355958</pubmed-id>
            <citation>Hashemy SI, Johansson C, Berndt C, Lillig CH, Holmgren A: Oxidation and S-nitrosylation of cysteines in human cytosolic and mitochondrial glutaredoxins: effects on structure and activity. J Biol Chem. 2007 May 11;282(19):14428-36. Epub 2007 Mar 13.</citation>
          </article>
          <article>
            <pubmed-id>17546662</pubmed-id>
            <citation>Sagemark J, Elgan TH, Burglin TR, Johansson C, Holmgren A, Berndt KD: Redox properties and evolution of human glutaredoxins. Proteins. 2007 Sep 1;68(4):879-92.</citation>
          </article>
          <article>
            <pubmed-id>17401194</pubmed-id>
            <citation>Sheng J, Ye J, Rosen BP: Crystallization and preliminary X-ray crystallographic analysis of Escherichia coliglutaredoxin 2 in complex with glutathione and of a cysteine-less variant without glutathione. Acta Crystallogr Sect F Struct Biol Cryst Commun. 2007 Apr 1;63(Pt 4):280-2. Epub 2007 Mar 12.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NS18" source="Swiss-Prot">
    <name>Glutaredoxin-2, mitochondrial</name>
    <general-function>Protein disulfide oxidoreductase activity</general-function>
    <specific-function>Glutathione-dependent oxidoreductase that facilitates the maintenance of mitochondrial redox homeostasis upon induction of apoptosis by oxidative stress. Involved in response to hydrogen peroxide and regulation of apoptosis caused by oxidative stress. Acts as a very efficient catalyst of monothiol reactions because of its high affinity for protein glutathione-mixed disulfides. Can receive electrons not only from glutathione (GSH), but also from thioredoxin reductase supporting both monothiol and dithiol reactions. Efficiently catalyzes both glutathionylation and deglutathionylation of mitochondrial complex I, which in turn regulates the superoxide production by the complex. Overexpression decreases the susceptibility to apoptosis and prevents loss of cardiolipin and cytochrome c release.</specific-function>
    <gene-name>GLRX2</gene-name>
    <locus>1q31.2-q31.3</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.49</theoretical-pi>
    <molecular-weight>18051.515</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16065</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLRX2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF132495</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>9507250</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9NS18</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GLRX2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>GRX2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004500|Glutaredoxin-2, mitochondrial
MIWRRAALAGTRLVWSRSGSAGWLDRAAGAAGAAAAAASGMESNTSSSLENLATAPVNQI
QETISDNCVVIFSKTSCSYCTMAKKLFHDMNVNYKVVELDLLEYGNQFQDALYKMTGERT
VPRIFVNGTFIGGATDTHRLHKEGKLLPLVHQCYLKKSKRKEFQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011651|Glutaredoxin-2, mitochondrial (GLRX2)
ATGGAGAGCAATACATCATCATCTTTGGAGAATTTAGCGACGGCGCCTGTGAACCAGATC
CAAGAAACAATTTCTGATAATTGTGTGGTGATTTTCTCAAAAACATCCTGTTCTTACTGT
ACAATGGCAAAAAAGCTTTTCCATGACATGAATGTTAACTATAAAGTGGTGGAACTGGAC
CTGCTTGAATATGGAAACCAGTTCCAAGATGCTCTTTACAAAATGACTGGTGAAAGAACT
GTTCCAAGAATATTTGTCAATGGTACTTTTATTGGAGGTGCAACTGACACTCATAGGCTT
CACAAAGAAGGAAAATTGCTCCCACTAGTTCATCAGTGTTATTTAAAAAAAAGTAAGAGG
AAAGAATTTCAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00462</identifier>
        <name>Glutaredoxin</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>dendrite</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>neuronal cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein disulfide isomerase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione disulfide oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein disulfide oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>arsenate reductase (glutaredoxin) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>2 iron, 2 sulfur cluster binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein folding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to superoxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to temperature stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>DNA protection</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to redox state</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription, DNA-templated</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hydrogen peroxide</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000962</id>
      <name>Lactoylglutathione lyase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17609286</pubmed-id>
            <citation>Barati MT, Merchant ML, Kain AB, Jevans AW, McLeish KR, Klein JB: Proteomic analysis defines altered cellular redox pathways and advanced glycation end-product metabolism in glomeruli of db/db diabetic mice. Am J Physiol Renal Physiol. 2007 Oct;293(4):F1157-65. Epub 2007 Jul 3.</citation>
          </article>
          <article>
            <pubmed-id>17664277</pubmed-id>
            <citation>Deponte M, Sturm N, Mittler S, Harner M, Mack H, Becker K: Allosteric coupling of two different functional active sites in monomeric Plasmodium falciparum glyoxalase I. J Biol Chem. 2007 Sep 28;282(39):28419-30. Epub 2007 Jul 30.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q04760" source="Swiss-Prot">
    <name>Lactoylglutathione lyase</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>Catalyzes the conversion of hemimercaptal, formed from methylglyoxal and glutathione, to S-lactoylglutathione. Involved in the regulation of TNF-induced transcriptional activity of NF-kappa-B. Required for normal osteoclastogenesis.</specific-function>
    <gene-name>GLO1</gene-name>
    <locus>6p21.3-p21.1</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>4.92</theoretical-pi>
    <molecular-weight>20777.515</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4323</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GLO1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D13315</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>219664</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q04760</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>LGUL_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.4.1.5</synonym>
      <synonym>Aldoketomutase</synonym>
      <synonym>Glx I</synonym>
      <synonym>Glyoxalase I</synonym>
      <synonym>Ketone-aldehyde mutase</synonym>
      <synonym>Methylglyoxalase</synonym>
      <synonym>S-D-lactoylglutathione methylglyoxal lyase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001915|Lactoylglutathione lyase
MAEPQPPSGGLTDEAALSCCSDADPSTKDFLLQQTMLRVKDPKKSLDFYTRVLGMTLIQK
CDFPIMKFSLYFLAYEDKNDIPKEKDEKIAWALSRKATLELTHNWGTEDDETQSYHNGNS
DPRGFGHIGIAVPDVYSACKRFEELGVKFVKKPDDGKMKGLAFIQDPDGYWIEILNPNKM
ATLM</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016267|Lactoylglutathione lyase (GLO1)
ATGGCAGAACCGCAGCCCCCGTCCGGCGGCCTCACGGACGAGGCCGCCCTCAGTTGCTGC
TCCGACGCGGACCCCAGTACCAAGGATTTTCTATTGCAGCAGACCATGCTACGAGTGAAG
GATCCTAAGAAGTCACTGGATTTTTATACTAGAGTTCTTGGAATGACGCTAATCCAAAAA
TGTGATTTTCCCATTATGAAGTTTTCACTCTACTTCTTGGCTTATGAGGATAAAAATGAC
ATCCCTAAAGAAAAAGATGAAAAAATAGCCTGGGCGCTCTCCAGAAAAGCTACACTTGAG
CTGACACACAATTGGGGCACTGAAGATGATGAGACCCAGAGTTACCACAATGGCAATTCA
GACCCTCGAGGATTCGGTCATATTGGAATTGCTGTTCCTGATGTATACAGTGCTTGTAAA
AGGTTTGAAGAACTGGGAGTCAAATTTGTGAAGAAACCTGATGATGGTAAAATGAAAGGC
CTGGCATTTATTCAAGATCCTGATGGCTACTGGATTGAAATTTTGAATCCTAACAAAATG
GCAACCTTAATGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00903</identifier>
        <name>Glyoxalase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lactoylglutathione lyase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of transcription from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>osteoclast differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylglyoxal metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>pyruvate metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0001117</id>
      <name>Leukotriene C4 synthase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17632546</pubmed-id>
            <citation>Martinez Molina D, Wetterholm A, Kohl A, McCarthy AA, Niegowski D, Ohlson E, Hammarberg T, Eshaghi S, Haeggstrom JZ, Nordlund P: Structural basis for synthesis of inflammatory mediators by human leukotriene C4 synthase. Nature. 2007 Aug 2;448(7153):613-6. Epub 2007 Jul 15.</citation>
          </article>
          <article>
            <pubmed-id>17632548</pubmed-id>
            <citation>Ago H, Kanaoka Y, Irikura D, Lam BK, Shimamura T, Austen KF, Miyano M: Crystal structure of a human membrane protein involved in cysteinyl leukotriene biosynthesis. Nature. 2007 Aug 2;448(7153):609-12. Epub 2007 Jul 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16873" source="Swiss-Prot">
    <name>Leukotriene C4 synthase</name>
    <general-function>Lipid binding</general-function>
    <specific-function>Catalyzes the conjugation of leukotriene A4 with reduced glutathione to form leukotriene C4.</specific-function>
    <gene-name>LTC4S</gene-name>
    <locus>5q35</locus>
    <cellular-location>Nucleus outer membrane</cellular-location>
    <transmembrane-regions>7-27
49-69
74-94
105-124</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>10.4</theoretical-pi>
    <molecular-weight>16566.465</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:6719</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>LTC4S</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U09353</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>520485</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1391</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16873</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>LTC4S_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>4.4.1.20</synonym>
      <synonym>Leukotriene-C(4) synthase</synonym>
      <synonym>LTC4 synthase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016318|Leukotriene C4 synthase
MKDEVALLAAVTLLGVLLQAYFSLQVISARRAFRVSPPLTTGPPEFERVYRAQVNCSEYF
PLFLATLWVAGIFFHEGAAALCGLVYLFARLRYFQGYARSAQLRLAPLYASARALWLLVA
LAALGLLAHFLPAALRAALLGRLRTLLPWA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016319|Leukotriene C4 synthase (LTC4S)
ATGAAGGACGAGGTAGCTCTACTGGCTGCTGTCACCCTCCTGGGAGTCCTGCTGCAAGCC
TACTTCTCCCTGCAGGTGATCTCGGCGCGCAGGGCCTTCCGCGTGTCGCCGCCGCTCACC
ACCGGCCCACCCGAGTTCGAGCGCGTCTACCGAGCCCAGGTGAACTGCAGCGAGTACTTC
CCGCTGTTCCTCGCCACGCTCTGGGTCGCCGGCATCTTCTTTCATGAAGGGGCGGCGGCC
CTGTGCGGCCTGGTCTACCTGTTCGCGCGCCTCCGCTACTTCCAGGGCTACGCGCGCTCC
GCGCAGCTCAGGCTGGCACCGCTGTACGCGAGCGCGCGCGCCCTCTGGCTGCTGGTGGCG
CTGGCTGCGCTCGGCCTGCTCGCCCACTTCCTCCCGGCCGCGCTGCGCGCCGCGCTCCTC
GGACGGCTCCGGACGCTGCTGCCGTGGGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01124</identifier>
        <name>MAPEG</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear envelope</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear outer membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme activator activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>leukotriene-C4 synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>lipid binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to axon injury</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoxin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoxygenase pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to inorganic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to vitamin A</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipopolysaccharide</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000648</id>
      <name>Glutathione reductase, mitochondrial</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17303537</pubmed-id>
            <citation>Messarah M, Boulakoud MS, Boumendjel A, Abdennour C, El Feki A: The impact of thyroid activity variations on some oxidizing-stress parameters in rats. C R Biol. 2007 Feb;330(2):107-12. Epub 2006 Dec 12.</citation>
          </article>
          <article>
            <pubmed-id>17327255</pubmed-id>
            <citation>Brocardo PS, Assini F, Franco JL, Pandolfo P, Muller YM, Takahashi RN, Dafre AL, Rodrigues AL: Zinc attenuates malathion-induced depressant-like behavior and confers neuroprotection in the rat brain. Toxicol Sci. 2007 May;97(1):140-8. Epub 2007 Feb 27.</citation>
          </article>
          <article>
            <pubmed-id>17338281</pubmed-id>
            <citation>Guruvayoorappan C, Afira AH, Kuttan G: Antioxidant potential of Biophytum sensitivum extract in vitro and in vivo. J Basic Clin Physiol Pharmacol. 2006;17(4):255-67.</citation>
          </article>
          <article>
            <pubmed-id>17369902</pubmed-id>
            <citation>Markaryan AA, Dubinskaya VA, Dargaeva TD: Peroxide-eliminating oxidoreductases as biosensors of antioxidant components of medicinal plants. Bull Exp Biol Med. 2006 Jul;142(1):55-6.</citation>
          </article>
          <article>
            <pubmed-id>17512104</pubmed-id>
            <citation>Maity S, Roy S, Chaudhury S, Bhattacharya S: Antioxidant responses of the earthworm Lampito mauritii exposed to Pb and Zn contaminated soil. Environ Pollut. 2008 Jan;151(1):1-7. Epub 2007 May 23.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P00390" source="Swiss-Prot">
    <name>Glutathione reductase, mitochondrial</name>
    <general-function>Nadp binding</general-function>
    <specific-function>Maintains high levels of reduced glutathione in the cytosol.</specific-function>
    <gene-name>GSR</gene-name>
    <locus>8p21.1</locus>
    <cellular-location>Mitochondrion</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.66</theoretical-pi>
    <molecular-weight>56256.565</molecular-weight>
    <chromosome-location>8</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4623</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSR</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X15722</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31825</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P00390</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSHR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.8.1.7</synonym>
      <synonym>GLUR</synonym>
      <synonym>GR</synonym>
      <synonym>GRD1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001292|Glutathione reductase, mitochondrial
MALLPRALSAGAGPSWRRAARAFRGFLLLLPEPAALTRALSRAMACRQEPQPQGPPPAAG
AVASYDYLVIGGGSGGLASARRAAELGARAAVVESHKLGGTCVNVGCVPKKVMWNTAVHS
EFMHDHADYGFPSCEGKFNWRVIKEKRDAYVSRLNAIYQNNLTKSHIEIIRGHAAFTSDP
KPTIEVSGKKYTAPHILIATGGMPSTPHESQIPGASLGITSDGFFQLEELPGRSVIVGAG
YIAVEMAGILSALGSKTSLMIRHDKVLRSFDSMISTNCTEELENAGVEVLKFSQVKEVKK
TLSGLEVSMVTAVPGRLPVMTMIPDVDCLLWAIGRVPNTKDLSLNKLGIQTDDKGHIIVD
EFQNTNVKGIYAVGDVCGKALLTPVAIAAGRKLAHRLFEYKEDSKLDYNNIPTVVFSHPP
IGTVGLTEDEAIHKYGIENVKTYSTSFTPMYHAVTKRKTKCVMKMVCANKEEKVVGIHMQ
GLGCDEMLQGFAVAVKMGATKADFDNTVAIHPTSSEELVTLR</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016164|Glutathione reductase, mitochondrial (GSR)
ATGGCCCTGCTGCCCCGAGCCCTGAGCGCCGGCGCGGGACCGAGCTGGCGGCGGGCGGCG
CGCGCCTTCCGAGGCTTCCTGCTGCTTCTGCCCGAGCCCGCGGCCCTCACGCGCGCCCTC
TCCCGTGCCATGGCCTGCAGGCAGGAGCCGCAGCCGCAGGGCCCGCCGCCCGCTGCTGGC
GCCGTGGCCTCCTATGACTACCTGGTGATCGGGGGCGGCTCGGGCGGGCTGGCCAGCGCG
CGCAGGGCGGCCGAGCTGGGTGCCAGGGCCGCCGTGGTGGAGAGCCACAAGCTGGGTGGC
ACTTGCGTGAATGTTGGATGTGTACCCAAAAAGGTAATGTGGAACACAGCTGTCCACTCT
GAATTCATGCATGATCATGCTGATTATGGCTTTCCAAGTTGTGAGGGTAAATTCAATTGG
CGTGTTATTAAGGAAAAGCGGGATGCCTATGTGAGCCGCCTGAATGCCATCTATCAAAAC
AATCTCACCAAGTCCCATATAGAAATCATCCGTGGCCATGCAGCCTTCACGAGTGATCCC
AAGCCCACAATAGAGGTCAGTGGGAAAAAGTACACCGCCCCACACATCCTGATCGCCACA
GGTGGTATGCCCTCCACCCCTCATGAGAGCCAGATCCCCGGTGCCAGCTTAGGAATAACC
AGCGATGGATTTTTTCAGCTGGAAGAATTGCCCGGCCGCAGCGTCATTGTTGGTGCAGGT
TACATTGCTGTGGAGATGGCAGGGATCCTGTCAGCCCTGGGTTCTAAGACATCACTGATG
ATACGGCATGATAAGGTACTTAGAAGTTTTGATTCAATGATCAGCACCAACTGCACGGAG
GAGCTGGAGAACGCTGGCGTGGAGGTGCTGAAGTTCTCCCAGGTCAAGGAGGTTAAAAAG
ACTTTGTCGGGCTTGGAAGTCAGCATGGTTACTGCAGTTCCCGGTAGGCTACCAGTCATG
ACCATGATTCCAGATGTTGACTGCCTGCTCTGGGCCATTGGGCGGGTCCCGAATACCAAG
GACCTGAGTTTAAACAAACTGGGGATTCAAACCGATGACAAGGGTCATATCATCGTAGAC
GAATTCCAGAATACCAACGTCAAAGGCATCTATGCAGTTGGGGATGTATGTGGAAAAGCT
CTTCTTACTCCAGTTGCAATAGCTGCTGGCCGAAAACTTGCCCATCGACTTTTTGAATAT
AAGGAAGATTCCAAATTAGATTATAACAACATCCCAACTGTGGTCTTCAGCCACCCCCCT
ATTGGGACAGTGGGACTCACGGAAGATGAAGCCATTCATAAATATGGAATAGAAAATGTG
AAGACCTATTCAACGAGCTTTACCCCGATGTATCACGCAGTTACCAAAAGGAAAACAAAA
TGTGTGATGAAAATGGTCTGTGCTAACAAGGAAGAAAAGGTGGTTGGGATCCATATGCAG
GGACTTGGGTGTGATGAAATGCTGCAGGGTTTTGCTGTTGCAGTGAAGATGGGAGCAACG
AAGGCAGACTTTGACAACACAGTCGCCATTCACCCTACCTCTTCAGAAGAGCTGGTCACA
CTTCGTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF07992</identifier>
        <name>Pyr_redox_2</name>
      </pfam>
      <pfam>
        <identifier>PF02852</identifier>
        <name>Pyr_redox_dim</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>external side of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>NADP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>flavin adenine dinucleotide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione-disulfide reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule interconversion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000185</id>
      <name>Glutathione synthetase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17452339</pubmed-id>
            <citation>Herrera K, Cahoon RE, Kumaran S, Jez J: Reaction mechanism of glutathione synthetase from Arabidopsis thaliana: site-directed mutagenesis of active site residues. J Biol Chem. 2007 Jun 8;282(23):17157-65. Epub 2007 Apr 22.</citation>
          </article>
          <article>
            <pubmed-id>17607728</pubmed-id>
            <citation>Mohanpuria P, Rana NK, Yadav SK: Cadmium induced oxidative stress influence on glutathione metabolic genes of Camellia sinensis (L.) O. Kuntze. Environ Toxicol. 2007 Aug;22(4):368-74.</citation>
          </article>
          <article>
            <pubmed-id>17630655</pubmed-id>
            <citation>Forcella M, Berra E, Giacchini R, Parenti P: Antioxidant defenses preserve membrane transport activity in Chironomus riparius larvae exposed to anoxia. Arch Insect Biochem Physiol. 2007 Aug;65(4):181-94.</citation>
          </article>
          <article>
            <pubmed-id>17401648</pubmed-id>
            <citation>Janaky R, Dohovics R, Saransaari P, Oja SS: Modulation of [3H]dopamine release by glutathione in mouse striatal slices. Neurochem Res. 2007 Aug;32(8):1357-64. Epub 2007 Mar 31.</citation>
          </article>
          <article>
            <pubmed-id>17467761</pubmed-id>
            <citation>Bridges CC, Battle JR, Zalups RK: Transport of thiol-conjugates of inorganic mercury in human retinal pigment epithelial cells. Toxicol Appl Pharmacol. 2007 Jun 1;221(2):251-60. Epub 2007 Mar 23.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P48637" source="Swiss-Prot">
    <name>Glutathione synthetase</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function/>
    <gene-name>GSS</gene-name>
    <locus>20q11.2</locus>
    <cellular-location/>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.73</theoretical-pi>
    <molecular-weight>52384.325</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4624</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSS</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L42531</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>886284</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P48637</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSHB_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>6.3.2.3</synonym>
      <synonym>Glutathione synthase</synonym>
      <synonym>GSH synthetase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000369|Glutathione synthetase
MATNWGSLLQDKQQLEELARQAVDRALAEGVLLRTSQEPTSSEVVSYAPFTLFPSLVPSA
LLEQAYAVQMDFNLLVDAVSQNAAFLEQTLSSTIKQDDFTARLFDIHKQVLKEGIAQTVF
LGLNRSDYMFQRSADGSPALKQIEINTISASFGGLASRTPAVHRHVLSVLSKTKEAGKIL
SNNPSKGLALGIAKAWELYGSPNALVLLIAQEKERNIFDQRAIENELLARNIHVIRRTFE
DISEKGSLDQDRRLFVDGQEIAVVYFRDGYMPRQYSLQNWEARLLLERSHAAKCPDIATQ
LAGTKKVQQELSRPGMLEMLLPGQPEAVARLRATFAGLYSLDVGEEGDQAIAEALAAPSR
FVLKPQREGGGNNLYGEEMVQALKQLKDSEERASYILMEKIEPEPFENCLLRPGSPARVV
QCISELGIFGVYVRQEKTLVMNKHVGHLLRTKAIEHADGGVAAGVAVLDNPYPV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016029|Glutathione synthetase (GSS)
ATGGCCACCAACTGGGGGAGCCTCTTGCAGGATAAACAGCAGCTAGAGGAGCTGGCACGG
CAGGCCGTGGACCGGGCCCTGGCTGAGGGAGTATTGCTGAGGACCTCACAGGAGCCCACT
TCCTCGGAGGTGGTGAGCTATGCCCCATTCACGCTCTTCCCCTCACTGGTCCCCAGTGCC
CTGCTGGAGCAAGCCTATGCTGTGCAGATGGACTTCAACCTGCTAGTGGATGCTGTCAGC
CAGAACGCTGCCTTCCTGGAGCAAACTCTTTCCAGCACCATCAAACAGGATGACTTTACC
GCTCGTCTCTTTGACATCCACAAGCAAGTCCTAAAAGAGGGCATTGCCCAGACTGTGTTC
CTGGGCCTGAATCGCTCAGACTACATGTTCCAGCGCAGCGCAGATGGCTCCCCAGCCCTG
AAACAGATCGAAATCAACACCATCTCTGCCAGCTTTGGGGGCCTGGCCTCCCGGACCCCA
GCTGTGCACCGACATGTTCTCAGTGTCCTGAGTAAGACCAAAGAAGCTGGCAAGATCCTC
TCTAATAATCCCAGCAAGGGACTGGCCCTGGGAATTGCCAAAGCCTGGGAGCTCTACGGC
TCACCCAATGCTCTGGTGCTACTGATTGCTCAAGAGAAGGAAAGAAACATATTTGACCAG
CGTGCCATAGAGAATGAGCTACTGGCCAGGAACATCCATGTGATCCGACGAACATTTGAA
GATATCTCTGAAAAGGGGTCTCTGGACCAAGACCGAAGGCTGTTTGTGGATGGCCAGGAA
ATTGCTGTGGTTTACTTCCGGGATGGCTACATGCCTCGTCAGTACAGTCTACAGAATTGG
GAAGCACGTCTACTGCTGGAGAGGTCACATGCTGCCAAGTGCCCAGACATTGCCACCCAG
CTGGCTGGGACTAAGAAGGTGCAGCAGGAGCTAAGCAGGCCGGGCATGCTGGAGATGTTG
CTCCCTGGCCAGCCTGAGGCTGTGGCCCGCCTCCGCGCCACCTTTGCTGGCCTCTACTCA
CTGGATGTGGGTGAAGAAGGGGACCAGGCCATCGCCGAGGCCCTTGCTGCCCCTAGCCGG
TTTGTGCTAAAGCCCCAGAGAGAGGGTGGAGGTAACAACCTATATGGGGAGGAAATGGTA
CAGGCCCTGAAACAGCTGAAGGACAGTGAGGAGAGGGCCTCCTACATCCTCATGGAGAAG
ATCGAACCTGAGCCTTTTGAGAATTGCCTGCTACGGCCTGGCAGCCCTGCCCGAGTGGTC
CAGTGCATTTCAGAGCTGGGCATCTTTGGGGTCTATGTCAGGCAGGAAAAGACACTCGTG
ATGAACAAGCACGTGGGGCATCTACTTCGAACCAAAGCCATCGAGCATGCAGATGGTGGT
GTGGCAGCGGGAGTGGCAGTCCTGGACAACCCATACCCTGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03917</identifier>
        <name>GSH_synth_ATP</name>
      </pfam>
      <pfam>
        <identifier>PF03199</identifier>
        <name>GSH_synthase</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione synthase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>magnesium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glycine binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to amino acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to cadmium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular amino acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to tumor necrosis factor</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nutrient levels</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000807</id>
      <name>Glutathione S-transferase Mu 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17311259</pubmed-id>
            <citation>Moore LE, Malats N, Rothman N, Real FX, Kogevinas M, Karami S, Garcia-Closas R, Silverman D, Chanock S, Welch R, Tardon A, Serra C, Carrato A, Dosemeci M, Garcia-Closas M: Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer. 2007 Jun 1;120(11):2452-8.</citation>
          </article>
          <article>
            <pubmed-id>17624589</pubmed-id>
            <citation>Sakoda LC, Blackston CR, Xue K, Doherty JA, Ray RM, Lin MG, Stalsberg H, Gao DL, Feng Z, Thomas DB, Chen C: Glutathione S-transferase M1 and P1 polymorphisms and risk of breast cancer and fibrocystic breast conditions in Chinese women. Breast Cancer Res Treat. 2008 May;109(1):143-55. Epub 2007 Jul 12.</citation>
          </article>
          <article>
            <pubmed-id>17381051</pubmed-id>
            <citation>Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M, Hassine LB, Ayed M, Elgaaied AB: The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol. 2006 Sep-Dec;33(5-6):529-35.</citation>
          </article>
          <article>
            <pubmed-id>17427177</pubmed-id>
            <citation>Contreras-Vergara CA, Valenzuela-Soto E, Garcia-Orozco KD, Sotelo-Mundo RR, Yepiz-Plascencia G: A Mu-class glutathione S-transferase from gills of the marine shrimp Litopenaeus vannamei: purification and characterization. J Biochem Mol Toxicol. 2007;21(2):62-7.</citation>
          </article>
          <article>
            <pubmed-id>17372252</pubmed-id>
            <citation>Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M: An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):559-65.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09488" source="Swiss-Prot">
    <name>Glutathione S-transferase Mu 1</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTM1</gene-name>
    <locus>1p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.67</theoretical-pi>
    <molecular-weight>25711.555</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4632</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTM1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X08020</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31924</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P09488</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTM1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-mu 1</synonym>
      <synonym>GST HB subunit 4</synonym>
      <synonym>GST1</synonym>
      <synonym>GSTM1-1</synonym>
      <synonym>GSTM1a-1a</synonym>
      <synonym>GSTM1b-1b</synonym>
      <synonym>GTH4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037080|Glutathione S-transferase Mu 1
MPMILGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNL
PYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQTMDNHMQLGMICYNPEF
EKLKPKYLEELPEKLKLYSEFLGKRPWFAGNKITFVDFLVYDVLDLHRIFEPKCLDAFPN
LKDFISRFEGLEKISAYMKSSRFLPRPVFSKMAVWGNK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020484|Glutathione S-transferase Mu 1 (GSTM1)
ATGCCCATGATACTGGGGTACTGGGACATCCGCGGGCTGGCCCACGCCATCCGCCTGCTC
CTGGAATACACAGACTCAAGCTATGAGGAAAAGAAGTACACGATGGGGGACGCTCCTGAT
TATGACAGAAGCCAGTGGCTGAATGAAAAATTCAAGCTGGGCCTGGACTTTCCCAATCTG
CCCTACTTGATTGATGGGGCTCACAAGATCACCCAGAGCAACGCCATCTTGTGCTACATT
GCCCGCAAGCACAACCTGTGTGGGGAGACAGAAGAGGAGAAGATTCGTGTGGACATTTTG
GAGAACCAGACCATGGACAACCATATGCAGCTGGGCATGATCTGCTACAATCCAGAATTT
GAGAAACTGAAGCCAAAGTACTTGGAGGAACTCCCTGAAAAGCTAAAGCTCTACTCAGAG
TTTCTGGGGAAGCGGCCATGGTTTGCAGGAAACAAGATCACTTTTGTAGATTTTCTCGTC
TATGATGTCCTTGACCTCCACCGTATATTTGAGCCCAAGTGCTTGGACGCCTTCCCAAAT
CTGAAGGACTTCATCTCCCGCTTTGAGGGCTTGGAGAAGATCTCTGCCTACATGAAGTCC
AGCCGCTTCCTCCCAAGACCTGTGTTCTCAAAGATGGCTGTCTGGGGCAACAAGTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitrobenzene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular detoxification of nitrogen compound</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000808</id>
      <name>Glutathione S-transferase kappa 1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>14709161</pubmed-id>
            <citation>Robinson A, Huttley GA, Booth HS, Board PG: Modelling and bioinformatics studies of the human Kappa-class glutathione transferase predict a novel third glutathione transferase family with similarity to prokaryotic 2-hydroxychromene-2-carboxylate isomerases. Biochem J. 2004 May 1;379(Pt 3):541-52.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9Y2Q3" source="Swiss-Prot">
    <name>Glutathione S-transferase kappa 1</name>
    <general-function>Receptor binding</general-function>
    <specific-function>Significant glutathione conjugating activity is found only with the model substrate, 1-chloro-2,4-dinitrobenzene (CDNB).</specific-function>
    <gene-name>GSTK1</gene-name>
    <locus>-</locus>
    <cellular-location>Peroxisome</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.69</theoretical-pi>
    <molecular-weight>25496.625</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:16906</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTK1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AY520571</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>41351794</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9Y2Q3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTK1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase subunit 13</synonym>
      <synonym>GST 13-13</synonym>
      <synonym>GST class-kappa</synonym>
      <synonym>GSTK1-1</synonym>
      <synonym>hGSTK1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037081|Glutathione S-transferase kappa 1
MGPLPRTVELFYDVLSPYSWLGFEILCRYQNIWNINLQLRPSLITGIMKDSGNKPPGLLP
RKGLYMANDLKLLRHHLQIPIHFPKDFLSVMLEKGSLSAMRFLTAVNLEHPEMLEKASRE
LWMRVWSRNEDITEPQSILAAAEKAGMSAEQAQGLLEKIATPKVKNQLKETTEAACRYGA
FGLPITVAHVDGQTHMLFGSDRMELLAHLLGEKWMGPIPPAVNARL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016214|Glutathione S-transferase kappa 1 (GSTK1)
ATGGGGCCCCTGCCGCGCACCGTGGAGCTCTTCTATGACGTGCTGTCCCCCTACTCCTGG
CTGGGCTTCGAGATCCTGTGCCGGTATCAGAATATCTGGAACATCAACCTGCAGTTGCGG
CCCAGCCTCATAACAGGGATCATGAAAGACAGTGGAAACAAGCCTCCAGGTCTGCTTCCC
CGCAAAGGACTATACATGGCAAATGACTTAAAGCTCCTGAGACACCATCTCCAGATTCCC
ATCCACTTCCCCAAGGATTTCTTGTCTGTGATGCTTGAAAAAGGAAGTTTGTCTGCCATG
CGTTTCCTCACCGCCGTGAACTTGGAGCATCCAGAGATGCTGGAGAAAGCGTCCCGGGAG
CTGTGGATGCGCGTCTGGTCAAGGGTGAGTGTGGGGCTCTGGGAATCCTCTGGGAGGACC
TTGGATGACTTTCTGACCTTCCCCAGGCACGTTTTCAGGGTCATGATCCTGCCCCCGCCC
GGGGGATCTACTGTCCTCCCAGTCACACCCCTCTCCCCGCACCGCCTTCCTGCTGTCTTC
TCTTCTTCCCAGAATGAAGACATCACCGAGCCGCAGAGCATCCTGGCGGCTGCAGAGAAG
GCTGGTATGTCTGCAGAACAAGCCCAGGGACTTCTGGAAAAGATCGCAACGCCAAAGGTG
AAGAACCAGCTCAAGGAGACCACTGAGGCAGCCTGCAGATACGGAGCCTTTGGGCTGCCC
ATCACCGTGGCCCATGTGGATGGCCAAACCCACATGTTATTTGGCTCTGACCGGATGGAG
CTGCTGGCGCACCTGCTGGGAGAGAAGTGGATGGGCCCTATACCTCCAGCCGTGAATGCC
AGACTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF01323</identifier>
        <name>DSBA</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>peroxisome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial inner membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein disulfide oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000809</id>
      <name>Glutathione S-transferase A3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>9480897</pubmed-id>
            <citation>Board PG: Identification of cDNAs encoding two human alpha class glutathione transferases (GSTA3 and GSTA4) and the heterologous expression of GSTA4-4. Biochem J. 1998 Mar 1;330 ( Pt 2):827-31.</citation>
          </article>
          <article>
            <pubmed-id>8910329</pubmed-id>
            <citation>McHugh TE, Atkins WM, Racha JK, Kunze KL, Eaton DL: Binding of the aflatoxin-glutathione conjugate to mouse glutathione S-transferase A3-3 is saturated at only one ligand per dimer. J Biol Chem. 1996 Nov 1;271(44):27470-4.</citation>
          </article>
          <article>
            <pubmed-id>10085232</pubmed-id>
            <citation>McDonagh PD, Judah DJ, Hayes JD, Lian LY, Neal GE, Wolf CR, Roberts GC: Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione S-transferases. Biochem J. 1999 Apr 1;339 ( Pt 1):95-101.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16772" source="Swiss-Prot">
    <name>Glutathione S-transferase A3</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Catalyzes isomerization reactions that contribute to the biosynthesis of steroid hormones. Efficiently catalyze obligatory double-bond isomerizations of delta(5)-androstene-3,17-dione and delta(5)-pregnene-3,20-dione, precursors to testosterone and progesterone, respectively.</specific-function>
    <gene-name>GSTA3</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.69</theoretical-pi>
    <molecular-weight>25301.355</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4628</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L13275</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>951352</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16772</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase A3-3</synonym>
      <synonym>GST class-alpha member 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001614|Glutathione S-transferase A3
MAGKPKLHYFNGRGRMEPIRWLLAAAGVEFEEKFIGSAEDLGKLRNDGSLMFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYTEGMADLNEMILLLPLCRPEEKDAK
IALIKEKTKSRYFPAFEKVLQSHGQDYLVGNKLSRADISLVELLYYVEELDSSLISNFPL
LKALKTRISNLPTVKKFLQPGSPRKPPADAKALEEARKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010569|Glutathione S-transferase A3 (GSTA3)
ATGGCAGGGAAGCCCAAGCTTCACTACTTCAATGGACGGGGCAGAATGGAGCCCATCCGG
TGGCTCTTGGCTGCAGCTGGAGTGGAGTTTGAAGAGAAATTTATAGGATCTGCAGAAGAT
TTGGGAAAGTTAAGAAATGATGGGAGTTTGATGTTCCAGCAAGTACCAATGGTTGAGATT
GATGGGATGAAGTTGGTACAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
CTCTACGGGAAAGACATAAAGGAGAGAGCCCTAATTGATATGTATACAGAAGGTATGGCA
GATTTGAATGAAATGATCCTTCTTCTGCCCTTATGTCGACCTGAGGAAAAAGATGCCAAG
ATTGCCTTGATCAAAGAGAAAACAAAAAGTCGCTATTTCCCTGCCTTCGAAAAAGTGTTA
CAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTAGCCTG
GTGGAACTTCTCTACTATGTGGAAGAGCTTGACTCCAGCCTTATCTCCAACTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTACAGCCT
GGCAGCCCAAGGAAGCCTCCCGCAGATGCAAAAGCTTTAGAAGAAGCCAGAAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000810</id>
      <name>Glutathione S-transferase Mu 3</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17372252</pubmed-id>
            <citation>Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M: An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):559-65.</citation>
          </article>
          <article>
            <pubmed-id>17617661</pubmed-id>
            <citation>Moore LE, Brennan P, Karami S, Hung RJ, Hsu C, Boffetta P, Toro J, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Welch R, Chanock S, Rothman N, Chow WH: Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis. 2007 Sep;28(9):1960-4. Epub 2007 Jul 7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P21266" source="Swiss-Prot">
    <name>Glutathione S-transferase Mu 3</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. May govern uptake and detoxification of both endogenous compounds and xenobiotics at the testis and brain blood barriers.</specific-function>
    <gene-name>GSTM3</gene-name>
    <locus>1p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.19</theoretical-pi>
    <molecular-weight>26559.32</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4635</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTM3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J05459</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306820</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P21266</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTM3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-mu 3</synonym>
      <synonym>GST5</synonym>
      <synonym>GSTM3-3</synonym>
      <synonym>hGSTM3-3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010570|Glutathione S-transferase Mu 3
MSCESSMVLGYWDIRGLAHAIRLLLEFTDTSYEEKRYTCGEAPDYDRSQWLDVKFKLDLD
FPNLPYLLDGKNKITQSNAILRYIARKHNMCGETEEEKIRVDIIENQVMDFRTQLIRLCY
SSDHEKLKPQYLEELPGQLKQFSMFLGKFSWFAGEKLTFVDFLTYDILDQNRIFDPKCLD
EFPNLKAFMCRFEALEKIAAYLQSDQFCKMPINNKMAQWGNKPVC</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010571|Glutathione S-transferase Mu 3 (GSTM3)
ATGTCGTGCGAGTCGTCTATGGTTCTCGGGTACTGGGATATTCGTGGGCTGGCGCACGCC
ATCCGCCTGCTCCTGGAGTTCACGGATACCTCTTATGAGGAGAAACGGTACACGTGCGGG
GAAGCTCCTGACTATGATCGAAGCCAATGGCTGGATGTGAAATTCAAGCTAGACCTGGAC
TTTCCTAATCTGCCCTACCTCCTGGATGGGAAGAACAAGATCACCCAGAGCAATGCCATC
TTGCGCTACATCGCTCGCAAGCACAACATGTGTGGTGAGACTGAAGAAGAAAAGATTCGA
GTGGACATCATAGAGAACCAAGTAATGGATTTCCGCACACAACTGATAAGGCTCTGTTAC
AGCTCTGACCACGAAAAACTGAAGCCTCAGTACTTGGAAGAGCTACCTGGACAACTGAAA
CAATTCTCCATGTTTCTGGGGAAATTCTCATGGTTTGCCGGGGAAAAGCTCACCTTTGTG
GATTTTCTCACCTATGATATCTTGGATCAGAACCGTATATTTGACCCCAAGTGCCTGGAT
GAGTTCCCAAACCTGAAGGCTTTCATGTGCCGTTTTGAGGCTTTGGAGAAAATCGCTGCC
TACTTACAGTCTGATCAGTTCTGCAAGATGCCCATCAACAACAAGATGGCCCAGTGGGGC
AACAAGCCTGTATGCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sperm fibrous sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular detoxification of nitrogen compound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>establishment of blood-nerve barrier</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitrobenzene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estrogen</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000811</id>
      <name>Glutathione S-transferase A4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17553661</pubmed-id>
            <citation>Gallagher EP, Huisden CM, Gardner JL: Transfection of HepG2 cells with hGSTA4 provides protection against 4-hydroxynonenal-mediated oxidative injury. Toxicol In Vitro. 2007 Dec;21(8):1365-72. Epub 2007 Apr 27.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15217" source="Swiss-Prot">
    <name>Glutathione S-transferase A4</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. This isozyme has a high catalytic efficiency with 4-hydroxyalkenals such as 4-hydroxynonenal (4-HNE).</specific-function>
    <gene-name>GSTA4</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.72</theoretical-pi>
    <molecular-weight>25703.905</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4629</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y13047</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2597924</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15217</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase A4-4</synonym>
      <synonym>GST class-alpha member 4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001618|Glutathione S-transferase A4
MAARPKLHYPNGRGRMESVRWVLAAAGVEFDEEFLETKEQLYKLQDGNHLLFQQVPMVEI
DGMKLVQTRSILHYIADKHNLFGKNLKERTLIDMYVEGTLDLLELLIMHPFLKPDDQQKE
VVNMAQKAIIRYFPVFEKILRGHGQSFLVGNQLSLADVILLQTILALEEKIPNILSAFPF
LQEYTVKLSNIPTIKRFLEPGSKKKPPPDEIYVRTVYNIFRP</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016216|Glutathione S-transferase A4 (GSTA4)
ATGGCAGCAAGGCCCAAGCTCCACTATCCCAACGGAAGAGGCCGGATGGAGTCCGTGAGA
TGGGTTTTAGCTGCCGCCGGAGTCGAGTTTGATGAAGAATTTCTGGAAACAAAAGAACAG
TTGTACAAGTTGCAGGATGGTAACCACCTGCTGTTCCAACAAGTGCCCATGGTTGAAATT
GACGGGATGAAGTTGGTACAGACCCGAAGCATTCTCCACTACATAGCAGACAAGCACAAT
CTCTTTGGCAAGAACCTCAAGGAGAGAACCCTGATTGACATGTACGTGGAGGGGACACTG
GATCTGCTGGAACTGCTTATCATGCATCCTTTCTTAAAACCAGATGATCAGCAAAAGGAA
GTGGTTAACATGGCCCAGAAGGCTATAATTAGATACTTTCCTGTGTTTGAAAAGATTTTA
AGGGGTCACGGACAAAGCTTTCTTGTTGGTAATCAGCTGAGCCTTGCAGATGTGATTTTA
CTCCAAACCATTTTAGCTCTAGAAGAGAAAATTCCTAATATCCTGTCTGCATTTCCTTTC
CTCCAGGAATACACAGTGAAACTAAGTAATATCCCTACAATTAAGAGATTCCTTGAACCT
GGCAGCAAGAAGAAGCCTCCCCCTGATGAAATTTATGTGAGAACCGTCTACAACATCTTT
AGGCCATAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000812</id>
      <name>Glutathione S-transferase Mu 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>7974294</pubmed-id>
            <citation>Cantlay AM, Smith CA, Wallace WA, Yap PL, Lamb D, Harrison DJ: Heterogeneous expression and polymorphic genotype of glutathione S-transferases in human lung. Thorax. 1994 Oct;49(10):1010-4.</citation>
          </article>
          <article>
            <pubmed-id>10905636</pubmed-id>
            <citation>Beuckmann CT, Fujimori K, Urade Y, Hayaishi O: Identification of mu-class glutathione transferases M2-2 and M3-3 as cytosolic prostaglandin E synthases in the human brain. Neurochem Res. 2000 May;25(5):733-8.</citation>
          </article>
          <article>
            <pubmed-id>15796179</pubmed-id>
            <citation>Efferth T, Volm M: Glutathione-related enzymes contribute to resistance of tumor cells and low toxicity in normal organs to artesunate. In Vivo. 2005 Jan-Feb;19(1):225-32.</citation>
          </article>
          <article>
            <pubmed-id>10592235</pubmed-id>
            <citation>Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE: The Protein Data Bank. Nucleic Acids Res. 2000 Jan 1;28(1):235-42.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q03013" source="Swiss-Prot">
    <name>Glutathione S-transferase Mu 4</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Active on 1-chloro-2,4-dinitrobenzene.</specific-function>
    <gene-name>GSTM4</gene-name>
    <locus>1p13.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.69</theoretical-pi>
    <molecular-weight>25561.095</molecular-weight>
    <chromosome-location>1</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4636</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTM4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M96234</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306819</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q03013</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTM4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-mu 4</synonym>
      <synonym>GST-Mu2</synonym>
      <synonym>GSTM4-4</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037082|Glutathione S-transferase Mu 4
MSMTLGYWDIRGLAHAIRLLLEYTDSSYEEKKYTMGDAPDYDRSQWLNEKFKLGLDFPNL
PYLIDGAHKITQSNAILCYIARKHNLCGETEEEKIRVDILENQAMDVSNQLARVCYSPDF
EKLKPEYLEELPTMMQHFSQFLGKRPWFVGDKITFVDFLAYDVLDLHRIFEPNCLDAFPN
LKDFISRFEGLEKISAYMKSSRFLPKPLYTRVAVWGNK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019013|Glutathione S-transferase Mu 4 (GSTM4)
ATGTCCATGACACTGGGGTACTGGGACATCCGCGGGCTGGCCCACGCCATCCGCCTGCTC
CTGGAATACACAGACTCAAGCTACGAGGAAAAGAAGTATACGATGGGGGACGCTCCTGAC
TATGACAGAAGCCAGTGGCTGAATGAAAAATTCAAGCTGGGCCTGGACTTTCCCAATCTG
CCCTACTTGATTGATGGGGCTCACAAGATCACCCAGAGCAACGCCATCCTGTGCTACATT
GCCCGCAAGCACAACCTGTGTGGGGAGACAGAAGAGGAGAAGATTCGTGTGGACATTTTG
GAGAACCAGGCTATGGACGTCTCCAATCAGCTGGCCAGAGTCTGCTACAGCCCTGACTTT
GAGAAACTGAAGCCAGAATACTTGGAGGAACTTCCTACAATGATGCAGCACTTCTCACAG
TTCCTGGGGAAGAGGCCATGGTTTGTTGGAGACAAGATCACCTTTGTAGATTTCCTCGCC
TATGATGTCCTTGACCTCCACCGTATATTTGAGCCCAACTGCTTGGACGCCTTTCCAAAT
CTGAAGGACTTCATCTCCCGCTTTGAGGGCTTGGAGAAGATCTCTGCCTACATGAAGTCC
AGCCGCTTCCTCCCAAAACCTCTGTACACAAGGGTGGCTGTCTGGGGCAACAAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitrobenzene metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000813</id>
      <name>Glutathione S-transferase A5</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>10085232</pubmed-id>
            <citation>McDonagh PD, Judah DJ, Hayes JD, Lian LY, Neal GE, Wolf CR, Roberts GC: Determinants of specificity for aflatoxin B1-8,9-epoxide in alpha-class glutathione S-transferases. Biochem J. 1999 Apr 1;339 ( Pt 1):95-101.</citation>
          </article>
          <article>
            <pubmed-id>9331086</pubmed-id>
            <citation>McLeod R, Ellis EM, Arthur JR, Neal GE, Judah DJ, Manson MM, Hayes JD: Protection conferred by selenium deficiency against aflatoxin B1 in the rat is associated with the hepatic expression of an aldo-keto reductase and a glutathione S-transferase subunit that metabolize the mycotoxin. Cancer Res. 1997 Oct 1;57(19):4257-66.</citation>
          </article>
          <article>
            <pubmed-id>12076520</pubmed-id>
            <citation>Kazi S, Ellis EM: Expression of rat liver glutathione-S-transferase GSTA5 in cell lines provides increased resistance to alkylating agents and toxic aldehydes. Chem Biol Interact. 2002 May 20;140(2):121-35.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q7RTV2" source="Swiss-Prot">
    <name>Glutathione S-transferase A5</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function/>
    <gene-name>GSTA5</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.37</theoretical-pi>
    <molecular-weight>25721.725</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:19662</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>BK000212</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>23197582</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q7RTV2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase A5-5</synonym>
      <synonym>GST class-alpha member 5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010572|Glutathione S-transferase A5
MAEKPKLHYSNARGSMESIRWLLAAAGVELEEKFLESAEDLDKLRNDGSLLFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDMKERALIDMYTEGIVDLTEMILLLLICQPEERDAK
TALVKEKIKNRYFPAFEKVLKSHRQDYLVGNKLSWADIHLVELFYYVEELDSSLISSFPL
LKALKTRISNLPTVKKFLQPGSQRKPPMDEKSLEEARKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010573|Glutathione S-transferase A5 (GSTA5)
ATGGCAGAGAAGCCCAAGCTCCACTACTCCAATGCACGGGGCAGTATGGAGTCCATTCGG
TGGCTCCTGGCTGCAGCTGGAGTAGAGTTGGAAGAGAAATTTCTAGAATCTGCAGAAGAT
TTGGACAAGTTAAGAAATGATGGGAGTTTGCTGTTCCAGCAAGTACCAATGGTTGAGATT
GACGGGATGAAGCTGGTGCAGACCAGAGCCATTCTTAACTACATTGCCAGCAAATACAAC
CTTTATGGGAAAGACATGAAGGAGAGAGCCCTGATTGATATGTACACAGAAGGTATAGTA
GATTTGACTGAAATGATCCTTCTTCTGCTCATATGTCAACCAGAGGAAAGAGATGCCAAG
ACTGCCTTGGTCAAAGAGAAAATAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
AAGAGCCACAGACAAGACTACCTTGTTGGCAACAAGCTGAGCTGGGCTGACATTCACCTG
GTGGAACTTTTCTACTACGTGGAAGAGCTTGACTCGAGTCTTATCTCCAGCTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACGGTGAAGAAGTTTCTGCAGCCT
GGCAGCCAGAGAAAGCCTCCCATGGATGAGAAATCTTTAGAAGAAGCAAGGAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000814</id>
      <name>Glutathione S-transferase P</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17465221</pubmed-id>
            <citation>Ramachandran K, Navarro L, Gordian E, Das PM, Singal R: Methylation-mediated silencing of genes is not altered by selenium treatment of prostate cancer cells. Anticancer Res. 2007 Mar-Apr;27(2):921-5.</citation>
          </article>
          <article>
            <pubmed-id>17517071</pubmed-id>
            <citation>Kadokawa Y, Ohba K, Omagari K, Akazawa S, Hayashida K, Ohnita K, Takeshima F, Mizuta Y, Kohno S: Intracellular balance of oxidative stress and cytoprotective molecules in damaged interlobular bile ducts in autoimmune hepatitis and primary biliary cirrhosis: In situ detection of 8-hydroxydeoxyguanosine and glutathione-S-transferase-pi. Hepatol Res. 2007 Aug;37(8):620-7. Epub 2007 May 22.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09211" source="Swiss-Prot">
    <name>Glutathione S-transferase P</name>
    <general-function>S-nitrosoglutathione binding</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Regulates negatively CDK5 activity via p25/p35 translocation to prevent neurodegeneration.</specific-function>
    <gene-name>GSTP1</gene-name>
    <locus>11q13</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>5.3</theoretical-pi>
    <molecular-weight>23355.625</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4638</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTP1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M24485</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>31946</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P09211</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTP1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>FAEES3</synonym>
      <synonym>GST class-pi</synonym>
      <synonym>GST3</synonym>
      <synonym>GSTP1-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010574|Glutathione S-transferase P
MPPYTVVYFPVRGRCAALRMLLADQGQSWKEEVVTVETWQEGSLKASCLYGQLPKFQDGD
LTLYQSNTILRHLGRTLGLYGKDQQEAALVDMVNDGVEDLRCKYISLIYTNYEAGKDDYV
KALPGQLKPFETLLSQNQGGKTFIVGDQISFADYNLLDLLLIHEVLAPGCLDAFPLLSAY
VGRLSARPKLKAFLASPEYVNLPINGNGKQ</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010575|Glutathione S-transferase P (GSTP1)
ATGCCGCCCTACACCGTGGTCTATTTCCCAGTTCGAGGCCGCTGCGCGGCCCTGCGCATG
CTGCTGGCAGATCAGGGCCAGAGCTGGAAGGAGGAGGTGGTGACCGTGGAGACGTGGCAG
GAGGGCTCACTCAAAGCCTCCTGCCTATACGGGCAGCTCCCCAAGTTCCAGGACGGAGAC
CTCACCCTGTACCAGTCCAATACCATCCTGCGTCACCTGGGCCGCACCCTTGGGCTCTAT
GGGAAGGACCAGCAGGAGGCAGCCCTGGTGGACATGGTGAATGACGGCGTGGAGGACCTC
CGCTGCAAATACATCTCCCTCATCTACACCAACTATGAGGCGGGCAAGGATGACTATGTG
AAGGCACTGCCCGGGCAACTGAAGCCTTTTGAGACCCTGCTGTCCCAGAACCAGGGAGGC
AAGACCTTCATTGTGGGAGACCAGATCTCCTTCGCTGACTACAACCTGCTGGACTTGCTG
CTGATCCATGAGGTCCTAGCCCCTGGCTGCCTGGATGCGTTCCCCCTGCTCTCAGCATAT
GTGGGGCGCCTCAGTGCCCGGCCCAAGCTCAAGGCCTTCCTGGCCTCCCCTGAGTACGTG
AACCTCCCCATCAATGGCAACGGGAAACAGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>intracellular</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>TRAF2-GSTP1 complex</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>dinitrosyl-iron complex binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>JUN kinase binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>S-nitrosoglutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>nitric oxide binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>kinase regulator activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of interleukin-1 beta production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of stress-activated MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of MAP kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of JUN kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of leukocyte proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to lipopolysaccharide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of monocyte chemotactic protein-1 production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of extrinsic apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of nitric-oxide synthase biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>common myeloid progenitor cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of stress-activated MAPK cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of acute inflammatory response</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of tumor necrosis factor production</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of ERK1 and ERK2 cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of protein kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of tumor necrosis factor-mediated signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of fibroblast proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nitric oxide storage</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>central nervous system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of I-kappaB kinase/NF-kappaB signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of superoxide anion generation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of ERK1 and ERK2 cascade</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000815</id>
      <name>Glutathione S-transferase omega-1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17537474</pubmed-id>
            <citation>Tulayakul P, Dong KS, Li JY, Manabe N, Kumagai S: The effect of feeding piglets with the diet containing green tea extracts or coumarin on in vitro metabolism of aflatoxin B1 by their tissues. Toxicon. 2007 Sep 1;50(3):339-48. Epub 2007 Apr 22.</citation>
          </article>
          <article>
            <pubmed-id>17617905</pubmed-id>
            <citation>Harju TH, Peltoniemi MJ, Rytila PH, Soini Y, Salmenkivi KM, Board PG, Ruddock LW, Kinnula VL: Glutathione S-transferase omega in the lung and sputum supernatants of COPD patients. Respir Res. 2007 Jul 6;8:48.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P78417" source="Swiss-Prot">
    <name>Glutathione S-transferase omega-1</name>
    <general-function>Oxidoreductase activity</general-function>
    <specific-function>Exhibits glutathione-dependent thiol transferase and dehydroascorbate reductase activities. Has S-(phenacyl)glutathione reductase activity. Has also glutathione S-transferase activity. Participates in the biotransformation of inorganic arsenic and reduces monomethylarsonic acid (MMA) and dimethylarsonic acid.</specific-function>
    <gene-name>GSTO1</gene-name>
    <locus>10q25.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.54</theoretical-pi>
    <molecular-weight>27565.6</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:13312</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTO1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U90313</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2393722</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P78417</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTO1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione S-transferase omega 1-1</synonym>
      <synonym>Glutathione-dependent dehydroascorbate reductase</synonym>
      <synonym>GSTO 1-1</synonym>
      <synonym>GSTO-1</synonym>
      <synonym>GSTTLP28</synonym>
      <synonym>MMA(V) reductase</synonym>
      <synonym>Monomethylarsonic acid reductase</synonym>
      <synonym>S-(Phenacyl)glutathione reductase</synonym>
      <synonym>SPG-R</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001626|Glutathione S-transferase omega-1
MSGESARSLGKGSAPPGPVPEGSIRIYSMRFCPFAERTRLVLKAKGIRHEVININLKNKP
EWFFKKNPFGLVPVLENSQGQLIYESAITCEYLDEAYPGKKLLPDDPYEKACQKMILELF
SKVPSLVGSFIRSQNKEDYAGLKEEFRKEFTKLEEVLTNKKTTFFGGNSISMIDYLIWPW
FERLEAMKLNECVDHTPKLKLWMAAMKEDPTVSALLTSEKDWQGFLELYLQNSPEACDYG
L</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016215|Glutathione S-transferase omega-1 (GSTO1)
ATGTCCGGGGAGTCAGCCAGGAGCTTGGGGAAGGGAAGCGCGCCCCCGGGGCCGGTCCCG
GAGGGCTCGATCCGCATCTACAGCATGAGGTTCTGCCCGTTTGCTGAGAGGACGCGTCTA
GTCCTGAAGGCCAAGGGAATCAGGCATGAAGTCATCAATATCAACCTGAAAAATAAGCCT
GAGTGGTTCTTTAAGAAAAATCCCTTTGGTCTGGTGCCAGTTCTGGAAAACAGTCAGGGT
CAGCTGATCTACGAGTCTGCCATCACCTGTGAGTACCTGGATGAAGCATACCCAGGGAAG
AAGCTGTTGCCGGATGACCCCTATGAGAAAGCTTGCCAGAAGATGATCTTAGAGTTGTTT
TCTAAGGTTCTGACTAATAAGAAGACGACCTTCTTTGGTGGCAATTCTATCTCTATGATT
GATTACCTCATCTGGCCCTGGTTTGAACGGCTGGAAGCAATGAAGTTAAATGAGTGTGTA
GACCACACTCCAAAACTGAAACTGTGGATGGCAGCCATGAAGGAAGATCCCACAGTCTCA
GCCCTGCTTACTAGTGAGAAAGACTGGCAAGGTTTCCTAGAGCTCTACTTACAGAACAGC
CCTGAGGCCTGTGACTATGGGCTCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF13417</identifier>
        <name>GST_N_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cell body</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basement membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>axon</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>myelin sheath</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nuclear membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione dehydrogenase (ascorbate) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>methylarsonate reductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-ascorbic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of ryanodine-sensitive calcium-release channel activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of skeletal muscle contraction by regulation of release of sequestered calcium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>methylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to arsenic-containing substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000816</id>
      <name>Glutathione peroxidase 1</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>2742004</pubmed-id>
            <citation>Destro-Bisol G, Spedini G: Anthropological survey on red cell glutathione peroxidase (GPX1) polymorphism in central western Africa: a tentative hypothesis on the interaction between GPX1*2 and Hb beta *S allelic products. Am J Phys Anthropol. 1989 Jun;79(2):217-24.</citation>
          </article>
          <article>
            <pubmed-id>16721761</pubmed-id>
            <citation>Liddell JR, Hoepken HH, Crack PJ, Robinson SR, Dringen R: Glutathione peroxidase 1 and glutathione are required to protect mouse astrocytes from iron-mediated hydrogen peroxide toxicity. J Neurosci Res. 2006 Aug 15;84(3):578-86.</citation>
          </article>
          <article>
            <pubmed-id>15679624</pubmed-id>
            <citation>Ursini F, Maiorino M: Native specific activity of glutathione peroxidase (GPx-1), phospholipid hydroperoxide glutathione peroxidase (PHGPx) and glutathione reductase (GR) does not differ between normo- and hypomotile human sperm samples. Int J Androl. 2005 Feb;28(1):61-2; author reply 63-4.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P07203" source="Swiss-Prot">
    <name>Glutathione peroxidase 1</name>
    <general-function>Sh3 domain binding</general-function>
    <specific-function>Protects the hemoglobin in erythrocytes from oxidative breakdown.</specific-function>
    <gene-name>GPX1</gene-name>
    <locus>3p21.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.5</theoretical-pi>
    <molecular-weight>22087.94</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4553</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>Y00433</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>577777</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P07203</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>Cellular glutathione peroxidase</synonym>
      <synonym>GPx-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037083|Glutathione peroxidase 1
MCAARLAAAAAAAQSVYAFSARPLAGGEPVSLGSLRGKVLLIENVASLUGTTVRDYTQMN
ELQRRLGPRGLVVLGFPCNQFGHQENAKNEEILNSLKYVRPGGGFEPNFMLFEKCEVNGA
GAHPLFAFLREALPAPSDDATALMTDPKLITWSPVCRNDVAWNFEKFLVGPDGVPLRRYS
RRFQTIDIEPDIEALLSQGPSCA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0020489|Glutathione peroxidase 1 (GPX1)
ATGTGTGCTGCTCGGCTAGCGGCGGCGGCGGCGGCGGCCCAGTCGGTGTATGCCTTCTCG
GCGCGCCCGCTGGCCGGCGGGGAGCCTGTGAGCCTGGGCTCCCTGCGGGGCAAGGTACTA
CTTATCGAGAATGTGGCGTCCCTCTGAGGCACCACGGTCCGGGACTACACCCAGATGAAC
GAGCTGCAGCGGCGCCTCGGACCCCGGGGCCTGGTGGTGCTCGGCTTCCCGTGCAACCAG
TTTGGGCATCAGGAGAACGCCAAGAACGAAGAGATTCTGAATTCCCTCAAGTACGTCCGG
CCTGGTGGTGGGTTCGAGCCCAACTTCATGCTCTTCGAGAAGTGCGAGGTGAACGGTGCG
GGGGCGCACCCTCTCTTCGCCTTCCTGCGGGAGGCCCTGCCAGCTCCCAGCGACGACGCC
ACCGCGCTTATGACCGACCCCAAGCTCATCACCTGGTCTCCGGTGTGTCGCAACGATGTT
GCCTGGAACTTTGAGAAGTTCCTGGTGGGCCCTGACGGTGTGCCCCTACGCAGGTACAGC
CGCCGCTTCCAGACCATTGACATCGAGCCTGACATCGAAGCCCTGCTGTCTCAAGGGCCC
AGCTGTGCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleus</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mitochondrial matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>phospholipid-hydroperoxide glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>selenium binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>SH3 domain binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to folic acid</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estradiol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of release of cytochrome c from mitochondria</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endothelial cell development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleotide catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of inflammatory response to antigenic stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to gamma radiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to hydrogen peroxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>interaction with symbiont</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>aging</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>triglyceride metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sensory perception of sound</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fat cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of mammary gland epithelial cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to selenium ion</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cysteine-type endopeptidase activity involved in apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intrinsic apoptotic signaling pathway in response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to symbiotic bacterium</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to nicotine</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of extrinsic apoptotic signaling pathway via death domain receptors</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>UV protection</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>temperature homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell redox homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>nucleobase-containing small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of proteasomal protein catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipid hydroperoxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>purine nucleobase metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of oxidative stress-induced intrinsic apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to glucose</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood vessel endothelial cell migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to toxic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heart contraction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hydrogen peroxide catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of gene expression, epigenetic</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>regulation of neuron apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of fibril organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of protein kinase B signaling</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vasodilation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>skeletal muscle tissue regeneration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to xenobiotic stimulus</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>angiogenesis involved in wound healing</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>myoblast proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein oxidation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipoxygenase pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>skeletal muscle fiber development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000817</id>
      <name>Glutathione peroxidase 2</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17510403</pubmed-id>
            <citation>Walshe J, Serewko-Auret MM, Teakle N, Cameron S, Minto K, Smith L, Burcham PC, Russell T, Strutton G, Griffin A, Chu FF, Esworthy S, Reeve V, Saunders NA: Inactivation of glutathione peroxidase activity contributes to UV-induced squamous cell carcinoma formation. Cancer Res. 2007 May 15;67(10):4751-8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P18283" source="Swiss-Prot">
    <name>Glutathione peroxidase 2</name>
    <general-function>Glutathione peroxidase activity</general-function>
    <specific-function>Could play a major role in protecting mammals from the toxicity of ingested organic hydroperoxides. Tert-butyl hydroperoxide, cumene hydroperoxide and linoleic acid hydroperoxide but not phosphatidycholine hydroperoxide, can act as acceptors.</specific-function>
    <gene-name>GPX2</gene-name>
    <locus>14q24.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.84</theoretical-pi>
    <molecular-weight>21953.835</molecular-weight>
    <chromosome-location>14</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4554</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X53463</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4902773</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P18283</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>Gastrointestinal glutathione peroxidase</synonym>
      <synonym>Glutathione peroxidase-gastrointestinal</synonym>
      <synonym>Glutathione peroxidase-related protein 2</synonym>
      <synonym>GPRP-2</synonym>
      <synonym>GPx-2</synonym>
      <synonym>GPx-GI</synonym>
      <synonym>GSHPx-GI</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010576|Glutathione peroxidase 2
MAFIAKSFYDLSAISLDGEKVDFNTFRGRAVLIENVASLUGTTTRDFTQLNELQCRFPRR
LVVLGFPCNQFGHQENCQNEEILNSLKYVRPGGGYQPTFTLVQKCEVNGQNEHPVFAYLK
DKLPYPYDDPFSLMTDPKLIIWSPVRRSDVAWNFEKFLIGPEGEPFRRYSRTFPTINIEP
DIKRLLKVAI</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010577|Glutathione peroxidase 2 (GPX2)
ATGGCTTTCATTGCCAAGTCCTTCTATGACCTCAGTGCCATCAGCCTGGATGGGGAGAAG
GTAGATTTCAATACGTTCCGGGGCAGGGCCGTGCTGATTGAGAATGTGGCTTCGCTCTGA
GGCACAACCACCCGGGACTTCACCCAGCTCAACGAGCTGCAATGCCGCTTTCCCAGGCGC
CTGGTGGTCCTTGGCTTCCCTTGCAACCAATTTGGACATCAGGAGAACTGTCAGAATGAG
GAGATCCTGAACAGTCTCAAGTATGTCCGTCCTGGGGGTGGATACCAGCCCACCTTCACC
CTTGTCCAAAAATGTGAGGTGAATGGGCAGAACGAGCATCCTGTCTTCGCCTACCTGAAG
GACAAGCTCCCCTACCCTTATGATGACCCATTTTCCCTCATGACCGATCCCAAGCTCATC
ATTTGGAGCCCTGTGCGCCGCTCAGATGTGGCCTGGAACTTTGAGAAGTTCCTCATAGGG
CCGGAGGGAGAGCCCTTCCGACGCTACAGCCGCACCTTCCCAACCATCAACATTGAGCCT
GACATCAAGCGCCTCCTTAAAGTTGCCATATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>gene expression</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transcription initiation from RNA polymerase II promoter</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000818</id>
      <name>Glutathione S-transferase theta-1</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17381051</pubmed-id>
            <citation>Ouerhani S, Tebourski F, Slama MR, Marrakchi R, Rabeh M, Hassine LB, Ayed M, Elgaaied AB: The role of glutathione transferases M1 and T1 in individual susceptibility to bladder cancer in a Tunisian population. Ann Hum Biol. 2006 Sep-Dec;33(5-6):529-35.</citation>
          </article>
          <article>
            <pubmed-id>17372252</pubmed-id>
            <citation>Schwartzbaum JA, Ahlbom A, Lonn S, Warholm M, Rannug A, Auvinen A, Christensen HC, Henriksson R, Johansen C, Lindholm C, Malmer B, Salminen T, Schoemaker MJ, Swerdlow AJ, Feychting M: An international case-control study of glutathione transferase and functionally related polymorphisms and risk of primary adult brain tumors. Cancer Epidemiol Biomarkers Prev. 2007 Mar;16(3):559-65.</citation>
          </article>
          <article>
            <pubmed-id>17617661</pubmed-id>
            <citation>Moore LE, Brennan P, Karami S, Hung RJ, Hsu C, Boffetta P, Toro J, Zaridze D, Janout V, Bencko V, Navratilova M, Szeszenia-Dabrowska N, Mates D, Mukeria A, Holcatova I, Welch R, Chanock S, Rothman N, Chow WH: Glutathione S-transferase polymorphisms, cruciferous vegetable intake and cancer risk in the Central and Eastern European Kidney Cancer Study. Carcinogenesis. 2007 Sep;28(9):1960-4. Epub 2007 Jul 7.</citation>
          </article>
          <article>
            <pubmed-id>17653748</pubmed-id>
            <citation>Gawecki W, Kostrzewska-Poczekaj M, Gajecka M, Milecki P, Szyfter K, Szyfter W: The role of genetic factor in etiopathogenesis of squamous cell carcinoma of the head and neck in young adults. Eur Arch Otorhinolaryngol. 2007 Dec;264(12):1459-65. Epub 2007 Jul 26.</citation>
          </article>
          <article>
            <pubmed-id>17333241</pubmed-id>
            <citation>Jonsson LS, Broberg K, Bergendorf U, Axmon A, Littorin M, Jonsson BA: Levels of 2-thiothiazolidine-4-carboxylic acid (TTCA) and effect modification of polymorphisms of glutathione-related genes in vulcanization workers in the southern Sweden rubber industries. Int Arch Occup Environ Health. 2007 Jul;80(7):589-98. Epub 2007 Feb 28.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P30711" source="Swiss-Prot">
    <name>Glutathione S-transferase theta-1</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles. Acts on 1,2-epoxy-3-(4-nitrophenoxy)propane, phenethylisothiocyanate 4-nitrobenzyl chloride and 4-nitrophenethyl bromide. Displays glutathione peroxidase activity with cumene hydroperoxide.</specific-function>
    <gene-name>GSTT1</gene-name>
    <locus>22q11.23</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.6</theoretical-pi>
    <molecular-weight>27334.755</molecular-weight>
    <chromosome-location>22</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4641</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTT1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>X79389</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>510905</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P30711</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTT1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>Glutathione transferase T1-1</synonym>
      <synonym>GST class-theta-1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037084|Glutathione S-transferase theta-1
MGLELYLDLLSQPCRAVYIFAKKNDIPFELRIVDLIKGQHLSDAFAQVNPLKKVPALKDG
DFTLTESVAILLYLTRKYKVPDYWYPQDLQARARVDEYLAWQHTTLRRSCLRALWHKVMF
PVFLGEPVSPQTLAATLAELDVTLQLLEDKFLQNKAFLTGPHISLADLVAITELMHPVGA
GCQVFEGRPKLATWRQRVEAAVGEDLFQEAHEVILKAKDFPPADPTIKQKLMPWVLAMIR
</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010578|Glutathione S-transferase theta-1 (GSTT1)
ATGGGCCTGGAGCTGTACCTGGACCTGCTGTCCCAGCCCTGCCGCGCTGTTTACATCTTT
GCCAAGAAGAACGACATTCCCTTCGAGCTGCGCATCGTGGATCTGATTAAAGGTCAGCAC
TTAAGCGATGCCTTTGCCCAGGTGAACCCCCTCAAGAAGGTGCCAGCCTTGAAGGACGGG
GACTTCACCTTGACGGAGAGTGTGGCCATCCTGCTCTACCTGACGCGCAAATATAAGGTC
CCTGACTACTGGTACCCTCAGGACCTGCAGGCCCGTGCCCGTGTGGATGAGTACCTGGCA
TGGCAGCACACGACTCTGCGGAGAAGCTGCCTCCGGGCCTTGTGGCATAAGGTGATGTTC
CCTGTTTTCCTGGGTGAGCCAGTATCTCCCCAGACACTGGCAGCCACCCTGGCAGAGTTG
GATGTGACCCTGCAGTTGCTCGAGGACAAGTTCCTCCAGAACAAGGCCTTCCTTACTGGT
CCTCACATCTCCTTAGCTGACCTCGTAGCCATCACGGAGCTGATGCATCCCGTGGGTGCT
GGCTGCCAAGTCTTCGAAGGCCGACCCAAGCTGGCCACATGGCGGCAGCGCGTGGAGGCA
GCAGTGGGGGAGGACCTCTTCCAGGAGGCCCATGAGGTCATTCTGAAGGCCAAGGACTTC
CCACCTGCAGACCCCACCATAAAGCAGAAGCTGATGCCCTGGGTGCTGGCCATGATCCGG
TGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000819</id>
      <name>Maleylacetoacetate isomerase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>12052898</pubmed-id>
            <citation>Fernandez-Canon JM, Baetscher MW, Finegold M, Burlingame T, Gibson KM, Grompe M: Maleylacetoacetate isomerase (MAAI/GSTZ)-deficient mice reveal a glutathione-dependent nonenzymatic bypass in tyrosine catabolism. Mol Cell Biol. 2002 Jul;22(13):4943-51.</citation>
          </article>
          <article>
            <pubmed-id>4019417</pubmed-id>
            <citation>Hagedorn SR, Chapman PJ: Glutathione-independent maleylacetoacetate isomerase in gram-positive bacteria. J Bacteriol. 1985 Aug;163(2):803-5.</citation>
          </article>
          <article>
            <pubmed-id>15277241</pubmed-id>
            <citation>Lim CE, Matthaei KI, Blackburn AC, Davis RP, Dahlstrom JE, Koina ME, Anders MW, Board PG: Mice deficient in glutathione transferase zeta/maleylacetoacetate isomerase exhibit a range of pathological changes and elevated expression of alpha, mu, and pi class glutathione transferases. Am J Pathol. 2004 Aug;165(2):679-93.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O43708" source="Swiss-Prot">
    <name>Maleylacetoacetate isomerase</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>Bifunctional enzyme showing minimal glutathione-conjugating activity with ethacrynic acid and 7-chloro-4-nitrobenz-2-oxa-1,3-diazole and maleylacetoacetate isomerase activity. Has also low glutathione peroxidase activity with T-butyl and cumene hydroperoxides. Is able to catalyze the glutathione dependent oxygenation of dichloroacetic acid to glyoxylic acid.</specific-function>
    <gene-name>GSTZ1</gene-name>
    <locus>14q24.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>8.71</theoretical-pi>
    <molecular-weight>24212.005</molecular-weight>
    <chromosome-location>14</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4643</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTZ1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ001838</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2832731</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O43708</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MAAI_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>5.2.1.2</synonym>
      <synonym>Glutathione S-transferase zeta 1</synonym>
      <synonym>GSTZ1-1</synonym>
      <synonym>MAAI</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037085|Maleylacetoacetate isomerase
MQAGKPILYSYFRSSCSWRVRIALALKGIDYKTVPINLIKDRGQQFSKDFQALNPMKQVP
TLKIDGITIHQSLAIIEYLEEMRPTPRLLPQDPKKRASVRMISDLIAGGIQPLQNLSVLK
QVGEEMQLTWAQNAITCGFNALEQILQSTAGIYCVGDEVTMADLCLVPQVANAERFKVDL
TPYPTISSINKRLLVLEAFQVSHPCRQPDTPTELRA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016217|Maleylacetoacetate isomerase (GSTZ1)
ATGAAGCAGGTGCCAACCCTGAAGATTGATGGAATCACCATTCACCAGTCACTGGCCATC
ATTGAGTATCTAGAGGAGATGCGTCCCACTCCGCGACTTCTGCCTCAGGACCCAAAGAAG
AGGGCCAGCGTGCGTATGATTTCTGACCTCATCGCTGGTGGCATCCAGCCCCTGCAGAAC
CTGTCTGTCCTGAAGCAAGTGGGAGAGGAGATGCAGCTGACCTGGGCCCAGAACGCCATC
ACTTGTGGCTTTAACGCCCTGGAGCAGATCCTACAGAGCACAGCGGGCATATACTGTGTA
GGAGACGAGGTGACCATGGCTGATCTGTGCTTGGTGCCTCAGGTGGCAAATGCTGAAAGA
TTCAAGGTGGATCTCACCCCCTACCCTACCATCAGCTCCATCAACAAGAGGCTGCTGGTC
TTGGAGGCCTTCCAGGTGTCTCACCCCTGCCGGCAGCCAGATACACCCACTGAGCTGAGG
GCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF13417</identifier>
        <name>GST_N_3</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>mitochondrion</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>maleylacetoacetate isomerase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>L-phenylalanine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tyrosine catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular nitrogen compound metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000820</id>
      <name>Epididymal secretory glutathione peroxidase</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17531267</pubmed-id>
            <citation>Koh CS, Didierjean C, Navrot N, Panjikar S, Mulliert G, Rouhier N, Jacquot JP, Aubry A, Shawkataly O, Corbier C: Crystal structures of a poplar thioredoxin peroxidase that exhibits the structure of glutathione peroxidases: insights into redox-driven conformational changes. J Mol Biol. 2007 Jul 13;370(3):512-29. Epub 2007 Apr 19.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O75715" source="Swiss-Prot">
    <name>Epididymal secretory glutathione peroxidase</name>
    <general-function>Glutathione peroxidase activity</general-function>
    <specific-function>Protects cells and enzymes from oxidative damage, by catalyzing the reduction of hydrogen peroxide, lipid peroxides and organic hydroperoxide, by glutathione. May constitute a glutathione peroxidase-like protective system against peroxide damage in sperm membrane lipids.</specific-function>
    <gene-name>GPX5</gene-name>
    <locus>6p22.1</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-21</signal-regions>
    <theoretical-pi>8.89</theoretical-pi>
    <molecular-weight>25202.14</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4557</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX5</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AJ005277</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3288455</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O75715</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>EGLP</synonym>
      <synonym>Epididymis-specific glutathione peroxidase-like protein</synonym>
      <synonym>Glutathione peroxidase 5</synonym>
      <synonym>GPx-5</synonym>
      <synonym>GSHPx-5</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001636|Epididymal secretory glutathione peroxidase
MTTQLRVVHLLPLLLACFVQTSPKQEKMKMDCHKDEKGTIYDYEAIALNKNEYVSFKQYV
GKHILFVNVATYCGLTAQYPELNALQEELKPYGLVVLGFPCNQFGKQEPGDNKEILPGLK
YVRPGGGFVPSFQLFEKGDVNGEKEQKVFSFLKHSCPHPSEILGTFKSISWDPVKVHDIR
WNFEKFLVGPDGIPVMRWSHRATVSSVKTDILAYLKQFKTK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016218|Epididymal secretory glutathione peroxidase (GPX5)
ATGACTACACAGTTAAGGGTCGTCCATCTGCTTCCCCTTCTCCTAGCCTGCTTTGTGCAA
ACAAGTCCCAAGCAGGAGAAGATGAAGATGGATTGCCACAAAGACGAGAAAGGCACCATC
TATGACTATGAGGCCATCGCACTTAATAAGAATGAATATGTTTCCTTCAAGCAGTATGTG
GGCAAGCACATCCTCTTCGTCAACGTGGCCACCTACTGTGGTCTGACAGCGCAATATCCT
GAACTAAATGCACTCCAGGAGGAGCTGAAGCCCTATGGTCTAGTTGTGTTGGGCTTTCCC
TGCAACCAATTTGGAAAGCAAGAACCAGGAGATAACAAAGAGATTCTTCCTGGGCTCAAG
TATGTCCGTCCAGGGGGAGGATTTGTACCTAGTTTCCAGCTTTTTGAGAAAGGGGATGTG
AATGGTGAAAAAGAACAGAAAGTCTTCAGTTTCTTGAAGCACTCCTGTCCTCATCCCTCT
GAGATTTTGGGCACATTCAAATCTATATCCTGGGACCCTGTAAAGGTCCATGACATCCGT
TGGAACTTTGAAAAGTTCCTGGTGGGGCCTGATGGAATCCCTGTCATGCGCTGGTCCCAC
CGGGCTACGGTCAGCTCAGTCAAGACAGACATCCTGGCGTACTTGAAGCAATTCAAAACC
AAATAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>sperm plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0000821</id>
      <name>Glutathione peroxidase 3</name>
      <organism>Human</organism>
      <actions>
        <action>cofactor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>17558897</pubmed-id>
            <citation>Jacobson GA, Yee KC, Ng CH: Elevated plasma glutathione peroxidase concentration in acute severe asthma: comparison with plasma glutathione peroxidase activity, selenium and malondialdehyde. Scand J Clin Lab Invest. 2007;67(4):423-30.</citation>
          </article>
          <article>
            <pubmed-id>17578749</pubmed-id>
            <citation>Carmeli E, Bachar A, Barchad S: Biochemical assessments of total antioxidant status in active and nonactive female adults with intellectual disability. Res Sports Med. 2007 Apr-Jun;15(2):93-101.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P22352" source="Swiss-Prot">
    <name>Glutathione peroxidase 3</name>
    <general-function>Transcription factor binding</general-function>
    <specific-function>Protects cells and enzymes from oxidative damage, by catalyzing the reduction of hydrogen peroxide, lipid peroxides and organic hydroperoxide, by glutathione.</specific-function>
    <gene-name>GPX3</gene-name>
    <locus>5q23</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-20</signal-regions>
    <theoretical-pi>8.19</theoretical-pi>
    <molecular-weight>25552.185</molecular-weight>
    <chromosome-location>5</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4555</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GPX3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D00632</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>2160390</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P22352</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GPX3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.11.1.9</synonym>
      <synonym>Extracellular glutathione peroxidase</synonym>
      <synonym>GPx-3</synonym>
      <synonym>GPx-P</synonym>
      <synonym>GPXP</synonym>
      <synonym>GSHPx-P</synonym>
      <synonym>Plasma glutathione peroxidase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010579|Glutathione peroxidase 3
MARLLQASCLLSLLLAGFVSQSRGQEKSKMDCHGGISGTIYEYGALTIDGEEYIPFKQYA
GKYVLFVNVASYUGLTGQYIELNALQEELAPFGLVILGFPCNQFGKQEPGENSEILPTLK
YVRPGGGFVPNFQLFEKGDVNGEKEQKFYTFLKNSCPPTSELLGTSDRLFWEPMKVHDIR
WNFEKFLVGPDGIPIMRWHHRTTVSNVKMDILSYMRRQAALGVKRK</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010580|Glutathione peroxidase 3 (GPX3)
ATGGCCCGGCTGCTGCAGGCGTCCTGCCTGCTTTCCCTGCTCCTGGCCGGCTTCGTCTCG
CAGAGCCGGGGACAAGAGAAGTCGAAGATGGACTGCCATGGTGGCATAAGTGGCACCATT
TACGAGTACGGAGCCCTCACCATTGATGGGGAGGAGTACATCCCCTTCAAGCAGTATGCT
GGCAAATACGTCCTCTTTGTCAACGTGGCCAGCTACTGAGGCCTGACGGGCCAGTACATT
GAACTGAATGCACTACAGGAAGAGCTTGCACCATTCGGTCTGGTCATTCTGGGCTTTCCC
TGCAACCAATTTGGAAAACAGGAACCAGGAGAGAACTCAGAGATCCTTCCTACCCTCAAG
TATGTCCGACCAGGTGGAGGCTTTGTCCCTAATTTCCAGCTCTTTGAGAAAGGGGATGTC
AATGGAGAGAAAGAGCAGAAATTCTACACTTTCCTAAAGAACTCCTGTCCTCCCACCTCG
GAGCTCCTGGGTACATCTGACCGCCTCTTCTGGGAACCCATGAAGGTTCACGACATCCGC
TGGAACTTTGAGAAGTTCCTGGTGGGGCCAGATGGTATACCCATCATGCGCTGGCACCAC
CGGACCACGGTCAGCAACGTCAAGATGGACATCCTGTCCTACATGAGGCGGCAGGCAGCC
CTGGGGGTCAAGAGGAAGTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00255</identifier>
        <name>GSHPx</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>selenium binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione peroxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transcription factor binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homotetramerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hydrogen peroxide catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to reactive oxygen species</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to lipid hydroperoxide</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="6">
      <id>BE0000747</id>
      <name>Aldose reductase</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>11306073</pubmed-id>
            <citation>Ramana KV, Dixit BL, Srivastava S, Bhatnagar A, Balendiran GK, Watowich SJ, Petrash JM, Srivastava SK: Characterization of the glutathione binding site of aldose reductase. Chem Biol Interact. 2001 Jan 30;130-132(1-3):537-48.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P15121" source="Swiss-Prot">
    <name>Aldose reductase</name>
    <general-function>Glyceraldehyde oxidoreductase activity</general-function>
    <specific-function>Catalyzes the NADPH-dependent reduction of a wide variety of carbonyl-containing compounds to their corresponding alcohols with a broad range of catalytic efficiencies.</specific-function>
    <gene-name>AKR1B1</gene-name>
    <locus>7q35</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.99</theoretical-pi>
    <molecular-weight>35853.125</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:381</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>AKR1B1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J04795</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>178487</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>2768</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P15121</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>ALDR_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1.1.1.21</synonym>
      <synonym>Aldehyde reductase</synonym>
      <synonym>Aldo-keto reductase family 1 member B1</synonym>
      <synonym>ALDR1</synonym>
      <synonym>AR</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0016194|Aldose reductase
MASRLLLNNGAKMPILGLGTWKSPPGQVTEAVKVAIDVGYRHIDCAHVYQNENEVGVAIQ
EKLREQVVKREELFIVSKLWCTYHEKGLVKGACQKTLSDLKLDYLDLYLIHWPTGFKPGK
EFFPLDESGNVVPSDTNILDTWAAMEELVDEGLVKAIGISNFNHLQVEMILNKPGLKYKP
AVNQIECHPYLTQEKLIQYCQSKGIVVTAYSPLGSPDRPWAKPEDPSLLEDPRIKAIAAK
HNKTTAQVLIRFPMQRNLVVIPKSVTPERIAENFKVFDFELSSQDMTTLLSYNRNWRVCA
LLSCTSHKDYPFHEEF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016195|Aldose reductase (AKR1B1)
ATGGCAAGCCGTCTCCTGCTCAACAACGGCGCCAAGATGCCCATCCTGGGGTTGGGTACC
TGGAAGTCCCCTCCAGGGCAGGTGACTGAGGCCGTGAAGGTGGCCATTGACGTCGGGTAC
CGCCACATCGACTGTGCCCATGTGTACCAGAATGAGAATGAGGTGGGGGTGGCCATTCAG
GAGAAGCTCAGGGAGCAGGTGGTGAAGCGTGAGGAGCTCTTCATCGTCAGCAAGCTGTGG
TGCACGTACCATGAGAAGGGCCTGGTGAAAGGAGCCTGCCAGAAGACACTCAGCGACCTG
AAGCTGGACTACCTGGACCTCTACCTTATTCACTGGCCGACTGGCTTTAAGCCTGGGAAG
GAATTTTTCCCATTGGATGAGTCGGGCAATGTGGTTCCCAGTGACACCAACATTCTGGAC
ACGTGGGCGGCCATGGAAGAGCTGGTGGATGAAGGGCTGGTGAAAGCTATTGGCATCTCC
AACTTCAACCATCTCCAGGTGGAGATGATCTTAAACAAACCTGGCTTGAAGTATAAGCCT
GCAGTTAACCAGATTGAGTGCCACCCATATCTCACTCAGGAGAAGTTAATCCAGTACTGC
CAGTCCAAAGGCATCGTGGTGACCGCCTACAGCCCCCTCGGCTCTCCTGACAGGCCCTGG
GCCAAGCCCGAGGACCCTTCTCTCCTGGAGGATCCCAGGATCAAGGCGATCGCAGCCAAG
CACAATAAAACTACAGCCCAGGTCCTGATCCGGTTCCCCATGCAGAGGAACTTGGTGGTG
ATCCCCAAGTCTGTGACACCAGAACGCATTGCTGAGAACTTTAAGGTCTTTGACTTTGAA
CTGAGCAGCCAGGATATGACCACCTTACTCAGCTACAACAGGAACTGGAGGGTCTGTGCC
TTGTTGAGCTGTACCTCCCACAAGGATTACCCCTTCCATGAAGAGTTTTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00248</identifier>
        <name>Aldo_ket_red</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Schmidt-Lanterman incisure</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>paranodal junction</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>nucleoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>mast cell granule</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell projection cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>perinuclear region of cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>Schwann cell microvillus</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glyceraldehyde oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aldo-keto reductase (NADP) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>electron carrier activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>alditol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of smooth muscle cell proliferation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to methylglyoxal</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>tissue homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>norepinephrine metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to peptide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular response to hydrogen peroxide</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of JAK-STAT cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>inner medullary collecting duct development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>maternal process involved in female pregnancy</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>naphthalene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to water deprivation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>sorbitol biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>fructose metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to thyroid hormone</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>stress-activated protein kinase signaling cascade</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>C21-steroid hormone biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>daunorubicin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>doxorubicin metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="7">
      <id>BE0000058</id>
      <name>Matrix metalloproteinase-9</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17015178</pubmed-id>
            <citation>Pei P, Horan MP, Hille R, Hemann CF, Schwendeman SP, Mallery SR: Reduced nonprotein thiols inhibit activation and function of MMP-9: implications for chemoprevention. Free Radic Biol Med. 2006 Oct 15;41(8):1315-24. Epub 2006 Jul 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P14780" source="Swiss-Prot">
    <name>Matrix metalloproteinase-9</name>
    <general-function>Zinc ion binding</general-function>
    <specific-function>May play an essential role in local proteolysis of the extracellular matrix and in leukocyte migration. Could play a role in bone osteoclastic resorption. Cleaves KiSS1 at a Gly-|-Leu bond. Cleaves type IV and type V collagen into large C-terminal three quarter fragments and shorter N-terminal one quarter fragments. Degrades fibronectin but not laminin or Pz-peptide.</specific-function>
    <gene-name>MMP9</gene-name>
    <locus>20q11.2-q13.1</locus>
    <cellular-location>Secreted</cellular-location>
    <transmembrane-regions/>
    <signal-regions>1-19</signal-regions>
    <theoretical-pi>5.92</theoretical-pi>
    <molecular-weight>78457.51</molecular-weight>
    <chromosome-location>20</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:7176</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>MMP9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>J05070</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>177205</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1633</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P14780</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MMP9_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>3.4.24.35</synonym>
      <synonym>92 kDa gelatinase</synonym>
      <synonym>92 kDa type IV collagenase</synonym>
      <synonym>CLG4B</synonym>
      <synonym>Gelatinase B</synonym>
      <synonym>GELB</synonym>
      <synonym>MMP-9</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010144|Matrix metalloproteinase-9
MSLWQPLVLVLLVLGCCFAAPRQRQSTLVLFPGDLRTNLTDRQLAEEYLYRYGYTRVAEM
RGESKSLGPALLLLQKQLSLPETGELDSATLKAMRTPRCGVPDLGRFQTFEGDLKWHHHN
ITYWIQNYSEDLPRAVIDDAFARAFALWSAVTPLTFTRVYSRDADIVIQFGVAEHGDGYP
FDGKDGLLAHAFPPGPGIQGDAHFDDDELWSLGKGVVVPTRFGNADGAACHFPFIFEGRS
YSACTTDGRSDGLPWCSTTANYDTDDRFGFCPSERLYTQDGNADGKPCQFPFIFQGQSYS
ACTTDGRSDGYRWCATTANYDRDKLFGFCPTRADSTVMGGNSAGELCVFPFTFLGKEYST
CTSEGRGDGRLWCATTSNFDSDKKWGFCPDQGYSLFLVAAHEFGHALGLDHSSVPEALMY
PMYRFTEGPPLHKDDVNGIRHLYGPRPEPEPRPPTTTTPQPTAPPTVCPTGPPTVHPSER
PTAGPTGPPSAGPTGPPTAGPSTATTVPLSPVDDACNVNIFDAIAEIGNQLYLFKDGKYW
RFSEGRGSRPQGPFLIADKWPALPRKLDSVFEERLSKKLFFFSGRQVWVYTGASVLGPRR
LDKLGLGADVAQVTGALRSGRGKMLLFSGRRLWRFDVKAQMVDPRSASEVDRMFPGVPLD
THDVFQYREKAYFCQDRFYWRVSSRSELNQVDQVGYVTYDILQCPED</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010145|Matrix metalloproteinase-9 (MMP9)
ATGAGCCTCTGGCAGCCCCTGGTCCTGGTGCTCCTGGTGCTGGGCTGCTGCTTTGCTGCC
CCCAGACAGCGCCAGTCCACCCTTGTGCTCTTCCCTGGAGACCTGAGAACCAATCTCACC
GACAGGCAGCTGGCAGAGGAATACCTGTACCGCTATGGTTACACTCGGGTGGCAGAGATG
CGTGGAGAGTCGAAATCTCTGGGGCCTGCGCTGCTGCTTCTCCAGAAGCAACTGTCCCTG
CCCGAGACCGGTGAGCTGGATAGCGCCACGCTGAAGGCCATGCGAACCCCACGGTGCGGG
GTCCCAGACCTGGGCAGATTCCAAACCTTTGAGGGCGACCTCAAGTGGCACCACCACAAC
ATCACCTATTGGATCCAAAACTACTCGGAAGACTTGCCGCGGGCGGTGATTGACGACGCC
TTTGCCCGCGCCTTCGCACTGTGGAGCGCGGTGACGCCGCTCACCTTCACTCGCGTGTAC
AGCCGGGACGCAGACATCGTCATCCAGTTTGGTGTCGCGGAGCACGGAGACGGGTATCCC
TTCGACGGGAAGGACGGGCTCCTGGCACACGCCTTTCCTCCTGGCCCCGGCATTCAGGGA
GACGCCCATTTCGACGATGACGAGTTGTGGTCCCTGGGCAAGGGCGTCGTGGTTCCAACT
CGGTTTGGAAACGCAGATGGCGCGGCCTGCCACTTCCCCTTCATCTTCGAGGGCCGCTCC
TACTCTGCCTGCACCACCGACGGTCGCTCCGACGGCTTGCCCTGGTGCAGTACCACGGCC
AACTACGACACCGACGACCGGTTTGGCTTCTGCCCCAGCGAGAGACTCTACACCCAGGAC
GGCAATGCTGATGGGAAACCCTGCCAGTTTCCATTCATCTTCCAAGGCCAATCCTACTCC
GCCTGCACCACGGACGGTCGCTCCGACGGCTACCGCTGGTGCGCCACCACCGCCAACTAC
GACCGGGACAAGCTCTTCGGCTTCTGCCCGACCCGAGCTGACTCGACGGTGATGGGGGGC
AACTCGGCGGGGGAGCTGTGCGTCTTCCCCTTCACTTTCCTGGGTAAGGAGTACTCGACC
TGTACCAGCGAGGGCCGCGGAGATGGGCGCCTCTGGTGCGCTACCACCTCGAACTTTGAC
AGCGACAAGAAGTGGGGCTTCTGCCCGGACCAAGGATACAGTTTGTTCCTCGTGGCGGCG
CATGAGTTCGGCCACGCGCTGGGCTTAGATCATTCCTCAGTGCCGGAGGCGCTCATGTAC
CCTATGTACCGCTTCACTGAGGGGCCCCCCTTGCATAAGGACGACGTGAATGGCATCCGG
CACCTCTATGGTCCTCGCCCTGAACCTGAGCCACGGCCTCCAACCACCACCACACCGCAG
CCCACGGCTCCCCCGACGGTCTGCCCCACCGGACCCCCCACTGTCCACCCCTCAGAGCGC
CCCACAGCTGGCCCCACAGGTCCCCCCTCAGCTGGCCCCACAGGTCCCCCCACTGCTGGC
CCTTCTACGGCCACTACTGTGCCTTTGAGTCCGGTGGACGATGCCTGCAACGTGAACATC
TTCGACGCCATCGCGGAGATTGGGAACCAGCTGTATTTGTTCAAGGATGGGAAGTACTGG
CGATTCTCTGAGGGCAGGGGGAGCCGGCCGCAGGGCCCCTTCCTTATCGCCGACAAGTGG
CCCGCGCTGCCCCGCAAGCTGGACTCGGTCTTTGAGGAGCGGCTCTCCAAGAAGCTTTTC
TTCTTCTCTGGGCGCCAGGTGTGGGTGTACACAGGCGCGTCGGTGCTGGGCCCGAGGCGT
CTGGACAAGCTGGGCCTGGGAGCCGACGTGGCCCAGGTGACCGGGGCCCTCCGGAGTGGC
AGGGGGAAGATGCTGCTGTTCAGCGGGCGGCGCCTCTGGAGGTTCGACGTGAAGGCGCAG
ATGGTGGATCCCCGGAGCGCCAGCGAGGTGGACCGGATGTTCCCCGGGGTGCCTTTGGAC
ACGCACGACGTCTTCCAGTACCGAGAGAAAGCCTATTTCTGCCAGGACCGCTTCTACTGG
CGCGTGAGTTCCCGGAGTGAGTTGAACCAGGTGGACCAAGTGGGCTACGTGACCTATGAC
ATCCTGCAGTGCCCTGAGGACTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00040</identifier>
        <name>fn2</name>
      </pfam>
      <pfam>
        <identifier>PF00045</identifier>
        <name>Hemopexin</name>
      </pfam>
      <pfam>
        <identifier>PF00413</identifier>
        <name>Peptidase_M10</name>
      </pfam>
      <pfam>
        <identifier>PF01471</identifier>
        <name>PG_binding_1</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>extracellular space</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>proteinaceous extracellular matrix</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular region</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metallopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metalloendopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>collagen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>identical protein binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>zinc ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>endopeptidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>skeletal system development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of intrinsic apoptotic signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of apoptotic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of DNA binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ossification</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>embryo implantation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of keratinocyte migration</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>axon guidance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of receptor binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of protein phosphorylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>positive regulation of release of cytochrome c from mitochondria</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endodermal cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>collagen catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>ephrin receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix disassembly</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>macrophage differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>proteolysis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>extracellular matrix organization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>negative regulation of cation channel activity</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target position="8">
      <id>BE0002638</id>
      <name>Cytochrome P450 3A4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>18206979</pubmed-id>
            <citation>Davydov DR, Davydova NY, Tsalkova TN, Halpert JR: Effect of glutathione on homo- and heterotropic cooperativity in cytochrome P450 3A4. Arch Biochem Biophys. 2008 Mar 15;471(2):134-45. doi: 10.1016/j.abb.2008.01.001.  Epub 2008 Jan 11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08684" source="Swiss-Prot">
    <name>Cytochrome P450 3A4</name>
    <general-function>Vitamin d3 25-hydroxylase activity</general-function>
    <specific-function>Cytochromes P450 are a group of heme-thiolate monooxygenases. In liver microsomes, this enzyme is involved in an NADPH-dependent electron transport pathway. It performs a variety of oxidation reactions (e.g. caffeine 8-oxidation, omeprazole sulphoxidation, midazolam 1'-hydroxylation and midazolam 4-hydroxylation) of structurally unrelated compounds, including steroids, fatty acids, and xenobiotics. Acts as a 1,8-cineole 2-exo-monooxygenase. The enzyme also hydroxylates etoposide (PubMed:11159812). Catalyzes 4-beta-hydroxylation of cholesterol. May catalyze 25-hydroxylation of cholesterol in vitro (PubMed:21576599).</specific-function>
    <gene-name>CYP3A4</gene-name>
    <locus>7q21.1</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>2-22</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.25</theoretical-pi>
    <molecular-weight>57342.67</molecular-weight>
    <chromosome-location>7</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2637</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>CYP3A4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M18907</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>1337</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P08684</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>CP3A4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>1,8-cineole 2-exo-monooxygenase</synonym>
      <synonym>1.14.13.-</synonym>
      <synonym>Albendazole monooxygenase</synonym>
      <synonym>Albendazole sulfoxidase</synonym>
      <synonym>Cholesterol 25-hydroxylase</synonym>
      <synonym>CYP3A3</synonym>
      <synonym>CYPIIIA3</synonym>
      <synonym>CYPIIIA4</synonym>
      <synonym>Cytochrome P450 3A3</synonym>
      <synonym>Cytochrome P450 HLp</synonym>
      <synonym>Cytochrome P450 NF-25</synonym>
      <synonym>Cytochrome P450-PCN1</synonym>
      <synonym>Nifedipine oxidase</synonym>
      <synonym>Quinine 3-monooxygenase</synonym>
      <synonym>Taurochenodeoxycholate 6-alpha-hydroxylase</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0021936|Cytochrome P450 3A4
MALIPDLAMETWLLLAVSLVLLYLYGTHSHGLFKKLGIPGPTPLPFLGNILSYHKGFCMF
DMECHKKYGKVWGFYDGQQPVLAITDPDMIKTVLVKECYSVFTNRRPFGPVGFMKSAISI
AEDEEWKRLRSLLSPTFTSGKLKEMVPIIAQYGDVLVRNLRREAETGKPVTLKDVFGAYS
MDVITSTSFGVNIDSLNNPQDPFVENTKKLLRFDFLDPFFLSITVFPFLIPILEVLNICV
FPREVTNFLRKSVKRMKESRLEDTQKHRVDFLQLMIDSQNSKETESHKALSDLELVAQSI
IFIFAGYETTSSVLSFIMYELATHPDVQQKLQEEIDAVLPNKAPPTYDTVLQMEYLDMVV
NETLRLFPIAMRLERVCKKDVEINGMFIPKGVVVMIPSYALHRDPKYWTEPEKFLPERFS
KKNKDNIDPYIYTPFGSGPRNCIGMRFALMNMKLALIRVLQNFSFKPCKETQIPLKLSLG
GLLQPEKPVVLKVESRDGTVSGA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0021937|Cytochrome P450 3A4 (CYP3A4)
ATGGCTCTCATCCCAGACTTGGCCATGGAAACCTGGCTTCTCCTGGCTGTCAGCCTGGTG
CTCCTCTATCTATATGGAACCCATTCACATGGACTTTTTAAGAAGCTTGGAATTCCAGGG
CCCACACCTCTGCCTTTTTTGGGAAATATTTTGTCCTACCATAAGGGCTTTTGTATGTTT
GACATGGAATGTCATAAAAAGTATGGAAAAGTGTGGGGCTTTTATGATGGTCAACAGCCT
GTGCTGGCTATCACAGATCCTGACATGATCAAAACAGTGCTAGTGAAAGAATGTTATTCT
GTCTTCACAAACCGGAGGCCTTTTGGTCCAGTGGGATTTATGAAAAGTGCCATCTCTATA
GCTGAGGATGAAGAATGGAAGAGATTACGATCATTGCTGTCTCCAACCTTCACCAGTGGA
AAACTCAAGGAGATGGTCCCTATCATTGCCCAGTATGGAGATGTGTTGGTGAGAAATCTG
AGGCGGGAAGCAGAGACAGGCAAGCCTGTCACCTTGAAAGACGTCTTTGGGGCCTACAGC
ATGGATGTGATCACTAGCACATCATTTGGAGTGAACATCGACTCTCTCAACAATCCACAA
GACCCCTTTGTGGAAAACACCAAGAAGCTTTTAAGATTTGATTTTTTGGATCCATTCTTT
CTCTCAATAATCTTTCCATTCCTCATCCCAATTCTTGAAGTATTAAATATCTGTGTGTTT
CCAAGAGAAGTTACAAATTTTTTAAGAAAATCTGTAAAAAGGATGAAAGAAAGTCGCCTC
GAAGATACACAAAAGCACCGAGTGGATTTCCTTCAGCTGATGATTGACTCTCAGAATTCA
AAAGAAACTGAGTCCCACAAAGCTCTGTCCGATCTGGAGCTCGTGGCCCAATCAATTATC
TTTATTTTTGCTGGCTATGAAACCACGAGCAGTGTTCTCTCCTTCATTATGTATGAACTG
GCCACTCACCCTGATGTCCAGCAGAAACTGCAGGAGGAAATTGATGCAGTTTTACCCAAT
AAGGCACCACCCACCTATGATACTGTGCTACAGATGGAGTATCTTGACATGGTGGTGAAT
GAAACGCTCAGATTATTCCCAATTGCTATGAGACTTGAGAGGGTCTGCAAAAAAGATGTT
GAGATCAATGGGATGTTCATTCCCAAAGGGGTGGTGGTGATGATTCCAAGCTATGCTCTT
CACCGTGACCCAAAGTACTGGACAGAGCCTGAGAAGTTCCTCCCTGAAAGATTCAGCAAG
AAGAACAAGGACAACATAGATCCTTACATATACACACCCTTTGGAAGTGGACCCAGAAAC
TGCATTGGCATGAGGTTTGCTCTCATGAACATGAAACTTGCTCTAATCAGAGTCCTTCAG
AACTTCTCCTTCAAACCTTGTAAAGAAACACAGATCCCCCTGAAATTAAGCTTAGGAGGA
CTTCTTCAACCAGAAAAACCCGTTGTTCTAAAGGTTGAGTCAAGGGATGGCACCGTAAGT
GGAGCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00067</identifier>
        <name>p450</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>intracellular membrane-bounded organelle</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>taurochenodeoxycholate 6alpha-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxygen binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>steroid hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D 24-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>enzyme binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>testosterone 6-beta-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>vitamin D3 25-hydroxylase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>oxidoreductase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>aromatase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>albendazole monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>iron ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>caffeine oxidase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>quinine 3-monooxygenase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>heme binding</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>drug catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>lipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>heterocycle metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>monoterpenoid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>drug metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidative demethylation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>androgen metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>calcitriol biosynthetic process from calciol</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin D metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>exogenous drug catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>alkaloid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid catabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>steroid metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
  </targets>
  <enzymes>
    <enzyme>
      <id>BE0002189</id>
      <name>Glutathione S-transferase A2</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>15822171</pubmed-id>
            <citation>Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.</citation>
          </article>
          <article>
            <pubmed-id>1782341</pubmed-id>
            <citation>Armstrong RN: Glutathione S-transferases: reaction mechanism, structure, and function. Chem Res Toxicol. 1991 Mar-Apr;4(2):131-40.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P09210" source="Swiss-Prot">
    <name>Glutathione S-transferase A2</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTA2</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.07</theoretical-pi>
    <molecular-weight>25663.675</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4627</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M16594</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306811</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P09210</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-alpha member 2</synonym>
      <synonym>GST HA subunit 2</synonym>
      <synonym>GST-gamma</synonym>
      <synonym>GST2</synonym>
      <synonym>GSTA2-2</synonym>
      <synonym>GTH2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011580|Glutathione S-transferase A2
MAEKPKLHYSNIRGRMESIRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDIKEKALIDMYIEGIADLGEMILLLPFSQPEEQDAK
LALIQEKTKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPL
LKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEESRKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011581|Glutathione S-transferase A2 (GSTA2)
ATGGCAGAGAAGCCCAAGCTCCACTACTCCAATATACGGGGCAGAATGGAGTCCATCCGG
TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
CTCTATGGGAAAGACATAAAGGAGAAAGCCCTGATTGATATGTATATAGAAGGTATAGCA
GATTTGGGTGAAATGATCCTTCTTCTGCCCTTTAGTCAACCTGAGGAACAAGATGCCAAG
CTTGCCTTGATCCAAGAGAAAACAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
AAGAGCCACGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCACCTG
GTGGAACTTCTCTACTACGTGGAAGAGCTTGACTCTAGCCTTATTTCCAGCTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGTAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAATCAAGGAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
    <enzyme>
      <id>BE0002281</id>
      <name>Glutathione S-transferase A1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>15822171</pubmed-id>
            <citation>Hayes JD, Flanagan JU, Jowsey IR: Glutathione transferases. Annu Rev Pharmacol Toxicol. 2005;45:51-88.</citation>
          </article>
          <article>
            <pubmed-id>1782341</pubmed-id>
            <citation>Armstrong RN: Glutathione S-transferases: reaction mechanism, structure, and function. Chem Res Toxicol. 1991 Mar-Apr;4(2):131-40.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P08263" source="Swiss-Prot">
    <name>Glutathione S-transferase A1</name>
    <general-function>Glutathione transferase activity</general-function>
    <specific-function>Conjugation of reduced glutathione to a wide number of exogenous and endogenous hydrophobic electrophiles.</specific-function>
    <gene-name>GSTA1</gene-name>
    <locus>6p12.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>9.34</theoretical-pi>
    <molecular-weight>25630.785</molecular-weight>
    <chromosome-location>6</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:4626</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>GSTA1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>M15872</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>306809</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P08263</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>GSTA1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.5.1.18</synonym>
      <synonym>GST class-alpha member 1</synonym>
      <synonym>GST HA subunit 1</synonym>
      <synonym>GST-epsilon</synonym>
      <synonym>GSTA1-1</synonym>
      <synonym>GTH1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0011643|Glutathione S-transferase A1
MAEKPKLHYFNARGRMESTRWLLAAAGVEFEEKFIKSAEDLDKLRNDGYLMFQQVPMVEI
DGMKLVQTRAILNYIASKYNLYGKDIKERALIDMYIEGIADLGEMILLLPVCPPEEKDAK
LALIKEKIKNRYFPAFEKVLKSHGQDYLVGNKLSRADIHLVELLYYVEELDSSLISSFPL
LKALKTRISNLPTVKKFLQPGSPRKPPMDEKSLEEARKIFRF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011644|Glutathione S-transferase A1 (GSTA1)
ATGGCAGAGAAGCCCAAGCTCCACTACTTCAATGCACGGGGCAGAATGGAGTCCACCCGG
TGGCTCCTGGCTGCAGCTGGAGTAGAGTTTGAAGAGAAATTTATAAAATCTGCAGAAGAT
TTGGACAAGTTAAGAAATGATGGATATTTGATGTTCCAGCAAGTGCCAATGGTTGAGATT
GATGGGATGAAGCTGGTGCAGACCAGAGCCATTCTCAACTACATTGCCAGCAAATACAAC
CTCTATGGGAAAGACATAAAGGAGAGAGCCCTGATTGATATGTATATAGAAGGTATAGCA
GATTTGGGTGAAATGATCCTCCTTCTGCCCGTATGTCCACCTGAGGAAAAAGATGCCAAG
CTTGCCTTGATCAAAGAGAAAATAAAAAATCGCTACTTCCCTGCCTTTGAAAAAGTCTTA
AAGAGCCATGGACAAGACTACCTTGTTGGCAACAAGCTGAGCCGGGCTGACATTCATCTG
GTGGAACTTCTCTACTACGTCGAGGAGCTTGACTCCAGTCTTATCTCCAGCTTCCCTCTG
CTGAAGGCCCTGAAAACCAGAATCAGCAACCTGCCCACAGTGAAGAAGTTTCTACAGCCT
GGCAGCCCAAGGAAGCCTCCCATGGATGAGAAATCTTTAGAAGAAGCAAGGAAGATTTTC
AGGTTTTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00043</identifier>
        <name>GST_C</name>
      </pfam>
      <pfam>
        <identifier>PF02798</identifier>
        <name>GST_N</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytosol</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>glutathione transferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>xenobiotic metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glutathione derivative biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epithelial cell differentiation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
      <inhibition-strength>unknown</inhibition-strength>
      <induction-strength>unknown</induction-strength>
    </enzyme>
  </enzymes>
  <carriers/>
  <transporters>
    <transporter position="1">
      <id>BE0000785</id>
      <name>Multidrug resistance-associated protein 1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>9188796</pubmed-id>
            <citation>Heijn M, Hooijberg JH, Scheffer GL, Szabo G, Westerhoff HV, Lankelma J: Anthracyclines modulate multidrug resistance protein (MRP) mediated organic anion transport. Biochim Biophys Acta. 1997 May 22;1326(1):12-22.</citation>
          </article>
          <article>
            <pubmed-id>10917554</pubmed-id>
            <citation>Evers R, de Haas M, Sparidans R, Beijnen J, Wielinga PR, Lankelma J, Borst P: Vinblastine and sulfinpyrazone export by the multidrug resistance protein MRP2 is associated with glutathione export. Br J Cancer. 2000 Aug;83(3):375-83.</citation>
          </article>
          <article>
            <pubmed-id>8640791</pubmed-id>
            <citation>Jedlitschky G, Leier I, Buchholz U, Barnouin K, Kurz G, Keppler D: Transport of glutathione, glucuronate, and sulfate conjugates by the MRP gene-encoded conjugate export pump. Cancer Res. 1996 Mar 1;56(5):988-94.</citation>
          </article>
          <article>
            <pubmed-id>16539673</pubmed-id>
            <citation>Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R: The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem. 2006 Apr;97(2):373-84. Epub 2006 Mar 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P33527" source="Swiss-Prot">
    <name>Multidrug resistance-associated protein 1</name>
    <general-function>Transporter activity</general-function>
    <specific-function>Mediates export of organic anions and drugs from the cytoplasm. Mediates ATP-dependent transport of glutathione and glutathione conjugates, leukotriene C4, estradiol-17-beta-o-glucuronide, methotrexate, antiviral drugs and other xenobiotics. Confers resistance to anticancer drugs. Hydrolyzes ATP with low efficiency.</specific-function>
    <gene-name>ABCC1</gene-name>
    <locus>16p13.1</locus>
    <cellular-location>Cell membrane</cellular-location>
    <transmembrane-regions>34-54
75-95
101-121
134-154
173-193
317-337
364-384
441-461
465-485
548-568
591-611
968-988
1026-1046
1090-1110
1112-1132
1204-1224
1227-1247</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.11</theoretical-pi>
    <molecular-weight>171589.5</molecular-weight>
    <chromosome-location>16</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:51</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ABCC1</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>L05628</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1835659</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>779</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P33527</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MRP1_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ATP-binding cassette sub-family C member 1</synonym>
      <synonym>Leukotriene C(4) transporter</synonym>
      <synonym>LTC4 transporter</synonym>
      <synonym>MRP</synonym>
      <synonym>MRP1</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037076|Multidrug resistance-associated protein 1
MALRGFCSADGSDPLWDWNVTWNTSNPDFTKCFQNTVLVWVPCFYLWACFPFYFLYLSRH
DRGYIQMTPLNKTKTALGFLLWIVCWADLFYSFWERSRGIFLAPVFLVSPTLLGITMLLA
TFLIQLERRKGVQSSGIMLTFWLVALVCALAILRSKIMTALKEDAQVDLFRDITFYVYFS
LLLIQLVLSCFSDRSPLFSETIHDPNPCPESSASFLSRITFWWITGLIVRGYRQPLEGSD
LWSLNKEDTSEQVVPVLVKNWKKECAKTRKQPVKVVYSSKDPAQPKESSKVDANEEVEAL
IVKSPQKEWNPSLFKVLYKTFGPYFLMSFFFKAIHDLMMFSGPQILKLLIKFVNDTKAPD
WQGYFYTVLLFVTACLQTLVLHQYFHICFVSGMRIKTAVIGAVYRKALVITNSARKSSTV
GEIVNLMSVDAQRFMDLATYINMIWSAPLQVILALYLLWLNLGPSVLAGVAVMVLMVPVN
AVMAMKTKTYQVAHMKSKDNRIKLMNEILNGIKVLKLYAWELAFKDKVLAIRQEELKVLK
KSAYLSAVGTFTWVCTPFLVALCTFAVYVTIDENNILDAQTAFVSLALFNILRFPLNILP
MVISSIVQASVSLKRLRIFLSHEELEPDSIERRPVKDGGGTNSITVRNATFTWARSDPPT
LNGITFSIPEGALVAVVGQVGCGKSSLLSALLAEMDKVEGHVAIKGSVAYVPQQAWIQND
SLRENILFGCQLEEPYYRSVIQACALLPDLEILPSGDRTEIGEKGVNLSGGQKQRVSLAR
AVYSNADIYLFDDPLSAVDAHVGKHIFENVIGPKGMLKNKTRILVTHSMSYLPQVDVIIV
MSGGKISEMGSYQELLARDGAFAEFLRTYASTEQEQDAEENGVTGVSGPGKEAKQMENGM
LVTDSAGKQLQRQLSSSSSYSGDISRHHNSTAELQKAEAKKEETWKLMEADKAQTGQVKL
SVYWDYMKAIGLFISFLSIFLFMCNHVSALASNYWLSLWTDDPIVNGTQEHTKVRLSVYG
ALGISQGIAVFGYSMAVSIGGILASRCLHVDLLHSILRSPMSFFERTPSGNLVNRFSKEL
DTVDSMIPEVIKMFMGSLFNVIGACIVILLATPIAAIIIPPLGLIYFFVQRFYVASSRQL
KRLESVSRSPVYSHFNETLLGVSVIRAFEEQERFIHQSDLKVDENQKAYYPSIVANRWLA
VRLECVGNCIVLFAALFAVISRHSLSAGLVGLSVSYSLQVTTYLNWLVRMSSEMETNIVA
VERLKEYSETEKEAPWQIQETAPPSSWPQVGRVEFRNYCLRYREDLDFVLRHINVTINGG
EKVGIVGRTGAGKSSLTLGLFRINESAEGEIIIDGINIAKIGLHDLRFKITIIPQDPVLF
SGSLRMNLDPFSQYSDEEVWTSLELAHLKDFVSALPDKLDHECAEGGENLSVGQRQLVCL
ARALLRKTKILVLDEATAAVDLETDDLIQSTIRTQFEDCTVLTIAHRLNTIMDYTRVIVL
DKGEIQEYGAPSDLLQQRGLFYSMAKDAGLV</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010554|Multidrug resistance-associated protein 1 (ABCC1)
ATGGCGCTCCGGGGCTTCTGCAGCGCCGATGGCTCCGACCCGCTCTGGGACTGGAATGTC
ACGTGGAATACCAGCAACCCCGACTTCACCAAGTGCTTTCAGAACACGGTCCTCGTGTGG
GTGCCTTGTTTTTACCTCTGGGCCTGTTTCCCCTTCTACTTCCTCTATCTCTCCCGACAT
GACCGAGGCTACATTCAGATGACACCTCTCAACAAAACCAAAACTGCCTTGGGATTTTTG
CTGTGGATCGTCTGCTGGGCAGACCTCTTCTACTCTTTCTGGGAAAGAAGTCGGGGCATA
TTCCTGGCCCCAGTGTTTCTGGTCAGCCCAACTCTCTTGGGCATCACCATGCTGCTTGCT
ACCTTTTTAATTCAGCTGGAGAGGAGGAAGGGAGTTCAGTCTTCAGGGATCATGCTCACT
TTCTGGCTGGTAGCCCTAGTGTGTGCCCTAGCCATCCTGAGATCCAAAATTATGACAGCC
TTAAAAGAGGATGCCCAGGTGGACCTGTTTCGTGACATCACTTTCTACGTCTACTTTTCC
CTCTTACTCATTCAGCTCGTCTTGTCCTGTTTCTCAGATCGCTCACCCCTGTTCTCGGAA
ACCATCCACGACCCTAATCCCTGCCCAGAGTCCAGCGCTTCCTTCCTGTCGAGGATCACC
TTCTGGTGGATCACAGGGTTGATTGTCCGGGGCTACCGCCAGCCCCTGGAGGGCAGTGAC
CTCTGGTCCTTAAACAAGGAGGACACGTCGGAACAAGTCGTGCCTGTTTTGGTAAAGAAC
TGGAAGAAGGAATGCGCCAAGACTAGGAAGCAGCCGGTGAAGGTTGTGTACTCCTCCAAG
GATCCTGCCCAGCCGAAAGAGAGTTCCAAGGTGGATGCGAATGAGGAGGTGGAGGCTTTG
ATCGTCAAGTCCCCACAGAAGGAGTGGAACCCCTCTCTGTTTAAGGTGTTATACAAGACC
TTTGGGCCCTACTTCCTCATGAGCTTCTTCTTCAAGGCCATCCACGACCTGATGATGTTT
TCCGGGCCGCAGATCTTAAAGTTGCTCATCAAGTTCGTGAATGACACGAAGGCCCCAGAC
TGGCAGGGCTACTTCTACACCGTGCTGCTGTTTGTCACTGCCTGCCTGCAGACCCTCGTG
CTGCACCAGTACTTCCACATCTGCTTCGTCAGTGGCATGAGGATCAAGACCGCTGTCATT
GGGGCTGTCTATCGGAAGGCCCTGGTGATCACCAATTCAGCCAGAAAATCCTCCACGGTC
GGGGAGATTGTCAACCTCATGTCTGTGGACGCTCAGAGGTTCATGGACTTGGCCACGTAC
ATTAACATGATCTGGTCAGCCCCCCTGCAAGTCATCCTTGCTCTCTACCTCCTGTGGCTG
AATCTGGGCCCTTCCGTCCTGGCTGGAGTGGCGGTGATGGTCCTCATGGTGCCCGTCAAT
GCTGTGATGGCGATGAAGACCAAGACGTATCAGGTGGCCCACATGAAGAGCAAAGACAAT
CGGATCAAGCTGATGAACGAAATTCTCAATGGGATCAAAGTGCTAAAGCTTTATGCCTGG
GAGCTGGCATTCAAGGACAAGGTGCTGGCCATCAGGCAGGAGGAGCTGAAGGTGCTGAAG
AAGTCTGCCTACCTGTCAGCCGTGGGCACCTTCACCTGGGTCTGCACGCCCTTTCTGGTG
GCCTTGTGCACATTTGCCGTCTACGTGACCATTGACGAGAACAACATCCTGGATGCCCAG
ACAGCCTTCGTGTCTTTGGCCTTGTTCAACATCCTCCGGTTTCCCCTGAACATTCTCCCC
ATGGTCATCAGCAGCATCGTGCAGGCGAGTGTCTCCCTCAAACGCCTGAGGATCTTTCTC
TCCCATGAGGAGCTGGAACCTGACAGCATCGAGCGACGGCCTGTCAAAGACGGCGGGGGC
ACGAACAGCATCACCGTGAGGAATGCCACATTCACCTGGGCCAGGAGCGACCCTCCCACA
CTGAATGGCATCACCTTCTCCATCCCCGAAGGTGCTTTGGTGGCCGTGGTGGGCCAGGTG
GGCTGCGGAAAGTCGTCCCTGCTCTCAGCCCTCTTGGCTGAGATGGACAAAGTGGAGGGG
CACGTGGCTATCAAGGGCTCCGTGGCCTATGTGCCACAGCAGGCCTGGATTCAGAATGAT
TCTCTCCGAGAAAACATCCTTTTTGGATGTCAGCTGGAGGAACCATATTACAGGTCCGTG
ATACAGGCCTGTGCCCTCCTCCCAGACCTGGAAATCCTGCCCAGTGGGGATCGGACAGAG
ATTGGCGAGAAGGGCGTGAACCTGTCTGGGGGCCAGAAGCAGCGCGTGAGCCTGGCCCGG
GCCGTGTACTCCAACGCTGACATTTACCTCTTCGATGATCCCCTCTCAGCAGTGGATGCC
CATGTGGGAAAACACATCTTTGAAAATGTGATTGGCCCCAAGGGGATGCTGAAGAACAAG
ACGCGGATCTTGGTCACGCACAGCATGAGCTACTTGCCGCAGGTGGACGTCATCATCGTC
ATGAGTGGCGGCAAGATCTCTGAGATGGGCTCCTACCAGGAGCTGCTGGCTCGAGACGGC
GCCTTCGCTGAGTTCCTGCGTACCTATGCCAGCACAGAGCAGGAGCAGGATGCAGAGGAG
AACGGGGTCACGGGCGTCAGCGGTCCAGGGAAGGAAGCAAAGCAAATGGAGAATGGCATG
CTGGTGACGGACAGTGCAGGGAAGCAACTGCAGAGACAGCTCAGCAGCTCCTCCTCCTAT
AGTGGGGACATCAGCAGGCACCACAACAGCACCGCAGAACTGCAGAAAGCTGAGGCCAAG
AAGGAGGAGACCTGGAAGCTGATGGAGGCTGACAAGGCGCAGACAGGGCAGGTCAAGCTT
TCCGTGTACTGGGACTACATGAAGGCCATCGGACTCTTCATCTCCTTCCTCAGCATCTTC
CTTTTCATGTGTAACCATGTGTCCGCGCTGGCTTCCAACTATTGGCTCAGCCTCTGGACT
GATGACCCCATCGTCAACGGGACTCAGGAGCACACGAAAGTCCGGCTGAGCGTCTATGGA
GCCCTGGGCATTTCACAAGGGATCGCCGTGTTTGGCTACTCCATGGCCGTGTCCATCGGG
GGGATCTTGGCTTCCCGCTGTCTGCACGTGGACCTGCTGCACAGCATCCTGCGGTCACCC
ATGAGCTTCTTTGAGCGGACCCCCAGTGGGAACCTGGTGAACCGCTTCTCCAAGGAGCTG
GACACAGTGGACTCCATGATCCCGGAGGTCATCAAGATGTTCATGGGCTCCCTGTTCAAC
GTCATTGGTGCCTGCATCGTTATCCTGCTGGCCACGCCCATCGCCGCCATCATCATCCCG
CCCCTTGGCCTCATCTACTTCTTCGTCCAGAGGTTCTACGTGGCTTCCTCCCGGCAGCTG
AAGCGCCTCGAGTCGGTCAGCCGCTCCCCGGTCTATTCCCATTTCAACGAGACCTTGCTG
GGGGTCAGCGTCATTCGAGCCTTCGAGGAGCAGGAGCGCTTCATCCACCAGAGTGACCTG
AAGGTGGACGAGAACCAGAAGGCCTATTACCCCAGCATCGTGGCCAACAGGTGGCTGGCC
GTGCGGCTGGAGTGTGTGGGCAACTGCATCGTTCTGTTTGCTGCCCTGTTTGCGGTGATC
TCCAGGCACAGCCTCAGTGCTGGCTTGGTGGGCCTCTCAGTGTCTTACTCATTGCAGGTC
ACCACGTACTTGAACTGGCTGGTTCGGATGTCATCTGAAATGGAAACCAACATCGTGGCC
GTGGAGAGGCTCAAGGAGTATTCAGAGACTGAGAAGGAGGCGCCCTGGCAAATCCAGGAG
ACAGCTCCGCCCAGCAGCTGGCCCCAGGTGGGCCGAGTGGAATTCCGGAACTACTGCCTG
CGCTACCGAGAGGACCTGGACTTCGTTCTCAGGCACATCAATGTCACGATCAATGGGGGA
GAAAAGGTCGGCATCGTGGGGCGGACGGGAGCTGGGAAGTCGTCCCTGACCCTGGGCTTA
TTTCGGATCAACGAGTCTGCCGAAGGAGAGATCATCATCGATGGCATCAACATCGCCAAG
ATCGGCCTGCACGACCTCCGCTTCAAGATCACCATCATCCCCCAGGACCCTGTTTTGTTT
TCGGGTTCCCTCCGAATGAACCTGGACCCATTCAGCCAGTACTCGGATGAAGAAGTCTGG
ACGTCCCTGGAGCTGGCCCACCTGAAGGACTTCGTGTCAGCCCTTCCTGACAAGCTAGAC
CATGAATGTGCAGAAGGCGGGGAGAACCTCAGTGTCGGGCAGCGCCAGCTTGTGTGCCTA
GCCCGGGCCCTGCTGAGGAAGACGAAGATCCTTGTGTTGGATGAGGCCACGGCAGCCGTG
GACCTGGAAACGGACGACCTCATCCAGTCCACCATCCGGACACAGTTCGAGGACTGCACC
GTCCTCACCATCGCCCACCGGCTCAACACCATCATGGACTACACAAGGGTGATCGTCTTG
GACAAAGGAGAAATCCAGGAGTACGGCGCCCCATCGGACCTCCTGCAGCAGAGAGGTCTT
TTCTACAGCATGGCCAAAGACGCCGGCTTGGTGTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00005</identifier>
        <name>ABC_tran</name>
      </pfam>
      <pfam>
        <identifier>PF00664</identifier>
        <name>ABC_membrane</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>extracellular exosome</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity, coupled to transmembrane movement of substances</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>water-soluble vitamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to drug</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cobalamin metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>arachidonic acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>leukotriene metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="2">
      <id>BE0001069</id>
      <name>Canalicular multispecific organic anion transporter 1</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
        <action>inhibitor</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>10024515</pubmed-id>
            <citation>Paulusma CC, van Geer MA, Evers R, Heijn M, Ottenhoff R, Borst P, Oude Elferink RP: Canalicular multispecific organic anion transporter/multidrug resistance protein 2 mediates low-affinity transport of reduced glutathione. Biochem J. 1999 Mar 1;338 ( Pt 2):393-401.</citation>
          </article>
          <article>
            <pubmed-id>10491184</pubmed-id>
            <citation>Hagmann W, Nies AT, Konig J, Frey M, Zentgraf H, Keppler D: Purification of the human apical conjugate export pump MRP2 reconstitution and functional characterization as substrate-stimulated ATPase. Eur J Biochem. 1999 Oct 1;265(1):281-9.</citation>
          </article>
          <article>
            <pubmed-id>1430236</pubmed-id>
            <citation>Nishida T, Gatmaitan Z, Roy-Chowdhry J, Arias IM: Two distinct mechanisms for bilirubin glucuronide transport by rat bile canalicular membrane vesicles. Demonstration of defective ATP-dependent transport in rats (TR-) with inherited conjugated hyperbilirubinemia. J Clin Invest. 1992 Nov;90(5):2130-5.</citation>
          </article>
          <article>
            <pubmed-id>10648470</pubmed-id>
            <citation>Stieger B, Fattinger K, Madon J, Kullak-Ublick GA, Meier PJ: Drug- and estrogen-induced cholestasis through inhibition of the hepatocellular bile salt export pump (Bsep) of rat liver. Gastroenterology. 2000 Feb;118(2):422-30.</citation>
          </article>
          <article>
            <pubmed-id>10692506</pubmed-id>
            <citation>Madon J, Hagenbuch B, Landmann L, Meier PJ, Stieger B: Transport function and hepatocellular localization of mrp6 in rat liver. Mol Pharmacol. 2000 Mar;57(3):634-41.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q92887" source="Swiss-Prot">
    <name>Canalicular multispecific organic anion transporter 1</name>
    <general-function>Organic anion transmembrane transporter activity</general-function>
    <specific-function>Mediates hepatobiliary excretion of numerous organic anions. May function as a cellular cisplatin transporter.</specific-function>
    <gene-name>ABCC2</gene-name>
    <locus>10q24</locus>
    <cellular-location>Apical cell membrane</cellular-location>
    <transmembrane-regions>28-48
69-89
94-114
127-147
166-186
314-334
361-381
438-458
462-482
545-565
588-608
972-992
1034-1054
1098-1118
1120-1140
1212-1232
1235-1255</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.46</theoretical-pi>
    <molecular-weight>174205.64</molecular-weight>
    <chromosome-location>10</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:53</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ABCC2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>U63970</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>1764162</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>780</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q92887</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MRP2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ATP-binding cassette sub-family C member 2</synonym>
      <synonym>Canalicular multidrug resistance protein</synonym>
      <synonym>CMOAT</synonym>
      <synonym>CMOAT1</synonym>
      <synonym>CMRP</synonym>
      <synonym>MRP2</synonym>
      <synonym>Multidrug resistance-associated protein 2</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0010748|Canalicular multispecific organic anion transporter 1
MLEKFCNSTFWNSSFLDSPEADLPLCFEQTVLVWIPLGYLWLLAPWQLLHVYKSRTKRSS
TTKLYLAKQVFVGFLLILAAIELALVLTEDSGQATVPAVRYTNPSLYLGTWLLVLLIQYS
RQWCVQKNSWFLSLFWILSILCGTFQFQTLIRTLLQGDNSNLAYSCLFFISYGFQILILI
FSAFSENNESSNNPSSIASFLSSITYSWYDSIILKGYKRPLTLEDVWEVDEEMKTKTLVS
KFETHMKRELQKARRALQRRQEKSSQQNSGARLPGLNKNQSQSQDALVLEDVEKKKKKSG
TKKDVPKSWLMKALFKTFYMVLLKSFLLKLVNDIFTFVSPQLLKLLISFASDRDTYLWIG
YLCAILLFTAALIQSFCLQCYFQLCFKLGVKVRTAIMASVYKKALTLSNLARKEYTVGET
VNLMSVDAQKLMDVTNFMHMLWSSVLQIVLSIFFLWRELGPSVLAGVGVMVLVIPINAIL
STKSKTIQVKNMKNKDKRLKIMNEILSGIKILKYFAWEPSFRDQVQNLRKKELKNLLAFS
QLQCVVIFVFQLTPVLVSVVTFSVYVLVDSNNILDAQKAFTSITLFNILRFPLSMLPMMI
SSMLQASVSTERLEKYLGGDDLDTSAIRHDCNFDKAMQFSEASFTWEHDSEATVRDVNLD
IMAGQLVAVIGPVGSGKSSLISAMLGEMENVHGHITIKGTTAYVPQQSWIQNGTIKDNIL
FGTEFNEKRYQQVLEACALLPDLEMLPGGDLAEIGEKGINLSGGQKQRISLARATYQNLD
IYLLDDPLSAVDAHVGKHIFNKVLGPNGLLKGKTRLLVTHSMHFLPQVDEIVVLGNGTIV
EKGSYSALLAKKGEFAKNLKTFLRHTGPEEEATVHDGSEEEDDDYGLISSVEEIPEDAAS
ITMRRENSFRRTLSRSSRSNGRHLKSLRNSLKTRNVNSLKEDEELVKGQKLIKKEFIETG
KVKFSIYLEYLQAIGLFSIFFIILAFVMNSVAFIGSNLWLSAWTSDSKIFNSTDYPASQR
DMRVGVYGALGLAQGIFVFIAHFWSAFGFVHASNILHKQLLNNILRAPMRFFDTTPTGRI
VNRFAGDISTVDDTLPQSLRSWITCFLGIISTLVMICMATPVFTIIVIPLGIIYVSVQMF
YVSTSRQLRRLDSVTRSPIYSHFSETVSGLPVIRAFEHQQRFLKHNEVRIDTNQKCVFSW
ITSNRWLAIRLELVGNLTVFFSALMMVIYRDTLSGDTVGFVLSNALNITQTLNWLVRMTS
EIETNIVAVERITEYTKVENEAPWVTDKRPPPDWPSKGKIQFNNYQVRYRPELDLVLRGI
TCDIGSMEKIGVVGRTGAGKSSLTNCLFRILEAAGGQIIIDGVDIASIGLHDLREKLTII
PQDPILFSGSLRMNLDPFNNYSDEEIWKALELAHLKSFVASLQLGLSHEVTEAGGNLSIG
QRQLLCLGRALLRKSKILVLDEATAAVDLETDNLIQTTIQNEFAHCTVITIAHRLHTIMD
SDKVMVLDNGKIIECGSPEELLQIPGPFYFMAKEAGIENVNSTKF</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010749|Canalicular multispecific organic anion transporter 1 (ABCC2)
ATGCTGGAGAAGTTCTGCAACTCTACTTTTTGGAATTCCTCATTCCTGGACAGTCCGGAG
GCAGACCTGCCACTTTGTTTTGAGCAAACTGTTCTGGTGTGGATTCCCTTGGGCTTCCTA
TGGCTCCTGGCCCCCTGGCAGCTTCTCCACGTGTATAAATCCAGGACCAAGAGATCCTCT
ACCACCAAACTCTATCTTGCTAAGCAGGTATTCGTTGGTTTTCTTCTTATTCTAGCAGCC
ATAGAGCTGGCCCTTGTACTCACAGAAGACTCTGGACAAGCCACAGTCCCTGCTGTTCGA
TATACCAATCCAAGCCTCTACCTAGGCACATGGCTCCTGGTTTTGCTGATCCAATACAGC
AGACAATGGTGTGTACAGAAAAACTCCTGGTTCCTGTCCCTATTCTGGATTCTCTCGATA
CTCTGTGGCACTTTCCAATTTCAGACTCTGATCCGGACACTCTTACAGGGTGACAATTCT
AATCTAGCCTACTCCTGCCTGTTCTTCATCTCCTACGGATTCCAGATCCTGATCCTGATC
TTTTCAGCATTTTCAGAAAATAATGAGTCATCAAATAATCCATCATCCATAGCTTCATTC
CTGAGTAGCATTACCTACAGCTGGTATGACAGCATCATTCTGAAAGGCTACAAGCGTCCT
CTGACACTCGAGGATGTCTGGGAAGTTGATGAAGAGATGAAAACCAAGACATTAGTGAGC
AAGTTTGAAACGCACATGAAGAGAGAGCTGCAGAAAGCCAGGCGGGCACTCCAGAGACGG
CAGGAGAAGAGCTCCCAGCAGAACTCTGGAGCCAGGCTGCCTGGCTTGAACAAGAATCAG
AGTCAAAGCCAAGATGCCCTTGTCCTGGAAGATGTTGAAAAGAAAAAAAAGAAGTCTGGG
ACCAAAAAAGATGTTCCAAAATCCTGGTTGATGAAGGCTCTGTTCAAAACTTTCTACATG
GTGCTCCTGAAATCATTCCTACTGAAGCTAGTGAATGACATCTTCACGTTTGTGAGTCCT
CAGCTGCTGAAATTGCTGATCTCCTTTGCAAGTGACCGTGACACATATTTGTGGATTGGA
TATCTCTGTGCAATCCTCTTATTCACTGCGGCTCTCATTCAGTCTTTCTGCCTTCAGTGT
TATTTCCAACTGTGCTTCAAGCTGGGTGTAAAAGTACGGACAGCTATCATGGCTTCTGTA
TATAAGAAGGCATTGACCCTATCCAACTTGGCCAGGAAGGAGTACACCGTTGGAGAAACA
GTGAACCTGATGTCTGTGGATGCCCAGAAGCTCATGGATGTGACCAACTTCATGCACATG
CTGTGGTCAAGTGTTCTACAGATTGTCTTATCTATCTTCTTCCTATGGAGAGAGTTGGGA
CCCTCAGTCTTAGCAGGTGTTGGGGTGATGGTGCTTGTAATCCCAATTAATGCGATACTG
TCCACCAAGAGTAAGACCATTCAGGTCAAAAATATGAAGAATAAAGACAAACGTTTAAAG
ATCATGAATGAGATTCTTAGTGGAATCAAGATCCTGAAATATTTTGCCTGGGAACCTTCA
TTCAGAGACCAAGTACAAAACCTCCGGAAGAAAGAGCTCAAGAACCTGCTGGCCTTTAGT
CAACTACAGTGTGTAGTAATATTCGTCTTCCAGTTAACTCCAGTCCTGGTATCTGTGGTC
ACATTTTCTGTTTATGTCCTGGTGGATAGCAACAATATTTTGGATGCACAAAAGGCCTTC
ACCTCCATTACCCTCTTCAATATCCTGCGCTTTCCCCTGAGCATGCTTCCCATGATGATC
TCCTCCATGCTCCAGGCCAGTGTTTCCACAGAGCGGCTAGAGAAGTACTTGGGAGGGGAT
GACTTGGACACATCTGCCATTCGACATGACTGCAATTTTGACAAAGCCATGCAGTTTTCT
GAGGCCTCCTTTACCTGGGAACATGATTCGGAAGCCACAGTCCGAGATGTGAACCTGGAC
ATTATGGCAGGCCAACTTGTGGCTGTGATAGGCCCTGTCGGCTCTGGGAAATCCTCCTTG
ATATCAGCCATGCTGGGAGAAATGGAAAATGTCCACGGGCACATCACCATCAAGGGCACC
ACTGCCTATGTCCCACAGCAGTCCTGGATTCAGAATGGCACCATAAAGGACAACATCCTT
TTTGGAACAGAGTTTAATGAAAAGAGGTACCAGCAAGTACTGGAGGCCTGTGCTCTCCTC
CCAGACTTGGAAATGCTGCCTGGAGGAGATTTGGCTGAGATTGGAGAGAAGGGTATAAAT
CTTAGTGGGGGTCAGAAGCAGCGGATCAGCCTGGCCAGAGCTACCTACCAAAATTTAGAC
ATCTATCTTCTAGATGACCCCCTGTCTGCAGTGGATGCTCATGTAGGAAAACATATTTTT
AATAAGGTCTTGGGCCCCAATGGCCTGTTGAAAGGCAAGACTCGACTCTTGGTTACACAT
AGCATGCACTTTCTTCCTCAAGTGGATGAGATTGTAGTTCTGGGGAATGGAACAATTGTA
GAGAAAGGATCCTACAGTGCTCTCCTGGCCAAAAAAGGAGAGTTTGCTAAGAATCTGAAG
ACATTTCTAAGACATACAGGCCCTGAAGAGGAAGCCACAGTCCATGATGGCAGTGAAGAA
GAAGACGATGACTATGGGCTGATATCCAGTGTGGAAGAGATCCCCGAAGATGCAGCCTCC
ATAACCATGAGAAGAGAGAACAGCTTTCGTCGAACACTTAGCCGCAGTTCTAGGTCCAAT
GGCAGGCATCTGAAGTCCCTGAGAAACTCCTTGAAAACTCGGAATGTGAATAGCCTGAAG
GAAGACGAAGAACTAGTGAAAGGACAAAAACTAATTAAGAAGGAATTCATAGAAACTGGA
AAGGTGAAGTTCTCCATCTACCTGGAGTACCTACAAGCAATAGGATTGTTTTCGATATTC
TTCATCATCCTTGCGTTTGTGATGAATTCTGTGGCTTTTATTGGATCCAACCTCTGGCTC
AGTGCTTGGACCAGTGACTCTAAAATCTTCAATAGCACCGACTATCCAGCATCTCAGAGG
GACATGAGAGTTGGAGTCTACGGAGCTCTGGGATTAGCCCAAGGTATATTTGTGTTCATA
GCACATTTCTGGAGTGCCTTTGGTTTCGTCCATGCATCAAATATCTTGCACAAGCAACTG
CTGAACAATATCCTTCGAGCACCTATGAGATTTTTTGACACAACACCCACAGGCCGGATT
GTGAACAGGTTTGCCGGCGATATTTCCACAGTGGATGACACCCTGCCTCAGTCCTTGCGC
AGCTGGATTACATGCTTCCTGGGGATAATCAGCACCCTTGTCATGATCTGCATGGCCACT
CCTGTCTTCACCATCATCGTCATTCCTCTTGGCATTATTTATGTATCTGTTCAGATGTTT
TATGTGTCTACCTCCCGCCAGCTGAGGCGTCTGGACTCTGTCACCAGGTCCCCAATCTAC
TCTCACTTCAGCGAGACCGTATCAGGTTTGCCAGTTATCCGTGCCTTTGAGCACCAGCAG
CGATTTCTGAAACACAATGAGGTGAGGATTGACACCAACCAGAAATGTGTCTTTTCCTGG
ATCACCTCCAACAGGTGGCTTGCAATTCGCCTGGAGCTGGTTGGGAACCTGACTGTCTTC
TTTTCAGCCTTGATGATGGTTATTTATAGAGATACCCTAAGTGGGGACACTGTTGGCTTT
GTTCTGTCCAATGCACTCAATATCACACAAACCCTGAACTGGCTGGTGAGGATGACATCA
GAAATAGAGACCAACATTGTGGCTGTTGAGCGAATAACTGAGTACACAAAAGTGGAAAAT
GAGGCACCCTGGGTGACTGATAAGAGGCCTCCGCCAGATTGGCCCAGCAAAGGCAAGATC
CAGTTTAACAACTACCAAGTGCGGTACCGACCTGAGCTGGATCTGGTCCTCAGAGGGATC
ACTTGTGACATCGGTAGCATGGAGAAGATTGGTGTGGTGGGCAGGACAGGAGCTGGAAAG
TCATCCCTCACAAACTGCCTCTTCAGAATCTTAGAGGCTGCCGGTGGTCAGATTATCATT
GATGGAGTAGATATTGCTTCCATTGGGCTCCACGACCTCCGAGAGAAGCTGACCATCATC
CCCCAGGACCCCATCCTGTTCTCTGGAAGCCTGAGGATGAATCTCGACCCTTTCAACAAC
TACTCAGATGAGGAGATTTGGAAGGCCTTGGAGCTGGCTCACCTCAAGTCTTTTGTGGCC
AGCCTGCAACTTGGGTTATCCCACGAAGTGACAGAGGCTGGTGGCAACCTGAGCATAGGC
CAGAGGCAGCTGCTGTGCCTGGGCAGGGCTCTGCTTCGGAAATCCAAGATCCTGGTCCTG
GATGAGGCCACTGCTGCGGTGGATCTAGAGACAGACAACCTCATTCAGACGACCATCCAA
AACGAGTTCGCCCACTGCACAGTGATCACCATCGCCCACAGGCTGCACACCATCATGGAC
AGTGACAAGGTAATGGTCCTAGACAACGGGAAGATTATAGAGTGCGGCAGCCCTGAAGAA
CTGCTACAAATCCCTGGACCCTTTTACTTTATGGCTAAGGAAGCTGGCATTGAGAATGTG
AACAGCACAAAATTCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00005</identifier>
        <name>ABC_tran</name>
      </pfam>
      <pfam>
        <identifier>PF00664</identifier>
        <name>ABC_membrane</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cell surface</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>apical plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity, coupled to transmembrane movement of substances</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>drug transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to methotrexate</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to heat</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to arsenic-containing substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to oxidative stress</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cellular chloride ion homeostasis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>prostaglandin transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to estrogen</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>thyroid hormone transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="3">
      <id>BE0001061</id>
      <name>Canalicular multispecific organic anion transporter 2</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11581266</pubmed-id>
            <citation>Zelcer N, Saeki T, Reid G, Beijnen JH, Borst P: Characterization of drug transport by the human multidrug resistance protein 3 (ABCC3). J Biol Chem. 2001 Dec 7;276(49):46400-7.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15438" source="Swiss-Prot">
    <name>Canalicular multispecific organic anion transporter 2</name>
    <general-function>Organic anion transmembrane transporter activity</general-function>
    <specific-function>May act as an inducible transporter in the biliary and intestinal excretion of organic anions. Acts as an alternative route for the export of bile acids and glucuronides from cholestatic hepatocytes (By similarity).</specific-function>
    <gene-name>ABCC3</gene-name>
    <locus>17q22</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>33-53
74-94
100-120
133-153
172-192
303-323
350-370
427-447
451-471
534-554
577-597
964-984
1022-1042
1086-1106
1108-1128
1200-1220
1223-1243</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>7.2</theoretical-pi>
    <molecular-weight>169341.14</molecular-weight>
    <chromosome-location>17</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:54</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ABCC3</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB010887</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3132270</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15438</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MRP3_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ATP-binding cassette sub-family C member 3</synonym>
      <synonym>CMOAT2</synonym>
      <synonym>MLP2</synonym>
      <synonym>MOAT-D</synonym>
      <synonym>MRP3</synonym>
      <synonym>Multi-specific organic anion transporter D</synonym>
      <synonym>Multidrug resistance-associated protein 3</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0002113|Canalicular multispecific organic anion transporter 2
MDALCGSGELGSKFWDSNLSVHTENPDLTPCFQNSLLAWVPCIYLWVALPCYLLYLRHHC
RGYIILSHLSKLKMVLGVLLWCVSWADLFYSFHGLVHGRAPAPVFFVTPLVVGVTMLLAT
LLIQYERLQGVQSSGVLIIFWFLCVVCAIVPFRSKILLAKAEGEISDPFRFTTFYIHFAL
VLSALILACFREKPPFFSAKNVDPNPYPETSAGFLSRLFFWWFTKMAIYGYRHPLEEKDL
WSLKEEDRSQMVVQQLLEAWRKQEKQTARHKASAAPGKNASGEDEVLLGARPRPRKPSFL
KALLATFGSSFLISACFKLIQDLLSFINPQLLSILIRFISNPMAPSWWGFLVAGLMFLCS
MMQSLILQHYYHYIFVTGVKFRTGIMGVIYRKALVITNSVKRASTVGEIVNLMSVDAQRF
MDLAPFLNLLWSAPLQIILAIYFLWQNLGPSVLAGVAFMVLLIPLNGAVAVKMRAFQVKQ
MKLKDSRIKLMSEILNGIKVLKLYAWEPSFLKQVEGIRQGELQLLRTAAYLHTTTTFTWM
CSPFLVTLITLWVYVYVDPNNVLDAEKAFVSVSLFNILRLPLNMLPQLISNLTQASVSLK
RIQQFLSQEELDPQSVERKTISPGYAITIHSGTFTWAQDLPPTLHSLDIQVPKGALVAVV
GPVGCGKSSLVSALLGEMEKLEGKVHMKGSVAYVPQQAWIQNCTLQENVLFGKALNPKRY
QQTLEACALLADLEMLPGGDQTEIGEKGINLSGGQRQRVSLARAVYSDADIFLLDDPLSA
VDSHVAKHIFDHVIGPEGVLAGKTRVLVTHGISFLPQTDFIIVLADGQVSEMGPYPALLQ
RNGSFANFLCNYAPDEDQGHLEDSWTALEGAEDKEALLIEDTLSNHTDLTDNDPVTYVVQ
KQFMRQLSALSSDGEGQGRPVPRRHLGPSEKVQVTEAKADGALTQEEKAAIGTVELSVFW
DYAKAVGLCTTLAICLLYVGQSAAAIGANVWLSAWTNDAMADSRQNNTSLRLGVYAALGI
LQGFLVMLAAMAMAAGGIQAARVLHQALLHNKIRSPQSFFDTTPSGRILNCFSKDIYVVD
EVLAPVILMLLNSFFNAISTLVVIMASTPLFTVVILPLAVLYTLVQRFYAATSRQLKRLE
SVSRSPIYSHFSETVTGASVIRAYNRSRDFEIISDTKVDANQRSCYPYIISNRWLSIGVE
FVGNCVVLFAALFAVIGRSSLNPGLVGLSVSYSLQVTFALNWMIRMMSDLESNIVAVERV
KEYSKTETEAPWVVEGSRPPEGWPPRGEVEFRNYSVRYRPGLDLVLRDLSLHVHGGEKVG
IVGRTGAGKSSMTLCLFRILEAAKGEIRIDGLNVADIGLHDLRSQLTIIPQDPILFSGTL
RMNLDPFGSYSEEDIWWALELSHLHTFVSSQPAGLDFQCSEGGENLSVGQRQLVCLARAL
LRKSRILVLDEATAAIDLETDNLIQATIRTQFDTCTVLTIAHRLNTIMDYTRVLVLDKGV
VAEFDSPANLIAARGIFYGMARDAGLA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010744|Canalicular multispecific organic anion transporter 2 (ABCC3)
ATGGACGCCCTGTGCGGTTCCGGGGAGCTCGGCTCCAAGTTCTGGGACTCCAACCTGTCT
GTGCACACAGAAAACCCGGACCTCACTCCCTGCTTCCAGAACTCCCTGCTGGCCTGGGTG
CCCTGCATCTACCTGTGGGTCGCCCTGCCCTGCTACTTGCTCTACCTGCGGCACCATTGT
CGTGGCTACATCATCCTCTCCCACCTGTCCAAGCTCAAGATGGTCCTGGGTGTCCTGCTG
TGGTGCGTCTCCTGGGCGGACCTTTTTTACTCCTTCCATGGCCTGGTCCATGGCCGGGCC
CCTGCCCCTGTTTTCTTTGTCACCCCCTTGGTGGTGGGGGTCACCATGCTGCTGGCCACC
CTGCTGATACAGTATGAGCGGCTGCAGGGCGTACAGTCTTCGGGGGTCCTCATTATCTTC
TGGTTCCTGTGTGTGGTCTGCGCCATCGTCCCATTCCGCTCCAAGATCCTTTTAGCCAAG
GCAGAGGGTGAGATCTCAGACCCCTTCCGCTTCACCACCTTCTACATCCACTTTGCCCTG
GTACTCTCTGCCCTCATCTTGGCCTGCTTCAGGGAGAAACCTCCATTTTTCTCCGCAAAG
AATGTCGACCCTAACCCCTACCCTGAGACCAGCGCTGGCTTTCTCTCCCGCCTGTTTTTC
TGGTGGTTCACAAAGATGGCCATCTATGGCTACCGGCATCCCCTGGAGGAGAAGGACCTC
TGGTCCCTAAAGGAAGAGGACAGATCCCAGATGGTGGTGCAGCAGCTGCTGGAGGCATGG
AGGAAGCAGGAAAAGCAGACGGCACGACACAAGGCTTCAGCAGCACCTGGGAAAAATGCC
TCCGGCGAGGACGAGGTGCTGCTGGGTGCCCGGCCCAGGCCCCGGAAGCCCTCCTTCCTG
AAGGCCCTGCTGGCCACCTTCGGCTCCAGCTTCCTCATCAGTGCCTGCTTCAAGCTTATC
CAGGACCTGCTCTCCTTCATCAATCCACAGCTGCTCAGCATCCTGATCAGGTTTATCTCC
AACCCCATGGCCCCCTCCTGGTGGGGCTTCCTGGTGGCTGGGCTGATGTTCCTGTGCTCC
ATGATGCAGTCGCTGATCTTACAACACTATTACCACTACATCTTTGTGACTGGGGTGAAG
TTTCGTACTGGGATCATGGGTGTCATCTACAGGAAGGCTCTGGTTATCACCAACTCAGTC
AAACGTGCGTCCACTGTGGGGGAAATTGTCAACCTCATGTCAGTGGATGCCCAGCGCTTC
ATGGACCTTGCCCCCTTCCTCAATCTGCTGTGGTCAGCACCCCTGCAGATCATCCTGGCG
ATCTACTTCCTCTGGCAGAACCTAGGTCCCTCTGTCCTGGCTGGAGTCGCTTTCATGGTC
TTGCTGATTCCACTCAACGGAGCTGTGGCCGTGAAGATGCGCGCCTTCCAGGTAAAGCAA
ATGAAATTGAAGGACTCGCGCATCAAGCTGATGAGTGAGATCCTGAACGGCATCAAGGTG
CTGAAGCTGTACGCCTGGGAGCCCAGCTTCCTGAAGCAGGTGGAGGGCATCAGGCAGGGT
GAGCTCCAGCTGCTGCGCACGGCGGCCTACCTCCACACCACAACCACCTTCACCTGGATG
TGCAGCCCCTTCCTGGTGAGGCTTGGCACAGGGCTGGGTCCCTGCCTCCAGGGCTCTGGG
TGCCCAGGCATGGCCAGGGCTCATTGGACTCTACCCTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00005</identifier>
        <name>ABC_tran</name>
      </pfam>
      <pfam>
        <identifier>PF00664</identifier>
        <name>ABC_membrane</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity, coupled to transmembrane movement of substances</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>bile acid and bile salt transport</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="4">
      <id>BE0001188</id>
      <name>Multidrug resistance-associated protein 4</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>11802779</pubmed-id>
            <citation>Lai L, Tan TM: Role of glutathione in the multidrug resistance protein 4 (MRP4/ABCC4)-mediated efflux of cAMP and resistance to purine analogues. Biochem J. 2002 Feb 1;361(Pt 3):497-503.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15439" source="Swiss-Prot">
    <name>Multidrug resistance-associated protein 4</name>
    <general-function>Atpase activity, coupled to transmembrane movement of substances</general-function>
    <specific-function>May be an organic anion pump relevant to cellular detoxification.</specific-function>
    <gene-name>ABCC4</gene-name>
    <locus>13q32</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>93-113
136-156
207-227
228-248
328-348
351-371
440-460
710-730
771-791
836-856
858-878
954-974
977-997
1038-1058</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.39</theoretical-pi>
    <molecular-weight>149525.33</molecular-weight>
    <chromosome-location>13</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:55</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>ABCC4</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF071202</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>3335173</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>782</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15439</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MRP4_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ATP-binding cassette sub-family C member 4</synonym>
      <synonym>MOAT-B</synonym>
      <synonym>MRP/cMOAT-related ABC transporter</synonym>
      <synonym>MRP4</synonym>
      <synonym>Multi-specific organic anion transporter B</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037136|Multidrug resistance-associated protein 4
MLPVYQEVKPNPLQDANLCSRVFFWWLNPLFKIGHKRRLEEDDMYSVLPEDRSQHLGEEL
QGFWDKEVLRAENDAQKPSLTRAIIKCYWKSYLVLGIFTLIEESAKVIQPIFLGKIINYF
ENYDPMDSVALNTAYAYATVLTFCTLILAILHHLYFYHVQCAGMRLRVAMCHMIYRKALR
LSNMAMGKTTTGQIVNLLSNDVNKFDQVTVFLHFLWAGPLQAIAVTALLWMEIGISCLAG
MAVLIILLPLQSCFGKLFSSLRSKTATFTDARIRTMNEVITGIRIIKMYAWEKSFSNLIT
NLRKKEISKILRSSCLRGMNLASFFSASKIIVFVTFTTYVLLGSVITASRVFVAVTLYGA
VRLTVTLFFPSAIERVSEAIVSIRRIQTFLLLDEISQRNRQLPSDGKKMVHVQDFTAFWD
KASETPTLQGLSFTVRPGELLAVVGPVGAGKSSLLSAVLGELAPSHGLVSVHGRIAYVSQ
QPWVFSGTLRSNILFGKKYEKERYEKVIKACALKKDLQLLEDGDLTVIGDRGTTLSGGQK
ARVNLARAVYQDADIYLLDDPLSAVDAEVSRHLFELCICQILHEKITILVTHQLQYLKAA
SQILILKDGKMVQKGTYTEFLKSGIDFGSLLKKDNEESEQPPVPGTPTLRNRTFSESSVW
SQQSSRPSLKDGALESQDTENVPVTLSEENRSEGKVGFQAYKNYFRAGAHWIVFIFLILL
NTAAQVAYVLQDWWLSYWANKQSMLNVTVNGGGNVTEKLDLNWYLGIYSGLTVATVLFGI
ARSLLVFYVLVNSSQTLHNKMFESILKAPVLFFDRNPIGRILNRFSKDIGHLDDLLPLTF
LDFIQTLLQVVGVVSVAVAVIPWIAIPLVPLGIIFIFLRRYFLETSRDVKRLESTTRSPV
FSHLSSSLQGLWTIRAYKAEERCQELFDAHQDLHSEAWFLFLTTSRWFAVRLDAICAMFV
IIVAFGSLILAKTLDAGQVGLALSYALTLMGMFQWCVRQSAEVENMMISVERVIEYTDLE
KEAPWEYQKRPPPAWPHEGVIIFDNVNFMYSPGGPLVLKHLTALIKSQEKVGIVGRTGAG
KSSLISALFRLSEPEGKIWIDKILTTEIGLHDLRKKMSIIPQEPVLFTGTMRKNLDPFNE
HTDEELWNALQEVQLKETIEDLPGKMDTELAESGSNFSVGQRQLVCLARAILRKNQILII
DEATANVDPRTDELIQKKIREKFAHCTVLTIAHRLNTIIDSDKIMVLDSGRLKEYDEPYV
LLQNKESLFYKMVQQLGKAEAAALTETAKQVYFKRNYPHIGHTDHMVTNTSNGQPSTLTI
FETAL</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0010828|Multidrug resistance-associated protein 4 (ABCC4)
ATGCTGCCCGTGTACCAGGAGGTGAAGCCCAACCCGCTGCAGGACGCGAACCTCTGCTCA
CGCGTGTTCTTCTGGTGGCTCAATCCCTTGTTTAAAATTGGCCATAAACGGAGATTAGAG
GAAGATGATATGTATTCAGTGCTGCCAGAAGACCGCTCACAGCACCTTGGAGAGGAGTTG
CAAGGGTTCTGGGATAAAGAAGTTTTAAGAGCTGAGAATGACGCACAGAAGCCTTCTTTA
ACAAGAGCAATCATAAAGTGTTACTGGAAATCTTATTTAGTTTTGGGAATTTTTACGTTA
ATTGAGGAAAGTGCCAAAGTAATCCAGCCCATATTTTTGGGAAAAATTATTAATTATTTT
GAAAATTATGATCCCATGGATTCTGTGGCTTTGAACACAGCGTACGCCTATGCCACGGTG
CTGACTTTTTGCACGCTCATTTTGGCTATACTGCATCACTTATATTTTTATCACGTTCAG
TGTGCTGGGATGAGGTTACGAGTAGCCATGTGCCATATGATTTATCGGAAGGCACTTCGT
CTTAGTAACATGGCCATGGGGAAGACAACCACAGGCCAGATAGTCAATCTGCTGTCCAAT
GATGTGAACAAGTTTGATCAGGTGACAGTGTTCTTACACTTCCTGTGGGCAGGACCACTG
CAGGCGATTGCAGTGACTGCCCTACTCTGGATGGAGATAGGAATATCGTGCCTTGCTGGG
ATGGCAGTTCTAATCATTCTCCTGCCCTTGCAAAGCTGTTTTGGGAAGTTGTTCTCATCA
CTGAGGAGTAAAACTGCAACTTTCACGGATGCCAGGATCAGGACCATGAATGAAGTTATA
ACTGGTATAAGGATAATAAAAATGTACGCCTGGGAAAAGTCATTTTCAAATCTTATTACC
AATTTGAGAAAGAAGGAGATTTCCAAGATTCTGAGAAGTTCCTGCCTCAGAGGGATGAAT
TTGGCTTCATTTTTCAGTGCAAGCAAAATCATCGTGTTTGTGACCTTCACCACCTACGTG
CTCCTCGGCAGTGTGATCACAGCCAGCCGCGTGTTCGTGGCAGTGACGCTGTATGGGGCT
GTGCGGCTGACGGTTACCCTCTTCTTCCCCTCAGCCATTGAGAGGGTGTCAGAGGCAATC
GTCAGCATCCGAAGAATCCAGACCTTTTTGCTACTTGATGAGATATCACAGCGCAACCGT
CAGCTGCCGTCAGATGGTAAAAAGATGGTGCATGTGCAGGATTTTACTGCTTTTTGGGAT
AAGGCATCAGAGACCCCAACTCTACAAGGCCTTTCCTTTACTGTCAGACCTGGCGAATTG
TTAGCTGTGGTCGGCCCCGTGGGAGCAGGGAAGTCATCACTGTTAAGTGCCGTGCTCGGG
GAATTGGCCCCAAGTCACGGGCTGGTCAGCGTGCATGGAAGAATTGCCTATGTGTCTCAG
CAGCCCTGGGTGTTCTCGGGAACTCTGAGGAGTAATATTTTATTTGGGAAGAAATACGAA
AAGGAACGATATGAAAAAGTCATAAAGGCTTGTGCTCTGAAAAAGGATTTACAGCTGTTG
GAGGATGGTGATCTGACTGTGATAGGAGATCGGGGAACCACGCTGAGTGGAGGGCAGAAA
GCACGGGTAAACCTTGCAAGAGCAGTGTATCAAGATGCTGACATCTATCTCCTGGACGAT
CCTCTCAGTGCAGTAGATGCGGAAGTTAGCAGACACTTGTTCGAACTGTGTATTTGTCAA
ATTTTGCATGAGAAGATCACAATTTTAGTGACTCATCAGTTGCAGTACCTCAAAGCTGCA
AGTCAGATTCTGATATTGAAAGATGGTAAAATGGTGCAGAAGGGGACTTACACTGAGTTC
CTAAAATCTGGTATAGATTTTGGCTCCCTTTTAAAGAAGGATAATGAGGAAAGTGAACAA
CCTCCAGTTCCAGGAACTCCCACACTAAGGAATCGTACCTTCTCAGAGTCTTCGGTTTGG
TCTCAACAATCTTCTAGACCCTCCTTGAAAGATGGTGCTCTGGAGAGCCAAGATACAGAG
AATGTCCCAGTTACACTATCAGAGGAGAACCGTTCTGAAGGAAAAGTTGGTTTTCAGGCC
TATAAGAATTACTTCAGAGCTGGTGCTCACTGGATTGTCTTCATTTTCCTTATTCTCCTA
AACACTGCAGCTCAGGTTGCCTATGTGCTTCAAGATTGGTGGCTTTCATACTGGGCAAAC
AAACAAAGTATGCTAAATGTCACTGTAAATGGAGGAGGAAATGTAACCGAGAAGCTAGAT
CTTAACTGGTACTTAGGAATTTATTCAGGTTTAACTGTAGCTACCGTTCTTTTTGGCATA
GCAAGATCTCTATTGGTATTCTACGTCCTTGTTAACTCTTCACAAACTTTGCACAACAAA
ATGTTTGAGTCAATTCTGAAAGCTCCGGTATTATTCTTTGATAGAAATCCAATAGGAAGA
ATTTTAAATCGTTTCTCCAAAGACATTGGACACTTGGATGATTTGCTGCCGCTGACGTTT
TTAGATTTCATCCAGAGATGGGATCTCGCTGTGTTGTCCTGGCTGGTCTCAAACTCCTAG
</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00005</identifier>
        <name>ABC_tran</name>
      </pfam>
      <pfam>
        <identifier>PF00664</identifier>
        <name>ABC_membrane</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>platelet dense granule membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>basolateral plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>15-hydroxyprostaglandin dehydrogenase (NAD+) activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity, coupled to transmembrane movement of substances</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet activation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>oxidation-reduction process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet degranulation</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
    <transporter position="5">
      <id>BE0003639</id>
      <name>Multidrug resistance-associated protein 5</name>
      <organism>Human</organism>
      <actions>
        <action>substrate</action>
      </actions>
      <references>
        <articles>
          <article>
            <pubmed-id>16539673</pubmed-id>
            <citation>Minich T, Riemer J, Schulz JB, Wielinga P, Wijnholds J, Dringen R: The multidrug resistance protein 1 (Mrp1), but not Mrp5, mediates export of glutathione and glutathione disulfide from brain astrocytes. J Neurochem. 2006 Apr;97(2):373-84. Epub 2006 Mar 15.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="O15440" source="Swiss-Prot">
    <name>Multidrug resistance-associated protein 5</name>
    <general-function>Organic anion transmembrane transporter activity</general-function>
    <specific-function>Acts as a multispecific organic anion pump which can transport nucleotide analogs.</specific-function>
    <gene-name>ABCC5</gene-name>
    <locus>3q27</locus>
    <cellular-location>Membrane</cellular-location>
    <transmembrane-regions>179-199
219-239
296-316
317-337
400-420
434-454
608-628
848-868
917-937
997-1017
1018-1038
1104-1124
1127-1147</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>8.89</theoretical-pi>
    <molecular-weight>160658.8</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:56</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AF104942</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>4140698</identifier>
      </external-identifier>
      <external-identifier>
        <resource>Guide to Pharmacology</resource>
        <identifier>783</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>O15440</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>MRP5_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>ATP-binding cassette sub-family C member 5</synonym>
      <synonym>MOAT-C</synonym>
      <synonym>MRP5</synonym>
      <synonym>Multi-specific organic anion transporter C</synonym>
      <synonym>pABC11</synonym>
      <synonym>SMRP</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0006995|Multidrug resistance-associated protein 5
MKDIDIGKEYIIPSPGYRSVRERTSTSGTHRDREDSKFRRTRPLECQDALETAARAEGLS
LDASMHSQLRILDEEHPKGKYHHGLSALKPIRTTSKHQHPVDNAGLFSCMTFSWLSSLAR
VAHKKGELSMEDVWSLSKHESSDVNCRRLERLWQEELNEVGPDAASLRRVVWIFCRTRLI
LSIVCLMITQLAGFSGPAFMVKHLLEYTQATESNLQYSLLLVLGLLLTEIVRSWSLALTW
ALNYRTGVRLRGAILTMAFKKILKLKNIKEKSLGELINICSNDGQRMFEAAAVGSLLAGG
PVVAILGMIYNVIILGPTGFLGSAVFILFYPAMMFASRLTAYFRRKCVAATDERVQKMNE
VLTYIKFIKMYAWVKAFSQSVQKIREEERRILEKAGYFQSITVGVAPIVVVIASVVTFSV
HMTLGFDLTAAQAFTVVTVFNSMTFALKVTPFSVKSLSEASVAVDRFKSLFLMEEVHMIK
NKPASPHIKIEMKNATLAWDSSHSSIQNSPKLTPKMKKDKRASRGKKEKVRQLQRTEHQA
VLAEQKGHLLLDSDERPSPEEEEGKHIHLGHLRLQRTLHSIDLEIQEGKLVGICGSVGSG
KTSLISAILGQMTLLEGSIAISGTFAYVAQQAWILNATLRDNILFGKEYDEERYNSVLNS
CCLRPDLAILPSSDLTEIGERGANLSGGQRQRISLARALYSDRSIYILDDPLSALDAHVG
NHIFNSAIRKHLKSKTVLFVTHQLQYLVDCDEVIFMKEGCITERGTHEELMNLNGDYATI
FNNLLLGETPPVEINSKKETSGSQKKSQDKGPKTGSVKKEKAVKPEEGQLVQLEEKGQGS
VPWSVYGVYIQAAGGPLAFLVIMALFMLNVGSTAFSTWWLSYWIKQGSGNTTVTRGNETS
VSDSMKDNPHMQYYASIYALSMAVMLILKAIRGVVFVKGTLRASSRLHDELFRRILRSPM
KFFDTTPTGRILNRFSKDMDEVDVRLPFQAEMFIQNVILVFFCVGMIAGVFPWFLVAVGP
LVILFSVLHIVSRVLIRELKRLDNITQSPFLSHITSSIQGLATIHAYNKGQEFLHRYQEL
LDDNQAPFFLFTCAMRWLAVRLDLISIALITTTGLMIVLMHGQIPPAYAGLAISYAVQLT
GLFQFTVRLASETEARFTSVERINHYIKTLSLEAPARIKNKAPSPDWPQEGEVTFENAEM
RYRENLPLVLKKVSFTIKPKEKIGIVGRTGSGKSSLGMALFRLVELSGGCIKIDGVRISD
IGLADLRSKLSIIPQEPVLFSGTVRSNLDPFNQYTEDQIWDALERTHMKECIAQLPLKLE
SEVMENGDNFSVGERQLLCIARALLRHCKILILDEATAAMDTETDLLIQETIREAFADCT
MLTIAHRLHTVLGSDRIMVLAQGQVVEFDTPSVLLSNDSSRFYAMFAAAENKVAVKG</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0012531|Multidrug resistance-associated protein 5 (ABCC5)
ATGAAGGATATCGACATAGGAAAAGAGTATATCATCCCCAGTCCTGGGTATAGAAGTGTG
AGGGAGAGAACCAGCACTTCTGGGACGCACAGAGACCGTGAAGATTCCAAGTTCAGGAGA
ACTCGACCGTTGGAATGCCAAGATGCCTTGGAAACAGCAGCCCGAGCCGAGGGCCTCTCT
CTTGATGCCTCCATGCATTCTCAGCTCAGAATCCTGGATGAGGAGCATCCCAAGGGAAAG
TACCATCATGGCTTGAGTGCTCTGAAGCCCATCCGGACTACTTCCAAACACCAGCACCCA
GTGGACAATGCTGGGCTTTTTTCCTGTATGACTTTTTCGTGGCTTTCTTCTCTGGCCCGT
GTGGCCCACAAGAAGGGGGAGCTCTCAATGGAAGACGTGTGGTCTCTGTCCAAGCACGAG
TCTTCTGACGTGAACTGCAGAAGACTAGAGAGACTGTGGCAAGAAGAGCTGAATGAAGTT
GGGCCAGACGCTGCTTCCCTGCGAAGGGTTGTGTGGATCTTCTGCCGCACCAGGCTCATC
CTGTCCATCGTGTGCCTGATGATCACGCAGCTGGCTGGCTTCAGTGGACCAAATTTTCAG
GATGGCTGTATTCTGCGGTCAGAATGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00005</identifier>
        <name>ABC_tran</name>
      </pfam>
      <pfam>
        <identifier>PF00664</identifier>
        <name>ABC_membrane</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATPase activity, coupled to transmembrane movement of substances</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>organic anion transmembrane transporter activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hyaluronan metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>hyaluronan biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>carbohydrate metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>transmembrane transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycosaminoglycan metabolic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </transporter>
  </transporters>
</drug>
<drug type="small molecule" created="2005-06-13" updated="2017-09-01">
  <drugbank-id primary="true">DB00144</drugbank-id>
  <drugbank-id>NUTR00048</drugbank-id>
  <name>Phosphatidyl serine</name>
  <description>Phosphatidyl serine (PS) is a phospholipid nutrient found in fish, green leafy vegetables, soybeans and rice, and is essential for the normal functioning of neuronal cell membranes and activates Protein kinase C (PKC) which has been shown to be involved in memory function. In apoptosis, phosphatidyl serine is transferred to the outer leaflet of the plasma membrane. This is part of the process by which the cell is targeted for phagocytosis. PS has been shown to slow cognitive decline in animal models. PS has been investigated in a small number of double-blind placebo trials and has been shown to increase memory performance in the elderly. Because of the potentail cognitive benefits of phosphatidylserine, the substance is sold as a dietary supplement to people who believe they can benefit from an increased intake.&#13;
&#13;
The dietary supplement was originally processed from bovine sources however Prion disease scares in the 1990s outlawed this process, and a soy-based alternative was adopted.</description>
  <cas-number>1446756-47-3</cas-number>
  <unii>394XK0IH40</unii>
  <average-mass>385.3041</average-mass>
  <monoisotopic-mass>385.113782505</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
    <group>nutraceutical</group>
  </groups>
  <general-references>
    <articles/>
    <textbooks/>
    <links/>
  </general-references>
  <synthesis-reference>Lorenzo De Ferra, Pietro Massardo, Oreste Piccolo, Stefano Servi, "Process for the industrial preparation of phosphatidylserine." U.S. Patent US5700668, issued January, 1992.</synthesis-reference>
  <indication>Phosphatidylserine has demonstrated some usefulness in treating cognitive impairment, including Alzheimer's disease, age-associated memory impairment and some non-Alzheimer's dementias. More research is needed before phosphatidylserine can be indicated for immune enhancement or for reduction of exercise stress.</indication>
  <pharmacodynamics>Phosphatidylserine is indicated in the treatment of cognitive impairment, including Alzheimer's disease, age-associated memory impairment and some non-Alzheimer's dementias. Further research is required before phosphatidylserine can be indicated for immune enhancement or for reduction of exercise stress. Phosphatidylserine was first isolated from brain lipids called cephalins. The major cephalins are phosphatidylserine and phophatidylethanolamine. Phosphatidylserine is involved in signal transduction activity as well as being a basic structural component of biologic membranes.</pharmacodynamics>
  <mechanism-of-action>Cholinergic hypofunction is thought to account in part for the cognitive deficits found in Alzheimer's disease. The most commonly used drugs for the treatment of Alzheimer's disease are reversible acetylcholinesterase inhibitors. The rationale of these drugs is to increase acetylcholine levels in the brains of Alzheimer's patients, and they may be somewhat effective in some cases. Phosphatidylserine restores acetylcholine release in aging humans by maintaining an adequate supply of the molecule and is able to increase the availability of endogenous choline for de novo acetylcholine synthesis. The hippocampus of the brain is believed to be important for cognitive processes and is affected in those with Alzheimer's disease. The dendritic spines of pyramidal cells, the post-synaptic target of the excitatory input to the hippocampus, have been proposed as a substrate for information storage. Age-dependent dendritic spine loss in pyramidal neurons has been reported in the human brain, and the extent of synaptic loss appears to correlate with the degree of cognitive impairment. Phosphatidylserine treatment prevents the age-related reduction in dendritic spine density in rat hippocampus. Protein kinase C facilitation of acetylcholine release has been reported in rats. Phosphatidylserine was found to restore protein kinase C activity in aging rats. Stimulation of calcium uptake by brain synaptosomes and activation of protein kinase C are yet other speculative mechanisms of phosphatidylserine's putative cognition-enhancing action.</mechanism-of-action>
  <toxicity>There are no reports of overdosage. LD&lt;sub&gt;50&lt;/sub&gt; in rats is more than 5g/kg, and in rabbits is more than 2g/kg.</toxicity>
  <metabolism>Following absorption, lysophosphatidylserine is metabolized in intestinal mucosa cells, and its metabolites, which include some phosphatidylserine, enter the lymphatics draining the small intestine.</metabolism>
  <absorption>Absorbed in the small intestine.</absorption>
  <half-life/>
  <protein-binding/>
  <route-of-elimination/>
  <volume-of-distribution/>
  <clearance/>
  <classification>
    <description>This compound belongs to the class of chemical entities known as phosphatidylserines. These are glycerophosphoserines in which two fatty acids are bonded to the glycerol moiety through ester linkages. As is the case with diacylglycerols, phosphatidylserines can have many different combinations of fatty acids of varying lengths and saturation attached to the C-1 and C-2 positions.</description>
    <direct-parent>Phosphatidylserines</direct-parent>
    <kingdom>Chemical entities</kingdom>
    <superclass>Organic compounds</superclass>
    <class>Lipids and lipid-like molecules</class>
    <subclass>Glycerophospholipids</subclass>
    <alternative-parent>Amino acids</alternative-parent>
    <alternative-parent>Carbonyl compounds</alternative-parent>
    <alternative-parent>Carboxylic acid esters</alternative-parent>
    <alternative-parent>Carboxylic acids</alternative-parent>
    <alternative-parent>Dialkyl phosphates</alternative-parent>
    <alternative-parent>Fatty acid esters</alternative-parent>
    <alternative-parent>Hydrocarbon derivatives</alternative-parent>
    <alternative-parent>L-alpha-amino acids</alternative-parent>
    <alternative-parent>Monoalkylamines</alternative-parent>
    <alternative-parent>Organic oxides</alternative-parent>
    <alternative-parent>Organopnictogen compounds</alternative-parent>
    <alternative-parent>Phosphoethanolamines</alternative-parent>
    <alternative-parent>Tricarboxylic acids and derivatives</alternative-parent>
    <substituent>Aliphatic acyclic compound</substituent>
    <substituent>Alkyl phosphate</substituent>
    <substituent>Alpha-amino acid</substituent>
    <substituent>Alpha-amino acid or derivatives</substituent>
    <substituent>Amine</substituent>
    <substituent>Amino acid</substituent>
    <substituent>Amino acid or derivatives</substituent>
    <substituent>Carbonyl group</substituent>
    <substituent>Carboxylic acid</substituent>
    <substituent>Carboxylic acid derivative</substituent>
    <substituent>Carboxylic acid ester</substituent>
    <substituent>Diacyl-glycerol-3-phosphoserine</substituent>
    <substituent>Dialkyl phosphate</substituent>
    <substituent>Fatty acid ester</substituent>
    <substituent>Fatty acyl</substituent>
    <substituent>Hydrocarbon derivative</substituent>
    <substituent>L-alpha-amino acid</substituent>
    <substituent>Organic nitrogen compound</substituent>
    <substituent>Organic oxide</substituent>
    <substituent>Organic oxygen compound</substituent>
    <substituent>Organic phosphoric acid derivative</substituent>
    <substituent>Organonitrogen compound</substituent>
    <substituent>Organooxygen compound</substituent>
    <substituent>Organopnictogen compound</substituent>
    <substituent>Phosphoethanolamine</substituent>
    <substituent>Phosphoric acid ester</substituent>
    <substituent>Primary aliphatic amine</substituent>
    <substituent>Primary amine</substituent>
    <substituent>Tricarboxylic acid or derivatives</substituent>
  </classification>
  <salts/>
  <synonyms>
    <synonym language="" coder="">Phosphatidyl-L-serine</synonym>
    <synonym language="" coder="">Phosphatidylserine</synonym>
    <synonym language="" coder="">PS</synonym>
    <synonym language="" coder="">Ptd-L-Ser</synonym>
  </synonyms>
  <products>
    <product>
      <name>EnBrace HR</name>
      <labeller>Jaymac Pharmaceuticals, Llc</labeller>
      <ndc-id/>
      <ndc-product-code>64661-650</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2015-04-08</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, delayed release pellets</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>EnLyte</name>
      <labeller>Jaymac Pharmaceuticals Llc</labeller>
      <ndc-id/>
      <ndc-product-code>64661-711</ndc-product-code>
      <dpd-id/>
      <started-marketing-on>2011-10-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Capsule, delayed release pellets</dosage-form>
      <strength/>
      <route>Oral</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>false</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
  </products>
  <international-brands>
    <international-brand>
      <name>LifeExtension PS Caps</name>
      <company/>
    </international-brand>
  </international-brands>
  <mixtures>
    <mixture>
      <name>EnLyte</name>
      <ingredients>1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium + 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium + Citric Acid + Cobamamide + Cocarboxylase + Ferrous cysteine glycinate + Flavin adenine dinucleotide + Folic Acid + Glycine betaine + Leucovorin + Levomefolic acid + NADH + Phosphatidyl serine + Pyridoxal Phosphate + Sodium Citrate + Threonate + Vitamin C + Vitamin C</ingredients>
    </mixture>
    <mixture>
      <name>EnBrace HR</name>
      <ingredients>1,2-docosahexanoyl-sn-glycero-3-phosphoserine calcium + 1,2-icosapentoyl-sn-glycero-3-phosphoserine calcium + Cobamamide + Cocarboxylase + Ferrous cysteine glycinate + Flavin adenine dinucleotide + Folic Acid + Glycine betaine + Leucovorin + Levomefolic acid + NADH + Phosphatidyl serine + Pyridoxal Phosphate + Threonate + Vitamin C + Vitamin C</ingredients>
    </mixture>
  </mixtures>
  <packagers>
    <packager>
      <name>Professional Co.</name>
      <url/>
    </packager>
  </packagers>
  <manufacturers/>
  <prices>
    <price>
      <description>Phosphatidylserine 40% powder</description>
      <cost currency="USD">13.2</cost>
      <unit>g</unit>
    </price>
  </prices>
  <categories>
    <category>
      <category>Dietary Supplements</category>
      <mesh-id>D019587</mesh-id>
    </category>
    <category>
      <category>Supplements</category>
      <mesh-id/>
    </category>
  </categories>
  <affected-organisms>
    <affected-organism>Humans and other mammals</affected-organism>
  </affected-organisms>
  <dosages>
    <dosage>
      <form>Capsule, delayed release pellets</form>
      <route>Oral</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes/>
  <pdb-entries>
    <pdb-entry>1DSY</pdb-entry>
  </pdb-entries>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>-1</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-2</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>3.70e+00 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>-1.6</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(2S)-2-amino-3-({[(2R)-2-(butanoyloxy)-3-(propanoyloxy)propoxy](hydroxy)phosphoryl}oxy)propanoic acid</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>phosphatidylserine</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>385.3041</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>385.113782505</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CCCC(=O)O[C@H](COC(=O)CC)COP(O)(=O)OC[C@H](N)C(O)=O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C13H24NO10P</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C13H24NO10P/c1-3-5-12(16)24-9(6-21-11(15)4-2)7-22-25(19,20)23-8-10(14)13(17)18/h9-10H,3-8,14H2,1-2H3,(H,17,18)(H,19,20)/t9-,10+/m1/s1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>UNJJBGNPUUVVFQ-ZJUUUORDSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>171.68</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>81.81</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>35.58</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>15</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>7</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest acidic)</kind>
      <value>1.47</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>9.38</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>-1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>logP</kind>
      <value>-3.5</value>
      <source/>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>18303</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>6323481</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>46505650</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>13628254</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PharmGKB</resource>
      <identifier>PA164768860</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PDB</resource>
      <identifier>PSF</identifier>
    </external-identifier>
    <external-identifier>
      <resource>IUPHAR</resource>
      <identifier>3638</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Guide to Pharmacology</resource>
      <identifier>3638</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Phosphatidylserine</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links>
    <external-link>
      <resource>PDRhealth</resource>
      <url>http://www.pdrhealth.com/drug_info/nmdrugprofiles/nutsupdrugs/pho_0202.shtml</url>
    </external-link>
  </external-links>
  <pathways>
    <pathway>
      <smpdb-id>SMP14237</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(14:0/22:1(13Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14249</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(14:1(9Z)/16:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14252</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(14:1(9Z)/18:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14264</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(14:1(9Z)/20:5(5Z,8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14276</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(15:0/15:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14292</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(15:0/20:4(8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14293</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(15:0/20:5(5Z,8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14301</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(15:0/24:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14304</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/14:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14307</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/16:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14310</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/18:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14316</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/20:1(11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14321</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/20:4(8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14322</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:0/20:5(5Z,8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14332</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:1(9Z)/14:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14347</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(5Z,8Z,11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14348</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:1(9Z)/20:3(8Z,11Z,14Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14353</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:1(13Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14355</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(16:1(9Z)/22:4(7Z,10Z,13Z,16Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14365</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:0/16:1(9Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14366</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:0/18:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14374</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:0/20:1(11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14388</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:0/24:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14393</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/16:0)</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14398</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/18:2(9Z,12Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14399</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/18:3(6Z,9Z,12Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14400</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/18:3(9Z,12Z,15Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14405</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/20:3(5Z,8Z,11Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14406</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/20:3(8Z,11Z,14Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
    <pathway>
      <smpdb-id>SMP14408</smpdb-id>
      <name>Phosphatidylcholine Biosynthesis PC(18:1(11Z)/20:4(8Z,11Z,14Z,17Z))</name>
      <category>metabolic</category>
      <drugs>
        <drug>
          <drugbank-id>DB00118</drugbank-id>
          <name>Ademetionine</name>
        </drug>
        <drug>
          <drugbank-id>DB00122</drugbank-id>
          <name>Choline</name>
        </drug>
        <drug>
          <drugbank-id>DB00144</drugbank-id>
          <name>Phosphatidyl serine</name>
        </drug>
        <drug>
          <drugbank-id>DB00171</drugbank-id>
          <name>ATP</name>
        </drug>
        <drug>
          <drugbank-id>DB02431</drugbank-id>
          <name>Cytidine-5'-Triphosphate</name>
        </drug>
        <drug>
          <drugbank-id>DB03945</drugbank-id>
          <name>N,N,N-Trimethyl-2-(phosphonooxy)ethanaminium</name>
        </drug>
        <drug>
          <drugbank-id>DB03994</drugbank-id>
          <name>Ethanolamine</name>
        </drug>
        <drug>
          <drugbank-id>DB04160</drugbank-id>
          <name>Pyrophosphoric acid</name>
        </drug>
      </drugs>
      <enzymes>
        <uniprot-id>P49585</uniprot-id>
        <uniprot-id>Q99447</uniprot-id>
        <uniprot-id>P35790</uniprot-id>
        <uniprot-id>Q9Y6K0</uniprot-id>
        <uniprot-id>Q9UG56</uniprot-id>
        <uniprot-id>Q9UBM1</uniprot-id>
      </enzymes>
    </pathway>
  </pathways>
  <reactions/>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target>
      <id>BE0002296</id>
      <name>Diacylglycerol kinase gamma</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16905533</pubmed-id>
            <citation>Yamaguchi Y, Shirai Y, Matsubara T, Sanse K, Kuriyama M, Oshiro N, Yoshino K, Yonezawa K, Ono Y, Saito N: Phosphorylation and up-regulation of diacylglycerol kinase gamma via its interaction with protein kinase C gamma. J Biol Chem. 2006 Oct 20;281(42):31627-37. Epub 2006 Aug 11.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P49619" source="Swiss-Prot">
    <name>Diacylglycerol kinase gamma</name>
    <general-function>Diacylglycerol kinase activity</general-function>
    <specific-function>Reverses the normal flow of glycerolipid biosynthesis by phosphorylating diacylglycerol back to phosphatidic acid.</specific-function>
    <gene-name>DGKG</gene-name>
    <locus>3q27.2-q27.3</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>6.73</theoretical-pi>
    <molecular-weight>89123.27</molecular-weight>
    <chromosome-location>3</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2853</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>DGKG</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>D26135</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>516758</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>P49619</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DGKG_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.1.107</synonym>
      <synonym>DAG kinase gamma</synonym>
      <synonym>DAGK3</synonym>
      <synonym>DGK-gamma</synonym>
      <synonym>Diglyceride kinase gamma</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0037187|Diacylglycerol kinase gamma
MGEERWVSLTPEEFDQLQKYSEYSSKKIKDALTEFNEGGSLKQYDPHEPISYDVFKLFMR
AYLEVDLPQPLSTHLFLAFSQKPRHETSDHPTEGASNSEANSADTNIQNADNATKADEAC
APDTESNMAEKQAPAEDQVAATPLEPPVPRSSSSESPVVYLKDVVCYLSLLETGRPQDKL
EFMFRLYDSDENGLLDQAEMDCIVNQMLHIAQYLEWDPTELRPILKEMLQGMDYDRDGFV
SLQEWVHGGMTTIPLLVLLGMDDSGSKGDGRHAWTMKHFKKPTYCNFCHIMLMGVRKQGL
CCTYCKYTVHERCVSRNIPGCVKTYSKAKRSGEVMQHAWVEGNSSVKCDRCHKSIKCYQS
VTARHCVWCRMTFHRKCELSTLCDGGELRDHILLPTSICPITRDRPGEKSDGCVSAKGEL
VMQYKIIPTPGTHPLLVLVNPKSGGRQGERILRKFHYLLNPKQVFNLDNGGPTPGLNFFR
DTPDFRVLACGGDGTVGWILDCIDKANFAKHPPVAVLPLGTGNDLARCLRWGGGYEGGSL
TKILKDIEQSPLVMLDRWHLEVIPREEVENGDQVPYSIMNNYFSIGVDASIAHRFHVMRE
KHPEKFNSRMKNKLWYFEFGTSETFAATCKKLHDHIELECDGVGVDLSNIFLEGIAILNI
PSMYGGTNLWGENKKNRAVIRESRKGVTDPKELKFCVQDLSDQLLEVVGLEGAMEMGQIY
TGLKSAGRRLAQCASVTIRTNKLLPMQVDGEPWMQPCCTIKITHKNQAPMMMGPPQKSSF
FSLRRKSRSKD</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0016744|Diacylglycerol kinase gamma (DGKG)
ATGGGTGAAGAACGGTGGGTCTCCCTCACTCCAGAAGAATTTGACCAACTCCAGAAATAT
TCAGAATATTCCTCCAAGAAGATAAAAGATGCCTTGACTGAATTTAATGAGGGTGGGAGC
CTCAAACAATATGACCCACATGAGCCGATTAGCTATGATGTCTTCAAGCTGTTCATGAGG
GCGTACCTGGAGGTGGACCTTCCCCAGCCACTGAGCACTCACCTCTTCCTGGCCTTCAGC
CAGAAGCCCAGACACGAGACCTCTGACCACCCGACGGAGGGAGCCAGCAACAGTGAGGCC
AACAGCGCAGATACTAATATACAGAATGCAGATAATGCCACCAAAGCAGACGAGGCCTGT
GCCCCTGATACTGAATCAAATATGGCTGAGAAGCAAGCACCAGCTGAAGACCAAGTGGCT
GCGACCCCCCTGGAACCCCCCGTCCCTCGGTCTTCAAGCTCGGAATCCCCAGTGGTATAC
CTGAAGGATGTTGTGTGCTACCTGTCCCTGCTGGAGACGGGGAGGCCTCAGGATAAGCTG
GAGTTCATGTTTCGCCTCTATGATTCAGATGAGAACGGTCTCCTGGACCAAGCGGAGATG
GATTGCATTGTCAACCAAATGCTGCATATTGCCCAGTACCTGGAGTGGGATCCCACAGAG
CTGAGGCCTATATTGAAGGAGATGCTGCAAGGGATGGACTACGACCGGGACGGCTTTGTG
TCTCTACAGGAATGGGTCCATGGAGGGATGACCACCATCCCATTGCTGGTCCTCCTGGGG
ATGGATGACTCTGGCTCCAAGGGGGATGGGCGGCACGCCTGGACCATGAAGCACTTCAAG
AAACCAACCTACTGCAACTTCTGCCATATCATGCTCATGGGCGTCCGCAAGCAAGGCCTG
TGCTGCACTTACTGTAAATACACTGTCCACGAACGCTGTGTGTCCAGAAACATTCCTGGT
TGTGTCAAAACGTACTCAAAAGCCAAAAGGAGTGGTGAGGTGATGCAGCACGCATGGGTG
GAAGGGAACTCCTCCGTCAAGTGTGACCGGTGCCACAAAAGTATCAAGTGCTACCAGAGT
GTCACCGCGCGGCACTGCGTGTGGTGCCGGATGACGTTTCACCGCAAATGTGAATTATCA
ACGTTGTGTGACGGTGGGGAACTCAGAGACCACATCTTACTGCCCACCTCCATATGCCCC
ATCACCCGGGACAGGCCAGGTGAGAAGTCTGATGGCTGCGTGTCCGCCAAGGGCGAACTT
GTCATGCAGTATAAGATCATCCCCACCCCGGGTACCCACCCCCTGCTGGTCTTGGTGAAC
CCCAAGAGTGGAGGGAGACAAGGAGAAAGGTTGAACTTTTTCCGTGATACTCCAGACTTC
CGTGTTTTGGCCTGTGGTGGAGATGGGACAGTTGGCTGGATTTTGGATTGCATTGATAAG
GCCAACTTTGCAAAGCATCCACCAGTGGCTGTCCTGCCTCTTGGAACAGGAAATGACCTT
GCCCGTTGTCTCCGCTGGGGAGGAGGTTATGAAGGGGGCAGCTTGACAAAAATCCTGAAA
GACATTGAGCAGAGCCCCTTGGTGATGCTGGACCGCTGGCATCTGGAAGTCATCCCCAGA
GAGGAAGTGGAAAACGGGGACCAGGTCCCATACAGCATCATGAACAACTATTTCTCCATT
GGTGTGGACGCTTCCATTGCACACAGATTCCATGTGATGAGAGAGAAACATCCTGAAAAA
TTCAACAGCAGGATGAAGAACAAGCTGTGGTACTTTGAATTTGGCACCTCGGAGACTTTT
GCAGCGACCTGCAAGAAACTCCACGACCACATTGAGTTGGAGTGTGATGGGGTTGGGGTG
GACCTGAGCAACATCTTCCTGGAAGGCATTGCCATTCTCAACATTCCCAGCATGTACGGA
GGCACCAATCTCTGGGGAGAAAACAAGAAGAACCGGGCTGTGATCCGGGAAAGCAGGAAG
GGTGTCACTGACCCCAAAGAACTGAAATTCTGCGTTCAAGACCTCAGTGACCAGCTCCTT
GAAGTGGTGGGGCTAGAAGGAGCCATGGAGATGGGGCAGATCTACACCGGCCTGAAGAGT
GCAGGCAGGAGGCTGGCCCAGTGCGCCTCTGTCACCATCAGGACAAACAAGCTGCTGCCA
ATGCAAGTGGATGGAGAACCCTGGATGCAGCCATGTTGCACGATTAAAATTACTCACAAG
AACCAAGCGCCCATGATGATGGGGCCTCCCCAGAAGAGCAGCTTCTTCTCGTTGAGAAGG
AAGAGCCGTTCAAAAGACTAA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00130</identifier>
        <name>C1_1</name>
      </pfam>
      <pfam>
        <identifier>PF00609</identifier>
        <name>DAGK_acc</name>
      </pfam>
      <pfam>
        <identifier>PF00781</identifier>
        <name>DAGK_cat</name>
      </pfam>
      <pfam>
        <identifier>PF14513</identifier>
        <name>DAG_kinase_N</name>
      </pfam>
      <pfam>
        <identifier>PF13499</identifier>
        <name>EF-hand_7</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>calcium ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>diacylglycerol kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet activation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>intracellular signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein kinase C-activating G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>neuron development</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002297</id>
      <name>Diacylglycerol kinase delta</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>17139284</pubmed-id>
            <citation>Overington JP, Al-Lazikani B, Hopkins AL: How many drug targets are there? Nat Rev Drug Discov. 2006 Dec;5(12):993-6.</citation>
          </article>
          <article>
            <pubmed-id>17016423</pubmed-id>
            <citation>Imming P, Sinning C, Meyer A: Drugs, their targets and the nature and number of drug targets. Nat Rev Drug Discov. 2006 Oct;5(10):821-34.</citation>
          </article>
          <article>
            <pubmed-id>11309392</pubmed-id>
            <citation>Bregoli L, Baldassare JJ, Raben DM: Nuclear diacylglycerol kinase-theta is activated in response to alpha-thrombin. J Biol Chem. 2001 Jun 29;276(26):23288-95. Epub 2001 Apr 17.</citation>
          </article>
          <article>
            <pubmed-id>8626538</pubmed-id>
            <citation>Sakane F, Imai S, Kai M, Wada I, Kanoh H: Molecular cloning of a novel diacylglycerol kinase isozyme with a pleckstrin homology domain and a C-terminal tail similar to those of the EPH family of protein-tyrosine kinases. J Biol Chem. 1996 Apr 5;271(14):8394-401.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q16760" source="Swiss-Prot">
    <name>Diacylglycerol kinase delta</name>
    <general-function>Protein homodimerization activity</general-function>
    <specific-function>May function as signaling molecule.Isoform 2 may be involved in cell growth and tumorigenesis. Involved in clathrin-dependent endocytosis.</specific-function>
    <gene-name>DGKD</gene-name>
    <locus>2q37.1</locus>
    <cellular-location>Cytoplasm</cellular-location>
    <transmembrane-regions/>
    <signal-regions/>
    <theoretical-pi>7.58</theoretical-pi>
    <molecular-weight>134524.235</molecular-weight>
    <chromosome-location>2</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:2851</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>DGKD</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AB078966</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>22773821</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q16760</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>DGKD_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>130 kDa diacylglycerol kinase</synonym>
      <synonym>2.7.1.107</synonym>
      <synonym>DAG kinase delta</synonym>
      <synonym>DGK-delta</synonym>
      <synonym>Diglyceride kinase delta</synonym>
      <synonym>KIAA0145</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0004510|Diacylglycerol kinase delta
MAAAAGAPPPGPPQPPPPPPPEESSDSEPEAEPGSPQKLIRKVSTSGQIRQKTIIKEGML
TKQNNSFQRSKRRYFKLRGRTLYYAKTAKSIIFDEVDLTDASVAESSTKNVNNSFTVITP
CRKLILCADNRKEMEDWIAALKTVQNREHFEPTQYSMDHFSGMHNWYACSHARPTYCNVC
REALSGVTSHGLSCEVCKFKAHKRCAVRATNNCKWTTLASIGKDIIEDADGIAMPHQWLE
GNLPVSAKCTVCDKTCGSVLRLQDWRCLWCKAMVHTSCKESLLTKCPLGLCKVSVIPPTA
LNSIDSDGFWKASCPPSCTSPLLVFVNSKSGDNQGVKFLRRFKQLLNPAQVFDLMNGGPH
LGLRLFQKFDTFRILVCGGDGSVGWVLSEIDSLNLHKQCQLGVLPLGTGNDLARVLGWGS
ACDDDTQLPQILEKLERASTKMLDRWSVMAYEAKLPRQASSSTVTEDFSEDSEVQQILFY
EDSVAAHLSKILTSDQHSVVISSAKVLCETVKDFVARVGKAYEKTTESSEESEVMAKKCS
VLKEKLDSLLKTLDDESQASSSLPNPPPTIAEEAEDGDGSGSICGSTGDRLVASACPARP
QIFRPREQLMLRANSLKKAIRQIIEHTEKAVDEQNAQTQEQEGFVLGLSESEEKMDHRVC
PPLSHSESFGVPKGRSQRKVSKSPCEKLISKGSLSLGSSASLPPQPGSRDGLPALNTKIL
YPNVRAGMSGSLPGGSVISRLLINADPFNSEPETLEYYTEKCVMNNYFGIGLDAKISLDF
NNKRDEHPEKCRSRTKNMMWYGVLGTKELLHRTYKNLEQKVLLECDGRPIPLPSLQGIAV
LNIPSYAGGTNFWGGTKEDDTFAAPSFDDKILEVVAVFGSMQMAVSRVIRLQHHRIAQCR
TVKISILGDEGVPVQVDGEAWVQPPGYIRIVHKNRAQTLTRDRAFESTLKSWEDKQKCEL
PRPPSCSLHPEMLSEEEATQMDQFGQAAGVLIHSIREIAQSHRDMEQELAHAVNASSKSM
DRVYGKPRTTEGLNCSFVLEMVNNFRALRSETELLLSGKMALQLDPPQKEQLGSALAEMD
RQLRRLADTPWLCQSAEPGDEESVMLDLAKRSRSGKFRLVTKFKKEKNNKNKEAHSSLGA
PVHLWGTEEVAAWLEHLSLCEYKDIFTRHDIRGSELLHLERRDLKDLGVTKVGHMKRILC
GIKELSRSAPAVEA</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0011654|Diacylglycerol kinase delta (DGKD)
ATGAATATGTTTCTGTACTTTCAGACCATCATCAAAGAGGGGATGCTGACCAAACAGAAC
AATTCATTCCAGCGATCAAAAAGGAGATACTTTAAGCTTCGAGGGCGAACGCTTTACTAT
GCCAAAACGGCAAAGTCAATCATATTTGATGAGGTGGATCTGACAGATGCCAGCGTAGCT
GAATCCAGTACCAAAAACGTCAACAACAGTTTTACGGTCATAACTCCATGCAGGAAGCTC
ATCTTGTGTGCTGATAACAGAAAAGAAATGGAAGATTGGATTGCAGCATTAAAGACTGTG
CAGAACAGGGAGCACTTTGAGCCCACCCAGTACAGCATGGACCACTTCTCAGGGATGCAC
AATTGGTACGCCTGTTCCCACGCGAGGCCGACCTACTGCAATGTGTGCCGTGAGGCTCTG
TCTGGGGTCACGTCGCACGGGCTGTCCTGCGAGGTGTGCAAATTTAAGGCCCACAAGCGC
TGTGCTGTGCGTGCAACCAATAACTGCAAGTGGACCACACTGGCCTCGATCGGGAAGGAC
ATCATTGAAGATGCAGATGGGATTGCAATGCCCCACCAGTGGTTGGAAGGAAACCTACCT
GTGAGCGCCAAGTGCACTGTGTGCGACAAGACCTGTGGCAGTGTGCTGCGCCTGCAGGAC
TGGCGCTGCCTCTGGTGCAAGGCCATGGTTCACACATCGTGTAAAGAATCCTTGCTGACC
AAGTGCCCACTTGGCCTGTGCAAAGTGTCAGTCATCCCACCCACGGCTCTCAACAGCATC
GACTCCGATGGGTTCTGGAAGGCCAGCTGTCCTCCTTCTTGCACAAGCCCACTGTTGGTC
TTCGTCAATTCAAAAAGTGGGGACAACCAGGGTGTGAAGTTCCTCAGAAGATTCAAACAG
CTACTAAACCCCGCCCAGGTCTTCGACCTCATGAACGGAGGCCCACACCTCGGCTTACGG
TTATTCCAGAAGTTTGACACATTCCGGATTCTGGTTTGTGGCGGGGATGGAAGTGTTGGC
TGGGTCCTCTCCGAAATCGACAGCCTCAACCTTCATAAACAGTGTCAGCTGGGAGTGCTG
CCGCTCGGCACAGGGAACGACTTGGCCCGAGTACTGGGCTGGGGCTCAGCCTGCGATGAC
GACACCCAGCTCCCCCAGATCTTGGAGAAGTTGGAGAGAGCCAGCACCAAGATGCTGGAC
AGGTGGAGCGTCATGGCATACGAGGCCAAGCTCCCCCGGCAGGCCTCCTCCTCTACCGTC
ACCGAAGACTTCAGCGAGGATTCCGAGGTACAGCAGATTCTCTTCTATGAAGACTCGGTT
GCAGCCCACCTTTCTAAAATCCTCACCTCGGACCAGCACTCGGTGGTCATCTCCTCGGCC
AAAGTGCTCTGTGAGACGGTGAAGGACTTCGTGGCACGGGTGGGGAAGGCCTATGAGAAG
ACGACCGAGAGCTCGGAGGAGTCAGAGGTCATGGCCAAGAAGTGCTCTGTCCTGAAAGAG
AAGCTGGATTCCCTTCTCAAGACCTTGGACGATGAGTCCCAGGCCTCGTCCTCTCTGCCC
AACCCGCCCCCCACCATTGCCGAGGAGGCTGAAGATGGAGATGGGTCGGGCAGCATCTGC
GGTTCCACCGGAGACCGCTTGGTGGCATCAGCTTGCCCGGCCCGGCCGCAGATATTCCGG
CCTCGAGAACAGCTCATGCTGAGAGCCAACAGCCTGAAGAAAGCAATTCGTCAGATCATA
GAACACACAGAAAAAGCTGTCGATGAGCAGAATGCCCAGACCCAGGAGCAGGAGGGCTTC
GTCCTGGGCCTCTCTGAGTCAGAGGAGAAGATGGACCACAGAGTGTGCCCACCACTGTCC
CACAGCGAGAGCTTCGGGGTCCCCAAGGGGAGGAGCCAGCGCAAAGTGTCGAAATCTCCG
TGTGAAAAGCTGATCAGCAAAGGGAGTCTGTCCCTAGGCAGTTCTGCTTCCCTTCCGCCC
CAGCCGGGAAGCCGGGACGGCCTGCCTGCGCTCAACACCAAGATCCTGTACCCAAATGTC
CGGGCTGGAATGTCTGGTTCCTTACCCGGTGGCTCAGTCATCAGTCGCCTGTTAATTAAT
GCTGATCCCTTCAACTCTGAACCAGAAACCCTAGAGTATTACACGGAGAAATGTGTCATG
AACAACTATTTTGGCATTGGCCTGGATGCGAAGATATCCCTGGACTTTAACAACAAGCGC
GATGAGCACCCAGAGAAGTGCAGGAGCCGAACCAAGAACATGATGTGGTATGGAGTTCTT
GGAACCAAAGAGTTGCTGCACAGAACCTACAAGAACCTGGAGCAAAAGGTCTTGCTGGAG
TGTGACGGGCGACCCATCCCACTCCCCAGTCTTCAGGGAATTGCTGTCCTTAACATTCCC
AGCTATGCCGGAGGAACCAACTTCTGGGGGGGTACCAAGGAAGATGATACTTTCGCAGCT
CCATCATTCGATGACAAGATTCTGGAGGTGGTCGCCGTGTTCGGCAGCATGCAGATGGCC
GTCTCTCGAGTCATCAGGCTACAGCATCATCGGATCGCCCAGTGTCGCACGGTGAAGATC
TCCATCCTTGGGGATGAGGGCGTGCCTGTGCAGGTGGACGGAGAGGCCTGGGTCCAGCCG
CCAGGGTACATTCGGATTGTCCACAAGAACCGGGCACAGACACTGACCAGAGACAGGGCA
TTTGAGAGCACCCTGAAGTCCTGGGAAGACAAGCAGAAGTGCGAGCTGCCCCGCCCTCCA
TCCTGTTCCCTGCACCCGGAGATGCTGTCCGAGGAGGAGGCCACCCAGATGGACCAGTTT
GGGCAGGCAGCAGGGGTCCTCATTCACAGTATCCGAGAAATAGCTCAGTCTCACCGGGAC
ATGGAGCAGGAACTGGCCCACGCCGTCAATGCCAGCTCCAAGTCCATGGACCGTGTGTAT
GGCAAGCCCAGAACCACAGAGGGGCTCAACTGCAGCTTCGTCCTGGAAATGGTGAATAAC
TTCAGAGCTCTGCGCAGTGAGACGGAGCTGCTGCTGTCTGGGAAGATGGCCCTGCAGCTG
GATCCGCCTCAGAAGGAGCAGCTGGGGAGTGCTCTTGCCGAGATGGACCGACAGCTCAGG
AGGCTGGCAGACACCCCGTGGCTCTGCCAGTCCGCAGAGCCCGGCGACGAAGAGAGTGTG
ATGCTGGATCTTGCCAAGCGCAGTCGCAGTGGTAAATTCCGCCTCGTGACCAAGTTTAAA
AAGGAGAAAAACAACAAGAACAAAGAAGCTCACAGTAGCCTGGGAGCCCCGGTTCACCTC
TGGGGGACAGAGGAGGTTGCTGCCTGGCTGGAGCACCTCAGTCTCTGTGAGTATAAGGAC
ATCTTCACACGGCACGACATCCGGGGCTCTGAGCTCCTGCACCTGGAGCGGAGGGACCTC
AAGGACCTGGGCGTGACCAAGGTGGGCCACATGAAGAGGATCCTGTGTGGCATCAAGGAG
CTGAGCCGCAGCGCCCCCGCCGTCGAGGCCTAG</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF00169</identifier>
        <name>PH</name>
      </pfam>
      <pfam>
        <identifier>PF00130</identifier>
        <name>C1_1</name>
      </pfam>
      <pfam>
        <identifier>PF00609</identifier>
        <name>DAGK_acc</name>
      </pfam>
      <pfam>
        <identifier>PF00781</identifier>
        <name>DAGK_cat</name>
      </pfam>
      <pfam>
        <identifier>PF07647</identifier>
        <name>SAM_2</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>cytoplasm</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>cytoplasmic membrane-bounded vesicle</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>plasma membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>ATP binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein heterodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>diacylglycerol kinase activity</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>metal ion binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>diacylglycerol binding</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>protein homodimerization activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>epidermal growth factor receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>signal transduction</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>multicellular organismal development</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein kinase C-activating G-protein coupled receptor signaling pathway</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>blood coagulation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein transport</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>protein homooligomerization</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>endocytosis</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>cell growth</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>response to organic substance</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>platelet activation</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>diacylglycerol metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>second-messenger-mediated signaling</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002299</id>
      <name>Phosphatidylserine synthase 2</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>12361952</pubmed-id>
            <citation>Bergo MO, Gavino BJ, Steenbergen R, Sturbois B, Parlow AF, Sanan DA, Skarnes WC, Vance JE, Young SG: Defining the importance of phosphatidylserine synthase 2 in mice. J Biol Chem. 2002 Dec 6;277(49):47701-8. Epub 2002 Oct 1.</citation>
          </article>
          <article>
            <pubmed-id>15052332</pubmed-id>
            <citation>Vance JE, Vance DE: Phospholipid biosynthesis in mammalian cells. Biochem Cell Biol. 2004 Feb;82(1):113-28.</citation>
          </article>
          <article>
            <pubmed-id>12833164</pubmed-id>
            <citation>Dygas A, Baranska J, Santella L: Ca2+-dependent phosphatidylserine synthesis in immature and mature starfish oocytes. Acta Biochim Pol. 2003;50(2):377-87.</citation>
          </article>
          <article>
            <pubmed-id>14984733</pubmed-id>
            <citation>Grandmaison PA, Nanowski TS, Vance JE: Externalization of phosphatidylserine during apoptosis does not specifically require either isoform of phosphatidylserine synthase. Biochim Biophys Acta. 2004 Feb 27;1636(1):1-11.</citation>
          </article>
          <article>
            <pubmed-id>17387686</pubmed-id>
            <citation>Wen Z, Kim HY: Inhibition of phosphatidylserine biosynthesis in developing rat brain by maternal exposure to ethanol. J Neurosci Res. 2007 May 15;85(7):1568-78.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9BVG9" source="Swiss-Prot">
    <name>Phosphatidylserine synthase 2</name>
    <general-function>Cdp-diacylglycerol-serine o-phosphatidyltransferase activity</general-function>
    <specific-function>Catalyzes a base-exchange reaction in which the polar head group of phosphatidylethanolamine (PE) or phosphatidylcholine (PC) is replaced by L-serine. PTDSS2 is specific for phosphatatidylethanolamine and does not act on phosphatidylcholine.</specific-function>
    <gene-name>PTDSS2</gene-name>
    <locus>11p15</locus>
    <cellular-location>Endoplasmic reticulum membrane</cellular-location>
    <transmembrane-regions>63-83
97-117
127-147
314-334
336-356
377-397
404-424</transmembrane-regions>
    <signal-regions/>
    <theoretical-pi>6.19</theoretical-pi>
    <molecular-weight>56252.55</molecular-weight>
    <chromosome-location>11</chromosome-location>
    <organism ncbi-taxonomy-id="9606">Human</organism>
    <external-identifiers>
      <external-identifier>
        <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
        <identifier>HGNC:15463</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenAtlas</resource>
        <identifier>PTDSS2</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Gene Database</resource>
        <identifier>AL834357</identifier>
      </external-identifier>
      <external-identifier>
        <resource>GenBank Protein Database</resource>
        <identifier>21740008</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProtKB</resource>
        <identifier>Q9BVG9</identifier>
      </external-identifier>
      <external-identifier>
        <resource>UniProt Accession</resource>
        <identifier>PTSS2_HUMAN</identifier>
      </external-identifier>
    </external-identifiers>
    <synonyms>
      <synonym>2.7.8.29</synonym>
      <synonym>PSS-2</synonym>
      <synonym>PSS2</synonym>
      <synonym>Serine-exchange enzyme II</synonym>
    </synonyms>
    <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0019267|Phosphatidylserine synthase 2
MRRGERRDAGGPRPESPVPAGRASLEEPPDGPSAGQATGPGEGRRSTESEVYDDGTNTFF
WRAHTLTVLFILTCTLGYVTLLEETPQDTAYNTKRGIVASILVFLCFGVTQAKDGPFSRP
HPAYWRFWLCVSVVYELFLIFILFQTVQDGRQFLKYVDPKLGVPLPERDYGGNCLIYDPD
NETDPFHNIWDKLDGFVPAHFLGWYLKTLMIRDWWMCMIISVMFEFLEYSLEHQLPNFSE
CWWDHWIMDVLVCNGLGIYCGMKTLEWLSLKTYKWQGLWNIPTYKGKMKRIAFQFTPYSW
VRFEWKPASSLRRWLAVCGIILVFLLAELNTFYLKFVLWMPPEHYLVLLRLVFFVNVGGV
AMREIYDFMDDPKPHKKLGPQAWLVAAITATELLIVVKYDPHTLTLSLPFYISQCWTLGS
VLALTWTVWRFFLRDITLRYKETRWQKWQNKDDQGSTVGNGDQHPLGLDEDLLGPGVAEG
EGAPTPN</amino-acid-sequence>
    <gene-sequence format="FASTA">&gt;lcl|BSEQ0019268|Phosphatidylserine synthase 2 (PTDSS2)
ATGCGGAGGGGCGAGCGCAGGGACGCCGGAGGTCCGCGGCCCGAGTCCCCGGTGCCCGCG
GGCAGGGCCTCGCTGGAGGAGCCGCCTGACGGGCCGTCTGCCGGCCAAGCCACCGGGCCG
GGCGAGGGCCGCCGCAGCACCGAGTCCGAGGTCTACGACGACGGCACCAACACCTTCTTC
TGGCGAGCCCACACCTTAACCGTGCTCTTCATCCTCACCTGTACGCTTGGCTATGTGACG
CTGCTGGAGGAAACACCTCAGGACACGGCCTACAACACCAAGAGAGGTATTGTGGCCAGT
ATTTTGGTTTTCTTATGTTTTGGAGTCACACAAGCTAAAGACGGGCCATTTTCCAGACCT
CATCCAGCTTACTGGAGGTTTTGGCTCTGCGTGAGTGTGGTCTACGAGCTGTTTCTCATC
TTTATACTCTTCCAGACTGTCCAGGACGGCCGGCAGTTTCTAAAGTATGTTGACCCCAAG
CTGGGAGTCCCACTGCCAGAGAGAGACTACGGGGGAAACTGCCTCATCTACGACCCAGAC
AATGAGACTGACCCCTTTCACAACATCTGGGACAAGTTGGATGGCTTTGTTCCCGCGCAC
TTTCTTGGCTGGTACCTGAAGACCCTGATGATCCGAGACTGGTGGATGTGCATGATCATC
AGCGTGATGTTCGAGTTCCTGGAGTACAGCCTGGAGCACCAGCTGCCCAACTTCAGCGAG
TGCTGGTGGGATCACTGGATCATGGACGTGCTCGTCTGCAACGGGCTGGGCATCTACTGC
GGCATGAAGACCCTTGAGTGGCTGTCCCTGAAGACGTACAAGTGGCAGGGCCTCTGGAAC
ATTCCGACCTACAAGGGCAAGATGAAGAGGATCGCCTTCCAGTTCACGCCGTACAGCTGG
GTTCGCTTCGAGTGGAAGCCGGCCTCCAGCCTGCGTCGCTGGCTGGCCGTGTGCGGCATC
ATCCTGGTGTTCCTGTTGGCAGAACTGAACACGTTCTACCTGAAGTTTGTGCTGTGGATG
CCCCCGGAGCACTACCTGGTCCTCCTGCGGCTCGTCTTCTTCGTGAACGTGGGTGGCGTG
GCCATGCGTGAGATCTACGACTTCATGGATGACCCGAAGCCCCACAAGAAGCTGGGCCCG
CAGGCCTGGCTGGTGGCGGCCATCACGGCCACGGAGCTGCTCATCGTGGTGAAGTACGAC
CCCCACACGCTCACCCTGTCCCTGCCCTTCTACATCTCCCAGTGCTGGACCCTCGGCTCC
GTCCTGGCGCTCACCTGGACCGTCTGGCGCTTCTTCCTGCGGGACATCACATTGAGGTAC
AAGGAGACCCGGTGGCAGAAGTGGCAGAACAAGGATGACCAGGGCAGCACCGTCGGCAAC
GGGGACCAGCACCCACTGGGGCTGGACGAAGACCTGCTGGGGCCTGGGGTGGCCGAGGGC
GAGGGAGCACCAACTCCAAACTGA</gene-sequence>
    <pfams>
      <pfam>
        <identifier>PF03034</identifier>
        <name>PSS</name>
      </pfam>
    </pfams>
    <go-classifiers>
      <go-classifier>
        <category>component</category>
        <description>membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>endoplasmic reticulum membrane</description>
      </go-classifier>
      <go-classifier>
        <category>component</category>
        <description>integral component of membrane</description>
      </go-classifier>
      <go-classifier>
        <category>function</category>
        <description>CDP-diacylglycerol-serine O-phosphatidyltransferase activity</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>small molecule metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>glycerophospholipid biosynthetic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phospholipid metabolic process</description>
      </go-classifier>
      <go-classifier>
        <category>process</category>
        <description>phosphatidylserine biosynthetic process</description>
      </go-classifier>
    </go-classifiers>
  </polypeptide>
    </target>
    <target>
      <id>BE0002300</id>
      <name>Sphingomyelin phosphodiesterase 4</name>
      <organism>Human</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <pubmed-id>16517606</pubmed-id>
            <citation>Krut O, Wiegmann K, Kashkar H, Yazdanpanah B, Kronke M: Novel tumor necrosis factor-responsive mammalian neutral sphingomyelinase-3 is a C-tail-anchored protein. J Biol Chem. 2006 May 12;281(19):13784-93. Epub 2006 Mar 3.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q9NXE4" source="Swiss-Prot">
    <name>Sphingomyelin phosphodiesterase 4</name>
